Citrus Sinensis ID: 003911
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 787 | 2.2.26 [Sep-21-2011] | |||||||
| P43298 | 942 | Probable receptor protein | yes | no | 0.941 | 0.786 | 0.726 | 0.0 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.841 | 0.548 | 0.292 | 2e-65 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.841 | 0.548 | 0.291 | 2e-64 | |
| Q9SYQ8 | 980 | Receptor protein kinase C | no | no | 0.791 | 0.635 | 0.296 | 2e-58 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.844 | 0.532 | 0.287 | 8e-57 | |
| Q9ZPS9 | 1143 | Serine/threonine-protein | no | no | 0.846 | 0.582 | 0.272 | 2e-55 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.848 | 0.533 | 0.275 | 3e-54 | |
| C0LGJ1 | 1106 | Probable LRR receptor-lik | no | no | 0.808 | 0.575 | 0.277 | 7e-54 | |
| C0LGS2 | 1136 | Probable LRR receptor-lik | no | no | 0.824 | 0.571 | 0.273 | 2e-52 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.349 | 0.381 | 0.380 | 3e-52 |
| >sp|P43298|TMK1_ARATH Probable receptor protein kinase TMK1 OS=Arabidopsis thaliana GN=TMK1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1097 bits (2837), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 545/750 (72%), Positives = 629/750 (83%), Gaps = 9/750 (1%)
Query: 30 DGDAAVMLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQ 89
DGD + ML+LKKSLNPP S GWSD DPCKW H+VC KR+TRIQIGH LQGTL +L+
Sbjct: 26 DGDLSAMLSLKKSLNPPSSFGWSDPDPCKWTHIVCTGTKRVTRIQIGHSGLQGTLSPDLR 85
Query: 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
NL++LERLELQWN+ISGP+PSL+GLASL+V+MLSNN F S+PSD F GL+SLQS+EIDNN
Sbjct: 86 NLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQGLTSLQSVEIDNN 145
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209
PF SWEIP+SLRNAS LQNFSANSAN++G +P F GPDEFPGL+ILHLAFN L G LP S
Sbjct: 146 PFKSWEIPESLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHLAFNNLEGELPMS 205
Query: 210 FSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLS 269
+GSQ+QSLW+NGQ KL G I V+QNMT LKE+WLHSN FSGPLPDFSG+K+LESLS
Sbjct: 206 LAGSQVQSLWLNGQ----KLTGDITVLQNMTGLKEVWLHSNKFSGPLPDFSGLKELESLS 261
Query: 270 LRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGAC 329
LRDN FTGPVP SL+ LESLK+VN+TNN LQGPVP F SVS+D+ K SN+FCL SPG C
Sbjct: 262 LRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSFCLSSPGEC 321
Query: 330 DPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE 389
DPR+ +LL + YP R AE+WKGNDPC++WIG+ C+ GNITVI+ +KM LTGTISPE
Sbjct: 322 DPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIACSNGNITVISLEKMELTGTISPE 381
Query: 390 FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNP 449
F + KSLQR+IL NNL+GMIP+ L+ L LK LDVS+N+L+GK+P F+SN +VNT+GNP
Sbjct: 382 FGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNVVVNTNGNP 441
Query: 450 DIGKEKSSSFQGSPSGSPTGTGSG-NASSTENGVKNSSALITVILFCVIGGAFVISLTGV 508
DIGK+KSS S G+GSG N G+K SS I +I+ V+GG I L G+
Sbjct: 442 DIGKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMK-SSTFIGIIVGSVLGGLLSIFLIGL 500
Query: 509 LVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVP-S 567
LVFC KK+QKRFS +S NA+V+HPRHSGS+N ESVKITVAGS+VSVG IS+T+T+P +
Sbjct: 501 LVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDN-ESVKITVAGSSVSVGGISDTYTLPGT 559
Query: 568 SEPGD-IQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRME 626
SE GD IQM+EAGNM+ISIQVLR+VTNNFS +NILG GGFG VYKGELHDGTKIAVKRME
Sbjct: 560 SEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIAVKRME 619
Query: 627 AGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA 686
GVI+GKG EFKSEIAVLTKVRHRHLV LLG+CLDGNEKLLV+EYMPQGTLSRH+F W+
Sbjct: 620 NGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEWS 679
Query: 687 EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746
EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV
Sbjct: 680 EEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 739
Query: 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
RLAPEGKGSIETRIAGTFGYLAPEYAV R
Sbjct: 740 RLAPEGKGSIETRIAGTFGYLAPEYAVTGR 769
|
Probable receptor. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 250 bits (639), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 233/796 (29%), Positives = 374/796 (46%), Gaps = 134/796 (16%)
Query: 79 NLQGTLPSNLQNLTK-LERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFT-SVPSDFF 135
+ QG P+ L +L K + L+L +N+ SG +P SL +SLE+V +SNN F+ +P D
Sbjct: 314 DFQGVYPNQLADLCKTVVELDLSYNNFSGMVPESLGECSSLELVDISNNNFSGKLPVDTL 373
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL 195
LS+++++ + N F +P S N L+ +S N+TG IPS D L +L
Sbjct: 374 LKLSNIKTMVLSFNKFVGG-LPDSFSNLPKLETLDMSSNNLTGIIPSGICKDPMNNLKVL 432
Query: 196 HL------------------------AFNQLIGGLPASF-SGSQIQSL--WVNGQNGNAK 228
+L +FN L G +P+S S S+++ L W+N +
Sbjct: 433 YLQNNLFKGPIPDSLSNCSQLVSLDLSFNYLTGSIPSSLGSLSKLKDLILWLN------Q 486
Query: 229 LGGGI-DVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKL 286
L G I + + +L+ + L N +GP+P S +L +SL +N +G +P SL +L
Sbjct: 487 LSGEIPQELMYLQALENLILDFNDLTGPIPASLSNCTKLNWISLSNNQLSGEIPASLGRL 546
Query: 287 ESLKIVNMTNNLLQGPVP-EFDRSVSLDMAKGSNNFCLPSPGACDPRLN--------ALL 337
+L I+ + NN + G +P E SL + NF G+ P L ALL
Sbjct: 547 SNLAILKLGNNSISGNIPAELGNCQSLIWLDLNTNFL---NGSIPPPLFKQSGNIAVALL 603
Query: 338 S--------------------VVKLMGYPQRFAENWKGNDPCS---DWIGVTCT----KG 370
+ +++ G Q + PC+ + G+T G
Sbjct: 604 TGKRYVYIKNDGSKECHGAGNLLEFGGIRQEQLDRISTRHPCNFTRVYRGITQPTFNHNG 663
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE------------------ 412
++ ++ L G+I E + L L L N+LSGMIP+
Sbjct: 664 SMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRF 723
Query: 413 ------GLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNPDIGKEKSSSFQGSPSGS 466
L+ L L E+D+SNN L G IP D PD + ++S G P
Sbjct: 724 NGTIPNSLTSLTLLGEIDLSNNNLSGMIPESAP-----FDTFPDY-RFANNSLCGYPLPL 777
Query: 467 PTGTG-SGNASSTENGVKNSSALITVILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQ 525
P +G +A+ + + ++L + ++ F I G+++ + KK++R
Sbjct: 778 PCSSGPKSDANQHQKSHRRQASLAGSVAMGLLFSLFCI--FGLIIVAIETKKRRRKKEAA 835
Query: 526 SPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISI 585
M H HS + NS + K T A +S+ ++ E ++
Sbjct: 836 LEAYMDGH-SHSATANS-AWKFTSAREALSI---------------NLAAFEKPLRKLTF 878
Query: 586 QVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVL 645
L TN F ++++G GGFG VYK +L DG+ +A+K++ +SG+G EF +E+ +
Sbjct: 879 ADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIH--VSGQGDREFTAEMETI 936
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
K++HR+LV LLG+C G E+LLV+EYM G+L + + + G+K L W R IA+
Sbjct: 937 GKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIK-LNWPARRKIAIGA 995
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--APEGKGSIETRIAGT 763
ARG+ +LH IHRD+K SN+LL +++ A+V+DFG+ RL A + S+ T +AGT
Sbjct: 996 ARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVST-LAGT 1054
Query: 764 FGYLAPEYAVHTRWSS 779
GY+ PEY R S+
Sbjct: 1055 PGYVPPEYYQSFRCST 1070
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 247 bits (631), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 232/796 (29%), Positives = 374/796 (46%), Gaps = 134/796 (16%)
Query: 79 NLQGTLPSNLQNLTK-LERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFT-SVPSDFF 135
+ QG P+ L +L K + L+L +N+ SG +P SL +SLE+V +S N F+ +P D
Sbjct: 314 DFQGVYPNQLADLCKTVVELDLSYNNFSGMVPESLGECSSLELVDISYNNFSGKLPVDTL 373
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL 195
+ LS+++++ + N F +P S N L+ +S N+TG IPS D L +L
Sbjct: 374 SKLSNIKTMVLSFNKFVGG-LPDSFSNLLKLETLDMSSNNLTGVIPSGICKDPMNNLKVL 432
Query: 196 HL------------------------AFNQLIGGLPASF-SGSQIQSL--WVNGQNGNAK 228
+L +FN L G +P+S S S+++ L W+N +
Sbjct: 433 YLQNNLFKGPIPDSLSNCSQLVSLDLSFNYLTGSIPSSLGSLSKLKDLILWLN------Q 486
Query: 229 LGGGI-DVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKL 286
L G I + + +L+ + L N +GP+P S +L +SL +N +G +P SL +L
Sbjct: 487 LSGEIPQELMYLQALENLILDFNDLTGPIPASLSNCTKLNWISLSNNQLSGEIPASLGRL 546
Query: 287 ESLKIVNMTNNLLQGPVP-EFDRSVSLDMAKGSNNFCLPSPGACDPRL--------NALL 337
+L I+ + NN + G +P E SL + NF G+ P L ALL
Sbjct: 547 SNLAILKLGNNSISGNIPAELGNCQSLIWLDLNTNFL---NGSIPPPLFKQSGNIAVALL 603
Query: 338 S--------------------VVKLMGYPQRFAENWKGNDPCS---DWIGVTCT----KG 370
+ +++ G Q + PC+ + G+T G
Sbjct: 604 TGKRYVYIKNDGSKECHGAGNLLEFGGIRQEQLDRISTRHPCNFTRVYRGITQPTFNHNG 663
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE------------------ 412
++ ++ L G+I E + L L L N+LSGMIP+
Sbjct: 664 SMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRF 723
Query: 413 ------GLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNPDIGKEKSSSFQGSPSGS 466
L+ L L E+D+SNN L G IP D PD + ++S G P
Sbjct: 724 NGTIPNSLTSLTLLGEIDLSNNNLSGMIPESAP-----FDTFPDY-RFANNSLCGYPLPI 777
Query: 467 PTGTG-SGNASSTENGVKNSSALITVILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQ 525
P +G +A+ + + ++L + ++ F I G+++ + KK++R
Sbjct: 778 PCSSGPKSDANQHQKSHRRQASLAGSVAMGLLFSLFCI--FGLIIVAIETKKRRRKKEAA 835
Query: 526 SPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISI 585
M H HS + NS + K T A +S+ ++ E ++
Sbjct: 836 LEAYMDGH-SHSATANS-AWKFTSAREALSI---------------NLAAFEKPLRKLTF 878
Query: 586 QVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVL 645
L TN F ++++G GGFG VYK +L DG+ +A+K++ +SG+G EF +E+ +
Sbjct: 879 ADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIH--VSGQGDREFTAEMETI 936
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
K++HR+LV LLG+C G E+LLV+EYM G+L + + + G+K L W R IA+
Sbjct: 937 GKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIGIK-LNWPARRKIAIGA 995
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--APEGKGSIETRIAGT 763
ARG+ +LH IHRD+K SN+LL +++ A+V+DFG+ RL A + S+ T +AGT
Sbjct: 996 ARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVST-LAGT 1054
Query: 764 FGYLAPEYAVHTRWSS 779
GY+ PEY R S+
Sbjct: 1055 PGYVPPEYYQSFRCST 1070
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 228 bits (580), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 217/733 (29%), Positives = 337/733 (45%), Gaps = 110/733 (15%)
Query: 68 KRITRIQIGHQN-LQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNN 125
K + + IG+ N G +P LTKLE L++ +++G +P SL+ L L + L N
Sbjct: 216 KNLREMYIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSLSNLKHLHTLFLHIN 275
Query: 126 QFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFG 185
T +GL SL+S+++ N + EIPQS N + + N+ GQIP G
Sbjct: 276 NLTGHIPPELSGLVSLKSLDLSINQLTG-EIPQSFINLGNITLINLFRNNLYGQIPEAIG 334
Query: 186 PDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEI 245
E P L + + N LPA+ G+NGN L ++
Sbjct: 335 --ELPKLEVFEVWENNFTLQLPANL-----------GRNGN---------------LIKL 366
Query: 246 WLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304
+ N +G +P D ++LE L L +NFF GP+P+ L K +SL + + NLL G VP
Sbjct: 367 DVSDNHLTGLIPKDLCRGEKLEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVP 426
Query: 305 E--FDRSVSLDMAKGSNNFC--LPSPGACDPRLNALLSVVKLMGYPQRFAENW-KGNDPC 359
F+ + + N F LP + D +L + L + NW G P
Sbjct: 427 AGLFNLPLVTIIELTDNFFSGELPVTMSGD-----VLDQIYL-------SNNWFSGEIPP 474
Query: 360 SDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGA 419
+ IG N+ + + G I E K L R+ + NN++G IP+ +S
Sbjct: 475 A--IG---NFPNLQTLFLDRNRFRGNIPREIFELKHLSRINTSANNITGGIPDSISRCST 529
Query: 420 LKELDVSNNQLYGKIP----SFKSNAIVNTDGNPDIGKEKSSSFQGSPSGSPTGTGSGNA 475
L +D+S N++ G+IP + K+ +N GN G PTG G+ +
Sbjct: 530 LISVDLSRNRINGEIPKGINNVKNLGTLNISGNQLTGS------------IPTGIGNMTS 577
Query: 476 SSTEN-GVKNSSALITVILFCVIGGAFVI----SLTGVLVFCLCKKKQKRFSRVQSPNAM 530
+T + + S + +GG F++ S G CL R S P
Sbjct: 578 LTTLDLSFNDLSGRVP------LGGQFLVFNETSFAGNTYLCL----PHRVSCPTRPGQT 627
Query: 531 VIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNM------VIS 584
H H+ + + ITV + + IS QM + N + +
Sbjct: 628 SDH-NHTALFSPSRIVITVIAAITGLILISVAIR---------QMNKKKNQKSLAWKLTA 677
Query: 585 IQVL----RNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKS 640
Q L +V EENI+G+GG G VY+G + + +A+KR+ G +G+ F +
Sbjct: 678 FQKLDFKSEDVLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRL-VGRGTGRSDHGFTA 736
Query: 641 EIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT 700
EI L ++RHRH+V LLG+ + + LL++EYMP G+L + + ++ G L+W R
Sbjct: 737 EIQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGE-LLHGSKGG--HLQWETRHR 793
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS-IETR 759
+A++ A+G+ YLH +HRD+K +NILL D A VADFGL + +G S +
Sbjct: 794 VAVEAAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSS 853
Query: 760 IAGTFGYLAPEYA 772
IAG++GY+APEYA
Sbjct: 854 IAGSYGYIAPEYA 866
|
Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 222 bits (566), Expect = 8e-57, Method: Compositional matrix adjust.
Identities = 227/790 (28%), Positives = 348/790 (44%), Gaps = 125/790 (15%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQF 127
+T + + + L+GTL ++ NLT L+ L L N++ G LP ++ L LEV+ L N+F
Sbjct: 385 ELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRF 444
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
+ +SL+ I++ N F EIP S+ L + G +P+ G
Sbjct: 445 SGEIPQEIGNCTSLKMIDMFGNHFEG-EIPPSIGRLKELNLLHLRQNELVGGLPASLG-- 501
Query: 188 EFPGLTILHLAFNQLIGGLPASF---SGSQIQSLWVNGQNGNA----------------- 227
L IL LA NQL G +P+SF G + L+ N GN
Sbjct: 502 NCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSH 561
Query: 228 -KLGGGI------------DV------------IQNMTSLKEIWLHSNAFSGPLP-DFSG 261
+L G I DV + N +L + L N +G +P
Sbjct: 562 NRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGK 621
Query: 262 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSL--DMAKGSN 319
+++L L + N TG +P LV + L +++ NN L GP+P + +S ++ SN
Sbjct: 622 IRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSN 681
Query: 320 NFCLPSPGA---CDPRLNALLSVVKLMG-YPQRFAE-------NWKGNDPCSDWIGVTCT 368
F P C L L L G PQ N N
Sbjct: 682 QFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGK 741
Query: 369 KGNITVINFQKMNLTGTISPEFASFKSLQR-LILADNNLSGMIPEGLSVLGALKELDVSN 427
+ + + +LTG I E + LQ L L+ NN +G IP + L L+ LD+S+
Sbjct: 742 LSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSH 801
Query: 428 NQLYGKIP----SFKSNAIVNTDGNPDIGKEKSSSFQGSPSGSPTG-TG-SGNASSTENG 481
NQL G++P KS +N N ++G + F P+ S G TG G+ S N
Sbjct: 802 NQLTGEVPGSVGDMKSLGYLNVSFN-NLGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNR 860
Query: 482 VKNSS-----ALITVILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRH 536
V++++ + +V++ I I L +++ K++ F +V H
Sbjct: 861 VRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVG----------H 910
Query: 537 SGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFS 596
+ + S + A TH P G A I + + T+N S
Sbjct: 911 GSTAYTSSSSSSQA-----------THK-PLFRNG------ASKSDIRWEDIMEATHNLS 952
Query: 597 EENILGRGGFGTVYKGELHDGTKIAVKRM--EAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
EE ++G GG G VYK EL +G +AVK++ + ++S K F E+ L ++RHRHLV
Sbjct: 953 EEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKS---FSREVKTLGRIRHRHLV 1009
Query: 655 ALLGHCLDGNE--KLLVFEYMPQGTLSRHIFNWA-------EEGLKPLEWNRRLTIALDV 705
L+G+C +E LL++EYM G+ I++W E+ K L+W RL IA+ +
Sbjct: 1010 KLMGYCSSKSEGLNLLIYEYMKNGS----IWDWLHEDKPVLEKKKKLLDWEARLRIAVGL 1065
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG---KGSIETRIAG 762
A+GVEYLH +HRD+K SN+LL +M A + DFGL ++ E T A
Sbjct: 1066 AQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFAC 1125
Query: 763 TFGYLAPEYA 772
++GY+APEYA
Sbjct: 1126 SYGYIAPEYA 1135
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 218 bits (554), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 216/792 (27%), Positives = 345/792 (43%), Gaps = 126/792 (15%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNN 125
+ + +++ + N G +P +L + + L+ L+L N+ISGP P+ L SL++++LSNN
Sbjct: 277 RSLQNLRLSYNNFTGVIPESLSSCSWLQSLDLSNNNISGPFPNTILRSFGSLQILLLSNN 336
Query: 126 QFTSVPSDFFTGLSSLQSIEIDN---NPFSSWEIPQSLRNASGLQNFSANSANITGQIPS 182
+ DF T +S+ +S+ I + N FS P A+ L+ +TG+IP
Sbjct: 337 L---ISGDFPTSISACKSLRIADFSSNRFSGVIPPDLCPGAASLEELRLPDNLVTGEIPP 393
Query: 183 FFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
+ L + L+ N L G +P Q ++ N A G I + +L
Sbjct: 394 AI--SQCSELRTIDLSLNYLNGTIPPEIGNLQKLEQFIAWYNNIA--GEIPPEIGKLQNL 449
Query: 243 KEIWLHSNAFSGPLP-------------------------DFSGVKQLESLSLRDNFFTG 277
K++ L++N +G +P DF + +L L L +N FTG
Sbjct: 450 KDLILNNNQLTGEIPPEFFNCSNIEWVSFTSNRLTGEVPKDFGILSRLAVLQLGNNNFTG 509
Query: 278 PVPDSLVKLESLKIVNMTNNLLQGPVP---------------------EFDRSVSLDMAK 316
+P L K +L +++ N L G +P F R+V + K
Sbjct: 510 EIPPELGKCTTLVWLDLNTNHLTGEIPPRLGRQPGSKALSGLLSGNTMAFVRNVG-NSCK 568
Query: 317 GSNNFC------------LPSPGACD-------PRLNALLSVVKLMGYPQRFAENWKGND 357
G +PS +CD P L +L + + + Y +G
Sbjct: 569 GVGGLVEFSGIRPERLLQIPSLKSCDFTRMYSGPIL-SLFTRYQTIEYLDLSYNQLRGKI 627
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL 417
P D IG + V+ L+G I K+L +DN L G IPE S L
Sbjct: 628 P--DEIGEMIA---LQVLELSHNQLSGEIPFTIGQLKNLGVFDASDNRLQGQIPESFSNL 682
Query: 418 GALKELDVSNNQLYGKIPS---FKSNAIVNTDGNPDIGKEKSSSFQGSPSGSPTGTGSGN 474
L ++D+SNN+L G IP + NP + + + P GT G
Sbjct: 683 SFLVQIDLSNNELTGPIPQRGQLSTLPATQYANNPGLCGVPLPECKNGNNQLPAGTEEGK 742
Query: 475 ASSTENGVKNSSALITVILFCVIGGAFVISLT----GVLVFCLCKKKQKRFSRVQSPNAM 530
+ ++G + +S +++L +I A V L V K +Q+ N+
Sbjct: 743 RA--KHGTRAASWANSIVLGVLISAASVCILIVWAIAVRARRRDADDAKMLHSLQAVNSA 800
Query: 531 VIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRN 590
+ E + I VA + + + Q++EA
Sbjct: 801 TTWKIE---KEKEPLSINVATFQRQLRKLKFS-----------QLIEA------------ 834
Query: 591 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
TN FS +++G GGFG V+K L DG+ +A+K++ +S +G EF +E+ L K++H
Sbjct: 835 -TNGFSAASMIGHGGFGEVFKATLKDGSSVAIKKLIR--LSCQGDREFMAEMETLGKIKH 891
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN-WAEEGLKPLEWNRRLTIALDVARGV 709
R+LV LLG+C G E+LLV+E+M G+L + E + L W R IA A+G+
Sbjct: 892 RNLVPLLGYCKIGEERLLVYEFMQYGSLEEVLHGPRTGEKRRILGWEERKKIAKGAAKGL 951
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--APEGKGSIETRIAGTFGYL 767
+LH IHRD+K SN+LL DM A+V+DFG+ RL A + S+ T +AGT GY+
Sbjct: 952 CFLHHNCIPHIIHRDMKSSNVLLDQDMEARVSDFGMARLISALDTHLSVST-LAGTPGYV 1010
Query: 768 APEYAVHTRWSS 779
PEY R ++
Sbjct: 1011 PPEYYQSFRCTA 1022
|
Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 214 bits (544), Expect = 3e-54, Method: Compositional matrix adjust.
Identities = 220/799 (27%), Positives = 344/799 (43%), Gaps = 131/799 (16%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNG-LASLEVVMLSNNQF 127
+T + + + +L+GTL S++ NLT L+ L N++ G +P G L LE++ L N+F
Sbjct: 386 ELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRF 445
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
+ + LQ I+ N S EIP S+ L + G IP+ G
Sbjct: 446 SGEMPVEIGNCTRLQEIDWYGNRLSG-EIPSSIGRLKDLTRLHLRENELVGNIPASLG-- 502
Query: 188 EFPGLTILHLAFNQLIGGLPASF---SGSQIQSLWVNGQNGNA----------------- 227
+T++ LA NQL G +P+SF + ++ ++ N GN
Sbjct: 503 NCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSS 562
Query: 228 -KLGGGI------------DVIQN------------MTSLKEIWLHSNAFSGPLP-DFSG 261
K G I DV +N T+L + L N F+G +P F
Sbjct: 563 NKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGK 622
Query: 262 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSL--DMAKGSN 319
+ +L L + N +G +P L + L +++ NN L G +P + + L ++ SN
Sbjct: 623 ISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSN 682
Query: 320 NFCLPSPGACDPRLNALLSVVKLM--------GYPQRF-------AENWKGNDPCSDWIG 364
F G+ + +L +++ L PQ A N + N
Sbjct: 683 KFV----GSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPS 738
Query: 365 VTCTKGNITVINFQKMNLTGTISPEFASFKSLQR-LILADNNLSGMIPEGLSVLGALKEL 423
+ + + LTG I E + LQ L L+ NN +G IP +S L L+ L
Sbjct: 739 TIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESL 798
Query: 424 DVSNNQLYGKIP----SFKSNAIVNTDGNPDIGKEKS--SSFQGSP-SGSPTGTGSGNAS 476
D+S+NQL G++P KS +N N GK K S +Q G+ GS +
Sbjct: 799 DLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCGSPLSH 858
Query: 477 STENGVKNSSAL--ITVILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHP 534
G KN +L TV++ I I+L +++ K+ F +V+
Sbjct: 859 CNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVR--------- 909
Query: 535 RHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNN 594
G N + + S + P G I + T+
Sbjct: 910 ----------------GGNSAFSSNSSSSQAPLFSNG------GAKSDIKWDDIMEATHY 947
Query: 595 FSEENILGRGGFGTVYKGELHDGTKIAVKRM--EAGVISGKGLTEFKSEIAVLTKVRHRH 652
+EE ++G GG G VYK EL +G IAVK++ + ++S K F E+ L +RHRH
Sbjct: 948 LNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKS---FNREVKTLGTIRHRH 1004
Query: 653 LVALLGHCLDGNE--KLLVFEYMPQGTLSRHIFNW--AEEGLKPLE---WNRRLTIALDV 705
LV L+G+C + LL++EYM G+ +++W A E K E W RL IAL +
Sbjct: 1005 LVKLMGYCSSKADGLNLLIYEYMANGS----VWDWLHANENTKKKEVLGWETRLKIALGL 1060
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP---EGKGSIETRIAG 762
A+GVEYLH +HRD+K SN+LL ++ A + DFGL ++ + T AG
Sbjct: 1061 AQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAG 1120
Query: 763 TFGYLAPEYAVHTRWSSCS 781
++GY+APEYA + + S
Sbjct: 1121 SYGYIAPEYAYSLKATEKS 1139
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGJ1|Y1743_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g74360 OS=Arabidopsis thaliana GN=At1g74360 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (541), Expect = 7e-54, Method: Compositional matrix adjust.
Identities = 208/749 (27%), Positives = 330/749 (44%), Gaps = 113/749 (15%)
Query: 73 IQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNG-LASLEVVMLSNNQFTS-V 130
+ +G+ +P L NLT L L+L N G + + G ++ ++L N + +
Sbjct: 305 LYLGNNTFSRDIPETLLNLTNLVFLDLSRNKFGGDIQEIFGRFTQVKYLVLHANSYVGGI 364
Query: 131 PSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFP 190
S L +L +++ N FS ++P + L+ N +G IP +G P
Sbjct: 365 NSSNILKLPNLSRLDLGYNNFSG-QLPTEISQIQSLKFLILAYNNFSGDIPQEYG--NMP 421
Query: 191 GLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHS 249
GL L L+FN+L G +PASF G LW+ N L G I I N TSL + +
Sbjct: 422 GLQALDLSFNKLTGSIPASF-GKLTSLLWL--MLANNSLSGEIPREIGNCTSLLWFNVAN 478
Query: 250 NAFSGPL-PDFSGVKQLESLSLRDNFFTGPVPDSLVKLESL-KIVNMTNNLLQ------G 301
N SG P+ + + + P P V ++ KI+ + L
Sbjct: 479 NQLSGRFHPELTRMG------------SNPSPTFEVNRQNKDKIIAGSGECLAMKRWIPA 526
Query: 302 PVPEFD-----------RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFA 350
P F+ RS+ + KG F + S G+ + +K+ Y Q
Sbjct: 527 EFPPFNFVYAILTKKSCRSLWDHVLKGYGLFPVCSAGST-------VRTLKISAYLQLSG 579
Query: 351 ENWKGNDPCSD---------WIGVTCTKGNI---------TVINFQKMNLTGTISPEFAS 392
+ G P S +G +G + +N + N +G I E +
Sbjct: 580 NKFSGEIPASISQMDRLSTLHLGFNEFEGKLPPEIGQLPLAFLNLTRNNFSGEIPQEIGN 639
Query: 393 FKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ-LYGKIPSFKSNAIVNTD---GN 448
K LQ L L+ NN SG P L+ L L + ++S N + G IP+ A + D GN
Sbjct: 640 LKCLQNLDLSFNNFSGNFPTSLNDLNELSKFNISYNPFISGAIPTTGQVATFDKDSFLGN 699
Query: 449 PDIGKEKSSSFQGSPSGSPTGTGSGNASSTENGVKNSSALITVILFCVIGGAFVISLTGV 508
P + + G+ + + GN T + S AL + C++ ++G+
Sbjct: 700 PLLRFPSFFNQSGNNTRKISNQVLGNRPRTLLLIWISLALALAFIACLV-------VSGI 752
Query: 509 LVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSS 568
++ + ++ + GS+ + + GS+ +
Sbjct: 753 VLMVVKASREAEIDLLD------------GSKTRHDMTSSSGGSSPWLS----------- 789
Query: 569 EPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAG 628
G I+++ + + T+NFSEE ++GRGG+GTVY+G L DG ++AVK+++
Sbjct: 790 --GKIKVIRLDKSTFTYADILKATSNFSEERVVGRGGYGTVYRGVLPDGREVAVKKLQRE 847
Query: 629 VISGKGLTEFKSEIAVLT-----KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIF 683
+ EF++E+ VL+ H +LV L G CLDG+EK+LV EYM G+L I
Sbjct: 848 GTEAE--KEFRAEMEVLSANAFGDWAHPNLVRLYGWCLDGSEKILVHEYMGGGSLEELIT 905
Query: 684 NWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743
+ + L+W +R+ IA DVARG+ +LH + S +HRD+K SN+LL A+V DF
Sbjct: 906 DKTK-----LQWKKRIDIATDVARGLVFLHHECYPSIVHRDVKASNVLLDKHGNARVTDF 960
Query: 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
GL RL G + T IAGT GY+APEY
Sbjct: 961 GLARLLNVGDSHVSTVIAGTIGYVAPEYG 989
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGS2|Y4361_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g36180 OS=Arabidopsis thaliana GN=At4g36180 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 207 bits (528), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 194/709 (27%), Positives = 331/709 (46%), Gaps = 60/709 (8%)
Query: 82 GTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSS 140
G +P ++ NL +LE L+L NS++G +P + SL+V+ N +F + +
Sbjct: 346 GEIPPDIGNLKRLEELKLANNSLTGEIPVEIKQCGSLDVLDFEGNSLKGQIPEFLGYMKA 405
Query: 141 LQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFN 200
L+ + + N FS + +P S+ N L+ + N+ G P L+ L L+ N
Sbjct: 406 LKVLSLGRNSFSGY-VPSSMVNLQQLERLNLGENNLNGSFPVELM--ALTSLSELDLSGN 462
Query: 201 QLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DF 259
+ G +P S S + +L +GN G + N+ L + L SG +P +
Sbjct: 463 RFSGAVPVSIS--NLSNLSFLNLSGNGFSGEIPASVGNLFKLTALDLSKQNMSGEVPVEL 520
Query: 260 SGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGS 318
SG+ ++ ++L+ N F+G VP+ L SL+ VN+++N G +P+ F L S
Sbjct: 521 SGLPNVQVIALQGNNFSGVVPEGFSSLVSLRYVNLSSNSFSGEIPQTFGFLRLLVSLSLS 580
Query: 319 NNFCL----PSPGACDPRLNALLSVVKLMGY--------PQRFAENWKGNDPCSDWIGVT 366
+N P G C L +LMG+ P+ + N+ +
Sbjct: 581 DNHISGSIPPEIGNCSALEVLELRSNRLMGHIPADLSRLPRLKVLDLGQNNLSGEIPPEI 640
Query: 367 CTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGA-LKELDV 425
++ ++ +L+G I F+ +L ++ L+ NNL+G IP L+++ + L +V
Sbjct: 641 SQSSSLNSLSLDHNHLSGVIPGSFSGLSNLTKMDLSVNNLTGEIPASLALISSNLVYFNV 700
Query: 426 SNNQLYGKIPSFKSNAIVNTDGNPDIGKEKSSSFQGSPSGSPTGTGSGNASSTENGVKNS 485
S+N L G+IP+ + I NT S F G+ SST G K
Sbjct: 701 SSNNLKGEIPASLGSRINNT-----------SEFSGNTELCGKPLNRRCESSTAEGKKKK 749
Query: 486 SALITVILFCVIGGAFVISL-TGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSES 544
+I +I+ I GAF++SL V+ L K ++K + + + E S
Sbjct: 750 RKMILMIVMAAI-GAFLLSLFCCFYVYTLLKWRKK------------LKQQSTTGEKKRS 796
Query: 545 VKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRG 604
T AGS + + + S+E G+ +++ N + + + T F EEN+L R
Sbjct: 797 PGRTSAGS-----RVRSSTSRSSTENGEPKLVMFNNKITLAETIE-ATRQFDEENVLSRT 850
Query: 605 GFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN 664
+G ++K +DG ++++R+ G + + L FK E VL KV+HR++ L G+
Sbjct: 851 RYGLLFKANYNDGMVLSIRRLPNGSLLNENL--FKKEAEVLGKVKHRNITVLRGYYAGPP 908
Query: 665 E-KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHR 723
+ +LLV++YMP G LS + + + L W R IAL +ARG+ +LH + +H
Sbjct: 909 DLRLLVYDYMPNGNLSTLLQEASHQDGHVLNWPMRHLIALGIARGLGFLH---QSNMVHG 965
Query: 724 DLKPSNILLGDDMRAKVADFGLVRLA--PEGKGSIETRIAGTFGYLAPE 770
D+KP N+L D A ++DFGL RL + ++ GT GY++PE
Sbjct: 966 DIKPQNVLFDADFEAHISDFGLDRLTIRSPSRSAVTANTIGTLGYVSPE 1014
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 207 bits (527), Expect = 3e-52, Method: Compositional matrix adjust.
Identities = 116/305 (38%), Positives = 175/305 (57%), Gaps = 30/305 (9%)
Query: 491 VILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHS------------- 537
++ + G +++L GV+ L ++K+KR + + + HP S
Sbjct: 246 TMVGMAVAGFAIMALIGVVF--LVRRKKKRNIDSYNHSQYLPHPNFSVKSDGFLYGQDPG 303
Query: 538 --------GS--ENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQV 587
GS NS+ + ++ S + G H + SS D +L +G S +
Sbjct: 304 KGYSSGPNGSMYNNSQQQQSSMGNSYGTAGGGYPHHQMQSSGTPDSAILGSGQTHFSYEE 363
Query: 588 LRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
L +T F+ +NILG GGFG VYKG L DG +AVK+++AG SG+G EFK+E+ ++++
Sbjct: 364 LAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAG--SGQGDREFKAEVEIISR 421
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
V HRHLV+L+G+C+ +LL++EY+ TL H+ +GL LEW++R+ IA+ A+
Sbjct: 422 VHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHG---KGLPVLEWSKRVRIAIGSAK 478
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
G+ YLH H IHRD+K +NILL D+ A+VADFGL RL + + TR+ GTFGYL
Sbjct: 479 GLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGYL 538
Query: 768 APEYA 772
APEYA
Sbjct: 539 APEYA 543
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 787 | ||||||
| 224069210 | 945 | predicted protein [Populus trichocarpa] | 0.979 | 0.815 | 0.763 | 0.0 | |
| 255585572 | 951 | receptor protein kinase, putative [Ricin | 0.984 | 0.814 | 0.744 | 0.0 | |
| 224077350 | 946 | predicted protein [Populus trichocarpa] | 0.979 | 0.815 | 0.748 | 0.0 | |
| 359476563 | 889 | PREDICTED: probable receptor protein kin | 0.909 | 0.805 | 0.762 | 0.0 | |
| 449445063 | 953 | PREDICTED: probable receptor protein kin | 0.945 | 0.780 | 0.750 | 0.0 | |
| 351727489 | 941 | NAK-type protein kinase precursor [Glyci | 0.969 | 0.810 | 0.715 | 0.0 | |
| 224589461 | 942 | leucine-rich repeat receptor-like protei | 0.941 | 0.786 | 0.726 | 0.0 | |
| 29824403 | 942 | putative receptor protein kinase (TMK1) | 0.941 | 0.786 | 0.726 | 0.0 | |
| 15218941 | 942 | putative receptor protein kinase TMK1 [A | 0.941 | 0.786 | 0.726 | 0.0 | |
| 297838257 | 937 | hypothetical protein ARALYDRAFT_475717 [ | 0.954 | 0.801 | 0.713 | 0.0 |
| >gi|224069210|ref|XP_002302927.1| predicted protein [Populus trichocarpa] gi|222844653|gb|EEE82200.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1194 bits (3088), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 595/779 (76%), Positives = 674/779 (86%), Gaps = 8/779 (1%)
Query: 1 MKEKTCVGFKLLTLY-VGFCSILFVSASGDDGDAAVMLALKKSLNPPESLGWSDTDPCKW 59
MK ++ KLL ++ VGF SI + S DA VM +LKKSLN P+SLGWSD DPC W
Sbjct: 1 MKRRSHRRTKLLLVFLVGFSSIFHFANSQTSPDAEVMFSLKKSLNVPDSLGWSDPDPCNW 60
Query: 60 NHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEV 119
NHVVC ++KR+TRIQIG QNLQGTLPSNL+NL +LERLELQ+N+ISGPLPSLNGL+SL+V
Sbjct: 61 NHVVCSDEKRVTRIQIGRQNLQGTLPSNLRNLAQLERLELQYNNISGPLPSLNGLSSLQV 120
Query: 120 VMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQ 179
++LS+N+F SVPSDFFTGLSSLQS+EIDNNPFS+W IP+S++NAS LQNFSANSANI+G
Sbjct: 121 ILLSDNKFISVPSDFFTGLSSLQSVEIDNNPFSNWVIPESIKNASALQNFSANSANISGS 180
Query: 180 IPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNM 239
IP FFGPD FPGLTIL LAFN L G LPASFSGSQ+QSLW+NGQ KL GGIDVIQNM
Sbjct: 181 IPGFFGPDSFPGLTILRLAFNDLEGELPASFSGSQVQSLWLNGQ----KLSGGIDVIQNM 236
Query: 240 TSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
T L+E+WLHSN FSGPLPDFSG+K LESLSLRDN FTG VP+SLV LESLK VN++NNLL
Sbjct: 237 TLLREVWLHSNGFSGPLPDFSGLKDLESLSLRDNSFTGLVPESLVNLESLKFVNLSNNLL 296
Query: 300 QGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPC 359
QGP+P F SVS+DM K SN FCLP+P CD R+N LLS+VK M YPQR A++WKGNDPC
Sbjct: 297 QGPMPVFKSSVSVDMVKDSNRFCLPTPDLCDSRVNTLLSIVKSMDYPQRLADSWKGNDPC 356
Query: 360 SDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGA 419
+DWIG+TC GNITV+NF+KM LTG+ISP+FAS KSL+RL+LA+NNL+G IP+ ++ L
Sbjct: 357 ADWIGITCNNGNITVVNFEKMGLTGSISPDFASVKSLERLVLANNNLTGSIPQEITTLPG 416
Query: 420 LKELDVSNNQLYGKIPSFKSNAIVNTDGNPDIGKEKS--SSFQGSPSGSPTGTGSGNASS 477
LK LDVSNN LYG++P+F SN IVNT+GNP+IGK+ + +S + + TGSG+ S
Sbjct: 417 LKVLDVSNNHLYGRVPAFTSNVIVNTNGNPNIGKDVNISTSSESPSASPSANTGSGSGGS 476
Query: 478 TENGVKNSSALITVILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHS 537
+ K SS LI VI+F VIGG F++SL G+LVFCL KKKQKRFSRVQSPN MVIHPRHS
Sbjct: 477 SRKSGKKSSTLIVVIIFSVIGGVFLLSLIGLLVFCLYKKKQKRFSRVQSPNEMVIHPRHS 536
Query: 538 GSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSE 597
GS+N ESVKITVAGS++SVGAISETHT+P+SE GDIQM+EAGNMVISIQVLRNVTNNFSE
Sbjct: 537 GSDN-ESVKITVAGSSISVGAISETHTIPASEQGDIQMVEAGNMVISIQVLRNVTNNFSE 595
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
ENILG GGFG VYKGELHDGTKIAVKRME+GVISGKGLTEFKSEIAVLTKVRHRHLVALL
Sbjct: 596 ENILGWGGFGVVYKGELHDGTKIAVKRMESGVISGKGLTEFKSEIAVLTKVRHRHLVALL 655
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
G+CLDGNEKLLV+EYMPQGTLSRHIFNWAEEGLKPLEW RRLTIALDVARGVEYLHGLAH
Sbjct: 656 GYCLDGNEKLLVYEYMPQGTLSRHIFNWAEEGLKPLEWTRRLTIALDVARGVEYLHGLAH 715
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV R
Sbjct: 716 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 774
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585572|ref|XP_002533475.1| receptor protein kinase, putative [Ricinus communis] gi|223526668|gb|EEF28907.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1187 bits (3070), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 581/780 (74%), Positives = 670/780 (85%), Gaps = 5/780 (0%)
Query: 1 MKEKTCVGFKLLTLYV-GFCSILF-VSASGDDG-DAAVMLALKKSLNPPESLGWSDTDPC 57
M+++ + FK L +++ GFCS VS G DA VM AL+KSLN P+SLGWSD DPC
Sbjct: 1 MEKRVYIKFKSLLIFLSGFCSFFVNVSCQGSPSEDAPVMFALRKSLNVPDSLGWSDPDPC 60
Query: 58 KWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASL 117
W HV C ++KR+TRIQIG QNL+GTLPSNLQNLT+LERLELQWNSISGPLP+L GLASL
Sbjct: 61 NWKHVTCSDEKRVTRIQIGRQNLEGTLPSNLQNLTQLERLELQWNSISGPLPTLKGLASL 120
Query: 118 EVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANIT 177
VVMLS NQFTS+PSDFFTGLSSLQS+EID+NPFS+W IP+S+++AS LQNFSANSAN++
Sbjct: 121 LVVMLSGNQFTSIPSDFFTGLSSLQSVEIDDNPFSTWVIPESIKDASALQNFSANSANLS 180
Query: 178 GQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQ 237
G IP FFGPD FPGLTILHLA N+L GGLP +FSGSQIQSLW+NGQ KL GGIDVI+
Sbjct: 181 GSIPDFFGPDSFPGLTILHLALNELQGGLPGTFSGSQIQSLWLNGQTSKGKLTGGIDVIK 240
Query: 238 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
NMT LK++WLHSN FSGPLPDFSG+K LE LS+RDN FTGP+P SL L SLK VN++NN
Sbjct: 241 NMTLLKDVWLHSNGFSGPLPDFSGLKDLEVLSIRDNSFTGPIPLSLTALASLKAVNLSNN 300
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 357
L QGP+P F R VS+D+ SN+FCLPSPG CD R+ LL + K +GYPQRFAE+WKGND
Sbjct: 301 LFQGPMPVFKRLVSVDLTADSNSFCLPSPGDCDSRVKTLLLIAKSVGYPQRFAESWKGND 360
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL 417
PC+DW+G+TCT GNITV+NFQKM LTGT++PEFA SLQRL+L +NNL+G IP+ L+ L
Sbjct: 361 PCADWVGITCTGGNITVVNFQKMGLTGTVAPEFAMLLSLQRLVLDNNNLTGSIPQELTTL 420
Query: 418 GALKELDVSNNQLYGKIPSFKSNAIVNTDGNPDIGKE-KSSSFQGSPSGSPTGTGSGNAS 476
ALK+LDVSNNQ+ GKIP+FKSN +VNT+GNPDIGK+ +S+ GSPSG+ +
Sbjct: 421 PALKQLDVSNNQISGKIPTFKSNVMVNTNGNPDIGKDVNTSTTPGSPSGATMAGTGSGSG 480
Query: 477 STENGVKNSSALITVILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRH 536
++ NG K SS+ I VILF VIGG FVISL G+L+FC+ KKKQKRFS+VQSPNAMVIHPRH
Sbjct: 481 NSGNGGKKSSSNIGVILFSVIGGVFVISLIGLLIFCIYKKKQKRFSKVQSPNAMVIHPRH 540
Query: 537 SGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFS 596
SGS+N ESVKITVAGS+VSVGAISETHT P+SE GDIQM+E+GNMVISIQVLRNVTNNFS
Sbjct: 541 SGSDN-ESVKITVAGSSVSVGAISETHTFPASEQGDIQMVESGNMVISIQVLRNVTNNFS 599
Query: 597 EENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
E+N+LG+GGFG VYKGELHDGTKIAVKRME+GVISGKGL EFKSEIAVL KVRHRHLVAL
Sbjct: 600 EDNLLGQGGFGKVYKGELHDGTKIAVKRMESGVISGKGLAEFKSEIAVLNKVRHRHLVAL 659
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
LG+CLDGNEKLLV+E+MPQG LSRH+F+WA++GLKPLEW RRL IALDVARGVEYLHGLA
Sbjct: 660 LGYCLDGNEKLLVYEFMPQGALSRHLFHWADDGLKPLEWTRRLIIALDVARGVEYLHGLA 719
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP+GKGSIETRIAGTFGYLAPEYAV R
Sbjct: 720 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPDGKGSIETRIAGTFGYLAPEYAVTGR 779
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224077350|ref|XP_002305223.1| predicted protein [Populus trichocarpa] gi|222848187|gb|EEE85734.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1171 bits (3029), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 583/779 (74%), Positives = 667/779 (85%), Gaps = 8/779 (1%)
Query: 1 MKEKTCVGFKLLTLY-VGFCSILFVSASGDDGDAAVMLALKKSLNPPESLGWSDTDPCKW 59
MK K+ KL ++ VGF SI ++S DA VML+LKKSLN P+SLGWSD DPCKW
Sbjct: 1 MKRKSSQSLKLFLIFLVGFSSIFRYASSQASPDAEVMLSLKKSLNVPDSLGWSDPDPCKW 60
Query: 60 NHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEV 119
NHV C ++KR+TRIQIG QNLQGTLPSNLQNLT+LERLELQ+N+ISG LPSLNGL+SL+V
Sbjct: 61 NHVGCSDEKRVTRIQIGRQNLQGTLPSNLQNLTQLERLELQYNNISGHLPSLNGLSSLQV 120
Query: 120 VMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQ 179
++LS+N+FTSVPSDFF GLSSLQS+EIDNNPFS+W IP+S++NASGLQNFSANSANI+G
Sbjct: 121 ILLSDNKFTSVPSDFFAGLSSLQSVEIDNNPFSNWVIPESIQNASGLQNFSANSANISGS 180
Query: 180 IPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNM 239
IPSFFGPD FP LTIL LAFN L G LPASFSG Q+QSLW+NGQ KL G I VIQNM
Sbjct: 181 IPSFFGPDAFPALTILRLAFNDLEGELPASFSGLQVQSLWLNGQ----KLSGSIYVIQNM 236
Query: 240 TSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
T L+E+WL SN FSGPLPDFSG+K LESL+LRDN FTGPVP+SLV LESLK+VN++NNLL
Sbjct: 237 TLLREVWLQSNGFSGPLPDFSGLKDLESLNLRDNSFTGPVPESLVNLESLKVVNLSNNLL 296
Query: 300 QGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPC 359
QGP+P F SVS+D+ K SN FCL +PG CD R+N LLS+VK M YP R A+ WKGNDPC
Sbjct: 297 QGPMPVFKSSVSVDVVKDSNRFCLSTPGPCDSRVNTLLSIVKSMYYPHRLADGWKGNDPC 356
Query: 360 SDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGA 419
+DW G+TC KGNITV+NF+KM LTG+ISP+FAS KSL+RL+LA+NNL+G+IP+ ++ L
Sbjct: 357 ADWFGITCNKGNITVVNFEKMGLTGSISPDFASLKSLERLVLANNNLTGLIPQEITTLPR 416
Query: 420 LKELDVSNNQLYGKIPSFKSNAIVNTDGNPDIGKE--KSSSFQGSPSGSPTGTGSGNASS 477
LK LDVSNNQ+YGK+P+F +N IVNT+GNP IGK+ S+S + TGSG+ +
Sbjct: 417 LKALDVSNNQIYGKVPAFTNNVIVNTNGNPRIGKDVNSSTSPGSPSASPSANTGSGSGGN 476
Query: 478 TENGVKNSSALITVILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHS 537
+ K SSA I VI+F V+GG F++ L G++VFCL KKKQKRFSRVQSPN MVIHPRHS
Sbjct: 477 SGKSGKKSSAFIGVIVFSVVGGVFLLFLIGLVVFCLYKKKQKRFSRVQSPNEMVIHPRHS 536
Query: 538 GSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSE 597
S+N ESVKITVAGS+VSVGAISETHT+P+SE GDIQM EAGNMVISIQVLRNVTNNFSE
Sbjct: 537 VSDN-ESVKITVAGSSVSVGAISETHTIPTSEQGDIQMGEAGNMVISIQVLRNVTNNFSE 595
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
ENILG+GGFG VYKGELHDGTKIAVKRM +GVIS KGL EFKSEIAVLTKVRHRHLVALL
Sbjct: 596 ENILGQGGFGVVYKGELHDGTKIAVKRMGSGVISSKGLNEFKSEIAVLTKVRHRHLVALL 655
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
G+CLDGNEKLLV+EYMPQGTLSRH+FNWAEEGLKP+EW RRLTIALDVARGVEYLHGLAH
Sbjct: 656 GYCLDGNEKLLVYEYMPQGTLSRHLFNWAEEGLKPMEWTRRLTIALDVARGVEYLHGLAH 715
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
QSFIHRDLKPSNILLGDDMRAKV+DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV R
Sbjct: 716 QSFIHRDLKPSNILLGDDMRAKVSDFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 774
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476563|ref|XP_002265087.2| PREDICTED: probable receptor protein kinase TMK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1156 bits (2990), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 565/741 (76%), Positives = 631/741 (85%), Gaps = 25/741 (3%)
Query: 36 MLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLE 95
MLALK SL+ ESLGWS DPC+W HVVC EDKR+TRIQ+G Q LQGTLPS+L NLT+LE
Sbjct: 1 MLALKDSLSNSESLGWSGPDPCEWKHVVCSEDKRVTRIQVGRQGLQGTLPSSLGNLTELE 60
Query: 96 RLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWE 155
RLELQWN+ISGPLPSL GL+SL+V+MLSNNQFT +P DFF+GLSSLQS+EIDNNPFS+WE
Sbjct: 61 RLELQWNNISGPLPSLKGLSSLQVLMLSNNQFTYIPVDFFSGLSSLQSVEIDNNPFSAWE 120
Query: 156 IPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQI 215
IPQSL+NAS LQNFSANSANITG IP F GP FPGL LHLAFN L+GGLP++ SGS I
Sbjct: 121 IPQSLKNASALQNFSANSANITGNIPDFLGPVAFPGLVNLHLAFNALVGGLPSALSGSLI 180
Query: 216 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFF 275
+SLWVNGQ KL G IDVIQNMTSLKE+WLHSNAFSGPLPDFSG+K L+SLSLRDN F
Sbjct: 181 ESLWVNGQMSEEKLSGTIDVIQNMTSLKEVWLHSNAFSGPLPDFSGLKDLQSLSLRDNLF 240
Query: 276 TGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNA 335
TG VP SLV L SL+ VN+TNN LQGPVPEF SV++DM N+FCLP PG CDPR+N
Sbjct: 241 TGVVPVSLVNLGSLEAVNLTNNFLQGPVPEFKNSVAVDMTPDGNSFCLPKPGECDPRVNI 300
Query: 336 LLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKS 395
LLS+VK GYP +FA+NWKGNDPC++W G+TC GNITV+NFQKM LTGTIS F+S S
Sbjct: 301 LLSIVKSFGYPTKFAKNWKGNDPCTEWFGITCNNGNITVVNFQKMGLTGTISSNFSSLIS 360
Query: 396 LQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNPDIGKEK 455
LQ+L+LADNN++G IP+ L+ L AL +LDVSNNQLYGKIPSFK N +VN +G+ D G
Sbjct: 361 LQKLVLADNNITGSIPKELTTLPALTQLDVSNNQLYGKIPSFKGNVLVNANGSQDSG--- 417
Query: 456 SSSFQGSPSGSPTGTGSGNASSTENGVKNSSALITVILFCVIGGAFVISLTGVLVFCLCK 515
S+ NG K SS+LI +I+F VIGG FVI L G+LVFCL K
Sbjct: 418 ---------------------SSMNGGKKSSSLIGIIVFSVIGGVFVIFLIGLLVFCLYK 456
Query: 516 KKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQM 575
+KQKRF+RVQSPNAMVIHPRHSGS+N +SVKITVAGS+VSVGAISETHT PSSEP DIQM
Sbjct: 457 RKQKRFTRVQSPNAMVIHPRHSGSDN-DSVKITVAGSSVSVGAISETHTHPSSEPNDIQM 515
Query: 576 LEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGL 635
+EAGNMVISIQVLRNVTNNFSEENILG+GGFGTVY+GELHDGTKIAVKRME+GVI+GKGL
Sbjct: 516 VEAGNMVISIQVLRNVTNNFSEENILGQGGFGTVYRGELHDGTKIAVKRMESGVITGKGL 575
Query: 636 TEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEW 695
EFKSEIAVLTKVRHRHLVALLG+CLDGNEKLLV+EYMPQGTLSRH+F+W EEG+KPLEW
Sbjct: 576 AEFKSEIAVLTKVRHRHLVALLGYCLDGNEKLLVYEYMPQGTLSRHLFSWPEEGIKPLEW 635
Query: 696 NRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755
RRL IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS
Sbjct: 636 TRRLAIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 695
Query: 756 IETRIAGTFGYLAPEYAVHTR 776
IETRIAGTFGYLAPEYAV R
Sbjct: 696 IETRIAGTFGYLAPEYAVTGR 716
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449445063|ref|XP_004140293.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus] gi|449479894|ref|XP_004155738.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1152 bits (2980), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 563/750 (75%), Positives = 635/750 (84%), Gaps = 6/750 (0%)
Query: 32 DAAVMLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNL 91
DA M ALKKSLNP ESLGWSD +PCKWNHV+C +D R+TRIQIG QNLQG LP NLQNL
Sbjct: 33 DAPAMTALKKSLNPTESLGWSDPNPCKWNHVLCSDDNRVTRIQIGRQNLQGMLPLNLQNL 92
Query: 92 TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF 151
T LERLELQWN ISGPLPSL+GL SL+V++LS NQFTS+PSDFF G++SLQ++EID NPF
Sbjct: 93 TALERLELQWNKISGPLPSLSGLTSLQVLLLSGNQFTSIPSDFFAGMTSLQAVEIDENPF 152
Query: 152 SSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFS 211
S+WEIP SLRNAS LQNFSANSAN+TG+IP F G ++ PGLT LHLAFN L GGLP+SFS
Sbjct: 153 SAWEIPASLRNASTLQNFSANSANVTGRIPEFLGGEDIPGLTNLHLAFNNLEGGLPSSFS 212
Query: 212 GSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLR 271
GSQ++SLWVNGQN KL G IDV+QNMTSL E+WLHSN+FSGPLPDFS +K L++LSLR
Sbjct: 213 GSQLESLWVNGQNSADKLSGSIDVLQNMTSLIEVWLHSNSFSGPLPDFSRLKDLQALSLR 272
Query: 272 DNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDP 331
DN FTGPVP SLV SLK+VN+TNNLLQGP+P F V +DM SN+FCL PG CD
Sbjct: 273 DNKFTGPVPSSLVNSPSLKVVNLTNNLLQGPIPLFKTGVVVDMTNDSNSFCLQDPGECDS 332
Query: 332 RLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFA 391
R+N LLS+VK MGYPQRFAENWKGNDPC++WIG++C +IT++NFQKM L+G ISPEFA
Sbjct: 333 RVNTLLSIVKFMGYPQRFAENWKGNDPCAEWIGISCRNQSITIVNFQKMGLSGMISPEFA 392
Query: 392 SFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNPDI 451
S K L+RL+LADN+L+G IPE L+ L L ELDVSNNQL GKIP F+SN ++ GNPDI
Sbjct: 393 SLKGLERLVLADNHLTGSIPEELTTLPFLTELDVSNNQLSGKIPKFRSNVMMTITGNPDI 452
Query: 452 GKEK--SSSFQGSPSGSPTGTGSGNASSTENGV---KNSSALITVILFCVIGGAFVISLT 506
GKEK SSS SPS S T ++ N K S+++ VI+ V+GG FV+ L
Sbjct: 453 GKEKTDSSSNGASPSASSNDTKEAGSNGGGNSGDGEKKPSSMVGVIVLSVVGGVFVLFLI 512
Query: 507 GVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVP 566
G++V C+ K KQKRFS+VQSPNAMVIHPRHSGS+N ESVKITVAGS+V VGAISET
Sbjct: 513 GLVVLCVYKMKQKRFSQVQSPNAMVIHPRHSGSDN-ESVKITVAGSSVRVGAISETQNGA 571
Query: 567 SSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRME 626
SSE GDIQM+EAGNMVISIQVL+NVTNNFSEENILG+GGFGTVYKGELHDGTKIAVKRME
Sbjct: 572 SSETGDIQMVEAGNMVISIQVLKNVTNNFSEENILGQGGFGTVYKGELHDGTKIAVKRME 631
Query: 627 AGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA 686
+GVI GKGLTEFKSEIAVLTKVRHRHLVALLG+CLDGNEKLLV+EYMPQGTLSRH+FNW
Sbjct: 632 SGVIKGKGLTEFKSEIAVLTKVRHRHLVALLGYCLDGNEKLLVYEYMPQGTLSRHLFNWP 691
Query: 687 EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746
EEGLKPLEW +RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV
Sbjct: 692 EEGLKPLEWTKRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 751
Query: 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
RLAPEGKGSIETRIAGTFGYLAPEYAV R
Sbjct: 752 RLAPEGKGSIETRIAGTFGYLAPEYAVTGR 781
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727489|ref|NP_001238698.1| NAK-type protein kinase precursor [Glycine max] gi|223452361|gb|ACM89508.1| NAK-type protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1122 bits (2903), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 552/772 (71%), Positives = 636/772 (82%), Gaps = 9/772 (1%)
Query: 8 GFKLLTLYVGFCSILFVSASGDDGDAAVMLALKKSLNPPESLGWSDTDPCKWNHVVCIED 67
LL + V F ++ D DA+VMLALK SLNPP GWSD DPCKW V+C +D
Sbjct: 3 ALALLAIIV-FTLLVRSQEEEDYDDASVMLALKNSLNPP---GWSDPDPCKWARVLCSDD 58
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127
KR+TRIQIG NLQGTLP+ LQ LT LE LELQ+N+ISGPLPSLNGL SL V + SNN+F
Sbjct: 59 KRVTRIQIGRLNLQGTLPTTLQKLTHLEHLELQYNNISGPLPSLNGLTSLRVFLASNNRF 118
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
++VP+DFF G+S LQ++EID+NPF WEIPQSLRNASGLQNFSANSAN+ G IP FFG D
Sbjct: 119 SAVPADFFAGMSQLQAVEIDSNPFEPWEIPQSLRNASGLQNFSANSANVGGSIPEFFGSD 178
Query: 188 EFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWL 247
FPGLT+LHLA N L G LP SFSGSQIQSLW+NGQ KLGG ++V+QNMT L ++WL
Sbjct: 179 VFPGLTLLHLAMNNLEGTLPLSFSGSQIQSLWLNGQKSVNKLGGSVEVLQNMTFLTDVWL 238
Query: 248 HSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVP-DSLVKLESLKIVNMTNNLLQGPVPEF 306
SNAF+GPLPD SG+K L LSLRDN FTGPVP S V L++LK+VN+TNNL QGP+P F
Sbjct: 239 QSNAFTGPLPDLSGLKSLRDLSLRDNRFTGPVPVASFVGLKTLKVVNLTNNLFQGPMPVF 298
Query: 307 DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVT 366
V +D K SN+FCLPSPG CDPR++ LLSVV +MGYP RFAE+WKGNDPC+ WIG+T
Sbjct: 299 GDGVVVDNVKDSNSFCLPSPGDCDPRVDVLLSVVGVMGYPPRFAESWKGNDPCAYWIGIT 358
Query: 367 CTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVS 426
C+ G ITV+NFQKM L+G ISPEFA KSLQR++LADNNL+G IPE L+ L AL +L+V+
Sbjct: 359 CSNGYITVVNFQKMELSGVISPEFAKLKSLQRIVLADNNLTGSIPEELATLPALTQLNVA 418
Query: 427 NNQLYGKIPSFKSNAIVNTDGNPDIGKEKSS-SFQG-SPSGSPTGTGSGNASSTENGVKN 484
NNQLYGK+PSF+ N +V+T+GN DIGK+KSS S QG P +P G S G K
Sbjct: 419 NNQLYGKVPSFRKNVVVSTNGNTDIGKDKSSLSPQGLVPPMAPNAKGDSGGVSGIGG-KK 477
Query: 485 SSALITVILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSES 544
SS+ + VI+F VIG FV+S+ G LVFCL + KQK+ SRVQSPNA+VIHPRHSGS+N ES
Sbjct: 478 SSSHVGVIVFSVIGAVFVVSMIGFLVFCLFRMKQKKLSRVQSPNALVIHPRHSGSDN-ES 536
Query: 545 VKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRG 604
VKITVAGS+VSVGA SET TVP SE DIQM+EAGNMVISIQVL+NVT+NFSE+N+LG+G
Sbjct: 537 VKITVAGSSVSVGAASETRTVPGSEASDIQMVEAGNMVISIQVLKNVTDNFSEKNVLGQG 596
Query: 605 GFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN 664
GFGTVY+GELHDGT+IAVKRME G I+GKG EFKSEIAVLTKVRHRHLV+LLG+CLDGN
Sbjct: 597 GFGTVYRGELHDGTRIAVKRMECGAIAGKGAAEFKSEIAVLTKVRHRHLVSLLGYCLDGN 656
Query: 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRD 724
EKLLV+EYMPQGTLSRH+F+W EEGL+PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRD
Sbjct: 657 EKLLVYEYMPQGTLSRHLFDWPEEGLEPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRD 716
Query: 725 LKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
LKPSNILLGDDMRAKVADFGLVRLAPEGK SIETRIAGTFGYLAPEYAV R
Sbjct: 717 LKPSNILLGDDMRAKVADFGLVRLAPEGKASIETRIAGTFGYLAPEYAVTGR 768
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224589461|gb|ACN59264.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1098 bits (2839), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 545/750 (72%), Positives = 629/750 (83%), Gaps = 9/750 (1%)
Query: 30 DGDAAVMLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQ 89
DGD + ML+LKKSLNPP S GWSD DPCKW H+VC KR+TRIQIGH LQGTL +L+
Sbjct: 26 DGDLSAMLSLKKSLNPPSSFGWSDPDPCKWTHIVCTGTKRVTRIQIGHSGLQGTLSPDLR 85
Query: 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
NL++LERLELQWN+ISGP+PSL+GLASL+V+MLSNN F S+PSD F GL+SLQS+EIDNN
Sbjct: 86 NLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQGLTSLQSVEIDNN 145
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209
PF SWEIP+SLRNAS LQNFSANSAN++G +P F GPDEFPGL+ILHLAFN L G LP S
Sbjct: 146 PFKSWEIPESLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHLAFNNLEGELPMS 205
Query: 210 FSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLS 269
+GSQ+QSLW+NGQ KL G I V+QNMT LKE+WLHSN FSGPLPDFSG+K+LESLS
Sbjct: 206 LAGSQVQSLWLNGQ----KLTGDITVLQNMTGLKEVWLHSNKFSGPLPDFSGLKELESLS 261
Query: 270 LRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGAC 329
LRDN FTGPVP SL+ LESLK+VN+TNN LQGPVP F SVS+D+ K SN+FCL SPG C
Sbjct: 262 LRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSFCLSSPGEC 321
Query: 330 DPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE 389
DPR+ +LL + YP R AE+WKGNDPC++WIG+ C+ GNITVI+ +KM LTGTISPE
Sbjct: 322 DPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIACSNGNITVISLEKMELTGTISPE 381
Query: 390 FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNP 449
F + KSLQR+IL NNL+GMIP+ L+ L LK LDVS+N+L+GK+P F+SN +VNT+GNP
Sbjct: 382 FGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNVVVNTNGNP 441
Query: 450 DIGKEKSSSFQGSPSGSPTGTGSG-NASSTENGVKNSSALITVILFCVIGGAFVISLTGV 508
DIGK+KSS S G+GSG N G+K SS I +I+ V+GG I L G+
Sbjct: 442 DIGKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMK-SSTFIGIIVGSVLGGLLSIFLIGL 500
Query: 509 LVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVP-S 567
LVFC KK+QKRFS +S NA+V+HPRHSGS+N ESVKITVAGS+VSVG IS+T+T+P +
Sbjct: 501 LVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDN-ESVKITVAGSSVSVGGISDTYTLPGT 559
Query: 568 SEPGD-IQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRME 626
SE GD IQM+EAGNM+ISIQVLR+VTNNFS +NILG GGFG VYKGELHDGTKIAVKRME
Sbjct: 560 SEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIAVKRME 619
Query: 627 AGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA 686
GVI+GKG EFKSEIAVLTKVRHRHLV LLG+CLDGNEKLLV+EYMPQGTLSRH+F W+
Sbjct: 620 NGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEWS 679
Query: 687 EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746
EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV
Sbjct: 680 EEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 739
Query: 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
RLAPEGKGSIETRIAGTFGYLAPEYAV R
Sbjct: 740 RLAPEGKGSIETRIAGTFGYLAPEYAVTGR 769
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|29824403|gb|AAP04161.1| putative receptor protein kinase (TMK1) [Arabidopsis thaliana] gi|110737237|dbj|BAF00566.1| putative receptor protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1097 bits (2837), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 545/750 (72%), Positives = 629/750 (83%), Gaps = 9/750 (1%)
Query: 30 DGDAAVMLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQ 89
DGD + ML+LKKSLNPP S GWSD DPCKW H+VC KR+TRIQIGH LQGTL +L+
Sbjct: 26 DGDLSAMLSLKKSLNPPSSFGWSDPDPCKWTHIVCTGTKRVTRIQIGHSGLQGTLSPDLR 85
Query: 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
NL++LERLELQWN+ISGP+PSL+GLASL+V+MLSNN F S+PSD F GL+SLQS+EIDNN
Sbjct: 86 NLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQGLTSLQSVEIDNN 145
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209
PF SWEIP+SLRNAS LQNFSANSAN++G +P F GPDEFPGL+ILHLAFN L G LP S
Sbjct: 146 PFKSWEIPESLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHLAFNNLEGELPMS 205
Query: 210 FSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLS 269
+GSQ+QSLW+NGQ KL G I V+QNMT LKE+WLHSN FSGPLPDFSG+K+LESLS
Sbjct: 206 LAGSQVQSLWLNGQ----KLTGDITVLQNMTGLKEVWLHSNKFSGPLPDFSGLKELESLS 261
Query: 270 LRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGAC 329
LRDN FTGPVP SL+ LESLK+VN+TNN LQGPVP F SVS+D+ K SN+FCL SPG C
Sbjct: 262 LRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSFCLSSPGEC 321
Query: 330 DPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE 389
DPR+ +LL + YP R AE+WKGNDPC++WIG+ C+ GNITVI+ +KM LTGTISPE
Sbjct: 322 DPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIACSNGNITVISLEKMELTGTISPE 381
Query: 390 FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNP 449
F + KSLQR+IL NNL+GMIP+ L+ L LK LDVS+N+L+GK+P F+SN +VNT+GNP
Sbjct: 382 FGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNVVVNTNGNP 441
Query: 450 DIGKEKSSSFQGSPSGSPTGTGSG-NASSTENGVKNSSALITVILFCVIGGAFVISLTGV 508
DIGK+KSS S G+GSG N G+K SS I +I+ V+GG I L G+
Sbjct: 442 DIGKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMK-SSTFIGIIVGSVLGGLLSIFLIGL 500
Query: 509 LVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVP-S 567
LVFC KK+QKRFS +S NA+V+HPRHSGS+N ESVKITVAGS+VSVG IS+T+T+P +
Sbjct: 501 LVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDN-ESVKITVAGSSVSVGGISDTYTLPGT 559
Query: 568 SEPGD-IQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRME 626
SE GD IQM+EAGNM+ISIQVLR+VTNNFS +NILG GGFG VYKGELHDGTKIAVKRME
Sbjct: 560 SEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIAVKRME 619
Query: 627 AGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA 686
GVI+GKG EFKSEIAVLTKVRHRHLV LLG+CLDGNEKLLV+EYMPQGTLSRH+F W+
Sbjct: 620 NGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEWS 679
Query: 687 EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746
EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV
Sbjct: 680 EEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 739
Query: 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
RLAPEGKGSIETRIAGTFGYLAPEYAV R
Sbjct: 740 RLAPEGKGSIETRIAGTFGYLAPEYAVTGR 769
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15218941|ref|NP_176789.1| putative receptor protein kinase TMK1 [Arabidopsis thaliana] gi|1174718|sp|P43298.1|TMK1_ARATH RecName: Full=Probable receptor protein kinase TMK1; Flags: Precursor gi|12322608|gb|AAG51302.1|AC026480_9 receptor protein kinase (TMK1), putative [Arabidopsis thaliana] gi|166888|gb|AAA32876.1| protein kinase [Arabidopsis thaliana] gi|332196347|gb|AEE34468.1| putative receptor protein kinase TMK1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1097 bits (2837), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 545/750 (72%), Positives = 629/750 (83%), Gaps = 9/750 (1%)
Query: 30 DGDAAVMLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQ 89
DGD + ML+LKKSLNPP S GWSD DPCKW H+VC KR+TRIQIGH LQGTL +L+
Sbjct: 26 DGDLSAMLSLKKSLNPPSSFGWSDPDPCKWTHIVCTGTKRVTRIQIGHSGLQGTLSPDLR 85
Query: 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
NL++LERLELQWN+ISGP+PSL+GLASL+V+MLSNN F S+PSD F GL+SLQS+EIDNN
Sbjct: 86 NLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQGLTSLQSVEIDNN 145
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209
PF SWEIP+SLRNAS LQNFSANSAN++G +P F GPDEFPGL+ILHLAFN L G LP S
Sbjct: 146 PFKSWEIPESLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHLAFNNLEGELPMS 205
Query: 210 FSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLS 269
+GSQ+QSLW+NGQ KL G I V+QNMT LKE+WLHSN FSGPLPDFSG+K+LESLS
Sbjct: 206 LAGSQVQSLWLNGQ----KLTGDITVLQNMTGLKEVWLHSNKFSGPLPDFSGLKELESLS 261
Query: 270 LRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGAC 329
LRDN FTGPVP SL+ LESLK+VN+TNN LQGPVP F SVS+D+ K SN+FCL SPG C
Sbjct: 262 LRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSFCLSSPGEC 321
Query: 330 DPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE 389
DPR+ +LL + YP R AE+WKGNDPC++WIG+ C+ GNITVI+ +KM LTGTISPE
Sbjct: 322 DPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIACSNGNITVISLEKMELTGTISPE 381
Query: 390 FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNP 449
F + KSLQR+IL NNL+GMIP+ L+ L LK LDVS+N+L+GK+P F+SN +VNT+GNP
Sbjct: 382 FGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNVVVNTNGNP 441
Query: 450 DIGKEKSSSFQGSPSGSPTGTGSG-NASSTENGVKNSSALITVILFCVIGGAFVISLTGV 508
DIGK+KSS S G+GSG N G+K SS I +I+ V+GG I L G+
Sbjct: 442 DIGKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMK-SSTFIGIIVGSVLGGLLSIFLIGL 500
Query: 509 LVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVP-S 567
LVFC KK+QKRFS +S NA+V+HPRHSGS+N ESVKITVAGS+VSVG IS+T+T+P +
Sbjct: 501 LVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDN-ESVKITVAGSSVSVGGISDTYTLPGT 559
Query: 568 SEPGD-IQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRME 626
SE GD IQM+EAGNM+ISIQVLR+VTNNFS +NILG GGFG VYKGELHDGTKIAVKRME
Sbjct: 560 SEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIAVKRME 619
Query: 627 AGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA 686
GVI+GKG EFKSEIAVLTKVRHRHLV LLG+CLDGNEKLLV+EYMPQGTLSRH+F W+
Sbjct: 620 NGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEWS 679
Query: 687 EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746
EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV
Sbjct: 680 EEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 739
Query: 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
RLAPEGKGSIETRIAGTFGYLAPEYAV R
Sbjct: 740 RLAPEGKGSIETRIAGTFGYLAPEYAVTGR 769
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297838257|ref|XP_002887010.1| hypothetical protein ARALYDRAFT_475717 [Arabidopsis lyrata subsp. lyrata] gi|297332851|gb|EFH63269.1| hypothetical protein ARALYDRAFT_475717 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1090 bits (2818), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 542/760 (71%), Positives = 633/760 (83%), Gaps = 9/760 (1%)
Query: 20 SILFVSASGDDGDAAVMLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQN 79
S F+ S DGD + M++LKKSLNPP S GWSD DPCKW H+VC KR+TRIQIGH
Sbjct: 11 SFTFLLKSDSDGDLSAMISLKKSLNPPSSFGWSDPDPCKWTHIVCTGTKRVTRIQIGHSG 70
Query: 80 LQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLS 139
LQGTL +L+NL++LERLELQWN+ISGP+PSL+GLASL+V+MLSNN F S+PSD F GL+
Sbjct: 71 LQGTLSPDLRNLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFEGLT 130
Query: 140 SLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAF 199
SLQS+EIDNNPF +WEIP+SLRNAS LQNFSANSAN++G++P FFGPDEFPGL+ILHLAF
Sbjct: 131 SLQSVEIDNNPFKAWEIPESLRNASALQNFSANSANVSGKLPGFFGPDEFPGLSILHLAF 190
Query: 200 NQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDF 259
N L G LP S +GSQ+QSLW+NGQ KL G I+V+QNMT LKE+WLHSN FSGPLPDF
Sbjct: 191 NSLGGELPLSLAGSQVQSLWLNGQ----KLTGEINVLQNMTGLKEVWLHSNVFSGPLPDF 246
Query: 260 SGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSN 319
SG+K+LESLSLRDN FTGPVP SL+ LESLK++N+TNN LQGPVP F SVS+D+ K SN
Sbjct: 247 SGLKELESLSLRDNAFTGPVPTSLLSLESLKVLNLTNNHLQGPVPVFKSSVSVDLDKDSN 306
Query: 320 NFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQK 379
+FCLPSP CD R+ +LL + YPQR AE+WKGNDPC++WIG+ C+ GNITVIN +K
Sbjct: 307 SFCLPSPDECDSRVKSLLLIASSFDYPQRLAESWKGNDPCTNWIGIACSNGNITVINLEK 366
Query: 380 MNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS 439
M LTGTISPEF S KSLQR+IL NNL+G IP+ L+ L LK LDVS+N+L+GK+P F+S
Sbjct: 367 MGLTGTISPEFGSIKSLQRIILGINNLTGTIPQELTTLPNLKTLDVSSNKLFGKVPGFRS 426
Query: 440 NAIVNTDGNPDIGKEKSSSFQGSPSGSPTGTGSG-NASSTENGVKNSSALITVILFCVIG 498
N +V+T+GNPDIGK+KSS S G+GSG N G+K SS I +++ V+G
Sbjct: 427 NVVVSTNGNPDIGKDKSSLPSPGSSSPSGGSGSGINGDKDRRGMK-SSTFIGIVVGSVLG 485
Query: 499 GAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGA 558
G I + G+LVFC KK+QK +R +S NA+V+HPRHSGS+N ESVKITVAGS+VSVG
Sbjct: 486 GLLSIFMIGLLVFCWYKKRQKCNTRGESSNAVVVHPRHSGSDN-ESVKITVAGSSVSVGG 544
Query: 559 ISETHTVP-SSEPGD-IQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHD 616
IS+T+T+P +SE GD IQM+EAGNM+ISIQVLR+VTNNFS +NILG GGFG VYKGELHD
Sbjct: 545 ISDTYTLPGTSEVGDNIQMVEAGNMLISIQVLRSVTNNFSADNILGSGGFGVVYKGELHD 604
Query: 617 GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676
GTKIAVKRME GVI GKG EFKSEIAVLTKVRHRHLV LLG+CLDGNEKLLV+EYMPQG
Sbjct: 605 GTKIAVKRMENGVIVGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQG 664
Query: 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736
TLSRH+F W+EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM
Sbjct: 665 TLSRHLFEWSEEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 724
Query: 737 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV R
Sbjct: 725 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 764
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 787 | ||||||
| TAIR|locus:2013825 | 942 | TMK1 "transmembrane kinase 1" | 0.958 | 0.800 | 0.706 | 7.7e-293 | |
| TAIR|locus:2059703 | 943 | AT2G01820 [Arabidopsis thalian | 0.933 | 0.779 | 0.566 | 2.6e-221 | |
| TAIR|locus:2024016 | 886 | AT1G24650 [Arabidopsis thalian | 0.542 | 0.481 | 0.506 | 3.4e-204 | |
| TAIR|locus:2095188 | 928 | AT3G23750 [Arabidopsis thalian | 0.945 | 0.801 | 0.445 | 1.5e-161 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.237 | 0.197 | 0.476 | 2.4e-68 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.237 | 0.196 | 0.471 | 3.8e-65 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.227 | 0.178 | 0.437 | 7.7e-65 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.257 | 0.193 | 0.451 | 7.8e-65 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.227 | 0.178 | 0.432 | 2.1e-64 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.235 | 0.168 | 0.422 | 5.5e-64 |
| TAIR|locus:2013825 TMK1 "transmembrane kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2812 (994.9 bits), Expect = 7.7e-293, P = 7.7e-293
Identities = 538/761 (70%), Positives = 623/761 (81%)
Query: 18 FCSILFVSASGDDGDAAVMLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGH 77
F +L +S + DGD + ML+LKKSLNPP S GWSD DPCKW H+VC KR+TRIQIGH
Sbjct: 14 FLLLLSLSKADSDGDLSAMLSLKKSLNPPSSFGWSDPDPCKWTHIVCTGTKRVTRIQIGH 73
Query: 78 QNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTG 137
LQGTL +L+NL++LERLELQWN+ISGP+PSL+GLASL+V+MLSNN F S+PSD F G
Sbjct: 74 SGLQGTLSPDLRNLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQG 133
Query: 138 LSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHL 197
L+SLQS+EIDNNPF SWEIP+SLRNAS LQNFSANSAN++G +P F GPDEFPGL+ILHL
Sbjct: 134 LTSLQSVEIDNNPFKSWEIPESLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHL 193
Query: 198 AFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP 257
AFN L G LP S +GSQ+QSLW+NGQ KL G I V+QNMT LKE+WLHSN FSGPLP
Sbjct: 194 AFNNLEGELPMSLAGSQVQSLWLNGQ----KLTGDITVLQNMTGLKEVWLHSNKFSGPLP 249
Query: 258 DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKG 317
DFSG+K+LESLSLRDN FTGPVP SL+ LESLK+VN+TNN LQGPVP F SVS+D+ K
Sbjct: 250 DFSGLKELESLSLRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKD 309
Query: 318 SNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINF 377
SN+FCL SPG CDPR+ +LL + YP R AE+WKGNDPC++WIG+ C+ GNITVI+
Sbjct: 310 SNSFCLSSPGECDPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIACSNGNITVISL 369
Query: 378 QKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF 437
+KM LTGTISPEF + KSLQR+IL NNL+GMIP+ L+ L LK LDVS+N+L+GK+P F
Sbjct: 370 EKMELTGTISPEFGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGF 429
Query: 438 KSNAIVNTDGNPDIGKEKXXXXXXXXXXXXXXXXXXXXXXXXXXVKNSSALITVILFCVI 497
+SN +VNT+GNPDIGK+K SS I +I+ V+
Sbjct: 430 RSNVVVNTNGNPDIGKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMKSSTFIGIIVGSVL 489
Query: 498 GGAFVISLTGVLVFCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVG 557
GG I L G+LVFC KK+QKRFS +S NA+V+HPRHSGS+N ESVKITVAGS+VSVG
Sbjct: 490 GGLLSIFLIGLLVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDN-ESVKITVAGSSVSVG 548
Query: 558 AISETHTVP-SSEPGD-IQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELH 615
IS+T+T+P +SE GD IQM+EAGNM+ISIQVLR+VTNNFS +NILG GGFG VYKGELH
Sbjct: 549 GISDTYTLPGTSEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELH 608
Query: 616 DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675
DGTKIAVKRME GVI+GKG EFKSEIAVLTKVRHRHLV LLG+CLDGNEKLLV+EYMPQ
Sbjct: 609 DGTKIAVKRMENGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQ 668
Query: 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735
GTLSRH+F W+EEGLKPL W +RLT+ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD
Sbjct: 669 GTLSRHLFEWSEEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 728
Query: 736 MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV R
Sbjct: 729 MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGR 769
|
|
| TAIR|locus:2059703 AT2G01820 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2137 (757.3 bits), Expect = 2.6e-221, P = 2.6e-221
Identities = 424/748 (56%), Positives = 539/748 (72%)
Query: 32 DAAVMLALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNL 91
D + M +LK SLN + WS+ +PCKW V C R+T+IQ+ + ++GTLP+NLQ+L
Sbjct: 29 DDSTMQSLKSSLNLTSDVDWSNPNPCKWQSVQCDGSNRVTKIQLKQKGIRGTLPTNLQSL 88
Query: 92 TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF 151
++L LEL N ISGP+P L+GL+ L+ + L +N FTSVP + F+G+SSLQ + ++NNPF
Sbjct: 89 SELVILELFLNRISGPIPDLSGLSRLQTLNLHDNLFTSVPKNLFSGMSSLQEMYLENNPF 148
Query: 152 SSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFS 211
W IP +++ A+ LQN + ++ +I G+IP FFG P LT L L+ N L G LP SF+
Sbjct: 149 DPWVIPDTVKEATSLQNLTLSNCSIIGKIPDFFGSQSLPSLTNLKLSQNGLEGELPMSFA 208
Query: 212 GSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLR 271
G+ IQSL++NGQ KL G I V+ NMTSL E+ L N FSGP+PD SG+ L ++R
Sbjct: 209 GTSIQSLFLNGQ----KLNGSISVLGNMTSLVEVSLQGNQFSGPIPDLSGLVSLRVFNVR 264
Query: 272 DNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPG-ACD 330
+N TG VP SLV L SL VN+TNN LQGP P F +SV +D+ N+FC G ACD
Sbjct: 265 ENQLTGVVPQSLVSLSSLTTVNLTNNYLQGPTPLFGKSVGVDIVNNMNSFCTNVAGEACD 324
Query: 331 PRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEF 390
PR++ L+SV + GYP + AE+WKGN+PC +W+G+TC+ GNITV+N +K +L+GTISP
Sbjct: 325 PRVDTLVSVAESFGYPVKLAESWKGNNPCVNWVGITCSGGNITVVNMRKQDLSGTISPSL 384
Query: 391 ASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNPD 450
A SL+ + LADN LSG IP+ L+ L L+ LDVSNN YG P F+ + T+GN +
Sbjct: 385 AKLTSLETINLADNKLSGHIPDELTTLSKLRLLDVSNNDFYGIPPKFRDTVTLVTEGNAN 444
Query: 451 IGKEKXXXXXXXXXXXXXXXXXXXXXXXXXXVKNSSALITVILFCVIGGAF-VISLTGVL 509
+GK K+S+ I V V+GG + L G+
Sbjct: 445 MGKNGPNKTSDAPGASPGSKPSGGSDGSETSKKSSNVKIIVP---VVGGVVGALCLVGLG 501
Query: 510 VFCLCKKKQKRFSRVQSPNA-MVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSS 568
V CL KK+KR +RVQSP++ MVIHP HSG +++ +K+TVA S+++ G S++++ S
Sbjct: 502 V-CLYAKKRKRPARVQSPSSNMVIHPHHSG--DNDDIKLTVAASSLNSGGGSDSYSHSGS 558
Query: 569 EPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAG 628
DI ++EAGN+VISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRME+
Sbjct: 559 AASDIHVVEAGNLVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMESS 618
Query: 629 VISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE 688
V+S KGLTEFKSEI VLTK+RHRHLVALLG+CLDGNE+LLV+EYMPQGTLS+H+F+W EE
Sbjct: 619 VVSDKGLTEFKSEITVLTKMRHRHLVALLGYCLDGNERLLVYEYMPQGTLSQHLFHWKEE 678
Query: 689 GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748
G KPL+W RRL IALDVARGVEYLH LAHQSFIHRDLKPSNILLGDDMRAKV+DFGLVRL
Sbjct: 679 GRKPLDWTRRLAIALDVARGVEYLHTLAHQSFIHRDLKPSNILLGDDMRAKVSDFGLVRL 738
Query: 749 APEGKGSIETRIAGTFGYLAPEYAVHTR 776
AP+GK SIETR+AGTFGYLAPEYAV R
Sbjct: 739 APDGKYSIETRVAGTFGYLAPEYAVTGR 766
|
|
| TAIR|locus:2024016 AT1G24650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1106 (394.4 bits), Expect = 3.4e-204, Sum P(2) = 3.4e-204
Identities = 220/434 (50%), Positives = 291/434 (67%)
Query: 19 CSILFVSASGDDGDAAVMLALKKSLNPPESLGWSDTDPCKWNHVV-CIEDKRITRIQIGH 77
C I V+ D AVM+AL+ SL + WS +DPCKW+ + C R+T IQIG
Sbjct: 11 CFIALVNVESSP-DEAVMIALRDSLKLSGNPNWSGSDPCKWSMFIKCDASNRVTAIQIGD 69
Query: 78 QNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTG 137
+ + G LP +L LT L + E+ N ++GP+PSL GL SL V ++N FTSVP DFF+G
Sbjct: 70 RGISGKLPPDLGKLTSLTKFEVMRNRLTGPIPSLAGLKSLVTVYANDNDFTSVPEDFFSG 129
Query: 138 LSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSF-FGPDEFPGLTILH 196
LSSLQ + +DNNPF SW IP SL NA+ L +FSA + N++G+IP + F +F LT L
Sbjct: 130 LSSLQHVSLDNNPFDSWVIPPSLENATSLVDFSAVNCNLSGKIPDYLFEGKDFSSLTTLK 189
Query: 197 LAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL 256
L++N L+ P +FS S++Q L +NGQ G KL G I +Q MTSL + L N+FSGPL
Sbjct: 190 LSYNSLVCEFPMNFSDSRVQVLMLNGQKGREKLHGSISFLQKMTSLTNVTLQGNSFSGPL 249
Query: 257 PDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDR-SVSLDMA 315
PDFSG+ L+S ++R+N +G VP SL +L+SL V + NNLLQGP P F + D+
Sbjct: 250 PDFSGLVSLKSFNVRENQLSGLVPSSLFELQSLSDVALGNNLLQGPTPNFTAPDIKPDL- 308
Query: 316 KGSNNFCLPSPG-ACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITV 374
G N+FCL +PG +CDPR+N LLS+V+ GYP FAE WKGNDPCS W+G+TCT +ITV
Sbjct: 309 NGLNSFCLDTPGTSCDPRVNTLLSIVEAFGYPVNFAEKWKGNDPCSGWVGITCTGTDITV 368
Query: 375 INFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKI 434
INF+ + L GTISP FA F SL+ + L+ NNL+G IP+ L+ L LK LDVS N+L G++
Sbjct: 369 INFKNLGLNGTISPRFADFASLRVINLSQNNLNGTIPQELAKLSNLKTLDVSKNRLCGEV 428
Query: 435 PSFKSNAIVNTDGN 448
P F + IVNT GN
Sbjct: 429 PRFNTT-IVNTTGN 441
|
|
| TAIR|locus:2095188 AT3G23750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1573 (558.8 bits), Expect = 1.5e-161, P = 1.5e-161
Identities = 345/774 (44%), Positives = 467/774 (60%)
Query: 12 LTLYVGFCSILFVSASGDDGDAAVMLALKKSLNPPESLGWSDT-DPCKWNHVVCIEDKRI 70
L L V +I F + S D D MLAL KS NPP S WS T D CKW+ V C R+
Sbjct: 7 LLLLVLLTTITFFTTSVAD-DQTAMLALAKSFNPPPS-DWSSTTDFCKWSGVRCTGG-RV 63
Query: 71 TRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSV 130
T I + ++L G + + L++L+ + +Q N +SG +PS L+SL+ + + N F V
Sbjct: 64 TTISLADKSLTGFIAPEISTLSELKSVSIQRNKLSGTIPSFAKLSSLQEIYMDENNFVGV 123
Query: 131 PSDFFTGLSSLQSIEI-DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEF 189
+ F GL+SLQ + + DNN ++W P L +++ L ++ NI G +P F D
Sbjct: 124 ETGAFAGLTSLQILSLSDNNNITTWSFPSELVDSTSLTTIYLDNTNIAGVLPDIF--DSL 181
Query: 190 PGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS 249
L L L++N + G LP S S IQ+LW+N Q+ + G I+V+ +MTSL + WLH
Sbjct: 182 ASLQNLRLSYNNITGVLPPSLGKSSIQNLWINNQD--LGMSGTIEVLSSMTSLSQAWLHK 239
Query: 250 NAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS 309
N F GP+PD S + L L LRDN TG VP +L+ L SLK +++ NN QGP+P F
Sbjct: 240 NHFFGPIPDLSKSENLFDLQLRDNDLTGIVPPTLLTLASLKNISLDNNKFQGPLPLFSPE 299
Query: 310 VSLDMAKGSNNFCLPSPG-ACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCT 368
V + + N FC G +C P++ LL+V +GYP AE+W+G+D CS W V+C
Sbjct: 300 VKVTI--DHNVFCTTKAGQSCSPQVMTLLAVAGGLGYPSMLAESWQGDDACSGWAYVSCD 357
Query: 369 KG--NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVS 426
N+ +N K TG ISP A+ SL+ L L N+L+G+IP+ L+ + +L+ +DVS
Sbjct: 358 SAGKNVVTLNLGKHGFTGFISPAIANLTSLKSLYLNGNDLTGVIPKELTFMTSLQLIDVS 417
Query: 427 NNQLYGKIPSFKSNAIVN-TDGNPDIGKEKXXXXXXXXXXXXXXXXXXXXXXXXXXVKNS 485
NN L G+IP F + + GN +G
Sbjct: 418 NNNLRGEIPKFPATVKFSYKPGNALLGTNGGDGSSPGTGGASGGPGGSSGGGGSKVGVIV 477
Query: 486 SALITVILFCVIGGAFVISLTGVLVFCLCKKKQKRFSRV--QSPNAMVIHPRHSGSENSE 543
++ V++F I G FV V F + K+K RF+R + +++ S +
Sbjct: 478 GVIVAVLVFLAILG-FV-----VYKFVM-KRKYGRFNRTDPEKVGKILVSDAVSNGGSGN 530
Query: 544 SVKITVAGSNVSVGAISETHTVPSS-EPGDIQMLEAGNMVISIQVLRNVTNNFSEENILG 602
G+N + A++ PSS + D +LE G++ I ++VLR VTNNFSE+NILG
Sbjct: 531 GGYANGHGAN-NFNALNS----PSSGDNSDRFLLEGGSVTIPMEVLRQVTNNFSEDNILG 585
Query: 603 RGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 662
RGGFG VY GELHDGTK AVKRME + KG++EF++EIAVLTKVRHRHLVALLG+C++
Sbjct: 586 RGGFGVVYAGELHDGTKTAVKRMECAAMGNKGMSEFQAEIAVLTKVRHRHLVALLGYCVN 645
Query: 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIH 722
GNE+LLV+EYMPQG L +H+F W+E G PL W +R++IALDVARGVEYLH LA QSFIH
Sbjct: 646 GNERLLVYEYMPQGNLGQHLFEWSELGYSPLTWKQRVSIALDVARGVEYLHSLAQQSFIH 705
Query: 723 RDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
RDLKPSNILLGDDMRAKVADFGLV+ AP+GK S+ETR+AGTFGYLAPEYA R
Sbjct: 706 RDLKPSNILLGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGR 759
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 439 (159.6 bits), Expect = 2.4e-68, Sum P(2) = 2.4e-68
Identities = 93/195 (47%), Positives = 128/195 (65%)
Query: 579 GNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEF 638
G + + L TNNFS+ N +G GG+G VYKG L +G IA+KR + G S +G EF
Sbjct: 618 GTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQG--SMQGAFEF 675
Query: 639 KSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR 698
K+EI +L++V H+++V LLG C D E++LV+EY+P G+L + + G+K L+W RR
Sbjct: 676 KTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSG--KNGVK-LDWTRR 732
Query: 699 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA--PEGKGSI 756
L IAL +G+ YLH LA IHRD+K +NILL + + AKVADFGL +L PE K +
Sbjct: 733 LKIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVGDPE-KAHV 791
Query: 757 ETRIAGTFGYLAPEY 771
T++ GT GYL PEY
Sbjct: 792 TTQVKGTMGYLDPEY 806
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 436 (158.5 bits), Expect = 3.8e-65, Sum P(2) = 3.8e-65
Identities = 92/195 (47%), Positives = 131/195 (67%)
Query: 579 GNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEF 638
G + + L+ T+NFSE N +G GG+G VY+G L +G IA+KR + G + G GL EF
Sbjct: 615 GAKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIKRAQQGSLQG-GL-EF 672
Query: 639 KSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR 698
K+EI +L++V H+++V LLG C D NE++LV+EY+ G+L + + G++ L+W RR
Sbjct: 673 KTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSG--KSGIR-LDWTRR 729
Query: 699 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA--PEGKGSI 756
L IAL +G+ YLH LA IHRD+K +NILL +++ AKVADFGL +L PE K +
Sbjct: 730 LKIALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKLVGDPE-KTHV 788
Query: 757 ETRIAGTFGYLAPEY 771
T++ GT GYL PEY
Sbjct: 789 TTQVKGTMGYLDPEY 803
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 374 (136.7 bits), Expect = 7.7e-65, Sum P(2) = 7.7e-65
Identities = 81/185 (43%), Positives = 113/185 (61%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKV 648
+V ++ E+NI+G+GG G VYKG + G +AVKR+ A + G F +EI L ++
Sbjct: 685 DVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRL-ATMSHGSSHDHGFNAEIQTLGRI 743
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
RHRH+V LLG C + LLV+EYMP G+L + + + G L WN R IAL+ A+G
Sbjct: 744 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGE-VLHGKKGG--HLHWNTRYKIALEAAKG 800
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYL 767
+ YLH +HRD+K +NILL + A VADFGL + L G + IAG++GY+
Sbjct: 801 LCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 860
Query: 768 APEYA 772
APEYA
Sbjct: 861 APEYA 865
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 456 (165.6 bits), Expect = 7.8e-65, Sum P(2) = 7.8e-65
Identities = 94/208 (45%), Positives = 133/208 (63%)
Query: 566 PSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRM 625
P ++ +I ++ + L+N T +F N LG GGFG VYKG L+DG ++AVK++
Sbjct: 681 PYTDDEEILSMDVKPYTFTYSELKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQL 740
Query: 626 EAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW 685
G GKG +F +EI ++ V HR+LV L G C +G+ +LLV+EY+P G+L + +F
Sbjct: 741 SIGSRQGKG--QFVAEIIAISSVLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFG- 797
Query: 686 AEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745
++ L L+W+ R I L VARG+ YLH A IHRD+K SNILL ++ KV+DFGL
Sbjct: 798 -DKSLH-LDWSTRYEICLGVARGLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGL 855
Query: 746 VRLAPEGKGSIETRIAGTFGYLAPEYAV 773
+L + K I TR+AGT GYLAPEYA+
Sbjct: 856 AKLYDDKKTHISTRVAGTIGYLAPEYAM 883
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 372 (136.0 bits), Expect = 2.1e-64, Sum P(2) = 2.1e-64
Identities = 80/185 (43%), Positives = 114/185 (61%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKV 648
+V ++ E+NI+G+GG G VYKG + +G +AVKR+ A + G F +EI L ++
Sbjct: 689 DVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRL-AAMSRGSSHDHGFNAEIQTLGRI 747
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
RHRH+V LLG C + LLV+EYMP G+L + + + G L W+ R IAL+ A+G
Sbjct: 748 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGE-VLHGKKGG--HLHWDTRYKIALEAAKG 804
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYL 767
+ YLH +HRD+K +NILL + A VADFGL + L G + IAG++GY+
Sbjct: 805 LCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 864
Query: 768 APEYA 772
APEYA
Sbjct: 865 APEYA 869
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 380 (138.8 bits), Expect = 5.5e-64, Sum P(2) = 5.5e-64
Identities = 79/187 (42%), Positives = 111/187 (59%)
Query: 586 QVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVL 645
Q L + T NFSE+ +LGRG GTVYK E+ G IAVK++ + F++EI+ L
Sbjct: 790 QGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEISTL 849
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
K+RHR++V L G C N LL++EYM +G+L + + L L+WN R IAL
Sbjct: 850 GKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCL--LDWNARYRIALGA 907
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 765
A G+ YLH +HRD+K +NILL + +A V DFGL +L + +AG++G
Sbjct: 908 AEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYG 967
Query: 766 YLAPEYA 772
Y+APEYA
Sbjct: 968 YIAPEYA 974
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P43298 | TMK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7266 | 0.9415 | 0.7866 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 787 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-37 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-34 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-25 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-22 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-22 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-05 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 8e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-04 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.001 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.001 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.003 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.004 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 2e-43
Identities = 69/172 (40%), Positives = 88/172 (51%), Gaps = 11/172 (6%)
Query: 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
LG GGFGTVY G K+A+K ++ S L E EI +L K+ H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED-SSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
D N LV EY G+L + L + L I L + G+EYLH
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLH---SNG 112
Query: 720 FIHRDLKPSNILLG-DDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
IHRDLKP NILL D+ + K+ADFGL +L K S+ I GT Y+APE
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-SLLKTIVGTPAYMAPE 163
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 63/172 (36%), Positives = 87/172 (50%), Gaps = 10/172 (5%)
Query: 600 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
LG G FGTVYK + G +AVK ++ K + EI +L ++ H ++V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
D + LV EY G L ++ PL + IAL + RG+EYLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSR-----GGPLSEDEAKKIALQILRGLEYLHS---N 117
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
IHRDLKP NILL ++ K+ADFGL + + S+ T GT Y+APE
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPE 168
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 56/177 (31%), Positives = 79/177 (44%), Gaps = 12/177 (6%)
Query: 595 FSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
+ LG G FG VY + G +A+K ++ I EI +L K++H ++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD-RERILREIKILKKLKHPNI 59
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
V L D ++ LV EY G L + L + + +EYLH
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR-----GRLSEDEARFYLRQILSALEYLH 114
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+ +HRDLKP NILL +D K+ADFGL R G+ T GT Y+APE
Sbjct: 115 S---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPE 166
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 62/192 (32%), Positives = 90/192 (46%), Gaps = 39/192 (20%)
Query: 599 NILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG G FG VYKG+L T++AVK ++ + +F E V+ K+ H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE-RKDFLKEARVMKKLGHPNVV 59
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTL------SRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
LLG C + LV EYM G L SR +F L L+ A+ +A+G
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFP--SPEKSTLSLKDLLSFAIQIAKG 117
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR--------------------L 748
+EYL + F+HRDL N L+G+D+ K++DFGL R +
Sbjct: 118 MEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174
Query: 749 APEGKGSIETRI 760
APE S++ I
Sbjct: 175 APE---SLKDGI 183
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 7e-37
Identities = 125/415 (30%), Positives = 203/415 (48%), Gaps = 38/415 (9%)
Query: 35 VMLALKKSLNPPESL--GWSDT-DPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNL 91
++L+ K S+N P W+ + D C W + C R+ I + +N+ G + S + L
Sbjct: 33 LLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRL 92
Query: 92 TKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFT-SVPSDFFTGLSSLQSIEIDN 148
++ + L N +SGP+P +SL + LSNN FT S+P + +L+++++ N
Sbjct: 93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGS---IPNLETLDLSN 149
Query: 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPA 208
N S EIP + + S L+ + G+IP+ L L LA NQL+G +P
Sbjct: 150 NMLSG-EIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT--NLTSLEFLTLASNQLVGQIPR 206
Query: 209 SFSGSQIQSL-WVNGQNGNAKLGGGIDV-IQNMTSLKEIWLHSNAFSGPLP-DFSGVKQL 265
Q++SL W+ G L G I I +TSL + L N +GP+P +K L
Sbjct: 207 EL--GQMKSLKWI--YLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNL 262
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSV-SLDMAK-GSNNFCL 323
+ L L N +GP+P S+ L+ L +++++N L G +PE + +L++ SNNF
Sbjct: 263 QYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTG 322
Query: 324 PSPGACD--PRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 381
P A PRL L Q ++ + G P + +G N+TV++ N
Sbjct: 323 KIPVALTSLPRLQVL----------QLWSNKFSGEIPKN--LG---KHNNLTVLDLSTNN 367
Query: 382 LTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436
LTG I S +L +LIL N+L G IP+ L +L+ + + +N G++PS
Sbjct: 368 LTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422
|
Length = 968 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 55/161 (34%), Positives = 85/161 (52%), Gaps = 13/161 (8%)
Query: 598 ENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
LG G FG VYKG+L ++AVK ++ S + + EF E ++ K+ H +
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLDHPN 62
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V LLG C + +V EYM G L ++ + L + L+ AL +ARG+EYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753
++FIHRDL N L+G+++ K++DFGL R +
Sbjct: 119 E---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 156
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 57/161 (35%), Positives = 87/161 (54%), Gaps = 12/161 (7%)
Query: 598 ENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
LG G FG VYKG L ++AVK ++ S + + EF E ++ K+ H +
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA-SEQQIEEFLREARIMRKLDHPN 62
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V LLG C + ++V EYMP G L ++ + K L + L+ AL +ARG+EYL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL---RKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753
++FIHRDL N L+G+++ K++DFGL R +
Sbjct: 120 E---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 58/178 (32%), Positives = 87/178 (48%), Gaps = 16/178 (8%)
Query: 599 NILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+LGRG FG+VY D G +AVK +E S + L + EI +L+ ++H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 658 GHCLDGNEK-LLVF-EYMPQGTLSRHIFNWAEEGLKPLEWN--RRLTIALDVARGVEYLH 713
G D + L +F EY+ G+LS + + L R+ T + G+ YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL-----KKFGKLPEPVIRKYTR--QILEGLAYLH 118
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIAGTFGYLAPE 770
+HRD+K +NIL+ D K+ADFG RL G + GT ++APE
Sbjct: 119 S---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 57/153 (37%), Positives = 84/153 (54%), Gaps = 13/153 (8%)
Query: 601 LGRGGFGTVYKGELHD-----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 655
LG G FG VYKG L TK+AVK ++ G S + EF E +++ K+ H ++V
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA-SEEEREEFLEEASIMKKLSHPNIVR 65
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
LLG C G +V EYMP G L + + + L L +AL +A+G+EYL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL----RKHGEKLTLKDLLQMALQIAKGMEYLES- 120
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748
++F+HRDL N L+ +++ K++DFGL R
Sbjct: 121 --KNFVHRDLAARNCLVTENLVVKISDFGLSRD 151
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 7e-31
Identities = 105/371 (28%), Positives = 171/371 (46%), Gaps = 31/371 (8%)
Query: 73 IQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFT-SV 130
I +G+ NL G +P + LT L L+L +N+++GP+P SL L +L+ + L N+ + +
Sbjct: 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276
Query: 131 PSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFP 190
P F L L S+++ +N S EIP+ + L+ S N TG+IP P
Sbjct: 277 PPSIF-SLQKLISLDLSDN-SLSGEIPELVIQLQNLEILHLFSNNFTGKIPV--ALTSLP 332
Query: 191 GLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
L +L L N+ G +P + G +L V + N G + + + +L ++ L SN
Sbjct: 333 RLQVLQLWSNKFSGEIPKNL-GKH-NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSN 390
Query: 251 AFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP----E 305
+ G +P + L + L+DN F+G +P KL + ++++NN LQG + +
Sbjct: 391 SLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWD 450
Query: 306 FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMG-YPQRFAENWKGNDPCSDWIG 364
L +A+ LP N LS + G P++
Sbjct: 451 MPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLG-------------- 496
Query: 365 VTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELD 424
+ + + + L+G I E +S K L L L+ N LSG IP S + L +LD
Sbjct: 497 ---SLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553
Query: 425 VSNNQLYGKIP 435
+S NQL G+IP
Sbjct: 554 LSQNQLSGEIP 564
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 66/188 (35%), Positives = 100/188 (53%), Gaps = 28/188 (14%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
+G+G FG V G+ G K+AVK ++ F +E +V+T +RH +LV LLG
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 661 LDGNEKLLVFEYMPQGTL-------SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
L GN +V EYM +G+L R + A+ +L ALDV G+EYL
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQ----------QLGFALDVCEGMEYLE 119
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV 773
++F+HRDL N+L+ +D+ AKV+DFGL + A +G+ S + + T APE
Sbjct: 120 E---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALR 172
Query: 774 HTRWSSCS 781
++S+ S
Sbjct: 173 EKKFSTKS 180
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 26/178 (14%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
+G+GGFG VYK G ++A+K ++ + S + + +EI +L K +H ++V G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVARGVEYLH 713
L +E +V E+ G+L + + N+ LT + ++ +G+EYLH
Sbjct: 66 YLKKDELWIVMEFCSGGSL-KDLLK---------STNQTLTESQIAYVCKELLKGLEYLH 115
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIAGTFGYLAPE 770
IHRD+K +NILL D K+ DFGL +L+ + GT ++APE
Sbjct: 116 S---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS---DTKARNTMVGTPYWMAPE 167
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 7e-27
Identities = 62/191 (32%), Positives = 88/191 (46%), Gaps = 20/191 (10%)
Query: 601 LGRGGFGTVYK-GELHDGTKIAVKRMEAGVISGKGLTEF-KSEIAVLTKVRHRHLVALLG 658
LG+G FG V + G A+K ++ I + E +E +L+++ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 659 HC-LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
H EKL LV EY P G L H+ ++EG E R A ++ +EYLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARF--YAAEIVLALEYLHS-- 111
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY---AV 773
I+RDLKP NILL D K+ DFGL + T GT YLAPE
Sbjct: 112 -LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKG 169
Query: 774 HTRWSSCSYWA 784
+ + + +W+
Sbjct: 170 YGK--AVDWWS 178
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 64/188 (34%), Positives = 100/188 (53%), Gaps = 11/188 (5%)
Query: 595 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
F+ E LG G FG V++G + ++A+K +++ +F+ E+ L ++RH+HL+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLI 65
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
+L C G ++ E M +G+L F + EG + L + +A VA G+ YL
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSL--LAFLRSPEG-QVLPVASLIDMACQVAEGMAYLE- 121
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE-TRIAGTFGYLAPEYAV 773
Q+ IHRDL NIL+G+D+ KVADFGL RL E +I + + APE A
Sbjct: 122 --EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAAS 177
Query: 774 HTRWSSCS 781
H +S+ S
Sbjct: 178 HGTFSTKS 185
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 58/184 (31%), Positives = 91/184 (49%), Gaps = 22/184 (11%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
N+ +++GRG FG VYKG L G +A+K++ I + L EI +L ++H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHI--FNWAEEGLKPLEWNRRLTIALDVA---R 707
+V +G + ++ EY G+L + I F E L +A+ V +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL----------VAVYVYQVLQ 110
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIAGTFGY 766
G+ YLH Q IHRD+K +NIL D K+ADFG+ +L K + + GT +
Sbjct: 111 GLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYW 165
Query: 767 LAPE 770
+APE
Sbjct: 166 MAPE 169
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 53/162 (32%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 601 LGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG G FG V+ GE +D +AVK ++ S +F+ E +LT +H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLTNFQHENIV 71
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSR-------HIFNWAEEGLKPLEWNRR--LTIALDV 705
G C +G+ ++VFEYM G L++ E L IA+ +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
A G+ Y LA Q F+HRDL N L+G D+ K+ DFG+ R
Sbjct: 132 ASGMVY---LASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 56/173 (32%), Positives = 90/173 (52%), Gaps = 14/173 (8%)
Query: 600 ILGRGGFGTVYKGELH--DGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 655
ILG G FG+V +G+L DG+ K+AVK M+ + + + EF SE A + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 656 LLGHCLDGNEK------LLVFEYMPQGTLSRHIF-NWAEEGLKPLEWNRRLTIALDVARG 708
L+G C + + +++ +M G L + + + L L +D+A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 761
+EYL ++++FIHRDL N +L +DM VADFGL + G + RIA
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 55/148 (37%), Positives = 83/148 (56%), Gaps = 9/148 (6%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG G FG V+ G + TK+AVK ++ G +S F E ++ K+RH LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720
+ +V EYM +G+L + + EG K L + + +A +A G+ YL +++
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKS--GEG-KKLRLPQLVDMAAQIAEGMAYLE---SRNY 124
Query: 721 IHRDLKPSNILLGDDMRAKVADFGLVRL 748
IHRDL NIL+G+++ K+ADFGL RL
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARL 152
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 103 bits (256), Expect = 1e-23
Identities = 60/190 (31%), Positives = 83/190 (43%), Gaps = 15/190 (7%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRH-RHLVALLG 658
LG G FG VY D +A+K + + S E F EI +L + H ++V L
Sbjct: 8 LGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
D LV EY+ G+L + PL + L I + +EYLH +
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKK--IGRKGPLSESEALFILAQILSALEYLH---SK 120
Query: 719 SFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPEGKGSIETR-----IAGTFGYLAPEYA 772
IHRD+KP NILL D K+ DFGL +L P+ + GT GY+APE
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 773 VHTRWSSCSY 782
+ + S
Sbjct: 181 LGLSLAYASS 190
|
Length = 384 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 58/173 (33%), Positives = 86/173 (49%), Gaps = 27/173 (15%)
Query: 595 FSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
F EE LG G FG VYKGEL T +A+K ++ K EF+ E +++ +
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDL 65
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIF-------------NWAEEGLKPLEW 695
+H ++V LLG C ++FEY+ G L H F + E L+
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDL--HEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 696 NRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748
+ L IA+ +A G+EY L+ F+HRDL N L+G+ + K++DFGL R
Sbjct: 124 SDFLHIAIQIAAGMEY---LSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD 173
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 6e-23
Identities = 58/181 (32%), Positives = 91/181 (50%), Gaps = 10/181 (5%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
+G G FG V+ G + K+A+K + G +S + +F E V+ K+ H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720
+ + LVFE+M G LS ++ A+ G L + LDV G+ YL +
Sbjct: 69 TERSPICLVFEFMEHGCLSDYL--RAQRGK--FSQETLLGMCLDVCEGMAYLE---SSNV 121
Query: 721 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWSSC 780
IHRDL N L+G++ KV+DFG+ R + + + T + +PE +++SS
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 781 S 781
S
Sbjct: 182 S 182
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 65/197 (32%), Positives = 101/197 (51%), Gaps = 23/197 (11%)
Query: 584 SIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIA 643
SIQ+LR LG G FG V++G ++ T +AVK ++ G + K +F +E
Sbjct: 7 SIQLLRK----------LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQ 53
Query: 644 VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
++ K+RH L+ L C +V E M G+L ++ + L+ + + +A
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG---GAGRALKLPQLIDMAA 110
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 763
VA G+ YL Q++IHRDL N+L+G++ KVADFGL R+ E E R
Sbjct: 111 QVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI--YEAREGAK 165
Query: 764 F--GYLAPEYAVHTRWS 778
F + APE A++ R+S
Sbjct: 166 FPIKWTAPEAALYNRFS 182
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 63/187 (33%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG G FG V+ G+ +A+K + G +S +F E V+ K+ H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720
+V EYM G L + +G EW L + DV +EYL F
Sbjct: 69 TKQRPIFIVTEYMANGCLLN--YLRERKGKLGTEW--LLDMCSDVCEAMEYLE---SNGF 121
Query: 721 IHRDLKPSNILLGDDMRAKVADFGLVR--LAPEGKGSIETRIAGTFGYLAPEYAVHTRWS 778
IHRDL N L+G+D KV+DFGL R L + S T+ + PE ++R+S
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSRFS 179
Query: 779 SCS-YWA 784
S S W+
Sbjct: 180 SKSDVWS 186
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 68/182 (37%), Positives = 97/182 (53%), Gaps = 16/182 (8%)
Query: 600 ILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
I+G G FG V +GE + G K+AVK ++ V + F E AV+TK+ H++LV LLG
Sbjct: 13 IIGEGEFGAVLQGE-YTGQKVAVKNIKCDVTA----QAFLEETAVMTKLHHKNLVRLLGV 67
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
L N +V E M +G L + G + + L +LDVA G+EYL +
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLES---KK 120
Query: 720 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWSS 779
+HRDL NIL+ +D AKV+DFGL R+ G + + + T APE H ++SS
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSS 176
Query: 780 CS 781
S
Sbjct: 177 KS 178
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 55/171 (32%), Positives = 83/171 (48%), Gaps = 9/171 (5%)
Query: 601 LGRGGFGTVYK-GELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
+G G G V+K + G +A+K++ + G + EI L +H ++V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
G+ +LV EYMP LS + + E L + + L +GV Y+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRD-EERPLPEAQ-VKSYMRML--LKGVAYMHAN---G 119
Query: 720 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+HRDLKP+N+L+ D K+ADFGL RL E + + + T Y APE
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 60/194 (30%), Positives = 94/194 (48%), Gaps = 21/194 (10%)
Query: 599 NILGRGGFGTVYKGE---LHDGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
LG G FG V L D T ++AVK + + ++F+ EI +L + H ++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-EEQHRSDFEREIEILRTLDHENI 68
Query: 654 VALLGHCLD--GNEKLLVFEYMPQGTLSRHI-FNWAEEGLKPLEWNRRLTIALDVARGVE 710
V G C G L+ EY+P G+L ++ + + LK L L + + +G++
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-----LLFSSQICKGMD 123
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG---TFGYL 767
YL Q +IHRDL NIL+ + K++DFGL ++ PE K + G F Y
Sbjct: 124 YLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 768 APEYAVHTRWSSCS 781
APE +++SS S
Sbjct: 180 APECLRTSKFSSAS 193
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-22
Identities = 56/163 (34%), Positives = 79/163 (48%), Gaps = 21/163 (12%)
Query: 601 LGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG G FG V+ E H D +AVK ++ S + +F+ E +LT ++H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR--QDFQREAELLTVLQHQHIV 70
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSR---------HIFNWAE-EGLKPLEWNRRLTIALD 704
G C +G L+VFEYM G L+R I E L + L IA
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 705 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+A G+ YL L F+HRDL N L+G + K+ DFG+ R
Sbjct: 131 IASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 70/194 (36%), Positives = 101/194 (52%), Gaps = 13/194 (6%)
Query: 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRH 652
F + +LG+GGFG V ++ G A KR+E I KG + +E +L KV +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 653 LVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
+V L + + + L LV M G L HI+N G E R L A ++ G+E
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF---EEERALFYAAEILCGLED 117
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
LH ++ ++RDLKP NILL D +++D GL PEG+ SI R+ GT GY+APE
Sbjct: 118 LH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIRGRV-GTVGYMAPEV 172
Query: 772 AVHTRWS-SCSYWA 784
+ R++ S YW
Sbjct: 173 LNNQRYTLSPDYWG 186
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (239), Expect = 6e-22
Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 16/183 (8%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ +G+G FG VY DG +K ++ +S K + +E+ +L K+ H +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP-----LEWNRRLTIALDVAR 707
++ + + +V EY G LS+ I +EG L+W +L +AL
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK--- 117
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
YLH + +HRD+KP NI L + K+ DFG+ ++ +T + GT YL
Sbjct: 118 ---YLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYL 170
Query: 768 APE 770
+PE
Sbjct: 171 SPE 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 7e-22
Identities = 68/194 (35%), Positives = 104/194 (53%), Gaps = 13/194 (6%)
Query: 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRH 652
F + +LG+GGFG V ++ G A K++E I KG + +E +L KV R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 653 LVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
+V+L + + + L LV M G L HI++ E G E R + A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF---EEGRAVFYAAEICCGLED 117
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
LH + ++RDLKP NILL D +++D GL PEG+ +I+ R+ GT GY+APE
Sbjct: 118 LH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRV-GTVGYMAPEV 172
Query: 772 AVHTRWS-SCSYWA 784
+ R++ S +WA
Sbjct: 173 VKNERYTFSPDWWA 186
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 61/193 (31%), Positives = 98/193 (50%), Gaps = 19/193 (9%)
Query: 598 ENILGRGGFGTVYKG--ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 655
++ LG G +G VY+G + + T +AVK ++ + + EF E AV+ +++H +LV
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLT-VAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQ 66
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
LLG C ++ E+M G L ++ + + + L +A ++ +EYL
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE-- 121
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLAPEYA 772
++FIHRDL N L+G++ KVADFGL RL G T AG + APE
Sbjct: 122 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESL 177
Query: 773 VHTRWSSCS-YWA 784
+ ++S S WA
Sbjct: 178 AYNKFSIKSDVWA 190
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 54/185 (29%), Positives = 79/185 (42%), Gaps = 38/185 (20%)
Query: 601 LGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEFKSEIAV----LTKVRHRHLV 654
LG+G G VYK H T A+K I G EF+ ++ L ++V
Sbjct: 9 LGQGSSGVVYKV-RHKPTGKIYALK-----KIHVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
G E +V EYM G+L+ + + E L IA + +G++Y
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA--------YIARQILKGLDY 114
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA------GTFG 765
LH H IHRD+KPSN+L+ K+ADFG+ +E + GT
Sbjct: 115 LHTKRHI--IHRDIKPSNLLINSKGEVKIADFGI-------SKVLENTLDQCNTFVGTVT 165
Query: 766 YLAPE 770
Y++PE
Sbjct: 166 YMSPE 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 62/193 (32%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+F LG+G +G+VYK + L D A+K ++ G +S K + +EI +L V H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+++ LDGN+ +V EY P G LS+ I ++ K + I + + RG++ L
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR-KLIPEQEIWRIFIQLLRGLQAL 119
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
H Q +HRDLK +NILL + K+ D G+ ++ K +T+I GT Y+APE
Sbjct: 120 H---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQI-GTPHYMAPEVW 173
Query: 773 VHTRWS-SCSYWA 784
+S W+
Sbjct: 174 KGRPYSYKSDIWS 186
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 60/185 (32%), Positives = 98/185 (52%), Gaps = 16/185 (8%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+G+G FG V G+ + G K+AVK ++ + F +E +V+T++RH +LV LL
Sbjct: 11 LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLL 65
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
G ++ L +V EYM +G+L ++ G L + L +LDV +EYL
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEA-- 120
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
+F+HRDL N+L+ +D AKV+DFGL + A + + + + T APE +
Sbjct: 121 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKK 175
Query: 777 WSSCS 781
+S+ S
Sbjct: 176 FSTKS 180
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (233), Expect = 6e-21
Identities = 49/158 (31%), Positives = 76/158 (48%), Gaps = 17/158 (10%)
Query: 595 FSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS----EIAVLTKVR 649
+ + LG G +G VYK + G +A+K++ S EI++L +++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR----LDNEEEGIPSTALREISLLKELK 56
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
H ++V LL + LVFEY L +++ ++ PL N +I + RG+
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL----DKRPGPLSPNLIKSIMYQLLRGL 111
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
Y H +HRDLKP NIL+ D K+ADFGL R
Sbjct: 112 AYCH---SHRILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 73/214 (34%), Positives = 107/214 (50%), Gaps = 47/214 (21%)
Query: 595 FSEENILGRGGFGTVYKG-ELHDGTKIAVKRM-----EAGV-ISGKGLTEFKSEIAVLTK 647
+ E +G G +GTVYK +L+ G +A+K++ E G+ +S EIA+L +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS------TLREIALLKQ 54
Query: 648 VR---HRHLVALL----GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 699
+ H ++V LL G D KL LVFE++ Q L+ ++ + GL P E + L
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPP-ETIKDL 112
Query: 700 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE-- 757
L RGV++LH +H +HRDLKP NIL+ D + K+ADFGL R+ S E
Sbjct: 113 MRQL--LRGVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLARIY-----SFEMA 162
Query: 758 -TRIAGTFGYLAPE------YAVHTRWSSCSYWA 784
T + T Y APE YA + W+
Sbjct: 163 LTSVVVTLWYRAPEVLLQSSYA-----TPVDMWS 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 22/164 (13%)
Query: 601 LGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG G FG V+ E + D +AVK ++ ++ + +F+ E +LT ++H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIV 70
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL-----KPLEWN------RRLTIAL 703
G C DG+ ++VFEYM G L++ + + + +P + + L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+A G+ Y LA Q F+HRDL N L+G ++ K+ DFG+ R
Sbjct: 131 QIASGMVY---LASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 9e-20
Identities = 59/179 (32%), Positives = 101/179 (56%), Gaps = 12/179 (6%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG+G FG V+ G + T++A+K ++ G +S + F E V+ K+RH LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 68
Query: 661 LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
+ E + +V EYM +G+L F E G K L + + +A +A G+ Y+ + +
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLD--FLKGEMG-KYLRLPQLVDMAAQIASGMAYVERM---N 122
Query: 720 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS 778
++HRDL+ +NIL+G+++ KVADFGL RL + + + + APE A++ R++
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 59/178 (33%), Positives = 85/178 (47%), Gaps = 27/178 (15%)
Query: 593 NNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
NN +G+G FG V++ T +AVK ++ S +F+ E A++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMA 63
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLK------------ 691
+ H ++V LLG C G L+FEYM G L+ RH A+ L
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 692 --PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
PL +L IA VA G+ YL + + F+HRDL N L+G++M K+ADFGL R
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 22/185 (11%)
Query: 592 TNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
+ +G G G VYK + G ++A+K+M + + +EI ++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKH 74
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTL----SRHIFNWAEEGLKPLEWNRRLTIALDVA 706
++V L G+E +V EYM G+L +++ E + + +V
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA--------YVCREVL 126
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIAGTFG 765
+G+EYLH Q+ IHRD+K NILL D K+ADFG +L E S + GT
Sbjct: 127 QGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--KSKRNSVVGTPY 181
Query: 766 YLAPE 770
++APE
Sbjct: 182 WMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 55/161 (34%), Positives = 85/161 (52%), Gaps = 19/161 (11%)
Query: 601 LGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG G FG V+ E + D +AVK ++ S +F E +LT ++H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIV 70
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA------EEGLKPLEW--NRRLTIALDVA 706
G C++G+ ++VFEYM G L++ + EG +P E ++ L IA +A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
G+ Y LA Q F+HRDL N L+G+++ K+ DFG+ R
Sbjct: 131 AGMVY---LASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 57/164 (34%), Positives = 81/164 (49%), Gaps = 27/164 (16%)
Query: 601 LGRGGFGTV--YKGE-LHDGTK--IAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLV 654
LG G FG V Y + +DGT +AVK ++ G+ T +K EI +L + H ++V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHENIV 69
Query: 655 ALLGHCLDGNEK--LLVFEYMPQGTL----SRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
G C + K L+ EY+P G+L +H N A+ L A + G
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ----------LLLFAQQICEG 119
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752
+ YLH Q +IHRDL N+LL +D K+ DFGL + PEG
Sbjct: 120 MAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 53/185 (28%), Positives = 76/185 (41%), Gaps = 31/185 (16%)
Query: 599 NILGRGGFGTVYKGE-LHDGTKIAVKRM------EAGVISGKGLTEFKSEIAVLTKVRHR 651
+G G +G VYK G +A+K++ E I+ EI +L K+RH
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPIT------AIREIKLLQKLRHP 58
Query: 652 HLVALLGHCLD--GNEKLLVFEYMP---QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
++V L +VFEYM G L + E +K +
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK--------CYMKQLL 110
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFG 765
G++YLH +HRD+K SNIL+ +D K+ADFGL R R+ T
Sbjct: 111 EGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLW 166
Query: 766 YLAPE 770
Y PE
Sbjct: 167 YRPPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 64/187 (34%), Positives = 91/187 (48%), Gaps = 15/187 (8%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG G FG V G+ +A+K ++ G +S EF E V+ K+ H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720
+V EYM G L N+ E K + ++ L + DV G+ YL + Q F
Sbjct: 69 TKQRPIYIVTEYMSNGCL----LNYLREHGKRFQPSQLLEMCKDVCEGMAYLE--SKQ-F 121
Query: 721 IHRDLKPSNILLGDDMRAKVADFGLVR--LAPEGKGSIETRIAGTFGYLAPEYAVHTRWS 778
IHRDL N L+ D KV+DFGL R L E S+ ++ + PE +++++S
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLYSKFS 179
Query: 779 SCS-YWA 784
S S WA
Sbjct: 180 SKSDVWA 186
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 62/170 (36%), Positives = 88/170 (51%), Gaps = 19/170 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGELH-DGTKI--AVKRMEAGVISGKGLTEFKSEIAVLTKV- 648
N+ ++++G G FG V K + DG ++ A+KRM+ S +F E+ VL K+
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLG 65
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTL------SRHI-----FNWAEEGLKPLEWNR 697
H +++ LLG C L EY P G L SR + F A L +
Sbjct: 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
L A DVARG++YL + + FIHRDL NIL+G++ AK+ADFGL R
Sbjct: 126 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 66/194 (34%), Positives = 100/194 (51%), Gaps = 13/194 (6%)
Query: 595 FSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRH 652
F +LG+GGFG V ++ K+ A K++E I KG +E +L KV R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 653 LVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
+V+L + + + L LV M G L HI+N G + R + A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF---DEERAVFYAAEITCGLED 117
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
LH + ++RDLKP NILL D +++D GL PEG+ +I R+ GT GY+APE
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIRGRV-GTVGYMAPEV 172
Query: 772 AVHTRWS-SCSYWA 784
+ R++ S +W
Sbjct: 173 VKNERYTFSPDWWG 186
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 61/179 (34%), Positives = 99/179 (55%), Gaps = 12/179 (6%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG G FG V+ G + TK+AVK ++ G +S + E E ++ K+RH LV L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE---EAQIMKKLRHDKLVQL--YA 68
Query: 661 LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
+ E + +V EYM +G+L F EG + L+ + +A VA G+ Y+ + +
Sbjct: 69 VVSEEPIYIVTEYMSKGSLL--DFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---N 122
Query: 720 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS 778
+IHRDL+ +NIL+GD + K+ADFGL RL + + + + APE A++ R++
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 57/180 (31%), Positives = 103/180 (57%), Gaps = 14/180 (7%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG+G FG V+ G + TK+A+K ++ G + + F E ++ K+RH LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPL--YA 68
Query: 661 LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGL-KPLEWNRRLTIALDVARGVEYLHGLAHQ 718
+ E + +V E+M +G+L ++ +EG K L+ + + +A +A G+ Y+ +
Sbjct: 69 VVSEEPIYIVTEFMGKGSL----LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM--- 121
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS 778
++IHRDL+ +NIL+GD++ K+ADFGL RL + + + + APE A++ R++
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 57/191 (29%), Positives = 88/191 (46%), Gaps = 15/191 (7%)
Query: 601 LGRGGFGTVYKGELHDGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
LG G FG V +GE +AVK +++ +S + +F E A++ + H +L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRL 61
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
G L + V E P G+L ++ L + A+ +A G+ YL
Sbjct: 62 YGVVLTHPLMM-VTELAPLGSLLD---RLRKDALGHFLISTLCDYAVQIANGMRYLE--- 114
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG--SIETRIAGTFGYLAPEYAVH 774
+ FIHRDL NILL D + K+ DFGL+R P+ + +E + F + APE
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 775 TRWSSCS-YWA 784
+S S W
Sbjct: 175 RTFSHASDVWM 185
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 61/181 (33%), Positives = 82/181 (45%), Gaps = 22/181 (12%)
Query: 599 NILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
N +G G FG VY L G +AVK + K + E E+ VL ++H +LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 658 G---HCLDGNEKLLVF-EYMPQGTLSRHIFNWAEEG-LKPLEWNRRLTIALDVARGVEYL 712
G H EK+ +F EY GTL E G + R T+ L G+ YL
Sbjct: 66 GVEVH----REKVYIFMEYCSGGTLEE----LLEHGRILDEHVIRVYTLQL--LEGLAYL 115
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGK--GSIETRIAGTFGYLAP 769
H +HRD+KP+NI L + K+ DFG V+L G +AGT Y+AP
Sbjct: 116 H---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
Query: 770 E 770
E
Sbjct: 173 E 173
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 56/188 (29%), Positives = 87/188 (46%), Gaps = 28/188 (14%)
Query: 601 LGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG+G FG VY+G T++A+K + + + EF +E +V+ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEASVMKEFNCHHVV 72
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
LLG G L+V E M +G L SR GL P + + +A ++A G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-------PEGKGSIETRIAG 762
YL F+HRDL N ++ +D+ K+ DFG+ R GKG + R
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 763 TFGYLAPE 770
++APE
Sbjct: 187 ---WMAPE 191
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 60/191 (31%), Positives = 94/191 (49%), Gaps = 20/191 (10%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVK--RMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
+G+G FG VYKG L T++AVK R + +F E +L + H ++V L+G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRST---LPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
C+ +V E +P G+L + L + L ++LD A G+EYL +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNR----LTVKKLLQMSLDAAAGMEYLES---K 112
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT----FGYLAPEYAVH 774
+ IHRDL N L+G++ K++DFG+ R E +G I T G + APE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 775 TRWSS-CSYWA 784
R++S W+
Sbjct: 170 GRYTSESDVWS 180
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 7e-19
Identities = 56/187 (29%), Positives = 84/187 (44%), Gaps = 40/187 (21%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS--------EIAVLTKV-RH 650
LG G FG+VY G +A+K+M+ +F S E+ L K+ H
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK---------KKFYSWEECMNLREVKSLRKLNEH 57
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
++V L + +E VFEYM +G L + + + KP + +I + +G+
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYM-EGNLYQLM---KDRKGKPFSESVIRSIIYQILQGLA 113
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
++H F HRDLKP N+L+ K+ADFGL R I +R T +
Sbjct: 114 HIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYT------D 157
Query: 771 YAVHTRW 777
Y V TRW
Sbjct: 158 Y-VSTRW 163
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 13/194 (6%)
Query: 594 NFSEENILGRGGFGTVYKGELHDGTKI-AVKRM-EAGVISGKGLTEFKSEIAVLTKVRHR 651
+F ++G+G FG V + D K+ A+K M + + + +E +L ++ H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
LV L D LV + + G L H+ + +K E + I ++ +EY
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKFWIC-EIVLALEY 115
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
LH + IHRD+KP NILL + + DF + + T +GT GY+APE
Sbjct: 116 LH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST--SGTPGYMAPEV 170
Query: 772 AVHTRWSSCS-YWA 784
+S +W+
Sbjct: 171 LCRQGYSVAVDWWS 184
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 62/191 (32%), Positives = 99/191 (51%), Gaps = 20/191 (10%)
Query: 601 LGRGGFGTVYK---GELHDGTK--IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 655
LG+G FG+V L D T +AVK+++ + + L +F+ EI +L ++H ++V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVK 69
Query: 656 LLGHCLD-GNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
G C G L LV EY+P G+L ++ E L+ + L A + +G+EYL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER----LDHRKLLLYASQICKGMEYL- 124
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG---TFGYLAPE 770
+ ++HRDL NIL+ + R K+ DFGL ++ P+ K + R G F Y APE
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APE 181
Query: 771 YAVHTRWSSCS 781
+++S S
Sbjct: 182 SLTESKFSVAS 192
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 64/193 (33%), Positives = 89/193 (46%), Gaps = 31/193 (16%)
Query: 599 NILGRGGFGTVYKG----ELHDGT---KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
N LG G FG VY+G L G+ ++AVK + G + EF E +++ H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNHP 59
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP--LEWNRRLTIALDVARGV 709
++V LLG CL + ++ E M G L ++ + E P L L I LDVA+G
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 710 EYLHGLAHQSFIHRDLKPSNILL----GDDMR-AKVADFGLVR-------LAPEGKGSIE 757
YL + FIHRDL N L+ D R K+ DFGL R EG+G +
Sbjct: 120 VYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 758 TRIAGTFGYLAPE 770
R ++APE
Sbjct: 177 VR------WMAPE 183
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 63/194 (32%), Positives = 97/194 (50%), Gaps = 12/194 (6%)
Query: 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRH 652
F +LG+GGFG V ++ G A K++E I KG +E +L KV R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 653 LVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
+V+L + + + L LV M G L HI+N G + R + A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF---DEQRAIFYAAELCCGLED 117
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
L + ++RDLKP NILL D +++D GL PEG+ ++ R+ GT GY+APE
Sbjct: 118 LQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TVRGRV-GTVGYMAPEV 172
Query: 772 AVHTRWSSCSYWAG 785
+ +++ W G
Sbjct: 173 INNEKYTFSPDWWG 186
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 61/188 (32%), Positives = 94/188 (50%), Gaps = 13/188 (6%)
Query: 601 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGK-GLTEFKSEIAVLTKVRHRHLVALLG 658
LG+GGFG V ++ K+ A K+++ + + G +E +L KV R +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 659 HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
+ + + L LV M G L HI+N E G R + A + G+E+LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPE---ARAIFYAAQIICGLEHLH---Q 113
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRW 777
+ ++RDLKP N+LL D +++D GL GK I+ R AGT GY+APE +
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-KIKGR-AGTPGYMAPEVLQGEVY 171
Query: 778 S-SCSYWA 784
S ++A
Sbjct: 172 DFSVDWFA 179
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 54/183 (29%), Positives = 88/183 (48%), Gaps = 19/183 (10%)
Query: 599 NILGRGGFGTVYK-GELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+G+G FGTV K DG + K ++ G ++ K + SE+ +L +++H ++V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 658 GHCLD-GNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLE----WN--RRLTIALDVARGV 709
+D N+ L +V EY G L++ I +E K +E W +L +AL
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER-KYIEEEFIWRILTQLLLALY----- 119
Query: 710 EYLHGLAH--QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
H + + +HRDLKP+NI L + K+ DFGL ++ S GT Y+
Sbjct: 120 -ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS-SFAKTYVGTPYYM 177
Query: 768 APE 770
+PE
Sbjct: 178 SPE 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 53/172 (30%), Positives = 88/172 (51%), Gaps = 15/172 (8%)
Query: 601 LGRGGFGTVYKGELHDGT---KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
LG G FG+V +G+L+ K+AVK M+ + + + +F SE + + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 658 GHCLDGNEK------LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL--DVARGV 709
G CL E +++ +M G L + ++ G P ++ + D+A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 761
EYL + +SFIHRDL N +L ++M VADFGL + G + RIA
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA 174
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 15/185 (8%)
Query: 592 TNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEA-GVISGKGLTEFKSEIAVLTKVR 649
NF E +G+G F VYK L DG +A+K+++ ++ K + EI +L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
H +++ L ++ NE +V E G LSR I ++ ++ + + + + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTIWKYFVQLCSAL 119
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA----GTFG 765
E++H + +HRD+KP+N+ + K+ D GL R S +T A GT
Sbjct: 120 EHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPY 171
Query: 766 YLAPE 770
Y++PE
Sbjct: 172 YMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 9e-18
Identities = 51/147 (34%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG G FG V+ G+ K+A+K + G +S + +F E V+ K+ H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720
+V E+M G L N+ + L + L++ DV G+EYL SF
Sbjct: 69 TQQKPLYIVTEFMENGCL----LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSF 121
Query: 721 IHRDLKPSNILLGDDMRAKVADFGLVR 747
IHRDL N L+ KV+DFG+ R
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 9e-18
Identities = 53/161 (32%), Positives = 78/161 (48%), Gaps = 32/161 (19%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISG--KGL--TEFKSEIAVLTKVRHRHLVA 655
LG G + VYK G +A+K+++ G G+ T + EI +L +++H +++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNIIG 66
Query: 656 LL---GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVA 706
LL GH N LVFE+M L + I + + LT L
Sbjct: 67 LLDVFGH--KSNIN-LVFEFME-TDLEKVIKD----------KSIVLTPADIKSYMLMTL 112
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
RG+EYLH +HRDLKP+N+L+ D K+ADFGL R
Sbjct: 113 RGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 55/178 (30%), Positives = 83/178 (46%), Gaps = 15/178 (8%)
Query: 595 FSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
F LG G +G+VYK +H G +A+K + + L E EI++L + +
Sbjct: 5 FDILEKLGEGSYGSVYKA-IHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSPY 59
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V G + +V EY G++S I + L E I +G+EYL
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVS-DIMKITNKTLTEEEIA---AILYQTLKGLEYL 115
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
H IHRD+K NILL ++ +AK+ADFG+ + T I GT ++APE
Sbjct: 116 H---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPE 169
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 52/155 (33%), Positives = 76/155 (49%), Gaps = 15/155 (9%)
Query: 599 NILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
++G+G FG VY G L D AVK + + + + +F E ++ H +++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR-ITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 655 ALLGHCLDGN-EKLLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTIALDVARGVEYL 712
+LLG CL L+V YM G L I + +K L + L VA+G+EYL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL 114
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
A + F+HRDL N +L + KVADFGL R
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 61/192 (31%), Positives = 94/192 (48%), Gaps = 21/192 (10%)
Query: 601 LGRGGFGTV------YKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG+GGFG V G+++ K+ KR++ SG+ + + EI L KV +V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK--SGEKMALLEKEI--LEKVNSPFIV 56
Query: 655 ALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
L + + L LV M G L HI+N E GL E R + + + G+ +LH
Sbjct: 57 NL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL---EMERVIHYSAQITCGILHLH 112
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV 773
+ ++RD+KP N+LL D +++D GL +GK T+ AGT GY+APE
Sbjct: 113 SM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI--TQRAGTNGYMAPEILK 167
Query: 774 HTRWS-SCSYWA 784
+S ++A
Sbjct: 168 EEPYSYPVDWFA 179
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 58/182 (31%), Positives = 91/182 (50%), Gaps = 8/182 (4%)
Query: 600 ILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
+LG+G FG V+KG L D T +AVK + + + +F SE +L + H ++V L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLIGV 60
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
C +V E +P G + +E L+ + + ALD A G+ YL ++
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE----LKTKQLVKFALDAAAGMAYLES---KN 113
Query: 720 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWSS 779
IHRDL N L+G++ K++DFG+ R +G S + APE + R+SS
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 780 CS 781
S
Sbjct: 174 ES 175
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 52/152 (34%), Positives = 78/152 (51%), Gaps = 16/152 (10%)
Query: 601 LGRGGFGTVYKG--ELHDGTKI--AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
LG G FG+V KG + G ++ AVK ++ I+ G EF E +V+ ++ H +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA-GKKEFLREASVMAQLDHPCIVRL 61
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAE-EGLKPLEWNRRLTIALDVARGVEYLHGL 715
+G C G +LV E P G L +++ E E A VA G+ YL
Sbjct: 62 IGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES- 113
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ F+HRDL N+LL + +AK++DFG+ R
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 53/160 (33%), Positives = 75/160 (46%), Gaps = 22/160 (13%)
Query: 600 ILGRGGFGTVYKG---ELHDGTKI--AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
+LG G FGTVYKG + KI A+K + S K E E V+ V H H+V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVV 72
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE--GLKPLEWNRRLTIALDVARGVEYL 712
LLG CL ++ L+ + MP G L ++ N + L W + +A+G+ YL
Sbjct: 73 RLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125
Query: 713 --HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750
L +HRDL N+L+ K+ DFGL +L
Sbjct: 126 EEKRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLLD 160
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 59/224 (26%), Positives = 84/224 (37%), Gaps = 49/224 (21%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKV-R 649
++F I+G G F TV E + A+K ++ +I K + K E VLT++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 650 HRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR- 707
H ++ L D E L V EY P G L ++I + ++ R
Sbjct: 61 HPGIIKLYYTFQD-EENLYFVLEYAPNGELLQYI-------------RKYGSLDEKCTRF 106
Query: 708 -------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRI 760
+EYLH IHRDLKP NILL DM K+ DFG ++ +
Sbjct: 107 YAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 761 A-------------------GTFGYLAPEYAVHTRWS-SCSYWA 784
GT Y++PE S WA
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWA 207
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 50/149 (33%), Positives = 87/149 (58%), Gaps = 12/149 (8%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG G FG V+ G + TK+A+K ++ G +S + F +E ++ +++H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---FLAEANLMKQLQHPRLVRL--YA 68
Query: 661 LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
+ E + ++ EYM G+L F EG+K L N+ + +A +A G+ ++ ++
Sbjct: 69 VVTQEPIYIITEYMENGSLVD--FLKTPEGIK-LTINKLIDMAAQIAEGMAFIE---RKN 122
Query: 720 FIHRDLKPSNILLGDDMRAKVADFGLVRL 748
+IHRDL+ +NIL+ + + K+ADFGL RL
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 38/199 (19%)
Query: 595 FSEENILGRGGFGTVYKG---ELHDGTKIAVKRMEAGVISGKGLTEFKS---EIAVLTKV 648
+ E +GRG +G VYK DG + A+K+ + G+++ S EIA+L ++
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQ--SACREIALLREL 59
Query: 649 RHRHLVALLGHCLDGNEKL--LVFEYMPQGTLSRHIFNWAEEG---------LKPLEWNR 697
+H ++V+L+ L+ +K L+F+Y I + + +K L W
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLW--QIIKFHRQAKRVSIPPSMVKSLLWQ- 116
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDM---RAKVADFGLVRL--APE 751
+ GV YLH +HRDLKP+NIL+ G+ K+ D GL RL AP
Sbjct: 117 -------ILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 752 GKGSIETRIAGTFGYLAPE 770
+ + T Y APE
Sbjct: 167 KPLADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 54/166 (32%), Positives = 77/166 (46%), Gaps = 22/166 (13%)
Query: 600 ILGRGGFGTVYKGEL-----HDGT-KIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRH 652
LG G FG V K E + T +AVK M + K L++ SE+ ++ + +H++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVK-MLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLT------I 701
++ LLG C +V EY G L +R P LT
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
A VARG+E+L A + IHRDL N+L+ +D K+ADFGL R
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 53/166 (31%), Positives = 88/166 (53%), Gaps = 18/166 (10%)
Query: 595 FSEENILGRGGFGTVYKGEL--HDGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
F+ +LG+G FG+V + +L DG+ K+AVK ++A + S + EF E A + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 651 RHLVALLGHCLDGNEK------LLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTI-- 701
+++ L+G L K +++ +M G L H F G +P + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL--HTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+D+A G+EYL + ++FIHRDL N +L ++M VADFGL +
Sbjct: 119 MIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 21/193 (10%)
Query: 598 ENILGRGGFGTVYKGELHDGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
E ++G G FG V +G L K +A+K ++AG S K +F +E +++ + H ++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNI 67
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
+ L G +++ EYM G+L + + + + + + +A G++YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYL- 122
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR-----IAGTFGYLA 768
+ +++HRDL NIL+ ++ KV+DFGL R + + + T+ I T A
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----A 176
Query: 769 PEYAVHTRWSSCS 781
PE + +++S S
Sbjct: 177 PEAIAYRKFTSAS 189
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 51/183 (27%), Positives = 77/183 (42%), Gaps = 17/183 (9%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRM----EAGVISGKGLTEFKSEIAVLTK 647
N + ++G G +G V K G +A+K+ + + L E+ VL +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL----REVKVLRQ 56
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+RH ++V L LVFEY+ + L + + GL P + R L +
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLL--ELLEASPGGLPP-DAVRSYIWQL--LQ 111
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
+ Y H + IHRD+KP NIL+ + K+ DFG R S T T Y
Sbjct: 112 AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYR 168
Query: 768 APE 770
APE
Sbjct: 169 APE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 59/181 (32%), Positives = 89/181 (49%), Gaps = 27/181 (14%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVRHRHLVAL 656
+G G +G VYK ++ G +A+K VI G + EI++L + RH ++VA
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIK-----VIKLEPGDDFEIIQQEISMLKECRHPNIVAY 65
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL---DVARGVEYLH 713
G L ++ +V EY G+L I+ PL L IA + +G+ YLH
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQ-DIYQ---VTRGPLS---ELQIAYVCRETLKGLAYLH 118
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFGYLAPEY 771
IHRD+K +NILL +D K+ADFG ++ + +I R GT ++APE
Sbjct: 119 ---ETGKIHRDIKGANILLTEDGDVKLADFG---VSAQLTATIAKRKSFIGTPYWMAPEV 172
Query: 772 A 772
A
Sbjct: 173 A 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 57/181 (31%), Positives = 97/181 (53%), Gaps = 28/181 (15%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKG---LTEFKSEIAVLTKVRHRHLVAL 656
LG G FG+VY+G L DG AVK + G + + + EIA+L+K++H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 657 LGHCLDGNEKLLVF-EYMPQGTLSRHI--FNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
LG + + L +F E +P G+L++ + + E + L + R++ + G+EYLH
Sbjct: 68 LGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL-YTRQILL------GLEYLH 119
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA----GTFGYLAP 769
++ +HRD+K +NIL+ + K+ADFG+ K +E A G+ ++AP
Sbjct: 120 D---RNTVHRDIKGANILVDTNGVVKLADFGM------AKQVVEFSFAKSFKGSPYWMAP 170
Query: 770 E 770
E
Sbjct: 171 E 171
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 49/160 (30%), Positives = 72/160 (45%), Gaps = 15/160 (9%)
Query: 599 NILGRGGFGTVYKGEL----HDGTKIAVK-RMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
LG G FG VY+G D ++ V + S + ++F E +++K H+++
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
V L+G + + ++ E M G L R E L L A DVA+G +
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERP-SSLTMKDLLFCARDVAKGCK 130
Query: 711 YLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVR 747
YL FIHRD+ N LL G AK+ADFG+ R
Sbjct: 131 YLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 65/193 (33%), Positives = 90/193 (46%), Gaps = 25/193 (12%)
Query: 587 VLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RM--EAGVISGKGLTEFKSE 641
R+VT F + N +G G +G VY+ + G +A+K RM E I L E
Sbjct: 2 RCRSVTE-FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL----RE 56
Query: 642 IAVLTKVRHRHLVALL----GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNR 697
I +L +RH ++V L G LD LV EY Q L+ + N P ++
Sbjct: 57 ITLLLNLRHPNIVELKEVVVGKHLD--SIFLVMEYCEQ-DLASLLDNMP----TPFSESQ 109
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 757
+ L + RG++YLH IHRDLK SN+LL D K+ADFGL R +
Sbjct: 110 VKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166
Query: 758 TRIAGTFGYLAPE 770
++ T Y APE
Sbjct: 167 PKVV-TLWYRAPE 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 23/208 (11%)
Query: 595 FSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
F EE LG FG +YKG L+ D ++ + + + + EF+ E +++ ++ H
Sbjct: 9 FMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH 66
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA----------EEGL--KPLEWNRR 698
++V LLG ++FEY+ QG L + + E+G L+
Sbjct: 67 PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 699 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIE 757
L IA+ +A G+EYL + F+H+DL NIL+G+ + K++D GL R + ++
Sbjct: 127 LHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 758 TRIAGTFGYLAPEYAVHTRWSSCS-YWA 784
+ ++ PE ++ ++SS S W+
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWS 211
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 55/164 (33%), Positives = 83/164 (50%), Gaps = 17/164 (10%)
Query: 598 ENILGRGGFGTVYKGELH-DGTKI-AVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLV 654
E+++G G FG V + + DG K+ A +M S +F E+ VL K+ H +++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTL------SRHI-----FNWAEEGLKPLEWNRRLTIAL 703
LLG C + + EY P G L SR + F L + L A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
DVA G++YL + + FIHRDL N+L+G+++ +K+ADFGL R
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 30/200 (15%)
Query: 601 LGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALL 657
+ +G +G V+ + T A+K ++ + K + +E +L++ + ++V L
Sbjct: 1 ISKGAYGRVFLAK-KKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSR--HIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
+ G + L LV EY+P G L+ +E + R+ IA ++ +EYLH
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA------RIYIA-EIVLALEYLHS 111
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLV------RLAPEGKGSIET-RIAGTFGYL 767
IHRDLKP NIL+ + K+ DFGL R E RI GT Y+
Sbjct: 112 N---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 768 APEYAV---HTRWSSCSYWA 784
APE + H++ + +W+
Sbjct: 169 APEVILGQGHSK--TVDWWS 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 59/191 (30%), Positives = 82/191 (42%), Gaps = 36/191 (18%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
++F LG G FG V K A+K + A ++ K + +E +L +RH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--- 707
LV L G D + LV EY+P G L F+ L + R VAR
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGEL----FSH-------LRKSGRFP--EPVARFYA 107
Query: 708 -----GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--- 759
+EYLH ++RDLKP N+LL D K+ DFG + ++ R
Sbjct: 108 AQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR-------VKGRTYT 157
Query: 760 IAGTFGYLAPE 770
+ GT YLAPE
Sbjct: 158 LCGTPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 60/178 (33%), Positives = 85/178 (47%), Gaps = 19/178 (10%)
Query: 601 LGRGGFGTVY------KGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG+GGFG V G+L+ K+ KR++ KG E +L KV R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK----KRKGYEGAMVEKRILAKVHSRFIV 56
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
+L + LV M G L HI+N EE R + G+E+LH
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEEN-PGFPEPRACFYTAQIISGLEHLH- 114
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETR-IAGTFGYLAPE 770
+ I+RDLKP N+LL +D +++D GL V L G +T+ AGT G++APE
Sbjct: 115 --QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELK---DGQSKTKGYAGTPGFMAPE 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 49/170 (28%), Positives = 89/170 (52%), Gaps = 9/170 (5%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG G FG V+ G ++ TK+AVK ++ G +S + F E ++ ++H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720
++ EYM +G+L F ++EG K + + + + +A G+ Y+ +++
Sbjct: 71 TKEEPIYIITEYMAKGSLLD--FLKSDEGGK-VLLPKLIDFSAQIAEGMAYIE---RKNY 124
Query: 721 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
IHRDL+ +N+L+ + + K+ADFGL R+ + + + + APE
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 56/181 (30%), Positives = 94/181 (51%), Gaps = 17/181 (9%)
Query: 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAG----VISGKGLTEFKSEIAVLTKVRHRHLV 654
+LG+G +GTVY G + G IAVK++E + + K + + E+ +L ++H ++V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
LG CLD N + E++P G++S + + G P + T + GV YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRF---GPLPEPVFCKYT--KQILDGVAYLH- 119
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-RLAPEG----KGSIETRIAGTFGYLAP 769
+ +HRD+K +N++L + K+ DFG RLA G ++ + GT ++AP
Sbjct: 120 --NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 770 E 770
E
Sbjct: 178 E 178
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 55/185 (29%), Positives = 86/185 (46%), Gaps = 16/185 (8%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKV 648
N+ +LG+G FG VY ++ G ++AVK++ S K + + EI +L +
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 649 RHRHLVALLGHCLDGNEKLLVF-EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+H +V G CL +E L +F EYMP G++ + + L +
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILE 115
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV-RL-APEGKGSIETRIAGTFG 765
GVEYLH +HRD+K +NIL K+ DFG RL G+ + GT
Sbjct: 116 GVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172
Query: 766 YLAPE 770
+++PE
Sbjct: 173 WMSPE 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 28/180 (15%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRM----EAGVISGKGLTEFKSEIAVLTKVRHRHLVA 655
+G G +G VYK + G +A+K++ E+ I L E K L ++ H +++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKL----LKELNHPNIIK 62
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY--LH 713
LL + LVFE+M + L L +R+ + + + Y L
Sbjct: 63 LLDVFRHKGDLYLVFEFM-------------DTDLYKLIKDRQRGLPESLIKSYLYQLLQ 109
Query: 714 GLAH---QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
GLA +HRDLKP N+L+ + K+ADFGL R T T Y APE
Sbjct: 110 GLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTRWYRAPE 168
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 54/171 (31%), Positives = 80/171 (46%), Gaps = 16/171 (9%)
Query: 603 RGGFGTVYKGELH-DGTKIAVKRM-EAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
+G FG+VY + G A+K + ++ +I+ +T K+E A++ VA L +
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 661 LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
+ L LV EY+ G + I G P +W + +V GVE LH +
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAK--QYIAEVVLGVEDLHQ---RG 117
Query: 720 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
IHRD+KP N+L+ K+ DFGL R G + GT YLAPE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPE 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 28/188 (14%)
Query: 601 LGRGGFGTVY----KGELHDG--TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG+G FG VY KG + D T++A+K + S + EF +E +V+ + H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 72
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE-----GLKPLEWNRRLTIALDVARGV 709
LLG G L++ E M +G L ++ + E P + + +A ++A G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE-------GKGSIETRIAG 762
YL+ F+HRDL N ++ +D K+ DFG+ R E GKG + R
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 763 TFGYLAPE 770
+++PE
Sbjct: 187 ---WMSPE 191
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 7/148 (4%)
Query: 601 LGRGGFGTVYKGELHDGTKIA---VKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+G G FG V GE H G A VK + A + L F E+ ++ H +++ L
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL-FLQEVQPYRELNHPNVLQCL 61
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
G C++ LLV E+ P G L ++ + + + + +A +VA G+ +LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-- 119
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGL 745
FIH DL N L D+ K+ D+GL
Sbjct: 120 -DFIHSDLALRNCQLTADLSVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 23/157 (14%)
Query: 595 FSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI----SGKGLTEFKSEIAVLTKVR 649
F+ +G+G FG VYK + +A+K VI + + + + EI L++ R
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIK-----VIDLEEAEDEIEDIQQEIQFLSQCR 57
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP--LEWNRRLTIALDVAR 707
++ G L G++ ++ EY G+ + LKP L+ I +V
Sbjct: 58 SPYITKYYGSFLKGSKLWIIMEYCGGGSCL--------DLLKPGKLDETYIAFILREVLL 109
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744
G+EYLH + IHRD+K +NILL ++ K+ADFG
Sbjct: 110 GLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFG 143
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 48/173 (27%), Positives = 75/173 (43%), Gaps = 29/173 (16%)
Query: 600 ILGRGGFGTVYKGE------LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
LG G FG V K T +AVK ++ S + L + SE +L +V H H+
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNLLKQVNHPHV 65
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTL-------------------SRHIFNWAEEGLKPLE 694
+ L G C LL+ EY G+L +R+ + L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 695 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
++ A ++RG++YL A +HRDL N+L+ + + K++DFGL R
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 29/177 (16%)
Query: 594 NFSEENILGRGGFGTVYKGELHDGTKI-----------------AVKRMEAGVISGKGLT 636
NF E+ LG G FG V+ E AVK +
Sbjct: 8 NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN-ARE 64
Query: 637 EFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL----SRHIF--NWAEEGL 690
+F E+ +L+++ ++ LLG C ++ EYM G L +H+ +
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
K L ++ L +A +A G+ YL L +F+HRDL N L+G + K+ADFG+ R
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 53/201 (26%), Positives = 101/201 (50%), Gaps = 26/201 (12%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
++ +++ ++G G FG V++G L + +A+K ++ G + K +F SE +++ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQF 63
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
H +++ L G +++ EYM G L +++ + E + L +A G
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQLVGMLR---GIAAG 119
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA---PEGK-----GSIETRI 760
++YL + +++HRDL NIL+ ++ KV+DFGL R+ PEG G I R
Sbjct: 120 MKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR- 175
Query: 761 AGTFGYLAPEYAVHTRWSSCS 781
+ APE + +++S S
Sbjct: 176 -----WTAPEAIAYRKFTSAS 191
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 592 TNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
+ E +LG+G +G VY +L +IA+K + + + EIA+ + ++H
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIP--ERDSRYVQPLHEEIALHSYLKH 64
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN-WAEEGLKPLEWNRRLTIAL---DVA 706
R++V LG + + E +P G+LS + + W PL+ N + TI +
Sbjct: 65 RNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG-----PLKDNEQ-TIIFYTKQIL 118
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLV-RLAPEGKGSIETRIAGTF 764
G++YLH +HRD+K N+L+ K++DFG RLA G GT
Sbjct: 119 EGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTETFTGTL 173
Query: 765 GYLAPE 770
Y+APE
Sbjct: 174 QYMAPE 179
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 55/198 (27%), Positives = 97/198 (48%), Gaps = 24/198 (12%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKIAVKRM----EAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG G F + Y+ ++ GT +AVK++ + + + EI ++ ++ H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 655 ALLGH-CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
+LG C D + L V E+M G++S + + + + + RG+ YLH
Sbjct: 67 RMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLH 120
Query: 714 GLAHQSFIHRDLKPSNILL---GDDMRAKVADFG-LVRLAPE--GKGSIETRIAGTFGYL 767
IHRD+K +N+L+ G +R +ADFG RLA + G G + ++ GT ++
Sbjct: 121 ---ENQIIHRDVKGANLLIDSTGQRLR--IADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 768 APEYAVHTRWS-SCSYWA 784
APE ++ SC W+
Sbjct: 176 APEVLRGEQYGRSCDVWS 193
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 51/171 (29%), Positives = 77/171 (45%), Gaps = 38/171 (22%)
Query: 595 FSEENILGRGGFGTVYKG-ELHDGTKI----AVKRMEAGVISGKGLTEFKSEIAVLTKVR 649
F + +LG G FGTVYKG + +G K+ A+K + S K E E V+ V
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVD 67
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTL------------SRHIFNWAEEGLKPLEWNR 697
+ H+ LLG CL +L+ + MP G L S+++ NW
Sbjct: 68 NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWC----------- 115
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748
+ +A+G+ YL + +HRDL N+L+ K+ DFGL +L
Sbjct: 116 -----VQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 61/201 (30%), Positives = 90/201 (44%), Gaps = 31/201 (15%)
Query: 601 LGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
LG+G FG VY+G D T++AVK + S + EF +E +V+ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVV 72
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE-----GLKPLEWNRRLTIALDVARGV 709
LLG G L+V E M G L ++ + E G P + +A ++A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE-------GKGSIETRIAG 762
YL+ + F+HRDL N ++ D K+ DFG+ R E GKG + R
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 763 TFGYLAPEY---AVHTRWSSC 780
++APE V T S
Sbjct: 187 ---WMAPESLKDGVFTTSSDM 204
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 16/179 (8%)
Query: 599 NILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
++G G VY L + K+A+KR++ + E + E+ +++ H ++V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 658 GHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
+ G+E LV Y+ G+L + + L+ T+ +V +G+EYLH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPR-----GGLDEAIIATVLKEVLKGLEYLHS 120
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETR--IAGTFGYLAPE 770
IHRD+K NILLG+D K+ADFG+ LA G + + R GT ++APE
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-14
Identities = 55/172 (31%), Positives = 77/172 (44%), Gaps = 33/172 (19%)
Query: 617 GTKIAVKRMEAGVISGKGL-TEFKSEIAVLTKVRHRHLVALL--GHCLDGNEKLL--VFE 671
G ++A+K + + F+ E A+ ++ H ++VALL G G LL VFE
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG---LLFAVFE 59
Query: 672 YMPQGTLSRHIFNWAEEG-LKPLEWNRRLTIALDVARGVEYLHGLAH---QSFIHRDLKP 727
Y+P TL + A +G L E R + LD LA Q +HRDLKP
Sbjct: 60 YVPGRTLREVL---AADGALPAGETGRLMLQVLD---------ALACAHNQGIVHRDLKP 107
Query: 728 SNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIA------GTFGYLAPE 770
NI++ G AKV DFG+ L P + + + GT Y APE
Sbjct: 108 QNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 62/197 (31%), Positives = 94/197 (47%), Gaps = 28/197 (14%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEA-GVISGKGLTEFKSEIAVLT 646
R V F +G G +G VYK D G +A+K++ G +T + EI +L
Sbjct: 4 RCVDK-FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILR 61
Query: 647 KVRHRHLVALLGHCLDGNEKL----------LVFEYMPQ---GTLSRHIFNWAEEGLKPL 693
++ HR++V L D + L LVFEYM G L + +++E+ +K
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121
Query: 694 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753
++L L+ G+ Y H ++F+HRD+K SNILL + + K+ADFGL RL +
Sbjct: 122 M--KQL---LE---GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170
Query: 754 GSIETRIAGTFGYLAPE 770
T T Y PE
Sbjct: 171 SRPYTNKVITLWYRPPE 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 50/177 (28%), Positives = 87/177 (49%), Gaps = 33/177 (18%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGL----------------TEFKSEIAV 644
LG G FG V+ E+ + + + V G+ L +F E+ +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 645 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEG---------L 690
L++++ +++ LLG C+D + ++ EYM G L S H+ + E G L
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ ++ L +AL +A G++YL L +F+HRDL N L+G+++ K+ADFG+ R
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 58/163 (35%), Positives = 81/163 (49%), Gaps = 17/163 (10%)
Query: 599 NILGRGGFGTVYKGELH-DGTKI-AVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVA 655
+++G G FG V K + DG ++ A + S +F E+ VL K+ H +++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 656 LLGHCLDGNEKLLVFEYMPQGTL------SRHI-----FNWAEEGLKPLEWNRRLTIALD 704
LLG C L EY P G L SR + F A L + L A D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 705 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
VARG++YL + + FIHRDL NIL+G++ AK+ADFGL R
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 8/155 (5%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
NF + LG G + TVYKG G +A+K + G T + EI+++ +++H +
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V L N+ +LVFEYM + L +++ G L+ N + + +G+ +
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRG--ALDPNTVKSFTYQLLKGIAFC 116
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
H +HRDLKP N+L+ K+ADFGL R
Sbjct: 117 H---ENRVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 51/167 (30%), Positives = 85/167 (50%), Gaps = 24/167 (14%)
Query: 601 LGRGGFGTVYKGEL--------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHR 651
LG G FG V E + TK+AVK +++ + K L++ SE+ ++ + +H+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHK 84
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHI-----------FNWAEEGLKPLEWNRRLT 700
+++ LLG C ++ EY +G L ++ +N + + L + ++
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
A VARG+EYL A + IHRDL N+L+ +D K+ADFGL R
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
E LG G FG V+ + TK+AVK M+ G +S + F +E V+ ++H LV L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKL- 66
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLK-PLEWNRRLTIALDVARGVEYLHGL 715
H + E + ++ E+M +G+L F ++EG K PL + + + +A G+ ++
Sbjct: 67 -HAVVTKEPIYIITEFMAKGSLLD--FLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE-- 119
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+++IHRDL+ +NIL+ + K+ADFGL R+ + + + + APE
Sbjct: 120 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 56/190 (29%), Positives = 85/190 (44%), Gaps = 26/190 (13%)
Query: 601 LGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFK---SEIAVLTKVRHRHLVA 655
LG G G V K LH G +AVK + + K E+ +L K ++V
Sbjct: 9 LGAGNSGVVSKV-LHRPTGKIMAVKTIRLEINE----AIQKQILRELDILHKCNSPYIVG 63
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
G + + + EYM G+L + I + + P ++ +A V +G+ YLH
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRI-PERILGKIAVA--VLKGLTYLHEK 119
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE----- 770
IHRD+KPSNIL+ + K+ DFG+ + S+ GT Y+APE
Sbjct: 120 HK--IIHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFVGTSSYMAPERIQGN 174
Query: 771 -YAVHTR-WS 778
Y+V + WS
Sbjct: 175 DYSVKSDIWS 184
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 51/187 (27%), Positives = 93/187 (49%), Gaps = 19/187 (10%)
Query: 601 LGRGGFGTV----YKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 655
LG G FG V Y E + G ++AVK ++ G + + K EI +L + H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVK 70
Query: 656 LLGHCLD--GNEKLLVFEYMPQGTLSRHI-FNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
G C + GN L+ E++P G+L ++ N + LK L A+ + +G++YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQ-----LKYAVQICKGMDYL 125
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG--SIETRIAGTFGYLAPE 770
+ ++HRDL N+L+ + + K+ DFGL + K +++ + + APE
Sbjct: 126 ---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 771 YAVHTRW 777
+ +++
Sbjct: 183 CLIQSKF 189
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 49/173 (28%), Positives = 81/173 (46%), Gaps = 10/173 (5%)
Query: 600 ILGRGGFG--TVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+LG+G FG T+Y+ D + + K + +S K + +EI +L+ ++H +++A
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
H +D N L+ EY GTL I + + E L + V Y+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIH---K 119
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+HRD+K NI L K+ DFG+ ++ ET + GT Y++PE
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 56/177 (31%), Positives = 90/177 (50%), Gaps = 15/177 (8%)
Query: 600 ILGRGGFGTVYKGELHDGT---KI-AVKRMEAGVI--SGKGLTEFKSEIAVLTKVRHRHL 653
+LG+GG+G V++ G KI A+K ++ I + K K+E +L V+H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
V L+ G + L+ EY+ G L H+ EG+ +E ++ +++ +E+LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIF-MEDTACFYLS-EISLALEHLH 117
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
Q I+RDLKP NILL K+ DFGL + + G++ GT Y+APE
Sbjct: 118 ---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTVTHTFCGTIEYMAPE 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 24/167 (14%)
Query: 601 LGRGGFGTVYKGEL--------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHR 651
LG G FG V E + +AVK ++ + K L++ SE+ ++ + +H+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHK 81
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHI-----------FNWAEEGLKPLEWNRRLT 700
+++ LLG C ++ EY +G L ++ ++ A + + + ++
Sbjct: 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
VARG+EYL A Q IHRDL N+L+ ++ K+ADFGL R
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 14/164 (8%)
Query: 594 NFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
N E LGRG FG V+ + T + VK ++ +EF+ E+ + K
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK-TKDENLQSEFRRELDMFRK 64
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRH--IFNWAEEGLK--PLEWNRRLTIAL 703
+ H+++V LLG C + ++ EY G L + +E LK PL +++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+A G+++ L++ F+HRDL N L+ KV+ L +
Sbjct: 125 QIALGMDH---LSNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 53/194 (27%), Positives = 93/194 (47%), Gaps = 25/194 (12%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKG-------LTEFKSEIAVLTKVRHR 651
++G G FG+VY G G +AVK++E +S L EIA+L +++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA--EEGLKPLEWNRRLTIALDVARGV 709
++V LG LD + + EY+P G+++ + N+ EE L + +G+
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-------NFVRQILKGL 119
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-----LAPEGKGSIETRIAGTF 764
YLH ++ IHRD+K +NIL+ + K++DFG+ + + G+
Sbjct: 120 NYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 765 GYLAPEYAVHTRWS 778
++APE T ++
Sbjct: 177 FWMAPEVVKQTSYT 190
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 572 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI 630
D ++LE ++S+ + ++ +G+G GTVY ++ G ++A+K+M
Sbjct: 1 DEEILEKLRTIVSVG---DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ 57
Query: 631 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA-EEG 689
K L +EI V+ + +H ++V L L G+E +V EY+ G+L+ + +EG
Sbjct: 58 PKKEL--IINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG 115
Query: 690 LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRL 748
+ + + + +E+LH IHRD+K NILLG D K+ DFG ++
Sbjct: 116 -------QIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165
Query: 749 APEGKGSIETRIAGTFGYLAPEYAVHTR 776
PE S + + GT ++APE V TR
Sbjct: 166 TPE--QSKRSTMVGTPYWMAPE--VVTR 189
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 24/167 (14%)
Query: 601 LGRGGFGTVYKGEL--------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHR 651
LG G FG V E + +AVK ++ + K L++ SE+ ++ + +H+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHK 78
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHI-----------FNWAEEGLKPLEWNRRLT 700
+++ LLG C ++ EY +G L ++ F+ + + L + ++
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
A VARG+EYL A Q IHRDL N+L+ +D K+ADFGL R
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 55/189 (29%), Positives = 95/189 (50%), Gaps = 25/189 (13%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISG------KGLTE-FKSEIAVLTKVRH 650
++G+G +G VY + G +AVK++E I+G K + + +SEI L + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 651 RHLVALLGHCLDGNEKLLVF-EYMPQGTLSRHIFNWA--EEGLKPLEWNRRLTIALDVAR 707
++V LG E L +F EY+P G++ + + EE L R T V
Sbjct: 68 LNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV-----RFFT--EQVLE 119
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE-TRIAGTFGY 766
G+ YLH + +HRDLK N+L+ D K++DFG+ + + + + + + G+ +
Sbjct: 120 GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 767 LAPEYAVHT 775
+APE +H+
Sbjct: 177 MAPE-VIHS 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 52/153 (33%), Positives = 72/153 (47%), Gaps = 12/153 (7%)
Query: 600 ILGRGGFGTVYKG---ELHDGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRHLVA 655
+LG G FGTVYKG + KI V +G K EF E ++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
LLG CL +L V + MP G L ++ E + L + +A+G+ YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCL----LDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE-- 126
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748
+ +HRDL N+L+ K+ DFGL RL
Sbjct: 127 -ERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 17/174 (9%)
Query: 601 LGRGGFGTVYKGELHDGTKI--AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
LG G FG VYK + H T + A K ++ S + L +F EI +L++ +H ++V L
Sbjct: 13 LGDGAFGKVYKAQ-HKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
N+ ++ E+ G L + E + L + + + + +LH
Sbjct: 70 AYFYENKLWILIEFCDGGALD----SIMLELERGLTEPQIRYVCRQMLEALNFLH---SH 122
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFGYLAPE 770
IHRDLK NILL D K+ADFG ++ + K +++ R GT ++APE
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFG---VSAKNKSTLQKRDTFIGTPYWMAPE 173
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 60/194 (30%), Positives = 85/194 (43%), Gaps = 22/194 (11%)
Query: 600 ILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTE-FKSEIAVL---TKVRHRHLV 654
+LGRG FG V E G A+K ++ G I + E E + RH LV
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 655 ALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
L C + + V EY G L HI + +P R + A V G++YLH
Sbjct: 66 NLFA-CFQTEDHVCFVMEYAAGGDLMMHIH--TDVFSEP----RAVFYAACVVLGLQYLH 118
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET--RIAGTFGYLAPEY 771
++RDLK N+LL + K+ADFGL + EG G + GT +LAPE
Sbjct: 119 ---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFLAPEV 172
Query: 772 AVHTRWS-SCSYWA 784
T ++ + +W
Sbjct: 173 LTETSYTRAVDWWG 186
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 20/180 (11%)
Query: 600 ILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKS----EIAVLTKVRHRHLV 654
++G G +G V K + + G +A+K+ + + K EI +L ++RH +LV
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
L+ LVFE++ + + E+ L+ +R + RG+E+ H
Sbjct: 64 NLIEVFRRKKRLYLVFEFV-----DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH- 117
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAPEYAV 773
+ IHRD+KP NIL+ K+ DFG R LA G + T T Y APE V
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA--APGEVYTDYVATRWYRAPELLV 173
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 54/175 (30%), Positives = 77/175 (44%), Gaps = 21/175 (12%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE----FKSEIAVLTKVRHRHLVA 655
+G G FG VY ++ +A+K+M SGK E E+ L ++RH + +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMS---YSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
G L + LV EY G+ S + E KPL+ I +G+ YLH
Sbjct: 80 YKGCYLREHTAWLVMEYC-LGSASDIL----EVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
IHRD+K NILL + K+ADFG L + GT ++APE
Sbjct: 135 ER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 51/179 (28%), Positives = 91/179 (50%), Gaps = 16/179 (8%)
Query: 595 FSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
F++ +G+G FG VYKG + +A+K ++ + + + + EI VL++ ++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYI 64
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP--LEWNRRLTIALDVARGVEY 711
G L G + ++ EY+ G+ A + LKP LE TI ++ +G++Y
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGS--------ALDLLKPGPLEETYIATILREILKGLDY 116
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
LH + IHRD+K +N+LL + K+ADFG+ + + T + F ++APE
Sbjct: 117 LHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPE 171
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 50/155 (32%), Positives = 81/155 (52%), Gaps = 22/155 (14%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVK--RMEA---GVISGKGLTEFKSEIAVLTKVRHRHLV 654
+G G +G VYK + G +A+K R+E GV S T + EI++L ++ H ++V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPS----TAIR-EISLLKELNHPNIV 61
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL--TIALDVARGVEYL 712
LL N+ LVFE++ L +++ + GL + L + + +G+ Y
Sbjct: 62 RLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGL-----DPPLIKSYLYQLLQGIAYC 115
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
H H+ +HRDLKP N+L+ + K+ADFGL R
Sbjct: 116 HS--HR-VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 24/167 (14%)
Query: 601 LGRGGFGTVYKGELHDGTK--------IAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHR 651
LG G FG V + E + K +AVK ++ + K L + SE+ ++ + +H+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHK 78
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHI-----------FNWAEEGLKPLEWNRRLT 700
+++ LLG C ++ EY +G L + F+ + + L + ++
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
A VARG+EYL + IHRDL N+L+ +D K+ADFGL R
Sbjct: 139 CAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 8e-13
Identities = 59/191 (30%), Positives = 86/191 (45%), Gaps = 38/191 (19%)
Query: 594 NFSE---ENILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKG----LTEFKSEIAV 644
+ SE N +G G GTVYK +H T A+K VI G + EI +
Sbjct: 72 SLSELERVNRIGSGAGGTVYK-VIHRPTGRLYALK-----VIYGNHEDTVRRQICREIEI 125
Query: 645 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS-RHIFNWAEEGLKPLEWNRRLTIAL 703
L V H ++V E ++ E+M G+L HI E+ L
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI--ADEQFLA------------ 171
Query: 704 DVAR----GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR 759
DVAR G+ YLH + +HRD+KPSN+L+ K+ADFG+ R+ + +
Sbjct: 172 DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228
Query: 760 IAGTFGYLAPE 770
+ GT Y++PE
Sbjct: 229 V-GTIAYMSPE 238
|
Length = 353 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 53/178 (29%), Positives = 78/178 (43%), Gaps = 26/178 (14%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
+G G FG V+ + A+K M VI K +E VL +V H ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVARGVEYL 712
D ++ EY+P G L F++ L + R + A ++ +EYL
Sbjct: 69 TEHDQRFLYMLMEYVPGGEL----FSY-------LRNSGRFSNSTGLFYASEIVCALEYL 117
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
H ++RDLKP NILL + K+ DFG A + + T + GT YLAPE
Sbjct: 118 HSK---EIVYRDLKPENILLDKEGHIKLTDFG---FAKKLRDRTWT-LCGTPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 51/184 (27%), Positives = 83/184 (45%), Gaps = 22/184 (11%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVIS---GKGLTE-------FKSEIAVLTK-VR 649
LG G FG VYK + + + E V + GK E SE+ ++ + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLE---WNRRLTIALDVA 706
H ++V L+ + +V + + L H + E+ + E WN + + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL--- 124
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 766
+ YLH + +HRDL P+NI+LG+D + + DFGL + + S T + GT Y
Sbjct: 125 -ALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILY 179
Query: 767 LAPE 770
PE
Sbjct: 180 SCPE 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 59/192 (30%), Positives = 96/192 (50%), Gaps = 25/192 (13%)
Query: 601 LGRGGFGTVYKGELHDGT---KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+GRG +G VYK + DG + A+K++E IS EIA+L +++H +++AL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----REIALLRELKHPNVIALQ 64
Query: 658 GHCLDGNEK--LLVFEYMPQGTLSRHIFNW---AEEGLKPLEWNRRLTIAL--DVARGVE 710
L +++ L+F+Y HI + ++ KP++ R + +L + G+
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLW--HIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 711 YLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRL--APEGKGSIETRIAGTF 764
YLH +HRDLKP+NIL+ + R K+AD G RL +P + + TF
Sbjct: 123 YLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 765 GYLAPEYAVHTR 776
Y APE + R
Sbjct: 180 WYRAPELLLGAR 191
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 50/162 (30%), Positives = 75/162 (46%), Gaps = 14/162 (8%)
Query: 593 NNFSEENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
NN S LG G FG V + + K+AVK ++ S + SE+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER-EALMSELKIMS 93
Query: 647 KV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
+ H ++V LLG C G L++ EY G L + E L L+ + V
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQV 150
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
A+G+ +L A ++ IHRDL N+LL K+ DFGL R
Sbjct: 151 AKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 50/155 (32%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 600 ILGRGGFGTVYKG---ELHDGTKIAVKRMEAGVISGK-GLTEFKSEIAVLTKVRHRHLVA 655
+LG G FGTV+KG D KI V SG+ E + + + H ++V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
LLG C G LV + P G+L H+ + L P R L + +A+G+ YL
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHV-RQHRDSLDP---QRLLNWCVQIAKGMYYLE-- 126
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750
+HR+L NILL D ++ADFG+ L
Sbjct: 127 -EHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 58/191 (30%), Positives = 83/191 (43%), Gaps = 21/191 (10%)
Query: 601 LGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 658
LG GGFG V ++ A+K ++ I G E SE +L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 659 HCLDGNEKLLVF--EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+ ++K + EY G L I + GL E+ R IA V EYLH
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGEL-WTILR--DRGLFD-EYTARFYIAC-VVLAFEYLH--- 110
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV--- 773
++ I+RDLKP N+LL + K+ DFG + G GT Y+APE +
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL--KSGQKTWTFCGTPEYVAPEIILNKG 168
Query: 774 HTRWSSCSYWA 784
+ S YW+
Sbjct: 169 YDF--SVDYWS 177
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 11/185 (5%)
Query: 600 ILGRGGFGTVYKGELHD--GTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVAL 656
+G G FG VY+G KIAV + + E F E ++ + H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+G + N +V E P G L ++ L+ + + ++ + YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQVNKYS----LDLASLILYSYQLSTALAYLES-- 125
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
+ F+HRD+ N+L+ K+ DFGL R + ++ ++APE R
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 777 WSSCS 781
++S S
Sbjct: 185 FTSAS 189
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 57/218 (26%), Positives = 85/218 (38%), Gaps = 43/218 (19%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKIAVKRM-EAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
++GRG FG V+ + G A+K + ++ +I + ++E +L +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
D LV EYMP G L + + + P E R L +A ++ +H L
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIR---KDVFPEETARFYIAELVLA--LDSVHKLG- 121
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGL------------------VRLAPEGKGSIETR 759
FIHRD+KP NIL+ D K+ADFGL L +
Sbjct: 122 --FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 760 ----------IAGTFGYLAPEYAVHTRWS---SCSYWA 784
GT Y+APE V C +W+
Sbjct: 180 HKQRRVRANSTVGTPDYIAPE--VLRGTPYGLECDWWS 215
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 36/169 (21%)
Query: 599 NILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKS-------------EIAV 644
LG G +G V K G +A+K+++ IS +T+ + E+ +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEIS-NDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 645 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT---- 700
+ +++H +++ L+ ++G+ LV + M L K ++ RLT
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLK-----------KVVDRKIRLTESQV 121
Query: 701 --IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
I L + G+ LH F+HRDL P+NI + K+ADFGL R
Sbjct: 122 KCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 52/152 (34%), Positives = 79/152 (51%), Gaps = 18/152 (11%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVK--RMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
LG G + TVYKG G +A+K R+E G T + E ++L ++H ++V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIR-EASLLKDLKHANIVTL- 68
Query: 658 GHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
H + +K L VFEY+ L +++ + GL N RL + + RG+ Y H
Sbjct: 69 -HDIIHTKKTLTLVFEYL-DTDLKQYM-DDCGGGLSMH--NVRLFL-FQLLRGLAYCH-- 120
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ +HRDLKP N+L+ + K+ADFGL R
Sbjct: 121 -QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 60/191 (31%), Positives = 90/191 (47%), Gaps = 18/191 (9%)
Query: 588 LRNVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
LR+ F ++G G +G VYKG + G A+K M+ ++G E K EI +L
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLK 57
Query: 647 KV-RHRHLVALLGHCLDGN------EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 699
K HR++ G + N + LV E+ G+++ I N LK EW
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE-EW--IA 114
Query: 700 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR 759
I ++ RG+ +LH IHRD+K N+LL ++ K+ DFG+ G T
Sbjct: 115 YICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 171
Query: 760 IAGTFGYLAPE 770
I GT ++APE
Sbjct: 172 I-GTPYWMAPE 181
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 48/178 (26%), Positives = 82/178 (46%), Gaps = 8/178 (4%)
Query: 594 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+F N +G+G FG V+K D A+K+++ ++ + E E VL K+ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
++ LD + +V EY G L H + G +PL ++ + + G+ +L
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDL--HKLLKMQRG-RPLPEDQVWRFFIQILLGLAHL 117
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
H + +HRD+K N+ L K+ D G+ +L + T I GT YL+PE
Sbjct: 118 HS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 37/197 (18%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKR--MEAGVISGKGLTEFKSEIAVL 645
R+V + + + N + G +G VY+ + G +A+K+ ME G +T + EI +L
Sbjct: 2 RSV-DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSLR-EINIL 58
Query: 646 TKVRHRHLVAL----LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPL--EWNRRL 699
K++H ++V + +G LD + +V EY+ E LK L +
Sbjct: 59 LKLQHPNIVTVKEVVVGSNLD--KIYMVMEYV-------------EHDLKSLMETMKQPF 103
Query: 700 TIA------LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753
+ L + GV +LH +HRDLK SN+LL + K+ DFGL R
Sbjct: 104 LQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160
Query: 754 GSIETRIAGTFGYLAPE 770
T++ T Y APE
Sbjct: 161 KPY-TQLVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 28/197 (14%)
Query: 588 LRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
L + T F ++G G +G VYK G +A+K M+ I E K E +L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEEIKEEYNILR 57
Query: 647 KV-RHRHLVALLG------HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 699
K H ++ G + ++ LV E G+++ + +GL+ +RL
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKK--GKRL 110
Query: 700 T------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753
I + RG+ YLH ++ IHRD+K NILL + K+ DFG+
Sbjct: 111 KEEWIAYILRETLRGLAYLH--ENK-VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL 167
Query: 754 GSIETRIAGTFGYLAPE 770
G T I GT ++APE
Sbjct: 168 GRRNTFI-GTPYWMAPE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 51/160 (31%), Positives = 82/160 (51%), Gaps = 18/160 (11%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRME-----AGVISGKGLTEFKSEIAVLTK 647
NF + +G G +G VYK G +A+K++ GV S T + EI++L +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS----TAIR-EISLLKE 55
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+ H ++V LL N+ LVFE++ Q L + + G+ PL + L +
Sbjct: 56 LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGI-PLPLIKSYLFQL--LQ 111
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
G+ + H +H+ +HRDLKP N+L+ + K+ADFGL R
Sbjct: 112 GLAFCH--SHR-VLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 57/189 (30%), Positives = 86/189 (45%), Gaps = 19/189 (10%)
Query: 601 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKG-LTEFKSEIAVLTKVRHRHLVALLG 658
+G+GG+G V+ + D +I A+KRM+ ++ + +E +LT + LV LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
D L EY+P G R + N L E + R +A V+ LH L
Sbjct: 69 AFQDDEYLYLAMEYVPGGDF-RTLLN-NLGVLS--EDHARFYMAEMFE-AVDALHELG-- 121
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE--TRIAGTFGYLAPEYAVHTR 776
+IHRDLKP N L+ K+ DFGL KG + + G+ Y+APE
Sbjct: 122 -YIHRDLKPENFLIDASGHIKLTDFGL------SKGIVTYANSVVGSPDYMAPEVLRGKG 174
Query: 777 WS-SCSYWA 784
+ + YW+
Sbjct: 175 YDFTVDYWS 183
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 601 LGRGGFGTVYKGEL---------------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVL 645
LG G FG V+ E +AVK + A V +F EI ++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK-TARNDFLKEIKIM 71
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS-----RHIFNW--AEEGLKPLEWNRR 698
+++++ +++ LLG C+ + ++ EYM G L+ R I + + +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 699 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIE 757
L +A+ +A G++YL L +F+HRDL N L+G+ K+ADFG+ R L I+
Sbjct: 132 LYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 758 TRIAGTFGYLAPEYAVHTRWSSCS-YWA 784
R ++A E + ++++ S WA
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWA 216
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 51/180 (28%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEA-GVISGKGLTEFKSEIAVLTKVRHR 651
NF E +GRG F VY+ L DG +A+K+++ ++ K + EI +L ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEG-LKPLEWNRRLTIALDVARGVE 710
+++ ++ NE +V E G LSR I ++ ++ L P + + + L A +E
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LE 120
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
++H + +HRD+KP+N+ + K+ D GL R K + + GT Y++PE
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 46/182 (25%), Positives = 83/182 (45%), Gaps = 16/182 (8%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ + ++GRG FG V+ D + +K++ ++ ++E VL + H +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP---LEWNRRLTIALDVARGV 709
++ + L+ ++V EY P GTL+ +I L L + ++ +A
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------- 113
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 768
LH + + +HRDLK NILL M K+ DFG+ ++ S + GT Y++
Sbjct: 114 --LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYIS 169
Query: 769 PE 770
PE
Sbjct: 170 PE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 41/164 (25%)
Query: 601 LGRGGFGTVYKGELHD-GTKIAVKRM-----EAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
+G G +GTV+K + + +A+KR+ + GV S EI +L +++H+++V
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-----LREICLLKELKHKNIV 62
Query: 655 ALLGHCLDGNEKL-LVFEYMPQ----------GTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
L L ++KL LVFEY Q G + I +
Sbjct: 63 RLY-DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK---------------SFMF 106
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ +G+ + H + +HRDLKP N+L+ + K+ADFGL R
Sbjct: 107 QLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 60/177 (33%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 600 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFK---SEIAVLTK-VRHRHLV 654
++G+G FG V + DG AVK ++ I K E K +E VL K V+H LV
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK--KEQKHIMAERNVLLKNVKHPFLV 59
Query: 655 ALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
L + +KL V +Y+ G L H+ + + R A ++A + YLH
Sbjct: 60 GL-HYSFQTADKLYFVLDYVNGGELFFHL-----QRERSFPEPRARFYAAEIASALGYLH 113
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
L + I+RDLKP NILL + DFGL + E + T GT YLAPE
Sbjct: 114 SL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 8e-12
Identities = 57/196 (29%), Positives = 84/196 (42%), Gaps = 47/196 (23%)
Query: 599 NILGRGGFGTVYKGE-LHDGTKIAVKRME---AGVISGKGLTEFKSEIAVLTKVRHRHLV 654
+G G +G V G K+A+K++ +I K + EI +L +RH +++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR---EIKLLRHLRHENII 62
Query: 655 ALL-----GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IAL 703
LL D N+ +V E M + L + I + + LT
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKS-----------PQPLTDDHIQYFLY 110
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA--PEGKGSIETRIA 761
+ RG++YLH A+ IHRDLKPSNIL+ + K+ DFGL R E + T
Sbjct: 111 QILRGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT--- 164
Query: 762 GTFGYLAPEYAVHTRW 777
EY V TRW
Sbjct: 165 --------EYVV-TRW 171
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 50/154 (32%), Positives = 72/154 (46%), Gaps = 14/154 (9%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKI----AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
+LG G FGTVYKG + DG + A+K + S K E E V+ V ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVC 72
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
LLG CL +L V + MP G L ++ E + L + +A+G+ YL
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYV----RENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748
+ +HRDL N+L+ K+ DFGL RL
Sbjct: 128 V---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 56/207 (27%), Positives = 84/207 (40%), Gaps = 43/207 (20%)
Query: 592 TNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKR-MEAGVISGKGLTEFKSEIAVLTKVR 649
++ LG G FG VYK ++ G +A+K+ + G +T + EI +L K++
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLK 65
Query: 650 HRHLVALL--------GHCLDGNEKLLVFEYMPQ---GTLSRHIFNWAEEGLKPLEWNRR 698
H ++V L+ +V YM G L E +K
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK------- 118
Query: 699 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL------APEG 752
L + G+ YLH +HRD+K +NIL+ + K+ADFGL R P+G
Sbjct: 119 -CYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 753 KGSIETRIAGTFGYLAPEYA--VHTRW 777
G TR +Y V TRW
Sbjct: 175 GGGGGTR----------KYTNLVVTRW 191
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 9/149 (6%)
Query: 601 LGRGGFGTVYKGELHDG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+G G FG V GE++ G ++ VK + S + +F E ++H +L+ L
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
G C + LLV E+ P G L ++ + E + P + +A ++A G+ +LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-DPTTLQRMACEIALGLLHLH--- 117
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGL 745
+FIH DL N LL D+ K+ D+GL
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 55/188 (29%), Positives = 91/188 (48%), Gaps = 28/188 (14%)
Query: 591 VTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRM----EAGVISGKGLTEFKSEIAVL 645
+TN + + +G G FG V + G +A+K++ V++ + E K +L
Sbjct: 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK----LL 63
Query: 646 TKVRHRHLVALLGHCLDGNEKL-LVFEYMPQGT-LSRHIFNWAEEGLKPLEWNRRLTIAL 703
+RH ++++L + E + V E + GT L R + + +PLE
Sbjct: 64 KHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTS------RPLEKQFIQYFLY 115
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSIETRIAG 762
+ RG++Y+H +HRDLKPSNIL+ ++ K+ DFGL R+ P+ G + TR
Sbjct: 116 QILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-- 170
Query: 763 TFGYLAPE 770
Y APE
Sbjct: 171 ---YRAPE 175
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 49/180 (27%), Positives = 88/180 (48%), Gaps = 9/180 (5%)
Query: 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEA-GVISGKGLTEFKSEIAVLTKVRHR 651
NF E +GRG F VY+ D +A+K+++ ++ K + EI +L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL-TIALDVARGVE 710
+++ L ++ NE +V E G LS+ I + ++ K L R + + + VE
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVE 120
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
++H + +HRD+KP+N+ + K+ D GL R K + + GT Y++PE
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 55/178 (30%), Positives = 83/178 (46%), Gaps = 25/178 (14%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKG---LTEFKSEIAVLTKVRHRHLVALL 657
LG G FG VYK + + +A A VI K L ++ EI +L H ++V LL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAA----AKVIETKSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT---IALDVARGVEYLHG 714
G + ++ E+ P G + + LE +R LT I + + +E L
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAVDAIM----------LELDRGLTEPQIQVICRQMLEALQY 125
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFGYLAPE 770
L IHRDLK N+LL D K+ADFG ++ + +++ R GT ++APE
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPE 180
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 30/199 (15%)
Query: 598 ENILGRGGFGTVYKGEL-HDGTK---IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
E ++G G FG V +G L G + +A+K +++G + K +F SE +++ + H ++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNI 67
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEG-LKPLEWNRRLTIALDVARGVEYL 712
+ L G +++ E+M G L F +G ++ + + +A G++YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDS--FLRQNDGQFTVIQL---VGMLRGIAAGMKYL 122
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK----------GSIETRIAG 762
+ +++HRDL NIL+ ++ KV+DFGL R + G I R
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR--- 176
Query: 763 TFGYLAPEYAVHTRWSSCS 781
+ APE + +++S S
Sbjct: 177 ---WTAPEAIAYRKFTSAS 192
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
RN +F +G G +G VYK ++ G A+K ++ + G+ + EI ++
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKD 62
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+H ++VA G L ++ + E+ G+L + I++ PL ++ ++ + +
Sbjct: 63 CKHSNIVAYFGSYLRRDKLWICMEFCGGGSL-QDIYHVT----GPLSESQIAYVSRETLQ 117
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFG 765
G+ YLH + +HRD+K +NILL D+ K+ADFG ++ + +I R GT
Sbjct: 118 GLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFG---VSAQITATIAKRKSFIGTPY 171
Query: 766 YLAPEYAVHTRWSS----CSYWA 784
++APE A R C WA
Sbjct: 172 WMAPEVAAVERKGGYNQLCDIWA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 61/175 (34%), Positives = 84/175 (48%), Gaps = 14/175 (8%)
Query: 600 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTK-VRHRHLVAL 656
++G+G FG V + DG+ AVK ++ I K +E VL K ++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 657 LGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
+ EKL V +Y+ G L H+ L+P R A +VA + YLH L
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHL-QRERCFLEP----RARFYAAEVASAIGYLHSL 115
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+ I+RDLKP NILL + DFGL + E + + T GT YLAPE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 50/175 (28%), Positives = 76/175 (43%), Gaps = 29/175 (16%)
Query: 68 KRITRIQIGHQNLQGTLPS----------------NLQ--------NLTKLERLELQWNS 103
+ + R+++ + G LPS NLQ ++ L+ L L N
Sbjct: 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK 463
Query: 104 ISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNA 163
G LP G LE + LS NQF+ LS L +++ N S EIP L +
Sbjct: 464 FFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSG-EIPDELSSC 522
Query: 164 SGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSL 218
L + + ++GQIP+ F E P L+ L L+ NQL G +P + ++SL
Sbjct: 523 KKLVSLDLSHNQLSGQIPASFS--EMPVLSQLDLSQNQLSGEIPKNLGN--VESL 573
|
Length = 968 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 53/207 (25%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRM---EAGVISGKGLTEFKSEIAVL 645
+V + + +G G +G V G K+A+K++ E + L E K +L
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----IL 57
Query: 646 TKVRHRHLVALL-----GHCLDGNEKLLVFEYMP---------QGTLSRHIFNWAEEGLK 691
+ +H +++ +L N+ +V E M Q + HI + + L
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQIL- 116
Query: 692 PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-P 750
RG++Y+H + +HRDLKPSN+LL + K+ DFGL R+A P
Sbjct: 117 ---------------RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158
Query: 751 EGKGSIETRIAGTFGYLAPEYAVHTRW 777
E + G+L EY V TRW
Sbjct: 159 EHDHT---------GFLT-EY-VATRW 174
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 58/192 (30%), Positives = 94/192 (48%), Gaps = 25/192 (13%)
Query: 601 LGRGGFGTVYKGELHDGTK---IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+GRG +G VYK + DG A+K++E IS EIA+L +++H ++++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----REIALLRELKHPNVISLQ 64
Query: 658 GHCLDGNEK--LLVFEYMPQGTLSRHIFNW---AEEGLKPLEWNRRLTIAL--DVARGVE 710
L ++ L+F+Y HI + ++ KP++ R + +L + G+
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 711 YLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRL--APEGKGSIETRIAGTF 764
YLH +HRDLKP+NIL+ + R K+AD G RL +P + + TF
Sbjct: 123 YLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 765 GYLAPEYAVHTR 776
Y APE + R
Sbjct: 180 WYRAPELLLGAR 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 28/204 (13%)
Query: 574 QMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISG 632
Q A +V+S R ++F + +G G G V E H G ++AVK+M+
Sbjct: 6 QFRAALQLVVSPGDPREYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR 62
Query: 633 KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN--WAEEGL 690
+ L +E+ ++ H ++V + L G+E +V E++ G L+ + + EE +
Sbjct: 63 REL--LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI 120
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV---- 746
T+ L V R + YLH +Q IHRD+K +ILL D R K++DFG
Sbjct: 121 A--------TVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169
Query: 747 RLAPEGKGSIETRIAGTFGYLAPE 770
+ P+ K + GT ++APE
Sbjct: 170 KEVPKRKS-----LVGTPYWMAPE 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 54/193 (27%), Positives = 80/193 (41%), Gaps = 35/193 (18%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKS----EIAVLTKV 648
E + LG G G+V K L + I + I+ + + E+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALK----TITTDPNPDLQKQILRELEINKSC 56
Query: 649 RHRHLVALLGHCLDGNEKLL--VFEYMPQGTLSRHIF-----NWAEEGLKPLEWNRRLTI 701
+ ++V G LD + + EY G+L I+ G K L I
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVL-----GKI 110
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 761
A V +G+ YLH + IHRD+KPSNILL + K+ DFG+ G + +A
Sbjct: 111 AESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGV-------SGELVNSLA 160
Query: 762 GTFG----YLAPE 770
GTF Y+APE
Sbjct: 161 GTFTGTSFYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 61/190 (32%), Positives = 100/190 (52%), Gaps = 21/190 (11%)
Query: 601 LGRGGFGTVYKG-ELHDGTK-IAVKRMEAGVIS-GKGLTEFKSEIAVLTKVR---HRHLV 654
+G G +G V+K +L +G + +A+KR+ G L+ + E+AVL + H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 67
Query: 655 ALLGHCL----DGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
L C D KL LVFE++ Q L+ ++ E G+ P E + + L RG+
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV-PTETIKDMMFQL--LRGL 123
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
++LH +H+ +HRDLKP NIL+ + K+ADFGL R+ T + T Y AP
Sbjct: 124 DFLH--SHR-VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAP 178
Query: 770 EYAVHTRWSS 779
E + + +++
Sbjct: 179 EVLLQSSYAT 188
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 572 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI 630
D ++LE ++S+ + F + +G+G GTVY ++ G ++A+++M
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 631 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 690
K L +EI V+ + ++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 59 PKKEL--IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---- 112
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLA 749
++ + + + + +E+LH IHRD+K NILLG D K+ DFG ++
Sbjct: 113 --MDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 750 PEGKGSIETRIAGTFGYLAPE 770
PE S + + GT ++APE
Sbjct: 168 PE--QSKRSTMVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 53/149 (35%), Positives = 79/149 (53%), Gaps = 12/149 (8%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
LG G + TVYKG +G +A+K + G T + E ++L ++H ++V LL
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIV-LLHD 70
Query: 660 CLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
+ E L VFEYM L++++ GL P +N RL + + RG+ Y+H Q
Sbjct: 71 IIHTKETLTFVFEYM-HTDLAQYMIQ-HPGGLHP--YNVRLFM-FQLLRGLAYIH---GQ 122
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+HRDLKP N+L+ K+ADFGL R
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 24/195 (12%)
Query: 598 ENILGRGGFGTVYKGELHDGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
E ++G G FG V G L K +A+K ++AG + K +F SE +++ + H ++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNI 67
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL-----DVARG 708
+ L G ++V EYM G+L F +G + I L +A G
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDA--FLRKHDG-------QFTVIQLVGMLRGIASG 118
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG--Y 766
++YL + ++HRDL NIL+ ++ KV+DFGL R+ + + T G +
Sbjct: 119 MKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 175
Query: 767 LAPEYAVHTRWSSCS 781
APE + +++S S
Sbjct: 176 TAPEAIAYRKFTSAS 190
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 18/196 (9%)
Query: 583 ISIQVLRNVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSE 641
I + LR+ F ++G G +G VYKG + G A+K M+ ++ E K E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLE 62
Query: 642 IAVLTKV-RHRHLVALLGHCL------DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLE 694
I +L K HR++ G + ++ LV E+ G+++ + N LK +
Sbjct: 63 INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-D 121
Query: 695 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754
W I ++ RG+ +LH AH+ IHRD+K N+LL ++ K+ DFG+ G
Sbjct: 122 W--IAYICREILRGLAHLH--AHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176
Query: 755 SIETRIAGTFGYLAPE 770
T I GT ++APE
Sbjct: 177 RRNTFI-GTPYWMAPE 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 572 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI 630
D ++LE ++S+ + F + +G+G GTVY ++ G ++A+K+M
Sbjct: 1 DEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQ 57
Query: 631 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 690
K L +EI V+ + ++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 58 PKKEL--IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---- 111
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLA 749
++ + + + + +++LH IHRD+K NILLG D K+ DFG ++
Sbjct: 112 --MDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166
Query: 750 PEGKGSIETRIAGTFGYLAPE 770
PE S + + GT ++APE
Sbjct: 167 PE--QSKRSTMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 55/182 (30%), Positives = 80/182 (43%), Gaps = 26/182 (14%)
Query: 601 LGRGGFGTVYKGELHD-GTKIAVKRM----EAGVISGKGLTEFKSEIAVLTKVRHRHLVA 655
+G G +G V+K + G +A+K+ + VI L EI +L +++H +LV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL----REIRMLKQLKHPNLVN 64
Query: 656 LLGHCLDGNEKL-LVFEYMPQ---GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
L+ KL LVFEY L ++ E +K + W + V +
Sbjct: 65 LI-EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ--------TLQAVNF 115
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
H H IHRD+KP NIL+ + K+ DFG R+ G G T T Y APE
Sbjct: 116 CH--KHNC-IHRDVKPENILITKQGQIKLCDFGFARIL-TGPGDDYTDYVATRWYRAPEL 171
Query: 772 AV 773
V
Sbjct: 172 LV 173
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 12/150 (8%)
Query: 601 LGRGGFGTVYKGELHDGTKIA---VKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+G G FG V E++ T +A VK ++A S K EF + ++H +++ L
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFN--WAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
G C++ LLVFEY G L ++ W + L R +A ++A GV ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMHKH 118
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGL 745
+F+H DL N L D+ KV D+G+
Sbjct: 119 ---NFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 47/185 (25%), Positives = 90/185 (48%), Gaps = 10/185 (5%)
Query: 595 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
F++ +G+G FG V+KG + K+ ++ + + + + EI VL++ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
G L + ++ EY+ G+ + E G PL+ + TI ++ +G++YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPG--PLDETQIATILREILKGLDYLHS 119
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVH 774
+ IHRD+K +N+LL + K+ADFG+ + + GT ++APE
Sbjct: 120 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQ 175
Query: 775 TRWSS 779
+ + S
Sbjct: 176 SAYDS 180
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 29/176 (16%)
Query: 595 FSEENILGRGGFGTVYKGE---LHDGTK--------------IAVKRMEAGVISGKGLTE 637
F E+ LG G FG V+ E + +AVK + + +
Sbjct: 9 FKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARND 65
Query: 638 FKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL----SRHIF--NWAEEGLK 691
F EI ++++++ +++ LL C+ + ++ EYM G L SRH + +
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 692 PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ ++ + +A +A G++YL L +F+HRDL N L+G + K+ADFG+ R
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 58/183 (31%), Positives = 93/183 (50%), Gaps = 14/183 (7%)
Query: 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
LG G + TVYKG+ +G +A+K + G T + E ++L ++H ++V LL
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIV-LLHD 70
Query: 660 CLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
+ E L LVFEY+ L +++ + GL P N +L + + RG+ Y+H +
Sbjct: 71 IIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPE--NVKLFL-FQLLRGLSYIH---QR 122
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV-HTRW 777
+HRDLKP N+L+ D K+ADFGL R + + T Y P+ + T +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 778 SSC 780
S+C
Sbjct: 182 STC 184
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
RN +++ +G G +G VYK LH G AVK ++ + G + + EI ++ +
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKE 62
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+H ++VA G L + + EY G+L + I++ PL + + + +
Sbjct: 63 CKHCNIVAYFGSYLSREKLWICMEYCGGGSL-QDIYHVT----GPLSELQIAYVCRETLQ 117
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFG 765
G+ YLH +HRD+K +NILL D+ K+ADFG +A + +I R GT
Sbjct: 118 GLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFG---VAAKITATIAKRKSFIGTPY 171
Query: 766 YLAPEYAVHTRWSS----CSYWA 784
++APE A + C WA
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 7e-11
Identities = 62/224 (27%), Positives = 94/224 (41%), Gaps = 44/224 (19%)
Query: 582 VISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEF--- 638
I LR +F ++GRG FG V ++ + V + K L++F
Sbjct: 32 AEKITKLRMKAEDFDVIKVIGRGAFGEV---------QLVRHKSSKQVYAMKLLSKFEMI 82
Query: 639 -KSEIAVLTKVRH-------RHLVALLGHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEE 688
+S+ A + R +V L H ++K L V EYMP G L + N+
Sbjct: 83 KRSDSAFFWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-- 138
Query: 689 GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VR 747
P +W R T A V L + FIHRD+KP N+LL K+ADFG ++
Sbjct: 139 --IPEKWARFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191
Query: 748 LAPEGKGSIETRIAGTFGYLAPE-------YAVHTRWSSCSYWA 784
+ G +T + GT Y++PE + R C +W+
Sbjct: 192 MDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGR--ECDWWS 232
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 59/188 (31%), Positives = 91/188 (48%), Gaps = 22/188 (11%)
Query: 594 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRME---AGVISGKGLTEFKSEIAVLTKVR 649
N+ +LGRG FG VY + G ++AVK++ + K + + EI +L +R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 650 HRHLVALLGHCLDGNE--KLLVF-EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
H +V G CL E KL +F EYMP G++ + + G RR T +
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAY---GALTENVTRRYT--RQIL 116
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR----LAPEGKGSIETRIAG 762
+GV YLH +HRD+K +NIL K+ DFG + + G G I++ + G
Sbjct: 117 QGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG-IKS-VTG 171
Query: 763 TFGYLAPE 770
T +++PE
Sbjct: 172 TPYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 47/187 (25%), Positives = 95/187 (50%), Gaps = 14/187 (7%)
Query: 595 FSEENILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
F++ +G+G FG V+KG + + T+ +A+K ++ + + + + EI VL++ +
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPY 63
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+ G L G + ++ EY+ G+ + G P + + T+ ++ +G++YL
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAG--PFDEFQIATMLKEILKGLDYL 117
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
H + IHRD+K +N+LL + K+ADFG+ + + T + F ++APE
Sbjct: 118 HS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVI 173
Query: 773 VHTRWSS 779
+ + S
Sbjct: 174 QQSAYDS 180
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 56/190 (29%), Positives = 89/190 (46%), Gaps = 16/190 (8%)
Query: 598 ENILGRGGFGTVYKGELHDGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
E ILG G FG + +G L +K +A+ + AG S K F +E L + H ++
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNI 68
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
V L G GN ++V EYM G L F EG L + + + +A G++Y
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDS--FLRKHEG--QLVAGQLMGMLPGLASGMKY-- 122
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL--APEY 771
L+ ++H+ L +L+ D+ K++ F RL + +I T ++G L APE
Sbjct: 123 -LSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 772 AVHTRWSSCS 781
+ +SS S
Sbjct: 180 IQYHHFSSAS 189
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 53/191 (27%), Positives = 84/191 (43%), Gaps = 23/191 (12%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRM-----EAGVISGKGLTEFKSEIAVLT 646
+ + + +G G +G VYK + + G +A+K+ E G+ T + EI++L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPP----TALR-EISLLQ 55
Query: 647 KVRHR-HLVALLG--HCLDGNEKL---LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT 700
+ ++V LL H + N K LVFEY+ L + + + +PL +
Sbjct: 56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKS 114
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLVRLAPEGKGSIETR 759
+ +GV + H +HRDLKP N+L+ K+AD GL R S
Sbjct: 115 FMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE 171
Query: 760 IAGTFGYLAPE 770
I T Y APE
Sbjct: 172 IV-TLWYRAPE 181
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 574 QMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISG 632
Q A +V+ R+ +NF + +G G G V + G ++AVK+M+
Sbjct: 3 QFRAALQLVVDPGDPRSYLDNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR 59
Query: 633 KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI--FNWAEEGL 690
+ L +E+ ++ +H ++V + L G+E +V E++ G L+ + EE +
Sbjct: 60 REL--LFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI 117
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750
T+ L V + + +LH Q IHRD+K +ILL D R K++DFG
Sbjct: 118 A--------TVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFC---- 162
Query: 751 EGKGSIET----RIAGTFGYLAPE 770
+ S E + GT ++APE
Sbjct: 163 -AQVSKEVPRRKSLVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-10
Identities = 42/133 (31%), Positives = 66/133 (49%), Gaps = 13/133 (9%)
Query: 39 LKKSLNPPESLGWSDTDPC-----KWNHVVCIEDKRITR-----IQIGHQNLQGTLPSNL 88
LK SL P GW + DPC W+ C D + + + +Q L+G +P+++
Sbjct: 380 LKSSLGLPLRFGW-NGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDI 438
Query: 89 QNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147
L L+ + L NSI G +P SL + SLEV+ LS N F + L+SL+ + ++
Sbjct: 439 SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498
Query: 148 NNPFSSWEIPQSL 160
N S +P +L
Sbjct: 499 GN-SLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 57/189 (30%), Positives = 86/189 (45%), Gaps = 24/189 (12%)
Query: 598 ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
+ ILG G GTVYK L +AVK + I+ + + SE+ +L K +++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
G N + E+M G+L + P R IA+ V +G+ YL L
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY-------RKIPEHVLGR--IAVAVVKGLTYLWSL- 114
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE------ 770
+HRD+KPSN+L+ + K+ DFG+ + SI GT Y+APE
Sbjct: 115 --KILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQ 169
Query: 771 YAVHTR-WS 778
Y +H+ WS
Sbjct: 170 YGIHSDVWS 178
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 60/190 (31%), Positives = 96/190 (50%), Gaps = 22/190 (11%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVK--RMEAGVISGKGLTEFKSEIAVLTKVR---HRHLV 654
+G G +GTVYK + H G +A+K R++ G L+ + E+A+L ++ H ++V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVR-EVALLKRLEAFDHPNIV 65
Query: 655 ALLGHC----LDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
L+ C D K+ LVFE++ Q L ++ GL P E + L RG+
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGL-PAETIKDLMRQF--LRGL 121
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
++LH +HRDLKP NIL+ + K+ADFGL R+ T + T Y AP
Sbjct: 122 DFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL--TPVVVTLWYRAP 176
Query: 770 EYAVHTRWSS 779
E + + +++
Sbjct: 177 EVLLQSTYAT 186
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 51/205 (24%), Positives = 81/205 (39%), Gaps = 57/205 (27%)
Query: 591 VTNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKS--------- 640
V + + + +G G +G V G K+A+K++ F+S
Sbjct: 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL---------SRPFQSAIHAKRTYR 63
Query: 641 EIAVLTKVRHRHLVALLG--HCLDGNEKL----LVFEYMPQ--GTLSRHIFNWAEEGLKP 692
E+ +L + H +++ LL E LV M + +
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC----------- 112
Query: 693 LEWNRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746
++L+ + + RG++Y+H A IHRDLKPSNI + +D K+ DFGL
Sbjct: 113 ----QKLSDDHIQFLVYQILRGLKYIHS-AG--IIHRDLKPSNIAVNEDCELKILDFGLA 165
Query: 747 RLAP-EGKGSIETRIAGTFGYLAPE 770
R E G + TR Y APE
Sbjct: 166 RHTDDEMTGYVATR-----WYRAPE 185
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 15/178 (8%)
Query: 595 FSEENILGRGGFGTVY-KGELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRHRH 652
F++ +G G FG VY ++ +A+K+M +G S + + E+ L +++H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+ G L + LV EY G+ S + E KPL+ I +G+ YL
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGSAS----DLLEVHKKPLQEVEIAAITHGALQGLAYL 141
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
H + IHRD+K NILL + + K+ADFG +A S GT ++APE
Sbjct: 142 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA-----SPANSFVGTPYWMAPE 191
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 3e-10
Identities = 30/71 (42%), Positives = 39/71 (54%), Gaps = 11/71 (15%)
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 766
+ ++Y+H + IHRDLKPSNILL D R K+ADFGL R E + + T
Sbjct: 118 KALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN-PENPVLT--- 170
Query: 767 LAPEYAVHTRW 777
+Y V TRW
Sbjct: 171 ---DY-VATRW 177
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 3e-10
Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 572 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI 630
D +++E ++SI + ++ +G+G GTV+ ++ G ++A+K++
Sbjct: 1 DEEIMEKLRTIVSIG---DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ 57
Query: 631 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 690
K L +EI V+ ++++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 58 PKKEL--IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC---- 111
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLA 749
++ + + + + +E+LH IHRD+K N+LLG D K+ DFG ++
Sbjct: 112 --MDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166
Query: 750 PEGKGSIETRIAGTFGYLAPE 770
PE S + + GT ++APE
Sbjct: 167 PE--QSKRSTMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 43/153 (28%), Positives = 78/153 (50%), Gaps = 17/153 (11%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRM-----EAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
+G G +G VYKG G +A+K++ E GV S T + EI++L +++H ++V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPS----TAIR-EISLLKELQHPNIV 62
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
L + + L+FE++ L +++ + + E + + +G+ + H
Sbjct: 63 CLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYL--YQILQGILFCH- 118
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ +HRDLKP N+L+ + K+ADFGL R
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 58/192 (30%), Positives = 89/192 (46%), Gaps = 19/192 (9%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKV-RHRHLVAL 656
+LG+G FG V EL ++ AVK ++ VI E +E VL +H L L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 657 LGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
C ++L V EY+ G L HI + + R A ++ G+++LH
Sbjct: 62 HS-CFQTKDRLFFVMEYVNGGDLMFHI-----QRSGRFDEPRARFYAAEIVLGLQFLH-- 113
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG--KGSIETRIAGTFGYLAPEYAV 773
+ I+RDLK N+LL + K+ADFG+ + EG G + GT Y+APE
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAPEILS 169
Query: 774 HTRWS-SCSYWA 784
+ + + +WA
Sbjct: 170 YQPYGPAVDWWA 181
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 47/151 (31%), Positives = 76/151 (50%), Gaps = 16/151 (10%)
Query: 601 LGRGGFGTVYKG--ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
LG G + TVYKG +L D +A+K + G T + E+++L ++H ++V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL-- 69
Query: 659 HCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
H + EK LVFEY L + + + ++ + + + RG+ Y H
Sbjct: 70 HDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH--- 121
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ +HRDLKP N+L+ + K+ADFGL R
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 15/178 (8%)
Query: 595 FSEENILGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRHRH 652
FS+ +G G FG VY ++ + +A+K+M +G S + + E+ L K+RH +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+ G L + LV EY G+ S + E KPL+ + +G+ YL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGSAS----DLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
H + IHRD+K NILL + K+ DFG + + GT ++APE
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 37/204 (18%)
Query: 594 NFSEENILGRGGFGTV----YKGELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKV 648
+F+ LG G FG V YK E D +A+KR E + +I K + SE +L +
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IA 702
H V L G D + LV E++ G E L N+R A
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGG-----------EFFTFLRRNKRFPNDVGCFYA 137
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--- 759
+ EYL L + ++RDLKP N+LL D K+ DFG ++ ++TR
Sbjct: 138 AQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV-------VDTRTYT 187
Query: 760 IAGTFGYLAPEYAVHTRWSSCSYW 783
+ GT Y+APE ++ + W
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADW 211
|
Length = 340 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 52/171 (30%), Positives = 85/171 (49%), Gaps = 12/171 (7%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
LG G G+V K + + GT +A K + G S + E+ ++ + R ++V+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS-SVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
L+ N + E+M G+L R I+ + P+ IA+ V G+ YL+ +
Sbjct: 72 FLNENNICMCMEFMDCGSLDR-IY----KKGGPIPVEILGKIAVAVVEGLTYLYNVHR-- 124
Query: 720 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+HRD+KPSNIL+ + K+ DFG ++ E SI GT Y++PE
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFG---VSGELINSIADTFVGTSTYMSPE 172
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 21/187 (11%)
Query: 594 NFSEENILGRGGFGTVY----KGELHDGTKIAVKRMEAGVISGKGLT--EFKSEIAVLTK 647
NF +LG G +G V+ G G A+K ++ I K T ++E VL
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 648 VRHRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIF---NWAEEGLKPLEWNRRLTIAL 703
VR + L + + KL L+ +Y+ G L H++ ++ E + R+ IA
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEV-------RVYIA- 112
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 763
++ +++LH L I+RD+K NILL + + DFGL + + GT
Sbjct: 113 EIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT 169
Query: 764 FGYLAPE 770
Y+APE
Sbjct: 170 IEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 55/191 (28%), Positives = 83/191 (43%), Gaps = 17/191 (8%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEFK-SEIAVLTKVRHRHLVALL 657
+LG+G FG V EL ++ A+K ++ VI + +E +L + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 658 GHCLDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
C ++L V EY+ G L I + + + R A +V + +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQI-----QRSRKFDEPRSRFYAAEVTLALMFLH--- 113
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG--KGSIETRIAGTFGYLAPEYAVH 774
I+RDLK NILL + K+ADFG+ + EG G T GT Y+APE
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQE 170
Query: 775 TRWS-SCSYWA 784
+ S +WA
Sbjct: 171 LEYGPSVDWWA 181
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 56/175 (32%), Positives = 78/175 (44%), Gaps = 21/175 (12%)
Query: 601 LGRGGFGTVY-KGELHDGTKIAVKRMEAGVISGKGLTE----FKSEIAVLTKVRHRHLVA 655
+G G FG VY H +AVK+M SGK E E+ L +++H + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMS---YSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
G L + LV EY G+ S + E KPL+ I +G+ YLH
Sbjct: 86 YKGCYLKEHTAWLVMEYC-LGSAS----DLLEVHKKPLQEVEIAAITHGALQGLAYLHS- 139
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+ IHRD+K NILL + + K+ADFG K S GT ++APE
Sbjct: 140 --HNMIHRDIKAGNILLTEPGQVKLADFG-----SASKSSPANSFVGTPYWMAPE 187
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 26/186 (13%)
Query: 597 EENILGRGGFGTVYKG-ELHDGTKIAVKRM----EAGVISGKGLTEFKSEIAVLTKVRHR 651
ENI G G +G V + G K+A+K++ + ++ + L E K +L +H
Sbjct: 10 IENI-GSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRHFKHD 64
Query: 652 HLVALLGHCL----DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+++A+ D + +V + M + L I +PL + R
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIH-----SDQPLTEEHIRYFLYQLLR 118
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA---PEGKGSIETRIAGTF 764
G++Y+H + IHRDLKPSN+L+ +D ++ DFG+ R P T T
Sbjct: 119 GLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 765 GYLAPE 770
Y APE
Sbjct: 176 WYRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 56/196 (28%), Positives = 85/196 (43%), Gaps = 27/196 (13%)
Query: 600 ILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFK-SEIAVLTKVRHRHLVALL 657
+LG+G FG V L G AVK ++ VI E +E +L+ R+ + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 658 GHCLDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
C ++L V E++ G L HI + + + R A ++ + +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHI-----QKSRRFDEARARFYAAEITSALMFLH--- 113
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG--KGSIETRIAGTFGYLAPE---- 770
+ I+RDLK N+LL + K+ADFG+ + EG G + GT Y+APE
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 771 --YAVHTRWSSCSYWA 784
Y W WA
Sbjct: 171 MLYGPSVDW-----WA 181
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 53/189 (28%), Positives = 83/189 (43%), Gaps = 13/189 (6%)
Query: 585 IQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAG--VISGKGLTEFKSEI 642
I+ LR ++ ++GRG FG V K+ ++ + +I F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 643 AVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIA 702
++ +V L D +V EYMP G L + N+ P +W R T
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAE 150
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIA 761
+ +A L + FIHRD+KP N+LL K+ADFG +++ EG +T +
Sbjct: 151 VVLA-----LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV- 204
Query: 762 GTFGYLAPE 770
GT Y++PE
Sbjct: 205 GTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 2/106 (1%)
Query: 333 LNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGN-ITVINFQKMNLTGTISPEFA 391
L LLS + P ++ NW + W G+TC + + I+ N++G IS
Sbjct: 31 LELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIF 90
Query: 392 SFKSLQRLILADNNLSGMIPEGLSVLG-ALKELDVSNNQLYGKIPS 436
+Q + L++N LSG IP+ + +L+ L++SNN G IP
Sbjct: 91 RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR 136
|
Length = 968 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 52/190 (27%), Positives = 86/190 (45%), Gaps = 27/190 (14%)
Query: 591 VTNNFSEENILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 649
V + + + +G G +GTV + G K+A+K++ S E+ +L ++
Sbjct: 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK 72
Query: 650 HRHLVALLG-----HCLDG-NEKLLVFEYMPQ--GTLSRHIFNWAEEGLKPLEWNRRLTI 701
H +++ LL LD ++ LV +M G L +H + L +R +
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH---------EKLSEDRIQFL 123
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSIETRI 760
+ +G++Y+H IHRDLKP N+ + +D K+ DFGL R E G + TR
Sbjct: 124 VYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR- 179
Query: 761 AGTFGYLAPE 770
Y APE
Sbjct: 180 ----WYRAPE 185
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 47/179 (26%), Positives = 82/179 (45%), Gaps = 23/179 (12%)
Query: 600 ILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEFKSEIAVLTKVRH---RHLV 654
++GRG +G VY+G H T +A+K + +++ + E+A+L+++R ++
Sbjct: 8 LIGRGAYGAVYRG-KHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQPPNIT 65
Query: 655 ALLGHCLDGNEKLLVFEYMPQG---TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
G L G ++ EY G TL + P+ I +V ++Y
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMK---------AGPIAEKYISVIIREVLVALKY 116
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+H IHRD+K +NIL+ + K+ DFG+ L + T GT ++APE
Sbjct: 117 IH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPE 171
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 574 QMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISG 632
Q A MV+ R++ N+ + +G G G V E H G ++AVK M+
Sbjct: 5 QFKAALRMVVDQGDPRSLLENYIK---IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR 61
Query: 633 KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI--FNWAEEGL 690
+ L +E+ ++ +H+++V + L G E ++ E++ G L+ + EE +
Sbjct: 62 REL--LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQI 119
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LV 746
T+ V + + YLH Q IHRD+K +ILL D R K++DFG +
Sbjct: 120 A--------TVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168
Query: 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTRWSS 779
+ P+ K + GT ++APE T + +
Sbjct: 169 KDVPKRKS-----LVGTPYWMAPEVISRTPYGT 196
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 54/160 (33%), Positives = 84/160 (52%), Gaps = 31/160 (19%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRM-----EAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
+G G +G VYK + IA+K++ + GV S T + EI++L +++H ++V
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPS----TAIR-EISLLKEMQHGNIV 64
Query: 655 ALLGHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL--TIALDVARGVE 710
L + +EK LVFEY+ L +H+ + + N RL T + RG+
Sbjct: 65 RL--QDVVHSEKRLYLVFEYLDL-DLKKHMDSSPD-----FAKNPRLIKTYLYQILRGIA 116
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRA---KVADFGLVR 747
Y H +H+ +HRDLKP N+L+ D R K+ADFGL R
Sbjct: 117 YCH--SHR-VLHRDLKPQNLLI--DRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 20/187 (10%)
Query: 594 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVR 649
N+ +LG+G FG VY ++ G ++A K+++ S K ++ + EI +L ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 650 HRHLVALLGHCLDGNEKLLV--FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
H +V G D EK L EYMP G++ + + G R+ T +
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY---GALTESVTRKYT--RQILE 117
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPEGKGSIETRIAGT 763
G+ YLH +HRD+K +NIL K+ DFG L + G G + GT
Sbjct: 118 GMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI--RSVTGT 172
Query: 764 FGYLAPE 770
+++PE
Sbjct: 173 PYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 52/183 (28%), Positives = 83/183 (45%), Gaps = 10/183 (5%)
Query: 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
+GRG FG V+ G L D T +AVK + +F E +L + H ++V L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRE-TLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS 719
C +V E + G + EG + L+ + + + A G+EYL +
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRT---EGPR-LKVKELIQMVENAAAGMEYLES---KH 114
Query: 720 FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT-FGYLAPEYAVHTRWS 778
IHRDL N L+ + K++DFG+ R +G + + + APE + R+S
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 779 SCS 781
S S
Sbjct: 175 SES 177
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 24/205 (11%)
Query: 593 NNFSEENILGRGGFGTVY-KGELHDGTKIAVKRMEAGVISGKGLTEF-KSEIAVLTKVRH 650
+F ++++GRG FG V E G A+K M+ V+ + F + E +L+
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTL----SRHIFNWAEEGLKPLEWNRRLTIALDVA 706
+ L D + LV EY P G L +R+ + E+ +A
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDED-----------MAQFYLA 109
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 766
V +H + ++HRD+KP N+L+ K+ADFG K GT Y
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 767 LAPE-------YAVHTRWSSCSYWA 784
+APE T C +W+
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWS 194
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-09
Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 38/201 (18%)
Query: 600 ILGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVA 655
++G+GG G VY +D ++A+K++ + L + F E + + H +V
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 656 LLGHCLDGNEKLLVFEYMP--QGTLSRHIFN--WAEEGL-KPLEWNRR----LTIALDVA 706
+ C DG+ V+ MP +G + + W +E L K L L+I +
Sbjct: 67 VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL---VRLAPEGKGSIET----- 758
+EY+H + +HRDLKP NILLG + D+G +L E I+
Sbjct: 124 ATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 759 ---------RIAGTFGYLAPE 770
+I GT Y+APE
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPE 201
|
Length = 932 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 53/182 (29%), Positives = 81/182 (44%), Gaps = 28/182 (15%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
+LG+G FG V EL + A+K ++ V+ L + E ++ R ++AL
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVV----LEDDDVECTMV----ERRVLALAW 53
Query: 659 HC---------LDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
E L V EY+ G L HI + + R A ++ G
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHI-----QSSGRFDEARARFYAAEIICG 108
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 768
+++LH + I+RDLK N+LL D K+ADFG+ + G+G T GT Y+A
Sbjct: 109 LQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIA 164
Query: 769 PE 770
PE
Sbjct: 165 PE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 46/180 (25%), Positives = 83/180 (46%), Gaps = 11/180 (6%)
Query: 594 NFSEENILGRGGFGTVY--KGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+ +G G FG +Y K + D +K ++ + K K E+ +L K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
++V + +V EY G L + I + G+ ++ L+ + ++ G+++
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINR--QRGVL-FSEDQILSWFVQISLGLKH 116
Query: 712 LHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+H + +HRD+K NI L + M AK+ DFG+ R + T GT YL+PE
Sbjct: 117 IH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 20/187 (10%)
Query: 594 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVR 649
N+ +LG+G FG VY + G ++AVK+++ S K + + EI +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 650 HRHLVALLGHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
H +V G D E+ L E+MP G++ + ++ G R+ T +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY---GALTENVTRKYT--RQILE 117
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPEGKGSIETRIAGT 763
GV YLH +HRD+K +NIL K+ DFG L + G G + GT
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGT 172
Query: 764 FGYLAPE 770
+++PE
Sbjct: 173 PYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 60/186 (32%), Positives = 85/186 (45%), Gaps = 13/186 (6%)
Query: 601 LGRGGFGTVYKGELHDGTKI-AVKRM-EAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
+G+G FG V + D +I A+K + +A ++S +T +E VL +V +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 659 HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
EKL LV ++ G L H+ EG L R T L A +E LH
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAELLCA--LENLHKF-- 112
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRW 777
+ I+RDLKP NILL + DFGL +L + T GT YLAPE + +
Sbjct: 113 -NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGY 170
Query: 778 SSCSYW 783
+ W
Sbjct: 171 TKAVDW 176
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 55/202 (27%), Positives = 85/202 (42%), Gaps = 37/202 (18%)
Query: 594 NFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLT--EFKS--------EIA 643
+F + LG G G V K V +G+I + L E K E+
Sbjct: 2 DFEKLGELGAGNGGVVTK----------VLHRPSGLIMARKLIHLEIKPAIRNQIIRELK 51
Query: 644 VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
VL + ++V G E + E+M G+L + + + G P +++IA
Sbjct: 52 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIA- 107
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 763
V RG+ YL +HRD+KPSNIL+ K+ DFG ++ + S+ GT
Sbjct: 108 -VLRGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGT 161
Query: 764 FGYLAPE------YAVHTR-WS 778
Y++PE Y V + WS
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWS 183
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 17/185 (9%)
Query: 594 NFSEENILGRGGFGTVY---KGELHDGTKI-AVKRMEAGVISGKGLT--EFKSEIAVLTK 647
NF +LG G +G V+ K HD K+ A+K ++ I K T ++E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 648 VRHRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL-DV 705
+R + L + + KL L+ +Y+ G L H+ E K E + I ++
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ--RERFKEQE----VQIYSGEI 114
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 765
+E+LH L I+RD+K NILL + + DFGL + E + GT
Sbjct: 115 VLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIE 171
Query: 766 YLAPE 770
Y+AP+
Sbjct: 172 YMAPD 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 46/176 (26%), Positives = 76/176 (43%), Gaps = 29/176 (16%)
Query: 592 TNNFSEENILGRGGFGTVYKGELHDGT------KIAVKRMEAGVISGKGLTEFKSEIAVL 645
T F EE LG FG VYKG L +A+K ++ G EFK E +
Sbjct: 6 TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMR 62
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIF--------------NWAEEGLK 691
++++H ++V LLG ++F Y L + + L+
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 692 PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
P ++ + I +A G+E+L + +H+DL N+L+ D + K++D GL R
Sbjct: 123 PADF---VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 57/174 (32%), Positives = 80/174 (45%), Gaps = 12/174 (6%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEA-GVISGKGLTEFKSEIAVLTK-VRHRHLVAL 656
++G+G FG V K AVK ++ ++ K SE VL K V+H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
++ V +Y+ G L H+ L+P R A ++A + YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHL-QRERCFLEP----RARFYAAEIASALGYLHSL- 115
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+ ++RDLKP NILL + DFGL + E G+ T GT YLAPE
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 55/178 (30%), Positives = 80/178 (44%), Gaps = 25/178 (14%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKG---LTEFKSEIAVLTKVRHRHLVALL 657
LG G FG VYK + + +A A VI K L ++ EI +L H ++V LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAA----AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT---IALDVARGVEYLHG 714
N ++ E+ G + + LE R LT I + + +E L+
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVM----------LELERPLTEPQIRVVCKQTLEALNY 118
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFGYLAPE 770
L IHRDLK NIL D K+ADFG ++ + +I+ R GT ++APE
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPE 173
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 20/160 (12%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRH 650
++F ++GRG FG V + D I A+K++ + K ++E +L + +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQG---TL--SRHIFNWAEEGLKPLEWNRRLTIALDV 705
+V L D N L+ EY+P G TL + F EE R IA +
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTF--TEEE-------TRFYIA-ET 110
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745
++ +H L +IHRD+KP N+LL K++DFGL
Sbjct: 111 ILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
LG G + TV+KG +A+K + G T + E+++L ++H ++V L H
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTL--H 69
Query: 660 CLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
+ E+ LVFEY+ L +++ N + + + RG+ Y H
Sbjct: 70 DIIHTERCLTLVFEYL-DSDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCH---K 121
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ +HRDLKP N+L+ + K+ADFGL R
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 600 ILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKG-LTEFKSEIAVLTKVRHRHLVALL 657
+LG+G FG V E G A+K + VI K + +E VL RH L AL
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+ +++L V EY G L F+ + E + R ++ +EYLH
Sbjct: 61 KYAFQTHDRLCFVMEYANGGEL---FFHLSRE--RVFTEERARFYGAEIVSALEYLHS-- 113
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+ ++RD+K N++L D K+ DFGL + +++T GT YLAPE
Sbjct: 114 -RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 54/181 (29%), Positives = 81/181 (44%), Gaps = 17/181 (9%)
Query: 598 ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
+ ++G+G +G V + H G K+A+K++ T EI +L +RH +V +
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64
Query: 657 LGHCL-----DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
L + + +VFE M H A + L P L L R ++Y
Sbjct: 65 KHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEHHQFFLYQLL---RALKY 118
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSI-ETRIAGTFGYLAP 769
+H + HRDLKP NIL D + K+ DFGL R+A + +I T T Y AP
Sbjct: 119 IHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 770 E 770
E
Sbjct: 176 E 176
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 5e-09
Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 23/176 (13%)
Query: 597 EENILGRGGFGTVYKGE-LHDGTKIAVKRM-EAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
EEN++ RG G YKG+ + +G + VK + + I SEIA + K++H ++V
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-------SSEIADMGKLQHPNIV 746
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
L+G C L+ EY+ LS E L+ L W RR IA+ +A+ + +LH
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNLS--------EVLRNLSWERRRKIAIGIAKALRFLHC 798
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+ + +L P I++ D +RL+ G +T+ + Y+APE
Sbjct: 799 RCSPAVVVGNLSPEKIII------DGKDEPHLRLSLPGLLCTDTKCFISSAYVAPE 848
|
Length = 968 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 12/186 (6%)
Query: 601 LGRGGFGTVY-----KGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 655
LG+G FGTVY K + K+ +K + G ++ + E +L+K+ H +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKV-LKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
L+ + ++ EY L + G K L N+ + + GV Y+H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTG-KTLSENQVCEWFIQLLLGVHYMH-- 123
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHT 775
+ +HRDLK NI L +++ K+ DFG+ RL G + T GT Y++PE H
Sbjct: 124 -QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 776 RWSSCS 781
+ S S
Sbjct: 181 GYDSKS 186
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 58/199 (29%), Positives = 86/199 (43%), Gaps = 42/199 (21%)
Query: 591 VTNNFSEENILGRGGFGTVYKGELHD--GTKIAVKRMEAGVISGKGLTEFKSEIAVLTK- 647
+ + +GRG FGTV K LH GT +AVKR+ + V K ++ V+ +
Sbjct: 2 TAEDLKDLGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRS 59
Query: 648 ------VRHRHLVALLGHC------LDGN-EKLLVFEYMPQGTLSRHIFNWAEEGLKPLE 694
V+ + G C +D + +K + Y + + EE L
Sbjct: 60 SDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL----KSVIP--EEILG--- 110
Query: 695 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK- 753
IA+ + + YL IHRD+KPSNILL + K+ DFG+ G+
Sbjct: 111 -----KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGI-----SGQL 158
Query: 754 -GSI-ETRIAGTFGYLAPE 770
SI +TR AG Y+APE
Sbjct: 159 VDSIAKTRDAGCRPYMAPE 177
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 54/189 (28%), Positives = 84/189 (44%), Gaps = 13/189 (6%)
Query: 600 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKS-EIAVLTKVRHRHLVALL 657
+LG+G FG V+ EL A+K ++ V+ E E VL+ + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 658 GHCLDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
E L V EY+ G L HI + + R A ++ G+++LH
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHI-----QSCHKFDLPRATFYAAEIICGLQFLHS-- 114
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
+ ++RDLK NILL D K+ADFG+ + G T GT Y+APE + +
Sbjct: 115 -KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQK 172
Query: 777 WS-SCSYWA 784
++ S +W+
Sbjct: 173 YNTSVDWWS 181
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 51/187 (27%), Positives = 92/187 (49%), Gaps = 16/187 (8%)
Query: 601 LGRGGFGTVYKGELHDGTK---IAVKRMEAGVISGKGLT-EFKSEIAVLTKVRHRHLVAL 656
LG G FG V KG K +A+K ++ + K + E E ++ ++ + ++V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+G C + +LV E G L++ + +E + + + + V+ G++YL G
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNKFLSGKKDE----ITVSNVVELMHQVSMGMKYLEG-- 113
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLAPEYAVH 774
++F+HRDL N+LL + AK++DFGL + + R AG + + APE
Sbjct: 114 -KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 775 TRWSSCS 781
++SS S
Sbjct: 173 RKFSSRS 179
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 59/177 (33%), Positives = 85/177 (48%), Gaps = 18/177 (10%)
Query: 600 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTK-VRHRHLVAL 656
++G+G FG V + DG AVK ++ ++ + K +E VL K V+H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 657 LGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
+ EKL V +++ G L F+ E P E R A ++A + YLH +
Sbjct: 62 -HYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFP-EPRARFYAA-EIASALGYLHSI 115
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG--KGSIETRIAGTFGYLAPE 770
+ ++RDLKP NILL + DFGL + EG + T GT YLAPE
Sbjct: 116 ---NIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 55/189 (29%), Positives = 88/189 (46%), Gaps = 12/189 (6%)
Query: 600 ILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKG-LTEFKSEIAVLTKVRHRHLVALL 657
+LG+G FG V E G A+K ++ VI K + +E VL RH L AL
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+ +++L V EY G L F+ + E + +R ++ ++YLH +
Sbjct: 61 KYSFQTHDRLCFVMEYANGGEL---FFHLSRE--RVFSEDRARFYGAEIVSALDYLH--S 113
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
++ ++RDLK N++L D K+ DFGL + + +++T GT YLAPE
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDND 172
Query: 777 WSSCSYWAG 785
+ W G
Sbjct: 173 YGRAVDWWG 181
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 52/187 (27%), Positives = 86/187 (45%), Gaps = 21/187 (11%)
Query: 594 NFSEENILGRGGFGTVY---KGELHDGTKI---AVKRMEAGVISGKGLTEFKSEIAVLTK 647
NF +LG G +G V+ K HD K+ V + A V K + ++E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 648 VRHRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIF---NWAEEGLKPLEWNRRLTIAL 703
VR + L + KL L+ +Y+ G + H++ N++E+ ++ ++ + +AL
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF--YSGEIILAL 118
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 763
E+LH L ++RD+K NILL + + DFGL + + GT
Sbjct: 119 ------EHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGT 169
Query: 764 FGYLAPE 770
Y+APE
Sbjct: 170 IEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-08
Identities = 42/128 (32%), Positives = 59/128 (46%), Gaps = 17/128 (13%)
Query: 335 ALLSVVKLMGYPQRFAENWKGNDPCSD----WIGVTC----TKGN--ITVINFQKMNLTG 384
AL ++ +G P RF W G DPC W G C TKG I + L G
Sbjct: 376 ALQTLKSSLGLPLRFG--WNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRG 432
Query: 385 TISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS----FKSN 440
I + + + LQ + L+ N++ G IP L + +L+ LD+S N G IP S
Sbjct: 433 FIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSL 492
Query: 441 AIVNTDGN 448
I+N +GN
Sbjct: 493 RILNLNGN 500
|
Length = 623 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 53/188 (28%), Positives = 81/188 (43%), Gaps = 11/188 (5%)
Query: 600 ILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKG-LTEFKSEIAVLTKVRHRHLVALL 657
+LG+G FG V E G A+K ++ VI K + +E VL RH L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
+ V EY+ G L F+ + E + +R ++ ++YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGEL---FFHLSRE--RVFSEDRTRFYGAEIVSALDYLHS--- 113
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRW 777
++RDLK N++L D K+ DFGL + +++T GT YLAPE +
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDY 172
Query: 778 SSCSYWAG 785
W G
Sbjct: 173 GRAVDWWG 180
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 50/181 (27%), Positives = 81/181 (44%), Gaps = 28/181 (15%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLG 658
+G G F V K G A+K M+ S + + EI L ++ H +++ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLIE 65
Query: 659 HCLD-GNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
D +L LVFE M +++ + +PL R + + + ++++H
Sbjct: 66 VLFDRKTGRLALVFELMDM-----NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR-- 118
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
+ F HRD+KP NIL+ DD K+ADFG R I ++ T EY + TR
Sbjct: 119 NGIF-HRDIKPENILIKDD-ILKLADFGSCR-------GIYSKPPYT------EY-ISTR 162
Query: 777 W 777
W
Sbjct: 163 W 163
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 59/195 (30%), Positives = 84/195 (43%), Gaps = 25/195 (12%)
Query: 600 ILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKG-----LTEFKSEIAVLTKVRHRHL 653
+LG+G FG V E G A+K ++ VI K LTE + VL RH L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESR----VLQNTRHPFL 57
Query: 654 VALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
AL + +++L V EY G L H+ + E + +R ++ + YL
Sbjct: 58 TAL-KYSFQTHDRLCFVMEYANGGELFFHL---SRERV--FSEDRARFYGAEIVSALGYL 111
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG--KGSIETRIAGTFGYLAPE 770
H ++RDLK N++L D K+ DFGL + EG G+ GT YLAPE
Sbjct: 112 H---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 165
Query: 771 YAVHTRWSSCSYWAG 785
+ W G
Sbjct: 166 VLEDNDYGRAVDWWG 180
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 58/217 (26%), Positives = 84/217 (38%), Gaps = 74/217 (34%)
Query: 598 ENILGRGGFGTVYKGELHDGTK------IAVKRMEAGVISGKGLTEFK---SEIAVLTKV 648
LGRG FG V + K +AVK ++ G + +E+K +E+ +L +
Sbjct: 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA----SEYKALMTELKILIHI 67
Query: 649 -RHRHLVALLGHCLDGNEKLLVF-EYMPQGTLS------RHIF----------------- 683
H ++V LLG C L+V EY G LS R F
Sbjct: 68 GHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKE 127
Query: 684 ------------------NWAEE-GLKPLE--------WNRRLTI------ALDVARGVE 710
+ E+ L +E + LT+ + VARG+E
Sbjct: 128 GKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGME 187
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+L A + IHRDL NILL ++ K+ DFGL R
Sbjct: 188 FL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 53/192 (27%), Positives = 90/192 (46%), Gaps = 26/192 (13%)
Query: 601 LGRGGFGTVYKG--ELHDGTK-IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
LG G FGTV KG ++ K +AVK ++ E E V+ ++ + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVARGVEY 711
G C + +LV E G L+ K L+ N+ +T + V+ G++Y
Sbjct: 63 GIC-EAESWMLVMELAELGPLN-----------KFLQKNKHVTEKNITELVHQVSMGMKY 110
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLAP 769
L +F+HRDL N+LL AK++DFGL + + + + G + + AP
Sbjct: 111 LE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167
Query: 770 EYAVHTRWSSCS 781
E + ++SS S
Sbjct: 168 ECMNYYKFSSKS 179
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 56/191 (29%), Positives = 81/191 (42%), Gaps = 38/191 (19%)
Query: 594 NFSEENILGRGGFGTVYKGELHDGT------KIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
+F LG G FG V + H GT K KR ++ K + E ++L +
Sbjct: 19 DFEMGETLGTGSFGRVRIAK-HKGTGEYYAIKCLKKRE---ILKMKQVQHVAQEKSILME 74
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+ H +V ++ D N + E++ G L H+ + G P N DVA+
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFP---N-------DVAK 121
Query: 708 --------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR 759
EYLH I+RDLKP N+LL + KV DFG + P+ +
Sbjct: 122 FYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT---- 174
Query: 760 IAGTFGYLAPE 770
+ GT YLAPE
Sbjct: 175 LCGTPEYLAPE 185
|
Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-08
Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 603 RGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLGHC 660
RG FG VY G + +K+ AVK ++ + K + ++E L + +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 661 LDGNEKLLVFEYMPQGTLSR--HIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
N LV EY+ G + HI+ + +E + I+ +VA ++YLH
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA------VKYIS-EVALALDYLH---RH 123
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRL 748
IHRDLKP N+L+ ++ K+ DFGL ++
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 13/189 (6%)
Query: 600 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKS-EIAVLTKVRHRHLVALL 657
+LG+G FG V EL G AVK ++ V+ E E VL + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 658 GHCLDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
E L V E++ G L HI ++G + R A ++ G+++LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHI---QDKG--RFDLYRATFYAAEIVCGLQFLHS-- 114
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
+ I+RDLK N++L D K+ADFG+ + G T GT Y+APE +
Sbjct: 115 -KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLK 172
Query: 777 WS-SCSYWA 784
++ S +W+
Sbjct: 173 YTFSVDWWS 181
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 601 LGRGGFGTVYKG--ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
LG G + TV+KG +L + +A+K + G T + E+++L ++H ++V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
LVFEY L + + + ++ + + + RG+ Y H +
Sbjct: 72 IVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RR 123
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+HRDLKP N+L+ + K+ADFGL R
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 54/181 (29%), Positives = 87/181 (48%), Gaps = 25/181 (13%)
Query: 600 ILGRGGFGTVY-----KGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
+LG+G FG V+ G G A+K ++ + + K E +L +V H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 655 ALLGHCLDGNEKL-LVFEYMPQGT----LSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
L + KL L+ +++ G LS+ + + EE +K + L +ALD
Sbjct: 62 KL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVM-FTEEDVK--FYLAELALALD----- 112
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
+LH L I+RDLKP NILL ++ K+ DFGL + + + + + GT Y+AP
Sbjct: 113 -HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAP 167
Query: 770 E 770
E
Sbjct: 168 E 168
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 601 LGRGGFGTVYKGELHDGTKI--AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
LG+G +G+VYK LH T + A+K + + K + E+ +L K ++V G
Sbjct: 9 LGKGNYGSVYKV-LHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYG 66
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
+ EYM G+L + P + RR+T A V +G+++L
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLKFLK--EEH 122
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA----GTFGYLAPE 770
+ IHRD+KP+N+L+ + + K+ DFG+ G++ +A G Y+APE
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGV-------SGNLVASLAKTNIGCQSYMAPE 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 24/186 (12%)
Query: 599 NILGRGGFGTVYKG-ELHDGTKIAVKR--MEAGVISGKGLTEFKSEIAVLTKVRHRHLVA 655
+G+G FG V+K +A+K+ ME G +T + EI +L ++H ++V
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALR-EIKILQLLKHENVVN 75
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-------- 707
L+ C + Y L +F + E L L N+ + L +
Sbjct: 76 LIEIC--RTKATPYNRYKGSFYL---VFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR---LAPEGKGSIETRIAGTF 764
G+ Y+H +HRD+K +NIL+ D K+ADFGL R L+ K + T T
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 765 GYLAPE 770
Y PE
Sbjct: 188 WYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 47/163 (28%), Positives = 71/163 (43%), Gaps = 26/163 (15%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKG-LTEFKSEIAVLTKVRH 650
+F ++G+G FG V + D KI A+K + + K L K+E VL +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--- 707
+V+L D L+ E++P G L + + T + DV R
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD-------------TFSEDVTRFYM 107
Query: 708 -----GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745
+E +H L FIHRD+KP NIL+ K++DFGL
Sbjct: 108 AECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 34/147 (23%), Positives = 62/147 (42%), Gaps = 13/147 (8%)
Query: 600 ILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
+ K + T +AVK++ S + L + EI +++H +++ +
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL---DVARGVEYLHGLA 716
+ +E +V M G+ + EGL L IA DV ++Y+H
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP------ELAIAFILKDVLNALDYIH--- 118
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADF 743
+ FIHR +K S+ILL D + ++
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 53/176 (30%), Positives = 87/176 (49%), Gaps = 16/176 (9%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGK-GLTEFKSEIAVLTKVRHRH--LVA 655
I+GRGGFG VY D K+ A+K ++ I K G T +E +L+ V +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 656 LLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
+ + +KL + + M G L H+ ++ G+ E R A ++ G+E++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFS-EKEMRF-YATEIILGLEHMH- 114
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
++ ++RDLKP+NILL + +++D GL + K GT GY+APE
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 46/152 (30%), Positives = 68/152 (44%), Gaps = 20/152 (13%)
Query: 601 LGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
+G G FG V D + A+K + A V+ K+E +L + + +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 659 HCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
D + V +Y+P G + IF EE L R IA ++ +E +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIF---EEDLA------RFYIA-ELTCAIESVH 118
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745
+ FIHRD+KP NIL+ D K+ DFGL
Sbjct: 119 KMG---FIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 23/178 (12%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
+G G +G+V + G ++AVK++ S E+ +L ++H +++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL-- 82
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVARGVEYLH 713
D E L H+ L + ++LT + + RG++Y+H
Sbjct: 83 --DVFTPARSLEEFNDVYLVTHLMG---ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 137
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAPE 770
IHRDLKPSN+ + +D K+ DFGL R E G + TR Y APE
Sbjct: 138 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 187
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 53/180 (29%), Positives = 87/180 (48%), Gaps = 24/180 (13%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGK-GLTEFKSEIAVLTKVRHRH--LVA 655
I+GRGGFG VY D K+ A+K ++ I K G T +E +L+ V +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 656 LLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
+ + +KL + + M G L H+ ++ G+ E R A ++ G+E++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFS-EAEMRF-YAAEIILGLEHMH- 114
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLV----RLAPEGKGSIETRIAGTFGYLAPE 770
++ ++RDLKP+NILL + +++D GL + P GT GY+APE
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-------VGTHGYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 28/164 (17%)
Query: 601 LGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
LG G G V+ D ++AVK++ + + + EI ++ ++ H ++V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIV--LTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 660 CLDGNEKL--------------LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
L +V EYM + L+ + E+G E R L
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL----EQGPLSEEHARLFMYQL-- 123
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRL 748
RG++Y+H + +HRDLKP+N+ + +D+ K+ DFGL R+
Sbjct: 124 LRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 28/204 (13%)
Query: 574 QMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISG 632
Q A MV+ R +NF + +G G G V + G +AVK+M+
Sbjct: 4 QFRAALQMVVDPGDPRTYLDNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR 60
Query: 633 KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN--WAEEGL 690
+ L +E+ ++ +H ++V + L G+E +V E++ G L+ + + EE +
Sbjct: 61 REL--LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI 118
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV---- 746
+ L V + + LH Q IHRD+K +ILL D R K++DFG
Sbjct: 119 A--------AVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 167
Query: 747 RLAPEGKGSIETRIAGTFGYLAPE 770
+ P K + GT ++APE
Sbjct: 168 KEVPRRKS-----LVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 52/175 (29%), Positives = 77/175 (44%), Gaps = 14/175 (8%)
Query: 601 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRH---LVA 655
+G+G FG VY+ D +I A+K + I + K + E +L + +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
L ++ LV +YM G L H+ +EG E + IA ++ +E+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL---QKEGRFS-EDRAKFYIA-ELVLALEHLH-- 113
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
++RDLKP NILL + DFGL + A GT YLAPE
Sbjct: 114 -KYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPE 166
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 25/64 (39%), Positives = 36/64 (56%), Gaps = 3/64 (4%)
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 766
RG++YLH A +HRD+KP N+L+ + K+ DFGL R+ + T+ T Y
Sbjct: 114 RGLKYLHS-AG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 767 LAPE 770
APE
Sbjct: 171 RAPE 174
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 29/64 (45%), Positives = 37/64 (57%), Gaps = 4/64 (6%)
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 766
RG++Y+H + +HRDLKPSN+LL + K+ DFGL R E KG T T Y
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-KGDFMTEYVVTRWY 174
Query: 767 LAPE 770
APE
Sbjct: 175 RAPE 178
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 30/75 (40%), Positives = 44/75 (58%), Gaps = 14/75 (18%)
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LV-RLAPEGKGS 755
IA+ + + +EYLH + S IHRD+KPSN+L+ + + K+ DFG LV +A
Sbjct: 108 IAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA------ 159
Query: 756 IETRIAGTFGYLAPE 770
+T AG Y+APE
Sbjct: 160 -KTIDAGCKPYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 63/250 (25%), Positives = 104/250 (41%), Gaps = 14/250 (5%)
Query: 54 TDPCKWNHV---VCIEDKRITRIQIGHQNLQGTL-PSNLQNLTKLERLELQWNSISGPLP 109
T P N +E + R+ + + L PS+L L L+ L S
Sbjct: 28 TTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSE 87
Query: 110 SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNF 169
+L L L + L+ N+ S S L++L S+++DNN + P S L+
Sbjct: 88 NLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNITDIP-PLIGLLKSNLKEL 145
Query: 170 SANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKL 229
+ I +PS P L L L+FN L LP S S N K+
Sbjct: 146 DLSDNKIE-SLPS--PLRNLPNLKNLDLSFNDLSD-LPKLLSNL---SNLNNLDLSGNKI 198
Query: 230 GGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESL 289
I+ +++L+E+ L +N+ L S +K L L L +N P+S+ L +L
Sbjct: 199 SDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDL-PESIGNLSNL 257
Query: 290 KIVNMTNNLL 299
+ ++++NN +
Sbjct: 258 ETLDLSNNQI 267
|
Length = 394 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 5/63 (7%)
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
G+++LH IHRDLKPSNI++ D K+ DFGL R A G + T T Y
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 184
Query: 768 APE 770
APE
Sbjct: 185 APE 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 21/185 (11%)
Query: 594 NFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRHR 651
+F ++GRG FG V +L + K+ A+K + + + T F+ E VL ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNR----RLTIALDVAR 707
+ L D N LV +Y G L + + E P + R + IA+D
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAID--- 116
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPEGKGSIETRIA-GTFG 765
V LH ++HRD+KP NIL+ + ++ADFG ++L + G++++ +A GT
Sbjct: 117 SVHQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED--GTVQSSVAVGTPD 168
Query: 766 YLAPE 770
Y++PE
Sbjct: 169 YISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 56/196 (28%), Positives = 88/196 (44%), Gaps = 15/196 (7%)
Query: 594 NFSEENILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEFK-SEIAVLTKVRH 650
+F+ +LG+G FG V E GT A+K ++ VI E E VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
+ L C ++L V EY+ G L HI + + + + A ++A G+
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPHAVFYAAEIAIGL 114
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
+LH + I+RDLK N++L + K+ADFG+ + G + T GT Y+AP
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAP 170
Query: 770 EYAVHTRW-SSCSYWA 784
E + + S +WA
Sbjct: 171 EIIAYQPYGKSVDWWA 186
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 53/208 (25%), Positives = 76/208 (36%), Gaps = 52/208 (25%)
Query: 601 LGRGGFGTVYKGELHD-GTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
LG+G G V+ L G A+K ++ +I + +E +L + H L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVE 710
LV +Y P G L R L + + L+ +VAR +E
Sbjct: 69 SFQTETYLCLVMDYCPGGELFR---------LLQRQPGKCLSE--EVARFYAAEVLLALE 117
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEG----------------- 752
YLH L ++RDLKP NILL + ++DF L + E
Sbjct: 118 YLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 753 KGSIETRIA----------GTFGYLAPE 770
ET GT Y+APE
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPE 202
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 48/195 (24%), Positives = 78/195 (40%), Gaps = 41/195 (21%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEFKS----EIAVLT 646
N F ++G G +G V K H TK +A+K+ + + E K E+ +L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCR-HKETKEIVAIKKFK----DSEENEEVKETTLRELKMLR 55
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEY-----------MPQGTLSRHIFNWAEEGLKPLEW 695
++ ++V L + LVFEY MP G + ++ + +K + W
Sbjct: 56 TLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 696 NRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755
+ I +HRD+KP N+L+ + K+ DFG R EG +
Sbjct: 116 CHKNDI-------------------VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156
Query: 756 IETRIAGTFGYLAPE 770
T T Y +PE
Sbjct: 157 NYTEYVATRWYRSPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 13/193 (6%)
Query: 581 MVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAG--VISGKGLTEF 638
+V I+ L+ ++ ++GRG FG V K+ ++ + +I F
Sbjct: 31 IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 639 KSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR 698
E ++ +V L D +V EYMP G L + N+ P +W +
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKF 146
Query: 699 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIE 757
T +V ++ +H + IHRD+KP N+LL K+ADFG +++ G +
Sbjct: 147 YTA--EVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201
Query: 758 TRIAGTFGYLAPE 770
T + GT Y++PE
Sbjct: 202 TAV-GTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 51/178 (28%), Positives = 80/178 (44%), Gaps = 10/178 (5%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
LG G G V K + I +++ I + E+ VL + ++V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720
E + E+M G+L + + E P E +++IA V RG+ YL HQ
Sbjct: 73 YSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIA--VLRGLAYLRE-KHQ-I 125
Query: 721 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS 778
+HRD+KPSNIL+ K+ DFG ++ + S+ GT Y++PE T +S
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTRSYMSPERLQGTHYS 180
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 27/203 (13%)
Query: 599 NILGRGGFGTVYKGELHDGT-----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
++L G FG ++ G L D ++ VK ++ S +T E +L + H+++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNI 70
Query: 654 VALLGHCLDGNEKLLV-FEYMPQGTL------SRHIFNWAEEGLKPLEWNRRLTIALDVA 706
+ +L C++ E V + YM G L R + L + + +A+ +A
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLG---EANNPQALSTQQLVHMAIQIA 127
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGK---GSIETRIAG 762
G+ YLH IH+D+ N ++ ++++ K+ D L R L P G E R
Sbjct: 128 CGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR--- 181
Query: 763 TFGYLAPEYAVHTRWSSCS-YWA 784
++A E V+ +SS S W+
Sbjct: 182 PVKWMALESLVNKEYSSASDVWS 204
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 18/176 (10%)
Query: 601 LGRGGFG-TVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
+G G FG + DG + +K + +S K E + E+AVL+ ++H ++V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFN-----WAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
+ +V +Y G L + I + E+ + L+W ++ +AL +++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI--LDWFVQICLAL------KHVH- 118
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+ +HRD+K NI L D K+ DFG+ R+ T I GT YL+PE
Sbjct: 119 --DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 11/181 (6%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRH 650
++F ++GRG FG V ++ +I A+K + + + T F+ E VL
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+ + L D N LV +Y G L + + E P + R +A V
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF--EDRLPEDMAR-----FYIAEMVL 113
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA-GTFGYLAP 769
+H + ++HRD+KP N+LL + ++ADFG L G++++ +A GT Y++P
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC-LKMNQDGTVQSSVAVGTPDYISP 172
Query: 770 E 770
E
Sbjct: 173 E 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 6e-07
Identities = 54/188 (28%), Positives = 83/188 (44%), Gaps = 32/188 (17%)
Query: 601 LGRGGFGTVYKG---ELHDGTKIAVKRMEAGVISGKGLTEFK-SEIAVLTKVR-HRHLVA 655
LG+G +G V E + +A+K++ V S K L + E+ +L R H+++
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKI-TNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 656 LLGHCLDG------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
L +D NE L E M + L + I +PL + + G+
Sbjct: 67 LYD--MDIVFPGNFNELYLYEELM-EADLHQII-----RSGQPLTDAHFQSFIYQILCGL 118
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
+Y+H + +HRDLKP N+L+ D K+ DFGL R E G G++
Sbjct: 119 KYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA-------GFMT- 167
Query: 770 EYAVHTRW 777
EY V TRW
Sbjct: 168 EY-VATRW 174
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 41/162 (25%), Positives = 82/162 (50%), Gaps = 21/162 (12%)
Query: 601 LGRGGFGTVYKG---ELHDG-----TKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHR 651
LG+G F ++KG E+ D T++ +K ++ S + +E F ++++++ H+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK---SHRNYSESFFEAASMMSQLSHK 59
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
HLV G C+ G+E ++V EY+ G+L ++ + L + W L+VA+ + +
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK--NKNLINISWK------LEVAKQLAW 111
Query: 712 -LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752
LH L + H ++ N+LL + K + ++L+ G
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 50/179 (27%), Positives = 82/179 (45%), Gaps = 26/179 (14%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL-- 657
+G G +G+V + G K+A+K++ S E+ +L ++H +++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 658 ---GHCLDGNEKL-LVFEYMPQGTLSRHI-FNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
D + LV YM Q L + + +E+ ++ L + + G++Y+
Sbjct: 83 FTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSEDKVQYLVYQ--------MLCGLKYI 133
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSIETRIAGTFGYLAPE 770
H IHRDLKP N+ + +D K+ DFGL R A E G + TR Y APE
Sbjct: 134 HS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPE 184
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 39/207 (18%)
Query: 582 VISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGT-KIAVKRMEAGVISGKGLTEFKS 640
+I + R+ ++ NI+G G FG VY+ D + K+A+K++ ++K+
Sbjct: 55 MIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-------PQYKN 107
Query: 641 -EIAVLTKVRHRHLVALLGH----CLDGNEKLL----VFEYMPQGTLSRHIFNWAEEGLK 691
E+ ++ + H +++ L + C NEK + V E++PQ T+ +++ ++A
Sbjct: 108 RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARN--- 163
Query: 692 PLEWNRRLTIAL------DVARGVEYLHGLAHQSFI-HRDLKPSNILLGDDMRA-KVADF 743
N L + L + R + Y+H FI HRDLKP N+L+ + K+ DF
Sbjct: 164 ----NHALPLFLVKLYSYQLCRALAYIH----SKFICHRDLKPQNLLIDPNTHTLKLCDF 215
Query: 744 GLVRLAPEGKGSIETRIAGTFGYLAPE 770
G + G+ S+ + I F Y APE
Sbjct: 216 GSAKNLLAGQRSV-SYICSRF-YRAPE 240
|
Length = 440 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 51/180 (28%), Positives = 82/180 (45%), Gaps = 27/180 (15%)
Query: 601 LGRGGFGTV---YKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+G G +G+V Y L K+AVK++ S E+ +L ++H +++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 658 ------GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
+ NE LV M G +I + + +++ + + RG++Y
Sbjct: 81 DVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQF-----LIYQLLRGLKY 133
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEGKGSIETRIAGTFGYLAPE 770
+H IHRDLKPSN+ + +D ++ DFGL R A E G + TR Y APE
Sbjct: 134 IHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPE 185
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 31/81 (38%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 226 NAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSL 283
N L G I + I + L+ I L N+ G +P + LE L L N F G +P+SL
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 284 VKLESLKIVNMTNNLLQGPVP 304
+L SL+I+N+ N L G VP
Sbjct: 487 GQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 51/195 (26%), Positives = 87/195 (44%), Gaps = 13/195 (6%)
Query: 594 NFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEFKS-EIAVLTKVRHR 651
+F+ +LG+G FG V E ++ A+K ++ V+ E E VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 652 HLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+ L C ++L V EY+ G L HI + + + + + A +++ G+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPQAVFYAAEISVGLF 115
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+LH + I+RDLK N++L + K+ADFG+ + G GT Y+APE
Sbjct: 116 FLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAPE 171
Query: 771 YAVHTRWS-SCSYWA 784
+ + S +WA
Sbjct: 172 IIAYQPYGKSVDWWA 186
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 24/53 (45%), Positives = 30/53 (56%), Gaps = 2/53 (3%)
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
IHRD+KPSNILL K+ DFG+ + K +TR AG Y+APE
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--KTRSAGCAAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 10/186 (5%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
++F + + LG G G V+K I +++ I + E+ VL + +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V G E + E+M G+L + + + G P + +++IA V +G+ YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIA--VIKGLTYL 119
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
+HRD+KPSNIL+ K+ DFG ++ + S+ GT Y++PE
Sbjct: 120 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTRSYMSPERL 174
Query: 773 VHTRWS 778
T +S
Sbjct: 175 QGTHYS 180
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 45/174 (25%), Positives = 84/174 (48%), Gaps = 11/174 (6%)
Query: 600 ILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
++G+G +G V DG + +K++ S + + E +L++++H ++VA
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY-R 65
Query: 659 HCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+G + LL V + G L + E+ K L N+ + + +A ++YLH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKL---KEQKGKLLPENQVVEWFVQIAMALQYLH--- 119
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+ +HRDLK N+ L KV D G+ R+ E + + + + GT Y++PE
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 11/92 (11%)
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-- 748
+PL ++ L I + G+ YLH Q IHRD+K NI + D + + D G +
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208
Query: 749 -APEGKGSIETRIAGTFGYLAPEYAVHTRWSS 779
AP G +AGT APE +++S
Sbjct: 209 VAPAFLG-----LAGTVETNAPEVLARDKYNS 235
|
Length = 357 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 13/175 (7%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALL 657
++GRG FG V ++ + ++ A+K + + + T F+ E VL R + L
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
D N LV +Y G L + + E+ L P + R +A V + +
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRL-PEDMAR-----FYLAEMVLAIDSVHQ 120
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPEGKGSIETRIA-GTFGYLAPE 770
++HRD+KP N+LL + ++ADFG +RL + G++++ +A GT Y++PE
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD--GTVQSNVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 39/155 (25%), Positives = 73/155 (47%), Gaps = 10/155 (6%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRM--EAGVISGKGLTEFKSEIAVLTKVRH 650
++F ++GRG FG V + D I ++ +A ++ + + ++E +L +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+V + D L+ E++P G + + ++ L E + IA + ++
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK--KDTLS--EEATQFYIA-ETVLAID 115
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745
+H L FIHRD+KP N+LL K++DFGL
Sbjct: 116 AIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 6e-06
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 43/206 (20%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEA----GVISGKGLTEFKS-----EIAVLTKVRHR 651
+G G FG V+ + KR + IS +GL E + E+ V+ +++H+
Sbjct: 21 IGNGRFGEVFL--------VKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 652 HLVALLGHCLD-GNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
++V + L+ N+KL ++ E+ G LSR+I + +E + + I + +
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI-QKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 710 EYLHGLAH----QSFIHRDLKPSNILLGDDMR-----------------AKVADFGLVRL 748
Y H L + +HRDLKP NI L +R AK+ DFGL +
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 749 APEGKGSIETRIAGTFGYLAPEYAVH 774
G S+ GT Y +PE +H
Sbjct: 192 I--GIESMAHSCVGTPYYWSPELLLH 215
|
Length = 1021 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 49/189 (25%), Positives = 84/189 (44%), Gaps = 13/189 (6%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALL 657
++GRG + V L +I A+K ++ ++ + + ++E V + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
C +L LV EY+ G L +F+ + P E R A ++ + +LH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHAR--FYAAEICIALNFLH--- 113
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
+ I+RDLK N+LL D K+ D+G+ + G G + GT Y+APE
Sbjct: 114 ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL-GPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 777 WS-SCSYWA 784
+ S +WA
Sbjct: 173 YGFSVDWWA 181
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 17/191 (8%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRHLVALL 657
++GRG + V L +I A+K ++ +++ + + ++E V + + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 658 GHCLDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
C +L V EY+ G L +F+ + P E R + + +A + YLH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA--LNYLH--- 113
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR--LAPEGKGSIETRIAGTFGYLAPEYAVH 774
+ I+RDLK N+LL + K+ D+G+ + L P G + GT Y+APE
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP---GDTTSTFCGTPNYIAPEILRG 170
Query: 775 TRWS-SCSYWA 784
+ S +WA
Sbjct: 171 EDYGFSVDWWA 181
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 9e-06
Identities = 40/140 (28%), Positives = 61/140 (43%), Gaps = 27/140 (19%)
Query: 641 EIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT 700
E+ ++ V H+++++LL + PQ +L + L + +
Sbjct: 66 ELVLMKCVNHKNIISLLN------------VFTPQKSLEEFQDVYLVMELMDANLCQVIQ 113
Query: 701 IALDVAR----------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750
+ LD R G+++LH IHRDLKPSNI++ D K+ DFGL R A
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 169
Query: 751 EGKGSIETRIAGTFGYLAPE 770
G + T T Y APE
Sbjct: 170 -GTSFMMTPYVVTRYYRAPE 188
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 10/154 (6%)
Query: 594 NFSEENILGRGGFGTVYKGELHD-GTKIAVKRM-EAGVISGKGLTEFKSEIAVLTKVRHR 651
+F ++GRG FG V + D G A+K + +A ++ + + ++E +L +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
+V + D L+ E++P G + + ++ L E + IA + ++
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLT--EEETQFYIA-ETVLAIDS 116
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745
+H L FIHRD+KP N+LL K++DFGL
Sbjct: 117 IHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 45/153 (29%), Positives = 68/153 (44%), Gaps = 10/153 (6%)
Query: 595 FSEENILGRGGFGTVYKGELHD-GTKIAVKRM-EAGVISGKGLTEFKSEIAVLTKVRHRH 652
F + LG G FG V D A+K + + V+ + K+E +L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V L D + V +Y+P G + + G+ P + R L A VE +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCA--VESV 117
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745
H + FIHRD+KP NIL+ D K+ DFGL
Sbjct: 118 HKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 50/189 (26%), Positives = 82/189 (43%), Gaps = 13/189 (6%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEFKS-EIAVLTKVRHRHLVALL 657
+LG+G FG V E ++ A+K ++ V+ E E VL + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
C ++L V EY+ G L I + + + + A ++A G+ +LH
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQI-----QQVGRFKEPHAVFYAAEIAIGLFFLHS-- 119
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
+ I+RDLK N++L + K+ADFG+ + G GT Y+APE +
Sbjct: 120 -KGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAPEIIAYQP 177
Query: 777 WS-SCSYWA 784
+ S +WA
Sbjct: 178 YGKSVDWWA 186
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 24/60 (40%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 688 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
E PL+ + L + VA+G+++L A ++ IHRD+ N+LL D AK+ DFGL R
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 48/193 (24%), Positives = 77/193 (39%), Gaps = 19/193 (9%)
Query: 600 ILGRGGFGTV-YKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL-- 656
+LG G GTV + DG AVK ++ +S ++E+ L +V
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 657 -LGHCLDGNEKL-----LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
N + LV +Y G L + I + A+ + + + + V V
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTN-RTFREHEAGLLFIQVLLAVH 157
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-APEGKGSIETRIAGTFGYLAP 769
++H + IHRD+K +NILL + K+ DFG ++ A + GT Y+AP
Sbjct: 158 HVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214
Query: 770 EYAVHTRWSSCSY 782
E W Y
Sbjct: 215 EI-----WRRKPY 222
|
Length = 496 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 5/63 (7%)
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
G+++LH IHRDLKPSNI++ D K+ DFGL R A G + T T Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 192
Query: 768 APE 770
APE
Sbjct: 193 APE 195
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 39/120 (32%), Positives = 56/120 (46%), Gaps = 28/120 (23%)
Query: 668 LVFEYMPQG---TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRD 724
+V EY+ G TL ++I G P++ R + A V +EYLH +HRD
Sbjct: 78 MVMEYVEGGDCATLLKNI------GALPVDMAR-MYFAETVL-ALEYLHNYG---IVHRD 126
Query: 725 LKPSNILLGDDMRAKVADFGLVRLA--------PEGKGSIETR------IAGTFGYLAPE 770
LKP N+L+ K+ DFGL ++ EG +TR + GT Y+APE
Sbjct: 127 LKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 2e-05
Identities = 21/61 (34%), Positives = 37/61 (60%), Gaps = 3/61 (4%)
Query: 93 KLERLELQWNSISGPLP--SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNP 150
L+ L+L N ++ +P + GL +L+V+ LS N TS+ + F+GL SL+S+++ N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 151 F 151
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 10/153 (6%)
Query: 595 FSEENILGRGGFGTV-YKGELHDGTKIAVKRM-EAGVISGKGLTEFKSEIAVLTKVRHRH 652
F + LG G FG V ++ A+K + + V++ + K+E +L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V L D + V +Y+P G + + + P E R IA ++ +E +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM---EVFP-EVLARFYIA-ELTLAIESV 117
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745
H + FIHRD+KP NIL+ D K+ DFGL
Sbjct: 118 HKMG---FIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 23/57 (40%), Positives = 32/57 (56%), Gaps = 3/57 (5%)
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
K L + + VA+G+E+L A + IHRDL NILL ++ K+ DFGL R
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 24/58 (41%), Positives = 32/58 (55%), Gaps = 3/58 (5%)
Query: 690 LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
PL + + VARG+E+L A + IHRDL NILL ++ K+ DFGL R
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 20/178 (11%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVIS-GKGLTEFKSEIAVL-TKVRHRHLVAL 656
++GRG + V EL +I A+K ++ +++ + + ++E V T H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 657 LGH-CLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
H C +L V E++ G L +F+ + P E R + + +A L+
Sbjct: 62 --HSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLA-----LNF 111
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG--KGSIETRIAGTFGYLAPE 770
L + I+RDLK N+LL + K+ D+G+ + EG G + GT Y+APE
Sbjct: 112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYIAPE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 21/42 (50%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749
G+++LH IHRDLKPSNI++ D K+ DFGL R A
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 27/95 (28%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 638 FKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNR 697
F +++++V H HL + G C+ G+E ++V E++ G L + E+G P+ W
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD--VCLRKEKGRVPVAW-- 118
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732
++T+A +A + YL ++ +H ++ NILL
Sbjct: 119 KITVAQQLASALSYLE---DKNLVHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 8e-05
Identities = 21/61 (34%), Positives = 32/61 (52%), Gaps = 2/61 (3%)
Query: 371 NITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ 429
N+ ++ LT I F +L+ L L+ NNL+ + PE S L +L+ LD+S N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 430 L 430
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 21/105 (20%), Positives = 31/105 (29%), Gaps = 9/105 (8%)
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
R L L H + L + L R + + +R + +
Sbjct: 99 ARLLARL--HSVPPEALPLARRLRRRLKLLRQLAAALRRLVAAELLDRLAELWERLLA-- 154
Query: 710 EYLHGLAHQS---FIHRDLKPSNILLGDDMR-AKVADFGLVRLAP 750
L L +H DL P N+L+ R V DF L
Sbjct: 155 -ALLALLPALPLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLGD 198
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 32/116 (27%), Positives = 59/116 (50%), Gaps = 2/116 (1%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS-LNGLASLEVVMLSNNQ 126
KR+ + + G +P L +L++L +L+L N +SG +P L+ L + LS+NQ
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPS 182
+ F+ + L +++ N S EIP++L N L + + ++ G +PS
Sbjct: 535 LSGQIPASFSEMPVLSQLDLSQNQLSG-EIPKNLGNVESLVQVNISHNHLHGSLPS 589
|
Length = 968 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 1e-04
Identities = 16/41 (39%), Positives = 19/41 (46%), Gaps = 5/41 (12%)
Query: 29 DDGDAAVMLALKKSLNPPES---LGW--SDTDPCKWNHVVC 64
+ D +LA K SLN S W S +DPC W V C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 29/204 (14%)
Query: 581 MVISIQVLRNVTNNFSEENILGRGGFGTVYK-GELHDGTKIAVKRMEAGVISGKGLTEFK 639
++ ++ L + T+ + +G+G +G VYK DG+ AVK ++ IS E +
Sbjct: 10 SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP--ISDVD-EEIE 66
Query: 640 SEIAVLTKV-RHRHLVALLG------HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP 692
+E +L + H ++V G + G + LV E G+++ + +GL
Sbjct: 67 AEYNILQSLPNHPNVVKFYGMFYKADKLV-GGQLWLVLELCNGGSVTELV-----KGL-- 118
Query: 693 LEWNRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746
L +RL I G+++LH + IHRD+K +NILL + K+ DFG+
Sbjct: 119 LICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175
Query: 747 RLAPEGKGSIETRIAGTFGYLAPE 770
+ T + GT ++APE
Sbjct: 176 AQLTSTRLRRNTSV-GTPFWMAPE 198
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 23/179 (12%)
Query: 600 ILGRGGFGT--VYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
++G G FG + + D K A+K + S + + + E +L K++H ++VA
Sbjct: 7 VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAF- 63
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFN-----WAEEGLKPLEWNRRLTIALDVARGVEY 711
+ + L +V EY G L + I + E+ + L+W ++ + GV++
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI--LQWFVQMCL------GVQH 115
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+H + +HRD+K NI L + + K+ DFG RL G+ GT Y+ PE
Sbjct: 116 IH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS-PGAYACTYVGTPYYVPPE 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 23/62 (37%), Positives = 35/62 (56%), Gaps = 3/62 (4%)
Query: 686 AEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745
+++G + L L+ VARG+E+L A ++ +HRDL N+LL K+ DFGL
Sbjct: 227 SDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGL 283
Query: 746 VR 747
R
Sbjct: 284 AR 285
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 22/84 (26%), Positives = 34/84 (40%), Gaps = 16/84 (19%)
Query: 662 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFI 721
D + K +V EY+ L + ++ I V + LH +
Sbjct: 68 DPDNKTIVMEYIEGKPLK--------DVIEEGNDELLREIGRLVGK----LHKA---GIV 112
Query: 722 HRDLKPSNILLGDDMRAKVADFGL 745
H DL SNI++ DD + + DFGL
Sbjct: 113 HGDLTTSNIIVRDD-KLYLIDFGL 135
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 3/49 (6%)
Query: 699 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
L+ + VA+G+ +L A ++ IHRDL NILL K+ DFGL R
Sbjct: 217 LSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 262
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 25/66 (37%), Positives = 36/66 (54%), Gaps = 2/66 (3%)
Query: 375 INFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKI 434
+N N TG+I +L+ L L++N LSG IP + +LK LD+ N L GKI
Sbjct: 123 LNLSNNNFTGSIPRGSIP--NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 435 PSFKSN 440
P+ +N
Sbjct: 181 PNSLTN 186
|
Length = 968 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.001
Identities = 27/84 (32%), Positives = 34/84 (40%), Gaps = 16/84 (19%)
Query: 662 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFI 721
D + L+V EY+ G L LK R + +V R V LH +
Sbjct: 70 DPDNGLIVMEYIE-GEL-----------LKDALEEARPDLLREVGRLVGKLH---KAGIV 114
Query: 722 HRDLKPSNILLGDDMRAKVADFGL 745
H DL SNI+L R DFGL
Sbjct: 115 HGDLTTSNIILSGG-RIYFIDFGL 137
|
Length = 204 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.001
Identities = 17/41 (41%), Positives = 24/41 (58%), Gaps = 1/41 (2%)
Query: 92 TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPS 132
T LE L+L N I+ LP L+ L +LE + LS N+ T +
Sbjct: 1 TNLETLDLSNNQITD-LPPLSNLPNLETLDLSGNKITDLSP 40
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 33/138 (23%), Positives = 55/138 (39%), Gaps = 21/138 (15%)
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWA---EEGLKPLEWNRRLTIALDVARG 708
++V L + + + LV ++ G L HI + EE +K W + +ALD
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK--RWAAEMVVALD---- 99
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPEGKGSIETRIAGTFGYL 767
L + + RDL P+NILL D ++ F + G + Y
Sbjct: 100 -----ALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YC 149
Query: 768 APEY-AVHTRWSSCSYWA 784
APE + +C +W+
Sbjct: 150 APEVGGISEETEACDWWS 167
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 38/141 (26%), Positives = 62/141 (43%), Gaps = 5/141 (3%)
Query: 639 KSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR 698
+SE+ L H +V ++ LL+ EY G L++ I +E L E+
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 699 LTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG-SIE 757
L + + ++ +H + +HRDLK +NI L K+ DFG + + +
Sbjct: 173 L-LFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 758 TRIAGTFGYLAPEYAVHTRWS 778
+ GT YLAPE R+S
Sbjct: 229 SSFCGTPYYLAPELWERKRYS 249
|
Length = 478 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.002
Identities = 13/38 (34%), Positives = 24/38 (63%)
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSS 153
+L+ + LSNN+ T +P F GL +L+ +++ N +S
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS 38
|
Length = 60 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 34/129 (26%), Positives = 56/129 (43%), Gaps = 16/129 (12%)
Query: 616 DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675
K+ VK ++G EI +L + HR ++ L+ + +V MP+
Sbjct: 118 QRKKVIVK-----AVTGGKTPG--REIDILKTISHRAIINLIHAYRWKSTVCMV---MPK 167
Query: 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735
+F + + PL + +TI + + YLHG + IHRD+K NI L +
Sbjct: 168 YKCD--LFTYVD-RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEP 221
Query: 736 MRAKVADFG 744
A + DFG
Sbjct: 222 ENAVLGDFG 230
|
Length = 392 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 19/61 (31%), Positives = 33/61 (54%), Gaps = 3/61 (4%)
Query: 241 SLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 298
+LK + L +N + +PD F G+ L+ L L N T P++ L SL+ ++++ N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 299 L 299
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 0.003
Identities = 33/134 (24%), Positives = 49/134 (36%), Gaps = 37/134 (27%)
Query: 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVARGVEYLHGLAH 717
+L+ +Y+ G L F+ L+ +L+ I + + LH H
Sbjct: 82 KGHVLIMDYIKDGDL----FDL-------LKKEGKLSEAEVKKIIRQLVEALNDLH--KH 128
Query: 718 QSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE------ 770
IH D+K N+L R + D+GL + G S GT Y +PE
Sbjct: 129 N-IIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTPSCYD---GTLDYFSPEKIKGHN 182
Query: 771 YAVHTRWSSCSYWA 784
Y V W WA
Sbjct: 183 YDVSFDW-----WA 191
|
Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 28/186 (15%)
Query: 601 LGRGGFGTVYKGELHD--GTKIAVKRMEAGVI------SGKGLTEFKSEIAVLTKVRHRH 652
LG+G F +YKG L I E V+ + F ++++++ H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
LV L G C+ +E ++V EY+ G L +F E+ L W +L +A +A + YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLD--VFLHREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 713 HGLAHQSFIHRDLKPSNILL---GDDMR----AKVADFGLVRLAPEGKGSIETRIAGTFG 765
+ +H ++ NIL+ G + K++D G + + + RI
Sbjct: 118 E---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG-IPITVLSREERVERIP---- 169
Query: 766 YLAPEY 771
++APE
Sbjct: 170 WIAPEC 175
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.004
Identities = 25/116 (21%), Positives = 41/116 (35%), Gaps = 14/116 (12%)
Query: 638 FKSEIAVLTKVRHRHLVA--LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEW 695
+ E+A+L + + L +L L+ E++ TL +
Sbjct: 38 REREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD------------EVSE 85
Query: 696 NRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751
+ IA +A + LH L H DL P NIL+ D + D+ P
Sbjct: 86 EEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 787 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.98 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.98 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.98 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.96 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.96 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.96 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.96 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.96 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.96 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.96 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.96 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.96 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.96 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.96 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.96 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.96 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.96 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.96 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.96 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.96 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.96 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.96 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.96 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.96 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.96 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.96 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.96 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.96 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.96 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.96 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.96 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.95 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.95 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.95 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.95 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.95 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.95 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.95 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.95 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.95 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.95 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.95 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.95 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.95 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.95 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.95 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.95 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.95 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.95 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.95 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.95 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.95 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.95 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.95 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.94 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.94 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.94 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.94 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.94 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.94 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.94 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.94 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.94 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.94 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.94 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.94 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.94 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.94 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.94 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.94 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.94 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.94 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.94 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.94 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.94 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.94 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.94 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.94 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.94 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.94 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.94 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.94 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.94 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.94 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.94 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.94 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.94 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.94 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.94 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.93 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.93 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.93 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.93 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.93 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.93 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.93 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.93 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.93 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.93 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.93 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.93 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.93 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.93 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.93 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.93 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.93 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.93 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.93 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.93 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.93 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.93 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.93 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.93 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.93 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.93 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.93 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.93 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.93 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.93 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.93 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.93 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.93 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.93 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.93 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.93 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.93 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.93 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.93 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.93 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.92 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.92 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.92 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.92 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.92 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.92 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.92 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.92 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.92 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.92 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.92 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.92 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.92 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.92 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.92 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.92 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.92 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.92 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.92 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.92 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.92 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.92 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.92 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.92 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.92 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.92 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.92 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.92 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.91 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.91 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.91 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.91 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.91 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.91 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.91 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.91 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.9 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.9 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.9 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.9 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.89 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.88 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.88 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.88 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.87 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.86 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.86 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.85 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.85 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.84 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.81 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.81 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.7 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.59 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.55 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.46 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.43 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.41 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.41 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.4 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.38 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.38 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.3 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.18 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.16 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.16 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.14 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.13 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.11 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.11 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.06 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.04 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.04 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.0 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.97 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.95 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.94 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.83 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.76 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.76 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.75 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.73 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.65 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.63 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.62 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.61 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.57 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.56 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.54 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.52 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.47 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.45 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.42 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.41 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.36 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-75 Score=710.64 Aligned_cols=688 Identities=27% Similarity=0.425 Sum_probs=400.4
Q ss_pred CChhHHHHHHHHHHhcCCCCC--CCCC-CCCCCCcccEEEcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCC
Q 003911 28 GDDGDAAVMLALKKSLNPPES--LGWS-DTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSI 104 (787)
Q Consensus 28 ~~~~d~~~l~~~k~~~~~~~~--~~w~-~~~~C~w~gv~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l 104 (787)
.++.|++||++||+++.++.. .+|+ ..|||.|.||+|+..++|+.|+|++++++|.+|+.|..+++|+.|+|++|++
T Consensus 26 ~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~ 105 (968)
T PLN00113 26 LHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQL 105 (968)
T ss_pred CCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCcc
Confidence 366899999999999987653 4896 4689999999998888999999999999999998899999999999999998
Q ss_pred CCCCC-C-CCCCCCCcEEEcccccCCc----------------------CCCccccCCCCCcEEEccCCCCCCCCCChhh
Q 003911 105 SGPLP-S-LNGLASLEVVMLSNNQFTS----------------------VPSDFFTGLSSLQSIEIDNNPFSSWEIPQSL 160 (787)
Q Consensus 105 ~~~~~-~-~~~l~~L~~L~L~~N~l~~----------------------~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~ 160 (787)
++.+| . +.++++|++|+|++|++++ ..|..|+++++|++|+|++|.+.+ .+|..+
T Consensus 106 ~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~ 184 (968)
T PLN00113 106 SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG-KIPNSL 184 (968)
T ss_pred CCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccc-cCChhh
Confidence 87666 3 4466666666666666654 334445555666666666665554 455555
Q ss_pred hcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCccc-ccccceeeccCCC--------------
Q 003911 161 RNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNG-------------- 225 (787)
Q Consensus 161 ~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~L~~~~~~~-------------- 225 (787)
.++++|++|++++|++++.+|..++ .+++|++|+|++|++++.+|..+.. .+|+.|++.++..
T Consensus 185 ~~l~~L~~L~L~~n~l~~~~p~~l~--~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 262 (968)
T PLN00113 185 TNLTSLEFLTLASNQLVGQIPRELG--QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNL 262 (968)
T ss_pred hhCcCCCeeeccCCCCcCcCChHHc--CcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCC
Confidence 5566666666666655555555554 5555555555555555555555443 3344444433221
Q ss_pred -------CCcCCCCccccccCccCceEeccccccccCCCC-CCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCC
Q 003911 226 -------NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297 (787)
Q Consensus 226 -------~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 297 (787)
+...+..|..+.++++|+.|+|++|.+++.+|. +.++++|+.|++++|.+++.+|..+..+++|+.|+|++|
T Consensus 263 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n 342 (968)
T PLN00113 263 QYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342 (968)
T ss_pred CEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCC
Confidence 111112223334444444444444444443332 344444444444444444444444444444555555555
Q ss_pred cccccCCC-CCCceeeeccccCCCccCC-CCCCC--------------------CchhhHHHHHHHH-------h-CCCh
Q 003911 298 LLQGPVPE-FDRSVSLDMAKGSNNFCLP-SPGAC--------------------DPRLNALLSVVKL-------M-GYPQ 347 (787)
Q Consensus 298 ~l~~~~p~-~~~~~~L~~l~~~~n~~~~-~~~~~--------------------~~~~~~l~~~~~~-------~-~~~~ 347 (787)
++++.+|. +..+.+|+.+++++|.+.. .|... ......+..+..+ . ..+.
T Consensus 343 ~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~ 422 (968)
T PLN00113 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422 (968)
T ss_pred CCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECCh
Confidence 54444332 3333344444444443321 11000 0000000000000 0 0000
Q ss_pred hhh------------cc------------------------cCCCCC------------------CCCccccccCCCceE
Q 003911 348 RFA------------EN------------------------WKGNDP------------------CSDWIGVTCTKGNIT 373 (787)
Q Consensus 348 ~~~------------~~------------------------~~~~~~------------------~~~~~~~~~~~~~L~ 373 (787)
.+. +. ..+..| .......+..+++|+
T Consensus 423 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~ 502 (968)
T PLN00113 423 EFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELM 502 (968)
T ss_pred hHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccC
Confidence 000 00 000000 000111222334566
Q ss_pred EEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCC----CCCCceeecCCCC
Q 003911 374 VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNP 449 (787)
Q Consensus 374 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~----~~~~~~~~~~gn~ 449 (787)
.|+|++|++.+.+|..++.+++|+.|+|++|+++|.+|..+..+++|++|||++|+++|.+|. +..+..+.+.+|+
T Consensus 503 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~ 582 (968)
T PLN00113 503 QLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH 582 (968)
T ss_pred EEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCc
Confidence 777777777777777777777777777777777777777777777777777777777777775 3445666777777
Q ss_pred CCCCCCCCC---------CCCCCCCCCCCCCCCCCCCCCCCCcCCCcceEEeeeehhhHHHHHHHHHhhhheeeeccccc
Q 003911 450 DIGKEKSSS---------FQGSPSGSPTGTGSGNASSTENGVKNSSALITVILFCVIGGAFVISLTGVLVFCLCKKKQKR 520 (787)
Q Consensus 450 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~ig~~~~~~~~~~~~~~~~~~~~~~ 520 (787)
..+..|... +.+.+.-+........ .+.....+ . ....+++++++++++++++++++++ +++++++.
T Consensus 583 l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~-~~c~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 658 (968)
T PLN00113 583 LHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGL-PPCKRVRK-T-PSWWFYITCTLGAFLVLALVAFGFV-FIRGRNNL 658 (968)
T ss_pred ceeeCCCcchhcccChhhhcCCccccCCccccCC-CCCccccc-c-ceeeeehhHHHHHHHHHHHHHHHHH-HHHhhhcc
Confidence 665433211 0111100000000000 00000111 1 1122222223333322222222222 22222111
Q ss_pred ccccCCCCcccccCCCCCCCCCcceeeeecCCCcccccccccccCCCCCCcchhhhc-cCceeeeHHHHHhhcCCCcccc
Q 003911 521 FSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLE-AGNMVISIQVLRNVTNNFSEEN 599 (787)
Q Consensus 521 ~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 599 (787)
..+..+ . ..+ ..+ . ..+. .....+.. ......|...+
T Consensus 659 ~~~~~~------~--~~~--~~~---~--------------------------~~~~~~~~~~~~~---~~~~~~~~~~~ 696 (968)
T PLN00113 659 ELKRVE------N--EDG--TWE---L--------------------------QFFDSKVSKSITI---NDILSSLKEEN 696 (968)
T ss_pred cccccc------c--ccc--ccc---c--------------------------cccccccchhhhH---HHHHhhCCccc
Confidence 000000 0 000 000 0 0000 00001122 22334577788
Q ss_pred eeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCCCH
Q 003911 600 ILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (787)
Q Consensus 600 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (787)
.||+|+||.||+|+. .++..||||+++.... ...+|++++++++|||||++++++.+.+..|+||||+++|+|
T Consensus 697 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L 770 (968)
T PLN00113 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL 770 (968)
T ss_pred EEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcH
Confidence 999999999999986 4789999998864221 123568899999999999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCceee
Q 003911 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 758 (787)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 758 (787)
.++++ .++|.++.+++.|+++|++|||+.+.++|+||||||+||+++.++.+++. ||.+...... .
T Consensus 771 ~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~ 836 (968)
T PLN00113 771 SEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----T 836 (968)
T ss_pred HHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----C
Confidence 99983 37899999999999999999996555899999999999999998888875 6665443221 1
Q ss_pred eeccccCcccccccccCCcC-cceeec
Q 003911 759 RIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 759 ~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
...||+.|||||++.+..++ ++||||
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S 863 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYG 863 (968)
T ss_pred CccccccccCcccccCCCCCcccchhh
Confidence 23689999999999998888 899998
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=336.78 Aligned_cols=185 Identities=31% Similarity=0.516 Sum_probs=167.5
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
...+|...+.||+|+||+||+|+++ ++..||||.+.+.....+..+.+..|+++|+.++|||||++++++..++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3467899999999999999999876 689999999988766777888899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC------CcEEEeec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD------MRAKVADF 743 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DF 743 (787)
||||.||||.+|++. .+.+++..++.++.|+|.||++||+ ++||||||||+|||++.. -.+||+||
T Consensus 88 MEyC~gGDLs~yi~~-----~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRR-----RGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 999999999999965 3478999999999999999999998 899999999999999864 46899999
Q ss_pred ccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|+|+...+.. .....+|+|.|||||+++.++|+ ++|+||.
T Consensus 160 GfAR~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSi 200 (429)
T KOG0595|consen 160 GFARFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSI 200 (429)
T ss_pred chhhhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHH
Confidence 9999986543 34458999999999999999999 9999995
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=391.52 Aligned_cols=373 Identities=26% Similarity=0.408 Sum_probs=279.2
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (787)
.+++.|+|++|++++.+|..|+++++|++|+|++|++++.+| .|.++++|++|+|++|++++..|..+.++++|++|+|
T Consensus 212 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 291 (968)
T PLN00113 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL 291 (968)
T ss_pred CCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEEC
Confidence 468889999999998889889999999999999999888777 6888888899999888888877777888888888888
Q ss_pred cCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCccc-ccccceeeccCCC
Q 003911 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNG 225 (787)
Q Consensus 147 ~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~L~~~~~~~ 225 (787)
++|.+.+ .+|..+.++++|+.|++++|.+++.+|..+. .+++|+.|+|++|++++.+|..+.. .+|+.|++.++..
T Consensus 292 s~n~l~~-~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~--~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l 368 (968)
T PLN00113 292 SDNSLSG-EIPELVIQLQNLEILHLFSNNFTGKIPVALT--SLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368 (968)
T ss_pred cCCeecc-CCChhHcCCCCCcEEECCCCccCCcCChhHh--cCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCee
Confidence 8888876 7788888888888888888888888887775 7788888888888888777776654 3455555544321
Q ss_pred ---------------------CCcCCCCccccccCccCceEeccccccccCCC-CCCCCCCCCEEecCCCcccccCCccc
Q 003911 226 ---------------------NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSL 283 (787)
Q Consensus 226 ---------------------~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l 283 (787)
|...+..|..++++++|+.|+|++|++++.+| .+..+++|+.|+|++|++++.+|..+
T Consensus 369 ~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 448 (968)
T PLN00113 369 TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRK 448 (968)
T ss_pred EeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhh
Confidence 12223344556667777777777777776555 36667777777777777777777777
Q ss_pred cCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCcc
Q 003911 284 VKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWI 363 (787)
Q Consensus 284 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (787)
..+++|+.|+|++|++.+.+|......+|+.+++++|.+......... .+..+.. ....++.......
T Consensus 449 ~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~---~l~~L~~---------L~Ls~N~l~~~~p 516 (968)
T PLN00113 449 WDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLG---SLSELMQ---------LKLSENKLSGEIP 516 (968)
T ss_pred ccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhh---hhhccCE---------EECcCCcceeeCC
Confidence 777777777777777777777766666777777777766533221111 1111000 0001111111122
Q ss_pred ccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCC---CCCC
Q 003911 364 GVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS---FKSN 440 (787)
Q Consensus 364 ~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~---~~~~ 440 (787)
..+..+.+|+.|+|++|+++|.+|..|..+++|+.|+|++|+++|.+|..+..+++|+.|++++|+++|.+|+ +..+
T Consensus 517 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~ 596 (968)
T PLN00113 517 DELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAI 596 (968)
T ss_pred hHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhccc
Confidence 2344567899999999999999999999999999999999999999999999999999999999999999997 4445
Q ss_pred ceeecCCCCCCCCCC
Q 003911 441 AIVNTDGNPDIGKEK 455 (787)
Q Consensus 441 ~~~~~~gn~~~~~~~ 455 (787)
....+.||+.+|+.+
T Consensus 597 ~~~~~~~n~~lc~~~ 611 (968)
T PLN00113 597 NASAVAGNIDLCGGD 611 (968)
T ss_pred ChhhhcCCccccCCc
Confidence 567789999999754
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=332.24 Aligned_cols=201 Identities=51% Similarity=0.888 Sum_probs=175.2
Q ss_pred CceeeeHHHHHhhcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEe
Q 003911 579 GNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658 (787)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 658 (787)
....|++++++.++++|....+||+|+||.||+|...+|..||||++....... ..+|..|++++.+++|||+|+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 456799999999999999999999999999999999989999999886633221 456999999999999999999999
Q ss_pred EEEeCC-eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc
Q 003911 659 HCLDGN-EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (787)
Q Consensus 659 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 737 (787)
||.+.+ +.++|+|||++|+|.++++..... +++|.+|++||.++|+||+|||+.+...||||||||+|||+|++++
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 999998 599999999999999999763221 7899999999999999999999987778999999999999999999
Q ss_pred EEEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 738 AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 738 ~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+||+|||+|+..........+...||.+|+|||++..+..+ ++||||
T Consensus 216 aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVyS 263 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYS 263 (361)
T ss_pred EEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCccccccc
Confidence 99999999976654111111111799999999999988888 999998
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=309.83 Aligned_cols=180 Identities=28% Similarity=0.443 Sum_probs=161.3
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC-eeEEEEEe
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-EKLLVFEY 672 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~ 672 (787)
.+..+.||+|..|+||++.++ +++.+|+|++.. .......+++.+|++++++++||+||.+||.|+... +..|+|||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 344678999999999999876 788999999954 445667789999999999999999999999999998 59999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
|++|+|.+++.. .+.+++...-+|+.++++||.|||+ .++||||||||+|||++..|+|||||||.++.+...
T Consensus 160 MDgGSLd~~~k~-----~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDILKR-----VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999998854 2579999999999999999999996 389999999999999999999999999999887654
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
....++||..|||||.++++.|+ ++||||-
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSL 263 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSL 263 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecc
Confidence 34568999999999999999999 9999983
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=305.73 Aligned_cols=191 Identities=26% Similarity=0.475 Sum_probs=168.2
Q ss_pred CCCcccceeccccceEEEEEE-EeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEe-EEEeCCe-eEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG-HCLDGNE-KLLV 669 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~lv 669 (787)
.+|++.++||+|.||+||++. ..+|..||.|.++-...+.+..++...|+.+|++++|||||++++ .+.++.+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468899999999999999996 458999999999977778888899999999999999999999999 4455555 7899
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||..|||...++.+.++ .+.+++..+++++.|++.||.++|+..++ -|+||||||.||+++.+|.|||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999876655 46899999999999999999999984322 389999999999999999999999999998
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+.... ......+|||.||+||.+.+.+|+ ++||||.
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWsl 214 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSL 214 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHH
Confidence 86543 333458999999999999999999 9999983
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=309.00 Aligned_cols=185 Identities=29% Similarity=0.474 Sum_probs=159.7
Q ss_pred hcCCCcccceeccccceEEEEEE-EeCCcEEEEEEeecccccch-----hHHHHHHHHHHHHhcCCCccceEEeEEEeCC
Q 003911 591 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGK-----GLTEFKSEIAVLTKVRHRHLVALLGHCLDGN 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 664 (787)
+.+.|.+.+.||+|+||.|-+|. .++|+.||||++.+...... .....++|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45678999999999999999995 55899999999987644321 2334679999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC---CcEEEe
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVA 741 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~ 741 (787)
..||||||++||+|.+.+-. .+.+.+.....+++|++.|+.|||+ +||+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~-----nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA-----NKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHh-----ccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEec
Confidence 99999999999999998843 3567778889999999999999998 899999999999999755 679999
Q ss_pred ecccceecCCCCCceeeeeccccCcccccccccCCcC----cceeecC
Q 003911 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS----SCSYWAG 785 (787)
Q Consensus 742 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~DiWS~ 785 (787)
|||+|+.... .......+|||.|.|||++.+..++ ++|+||.
T Consensus 322 DFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSl 367 (475)
T KOG0615|consen 322 DFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSL 367 (475)
T ss_pred ccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeec
Confidence 9999998863 3455668999999999999876544 6899995
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=303.87 Aligned_cols=184 Identities=27% Similarity=0.484 Sum_probs=163.7
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.++||+|+||+||.++.+ +++.+|+|++++.... ....+...+|..++.+++||+||+++..|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 367999999999999999999755 7899999999886544 44677899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
+||+.||+|..+|.+ .+.+++..+..++..|+.||.|||+ ++||||||||+|||+|++|+++|+|||+++..
T Consensus 104 ld~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EeccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 999999999999943 3579999999999999999999998 99999999999999999999999999999865
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
-... .....++||+.|||||++.+..|+ ++|-||
T Consensus 176 ~~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWs 210 (357)
T KOG0598|consen 176 LKDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWS 210 (357)
T ss_pred ccCC-CccccccCCccccChHHHhcCCCCcccchHh
Confidence 4433 234458999999999999999999 677776
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=317.13 Aligned_cols=184 Identities=27% Similarity=0.465 Sum_probs=166.9
Q ss_pred CCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.+|...+.||+|+|+.||+++. .+|+.||+|++.+... .....+.+.+||++.++++|||||+++++|++.+.+|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999987 7899999999987543 3556778999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
|+|+.++|.++++ ..+++++.+++.+++||+.||.|||+ .+|||||||..|++++++++|||+|||+|....
T Consensus 98 ELC~~~sL~el~K-----rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-----RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHH-----hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence 9999999999884 34689999999999999999999998 899999999999999999999999999999886
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... .....+|||.|.|||++.....+ .+||||.
T Consensus 170 ~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSl 204 (592)
T KOG0575|consen 170 YDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSL 204 (592)
T ss_pred Cccc-ccceecCCCcccChhHhccCCCCCchhhhhh
Confidence 5533 33458999999999999988888 9999995
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=307.76 Aligned_cols=183 Identities=37% Similarity=0.616 Sum_probs=158.9
Q ss_pred CcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC-eeEEEEEec
Q 003911 595 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-EKLLVFEYM 673 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~ 673 (787)
....+.+|+|+||+||+|.++....||||++..........++|.+|+.++.+++|||||+++|+|.+.. ..++||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 3445669999999999999984444999999886666555789999999999999999999999999887 789999999
Q ss_pred CCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEcCCCCCCEEECCCC-cEEEeecccceecCC
Q 003911 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS-FIHRDLKPSNILLGDDM-RAKVADFGLVRLAPE 751 (787)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~ 751 (787)
++|+|.++++.. ....+++..++++|.|||+||+|||+ .+ ||||||||+|||++.++ ++||+|||+++....
T Consensus 123 ~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 123 PGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 999999999663 34689999999999999999999998 56 99999999999999997 999999999987754
Q ss_pred CCCceeeeeccccCcccccccc--cCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAV--HTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~-~~DiWS 784 (787)
.. ...+...||+.|||||++. ...|+ ++||||
T Consensus 197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvyS 231 (362)
T KOG0192|consen 197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYS 231 (362)
T ss_pred cc-ccccCCCCCccccChhhhcCCCCcCCccchhhh
Confidence 32 2223367999999999999 55888 999998
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=299.75 Aligned_cols=186 Identities=26% Similarity=0.399 Sum_probs=163.0
Q ss_pred cCCCcccceeccccceEEEEEE-EeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC--CeeEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLL 668 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 668 (787)
.+.|+.+++||+|+||.||+|+ ..+|+.||+|++......+.......+||.+|++++||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4568889999999999999996 45899999999988666666777889999999999999999999999876 68999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
|+|||+. ||.-++. ...-.+++.++..++.|++.||+|+|+ ++|+|||||.+|||||.+|.+||+|||+|+.
T Consensus 196 VFeYMdh-DL~GLl~----~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS----SPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEecccc-hhhhhhc----CCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceee
Confidence 9999965 7877663 233478999999999999999999998 8999999999999999999999999999998
Q ss_pred cCCCCCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
+........+..+-|..|+|||++.|. .|+ +.|+||.
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~ 306 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSV 306 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhh
Confidence 876665545556679999999999986 666 9999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=282.86 Aligned_cols=184 Identities=25% Similarity=0.361 Sum_probs=158.7
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
+.|+...++|+|+||+||+++.+ +|+.||||++.....++.-.+-..+|++++++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999876 79999999998755555555667899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
||+.. +.+-+. .....++.+.+..+.+|++.|+.|+|+ +++|||||||+|||++.++.+||||||+|+.+..
T Consensus 82 ~~dhT-vL~eLe----~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHT-VLHELE----RYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchH-HHHHHH----hccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99763 333332 234568899999999999999999997 8999999999999999999999999999998874
Q ss_pred CCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
. +...+.++.|..|+|||.+.| .+|. ++||||-
T Consensus 154 p-gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAi 188 (396)
T KOG0593|consen 154 P-GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAI 188 (396)
T ss_pred C-cchhhhhhhhhhccChhhhcccCcCCCcccchhh
Confidence 3 344566888999999999988 5777 8999983
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=301.36 Aligned_cols=183 Identities=29% Similarity=0.466 Sum_probs=167.4
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+....++..+.+++|++++++++||||+.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999765 78999999998877677788899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+.| +|..++.. .+.++++.+..++.+++.||.|||+ .+|+|||+||.|||++..|.+|++|||+|+.+..
T Consensus 82 ~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9976 99999843 4579999999999999999999998 8999999999999999999999999999998865
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
. ....+...|||.|||||++.++.|+ .+|.||.
T Consensus 153 ~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWsl 186 (808)
T KOG0597|consen 153 N-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSL 186 (808)
T ss_pred C-ceeeeeccCcccccCHHHHcCCCccchhhHHHH
Confidence 4 3556678899999999999999999 9999983
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=275.54 Aligned_cols=180 Identities=30% Similarity=0.468 Sum_probs=161.1
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccc-ccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|+..+.||.|+||.|..++.+ +|..+|+|++.+.. ...+..+...+|..+++.+.||+++++++.+.+.+..||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46888999999999999999865 78999999998754 33556677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||++||.|..+++. .+++++..++.+|.||+.|++|||+ .+|++||+||+|||+|.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999954 3579999999999999999999998 899999999999999999999999999999885
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.. ....+|||.|+|||+++...|. ++|-||
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWa 226 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWA 226 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHH
Confidence 43 3458999999999999999999 555554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=267.63 Aligned_cols=184 Identities=28% Similarity=0.441 Sum_probs=161.5
Q ss_pred CCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|...+++|+|.||.||+|+. ++|+.||||+++.....+.......+||+.++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688899999999999999964 589999999999876555556678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
||+ .+|+..+++ ....+...++..++.++++|++|+|+ +.|+||||||.|+|++.+|.+||+|||+|+.+..
T Consensus 82 fm~-tdLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred ecc-ccHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 995 599888854 44578999999999999999999997 8999999999999999999999999999999876
Q ss_pred CCCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
....... .+-|..|+|||.+.|. .|+ .+|+||.
T Consensus 154 p~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWav 188 (318)
T KOG0659|consen 154 PNRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAV 188 (318)
T ss_pred CCccccc-ceeeeeccChHHhccchhcCCcchhhhH
Confidence 6543333 3669999999999886 455 8999984
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=294.31 Aligned_cols=188 Identities=30% Similarity=0.464 Sum_probs=164.9
Q ss_pred HhhcCCCcccceeccccceEEEEEEE-eCCcEEEEEEeeccccc-chhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCe
Q 003911 589 RNVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNE 665 (787)
Q Consensus 589 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 665 (787)
+.-..+|.+++.||+|+|++|++|+. ++++.||||++.++... +...+-+.+|-++|.++ .||.|++++..|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44557899999999999999999965 47999999999876543 33455678899999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.|+|+||+++|+|.++|+. .+.+++...+.++.||+.||+|||+ +|||||||||+|||+|++|+++|+|||.
T Consensus 149 LYFvLe~A~nGdll~~i~K-----~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK-----YGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred eEEEEEecCCCcHHHHHHH-----hCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccc
Confidence 9999999999999999965 3579999999999999999999998 9999999999999999999999999999
Q ss_pred ceecCCCCCc------------eeeeeccccCcccccccccCCcC-cceeec
Q 003911 746 VRLAPEGKGS------------IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 746 a~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
|+.+.+.... ....++||..|.+||++.++..+ .+|+|+
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWA 272 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWA 272 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHH
Confidence 9877543211 11458999999999999999888 899997
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=297.42 Aligned_cols=186 Identities=30% Similarity=0.479 Sum_probs=162.2
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc---chhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCe
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNE 665 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 665 (787)
..++|.+.+.||+|+||.|+.|... +++.||+|++.++... ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568999999999999999999654 7899999987764222 134567779999999998 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC-CcEEEeecc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFG 744 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG 744 (787)
.++||||+.+|+|.+++.+ ..++.+..+.++++|++.|++|+|+ ++|+||||||+|||++.+ +++||+|||
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred EEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999954 3578889999999999999999998 899999999999999999 999999999
Q ss_pred cceecCCCCCceeeeeccccCcccccccccCC-cC--cceeecC
Q 003911 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR-WS--SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~--~~DiWS~ 785 (787)
++.... .........+||+.|+|||++.+.. |+ ++||||.
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~ 209 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSL 209 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhh
Confidence 999874 2222345578999999999999988 87 8999995
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=279.69 Aligned_cols=186 Identities=24% Similarity=0.415 Sum_probs=161.9
Q ss_pred cCCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||.|..++||+|+. ..++.||||++..+..... .+.+++|+..|+.++||||++++..|..+...|+||
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 35799999999999999999975 4789999999987655444 789999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
.||.+|++.+.++..... .+++..+..|.+++++||.|||. +|.||||||+.||||+.+|.|||+|||.+..+.
T Consensus 104 pfMa~GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred hhhcCCcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999876554 48999999999999999999997 899999999999999999999999999876544
Q ss_pred CCCCcee---eeeccccCccccccccc--CCcC-cceeec
Q 003911 751 EGKGSIE---TRIAGTFGYLAPEYAVH--TRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~---~~~~gt~~y~aPE~~~~--~~~~-~~DiWS 784 (787)
+...... ..++||+.|||||+++. ..|+ ++||||
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwS 217 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWS 217 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhh
Confidence 4322111 34689999999999654 3566 999998
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=290.52 Aligned_cols=181 Identities=32% Similarity=0.540 Sum_probs=157.9
Q ss_pred CcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecC
Q 003911 595 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 674 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (787)
++..+.||+|-||+||.|.+....+||+|.++.... ..++|.+|+++|++++|++||+++++|..++.+|||||||+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m---~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM---SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecccc---ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 455688999999999999998777999999987533 34688899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCC
Q 003911 675 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754 (787)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 754 (787)
.|+|.++++. .....+...+.+.++.|||+|++||++ +++|||||.++||||+++..+||+|||+|+...++..
T Consensus 285 ~GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 285 KGSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred cCcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 9999999965 334578889999999999999999998 8999999999999999999999999999996655443
Q ss_pred ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 755 SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 755 ~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.......-...|.|||.+..++++ +|||||
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWS 389 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWS 389 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceee
Confidence 322222235689999999999999 999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=279.18 Aligned_cols=184 Identities=32% Similarity=0.516 Sum_probs=155.6
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC--eeEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN--EKLLV 669 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv 669 (787)
.+|...+.||+|+||.||++... +|+..|||.+.... ....+.+++|+++|++++|||||+++|...... .++++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 45777899999999999999765 58999999987642 222677999999999999999999999865554 58899
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC-CCcEEEeeccccee
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRL 748 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~ 748 (787)
|||+++|+|.+++.+. +. .+++..+.++++||++||+|||+ +|||||||||+|||++. ++.+||+|||+++.
T Consensus 95 mEy~~~GsL~~~~~~~---g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRY---GG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeccCCCcHHHHHHHc---CC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 9999999999999652 22 68999999999999999999998 89999999999999999 79999999999987
Q ss_pred cCC--CCCceeeeeccccCcccccccccCCcC--cceeecC
Q 003911 749 APE--GKGSIETRIAGTFGYLAPEYAVHTRWS--SCSYWAG 785 (787)
Q Consensus 749 ~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~DiWS~ 785 (787)
... ........+.||+.|||||++.++... ++||||-
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSl 208 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSL 208 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhc
Confidence 763 112223347899999999999965444 8999995
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-33 Score=278.74 Aligned_cols=185 Identities=25% Similarity=0.442 Sum_probs=166.6
Q ss_pred hcCCCcccceeccccceEEEEEE-EeCCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
...+|++.+.||+|+||.|-+|. ...|+.||||.+++... ++++.-.+++||+||..++||||+++|.+|+..+...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 34579999999999999999995 46899999999987644 35567789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||..+|.|++|+.. .+.+++.++.++++||..|+.|.|. ++++|||||.+|||+|.++++||+|||++..
T Consensus 131 vMEYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhh
Confidence 9999999999999944 4579999999999999999999996 8999999999999999999999999999988
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC--cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS--SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~DiWS~ 785 (787)
+.+.. ....++|+|-|.+||++.|.+|. .+|-||.
T Consensus 203 y~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsL 239 (668)
T KOG0611|consen 203 YADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSL 239 (668)
T ss_pred hcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhH
Confidence 86543 44568999999999999999998 7999984
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=288.59 Aligned_cols=184 Identities=28% Similarity=0.412 Sum_probs=159.4
Q ss_pred hcCCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCC-eeE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGN-EKL 667 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~ 667 (787)
+.++|.+.+.||.|+||.||+|+. .+++.||||+++++...- +...=.+|+..|+++. |||||++.+++.+.+ ..|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH-HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 456899999999999999999975 479999999999866542 2233468999999998 999999999999988 899
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+||||| ..+|++.++++ .+.+++.+++.|++||++||+|+|. +|+.|||+||+|||+.....+||+|||+|+
T Consensus 87 fVfE~M-d~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred eeHHhh-hhhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccc
Confidence 999999 56999999663 4689999999999999999999996 999999999999999988899999999999
Q ss_pred ecCCCCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 748 LAPEGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
...... ..+.++.|..|+|||++.. +.|+ +.|+||.
T Consensus 159 ev~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~ 196 (538)
T KOG0661|consen 159 EVRSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAV 196 (538)
T ss_pred ccccCC--CcchhhhcccccchHHhhhccccCCchHHHHH
Confidence 886544 3455788999999999754 5666 9999984
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=288.28 Aligned_cols=182 Identities=27% Similarity=0.491 Sum_probs=161.7
Q ss_pred cCCCcccceeccccceEEEEEE-EeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
...|...+.||+|+.|.||.|. ..+++.||||++..... ...+-+.+|+.+|+..+|+|||.+++.|...++.|+||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 3467778899999999999995 55789999999987432 23456789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
|||+||+|.+.+.. ..+++.++..|+++++.||+|||. ++|+|||||.+|||++.+|.+||+|||++..+.
T Consensus 350 Eym~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred eecCCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 99999999998843 358999999999999999999998 899999999999999999999999999998886
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... .....+|||+|||||++....|. ++||||.
T Consensus 421 ~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSL 455 (550)
T KOG0578|consen 421 EEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSL 455 (550)
T ss_pred cccC-ccccccCCCCccchhhhhhcccCccccchhh
Confidence 6543 44568999999999999999998 9999984
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=283.15 Aligned_cols=189 Identities=24% Similarity=0.417 Sum_probs=162.1
Q ss_pred HhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 589 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 589 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
+...++|++++.||+|+||.||.|+-+ +|..+|+|++++... .....+.++.|-.+|...++|.||++|..|++.+..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345678999999999999999999755 799999999987643 345567789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
||||||++|||+..+|.. ...+++..+..++.+++.|++-||. .|+|||||||+|+|||..|++||+|||++
T Consensus 217 YLiMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred EEEEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeecccccc
Confidence 999999999999999843 3578999999999999999999997 89999999999999999999999999998
Q ss_pred eecCC----------------------CCCc-----ee-------------------eeeccccCcccccccccCCcC-c
Q 003911 747 RLAPE----------------------GKGS-----IE-------------------TRIAGTFGYLAPEYAVHTRWS-S 779 (787)
Q Consensus 747 ~~~~~----------------------~~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~-~ 779 (787)
.-+.. .... .. ...+|||-|||||++++..|+ .
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~ 368 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE 368 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence 42211 0000 00 124799999999999999999 8
Q ss_pred ceeecC
Q 003911 780 CSYWAG 785 (787)
Q Consensus 780 ~DiWS~ 785 (787)
+|.||.
T Consensus 369 cDwWSL 374 (550)
T KOG0605|consen 369 CDWWSL 374 (550)
T ss_pred ccHHHH
Confidence 999983
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=275.96 Aligned_cols=190 Identities=27% Similarity=0.455 Sum_probs=159.0
Q ss_pred eeHHHHHhhcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhc--CCCccceEEeEE
Q 003911 583 ISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV--RHRHLVALLGHC 660 (787)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~ 660 (787)
.++-.-+.+..+..+.+.||+|.||+||+|+++ |+.||||++.. .+.+.+.+|.++++.+ +|+||+.+++.-
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhcc
Confidence 344455667788899999999999999999998 99999999865 3346788888888876 999999999876
Q ss_pred EeCC----eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEEcCCCCCCEE
Q 003911 661 LDGN----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG-----LAHQSFIHRDLKPSNIL 731 (787)
Q Consensus 661 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-----~~~~~ivH~Dlkp~NIl 731 (787)
..+. +.|+|++|.+.|+|+||+.. ..++.+..++++..+|.||+|||. +.++.|.|||||+.|||
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL 348 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 348 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence 5443 57999999999999999944 468899999999999999999993 45788999999999999
Q ss_pred ECCCCcEEEeecccceecCCCCCce---eeeeccccCcccccccccC-------CcCcceeec
Q 003911 732 LGDDMRAKVADFGLVRLAPEGKGSI---ETRIAGTFGYLAPEYAVHT-------RWSSCSYWA 784 (787)
Q Consensus 732 l~~~~~~kl~DFG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-------~~~~~DiWS 784 (787)
|.+++.+.|+|+|+|.......... ....+||.+|||||++... .|-.+||||
T Consensus 349 VKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYa 411 (513)
T KOG2052|consen 349 VKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYA 411 (513)
T ss_pred EccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHH
Confidence 9999999999999998776543222 2457899999999999653 233699997
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=267.46 Aligned_cols=183 Identities=28% Similarity=0.411 Sum_probs=156.6
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC--CeeEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLLV 669 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 669 (787)
+.|+....|++|+||.||+|+.+ +++.||+|+++.+.......-.-.+||.++.+++|||||.+-.+.... +.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 46888899999999999999765 789999999987554444445668999999999999999999887643 579999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
||||+. ||..++.... +++...++..++.|+++|++|||. ..|+||||||+|+|+++.|.+||+|||+|+.+
T Consensus 156 Me~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred HHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhh
Confidence 999965 8988885532 578899999999999999999997 89999999999999999999999999999999
Q ss_pred CCCCCceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
...... .+..+-|..|+|||++.|. .|+ +.|+||
T Consensus 228 gsp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWS 263 (419)
T KOG0663|consen 228 GSPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWS 263 (419)
T ss_pred cCCccc-CcceEEEeeecCHHHhcCCcccCcchhhhh
Confidence 776433 3446679999999999886 455 899998
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=273.24 Aligned_cols=179 Identities=28% Similarity=0.504 Sum_probs=149.1
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC---e--eE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN---E--KL 667 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~--~~ 667 (787)
.|+..+++|.|+||.||+|... +++.||||++-.+. +.-.+|+++|++++|||||++..+|.... + ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 4666799999999999999765 57999999986532 12247999999999999999998887543 2 24
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC-CcEEEeecccc
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLV 746 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a 746 (787)
+|||||+. +|.++++.+...+ ..++...+.-+++||.+||.|||+ .+|+||||||.|+|+|.+ |.+||||||.|
T Consensus 99 lVleymP~-tL~~~~r~~~~~~-~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRAN-QRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcC-CCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 89999975 9999997654433 467888889999999999999998 899999999999999965 89999999999
Q ss_pred eecCCCCCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
+....+... ..+..|..|+|||.+.|. .|+ +.||||+
T Consensus 174 K~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSa 212 (364)
T KOG0658|consen 174 KVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSA 212 (364)
T ss_pred eeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhh
Confidence 998776644 335679999999999886 566 9999996
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=288.34 Aligned_cols=182 Identities=27% Similarity=0.436 Sum_probs=163.6
Q ss_pred CCCcccceeccccceEEEEEEE-eCCcEEEEEEeecc-cccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAG-VISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
+-|++++.||+|+.|.|-.|++ .+|+.+|||++.+. .........+++||-+|+.+.||||+++|+++++..+.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4588899999999999999975 58999999999876 344555678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|.|.+++.. .+++++.++.++++||+.|+.|+|. .+|+|||+||+|+|+|..+++||+|||+|..-.
T Consensus 92 Eyv~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EecCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 99999999999844 3578999999999999999999997 899999999999999999999999999998765
Q ss_pred CCCCceeeeeccccCcccccccccCCcC--cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS--SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~DiWS 784 (787)
++. .-...||+|.|+|||+++|.+|. ++||||
T Consensus 164 ~gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWS 197 (786)
T KOG0588|consen 164 PGK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWS 197 (786)
T ss_pred CCc--cccccCCCcccCCchhhcCCCCCCCccccch
Confidence 443 34457999999999999999998 999998
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=299.18 Aligned_cols=189 Identities=29% Similarity=0.523 Sum_probs=159.3
Q ss_pred CCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
.+....+.||+|+||+||+|+.. +...||||.++. ..+.+..++|++|+++++.++|||||+++|.|..++..
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd-~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD-KAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc-cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 34455688999999999999753 356799999987 34555789999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEG---------LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 737 (787)
+||+|||..|||.++++...... ..+++..+.+.||.|||.|++||-+ +.+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence 99999999999999997543211 2348889999999999999999997 88999999999999999999
Q ss_pred EEEeecccceecCCCCCceee-eeccccCcccccccccCCcC-cceeecC
Q 003911 738 AKVADFGLVRLAPEGKGSIET-RIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 738 ~kl~DFG~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|||+|||+++..-..+.+... ...=..+|||||.++.++|+ ++||||-
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~ 691 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSF 691 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhh
Confidence 999999999866544332221 22335689999999999999 9999983
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=268.73 Aligned_cols=187 Identities=27% Similarity=0.413 Sum_probs=157.5
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCc-cceEEeEEEeCC------
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH-LVALLGHCLDGN------ 664 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~------ 664 (787)
..|+..++||+|+||+||+|+.+ +|+.||+|++......+.......+|+.++++++|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45777888999999999999755 7999999999875443344566789999999999999 999999999877
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..++|+||+ .-+|.+++....... ..++...+..+++||+.||+|+|+ ++|+||||||+||||+++|.+||+|||
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccc
Confidence 788999999 569999986543321 356778899999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
+|+...-+.. ..+..++|..|+|||++.|. .|+ ..||||.
T Consensus 166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~ 207 (323)
T KOG0594|consen 166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSL 207 (323)
T ss_pred hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhH
Confidence 9997653332 23456789999999999998 566 8999984
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-33 Score=287.40 Aligned_cols=367 Identities=22% Similarity=0.241 Sum_probs=289.8
Q ss_pred CEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCC-CCCCcEEEcccccCCcCCCccccCCCCCcEEEcc
Q 003911 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNG-LASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (787)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 147 (787)
.+..||+++|.|+..-+..|-++++|+.++|.+|.++. +|.|++ ..+|+.|+|.+|.|+.+..+.+..++.|++||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~-IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTR-IPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhhh-cccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 57789999999998888889999999999999999995 455555 4559999999999999999999999999999999
Q ss_pred CCCCCCCCCC-hhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCccc-ccccceeeccCCC
Q 003911 148 NNPFSSWEIP-QSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNG 225 (787)
Q Consensus 148 ~N~l~~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~L~~~~~~~ 225 (787)
.|.|+ ++| ..|..-.++++|+|++|.|+..-...|. .+.+|..|.|+.|+++...+..|.. .+|+.|++..
T Consensus 158 rN~is--~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~--~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnr--- 230 (873)
T KOG4194|consen 158 RNLIS--EIPKPSFPAKVNIKKLNLASNRITTLETGHFD--SLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNR--- 230 (873)
T ss_pred hchhh--cccCCCCCCCCCceEEeecccccccccccccc--ccchheeeecccCcccccCHHHhhhcchhhhhhccc---
Confidence 99999 455 3566678999999999999988888886 8999999999999999888888863 5566666543
Q ss_pred CCcCCCCccccccCccCceEeccccccccCCC-CCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCC
Q 003911 226 NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304 (787)
Q Consensus 226 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 304 (787)
|.+-.-.--.|.++++|+.|.|..|.++..-. .|..+.++++|+|+.|+++..--.++.+|+.|+.|+||+|.|...-+
T Consensus 231 N~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~ 310 (873)
T KOG4194|consen 231 NRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHI 310 (873)
T ss_pred cceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeec
Confidence 32222222357889999999999999987665 48889999999999999997777889999999999999999987544
Q ss_pred -CCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCccc
Q 003911 305 -EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLT 383 (787)
Q Consensus 305 -~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~ 383 (787)
.|...++|+.+++++|.+..++......+..+..+. +..+.. ..--.+.+....+|+.|||++|.++
T Consensus 311 d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~Ln----Ls~Nsi--------~~l~e~af~~lssL~~LdLr~N~ls 378 (873)
T KOG4194|consen 311 DSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELN----LSHNSI--------DHLAEGAFVGLSSLHKLDLRSNELS 378 (873)
T ss_pred chhhhcccceeEeccccccccCChhHHHHHHHhhhhc----ccccch--------HHHHhhHHHHhhhhhhhcCcCCeEE
Confidence 588888999999999999888876655544443321 111100 0001245556679999999999999
Q ss_pred ccCch---hhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCC-CC--CCceeecCCCCCCCCCC
Q 003911 384 GTISP---EFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS-FK--SNAIVNTDGNPDIGKEK 455 (787)
Q Consensus 384 g~~p~---~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~-~~--~~~~~~~~gn~~~~~~~ 455 (787)
+.|.+ .|..|++|+.|+|.+|+|...--..|..+..|+.|||.+|.+-..-|. |. .+..+.+..-..+|++.
T Consensus 379 ~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCq 456 (873)
T KOG4194|consen 379 WCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQ 456 (873)
T ss_pred EEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEecc
Confidence 87754 478899999999999999954456899999999999999999876664 22 33445555555667643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=271.04 Aligned_cols=178 Identities=30% Similarity=0.488 Sum_probs=150.2
Q ss_pred CcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhc--CCCccceEEeEEEeCC----eeEE
Q 003911 595 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV--RHRHLVALLGHCLDGN----EKLL 668 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~----~~~l 668 (787)
.+..+++|+|+||.||+|++. ++.||||++.. +..+.|+.|-+|++.. +|+||++++++-.... +++|
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 445688999999999999986 69999999864 4567888888888875 7999999999877655 8899
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEEcCCCCCCEEECCCCcEEEee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL------AHQSFIHRDLKPSNILLGDDMRAKVAD 742 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~D 742 (787)
|+||.+.|+|.++++. ..++|....+|+..+++||+|||+. .+++|+|||||++||||..|+++.|+|
T Consensus 286 Vt~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EeeeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 9999999999999955 4689999999999999999999963 467899999999999999999999999
Q ss_pred cccceecCCCCCce-eeeeccccCcccccccccCC----cC---cceeec
Q 003911 743 FGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVHTR----WS---SCSYWA 784 (787)
Q Consensus 743 FG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~----~~---~~DiWS 784 (787)
||+|..+....... ....+||.+|||||++.|.- .+ +.|+||
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYa 409 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYA 409 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHH
Confidence 99998876543221 22368999999999998741 12 588886
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=255.72 Aligned_cols=185 Identities=29% Similarity=0.482 Sum_probs=163.3
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++++.||+|-||.||.|+.+ ++..||+|++.+.... ..-..++++|+++-+.++||||+++|++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 468999999999999999999765 6888999999875433 33456899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
+||.++|++...+.+ .....+++.....+..|+|.|+.|+|. ++||||||||+|+|++..+..||+|||.+...
T Consensus 101 lEya~~gel~k~L~~---~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE---GRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEecCCchHHHHHHh---cccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999998854 334568888999999999999999997 89999999999999999999999999998766
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... .....+||.-|.|||+..+..++ .+|+|+.
T Consensus 175 p~~---kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~l 208 (281)
T KOG0580|consen 175 PSN---KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSL 208 (281)
T ss_pred CCC---CceeeecccccCCHhhcCCCCccchhhHHHH
Confidence 432 34558899999999999999998 8999984
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-33 Score=261.50 Aligned_cols=185 Identities=27% Similarity=0.448 Sum_probs=164.5
Q ss_pred hcCCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+.+.|++.+.||+|.|+.||++.. .+|+.+|+|++.....+....+++++|++|.+.++||||+++.+.+.+....|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 456799999999999999999854 4899999999988777777889999999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC---CCCcEEEeecccc
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGLV 746 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG~a 746 (787)
+|+|+|++|..-|-.. ..+++..+-.+++||++||.|.|. ++|||||+||+|+++. ...-+||+|||+|
T Consensus 89 Fe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999998766432 356788889999999999999998 8999999999999995 3446999999999
Q ss_pred eecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... .+.....++|||+|||||++...+|+ ++||||.
T Consensus 161 i~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~c 198 (355)
T KOG0033|consen 161 IEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 198 (355)
T ss_pred EEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhh
Confidence 9887 34556678999999999999999999 8999984
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=280.98 Aligned_cols=186 Identities=24% Similarity=0.401 Sum_probs=168.7
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe-eEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE-KLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 670 (787)
++|...+++|+|+||.++.++++ ++..+|+|.+.....+....+...+|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57899999999999999999765 68899999998877777777789999999999999999999999999888 89999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
+|++||++.+.+.... ...++++++..++.|++.|+.|||+ .+|+|||||+.||++++++.|||+|||+|+...
T Consensus 84 ~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999997643 3568999999999999999999997 899999999999999999999999999999987
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... ....++||+.||.||++.+.+|. ++||||.
T Consensus 158 ~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsL 192 (426)
T KOG0589|consen 158 PEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSL 192 (426)
T ss_pred Cchh-hhheecCCCcccCHHHhCCCCCCccCcchhh
Confidence 6542 34458899999999999999999 9999984
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=277.29 Aligned_cols=183 Identities=26% Similarity=0.443 Sum_probs=161.4
Q ss_pred CCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
..|+..+.||+|.||.||+|.. ++++.||+|++..+ ......+++++|+.++.+++++||.++|+.+..+...|++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 3577789999999999999965 47899999999874 345567899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
||.||++.+.+.. ...+++..+..|++++..|+.|||+ .+.+|||||+.||++..+|.+|++|||.+..+..
T Consensus 92 y~~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HhcCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeec
Confidence 9999999998832 2344777888899999999999998 8999999999999999999999999999988766
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... ..++|||.|||||++.+..|+ ++||||.
T Consensus 164 ~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSL 197 (467)
T KOG0201|consen 164 TVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSL 197 (467)
T ss_pred hhhcc-ccccccccccchhhhccccccchhhhhhh
Confidence 54333 568999999999999988888 9999984
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=271.05 Aligned_cols=188 Identities=32% Similarity=0.493 Sum_probs=154.4
Q ss_pred HhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccc------------hhHHHHHHHHHHHHhcCCCccce
Q 003911 589 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG------------KGLTEFKSEIAVLTKVRHRHLVA 655 (787)
Q Consensus 589 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~ 655 (787)
....++|++.+.||+|.||.|-+|+.. +++.||||++.+..... ...+..++||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 445678999999999999999999765 79999999997543221 12457899999999999999999
Q ss_pred EEeEEEeC--CeeEEEEEecCCCCHHHHHHhhhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 003911 656 LLGHCLDG--NEKLLVFEYMPQGTLSRHIFNWAEEGLKP-LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (787)
Q Consensus 656 ~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 732 (787)
++++..+. +..|||+|||..|.+.+.- ..++ +.+.+++.|++++..||+|||. ++||||||||+|+|+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p------~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl 243 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP------PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLL 243 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC------CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEE
Confidence 99999875 5689999999998874322 2234 8999999999999999999998 899999999999999
Q ss_pred CCCCcEEEeecccceecCCCCC----ceeeeeccccCcccccccccC---CcC--cceeecC
Q 003911 733 GDDMRAKVADFGLVRLAPEGKG----SIETRIAGTFGYLAPEYAVHT---RWS--SCSYWAG 785 (787)
Q Consensus 733 ~~~~~~kl~DFG~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~---~~~--~~DiWS~ 785 (787)
+++|+|||+|||.+........ ......+|||.|||||...++ .++ +.||||.
T Consensus 244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWal 305 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWAL 305 (576)
T ss_pred cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhh
Confidence 9999999999999886633211 112346899999999998773 344 8999983
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=283.18 Aligned_cols=184 Identities=30% Similarity=0.496 Sum_probs=161.6
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 667 (787)
..++|.+.++||+|.||+|+.|+.+ +++.+|||++++..+ ...+.+....|.+|+... +||.++.++.+|+..++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3468999999999999999999876 788999999998754 466778889999999888 5999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
.||||+.||++..+. ..+.+++..+..+|..++.||+|||+ ++||+||||.+|||+|.+|.+||+|||+++
T Consensus 446 fvmey~~Ggdm~~~~------~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI------HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEecCCCcEEEEE------ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccc
Confidence 999999999965444 23579999999999999999999998 999999999999999999999999999998
Q ss_pred ecCCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 748 LAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..... +...+.++|||.|||||++.++.|+ ++|=||
T Consensus 517 e~m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~ 553 (694)
T KOG0694|consen 517 EGMGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWG 553 (694)
T ss_pred ccCCC-CCccccccCChhhcChhhhccCcccchhhHHH
Confidence 65422 3355679999999999999999999 566665
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=274.01 Aligned_cols=189 Identities=26% Similarity=0.473 Sum_probs=161.5
Q ss_pred HhhcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 589 RNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 589 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
+...+...+.++||+|-||+|..++...+..||||.++.. .......+|.+|+++|.+++||||++++|+|..++.+++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 3345567888999999999999999987899999999874 345557899999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
|+|||++|+|.+++..... ...+-+...+|+.||+.|++||.+ .++||||+.++|+|++.++++||+|||+++-
T Consensus 613 I~EYmEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HHHHHhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccc
Confidence 9999999999999955321 124556677899999999999998 8999999999999999999999999999986
Q ss_pred cCCCCC-ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 749 APEGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 749 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+-.+.. ....+.+-..+|||||.+.-++++ ++|+|+
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWa 724 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWA 724 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhh
Confidence 544433 333445567899999999888888 999997
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=281.09 Aligned_cols=189 Identities=24% Similarity=0.361 Sum_probs=159.9
Q ss_pred HHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 588 LRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 588 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
.....++|++.+.||+|+||.||+|+.. +++.||+|++.+... .....+.+.+|+++++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3444578999999999999999999875 688999999875322 23345568899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEeccc
Confidence 9999999999999998843 247888999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCCceeeeeccccCcccccccccCC----cC-cceeecC
Q 003911 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVHTR----WS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~-~~DiWS~ 785 (787)
|+.............+||+.|||||++.+.. ++ ++|+||.
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSl 233 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEee
Confidence 9876543322223467999999999997643 55 8999984
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=282.04 Aligned_cols=185 Identities=24% Similarity=0.446 Sum_probs=158.1
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||+||+|+.. +++.||+|++..... .......+.+|++++.+++||+|+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999765 689999999976432 2334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999998853 2468999999999999999999997 899999999999999999999999999987543
Q ss_pred CCCC----------------------------------ceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKG----------------------------------SIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... ......+||+.|+|||++.+..++ ++|+||.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSl 222 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhh
Confidence 2110 001235799999999999988888 8999983
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=275.28 Aligned_cols=189 Identities=30% Similarity=0.546 Sum_probs=161.9
Q ss_pred HHHHhhcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 586 QVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 586 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
++.....+.+.+.+.||+|+||+||+|++. -.||||++.....+.+..+.|+.|+.++++-+|.||+-+.|||..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 455555667788899999999999999987 359999999888888889999999999999999999999999998877
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.||+.+|+|-+|+.+++... ..++..+.+.||+|||+|+.|||. ++|||||||..||++.++++|||+|||+
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred -eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccc
Confidence 99999999999999997633 468899999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCCc-eeeeeccccCcccccccccC---CcC-cceeec
Q 003911 746 VRLAPEGKGS-IETRIAGTFGYLAPEYAVHT---RWS-SCSYWA 784 (787)
Q Consensus 746 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~-~~DiWS 784 (787)
+.......+. .....-|...|||||+++.+ +|+ .+||||
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYa 578 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYA 578 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhh
Confidence 8654332211 11223478889999999754 667 899997
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=262.51 Aligned_cols=179 Identities=28% Similarity=0.472 Sum_probs=159.8
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEec
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (787)
|.+.++||+|+||.||+|.++ +|+.||+|.+.. ....+++.+|+.++++++.|++|++||.|......|+|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 677899999999999999654 799999999865 345789999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCC
Q 003911 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (787)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 753 (787)
..|+..+.++. ..+++.+.++..+.+..++||+|||. ..-||||||+.|||++.+|.+||+|||.|..+.+..
T Consensus 111 GAGSiSDI~R~----R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 111 GAGSISDIMRA----RRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred CCCcHHHHHHH----hcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99999999854 34689999999999999999999997 778999999999999999999999999998776543
Q ss_pred CceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 754 GSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
. ....+.|||.|||||+++.-.|. .+||||.
T Consensus 184 A-KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSL 215 (502)
T KOG0574|consen 184 A-KRNTVIGTPFWMAPEVIEEIGYDTKADIWSL 215 (502)
T ss_pred H-hhCccccCcccccHHHHHHhccchhhhHhhh
Confidence 2 23457899999999999998888 9999984
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=275.67 Aligned_cols=181 Identities=27% Similarity=0.458 Sum_probs=159.2
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57999999999999999999875 689999999976432 2344567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 98 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 99999999998853 2467888999999999999999998 899999999999999999999999999998764
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... ....||+.|+|||++.+..++ ++|+||.
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 201 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTM 201 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCCCCcceeech
Confidence 432 235799999999999988888 8999984
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=273.47 Aligned_cols=185 Identities=29% Similarity=0.461 Sum_probs=164.3
Q ss_pred hhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCee
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEK 666 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 666 (787)
.....|++.+.||+|.||.||+++.+ +|+.+|+|++.+.... ....+.+.+|+++|+++. |||||.+++.|++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34567999999999999999999876 5999999999876543 335678999999999998 99999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC----CcEEEee
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAKVAD 742 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D 742 (787)
++|||++.||.|.+.+... .+++..+..++.|++.|+.|||+ .||+|||+||+|+|+... +.+|++|
T Consensus 112 ~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEee
Confidence 9999999999999999653 38999999999999999999998 899999999999999632 5799999
Q ss_pred cccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 743 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
||+|..... .......+||+.|+|||++.+..|+ .+|+||+
T Consensus 183 FGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~ 224 (382)
T KOG0032|consen 183 FGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSI 224 (382)
T ss_pred CCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHH
Confidence 999998876 3455668999999999999988888 9999995
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=280.78 Aligned_cols=185 Identities=26% Similarity=0.447 Sum_probs=156.7
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+++|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999764 789999999875432 2344567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999998853 2468889999999999999999998 899999999999999999999999999986332
Q ss_pred CCCCc----------------------------------------------eeeeeccccCcccccccccCCcC-cceee
Q 003911 751 EGKGS----------------------------------------------IETRIAGTFGYLAPEYAVHTRWS-SCSYW 783 (787)
Q Consensus 751 ~~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~-~~DiW 783 (787)
..... .....+||+.|+|||++.+..++ ++|+|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 11000 00124699999999999988888 89999
Q ss_pred cC
Q 003911 784 AG 785 (787)
Q Consensus 784 S~ 785 (787)
|.
T Consensus 233 Sl 234 (377)
T cd05629 233 SL 234 (377)
T ss_pred ec
Confidence 94
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=276.73 Aligned_cols=178 Identities=29% Similarity=0.468 Sum_probs=153.0
Q ss_pred CcccceeccccceEEEEEEE-eCCcEEEEEEeeccc-ccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 595 FSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
|.-.+-||.|+||.||-|+. ++.+.||||++.... .+...-.++.+|++.+++++|||++.+-|+|......|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55567799999999999975 478899999996532 2334456899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
| -|+-.+.+.- ..+++.+..+..|..+.+.||+|||+ .+.||||||+.|||+++.|.|||+|||.|....+.
T Consensus 108 C-lGSAsDlleV----hkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 108 C-LGSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred H-hccHHHHHHH----HhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 9 5677777632 33678999999999999999999998 89999999999999999999999999999877554
Q ss_pred CCceeeeeccccCcccccccc---cCCcC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAV---HTRWS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~---~~~~~-~~DiWS~ 785 (787)
. .++|||+|||||++. .+.|+ ++||||.
T Consensus 180 n-----sFvGTPywMAPEVILAMDEGqYdgkvDvWSL 211 (948)
T KOG0577|consen 180 N-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 211 (948)
T ss_pred h-----cccCCccccchhHheeccccccCCccceeec
Confidence 3 489999999999985 35677 9999994
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=280.03 Aligned_cols=185 Identities=24% Similarity=0.470 Sum_probs=157.8
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|+.. +++.||||++..... .......+.+|+++++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999875 689999999976432 2334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999998853 2368999999999999999999998 899999999999999999999999999987543
Q ss_pred CCCCc-------------------------------------eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGS-------------------------------------IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... .....+||+.|+|||++.+..++ ++|+||.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 225 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence 21100 01124699999999999988888 8999993
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=279.84 Aligned_cols=184 Identities=24% Similarity=0.412 Sum_probs=156.3
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.|++.+.||+|+||+||+|+.. +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999764 788999999976433 33455678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++++||+|||+++....
T Consensus 82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 82 YIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 9999999998853 2458889999999999999999997 8999999999999999999999999999754311
Q ss_pred CCC----------------------------------------------ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKG----------------------------------------------SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
... ......+||+.|+|||++.+..++ ++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 000 001235799999999999988888 899998
Q ss_pred C
Q 003911 785 G 785 (787)
Q Consensus 785 ~ 785 (787)
.
T Consensus 234 l 234 (381)
T cd05626 234 V 234 (381)
T ss_pred h
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=266.39 Aligned_cols=183 Identities=33% Similarity=0.534 Sum_probs=157.0
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.|+..+.||+|+||.||+|... +++.||+|++...... ......+.+|++++++++|++|+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3778899999999999999764 7999999998764332 2334567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++|+|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999998887542 22368899999999999999999998 8999999999999999999999999999987643
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.. ......||+.|||||++.+..++ ++|+||
T Consensus 155 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws 186 (285)
T cd05631 155 GE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWG 186 (285)
T ss_pred CC--eecCCCCCCCccCHhhhcCCCCCcccCchh
Confidence 32 22345789999999999998888 899998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=274.59 Aligned_cols=181 Identities=28% Similarity=0.416 Sum_probs=157.5
Q ss_pred CCCcccceeccccceEEEEEEEeC--CcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELHD--GTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
++|++.+.||+|+||.||+|.... +..||+|++..... .....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 579999999999999999997653 36899999875432 234456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999998843 2468899999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... .....||+.|||||++.+..++ ++|+||.
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 214 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTL 214 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccch
Confidence 432 2345799999999999988888 8999984
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=272.54 Aligned_cols=178 Identities=28% Similarity=0.411 Sum_probs=153.0
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (787)
+.||+|+||.||+|+.. +|+.||+|+++.... .......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 789999999986432 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCce
Q 003911 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 756 (787)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 756 (787)
+|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 151 (323)
T cd05571 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-AT 151 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cc
Confidence 99888843 2468899999999999999999998 899999999999999999999999999987543222 12
Q ss_pred eeeeccccCcccccccccCCcC-cceeecC
Q 003911 757 ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 757 ~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
....+||+.|+|||++.+..++ ++|+||.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 181 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCccc
Confidence 2346799999999999988888 8999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=271.94 Aligned_cols=181 Identities=28% Similarity=0.397 Sum_probs=157.9
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999865 789999999975432 2334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 99999999998843 2468899999999999999999998 899999999999999999999999999998664
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... ....||+.|+|||++.+..++ ++||||.
T Consensus 153 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 184 (291)
T cd05612 153 DRT----WTLCGTPEYLAPEVIQSKGHNKAVDWWAL 184 (291)
T ss_pred CCc----ccccCChhhcCHHHHcCCCCCchhhHHHH
Confidence 322 235689999999999988888 8999983
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=278.93 Aligned_cols=185 Identities=25% Similarity=0.426 Sum_probs=155.8
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.+|++.+.||+|+||.||+|+.. +++.||||++..... .......+.+|++++++++||||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999765 689999999875332 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|..+.
T Consensus 81 E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 81 DYIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 99999999999843 2457888999999999999999998 899999999999999999999999999975321
Q ss_pred CCC------------------------------------------CceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGK------------------------------------------GSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... .......+||+.|||||++.+..++ ++||||.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 230 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence 000 0001134799999999999998888 8999984
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=276.96 Aligned_cols=191 Identities=25% Similarity=0.359 Sum_probs=160.7
Q ss_pred HHHHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeC
Q 003911 586 QVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG 663 (787)
Q Consensus 586 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 663 (787)
.+.....++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344445679999999999999999999875 688999999875322 233445688999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
+..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeC
Confidence 999999999999999998843 247888899999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCCceeeeeccccCcccccccccCC----cC-cceeecC
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR----WS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~-~~DiWS~ 785 (787)
|+++.............+||+.|||||++.+.. ++ ++|+||.
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSl 233 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeeh
Confidence 999876543322233467999999999987643 55 8999994
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=274.24 Aligned_cols=181 Identities=28% Similarity=0.473 Sum_probs=158.7
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|+.. +++.||+|+++..... ......+.+|++++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999876 6899999999864322 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 99999999999843 2468899999999999999999998 899999999999999999999999999998664
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
. ......||+.|+|||++.+..++ ++|+||.
T Consensus 153 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 184 (333)
T cd05600 153 T----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSL 184 (333)
T ss_pred c----ccCCcccCccccChhHhcCCCCCCccceecc
Confidence 3 22345799999999999998888 8999984
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=259.00 Aligned_cols=186 Identities=28% Similarity=0.457 Sum_probs=159.1
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe-----CC
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-----GN 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~ 664 (787)
+...|...+.||+|+||.|+.|... +|+.||||++..........++..+|+++++.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456766899999999999999764 89999999998666667778899999999999999999999999875 34
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..|+|+|+| +.+|...++. .+.++.+.+..+++|+++||.|+|+ .+|+|||+||+|++++.+..+||+|||
T Consensus 100 DvYiV~elM-etDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred eeEEehhHH-hhHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEecccc
Confidence 689999999 6689888843 2358999999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCC-CceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 745 LVRLAPEGK-GSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
+|+...... ....+.++-|..|+|||++.. ..|+ +.||||.
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSv 214 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSV 214 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhh
Confidence 999885431 223356788999999998754 5787 8999995
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=278.45 Aligned_cols=184 Identities=26% Similarity=0.425 Sum_probs=155.6
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
+|++.+.||+|+||.||+|+.. +++.||+|++..... .......+.+|++++++++||||+++++.+.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999764 688999999976432 23445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 9999999998843 2357888999999999999999998 8999999999999999999999999999753210
Q ss_pred CC----------------------------------------------CceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GK----------------------------------------------GSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.. .......+||+.|+|||++.+..++ ++|+||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 00 0001124699999999999988888 999998
Q ss_pred C
Q 003911 785 G 785 (787)
Q Consensus 785 ~ 785 (787)
.
T Consensus 234 l 234 (382)
T cd05625 234 V 234 (382)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-31 Score=274.97 Aligned_cols=317 Identities=21% Similarity=0.203 Sum_probs=263.5
Q ss_pred CCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCC-CCcEEEccCCCCCCCCCChhhhcCCCCCEE
Q 003911 92 TKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLS-SLQSIEIDNNPFSSWEIPQSLRNASGLQNF 169 (787)
Q Consensus 92 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L 169 (787)
...+.|||++|+|+.+-+ .|.++++|++++|.+|.++.||. |+... +|+.|+|.+|.|+. .-.+++..++.|+.|
T Consensus 78 ~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~--f~~~sghl~~L~L~~N~I~s-v~se~L~~l~alrsl 154 (873)
T KOG4194|consen 78 SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPR--FGHESGHLEKLDLRHNLISS-VTSEELSALPALRSL 154 (873)
T ss_pred cceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhccc--ccccccceeEEeeecccccc-ccHHHHHhHhhhhhh
Confidence 356789999999998777 58999999999999999999986 55554 59999999999996 446789999999999
Q ss_pred eccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccc
Q 003911 170 SANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS 249 (787)
Q Consensus 170 ~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~ 249 (787)
||+.|.|+...-..|. .-.++++|+|++|+|+..--..|...+ +|.-..+..|.+....+..|+++++|+.|+|..
T Consensus 155 DLSrN~is~i~~~sfp--~~~ni~~L~La~N~It~l~~~~F~~ln--sL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnr 230 (873)
T KOG4194|consen 155 DLSRNLISEIPKPSFP--AKVNIKKLNLASNRITTLETGHFDSLN--SLLTLKLSRNRITTLPQRSFKRLPKLESLDLNR 230 (873)
T ss_pred hhhhchhhcccCCCCC--CCCCceEEeeccccccccccccccccc--hheeeecccCcccccCHHHhhhcchhhhhhccc
Confidence 9999999988777775 557899999999999988888886532 444444455666666667899999999999999
Q ss_pred cccccC-CCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCC-CCCceeeeccccCCCccCCCCC
Q 003911 250 NAFSGP-LPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPG 327 (787)
Q Consensus 250 N~l~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~L~~l~~~~n~~~~~~~ 327 (787)
|+|.-. .-.|.++++|+.|.|..|.|+..--..|..|.++++|+|+.|+++..-.. ++++..|+.+++++|.+..+..
T Consensus 231 N~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~ 310 (873)
T KOG4194|consen 231 NRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHI 310 (873)
T ss_pred cceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeec
Confidence 999854 33699999999999999999977778899999999999999999986664 7889999999999997765432
Q ss_pred CCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEeccccccc
Q 003911 328 ACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLS 407 (787)
Q Consensus 328 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 407 (787)
. .|. ..++|+.|+||+|+|+...+..|..|..|++|+|++|+++
T Consensus 311 d--------------------------------~Ws----ftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~ 354 (873)
T KOG4194|consen 311 D--------------------------------SWS----FTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID 354 (873)
T ss_pred c--------------------------------hhh----hcccceeEeccccccccCChhHHHHHHHhhhhcccccchH
Confidence 1 111 1248999999999999989999999999999999999998
Q ss_pred ccCCccCcCCCCCCeeeccCCcccccCCC-------CCCCceeecCCCCCC
Q 003911 408 GMIPEGLSVLGALKELDVSNNQLYGKIPS-------FKSNAIVNTDGNPDI 451 (787)
Q Consensus 408 g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~-------~~~~~~~~~~gn~~~ 451 (787)
..--..|..+++|++|||++|.|++.|.. ++++..+.+.||...
T Consensus 355 ~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk 405 (873)
T KOG4194|consen 355 HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK 405 (873)
T ss_pred HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee
Confidence 66666788999999999999999987764 444556777787653
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=270.55 Aligned_cols=186 Identities=23% Similarity=0.363 Sum_probs=157.7
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccc-ccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+++.. +++.||+|++.+.. ........+.+|+.++..++|++|+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999865 68899999987532 22334456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 999999999998542 2367889999999999999999997 899999999999999999999999999998765
Q ss_pred CCCCceeeeeccccCccccccccc-----CCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVH-----TRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~-~~DiWS~ 785 (787)
...........||+.|+|||++.+ +.++ ++|+||.
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSl 194 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSL 194 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEee
Confidence 443322333569999999999876 4455 8999984
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=270.67 Aligned_cols=186 Identities=25% Similarity=0.413 Sum_probs=159.4
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46899999999999999999765 789999999986433 2344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 999999999988542 2468899999999999999999998 899999999999999999999999999998775
Q ss_pred CCCCceeeeeccccCcccccccc------cCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAV------HTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~-~~DiWS~ 785 (787)
...........||+.|+|||++. +..++ ++||||.
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 195 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL 195 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecc
Confidence 44333333457999999999987 34555 8999984
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=269.94 Aligned_cols=186 Identities=24% Similarity=0.395 Sum_probs=157.4
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccc-ccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+++.. +++.||+|++.+.. ......+.+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999865 68999999997532 22334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 999999999988532 2358899999999999999999997 899999999999999999999999999997765
Q ss_pred CCCCceeeeeccccCccccccccc-----CCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVH-----TRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~-~~DiWS~ 785 (787)
...........||+.|||||++.+ ..++ ++|+||.
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl 194 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSL 194 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehh
Confidence 433322333569999999999873 3455 8999984
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=275.41 Aligned_cols=186 Identities=25% Similarity=0.368 Sum_probs=157.3
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
..++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|+++++.++||||+++++++.+....|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3468999999999999999999765 688999999975332 22334567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.
T Consensus 121 v~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 9999999999998843 247788899999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCceeeeeccccCcccccccccC----CcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHT----RWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~-~~DiWS~ 785 (787)
............+||+.|+|||++.+. .++ ++|+||.
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSl 233 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeeh
Confidence 644332222345799999999998764 355 8999983
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=276.98 Aligned_cols=183 Identities=26% Similarity=0.513 Sum_probs=160.5
Q ss_pred CCcccceeccccceEEEEEEEe----CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
...+.++||.|.||+||+|+++ ....||||.++.. .+++...+|..|..||.+++||||+++.|+.......+||
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 4577899999999999999876 2457999999874 4677788999999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
+|||++|+|..+++. ..+.+.+.+...+.++||.|+.||-+ +++|||||.++|||++.+..+|++|||+++.+
T Consensus 709 TEyMENGsLDsFLR~----~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred hhhhhCCcHHHHHhh----cCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999965 23568999999999999999999997 99999999999999999999999999999988
Q ss_pred CCCCCceeeeecc--ccCcccccccccCCcC-cceeec
Q 003911 750 PEGKGSIETRIAG--TFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 750 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.++.....+..-| ..+|.|||.+...+++ ++|+||
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWS 819 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWS 819 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccc
Confidence 6655333332222 3589999999999998 899998
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=273.87 Aligned_cols=185 Identities=24% Similarity=0.455 Sum_probs=157.8
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|+.. +++.||+|++..... .......+++|++++.+++||+|+++++.+.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999765 689999999975332 2344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999998843 2468899999999999999999997 899999999999999999999999999987543
Q ss_pred CCCC----------------------------------ceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKG----------------------------------SIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... ......+||+.|+|||++.+..++ ++|+||.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 222 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccc
Confidence 2110 001135799999999999998888 8999993
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-32 Score=286.65 Aligned_cols=334 Identities=24% Similarity=0.326 Sum_probs=251.4
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCC--cCCCccccCCCCCcEEE
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFT--SVPSDFFTGLSSLQSIE 145 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~ 145 (787)
.+++.|.|...++. .+|++++.|.+|++|.+++|++..+..++..|+.|+.+++.+|++. |+|++ +-.|..|+.||
T Consensus 32 t~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~d-iF~l~dLt~lD 109 (1255)
T KOG0444|consen 32 TQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTD-IFRLKDLTILD 109 (1255)
T ss_pred hheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCch-hcccccceeee
Confidence 57999999999998 8999999999999999999999988888999999999999999986 68887 55799999999
Q ss_pred ccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCC
Q 003911 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNG 225 (787)
Q Consensus 146 L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~ 225 (787)
||+|++. +.|..+..-+++-.|+|++|+|..++-+.|. +|+.|-+||||+|++....|..=....|+.|.++++-.
T Consensus 110 LShNqL~--EvP~~LE~AKn~iVLNLS~N~IetIPn~lfi--nLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL 185 (1255)
T KOG0444|consen 110 LSHNQLR--EVPTNLEYAKNSIVLNLSYNNIETIPNSLFI--NLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPL 185 (1255)
T ss_pred cchhhhh--hcchhhhhhcCcEEEEcccCccccCCchHHH--hhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChh
Confidence 9999999 8999999999999999999999866656664 89999999999999996555544446788888876543
Q ss_pred CC-cCCCCccccccCccCceEecccccc--ccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCccccc
Q 003911 226 NA-KLGGGIDVIQNMTSLKEIWLHSNAF--SGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302 (787)
Q Consensus 226 ~~-~~~~~~~~~~~l~~L~~L~L~~N~l--~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 302 (787)
+. ++.. +-.+++|+.|++++.+- ...|+.+..+.+|..+|||.|.+. .+|+.+.++.+|+.|+||+|+|+..
T Consensus 186 ~hfQLrQ----LPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL 260 (1255)
T KOG0444|consen 186 NHFQLRQ----LPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITEL 260 (1255)
T ss_pred hHHHHhc----CccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeee
Confidence 31 1222 23677888899988764 446678888999999999999999 8999999999999999999999876
Q ss_pred CCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCcccc---ccCCCceEEEEccC
Q 003911 303 VPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGV---TCTKGNITVINFQK 379 (787)
Q Consensus 303 ~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~L~~L~Ls~ 379 (787)
--......+|+.++++.|+++.+|.+. ..+..+..++...+.+. +.|+ +..+.+|+.+..++
T Consensus 261 ~~~~~~W~~lEtLNlSrNQLt~LP~av----cKL~kL~kLy~n~NkL~-----------FeGiPSGIGKL~~Levf~aan 325 (1255)
T KOG0444|consen 261 NMTEGEWENLETLNLSRNQLTVLPDAV----CKLTKLTKLYANNNKLT-----------FEGIPSGIGKLIQLEVFHAAN 325 (1255)
T ss_pred eccHHHHhhhhhhccccchhccchHHH----hhhHHHHHHHhccCccc-----------ccCCccchhhhhhhHHHHhhc
Confidence 666666778888999999888776431 22223333322211110 1111 11223445555555
Q ss_pred CcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCc
Q 003911 380 MNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ 429 (787)
Q Consensus 380 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~ 429 (787)
|++. ..|+.++.+.+|+.|.|++|+|. .+|+.+--|+.|+.|||..|+
T Consensus 326 N~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 326 NKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred cccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 5555 56666666666666666666666 566666666666666666664
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-32 Score=275.36 Aligned_cols=368 Identities=23% Similarity=0.296 Sum_probs=267.9
Q ss_pred CEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccC
Q 003911 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (787)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 148 (787)
-++.|++.+|+++ ++|++++.+..++.|+.++|+++..++.++.+.+|..|+.++|.+..++++ ++.+..|+.|+..+
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~el~~~-i~~~~~l~dl~~~~ 146 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELKELPDS-IGRLLDLEDLDATN 146 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhccccceeecCch-HHHHhhhhhhhccc
Confidence 4778888888888 788888888888888888888888877888888888888888888888876 77788888888888
Q ss_pred CCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCc
Q 003911 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAK 228 (787)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~ 228 (787)
|+++ .+|..++++.+|..|++.+|+++..+|..+ +++.|++||+..|-+. .+|+.+++ +++|...+...|..
T Consensus 147 N~i~--slp~~~~~~~~l~~l~~~~n~l~~l~~~~i---~m~~L~~ld~~~N~L~-tlP~~lg~--l~~L~~LyL~~Nki 218 (565)
T KOG0472|consen 147 NQIS--SLPEDMVNLSKLSKLDLEGNKLKALPENHI---AMKRLKHLDCNSNLLE-TLPPELGG--LESLELLYLRRNKI 218 (565)
T ss_pred cccc--cCchHHHHHHHHHHhhccccchhhCCHHHH---HHHHHHhcccchhhhh-cCChhhcc--hhhhHHHHhhhccc
Confidence 8888 678888888888888888888887777776 5888888898888887 67777654 44444444444433
Q ss_pred CCCCccccccCccCceEeccccccccCCCC-CCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCC
Q 003911 229 LGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFD 307 (787)
Q Consensus 229 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 307 (787)
. ..| +|.++..|++|+++.|+|+-.+.+ ...+++|.+|||++|+++ ..|++++-+.+|++||+|+|.+++.+++++
T Consensus 219 ~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLg 295 (565)
T KOG0472|consen 219 R-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLG 295 (565)
T ss_pred c-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccc
Confidence 3 223 678888899999999998876665 457899999999999999 899999999999999999999999999888
Q ss_pred CceeeeccccCCCccCCC--------------------------------------CCCCCchhhHHHHHHH-------H
Q 003911 308 RSVSLDMAKGSNNFCLPS--------------------------------------PGACDPRLNALLSVVK-------L 342 (787)
Q Consensus 308 ~~~~L~~l~~~~n~~~~~--------------------------------------~~~~~~~~~~l~~~~~-------~ 342 (787)
++ .|..+.+.+|.+..+ +...++....+..... +
T Consensus 296 nl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~ql 374 (565)
T KOG0472|consen 296 NL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQL 374 (565)
T ss_pred cc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccccccc
Confidence 88 777776666653211 0111111111111000 0
Q ss_pred hCCChhhh----------cccCCCCCC----------------------CCccc-cccCCCceEEEEccCCcccccCchh
Q 003911 343 MGYPQRFA----------ENWKGNDPC----------------------SDWIG-VTCTKGNITVINFQKMNLTGTISPE 389 (787)
Q Consensus 343 ~~~~~~~~----------~~~~~~~~~----------------------~~~~~-~~~~~~~L~~L~Ls~N~l~g~~p~~ 389 (787)
..-|...+ .++..+..| -+|++ ..+.+++|+.|+|++|-+. .+|.+
T Consensus 375 t~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e 453 (565)
T KOG0472|consen 375 TLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEE 453 (565)
T ss_pred ccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchh
Confidence 00111000 001111111 13333 3456788999999988777 78999
Q ss_pred hcCCCCCCEEeccccccc----------------------ccCCcc-CcCCCCCCeeeccCCcccccCCCC---CCCcee
Q 003911 390 FASFKSLQRLILADNNLS----------------------GMIPEG-LSVLGALKELDVSNNQLYGKIPSF---KSNAIV 443 (787)
Q Consensus 390 ~~~l~~L~~L~Ls~N~l~----------------------g~ip~~-l~~l~~L~~L~Ls~N~l~g~iP~~---~~~~~~ 443 (787)
++.+..|+.||+|+|+|. +.+|.+ +.+|.+|..|||.+|.+...+|-+ .....+
T Consensus 454 ~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hL 533 (565)
T KOG0472|consen 454 MGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHL 533 (565)
T ss_pred hhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEE
Confidence 999999999999999874 233433 888999999999999998777754 455678
Q ss_pred ecCCCCCC
Q 003911 444 NTDGNPDI 451 (787)
Q Consensus 444 ~~~gn~~~ 451 (787)
.+.|||+.
T Consensus 534 eL~gNpfr 541 (565)
T KOG0472|consen 534 ELDGNPFR 541 (565)
T ss_pred EecCCccC
Confidence 88999874
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=265.68 Aligned_cols=184 Identities=22% Similarity=0.379 Sum_probs=157.9
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|+||.||+|+.. +++.||+|+++.........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46999999999999999999876 68899999998654444556778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|++++.+..+. . ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~~l~~~~-~----~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLE-E----MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHH-h----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 99987665443 1 22468899999999999999999997 8999999999999999999999999999987654
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..........||+.|+|||++.+..++ ++|+||
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 186 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWS 186 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHh
Confidence 332223345789999999999988888 899998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=270.74 Aligned_cols=184 Identities=29% Similarity=0.449 Sum_probs=154.8
Q ss_pred CCCcccceeccccceEEEEEEEeC--C---cEEEEEEeecc-cccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 593 NNFSEENILGRGGFGTVYKGELHD--G---TKIAVKRMEAG-VISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
++....++||+|+||.||+|+++. + ..||||..+.. ........+|.+|.++|++++|||||++||++......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 445566899999999999998653 2 23899998863 35677889999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
++|||+|.||+|.+++... ...++..+..+++.++|.||+|||+ +++|||||.++|+|++.++.+||+|||++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~----~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKN----KKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EEEEEecCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccc
Confidence 9999999999999999652 2368999999999999999999998 89999999999999999999999999998
Q ss_pred eecCCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+.-........ ...-..+|+|||.+....|+ ++||||
T Consensus 310 ~~~~~~~~~~~-~~klPirWLAPEtl~~~~~s~kTDV~s 347 (474)
T KOG0194|consen 310 RAGSQYVMKKF-LKKLPIRWLAPETLNTGIFSFKTDVWS 347 (474)
T ss_pred cCCcceeeccc-cccCcceecChhhhccCccccccchhh
Confidence 75531111110 01124689999999999998 999997
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=268.66 Aligned_cols=178 Identities=27% Similarity=0.425 Sum_probs=152.8
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (787)
+.||+|+||.||+++.. +++.||+|++..... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999765 789999999976432 2345567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCce
Q 003911 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 756 (787)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 756 (787)
+|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 151 (328)
T cd05593 81 ELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-T 151 (328)
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-c
Confidence 99888743 2468899999999999999999997 8999999999999999999999999999876432221 2
Q ss_pred eeeeccccCcccccccccCCcC-cceeecC
Q 003911 757 ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 757 ~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.....||+.|+|||++.+..++ ++|+||.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 181 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCcccc
Confidence 2335799999999999988888 8999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=267.37 Aligned_cols=179 Identities=27% Similarity=0.421 Sum_probs=152.2
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (787)
+.||+|+||.||+|+.. +++.||+|+++.... ......++..|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 789999999986432 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCce
Q 003911 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 756 (787)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 756 (787)
+|.+++.. ...+++.++..++.|++.||+|||+ ..+|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 99888743 2468999999999999999999996 36999999999999999999999999999876432221 2
Q ss_pred eeeeccccCcccccccccCCcC-cceeecC
Q 003911 757 ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 757 ~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.....||+.|+|||++.+..++ ++|+||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 182 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccc
Confidence 2335699999999999988888 8999994
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=274.08 Aligned_cols=185 Identities=28% Similarity=0.463 Sum_probs=160.7
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|+.. +++.||||+++..... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999875 7899999999864332 245567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999998542 468899999999999999999998 899999999999999999999999999998664
Q ss_pred CCC----------------------------CceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGK----------------------------GSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... ........||+.|+|||++.+..++ ++||||.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 216 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSL 216 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEec
Confidence 432 0112335699999999999999888 8999994
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=268.95 Aligned_cols=178 Identities=28% Similarity=0.417 Sum_probs=152.2
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (787)
+.||+|+||.||+++.. +|+.||+|+++.... .......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999764 789999999986432 2344567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCce
Q 003911 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 756 (787)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 756 (787)
+|..++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 151 (323)
T cd05595 81 ELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 151 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-c
Confidence 99887743 2468899999999999999999998 8999999999999999999999999999875432221 2
Q ss_pred eeeeccccCcccccccccCCcC-cceeecC
Q 003911 757 ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 757 ~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.....||+.|+|||++.+..++ ++|+||.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 181 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhh
Confidence 2335799999999999988888 8999983
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=272.23 Aligned_cols=189 Identities=28% Similarity=0.483 Sum_probs=153.8
Q ss_pred cCCCcccceeccccceEEEEEEE------eCCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCC
Q 003911 592 TNNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 664 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 664 (787)
.++|++.+.||+|+||.||+|.. .+++.||||+++.. ......+.+.+|+++++++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 46799999999999999999964 23568999998753 2334456789999999999 8999999999887654
Q ss_pred -eeEEEEEecCCCCHHHHHHhhhhc-------------------------------------------------------
Q 003911 665 -EKLLVFEYMPQGTLSRHIFNWAEE------------------------------------------------------- 688 (787)
Q Consensus 665 -~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 688 (787)
..++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 578999999999999998642110
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCce-eeeeccccC
Q 003911 689 --GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFG 765 (787)
Q Consensus 689 --~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~ 765 (787)
...++++.++..++.|+++||+|||+ ++|+||||||+||++++++.+||+|||+++......... .....+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 01347888999999999999999998 899999999999999999999999999998654332211 122345788
Q ss_pred cccccccccCCcC-cceeec
Q 003911 766 YLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 766 y~aPE~~~~~~~~-~~DiWS 784 (787)
|+|||++.+..++ ++||||
T Consensus 242 y~aPE~~~~~~~~~~sDiws 261 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWS 261 (338)
T ss_pred ccCcHHhhcCCCCcccCHHH
Confidence 9999999888888 899998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=266.59 Aligned_cols=176 Identities=27% Similarity=0.404 Sum_probs=152.0
Q ss_pred eccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCCCH
Q 003911 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (787)
Q Consensus 601 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (787)
||+|+||.||+|+.. +++.||+|+++.... .......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999865 688999999976432 334556788999999999999999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCceee
Q 003911 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 758 (787)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 758 (787)
.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 151 (312)
T cd05585 81 FHHLQR-----EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTN 151 (312)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccc
Confidence 998853 2468899999999999999999998 899999999999999999999999999998643322 2223
Q ss_pred eeccccCcccccccccCCcC-cceeecC
Q 003911 759 RIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 759 ~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
...||+.|+|||++.+..++ ++|+||.
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 179 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTL 179 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceech
Confidence 46799999999999998888 8999984
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=265.59 Aligned_cols=189 Identities=28% Similarity=0.520 Sum_probs=156.0
Q ss_pred cCCCcccceeccccceEEEEEEEeC-----------------CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccc
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHD-----------------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 654 (787)
.++|++.+.||+|+||.||+|.+++ +..||+|++.... ......++.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 3578999999999999999997532 3469999987532 344567899999999999999999
Q ss_pred eEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 003911 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE--------------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720 (787)
Q Consensus 655 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i 720 (787)
++++++.+.+..++||||+++|+|.+++...... ....+++.++.+++.|++.||+|||+ .+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCc
Confidence 9999999999999999999999999988543211 11346788999999999999999998 899
Q ss_pred EEcCCCCCCEEECCCCcEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeec
Q 003911 721 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 721 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+||||||+||++++++.+||+|||+++........ ......++..|||||++.++.++ ++|+||
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 225 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHH
Confidence 99999999999999999999999999866443221 11223457889999999888888 899998
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=268.90 Aligned_cols=184 Identities=23% Similarity=0.378 Sum_probs=155.7
Q ss_pred CCcccceeccccceEEEEEEE----eCCcEEEEEEeecccc--cchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCee
Q 003911 594 NFSEENILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 666 (787)
+|++.+.||+|+||.||+|+. .+++.||+|++.+... .....+.+.+|+++++++ +||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999965 2588999999975322 123346788999999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 999999999999998853 2468899999999999999999997 89999999999999999999999999999
Q ss_pred eecCCCCCceeeeeccccCcccccccccCC-cC-cceeecC
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS~ 785 (787)
+..............||+.|||||++.+.. ++ ++||||.
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 193 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSL 193 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccc
Confidence 865443333333467999999999998754 55 8999984
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=267.64 Aligned_cols=186 Identities=24% Similarity=0.379 Sum_probs=156.4
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+++.. +++.||+|++.+... .......+.+|+.++..++|++|+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999875 578899999865322 2333456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 81 ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 999999999998542 2368899999999999999999998 899999999999999999999999999997654
Q ss_pred CCCCceeeeeccccCccccccccc-----CCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVH-----TRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~-~~DiWS~ 785 (787)
..........+||+.|+|||++.+ ..++ ++|+||-
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSl 194 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSL 194 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEee
Confidence 433222334579999999999863 3455 8999983
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=258.94 Aligned_cols=178 Identities=29% Similarity=0.497 Sum_probs=158.0
Q ss_pred cceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCC
Q 003911 598 ENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (787)
.++||+|-||+||-|.+ ++|+.||||++.+.....+...++++|+.|+++++||.||.+...|+..+..++|||-+ .|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 48899999999999965 48999999999987777777899999999999999999999999999999999999999 66
Q ss_pred CHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC---CcEEEeecccceecCCCC
Q 003911 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVADFGLVRLAPEGK 753 (787)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFG~a~~~~~~~ 753 (787)
+..+.|.. ...+++++.....+..||+.||.|||. ++|+|+||||+|||+... ..+||||||+|+.+.+..
T Consensus 648 DMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 648 DMLEMILS---SEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 77777754 334578888888999999999999997 899999999999999643 479999999999987643
Q ss_pred CceeeeeccccCcccccccccCCcC-cceeec
Q 003911 754 GSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
....++|||.|.|||+++.+.|. .-|+||
T Consensus 722 --FRrsVVGTPAYLaPEVLrnkGyNrSLDMWS 751 (888)
T KOG4236|consen 722 --FRRSVVGTPAYLAPEVLRNKGYNRSLDMWS 751 (888)
T ss_pred --hhhhhcCCccccCHHHHhhcccccccccee
Confidence 44558999999999999999999 789998
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=245.27 Aligned_cols=188 Identities=31% Similarity=0.479 Sum_probs=159.5
Q ss_pred HHHhhcCCCcccceeccccceEEEEEEE-eCCcEEEEEEeeccccc------chhHHHHHHHHHHHHhc-CCCccceEEe
Q 003911 587 VLRNVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS------GKGLTEFKSEIAVLTKV-RHRHLVALLG 658 (787)
Q Consensus 587 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l-~h~niv~~~~ 658 (787)
..+.+.++|...+.+|.|..+.|-++.. .+|.++|+|++...... ..-.+.-.+|+.+++++ .||+|+++.+
T Consensus 11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 3445567788899999999999998855 47899999998653211 12245567899999999 6999999999
Q ss_pred EEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcE
Q 003911 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 738 (787)
Q Consensus 659 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 738 (787)
+|+.+...++|+|.|+.|.|.+++.. .-.+++....+|++|+.+|++|||. ++||||||||+|||+|++.++
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i 162 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNI 162 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccce
Confidence 99999999999999999999999943 3468899999999999999999997 899999999999999999999
Q ss_pred EEeecccceecCCCCCceeeeeccccCccccccccc------CCcC-cceeec
Q 003911 739 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVH------TRWS-SCSYWA 784 (787)
Q Consensus 739 kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~-~~DiWS 784 (787)
||+|||+|+.+..+. .-...+|||+|.|||.+.- ..|+ .+|+||
T Consensus 163 ~isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa 213 (411)
T KOG0599|consen 163 KISDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWA 213 (411)
T ss_pred EEeccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHH
Confidence 999999999987654 3345799999999999853 2455 799997
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=266.43 Aligned_cols=185 Identities=24% Similarity=0.405 Sum_probs=165.9
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
....|.+.+.||+|.|+.|..|++. ++..||+|.+.+........+.+.+|+++|+.++|||||+++.+.......|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3467999999999999999999765 799999999998777777667799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+.+|.+++++.. ...+.+..+..++.|+.+|++|+|+ +.|||||||++|||++.++++||+|||++..+
T Consensus 134 ~eya~~ge~~~yl~~-----~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 134 MEYASGGELFDYLVK-----HGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEeccCchhHHHHHh-----cccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceee
Confidence 999999999999954 2355668888999999999999998 89999999999999999999999999999988
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC--cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS--SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~DiWS~ 785 (787)
... ......+|++.|.|||+++|..|. ++|+||.
T Consensus 206 ~~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wsl 241 (596)
T KOG0586|consen 206 DYG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSL 241 (596)
T ss_pred ccc--ccccccCCCCCccChHhhcCcccCCcceehhhh
Confidence 643 344558999999999999999988 8999984
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=272.42 Aligned_cols=177 Identities=20% Similarity=0.287 Sum_probs=152.4
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
..+|++.+.||+|+||.||+|... +++.||+|+... ..+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 357999999999999999999764 789999996532 35678999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
|++. ++|.+++.. ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+|+...
T Consensus 163 e~~~-~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 163 PRYK-TDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred ecCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 9994 788887743 2457899999999999999999998 899999999999999999999999999997643
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
...........||+.|+|||++.+..++ ++|+||.
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 269 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSA 269 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHH
Confidence 3322233346799999999999988888 8999983
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=267.97 Aligned_cols=178 Identities=28% Similarity=0.389 Sum_probs=155.8
Q ss_pred CCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-C-----CccceEEeEEEeCCee
Q 003911 594 NFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-H-----RHLVALLGHCLDGNEK 666 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~ 666 (787)
+|++.+.||+|+||.|-+|.. ++++.||||+++.. .....+...|+.+|..++ | -|+|+++++|...++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 899999999999999999965 57999999999863 345567788999999996 4 4899999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC--CcEEEeecc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD--MRAKVADFG 744 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DFG 744 (787)
|||+|.+ ..+|+++++. .....++...++.|+.||+.||.+||+ .+|||+||||+|||+.+. ..+||+|||
T Consensus 264 ciVfELL-~~NLYellK~---n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKN---NKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred eeeehhh-hhhHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecc
Confidence 9999999 5699999976 445568999999999999999999997 899999999999999743 479999999
Q ss_pred cceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.|+...... ..++-+..|+|||++.|.+|+ +.|+||.
T Consensus 337 SSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSL 374 (586)
T KOG0667|consen 337 SSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSL 374 (586)
T ss_pred cccccCCcc----eeeeeccccccchhhccCCCCCccceeeh
Confidence 999775433 246678999999999999999 9999993
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=265.01 Aligned_cols=178 Identities=25% Similarity=0.395 Sum_probs=153.6
Q ss_pred ceeccccceEEEEEEE----eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecC
Q 003911 599 NILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 674 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (787)
+.||+|+||.||+++. .+|+.||+|+++...........+..|++++++++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 368899999998754444455677889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCC
Q 003911 675 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754 (787)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 754 (787)
+|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 9999988843 2468999999999999999999998 8999999999999999999999999999986544322
Q ss_pred ceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 755 SIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 755 ~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
......||+.|+|||++.+..++ ++|+||.
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 184 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSF 184 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceecc
Confidence 22346799999999999888777 8999984
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=264.74 Aligned_cols=183 Identities=28% Similarity=0.404 Sum_probs=154.9
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCC-ccceEEeEEEeCCeeEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHR-HLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~ 670 (787)
+|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+..|.+++..++|+ +|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999765 578999999976432 234456788899999999764 5888999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 99999999988843 2457899999999999999999997 899999999999999999999999999987543
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... .......||+.|+|||++.+..++ ++|+||.
T Consensus 153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 187 (324)
T cd05587 153 FGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187 (324)
T ss_pred CCC-CceeeecCCccccChhhhcCCCCCcccchhhh
Confidence 222 123346799999999999998888 8999984
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=265.75 Aligned_cols=181 Identities=30% Similarity=0.466 Sum_probs=152.2
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHH---HhcCCCccceEEeEEEeCCeeEEE
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVL---TKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
|++.+.||+|+||.||+|+.. +++.||||+++.... .....+.+.+|++++ ++++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999765 689999999986432 233445677776665 456799999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|..++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999887732 368999999999999999999998 89999999999999999999999999998754
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... .......||+.|||||++.+..++ ++|+||.
T Consensus 152 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 187 (324)
T cd05589 152 MGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGL 187 (324)
T ss_pred CCCC-CcccccccCccccCHhHhcCCCCCcccchhhH
Confidence 3222 222346799999999999988888 8999983
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=264.57 Aligned_cols=178 Identities=29% Similarity=0.489 Sum_probs=151.1
Q ss_pred ceeccccceEEEEEEE----eCCcEEEEEEeecccc--cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 599 NILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+.||+|+||.||+++. .+++.||+|+++.... .......+.+|++++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 3578999999976432 223345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++.. ...+.+..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 999999988843 2457888899999999999999998 89999999999999999999999999998754332
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
. .......||+.|+|||++.+..++ ++||||.
T Consensus 154 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 186 (323)
T cd05584 154 G-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSL 186 (323)
T ss_pred C-CcccccCCCccccChhhccCCCCCCcceeccc
Confidence 2 122335799999999999888887 8999983
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=264.91 Aligned_cols=178 Identities=24% Similarity=0.408 Sum_probs=152.3
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.||+|+||.||+|+.. +++.||+|+++..... ....+.+.+|..+++++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999765 6899999999865332 33456788999999998 799999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~ 151 (329)
T cd05588 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-D 151 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-C
Confidence 999888743 2468999999999999999999997 899999999999999999999999999987532221 1
Q ss_pred eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 756 IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
......||+.|+|||++.+..++ ++|+||.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceech
Confidence 22346799999999999998888 8999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=264.46 Aligned_cols=182 Identities=26% Similarity=0.402 Sum_probs=158.6
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+++.. ++..||+|++... ......+++.+|++++++++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 368999999999999999999876 6889999998763 23345578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+ +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 83 EHMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999998843 2357899999999999999999997 3479999999999999999999999999997664
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
... .....||+.|+|||++.+..++ ++|+||
T Consensus 156 ~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Diws 187 (331)
T cd06649 156 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWS 187 (331)
T ss_pred ccc---cccCCCCcCcCCHhHhcCCCCCchHhHHH
Confidence 322 2335689999999999988888 899998
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=271.25 Aligned_cols=183 Identities=30% Similarity=0.467 Sum_probs=156.9
Q ss_pred CCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC------ee
Q 003911 594 NFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------EK 666 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~ 666 (787)
.|...+.||+|+||.||+++. .+|+.||||.++... ..+..+..-+|++++++++|||||++++.-++.. ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 345568899999999999985 489999999997733 5667788999999999999999999998876543 56
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC--CCC--cEEEee
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDM--RAKVAD 742 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~D 742 (787)
.+|||||.+|||+..+.+. ++...+++.+.+.+..+++.||.|||+ ++||||||||.||++- ++| .-||+|
T Consensus 93 vlvmEyC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred eEEEeecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeec
Confidence 8999999999999999653 344679999999999999999999997 8999999999999984 334 369999
Q ss_pred cccceecCCCCCceeeeeccccCccccccccc-CCcC-cceeec
Q 003911 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWA 784 (787)
Q Consensus 743 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS 784 (787)
||.|+..+++. ....++||+.|.+||++.. +.|+ .+|.||
T Consensus 168 fG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS 209 (732)
T KOG4250|consen 168 FGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWS 209 (732)
T ss_pred ccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhh
Confidence 99999987654 5566899999999999995 6777 899998
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=265.54 Aligned_cols=168 Identities=30% Similarity=0.519 Sum_probs=150.1
Q ss_pred ccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCC
Q 003911 597 EENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (787)
Q Consensus 597 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (787)
..+-||.|+.|.||+|+++ ++.||||+++. .-+.+|+-|++++||||+.|.|+|.....+|||||||+.|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 3577999999999999997 88999998754 2246788999999999999999999999999999999999
Q ss_pred CHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCce
Q 003911 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 756 (787)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 756 (787)
-|+.+++. ...+.......+..+||.|+.|||. +.|||||||.-||||..+..|||+|||.++...+. ..
T Consensus 198 qL~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--ST 267 (904)
T KOG4721|consen 198 QLYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--ST 267 (904)
T ss_pred cHHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh--hh
Confidence 99999954 3467888889999999999999997 88999999999999999999999999999877554 23
Q ss_pred eeeeccccCcccccccccCCcC-cceeec
Q 003911 757 ETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 757 ~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
...++||..|||||++...+.+ ++||||
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwS 296 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWS 296 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceeh
Confidence 3458999999999999999999 999998
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=263.36 Aligned_cols=178 Identities=29% Similarity=0.477 Sum_probs=149.5
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.||+|+||.||+|+.. +++.||+|+++.... .....+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 688999999986432 223345566677777655 899999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~ 151 (316)
T cd05592 81 GDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence 999988843 2468899999999999999999998 899999999999999999999999999998653332 2
Q ss_pred eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 756 IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
......||+.|+|||++.+..++ ++|+||.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 182 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSF 182 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhH
Confidence 23346799999999999988888 8999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=263.74 Aligned_cols=183 Identities=26% Similarity=0.386 Sum_probs=154.7
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 670 (787)
+|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+..|.+++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999765 678999999986432 233445677788888887 5899999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999888743 2458899999999999999999998 899999999999999999999999999997643
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... .......||+.|+|||++.+..++ ++|+||.
T Consensus 153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 187 (323)
T cd05616 153 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187 (323)
T ss_pred CCC-CccccCCCChhhcCHHHhcCCCCCCccchhch
Confidence 222 122346799999999999998888 8999983
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=263.68 Aligned_cols=178 Identities=24% Similarity=0.413 Sum_probs=151.6
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.||+|+||.||+|+.. +++.||+|++++.... ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 6889999999875332 33456688899998887 799999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|+|..++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~ 151 (329)
T cd05618 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D 151 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-C
Confidence 999887743 2468999999999999999999998 899999999999999999999999999987543222 1
Q ss_pred eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 756 IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
......||+.|+|||++.+..++ ++|+||-
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecc
Confidence 22346799999999999998888 8999994
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=260.23 Aligned_cols=183 Identities=25% Similarity=0.415 Sum_probs=153.2
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|+||.||+|+.. +++.||+|+++... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 57999999999999999999765 78999999987532 22334567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|++ ++|.+++.. ....+++..+..++.||+.||+|||+ ++|+||||||+||++++++.+||+|||+++....
T Consensus 84 ~~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 84 YLD-SDLKQYLDN----CGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CCC-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 997 589888743 22357889999999999999999998 8999999999999999999999999999986543
Q ss_pred CCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
.... .....|++.|+|||++.+ ..++ ++|+||.
T Consensus 156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 190 (288)
T cd07871 156 PTKT-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGV 190 (288)
T ss_pred CCcc-ccCceecccccChHHhcCCcccCcHHHHHHH
Confidence 3221 223468999999999876 4566 8999983
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=250.24 Aligned_cols=186 Identities=31% Similarity=0.424 Sum_probs=157.8
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||.|.-|+||.++.+ ++..+|+|++.+.... .+...+.+.|.+||+.++||.++.+|+.++.++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 45778899999999999999887 4689999999886544 556678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
|||+||+|....+. +..+.+++..++.++.+++-||+|||- .|||.|||||+||||.++|++-|+||.++....
T Consensus 157 eyCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred ecCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999888754 445679999999999999999999997 899999999999999999999999999863211
Q ss_pred C---------------------------------C-C---------------------CceeeeeccccCcccccccccC
Q 003911 751 E---------------------------------G-K---------------------GSIETRIAGTFGYLAPEYAVHT 775 (787)
Q Consensus 751 ~---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~ 775 (787)
. . . +.....++||-.|.|||++.|.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0 0011236899999999999999
Q ss_pred CcC-cceeec
Q 003911 776 RWS-SCSYWA 784 (787)
Q Consensus 776 ~~~-~~DiWS 784 (787)
..+ ++|=|+
T Consensus 311 GHgsAVDWWt 320 (459)
T KOG0610|consen 311 GHGSAVDWWT 320 (459)
T ss_pred CCCchhhHHH
Confidence 888 666664
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=275.02 Aligned_cols=185 Identities=22% Similarity=0.350 Sum_probs=157.7
Q ss_pred CCcccceeccccceEEEEEEEe-C-CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-D-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.|.+.+.||+|++|.||+|... + ++.||+|.+... .......+++|+++++.++||||+++++++...+..|+|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 4889999999999999999654 4 678888876542 23444578889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++|+|.+++..... ...++++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 146 ~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred CCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 9999999998865433 23468899999999999999999998 8999999999999999999999999999987654
Q ss_pred CCC-ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
... ......+||+.|+|||++.+..++ ++||||
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 256 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWS 256 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHH
Confidence 322 123346799999999999988888 899998
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=262.26 Aligned_cols=178 Identities=30% Similarity=0.434 Sum_probs=151.2
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.||+|+||.||+|+.. +++.||+|+++.... .....+.+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999865 688999999976432 234456678899999876 799999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|+|..++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 151 (321)
T cd05591 81 GDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV- 151 (321)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence 999888743 2468899999999999999999998 8999999999999999999999999999876433221
Q ss_pred eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 756 IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
......||+.|+|||++.+..++ ++|+||.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 182 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWAL 182 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceech
Confidence 22345799999999999988888 8999994
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=262.38 Aligned_cols=178 Identities=28% Similarity=0.447 Sum_probs=151.1
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.||+|+||.||+|+.+ +++.||||++..... .....+.+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 688999999976432 234456677888888877 699999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~ 151 (320)
T cd05590 81 GDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-K 151 (320)
T ss_pred chHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-C
Confidence 999988743 2468899999999999999999997 899999999999999999999999999987643222 2
Q ss_pred eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 756 IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
......||+.|+|||++.+..++ ++|+||.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAM 182 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhh
Confidence 23345799999999999988888 8999984
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=256.35 Aligned_cols=183 Identities=34% Similarity=0.543 Sum_probs=156.5
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.|++.+.||+|+||.||++... +++.||+|++...... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999764 7899999999764332 2234567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++|+|.+++... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999887542 22468999999999999999999998 8999999999999999999999999999987643
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
... .....|++.|+|||++.+..++ ++|+||
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws 186 (285)
T cd05605 155 GET--IRGRVGTVGYMAPEVVKNERYTFSPDWWG 186 (285)
T ss_pred CCc--cccccCCCCccCcHHhcCCCCCccccchh
Confidence 321 2234689999999999988888 799998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=256.95 Aligned_cols=180 Identities=32% Similarity=0.474 Sum_probs=153.0
Q ss_pred eccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCCCH
Q 003911 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (787)
Q Consensus 601 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (787)
||+|+||+||++... +++.||+|++...... ....+.+..|++++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999765 7899999998764322 23346778899999999999999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCceee
Q 003911 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 758 (787)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 758 (787)
.+++..... ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 988754332 23468999999999999999999998 8999999999999999999999999999987654332 223
Q ss_pred eeccccCcccccccccCCcC-cceeecC
Q 003911 759 RIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 759 ~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
...||+.|+|||++.+..++ ++|+||.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~Dvwsl 183 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFAL 183 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHH
Confidence 35789999999999998888 8999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=262.31 Aligned_cols=178 Identities=28% Similarity=0.460 Sum_probs=148.4
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHH-HHHhcCCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIA-VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.||+|+||+||+|+.. +|+.||+|++..... ......++..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999765 789999999976432 2233445556655 46778999999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|+|..++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 151 (325)
T cd05604 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD- 151 (325)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-
Confidence 999887743 2468899999999999999999998 8999999999999999999999999999875432221
Q ss_pred eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 756 IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
......||+.|||||++.+..++ ++|+||.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 182 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCL 182 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccc
Confidence 22346799999999999998888 8999994
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=262.19 Aligned_cols=183 Identities=26% Similarity=0.392 Sum_probs=154.1
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCeeEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 670 (787)
+|+..+.||+|+||.||+|+.. +++.||+|++..... .....+.+..|.++++.+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999765 689999999976432 2334566788999998885 577888999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999988843 2468899999999999999999997 899999999999999999999999999987543
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... .......||+.|+|||++.+..++ ++|+||.
T Consensus 153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 187 (323)
T cd05615 153 VDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAY 187 (323)
T ss_pred CCC-ccccCccCCccccCHHHHcCCCCCCccchhhh
Confidence 222 122335699999999999988888 8999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=259.72 Aligned_cols=184 Identities=26% Similarity=0.402 Sum_probs=153.6
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 468999999999999999999875 789999999875332 223456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||++ ++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 83 EYVH-TDLCQYMDK----HPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred ECCC-cCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 9995 688777743 23458889999999999999999998 899999999999999999999999999997654
Q ss_pred CCCCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
.... ......||+.|+|||++.+. .++ ++|+||.
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 190 (303)
T cd07869 155 VPSH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGV 190 (303)
T ss_pred CCCc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHH
Confidence 3221 22335689999999998764 455 7999983
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=261.83 Aligned_cols=178 Identities=30% Similarity=0.461 Sum_probs=147.9
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHH-HHHhcCCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIA-VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.||+|+||.||+|+.. +++.||+|++..... ......++..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 688999999976432 2233345555554 67888999999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|+|..++.. ...+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 151 (321)
T cd05603 81 GELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE- 151 (321)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-
Confidence 999887743 2467888999999999999999997 8999999999999999999999999999875432221
Q ss_pred eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 756 IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
......||+.|+|||++.+..++ ++|+||.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCL 182 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCccccc
Confidence 22345799999999999988888 8999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=256.08 Aligned_cols=184 Identities=34% Similarity=0.504 Sum_probs=161.0
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
+.|+.-++||+|+||+||-++.+ +|+.+|+|++.++... .........|-.+++++..+.||.+--.|+..+..|+||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 46788899999999999999765 7999999998775544 344456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
..|.||||.-+|++. +...+++.+++.+|.+|+.||++||. .+||.||+||+|||+|+.|+++|+|+|+|..+.
T Consensus 265 tlMNGGDLkfHiyn~---g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNH---GNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EeecCCceeEEeecc---CCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 999999999998763 33579999999999999999999997 899999999999999999999999999999887
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
++... ...+||.+|||||++.++.|+ +.|-||
T Consensus 339 ~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~ 371 (591)
T KOG0986|consen 339 EGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFS 371 (591)
T ss_pred CCCcc--ccccCcccccCHHHHcCCcccCCccHHH
Confidence 66532 334899999999999999999 666665
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=276.16 Aligned_cols=191 Identities=24% Similarity=0.329 Sum_probs=161.7
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC-----
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----- 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 664 (787)
..++|++.+.||+|+||+||+|+.. +++.||||++............+.+|+.++..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3468999999999999999999754 7999999999876556666778899999999999999999988775432
Q ss_pred ---eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEe
Q 003911 665 ---EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 741 (787)
Q Consensus 665 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 741 (787)
..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEE
Confidence 367999999999999998654332 3568999999999999999999998 899999999999999999999999
Q ss_pred ecccceecCCCCC-ceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 742 DFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 742 DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|||+++....... .......||+.|+|||++.+..++ ++||||.
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSl 231 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSL 231 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHH
Confidence 9999987643321 122346799999999999998888 8999983
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=261.36 Aligned_cols=178 Identities=25% Similarity=0.408 Sum_probs=152.4
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.||+|+||.||+|+.. +++.||+|+++..... ....+.+.+|+.++.++ +||+|+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 6789999999864332 34456788999999998 699999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 151 (327)
T cd05617 81 GDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-D 151 (327)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-C
Confidence 999888743 2468999999999999999999998 899999999999999999999999999987543222 1
Q ss_pred eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 756 IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.....+||+.|+|||++.+..++ ++|+||.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWAL 182 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehh
Confidence 22346799999999999998888 8999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=261.28 Aligned_cols=178 Identities=30% Similarity=0.466 Sum_probs=148.0
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHH-HHHhcCCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIA-VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.||+|+||+||+|+.. +|+.||+|++...... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999875 7899999999764322 223344555544 56788999999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (323)
T cd05575 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-K 151 (323)
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-C
Confidence 999988843 2468899999999999999999998 899999999999999999999999999987543222 1
Q ss_pred eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 756 IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
......||+.|+|||++.+..++ ++|+||.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 182 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCL 182 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCcccccccc
Confidence 22345799999999999998888 8999994
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=280.70 Aligned_cols=189 Identities=25% Similarity=0.374 Sum_probs=158.5
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|... +++.||+|++...... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999765 6899999999764322 334567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 671 EYMPQGTLSRHIFNWAEE------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
||+++|+|.+++...... .....++..++.++.||++||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998653221 12345677889999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCC-----------------ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 745 LVRLAPEGKG-----------------SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 745 ~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+++....... ......+||+.|||||++.+..++ ++|+||
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWS 216 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYA 216 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHH
Confidence 9986621110 011225699999999999998888 899998
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=255.17 Aligned_cols=184 Identities=24% Similarity=0.401 Sum_probs=154.7
Q ss_pred CCCcccceeccccceEEEEEEEe----CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
++|++.+.||+|+||.||+|.++ .+..||+|.++... .......+.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 46889999999999999999753 36689999987642 33445678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++++|||.+..
T Consensus 84 v~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 84 VTEYMSNGALDSFLRK----HEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEeCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 9999999999998854 12468899999999999999999997 8999999999999999999999999998765
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.............++..|+|||.+.+..++ ++||||
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 193 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWS 193 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHH
Confidence 432221111123356789999999988888 899998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=262.14 Aligned_cols=182 Identities=25% Similarity=0.401 Sum_probs=157.5
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|... ++..+|+|++.... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 368999999999999999999876 68889999887632 3344567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ +.+|+||||||+||++++++.+||+|||++....
T Consensus 83 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 83 EHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999999843 2357889999999999999999997 3579999999999999999999999999987653
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
... .....||..|+|||++.+..++ ++|+||
T Consensus 156 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 187 (333)
T cd06650 156 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWS 187 (333)
T ss_pred hhc---cccCCCCccccCHHHhcCCCCCcHHHHHH
Confidence 321 2235689999999999988887 899998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=261.51 Aligned_cols=178 Identities=29% Similarity=0.447 Sum_probs=146.7
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHH-HHHHhcCCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEI-AVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.||+|+||.||+|+.. +++.||+|++...... .....++..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 6788999999764321 22233444444 456788999999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|+|.+++.. ...+.+..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~- 151 (325)
T cd05602 81 GELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG- 151 (325)
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-
Confidence 999988843 2357788889999999999999998 8999999999999999999999999999975433222
Q ss_pred eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 756 IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
......||+.|+|||++.+..++ ++|+||.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 182 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccc
Confidence 22346799999999999998888 8999994
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=274.01 Aligned_cols=186 Identities=30% Similarity=0.424 Sum_probs=153.1
Q ss_pred CCCcccceeccccceEEEEEEEeCC-cEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEe-EEEe------C
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDG-TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLG-HCLD------G 663 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~-~~~~------~ 663 (787)
.++++.+.|.+|||+.||.|+...+ .+||+|++-.. ++...+.+++|+++|++|+ |+|||.|++ .... .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3577889999999999999987755 99999998763 5677889999999999996 999999999 3332 2
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
-+++|.||||++|.|-+++..+... .+++.++++|+.|+++|+++||.+ +.+|||||||-+||||+.++..|||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 3678999999999999999765443 499999999999999999999984 578999999999999999999999999
Q ss_pred ccceecCCCCCce-e-------eeeccccCcccccccc---cCCcC-cceeec
Q 003911 744 GLVRLAPEGKGSI-E-------TRIAGTFGYLAPEYAV---HTRWS-SCSYWA 784 (787)
Q Consensus 744 G~a~~~~~~~~~~-~-------~~~~gt~~y~aPE~~~---~~~~~-~~DiWS 784 (787)
|.|.......... . ....-|+.|+|||++. +...+ ++||||
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWA 243 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWA 243 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHH
Confidence 9986432222110 0 1123699999999974 55666 999998
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=256.10 Aligned_cols=184 Identities=27% Similarity=0.413 Sum_probs=150.8
Q ss_pred CCCcccceeccccceEEEEEEEe--CCcEEEEEEeecccccchhHHHHHHHHHHHHhc---CCCccceEEeEEEe-----
Q 003911 593 NNFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV---RHRHLVALLGHCLD----- 662 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~----- 662 (787)
++|++.+.||+|+||.||+|+.. +++.||+|+++...........+.+|+++++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36899999999999999999763 468899999876443333345666787777766 69999999999863
Q ss_pred CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEee
Q 003911 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (787)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 742 (787)
....++||||++ ++|.+++... ....+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 345899999996 6898888542 22458899999999999999999998 8999999999999999999999999
Q ss_pred cccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 743 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
||+++...... ......||+.|+|||++.+..++ ++|+||.
T Consensus 154 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 195 (290)
T cd07862 154 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 195 (290)
T ss_pred ccceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHH
Confidence 99998764432 22345689999999999888887 8999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=259.84 Aligned_cols=178 Identities=29% Similarity=0.471 Sum_probs=150.2
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.||+|+||.||+|+.. +++.||+|+++..... ......+..|.+++... +||+|+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 6889999999864321 23445667788888765 899999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 151 (316)
T cd05620 81 GDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-N 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-C
Confidence 999988743 2467899999999999999999998 899999999999999999999999999987543222 2
Q ss_pred eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 756 IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
......||+.|+|||++.+..++ ++|+||.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSF 182 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhh
Confidence 23346799999999999998888 8999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=258.85 Aligned_cols=178 Identities=29% Similarity=0.491 Sum_probs=150.1
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.||+|+||.||+|+.. +++.||||+++.... .......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 578999999986432 123345667788888765 899999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05619 81 GDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA- 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence 999988843 2467889999999999999999998 8999999999999999999999999999876432221
Q ss_pred eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 756 IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
......||+.|+|||++.+..++ ++|+||.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 182 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSF 182 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhH
Confidence 22346799999999999988888 8999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=264.18 Aligned_cols=182 Identities=27% Similarity=0.442 Sum_probs=151.1
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC-----eeE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-----EKL 667 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 667 (787)
+|++.+.||+|+||.||+|... +++.||||++...........++.+|++++++++||||+++++++.... ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999765 7899999998754333444567889999999999999999999886432 479
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+||||++ ++|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999995 689888743 2368899999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCC--ceeeeeccccCccccccccc--CCcC-cceeec
Q 003911 748 LAPEGKG--SIETRIAGTFGYLAPEYAVH--TRWS-SCSYWA 784 (787)
Q Consensus 748 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~-~~DiWS 784 (787)
....... .......||+.|+|||++.+ ..++ ++||||
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwS 193 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 193 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHH
Confidence 6533221 11234579999999999876 4566 899998
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=266.68 Aligned_cols=189 Identities=28% Similarity=0.448 Sum_probs=155.7
Q ss_pred cCCCcccceeccccceEEEEEEE------eCCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCC
Q 003911 592 TNNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 664 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 664 (787)
.++|++.+.||+|+||.||+|.. .++..||||+++... .....+.+.+|+++++.+ +||||+++++++.+.+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 35788999999999999999963 246689999987532 234456788999999999 8999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhhhh---------------------------------------------------------
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAE--------------------------------------------------------- 687 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 687 (787)
..++||||+++|+|.+++.....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999864211
Q ss_pred -------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCC
Q 003911 688 -------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754 (787)
Q Consensus 688 -------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 754 (787)
.....+++..+..++.||++||+|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 011257889999999999999999998 8999999999999999999999999999987644322
Q ss_pred ce-eeeeccccCcccccccccCCcC-cceeec
Q 003911 755 SI-ETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 755 ~~-~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.. .....++..|+|||++.+..++ ++|+||
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~s 301 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWS 301 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHH
Confidence 11 1123346689999999988888 899998
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=254.83 Aligned_cols=186 Identities=24% Similarity=0.366 Sum_probs=165.0
Q ss_pred hcCCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+..-|.+.+.||+|.|++|-.|++ -+|++||||++.+...+......+.+|+++|+.++|||||++|++...+...|+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 345688899999999999999965 4899999999998777777778899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE-CCCCcEEEeeccccee
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRL 748 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DFG~a~~ 748 (787)
+|+-++|+|++||... ...+.++.+.+++.||+.|+.|.|. ..+|||||||+||.+ .+-|-|||+|||++..
T Consensus 96 LELGD~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNK 168 (864)
T ss_pred EEecCCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeecccccc
Confidence 9999999999999553 3468899999999999999999997 789999999999976 5678999999999987
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC--cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS--SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~DiWS~ 785 (787)
+.++. ..+..+|+..|-|||++.|..|. ++||||.
T Consensus 169 f~PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSL 205 (864)
T KOG4717|consen 169 FQPGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSL 205 (864)
T ss_pred CCCcc--hhhcccchhhccCchhhhcCccCCcchhhhHH
Confidence 76654 34457999999999999999998 7999984
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=265.73 Aligned_cols=189 Identities=29% Similarity=0.500 Sum_probs=155.1
Q ss_pred cCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCC
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 664 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 664 (787)
.++|++.+.||+|+||.||+|... ++..||+|+++... .....+.+.+|+++++.+ +||||+++++++...+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 357889999999999999998642 34579999997633 233456788999999999 8999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhhhh---------------------------------------------------------
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAE--------------------------------------------------------- 687 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 687 (787)
..++||||+++|+|.+++.....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999999864221
Q ss_pred --------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCce-ee
Q 003911 688 --------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI-ET 758 (787)
Q Consensus 688 --------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~ 758 (787)
....++++.++++++.||++||+|||+ ++|+||||||+||++++++.+||+|||+++......... ..
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 011347888999999999999999998 899999999999999999999999999998664332211 11
Q ss_pred eeccccCcccccccccCCcC-cceeec
Q 003911 759 RIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 759 ~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
...++..|||||++.+..++ ++|+||
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwS 299 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWS 299 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHH
Confidence 22356689999999888888 999998
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-31 Score=274.13 Aligned_cols=311 Identities=21% Similarity=0.295 Sum_probs=221.3
Q ss_pred CCEEEEEeCCCCccc-cCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEc
Q 003911 68 KRITRIQIGHQNLQG-TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (787)
.++..+++.+|++.. -||+.+..|..|+.||||+|++...|..+..-+++-+|+||+|+|..||...|.+|+.|-.|||
T Consensus 78 p~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDL 157 (1255)
T KOG0444|consen 78 PRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDL 157 (1255)
T ss_pred hhhHHHhhhccccccCCCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhcc
Confidence 345666667777653 3677777777788888888887776667777777777888888888877777777888888888
Q ss_pred cCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccc-cCCCcCccc-ccccceeeccCC
Q 003911 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI-GGLPASFSG-SQIQSLWVNGQN 224 (787)
Q Consensus 147 ~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~-~~l~~L~~~~~~ 224 (787)
|+|++. .+|..+..|..|++|.|++|.+...--..+. .+++|+.|++++.+=+ ..+|.++.. .+|..++++.
T Consensus 158 S~NrLe--~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLP--smtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~-- 231 (1255)
T KOG0444|consen 158 SNNRLE--MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLP--SMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSE-- 231 (1255)
T ss_pred ccchhh--hcCHHHHHHhhhhhhhcCCChhhHHHHhcCc--cchhhhhhhcccccchhhcCCCchhhhhhhhhccccc--
Confidence 888777 5777777778888888887776543333332 5666777777765433 356666543 4455555543
Q ss_pred CCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCccc--cc
Q 003911 225 GNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ--GP 302 (787)
Q Consensus 225 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~--~~ 302 (787)
+.++..|+++.++++|+.|+||+|+|+..--......+|++|+||+|+++ .+|+.++.|++|+.|++.+|+|+ |.
T Consensus 232 --N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGi 308 (1255)
T KOG0444|consen 232 --NNLPIVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGI 308 (1255)
T ss_pred --cCCCcchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCC
Confidence 34556677777888888888888888765545555677888888888888 78888888888888888888764 56
Q ss_pred CCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcc
Q 003911 303 VPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNL 382 (787)
Q Consensus 303 ~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l 382 (787)
|..++.+..|+++..+||.+.-+|. ..|..+.|+.|.|++|++
T Consensus 309 PSGIGKL~~Levf~aanN~LElVPE-------------------------------------glcRC~kL~kL~L~~NrL 351 (1255)
T KOG0444|consen 309 PSGIGKLIQLEVFHAANNKLELVPE-------------------------------------GLCRCVKLQKLKLDHNRL 351 (1255)
T ss_pred ccchhhhhhhHHHHhhccccccCch-------------------------------------hhhhhHHHHHhcccccce
Confidence 6667777778777777776655442 245567899999999999
Q ss_pred cccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeec
Q 003911 383 TGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDV 425 (787)
Q Consensus 383 ~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~L 425 (787)
. .+|+.|--|+.|+.|||..|.=--..|.--..-+.|+.-++
T Consensus 352 i-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~lefYNI 393 (1255)
T KOG0444|consen 352 I-TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFYNI 393 (1255)
T ss_pred e-echhhhhhcCCcceeeccCCcCccCCCCcchhhhcceeeec
Confidence 8 79999999999999999999755333332222245554443
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=279.91 Aligned_cols=188 Identities=31% Similarity=0.558 Sum_probs=157.8
Q ss_pred CCCcccceeccccceEEEEEEEeC--Cc----EEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 593 NNFSEENILGRGGFGTVYKGELHD--GT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
...+..+.||+|+||.||+|...+ +. .||||.+++ ..+.+...+|.+|..+|++++|||||+++|++.+....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~-~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR-LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc-cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 455677899999999999998653 33 489998876 34567788999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEE--GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
+|++|||++|||..+|++.+.. ....+...+.+.++.|||+|+.||++ +++|||||..+|+|+++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999764322 13467889999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCCceee-eeccccCcccccccccCCcC-cceeec
Q 003911 745 LVRLAPEGKGSIET-RIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 745 ~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+|+.+......... ...=...|||||.++.+.++ ++||||
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWs 889 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWS 889 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhh
Confidence 99955443322221 11224689999999999888 999998
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=264.43 Aligned_cols=183 Identities=26% Similarity=0.441 Sum_probs=153.9
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC-----eeE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-----EKL 667 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 667 (787)
+|++.+.||+|+||.||+|... +++.||+|++..........+++.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999864 7899999998754333445567899999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+||||+. ++|.+.+.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEecccccee
Confidence 9999996 678777632 3468999999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCCceeeeeccccCcccccccccCC-cC-cceeecC
Q 003911 748 LAPEGKGSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS~ 785 (787)
..............+|+.|+|||++.+.. ++ ++|+||.
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 191 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSV 191 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhH
Confidence 76543333333456899999999998754 56 8999983
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=249.38 Aligned_cols=182 Identities=29% Similarity=0.467 Sum_probs=155.0
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
++|++.+.||+|+||.||+|+.+++..+|+|.+.... ...+++.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 3588889999999999999998888899999886532 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||.++.....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 81 MENGCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred CCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 9999999988531 2358899999999999999999997 89999999999999999999999999998865433
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.........++..|+|||++.+..++ ++|+||
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 186 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHH
Confidence 22222223356689999999888887 899998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=263.14 Aligned_cols=178 Identities=26% Similarity=0.403 Sum_probs=148.5
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|+..+.||+|+||.||+|+.. +++.||||++.... .......+.+|++++++++|+||+++++++...+..++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 35667789999999999999765 68999999986532 33445778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++|+|.+.. ..++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 153 ~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 153 FMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred cCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 99999985432 34667788999999999999998 8999999999999999999999999999987643
Q ss_pred CCCceeeeeccccCccccccccc-----CCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVH-----TRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~-~~DiWS 784 (787)
... ......||..|+|||++.. ...+ ++||||
T Consensus 221 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvws 258 (353)
T PLN00034 221 TMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWS 258 (353)
T ss_pred ccc-cccccccCccccCccccccccccCcCCCcchhHHH
Confidence 321 1233579999999998743 2223 799998
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=257.25 Aligned_cols=178 Identities=30% Similarity=0.458 Sum_probs=151.3
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.||+|+||.||+|+.. +++.||||+++.... .......+..|.++++.+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 688999999986432 233456678899999888 799999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 151 (318)
T cd05570 81 GDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV- 151 (318)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence 999888743 2368999999999999999999997 8999999999999999999999999999875322221
Q ss_pred eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 756 IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.....+||+.|+|||++.+..++ ++|+||.
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 182 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWAL 182 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhH
Confidence 22335689999999999998888 8999983
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=262.28 Aligned_cols=189 Identities=27% Similarity=0.437 Sum_probs=156.2
Q ss_pred cCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCC
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGN 664 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 664 (787)
.++|++.+.||+|+||.||+|... .+..||||+++.. ......+.+.+|+++++++. ||||+++++++.+.+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 467899999999999999999753 2357999999653 23344578999999999996 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhc--------------------------------------------------------
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEE-------------------------------------------------------- 688 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 688 (787)
..|+||||+++|+|.+++......
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999999988653210
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC
Q 003911 689 -----------------------------------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 733 (787)
Q Consensus 689 -----------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 733 (787)
....+++.++..++.|+++||+|||+ .+|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 11347888899999999999999997 8999999999999999
Q ss_pred CCCcEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeec
Q 003911 734 DDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 734 ~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+++.+||+|||+++........ ......+++.|+|||++.+..++ ++||||
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwS 324 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWS 324 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHH
Confidence 9999999999999866433221 11224567889999999888888 899998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=249.19 Aligned_cols=184 Identities=24% Similarity=0.453 Sum_probs=158.1
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
++|++.+.||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 578999999999999999999888889999988653 22357889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++... ....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.++|+|||.++.....
T Consensus 83 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 83 MAKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999998642 23467889999999999999999997 89999999999999999999999999999876543
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.........++..|+|||++.+..++ ++|+||.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 190 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 190 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhh
Confidence 32222233457789999999888888 8999983
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=264.29 Aligned_cols=184 Identities=27% Similarity=0.416 Sum_probs=156.3
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.+.|.++.-||.|+||.||+|..+ ++-..|.|++.. .+....+++.-||+||+.++||+||++++.|+..+..||+.
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 345778889999999999999766 445567788765 34667889999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
|||.||-....+... ...+.+.++..+++|++.||.|||+ .+|||||||+.|||++-+|.++|+|||.+....
T Consensus 109 EFC~GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~ 181 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK 181 (1187)
T ss_pred eecCCchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccch
Confidence 999999998877542 2478999999999999999999998 899999999999999999999999999876443
Q ss_pred CCCCceeeeeccccCcccccccc-----cCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAV-----HTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~-~~DiWS~ 785 (787)
... .....++|||+|||||+.+ +.+|+ ++||||.
T Consensus 182 ~t~-qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSl 221 (1187)
T KOG0579|consen 182 STR-QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSL 221 (1187)
T ss_pred hHH-hhhccccCCcccccchheeeccccCCCchhhhhHHhh
Confidence 322 2234588999999999875 46787 9999984
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=260.96 Aligned_cols=182 Identities=28% Similarity=0.398 Sum_probs=153.2
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC-----
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----- 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 664 (787)
+.++|++.+.||+|+||.||+|... +|+.||+|++...........++.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999764 6899999999765444455677889999999999999999999986543
Q ss_pred -eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 665 -EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 665 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
..|+||||+++ ++.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecC
Confidence 46999999965 6666552 247888899999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|+++...... ......||+.|+|||++.+..++ ++|+||.
T Consensus 168 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 208 (359)
T cd07876 168 GLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 208 (359)
T ss_pred CCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHH
Confidence 9997653322 22335689999999999998888 8999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=248.89 Aligned_cols=177 Identities=32% Similarity=0.484 Sum_probs=150.3
Q ss_pred eccccceEEEEEEEe-CCcEEEEEEeecccccc-hhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCCCH
Q 003911 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (787)
Q Consensus 601 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (787)
||+|+||.||+++.+ +|+.||+|++....... .....+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999765 68999999997543322 2334566799999999999999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCceee
Q 003911 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 758 (787)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 758 (787)
.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++....... ...
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~ 152 (277)
T cd05607 81 KYHIYNV---GERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TIT 152 (277)
T ss_pred HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eee
Confidence 8887542 23458899999999999999999998 899999999999999999999999999998765432 223
Q ss_pred eeccccCcccccccccCCcC-cceeecC
Q 003911 759 RIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 759 ~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
...|++.|+|||++.+..++ ++|+||.
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 180 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAM 180 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHH
Confidence 35689999999999988888 8999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=249.14 Aligned_cols=183 Identities=35% Similarity=0.557 Sum_probs=155.9
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.|+..+.||+|+||.||+|... +++.||||.+...... ......+.+|+.++++++|++|+.+++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999765 7899999998764332 2234567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++... ....+++.++..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 81 LMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred ecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 99999999888542 22458899999999999999999997 8999999999999999999999999999976543
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
... .....|+..|+|||++.+..++ ++|+||
T Consensus 155 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Diws 186 (285)
T cd05630 155 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWA 186 (285)
T ss_pred Ccc--ccCCCCCccccChHHHcCCCCCCccccHH
Confidence 321 1234689999999999988888 899998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-29 Score=277.39 Aligned_cols=193 Identities=24% Similarity=0.381 Sum_probs=167.8
Q ss_pred eHHHHHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEE
Q 003911 584 SIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCL 661 (787)
Q Consensus 584 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 661 (787)
....++--.++|.+.++||+|+||.|..++++ +++.||+|++.+...- ......|..|-.+|..-+.+.|+.++-.|+
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 35566777889999999999999999999876 7889999999874332 444567899999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEe
Q 003911 662 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 741 (787)
Q Consensus 662 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 741 (787)
+..+.|+|||||+||||-..+.. ..++++.-+..++..|+-||+-||+ .|+|||||||+|||+|..|++||+
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk-----~~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSK-----FDRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred CccceEEEEecccCchHHHHHhh-----cCCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeec
Confidence 99999999999999999999844 3368899999999999999999997 999999999999999999999999
Q ss_pred ecccceecCCCCCceeeeeccccCccccccccc-----CCcC-cceeec
Q 003911 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVH-----TRWS-SCSYWA 784 (787)
Q Consensus 742 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~-~~DiWS 784 (787)
|||.+-.+.....-.....+|||-|.+||+++. +.|+ .||-||
T Consensus 218 DFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWS 266 (1317)
T KOG0612|consen 218 DFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWS 266 (1317)
T ss_pred cchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhh
Confidence 999988776555445556789999999999853 4566 799998
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=256.64 Aligned_cols=176 Identities=26% Similarity=0.406 Sum_probs=144.9
Q ss_pred eccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhc---CCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV---RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 601 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
||+|+||+||+|+.. +++.||||++..... .......+..|..++.+. +||+|+++++++.+....|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999765 689999999975332 222334455677777665 699999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~- 151 (330)
T cd05586 81 GELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK- 151 (330)
T ss_pred ChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-
Confidence 999888743 2468899999999999999999998 8999999999999999999999999999875433221
Q ss_pred eeeeeccccCcccccccccCC-cC-cceeecC
Q 003911 756 IETRIAGTFGYLAPEYAVHTR-WS-SCSYWAG 785 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS~ 785 (787)
......||+.|+|||++.+.. ++ ++|+||.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvwsl 183 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSL 183 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceecc
Confidence 223457999999999987654 55 8999994
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=248.70 Aligned_cols=182 Identities=36% Similarity=0.550 Sum_probs=155.6
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
|+..+.||+|+||+||+|... +++.||+|++...... ......+.+|++++++++|++|+.+++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 677789999999999999765 7899999998764333 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999888542 22468999999999999999999997 89999999999999999999999999999765433
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.. .....|+..|+|||++.+..++ ++|+||
T Consensus 156 ~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~s 186 (285)
T cd05632 156 ES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWG 186 (285)
T ss_pred Cc--ccCCCCCcCccChHHhcCCCCCcccchHH
Confidence 21 2235689999999999888888 899998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=218.00 Aligned_cols=183 Identities=25% Similarity=0.383 Sum_probs=156.1
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+|...++||+|.||+||+|+.+ +++.||+|+++....++.......+|+-+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 5677889999999999999754 789999999987665555567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
|. .+|..+.. .-.+.++.+.+..++.|+++|+.|.|+ +++.|||+||.|.+++.+|+.|++|||+|+.++-.
T Consensus 83 cd-qdlkkyfd----slng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 CD-QDLKKYFD----SLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred hh-HHHHHHHH----hcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 94 47766653 334578999999999999999999998 89999999999999999999999999999987654
Q ss_pred CCceeeeeccccCcccccccccCC-cC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS~ 785 (787)
.. ..+..+-|..|++|.++.|.+ |+ ..|+|||
T Consensus 155 vr-cysaevvtlwyrppdvlfgakly~tsidmwsa 188 (292)
T KOG0662|consen 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188 (292)
T ss_pred eE-eeeceeeeeeccCcceeeeeehhccchHhhhc
Confidence 32 223345699999999998864 44 8999997
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-29 Score=240.01 Aligned_cols=188 Identities=29% Similarity=0.437 Sum_probs=156.2
Q ss_pred CCCcccceeccccceEEEEEEEe---C--CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe-CCee
Q 003911 593 NNFSEENILGRGGFGTVYKGELH---D--GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNEK 666 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 666 (787)
..|+....||+|+||.||+|... + ...+|+|+++.+......-....+|+..++.++|||++.+..++.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46889999999999999999533 2 3378999998753222333567799999999999999999999887 7789
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC----CcEEEee
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAKVAD 742 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D 742 (787)
++++||.+. +|...|+-.+....+.++...+..|+.||+.|+.|||+ +=|+||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999965 89998876655555789999999999999999999998 789999999999999876 8999999
Q ss_pred cccceecCCCCCce--eeeeccccCcccccccccC-CcC-cceeec
Q 003911 743 FGLVRLAPEGKGSI--ETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 743 FG~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
||+|+.+...-... ...++-|..|+|||.+.|. .|+ +.|+||
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWA 225 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWA 225 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHH
Confidence 99999886654322 2346679999999999886 566 899998
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=270.59 Aligned_cols=193 Identities=18% Similarity=0.275 Sum_probs=150.5
Q ss_pred HhhcCCCcccceeccccceEEEEEEEe--CCcEEEEEEe--------------ecc-cccchhHHHHHHHHHHHHhcCCC
Q 003911 589 RNVTNNFSEENILGRGGFGTVYKGELH--DGTKIAVKRM--------------EAG-VISGKGLTEFKSEIAVLTKVRHR 651 (787)
Q Consensus 589 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~--------------~~~-~~~~~~~~~~~~E~~~l~~l~h~ 651 (787)
..+.++|++.+.||+|+||+||+|..+ ++..+++|.+ .+. .........+++|++++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 345678999999999999999998654 2222222211 110 11223455788999999999999
Q ss_pred ccceEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 003911 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (787)
Q Consensus 652 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 731 (787)
||+++++++.+.+..|+|+|++ ++++.+++..............++..++.|++.||+|||+ ++||||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence 9999999999999999999999 4678777754222212233456778899999999999998 89999999999999
Q ss_pred ECCCCcEEEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 732 LGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 732 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++.++.+||+|||+++.+............||+.|+|||++.+..++ ++||||.
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 354 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSC 354 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHH
Confidence 99999999999999987755443333446799999999999998888 8999983
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=245.81 Aligned_cols=184 Identities=31% Similarity=0.501 Sum_probs=156.3
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 35688999999999999999988778889999987532 235678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++... ....+++.++..++.|++.|+.|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 82 LMKYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cccCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 99999999998542 12468899999999999999999997 8999999999999999999999999999987753
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..........++..|+|||++.+..++ ++|+||
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 189 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWS 189 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHH
Confidence 322111112234579999999888888 899998
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=263.15 Aligned_cols=178 Identities=25% Similarity=0.358 Sum_probs=152.2
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
...|.+.+.||+|+||.||+|... +++.||||.... ..+.+|++++++++|+||+++++++...+..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 457999999999999999999765 588999996432 34578999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
|++ .++|.+++.. ....+++.+++.++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+++...
T Consensus 240 e~~-~~~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 240 PKY-RSDLYTYLGA----RLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred Ecc-CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 999 4788887743 22468999999999999999999997 899999999999999999999999999998764
Q ss_pred CCCC-ceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... .......||+.|||||++.+..++ ++||||.
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSl 348 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSA 348 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHH
Confidence 3321 122345799999999999998888 8999983
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=247.20 Aligned_cols=182 Identities=34% Similarity=0.558 Sum_probs=156.3
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEec
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (787)
|++.+.||+|+||+||++... +++.||+|++..............+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678899999999999999876 5678999999886544444445566999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCC
Q 003911 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (787)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 753 (787)
++++|.+++.. ...+++..+..++.|+++||+|||+ .+++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~- 151 (260)
T PF00069_consen 81 PGGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN- 151 (260)
T ss_dssp TTEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST-
T ss_pred ccccccccccc-----ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-
Confidence 99999999851 2468999999999999999999998 89999999999999999999999999999865222
Q ss_pred CceeeeeccccCcccccccc-cCCcC-cceeecC
Q 003911 754 GSIETRIAGTFGYLAPEYAV-HTRWS-SCSYWAG 785 (787)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~-~~~~~-~~DiWS~ 785 (787)
........++..|+|||++. +..++ ++|+||.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 185 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSL 185 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccc
Confidence 22334467899999999998 66666 8999983
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=249.17 Aligned_cols=188 Identities=29% Similarity=0.573 Sum_probs=156.6
Q ss_pred CCCcccceeccccceEEEEEEEeC------CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 593 NNFSEENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
++|++.+.||+|+||.||+|.... ...||+|.+.... ......++.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 468889999999999999997642 2579999987532 334456799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEG-----------LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 735 (787)
+++|||+++++|.+++....... ...+++.+++.++.|++.||+|||+ .+++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCC
Confidence 99999999999999986532211 1457889999999999999999998 899999999999999999
Q ss_pred CcEEEeecccceecCCCCC-ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 736 MRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 736 ~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+.+||+|||+++....... .......+++.|+|||++.+..++ ++|+||
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s 211 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWS 211 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHH
Confidence 9999999999986543321 122334568899999999888888 899998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=258.86 Aligned_cols=182 Identities=26% Similarity=0.382 Sum_probs=153.5
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC-----
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----- 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 664 (787)
..++|++.+.||+|+||.||+|... .++.||||++...........++.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999764 6899999999765444555677889999999999999999999886543
Q ss_pred -eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 665 -EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 665 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
..++||||+++ ++.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeC
Confidence 46999999964 6766652 247888999999999999999997 89999999999999999999999999
Q ss_pred ccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|+++...... ......||+.|+|||++.+..++ ++|+||.
T Consensus 164 g~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl 204 (355)
T cd07874 164 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 204 (355)
T ss_pred cccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHH
Confidence 9998654332 22335789999999999988888 8999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=245.24 Aligned_cols=182 Identities=30% Similarity=0.479 Sum_probs=154.8
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
++|++.+.||+|+||.||+|+..++..+|+|.++.... ..+++.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 46888899999999999999887777899999875332 346789999999999999999999999998899999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++|+|.+++... ...+++.+++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||.++.....
T Consensus 81 ~~~~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 81 MSNGCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 9999999988541 2368999999999999999999997 89999999999999999999999999998866443
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.........++..|+|||++.+..++ ++|+||
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~s 186 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHH
Confidence 22111223356789999999888887 899998
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=242.59 Aligned_cols=184 Identities=26% Similarity=0.434 Sum_probs=161.0
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+|++.+.||+|++|.||+|... +++.|++|.+..........+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999765 689999999976555566678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++... ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999998652 12468899999999999999999997 89999999999999999999999999999876543
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.. ......|++.|+|||+..+..++ ++|+||
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 186 (256)
T cd08529 155 TN-FANTIVGTPYYLSPELCEDKPYNEKSDVWA 186 (256)
T ss_pred cc-hhhccccCccccCHHHhcCCCCCCccchHH
Confidence 32 22335688999999999988877 899998
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=256.90 Aligned_cols=182 Identities=27% Similarity=0.427 Sum_probs=153.1
Q ss_pred hhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC-----
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG----- 663 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 663 (787)
.+.++|++.+.||+|+||.||+|... +++.||||++..........+++.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45678999999999999999999754 788999999876443344556788999999999999999999987543
Q ss_pred -CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEee
Q 003911 664 -NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (787)
Q Consensus 664 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 742 (787)
...|+++|++ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcC
Confidence 3468999988 7899877632 468999999999999999999998 8999999999999999999999999
Q ss_pred cccceecCCCCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 743 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
||+++...... ....||+.|+|||++.+ ..++ ++||||.
T Consensus 162 fg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 202 (343)
T cd07878 162 FGLARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202 (343)
T ss_pred CccceecCCCc----CCccccccccCchHhcCCccCCchhhhHhH
Confidence 99998764322 23568999999999877 4566 8999983
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=244.91 Aligned_cols=187 Identities=25% Similarity=0.437 Sum_probs=159.4
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccc-ccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|+.. +++.||||.++... .......++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999765 78999999886532 23444567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++..... ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||.+....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999998865433 23467889999999999999999997 899999999999999999999999999998765
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..... .....|++.|+|||.+.+..++ ++|+||
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 191 (267)
T cd08228 158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWS 191 (267)
T ss_pred chhHH-HhcCCCCccccChhhhccCCCCchhhHHH
Confidence 43221 1234688999999999888777 899998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=247.78 Aligned_cols=174 Identities=15% Similarity=0.278 Sum_probs=147.8
Q ss_pred ceeccccceEEEEEEEeCCcEEEEEEeecccccc-hhHHHHHHHHHHHHhcCCCccceEEeEEEe----CCeeEEEEEec
Q 003911 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEKLLVFEYM 673 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~ 673 (787)
..||+|++|.||+|.. +|+.||||+++...... ...+.+.+|++++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999988 58999999997643322 224778899999999999999999999977 34678999999
Q ss_pred CCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCC
Q 003911 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (787)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 753 (787)
++|+|.+++.. ...+++.....++.|++.|++|||+ ..+++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 105 TRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 99999999853 2468899999999999999999996 2488899999999999999999999999998654322
Q ss_pred CceeeeeccccCccccccccc--CCcC-cceeec
Q 003911 754 GSIETRIAGTFGYLAPEYAVH--TRWS-SCSYWA 784 (787)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~~--~~~~-~~DiWS 784 (787)
....|+..|+|||++.+ ..++ ++||||
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~S 207 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYS 207 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhH
Confidence 22468999999999976 5667 999998
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=244.74 Aligned_cols=181 Identities=30% Similarity=0.482 Sum_probs=153.5
Q ss_pred CCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEec
Q 003911 594 NFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (787)
+|++.+.||+|+||.||+|..+++..+|+|++..... ...++.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 5788899999999999999887778899999865332 2357888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCC
Q 003911 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (787)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 753 (787)
++++|.+++... ...+++..++.++.|++.|++|||+ .+++||||||+||++++++.+||+|||.++...+..
T Consensus 82 ~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 82 ANGCLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred CCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 999999988542 2368899999999999999999998 899999999999999999999999999998664332
Q ss_pred CceeeeeccccCcccccccccCCcC-cceeec
Q 003911 754 GSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
........++..|+|||.+.+..++ ++|+||
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~s 186 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS 186 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHH
Confidence 2111122234579999999988888 899998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=248.18 Aligned_cols=183 Identities=27% Similarity=0.426 Sum_probs=149.3
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc---CCCccceEEeEEEeC-----C
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV---RHRHLVALLGHCLDG-----N 664 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~-----~ 664 (787)
+|++.+.||+|+||.||+|+.. +++.||+|.++...........+.+|+++++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999765 789999999876433333334566777777765 699999999988642 4
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..++||||++ ++|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccC
Confidence 5789999997 5888887542 22358999999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+++...... ......||+.|+|||++.+..++ ++|+||.
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 193 (288)
T cd07863 154 LARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSV 193 (288)
T ss_pred ccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhH
Confidence 998764332 12335689999999999888887 8999993
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=262.61 Aligned_cols=182 Identities=23% Similarity=0.390 Sum_probs=147.3
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC------
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------ 663 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 663 (787)
...+|++.+.||+|+||.||+|... +++.||||++.... ....+|+.++++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 3467999999999999999999764 68999999885421 2345799999999999999999887532
Q ss_pred --CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC-cEEE
Q 003911 664 --NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKV 740 (787)
Q Consensus 664 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl 740 (787)
...++||||++ +++.+++...... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARN-NHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceee
Confidence 23579999997 5787777544332 3568999999999999999999998 8999999999999999654 7999
Q ss_pred eecccceecCCCCCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 741 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 741 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
+|||+|+....... .....||+.|+|||++.+. .++ ++||||.
T Consensus 213 ~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 257 (440)
T PTZ00036 213 CDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSL 257 (440)
T ss_pred eccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHH
Confidence 99999987644322 2235789999999998764 566 8999983
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=273.55 Aligned_cols=194 Identities=24% Similarity=0.413 Sum_probs=158.0
Q ss_pred HhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC--Ce
Q 003911 589 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NE 665 (787)
Q Consensus 589 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 665 (787)
....++|++.+.||+|+||.||+|... +++.||+|++............+..|+.++++++||||+++++++... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344578999999999999999999765 678899999886555556677899999999999999999999988653 56
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----CCCeEEcCCCCCCEEECC-------
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA----HQSFIHRDLKPSNILLGD------- 734 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----~~~ivH~Dlkp~NIll~~------- 734 (787)
.|+||||+++|+|.+++...... ...+++..++.|+.||+.||+|||+.. ..+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 89999999999999998654322 246899999999999999999999732 145999999999999964
Q ss_pred ----------CCcEEEeecccceecCCCCCceeeeeccccCcccccccccC--CcC-cceeecC
Q 003911 735 ----------DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHT--RWS-SCSYWAG 785 (787)
Q Consensus 735 ----------~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~~DiWS~ 785 (787)
.+.+||+|||++....... ......||+.|+|||++.+. .++ ++||||.
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSL 229 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHH
Confidence 2348999999998764332 22335799999999998653 455 8999983
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=244.81 Aligned_cols=182 Identities=31% Similarity=0.526 Sum_probs=153.6
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
++|++.+.||+|+||.||+|...+...||+|+++.... ..+++.+|++++++++||||+++++++. ....++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 56999999999999999999887677899999875332 3457899999999999999999999875 4567999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++|+|.+++... ....+++..+..++.|+++||+|||+ .+++||||||+||++++++.++|+|||.++.....
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 82 MSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred CCCCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999998542 22357899999999999999999997 89999999999999999999999999999876543
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.........++..|+|||+..+..++ ++|+||
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvws 188 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHH
Confidence 32222223467789999999888888 899998
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=257.69 Aligned_cols=182 Identities=26% Similarity=0.379 Sum_probs=153.5
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC------
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------ 663 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 663 (787)
..++|++.+.||+|+||.||+|... .++.||||++...........++.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999764 688999999976544455567788999999999999999999987643
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
...|+||||++ +++.+.+. ..+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeC
Confidence 35799999996 47776662 247888999999999999999997 89999999999999999999999999
Q ss_pred ccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|+++...... ......||+.|+|||++.+..++ ++|+||.
T Consensus 171 G~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 211 (364)
T cd07875 171 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 211 (364)
T ss_pred CCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhH
Confidence 9998654322 22335789999999999998888 8999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=220.39 Aligned_cols=186 Identities=28% Similarity=0.429 Sum_probs=154.2
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++....+.||+|++|.|-+-++. +|...|+|++.... ..+..++...|+.+..+. .+|.+|.+||.+.+....|+.|
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 34445677999999999887654 79999999998743 456677888899887776 7999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
|.| ..+|..+-+...+.+ ..+++.-.-+||..+.+||.|||+ +..+||||+||+|||++.+|++|+||||.+-++.
T Consensus 125 E~M-~tSldkfy~~v~~~g-~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 125 ELM-DTSLDKFYRKVLKKG-GTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHh-hhhHHHHHHHHHhcC-CcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 999 458877665544443 578999999999999999999999 6899999999999999999999999999998876
Q ss_pred CCCCceeeeeccccCcccccccccC----CcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHT----RWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~-~~DiWS~ 785 (787)
+.... +-..|...|||||.+..+ .|+ ++||||.
T Consensus 201 dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSL 238 (282)
T KOG0984|consen 201 DSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSL 238 (282)
T ss_pred hhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhh
Confidence 54322 224588899999998653 677 9999994
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=250.60 Aligned_cols=183 Identities=24% Similarity=0.407 Sum_probs=152.5
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|.+.+.||+|+||.||+|+.. +++.||+|+++... .......+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccc-cCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 57999999999999999999765 68889999987543 22334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++ +|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 85 YLDK-DLKQYMDD----CGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CCCC-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 9964 88877743 22357889999999999999999998 8999999999999999999999999999976543
Q ss_pred CCCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
... ......+|+.|+|||++.+. .++ ++|+||.
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 191 (309)
T cd07872 157 PTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGV 191 (309)
T ss_pred Ccc-ccccccccccccCCHHHhCCCCCCcHHHHHHH
Confidence 322 12234679999999998664 455 8999983
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=251.57 Aligned_cols=183 Identities=28% Similarity=0.498 Sum_probs=152.0
Q ss_pred CCCcccceeccccceEEEEEEEe-CCc----EEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
.+|++.+.||+|+||.||+|.+. +++ .||+|+++.. ......+++.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 46899999999999999999764 333 4899998652 2344567899999999999999999999999764 567
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 85 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeecCCCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence 99999999999998854 22357889999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCCcee-eeeccccCcccccccccCCcC-cceeec
Q 003911 748 LAPEGKGSIE-TRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 748 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.......... ....++..|+|||++.+..++ ++|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~s 196 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 196 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHH
Confidence 7654332211 112346789999999988888 899998
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=244.02 Aligned_cols=183 Identities=30% Similarity=0.488 Sum_probs=155.2
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.+|++.+.||+|+||.||+|... +++.||+|++... .....++.+|++++++++||||+++++++...+..++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 35788899999999999999765 5889999998653 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++.. .....+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||.+.....
T Consensus 83 ~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 83 FMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred eCCCCcHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999998854 223468899999999999999999997 8999999999999999999999999999987654
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..........++..|+|||.+.+..++ ++|+||
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 190 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 190 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHH
Confidence 322221222346689999999888888 899998
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=247.68 Aligned_cols=188 Identities=29% Similarity=0.564 Sum_probs=157.2
Q ss_pred CCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+.+|++++++++||||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 46888999999999999999763 34789999987532 233567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhh---------hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc
Q 003911 667 LLVFEYMPQGTLSRHIFNWA---------EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~---------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 737 (787)
++||||+++++|.+++.... ......+++.++..++.|++.|++|||+ .+++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 99999999999999996532 1122457889999999999999999997 89999999999999999999
Q ss_pred EEEeecccceecCCCCC-ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 738 AKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 738 ~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+||+|||+++....... .......+++.|+|||++.+..++ ++|+||
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 209 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 209 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHH
Confidence 99999999976533221 112233467889999999998888 899998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=243.75 Aligned_cols=184 Identities=25% Similarity=0.493 Sum_probs=155.5
Q ss_pred CCCcccceeccccceEEEEEEEe----CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
++|++.+.||+|+||.||+|.+. +...||||+++... ......++.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 57889999999999999999874 24579999886532 34456778999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++++|.+++.. ....+++.++..++.|++.|++|||+ .+|+||||||+||++++++.++|+|||+++.
T Consensus 83 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 83 ITEYMENGSLDKFLRE----NDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEcCCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 9999999999998854 22368899999999999999999997 8999999999999999999999999999987
Q ss_pred cCCCCCcee-eeeccccCcccccccccCCcC-cceeec
Q 003911 749 APEGKGSIE-TRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 749 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
......... ....++..|+|||.+.+..++ ++|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~s 193 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWS 193 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHH
Confidence 752222111 122346789999999988888 899998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-27 Score=244.25 Aligned_cols=176 Identities=27% Similarity=0.413 Sum_probs=153.0
Q ss_pred CCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|+||.||+|.. .+++.||+|++.... ......++.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3678889999999999999975 478999999987532 34455678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|..+. .+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 80 FMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred cCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 99999986442 46788899999999999999998 8999999999999999999999999999986643
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.. .....||..|+|||++.+..++ ++|+||
T Consensus 148 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 178 (279)
T cd06619 148 SI---AKTYVGTNAYMAPERISGEQYGIHSDVWS 178 (279)
T ss_pred cc---ccCCCCChhhcCceeecCCCCCCcchHHH
Confidence 32 2235789999999999988887 999998
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-27 Score=248.39 Aligned_cols=181 Identities=26% Similarity=0.392 Sum_probs=156.1
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|+||.||++... ++..+|+|.+.... ......++.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 46899999999999999999765 68889999887532 33445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++.. ...+++..+..++.|+++||+|||+ +.+++||||||+||++++++.+||+|||++.....
T Consensus 80 y~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 80 HMDGGSLDQVLKK-----AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred ccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 9999999999854 2468899999999999999999997 35899999999999999999999999999876533
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.. .....|+..|+|||++.+..++ ++|+||
T Consensus 153 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Diws 183 (308)
T cd06615 153 SM---ANSFVGTRSYMSPERLQGTHYTVQSDIWS 183 (308)
T ss_pred cc---cccCCCCcCccChhHhcCCCCCccchHHH
Confidence 22 2235689999999999888777 899998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-27 Score=242.92 Aligned_cols=183 Identities=31% Similarity=0.542 Sum_probs=154.4
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|++|+++++++. ....+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 357889999999999999999888888999999876432 3467899999999999999999999875 456899999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++.. .....+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||.+.....
T Consensus 81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 81 YMSKGSLLDFLKD---GEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred ecCCCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 9999999998854 223458899999999999999999998 8999999999999999999999999999987644
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..........++..|+|||++.+..++ ++|+||
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 188 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHH
Confidence 332222223456689999999888888 999998
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-27 Score=241.69 Aligned_cols=185 Identities=27% Similarity=0.435 Sum_probs=157.1
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc---chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
++|++.+.||+|++|.||+|... +++.||+|.+...... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999754 6899999998754322 2234678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
|+||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||.++.
T Consensus 82 v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 9999999999998854 2357889999999999999999997 8999999999999999999999999999976
Q ss_pred cCCCCCcee--eeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSIE--TRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
......... ....|+..|+|||++.+..++ ++|+||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSV 193 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHH
Confidence 543221111 234578899999999988887 8999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=246.31 Aligned_cols=191 Identities=26% Similarity=0.452 Sum_probs=155.9
Q ss_pred hcCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 664 (787)
..++|++.+.||+|+||.||+|... ++..||+|++.... ......++.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3567999999999999999998653 35679999886432 2334567899999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEE
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEE-----GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 739 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 739 (787)
..++||||+++++|.+++...... ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEE
Confidence 999999999999999998653211 12346788899999999999999997 8999999999999999999999
Q ss_pred EeecccceecCCCCCce-eeeeccccCcccccccccCCcC-cceeecC
Q 003911 740 VADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 740 l~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|+|||+++......... .....+++.|||||++.++.++ ++|+||.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 207 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHH
Confidence 99999987654332211 1123457789999999988888 8999983
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-27 Score=246.58 Aligned_cols=188 Identities=27% Similarity=0.503 Sum_probs=155.2
Q ss_pred CCCcccceeccccceEEEEEEE-----eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 593 NNFSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
++|++.+.||+|+||.||+|.. .++..||+|.+.... ......++.+|++++++++||||+++++++..+...|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4678889999999999999974 246789999987532 3444578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhh------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC
Q 003911 668 LVFEYMPQGTLSRHIFNWAE------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 735 (787)
+||||+++++|.+++..... .....+++.++..++.|++.||+|||+ ++++||||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCC
Confidence 99999999999999853211 012347888999999999999999997 899999999999999999
Q ss_pred CcEEEeecccceecCCCCC-ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 736 MRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 736 ~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+.+||+|||+++....... .......++..|+|||++.+..++ ++|+||
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 211 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS 211 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHH
Confidence 9999999999986543321 112223457789999999888777 899998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=255.89 Aligned_cols=176 Identities=22% Similarity=0.363 Sum_probs=150.1
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
..+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++......++||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 357999999999999999999875 5788999975432 2356899999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+ .++|.+++.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 137 e~~-~~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 137 PHY-SSDLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred Ecc-CCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 999 4688887743 23468999999999999999999998 899999999999999999999999999997543
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... ......||+.|+|||++.+..++ ++|+||.
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 242 (357)
T PHA03209 209 VAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSA 242 (357)
T ss_pred cCc--ccccccccccccCCeecCCCCCCchhhHHHH
Confidence 222 12335689999999999998888 9999983
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=238.77 Aligned_cols=184 Identities=24% Similarity=0.369 Sum_probs=157.8
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+|++.+.||+|+||.||+++.. +++.+|+|.++... .....+.+.+|+.++++++||||+++++.+.+++..++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 5788999999999999999765 78999999986532 234567888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++... ....+++..++.++.|++.||.|||+ .+|+|+||||+||++++++.++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 80 CDGGDLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 9999999887532 22457889999999999999999997 89999999999999999999999999999876443
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.. ......|++.|+|||++.+..++ ++|+||.
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~sl 186 (255)
T cd08219 154 GA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSL 186 (255)
T ss_pred cc-ccccccCCccccCHHHHccCCcCchhhhhhh
Confidence 21 22335689999999999888777 8999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=241.38 Aligned_cols=187 Identities=25% Similarity=0.450 Sum_probs=160.8
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|... +++.||+|.++.... .....+++.+|++++++++|++|+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999876 899999999875332 2344678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++..... ....+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 99999999998865332 23468899999999999999999997 899999999999999999999999999988664
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..... .....|++.|+|||.+.+..++ ++|+||
T Consensus 158 ~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~s 191 (267)
T cd08224 158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWS 191 (267)
T ss_pred CCCcc-cceecCCccccCHHHhccCCCCchhcHHH
Confidence 43221 2235689999999999888888 899998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=256.23 Aligned_cols=179 Identities=24% Similarity=0.346 Sum_probs=152.3
Q ss_pred hcCCCcccceeccccceEEEEEEEe---CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
...+|++.+.||+|+||.||+|... .+..||+|.+... ....+|++++++++||||+++++++......+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 3467999999999999999999653 4678999987542 24568999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+|||++. ++|.+++. ....+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||+++
T Consensus 163 lv~e~~~-~~l~~~l~-----~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 163 MVMPKYK-CDLFTYVD-----RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred EEehhcC-CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 9999995 68888772 23468999999999999999999997 899999999999999999999999999997
Q ss_pred ecCCCCCc-eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 748 LAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
........ ......||+.|+|||++.+..++ ++|+||.
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 273 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSA 273 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHH
Confidence 66543322 12345799999999999988888 8999983
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=245.59 Aligned_cols=181 Identities=31% Similarity=0.477 Sum_probs=157.9
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|++|.||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46899999999999999999765 689999999876432 2344577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRK-----SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 99999999998844 2468899999999999999999998 899999999999999999999999999998764
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.. .....|++.|+|||.+.+..++ ++|+||-
T Consensus 153 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 184 (290)
T cd05580 153 GR----TYTLCGTPEYLAPEIILSKGYGKAVDWWAL 184 (290)
T ss_pred CC----CCCCCCCccccChhhhcCCCCCccccHHHH
Confidence 43 2235689999999999888777 8999983
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=252.45 Aligned_cols=177 Identities=26% Similarity=0.460 Sum_probs=151.3
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGT 677 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 677 (787)
-+||+|+||+||-|+.. +...+|||.+..+ ..+..+-+..||..-++++|.|||+++|.+..++..-|.||-++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 36999999999999765 5677999998753 34456778999999999999999999999999999999999999999
Q ss_pred HHHHHHhhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC-CCCcEEEeecccceecCCCCC
Q 003911 678 LSRHIFNWAEEGLKPL--EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPEGKG 754 (787)
Q Consensus 678 L~~~l~~~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~ 754 (787)
|.+.++.. .+++ .+.+.-.+..||++||.|||+ ..|||||||-+||||+ -.|.+||+|||-++.+..-.
T Consensus 659 LSsLLrsk----WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin- 730 (1226)
T KOG4279|consen 659 LSSLLRSK----WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN- 730 (1226)
T ss_pred HHHHHHhc----cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC-
Confidence 99999652 3455 678888999999999999998 8999999999999997 67899999999998875433
Q ss_pred ceeeeeccccCcccccccccCC--cC-cceeecC
Q 003911 755 SIETRIAGTFGYLAPEYAVHTR--WS-SCSYWAG 785 (787)
Q Consensus 755 ~~~~~~~gt~~y~aPE~~~~~~--~~-~~DiWS~ 785 (787)
.....+.||..|||||++..++ |. ++||||-
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~ 764 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSF 764 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhc
Confidence 3444578999999999998764 44 8999993
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-28 Score=234.98 Aligned_cols=184 Identities=28% Similarity=0.406 Sum_probs=159.3
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
-++|...++||+|.||.|..++-+ +++.+|+|+++++..- ......-..|-++++..+||.+..+--.|+..+..|.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888999999999999999754 7999999999987543 44455667899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||..||.|..++.. .+.++++....+...|+.||.|||+ ++||.||+|.+|.|+|++|++||+|||+++.-
T Consensus 247 MeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhc
Confidence 999999999988843 3568889999999999999999998 89999999999999999999999999999854
Q ss_pred CCCCCceeeeeccccCcccccccccCCcCcceeec
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWSSCSYWA 784 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiWS 784 (787)
-.. +.....++|||.|.|||++....|..+-+|-
T Consensus 319 I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWW 352 (516)
T KOG0690|consen 319 IKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWW 352 (516)
T ss_pred ccc-cceeccccCChhhcCchhhccccccceeehh
Confidence 332 3345568999999999999999999555553
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=243.36 Aligned_cols=181 Identities=34% Similarity=0.582 Sum_probs=150.1
Q ss_pred ccceeccccceEEEEEEEe-----CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 597 EENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 597 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
+.+.||.|.||.||+|.+. .+..|+||.++. .......+++.+|++.+++++||||++++|++...+..++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 4688999999999999877 367899999965 3344457899999999999999999999999998888999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++|+|.+++... ....+++.++..|+.||++||+|||+ .+++|+||+++||++++++.+||+|||+++....
T Consensus 82 ~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp --TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999663 23468999999999999999999998 7999999999999999999999999999987733
Q ss_pred CCCc-eeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.... ......+...|+|||.+.+..++ ++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVys 190 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYS 190 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccc
Confidence 2211 11223467889999999999888 999998
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=260.84 Aligned_cols=184 Identities=25% Similarity=0.333 Sum_probs=148.0
Q ss_pred HHHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCC------CccceEEeE
Q 003911 587 VLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH------RHLVALLGH 659 (787)
Q Consensus 587 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~ 659 (787)
++....++|++.+.||+|+||+||+|... +++.||||+++.. .....++..|+++++.++| +++++++++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 34445688999999999999999999764 6889999998642 2233456678888877755 458888888
Q ss_pred EEeC-CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC--
Q 003911 660 CLDG-NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-- 736 (787)
Q Consensus 660 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 736 (787)
+... ...|+|||++ +++|.+++.. ...+++..+..|+.||+.||+|||+ +.+||||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTV 271 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcc
Confidence 8765 4688999988 7789888743 2468899999999999999999996 25999999999999998665
Q ss_pred --------------cEEEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 737 --------------RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 737 --------------~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.+||+|||.+..... .....+||+.|||||++.+..|+ ++||||.
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 331 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSM 331 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHH
Confidence 499999998864322 12346799999999999999888 8999983
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=238.89 Aligned_cols=185 Identities=25% Similarity=0.423 Sum_probs=160.8
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+|+..+.||+|+||.||.++.. +++.+++|.+...........++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999998754 689999999877655566677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++.... ...+++.++..++.|++.|++|||+ .+++||||||+||++++++.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999885421 2467899999999999999999997 89999999999999999999999999999876544
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.. ......|++.|+|||+..+..++ ++|+||.
T Consensus 155 ~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~sl 187 (256)
T cd08221 155 YS-MAETVVGTPYYMSPELCQGVKYNFKSDIWAL 187 (256)
T ss_pred cc-cccccCCCccccCHhhcCCCCCCCcchhHHH
Confidence 32 22345689999999999888777 8999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=239.29 Aligned_cols=178 Identities=31% Similarity=0.527 Sum_probs=150.4
Q ss_pred ceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCCCH
Q 003911 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (787)
++||+|+||.||+|...++..||+|++.... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999988888999999987532 334455788999999999999999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCceee
Q 003911 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 758 (787)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 758 (787)
.+++.. ....+++..+..++.|++.||.|+|+ .+++||||||+||++++++.+||+|||++............
T Consensus 80 ~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 80 LSFLRK----KKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 998743 22357899999999999999999997 89999999999999999999999999999765433221112
Q ss_pred eeccccCcccccccccCCcC-cceeec
Q 003911 759 RIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 759 ~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
...++..|+|||++.+..++ ++|+||
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~s 179 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWS 179 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHH
Confidence 22346789999999888887 899998
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-27 Score=241.21 Aligned_cols=183 Identities=26% Similarity=0.472 Sum_probs=155.3
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.++|++.++||+|+||.||+|..++++.||+|.+.... ...+++.+|++++++++||||+++++++. .+..+++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 46789999999999999999998889999999987533 23467899999999999999999999874 456899999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++.. .....+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||.+.....
T Consensus 81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 81 YMENGSLVDFLKT---PEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 9999999998854 223468899999999999999999997 8999999999999999999999999999987653
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..........++..|+|||++.+..++ ++|+||
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~s 188 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 188 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHH
Confidence 322222233457789999999888877 899998
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=243.93 Aligned_cols=184 Identities=33% Similarity=0.535 Sum_probs=158.3
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
..+|++.+.||+|+||.||+|...++..+|+|++.... .....++.+|+++++.++||||+++++++.+.+..++|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 45788999999999999999998889999999987632 2345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++... ....+++.++..++.|++.|++|||+ .+++||||||+||++++++.+||+|||.+.....
T Consensus 83 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 83 LMEKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred ecccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999998642 22468899999999999999999997 8999999999999999999999999999987644
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.... .....++..|+|||++.+..++ ++|+||
T Consensus 157 ~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Diws 189 (261)
T cd05148 157 DVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWS 189 (261)
T ss_pred cccc-ccCCCCceEecCHHHHccCCCCchhhHHH
Confidence 3221 1223457789999999888887 899998
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=245.27 Aligned_cols=187 Identities=29% Similarity=0.557 Sum_probs=155.3
Q ss_pred CCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
.+|.+.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 46888999999999999999742 3456899988652 334566899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhh--------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcE
Q 003911 667 LLVFEYMPQGTLSRHIFNWAE--------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 738 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 738 (787)
++||||+++++|.+++..... .....+++.+++.++.|++.||+|||+ ++++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence 999999999999999864321 122358999999999999999999997 899999999999999999999
Q ss_pred EEeecccceecCCCCC-ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 739 KVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 739 kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
||+|||+++....... .......+++.|+|||++.+..++ ++|+||
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiws 207 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 207 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHH
Confidence 9999999986543221 111223457789999999988888 899998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=247.01 Aligned_cols=188 Identities=27% Similarity=0.499 Sum_probs=154.4
Q ss_pred CCCcccceeccccceEEEEEEEeC---------------CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELHD---------------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 657 (787)
++|++.+.||+|+||.||+|+... ...||+|++... ........+.+|++++++++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 579999999999999999986532 235899998753 2344566799999999999999999999
Q ss_pred eEEEeCCeeEEEEEecCCCCHHHHHHhhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 003911 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE-------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 730 (787)
Q Consensus 658 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 730 (787)
+++...+..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+ .+++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence 9999999999999999999999998542211 11246888999999999999999998 8999999999999
Q ss_pred EECCCCcEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeec
Q 003911 731 LLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 731 ll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
++++++.+||+|||++......... ......++..|+|||++.++.++ ++|+||
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS 216 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHH
Confidence 9999999999999999765433211 11223456789999999888888 899998
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=245.40 Aligned_cols=189 Identities=27% Similarity=0.466 Sum_probs=157.2
Q ss_pred cCCCcccceeccccceEEEEEEEeC-----------------CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccc
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHD-----------------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 654 (787)
.++|++.+.||+|+||.||+|.... +..||+|++.... .....+++.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3578999999999999999987542 2468999887532 335567899999999999999999
Q ss_pred eEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 003911 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 728 (787)
Q Consensus 655 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 728 (787)
++++++...+..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchh
Confidence 9999999999999999999999999998654321 12368999999999999999999997 89999999999
Q ss_pred CEEECCCCcEEEeecccceecCCCCC-ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 729 NILLGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 729 NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
||++++++.++|+|||+++....... .......+++.|+|||++.+..++ ++|+||
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 217 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA 217 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhh
Confidence 99999999999999999976543321 112234567889999999887777 899998
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=238.32 Aligned_cols=184 Identities=23% Similarity=0.390 Sum_probs=157.1
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe-CCeeEEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNEKLLVFE 671 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 671 (787)
+|++.+.||+|++|.||++... +++.||+|++..........+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999765 67899999997655555566788999999999999999999998764 445789999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++... ....+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999988642 22458999999999999999999997 8999999999999999999999999999987644
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
... ......|++.|+|||++.+..++ ++|+||
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 187 (257)
T cd08223 155 QCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWA 187 (257)
T ss_pred cCC-ccccccCCcCccChhHhcCCCCCchhhhHH
Confidence 322 22335689999999999988887 899998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=224.48 Aligned_cols=190 Identities=28% Similarity=0.374 Sum_probs=155.8
Q ss_pred cCCCcccceeccccceEEEEEE-EeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC-----e
Q 003911 592 TNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-----E 665 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 665 (787)
.++|++.+.+|+|+|+-||.++ ..++..+|+|++... ..+..+...+|++..++++|||+++++++...+. +
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3689999999999999999997 568899999998753 3567788999999999999999999999876443 4
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.|++++|+..|+|.+.+.....++ ..+++.++++|+.++++||++||+.. .+++||||||.||++.+++.+++.|||.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg-~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKG-NFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 899999999999999997655443 47899999999999999999999832 3599999999999999999999999999
Q ss_pred ceecCCCCCc--------eeeeeccccCcccccccccC---CcC-cceeecC
Q 003911 746 VRLAPEGKGS--------IETRIAGTFGYLAPEYAVHT---RWS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~---~~~-~~DiWS~ 785 (787)
++...-.... .......|..|+|||.+.-+ ..+ ++||||.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSL 227 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSL 227 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhh
Confidence 8754321110 11123468999999998644 333 8999983
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=240.67 Aligned_cols=188 Identities=29% Similarity=0.482 Sum_probs=154.7
Q ss_pred CcccceeccccceEEEEEEEeC----CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe-----
Q 003911 595 FSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE----- 665 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 665 (787)
|++.+.||+|+||.||+|.... +..||+|+++...........+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999997642 3679999998655455566789999999999999999999998876554
Q ss_pred -eEEEEEecCCCCHHHHHHhhhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 666 -KLLVFEYMPQGTLSRHIFNWAE-EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 666 -~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
.+++|||+++|+|..++..... .....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 7899999999999998865332 123468999999999999999999997 89999999999999999999999999
Q ss_pred ccceecCCCCCce-eeeeccccCcccccccccCCcC-cceeecC
Q 003911 744 GLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|+++......... .....++..|+|||++.+..++ ++|+||.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~Sl 201 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF 201 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHH
Confidence 9998764432211 1112346789999999888787 8999993
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=240.59 Aligned_cols=183 Identities=28% Similarity=0.470 Sum_probs=154.4
Q ss_pred cCCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+++|+.++++++||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 35799999999999999999986 478899999987532 233457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++.. ...+++.++..++.|++.|++|||+ .+|+||||||+||++++++.++|+|||+++...
T Consensus 86 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 86 EYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999999998843 2367899999999999999999997 899999999999999999999999999998764
Q ss_pred CCCCceeeeeccccCccccccccc---CCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVH---TRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~-~~DiWS~ 785 (787)
.... ......|++.|+|||.+.+ ..++ ++|+||.
T Consensus 158 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~ 195 (267)
T cd06646 158 ATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAV 195 (267)
T ss_pred cccc-ccCccccCccccCHhHcccccCCCCcchhhHHHH
Confidence 3321 1223568899999999853 3355 8999983
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=254.57 Aligned_cols=188 Identities=25% Similarity=0.448 Sum_probs=154.3
Q ss_pred CCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCe
Q 003911 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNE 665 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 665 (787)
++|.+.+.||+|+||.||+|+++ .+..||+|+++... .....+.+.+|++++.++. ||||+++++++...+.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 45778899999999999999753 34689999997632 2333457889999999997 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhh----------------------------------------------------------
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAE---------------------------------------------------------- 687 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 687 (787)
.++||||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999865321
Q ss_pred -----------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 003911 688 -----------------------------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (787)
Q Consensus 688 -----------------------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 732 (787)
.....+++.++..++.|++.||+|||+ .+++||||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEE
Confidence 011246778889999999999999997 899999999999999
Q ss_pred CCCCcEEEeecccceecCCCCC-ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 733 GDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 733 ~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
++++.+||+|||+++....... .......+++.|||||++.+..++ ++|+||
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 326 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWS 326 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHH
Confidence 9999999999999986533221 111224578899999999888777 899998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=241.11 Aligned_cols=184 Identities=26% Similarity=0.470 Sum_probs=154.2
Q ss_pred CCCcccceeccccceEEEEEEEe-C---CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-D---GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
++|++.+.||+|+||.||+|+.. + +..+|+|.++... .....+.+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46888999999999999999764 2 3479999886532 34456789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++++|.+++.. ....+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++++|||.+..
T Consensus 83 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 83 VTEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 9999999999999854 22357899999999999999999997 8999999999999999999999999999987
Q ss_pred cCCCCCceee--eeccccCcccccccccCCcC-cceeec
Q 003911 749 APEGKGSIET--RIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 749 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.......... ...++..|+|||++.+..++ ++|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~s 194 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWS 194 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHH
Confidence 6543322211 12235689999999988888 899998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=240.78 Aligned_cols=185 Identities=32% Similarity=0.537 Sum_probs=157.5
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.++|++.+.||+|+||.||+|..++++.||||.+.... ...+++.+|+.++++++||||+++++++......++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 46799999999999999999988878899999987533 234678999999999999999999999999889999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++... ....+++.++..++.|++.|++|||+ .+++|+||||+||++++++.+||+|||.++....
T Consensus 82 ~~~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 82 YMSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred ccCCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999998542 22468899999999999999999997 8999999999999999999999999999987653
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..........++..|+|||.+.+..++ ++|+||.
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 190 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSF 190 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHH
Confidence 221111222346789999999988888 8999983
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=251.27 Aligned_cols=189 Identities=28% Similarity=0.488 Sum_probs=153.5
Q ss_pred cCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeC-
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG- 663 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~- 663 (787)
.++|++.+.||+|+||.||+|... +++.||+|+++... .....+.+.+|++++.++ +|+||+++++++...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 357999999999999999999532 35789999987532 334456788999999999 899999999988754
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhc-------------------------------------------------------
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEE------------------------------------------------------- 688 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 688 (787)
...+++|||+++++|.+++......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5678999999999999988542110
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCce-eeeeccccCc
Q 003911 689 -GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGY 766 (787)
Q Consensus 689 -~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y 766 (787)
....+++..+..++.||+.||+|||+ .+|+||||||+||++++++.++|+|||+++......... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 01368899999999999999999997 899999999999999999999999999998764332211 1223457789
Q ss_pred ccccccccCCcC-cceeec
Q 003911 767 LAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 767 ~aPE~~~~~~~~-~~DiWS 784 (787)
+|||++.+..++ ++|+||
T Consensus 242 ~aPE~~~~~~~~~~~Di~S 260 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWS 260 (337)
T ss_pred cCcHHhcCCCCCccccHHH
Confidence 999999988888 899998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=241.62 Aligned_cols=181 Identities=28% Similarity=0.483 Sum_probs=154.4
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 47888999999999999999764 68999999987532 2334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++.. ...+++.++..++.|++.|++|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 87 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 87 FCGGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred ccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 9999999998843 2468899999999999999999998 8999999999999999999999999999876643
Q ss_pred CCCceeeeeccccCcccccccc---cCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAV---HTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~-~~DiWS 784 (787)
... ......|++.|+|||++. ...++ ++|+||
T Consensus 159 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwS 194 (267)
T cd06645 159 TIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWA 194 (267)
T ss_pred ccc-ccccccCcccccChhhhccccCCCCCchhhhHH
Confidence 321 123356899999999974 34455 899998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=242.96 Aligned_cols=184 Identities=25% Similarity=0.538 Sum_probs=153.9
Q ss_pred CCcccceeccccceEEEEEEE-----eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC--Cee
Q 003911 594 NFSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEK 666 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 666 (787)
.|++.+.||+|+||.||+|.. .++..||+|.++... .......+.+|++++++++||||+++++++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 468889999999999999974 257889999987532 344457899999999999999999999998875 567
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
++||||+++++|.+++.. ....+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 84 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEEccCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccc
Confidence 899999999999998843 22358999999999999999999997 89999999999999999999999999999
Q ss_pred eecCCCCCc--eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 747 RLAPEGKGS--IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+........ ......|+..|+|||++.+..++ ++|+||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 198 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSF 198 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhh
Confidence 876443221 11234567789999999888777 8999993
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=241.86 Aligned_cols=187 Identities=27% Similarity=0.490 Sum_probs=151.5
Q ss_pred CcccceeccccceEEEEEEEeC-Cc--EEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC------Ce
Q 003911 595 FSEENILGRGGFGTVYKGELHD-GT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------NE 665 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 665 (787)
|.+.+.||+|+||.||+|+..+ +. .||+|.++.........+.+.+|++++++++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999998753 32 689999877554556677899999999999999999999987532 24
Q ss_pred eEEEEEecCCCCHHHHHHhhh-hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWA-EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
.+++|||+++|+|.+++.... ......+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874322 1223458899999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCCce-eeeeccccCcccccccccCCcC-cceeec
Q 003911 745 LVRLAPEGKGSI-ETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 745 ~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+++......... .....+++.|+|||+..+..++ ++|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~s 199 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWS 199 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHH
Confidence 998764432111 1122457789999999888887 899998
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=246.51 Aligned_cols=189 Identities=26% Similarity=0.463 Sum_probs=156.1
Q ss_pred cCCCcccceeccccceEEEEEEEe--------CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEe
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 662 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 662 (787)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+... .......++.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 457888999999999999999642 3457999988653 2344567899999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 003911 663 GNEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (787)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 731 (787)
....++||||+++|+|.+++...... ....+++.++..++.|+++||+|||+ .+++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEE
Confidence 99999999999999999998653211 12357888999999999999999998 89999999999999
Q ss_pred ECCCCcEEEeecccceecCCCCCce-eeeeccccCcccccccccCCcC-cceeec
Q 003911 732 LGDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 732 l~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+++++.+||+|||.++......... .....+++.|+|||++.+..++ ++|+||
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 224 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 224 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHH
Confidence 9999999999999998764432211 1223456789999999888887 899998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=240.62 Aligned_cols=182 Identities=26% Similarity=0.421 Sum_probs=147.4
Q ss_pred ceeccccceEEEEEEEe---CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.||+|+||.||+|... ++..+|+|.++... .......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 35899999999999764 34679999886543 233445788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|+|.+++...........++..+..++.|++.|++|||+ .+++||||||+||++++++.+||+|||.++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999966433333456778888999999999999998 89999999999999999999999999998754332211
Q ss_pred e-eeeeccccCcccccccccC-------CcC-cceeec
Q 003911 756 I-ETRIAGTFGYLAPEYAVHT-------RWS-SCSYWA 784 (787)
Q Consensus 756 ~-~~~~~gt~~y~aPE~~~~~-------~~~-~~DiWS 784 (787)
. .....|+..|+|||++.+. .++ ++|+||
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 194 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWS 194 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHH
Confidence 1 1234578889999998643 234 899998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=241.75 Aligned_cols=181 Identities=27% Similarity=0.411 Sum_probs=144.6
Q ss_pred eeccccceEEEEEEEeC---CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCC
Q 003911 600 ILGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (787)
Q Consensus 600 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (787)
.||+|+||.||+|...+ ...+|+|.+... ........+.+|+++++.++||||+++++++......++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999997543 356888877542 23444567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCce
Q 003911 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 756 (787)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 756 (787)
+|.+++...........++.....++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999866433223345678889999999999999998 899999999999999999999999999987543322111
Q ss_pred -eeeeccccCccccccccc-------CCcC-cceeec
Q 003911 757 -ETRIAGTFGYLAPEYAVH-------TRWS-SCSYWA 784 (787)
Q Consensus 757 -~~~~~gt~~y~aPE~~~~-------~~~~-~~DiWS 784 (787)
.....++..|+|||++.. ..++ ++|+||
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 194 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWS 194 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHH
Confidence 122345778999999753 2344 899998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=247.89 Aligned_cols=180 Identities=29% Similarity=0.424 Sum_probs=143.5
Q ss_pred cceeccccceEEEEEEEe---CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe--CCeeEEEEEe
Q 003911 598 ENILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNEKLLVFEY 672 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 672 (787)
.++||+|+||+||+|+.. +++.||+|++.... ....+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999764 46789999986532 23457889999999999999999998864 4567899999
Q ss_pred cCCCCHHHHHHhhhh----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE----CCCCcEEEeecc
Q 003911 673 MPQGTLSRHIFNWAE----EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 744 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFG 744 (787)
+. ++|.+++..... .....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 85 588887743211 112358899999999999999999998 899999999999999 456789999999
Q ss_pred cceecCCCCCc--eeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 745 LVRLAPEGKGS--IETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
+++........ ......||+.|+|||++.+. .++ ++|+||.
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 202 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 202 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHH
Confidence 99876543211 12346789999999999875 466 8999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=238.71 Aligned_cols=178 Identities=28% Similarity=0.454 Sum_probs=148.6
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGT 677 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 677 (787)
+.||+|+||.||+|... +++.||+|.+... ........+.+|++++++++||||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 46999999999999765 7899999988653 234455789999999999999999999999999999999999999999
Q ss_pred HHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCcee
Q 003911 678 LSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 757 (787)
Q Consensus 678 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 757 (787)
|.+++.. ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.+...........
T Consensus 80 L~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 80 FLTFLRT----EGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 9998843 22357899999999999999999997 8999999999999999999999999999876543211110
Q ss_pred -eeeccccCcccccccccCCcC-cceeec
Q 003911 758 -TRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 758 -~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
....++..|+|||.+.++.++ ++|+||
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 181 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWS 181 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHH
Confidence 111234579999999888887 899998
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=245.51 Aligned_cols=186 Identities=33% Similarity=0.529 Sum_probs=151.5
Q ss_pred CCCcccceeccccceEEEEEEEe-CCc--EEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (787)
++|++.+.||+|+||.||+|..+ ++. .+|+|.++.. .......++.+|++++.++ +||||+++++++...+..|+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 47888999999999999999865 454 4577776542 2344557889999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc
Q 003911 669 VFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 737 (787)
||||+++++|.+++..... .....+++.+++.++.|++.|++|||+ ++++||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 9999999999999865321 112357899999999999999999997 89999999999999999999
Q ss_pred EEEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 738 AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 738 ~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+||+|||+++...... ......++..|+|||++.+..++ ++|+||
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 208 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWS 208 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchh
Confidence 9999999986432111 11112246679999999888777 899998
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=238.27 Aligned_cols=184 Identities=25% Similarity=0.446 Sum_probs=155.8
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.++|++.+.||+|+||.||+|...++..+|+|.+... ....+.+.+|++++++++|+||+++++++.+ ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4679999999999999999998877888999988653 2345678999999999999999999999887 77899999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++... ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 81 FMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eCCCCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999998542 22457888999999999999999997 8999999999999999999999999999987644
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..........++..|+|||++.+..++ ++|+||-
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 189 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 189 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHH
Confidence 332222223456789999999888888 8999983
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=239.12 Aligned_cols=182 Identities=30% Similarity=0.518 Sum_probs=152.8
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
++|++.+.||+|++|.||+|....+..+|+|++.... ...+.+.+|++++++++|||++++++++. .+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 5688899999999999999988777789999886532 23467889999999999999999998875 4567899999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||.++.....
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 82 MGKGSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred CCCCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 9999999998542 22357899999999999999999997 89999999999999999999999999999876443
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.........++..|+|||...+..++ ++|+||
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~s 188 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHH
Confidence 32222223457789999999888888 899998
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=244.09 Aligned_cols=189 Identities=28% Similarity=0.469 Sum_probs=156.4
Q ss_pred cCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCC
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 664 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 664 (787)
.++|++.+.||+|+||.||++... ....+|+|.+... .......++.+|+++++++ +||||+++++++..++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC-CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 457889999999999999999764 2367999998753 2334556789999999999 8999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 733 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 733 (787)
..+++|||+++|+|.+++..... .....+++..++.++.|++.||+|||+ .+|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 99999999999999999865321 223468899999999999999999997 8999999999999999
Q ss_pred CCCcEEEeecccceecCCCCCce-eeeeccccCcccccccccCCcC-cceeec
Q 003911 734 DDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 734 ~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+++.+||+|||.++......... .....++..|+|||++.+..++ ++|+||
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 219 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 219 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceee
Confidence 99999999999998764432111 1112346789999999888887 899999
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-28 Score=274.35 Aligned_cols=190 Identities=28% Similarity=0.420 Sum_probs=162.1
Q ss_pred HHhhcCCCcccceeccccceEEEEEE-EeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 588 LRNVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 588 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
++.+.-+|.....||.|.||.||-|. ..+|+-.|+|.++......+..+.+.+|+.++..++|||+|++||+-.+++..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34556678888999999999999985 56899999999887655566778899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
+|.||||++|+|.+.+.. .+..++.....+..|++.|++|||+ .|||||||||+||+++.+|.+|++|||.|
T Consensus 1310 ~IFMEyC~~GsLa~ll~~-----gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH-----GRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHhccCcHHHHHHh-----cchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccce
Confidence 999999999999998833 2345666677888999999999997 89999999999999999999999999999
Q ss_pred eecCCCCCcee---eeeccccCcccccccccCC----cCcceeecC
Q 003911 747 RLAPEGKGSIE---TRIAGTFGYLAPEYAVHTR----WSSCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~----~~~~DiWS~ 785 (787)
..+........ ...+||+.|||||++.+.. ..++||||.
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWsl 1427 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSL 1427 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcc
Confidence 88765532221 3468999999999998754 338999994
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=242.48 Aligned_cols=190 Identities=28% Similarity=0.483 Sum_probs=157.1
Q ss_pred cCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
.++|++.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 357889999999999999999764 24689999986532 33445678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEE
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEE-----GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 740 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 740 (787)
.++||||+++|+|.+++...... ....+++..++.++.|++.||.|||+ .+++||||||+||++++++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEE
Confidence 99999999999999998653321 12347889999999999999999997 89999999999999999999999
Q ss_pred eecccceecCCCCC-ceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 741 ADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 741 ~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+|||+++....... .......++..|+|||.+.+..++ ++|+||.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSF 207 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHH
Confidence 99999876543321 112234567899999999888777 8999983
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=243.55 Aligned_cols=189 Identities=29% Similarity=0.485 Sum_probs=154.3
Q ss_pred cCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
.++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......++.+|+.++++++||||+++++++.+.+.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 468999999999999999999653 24579999886532 23344568899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEE
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEE-----GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 740 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 740 (787)
.++||||+++|+|.+++...... .....++..+..++.|++.||+|||+ ++|+||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999653221 12345677889999999999999997 89999999999999999999999
Q ss_pred eecccceecCCCCCce-eeeeccccCcccccccccCCcC-cceeec
Q 003911 741 ADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 741 ~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+|||+++......... .....++..|+|||.+.++.++ ++|+||
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dvws 206 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWS 206 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHH
Confidence 9999988653322111 1123456789999999888888 899998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=244.06 Aligned_cols=190 Identities=24% Similarity=0.466 Sum_probs=155.1
Q ss_pred cCCCcccceeccccceEEEEEEEe-----------------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccc
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-----------------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 654 (787)
.++|++.+.||+|+||.||+++.. ++..||+|++... .......++.+|++++++++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 357999999999999999998532 2346899998753 2344567899999999999999999
Q ss_pred eEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 003911 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 728 (787)
Q Consensus 655 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 728 (787)
++++++...+..++||||+++++|.+++...... ....+++.++..++.|++.||+|||+ .+++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChh
Confidence 9999999999999999999999999998653211 11347788999999999999999998 89999999999
Q ss_pred CEEECCCCcEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 729 NILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 729 NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
||++++++.++|+|||+++........ ......++..|+|||...++.++ ++|+||.
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSl 218 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAF 218 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHH
Confidence 999999999999999999865433211 11223346789999998888888 8999993
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=241.29 Aligned_cols=184 Identities=27% Similarity=0.373 Sum_probs=155.3
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|++|.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999876 68999999987643333344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|++++.+..++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 9999888776532 2358999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
... ......++..|+|||++.+ ..++ ++|+||.
T Consensus 153 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl 187 (286)
T cd07847 153 PGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAI 187 (286)
T ss_pred Ccc-cccCcccccccCCHHHHhCCCCcCchhhhHHH
Confidence 332 1223457889999999876 4455 8999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=240.12 Aligned_cols=187 Identities=25% Similarity=0.447 Sum_probs=159.5
Q ss_pred CCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|++|.||+|.. .+++.+|||.+..... ......++.+|+++++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999985 4799999998865332 2344568899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++..... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999998865332 23468999999999999999999997 899999999999999999999999999987664
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.... ......|+..|+|||++.+..++ ++|+||
T Consensus 158 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~s 191 (267)
T cd08229 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWS 191 (267)
T ss_pred cCCc-ccccccCCcCccCHHHhcCCCccchhhHHH
Confidence 4322 12235689999999999888887 899998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=241.32 Aligned_cols=183 Identities=27% Similarity=0.467 Sum_probs=149.9
Q ss_pred CCCcccceeccccceEEEEEEEe-CCc----EEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
++|++.+.||+|+||+||+|.+. +++ .|++|.+... .......++..|+.++++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 46888899999999999999764 444 4677776432 223345678889999999999999999998754 4578
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+++||+++|+|.+++.. ....+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||.++
T Consensus 85 ~i~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQ----HRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred EEEEeCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 99999999999999854 22468999999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCc-eeeeeccccCcccccccccCCcC-cceeec
Q 003911 748 LAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 748 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
........ ......++..|+|||++.++.++ ++|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~s 196 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWS 196 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHH
Confidence 76443221 12234567789999999888888 899998
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-29 Score=253.59 Aligned_cols=315 Identities=21% Similarity=0.264 Sum_probs=208.5
Q ss_pred EEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCC
Q 003911 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (787)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 149 (787)
+..||..+|-++ ++|++++.+.+|+.|+|.+|+|...| +|.++..|++|+++.|+|+.+|.+...+|++|..|||.+|
T Consensus 185 L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdN 262 (565)
T KOG0472|consen 185 LKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDN 262 (565)
T ss_pred HHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeecccc
Confidence 444444444444 66667777777777777777776443 6777777777777777777777666667777777777777
Q ss_pred CCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCccccc---ccceee--ccCC
Q 003911 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQ---IQSLWV--NGQN 224 (787)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~---l~~L~~--~~~~ 224 (787)
+++ +.|+.+.-+++|++||+++|.|++.+ ..++ ++ .|+.|.+.+|.+...-.+.+.+.. ++.|.- -+..
T Consensus 263 klk--e~Pde~clLrsL~rLDlSNN~is~Lp-~sLg--nl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dg 336 (565)
T KOG0472|consen 263 KLK--EVPDEICLLRSLERLDLSNNDISSLP-YSLG--NL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDG 336 (565)
T ss_pred ccc--cCchHHHHhhhhhhhcccCCccccCC-cccc--cc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCC
Confidence 777 56777777777777777777776543 3344 55 677777777765421111111110 111110 0000
Q ss_pred CC---------------------------------CcCCCCccccccCcc---CceEeccccccccCCCCCCCCCCCC-E
Q 003911 225 GN---------------------------------AKLGGGIDVIQNMTS---LKEIWLHSNAFSGPLPDFSGVKQLE-S 267 (787)
Q Consensus 225 ~~---------------------------------~~~~~~~~~~~~l~~---L~~L~L~~N~l~~~~~~~~~l~~L~-~ 267 (787)
.. ..++..|+....--. .+..+++.|++...|..+..++.+. .
T Consensus 337 lS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~ 416 (565)
T KOG0472|consen 337 LSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTD 416 (565)
T ss_pred CCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHH
Confidence 00 111112221111111 4566666666665555555544443 4
Q ss_pred EecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCCh
Q 003911 268 LSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQ 347 (787)
Q Consensus 268 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~ 347 (787)
+++++|.+. -+|..++.+++|..|+|++|.+...|.+++.+..|+.+++++|++...|..+..-
T Consensus 417 l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~l--------------- 480 (565)
T KOG0472|consen 417 LVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNRFRMLPECLYEL--------------- 480 (565)
T ss_pred HHhhcCccc-cchHHHHhhhcceeeecccchhhhcchhhhhhhhhheecccccccccchHHHhhH---------------
Confidence 556666665 8999999999999999999999999889999999999999999887766443211
Q ss_pred hhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccC
Q 003911 348 RFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSN 427 (787)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~ 427 (787)
..++.+-.++|++....|..+.+|.+|..|||.+|.|. .||..+++|.+|++|+|.+
T Consensus 481 ----------------------q~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~g 537 (565)
T KOG0472|consen 481 ----------------------QTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDG 537 (565)
T ss_pred ----------------------HHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecC
Confidence 13344445667888666667999999999999999999 9999999999999999999
Q ss_pred Cccc
Q 003911 428 NQLY 431 (787)
Q Consensus 428 N~l~ 431 (787)
|+|.
T Consensus 538 Npfr 541 (565)
T KOG0472|consen 538 NPFR 541 (565)
T ss_pred CccC
Confidence 9998
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=249.83 Aligned_cols=189 Identities=27% Similarity=0.463 Sum_probs=152.4
Q ss_pred cCCCcccceeccccceEEEEEEE------eCCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeC-
Q 003911 592 TNNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG- 663 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~- 663 (787)
.++|++.+.||+|+||.||+|.. .+++.||||+++... .......+.+|++++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 35799999999999999999963 357889999997532 233456788999999999 689999999988654
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhc-------------------------------------------------------
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEE------------------------------------------------------- 688 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 688 (787)
...++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4578999999999999998642110
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCce-eeee
Q 003911 689 -------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI-ETRI 760 (787)
Q Consensus 689 -------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~ 760 (787)
....+++.++..++.|+++||+|||+ ++|+||||||+||++++++.+||+|||+++......... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 01246888899999999999999997 899999999999999999999999999997653322111 1123
Q ss_pred ccccCcccccccccCCcC-cceeec
Q 003911 761 AGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 761 ~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.+++.|+|||++.+..++ ++|+||
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~s 266 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWS 266 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHH
Confidence 356789999999888888 899998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=241.49 Aligned_cols=184 Identities=30% Similarity=0.464 Sum_probs=158.2
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+|++.+.||+|++|.||+|... +++.||+|++..........+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999864 789999999987554455567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+ +++|.+++... ...+++.++..++.|+++||+|||+ .+++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~-~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 99999988542 2468999999999999999999998 89999999999999999999999999999876544
Q ss_pred CCceeeeeccccCcccccccccCC-cC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS~ 785 (787)
.........|+..|+|||++.+.. ++ ++|+||.
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 187 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAV 187 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHH
Confidence 322223356899999999987654 34 8999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=242.97 Aligned_cols=187 Identities=27% Similarity=0.476 Sum_probs=153.6
Q ss_pred CCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 594 NFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
+|++.+.||+|+||.||+|... ....+++|.+.... .....+++.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4778899999999999999753 23568888886532 3344578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhh-------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 003911 668 LVFEYMPQGTLSRHIFNWAE-------------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 728 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 728 (787)
+||||+++++|.+++..... .....+++.+++.++.|++.||+|||+ .+++||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhh
Confidence 99999999999999864321 112457899999999999999999997 89999999999
Q ss_pred CEEECCCCcEEEeecccceecCCCCCce-eeeeccccCcccccccccCCcC-cceeec
Q 003911 729 NILLGDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 729 NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
||++++++.+||+|||+++......... .....++..|+|||++.+..++ ++||||
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~s 214 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWS 214 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHH
Confidence 9999999999999999997653332211 1223456789999999888887 899998
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=240.51 Aligned_cols=184 Identities=29% Similarity=0.549 Sum_probs=152.2
Q ss_pred CCCcccceeccccceEEEEEEEe-----CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC--Ce
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NE 665 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 665 (787)
.+|++.+.||+|+||.||+|..+ +++.||+|++... .....+.+.+|++++++++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 47888999999999999999742 5789999998653 344567899999999999999999999987543 46
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.++||||+++++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQK----HRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred eEEEEEecCCCCHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcc
Confidence 7899999999999999853 12358899999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCCcee--eeeccccCcccccccccCCcC-cceeecC
Q 003911 746 VRLAPEGKGSIE--TRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++.......... ....++..|+|||++.+..++ ++|+||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 197 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSF 197 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHH
Confidence 987654332111 112234569999999888887 8999983
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=241.61 Aligned_cols=184 Identities=25% Similarity=0.428 Sum_probs=154.2
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+|++.+.||+|++|.||+|+.. +++.||+|+++...........+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4888999999999999999865 689999999876443444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
++ ++|.+++.... ....+++..+..++.|+++||+|||+ .+++||||||+||++++++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 97 68888875422 12468999999999999999999997 89999999999999999999999999999765433
Q ss_pred CCceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
.. ......+++.|+|||++.+. .++ ++|+||
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 187 (285)
T cd07861 155 VR-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWS 187 (285)
T ss_pred cc-cccCCcccccccChHHhcCCCCcCcHHHHHH
Confidence 21 12234578999999998765 345 899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=252.59 Aligned_cols=179 Identities=25% Similarity=0.411 Sum_probs=149.8
Q ss_pred ccceeccccceEEEEEEEe-CCcEEEEEEeecccc--cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe--eEEEEE
Q 003911 597 EENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE--KLLVFE 671 (787)
Q Consensus 597 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e 671 (787)
..++||+|+|-+||+|-+. +|-.||--.++.... .+...++|..|+++|+.|+||||+++|+++.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3578999999999999654 688887655544333 34556899999999999999999999999988665 678999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC-CCCcEEEeecccceecC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAP 750 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~~~ 750 (787)
.+..|+|..|++++ +.++...+..|++||++||.|||++ .++|||||||-+||+|+ ..|.|||+|+|+|....
T Consensus 124 L~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred cccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999998653 4577889999999999999999985 47999999999999998 56899999999998875
Q ss_pred CCCCceeeeeccccCcccccccccCCcCcceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWSSCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiWS 784 (787)
... ...++|||.|||||++....-..+||||
T Consensus 198 ~s~---aksvIGTPEFMAPEmYEE~YnE~VDVYa 228 (632)
T KOG0584|consen 198 KSH---AKSVIGTPEFMAPEMYEENYNELVDVYA 228 (632)
T ss_pred ccc---cceeccCccccChHHHhhhcchhhhhhh
Confidence 433 2337899999999999844444899997
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=240.01 Aligned_cols=180 Identities=29% Similarity=0.523 Sum_probs=149.5
Q ss_pred CcccceeccccceEEEEEEE-----eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC--CeeE
Q 003911 595 FSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKL 667 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 667 (787)
|++.+.||+|+||+||++.. .++..||+|.++... .......+.+|++++++++||||+++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 38889999999999988643 357889999987642 233456788999999999999999999988754 3578
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+||||+++++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++
T Consensus 85 lv~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeeccccc
Confidence 99999999999998843 358999999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCCce--eeeeccccCcccccccccCCcC-cceeec
Q 003911 748 LAPEGKGSI--ETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 748 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
......... .....++..|+|||++.+..++ ++|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s 195 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWS 195 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHH
Confidence 765432211 1122356779999999888777 899998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=240.88 Aligned_cols=195 Identities=24% Similarity=0.378 Sum_probs=158.5
Q ss_pred eeHHHHHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEE
Q 003911 583 ISIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHC 660 (787)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 660 (787)
+.++.+....++|++.+.||+|+||.||+|... +++.+|+|++... .....++..|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 444556667889999999999999999999764 6889999987542 22235788899999999 699999999988
Q ss_pred E-----eCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC
Q 003911 661 L-----DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735 (787)
Q Consensus 661 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 735 (787)
. .++..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+ .+++||||||+||+++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~ 160 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTE 160 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCC
Confidence 4 345689999999999999988653322 2468899999999999999999997 899999999999999999
Q ss_pred CcEEEeecccceecCCCCCceeeeeccccCccccccccc-----CCcC-cceeecC
Q 003911 736 MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVH-----TRWS-SCSYWAG 785 (787)
Q Consensus 736 ~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~-~~DiWS~ 785 (787)
+.++|+|||+++....... ......|++.|+|||++.. ..++ ++|+||.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 215 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSL 215 (286)
T ss_pred CCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhH
Confidence 9999999999987644321 2223468999999999853 3355 8999983
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=245.22 Aligned_cols=188 Identities=29% Similarity=0.466 Sum_probs=154.4
Q ss_pred CCCcccceeccccceEEEEEEEe--------CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeC
Q 003911 593 NNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG 663 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 663 (787)
++|.+.+.||+|+||.||+|+.. +...+|+|.++.. .......++.+|+++++++ +||||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 57899999999999999999753 2356999998753 2344556788999999999 799999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 732 (787)
+..|+||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ .+++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence 9999999999999999999653211 11358889999999999999999997 899999999999999
Q ss_pred CCCCcEEEeecccceecCCCCCce-eeeeccccCcccccccccCCcC-cceeec
Q 003911 733 GDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 733 ~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
++++.+||+|||.++......... .....+++.|+|||++.+..++ ++|+||
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 227 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 227 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHH
Confidence 999999999999987654322111 1112245689999999888887 899998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=237.37 Aligned_cols=184 Identities=26% Similarity=0.406 Sum_probs=152.9
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc---chhHHHHHHHHHHHHhcCCCccceEEeEEEeC--Cee
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEK 666 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 666 (787)
.+|++.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47899999999999999999764 6899999988643221 23456789999999999999999999998764 457
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.+
T Consensus 82 ~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS-----YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 899999999999998853 2357888899999999999999998 89999999999999999999999999998
Q ss_pred eecCCCCC--ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 747 RLAPEGKG--SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 747 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+....... .......|+..|+|||++.+..++ ++|+||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 194 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWS 194 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHH
Confidence 76532211 111234588999999999888877 899998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=250.35 Aligned_cols=194 Identities=26% Similarity=0.446 Sum_probs=164.2
Q ss_pred eeeHHHHHhhcCCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeE
Q 003911 582 VISIQVLRNVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGH 659 (787)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 659 (787)
...++.+...++.|++.+.||+|.+|.||+++. ++++.+|+|++.. .....++++.|.++++.. .|||++.++|+
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~---~~d~deEiE~eynil~~~~~hpnv~~fyg~ 84 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP---TEDEEEEIELEYNMLKKYSHHPNVATFYGA 84 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC---CccccHHHHHHHHHHHhccCCCCcceEEEE
Confidence 344555556678899999999999999999964 5789999998865 344557888999999998 69999999999
Q ss_pred EEe-----CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC
Q 003911 660 CLD-----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 734 (787)
Q Consensus 660 ~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 734 (787)
|.. +++.|+|||||.+|+..|++++.. ...+.|+.+..|.+.++.|+.+||. ..++|||||-.|||++.
T Consensus 85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~ 158 (953)
T KOG0587|consen 85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTE 158 (953)
T ss_pred EEEecCCCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEec
Confidence 974 568999999999999999998765 3578999999999999999999996 88999999999999999
Q ss_pred CCcEEEeecccceecCCCCCceeeeeccccCcccccccccC-----CcC-cceeecC
Q 003911 735 DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHT-----RWS-SCSYWAG 785 (787)
Q Consensus 735 ~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~-~~DiWS~ 785 (787)
++.||++|||.+......... ....+|||.|||||++.-. .|+ .+|+||.
T Consensus 159 e~~VKLvDFGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsL 214 (953)
T KOG0587|consen 159 NAEVKLVDFGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSL 214 (953)
T ss_pred cCcEEEeeeeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhc
Confidence 999999999999887655443 3347899999999998532 333 7999984
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=245.87 Aligned_cols=183 Identities=18% Similarity=0.271 Sum_probs=149.8
Q ss_pred ccceeccc--cceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEec
Q 003911 597 EENILGRG--GFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (787)
Q Consensus 597 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (787)
+.++||+| +|++||++..+ +|+.||+|++..........+.+++|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 67899999764 7899999999765444455667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCC
Q 003911 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (787)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 753 (787)
++|+|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++++||+.+.......
T Consensus 82 ~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999885422 2358899999999999999999997 899999999999999999999999998754332211
Q ss_pred Cc------eeeeeccccCccccccccc--CCcC-cceeecC
Q 003911 754 GS------IETRIAGTFGYLAPEYAVH--TRWS-SCSYWAG 785 (787)
Q Consensus 754 ~~------~~~~~~gt~~y~aPE~~~~--~~~~-~~DiWS~ 785 (787)
.. ......++..|+|||++.+ ..++ ++|+||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diwsl 196 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHH
Confidence 10 0112346788999999976 3466 8999983
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=241.92 Aligned_cols=188 Identities=29% Similarity=0.519 Sum_probs=155.4
Q ss_pred CCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+... .....+.+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 45888899999999999999743 3456888987642 233456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC
Q 003911 667 LLVFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 735 (787)
++||||+++++|.+++..... .....+++..++.++.|++.|++|||+ ++|+||||||+||+++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccC
Confidence 999999999999999865321 112357899999999999999999997 899999999999999999
Q ss_pred CcEEEeecccceecCCCCC-ceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 736 MRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 736 ~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+.++|+|||+++....... .......|+..|+|||++.+..++ ++|+||.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 211 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHH
Confidence 9999999999976543321 112234567889999999988888 8999983
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=242.70 Aligned_cols=187 Identities=25% Similarity=0.424 Sum_probs=153.7
Q ss_pred CCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 594 NFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
+|++.+.||+|+||.||+|... ++..||+|+++... .....+.+.+|+.++++++||||+++++++......+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4777899999999999999753 25789999987532 2334567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhh-----------hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC
Q 003911 668 LVFEYMPQGTLSRHIFNWA-----------EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 736 (787)
+++||+++++|.+++.... ......+++..+..++.|++.||+|||+ ++|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 9999999999999985321 0112357888999999999999999997 8999999999999999999
Q ss_pred cEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeec
Q 003911 737 RAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 737 ~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.+||+|||+++........ ......+++.|+|||++.++.++ ++|+||
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 211 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWS 211 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHH
Confidence 9999999998865433211 11223467899999999888777 899998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=241.60 Aligned_cols=181 Identities=25% Similarity=0.467 Sum_probs=156.1
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
..+|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++++..+...++||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 457999999999999999999754 789999999876332 23467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||.+....
T Consensus 97 e~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 97 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred cccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 99999999998843 357889999999999999999998 899999999999999999999999999987654
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..... .....|++.|+|||.+.+..++ ++|+||
T Consensus 168 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 201 (296)
T cd06654 168 PEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201 (296)
T ss_pred ccccc-cCcccCCccccCHHHHcCCCCCccchHHH
Confidence 33211 2234689999999999888777 899998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=237.71 Aligned_cols=184 Identities=29% Similarity=0.519 Sum_probs=155.9
Q ss_pred CCcccceeccccceEEEEEEEeCCcEEEEEEeeccccc----chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS----GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+|++.+.||+|+||.||+|...+++.+|+|.++..... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47888999999999999998888999999998753221 23346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|.+++.+ ...+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.++|+|||.+...
T Consensus 81 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999999843 2357889999999999999999997 89999999999999999999999999998754
Q ss_pred CCCC-----CceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGK-----GSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... ........|+..|+|||++.+..++ ++|+||.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl 194 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSI 194 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHH
Confidence 3211 1112235689999999999888777 8999983
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=244.57 Aligned_cols=182 Identities=25% Similarity=0.346 Sum_probs=155.8
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc------chhHHHHHHHHHHHHhcC---CCccceEEeEEEe
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS------GKGLTEFKSEIAVLTKVR---HRHLVALLGHCLD 662 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 662 (787)
.+|...+.+|+|+||.|+.|.++ +...|+||.+.++..- .+..-..-.||.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46899999999999999999876 4667999988764321 122234567999999997 9999999999999
Q ss_pred CCeeEEEEEec-CCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEe
Q 003911 663 GNEKLLVFEYM-PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 741 (787)
Q Consensus 663 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 741 (787)
++.+|++||-. ++.+|.++| +-...+++.++..|++|++.|+++||+ .+|||||||-+||.++.+|-+||+
T Consensus 641 dd~yyl~te~hg~gIDLFd~I-----E~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI-----EFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh-----hccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEe
Confidence 99999999975 456888888 334679999999999999999999998 899999999999999999999999
Q ss_pred ecccceecCCCCCceeeeeccccCcccccccccCCcC--cceeecC
Q 003911 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS--SCSYWAG 785 (787)
Q Consensus 742 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~DiWS~ 785 (787)
|||.|.+...+. ...++||..|.|||++.|.+|- +.|||+.
T Consensus 713 dfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwal 755 (772)
T KOG1152|consen 713 DFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWAL 755 (772)
T ss_pred eccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhh
Confidence 999998775543 3347899999999999999997 8999984
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=236.50 Aligned_cols=182 Identities=30% Similarity=0.520 Sum_probs=154.7
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
.+|++.+.||+|+||.||+|...++..+|+|++..... ...++.+|++++++++||+|+++++++......++||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 46888899999999999999887788999998875432 245788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++.. ....++++.+..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||.++.....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 81 MEHGCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred CCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 999999988853 22357899999999999999999997 89999999999999999999999999999866443
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.........++.+|+|||++.++.++ ++|+||
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~s 186 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186 (256)
T ss_pred cccccCCCccchhhcCHhHhccCCcChHHHHHH
Confidence 22222223356789999999888887 899998
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=239.45 Aligned_cols=185 Identities=29% Similarity=0.477 Sum_probs=153.7
Q ss_pred hhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeC----
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG---- 663 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~---- 663 (787)
.+.+.|++.+.||+|+||.||+|... +++.||+|++... .....++..|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC---CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 34567889999999999999999765 6889999998653 23346788999999999 799999999998753
Q ss_pred --CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEe
Q 003911 664 --NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 741 (787)
Q Consensus 664 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 741 (787)
...|+||||+++++|.+++... ....+++..+..++.|++.|++|||+ ++|+||||||+||++++++.++|+
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEc
Confidence 4578999999999999988542 22468899999999999999999998 899999999999999999999999
Q ss_pred ecccceecCCCCCceeeeeccccCccccccccc-----CCcC-cceeec
Q 003911 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVH-----TRWS-SCSYWA 784 (787)
Q Consensus 742 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~-~~DiWS 784 (787)
|||++........ ......|++.|+|||++.+ ..++ ++|+||
T Consensus 154 Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 201 (272)
T cd06637 154 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS 201 (272)
T ss_pred cCCCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHH
Confidence 9999986643322 2234568999999999863 3455 899998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=237.91 Aligned_cols=185 Identities=25% Similarity=0.485 Sum_probs=153.6
Q ss_pred CCCcccceeccccceEEEEEEEe-CC---cEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
.+|++.+.||+|+||.||+|... ++ ..||||+++.. .......+|..|++++++++||||+++++++..+...++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 35788999999999999999865 33 36999998753 234456789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++++|.+++.. ....+++.+++.++.|++.|++|||+ .+++||||||+||+++.++.+||+|||.++.
T Consensus 83 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 83 ITEFMENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEecCCCCcHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccc
Confidence 9999999999998854 22458899999999999999999997 8999999999999999999999999999876
Q ss_pred cCCCCCcee-e-eec--cccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSIE-T-RIA--GTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~-~-~~~--gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
......... . ... .+..|+|||++.+..++ ++|+||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvwsl 197 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSY 197 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhh
Confidence 543322111 1 111 24579999999988888 8999983
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-28 Score=230.00 Aligned_cols=186 Identities=26% Similarity=0.343 Sum_probs=151.6
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 671 (787)
+.+....||.|+||+|++-.++ .|+..|||+++... ..+.++++..|.+...+- +.||||++||.+...+..||.||
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n-~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN-IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc-chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 3444677999999999998765 79999999998754 356778899998876666 79999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
.| ..++..+-+....-....+++.-.-+|+...+.||+||.. ...|||||+||+|||++..|.+||||||++..+.+
T Consensus 144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 99 5577554433222333568888888999999999999997 57899999999999999999999999999877654
Q ss_pred CCCceeeeeccccCcccccccccC--CcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHT--RWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~~DiWS~ 785 (787)
.. ..+..+|...|||||.+... .|+ ++|+||.
T Consensus 221 Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSL 255 (361)
T KOG1006|consen 221 SI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSL 255 (361)
T ss_pred HH--HhhhccCCccccChhccCCccCCcchhhhhhhh
Confidence 32 23446789999999998643 466 9999994
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=244.07 Aligned_cols=189 Identities=27% Similarity=0.458 Sum_probs=154.5
Q ss_pred CCCcccceeccccceEEEEEEEe--------CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeC
Q 003911 593 NNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG 663 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 663 (787)
++|.+.+.||+|+||.||+|+.. ....||+|.++.. .......++.+|+++++++ +||||+++++++.+.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN-ATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC-CChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 57888999999999999999642 2457899988753 2344567789999999999 699999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 732 (787)
+..++||||+++|+|.+++..... .....+++.++..++.|++.||+|||+ .+++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence 999999999999999999965321 112458899999999999999999997 899999999999999
Q ss_pred CCCCcEEEeecccceecCCCCCce-eeeeccccCcccccccccCCcC-cceeecC
Q 003911 733 GDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 733 ~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++++.+||+|||.++......... .....++..|||||++.++.++ ++|+||.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 222 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSF 222 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHH
Confidence 999999999999998664322111 1112245679999999888887 8999983
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=239.22 Aligned_cols=184 Identities=29% Similarity=0.472 Sum_probs=152.1
Q ss_pred CCCcccceeccccceEEEEEEEe-CCc----EEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
++|++.+.||+|+||+||+|++. +++ .||+|+++.. .......++.+|+.+++.+.||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 57888999999999999999754 444 4899988653 2344567889999999999999999999998754 568
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
++|||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 85 l~~~~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE----NKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEcCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCcee
Confidence 99999999999988853 23468899999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCCcee-eeeccccCcccccccccCCcC-cceeecC
Q 003911 748 LAPEGKGSIE-TRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.......... ....+++.|+|||...+..++ ++|+||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 197 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSY 197 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHH
Confidence 7654322111 112346789999999888888 8999983
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=242.91 Aligned_cols=186 Identities=27% Similarity=0.436 Sum_probs=154.9
Q ss_pred CCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCe
Q 003911 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNE 665 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 665 (787)
++|.+.+.||+|+||.||+|... ++..||+|+++... .....+.+.+|+++++++ +||||+++++++...+.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 46889999999999999999642 35579999887532 234456899999999999 79999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.++||||+++|+|.+++... ....+++.++..++.|++.||+|||+ .+|+|+||||+||++++++.++++|||+
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK---RESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999998542 12347999999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCce-eeeeccccCcccccccccCCcC-cceeecC
Q 003911 746 VRLAPEGKGSI-ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++......... .....++..|+|||++.+..++ ++|+||.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 229 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 229 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHH
Confidence 98664332211 1123457789999999888887 8999983
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=265.79 Aligned_cols=189 Identities=28% Similarity=0.431 Sum_probs=152.3
Q ss_pred HhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe-----
Q 003911 589 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----- 662 (787)
Q Consensus 589 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 662 (787)
-+...+|++.+.||+|+||.||+++.+ ||+.||||++.... +......+.+|+..+++++|||||+++..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 345678999999999999999999877 89999999998755 56667789999999999999999999864321
Q ss_pred --------------------------------------------------C-----------------------------
Q 003911 663 --------------------------------------------------G----------------------------- 663 (787)
Q Consensus 663 --------------------------------------------------~----------------------------- 663 (787)
.
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0
Q ss_pred -----------------------------------CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHH
Q 003911 664 -----------------------------------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708 (787)
Q Consensus 664 -----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~ 708 (787)
...||-||||+...+++++.+. .. .-.....++++++|++|
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N---~~-~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN---HF-NSQRDEAWRLFREILEG 709 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc---cc-chhhHHHHHHHHHHHHH
Confidence 1136789999887777766431 11 11467789999999999
Q ss_pred HHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC-----------------CCCCceeeeeccccCcccccc
Q 003911 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP-----------------EGKGSIETRIAGTFGYLAPEY 771 (787)
Q Consensus 709 L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~-----------------~~~~~~~~~~~gt~~y~aPE~ 771 (787)
|+|+|+ +|||||||||.||+++++..|||+|||+|+... .......+..+||.-|+|||+
T Consensus 710 LaYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 999998 899999999999999999999999999998621 001123456789999999999
Q ss_pred cccCC---cC-cceeecC
Q 003911 772 AVHTR---WS-SCSYWAG 785 (787)
Q Consensus 772 ~~~~~---~~-~~DiWS~ 785 (787)
+.+.. |+ ++|+||.
T Consensus 787 l~~~~~~~Yn~KiDmYSL 804 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSL 804 (1351)
T ss_pred hcccccccccchhhhHHH
Confidence 98765 77 9999984
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=241.22 Aligned_cols=181 Identities=25% Similarity=0.469 Sum_probs=157.0
Q ss_pred cCCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
..+|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 46899999999999999999976 479999999987533 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||.+....
T Consensus 96 e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 96 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred cccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999998843 357889999999999999999998 899999999999999999999999999998764
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..... .....|++.|+|||.+.+..++ ++|+||
T Consensus 167 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 200 (297)
T cd06656 167 PEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200 (297)
T ss_pred CCccC-cCcccCCccccCHHHHcCCCCCcHHHHHH
Confidence 43321 2234688999999999888887 899998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-26 Score=235.21 Aligned_cols=175 Identities=26% Similarity=0.467 Sum_probs=144.8
Q ss_pred eccccceEEEEEEEe---CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCCC
Q 003911 601 LGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGT 677 (787)
Q Consensus 601 lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 677 (787)
||+|+||.||+|.+. ++..||+|++... ......+++.+|++++++++||||+++++++.. ...++||||+++++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 899999999999764 3557999998653 234455779999999999999999999998864 56899999999999
Q ss_pred HHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCcee
Q 003911 678 LSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 757 (787)
Q Consensus 678 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 757 (787)
|.+++.. ....+++.++++++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..........
T Consensus 81 L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 81 LNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 9998843 23468999999999999999999997 8999999999999999999999999999986544322111
Q ss_pred ee--eccccCcccccccccCCcC-cceeec
Q 003911 758 TR--IAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 758 ~~--~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.. ..+++.|+|||++.+..++ ++|+||
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 183 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWS 183 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHH
Confidence 11 2235789999999888877 899998
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=241.62 Aligned_cols=185 Identities=26% Similarity=0.380 Sum_probs=157.7
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|++|.||+|... +++.||+|+++.........+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999875 68899999987654445556789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|++++.+..+.. ....+++.++..++.|++.|++|||+ .+++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEA-----SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 998866655442 22458899999999999999999997 8999999999999999999999999999987655
Q ss_pred CCCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
..........++..|+|||++.+. .++ ++|+||.
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~sl 188 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAI 188 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHH
Confidence 433233346688999999999887 666 8999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=239.61 Aligned_cols=189 Identities=27% Similarity=0.429 Sum_probs=153.7
Q ss_pred cCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
.++|++.+.||+|++|.||+|... .+..||+|.+... ........+.+|+.++++++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 357889999999999999999765 3567899987642 233445678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC---cEEE
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEE--GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKV 740 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 740 (787)
.++||||+++++|.+++...... ....+++.++..++.||+.|++|||+ .+++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 99999999999999998654311 12358899999999999999999998 8999999999999998654 5999
Q ss_pred eecccceecCCCCCce-eeeeccccCcccccccccCCcC-cceeec
Q 003911 741 ADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 741 ~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+|||+++......... .....++..|+|||++.+..++ ++||||
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 206 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWS 206 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHH
Confidence 9999998763322111 1112335689999999988888 899998
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=234.57 Aligned_cols=184 Identities=24% Similarity=0.422 Sum_probs=158.4
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+|++.+.||+|+||.||++... +++.||+|++..........+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999764 689999999976544455567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++.. .....+++.++..++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINA---QRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 999999988854 222357889999999999999999997 89999999999999999999999999999876443
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.. ......|++.|+|||+..+..++ ++|+||
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~s 186 (256)
T cd08218 155 VE-LARTCIGTPYYLSPEICENRPYNNKSDIWA 186 (256)
T ss_pred hh-hhhhccCCccccCHHHhCCCCCCCccchhH
Confidence 21 12234688999999999888887 899998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=220.27 Aligned_cols=182 Identities=25% Similarity=0.396 Sum_probs=149.9
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCeeEEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 671 (787)
+.+....||.|+.|.||+++.+ +|...|||.+.+.. ..+..+++...++++.+.. +|.||+.+|||..+..+++.||
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 3455677999999999999876 68999999998743 4556677888888877774 8999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
.|. .-+..+++. -.+++++.-+-++...+++||.||.+ +++|+|||+||+|||+|+.|++|+||||++..+.+
T Consensus 172 lMs-~C~ekLlkr----ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 172 LMS-TCAEKLLKR----IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHH-HHHHHHHHH----hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec
Confidence 984 233444432 23468888888999999999999998 78999999999999999999999999999987766
Q ss_pred CCCceeeeeccccCcccccccccC---CcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHT---RWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~-~~DiWS~ 785 (787)
... .++.+|.+.|||||.+.-. .|+ .+|+||.
T Consensus 245 SkA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSl 280 (391)
T KOG0983|consen 245 SKA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSL 280 (391)
T ss_pred ccc--cccccCCccccCccccCCCCCCccchhhhhhhh
Confidence 543 3456799999999998644 566 8999984
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=228.60 Aligned_cols=178 Identities=26% Similarity=0.429 Sum_probs=148.5
Q ss_pred cceeccccceEEEEEE-EeCCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 598 ENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
.+.||+|+|+.|--+. ..+|.++|||++.+. ......+..+|++++.++ .|+||++++++|+++...|+|||-|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 4789999999999874 678999999999874 455677899999999999 599999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC---cEEEeecccceecCCC
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGLVRLAPEG 752 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a~~~~~~ 752 (787)
|.|..+|.. .+.+++.++.++..+|+.||.|||. +||.|||+||+|||..+.. -+||+||.++.-....
T Consensus 161 GplLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 161 GPLLSHIQK-----RKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred chHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence 999999854 3568999999999999999999997 9999999999999997544 4899999887533211
Q ss_pred ------CCceeeeeccccCcccccccc-----cCCcC-cceeecC
Q 003911 753 ------KGSIETRIAGTFGYLAPEYAV-----HTRWS-SCSYWAG 785 (787)
Q Consensus 753 ------~~~~~~~~~gt~~y~aPE~~~-----~~~~~-~~DiWS~ 785 (787)
........+|+..|||||+.. ...|+ ++|.||.
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSL 277 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSL 277 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHH
Confidence 111223467999999999874 23566 7999984
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=235.61 Aligned_cols=176 Identities=27% Similarity=0.418 Sum_probs=147.3
Q ss_pred eeccccceEEEEEEEe---CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCC
Q 003911 600 ILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (787)
Q Consensus 600 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (787)
.||+|+||.||+|.++ ++..+|+|+++.........+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999653 5788999998765444556678999999999999999999999885 45678999999999
Q ss_pred CHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCce
Q 003911 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 756 (787)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 756 (787)
+|.+++.. ...+++..+..++.|++.|++|||+ ++|+||||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 99998843 2368899999999999999999997 899999999999999999999999999998765433211
Q ss_pred e--eeeccccCcccccccccCCcC-cceeec
Q 003911 757 E--TRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 757 ~--~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
. ....++..|+|||.+.+..++ ++|+||
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 183 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWS 183 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHH
Confidence 1 112345789999999887777 899998
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=242.66 Aligned_cols=186 Identities=26% Similarity=0.391 Sum_probs=157.6
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|++|.||+|... +++.||+|.+...... ....+.+..|+++++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36889999999999999999765 5899999999765433 235567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++.. .....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQR---QPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHh---CCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 99999999998853 222468999999999999999999997 899999999999999999999999999987543
Q ss_pred CCCCc----------------------------eeeeeccccCcccccccccCCcC-cceeec
Q 003911 751 EGKGS----------------------------IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..... ......||..|+|||++.+..++ ++|+||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~s 217 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWT 217 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHH
Confidence 22110 11124689999999999888887 899998
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=242.50 Aligned_cols=183 Identities=24% Similarity=0.392 Sum_probs=153.5
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+|++.+.||+|+||.||+|... +|+.||+|+++...........+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4888899999999999999875 789999999976443344446788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
++ ++|.+++.. ....+++..++.++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDS----CNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 96 578777643 22468999999999999999999998 89999999999999999999999999999865433
Q ss_pred CCceeeeeccccCcccccccccCC-cC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS~ 785 (787)
... .....+++.|+|||++.+.. ++ ++|+||.
T Consensus 153 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 186 (284)
T cd07839 153 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 186 (284)
T ss_pred CCC-cCCCccccCCcChHHHhCCcccCcHHHHHHH
Confidence 221 22345789999999987754 45 8999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=239.19 Aligned_cols=188 Identities=25% Similarity=0.441 Sum_probs=155.2
Q ss_pred CCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
++|++.+.||+|+||.||+|+.+ +.+.|++|.+.... .....+++.+|++++++++||||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 57888999999999999999864 34679999876522 223457899999999999999999999999998999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEee
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEG----LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 742 (787)
++||||+++|+|.+++....... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999986532111 1258999999999999999999997 8999999999999999999999999
Q ss_pred cccceecCCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 743 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
||+++..............++..|+|||.+.+..++ ++|+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s 203 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWS 203 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHH
Confidence 999875433222222234567889999999887777 899998
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=239.42 Aligned_cols=183 Identities=27% Similarity=0.428 Sum_probs=155.7
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++..+...++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 457999999999999999999865 6899999998753 3345578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||.+....
T Consensus 82 e~~~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 82 EFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred eccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 999999999988542 2468999999999999999999998 899999999999999999999999999987654
Q ss_pred CCCCceeeeeccccCccccccccc-----CCcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVH-----TRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~-~~DiWS 784 (787)
.... ......|++.|+|||++.. ..++ ++|+||
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~s 193 (280)
T cd06611 155 STLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWS 193 (280)
T ss_pred cccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHH
Confidence 3322 2233568999999999853 3344 799998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-26 Score=237.00 Aligned_cols=182 Identities=27% Similarity=0.425 Sum_probs=152.8
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
.|++.+.||+|+||.||+|... ++..+++|.+... .....+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 3678899999999999999875 5788899988653 234567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|..++.. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 84 CAGGAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 156 (282)
T ss_pred cCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence 999999887743 22468999999999999999999998 89999999999999999999999999998765432
Q ss_pred CCceeeeeccccCcccccccc-----cCCcC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAV-----HTRWS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~-~~DiWS~ 785 (787)
.. ......|++.|+|||++. +..++ ++|+||.
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 194 (282)
T cd06643 157 IQ-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 194 (282)
T ss_pred cc-ccccccccccccCHhhccccCCCCCCCCccchhhhH
Confidence 21 122356899999999984 33455 8999983
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=240.94 Aligned_cols=189 Identities=32% Similarity=0.521 Sum_probs=156.1
Q ss_pred cCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
.++|++.+.||+|+||.||+|... ++..||+|++.... ......++.+|++++++++||||+++++++..++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 357899999999999999999753 46789999987532 33445779999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhh-----------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAE-----------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 728 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 728 (787)
.++||||+++|+|.+++..... .....+++.+++.++.|++.||+|||+ .+++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHh
Confidence 9999999999999999864321 112347888999999999999999997 89999999999
Q ss_pred CEEECCCCcEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeec
Q 003911 729 NILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 729 NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
||++++++.++|+|||.++........ ......++..|+|||.+.+..++ ++|+||
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 217 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWA 217 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHH
Confidence 999999999999999998765332211 11122346779999999888888 899998
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=234.94 Aligned_cols=178 Identities=35% Similarity=0.615 Sum_probs=154.5
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
++|++.+.||+|+||.||+|... ++.||+|.++.... ..+++.+|+.++++++|+||+++++++.+....++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 57888999999999999999875 88999999976432 467899999999999999999999999998999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++... ....+++..+..++.|++.|+.|||+ .+++||||||+||+++.++.++|+|||.++.....
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 82 MAKGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred cCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 9999999988542 22368999999999999999999997 89999999999999999999999999999876432
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.. ...++..|+|||++.+..++ ++|+||
T Consensus 156 ~~----~~~~~~~~~ape~~~~~~~~~~~Di~s 184 (256)
T cd05039 156 QD----SGKLPVKWTAPEALREKKFSTKSDVWS 184 (256)
T ss_pred cc----cCCCcccccCchhhcCCcCCcHHHHHH
Confidence 21 22346679999999888777 899998
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=237.83 Aligned_cols=184 Identities=28% Similarity=0.434 Sum_probs=155.0
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.+.|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++..++..++||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 357999999999999999999875 5889999998753 3445678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|..++.+. ...+++..+..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||.+....
T Consensus 89 e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 89 EFCPGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred ecCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999998877431 2358899999999999999999997 899999999999999999999999999987643
Q ss_pred CCCCceeeeeccccCccccccccc-----CCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVH-----TRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~-~~DiWS~ 785 (787)
.... ......+++.|+|||++.+ ..++ ++|+||.
T Consensus 162 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 201 (292)
T cd06644 162 KTLQ-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL 201 (292)
T ss_pred cccc-ccceecCCccccCceeeccccccCCCCCchhhhHhH
Confidence 3221 1223568899999999853 3345 7999983
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-26 Score=236.73 Aligned_cols=183 Identities=24% Similarity=0.422 Sum_probs=151.6
Q ss_pred CCCcccceeccccceEEEEEEEeC----CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
++|.+.+.||+|+||.||+|...+ ...||||...... .....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 468889999999999999997643 3468999886532 24456789999999999999999999998875 45789
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 84 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 84 VMELAPLGELRSYLQV----NKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEcCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeee
Confidence 9999999999999854 22358999999999999999999997 8999999999999999999999999999987
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.............++..|+|||.+.+..++ ++|+||
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 193 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWM 193 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHH
Confidence 654422222223345689999999888787 899998
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=237.57 Aligned_cols=185 Identities=27% Similarity=0.410 Sum_probs=149.9
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHH-HHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAV-LTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|... +|+.||+|+++..... ....++..|+.+ ++..+||||+++++++..++..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 47889999999999999999865 6999999998764332 233455556665 56668999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||++ |+|.+++...... ...+++..++.++.|++.||+|||+ +.+++||||||+||++++++.+||+|||.+....
T Consensus 80 e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9996 6888887654332 2568999999999999999999997 2389999999999999999999999999998664
Q ss_pred CCCCceeeeeccccCccccccccc----CCcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVH----TRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~-~~DiWS 784 (787)
... ......|+..|+|||++.+ ..++ ++|+||
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~s 192 (283)
T cd06617 156 DSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWS 192 (283)
T ss_pred ccc--ccccccCCccccChhhcCCcccccccCccccchh
Confidence 322 1223468899999999865 3345 899998
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-26 Score=240.44 Aligned_cols=186 Identities=30% Similarity=0.499 Sum_probs=151.0
Q ss_pred CCCcccceeccccceEEEEEEEe-CCc--EEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (787)
++|++.+.||+|+||.||+|... ++. .+++|.++. .......+.+.+|+++++++ +||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 57899999999999999999765 333 478888764 22334456789999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc
Q 003911 669 VFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 737 (787)
||||+++++|.+++...... ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCe
Confidence 99999999999998642210 11358889999999999999999997 89999999999999999999
Q ss_pred EEEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 738 AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 738 ~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+||+|||++........ ......+..|+|||++.+..++ ++||||
T Consensus 158 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS 203 (297)
T cd05089 158 SKIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWS 203 (297)
T ss_pred EEECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHH
Confidence 99999999864322111 1111235579999999888887 899998
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=240.93 Aligned_cols=183 Identities=25% Similarity=0.415 Sum_probs=152.5
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|+||.||+|... +++.||+|.++... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc-ccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 57999999999999999999765 68899999987533 22334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|++ ++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.....
T Consensus 85 ~~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 85 YLD-KDLKQYLDD----CGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred ccc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 996 588887743 22457899999999999999999998 8999999999999999999999999999976543
Q ss_pred CCCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
... ......+++.|+|||++.+. .++ ++|+||.
T Consensus 157 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 191 (301)
T cd07873 157 PTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGV 191 (301)
T ss_pred CCC-cccccceeecccCcHHHhCCCCCccHHHHHHH
Confidence 222 12234578999999998764 355 8999983
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=232.80 Aligned_cols=183 Identities=25% Similarity=0.443 Sum_probs=157.7
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+|+..+.||+|++|.||+|... +++.+|+|++............+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999764 788999999987555556678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC-CcEEEeecccceecCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGLVRLAPE 751 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a~~~~~ 751 (787)
+++++|.+++... ....+++..+..++.|++.|++|||+ .+++||||||+||+++++ +.+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999998542 22357899999999999999999998 899999999999999855 4689999999987654
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
... .....|+..|+|||.+.+..++ ++|+||
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 186 (256)
T cd08220 155 KSK--AYTVVGTPCYISPELCEGKPYNQKSDIWA 186 (256)
T ss_pred Ccc--ccccccCCcccCchhccCCCCCcccchHH
Confidence 322 2235689999999999888777 899998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=239.66 Aligned_cols=182 Identities=26% Similarity=0.406 Sum_probs=156.5
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|+||+||+|... +++.||+|++.... .....+++.+|+++++.++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 56888999999999999999765 68899999886532 34456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++.. .+.+++..+..++.|++.||.|||+ ..+++||||||+||++++++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 84 FMDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred cCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999988743 2468899999999999999999996 35899999999999999999999999999875532
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.. .....|+..|+|||++.+..++ ++|+||.
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl 188 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSL 188 (284)
T ss_pred hc---cCccccCcccCCHHHHccCCCCccchHHHH
Confidence 22 1235689999999999888777 9999983
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-26 Score=238.88 Aligned_cols=185 Identities=23% Similarity=0.409 Sum_probs=155.4
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|+||.||+|... ++..||+|.++.. .......++.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 46888999999999999999876 7899999998753 234445788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++... .....+++..+..++.|++.||+|||+ ..+|+||||||+||+++.++.++|+|||.+.....
T Consensus 80 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 80 YMDAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred ecCCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 99999998887542 112368999999999999999999996 35899999999999999999999999999876533
Q ss_pred CCCceeeeeccccCcccccccccCC------cC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTR------WS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~------~~-~~DiWS~ 785 (787)
.. .....|++.|+|||++.+.. ++ ++|+||.
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 193 (286)
T cd06622 156 SL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSL 193 (286)
T ss_pred Cc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhH
Confidence 22 12245788999999986543 34 8999983
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=234.37 Aligned_cols=184 Identities=26% Similarity=0.437 Sum_probs=153.5
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc---chhHHHHHHHHHHHHhcCCCccceEEeEEEeC--Cee
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEK 666 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 666 (787)
.+|+..+.||+|+||.||+|... ++..||+|++...... .+....+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46889999999999999999764 6899999998654322 23456789999999999999999999988753 567
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
+++|||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 899999999999998843 2357889999999999999999997 89999999999999999999999999998
Q ss_pred eecCCCC--CceeeeeccccCcccccccccCCcC-cceeec
Q 003911 747 RLAPEGK--GSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 747 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+...... ........|+..|+|||++.+..++ ++|+||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 194 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWS 194 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHH
Confidence 7653311 1111234588999999999988887 899998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-26 Score=234.73 Aligned_cols=190 Identities=26% Similarity=0.439 Sum_probs=160.0
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe--CCeeEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNEKLLVF 670 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 670 (787)
+|++.+.||.|+||.||+|... +++.||+|++..........+++..|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999754 78899999998755556667789999999999999999999998864 34578999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA--HQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||+++++|.+++..... ....+++..++.++.|++.||+|||..+ ..+++|+||||+||++++++.+||+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 99999999999866432 2357899999999999999999999321 38999999999999999999999999999987
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
...... ......|++.|+|||++.+..++ ++|+||.
T Consensus 160 ~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~sl 196 (265)
T cd08217 160 LGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSL 196 (265)
T ss_pred ccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHH
Confidence 754432 12335689999999999888877 8999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-26 Score=239.10 Aligned_cols=180 Identities=24% Similarity=0.476 Sum_probs=156.1
Q ss_pred CCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.+|++.+.||.|++|.||+|.. .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 4699999999999999999975 478999999986532 2335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++.. ..+++.++..++.|++.|++|||+ .+++||||||+||++++++.+||+|||++.....
T Consensus 97 ~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 97 YLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred ecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999988743 357899999999999999999998 8999999999999999999999999999876544
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
... ......|++.|+|||.+.+..++ ++|+||
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 200 (296)
T cd06655 168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200 (296)
T ss_pred ccc-cCCCcCCCccccCcchhcCCCCCchhhHHH
Confidence 322 12234688999999999888787 899998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=235.37 Aligned_cols=183 Identities=28% Similarity=0.544 Sum_probs=154.4
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccc-------hhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-------KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
+|.+.+.||+|++|.||+|... +++.||+|.+....... ...+.+++|++++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999764 68899999886543221 223578899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCC
Confidence 9999999999999999843 2467888999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCC-----ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 746 VRLAPEGKG-----SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 746 a~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
++....... .......|+..|+|||.+.+..++ ++|+||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~s 197 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWS 197 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHH
Confidence 887653211 111224588999999999888877 899998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-26 Score=237.63 Aligned_cols=189 Identities=22% Similarity=0.405 Sum_probs=156.5
Q ss_pred cCCCcccceeccccceEEEEEEEeC-----CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe-CCe
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHD-----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNE 665 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 665 (787)
.++|++.+.||+|+||.||+|.... +..|++|++.. .......+.+.+|+.++++++||||+++++++.. +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4678999999999999999998765 68899998864 3344556788999999999999999999998876 467
Q ss_pred eEEEEEecCCCCHHHHHHhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEee
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEE---GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 742 (787)
.++++||+++++|.+++...... ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998653221 11468999999999999999999997 8999999999999999999999999
Q ss_pred cccceecCCCCCce-eeeeccccCcccccccccCCcC-cceeec
Q 003911 743 FGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 743 FG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
||+++.+....... .....++..|+|||++.+..++ ++||||
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~s 204 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWS 204 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHH
Confidence 99998654332211 1223457789999999888887 899998
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=243.14 Aligned_cols=182 Identities=26% Similarity=0.501 Sum_probs=155.4
Q ss_pred CCCcccceeccccceEEEEEEEeC---C--cEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 593 NNFSEENILGRGGFGTVYKGELHD---G--TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
+.....++||.|-||.||+|.+.+ | -.||||..+.. .+....+.|..|..+|++++||||++++|+|.+. ..|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence 445667899999999999997542 3 34888988774 4555688999999999999999999999999864 589
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
||||.++-|.|..++.. ....++......+++||+.||+|||+ .++|||||..+|||+....-||++|||+++
T Consensus 467 ivmEL~~~GELr~yLq~----nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQ----NKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred EEEecccchhHHHHHHh----ccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhh
Confidence 99999999999999954 34578889999999999999999998 899999999999999999999999999999
Q ss_pred ecCCCCCceeeeeccccCcccccccccCCcC-cceee
Q 003911 748 LAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYW 783 (787)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiW 783 (787)
.+.+......+...=...|||||.+.-.+++ ++|+|
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVW 576 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVW 576 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHH
Confidence 9977665444433334579999999999998 99999
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-26 Score=238.26 Aligned_cols=187 Identities=30% Similarity=0.545 Sum_probs=154.8
Q ss_pred CCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
.+|...+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|++++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 46778899999999999999642 3567899987652 345567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhh----------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC
Q 003911 667 LLVFEYMPQGTLSRHIFNWAE----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 736 (787)
+++|||+++++|.+++..... .....+++.+++.++.|++.|++|||+ .+++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCC
Confidence 999999999999999865321 011357899999999999999999997 8999999999999999999
Q ss_pred cEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeec
Q 003911 737 RAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 737 ~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.+||+|||+++........ ......+++.|+|||++.+..++ ++|+||
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 209 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWS 209 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHH
Confidence 9999999999765432211 11223457889999999988888 899998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=233.53 Aligned_cols=183 Identities=30% Similarity=0.480 Sum_probs=157.2
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|... +++.+++|++.... ....+.+.+|++++++++||||+++++++.+.+..+++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 367999999999999999999764 67889999997643 235678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++... ...+++.++..++.|++.|++|||+ .+++|+||||+||++++++.+||+|||.+....
T Consensus 80 e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 80 EYCGGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred eCCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhh
Confidence 999999999987541 2468899999999999999999997 899999999999999999999999999987664
Q ss_pred CCCCceeeeeccccCcccccccccC---CcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHT---RWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~-~~DiWS 784 (787)
.... ......++..|+|||++.+. .++ ++|+||
T Consensus 153 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~s 189 (262)
T cd06613 153 ATIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWA 189 (262)
T ss_pred hhhh-ccccccCCccccCchhhcccccCCcCchhhhHH
Confidence 3221 22335688999999999776 666 899998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-26 Score=244.16 Aligned_cols=189 Identities=28% Similarity=0.449 Sum_probs=154.4
Q ss_pred CCCcccceeccccceEEEEEEEe--------CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeC
Q 003911 593 NNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG 663 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 663 (787)
.+|++.+.||+|+||.||+|+.. .+..||+|.++.. ......+++.+|+++++++ +||||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 46889999999999999999642 1236899988753 2344567899999999999 799999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 732 (787)
+..+++|||+++|+|.+++..... .....+++.+++.++.|++.||+|||+ ++++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEE
Confidence 999999999999999999865321 112357889999999999999999997 899999999999999
Q ss_pred CCCCcEEEeecccceecCCCCCce-eeeeccccCcccccccccCCcC-cceeecC
Q 003911 733 GDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 733 ~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++++.+||+|||+++......... .....++..|+|||++.+..++ ++|+||.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 222 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHH
Confidence 999999999999998664432111 1112345679999999888887 8999983
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.2e-26 Score=239.77 Aligned_cols=184 Identities=23% Similarity=0.428 Sum_probs=154.3
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||++... +++.||+|.+...... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36889999999999999999765 6789999998764322 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++.. ...+++..+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 99999999999843 2468899999999999999999997 899999999999999999999999999986421
Q ss_pred CCCC--------------ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 751 EGKG--------------SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.... .......|+..|+|||.+.+..++ ++|+||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 201 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWA 201 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHH
Confidence 1100 001124578899999999888777 899998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.2e-26 Score=233.91 Aligned_cols=182 Identities=32% Similarity=0.541 Sum_probs=154.0
Q ss_pred ceeccccceEEEEEEEeC----CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecC
Q 003911 599 NILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 674 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (787)
+.||+|+||.||+|.... +..||+|++....... ..+++.+|+++++.++|+||+++++++......++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999998753 7889999987643322 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 675 QGTLSRHIFNWAEE----GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 675 ~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
+++|.+++...... ....+++.++..++.|++.||+|||+ ++++||||||+||++++++.+||+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999998653111 02568999999999999999999997 899999999999999999999999999998765
Q ss_pred CCCC-ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 751 EGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.... .......+++.|+|||.+.+..++ ++|+||
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 192 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWS 192 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHH
Confidence 4321 112234578899999999888777 899998
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-26 Score=236.16 Aligned_cols=182 Identities=26% Similarity=0.431 Sum_probs=158.6
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
+|++.+.||.|+||.||+|... +++.||+|++...... ....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999875 6899999999764433 3556789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++.. ...+++..+..++.|+++||+|||+ .+++|+||||+||++++++.++|+|||.+.....
T Consensus 81 ~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQ-----KVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 9999999998843 1468899999999999999999997 8999999999999999999999999999887644
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.. ......|+..|+|||++.+..++ ++|+||.
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 185 (258)
T cd05578 153 DT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSL 185 (258)
T ss_pred Cc--cccccCCChhhcCHHHHcccCCCCcccchhh
Confidence 32 12235688999999999888877 9999983
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=224.24 Aligned_cols=180 Identities=27% Similarity=0.395 Sum_probs=148.6
Q ss_pred hcCCCccc-ceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEe----C
Q 003911 591 VTNNFSEE-NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD----G 663 (787)
Q Consensus 591 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~ 663 (787)
++++|++. ++||-|-.|.|-.+..+ +++++|+|++... ...++|++.--.. .|||||.++++|.. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 55677654 67999999999998654 8999999988652 3456777765555 69999999999864 3
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC---CCCcEEE
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKV 740 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl 740 (787)
....+|||.|+||.|...+.+ .+...+++.++-.|+.||+.|+.|||+ .+|.||||||+|+|.. .+..+||
T Consensus 132 kcLLiVmE~meGGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred eeeEeeeecccchHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEe
Confidence 456799999999999988855 455679999999999999999999998 8999999999999996 4557999
Q ss_pred eecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 741 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 741 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+|||+|+...... . ....+-||+|.|||++...+|+ .+|+||.
T Consensus 206 tDfGFAK~t~~~~-~-L~TPc~TPyYvaPevlg~eKydkscdmwSl 249 (400)
T KOG0604|consen 206 TDFGFAKETQEPG-D-LMTPCFTPYYVAPEVLGPEKYDKSCDMWSL 249 (400)
T ss_pred cccccccccCCCc-c-ccCCcccccccCHHHhCchhcCCCCCccch
Confidence 9999999765432 2 2235679999999999999999 8999984
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-26 Score=233.15 Aligned_cols=177 Identities=33% Similarity=0.544 Sum_probs=150.0
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEE-eCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCL-DGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e 671 (787)
++|++.+.||+|+||.||+|... +..||+|.++.. ...+.+.+|+.++++++|+|++++++++. ..+..++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 46888999999999999999765 888999988642 23467899999999999999999999765 4456899999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 81 YMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 99999999988542 22357899999999999999999997 8999999999999999999999999999886543
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
... ...++..|+|||++.+..++ ++|+||
T Consensus 155 ~~~----~~~~~~~y~aPE~~~~~~~~~~~Dv~s 184 (256)
T cd05082 155 TQD----TGKLPVKWTAPEALREKKFSTKSDVWS 184 (256)
T ss_pred cCC----CCccceeecCHHHHccCCCCchhhhHH
Confidence 221 22346689999999888888 899998
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=234.41 Aligned_cols=180 Identities=27% Similarity=0.403 Sum_probs=142.3
Q ss_pred eeccccceEEEEEEEeCCc---EEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCC
Q 003911 600 ILGRGGFGTVYKGELHDGT---KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (787)
Q Consensus 600 ~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (787)
.||+|+||.||+|+..++. .+++|.+... ......+.+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 5999999999999765443 4556665542 22345678999999999999999999999999999999999999999
Q ss_pred CHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCC-c
Q 003911 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG-S 755 (787)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~ 755 (787)
+|.+++..... .....++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........ .
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999865322 12356777888999999999999997 8999999999999999999999999999864322111 1
Q ss_pred eeeeeccccCcccccccccC-------CcC-cceeec
Q 003911 756 IETRIAGTFGYLAPEYAVHT-------RWS-SCSYWA 784 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~-------~~~-~~DiWS 784 (787)
......|+..|+|||++... .++ ++|+||
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 193 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWA 193 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHH
Confidence 11234678899999997532 234 799998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-26 Score=241.58 Aligned_cols=180 Identities=29% Similarity=0.428 Sum_probs=143.0
Q ss_pred cceeccccceEEEEEEEe---CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe--CCeeEEEEEe
Q 003911 598 ENILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNEKLLVFEY 672 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 672 (787)
...||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 367999999999999865 45789999886532 23467889999999999999999998854 4567899999
Q ss_pred cCCCCHHHHHHhhhh----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE----CCCCcEEEeecc
Q 003911 673 MPQGTLSRHIFNWAE----EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 744 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFG 744 (787)
++ ++|.+++..... .....+++..+..++.|++.||+|||+ .+|+||||||+||++ ++++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 86 578777743211 122357889999999999999999998 899999999999999 466789999999
Q ss_pred cceecCCCCCc--eeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 745 LVRLAPEGKGS--IETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
+++........ ......||+.|+|||++.+. .++ ++|+||.
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 202 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 202 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhH
Confidence 99876543221 12335689999999999774 456 8999983
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=233.10 Aligned_cols=184 Identities=28% Similarity=0.454 Sum_probs=153.7
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccc---ccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC--Cee
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV---ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEK 666 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 666 (787)
.+|++.+.||+|+||.||+|... +++.||+|++.... ........+++|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999764 68999999885432 1234456889999999999999999999998764 457
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 899999999999988843 2357888999999999999999997 89999999999999999999999999999
Q ss_pred eecCCCC--CceeeeeccccCcccccccccCCcC-cceeec
Q 003911 747 RLAPEGK--GSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 747 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+...... ........|+..|+|||++.+..++ ++|+||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 194 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWS 194 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHH
Confidence 7653211 1111235689999999999888777 899998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=240.42 Aligned_cols=183 Identities=27% Similarity=0.432 Sum_probs=155.1
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|+||.||+|..+ +++.||+|++..........+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999875 68999999987644334445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|++++++.++... ...+++.++..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999888776532 2358999999999999999999998 8999999999999999999999999999987644
Q ss_pred CCCceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
... ......++..|+|||++.+. .++ ++|+||
T Consensus 153 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 186 (286)
T cd07846 153 PGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWA 186 (286)
T ss_pred Ccc-ccCcccceeeccCcHHhccccccCchHhHHH
Confidence 332 22335688999999998764 344 899998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-26 Score=234.32 Aligned_cols=172 Identities=23% Similarity=0.398 Sum_probs=141.5
Q ss_pred ceeccccceEEEEEEEeC-------------CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 599 NILGRGGFGTVYKGELHD-------------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
+.||+|+||.||+|...+ ...||+|.+... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 468999999999997532 235888887652 23345678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc-------E
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-------A 738 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~ 738 (787)
.++||||+++|+|..++.. ....+++..+..++.||++||+|||+ ++|+||||||+||+++.++. +
T Consensus 79 ~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CEEEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCcee
Confidence 9999999999999887743 22458899999999999999999997 89999999999999986654 8
Q ss_pred EEeecccceecCCCCCceeeeeccccCcccccccc-cCCcC-cceeec
Q 003911 739 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV-HTRWS-SCSYWA 784 (787)
Q Consensus 739 kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~-~~DiWS 784 (787)
+++|||.+...... ....|+..|+|||.+. +..++ ++||||
T Consensus 152 ~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Diws 194 (262)
T cd05077 152 KLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWS 194 (262)
T ss_pred EeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHH
Confidence 99999998765322 1245788999999986 45566 899998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-26 Score=234.21 Aligned_cols=178 Identities=32% Similarity=0.548 Sum_probs=150.6
Q ss_pred ceeccccceEEEEEEEeC--C--cEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecC
Q 003911 599 NILGRGGFGTVYKGELHD--G--TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 674 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (787)
+.||+|++|.||+|.+.+ + ..||+|.+...... ...+++.+|++++++++||||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998643 2 36999999775443 566789999999999999999999999988 88999999999
Q ss_pred CCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCC
Q 003911 675 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754 (787)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 754 (787)
+++|.+++.+... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 79 LGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999999865221 468999999999999999999997 8999999999999999999999999999987654322
Q ss_pred ce--eeeeccccCcccccccccCCcC-cceeec
Q 003911 755 SI--ETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 755 ~~--~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.. .....++..|+|||++.+..++ ++|+||
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~s 185 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWM 185 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHH
Confidence 11 1124567899999999988888 899998
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=234.65 Aligned_cols=184 Identities=25% Similarity=0.505 Sum_probs=153.4
Q ss_pred CCCcccceeccccceEEEEEEEe-CC---cEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
++|+..+.||+|+||.||+|... ++ ..+|+|.++... .....+++..|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 46788899999999999999865 33 379999886532 33446788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++++|.+++.. ....+++.++..++.|++.|++|||+ .+++||||||+||++++++.+||+|||++..
T Consensus 84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 84 ITEYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 9999999999998853 22468899999999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCCceee--eeccccCcccccccccCCcC-cceeec
Q 003911 749 APEGKGSIET--RIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 749 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.......... ....+..|+|||++.+..++ ++|+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~s 195 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWS 195 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHH
Confidence 6443222111 11234579999999888777 899998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=235.15 Aligned_cols=183 Identities=30% Similarity=0.511 Sum_probs=152.1
Q ss_pred CCCcccceeccccceEEEEEEEe-CCc----EEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
.+|++.+.||+|+||.||+|... +|+ .||+|.+.... ......++.+|++++++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 56888999999999999999764 333 58999876532 24455788999999999999999999999987 7889
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+||||+++|+|.+++.. ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||.++
T Consensus 85 ~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 85 LITQLMPLGCLLDYVRN----HKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEecCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 99999999999998854 22358899999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCCceee-eeccccCcccccccccCCcC-cceeec
Q 003911 748 LAPEGKGSIET-RIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 748 ~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
........... ...++..|+|||.+....++ ++|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s 196 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWS 196 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHH
Confidence 76543322111 12235689999999888777 899998
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=232.80 Aligned_cols=183 Identities=28% Similarity=0.469 Sum_probs=157.7
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+|++.+.||+|+||.||+|... +++.||+|.++.........+.+..|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888899999999999999764 789999999987554445678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++.. ...+++..+..++.|++.|++|||+ .+++|+||||+||++++++.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999998843 2357888999999999999999997 89999999999999999999999999999876543
Q ss_pred CCceee---eeccccCcccccccccCC---cC-cceeec
Q 003911 753 KGSIET---RIAGTFGYLAPEYAVHTR---WS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~---~~~gt~~y~aPE~~~~~~---~~-~~DiWS 784 (787)
...... ...++..|+|||++.+.. ++ ++|+||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s 191 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWS 191 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHH
Confidence 322111 245788999999998765 55 899998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=234.98 Aligned_cols=181 Identities=27% Similarity=0.442 Sum_probs=158.2
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||.|++|.||+|... +++.||+|++.... .......+.+|+++++.++|+||+++++++.++...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 36888999999999999999765 68999999987542 34445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++.. ..+++..+..++.|++.|+.|||+ .+++||||+|+||++++++.++|+|||.++....
T Consensus 80 ~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 80 YCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred eeCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 9999999998843 268899999999999999999997 8999999999999999999999999999987754
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
... ......|++.|+|||++.+..++ ++|+||
T Consensus 151 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~s 183 (274)
T cd06609 151 TMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWS 183 (274)
T ss_pred ccc-ccccccCCccccChhhhccCCCCchhhHHH
Confidence 422 22335688999999999988887 899998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=232.13 Aligned_cols=181 Identities=27% Similarity=0.492 Sum_probs=155.7
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc---cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI---SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+|+..+.||+|++|.||+|... +++.|++|.+..... ..+..+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999876 789999999865332 234557899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|.+++.. ...+++..+..++.|++.|++|||+ .+++|+||||+||++++++.+||+|||.+...
T Consensus 81 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 999999999998853 2357899999999999999999998 89999999999999999999999999998876
Q ss_pred CCCCCceeeeeccccCcccccccccCC-cC-cceeec
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWA 784 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS 784 (787)
.... ......|+..|+|||.+.... ++ ++|+||
T Consensus 153 ~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~s 187 (258)
T cd06632 153 VEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWS 187 (258)
T ss_pred cccc--cccccCCCcceeCHHHhcCCCCCCchhhhHH
Confidence 4433 223356899999999987766 66 899998
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=232.31 Aligned_cols=187 Identities=27% Similarity=0.470 Sum_probs=158.9
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||.|+||+||+|... ++..+|+|++....... ..+.+.+|+++++.++|+||+++++.+...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 47899999999999999999754 68899999987543333 56789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++..... ...+++..+..++.|++.|++|||+ .+++||||||+||++++++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 80 YLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred ccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 9999999999854221 2468899999999999999999997 8999999999999999999999999999876654
Q ss_pred CCCc---eeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 752 GKGS---IETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~---~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
.... ......|+..|+|||++... .++ ++|+||.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~sl 193 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSF 193 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhH
Confidence 3322 22335689999999998877 566 8999983
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=236.54 Aligned_cols=194 Identities=25% Similarity=0.385 Sum_probs=158.0
Q ss_pred eeHHHHHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEE
Q 003911 583 ISIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHC 660 (787)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 660 (787)
+.++++....++|++.+.||+|+||.||+|... +++.+|+|++... .....++.+|+.+++++ +|||++++++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 334555566789999999999999999999764 6889999998652 22346778899999999 899999999998
Q ss_pred EeC-----CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC
Q 003911 661 LDG-----NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735 (787)
Q Consensus 661 ~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 735 (787)
... +..++||||+++++|.+++...... ...+++..++.++.|++.||+|||+ .+++||||||+||+++++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~ 164 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTE 164 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCC
Confidence 754 3579999999999999988653322 3468899999999999999999997 899999999999999999
Q ss_pred CcEEEeecccceecCCCCCceeeeeccccCcccccccccCC-----cC-cceeec
Q 003911 736 MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR-----WS-SCSYWA 784 (787)
Q Consensus 736 ~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~-~~DiWS 784 (787)
+.+||+|||.++....... ......|+..|+|||++.... ++ ++|+||
T Consensus 165 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s 218 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWS 218 (291)
T ss_pred CCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHH
Confidence 9999999999886543321 122346889999999986543 34 899998
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-26 Score=233.86 Aligned_cols=170 Identities=23% Similarity=0.428 Sum_probs=142.3
Q ss_pred ceeccccceEEEEEEEeCCc-----------EEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 599 NILGRGGFGTVYKGELHDGT-----------KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
+.||+|+||.||+|...+.. .|++|++.... .....+.+|+.++++++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999876332 47778765432 126788999999999999999999999988 7789
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC-------cEEE
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-------RAKV 740 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl 740 (787)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||
T Consensus 77 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 77 MVEEYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred EEEEcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEe
Confidence 999999999999988542 1268899999999999999999997 8999999999999999887 7999
Q ss_pred eecccceecCCCCCceeeeeccccCcccccccccC--CcC-cceeec
Q 003911 741 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHT--RWS-SCSYWA 784 (787)
Q Consensus 741 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~~DiWS 784 (787)
+|||++...... ....++..|+|||++.+. .++ ++|+||
T Consensus 150 ~Dfg~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~s 191 (259)
T cd05037 150 SDPGIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWS 191 (259)
T ss_pred CCCCcccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHH
Confidence 999999865431 124567889999999876 566 899998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-26 Score=235.06 Aligned_cols=184 Identities=25% Similarity=0.483 Sum_probs=154.9
Q ss_pred CCcccceeccccceEEEEEEE-eCCcEEEEEEeeccccc----chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 594 NFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS----GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
+|+..+.||+|++|.||+|.. .+++.||+|++...... ....+++.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999975 47899999998753321 2235688999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC-cEEEeecccce
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVR 747 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~ 747 (787)
||||+++++|.+++.. ..++++..+..++.|++.||+|||+ .+++||||||+||+++.++ .+||+|||.+.
T Consensus 81 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 9999999999998853 2467899999999999999999998 8999999999999998765 59999999987
Q ss_pred ecCCCCC---ceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 748 LAPEGKG---SIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
....... .......|+..|+|||++.+..++ ++|+||.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~sl 194 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSV 194 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHH
Confidence 6644321 111234688999999999888777 8999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=237.11 Aligned_cols=183 Identities=26% Similarity=0.417 Sum_probs=151.6
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|++|.||+|..+ +++.||+|.+..... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 67999999999999999999865 689999999876432 2223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|++ ++|.+++... ...+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 84 ~~~-~~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 84 YLD-TDLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred cCC-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 997 5998887532 2367899999999999999999997 8999999999999999999999999999875432
Q ss_pred CCCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
.... .....++..|+|||++.+. .++ ++|+||.
T Consensus 156 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~sl 190 (291)
T cd07844 156 PSKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGV 190 (291)
T ss_pred CCcc-ccccccccccCCcHHhhcCcccCcHHHHHHH
Confidence 2211 1223468899999998764 455 8999983
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-26 Score=238.19 Aligned_cols=181 Identities=27% Similarity=0.493 Sum_probs=155.4
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
+.|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 34777889999999999999764 68899999887532 23455789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++.. ..+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.++++|||++.....
T Consensus 83 ~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 83 YLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred ccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999999988732 367899999999999999999997 8999999999999999999999999999976644
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
... ......|+..|+|||++.+..++ ++|+||
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 186 (277)
T cd06642 154 TQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWS 186 (277)
T ss_pred cch-hhhcccCcccccCHHHhCcCCCchhhhHHH
Confidence 321 12234688999999999988887 899998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=231.11 Aligned_cols=184 Identities=32% Similarity=0.559 Sum_probs=154.1
Q ss_pred CcccceeccccceEEEEEEEeC-----CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 595 FSEENILGRGGFGTVYKGELHD-----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+++.+.||.|+||.||++.... +..||+|++.... .....+.+..|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567889999999999997653 3889999986532 223567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|.+++..... ..+++.++..++.|++.|++|||+ .+++||||||+||++++++.++|+|||.++..
T Consensus 80 ~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EeccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceec
Confidence 999999999999854221 128999999999999999999997 89999999999999999999999999999877
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
............+++.|+|||.+.+..++ ++|+||.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl 190 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSF 190 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHH
Confidence 55422222123367899999999877777 8999983
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=231.86 Aligned_cols=180 Identities=29% Similarity=0.468 Sum_probs=157.6
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|+||.||+|... +++.||+|.+.... ..+++.+|++++++++||||+++++++.+....|+++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 57999999999999999999876 48899999986532 26789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++.. ....+++..+..++.|++.|+.|||+ .+++||||+|+||++++++.++|+|||++.....
T Consensus 79 ~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 79 YCGAGSVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred cCCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 9999999998843 22468999999999999999999997 8999999999999999999999999999987654
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
... ......|+..|+|||++.+..++ ++|+||
T Consensus 152 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s 184 (256)
T cd06612 152 TMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWS 184 (256)
T ss_pred Ccc-ccccccCCccccCHHHHhcCCCCchhhHHH
Confidence 332 22334588999999999888888 899998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=235.95 Aligned_cols=183 Identities=27% Similarity=0.407 Sum_probs=150.9
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|+++++.++|+||+++++++..++..++||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT-EEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccC-cCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 468999999999999999999764 68999999987543 2233446788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+. +++.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQ----HPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9995 677776633 12357788889999999999999997 899999999999999999999999999987653
Q ss_pred CCCCceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
..... .....+++.|+|||++.+. .++ ++|+||
T Consensus 155 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 189 (291)
T cd07870 155 IPSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWG 189 (291)
T ss_pred CCCCC-CCCccccccccCCceeecCCCCCcHHHHHH
Confidence 32211 2234578999999998764 345 899998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=233.28 Aligned_cols=180 Identities=34% Similarity=0.539 Sum_probs=145.8
Q ss_pred ceeccccceEEEEEEEe-CCc--EEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEEEecC
Q 003911 599 NILGRGGFGTVYKGELH-DGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMP 674 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (787)
+.||+|+||.||+|... ++. .+|+|.++.. ......+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 36899999999999875 343 4688887642 2344556889999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHhhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 675 QGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 675 ~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
+|+|.+++..... .....+++.++..++.|++.|++|||+ .+++||||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence 9999999865321 112357899999999999999999997 89999999999999999999999999
Q ss_pred ccceecCCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
|++........ ......+..|+|||++.+..++ ++|+||
T Consensus 157 gl~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~s 196 (270)
T cd05047 157 GLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWS 196 (270)
T ss_pred CCccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHH
Confidence 99863321111 1112235679999999888888 899998
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=230.18 Aligned_cols=178 Identities=30% Similarity=0.521 Sum_probs=150.1
Q ss_pred ceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCCCH
Q 003911 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (787)
++||+|+||.||+|...+++.||+|++..... ....+.+.+|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP-PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 46999999999999877799999999876433 24567899999999999999999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCcee-
Q 003911 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE- 757 (787)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~- 757 (787)
.+++... ...+++..+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||.++..........
T Consensus 80 ~~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 80 LTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 9988541 2357889999999999999999997 8999999999999999999999999999986543221111
Q ss_pred eeeccccCcccccccccCCcC-cceeec
Q 003911 758 TRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 758 ~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
....++..|+|||++.++.++ ++|+||
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s 180 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWS 180 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHH
Confidence 112235679999999888887 899998
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=238.98 Aligned_cols=180 Identities=26% Similarity=0.444 Sum_probs=152.8
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
.|.....||+|+||.||++... ++..||||++... .....+.+.+|+.++++++||||+++++.+..++..++||||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 3444577999999999999764 6889999998652 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++......
T Consensus 101 ~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 101 LEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 999999988732 357889999999999999999998 89999999999999999999999999998765433
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.. ......|+..|+|||++.+..++ ++|+||.
T Consensus 172 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 204 (292)
T cd06658 172 VP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSL 204 (292)
T ss_pred cc-cCceeecCccccCHHHHccCCCCchhhHHHH
Confidence 22 12235689999999999888887 8999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=233.06 Aligned_cols=183 Identities=25% Similarity=0.456 Sum_probs=152.6
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc--------chhHHHHHHHHHHHHhcCCCccceEEeEEEeCC
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS--------GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN 664 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 664 (787)
+|.+.+.||+|+||.||+|... +++.||+|.++..... ....+.+.+|++++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999754 6899999988642111 112356888999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.++++|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999988542 468889999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCCc-eeeeeccccCcccccccccCC--cC-cceeec
Q 003911 745 LVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTR--WS-SCSYWA 784 (787)
Q Consensus 745 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~-~~DiWS 784 (787)
+++........ ......|+..|+|||.+.... ++ ++|+||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~s 197 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWS 197 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHH
Confidence 99765432211 122345889999999987654 55 899998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=235.36 Aligned_cols=183 Identities=25% Similarity=0.386 Sum_probs=153.4
Q ss_pred CCcccceeccccceEEEEEEE----eCCcEEEEEEeecccc--cchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCee
Q 003911 594 NFSEENILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 666 (787)
+|++.+.||+|+||.||+|+. .+|+.||+|++..... .....+.+.+|+++++++ +|++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999975 3689999999875332 123446788999999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 999999999999998853 2357889999999999999999997 89999999999999999999999999999
Q ss_pred eecCCCCCceeeeeccccCcccccccccCC--cC-cceeec
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTR--WS-SCSYWA 784 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~-~~DiWS 784 (787)
+..............|+..|+|||.+.+.. ++ ++|+||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~s 193 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWS 193 (290)
T ss_pred eecccccccccccccCCcccCChhhccCCCCCCCccccHHH
Confidence 876443322223456899999999987643 44 899998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=242.27 Aligned_cols=182 Identities=27% Similarity=0.387 Sum_probs=153.6
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC------
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------ 663 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 663 (787)
+.++|++.+.||+|+||.||+|... +++.||+|++...........++.+|++++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999765 789999999875444444556788899999999999999999988644
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
...|+||||+. ++|.+.+.. .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccC
Confidence 34699999995 588877632 27888999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|+++....... .....|++.|+|||++.+..++ ++|+||.
T Consensus 163 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 203 (353)
T cd07850 163 GLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSV 203 (353)
T ss_pred ccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhH
Confidence 99987644321 2234688999999999998888 8999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=236.23 Aligned_cols=183 Identities=26% Similarity=0.399 Sum_probs=153.8
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC--CeeEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLLV 669 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 669 (787)
++|++.+.||+|+||.||+|... +++.+|+|.++...........+.+|++++++++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47889999999999999999876 688999999976544444445678899999999999999999999877 789999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||++ ++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||.++..
T Consensus 85 ~e~~~-~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVE-HDLKSLMETM----KQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcC-cCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99996 5898887431 2368999999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCceeeeeccccCcccccccccCC-cC-cceeec
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWA 784 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS 784 (787)
..... ......+++.|+|||.+.+.. ++ ++|+||
T Consensus 157 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s 192 (293)
T cd07843 157 GSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWS 192 (293)
T ss_pred cCCcc-ccccccccccccCchhhcCCccccchhhHHH
Confidence 54422 122345789999999987654 34 899998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=231.45 Aligned_cols=183 Identities=25% Similarity=0.443 Sum_probs=150.9
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.+++.....||+|+||.||+|... ++..||+|.+... .....+.+.+|++++++++|+||+++++++..++..++|+
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 345555678999999999999754 6788999988653 2334568999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC-CCcEEEeecccce
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPL--EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVR 747 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~ 747 (787)
||+++++|.+++.... ..+ ++..+..++.|++.|++|||+ .+|+||||||+||+++. ++.++|+|||.+.
T Consensus 85 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 85 EQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred ecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999999985421 234 788889999999999999997 89999999999999986 6789999999987
Q ss_pred ecCCCCCceeeeeccccCcccccccccCC--cC-cceeec
Q 003911 748 LAPEGKGSIETRIAGTFGYLAPEYAVHTR--WS-SCSYWA 784 (787)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~-~~DiWS 784 (787)
....... ......|++.|+|||++.+.. ++ ++|+||
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~s 196 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWS 196 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHH
Confidence 6643222 122345899999999987654 44 899998
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=236.77 Aligned_cols=182 Identities=30% Similarity=0.430 Sum_probs=153.2
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc---chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+|++.+.||+|++|.||+|... +++.||||+++..... ......+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999865 6899999999765433 23345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+ +++|.+++.. ....+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~e~~-~~~L~~~i~~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKD----KSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 8999998843 11368999999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCCceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
...... .....+++.|+|||.+.+. .++ ++|+||
T Consensus 153 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 188 (298)
T cd07841 153 GSPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWS 188 (298)
T ss_pred cCCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHH
Confidence 543221 2223568889999998654 445 899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=235.36 Aligned_cols=187 Identities=26% Similarity=0.358 Sum_probs=152.6
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCe-----
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNE----- 665 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~----- 665 (787)
++|++.+.||+|+||.||+|... +++.||+|+++...........+.+|++++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999865 6899999998764333334567889999999995 6999999999987665
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC-CCcEEEeecc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFG 744 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG 744 (787)
.|+||||+++ +|.+++..........+++..++.++.||+.||+|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 89888865433323568999999999999999999997 89999999999999998 8899999999
Q ss_pred cceecCCCCCceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 745 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
.++........ .....+++.|+|||++.+. .++ ++|+||
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s 197 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWS 197 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHH
Confidence 99865433221 1223568899999988664 445 899998
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=233.17 Aligned_cols=181 Identities=25% Similarity=0.480 Sum_probs=156.3
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
..|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++++++.++...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 45778899999999999999765 68899999987532 23456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++.. ..+++.++..++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 83 YLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred cCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 9999999998842 357889999999999999999997 8999999999999999999999999999977644
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
... ......++..|+|||++.+..++ ++|+||
T Consensus 154 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~s 186 (277)
T cd06640 154 TQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWS 186 (277)
T ss_pred Ccc-ccccccCcccccCHhHhccCCCccHHHHHH
Confidence 321 22234678899999999888877 899998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-26 Score=235.98 Aligned_cols=184 Identities=24% Similarity=0.333 Sum_probs=155.4
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 671 (787)
..|++.++||+||.+.||++...+.+.+|+|++.....+......|..|+..|.++ .|.+||++++|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 46999999999999999999988888999998877667777888999999999999 59999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|- ..||..++..... ....| .++.+..||+.|+.++|. .||||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 441 ~G-d~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred cc-cccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 76 6799999865221 12234 678899999999999997 8999999999999995 46899999999998876
Q ss_pred CCCcee-eeeccccCcccccccccCCc-----------C-cceeecC
Q 003911 752 GKGSIE-TRIAGTFGYLAPEYAVHTRW-----------S-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~-~~~~gt~~y~aPE~~~~~~~-----------~-~~DiWS~ 785 (787)
...... ...+||+.||+||.+....+ + ++||||.
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSL 558 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSL 558 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhh
Confidence 654433 34789999999999864322 2 7999983
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=239.85 Aligned_cols=185 Identities=26% Similarity=0.465 Sum_probs=154.6
Q ss_pred CCCcccceeccccceEEEEEE-EeCCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.-|..++.||-|+||+|.+++ .++...+|+|.+++.+. ........+.|-.||+..+.+.||++|-.|++.+..|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 457788999999999999985 45677899999877543 3444567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce---
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR--- 747 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~--- 747 (787)
||++||++-.++.. .+.+++..+..++..+..|+++.|. .|+|||||||+|||||.+|++||+|||++.
T Consensus 709 dYIPGGDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred eccCCccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccce
Confidence 99999999988854 3468888899999999999999996 999999999999999999999999999974
Q ss_pred ------ecCCCCCcee--------------------------------eeeccccCcccccccccCCcC-cceeecC
Q 003911 748 ------LAPEGKGSIE--------------------------------TRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 748 ------~~~~~~~~~~--------------------------------~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++..+..... ...+||+.|+|||++....|+ .||-||-
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~ 857 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV 857 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence 2221111000 113699999999999999898 7999973
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=238.53 Aligned_cols=187 Identities=28% Similarity=0.423 Sum_probs=152.7
Q ss_pred CCcccceeccccceEEEEEEEe---CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeC--CeeE
Q 003911 594 NFSEENILGRGGFGTVYKGELH---DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKL 667 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 667 (787)
+|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+.+|++++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999764 478999999976431 123346678899999999999999999999988 7899
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC----CCcEEEeec
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD----DMRAKVADF 743 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DF 743 (787)
+||||++ +++.+.+..........+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 477777654433333478899999999999999999997 89999999999999999 899999999
Q ss_pred ccceecCCCCC--ceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 744 GLVRLAPEGKG--SIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 744 G~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
|+++....... .......+++.|+|||++.+. .++ ++|+||
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 201 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWA 201 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHH
Confidence 99986644322 112235678999999998775 355 899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=237.61 Aligned_cols=179 Identities=26% Similarity=0.415 Sum_probs=152.4
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEec
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (787)
|+....||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 444567999999999999764 78999999986532 233567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCC
Q 003911 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (787)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 753 (787)
++++|.+++.. ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 101 QGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred CCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 99999887632 357899999999999999999997 899999999999999999999999999987554332
Q ss_pred CceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 754 GSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
. ......|+..|+|||++.+..++ ++|+||.
T Consensus 172 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 203 (297)
T cd06659 172 P-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSL 203 (297)
T ss_pred c-cccceecCccccCHHHHccCCCCchhhHHHH
Confidence 1 12335689999999999888888 8999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=229.88 Aligned_cols=176 Identities=31% Similarity=0.533 Sum_probs=146.0
Q ss_pred ceeccccceEEEEEEEe-C---CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecC
Q 003911 599 NILGRGGFGTVYKGELH-D---GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 674 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (787)
+.||+|+||.||+|.+. . +..||+|.+...... ...+++.+|+++++++.||||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 46999999999999653 2 268999998764432 45678999999999999999999999876 456799999999
Q ss_pred CCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCC
Q 003911 675 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754 (787)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 754 (787)
+|+|.+++.. ...+++..+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||.++.......
T Consensus 79 ~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 79 LGPLLKYLKK-----RREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 9999999854 1268899999999999999999997 8999999999999999999999999999987644332
Q ss_pred ceeee--eccccCcccccccccCCcC-cceeec
Q 003911 755 SIETR--IAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 755 ~~~~~--~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..... ..++..|+|||.+.+..++ ++|+||
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 183 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWS 183 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHH
Confidence 21111 1235679999999888888 899998
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=234.17 Aligned_cols=171 Identities=23% Similarity=0.388 Sum_probs=139.4
Q ss_pred eeccccceEEEEEEEeC-------------------------CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccc
Q 003911 600 ILGRGGFGTVYKGELHD-------------------------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654 (787)
Q Consensus 600 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 654 (787)
.||+|+||.||+|.... ...||+|++.... .....++.+|++++++++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 59999999999996421 1358888886532 23346788899999999999999
Q ss_pred eEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC
Q 003911 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 734 (787)
Q Consensus 655 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 734 (787)
++++++.+....++||||+++|+|..++.. ....+++..+..++.|+++||+|||+ ++|+||||||+||++++
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLAR 152 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEec
Confidence 999999999999999999999999888743 23467899999999999999999997 89999999999999976
Q ss_pred CC-------cEEEeecccceecCCCCCceeeeeccccCccccccccc-CCcC-cceeec
Q 003911 735 DM-------RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWA 784 (787)
Q Consensus 735 ~~-------~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS 784 (787)
.+ .+|++|||.+....... ...++..|+|||.+.+ ..++ ++|+||
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~s 206 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWS 206 (274)
T ss_pred cCcccCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHH
Confidence 43 38999999886543221 2357888999998876 4455 899998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=233.45 Aligned_cols=190 Identities=28% Similarity=0.476 Sum_probs=155.1
Q ss_pred HHHHHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEe
Q 003911 585 IQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 662 (787)
Q Consensus 585 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 662 (787)
+.++....+.|++.+.||+|+||.||+|... +++.||+|++... .....++..|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 4444556678999999999999999999764 6889999998652 23446788999999999 69999999999863
Q ss_pred ------CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC
Q 003911 663 ------GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736 (787)
Q Consensus 663 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 736 (787)
....+++|||+++|+|.+++.... ...+++..+..++.|+++|++|||+ .+|+||||||+||++++++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENA 158 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCC
Confidence 456899999999999999885422 2357888899999999999999998 8999999999999999999
Q ss_pred cEEEeecccceecCCCCCceeeeeccccCcccccccc-----cCCcC-cceeec
Q 003911 737 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV-----HTRWS-SCSYWA 784 (787)
Q Consensus 737 ~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~-~~DiWS 784 (787)
.++|+|||++........ ......|++.|+|||++. +..++ ++|+||
T Consensus 159 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvws 211 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWS 211 (282)
T ss_pred CEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhH
Confidence 999999999876543221 122356899999999986 23455 899998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=232.41 Aligned_cols=188 Identities=29% Similarity=0.476 Sum_probs=152.7
Q ss_pred CcccceeccccceEEEEEEEe----CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC------
Q 003911 595 FSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------ 664 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 664 (787)
|++.+.||+|+||.||+|... +++.||||++..........+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 4688999999876555566778999999999999999999999886542
Q ss_pred eeEEEEEecCCCCHHHHHHhhh-hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWA-EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
..++++||+++|+|.+++.... ......+++..+..++.|++.|++|||+ .+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875322 1222357889999999999999999997 89999999999999999999999999
Q ss_pred ccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 744 GLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|.++........ ......+++.|++||.+.+..++ ++|+||.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~sl 201 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAF 201 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHH
Confidence 999866433211 11223456789999999888777 8999993
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=231.26 Aligned_cols=180 Identities=26% Similarity=0.481 Sum_probs=154.7
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
-|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++++++..+...++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 4777889999999999999764 68899999886532 234456889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++.. ..+++..+..++.|++.|++|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 84 LGGGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 999999988842 357899999999999999999997 89999999999999999999999999998766443
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.. ......|+..|+|||++.+..++ ++|+||
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~s 186 (277)
T cd06641 155 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWS 186 (277)
T ss_pred hh-hhccccCCccccChhhhccCCCCchhhHHH
Confidence 21 12234688999999999888777 899998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=234.71 Aligned_cols=183 Identities=27% Similarity=0.450 Sum_probs=153.5
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+|++.+.||+|++|.||+|+.. +++.||||++............+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4888999999999999999765 689999999876443444456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+. ++|.+++.. .....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDA---SPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 95 688888754 223468899999999999999999997 89999999999999999999999999998765433
Q ss_pred CCceeeeeccccCcccccccccCC-cC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS 784 (787)
... .....+++.|+|||++.+.. ++ ++|+||
T Consensus 154 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 186 (284)
T cd07860 154 VRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWS 186 (284)
T ss_pred ccc-cccccccccccCCeEEecCCCCCcHHHHHH
Confidence 221 22235788999999987755 35 799998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-25 Score=227.07 Aligned_cols=186 Identities=25% Similarity=0.473 Sum_probs=161.9
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+|++.+.||+|+||.||++... +++.||+|++..........+++.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888899999999999999765 689999999987555556677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++..... ....+++.++..++.|++.|++|||+ .+++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999998865332 12578999999999999999999998 79999999999999999999999999999876544
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
. .......|++.|+|||...+..++ ++|+||
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~s 188 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWS 188 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHH
Confidence 3 222335689999999999888887 899998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=232.52 Aligned_cols=176 Identities=33% Similarity=0.485 Sum_probs=149.3
Q ss_pred eccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCCCH
Q 003911 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (787)
Q Consensus 601 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (787)
||+|+||+||+|... +|+.||+|.+...... ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999754 6899999998764322 23345677899999999999999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCceee
Q 003911 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 758 (787)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 758 (787)
.+++... ....+++.++..++.|++.||.|||+ .+++||||||+||++++++.++|+|||.+....... ...
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 152 (277)
T cd05577 81 KYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIK 152 (277)
T ss_pred HHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccc
Confidence 9988542 22468999999999999999999997 899999999999999999999999999987654322 122
Q ss_pred eeccccCcccccccccCCcC-cceeec
Q 003911 759 RIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 759 ~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
...++..|+|||++.+..++ ++|+||
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~s 179 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFA 179 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHH
Confidence 34578899999999888877 899998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=236.90 Aligned_cols=183 Identities=29% Similarity=0.501 Sum_probs=149.9
Q ss_pred CCCcccceeccccceEEEEEEEe-CCc----EEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
++|+..+.||+|+||.||+|... +++ .||+|.+.... ......++.+|+.++++++||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 56788899999999999999764 444 47888876532 233445788999999999999999999998754 467
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+++||+++|+|.+++.. ....+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE----HKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeehhcCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccc
Confidence 99999999999998853 22357889999999999999999997 899999999999999999999999999998
Q ss_pred ecCCCCCc-eeeeeccccCcccccccccCCcC-cceeec
Q 003911 748 LAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 748 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
........ ......++..|+|||++.+..++ ++|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Diws 196 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWS 196 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHH
Confidence 76433221 11223457789999999888888 899998
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=230.22 Aligned_cols=178 Identities=29% Similarity=0.489 Sum_probs=143.9
Q ss_pred ceeccccceEEEEEEEe----CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe-CCeeEEEEEec
Q 003911 599 NILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNEKLLVFEYM 673 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 673 (787)
+.||+|+||.||+|... ++..||+|++... ......+.+.+|+.+++.++||||+++++++.. ++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999753 2457999987542 233446788899999999999999999998764 55678999999
Q ss_pred CCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCC
Q 003911 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (787)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 753 (787)
++|+|.+++... ....++..+..++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 80 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 80 KHGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 999999998541 2345777889999999999999997 899999999999999999999999999997653321
Q ss_pred Cc---eeeeeccccCcccccccccCCcC-cceeec
Q 003911 754 GS---IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 754 ~~---~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.. ......+++.|+|||++.+..++ ++|+||
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 187 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWS 187 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHH
Confidence 10 11123457789999999888887 999998
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-25 Score=231.61 Aligned_cols=184 Identities=28% Similarity=0.517 Sum_probs=153.9
Q ss_pred CCCcccceeccccceEEEEEEEe-----CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe--CCe
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNE 665 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 665 (787)
++|++.+.||+|+||.||+|.+. ++..||||++...... ...+++.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 46788899999999999999753 3688999999764332 356789999999999999999999999887 557
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.++||||+++++|.+++... ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||.
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred eEEEEecCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccc
Confidence 89999999999999998542 2258999999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCcee--eeeccccCcccccccccCCcC-cceeec
Q 003911 746 VRLAPEGKGSIE--TRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 746 a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+........... ....++..|+|||...+..++ ++|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~s 197 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWS 197 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHH
Confidence 987753322111 112345679999999888887 899998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-27 Score=226.44 Aligned_cols=180 Identities=28% Similarity=0.445 Sum_probs=151.3
Q ss_pred cccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC-----eeEEE
Q 003911 596 SEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-----EKLLV 669 (787)
Q Consensus 596 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv 669 (787)
+-.+.||-|+||.||.+.+ ++|+.||.|++..-..+-...+++-+|++++..++|.|++..++...-.. +.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3457899999999999965 48999999998764444455678899999999999999999998876543 46788
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
+|.| ..+|.+.+- ....++.+.+.-+.+||++||+|||+ .+|.||||||.|.|++.+...||+|||+|+..
T Consensus 136 TELm-QSDLHKIIV-----SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 136 TELM-QSDLHKIIV-----SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHH-Hhhhhheec-----cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEeccccccccc
Confidence 8988 457777662 34678888999999999999999998 89999999999999999999999999999987
Q ss_pred CCCCCceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
+.......+..+-|.+|+|||+++|. .|+ +.||||
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWS 243 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWS 243 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceeh
Confidence 66655555556679999999999987 566 899998
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=231.77 Aligned_cols=174 Identities=28% Similarity=0.413 Sum_probs=141.0
Q ss_pred eeccccceEEEEEEEe-CCcEEEEEEeecccccch-hHHHHHHHHHHHHh---cCCCccceEEeEEEeCCeeEEEEEecC
Q 003911 600 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGK-GLTEFKSEIAVLTK---VRHRHLVALLGHCLDGNEKLLVFEYMP 674 (787)
Q Consensus 600 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (787)
.||+|+||.||++... +++.+|+|.+........ ....+.+|..+++. .+||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 689999999876433322 22334444444433 479999999999999999999999999
Q ss_pred CCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCC
Q 003911 675 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754 (787)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 754 (787)
+++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 81 GGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 9999988743 2468999999999999999999998 899999999999999999999999999987654322
Q ss_pred ceeeeeccccCccccccccc-CCcC-cceeec
Q 003911 755 SIETRIAGTFGYLAPEYAVH-TRWS-SCSYWA 784 (787)
Q Consensus 755 ~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS 784 (787)
.....||..|+|||.+.+ ..++ ++|+||
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 181 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFS 181 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHH
Confidence 123468999999999864 4556 899998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=229.87 Aligned_cols=185 Identities=23% Similarity=0.432 Sum_probs=157.0
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+|++.+.||+|+||.||+|... +|..||+|.+..........+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999765 688999999876544445567888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC-cEEEeecccceecCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAPE 751 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~ 751 (787)
+++++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||||+||++++++ .+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999988542 22357899999999999999999998 8999999999999999875 469999999987654
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... ......|++.|+|||+..+..++ ++|+||.
T Consensus 155 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~sl 188 (257)
T cd08225 155 SME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSL 188 (257)
T ss_pred Ccc-cccccCCCccccCHHHHcCCCCCchhhHHHH
Confidence 322 22234689999999999888777 8999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=232.20 Aligned_cols=182 Identities=27% Similarity=0.418 Sum_probs=157.1
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|+..+.||+|++|.||+|... +++.||+|++.... .....+++.+|++++++++||||+++++.+...+..++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc-ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 36788899999999999999876 68999999987643 23456788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++... ...+++..+..++.|++.|++|||+ ..+++||||||+||++++++.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 80 YMDGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred ecCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 99999999988542 1568899999999999999999996 37999999999999999999999999999876543
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.... ...|+..|+|||++.+..++ ++|+||
T Consensus 154 ~~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~s 184 (265)
T cd06605 154 SLAK---TFVGTSSYMAPERIQGNDYSVKSDIWS 184 (265)
T ss_pred HHhh---cccCChhccCHHHHcCCCCCchhhHHH
Confidence 2211 15688999999999888888 899998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=233.20 Aligned_cols=180 Identities=27% Similarity=0.479 Sum_probs=155.2
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|+||.||++... ++..||+|.+... .....+.+.+|+.++++++||||+++++++...+..|+|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 57899999999999999999754 6889999998643 22335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++.+ ..+++.++..++.|++.|+.|||+ .+++||||||+||++++++.++|+|||++.....
T Consensus 97 ~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 97 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred cCCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999998843 357888999999999999999997 8999999999999999999999999999876644
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
... ......|++.|+|||++.+..++ ++|+||
T Consensus 168 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~s 200 (293)
T cd06647 168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200 (293)
T ss_pred ccc-ccccccCChhhcCchhhccCCCCchhhHHH
Confidence 332 22234688999999999888777 899998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=235.35 Aligned_cols=185 Identities=30% Similarity=0.430 Sum_probs=152.1
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC--CeeEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLL 668 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 668 (787)
.++|++.+.||+|+||.||+|... +|+.||+|+++...........+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357999999999999999999865 689999999876443333344567899999999999999999998765 46899
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||++ ++|.+++... ...+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||.+..
T Consensus 86 v~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 999996 5888877432 2468999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
....... .....+++.|+|||++.+. .++ ++|+||.
T Consensus 158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl 195 (309)
T cd07845 158 YGLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAV 195 (309)
T ss_pred cCCccCC-CCcccccccccChhhhcCCCCcCchHHHHHH
Confidence 6543222 2223468889999998764 455 8999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=228.73 Aligned_cols=177 Identities=37% Similarity=0.598 Sum_probs=149.4
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
++|++.+.||+|+||.||++.. +++.||+|.++... ..+.+.+|+.++++++||||+++++++... ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4688999999999999999975 58889999986522 346789999999999999999999998764 47999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++... ....+++..+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||.+......
T Consensus 80 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 80 MSKGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred CCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 9999999998542 22357899999999999999999997 89999999999999999999999999999765332
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
. .....+..|+|||++.+..++ ++|+||.
T Consensus 154 ~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl 183 (254)
T cd05083 154 V----DNSKLPVKWTAPEALKHKKFSSKSDVWSY 183 (254)
T ss_pred C----CCCCCCceecCHHHhccCCcCchhhHHHH
Confidence 1 112345679999999888887 8999983
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-25 Score=232.56 Aligned_cols=184 Identities=27% Similarity=0.399 Sum_probs=150.7
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|++|.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999865 78999999986644333445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC-CCcEEEeecccceecC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAP 750 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~ 750 (787)
|++ +++.+++.. ......++..+..++.||+.||+|||+ ++++||||||+||++++ ++.+||+|||++....
T Consensus 82 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDS---SPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHh---CCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 995 588777643 122346788888999999999999997 89999999999999985 5679999999997654
Q ss_pred CCCCceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
.... ......|++.|+|||++.+. .++ ++|+||
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~s 189 (294)
T PLN00009 155 IPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWS 189 (294)
T ss_pred CCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHH
Confidence 3221 11234578999999998764 345 899998
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-25 Score=230.63 Aligned_cols=180 Identities=24% Similarity=0.515 Sum_probs=154.3
Q ss_pred CCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcC---CCccceEEeEEEeCCeeEEE
Q 003911 594 NFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR---HRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv 669 (787)
.|++.+.||+|+||.||+|.. .+++.||+|.+.... .....+++.+|++++++++ |||++++++++......++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477889999999999999986 478999999987532 3445567889999999996 99999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.++|+|||.+...
T Consensus 81 ~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 81 MEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999988743 268899999999999999999997 89999999999999999999999999999877
Q ss_pred CCCCCceeeeeccccCcccccccccCC-cC-cceeec
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWA 784 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS 784 (787)
...... .....|+..|+|||.+.++. ++ ++|+||
T Consensus 152 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 187 (277)
T cd06917 152 NQNSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWS 187 (277)
T ss_pred CCCccc-cccccCCcceeCHHHhccCCccccchhHHH
Confidence 554322 23356899999999987643 45 899998
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-25 Score=230.53 Aligned_cols=184 Identities=27% Similarity=0.371 Sum_probs=155.5
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC--CeeEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLLV 669 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 669 (787)
++|+..+.||.|++|.||+|... +++.+|+|.+.... ......++.+|++++++++||||+++++++.+. +..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 46888999999999999999875 68899999987532 234567899999999999999999999998654 468999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|.+++..... ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 999999999988755333 23468889999999999999999998 89999999999999999999999999998765
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..... ....++..|+|||.+.+..++ ++|+||
T Consensus 156 ~~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~s 188 (287)
T cd06621 156 VNSLA---GTFTGTSFYMAPERIQGKPYSITSDVWS 188 (287)
T ss_pred ccccc---ccccCCccccCHHHhcCCCCCchhhHHH
Confidence 43221 234578899999999888888 899998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=230.24 Aligned_cols=187 Identities=28% Similarity=0.425 Sum_probs=155.1
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCC----
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN---- 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~---- 664 (787)
..++|++.+.||+|++|.||+|... +++.+++|++.... ...+++.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4578999999999999999999875 67899999987532 3456799999999999 7999999999997644
Q ss_pred --eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEee
Q 003911 665 --EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (787)
Q Consensus 665 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 742 (787)
..++||||+++++|.+++..... ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECC
Confidence 48999999999999998865332 23468899999999999999999997 8999999999999999999999999
Q ss_pred cccceecCCCCCceeeeeccccCcccccccccC-----CcC-cceeecC
Q 003911 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHT-----RWS-SCSYWAG 785 (787)
Q Consensus 743 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~-~~DiWS~ 785 (787)
||.+........ ......|++.|+|||++... .++ ++|+||-
T Consensus 157 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 204 (275)
T cd06608 157 FGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSL 204 (275)
T ss_pred Cccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHh
Confidence 999986644322 22335689999999998643 344 7999983
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-25 Score=228.19 Aligned_cols=175 Identities=28% Similarity=0.399 Sum_probs=151.5
Q ss_pred eccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCCCH
Q 003911 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (787)
Q Consensus 601 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (787)
||.|++|.||+|... +++.||+|++...... ....+.+.+|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999875 5899999999764332 34457899999999999999999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCceee
Q 003911 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 758 (787)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 758 (787)
.+++.. ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.++...... ...
T Consensus 81 ~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~ 150 (262)
T cd05572 81 WTILRD-----RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTW 150 (262)
T ss_pred HHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccc
Confidence 999854 2357889999999999999999997 899999999999999999999999999998765432 122
Q ss_pred eeccccCcccccccccCCcC-cceeecC
Q 003911 759 RIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 759 ~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
...|++.|+|||.+.+..++ ++|+||.
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~sl 178 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSL 178 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhh
Confidence 34689999999999888777 8999984
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-25 Score=225.44 Aligned_cols=183 Identities=30% Similarity=0.509 Sum_probs=159.6
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+|++.+.||+|++|.||+|... +++.|++|.+..........+.+.+|++++++++|||++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999765 688999999987654445667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++... ..+++..+..++.|++.|+.|||+ .+++||||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999988442 468999999999999999999997 89999999999999999999999999999877554
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... .....|+..|+|||...+..++ ++|+||.
T Consensus 153 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~l 185 (254)
T cd06627 153 SKD-DASVVGTPYWMAPEVIEMSGASTASDIWSL 185 (254)
T ss_pred ccc-ccccccchhhcCHhhhcCCCCCcchhHHHH
Confidence 322 2335689999999999877776 8999983
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=228.66 Aligned_cols=186 Identities=26% Similarity=0.494 Sum_probs=155.2
Q ss_pred CCcccceeccccceEEEEEEEeC--CcEEEEEEeeccc--------ccchhHHHHHHHHHHHHh-cCCCccceEEeEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELHD--GTKIAVKRMEAGV--------ISGKGLTEFKSEIAVLTK-VRHRHLVALLGHCLD 662 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 662 (787)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... .......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999998764 7889999886422 122344567788888875 699999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEee
Q 003911 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (787)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 742 (787)
.+..++||||+++++|.+++...... ...+++..++.++.|++.||.|||+ ..+++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988543322 3468899999999999999999995 36899999999999999999999999
Q ss_pred cccceecCCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 743 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
||.+....... ......|+..|+|||++.+..++ ++|+||
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~s 198 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWA 198 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHH
Confidence 99998765443 22345689999999999988887 899998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-26 Score=230.60 Aligned_cols=184 Identities=28% Similarity=0.403 Sum_probs=155.0
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (787)
..+|....+||+|+||.|..|+.+ +.+.+|||++++...- ....+--..|-++|+.- +-|.+++++.+|+.-+..|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 347888999999999999999765 6778999999886543 33344455677777776 67899999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+.||+|--++.. .+.+.+..+..+|..||-||-|||+ +|||.||||.+|||+|.+|++||+|||+++.
T Consensus 428 VMEyvnGGDLMyhiQQ-----~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ-----VGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred EEEEecCchhhhHHHH-----hcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccc
Confidence 9999999999888843 4567888899999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
---.. .....++|||.|+|||++..++|+ ++|-||
T Consensus 500 ni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa 535 (683)
T KOG0696|consen 500 NIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWA 535 (683)
T ss_pred cccCC-cceeeecCCCcccccceEEecccccchhHHH
Confidence 43332 344568999999999999999999 455554
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-26 Score=228.78 Aligned_cols=189 Identities=27% Similarity=0.410 Sum_probs=153.0
Q ss_pred hcCCCcccceeccccceEEEEE-EEeCCcEEEEEEeeccc-ccc----hhHHHHHHHHHHHHhcCCCccceEEeEEE-eC
Q 003911 591 VTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGV-ISG----KGLTEFKSEIAVLTKVRHRHLVALLGHCL-DG 663 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~-~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~ 663 (787)
..++|-...+||+|+|++||+| .+...+.||||+-.... +.. ...+...+|.+|-+.++||.||++|+|+. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3457888999999999999999 45578899999864322 111 12344678999999999999999999996 45
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC---CCCcEEE
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKV 740 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl 740 (787)
+..|-|+|||+|.+|.-+++. .+.+++.++..|+.||+.||.||.+. +.+|||-||||.|||+. .-|.+||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ccceeeeeecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 678899999999999988854 35789999999999999999999984 58999999999999995 3478999
Q ss_pred eecccceecCCCCCc------eeeeeccccCcccccccccC----CcC-cceeecC
Q 003911 741 ADFGLVRLAPEGKGS------IETRIAGTFGYLAPEYAVHT----RWS-SCSYWAG 785 (787)
Q Consensus 741 ~DFG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~-~~DiWS~ 785 (787)
+|||+++.+.+.... ..+...||..|.+||.+.-+ +.+ ++|+||-
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSv 670 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSV 670 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEee
Confidence 999999988665432 22456799999999987544 233 8999983
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=232.59 Aligned_cols=187 Identities=27% Similarity=0.371 Sum_probs=150.7
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|+..+.||+|+||.||++... +++.||+|++..... ......+.+|+.++.++. ||||+++++++..++..+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC-hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 35667789999999999999765 689999999875332 245667899999999996 999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+. +++.++...........+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9985 466554322222223568999999999999999999996 3589999999999999999999999999997654
Q ss_pred CCCCceeeeeccccCcccccccccC---CcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHT---RWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~-~~DiWS~ 785 (787)
.... .....|+..|+|||++.+. .++ ++|+||.
T Consensus 160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~sl 196 (288)
T cd06616 160 DSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSL 196 (288)
T ss_pred cCCc--cccccCccCccCHHHhccccccCCcchhhhhHH
Confidence 3321 1234589999999999776 466 8999983
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-25 Score=228.97 Aligned_cols=175 Identities=26% Similarity=0.388 Sum_probs=141.5
Q ss_pred eeccccceEEEEEEEe-CCcEEEEEEeecccccc-hhHHHHHHHHH---HHHhcCCCccceEEeEEEeCCeeEEEEEecC
Q 003911 600 ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-KGLTEFKSEIA---VLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 674 (787)
Q Consensus 600 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (787)
.||+|+||.||+|... +++.||+|.+....... .....+..|.. .++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 68999999987643332 11222333433 4444579999999999999999999999999
Q ss_pred CCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCC
Q 003911 675 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754 (787)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 754 (787)
+++|.+++.. ...+++..+..++.|+++|++|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 81 g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~- 151 (278)
T cd05606 81 GGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (278)
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence 9999888743 2468999999999999999999998 899999999999999999999999999987654322
Q ss_pred ceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 755 SIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 755 ~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
.....|+..|+|||++.++ .++ ++|+||.
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~ 182 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSL 182 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhH
Confidence 1234689999999998754 566 8999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=228.22 Aligned_cols=185 Identities=31% Similarity=0.486 Sum_probs=160.2
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+|++.+.||+|++|.||++... +++.+|+|.+...........++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5888999999999999999754 788999999987554555567888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++..... ....+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 999999999865332 23568999999999999999999997 89999999999999999999999999999876544
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
. .....|++.|+|||...+..++ ++|+||.
T Consensus 157 ~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~sl 187 (256)
T cd08530 157 M---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSL 187 (256)
T ss_pred C---cccccCCccccCHHHHCCCCCCchhhHHHH
Confidence 2 2224578999999999988888 8999983
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-25 Score=233.70 Aligned_cols=186 Identities=30% Similarity=0.446 Sum_probs=153.1
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC-----
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----- 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 664 (787)
..++|++.+.||+|+||.||+|... +++.||+|+++...........+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4568999999999999999999875 6899999999765433444567889999999999999999999987654
Q ss_pred -----eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEE
Q 003911 665 -----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 739 (787)
Q Consensus 665 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 739 (787)
..++|+||+++ ++...+.. ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+|
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEE
Confidence 78999999975 77666633 23468999999999999999999998 8999999999999999999999
Q ss_pred EeecccceecCCCCCceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 740 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 740 l~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
|+|||.+...............++..|+|||++.+. .++ ++|+||
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 203 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWS 203 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHH
Confidence 999999987654332222223468889999988654 345 899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=230.55 Aligned_cols=184 Identities=29% Similarity=0.453 Sum_probs=152.8
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+|++.+.||+|++|.||+|+.. +|+.||||+++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 5888999999999999999875 689999999876432 23346678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++ +|.+++..... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||.+......
T Consensus 80 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 80 MDK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred CCc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 974 88888754221 2468999999999999999999998 89999999999999999999999999999765432
Q ss_pred CCceeeeeccccCcccccccccCC-cC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS~ 785 (787)
.. ......++..|+|||++.+.. ++ ++|+||.
T Consensus 154 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 187 (284)
T cd07836 154 VN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSV 187 (284)
T ss_pred cc-ccccccccccccChHHhcCCCCCCcHHHHHHH
Confidence 21 112345788999999987653 44 8999983
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=233.57 Aligned_cols=185 Identities=26% Similarity=0.386 Sum_probs=150.2
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC------
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------ 664 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 664 (787)
.++|++.+.||+|+||.||+|... +++.||||++............+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999765 6899999998764433333456678999999999999999999987654
Q ss_pred --eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEee
Q 003911 665 --EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (787)
Q Consensus 665 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 742 (787)
..++||||+. +++.+.+.. ....+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECc
Confidence 3499999995 578777643 22368999999999999999999998 8999999999999999999999999
Q ss_pred cccceecCCCCCc---eeeeeccccCcccccccccCC-cC-cceeec
Q 003911 743 FGLVRLAPEGKGS---IETRIAGTFGYLAPEYAVHTR-WS-SCSYWA 784 (787)
Q Consensus 743 FG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS 784 (787)
||++......... ......++..|+|||++.+.. ++ ++|+||
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 209 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWG 209 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHH
Confidence 9999766433211 112345788999999987654 44 899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=223.56 Aligned_cols=183 Identities=26% Similarity=0.374 Sum_probs=155.0
Q ss_pred HhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-C-C----ccceEEeEEE
Q 003911 589 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-H-R----HLVALLGHCL 661 (787)
Q Consensus 589 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~~~~~~~ 661 (787)
....++|.+...+|+|+||.|-++..+ .+..||||+++. -.+..+...-|+++++++. + | -+|++.+||.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH---HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 344789999999999999999999654 578999999975 2445667788999999993 2 2 3788899999
Q ss_pred eCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC-------
Q 003911 662 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD------- 734 (787)
Q Consensus 662 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~------- 734 (787)
..++.|+|+|.+ |-++.+++.. .+..+++..++..|++|++++++|||+ .+++|-||||+|||+.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEe
Confidence 999999999998 7799999954 455689999999999999999999998 89999999999999832
Q ss_pred -------------CCcEEEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 735 -------------DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 735 -------------~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+..+||+|||.|....+.. +..+.|..|+|||++.+-.|+ +||+||.
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSi 295 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSI 295 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceee
Confidence 2358999999998765433 446789999999999999999 9999994
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=226.40 Aligned_cols=183 Identities=26% Similarity=0.448 Sum_probs=159.1
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|++|.||+|... +++.||+|++...... ....++.+|++.+.+++|+||+++++++...+..++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 36888999999999999999876 5999999998764322 456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++... ..+++..+..++.|+++|++|||+ ..+++||||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 80 YMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred ecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999998542 468999999999999999999995 27999999999999999999999999999987654
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..... ....++..|+|||.+.+..++ ++|+||
T Consensus 153 ~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~s 185 (264)
T cd06623 153 TLDQC-NTFVGTVTYMSPERIQGESYSYAADIWS 185 (264)
T ss_pred CCCcc-cceeecccccCHhhhCCCCCCchhhHHH
Confidence 43221 235688999999999888777 899998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-25 Score=236.33 Aligned_cols=186 Identities=26% Similarity=0.437 Sum_probs=153.9
Q ss_pred HHHHhhcCCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC-
Q 003911 586 QVLRNVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG- 663 (787)
Q Consensus 586 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 663 (787)
.++..+.++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+.+|++++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 45566778999999999999999999975 4789999999976433344456788999999999999999999988643
Q ss_pred -----CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcE
Q 003911 664 -----NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 738 (787)
Q Consensus 664 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 738 (787)
...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCE
Confidence 3467888877 7899877632 358899999999999999999998 899999999999999999999
Q ss_pred EEeecccceecCCCCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 739 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 739 kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
||+|||+++..... .....|+..|+|||.+.+ ..++ ++|+||.
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl 204 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 204 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHH
Confidence 99999998865332 123467899999999876 4555 8999983
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=230.69 Aligned_cols=172 Identities=22% Similarity=0.401 Sum_probs=142.1
Q ss_pred ceeccccceEEEEEEEe-C-------CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 599 NILGRGGFGTVYKGELH-D-------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
+.||+|+||.||+|... . ...||+|.+... .....+++.+|+.+++.++||||+++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 46999999999999753 2 234888877542 2334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc--------EEEee
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--------AKVAD 742 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~D 742 (787)
||+++|+|.+++.. ....+++..++.++.||+.||+|||+ ++|+||||||+||+++.++. ++++|
T Consensus 79 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 79 EYVKFGSLDTYLKK----NKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred ecCCCCcHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecc
Confidence 99999999999854 22357899999999999999999997 89999999999999987665 69999
Q ss_pred cccceecCCCCCceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 743 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
||.+...... ....++..|+|||++.+. .++ ++|+||
T Consensus 152 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Diws 190 (258)
T cd05078 152 PGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWS 190 (258)
T ss_pred cccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHH
Confidence 9988755322 124578899999999874 456 899998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=236.98 Aligned_cols=181 Identities=26% Similarity=0.448 Sum_probs=152.2
Q ss_pred hhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC----
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN---- 664 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 664 (787)
.+.++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|++++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 35678999999999999999999754 7899999998654434445567889999999999999999999987653
Q ss_pred --eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEee
Q 003911 665 --EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (787)
Q Consensus 665 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 742 (787)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.++|+|
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEee
Confidence 358999999 7799887732 368899999999999999999997 8999999999999999999999999
Q ss_pred cccceecCCCCCceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 743 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
||++....... ....+++.|+|||++.+. .++ ++|+||
T Consensus 162 fg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 201 (343)
T cd07880 162 FGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWS 201 (343)
T ss_pred cccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHH
Confidence 99998654322 234578999999998763 455 899998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=237.51 Aligned_cols=184 Identities=27% Similarity=0.452 Sum_probs=150.3
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC-----C
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----N 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 664 (787)
+.++|++.+.||+|+||.||+|... +|+.||+|++.... ......++.+|+.++++++||||+++++++... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 3578999999999999999999754 78999999986422 233456788899999999999999999987654 3
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..++|+||++ +++.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg 151 (336)
T cd07849 82 DVYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFG 151 (336)
T ss_pred eEEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECccc
Confidence 5799999996 588776632 468999999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCCc--eeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 745 LVRLAPEGKGS--IETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
+++........ ......||+.|+|||.+.+ ..++ ++|+||.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl 196 (336)
T cd07849 152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSV 196 (336)
T ss_pred ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHH
Confidence 99865432211 1123568999999998765 3456 8999983
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=228.42 Aligned_cols=183 Identities=29% Similarity=0.473 Sum_probs=158.3
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
..+.|+..+.||+|++|.||+|... ++..|++|++..... ..+.+.+|++++++++|+||+++++++...+..++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4567888999999999999999876 689999999976322 457789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.+...
T Consensus 94 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 94 MEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred EeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 99999999999986521 368999999999999999999997 89999999999999999999999999998765
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..... ......+++.|+|||++.+..++ ++|+||
T Consensus 167 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~s 201 (286)
T cd06614 167 TKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWS 201 (286)
T ss_pred ccchh-hhccccCCcccCCHhHhcCCCCCCccccHH
Confidence 43322 12234578899999999888877 899998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-25 Score=229.85 Aligned_cols=182 Identities=32% Similarity=0.530 Sum_probs=148.9
Q ss_pred ceeccccceEEEEEEEeC-------CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 599 NILGRGGFGTVYKGELHD-------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
+.||+|+||.||+|+..+ ++.+|+|.+... .......++.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc-cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 358999999999997642 257999988653 223446688999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC-----cEEEeecc
Q 003911 672 YMPQGTLSRHIFNWAEE--GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-----RAKVADFG 744 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DFG 744 (787)
|+++++|.+++...... ....+++.+++.++.|++.|++|||+ .+++|+||||+||+++.++ .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999653322 22347889999999999999999997 8999999999999999877 89999999
Q ss_pred cceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeec
Q 003911 745 LVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 745 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+++........ ......++..|+|||++.+..++ ++|+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 198 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWS 198 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHH
Confidence 99765432211 11123457889999999988888 899998
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=230.00 Aligned_cols=180 Identities=29% Similarity=0.450 Sum_probs=151.1
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
..|+..+.||+|+||.||+|... +++.||+|++..... .....+++.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56888999999999999999765 689999999865322 2344567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||++ |++.+.+.. ....+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.++|+|||++....
T Consensus 95 e~~~-g~l~~~~~~----~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEV----HKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHH----cccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9996 577766632 22468999999999999999999998 899999999999999999999999999987654
Q ss_pred CCCCceeeeeccccCcccccccc---cCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAV---HTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~-~~DiWS~ 785 (787)
... ...|++.|+|||++. ...++ ++|+||.
T Consensus 167 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~ 200 (307)
T cd06607 167 PAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200 (307)
T ss_pred CCC-----CccCCccccCceeeeccCCCCCCcccchHHH
Confidence 322 246788999999884 34455 8999983
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-25 Score=237.35 Aligned_cols=185 Identities=24% Similarity=0.411 Sum_probs=152.5
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe----CCee
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEK 666 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~ 666 (787)
.++|++.+.||+|++|.||+|... +++.||+|++............+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468999999999999999999765 69999999997644334456778899999999999999999998763 3467
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
++||||+. ++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccc
Confidence 99999995 688887732 2458999999999999999999997 89999999999999999999999999999
Q ss_pred eecCCCCCc---eeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 747 RLAPEGKGS---IETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
+........ ......|+..|+|||++.+ ..++ ++|+||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl 198 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSV 198 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHH
Confidence 765433211 1123568999999999866 3455 8999983
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=225.74 Aligned_cols=180 Identities=21% Similarity=0.287 Sum_probs=147.1
Q ss_pred HHHHhhcCCCccccee--ccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEE
Q 003911 586 QVLRNVTNNFSEENIL--GRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCL 661 (787)
Q Consensus 586 ~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 661 (787)
.+.....++|++.+.+ |+|+||.||++..+ ++..+|+|.+....... .|+.....+ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEe
Confidence 3444555677777776 99999999999764 68899999987532221 122222222 7999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC-cEEE
Q 003911 662 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKV 740 (787)
Q Consensus 662 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl 740 (787)
..+..++||||+++++|.+++.. ...+++.++..++.|+++|++|||+ .+++||||||+||+++.++ .++|
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l 151 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYL 151 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEE
Confidence 99999999999999999998853 1378999999999999999999997 8999999999999999888 9999
Q ss_pred eecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 741 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 741 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+|||.++...... ...|+..|+|||++.+..++ ++|+||.
T Consensus 152 ~dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 192 (267)
T PHA03390 152 CDYGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAV 192 (267)
T ss_pred ecCccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHH
Confidence 9999988664322 24589999999999988888 8999983
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=236.54 Aligned_cols=185 Identities=31% Similarity=0.466 Sum_probs=152.6
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeC--Cee
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG--NEK 666 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~ 666 (787)
+.++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999865 688999999865433344456778899999999 999999999998654 367
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
++||||++ ++|..++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+
T Consensus 85 ~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccch
Confidence 99999996 589887743 267888999999999999999998 89999999999999999999999999999
Q ss_pred eecCCCCC----ceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 747 RLAPEGKG----SIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
+....... .......||+.|+|||++.+. .++ ++|+||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~sl 199 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSV 199 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHH
Confidence 86644321 122345689999999988654 455 8999983
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=227.39 Aligned_cols=178 Identities=25% Similarity=0.453 Sum_probs=151.9
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEec
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (787)
|...+.||+|++|.||++... +++.+|+|++... .....+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 445578999999999999754 7899999988642 2233466889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCC
Q 003911 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (787)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 753 (787)
++++|.+++.. ..+++..+..++.|++.|++|||+ .+++||||||+||++++++.++|+|||.+.......
T Consensus 99 ~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 99 EGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred CCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 99999998843 357889999999999999999998 899999999999999999999999999887554322
Q ss_pred CceeeeeccccCcccccccccCCcC-cceeec
Q 003911 754 GSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
. ......|++.|+|||+..+..++ ++|+||
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 200 (285)
T cd06648 170 P-RRKSLVGTPYWMAPEVISRLPYGTEVDIWS 200 (285)
T ss_pred c-ccccccCCccccCHHHhcCCCCCCcccHHH
Confidence 1 12235689999999999888887 899998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=230.96 Aligned_cols=184 Identities=30% Similarity=0.476 Sum_probs=157.8
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCeeEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 669 (787)
++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|.+++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999765 799999999876432 2344567889999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 999999999998854 2368999999999999999999997 89999999999999999999999999998765
Q ss_pred CCCCC-------------------ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 750 PEGKG-------------------SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 750 ~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..... .......|+..|+|||+..+..++ ++|+||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~s 207 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWA 207 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHH
Confidence 44321 112234678999999999888777 899998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-25 Score=248.84 Aligned_cols=261 Identities=25% Similarity=0.296 Sum_probs=182.7
Q ss_pred EEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCC
Q 003911 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (787)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 149 (787)
-..|+|++++|+ .+|+.+. .+|+.|+|++|+|+.++. .+++|++|+|++|+|+.+|.. .++|++|+|++|
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~LP~---lp~~Lk~LdLs~N~LtsLP~l----p~sL~~L~Ls~N 272 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA---LPPELRTLEVSGNQLTSLPVL----PPGLLELSIFSN 272 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCCCC---CCCCCcEEEecCCccCcccCc----ccccceeeccCC
Confidence 457899999999 7898887 489999999999997543 258899999999999998752 478999999999
Q ss_pred CCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcC
Q 003911 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKL 229 (787)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~ 229 (787)
.++ .+|..+ ++|+.|++++|+|+.. |. .+++|++|+|++|+|++ +|...
T Consensus 273 ~L~--~Lp~lp---~~L~~L~Ls~N~Lt~L-P~-----~p~~L~~LdLS~N~L~~-Lp~lp------------------- 321 (788)
T PRK15387 273 PLT--HLPALP---SGLCKLWIFGNQLTSL-PV-----LPPGLQELSVSDNQLAS-LPALP------------------- 321 (788)
T ss_pred chh--hhhhch---hhcCEEECcCCccccc-cc-----cccccceeECCCCcccc-CCCCc-------------------
Confidence 998 566533 5788999999999854 43 34789999999999995 45422
Q ss_pred CCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCc
Q 003911 230 GGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS 309 (787)
Q Consensus 230 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 309 (787)
.+|+.|++++|+|++.+ .+ ..+|+.|+|++|+|+ .+|.. .++|+.|++++|+|++. |.+.
T Consensus 322 ----------~~L~~L~Ls~N~L~~LP-~l--p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~L-P~l~-- 381 (788)
T PRK15387 322 ----------SELCKLWAYNNQLTSLP-TL--PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTSL-PALP-- 381 (788)
T ss_pred ----------ccccccccccCcccccc-cc--ccccceEecCCCccC-CCCCC---CcccceehhhccccccC-cccc--
Confidence 23444455555554322 11 134555555555555 33332 13444455555555532 2211
Q ss_pred eeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchh
Q 003911 310 VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE 389 (787)
Q Consensus 310 ~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~ 389 (787)
..|+.+++++|.+..+|. ...+|+.|++++|+|++ +|..
T Consensus 382 ~~L~~LdLs~N~Lt~LP~----------------------------------------l~s~L~~LdLS~N~Lss-IP~l 420 (788)
T PRK15387 382 SGLKELIVSGNRLTSLPV----------------------------------------LPSELKELMVSGNRLTS-LPML 420 (788)
T ss_pred cccceEEecCCcccCCCC----------------------------------------cccCCCEEEccCCcCCC-CCcc
Confidence 233444444444433221 01268889999999985 6754
Q ss_pred hcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCC
Q 003911 390 FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436 (787)
Q Consensus 390 ~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~ 436 (787)
. .+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+|.+|.
T Consensus 421 ~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 421 P---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred h---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 3 46888999999999 8999999999999999999999998876
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-26 Score=237.71 Aligned_cols=182 Identities=26% Similarity=0.367 Sum_probs=159.3
Q ss_pred CCcccceeccccceEEEEEEEeCCc-EEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELHDGT-KIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
+++.+..||-|+||.|-.+..+... .+|+|++++... ..+..+.+..|-.+|..++.|.||++|..|.+....||.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4556678999999999998776333 489999987643 45566778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
-|-||.+...+++ .+.++..+...++..+++|++|||+ ++||.|||||+|.+++.+|.+||.|||+|+.+..
T Consensus 501 aClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 501 ACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999854 3578889999999999999999997 8999999999999999999999999999998866
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+. ..-.++|||.|.|||++.....+ ++|+||.
T Consensus 573 g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaL 605 (732)
T KOG0614|consen 573 GR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWAL 605 (732)
T ss_pred CC--ceeeecCCcccccchhhhccCcchhhHHHHH
Confidence 54 34458999999999999998888 9999983
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=235.47 Aligned_cols=182 Identities=30% Similarity=0.482 Sum_probs=155.6
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+.....+||-|-||.||.|.|+ -.-.||||.++.. ....++|.+|..+|+.++|||+|+++|+|......|||+||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 4455678999999999999886 4678999999763 34578999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
|..|+|.+|+++..+ ..++....+.+|.||..|++||.. +++|||||..+|+|+.++..|||+|||+++.+..+
T Consensus 345 M~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred ccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 999999999976433 346667788999999999999996 89999999999999999999999999999988655
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.........-...|.|||-+....++ ++|+|+
T Consensus 419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWA 451 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWA 451 (1157)
T ss_pred ceecccCccCcccccCcccccccccccchhhHH
Confidence 43222222224579999999999998 999997
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=251.27 Aligned_cols=183 Identities=23% Similarity=0.329 Sum_probs=154.1
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|.+.+.||+|+||.||+|... +++.||||+++.... .......+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57999999999999999999876 789999999976432 3344577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++.. ...+++..++.|+.||+.||+|||+ .+||||||||+|||++.++.+||+|||+++...
T Consensus 84 Ey~~g~~L~~li~~-----~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~ 155 (669)
T cd05610 84 EYLIGGDVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155 (669)
T ss_pred eCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence 99999999998853 2357888999999999999999997 799999999999999999999999999998765
Q ss_pred CCCCceeeeeccccCcccccccccCCcC--cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS--SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~DiWS 784 (787)
.... ......+|+.|+|||........ .+++||
T Consensus 156 ~~~~-~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s 190 (669)
T cd05610 156 NREL-NMMDILTTPSMAKPKNDYSRTPGQVLSLISS 190 (669)
T ss_pred CCcc-cccccccCccccCccccccCCCCceeeeeee
Confidence 4332 22346789999999976544333 455555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=229.36 Aligned_cols=183 Identities=25% Similarity=0.386 Sum_probs=152.9
Q ss_pred CCcccceeccccceEEEEEEEe----CCcEEEEEEeeccccc--chhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCee
Q 003911 594 NFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVIS--GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 666 (787)
+|++.+.||+|++|.||+|+.. +++.||||+++..... ....+.+.+|++++.++ +||+|+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999998642 5788999998753221 23446788999999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccc
Confidence 999999999999988843 2357889999999999999999997 89999999999999999999999999998
Q ss_pred eecCCCCCceeeeeccccCcccccccccCC--cC-cceeec
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTR--WS-SCSYWA 784 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~-~~DiWS 784 (787)
+..............|+..|+|||.+.+.. .+ ++|+||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~s 193 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWS 193 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHH
Confidence 765443322233356899999999987764 44 899998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=228.45 Aligned_cols=182 Identities=27% Similarity=0.430 Sum_probs=152.2
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEec
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (787)
|++.+.||+|++|.||+|... +|..||+|++............+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 667889999999999999764 7999999999765444444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCC
Q 003911 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (787)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 753 (787)
+ ++|.+++.... ...+++..+..++.|+++||+|||+ .+++||||+|+||++++++.++|+|||.++......
T Consensus 81 ~-~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 D-LDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred C-cCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 5 68988875421 1368999999999999999999997 899999999999999999999999999997654332
Q ss_pred CceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 754 GSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
.. .....+++.|+|||++.+. .++ ++|+||
T Consensus 154 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s 185 (283)
T cd07835 154 RT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWS 185 (283)
T ss_pred cc-cCccccccCCCCCceeecCcccCcHHHHHH
Confidence 21 1223568899999988765 445 899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.6e-25 Score=235.60 Aligned_cols=185 Identities=26% Similarity=0.442 Sum_probs=152.9
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC-----C
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----N 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 664 (787)
+.++|.+.+.||+|+||.||+|... +++.||||++...........++.+|+.+++.++||||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3467999999999999999999754 789999999876443444456778899999999999999999988654 3
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..++||||+. ++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCc
Confidence 4799999995 688887742 2468999999999999999999997 899999999999999999999999999
Q ss_pred cceecCCCCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
+++...... .......++..|+|||.+.+ ..++ ++|+||.
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 195 (337)
T cd07858 154 LARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSV 195 (337)
T ss_pred cccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHH
Confidence 998764432 22233567899999998865 3455 8999983
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=221.45 Aligned_cols=180 Identities=29% Similarity=0.515 Sum_probs=157.6
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++||+|+++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4778899999999999999875 789999999976432 4567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++... ...+++..+..++.|++.|++|||+ .+++||||+|+||++++++.++|+|||.+......
T Consensus 79 ~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 79 CSGGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCCCcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 9999999888542 1468999999999999999999997 89999999999999999999999999999876544
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.. .....|+..|+|||++.+..++ ++|+||
T Consensus 152 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s 182 (253)
T cd05122 152 KA--RNTMVGTPYWMAPEVINGKPYDYKADIWS 182 (253)
T ss_pred cc--ccceecCCcccCHHHHcCCCCCccccHHH
Confidence 32 2335689999999999888777 899998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=228.14 Aligned_cols=182 Identities=27% Similarity=0.406 Sum_probs=152.8
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC--CeeEEEEE
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLLVFE 671 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 671 (787)
|++.+.||+|++|.||+|... +++.+|+|++............+.+|++++++++|||++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667899999999999999876 589999999987543344456788999999999999999999999988 78999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|++ ++|.+++.. ....+++..++.++.|+++||+|||+ .+++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~~-~~l~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMD-HDLTGLLDS----PEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred ccc-ccHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 997 488887743 12468999999999999999999997 8999999999999999999999999999987755
Q ss_pred CCCceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
..........++..|+|||.+.+. .++ ++|+||
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~s 187 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWS 187 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHH
Confidence 432222334578899999987654 455 899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=228.45 Aligned_cols=176 Identities=25% Similarity=0.435 Sum_probs=150.5
Q ss_pred cceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCC
Q 003911 598 ENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (787)
...||+|+||.||++... +++.||+|++... .......+.+|+.+++.++|+||+++++++...+..++||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 467999999999999764 7899999988542 2334567899999999999999999999999999999999999999
Q ss_pred CHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCce
Q 003911 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSI 756 (787)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 756 (787)
+|.+++.. ..+++..+..++.|++.|++|||+ .+++||||||+||++++++.++|+|||++........ .
T Consensus 103 ~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~ 172 (292)
T cd06657 103 ALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 172 (292)
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-c
Confidence 99887632 357889999999999999999998 8999999999999999999999999999876543321 1
Q ss_pred eeeeccccCcccccccccCCcC-cceeecC
Q 003911 757 ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 757 ~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.....|++.|+|||++.+..++ ++|+||.
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl 202 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSL 202 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHH
Confidence 2335689999999999887777 8999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-27 Score=221.48 Aligned_cols=185 Identities=25% Similarity=0.410 Sum_probs=148.7
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe--------C
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--------G 663 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~ 663 (787)
..|+...+||+|.||+||+|+.+ +|+.||+|++-.+...........+|++++..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 35667788999999999999765 68889998765433333344567889999999999999999988753 2
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
...|+|+++|+. +|.-.+.+ ....++..++.+++.+++.||.|+|. ..|+|||+||+|+||+.++.+||+||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecc
Confidence 347999999964 78777733 23468899999999999999999997 89999999999999999999999999
Q ss_pred ccceecCCCCCc---eeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 744 GLVRLAPEGKGS---IETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
|+|+.+...... ..+..+-|..|++||.+.|. .|+ +.|+|.|
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgA 215 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGA 215 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhH
Confidence 999766443221 22334559999999999886 455 8999986
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=221.99 Aligned_cols=183 Identities=28% Similarity=0.461 Sum_probs=159.3
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC--CeeEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLLVF 670 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 670 (787)
+|++.+.||+|++|.||+|... +++.|++|++..........+.+.+|++++++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999876 789999999977544455678899999999999999999999999988 8899999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++... ..+++.++..++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 999999999988542 278999999999999999999998 899999999999999999999999999998775
Q ss_pred CCCCc-eeeeeccccCcccccccccCCcC-cceeec
Q 003911 751 EGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..... ......++..|+|||.+.+..++ ++|+||
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~s 188 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWS 188 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHH
Confidence 54321 12235688999999999888777 899998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=234.61 Aligned_cols=182 Identities=29% Similarity=0.452 Sum_probs=154.9
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC-----eeE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-----EKL 667 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 667 (787)
+|++.+.||+|++|.||+|... +++.||+|++..........+.+.+|+++++.++||||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999865 5899999999765433555678999999999999999999999998775 789
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+||||++ ++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||.+.
T Consensus 81 lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999997 588877743 2378999999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCC--ceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 748 LAPEGKG--SIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 748 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
....... .......+++.|+|||++.+. .++ ++|+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~s 192 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWS 192 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHH
Confidence 7655431 112335678999999999887 666 899998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=223.39 Aligned_cols=173 Identities=29% Similarity=0.438 Sum_probs=143.5
Q ss_pred ceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHH-hcCCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLT-KVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.||+|+||.||+|... +++.||+|++...... ......+..|..++. ..+|+||+++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999764 6899999998754322 222334455555444 45899999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 999998843 2367899999999999999999998 8999999999999999999999999999876533
Q ss_pred eeeeeccccCcccccccccCCcC-cceeec
Q 003911 756 IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.....|++.|+|||.+.+..++ ++|+||
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~s 178 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWS 178 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHH
Confidence 1234688999999999888777 899998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=232.01 Aligned_cols=180 Identities=18% Similarity=0.298 Sum_probs=146.3
Q ss_pred ceeccc--cceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRG--GFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.||+| +||+||+|+.. +|+.||+|++..........+.+++|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 89999999864 799999999876544455567899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
+++.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999886532 2358899999999999999999997 89999999999999999999999999865433221110
Q ss_pred e------eeeeccccCcccccccccC--CcC-cceeec
Q 003911 756 I------ETRIAGTFGYLAPEYAVHT--RWS-SCSYWA 784 (787)
Q Consensus 756 ~------~~~~~gt~~y~aPE~~~~~--~~~-~~DiWS 784 (787)
. .....++..|||||++.+. .++ ++|+||
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws 195 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYS 195 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHH
Confidence 0 0112346679999999774 345 899998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=231.77 Aligned_cols=183 Identities=27% Similarity=0.469 Sum_probs=152.6
Q ss_pred HhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe-CCee
Q 003911 589 RNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNEK 666 (787)
Q Consensus 589 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 666 (787)
..+.++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999755 79999999987644344455778899999999999999999999876 4578
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.++|+|||.+
T Consensus 86 ~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccc
Confidence 8999998 5688877732 357888888999999999999997 89999999999999999999999999998
Q ss_pred eecCCCCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
....... ....+++.|+|||.+.+ ..++ ++|+||.
T Consensus 156 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 192 (328)
T cd07856 156 RIQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSA 192 (328)
T ss_pred cccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHH
Confidence 7553321 23457889999998866 4556 8999983
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=242.34 Aligned_cols=180 Identities=28% Similarity=0.464 Sum_probs=151.7
Q ss_pred cccceeccccceEEEEEEEe-CC----cEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 596 SEENILGRGGFGTVYKGELH-DG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 596 ~~~~~lg~G~~g~Vy~~~~~-~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
+..++||+|+||+||+|.+- .| -+||+|++... ...+..+++.+|+-+|.+++|||+++++++|.... ..||+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34688999999999999653 34 46888988663 34556789999999999999999999999998776 78999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
+||+.|.|.++++. ....+.....+.|.+|||+|+.|||+ +++|||||.++||||..-..+||.|||+|+...
T Consensus 777 q~mP~G~LlDyvr~----hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE----HRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HhcccchHHHHHHH----hhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 99999999999965 33567888999999999999999997 899999999999999999999999999999876
Q ss_pred CCCCceeee-eccccCcccccccccCCcC-cceeec
Q 003911 751 EGKGSIETR-IAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~-~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
......... ..-.+.|||=|.+....|+ ++||||
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWs 885 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWS 885 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhh
Confidence 654332221 1224579999999999999 999998
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=225.23 Aligned_cols=176 Identities=27% Similarity=0.488 Sum_probs=150.1
Q ss_pred eccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCCCH
Q 003911 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (787)
Q Consensus 601 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (787)
||+|+||.||+++.. +++.+|+|++..... .....+.+.+|++++++++||||+++++.+......|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 599999999876432 234567889999999999999999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCC----
Q 003911 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG---- 754 (787)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---- 754 (787)
.+++... ..+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 9988542 368999999999999999999997 8999999999999999999999999999875533311
Q ss_pred ---ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 755 ---SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 755 ---~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.......++..|+|||...+..++ ++|+||
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~s 186 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWS 186 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHH
Confidence 122235678899999999888777 899998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=224.23 Aligned_cols=181 Identities=30% Similarity=0.470 Sum_probs=150.1
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc---CCCccceEEeEEEeCCe-----
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV---RHRHLVALLGHCLDGNE----- 665 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~----- 665 (787)
|++.+.||+|+||.||+|+.+ +++.||+|+++...........+.+|+++++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677899999999999999876 589999999976443333345667788877766 59999999999998776
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.+++|||+. ++|.+++... ....+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCc
Confidence 899999996 5888877542 12358999999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+........ .....++..|+|||++.+..++ ++|+||
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s 191 (287)
T cd07838 154 ARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWS 191 (287)
T ss_pred ceeccCCcc--cccccccccccChHHhccCCCCCcchhhh
Confidence 987644322 1234578899999999988887 899998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=226.11 Aligned_cols=168 Identities=27% Similarity=0.278 Sum_probs=131.1
Q ss_pred hhcCCCcccceeccccceEEEEEEEe--CCcEEEEEEeecccc---cchhHHHHHHHHHHHHhcCCCccce-EEeEEEeC
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVI---SGKGLTEFKSEIAVLTKVRHRHLVA-LLGHCLDG 663 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~ 663 (787)
...++|.+.+.||+|+||+||+|... +++.||||++..... .....+.+.+|++++++++|+|++. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34578999999999999999999764 577889998754211 2234567999999999999999985 4432
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC-CCCCEEECCCCcEEEee
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDL-KPSNILLGDDMRAKVAD 742 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~D 742 (787)
+..|+||||++|++|.... ... ...++.|+++||+|||+ +||+|||| ||+|||++.++.+||+|
T Consensus 91 ~~~~LVmE~~~G~~L~~~~---------~~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR---------PHG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred CCcEEEEEccCCCCHHHhC---------ccc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEE
Confidence 4579999999999996211 011 14678899999999998 89999999 99999999999999999
Q ss_pred cccceecCCCCCcee-------eeeccccCcccccccccCC
Q 003911 743 FGLVRLAPEGKGSIE-------TRIAGTFGYLAPEYAVHTR 776 (787)
Q Consensus 743 FG~a~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~ 776 (787)
||+|+.......... +...+++.|+|||++...+
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 999987654321111 2456889999999987654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=226.51 Aligned_cols=184 Identities=16% Similarity=0.180 Sum_probs=135.5
Q ss_pred cCCCcccceeccccceEEEEEEEeC----CcEEEEEEeecccccchh---------HHHHHHHHHHHHhcCCCccceEEe
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKG---------LTEFKSEIAVLTKVRHRHLVALLG 658 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~ 658 (787)
.++|++.+.||+|+||.||+|...+ +..+|+|+.......... ......+...+..++|++|+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999998653 445666654322111000 011223344556678999999999
Q ss_pred EEEeCC----eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC
Q 003911 659 HCLDGN----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 734 (787)
Q Consensus 659 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 734 (787)
++.... ..++++|++. .++.+.+.. ....++..+..++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR-----IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDG 161 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh-----hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcC
Confidence 776543 3467888774 466555532 1235678889999999999999997 89999999999999999
Q ss_pred CCcEEEeecccceecCCCCCc------eeeeeccccCcccccccccCCcC-cceeec
Q 003911 735 DMRAKVADFGLVRLAPEGKGS------IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 735 ~~~~kl~DFG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
++.++|+|||+|+........ ......||+.|+|||+..+..++ ++||||
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwS 218 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLES 218 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHH
Confidence 999999999999876432211 11224699999999999999888 899998
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-26 Score=241.35 Aligned_cols=185 Identities=30% Similarity=0.488 Sum_probs=158.7
Q ss_pred hhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
...++|+....+|.|+||.||||+.. +++..|+|+++.. ......-+++|+-+++.++||||+.+++.+...+..|+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeecc--CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 34578999999999999999999754 7999999999863 23455678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
.||||.+|+|++.-+ ...++++.++..+.+..++|++|||+ ++-+|||||-.||++++.|.+|++|||.+..
T Consensus 90 cMEycgggslQdiy~-----~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaq 161 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYH-----VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQ 161 (829)
T ss_pred EEEecCCCcccceee-----ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhh
Confidence 999999999988652 34689999999999999999999998 7889999999999999999999999999876
Q ss_pred cCCCCCceeeeeccccCcccccccc---cCCcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAV---HTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~-~~DiWS~ 785 (787)
+..... ....+.||++|||||+.. .+.|. .||||+-
T Consensus 162 itati~-KrksfiGtpywmapEvaaverkggynqlcdiwa~ 201 (829)
T KOG0576|consen 162 ITATIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAL 201 (829)
T ss_pred hhhhhh-hhhcccCCccccchhHHHHHhccccccccccccc
Confidence 654332 234478999999999973 34455 8999983
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=230.74 Aligned_cols=183 Identities=26% Similarity=0.382 Sum_probs=147.8
Q ss_pred CCcccceeccccceEEEEEEEe-C--CcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeC----Ce
Q 003911 594 NFSEENILGRGGFGTVYKGELH-D--GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG----NE 665 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~ 665 (787)
+|++.+.||+|+||.||+|+.. + +..||+|++..........+.+.+|+++++++ .||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999865 4 78899999875433333456788999999999 599999999875432 45
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.++++||+. ++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 788999885 688888742 3468899999999999999999997 8999999999999999999999999999
Q ss_pred ceecCCCCCc---eeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 746 VRLAPEGKGS---IETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
++........ ......||+.|+|||++.+. .++ ++|+||.
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~sl 196 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSV 196 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHH
Confidence 9866432211 12235689999999987663 455 8999983
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=226.29 Aligned_cols=178 Identities=29% Similarity=0.477 Sum_probs=149.3
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.|+..+.||+|+||.||+|... ++..||+|++..... ......++.+|++++++++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4777889999999999999764 689999999875322 23445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|++ |++.+.+.. ....+++.++..++.|++.|+.|||+ .+|+||||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~-g~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 106 YCL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCC-CCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 996 577776643 22468999999999999999999998 8999999999999999999999999999876533
Q ss_pred CCCceeeeeccccCcccccccc---cCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAV---HTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~-~~DiWS 784 (787)
. ....|++.|+|||++. ++.++ ++|+||
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~s 209 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWS 209 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHH
Confidence 2 2246889999999974 34455 899998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=229.79 Aligned_cols=185 Identities=28% Similarity=0.404 Sum_probs=149.4
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC------
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------ 664 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 664 (787)
.++|++.+.||+|+||.||+|... +++.||+|++............+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999865 6899999998765433333456788999999999999999999875433
Q ss_pred --eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEee
Q 003911 665 --EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (787)
Q Consensus 665 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 742 (787)
..++||||+.+ ++...+.. ....+++.++..++.|+++||+|||+ .+|+||||||+||++++++.++|+|
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECc
Confidence 46999999964 67666532 23468999999999999999999998 8999999999999999999999999
Q ss_pred cccceecCCCCCc----------eeeeeccccCcccccccccC-CcC-cceeec
Q 003911 743 FGLVRLAPEGKGS----------IETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 743 FG~a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
||+++........ ..+...|++.|+|||++.+. .++ ++|+||
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 212 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWG 212 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHH
Confidence 9999765432211 11234578899999988664 355 899998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=229.03 Aligned_cols=182 Identities=18% Similarity=0.224 Sum_probs=147.6
Q ss_pred cccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 596 SEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 596 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
.+.+.+|.|+++.||++.. +++.||||++..........+.+.+|++++++++||||+++++++...+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445555566655555544 699999999987545566678899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCC-
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG- 754 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 754 (787)
|+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 84 GSCEDLLKTHF---PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred CCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 99999986432 2357889999999999999999998 8999999999999999999999999998875533211
Q ss_pred -----ceeeeeccccCcccccccccC--CcC-cceeec
Q 003911 755 -----SIETRIAGTFGYLAPEYAVHT--RWS-SCSYWA 784 (787)
Q Consensus 755 -----~~~~~~~gt~~y~aPE~~~~~--~~~-~~DiWS 784 (787)
.......++..|+|||++.+. .++ ++|+||
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws 195 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYS 195 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHH
Confidence 111224578889999998764 455 899998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-25 Score=234.71 Aligned_cols=182 Identities=30% Similarity=0.528 Sum_probs=154.0
Q ss_pred CcccceeccccceEEEEEEEe--CCc--EEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 595 FSEENILGRGGFGTVYKGELH--DGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
....+.||+|.||.|++|.|. .|+ .||||.++...... ...+|.+|+.+|.+++|||++++||...+ ....|||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 345688999999999999875 343 58999998754433 67899999999999999999999999988 6678999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
|+++.|+|.+.+++ .....+-......++.|||.|+.||.+ +++|||||..+|+++-....|||+|||+.+.+.
T Consensus 190 ELaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 99999999999976 233567888899999999999999998 899999999999999988899999999999887
Q ss_pred CCCCceee--eeccccCcccccccccCCcC-cceeec
Q 003911 751 EGKGSIET--RIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
...+.... ...-...|+|||.+....++ ++|+|+
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWm 300 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWM 300 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhh
Confidence 66543321 11124579999999999999 999996
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=223.93 Aligned_cols=178 Identities=28% Similarity=0.370 Sum_probs=145.6
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeC--CeeEEEE
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDG--NEKLLVF 670 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~ 670 (787)
|++.+.||+|+||.||+|... +++.||+|+++...... ......+|+.+++++. |+||+++++++.+. +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 667889999999999999764 68999999987643222 2234457889999985 99999999999987 8899999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||++ +++.+.+.. ....+++.++..++.|++.||+|||+ .+++||||||+||++++ +.+||+|||.++...
T Consensus 80 e~~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 80 ELMD-MNLYELIKG----RKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred ecCC-ccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 9996 588777743 12468999999999999999999998 89999999999999999 999999999998764
Q ss_pred CCCCceeeeeccccCccccccccc-CCcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS 784 (787)
.... .....++..|+|||++.+ +.++ ++|+||
T Consensus 151 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 184 (282)
T cd07831 151 SKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWA 184 (282)
T ss_pred cCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHH
Confidence 3322 123457899999998754 4455 899998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=231.71 Aligned_cols=179 Identities=26% Similarity=0.457 Sum_probs=148.5
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC-----
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----- 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 664 (787)
..++|.+.+.||+|+||.||+|... +++.||+|++............+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3578999999999999999999764 7899999998764433444567889999999999999999999987543
Q ss_pred -eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 665 -EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 665 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
..++|+||+. .++..+. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+||
T Consensus 93 ~~~~lv~e~~~-~~l~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIM-------GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred ceEEEEecccc-cCHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeC
Confidence 4689999995 4666554 1257899999999999999999997 89999999999999999999999999
Q ss_pred ccceecCCCCCceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
|+++...... ....|++.|+|||++.+. .++ ++|+||
T Consensus 162 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 200 (342)
T cd07879 162 GLARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWS 200 (342)
T ss_pred CCCcCCCCCC----CCceeeecccChhhhcCccccCchHHHHH
Confidence 9987653321 234678999999998763 456 899998
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-25 Score=214.93 Aligned_cols=184 Identities=23% Similarity=0.413 Sum_probs=159.6
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (787)
.++|.+.++||+|+|+.|..++++ +.+.+|+|+++++... .+..+-.+.|-.+..+. +||.+|.+..+|+.....++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 357999999999999999999865 7888999999987554 44556677888888887 79999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
|.||++||+|--++.. .+.++++.+..+...|+-||.|||+ +|||.||+|.+|||+|..|++|++|+|+++.
T Consensus 329 vieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999777733 3568999999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
--.. +...+.++|||.|.|||+++|..|. .+|-|+
T Consensus 401 ~l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwa 436 (593)
T KOG0695|consen 401 GLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWA 436 (593)
T ss_pred CCCC-CcccccccCCCcccchhhhcccccCceehHHH
Confidence 4332 3345668999999999999999999 677665
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=224.83 Aligned_cols=182 Identities=27% Similarity=0.405 Sum_probs=154.5
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEec
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (787)
|++.+.||+|++|.||+|... +++.+++|++............+.+|++++++++|+||+++++++.+++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999765 7899999998765444445678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCC
Q 003911 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (787)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 753 (787)
++ ++.+++.. ....+++.++..++.|++.||+|||+ .+|+|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIKD----RQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHHh----hcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 65 88877743 12468999999999999999999998 899999999999999999999999999998775543
Q ss_pred CceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 754 GSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
.......++..|+|||.+.+. .++ ++|+||.
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~sl 185 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSV 185 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHH
Confidence 122234578899999998876 566 8999983
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=233.61 Aligned_cols=181 Identities=22% Similarity=0.277 Sum_probs=134.5
Q ss_pred hcCCCcccceeccccceEEEEEEE-----------------eCCcEEEEEEeeccccc------------chhHHHHHHH
Q 003911 591 VTNNFSEENILGRGGFGTVYKGEL-----------------HDGTKIAVKRMEAGVIS------------GKGLTEFKSE 641 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~------------~~~~~~~~~E 641 (787)
..++|++.++||+|+||.||+|.. ..++.||||++...... ....+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999953 23568999998642211 0011234457
Q ss_pred HHHHHhcCCCcc-----ceEEeEEEe--------CCeeEEEEEecCCCCHHHHHHhhhhc-------------------C
Q 003911 642 IAVLTKVRHRHL-----VALLGHCLD--------GNEKLLVFEYMPQGTLSRHIFNWAEE-------------------G 689 (787)
Q Consensus 642 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~ 689 (787)
+.++.+++|.++ ++++++|.. .+..|+||||+++++|.++++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 778888866554 677777753 35689999999999999998642110 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCceeeeeccccCcccc
Q 003911 690 LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769 (787)
Q Consensus 690 ~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aP 769 (787)
...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1235678899999999999999997 8999999999999999999999999999976543322111223358999999
Q ss_pred ccccc
Q 003911 770 EYAVH 774 (787)
Q Consensus 770 E~~~~ 774 (787)
|.+..
T Consensus 380 E~l~~ 384 (507)
T PLN03224 380 EELVM 384 (507)
T ss_pred hhhcC
Confidence 98754
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-24 Score=227.96 Aligned_cols=185 Identities=25% Similarity=0.383 Sum_probs=149.2
Q ss_pred cCCCc-ccceeccccceEEEEEEEe-CCcEEEEEEeecccccch------------hHHHHHHHHHHHHhcCCCccceEE
Q 003911 592 TNNFS-EENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGK------------GLTEFKSEIAVLTKVRHRHLVALL 657 (787)
Q Consensus 592 ~~~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~~~ 657 (787)
.++|. +.+.||+|+||+||+|... +++.||||+++....... ....+.+|++++++++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 45665 4577999999999999765 789999999875432210 112577899999999999999999
Q ss_pred eEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc
Q 003911 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (787)
Q Consensus 658 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 737 (787)
+++...+..++||||++ |+|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGI 157 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCC
Confidence 99999999999999996 689888743 2458899999999999999999997 89999999999999999999
Q ss_pred EEEeecccceecCCCC-------------CceeeeeccccCcccccccccCC-cC-cceeecC
Q 003911 738 AKVADFGLVRLAPEGK-------------GSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWAG 785 (787)
Q Consensus 738 ~kl~DFG~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS~ 785 (787)
++|+|||.++...... ........+++.|+|||++.+.. ++ ++|+||.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 220 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHH
Confidence 9999999997664110 01112234688999999987654 45 8999983
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-25 Score=247.08 Aligned_cols=372 Identities=21% Similarity=0.280 Sum_probs=248.9
Q ss_pred CEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccC
Q 003911 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (787)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 148 (787)
+++.||+++|.+. ..|..+..+.+|+.|+++.|.|...+-+..++.+|++|+|.+|++..+|.+ +..+.+|++||++.
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~~lP~~-~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQSLPAS-ISELKNLQYLDLSF 123 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhhcCchh-HHhhhcccccccch
Confidence 3889999999888 889999999999999999999998887899999999999999999988866 89999999999999
Q ss_pred CCCCCCCCChhhhcCCCCCEEeccCc-------------------eecccCCCCCCCCCCCCCcEEeccccccccCCCcC
Q 003911 149 NPFSSWEIPQSLRNASGLQNFSANSA-------------------NITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209 (787)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n-------------------~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 209 (787)
|++. .+|.-+..++.++.+.+++| .+.+.++.... .+.. .|+|.+|++....-..
T Consensus 124 N~f~--~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~--~l~~--~ldLr~N~~~~~dls~ 197 (1081)
T KOG0618|consen 124 NHFG--PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIY--NLTH--QLDLRYNEMEVLDLSN 197 (1081)
T ss_pred hccC--CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchh--hhhe--eeecccchhhhhhhhh
Confidence 9998 67776666666666666655 33333333222 2222 3777777765211111
Q ss_pred ccc--------ccccceeeccCCCCC------cCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcc
Q 003911 210 FSG--------SQIQSLWVNGQNGNA------KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFF 275 (787)
Q Consensus 210 ~~~--------~~l~~L~~~~~~~~~------~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l 275 (787)
+.. .++..+.+.+-+... .+. ..+.-.--.+|+.+++++|++++.+..+..+.+|+.|+..+|+|
T Consensus 198 ~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~-~~~~~p~p~nl~~~dis~n~l~~lp~wi~~~~nle~l~~n~N~l 276 (1081)
T KOG0618|consen 198 LANLEVLHCERNQLSELEISGPSLTALYADHNPLT-TLDVHPVPLNLQYLDISHNNLSNLPEWIGACANLEALNANHNRL 276 (1081)
T ss_pred ccchhhhhhhhcccceEEecCcchheeeeccCcce-eeccccccccceeeecchhhhhcchHHHHhcccceEecccchhH
Confidence 110 111122221111100 000 00111122468888888888888776677788888888888888
Q ss_pred cccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChh-------
Q 003911 276 TGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQR------- 348 (787)
Q Consensus 276 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~------- 348 (787)
+ .+|..+..+++|+.|++.+|.+.-.+|.......|+.|++..|.+...|.....-....+...........
T Consensus 277 ~-~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e 355 (1081)
T KOG0618|consen 277 V-ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEE 355 (1081)
T ss_pred H-hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccc
Confidence 6 78888888888888888888888888877778889999998888888776332222111111111000000
Q ss_pred -----hhcccCCCCCC-CCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCc----------
Q 003911 349 -----FAENWKGNDPC-SDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE---------- 412 (787)
Q Consensus 349 -----~~~~~~~~~~~-~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~---------- 412 (787)
+...+..++.. +.-+..+....+|+.|+|++|+|.......+.+++.|+.|+||+|+|+ .+|.
T Consensus 356 ~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~t 434 (1081)
T KOG0618|consen 356 NNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHT 434 (1081)
T ss_pred hhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHH
Confidence 00000111111 112233445578999999999988555555788888888888888876 3333
Q ss_pred ------------cCcCCCCCCeeeccCCcccc-cCCC---CCCCceeecCCCCCC
Q 003911 413 ------------GLSVLGALKELDVSNNQLYG-KIPS---FKSNAIVNTDGNPDI 451 (787)
Q Consensus 413 ------------~l~~l~~L~~L~Ls~N~l~g-~iP~---~~~~~~~~~~gn~~~ 451 (787)
++..++.|+.+|||.|+|+- .+|. .+.+..+++.||++.
T Consensus 435 L~ahsN~l~~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 435 LRAHSNQLLSFPELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred HhhcCCceeechhhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 56778889999999999984 3443 356788999999974
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=223.12 Aligned_cols=183 Identities=26% Similarity=0.418 Sum_probs=148.6
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||.||+|... +++.||||+++.... .....++..|++++.+. .||||+++++++.+....++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 357889999999999999999876 489999999976432 23345666777777777 499999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||++ +++.+.+... ...+++..+..++.|++.|++|||+ ..+|+||||+|+||++++++.+||+|||++...
T Consensus 93 ~e~~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 93 MELMS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eeccC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99984 5776665331 2368899999999999999999996 358999999999999999999999999998766
Q ss_pred CCCCCceeeeeccccCcccccccccCC----cC-cceeec
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTR----WS-SCSYWA 784 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~-~~DiWS 784 (787)
..... .....++..|+|||++.+.. ++ ++|+||
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~s 203 (296)
T cd06618 166 VDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWS 203 (296)
T ss_pred cCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHH
Confidence 43322 12235788999999997654 55 899998
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-24 Score=221.73 Aligned_cols=180 Identities=31% Similarity=0.467 Sum_probs=149.9
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCeeEEEEEe
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
|++.+.||+|++|.||+|... +++.||+|++...... .......+|+..+++++ ||||+++++++.+++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 667889999999999999875 5789999998764322 23334567999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+ +|+|.+++.... ...+++.++..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||.+......
T Consensus 80 ~-~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 80 M-EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred C-CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9 889988875421 2468999999999999999999998 89999999999999999999999999999876443
Q ss_pred CCceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
.. .....|+..|+|||++.+. .++ ++|+||
T Consensus 153 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s 184 (283)
T cd07830 153 PP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWA 184 (283)
T ss_pred CC--cCCCCCcccccCceeeecCcCcCCccchhh
Confidence 22 2235688999999988554 455 899998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-23 Score=221.32 Aligned_cols=177 Identities=28% Similarity=0.466 Sum_probs=147.8
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
|...+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999764 688999999875432 233446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+. |++.+++.. ....+++.++..++.|++.|++|||+ .+++||||||+||++++++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~ 174 (313)
T cd06633 103 CL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA 174 (313)
T ss_pred CC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC
Confidence 95 577776643 22468899999999999999999998 89999999999999999999999999998644221
Q ss_pred CCceeeeeccccCcccccccc---cCCcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAV---HTRWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~---~~~~~-~~DiWS 784 (787)
....|+..|+|||++. +..++ ++|+||
T Consensus 175 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s 205 (313)
T cd06633 175 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWS 205 (313)
T ss_pred -----CCccccccccChhhccccCCCCCCchhhHHH
Confidence 2356889999999984 34455 899998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=216.52 Aligned_cols=175 Identities=31% Similarity=0.472 Sum_probs=151.0
Q ss_pred eccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCCCH
Q 003911 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL 678 (787)
Q Consensus 601 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (787)
||+|+||.||++... +++.+|+|++...... ......+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999765 5899999998765432 23566889999999999999999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCceee
Q 003911 679 SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIET 758 (787)
Q Consensus 679 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 758 (787)
.+++.. ...+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (250)
T cd05123 81 FSHLSK-----EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTN 151 (250)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-ccc
Confidence 998843 2358899999999999999999997 8999999999999999999999999999987644321 223
Q ss_pred eeccccCcccccccccCCcC-cceeec
Q 003911 759 RIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 759 ~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
...|+..|+|||...+...+ ++|+||
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~s 178 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWS 178 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHH
Confidence 35688999999999888777 899998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-24 Score=219.60 Aligned_cols=185 Identities=25% Similarity=0.396 Sum_probs=150.8
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecc---cccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAG---VISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+|.+.+.||+|+||.||++... .+..+++|+++.. ........++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888899999999999999765 3455666665432 22233445677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|.+++...... ...+++.+++.++.|++.|++|||+ .+++|+||||+||++++ +.++|+|||.++..
T Consensus 81 ~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeec
Confidence 9999999999988654332 3468999999999999999999997 89999999999999975 56999999999876
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..... ......|++.|+|||...+..++ ++|+||
T Consensus 156 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~s 190 (260)
T cd08222 156 MGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWS 190 (260)
T ss_pred CCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHH
Confidence 44322 22235688999999999887777 899998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-24 Score=230.34 Aligned_cols=180 Identities=27% Similarity=0.444 Sum_probs=152.3
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe----
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE---- 665 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 665 (787)
+.++|++.+.||+|++|.||+|+.. +++.||+|++..........+.+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999875 68899999987643334445678889999999999999999998876654
Q ss_pred --eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 666 --KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 666 --~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.++|+||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 6799888743 468999999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCCceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
|++...... .....++..|+|||.+.+. .++ ++|+||
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dvws 201 (343)
T cd07851 163 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWS 201 (343)
T ss_pred ccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHH
Confidence 999866433 2234678899999998664 445 899998
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=222.29 Aligned_cols=179 Identities=28% Similarity=0.465 Sum_probs=149.3
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccc-ccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
+.|+..+.||+|+||.||+|... +++.||+|.+.... .......++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777889999999999999865 68899999986432 22344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+. |++.+.+.. ....+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 95 e~~~-~~l~~~~~~----~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 95 EYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EccC-CCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 9996 688776643 22457899999999999999999997 899999999999999999999999999987654
Q ss_pred CCCCceeeeeccccCccccccccc---CCcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVH---TRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~-~~DiWS 784 (787)
.. ....|++.|+|||++.+ ..++ ++|+||
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~s 199 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWS 199 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHH
Confidence 32 23467899999999753 3455 899998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=221.42 Aligned_cols=181 Identities=31% Similarity=0.450 Sum_probs=153.2
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEec
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (787)
|+..+.||+|++|.||+|... +++.||+|++..........+.+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999865 5999999999875434444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCC
Q 003911 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (787)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 753 (787)
+ ++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||+|+||++++++.++|+|||.++......
T Consensus 81 ~-~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 7 5899988542 1468899999999999999999998 899999999999999999999999999998764432
Q ss_pred CceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 754 GSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
.. .....++..|+|||++.+. .++ ++|+||
T Consensus 153 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~s 184 (282)
T cd07829 153 RT-YTHEVVTLWYRAPEILLGSKHYSTAVDIWS 184 (282)
T ss_pred cc-cCccccCcCcCChHHhcCCcCCCccccHHH
Confidence 21 2224467889999998776 666 899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-25 Score=223.33 Aligned_cols=256 Identities=25% Similarity=0.338 Sum_probs=203.7
Q ss_pred EEEcCC----------CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEccc-ccCCc
Q 003911 62 VVCIED----------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSN-NQFTS 129 (787)
Q Consensus 62 v~C~~~----------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~-N~l~~ 129 (787)
|.|+.. ...++|+|..|+|+..-|.+|+.+.+|++||||+|+|+.+-| +|.+|++|..|-+.+ |+|+.
T Consensus 51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~ 130 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD 130 (498)
T ss_pred EEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh
Confidence 788653 368999999999996667889999999999999999999888 799999987776655 99999
Q ss_pred CCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccc------
Q 003911 130 VPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI------ 203 (787)
Q Consensus 130 ~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~------ 203 (787)
++.++|++|..|+.|.+.-|++.- ...+.|..|++|..|.+.+|.+..+.-..|. .+..++.+.+..|.+.
T Consensus 131 l~k~~F~gL~slqrLllNan~i~C-ir~~al~dL~~l~lLslyDn~~q~i~~~tf~--~l~~i~tlhlA~np~icdCnL~ 207 (498)
T KOG4237|consen 131 LPKGAFGGLSSLQRLLLNANHINC-IRQDALRDLPSLSLLSLYDNKIQSICKGTFQ--GLAAIKTLHLAQNPFICDCNLP 207 (498)
T ss_pred hhhhHhhhHHHHHHHhcChhhhcc-hhHHHHHHhhhcchhcccchhhhhhcccccc--chhccchHhhhcCccccccccc
Confidence 999999999999999999999996 5578899999999999999999876666775 8899999999999832
Q ss_pred ------cCCCcCccccc---ccceeec-------------------cCCC-CCcCCCCc-cccccCccCceEeccccccc
Q 003911 204 ------GGLPASFSGSQ---IQSLWVN-------------------GQNG-NAKLGGGI-DVIQNMTSLKEIWLHSNAFS 253 (787)
Q Consensus 204 ------~~~p~~~~~~~---l~~L~~~-------------------~~~~-~~~~~~~~-~~~~~l~~L~~L~L~~N~l~ 253 (787)
...|..+++.. -..|+.. .... .......| ..|+.+++|+.|+|++|+++
T Consensus 208 wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~ 287 (498)
T KOG4237|consen 208 WLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKIT 287 (498)
T ss_pred hhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccc
Confidence 12232332210 0000000 0001 11222222 57999999999999999999
Q ss_pred cCCC-CCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCC-CCCceeeeccccCCC
Q 003911 254 GPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNN 320 (787)
Q Consensus 254 ~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~L~~l~~~~n 320 (787)
++-+ .|.++..++.|.|..|+|...-...|.++..|+.|+|.+|+|+..-|. |..+.+|..+++-.|
T Consensus 288 ~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~N 356 (498)
T KOG4237|consen 288 RIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSN 356 (498)
T ss_pred hhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccC
Confidence 8776 599999999999999999977778899999999999999999998776 555667777665554
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=240.53 Aligned_cols=187 Identities=28% Similarity=0.447 Sum_probs=155.9
Q ss_pred CCcccceeccccceEEEEEEEe----C----CcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCC
Q 003911 594 NFSEENILGRGGFGTVYKGELH----D----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 664 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 664 (787)
+..+.+.+|+|.||.|++|... . ...||||.++.... ....+.+..|+++|+.+ +|+||+.++|+|..++
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~-~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS-SSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccC-cHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 4455669999999999999643 1 45799999987543 47788999999999999 6999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhhh---------hcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWA---------EEGL--KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 733 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 733 (787)
..++|+||++.|+|.++++..+ .... ..+...+.+.++.|||.|++||++ .++|||||..+|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEec
Confidence 9999999999999999997755 1111 138889999999999999999998 8899999999999999
Q ss_pred CCCcEEEeecccceecCCCCCceeeeecc--ccCcccccccccCCcC-cceeec
Q 003911 734 DDMRAKVADFGLVRLAPEGKGSIETRIAG--TFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 734 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~-~~DiWS 784 (787)
++..+||+|||+|+..............| ...|||||.+....|+ ++|+||
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWS 506 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWS 506 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhH
Confidence 99999999999999765544333222223 3359999999999888 999998
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=226.23 Aligned_cols=181 Identities=24% Similarity=0.409 Sum_probs=146.5
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC-------
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------- 663 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------- 663 (787)
..+|++.+.||.|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 468999999999999999999764 68999999986643 24456788999999999999999999876543
Q ss_pred -------CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC-CC
Q 003911 664 -------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DD 735 (787)
Q Consensus 664 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~ 735 (787)
...++||||++ ++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||+++ ++
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~ 151 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTED 151 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCC
Confidence 35789999996 588877632 358899999999999999999997 8999999999999997 45
Q ss_pred CcEEEeecccceecCCCCCc--eeeeeccccCccccccccc-CCcC-cceeec
Q 003911 736 MRAKVADFGLVRLAPEGKGS--IETRIAGTFGYLAPEYAVH-TRWS-SCSYWA 784 (787)
Q Consensus 736 ~~~kl~DFG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS 784 (787)
+.+|++|||.++........ ......|+..|+|||++.+ ..++ ++||||
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwS 204 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 204 (342)
T ss_pred ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHH
Confidence 67899999999865432111 1122357889999998755 4455 899998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=212.83 Aligned_cols=163 Identities=20% Similarity=0.242 Sum_probs=136.8
Q ss_pred ccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCCCHHHHH
Q 003911 604 GGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI 682 (787)
Q Consensus 604 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l 682 (787)
|.+|.||+++.. +++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999764 78999999987632 2344555556667999999999999999999999999999999988
Q ss_pred HhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCceeeeecc
Q 003911 683 FNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG 762 (787)
Q Consensus 683 ~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~g 762 (787)
... ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.++++|||.+....... ....+
T Consensus 77 ~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~ 144 (237)
T cd05576 77 SKF-----LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAV 144 (237)
T ss_pred HHh-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCc
Confidence 542 358899999999999999999997 899999999999999999999999999876554321 22345
Q ss_pred ccCcccccccccCCcC-cceeecC
Q 003911 763 TFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 763 t~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+..|+|||+..+..++ ++|+||.
T Consensus 145 ~~~y~aPE~~~~~~~~~~~Dvwsl 168 (237)
T cd05576 145 ENMYCAPEVGGISEETEACDWWSL 168 (237)
T ss_pred CccccCCcccCCCCCCchhhHHHH
Confidence 7789999999887777 8999983
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.7e-23 Score=234.05 Aligned_cols=313 Identities=18% Similarity=0.263 Sum_probs=194.0
Q ss_pred ccCCChhHHHHHHHHHHhcCCCCCC-----CCCC-CCCCCccc----------------EEEcCCCCEEEEEeCCCCccc
Q 003911 25 SASGDDGDAAVMLALKKSLNPPESL-----GWSD-TDPCKWNH----------------VVCIEDKRITRIQIGHQNLQG 82 (787)
Q Consensus 25 ~~~~~~~d~~~l~~~k~~~~~~~~~-----~w~~-~~~C~w~g----------------v~C~~~~~v~~L~l~~~~l~~ 82 (787)
.+...+.+.+.++.+.+.+..|.-. +|++ +|.|.-.. |.|.. +.||.+..-+.-...
T Consensus 57 ~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~-~~vt~l~~~g~~~~~ 135 (754)
T PRK15370 57 PETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGG-KSVTYTRVTESEQAS 135 (754)
T ss_pred CCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCC-Ccccccccccccccc
Confidence 3455678999999999999777532 5864 57884332 66743 355655543311110
Q ss_pred c--------------------CCC--------C-----CCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCc
Q 003911 83 T--------------------LPS--------N-----LQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTS 129 (787)
Q Consensus 83 ~--------------------~~~--------~-----~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~ 129 (787)
. .+. + -+-..+...|+|++++++..+..+. +.|+.|+|++|+|+.
T Consensus 136 ~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~LtsLP~~Ip--~~L~~L~Ls~N~Lts 213 (754)
T PRK15370 136 SASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTTIPACIP--EQITTLILDNNELKS 213 (754)
T ss_pred cCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCcCCcccc--cCCcEEEecCCCCCc
Confidence 0 000 0 0112457788888888887655553 578888999998888
Q ss_pred CCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcC
Q 003911 130 VPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209 (787)
Q Consensus 130 ~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 209 (787)
+|...+ ++|++|+|++|+|+ .+|..+. .+|+.|++++|+++ .+|..+. ++|++|+|++|+|+ .+|..
T Consensus 214 LP~~l~---~nL~~L~Ls~N~Lt--sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~----s~L~~L~Ls~N~L~-~LP~~ 280 (754)
T PRK15370 214 LPENLQ---GNIKTLYANSNQLT--SIPATLP--DTIQEMELSINRIT-ELPERLP----SALQSLDLFHNKIS-CLPEN 280 (754)
T ss_pred CChhhc---cCCCEEECCCCccc--cCChhhh--ccccEEECcCCccC-cCChhHh----CCCCEEECcCCccC-ccccc
Confidence 877644 47888899988888 5676654 47888899988887 4565542 47888899988888 46654
Q ss_pred cccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCC
Q 003911 210 FSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESL 289 (787)
Q Consensus 210 ~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 289 (787)
+. ++|+.|+|++|+|++.++.+. ++|+.|++++|+|+ .+|..+. ++|
T Consensus 281 l~----------------------------~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL 327 (754)
T PRK15370 281 LP----------------------------EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLT-ALPETLP--PGL 327 (754)
T ss_pred cC----------------------------CCCcEEECCCCccccCcccch--hhHHHHHhcCCccc-cCCcccc--ccc
Confidence 42 356666666666665443332 35666666666666 3454332 456
Q ss_pred CEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCC
Q 003911 290 KIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTK 369 (787)
Q Consensus 290 ~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (787)
+.|++++|.|++.+..+. .+|+.+++++|.+..+|... .
T Consensus 328 ~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~~LP~~l---------------------------------------p 366 (754)
T PRK15370 328 KTLEAGENALTSLPASLP--PELQVLDVSKNQITVLPETL---------------------------------------P 366 (754)
T ss_pred eeccccCCccccCChhhc--CcccEEECCCCCCCcCChhh---------------------------------------c
Confidence 666666666665433222 24444444444443322110 0
Q ss_pred CceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccC----cCCCCCCeeeccCCccc
Q 003911 370 GNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL----SVLGALKELDVSNNQLY 431 (787)
Q Consensus 370 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l----~~l~~L~~L~Ls~N~l~ 431 (787)
++|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|..+ +.++.+..|+|.+|+|+
T Consensus 367 ~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 367 PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 25677777777777 4555554 25777777777777 555543 33466777777777775
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-23 Score=232.96 Aligned_cols=175 Identities=23% Similarity=0.263 Sum_probs=122.8
Q ss_pred hcCCCcccceeccccceEEEEEEEe-C----CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeE------
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-D----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH------ 659 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------ 659 (787)
..++|++.+.||+|+||.||+|... + +..||+|++..... .+....| .++...+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 4568999999999999999999875 4 68999998764211 1111111 1122222233222211
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHHhhhhc---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcC
Q 003911 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEE---------------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRD 724 (787)
Q Consensus 660 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 724 (787)
.......++||||+++++|.+++...... .........+..++.|++.||+|||+ ++|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCc
Confidence 23556789999999999999988542100 00011234466899999999999998 8999999
Q ss_pred CCCCCEEECC-CCcEEEeecccceecCCCCCceeeeeccccCccccccccc
Q 003911 725 LKPSNILLGD-DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVH 774 (787)
Q Consensus 725 lkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 774 (787)
|||+|||+++ ++.+||+|||+|+..............||+.|||||.+..
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~ 331 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM 331 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhc
Confidence 9999999985 5799999999998765444444455789999999997643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-23 Score=220.72 Aligned_cols=175 Identities=31% Similarity=0.456 Sum_probs=146.9
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (787)
+.+.|.+...+|.|+|+.|-++... +++..+||++.+. ..+..+|+.++... .||||+++.+.+.+..+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeecceecCCceeee
Confidence 4677888899999999999888654 7889999999764 23446778777777 69999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE-CCCCcEEEeecccce
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVR 747 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DFG~a~ 747 (787)
|||++.|+-+.+.+.. .+.....+..|+.+|+.|+.|||+ +||||||+||+|||+ +..++++|+|||.++
T Consensus 394 v~e~l~g~ell~ri~~------~~~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRS------KPEFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eehhccccHHHHHHHh------cchhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhh
Confidence 9999999988877743 122226677899999999999998 899999999999999 588999999999998
Q ss_pred ecCCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 748 LAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..... ....+-|..|.|||+.....|+ +||+||
T Consensus 465 ~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WS 498 (612)
T KOG0603|consen 465 ELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWS 498 (612)
T ss_pred hCchh----hcccchhhcccChhhhccCCCCcchhhHH
Confidence 77554 1123458899999999999999 899998
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=231.04 Aligned_cols=247 Identities=23% Similarity=0.222 Sum_probs=192.3
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEcc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 147 (787)
.+++.|++.+|+|+ .+|.. +++|++|+|++|+|+.+++. .++|+.|+|++|.|+.++.. .++|+.|+|+
T Consensus 222 ~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~LtsLP~l---p~sL~~L~Ls~N~L~~Lp~l----p~~L~~L~Ls 290 (788)
T PRK15387 222 AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTSLPVL---PPGLLELSIFSNPLTHLPAL----PSGLCKLWIF 290 (788)
T ss_pred cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCcccCc---ccccceeeccCCchhhhhhc----hhhcCEEECc
Confidence 36899999999999 57753 58899999999999976542 46899999999999988752 3678999999
Q ss_pred CCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCC
Q 003911 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (787)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~ 227 (787)
+|+++ .+|.. +++|+.|++++|+|++. |.. ..+|+.|++++|+|++ +|..
T Consensus 291 ~N~Lt--~LP~~---p~~L~~LdLS~N~L~~L-p~l-----p~~L~~L~Ls~N~L~~-LP~l------------------ 340 (788)
T PRK15387 291 GNQLT--SLPVL---PPGLQELSVSDNQLASL-PAL-----PSELCKLWAYNNQLTS-LPTL------------------ 340 (788)
T ss_pred CCccc--ccccc---ccccceeECCCCccccC-CCC-----cccccccccccCcccc-cccc------------------
Confidence 99999 56653 47899999999999974 442 2468889999999984 5531
Q ss_pred cCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCC
Q 003911 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFD 307 (787)
Q Consensus 228 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 307 (787)
..+|+.|+|++|+|++.++. ..+|+.|++++|+|+ .+|.. .++|+.|+|++|+|++.++..
T Consensus 341 -----------p~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt~LP~l~- 401 (788)
T PRK15387 341 -----------PSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTSLPVLP- 401 (788)
T ss_pred -----------ccccceEecCCCccCCCCCC---Ccccceehhhccccc-cCccc---ccccceEEecCCcccCCCCcc-
Confidence 24688888888888875542 256778888888888 56754 357888888888888644332
Q ss_pred CceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCc
Q 003911 308 RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS 387 (787)
Q Consensus 308 ~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p 387 (787)
..|..+++++|.+..+|.. ..+|+.|+|++|+|+ .+|
T Consensus 402 --s~L~~LdLS~N~LssIP~l----------------------------------------~~~L~~L~Ls~NqLt-~LP 438 (788)
T PRK15387 402 --SELKELMVSGNRLTSLPML----------------------------------------PSGLLSLSVYRNQLT-RLP 438 (788)
T ss_pred --cCCCEEEccCCcCCCCCcc----------------------------------------hhhhhhhhhccCccc-ccC
Confidence 3566777888877655421 125778999999998 789
Q ss_pred hhhcCCCCCCEEecccccccccCCccCcCC
Q 003911 388 PEFASFKSLQRLILADNNLSGMIPEGLSVL 417 (787)
Q Consensus 388 ~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l 417 (787)
..|+++++|+.|+|++|+|+|.+|..+..+
T Consensus 439 ~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 439 ESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred hHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 999999999999999999999988877443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-23 Score=224.55 Aligned_cols=180 Identities=30% Similarity=0.431 Sum_probs=144.5
Q ss_pred CcccceeccccceE-EEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEEEe
Q 003911 595 FSEENILGRGGFGT-VYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 595 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
|.-.+++|.|+.|+ ||+|... |+.||||++-.+ .....++|+..++.- +|||||++++.-.++...||..|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 44457799999875 7999886 899999988653 345678999999998 699999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC---C--CcEEEeecccce
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---D--MRAKVADFGLVR 747 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DFG~a~ 747 (787)
| ..+|.+++..... ..........+.+..|+++||++||+ .+||||||||.||||+. + .+++|+|||+++
T Consensus 585 C-~~sL~dlie~~~~-d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGL-DVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred h-hhhHHHHHhcccc-chhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 9 5699999965311 11111113456789999999999998 89999999999999975 2 478999999999
Q ss_pred ecCCCCCcee--eeeccccCcccccccccCCcC-cceeecC
Q 003911 748 LAPEGKGSIE--TRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
....+..... ....||.+|+|||++...+.+ ++||+|.
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFsl 700 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSL 700 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhc
Confidence 8876654332 346799999999999988777 8999984
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-23 Score=193.69 Aligned_cols=175 Identities=22% Similarity=0.419 Sum_probs=146.7
Q ss_pred cCCCcccceeccccceEEEEEE-EeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCC--eeE
Q 003911 592 TNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGN--EKL 667 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~~ 667 (787)
.++|++.+++|+|.+++||.|. ..+.++++||+++. ...+.+.+|+.+++.++ ||||+++++...++. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 4689999999999999999996 45789999999875 23568899999999997 999999999998765 457
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC-CCcEEEeecccc
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLV 746 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a 746 (787)
+|+||+.+.+..... ..++...+..++.++++||.|+|+ +||+|||+||.|+++|. .-.++|+|+|+|
T Consensus 112 LiFE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred hHhhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchH
Confidence 999999988876554 346677788999999999999998 99999999999999995 456999999999
Q ss_pred eecCCCCCceeeeeccccCcccccccccC-CcC-cceeec
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWA 784 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS 784 (787)
.++.++.. ....+.+..|--||.+..- .|+ +-|+||
T Consensus 181 EFYHp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS 218 (338)
T KOG0668|consen 181 EFYHPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWS 218 (338)
T ss_pred hhcCCCce--eeeeeehhhcCCchheeechhccccHHHHH
Confidence 98866542 2334567889999998765 455 899998
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-23 Score=202.52 Aligned_cols=178 Identities=26% Similarity=0.388 Sum_probs=150.6
Q ss_pred CCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC------e
Q 003911 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------E 665 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~ 665 (787)
.+|.-.+.+|.|.- .|..|-+ -.++.||+|++..........++..+|..++..+.|+||++++.++.-.. +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777788999988 5555533 36899999998776656667788899999999999999999999987543 5
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.|+||||| ..+|...+. ..++-+++..|.+|++.|++|||+ .+|+||||||+||++..+..+||.|||+
T Consensus 96 ~y~v~e~m-~~nl~~vi~-------~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL-------MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HHHHHHhh-hhHHHHHHH-------HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchh
Confidence 69999999 569988875 246778899999999999999998 9999999999999999999999999999
Q ss_pred ceecCCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
|+..... -..+.++.|..|.|||++.+..|. .+||||
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwS 202 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWS 202 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCCcccchhhh
Confidence 9865443 244667889999999999998888 899998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=197.61 Aligned_cols=182 Identities=34% Similarity=0.492 Sum_probs=153.4
Q ss_pred CcccceeccccceEEEEEEEeC-CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEec
Q 003911 595 FSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (787)
|++.+.||+|++|.||++...+ ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 5667899999999999998764 899999998764322 25678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCC
Q 003911 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (787)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 753 (787)
++++|.+++.... ..+++..+..++.+++.++.|||+ .+++|+|++|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 80 EGGDLFDYLRKKG----GKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 9999999885421 117889999999999999999997 799999999999999999999999999998775543
Q ss_pred CceeeeeccccCccccccc-ccCCcC-cceeec
Q 003911 754 GSIETRIAGTFGYLAPEYA-VHTRWS-SCSYWA 784 (787)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~-~~~~~~-~~DiWS 784 (787)
........++..|++||.. ....++ ++|+||
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~ 185 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWS 185 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHH
Confidence 1122335678899999998 555555 899998
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-22 Score=199.71 Aligned_cols=198 Identities=19% Similarity=0.289 Sum_probs=159.5
Q ss_pred eeHHHHHhhcCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceE
Q 003911 583 ISIQVLRNVTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656 (787)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 656 (787)
...+++.....+++...++.+|.||.||+|.+. +.+.|-||.++. ..++-....+..|...+..+.|||+..+
T Consensus 274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccce
Confidence 345666667778999999999999999999543 345677787765 3455666788999999999999999999
Q ss_pred EeEEEeC-CeeEEEEEecCCCCHHHHHHhhhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 003911 657 LGHCLDG-NEKLLVFEYMPQGTLSRHIFNWAE---EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (787)
Q Consensus 657 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 732 (787)
.+++.+. ...+.++.++.-|+|..++...+. ...+.+.-.+...++.|++.|++|||. .+|||.||..+|++|
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvI 429 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVI 429 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhccee
Confidence 9998754 557888999999999999974322 223456777889999999999999997 899999999999999
Q ss_pred CCCCcEEEeecccceecCCCCCcee-eeeccccCcccccccccCCcC-cceeec
Q 003911 733 GDDMRAKVADFGLVRLAPEGKGSIE-TRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 733 ~~~~~~kl~DFG~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
|+..++||+|=.+++..-+.+.+.- ........||+||.+....|+ ++|+||
T Consensus 430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWs 483 (563)
T KOG1024|consen 430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWS 483 (563)
T ss_pred hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHH
Confidence 9999999999999987655432211 112235689999999999998 899998
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=190.87 Aligned_cols=143 Identities=18% Similarity=0.216 Sum_probs=110.5
Q ss_pred cceeccccceEEEEEEEeCCcEEEEEEeecccccchh------------------------HHHHHHHHHHHHhcCCCcc
Q 003911 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKG------------------------LTEFKSEIAVLTKVRHRHL 653 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~ni 653 (787)
.+.||+|+||.||+|...+|+.||||+++........ ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999998878999999999764321111 1123459999999988877
Q ss_pred ceEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEcCCCCCCEEE
Q 003911 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL-HGLAHQSFIHRDLKPSNILL 732 (787)
Q Consensus 654 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~ivH~Dlkp~NIll 732 (787)
.....+.. ...++||||++++++...... ...+++.++..++.|++.+|+|+ |+ .+|+||||||+||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEE
Confidence 54443322 224899999998877544311 23678899999999999999999 66 799999999999999
Q ss_pred CCCCcEEEeecccceecCC
Q 003911 733 GDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 733 ~~~~~~kl~DFG~a~~~~~ 751 (787)
+ ++.++|+|||+|.....
T Consensus 152 ~-~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred E-CCcEEEEEccccccCCC
Confidence 8 47899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.7e-22 Score=203.41 Aligned_cols=193 Identities=22% Similarity=0.296 Sum_probs=161.3
Q ss_pred eeeeHHHHHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC------CCcc
Q 003911 581 MVISIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR------HRHL 653 (787)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~ni 653 (787)
-.+.+...+..-.+|.+....|+|-|++|.+|... .|+.||||+|.... ...+.=.+|+++|+++. -.|+
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHH
Confidence 35666666777889999999999999999999754 58899999998643 22344568999999994 3589
Q ss_pred ceEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC
Q 003911 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 733 (787)
Q Consensus 654 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 733 (787)
++++..|....+.|||+|-+ .-+|.++++.+... -.+....+..++.|+.-||..|.. .+|+|.||||+|||++
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVN 570 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVN 570 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEec
Confidence 99999999999999999988 56999999876543 357788899999999999999996 8999999999999999
Q ss_pred CC-CcEEEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 734 DD-MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 734 ~~-~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+. ..+||||||.|....+.. .+.+.-+..|.|||++.|-+|+ +-|+||.
T Consensus 571 E~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSv 621 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSV 621 (752)
T ss_pred cCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceee
Confidence 65 457999999998876543 2334457789999999999999 9999994
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-20 Score=231.35 Aligned_cols=307 Identities=19% Similarity=0.193 Sum_probs=169.6
Q ss_pred CCEEEEEeCCC------CccccCCCCCCCCC-CCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCC
Q 003911 68 KRITRIQIGHQ------NLQGTLPSNLQNLT-KLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSS 140 (787)
Q Consensus 68 ~~v~~L~l~~~------~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 140 (787)
.++..|.+..+ ++...+|..|..++ +|+.|++.+|.+...+..| .+.+|++|+|++|++..++.. +..+++
T Consensus 558 ~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~~L~~~-~~~l~~ 635 (1153)
T PLN03210 558 RNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLEKLWDG-VHSLTG 635 (1153)
T ss_pred ccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCcC-CccCCcEEECcCccccccccc-cccCCC
Confidence 34555655433 23334555555553 4666666666665554444 356666666666666665443 456666
Q ss_pred CcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceee
Q 003911 141 LQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWV 220 (787)
Q Consensus 141 L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~ 220 (787)
|++|+|++|.... .+|. +..+++|+.|++++|.....+|..++ .+++|+.|++++|...+.+|..+...+|+.|.+
T Consensus 636 Lk~L~Ls~~~~l~-~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~--~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~L 711 (1153)
T PLN03210 636 LRNIDLRGSKNLK-EIPD-LSMATNLETLKLSDCSSLVELPSSIQ--YLNKLEDLDMSRCENLEILPTGINLKSLYRLNL 711 (1153)
T ss_pred CCEEECCCCCCcC-cCCc-cccCCcccEEEecCCCCccccchhhh--ccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeC
Confidence 6666666554222 4443 55666666666666655555666554 666666666666554445555443344555554
Q ss_pred ccCCCCCcCCCCccccccCccCceEeccccccccCCCCC------------------------------CCCCCCCEEec
Q 003911 221 NGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDF------------------------------SGVKQLESLSL 270 (787)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~------------------------------~~l~~L~~L~L 270 (787)
.++.. +...|+ ..++|+.|+|++|.++..+..+ ...++|+.|+|
T Consensus 712 sgc~~---L~~~p~---~~~nL~~L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~L 785 (1153)
T PLN03210 712 SGCSR---LKSFPD---ISTNISWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFL 785 (1153)
T ss_pred CCCCC---cccccc---ccCCcCeeecCCCccccccccccccccccccccccchhhccccccccchhhhhccccchheeC
Confidence 44322 222221 1245566666666655433221 11345666777
Q ss_pred CCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCC-CCCCCCchhhHHHHHHHHhCCChhh
Q 003911 271 RDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLP-SPGACDPRLNALLSVVKLMGYPQRF 349 (787)
Q Consensus 271 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~ 349 (787)
++|...+.+|.+++++++|+.|+|++|..-+.+|....+.+|+.++++++.... +|
T Consensus 786 s~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p----------------------- 842 (1153)
T PLN03210 786 SDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFP----------------------- 842 (1153)
T ss_pred CCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcccccc-----------------------
Confidence 766666567777777777777777765433344443345555555555432110 00
Q ss_pred hcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEeccc-ccccccCCccCcCCCCCCeeeccCC
Q 003911 350 AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILAD-NNLSGMIPEGLSVLGALKELDVSNN 428 (787)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~-N~l~g~ip~~l~~l~~L~~L~Ls~N 428 (787)
....+|+.|+|++|.++ .+|.++..+++|+.|+|++ |+|. .+|..+..+++|+.++++++
T Consensus 843 -----------------~~~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 843 -----------------DISTNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred -----------------ccccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 01125666666666665 4566666666677777666 3344 46666666666666666665
|
syringae 6; Provisional |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=200.97 Aligned_cols=131 Identities=30% Similarity=0.435 Sum_probs=113.0
Q ss_pred CCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-----C---CccceEEeEEEe-
Q 003911 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-----H---RHLVALLGHCLD- 662 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~- 662 (787)
.+|.+.++||-|.|++||+|.+ .+.+.||+|+.+. .....+....||++|++++ | ..||+++++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 7899999999999999999954 5788999999976 3344567789999999994 3 369999999975
Q ss_pred ---CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 003911 663 ---GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (787)
Q Consensus 663 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 732 (787)
+.++|||+|++ |.+|..+|.. ...+.++...+..|++||+.||.|||. +.+|||-||||+|||+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~---s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKY---SNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHH---hCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 45789999999 7799888865 445678999999999999999999998 5799999999999999
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-22 Score=201.67 Aligned_cols=186 Identities=23% Similarity=0.358 Sum_probs=151.3
Q ss_pred HHHHHhhcCCCcccceeccccceEEEEEEEe----CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeE
Q 003911 585 IQVLRNVTNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGH 659 (787)
Q Consensus 585 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 659 (787)
.+......+.|..+++||+|.|++||+|... ..+.||+|.+... ....++..|++++..+ .+.||+++.++
T Consensus 28 ~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~ 103 (418)
T KOG1167|consen 28 RQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGC 103 (418)
T ss_pred HhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhh
Confidence 3445667788999999999999999999543 4678999988652 2346789999999999 59999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC-CCCcE
Q 003911 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRA 738 (787)
Q Consensus 660 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~ 738 (787)
+...+...+|+||++..+..++.. .++...+..+++.+..||+++|. .|||||||||+|++.+ +.++-
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg 172 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRG 172 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCc
Confidence 999999999999999988888773 46678899999999999999997 9999999999999998 45678
Q ss_pred EEeecccceecCCC---------------------------------CCc----------eeeeeccccCcccccccccC
Q 003911 739 KVADFGLVRLAPEG---------------------------------KGS----------IETRIAGTFGYLAPEYAVHT 775 (787)
Q Consensus 739 kl~DFG~a~~~~~~---------------------------------~~~----------~~~~~~gt~~y~aPE~~~~~ 775 (787)
.|+|||+|...... .+. .....+||++|+|||++...
T Consensus 173 ~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~ 252 (418)
T KOG1167|consen 173 VLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC 252 (418)
T ss_pred eEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc
Confidence 99999998621100 000 00124699999999999775
Q ss_pred C--cCcceeecC
Q 003911 776 R--WSSCSYWAG 785 (787)
Q Consensus 776 ~--~~~~DiWS~ 785 (787)
. .++.|+||+
T Consensus 253 ~~QttaiDiws~ 264 (418)
T KOG1167|consen 253 PRQTTAIDIWSA 264 (418)
T ss_pred cCcCCccceeec
Confidence 3 348999996
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-21 Score=221.92 Aligned_cols=243 Identities=22% Similarity=0.354 Sum_probs=192.9
Q ss_pred CCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcE
Q 003911 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTI 194 (787)
Q Consensus 115 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~ 194 (787)
.+.+.|+|+++.++.+|... .++|+.|+|++|+|+ .+|..+. ++|+.|++++|+|+. +|..+ .++|+.
T Consensus 178 ~~~~~L~L~~~~LtsLP~~I---p~~L~~L~Ls~N~Lt--sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l----~~~L~~ 245 (754)
T PRK15370 178 NNKTELRLKILGLTTIPACI---PEQITTLILDNNELK--SLPENLQ--GNIKTLYANSNQLTS-IPATL----PDTIQE 245 (754)
T ss_pred cCceEEEeCCCCcCcCCccc---ccCCcEEEecCCCCC--cCChhhc--cCCCEEECCCCcccc-CChhh----hccccE
Confidence 56889999999999988653 358999999999999 5787665 589999999999985 45544 257999
Q ss_pred EeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCc
Q 003911 195 LHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNF 274 (787)
Q Consensus 195 L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~ 274 (787)
|+|++|++. .+|..+ .++|+.|+|++|+|+..+..+. ++|+.|+|++|+
T Consensus 246 L~Ls~N~L~-~LP~~l----------------------------~s~L~~L~Ls~N~L~~LP~~l~--~sL~~L~Ls~N~ 294 (754)
T PRK15370 246 MELSINRIT-ELPERL----------------------------PSALQSLDLFHNKISCLPENLP--EELRYLSVYDNS 294 (754)
T ss_pred EECcCCccC-cCChhH----------------------------hCCCCEEECcCCccCccccccC--CCCcEEECCCCc
Confidence 999999998 667654 2479999999999997655554 589999999999
Q ss_pred ccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccC
Q 003911 275 FTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 354 (787)
Q Consensus 275 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 354 (787)
|+ .+|..+. ++|+.|++++|+|+..++.+. .+|+.+++++|.+..+|...
T Consensus 295 Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt~LP~~l------------------------- 344 (754)
T PRK15370 295 IR-TLPAHLP--SGITHLNVQSNSLTALPETLP--PGLKTLEAGENALTSLPASL------------------------- 344 (754)
T ss_pred cc-cCcccch--hhHHHHHhcCCccccCCcccc--ccceeccccCCccccCChhh-------------------------
Confidence 99 5776654 589999999999997655443 46788888888766554211
Q ss_pred CCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccC
Q 003911 355 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKI 434 (787)
Q Consensus 355 ~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~i 434 (787)
.++|+.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ..|+.|++++|+|++ +
T Consensus 345 --------------~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~~-L 403 (754)
T PRK15370 345 --------------PPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLVR-L 403 (754)
T ss_pred --------------cCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCccc-C
Confidence 137999999999998 5777664 68999999999999 6787765 479999999999984 4
Q ss_pred CC----C----CCCceeecCCCCCC
Q 003911 435 PS----F----KSNAIVNTDGNPDI 451 (787)
Q Consensus 435 P~----~----~~~~~~~~~gn~~~ 451 (787)
|. + .....+.+.+||..
T Consensus 404 P~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 404 PESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred chhHHHHhhcCCCccEEEeeCCCcc
Confidence 43 2 34467888999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-21 Score=195.18 Aligned_cols=169 Identities=34% Similarity=0.522 Sum_probs=145.5
Q ss_pred cceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCCCHHHHHH
Q 003911 605 GFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIF 683 (787)
Q Consensus 605 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 683 (787)
+||.||+|... +++.+|+|++........ .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999876 589999999876432221 6789999999999999999999999999999999999999999999884
Q ss_pred hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCceeeeeccc
Q 003911 684 NWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 763 (787)
Q Consensus 684 ~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt 763 (787)
.. ..+++..+..++.+++.++.|||+ .+++|+||+|+||++++++.++++|||.+....... ......++
T Consensus 80 ~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~ 149 (244)
T smart00220 80 KR-----GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGT 149 (244)
T ss_pred hc-----cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCC
Confidence 41 237889999999999999999997 799999999999999999999999999998775432 22335688
Q ss_pred cCcccccccccCCcC-cceeec
Q 003911 764 FGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 764 ~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..|+|||...+..++ ++|+||
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~s 171 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWS 171 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHH
Confidence 999999999877777 899998
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-20 Score=186.53 Aligned_cols=176 Identities=39% Similarity=0.607 Sum_probs=148.9
Q ss_pred eccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCCCHH
Q 003911 601 LGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS 679 (787)
Q Consensus 601 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 679 (787)
||+|.+|.||++... +++.+++|++....... ..+.+.+|++.++.++|++|+++++++......++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999876 48999999987643221 3578999999999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC-CCcEEEeecccceecCCCCCceee
Q 003911 680 RHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAPEGKGSIET 758 (787)
Q Consensus 680 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~ 758 (787)
+++.... ..+++..+..++.+++++++|||+ .+++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (215)
T cd00180 80 DLLKENE----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLK 151 (215)
T ss_pred HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhh
Confidence 9885421 357899999999999999999998 79999999999999998 89999999999987654421 122
Q ss_pred eeccccCcccccccccC-CcC-cceeecC
Q 003911 759 RIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 759 ~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
...+...|++||..... .++ +.|+|+.
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~l 180 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSL 180 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHH
Confidence 34578899999999876 555 8999974
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-21 Score=186.06 Aligned_cols=178 Identities=24% Similarity=0.394 Sum_probs=140.8
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeE-EEeCCeeE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGH-CLDGNEKL 667 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-~~~~~~~~ 667 (787)
..+.|.+.+.+|+|.||.+-.++++ +.+.+|+|.+.... ....+|.+|...--.+ .|.||+.-|+. |+..+.++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 4567999999999999999999876 67889999887643 3457888888766666 59999987764 56677788
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC--CCCcEEEeeccc
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGL 745 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFG~ 745 (787)
+++||++.|+|.+-+.. ..+-+....+++.|+++|++|||+ +++||||||.+||||- +..++||||||.
T Consensus 99 F~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeeccc
Confidence 99999999999877622 357788889999999999999998 8999999999999983 445899999999
Q ss_pred ceecCCCCCceeeeeccccCcccccccccC---CcC---cceeec
Q 003911 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVHT---RWS---SCSYWA 784 (787)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~---~~DiWS 784 (787)
.+..+..... ..-+..|.|||..... ++- .+|+|.
T Consensus 170 t~k~g~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~Wq 210 (378)
T KOG1345|consen 170 TRKVGTTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQ 210 (378)
T ss_pred ccccCceehh----hhhhcccCCcHHHhhccccceEecccccchh
Confidence 8866433211 2236679999987543 222 689995
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-23 Score=207.76 Aligned_cols=314 Identities=22% Similarity=0.257 Sum_probs=223.1
Q ss_pred EEcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCC
Q 003911 63 VCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSL 141 (787)
Q Consensus 63 ~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 141 (787)
+|++.+ =..+|.++.+|+ .+|..+. ...+.++|..|+|+.++| +|..+++|+.||||+|+|+.|-|++|.+|++|
T Consensus 42 ~Cs~~~-g~~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l 117 (498)
T KOG4237|consen 42 TCSDVE-GGIVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASL 117 (498)
T ss_pred ccCCCC-CceEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhh
Confidence 344333 356788899998 8888877 577899999999999988 79999999999999999999999999999999
Q ss_pred cEEEccC-CCCCCCCCC-hhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCc-Ccccccccce
Q 003911 142 QSIEIDN-NPFSSWEIP-QSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPA-SFSGSQIQSL 218 (787)
Q Consensus 142 ~~L~L~~-N~l~~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~~~l~~L 218 (787)
.+|-+.+ |+|+ .+| ..|.+|..|+.|.++-|++.-...+.|. .+++|..|.+..|.+. .++. +|
T Consensus 118 ~~Lvlyg~NkI~--~l~k~~F~gL~slqrLllNan~i~Cir~~al~--dL~~l~lLslyDn~~q-~i~~~tf-------- 184 (498)
T KOG4237|consen 118 LSLVLYGNNKIT--DLPKGAFGGLSSLQRLLLNANHINCIRQDALR--DLPSLSLLSLYDNKIQ-SICKGTF-------- 184 (498)
T ss_pred hHHHhhcCCchh--hhhhhHhhhHHHHHHHhcChhhhcchhHHHHH--Hhhhcchhcccchhhh-hhccccc--------
Confidence 8888776 9999 566 5688899999999999999888888875 8888888888888887 3333 33
Q ss_pred eeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCc
Q 003911 219 WVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 298 (787)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 298 (787)
..+.+++.+++..|.+-- .++++.|... +. ..|-+++...-..-..|.+++
T Consensus 185 ------------------~~l~~i~tlhlA~np~ic----dCnL~wla~~-~a------~~~ietsgarc~~p~rl~~~R 235 (498)
T KOG4237|consen 185 ------------------QGLAAIKTLHLAQNPFIC----DCNLPWLADD-LA------MNPIETSGARCVSPYRLYYKR 235 (498)
T ss_pred ------------------cchhccchHhhhcCcccc----ccccchhhhH-Hh------hchhhcccceecchHHHHHHH
Confidence 367778888888777431 2222222211 11 223334444444444444444
Q ss_pred ccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEcc
Q 003911 299 LQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQ 378 (787)
Q Consensus 299 l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls 378 (787)
+....+.=+... + . +++..+...-....+|. ..-+..+++|+.|+|+
T Consensus 236 i~q~~a~kf~c~-~------------------------e------sl~s~~~~~d~~d~~cP--~~cf~~L~~L~~lnls 282 (498)
T KOG4237|consen 236 INQEDARKFLCS-L------------------------E------SLPSRLSSEDFPDSICP--AKCFKKLPNLRKLNLS 282 (498)
T ss_pred hcccchhhhhhh-H------------------------H------hHHHhhccccCcCCcCh--HHHHhhcccceEeccC
Confidence 443322200000 0 0 00000000000000111 0123456799999999
Q ss_pred CCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCC----CCCCceeecCCCCCCCCC
Q 003911 379 KMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDIGKE 454 (787)
Q Consensus 379 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~----~~~~~~~~~~gn~~~~~~ 454 (787)
+|++++.-+.+|..+..|+.|.|..|+|...--..|.++..|+.|+|.+|+++..-|- ..++..+.+.+||+.|..
T Consensus 283 nN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC 362 (498)
T KOG4237|consen 283 NNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNC 362 (498)
T ss_pred CCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCcc
Confidence 9999999999999999999999999999866677899999999999999999987774 334567889999999976
Q ss_pred C
Q 003911 455 K 455 (787)
Q Consensus 455 ~ 455 (787)
.
T Consensus 363 ~ 363 (498)
T KOG4237|consen 363 R 363 (498)
T ss_pred c
Confidence 4
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=182.04 Aligned_cols=145 Identities=20% Similarity=0.210 Sum_probs=113.2
Q ss_pred cceeccccceEEEEEEEeCCcEEEEEEeecccccch------------------------hHHHHHHHHHHHHhcCCCcc
Q 003911 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK------------------------GLTEFKSEIAVLTKVRHRHL 653 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~~~E~~~l~~l~h~ni 653 (787)
.+.||+|++|.||+|...+|+.||||+++....... ....++.|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999877899999999986422100 02234689999999999988
Q ss_pred ceEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC
Q 003911 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 733 (787)
Q Consensus 654 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 733 (787)
.....+... ..++||||++++++...... ...++..++..++.|++.++.++|+ ..||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE
Confidence 655544433 24899999998865433211 1356788899999999999999996 37999999999999998
Q ss_pred CCCcEEEeecccceecCCC
Q 003911 734 DDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 734 ~~~~~kl~DFG~a~~~~~~ 752 (787)
++.++|+|||+|......
T Consensus 153 -~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 153 -DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred -CCCEEEEEcccceecCCC
Confidence 789999999999877543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6e-20 Score=172.68 Aligned_cols=180 Identities=21% Similarity=0.321 Sum_probs=145.4
Q ss_pred hcCCCcccceeccccceEEEEEE-EeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCC-CccceEEeEEEeCCeeEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH-RHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~l 668 (787)
...+|.+++.||.|+||.+|.|. ..+|+.||||+-.... ...++..|..+++.++| ..|+.+..|..+.....+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 45789999999999999999995 5689999999865432 23467889999999964 788888888888899999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC---CCCcEEEeeccc
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGL 745 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG~ 745 (787)
|||.. |.+|.+.+.- ..+.++..+++-+|-|++.-++|+|. +++|||||||+|+|.. ....+.++|||+
T Consensus 89 VMdLL-GPsLEdLfnf----C~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNF----CSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred eeecc-CccHHHHHHH----HhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccc
Confidence 99998 8899887632 22468889999999999999999997 8999999999999986 334689999999
Q ss_pred ceecCCCCCce------eeeeccccCcccccccccCCcCccee
Q 003911 746 VRLAPEGKGSI------ETRIAGTFGYLAPEYAVHTRWSSCSY 782 (787)
Q Consensus 746 a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~Di 782 (787)
|+.+.+..... .....||.+|.+-....+...+..|+
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDD 203 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDD 203 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhh
Confidence 98776543221 23357999999887777666665554
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.1e-22 Score=217.26 Aligned_cols=289 Identities=23% Similarity=0.294 Sum_probs=197.5
Q ss_pred CCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEec
Q 003911 92 TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSA 171 (787)
Q Consensus 92 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l 171 (787)
++|+.|+.++|.++...+.+. -.+|+++++++|+++++| ++++.+.+|+.|+..+|++. .+|..+..+++|+.|++
T Consensus 219 ~~l~~L~a~~n~l~~~~~~p~-p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~--~lp~ri~~~~~L~~l~~ 294 (1081)
T KOG0618|consen 219 PSLTALYADHNPLTTLDVHPV-PLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV--ALPLRISRITSLVSLSA 294 (1081)
T ss_pred cchheeeeccCcceeeccccc-cccceeeecchhhhhcch-HHHHhcccceEecccchhHH--hhHHHHhhhhhHHHHHh
Confidence 456666666666663333222 357999999999999999 99999999999999999997 79999999999999999
Q ss_pred cCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCcc-ccccCccCceEecccc
Q 003911 172 NSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGID-VIQNMTSLKEIWLHSN 250 (787)
Q Consensus 172 ~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~-~~~~l~~L~~L~L~~N 250 (787)
..|.+.-. |+... .++.|++|+|..|+|. ..|+.+-..-..+|+..+...+ .++..|. .=..++.|+.|+|.+|
T Consensus 295 ~~nel~yi-p~~le--~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n-~l~~lp~~~e~~~~~Lq~LylanN 369 (1081)
T KOG0618|consen 295 AYNELEYI-PPFLE--GLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSN-KLSTLPSYEENNHAALQELYLANN 369 (1081)
T ss_pred hhhhhhhC-CCccc--ccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhc-cccccccccchhhHHHHHHHHhcC
Confidence 99999855 44443 7999999999999998 4555432211111222222111 1111110 1114567999999999
Q ss_pred cccc-CCCCCCCCCCCCEEecCCCcccccCCc-cccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCC
Q 003911 251 AFSG-PLPDFSGVKQLESLSLRDNFFTGPVPD-SLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGA 328 (787)
Q Consensus 251 ~l~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~ 328 (787)
.|+. .+|.+-+.++|+.|+|++|+|. .+|+ .+.++..|++|+||+|+|+..+..+..+..|+.+...+|.+..+|.
T Consensus 370 ~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~~fPe- 447 (1081)
T KOG0618|consen 370 HLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLLSFPE- 447 (1081)
T ss_pred cccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCceeechh-
Confidence 9987 5567889999999999999999 6665 5788999999999999999877666667777776666665554431
Q ss_pred CCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccc
Q 003911 329 CDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG 408 (787)
Q Consensus 329 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 408 (787)
+...+.|+.+|+|.|+|+...-.+--..++|++|||++|.=..
T Consensus 448 -------------------------------------~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~ 490 (1081)
T KOG0618|consen 448 -------------------------------------LAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLV 490 (1081)
T ss_pred -------------------------------------hhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccc
Confidence 1122456666666666664433222233566666666665221
Q ss_pred cCCccCcCCCCCCeeeccCC
Q 003911 409 MIPEGLSVLGALKELDVSNN 428 (787)
Q Consensus 409 ~ip~~l~~l~~L~~L~Ls~N 428 (787)
.--..|..++++...++.-|
T Consensus 491 ~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 491 FDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred cchhhhHHhhhhhheecccC
Confidence 22334444555555555555
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4e-22 Score=177.60 Aligned_cols=166 Identities=33% Similarity=0.527 Sum_probs=123.1
Q ss_pred CCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCC
Q 003911 88 LQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ 167 (787)
Q Consensus 88 ~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~ 167 (787)
+.++++.+.|.||+|+++..+|.++.|.+|++|++++|+|+.+ |.+++.+++|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~l--------------------------p~~issl~klr 82 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEEL--------------------------PTSISSLPKLR 82 (264)
T ss_pred ccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhc--------------------------Chhhhhchhhh
Confidence 4445555566666666666555555555555555555555544 44555555555
Q ss_pred EEeccCceecccCCCCCCCCCCCCCcEEecccccccc-CCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEe
Q 003911 168 NFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIG-GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIW 246 (787)
Q Consensus 168 ~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~ 246 (787)
.|+++-|++. ..|..|| .++.|+.|||.+|++.. .+|..| ..++.|+.|+
T Consensus 83 ~lnvgmnrl~-~lprgfg--s~p~levldltynnl~e~~lpgnf--------------------------f~m~tlraly 133 (264)
T KOG0617|consen 83 ILNVGMNRLN-ILPRGFG--SFPALEVLDLTYNNLNENSLPGNF--------------------------FYMTTLRALY 133 (264)
T ss_pred heecchhhhh-cCccccC--CCchhhhhhccccccccccCCcch--------------------------hHHHHHHHHH
Confidence 5555555543 4566666 77888888888888764 455554 3688999999
Q ss_pred ccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCc
Q 003911 247 LHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS 309 (787)
Q Consensus 247 L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 309 (787)
|++|.|.-.||+++.+++|+.|.+.+|.+- .+|.+++.++.|++|++.+|+++-.+|++..+
T Consensus 134 l~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppel~~l 195 (264)
T KOG0617|consen 134 LGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELANL 195 (264)
T ss_pred hcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecChhhhhh
Confidence 999999999999999999999999999998 89999999999999999999999999986544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=177.66 Aligned_cols=165 Identities=15% Similarity=0.164 Sum_probs=127.3
Q ss_pred hhcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccc-hhHHH------HHHHHHHHHhcCCCccceEEeEEEe
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG-KGLTE------FKSEIAVLTKVRHRHLVALLGHCLD 662 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~------~~~E~~~l~~l~h~niv~~~~~~~~ 662 (787)
...++|++.+++|.|+||.||.+.. ++..+|+|++....... ..... +++|++.+.++.||+|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4578999999999999999999866 57789999997644322 22222 6899999999999999999998764
Q ss_pred C--------CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC
Q 003911 663 G--------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 734 (787)
Q Consensus 663 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 734 (787)
. ...++||||++|.+|.++. .++. ....+++.++..+|+ .|++|||+||+||++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~---------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP---------EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSK 170 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh---------hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeC
Confidence 3 3578999999999997763 1222 245699999999997 89999999999999998
Q ss_pred CCcEEEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 735 DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 735 ~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++ ++++|||........... ..+.....+. ++|+||-
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~l 208 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDL 208 (232)
T ss_pred CC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccce
Confidence 88 999999988765322211 1134444455 8999973
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.9e-20 Score=179.34 Aligned_cols=180 Identities=19% Similarity=0.324 Sum_probs=150.2
Q ss_pred CCCcccceeccccceEEEEEE-EeCCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 670 (787)
-+|++.++||+|+||+++.|+ +-+++.||||.-..+ ....+++.|.+.++.+ ..++|...|-+...+.+-.|||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 479999999999999999996 457999999975542 2346889999999999 5799999998888888899999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC-----CcEEEeeccc
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-----MRAKVADFGL 745 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DFG~ 745 (787)
|.+ |-+|.|+. ++ ..+.++..++..+|.|++.-++|+|+ +.+|.|||||+|+||... ..+.++|||+
T Consensus 104 dLL-GPSLEDLF-D~---CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 104 DLL-GPSLEDLF-DL---CGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhh-CcCHHHHH-HH---hcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 998 88998876 32 23578999999999999999999998 899999999999999743 3589999999
Q ss_pred ceecCCCCCcee------eeeccccCcccccccccCCcCcceeec
Q 003911 746 VRLAPEGKGSIE------TRIAGTFGYLAPEYAVHTRWSSCSYWA 784 (787)
Q Consensus 746 a~~~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~DiWS 784 (787)
|+.+.+...... ....||.+||+-....|...+..|+--
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLE 220 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLE 220 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHH
Confidence 998877654222 235699999999999998888777643
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.7e-19 Score=215.75 Aligned_cols=301 Identities=17% Similarity=0.215 Sum_probs=188.5
Q ss_pred CCEEEEEeCCCCccc--cCCCCCCCCCCCcEEEeecCCC------CCCCC-CCCCCC-CCcEEEcccccCCcCCCccccC
Q 003911 68 KRITRIQIGHQNLQG--TLPSNLQNLTKLERLELQWNSI------SGPLP-SLNGLA-SLEVVMLSNNQFTSVPSDFFTG 137 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~--~~~~~~~~l~~L~~L~L~~N~l------~~~~~-~~~~l~-~L~~L~L~~N~l~~~~~~~~~~ 137 (787)
.+|..+.+.-..+.. .-+.+|..+.+|+.|.+..+.+ ...+| .|..++ +|+.|++.+|.++.+|.. | .
T Consensus 532 ~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~-f-~ 609 (1153)
T PLN03210 532 KKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSN-F-R 609 (1153)
T ss_pred ceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCc-C-C
Confidence 345555554333331 2345789999999999977653 22334 576664 599999999999999876 4 5
Q ss_pred CCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccc
Q 003911 138 LSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQS 217 (787)
Q Consensus 138 l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~ 217 (787)
..+|++|+|++|++. .+|..+..+++|+.|+|+++...+.+|. +. .+++|++|+|++|.....+|..+.
T Consensus 610 ~~~L~~L~L~~s~l~--~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls--~l~~Le~L~L~~c~~L~~lp~si~------ 678 (1153)
T PLN03210 610 PENLVKLQMQGSKLE--KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LS--MATNLETLKLSDCSSLVELPSSIQ------ 678 (1153)
T ss_pred ccCCcEEECcCcccc--ccccccccCCCCCEEECCCCCCcCcCCc-cc--cCCcccEEEecCCCCccccchhhh------
Confidence 789999999999998 6888899999999999999876667775 43 789999999999887777887664
Q ss_pred eeeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCC
Q 003911 218 LWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297 (787)
Q Consensus 218 L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 297 (787)
++++|+.|++++|..-..+|...++++|+.|+|++|...+.+|.. .++|++|+|++|
T Consensus 679 --------------------~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n 735 (1153)
T PLN03210 679 --------------------YLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDET 735 (1153)
T ss_pred --------------------ccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccc---cCCcCeeecCCC
Confidence 566677777766543333343335667777777766554455542 346666777777
Q ss_pred cccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEc
Q 003911 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINF 377 (787)
Q Consensus 298 ~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~L 377 (787)
.+...+ ....+.+|..+.+.++..........+ +. + ......++|+.|+|
T Consensus 736 ~i~~lP-~~~~l~~L~~L~l~~~~~~~l~~~~~~----l~--------------------~-----~~~~~~~sL~~L~L 785 (1153)
T PLN03210 736 AIEEFP-SNLRLENLDELILCEMKSEKLWERVQP----LT--------------------P-----LMTMLSPSLTRLFL 785 (1153)
T ss_pred cccccc-ccccccccccccccccchhhccccccc----cc--------------------h-----hhhhccccchheeC
Confidence 665433 222344444444333211110000000 00 0 00011235666666
Q ss_pred cCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCC
Q 003911 378 QKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 435 (787)
Q Consensus 378 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP 435 (787)
++|...+.+|..++++++|+.|+|++|...+.+|..+ .+++|+.|+|++|..-..+|
T Consensus 786 s~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p 842 (1153)
T PLN03210 786 SDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFP 842 (1153)
T ss_pred CCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccc
Confidence 6666666666666666666666666654444566554 45556666665554433343
|
syringae 6; Provisional |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=190.61 Aligned_cols=182 Identities=25% Similarity=0.340 Sum_probs=144.9
Q ss_pred CCcccceeccccceEEEEEEEeCC--cEEEEEEeecccccchhHHHHHHHHHHHHhcCC----CccceEEeEE-EeCCee
Q 003911 594 NFSEENILGRGGFGTVYKGELHDG--TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH----RHLVALLGHC-LDGNEK 666 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~ 666 (787)
+|.+.+.||+|+||.||.|..... ..+|+|....... ... ..+..|+.++..+.. +++..+++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~-~~~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELG-SKP-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEeccc-CCC-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 799999999999999999986543 4788887765321 112 278889999998863 6899999999 477788
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC-----CcEEEe
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-----MRAKVA 741 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~ 741 (787)
|+||+.+ |.+|.++..... .+.++..++.+|+.|++.+|++||+ .|++||||||+|+++... ..+.|.
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred EEEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEE
Confidence 9999988 889998764422 4679999999999999999999998 899999999999999854 469999
Q ss_pred ecccce--ecCCCCCc----e---eeeeccccCcccccccccCCcC-cceeec
Q 003911 742 DFGLVR--LAPEGKGS----I---ETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 742 DFG~a~--~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
|||+|+ .+...... . ...+.||..|+++++..+...+ ..|+||
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles 222 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLES 222 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhh
Confidence 999998 33222211 0 1235699999999999999988 566666
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.2e-18 Score=166.53 Aligned_cols=138 Identities=20% Similarity=0.280 Sum_probs=105.7
Q ss_pred cccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhc-----CCCccceEEeEEEeCC---eeE
Q 003911 596 SEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-----RHRHLVALLGHCLDGN---EKL 667 (787)
Q Consensus 596 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~~~ 667 (787)
.-.+.||+|+||.||. .-.++.. +||++.... ....+++.+|+++++.+ .||||++++|+++++. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 3457899999999996 3334444 799886532 22456799999999999 5799999999998864 333
Q ss_pred -EEEEe--cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEcCCCCCCEEECC----CCcEE
Q 003911 668 -LVFEY--MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV-EYLHGLAHQSFIHRDLKPSNILLGD----DMRAK 739 (787)
Q Consensus 668 -lv~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~k 739 (787)
+|+|| +++|+|.+++.+ ..+++. ..++.|++.++ +|||+ .+|+||||||+|||++. +..++
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~ 149 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPV 149 (210)
T ss_pred EEEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEE
Confidence 78999 557999999943 124444 35677888787 99998 89999999999999974 33799
Q ss_pred Eee-ccccee
Q 003911 740 VAD-FGLVRL 748 (787)
Q Consensus 740 l~D-FG~a~~ 748 (787)
|+| ||.+..
T Consensus 150 LiDg~G~~~~ 159 (210)
T PRK10345 150 VCDNIGESTF 159 (210)
T ss_pred EEECCCCcce
Confidence 999 555444
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.3e-18 Score=163.20 Aligned_cols=158 Identities=18% Similarity=0.132 Sum_probs=118.4
Q ss_pred cccceeccccceEEEEEEEeCCcEEEEEEeeccccc--chhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCeeEEEEEe
Q 003911 596 SEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS--GKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 596 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
.+...|++|+||+||.+.. .+.+++.+.+.....- ......+++|+++++++. |++|++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999998766 6888888877653321 112236889999999995 5889999886 346999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC-CCCCEEECCCCcEEEeecccceecCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDL-KPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
++|.+|.+.... ....++.|++.+|+++|+ .||+|||| ||+|||++.++.++|+|||+|.....
T Consensus 80 I~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 80 LAGAAMYQRPPR------------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ecCccHHhhhhh------------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 999998654310 113477899999999998 89999999 79999999999999999999986544
Q ss_pred CCCc----e--------eeeeccccCcccccccc
Q 003911 752 GKGS----I--------ETRIAGTFGYLAPEYAV 773 (787)
Q Consensus 752 ~~~~----~--------~~~~~gt~~y~aPE~~~ 773 (787)
.... . ......++.|++|+...
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~ 178 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERR 178 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHh
Confidence 3210 0 00123678888888654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.5e-21 Score=170.36 Aligned_cols=131 Identities=24% Similarity=0.445 Sum_probs=107.2
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEcc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 147 (787)
.++|.|.|++|+++ .+|+.++.|.+|+.|++++|+|+..++++..|++|+.|+++-|++..+|.+ |+.++.|+.|||.
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~lprg-fgs~p~levldlt 110 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNILPRG-FGSFPALEVLDLT 110 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhcCccc-cCCCchhhhhhcc
Confidence 57999999999999 899999999999999999999999999999999999999999999988866 9999999999999
Q ss_pred CCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccc
Q 003911 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI 203 (787)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~ 203 (787)
+|++..-.+|..|..|+.|+.|+|++|.+. .+|..++ .+++|+.|.+..|.+.
T Consensus 111 ynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg--~lt~lqil~lrdndll 163 (264)
T KOG0617|consen 111 YNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVG--KLTNLQILSLRDNDLL 163 (264)
T ss_pred ccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhh--hhcceeEEeeccCchh
Confidence 999987567777777777776666666665 3344443 4555555555555544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=7e-18 Score=170.07 Aligned_cols=152 Identities=18% Similarity=0.138 Sum_probs=115.7
Q ss_pred HHhhcCCCcccceeccccceEEEEEE--EeCCcEEEEEEeecccccc----------------------hhHHHHHHHHH
Q 003911 588 LRNVTNNFSEENILGRGGFGTVYKGE--LHDGTKIAVKRMEAGVISG----------------------KGLTEFKSEIA 643 (787)
Q Consensus 588 ~~~~~~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~----------------------~~~~~~~~E~~ 643 (787)
+......|++.+.||+|++|.||+|. ..+|+.||+|+++...... .....+++|++
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33334458899999999999999998 4589999999987542110 01134678999
Q ss_pred HHHhcCCC--ccceEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-e
Q 003911 644 VLTKVRHR--HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS-F 720 (787)
Q Consensus 644 ~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-i 720 (787)
.++++.+. .+++++++ ...++||||++++++...... .......++..++.|++.++++||+ .+ |
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~g~i 170 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYK---EGEL 170 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHh---cCCE
Confidence 99999753 34455543 235899999999888654311 1245566678999999999999997 78 9
Q ss_pred EEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 721 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 721 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+||||||+||+++ ++.++|+|||.|......
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhccCCc
Confidence 9999999999999 789999999999866543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-20 Score=200.16 Aligned_cols=280 Identities=21% Similarity=0.267 Sum_probs=174.5
Q ss_pred EEEeCCCCcc-ccCCCCCCCCCCCcEEEeecCCCCCC----CC-CCCCCCCCcEEEcccccCCcC------CCccccCCC
Q 003911 72 RIQIGHQNLQ-GTLPSNLQNLTKLERLELQWNSISGP----LP-SLNGLASLEVVMLSNNQFTSV------PSDFFTGLS 139 (787)
Q Consensus 72 ~L~l~~~~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~----~~-~~~~l~~L~~L~L~~N~l~~~------~~~~~~~l~ 139 (787)
.|+|..+.++ ......+..+.+|+.|+|+++.++.. ++ .+...++|++|+++++.+.+. .+..|..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4667777776 34455566777788888888887552 22 456677788888888877632 223566777
Q ss_pred CCcEEEccCCCCCCCCCChhhhcCCC---CCEEeccCceecc----cCCCCCCCCCC-CCCcEEeccccccccCCCcCcc
Q 003911 140 SLQSIEIDNNPFSSWEIPQSLRNASG---LQNFSANSANITG----QIPSFFGPDEF-PGLTILHLAFNQLIGGLPASFS 211 (787)
Q Consensus 140 ~L~~L~L~~N~l~~~~~p~~~~~l~~---L~~L~l~~n~l~~----~~p~~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~ 211 (787)
+|++|+|++|.+.. ..+..+..+.+ |++|++++|++++ .+...+. .+ ++|+.|+|++|.+++..+..+.
T Consensus 82 ~L~~L~l~~~~~~~-~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~--~~~~~L~~L~L~~n~l~~~~~~~~~ 158 (319)
T cd00116 82 GLQELDLSDNALGP-DGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLK--DLPPALEKLVLGRNRLEGASCEALA 158 (319)
T ss_pred ceeEEEccCCCCCh-hHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHH--hCCCCceEEEcCCCcCCchHHHHHH
Confidence 88888888888775 45555655555 8888888887763 2222222 44 6788888888887753322211
Q ss_pred cccccceeeccCCCCCcCCCCccccccCccCceEeccccccccC-----CCCCCCCCCCCEEecCCCccccc----CCcc
Q 003911 212 GSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGP-----LPDFSGVKQLESLSLRDNFFTGP----VPDS 282 (787)
Q Consensus 212 ~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~p~~ 282 (787)
..+..+++|++|+|++|.+++. +..+..+++|+.|+|++|.+++. ++..
T Consensus 159 ----------------------~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~ 216 (319)
T cd00116 159 ----------------------KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAET 216 (319)
T ss_pred ----------------------HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHH
Confidence 2234567788888888887742 11244556788888888877633 3344
Q ss_pred ccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCc
Q 003911 283 LVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW 362 (787)
Q Consensus 283 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (787)
+..+++|++|++++|++++.... .+...
T Consensus 217 ~~~~~~L~~L~ls~n~l~~~~~~--------------------------------~l~~~-------------------- 244 (319)
T cd00116 217 LASLKSLEVLNLGDNNLTDAGAA--------------------------------ALASA-------------------- 244 (319)
T ss_pred hcccCCCCEEecCCCcCchHHHH--------------------------------HHHHH--------------------
Confidence 56677788888888877641100 00000
Q ss_pred cccccCCCceEEEEccCCccc----ccCchhhcCCCCCCEEeccccccccc----CCccCcCC-CCCCeeeccCCcc
Q 003911 363 IGVTCTKGNITVINFQKMNLT----GTISPEFASFKSLQRLILADNNLSGM----IPEGLSVL-GALKELDVSNNQL 430 (787)
Q Consensus 363 ~~~~~~~~~L~~L~Ls~N~l~----g~~p~~~~~l~~L~~L~Ls~N~l~g~----ip~~l~~l-~~L~~L~Ls~N~l 430 (787)
.......|+.|++++|.++ ..++..+..+++|+.|++++|.++.. +...+... +.|++||+.+|++
T Consensus 245 --~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 245 --LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred --HhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 0001136777888888776 23445566667788888888887744 34444444 6777777777754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-17 Score=178.48 Aligned_cols=183 Identities=33% Similarity=0.538 Sum_probs=152.0
Q ss_pred CcccceeccccceEEEEEEEeCCcEEEEEEeecccccch-hHHHHHHHHHHHHhcCCC-ccceEEeEEEeCCeeEEEEEe
Q 003911 595 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK-GLTEFKSEIAVLTKVRHR-HLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 672 (787)
|.+.+.||.|+||.||++... ..+++|.+........ ....+.+|+.+++.+.|+ +|+++++.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999876 8899999987544432 577899999999999988 799999999877778999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC-cEEEeecccceecCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAPE 751 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~ 751 (787)
+.++++.+++...... ..+.......++.|++.+++|+|+ .+++|||+||+||+++..+ .++++|||.++....
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999666331111 268889999999999999999997 7899999999999999888 799999999986654
Q ss_pred CCCc-----eeeeeccccCccccccccc---CCcC-cceeec
Q 003911 752 GKGS-----IETRIAGTFGYLAPEYAVH---TRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~-~~DiWS 784 (787)
.... ......||..|+|||.+.+ ..+. ..|+||
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s 196 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWS 196 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHH
Confidence 4322 2345679999999999987 3455 899995
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=162.91 Aligned_cols=141 Identities=22% Similarity=0.189 Sum_probs=110.8
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccc--------------------hhHHHHHHHHHHHHhcCCC-
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG--------------------KGLTEFKSEIAVLTKVRHR- 651 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~h~- 651 (787)
..|.+.+.||+|+||.||++...+|+.||||++....... .....+..|+.++.++.|+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3478889999999999999988889999999876532110 0112367899999999877
Q ss_pred -ccceEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 003911 652 -HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 730 (787)
Q Consensus 652 -niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 730 (787)
.++..++ ....++||||+++++|.+... ......++.+++.++.++|+ .+|+||||||+||
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-----------~~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Ni 156 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV-----------LEDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNI 156 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhccc-----------cccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccE
Confidence 4444443 244589999999999865431 02345788999999999997 8999999999999
Q ss_pred EECCCCcEEEeecccceecCC
Q 003911 731 LLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 731 ll~~~~~~kl~DFG~a~~~~~ 751 (787)
++++++.++|+|||.+.....
T Consensus 157 ll~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 157 LVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEcCCCcEEEEECCccccCCC
Confidence 999999999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.8e-17 Score=163.47 Aligned_cols=137 Identities=23% Similarity=0.344 Sum_probs=114.9
Q ss_pred ceeccccceEEEEEEEeCCcEEEEEEeecccccc------hhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG------KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
+.||+|++|.||+|.. +|..|++|+........ ....++.+|++++..++|++|+....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 57889999876432221 1234688999999999999998888888777888999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
++|++|.+++.. ..+ .+..++.+++.+|.++|+ .+++|||++|+||+++ ++.++|+|||.+...
T Consensus 81 ~~G~~L~~~~~~--------~~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINS--------NGM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHh--------ccH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 999999988732 112 778999999999999997 8999999999999998 788999999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.6e-17 Score=159.29 Aligned_cols=134 Identities=23% Similarity=0.342 Sum_probs=109.0
Q ss_pred eeccccceEEEEEEEeCCcEEEEEEeecccccc------hhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEec
Q 003911 600 ILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG------KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (787)
Q Consensus 600 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (787)
.||+|++|.||+|.+ ++..|++|+........ ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 57889999865432211 12356789999999999888766666666777789999999
Q ss_pred CCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
+|++|.+.+... .. .++.|++.+|.++|+ .+++|||++|+||+++ ++.++++|||.++...
T Consensus 80 ~g~~l~~~~~~~-----~~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEG-----ND-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhc-----HH-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 999998876321 00 789999999999997 8999999999999999 7899999999987653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.9e-19 Score=192.62 Aligned_cols=259 Identities=21% Similarity=0.228 Sum_probs=187.2
Q ss_pred EEEeecCCCCC-CCC-CCCCCCCCcEEEcccccCCcC----CCccccCCCCCcEEEccCCCCCC-----CCCChhhhcCC
Q 003911 96 RLELQWNSISG-PLP-SLNGLASLEVVMLSNNQFTSV----PSDFFTGLSSLQSIEIDNNPFSS-----WEIPQSLRNAS 164 (787)
Q Consensus 96 ~L~L~~N~l~~-~~~-~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~-----~~~p~~~~~l~ 164 (787)
.|+|..+.+++ ... .+..+.+|++|+++++.++.. .+..+...++|++|++++|.+.. ..++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 57889999985 333 467788899999999998642 33446678889999999998862 12345677888
Q ss_pred CCCEEeccCceecccCCCCCCCCCCC---CCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccC-c
Q 003911 165 GLQNFSANSANITGQIPSFFGPDEFP---GLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNM-T 240 (787)
Q Consensus 165 ~L~~L~l~~n~l~~~~p~~~~~~~l~---~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l-~ 240 (787)
+|+.|++++|.+.+..+..+. .+. +|++|++++|++++.....+ ...+..+ +
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~--~l~~~~~L~~L~ls~~~~~~~~~~~l----------------------~~~l~~~~~ 137 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLE--SLLRSSSLQELKLNNNGLGDRGLRLL----------------------AKGLKDLPP 137 (319)
T ss_pred ceeEEEccCCCCChhHHHHHH--HHhccCcccEEEeeCCccchHHHHHH----------------------HHHHHhCCC
Confidence 999999999999866655553 344 49999999999874221111 1123355 8
Q ss_pred cCceEeccccccccCCC-----CCCCCCCCCEEecCCCcccc----cCCccccCCCCCCEEEccCCcccccCCCCCCcee
Q 003911 241 SLKEIWLHSNAFSGPLP-----DFSGVKQLESLSLRDNFFTG----PVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVS 311 (787)
Q Consensus 241 ~L~~L~L~~N~l~~~~~-----~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 311 (787)
+|++|+|++|.+++... .+..+++|++|+|++|.+++ .++..+..+++|++|+|++|.+++....
T Consensus 138 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~------ 211 (319)
T cd00116 138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS------ 211 (319)
T ss_pred CceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH------
Confidence 89999999999985322 36667889999999999984 2445566778999999999988642111
Q ss_pred eeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhc
Q 003911 312 LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFA 391 (787)
Q Consensus 312 L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~ 391 (787)
.+ .......++|+.|++++|.+++.....+.
T Consensus 212 -----------------------~l--------------------------~~~~~~~~~L~~L~ls~n~l~~~~~~~l~ 242 (319)
T cd00116 212 -----------------------AL--------------------------AETLASLKSLEVLNLGDNNLTDAGAAALA 242 (319)
T ss_pred -----------------------HH--------------------------HHHhcccCCCCEEecCCCcCchHHHHHHH
Confidence 00 00112335899999999999975444443
Q ss_pred C-----CCCCCEEeccccccc----ccCCccCcCCCCCCeeeccCCccccc
Q 003911 392 S-----FKSLQRLILADNNLS----GMIPEGLSVLGALKELDVSNNQLYGK 433 (787)
Q Consensus 392 ~-----l~~L~~L~Ls~N~l~----g~ip~~l~~l~~L~~L~Ls~N~l~g~ 433 (787)
. .+.|+.|++++|.++ ..+...+..+++|++||+++|+++..
T Consensus 243 ~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 243 SALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 2 479999999999997 23456677779999999999999854
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.7e-17 Score=183.09 Aligned_cols=143 Identities=22% Similarity=0.289 Sum_probs=115.0
Q ss_pred hcCCCcccceeccccceEEEEEEEeCCcEEEEEEeeccccc------chhHHHHHHHHHHHHhcCCCccceEEeEEEeCC
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS------GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 664 (787)
....|...+.||+|+||.||+|.+.. ..+++|+....... ....+++.+|++++++++|++++....++.+..
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 34455678999999999999998753 44555543222111 122356889999999999999998888888877
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..++||||+++++|.+++. ....++.|++.+|.|||+ .+++|||+||+||++ +++.++|+|||
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCc
Confidence 8899999999999988873 345789999999999997 899999999999999 67799999999
Q ss_pred cceecCC
Q 003911 745 LVRLAPE 751 (787)
Q Consensus 745 ~a~~~~~ 751 (787)
+++....
T Consensus 473 la~~~~~ 479 (535)
T PRK09605 473 LGKYSDL 479 (535)
T ss_pred ccccCCc
Confidence 9987543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.5e-17 Score=185.33 Aligned_cols=135 Identities=32% Similarity=0.578 Sum_probs=105.1
Q ss_pred ccCCChhHHHHHHHHHHhcCCCCCCCCCCCCCC-----CcccEEEcCC-----CCEEEEEeCCCCccccCCCCCCCCCCC
Q 003911 25 SASGDDGDAAVMLALKKSLNPPESLGWSDTDPC-----KWNHVVCIED-----KRITRIQIGHQNLQGTLPSNLQNLTKL 94 (787)
Q Consensus 25 ~~~~~~~d~~~l~~~k~~~~~~~~~~w~~~~~C-----~w~gv~C~~~-----~~v~~L~l~~~~l~~~~~~~~~~l~~L 94 (787)
.++..+.|.+||+++|+++..+...+|++ |+| .|.||.|... .+|+.|+|++|++.|.+|+.++++++|
T Consensus 366 ~~~t~~~~~~aL~~~k~~~~~~~~~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L 444 (623)
T PLN03150 366 ESKTLLEEVSALQTLKSSLGLPLRFGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHL 444 (623)
T ss_pred ccccCchHHHHHHHHHHhcCCcccCCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCC
Confidence 34456789999999999998766568976 455 6999999632 248889999999999999888889999
Q ss_pred cEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhh
Q 003911 95 ERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLR 161 (787)
Q Consensus 95 ~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~ 161 (787)
+.|+|++|+|+|.+| .+..+++|+.|+|++|++++..|+.++++++|++|+|++|++++ .+|..+.
T Consensus 445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g-~iP~~l~ 511 (623)
T PLN03150 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG-RVPAALG 511 (623)
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccc-cCChHHh
Confidence 999998888888777 68888888888888888887666667777777777777776665 5555543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.6e-17 Score=198.70 Aligned_cols=130 Identities=15% Similarity=0.148 Sum_probs=96.7
Q ss_pred hcCC-CccceEEeEEE-------eCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 003911 647 KVRH-RHLVALLGHCL-------DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718 (787)
Q Consensus 647 ~l~h-~niv~~~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~ 718 (787)
.++| +||..+++++. ..+..+.++||+ +++|.+++.. ....+++.+++.++.||++||+|||+ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~ 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN----PDRSVDAFECFHVFRQIVEIVNAAHS---Q 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc----ccccccHHHHHHHHHHHHHHHHHHHh---C
Confidence 3445 57888888772 234567788987 6699999843 23468999999999999999999997 8
Q ss_pred CeEEcCCCCCCEEECCC-------------------CcEEEeecccceecCCCC---------------Cceeeeecccc
Q 003911 719 SFIHRDLKPSNILLGDD-------------------MRAKVADFGLVRLAPEGK---------------GSIETRIAGTF 764 (787)
Q Consensus 719 ~ivH~Dlkp~NIll~~~-------------------~~~kl~DFG~a~~~~~~~---------------~~~~~~~~gt~ 764 (787)
+|+||||||+||||+.. +.+|++|||+++...... .......+||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 99999999999999643 455666666665321100 00011245899
Q ss_pred CcccccccccCCcC-cceeec
Q 003911 765 GYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 765 ~y~aPE~~~~~~~~-~~DiWS 784 (787)
.|||||++.+..|+ ++||||
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwS 200 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYR 200 (793)
T ss_pred ceEChhhhccCCCCchhhhhh
Confidence 99999999999888 999998
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-17 Score=186.75 Aligned_cols=182 Identities=24% Similarity=0.326 Sum_probs=141.7
Q ss_pred cccceeccccceEEEEEEEe-CCcEEEEEEee----cccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 596 SEENILGRGGFGTVYKGELH-DGTKIAVKRME----AGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 596 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
...+++|.|++|.|+.+... ..+.++.|.+. ...........+..|..+-..+.|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999977776433 34445555433 21112222233677888888899999998888887777666669
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++ +|...+.. ...+...++..++.|++.|++|+|+ .||.|||+|++|+++..+|.+||+|||.+....
T Consensus 401 E~~~~-Dlf~~~~~-----~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS-----NGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhc-----ccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 99988843 1357778888999999999999998 899999999999999999999999999987654
Q ss_pred CCCC---ceeeeeccccCcccccccccCCcC--cceeecCC
Q 003911 751 EGKG---SIETRIAGTFGYLAPEYAVHTRWS--SCSYWAGN 786 (787)
Q Consensus 751 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~--~~DiWS~~ 786 (787)
.+.. ......+|+..|+|||++.+..|. ..||||++
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ 512 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCG 512 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhcc
Confidence 3322 344567899999999999999998 79999974
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.6e-16 Score=182.72 Aligned_cols=181 Identities=25% Similarity=0.303 Sum_probs=143.0
Q ss_pred hcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcC---CCccceEEeEEEeCCeeE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR---HRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~ 667 (787)
-.+.|.+.+.+|+|+||.||+|...+|+.||+|+-+....- +|.-=.+++.+|+ -+-|..+...+...+..+
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 45678899999999999999998888999999987654321 2222223344444 245556666666778889
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC-------CCCcEEE
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-------DDMRAKV 740 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~~kl 740 (787)
+|+||.+.|+|.+++. ..+.++|.-++.+..|++..+++||. .+|||+||||+|+||. +...++|
T Consensus 771 lv~ey~~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeccccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEE
Confidence 9999999999999984 45689999999999999999999997 8999999999999994 2345899
Q ss_pred eecccceecCCC-CCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 741 ADFGLVRLAPEG-KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 741 ~DFG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+|||.+..+.-- .+......++|-.+-.+|+..|..|+ ..|.|.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfG 888 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFG 888 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHH
Confidence 999998654332 22355667889999999999999999 899774
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=149.27 Aligned_cols=140 Identities=20% Similarity=0.203 Sum_probs=101.2
Q ss_pred cceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHH----------------------HHHHHHHHHhcCCCc--c
Q 003911 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTE----------------------FKSEIAVLTKVRHRH--L 653 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~h~n--i 653 (787)
.+.||+|+||.||+|...+++.||||++............ ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999998878999999998764322111111 145666777765433 4
Q ss_pred ceEEeEEEeCCeeEEEEEecCCCCHHHH-HHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 003911 654 VALLGHCLDGNEKLLVFEYMPQGTLSRH-IFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (787)
Q Consensus 654 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 732 (787)
.+.+++ ...++||||++++++... +.... .. .++..++.+++.++.++|. ..+|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEE
Confidence 455543 245899999998554321 11100 01 5677899999999999996 3799999999999999
Q ss_pred CCCCcEEEeecccceecCC
Q 003911 733 GDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 733 ~~~~~~kl~DFG~a~~~~~ 751 (787)
+ ++.++++|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 88999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.9e-15 Score=141.14 Aligned_cols=136 Identities=21% Similarity=0.211 Sum_probs=114.2
Q ss_pred ccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCC--CccceEEeEEEeCCeeEEEEEecC
Q 003911 597 EENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--RHLVALLGHCLDGNEKLLVFEYMP 674 (787)
Q Consensus 597 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~ 674 (787)
+.+.||+|.++.||++... +..+++|....... ...+.+|+.+++.++| ..+++++++....+..+++|||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 3577999999999999875 47899998865322 4678999999999976 589999998888888999999998
Q ss_pred CCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 675 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
++.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++..
T Consensus 77 g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 77 GETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred CeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 8766432 44566778999999999999754458999999999999999899999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.7e-15 Score=147.94 Aligned_cols=138 Identities=20% Similarity=0.246 Sum_probs=106.7
Q ss_pred ceec-cccceEEEEEEEeCCcEEEEEEeecccc-----------cchhHHHHHHHHHHHHhcCCCcc--ceEEeEEEeCC
Q 003911 599 NILG-RGGFGTVYKGELHDGTKIAVKRMEAGVI-----------SGKGLTEFKSEIAVLTKVRHRHL--VALLGHCLDGN 664 (787)
Q Consensus 599 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~ 664 (787)
..|| .|+.|+||+++.. +..+|||++..... ......++.+|++++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8899999999775 78899998864221 11234578899999999998875 67777654332
Q ss_pred ----eeEEEEEecCC-CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEE
Q 003911 665 ----EKLLVFEYMPQ-GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 739 (787)
Q Consensus 665 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 739 (787)
..++||||+++ .+|.+++.. ..++.. .+.|++.++.+||+ .||+||||||+|||++.++.++
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEE
Confidence 23599999997 688887732 234443 35789999999997 8999999999999999888999
Q ss_pred EeecccceecC
Q 003911 740 VADFGLVRLAP 750 (787)
Q Consensus 740 l~DFG~a~~~~ 750 (787)
|+|||.+....
T Consensus 183 LIDfg~~~~~~ 193 (239)
T PRK01723 183 LIDFDRGELRT 193 (239)
T ss_pred EEECCCcccCC
Confidence 99999988754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.9e-16 Score=151.52 Aligned_cols=176 Identities=20% Similarity=0.412 Sum_probs=141.4
Q ss_pred ccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCC
Q 003911 597 EENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676 (787)
Q Consensus 597 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (787)
+..+|.+...|+.|+|+++ |..+++|++.....+.+...+|..|.-.++-+.||||+.+++.|..+....++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3456888999999999997 778888998877777777789999999999999999999999999999999999999999
Q ss_pred CHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE-EcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFI-HRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv-H~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
+|+..+++. ..-..+..++.+++.++++|++|||+. .+++ ---+.+..+++|++.+++|. .+-+++.-...
T Consensus 273 slynvlhe~---t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltaris-mad~kfsfqe~-- 344 (448)
T KOG0195|consen 273 SLYNVLHEQ---TSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEV-- 344 (448)
T ss_pred HHHHHHhcC---ccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhhee-cccceeeeecc--
Confidence 999999762 223567788999999999999999996 3444 44689999999999988774 22222111111
Q ss_pred eeeeeccccCcccccccccCCcC----cceeec
Q 003911 756 IETRIAGTFGYLAPEYAVHTRWS----SCSYWA 784 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~----~~DiWS 784 (787)
...-.|.||+||.++..+.+ ++|+||
T Consensus 345 ---gr~y~pawmspealqrkped~n~raadmws 374 (448)
T KOG0195|consen 345 ---GRAYSPAWMSPEALQRKPEDLNIRAADMWS 374 (448)
T ss_pred ---ccccCcccCCHHHHhcCchhcchhhhhHHH
Confidence 12347899999999877554 799998
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.8e-14 Score=165.74 Aligned_cols=91 Identities=29% Similarity=0.417 Sum_probs=77.4
Q ss_pred CceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCCC-----CCCceee
Q 003911 370 GNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF-----KSNAIVN 444 (787)
Q Consensus 370 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~~-----~~~~~~~ 444 (787)
.+|+.|+|++|++.|.+|..++.+++|+.|+|++|+|+|.+|+.++.|++|++|||++|+|+|.+|.. .....+.
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~ 521 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN 521 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence 47788888888888889989999999999999999999999999999999999999999999999962 2345678
Q ss_pred cCCCCCCCCCCCCCCC
Q 003911 445 TDGNPDIGKEKSSSFQ 460 (787)
Q Consensus 445 ~~gn~~~~~~~~~~~~ 460 (787)
+.||+.+|+.+....|
T Consensus 522 ~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 522 FTDNAGLCGIPGLRAC 537 (623)
T ss_pred ecCCccccCCCCCCCC
Confidence 9999999987654444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.5e-16 Score=165.93 Aligned_cols=170 Identities=25% Similarity=0.344 Sum_probs=140.0
Q ss_pred eccccceEEEEEE----EeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCeeEEEEEecCC
Q 003911 601 LGRGGFGTVYKGE----LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 601 lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+|+|+||.|+.++ ...|.-+|+|+.++.............|..++..++ ||.++++...++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7899999999873 234777899988775544333346677888899996 99999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|++...+.. ...+++.....+...++-|++++|. .+|+|||+|++||+++.+|++++.|||.++...+...
T Consensus 82 g~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 82 GDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred chhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 999887733 3456677777888899999999997 8999999999999999999999999999987655432
Q ss_pred eeeeeccccCcccccccccCCcCcceeec
Q 003911 756 IETRIAGTFGYLAPEYAVHTRWSSCSYWA 784 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~~~DiWS 784 (787)
.+||..|||||++. +...++|-||
T Consensus 153 ----~cgt~eymApEI~~-gh~~a~D~ws 176 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN-GHLSAADWWS 176 (612)
T ss_pred ----cccchhhhhhHhhh-ccCCcccchh
Confidence 28999999999998 4444677776
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.3e-13 Score=149.69 Aligned_cols=144 Identities=24% Similarity=0.285 Sum_probs=100.9
Q ss_pred cceeccccceEEEEEEEeCCcEEEEEEeecccccch--------------------------------------hHHHHH
Q 003911 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK--------------------------------------GLTEFK 639 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--------------------------------------~~~~~~ 639 (787)
.+.||.|++|.||+|+.++|+.||||+.+......- ..-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 368999999999999999999999999865321100 001245
Q ss_pred HHHHHHHhcC-----CCccceEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 003911 640 SEIAVLTKVR-----HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-GVEYLH 713 (787)
Q Consensus 640 ~E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~-~L~~LH 713 (787)
+|.+.+.+++ ++++.-..-+.......++||||++|++|.+...... . .. ....++.+++. .+.++|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~---~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-A---GL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-c---CC---CHHHHHHHHHHHHHHHHH
Confidence 5666666652 3333222222223445799999999999988763211 1 12 23456666666 467888
Q ss_pred hCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 714 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
. .|++|+|+||.||+++++++++++|||++....+
T Consensus 275 ~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 R---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred h---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 6 8999999999999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.3e-14 Score=141.50 Aligned_cols=127 Identities=28% Similarity=0.413 Sum_probs=93.4
Q ss_pred CCCccceEEeEEEe---------------------------CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHH
Q 003911 649 RHRHLVALLGHCLD---------------------------GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTI 701 (787)
Q Consensus 649 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 701 (787)
+|||||++.++|.+ +...|+||.-++ .+|.+++.. ...+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc------CCCchHHHHHH
Confidence 59999999987764 234589999884 488888843 24455666778
Q ss_pred HHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC--CCC--cEEEeecccceecCCC-----CCceeeeeccccCccccccc
Q 003911 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDM--RAKVADFGLVRLAPEG-----KGSIETRIAGTFGYLAPEYA 772 (787)
Q Consensus 702 ~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DFG~a~~~~~~-----~~~~~~~~~gt~~y~aPE~~ 772 (787)
..|+++|+.|||. +||.|||+|++|||+. +|+ ...|+|||++-.-... ..+.....-|...-||||+.
T Consensus 347 laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 8899999999996 8999999999999984 443 4689999987432221 11112223478889999998
Q ss_pred ccC-------CcCcceeecC
Q 003911 773 VHT-------RWSSCSYWAG 785 (787)
Q Consensus 773 ~~~-------~~~~~DiWS~ 785 (787)
... .|+++|.|++
T Consensus 424 ta~PGp~avvny~kAD~WA~ 443 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAA 443 (598)
T ss_pred hcCCCCceeeccchhhhhhh
Confidence 642 4668999985
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.8e-15 Score=157.83 Aligned_cols=213 Identities=22% Similarity=0.306 Sum_probs=123.6
Q ss_pred EEEeecCCCCCCC-CCC-CCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccC
Q 003911 96 RLELQWNSISGPL-PSL-NGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173 (787)
Q Consensus 96 ~L~L~~N~l~~~~-~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~ 173 (787)
+|.|++-++..-+ +.. ..|..-...||+.|++..+|.+ +..+..|+.|.|.+|.+. .+|..+.++..|.+|+|+.
T Consensus 54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~elp~~-~~~f~~Le~liLy~n~~r--~ip~~i~~L~~lt~l~ls~ 130 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFSELPEE-ACAFVSLESLILYHNCIR--TIPEAICNLEALTFLDLSS 130 (722)
T ss_pred ccccccchhhcCCCccccccccchhhhhccccccccCchH-HHHHHHHHHHHHHhccce--ecchhhhhhhHHHHhhhcc
Confidence 3455555554422 221 3455556666777776666654 555566666666666666 4555555555555555555
Q ss_pred ceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccc
Q 003911 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253 (787)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (787)
|+++.. |..++ .| -|+.|-+++|+++
T Consensus 131 NqlS~l---------------------------p~~lC--------------------------~l-pLkvli~sNNkl~ 156 (722)
T KOG0532|consen 131 NQLSHL---------------------------PDGLC--------------------------DL-PLKVLIVSNNKLT 156 (722)
T ss_pred chhhcC---------------------------Chhhh--------------------------cC-cceeEEEecCccc
Confidence 555432 22221 11 2444555555555
Q ss_pred cCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchh
Q 003911 254 GPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRL 333 (787)
Q Consensus 254 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~ 333 (787)
..+++++.+..|..||.+.|.+. .+|..++.+.+|+.|++..|++...++++..+
T Consensus 157 ~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~L------------------------ 211 (722)
T KOG0532|consen 157 SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSL------------------------ 211 (722)
T ss_pred cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCC------------------------
Confidence 55555555556666666666665 56666666666666666666665555543211
Q ss_pred hHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCcc
Q 003911 334 NALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEG 413 (787)
Q Consensus 334 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~ 413 (787)
.|..||+|.|+++ .||..|.+|+.|++|-|.+|.|. ..|..
T Consensus 212 -------------------------------------pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAq 252 (722)
T KOG0532|consen 212 -------------------------------------PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQ 252 (722)
T ss_pred -------------------------------------ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHH
Confidence 4666777777777 77888888888888888888887 66776
Q ss_pred CcCCC---CCCeeeccCCc
Q 003911 414 LSVLG---ALKELDVSNNQ 429 (787)
Q Consensus 414 l~~l~---~L~~L~Ls~N~ 429 (787)
++... =.++|+..-.+
T Consensus 253 IC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 253 ICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred HHhccceeeeeeecchhcc
Confidence 64433 34566665553
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.6e-13 Score=151.16 Aligned_cols=213 Identities=24% Similarity=0.343 Sum_probs=155.0
Q ss_pred CCcccEEEcCCCCEE--EEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCC-CCcEEEcccccCCcCCCc
Q 003911 57 CKWNHVVCIEDKRIT--RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLA-SLEVVMLSNNQFTSVPSD 133 (787)
Q Consensus 57 C~w~gv~C~~~~~v~--~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~ 133 (787)
+.+.+..+....... .+++..+.+... ...+..++.++.|++.+|.++.+++....++ +|+.|++++|++..++ .
T Consensus 80 ~~~l~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~-~ 157 (394)
T COG4886 80 ISSLDGSENLLNLLPLPSLDLNLNRLRSN-ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLP-S 157 (394)
T ss_pred cccccccccccCCCCCceeeccccccccC-chhhhcccceeEEecCCcccccCccccccchhhcccccccccchhhhh-h
Confidence 556555554332222 477777776422 3345556788888888888887777777664 8888888888888875 2
Q ss_pred cccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccc
Q 003911 134 FFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGS 213 (787)
Q Consensus 134 ~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 213 (787)
.+..+++|+.|++++|++. .+|...+.++.|+.|++++|+++...+ ... ....|++|.+++|++. .++.
T Consensus 158 ~~~~l~~L~~L~l~~N~l~--~l~~~~~~~~~L~~L~ls~N~i~~l~~-~~~--~~~~L~~l~~~~N~~~-~~~~----- 226 (394)
T COG4886 158 PLRNLPNLKNLDLSFNDLS--DLPKLLSNLSNLNNLDLSGNKISDLPP-EIE--LLSALEELDLSNNSII-ELLS----- 226 (394)
T ss_pred hhhccccccccccCCchhh--hhhhhhhhhhhhhheeccCCccccCch-hhh--hhhhhhhhhhcCCcce-ecch-----
Confidence 3778888888888888888 677777788888888888888874433 321 3455888888888633 1222
Q ss_pred cccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEE
Q 003911 214 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 293 (787)
Q Consensus 214 ~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 293 (787)
.+.+++++..|.+.+|++...+..+..+++|++|++++|+++ .++. +..+.+|+.|+
T Consensus 227 ---------------------~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~ 283 (394)
T COG4886 227 ---------------------SLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELD 283 (394)
T ss_pred ---------------------hhhhcccccccccCCceeeeccchhccccccceecccccccc-cccc-ccccCccCEEe
Confidence 244778888888999998876667788888999999999998 5555 88889999999
Q ss_pred ccCCcccccCCC
Q 003911 294 MTNNLLQGPVPE 305 (787)
Q Consensus 294 Ls~N~l~~~~p~ 305 (787)
+++|.++..+|.
T Consensus 284 ~s~n~~~~~~~~ 295 (394)
T COG4886 284 LSGNSLSNALPL 295 (394)
T ss_pred ccCccccccchh
Confidence 999998877775
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.4e-15 Score=157.16 Aligned_cols=201 Identities=22% Similarity=0.377 Sum_probs=166.4
Q ss_pred EEEeCCCCccccCC--CCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCC
Q 003911 72 RIQIGHQNLQGTLP--SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (787)
Q Consensus 72 ~L~l~~~~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 149 (787)
.|.|++..+. ..| .+=-.|+.-...||+.|++..++..+..+..|+.|.|.+|.+..+++. +.+|..|++|||+.|
T Consensus 54 ~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r~ip~~-i~~L~~lt~l~ls~N 131 (722)
T KOG0532|consen 54 RLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFSELPEEACAFVSLESLILYHNCIRTIPEA-ICNLEALTFLDLSSN 131 (722)
T ss_pred ccccccchhh-cCCCccccccccchhhhhccccccccCchHHHHHHHHHHHHHHhccceecchh-hhhhhHHHHhhhccc
Confidence 3555555555 333 222456777889999999997777788888899999999999988765 889999999999999
Q ss_pred CCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcC
Q 003911 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKL 229 (787)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~ 229 (787)
+++ .+|..+..|+ |+.|-+++|+++ .+|+.++ .++.|..||.+.|++. .+|..+
T Consensus 132 qlS--~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig--~~~tl~~ld~s~nei~-slpsql------------------- 185 (722)
T KOG0532|consen 132 QLS--HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIG--LLPTLAHLDVSKNEIQ-SLPSQL------------------- 185 (722)
T ss_pred hhh--cCChhhhcCc-ceeEEEecCccc-cCCcccc--cchhHHHhhhhhhhhh-hchHHh-------------------
Confidence 999 6788888775 899999999997 5666676 7889999999999998 555544
Q ss_pred CCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCc
Q 003911 230 GGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS 309 (787)
Q Consensus 230 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 309 (787)
+++.+|+.|.+..|++...++++. .-.|..||++.|+++ .+|-.|.+|+.|++|-|.+|.|+..+.+++..
T Consensus 186 -------~~l~slr~l~vrRn~l~~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAqIC~k 256 (722)
T KOG0532|consen 186 -------GYLTSLRDLNVRRNHLEDLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQICEK 256 (722)
T ss_pred -------hhHHHHHHHHHhhhhhhhCCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChHHHHhc
Confidence 489999999999999999999888 446889999999999 99999999999999999999999776665443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.4e-13 Score=149.78 Aligned_cols=59 Identities=29% Similarity=0.493 Sum_probs=40.8
Q ss_pred EEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCC
Q 003911 375 INFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436 (787)
Q Consensus 375 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~ 436 (787)
+.+++|++.. ++..++.++.|+.|++++|+++ .++. ++.+.+|+.||+++|.++..+|.
T Consensus 237 l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 237 LELSNNKLED-LPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred cccCCceeee-ccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchh
Confidence 3344444432 2456677777888888888887 5554 78888888888888888877664
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.7e-13 Score=135.19 Aligned_cols=182 Identities=23% Similarity=0.351 Sum_probs=116.3
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeeccc-ccchhHHHHHHHHHHHHhcCC----------CccceEEeEEEe
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRH----------RHLVALLGHCLD 662 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~~~ 662 (787)
+...+.||.|+++.||.+++. +++++|||++.... ......+++++|.-....+.+ -.++..++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 455789999999999999876 69999999986543 234456778887766655432 223333333221
Q ss_pred ---------C---C-----eeEEEEEecCCCCHHHHHHhhhhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEc
Q 003911 663 ---------G---N-----EKLLVFEYMPQGTLSRHIFNWAEEGLK--PLEWNRRLTIALDVARGVEYLHGLAHQSFIHR 723 (787)
Q Consensus 663 ---------~---~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 723 (787)
. . ..+++|+-+ .+||.+.+......... ......++.+..|+++.+++||+ .|+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 1 1 125677777 67998876543322221 23344566778999999999998 899999
Q ss_pred CCCCCCEEECCCCcEEEeecccceecCCCCCceeeeeccccCcccccccccC--------CcC-cceeec
Q 003911 724 DLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHT--------RWS-SCSYWA 784 (787)
Q Consensus 724 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~-~~DiWS 784 (787)
||||+|++++++|.++|+||+.....+... .....+..|.+||..... .++ +.|-|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ 235 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEE----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCcee----eccCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence 999999999999999999999877654321 112346789999987442 344 678875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.9e-13 Score=130.22 Aligned_cols=88 Identities=23% Similarity=0.234 Sum_probs=75.5
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|+|.+++... ...+++.+++.++.|+++||+|||+ .+ ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc--
Confidence 6888888541 2469999999999999999999997 44 999999999999999 99998764432
Q ss_pred eeeeeccccCcccccccccCCcC-cceeec
Q 003911 756 IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 756 ~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..||+.|||||++.+..++ ++||||
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwS 89 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYS 89 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHH
Confidence 2589999999999999888 899998
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=8.1e-14 Score=157.21 Aligned_cols=170 Identities=21% Similarity=0.206 Sum_probs=127.1
Q ss_pred CCcccceeccccceEEEEEEEeCCcEEEEEEeeccc--ccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGV--ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
+|...+.||++.|=+|.+|+++.|. |+||++-+.. .+-....+-.+|++ ....+|||++++.-+-...+..|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5666789999999999999998887 9999987643 22222333334444 555589999999888777777888888
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee--c
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--A 749 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~--~ 749 (787)
|. .-+|+|.+. .+.-+...+.+.|+.|++.||..+|. .||+|||||.+||||+.-.-+.|+||..-+. +
T Consensus 102 yv-khnLyDRlS-----TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 102 YV-KHNLYDRLS-----TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HH-hhhhhhhhc-----cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccC
Confidence 88 458888873 33456777888999999999999997 8999999999999999999999999987653 2
Q ss_pred CCCCCceeeeeccc----cCccccccccc
Q 003911 750 PEGKGSIETRIAGT----FGYLAPEYAVH 774 (787)
Q Consensus 750 ~~~~~~~~~~~~gt----~~y~aPE~~~~ 774 (787)
.+++....+-+..| ..|.|||.+..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~ 201 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVS 201 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhc
Confidence 22222222222222 35999998855
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.8e-13 Score=148.41 Aligned_cols=151 Identities=20% Similarity=0.248 Sum_probs=95.6
Q ss_pred hhcCCCcccceeccccceEEEEEEEeC-CcEEEEEEeecccccc--------------------------------hhHH
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISG--------------------------------KGLT 636 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--------------------------------~~~~ 636 (787)
.....|+. +.||+|++|.||+|+.++ |+.||||+.++..... +..+
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 34456776 789999999999999887 9999999997542100 0111
Q ss_pred ------HHHHHHHHHHhcC----CCccceEEeEEEe-CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHH
Q 003911 637 ------EFKSEIAVLTKVR----HRHLVALLGHCLD-GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705 (787)
Q Consensus 637 ------~~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi 705 (787)
++.+|...+.+++ +...+.+-.++.+ ....+|||||++|+.+.+.-.- ... ..+.. .++...
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~---g~d~~---~la~~~ 268 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAA---GTDMK---LLAERG 268 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-Hhc---CCCHH---HHHHHH
Confidence 2344554444442 3333333333322 4567899999999999774211 111 11111 122222
Q ss_pred HHH-HHHHHhCCCCCeEEcCCCCCCEEECCCC----cEEEeecccceecCC
Q 003911 706 ARG-VEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVADFGLVRLAPE 751 (787)
Q Consensus 706 ~~~-L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG~a~~~~~ 751 (787)
+.. +..++. .|++|+|+||.||+++.++ +++++|||++.....
T Consensus 269 v~~~~~Qif~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 269 VEVFFTQVFR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHHh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 221 222333 7999999999999999888 999999999987754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.5e-13 Score=153.86 Aligned_cols=187 Identities=23% Similarity=0.313 Sum_probs=147.8
Q ss_pred CCcccceeccccceEEEEEEEe--CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCeeEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 670 (787)
.|.+.+.||+|+|+.|-.+... ....+|+|.+...............|..+-+.+. |+|++.+++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4667778999999999887543 3455677766554333444566677888888886 999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC-cEEEeecccceec
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRLA 749 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~ 749 (787)
||..++++.+.+. .......+......++.|+..++.|+|. ..++.|||+||+|.+++..+ ..+++|||+|..+
T Consensus 101 ~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred Ccccccccccccc---cCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999987763 1222245566777899999999999993 28999999999999999999 9999999999877
Q ss_pred CC--CCCceeeeecc-ccCcccccccccCCcC--cceeecC
Q 003911 750 PE--GKGSIETRIAG-TFGYLAPEYAVHTRWS--SCSYWAG 785 (787)
Q Consensus 750 ~~--~~~~~~~~~~g-t~~y~aPE~~~~~~~~--~~DiWS~ 785 (787)
.. +........+| ++.|+|||...+..+. ..|+||.
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~ 216 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSL 216 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccc
Confidence 65 22233345678 9999999999885444 7999985
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.9e-12 Score=120.26 Aligned_cols=132 Identities=20% Similarity=0.162 Sum_probs=96.9
Q ss_pred cceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCcc-ceEEeEEEeCCeeEEEEEecCCC
Q 003911 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL-VALLGHCLDGNEKLLVFEYMPQG 676 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g 676 (787)
.+.++.|.++.||+++.. +..|++|+...... ....+++|+++++.+.+.++ ++++.+. ....++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 367899999999999875 78899998755321 22356889999999865554 4455443 33458999999998
Q ss_pred CHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA--HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
++.+.- . ....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+...
T Consensus 77 ~l~~~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 77 ELLTED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccccc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 775320 0 11245679999999999732 22369999999999998 668999999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=4e-11 Score=115.50 Aligned_cols=139 Identities=14% Similarity=0.135 Sum_probs=100.0
Q ss_pred ceeccccceEEEEEEEeC-------CcEEEEEEeeccccc--------------------chhHHHH----HHHHHHHHh
Q 003911 599 NILGRGGFGTVYKGELHD-------GTKIAVKRMEAGVIS--------------------GKGLTEF----KSEIAVLTK 647 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~--------------------~~~~~~~----~~E~~~l~~ 647 (787)
..||.|--+.||.|...+ +..+|||+.+..... ....+.+ ++|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999996543 479999988632110 0012223 389999999
Q ss_pred cCC--CccceEEeEEEeCCeeEEEEEecCCCCHHH-HHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEc
Q 003911 648 VRH--RHLVALLGHCLDGNEKLLVFEYMPQGTLSR-HIFNWAEEGLKPLEWNRRLTIALDVARGVEYL-HGLAHQSFIHR 723 (787)
Q Consensus 648 l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~ivH~ 723 (787)
+.. -++++++++ ...++||||+.+..+.. .+++ ..++.++...+..+++.++..| |. .++|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 953 566677764 45689999997654421 2211 1344456677889999999999 75 899999
Q ss_pred CCCCCCEEECCCCcEEEeecccceecCC
Q 003911 724 DLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 724 Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++.||+++ ++.+.++|||.|.....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 9999999996 46799999998876643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.6e-12 Score=145.17 Aligned_cols=146 Identities=28% Similarity=0.540 Sum_probs=101.2
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
..+|..++.|..|+||.||.++++ +.+.+|+| +.+...- +++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li------lRn---ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI------LRN---ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh------hhc---cccccCCccee----------------
Confidence 467899999999999999999876 57788884 3331110 010 22333344443
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||-...++ ..++++. +++.+++|+|+ .+|+|||+||+|.+|+.-|++|++|||+.+..-
T Consensus 136 -----gDc~tllk-----~~g~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 -----GDCATLLK-----NIGPLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred -----chhhhhcc-----cCCCCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 44444442 2233443 33788999997 899999999999999999999999999976432
Q ss_pred CCC------C--------ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 751 EGK------G--------SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~------~--------~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
... + -....++|||.|+|||++..+.|. ++|-|+
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwa 243 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWA 243 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHH
Confidence 110 0 011346899999999999999999 677665
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.1e-10 Score=107.99 Aligned_cols=135 Identities=24% Similarity=0.314 Sum_probs=104.4
Q ss_pred ceeccccceEEEEEEEeCCcEEEEEEeecccccch------hHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK------GLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
..+++|+-+.+|.+.+. |.++++|.-.++..... ...+..+|.+++.+++--.|...+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999775 55577775443333222 234577899999999877777766677788888999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
++|..|.+.+... ...++..+-.-+.-||. .+|||+|+.++||++..+. +.++|||++....
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 9998888887431 23567777788888996 9999999999999997664 9999999997543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3e-12 Score=135.41 Aligned_cols=112 Identities=30% Similarity=0.438 Sum_probs=94.2
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..|+.|++|...+|.+++.... .....++.....++.|++.|++| ++.+|||+||.||++..+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 4689999999999999996432 22346777888999999999999 479999999999999999999999999
Q ss_pred cceecCCCC-----CceeeeeccccCcccccccccCCcC-cceeec
Q 003911 745 LVRLAPEGK-----GSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 745 ~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+........ ....+..+||..||+||.+.++.|+ ++||||
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIya 447 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYA 447 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhh
Confidence 987665443 2233456899999999999999999 999997
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.17 E-value=9e-12 Score=117.57 Aligned_cols=106 Identities=26% Similarity=0.392 Sum_probs=32.2
Q ss_pred CEEEEEeCCCCccccCCCCCC-CCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEcc
Q 003911 69 RITRIQIGHQNLQGTLPSNLQ-NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (787)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 147 (787)
++++|+|++|.|+. | +.++ .+++|+.|+|++|.|+.+ +.+..+++|++|+|++|+|+.+.+.....+++|++|+|+
T Consensus 20 ~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~ 96 (175)
T PF14580_consen 20 KLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLS 96 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS---S-CHHHHHH-TT--EEE-T
T ss_pred cccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEECc
Confidence 35566666666662 3 2344 456666666666666643 345566666666666666666544322356666666666
Q ss_pred CCCCCCCCCChhhhcCCCCCEEeccCceec
Q 003911 148 NNPFSSWEIPQSLRNASGLQNFSANSANIT 177 (787)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~ 177 (787)
+|+|..+..-..+..+++|+.|++.+|.++
T Consensus 97 ~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 97 NNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp TS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 666664433345556666666666666665
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.5e-10 Score=115.10 Aligned_cols=144 Identities=20% Similarity=0.297 Sum_probs=109.8
Q ss_pred ceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCC--CccceEEeEEEeCC---eeEEEEEec
Q 003911 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--RHLVALLGHCLDGN---EKLLVFEYM 673 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~---~~~lv~e~~ 673 (787)
+.++.|..+.||+++..+|+.+++|+....... ....++..|.++++.+++ ..+++++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998876789999987653221 234678999999999975 34677777766542 568999999
Q ss_pred CCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 003911 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA------------------------------------- 716 (787)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------------- 716 (787)
+|.++.+.+.. ..++..+...++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 83 DGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99888654410 24566777778888888888888421
Q ss_pred ----------------CCCeEEcCCCCCCEEECC--CCcEEEeecccceec
Q 003911 717 ----------------HQSFIHRDLKPSNILLGD--DMRAKVADFGLVRLA 749 (787)
Q Consensus 717 ----------------~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~~~ 749 (787)
+..++|+|++|.||+++. ++.+.|+||+.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 246899999999999998 667899999988643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.1e-11 Score=115.06 Aligned_cols=85 Identities=36% Similarity=0.518 Sum_probs=21.6
Q ss_pred CCCCCCCcEEEeecCCCCCCCCCCC-CCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhh-hcCCC
Q 003911 88 LQNLTKLERLELQWNSISGPLPSLN-GLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSL-RNASG 165 (787)
Q Consensus 88 ~~~l~~L~~L~L~~N~l~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~-~~l~~ 165 (787)
+.+..++++|+|++|.|+.+ ..++ .+.+|++|+|++|.|+.+.. +..+++|++|++++|+|+ .++..+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I-e~L~~~l~~L~~L~Ls~N~I~~l~~--l~~L~~L~~L~L~~N~I~--~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI-ENLGATLDKLEVLDLSNNQITKLEG--LPGLPRLKTLDLSNNRIS--SISEGLDKNLPN 89 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S--TT------TT--EEE--SS-----S-CHHHHHH-TT
T ss_pred cccccccccccccccccccc-cchhhhhcCCCEEECCCCCCccccC--ccChhhhhhcccCCCCCC--ccccchHHhCCc
Confidence 44455677888888888754 3454 46777888888888777653 667777777777777777 344433 24555
Q ss_pred CCEEeccCceec
Q 003911 166 LQNFSANSANIT 177 (787)
Q Consensus 166 L~~L~l~~n~l~ 177 (787)
|+.|++++|+|.
T Consensus 90 L~~L~L~~N~I~ 101 (175)
T PF14580_consen 90 LQELYLSNNKIS 101 (175)
T ss_dssp --EEE-TTS---
T ss_pred CCEEECcCCcCC
Confidence 555555555554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.4e-10 Score=102.13 Aligned_cols=146 Identities=23% Similarity=0.264 Sum_probs=110.3
Q ss_pred ccceeccccceEEEEEEEeCCcEEEEEEeecccccc------hhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 597 EENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG------KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 597 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
....+-+|+-+.|+++.+. |+..+||.-..+.... -...+..+|++.+.+++--.|....=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578999999999999886 8888888544333221 23456789999999997667776666777777778999
Q ss_pred EecCC-CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC---cEEEeecccc
Q 003911 671 EYMPQ-GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGLV 746 (787)
Q Consensus 671 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a 746 (787)
||++| .++.+++...... ....+....++.+|-+.+.-||. .+|||+||..+||++..++ .+.++|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecch
Confidence 99976 4777777553322 22233336788999999999997 8999999999999997554 3589999998
Q ss_pred eec
Q 003911 747 RLA 749 (787)
Q Consensus 747 ~~~ 749 (787)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.9e-12 Score=139.52 Aligned_cols=174 Identities=25% Similarity=0.330 Sum_probs=93.9
Q ss_pred CCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEE
Q 003911 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNF 169 (787)
Q Consensus 90 ~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L 169 (787)
.+..++.+++..|.|......+..+++|+.|++.+|+|..+... +..+++|++|+|++|.|+.+ ..+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i~~~-l~~~~~L~~L~ls~N~I~~i---~~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKIENL-LSSLVNLQVLDLSFNKITKL---EGLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhhhhcccccccceeeeeccccchhhcccc-hhhhhcchheeccccccccc---cchhhccchhhh
Confidence 44555556666666665444466666666666666666665543 45566666666666666642 234445556666
Q ss_pred eccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccc
Q 003911 170 SANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS 249 (787)
Q Consensus 170 ~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~ 249 (787)
++.+|.|+.. ..+. .++.|+.+++++|++...-+.. +..+.+|+.+++.+
T Consensus 146 ~l~~N~i~~~--~~~~--~l~~L~~l~l~~n~i~~ie~~~--------------------------~~~~~~l~~l~l~~ 195 (414)
T KOG0531|consen 146 NLSGNLISDI--SGLE--SLKSLKLLDLSYNRIVDIENDE--------------------------LSELISLEELDLGG 195 (414)
T ss_pred eeccCcchhc--cCCc--cchhhhcccCCcchhhhhhhhh--------------------------hhhccchHHHhccC
Confidence 6666666533 1221 3666777777777766333310 11455666666666
Q ss_pred cccccCCCCCCCCCCCCEEecCCCcccccCCccccCCC--CCCEEEccCCccc
Q 003911 250 NAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLE--SLKIVNMTNNLLQ 300 (787)
Q Consensus 250 N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~--~L~~L~Ls~N~l~ 300 (787)
|.+. .+..+..+..+..+++..|.++-.-+ +..+. +|+.+++++|++.
T Consensus 196 n~i~-~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~ 245 (414)
T KOG0531|consen 196 NSIR-EIEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS 245 (414)
T ss_pred Cchh-cccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc
Confidence 6665 22233334444445666666652222 11122 2566666666655
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.13 E-value=5e-12 Score=129.84 Aligned_cols=185 Identities=21% Similarity=0.218 Sum_probs=115.1
Q ss_pred CCCCCCcEEEeecCCCCCCCC--CCCCCCCCcEEEcccccCCcCC--CccccCCCCCcEEEccCCCCCCCCCChhhhcCC
Q 003911 89 QNLTKLERLELQWNSISGPLP--SLNGLASLEVVMLSNNQFTSVP--SDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNAS 164 (787)
Q Consensus 89 ~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~ 164 (787)
.++.+|+...|.+..+..... ....|++++.||||+|-|.... ......|++|+.|+|+.|++....-...-..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 356777777777777765432 3566777888888888777532 234567788888888888776421112223566
Q ss_pred CCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCce
Q 003911 165 GLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKE 244 (787)
Q Consensus 165 ~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~ 244 (787)
+|+.|.++.|.|+..--..+. ..+|+|+.|+|..|...+..... ...+..|++
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~-~~fPsl~~L~L~~N~~~~~~~~~--------------------------~~i~~~L~~ 250 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWIL-LTFPSLEVLYLEANEIILIKATS--------------------------TKILQTLQE 250 (505)
T ss_pred hhheEEeccCCCCHHHHHHHH-HhCCcHHHhhhhcccccceecch--------------------------hhhhhHHhh
Confidence 777788887777632211111 25677888888887522111111 124566777
Q ss_pred EeccccccccCC--CCCCCCCCCCEEecCCCccccc-CCcc-----ccCCCCCCEEEccCCccc
Q 003911 245 IWLHSNAFSGPL--PDFSGVKQLESLSLRDNFFTGP-VPDS-----LVKLESLKIVNMTNNLLQ 300 (787)
Q Consensus 245 L~L~~N~l~~~~--~~~~~l~~L~~L~L~~N~l~~~-~p~~-----l~~l~~L~~L~Ls~N~l~ 300 (787)
|||++|++-... +..+.++.|+.|.++.+.++.. +|+. ....++|++|+++.|++.
T Consensus 251 LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 251 LDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred ccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 777777776544 4566777777777777777632 2332 345677777888777774
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.5e-11 Score=118.52 Aligned_cols=136 Identities=23% Similarity=0.311 Sum_probs=108.6
Q ss_pred ccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeec
Q 003911 235 VIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDM 314 (787)
Q Consensus 235 ~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~ 314 (787)
.+..+..|++||||+|.|+..-.+..-++.++.|++++|.|+ .+.. +..+++|+.||||+|.|+...
T Consensus 279 ~~dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~~~----------- 345 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAECV----------- 345 (490)
T ss_pred ecchHhhhhhccccccchhhhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhHhhh-----------
Confidence 445677899999999999977667777899999999999998 4443 889999999999999887321
Q ss_pred cccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCC
Q 003911 315 AKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFK 394 (787)
Q Consensus 315 l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~ 394 (787)
|....+++++.|.|++|.+... ..++.+-
T Consensus 346 -------------------------------------------------Gwh~KLGNIKtL~La~N~iE~L--SGL~KLY 374 (490)
T KOG1259|consen 346 -------------------------------------------------GWHLKLGNIKTLKLAQNKIETL--SGLRKLY 374 (490)
T ss_pred -------------------------------------------------hhHhhhcCEeeeehhhhhHhhh--hhhHhhh
Confidence 1122456899999999998732 2366778
Q ss_pred CCCEEeccccccccc-CCccCcCCCCCCeeeccCCcccccC
Q 003911 395 SLQRLILADNNLSGM-IPEGLSVLGALKELDVSNNQLYGKI 434 (787)
Q Consensus 395 ~L~~L~Ls~N~l~g~-ip~~l~~l~~L~~L~Ls~N~l~g~i 434 (787)
+|..||+++|+|... --..+++|+.|+.|.|.+|+|.+.+
T Consensus 375 SLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 375 SLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 899999999999732 1346899999999999999998744
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.8e-12 Score=128.46 Aligned_cols=91 Identities=19% Similarity=0.231 Sum_probs=51.8
Q ss_pred CCCCCCcEEEcccccCCcCCC-ccccCCCCCcEEEccCCCCCCCCC-ChhhhcCCCCCEEeccCceecccCCCCCCCCCC
Q 003911 112 NGLASLEVVMLSNNQFTSVPS-DFFTGLSSLQSIEIDNNPFSSWEI-PQSLRNASGLQNFSANSANITGQIPSFFGPDEF 189 (787)
Q Consensus 112 ~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~-p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l 189 (787)
.++.+|++..|.+..+...+. +....+++++.||||.|-+..+.. -.....|++|+.|+++.|.+.-....... ..+
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~-~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTT-LLL 196 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccch-hhh
Confidence 346777777777777765543 445677777888888777764321 12334556666666666655433332221 234
Q ss_pred CCCcEEeccccccc
Q 003911 190 PGLTILHLAFNQLI 203 (787)
Q Consensus 190 ~~L~~L~L~~N~l~ 203 (787)
+.|+.|.|+.|.|+
T Consensus 197 ~~lK~L~l~~CGls 210 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLS 210 (505)
T ss_pred hhhheEEeccCCCC
Confidence 55555555555554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.2e-11 Score=118.88 Aligned_cols=188 Identities=21% Similarity=0.261 Sum_probs=126.6
Q ss_pred cCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCC---Cc--------------------cccCCC
Q 003911 83 TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVP---SD--------------------FFTGLS 139 (787)
Q Consensus 83 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~--------------------~~~~l~ 139 (787)
.+|-.+.-+.+|..+.+|++.-..+..-...-+.|+++...+..++..+ |. ....-.
T Consensus 205 ~l~f~l~~f~~l~~~~~s~~~~~~i~~~~~~kptl~t~~v~~s~~~~~~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq 284 (490)
T KOG1259|consen 205 RLSFNLNAFRNLKTLKFSALSTENIVDIELLKPTLQTICVHNTTIQDVPSLLPETILADPSGSEPSTSNGSALVSADTWQ 284 (490)
T ss_pred ccccchHHhhhhheeeeeccchhheeceeecCchhheeeeecccccccccccchhhhcCccCCCCCccCCceEEecchHh
Confidence 3454556667777777777654333222222355667766665554322 10 011223
Q ss_pred CCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCccccccccee
Q 003911 140 SLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLW 219 (787)
Q Consensus 140 ~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~ 219 (787)
.|++||||+|.|+ .+.++..-++.++.|++++|.|...-. +. .+++|+.|||++|.++...--.
T Consensus 285 ~LtelDLS~N~I~--~iDESvKL~Pkir~L~lS~N~i~~v~n--La--~L~~L~~LDLS~N~Ls~~~Gwh---------- 348 (490)
T KOG1259|consen 285 ELTELDLSGNLIT--QIDESVKLAPKLRRLILSQNRIRTVQN--LA--ELPQLQLLDLSGNLLAECVGWH---------- 348 (490)
T ss_pred hhhhccccccchh--hhhhhhhhccceeEEeccccceeeehh--hh--hcccceEeecccchhHhhhhhH----------
Confidence 5788999999888 678888888899999999998875432 32 6888999999999887332211
Q ss_pred eccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccC-CccccCCCCCCEEEccCCc
Q 003911 220 VNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPV-PDSLVKLESLKIVNMTNNL 298 (787)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~ 298 (787)
.++-+++.|.|++|.|.. ...+..+.+|..||+++|+|...- -..+++++.|++|.|.+|.
T Consensus 349 -----------------~KLGNIKtL~La~N~iE~-LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NP 410 (490)
T KOG1259|consen 349 -----------------LKLGNIKTLKLAQNKIET-LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNP 410 (490)
T ss_pred -----------------hhhcCEeeeehhhhhHhh-hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCC
Confidence 156678888888888762 335666788889999999887322 3568888899999999998
Q ss_pred ccccCC
Q 003911 299 LQGPVP 304 (787)
Q Consensus 299 l~~~~p 304 (787)
|.+.+.
T Consensus 411 l~~~vd 416 (490)
T KOG1259|consen 411 LAGSVD 416 (490)
T ss_pred ccccch
Confidence 886543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.9e-11 Score=122.50 Aligned_cols=196 Identities=21% Similarity=0.324 Sum_probs=102.7
Q ss_pred CCEEEEEeCCCCcccc----CCCCCCCCCCCcEEEeecCCCCC----CCC--------CCCCCCCCcEEEcccccCCcCC
Q 003911 68 KRITRIQIGHQNLQGT----LPSNLQNLTKLERLELQWNSISG----PLP--------SLNGLASLEVVMLSNNQFTSVP 131 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~----~~~~~~~l~~L~~L~L~~N~l~~----~~~--------~~~~l~~L~~L~L~~N~l~~~~ 131 (787)
..++.|+|++|.+... +.+.+.+.++|+..++|+= ++| .+| ++.+.++|++||||+|.|..--
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g 108 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKG 108 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccc
Confidence 3566666666665532 3344555566666666542 222 111 2334455666666666554211
Q ss_pred C----ccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCC
Q 003911 132 S----DFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLP 207 (787)
Q Consensus 132 ~----~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p 207 (787)
+ +.+..+..|++|.|.+|.+.. .-...++. .|..|. .|+. . ..-++|+.++.++|++.....
T Consensus 109 ~~~l~~ll~s~~~L~eL~L~N~Glg~-~ag~~l~~--al~~l~--~~kk-------~--~~~~~Lrv~i~~rNrlen~ga 174 (382)
T KOG1909|consen 109 IRGLEELLSSCTDLEELYLNNCGLGP-EAGGRLGR--ALFELA--VNKK-------A--ASKPKLRVFICGRNRLENGGA 174 (382)
T ss_pred hHHHHHHHHhccCHHHHhhhcCCCCh-hHHHHHHH--HHHHHH--HHhc-------c--CCCcceEEEEeeccccccccH
Confidence 1 123344555555555554441 00011110 111111 1111 1 134578888888888763222
Q ss_pred cCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCC-----CCCCCCCCCEEecCCCccccc----
Q 003911 208 ASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-----DFSGVKQLESLSLRDNFFTGP---- 278 (787)
Q Consensus 208 ~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-----~~~~l~~L~~L~L~~N~l~~~---- 278 (787)
..+ ...|...+.|+.+.++.|.|...-- .+..+++|+.|||.+|.|+-.
T Consensus 175 ~~~----------------------A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~ 232 (382)
T KOG1909|consen 175 TAL----------------------AEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVA 232 (382)
T ss_pred HHH----------------------HHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHH
Confidence 211 1235566788888888888753211 366778888888888888732
Q ss_pred CCccccCCCCCCEEEccCCccc
Q 003911 279 VPDSLVKLESLKIVNMTNNLLQ 300 (787)
Q Consensus 279 ~p~~l~~l~~L~~L~Ls~N~l~ 300 (787)
+...++.+++|++|+++++.+.
T Consensus 233 LakaL~s~~~L~El~l~dcll~ 254 (382)
T KOG1909|consen 233 LAKALSSWPHLRELNLGDCLLE 254 (382)
T ss_pred HHHHhcccchheeecccccccc
Confidence 3345666777888888777765
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.4e-10 Score=122.56 Aligned_cols=135 Identities=27% Similarity=0.389 Sum_probs=107.7
Q ss_pred HHhcCCCccceEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcC
Q 003911 645 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRD 724 (787)
Q Consensus 645 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 724 (787)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....+++.-...+.++|++||+|+|.. .-..|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeee
Confidence 3567899999999999999999999999999999999955 335688888999999999999999972 3339999
Q ss_pred CCCCCEEECCCCcEEEeecccceecCCCC-CceeeeeccccCcccccccccCC-------cC-cceeecC
Q 003911 725 LKPSNILLGDDMRAKVADFGLVRLAPEGK-GSIETRIAGTFGYLAPEYAVHTR-------WS-SCSYWAG 785 (787)
Q Consensus 725 lkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-------~~-~~DiWS~ 785 (787)
+++.|+++|....+|++|||+........ ........-..-|.|||.+.+.. .+ +.|+||-
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~ 144 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF 144 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence 99999999999999999999987764310 01111122345799999998741 22 6899973
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.3e-09 Score=101.18 Aligned_cols=129 Identities=22% Similarity=0.253 Sum_probs=84.5
Q ss_pred EEEEEEEeCCcEEEEEEeeccccc------------------------chhHHHHHHHHHHHHhcCCC--ccceEEeEEE
Q 003911 608 TVYKGELHDGTKIAVKRMEAGVIS------------------------GKGLTEFKSEIAVLTKVRHR--HLVALLGHCL 661 (787)
Q Consensus 608 ~Vy~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~ 661 (787)
.||.|...+|..+|||+.+..... .......++|.+.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999888999999987632110 01124578899999999765 566776552
Q ss_pred eCCeeEEEEEecC--CCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEcCCCCCCEEECCCCcE
Q 003911 662 DGNEKLLVFEYMP--QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL-HGLAHQSFIHRDLKPSNILLGDDMRA 738 (787)
Q Consensus 662 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~ivH~Dlkp~NIll~~~~~~ 738 (787)
..++||||++ |..+..+. +. .++.+....++.+++..+..+ |. .||||+|+.+.||+++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~------~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DV------DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HC------GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHH-hc------cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eE
Confidence 3479999998 55554432 21 111334556777888866664 65 899999999999999887 89
Q ss_pred EEeecccceecCC
Q 003911 739 KVADFGLVRLAPE 751 (787)
Q Consensus 739 kl~DFG~a~~~~~ 751 (787)
.++|||.+.....
T Consensus 146 ~iIDf~qav~~~~ 158 (188)
T PF01163_consen 146 YIIDFGQAVDSSH 158 (188)
T ss_dssp EE--GTTEEETTS
T ss_pred EEEecCcceecCC
Confidence 9999999876643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.6e-11 Score=132.62 Aligned_cols=61 Identities=28% Similarity=0.339 Sum_probs=39.5
Q ss_pred cCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCcc-ccCCCCCCEEEccCCccc
Q 003911 238 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDS-LVKLESLKIVNMTNNLLQ 300 (787)
Q Consensus 238 ~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~ 300 (787)
.++.|+.|++++|.|+ .+..+..++.|+.+++++|+++..-+ . +..+.+|+.+++.+|.+.
T Consensus 138 ~l~~L~~L~l~~N~i~-~~~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 138 TLTLLKELNLSGNLIS-DISGLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIR 199 (414)
T ss_pred hccchhhheeccCcch-hccCCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchh
Confidence 4555777777777776 33445557777777777777773333 2 466777777777777665
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.7e-10 Score=122.16 Aligned_cols=185 Identities=23% Similarity=0.218 Sum_probs=143.1
Q ss_pred CCCcccceecc--ccceEEEEEEE---eCCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCee
Q 003911 593 NNFSEENILGR--GGFGTVYKGEL---HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 593 ~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 666 (787)
..|.+.+.+|. |.+|.||.+.. .++..+|+|+-+..........+=.+|+...+++ .|++.++.+..+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34666788999 99999999976 4788999998554333233333445666767777 499999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEcCCCCCCEEECCC-CcEEEe
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR----GVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVA 741 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~ 741 (787)
++-+|++ +.++..+.+. ....++....+.+..+... |+.++|+ .+++|-|+||.||+...+ ...+++
T Consensus 194 fiqtE~~-~~sl~~~~~~----~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHT----PCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred eeeeccc-cchhHHhhhc----ccccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecC
Confidence 9999998 5677776643 2234667777888888888 9999998 899999999999999988 889999
Q ss_pred ecccceecCCCCCc----eeeeeccccCcccccccccCCcCcceeecC
Q 003911 742 DFGLVRLAPEGKGS----IETRIAGTFGYLAPEYAVHTRWSSCSYWAG 785 (787)
Q Consensus 742 DFG~a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~DiWS~ 785 (787)
|||+...+.+..-. ...+..|...|++||...+......|++|-
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl 313 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSL 313 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcch
Confidence 99999887665421 112235788899999998877778888863
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.3e-08 Score=104.03 Aligned_cols=143 Identities=15% Similarity=0.160 Sum_probs=101.7
Q ss_pred ceeccccceEEEEEEEeCCcEEEEEEeecccccc---------hhHHHHHHHHHHHHhcCCCcc--ceEEeEEEe-----
Q 003911 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG---------KGLTEFKSEIAVLTKVRHRHL--VALLGHCLD----- 662 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~----- 662 (787)
+.+-.-....|++.+. +|+.|.||+........ .....+.+|.+.+.++...+| ++++++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444445667766 47899999774322110 111247899999998854343 344556543
Q ss_pred CCeeEEEEEecCCC-CHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC-------
Q 003911 663 GNEKLLVFEYMPQG-TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD------- 734 (787)
Q Consensus 663 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~------- 734 (787)
....++|||++++. +|.+++..+.. .+.+......++.+++..+.-||. .||+|+|++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCC
Confidence 23578999999876 78888754322 234566777899999999999998 89999999999999975
Q ss_pred CCcEEEeeccccee
Q 003911 735 DMRAKVADFGLVRL 748 (787)
Q Consensus 735 ~~~~kl~DFG~a~~ 748 (787)
+..+.++||+.++.
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46899999998864
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.9e-10 Score=87.55 Aligned_cols=60 Identities=38% Similarity=0.627 Sum_probs=43.8
Q ss_pred CCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCC
Q 003911 92 TKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF 151 (787)
Q Consensus 92 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 151 (787)
++|++|+|++|+|+.+++ .|.++++|++|++++|+|+.+++++|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 456777777777776665 577777777777777777777777777777777777777754
|
... |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=8.5e-11 Score=117.86 Aligned_cols=251 Identities=19% Similarity=0.245 Sum_probs=153.7
Q ss_pred CCCCCCCCCcEEEeecCCCCCCC-----CCCCCCCCCcEEEcccccCCc----CCC------ccccCCCCCcEEEccCCC
Q 003911 86 SNLQNLTKLERLELQWNSISGPL-----PSLNGLASLEVVMLSNNQFTS----VPS------DFFTGLSSLQSIEIDNNP 150 (787)
Q Consensus 86 ~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~L~~N~l~~----~~~------~~~~~l~~L~~L~L~~N~ 150 (787)
+.+..+..++.|+||+|.|...- +.+.+.++|+..++|+=...- +|+ .++...++|++||||+|-
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 44667788889999999886532 246777788888887643221 111 234455677777777777
Q ss_pred CCCCCCChh----hhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCC
Q 003911 151 FSSWEIPQS----LRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGN 226 (787)
Q Consensus 151 l~~~~~p~~----~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~ 226 (787)
|.. .-+.. +.+...|++|+|.+|.+.-.--..++ ..|..|. .|+
T Consensus 104 ~G~-~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~----~al~~l~--~~k------------------------- 151 (382)
T KOG1909|consen 104 FGP-KGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLG----RALFELA--VNK------------------------- 151 (382)
T ss_pred cCc-cchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHH----HHHHHHH--HHh-------------------------
Confidence 664 22222 33344444444444443211111111 0111111 111
Q ss_pred CcCCCCccccccCccCceEeccccccccCCC-----CCCCCCCCCEEecCCCcccc----cCCccccCCCCCCEEEccCC
Q 003911 227 AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-----DFSGVKQLESLSLRDNFFTG----PVPDSLVKLESLKIVNMTNN 297 (787)
Q Consensus 227 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-----~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N 297 (787)
.++.-+.|+.+..++|++..... .|...+.|+.+.++.|.|.- .+-..|..+++|++|||.+|
T Consensus 152 --------k~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DN 223 (382)
T KOG1909|consen 152 --------KAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDN 223 (382)
T ss_pred --------ccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccc
Confidence 12245689999999999976543 26667899999999998862 23456788999999999999
Q ss_pred cccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEc
Q 003911 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINF 377 (787)
Q Consensus 298 ~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~L 377 (787)
-|+..-.. .+ -...+.++.|+.|++
T Consensus 224 tft~egs~--------------------------------~L-----------------------akaL~s~~~L~El~l 248 (382)
T KOG1909|consen 224 TFTLEGSV--------------------------------AL-----------------------AKALSSWPHLRELNL 248 (382)
T ss_pred hhhhHHHH--------------------------------HH-----------------------HHHhcccchheeecc
Confidence 88732110 00 012234457888888
Q ss_pred cCCcccccCchhhc-----CCCCCCEEecccccccc----cCCccCcCCCCCCeeeccCCccc
Q 003911 378 QKMNLTGTISPEFA-----SFKSLQRLILADNNLSG----MIPEGLSVLGALKELDVSNNQLY 431 (787)
Q Consensus 378 s~N~l~g~~p~~~~-----~l~~L~~L~Ls~N~l~g----~ip~~l~~l~~L~~L~Ls~N~l~ 431 (787)
+++.+...-...|. ..++|++|.|.+|.++. .+-..+...+.|..|+|++|.|.
T Consensus 249 ~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 249 GDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred cccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 88888865544442 36788888888888862 23334566788888888888883
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.7e-09 Score=81.39 Aligned_cols=61 Identities=33% Similarity=0.517 Sum_probs=57.2
Q ss_pred CceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcc
Q 003911 370 GNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430 (787)
Q Consensus 370 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l 430 (787)
++|+.|++++|+++...+..|..+++|++|+|++|+++...|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3789999999999988888999999999999999999988888999999999999999986
|
... |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.4e-08 Score=107.24 Aligned_cols=125 Identities=15% Similarity=0.184 Sum_probs=103.0
Q ss_pred EEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCC
Q 003911 613 ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP 692 (787)
Q Consensus 613 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~ 692 (787)
+..++.+|.|+.++.... ...+...+-++.++.+|||+|+++++.++..+..|+|+|-+. .|..++..
T Consensus 33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------- 100 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------- 100 (690)
T ss_pred eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------
Confidence 344788999998876432 344567788899999999999999999999999999999884 56666643
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 693 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 693 l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
+....+...++||+.||.|||. +.+++|++|.-+-|+|+..|+.||++|..+.....
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~ 157 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASG 157 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEecccc
Confidence 2245566778999999999997 58999999999999999999999999998865533
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=7.5e-09 Score=121.99 Aligned_cols=179 Identities=19% Similarity=0.300 Sum_probs=81.9
Q ss_pred CCcEEEccccc--CCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCc
Q 003911 116 SLEVVMLSNNQ--FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLT 193 (787)
Q Consensus 116 ~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~ 193 (787)
+|++|-+..|. +..++.+.|..++.|+.|||++|.=-+ .+|..++.|-+|++|++++..++ .+|..++ +|.+|.
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~-~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~--~Lk~L~ 621 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLS-KLPSSIGELVHLRYLDLSDTGIS-HLPSGLG--NLKKLI 621 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccC-cCChHHhhhhhhhcccccCCCcc-ccchHHH--HHHhhh
Confidence 34444444443 444444444444444444444433222 44444444444444444444444 3333333 444444
Q ss_pred EEeccccccccCCCcCcc-cccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCC----EE
Q 003911 194 ILHLAFNQLIGGLPASFS-GSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLE----SL 268 (787)
Q Consensus 194 ~L~L~~N~l~~~~p~~~~-~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~----~L 268 (787)
+|++..+.-...+|.... -.+|+.|.+.... ..........+.++.+|+.+....... .....+..+..|. .+
T Consensus 622 ~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~-~~~~~~~l~el~~Le~L~~ls~~~~s~-~~~e~l~~~~~L~~~~~~l 699 (889)
T KOG4658|consen 622 YLNLEVTGRLESIPGILLELQSLRVLRLPRSA-LSNDKLLLKELENLEHLENLSITISSV-LLLEDLLGMTRLRSLLQSL 699 (889)
T ss_pred eeccccccccccccchhhhcccccEEEeeccc-cccchhhHHhhhcccchhhheeecchh-HhHhhhhhhHHHHHHhHhh
Confidence 444444443333333222 1223333332211 011111122334556666666544433 1222233333332 44
Q ss_pred ecCCCcccccCCccccCCCCCCEEEccCCcccc
Q 003911 269 SLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301 (787)
Q Consensus 269 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 301 (787)
.+.++... ..+..+..+.+|+.|.+.+.....
T Consensus 700 ~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e 731 (889)
T KOG4658|consen 700 SIEGCSKR-TLISSLGSLGNLEELSILDCGISE 731 (889)
T ss_pred hhcccccc-eeecccccccCcceEEEEcCCCch
Confidence 44444444 567778888999999988887764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.6e-09 Score=113.15 Aligned_cols=183 Identities=18% Similarity=0.213 Sum_probs=134.5
Q ss_pred hhcCCCcccceeccccceEEEEEEEe--CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCee
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 666 (787)
....+|..+..||.|.|+.|++...+ ++..+++|..............-..|+.+...+ .|.+++.++..+...+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888999999999999998643 678899998876554433333344566666666 599999988888877788
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC-CcEEEeeccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFGL 745 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~ 745 (787)
|+-.||++++++...+. -...+++..++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||.
T Consensus 342 ~ip~e~~~~~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred cCchhhhcCcchhhhhH-----HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccc
Confidence 89999999998876652 12356778889999999999999997 899999999999999875 7889999999
Q ss_pred ceecCCCCCceeeeeccccCcc-ccccccc-CCcC-cceeec
Q 003911 746 VRLAPEGKGSIETRIAGTFGYL-APEYAVH-TRWS-SCSYWA 784 (787)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~-aPE~~~~-~~~~-~~DiWS 784 (787)
+..+.-.. ....++-+++ .+|++.. ..+- ++|++|
T Consensus 414 ~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~s 451 (524)
T KOG0601|consen 414 WTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFS 451 (524)
T ss_pred ccccceec----ccccccccccccchhhcccccccccccccc
Confidence 86432111 1122344455 2555444 3333 777776
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=7.3e-08 Score=94.84 Aligned_cols=141 Identities=22% Similarity=0.190 Sum_probs=100.3
Q ss_pred CCcccceeccccceEEEEEEEeCCcEEEEEEeeccccc--------------------chhHHHHHHHHHHHHhcCCC--
Q 003911 594 NFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS--------------------GKGLTEFKSEIAVLTKVRHR-- 651 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------~~~~~~~~~E~~~l~~l~h~-- 651 (787)
-+.+...||-|--+.||.|....|.++|||.=+....+ .......++|.++|.++...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 35567899999999999999989999999954321110 11234568899999999654
Q ss_pred ccceEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 003911 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (787)
Q Consensus 652 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 731 (787)
.+++.+++ +...+||||++|-.|...- ++.+..-.++..|++-+.-+-. .||||+|+.+=||+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIl 234 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNIL 234 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEE
Confidence 77777765 4467999999987664321 1222233344444444443333 79999999999999
Q ss_pred ECCCCcEEEeecccceecCC
Q 003911 732 LGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 732 l~~~~~~kl~DFG~a~~~~~ 751 (787)
++++|.+.++||--+.....
T Consensus 235 V~~dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 235 VTEDGDIVVIDWPQAVPISH 254 (304)
T ss_pred EecCCCEEEEeCcccccCCC
Confidence 99999999999987765443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.4e-07 Score=90.64 Aligned_cols=109 Identities=26% Similarity=0.352 Sum_probs=84.9
Q ss_pred hHHHHHHHHHHHHhcCCC--ccceEEeEEEeCC----eeEEEEEecCCC-CHHHHHHhhhhcCCCCCCHHHHHHHHHHHH
Q 003911 634 GLTEFKSEIAVLTKVRHR--HLVALLGHCLDGN----EKLLVFEYMPQG-TLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706 (787)
Q Consensus 634 ~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~ 706 (787)
...+..+|.+.+.++... .+++.+++.+... ..++|+|++++. +|.+++.... ..+......++.+++
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~ 128 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALA 128 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHH
Confidence 345678888888888533 3456666666532 458999999874 7888874421 245566788999999
Q ss_pred HHHHHHHhCCCCCeEEcCCCCCCEEECCCC---cEEEeecccceecC
Q 003911 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGLVRLAP 750 (787)
Q Consensus 707 ~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a~~~~ 750 (787)
..+.-||+ .||+|+|+++.|||++.+. .+.++||+-++...
T Consensus 129 ~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 129 RLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999998 8999999999999999887 89999999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=3e-08 Score=117.02 Aligned_cols=202 Identities=20% Similarity=0.217 Sum_probs=135.9
Q ss_pred CEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCC--CCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEE
Q 003911 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNS--ISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145 (787)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~--l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 145 (787)
.+..+.+-+|.+. .++....+ ++|++|-+..|. +..... .|..++.|++|||++|.=-+-.|..++.|-+|++|+
T Consensus 524 ~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred heeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 4555666666655 44444433 379999999996 444444 388899999999999865555556799999999999
Q ss_pred ccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccc--cCCCcCcccccccceeeccC
Q 003911 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI--GGLPASFSGSQIQSLWVNGQ 223 (787)
Q Consensus 146 L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~~~l~~L~~~~~ 223 (787)
|++..++ .+|..+.+|+.|.+|++..+.-...+|.... .|++|++|.|..-... ...-..+ .+++.|.....
T Consensus 602 L~~t~I~--~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~--~L~~Lr~L~l~~s~~~~~~~~l~el--~~Le~L~~ls~ 675 (889)
T KOG4658|consen 602 LSDTGIS--HLPSGLGNLKKLIYLNLEVTGRLESIPGILL--ELQSLRVLRLPRSALSNDKLLLKEL--ENLEHLENLSI 675 (889)
T ss_pred ccCCCcc--ccchHHHHHHhhheeccccccccccccchhh--hcccccEEEeeccccccchhhHHhh--hcccchhhhee
Confidence 9999999 7999999999999999999887777777664 6999999998765522 1111111 23333333322
Q ss_pred CCCCcCCCCccccccCcc----CceEeccccccccCCCCCCCCCCCCEEecCCCcccccCC
Q 003911 224 NGNAKLGGGIDVIQNMTS----LKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVP 280 (787)
Q Consensus 224 ~~~~~~~~~~~~~~~l~~----L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p 280 (787)
..... .....+..++. .+.+.+..+.....+..+..+.+|+.|.+.++.+.....
T Consensus 676 ~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~e~~~ 734 (889)
T KOG4658|consen 676 TISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKRTLISSLGSLGNLEELSILDCGISEIVI 734 (889)
T ss_pred ecchh--HhHhhhhhhHHHHHHhHhhhhcccccceeecccccccCcceEEEEcCCCchhhc
Confidence 11111 01111222332 234444445556666678889999999999999874333
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.5e-08 Score=97.59 Aligned_cols=142 Identities=18% Similarity=0.248 Sum_probs=103.9
Q ss_pred HHHHHhcCCCccceEEeEEEeCC-----eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 003911 642 IAVLTKVRHRHLVALLGHCLDGN-----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716 (787)
Q Consensus 642 ~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 716 (787)
..-+-++.|.|||+++.|+.+.. +..++.|||..|++..++++..+.. ..+......+++.||..||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 34455567999999999987654 4678999999999999998766544 4677788889999999999999984
Q ss_pred CCCeEEcCCCCCCEEECCCCcEEEeecccceecCC---CCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE---GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 717 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
...|+|+++.-+-|++..++-+|+.--.-...... ........-.|-++|.|||.=.....+ ++|||+.
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~f 268 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKF 268 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhh
Confidence 68999999999999999998888742111111000 000111123467899999986555544 8999874
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.61 E-value=5.8e-09 Score=102.26 Aligned_cols=195 Identities=19% Similarity=0.235 Sum_probs=104.9
Q ss_pred CCCCcEEEeecCCCCC--CCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCC
Q 003911 91 LTKLERLELQWNSISG--PLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ 167 (787)
Q Consensus 91 l~~L~~L~L~~N~l~~--~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~ 167 (787)
.+.++.|||.+|.|+. .+. -+.+|+.|++|+|+.|++...+...-..+.+|++|-|.+..+.-......+..++.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 3556666666666655 222 2455666666666666666544332234556666666665554323334445555555
Q ss_pred EEeccCceecccC----------CCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccc
Q 003911 168 NFSANSANITGQI----------PSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQ 237 (787)
Q Consensus 168 ~L~l~~n~l~~~~----------p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~ 237 (787)
.|+++.|++.... |.......++.+..+.++-|++..
T Consensus 150 elHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r--------------------------------- 196 (418)
T KOG2982|consen 150 ELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSR--------------------------------- 196 (418)
T ss_pred hhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHh---------------------------------
Confidence 5555555332111 111000012233333333334332
Q ss_pred cCccCceEeccccccccCCC--CCCCCCCCCEEecCCCcccccC-CccccCCCCCCEEEccCCcccccCCC-------CC
Q 003911 238 NMTSLKEIWLHSNAFSGPLP--DFSGVKQLESLSLRDNFFTGPV-PDSLVKLESLKIVNMTNNLLQGPVPE-------FD 307 (787)
Q Consensus 238 ~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~-------~~ 307 (787)
-.+++..+.+..|.+...-. .+..++.+..|.|+.|+|...- -+.+.++++|..|.+++|+|...+.. +.
T Consensus 197 ~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIa 276 (418)
T KOG2982|consen 197 IFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIA 276 (418)
T ss_pred hcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEe
Confidence 23456666666666654322 2445666777888888886332 25577788888888888887755442 45
Q ss_pred CceeeeccccC
Q 003911 308 RSVSLDMAKGS 318 (787)
Q Consensus 308 ~~~~L~~l~~~ 318 (787)
++.++++++.+
T Consensus 277 RL~~v~vLNGs 287 (418)
T KOG2982|consen 277 RLTKVQVLNGS 287 (418)
T ss_pred eccceEEecCc
Confidence 66667777655
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.3e-07 Score=102.77 Aligned_cols=143 Identities=20% Similarity=0.260 Sum_probs=95.5
Q ss_pred ceeccccceEEEEEEEeCCcEEEEEEeecccccc----------------------------hh----------HHHHHH
Q 003911 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG----------------------------KG----------LTEFKS 640 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------~~----------~~~~~~ 640 (787)
+.|+.++-|.||+|++++|+.||||+.+...... .. .-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 7799999999999999999999999876421100 00 112445
Q ss_pred HHHHHHhcC-----CCccceEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHH-HHHHHh
Q 003911 641 EIAVLTKVR-----HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG-VEYLHG 714 (787)
Q Consensus 641 E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~-L~~LH~ 714 (787)
|..-+.+++ .+.+.-..=|++......|+|||++|..+.+...-.. ...+. ..++..++++ +..+-
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~---k~ia~~~~~~f~~q~~- 282 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDR---KELAELLVRAFLRQLL- 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCH---HHHHHHHHHHHHHHHH-
Confidence 666565552 3444333333444567789999999998887742211 12332 2344444333 22222
Q ss_pred CCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 715 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
+.|++|.|.+|.||+++.++++.+.|||+.....+
T Consensus 283 --~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 --RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 26899999999999999999999999999876654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.1e-06 Score=88.21 Aligned_cols=143 Identities=17% Similarity=0.191 Sum_probs=87.2
Q ss_pred ceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCc--cceEEeEEEeCCeeEEEEEecCCC
Q 003911 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH--LVALLGHCLDGNEKLLVFEYMPQG 676 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g 676 (787)
..||+|..+.||+. .+..+++|...... .....++|.++++.+..-. +.+.+++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 56899999999984 25567888876422 3356789999999986433 577888887777888999999886
Q ss_pred C-HHHHH--------------Hh----hhhcCCCCCCHHHH-HHHHHH----------HHH-HHHHHHhC-CCCCeEEcC
Q 003911 677 T-LSRHI--------------FN----WAEEGLKPLEWNRR-LTIALD----------VAR-GVEYLHGL-AHQSFIHRD 724 (787)
Q Consensus 677 s-L~~~l--------------~~----~~~~~~~~l~~~~~-~~i~~q----------i~~-~L~~LH~~-~~~~ivH~D 724 (787)
+ +...+ .. ...-.......... .++..+ +.. ..++|... ....++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 4 21111 00 00000001111100 000000 001 12222211 134678999
Q ss_pred CCCCCEEECCCCcEEEeecccceec
Q 003911 725 LKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 725 lkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
+.|.||++++++ +.++||+.+..-
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCcC
Confidence 999999999887 999999988643
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=2e-06 Score=83.07 Aligned_cols=141 Identities=21% Similarity=0.176 Sum_probs=102.9
Q ss_pred eccccceEEEEEEEeCCcEEEEEEeeccc---cc-chhHHHHHHHHHHHHhcCCC--ccceEEeEEEeC----CeeEEEE
Q 003911 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGV---IS-GKGLTEFKSEIAVLTKVRHR--HLVALLGHCLDG----NEKLLVF 670 (787)
Q Consensus 601 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~-~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~----~~~~lv~ 670 (787)
-|+|+.+.|++.... |+.+=+|+-.... .. +.....|.+|+..+.++... .+++........ ...+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467888999998775 5578888765211 11 34667899999999999532 245555222221 2357999
Q ss_pred EecCC-CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc--EEEeecccce
Q 003911 671 EYMPQ-GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--AKVADFGLVR 747 (787)
Q Consensus 671 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFG~a~ 747 (787)
|-+++ .+|.+++.+ ....+.+......+..+++..+.-||+ .|+.|+|+-+.||+++.++. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~---~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQ---HAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhc---CCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97754 588877743 222356777788999999999999997 89999999999999986666 9999998776
Q ss_pred e
Q 003911 748 L 748 (787)
Q Consensus 748 ~ 748 (787)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.1e-07 Score=67.36 Aligned_cols=36 Identities=44% Similarity=0.930 Sum_probs=26.1
Q ss_pred hhHHHHHHHHHHhcCC-CC--CCCCCC---CCCCCcccEEEc
Q 003911 30 DGDAAVMLALKKSLNP-PE--SLGWSD---TDPCKWNHVVCI 65 (787)
Q Consensus 30 ~~d~~~l~~~k~~~~~-~~--~~~w~~---~~~C~w~gv~C~ 65 (787)
++|++||++||+++.. +. ..+|+. ++||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 5799999999999985 42 348974 589999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1e-06 Score=93.56 Aligned_cols=143 Identities=19% Similarity=0.240 Sum_probs=108.8
Q ss_pred ceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe----CCeeEEEEEecCC-CCHH
Q 003911 606 FGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEKLLVFEYMPQ-GTLS 679 (787)
Q Consensus 606 ~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-gsL~ 679 (787)
-.+.|++.. .||..|++|+++.... ........-+++++++.|+|+|++.+++.. +...++|++|+++ ++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 357899964 4899999999944221 111123345788999999999999998863 4467899999986 5776
Q ss_pred HHHHhhhh----------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 680 RHIFNWAE----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 680 ~~l~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
++-..... ......+++..+.++.|+..||.++|+ .|+.-+-|.|.+|+++.+.+++|+..|.....
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeee
Confidence 65433111 112346788999999999999999998 89999999999999999999999999987766
Q ss_pred CCCC
Q 003911 750 PEGK 753 (787)
Q Consensus 750 ~~~~ 753 (787)
..+.
T Consensus 444 ~~d~ 447 (655)
T KOG3741|consen 444 QEDP 447 (655)
T ss_pred cCCC
Confidence 5443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.2e-06 Score=83.04 Aligned_cols=140 Identities=19% Similarity=0.249 Sum_probs=92.4
Q ss_pred hcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccch-hH------HHHHHHHHHHHhcCCCc---cceEEeEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK-GL------TEFKSEIAVLTKVRHRH---LVALLGHC 660 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~------~~~~~E~~~l~~l~h~n---iv~~~~~~ 660 (787)
...+|.+.+++-......|.+-+. +|..+++|..+......+ .. ....+++..+.+++... ...++...
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 456788888888877777766666 488999998765332111 11 12344555555553322 22322222
Q ss_pred E-----eCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC
Q 003911 661 L-----DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735 (787)
Q Consensus 661 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 735 (787)
. .....+++|||++|..|.+.. .+++ .++..+++++.-+|. .|++|+|..|.|++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~---------~i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE---------DIDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch---------hcCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC
Confidence 2 123457999999998886543 1222 245677788999997 899999999999999865
Q ss_pred CcEEEeeccccee
Q 003911 736 MRAKVADFGLVRL 748 (787)
Q Consensus 736 ~~~kl~DFG~a~~ 748 (787)
.++++||+..+.
T Consensus 172 -~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 -GIRIIDTQGKRM 183 (229)
T ss_pred -cEEEEECccccc
Confidence 499999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.6e-06 Score=82.33 Aligned_cols=157 Identities=20% Similarity=0.218 Sum_probs=104.0
Q ss_pred eeHHHHHhhcCCCcccce---eccccceEEEEEEEeCCcEEEEEEeecccccchh-----------------H-----HH
Q 003911 583 ISIQVLRNVTNNFSEENI---LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKG-----------------L-----TE 637 (787)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~---lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-----------------~-----~~ 637 (787)
.+.+.+.....+..+.+. |+.|.-+.||+|...++..+|||+++.....-+. . .-
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 345556666666665555 4567778999998888999999998753221110 0 11
Q ss_pred HHHHHHHHHhcC--CCccceEEeEEEeCCeeEEEEEecCCCC-HHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 003911 638 FKSEIAVLTKVR--HRHLVALLGHCLDGNEKLLVFEYMPQGT-LSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714 (787)
Q Consensus 638 ~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 714 (787)
.++|..-|+++. +-.+++.+++. ...+||||+.... -.-.|.+ -++..++...+..++++.+.-|-.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHH
Confidence 356777777773 44555666553 3479999996431 1111111 122233566777788888887764
Q ss_pred CCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 715 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
..++||+||..=|||+. ++.+.|+|||-|.....+
T Consensus 185 --~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 185 --EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred --hcCcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 47999999999999998 789999999998766543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=8.2e-09 Score=112.45 Aligned_cols=131 Identities=28% Similarity=0.263 Sum_probs=95.9
Q ss_pred CccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccC
Q 003911 239 MTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGS 318 (787)
Q Consensus 239 l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~ 318 (787)
+-.|...+.+.|.+...-..+.-++.|+.|+|++|+++. .. .+..|++|++|||++|.|+-. |.+..
T Consensus 163 Wn~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~~v-p~l~~---------- 229 (1096)
T KOG1859|consen 163 WNKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLRHV-PQLSM---------- 229 (1096)
T ss_pred hhhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhh-hH-HHHhcccccccccccchhccc-cccch----------
Confidence 456888888899888666667778899999999999983 33 788899999999999998743 22110
Q ss_pred CCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCE
Q 003911 319 NNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQR 398 (787)
Q Consensus 319 ~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 398 (787)
.- -.|+.|+|++|.++.. ..+.+|++|+.
T Consensus 230 ----------------------------------------------~g---c~L~~L~lrnN~l~tL--~gie~LksL~~ 258 (1096)
T KOG1859|consen 230 ----------------------------------------------VG---CKLQLLNLRNNALTTL--RGIENLKSLYG 258 (1096)
T ss_pred ----------------------------------------------hh---hhheeeeecccHHHhh--hhHHhhhhhhc
Confidence 00 1477777777777633 24778899999
Q ss_pred EecccccccccCC-ccCcCCCCCCeeeccCCccccc
Q 003911 399 LILADNNLSGMIP-EGLSVLGALKELDVSNNQLYGK 433 (787)
Q Consensus 399 L~Ls~N~l~g~ip-~~l~~l~~L~~L~Ls~N~l~g~ 433 (787)
|||++|-|++.-- .-+..|..|+.|+|.+|++...
T Consensus 259 LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 259 LDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred cchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 9999998875422 2245667888999999998753
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.9e-08 Score=95.89 Aligned_cols=112 Identities=21% Similarity=0.235 Sum_probs=70.6
Q ss_pred CCCCCcEEEeecCCCCCCCC--CCC-CCCCCcEEEcccccCCcC--CCccccCCCCCcEEEccCCCCCCCCCChhhhcCC
Q 003911 90 NLTKLERLELQWNSISGPLP--SLN-GLASLEVVMLSNNQFTSV--PSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNAS 164 (787)
Q Consensus 90 ~l~~L~~L~L~~N~l~~~~~--~~~-~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~ 164 (787)
.+..++.|-|.+..|...-. .|+ ..+.++.|||.+|+|+.- ....+.+|+.|++|+|+.|++.. .|...-..++
T Consensus 43 s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s-~I~~lp~p~~ 121 (418)
T KOG2982|consen 43 SLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSS-DIKSLPLPLK 121 (418)
T ss_pred cccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCC-ccccCccccc
Confidence 33445566666666644322 343 356788889999988863 22346788888888888888875 3322224667
Q ss_pred CCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccc
Q 003911 165 GLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI 203 (787)
Q Consensus 165 ~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~ 203 (787)
+|+.|-|++..+.-.--..+. ..+|.+++|+++.|++.
T Consensus 122 nl~~lVLNgT~L~w~~~~s~l-~~lP~vtelHmS~N~~r 159 (418)
T KOG2982|consen 122 NLRVLVLNGTGLSWTQSTSSL-DDLPKVTELHMSDNSLR 159 (418)
T ss_pred ceEEEEEcCCCCChhhhhhhh-hcchhhhhhhhccchhh
Confidence 777787777766543333332 36677777777777554
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 787 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-32 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-17 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-17 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 9e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 8e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-06 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 3e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-06 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 4e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-06 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 5e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 6e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-05 | ||
| 3v47_A | 455 | Crystal Structure Of The N-Tetminal Fragment Of Zeb | 8e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-05 | ||
| 3zyi_A | 452 | Netring2 In Complex With Ngl2 Length = 452 | 9e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-04 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 1e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 1e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-04 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-04 | ||
| 1ziw_A | 680 | Human Toll-Like Receptor 3 Extracellular Domain Str | 2e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3ZYI|A Chain A, Netring2 In Complex With Ngl2 Length = 452 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 2e-90
Identities = 81/212 (38%), Positives = 118/212 (55%), Gaps = 15/212 (7%)
Query: 569 EPGDIQMLEAGNMVISIQVLRNVTNNFSEE------NILGRGGFGTVYKGELHDGTKIAV 622
E +++ + S L+NVTNNF E N +G GGFG VYKG + + T +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 623 KRMEAGVI--SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSR 680
K++ A V + + +F EI V+ K +H +LV LLG DG++ LV+ YMP G+L
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 681 HIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 740
+ +G PL W+ R IA A G+ +LH IHRD+K +NILL + AK+
Sbjct: 120 RLSCL--DGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKI 174
Query: 741 ADFGLVRLAPEGKGS-IETRIAGTFGYLAPEY 771
+DFGL R + + + + +RI GT Y+APE
Sbjct: 175 SDFGLARASEKFAQTVMTSRIVGTTAYMAPEA 206
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 282 bits (725), Expect = 3e-89
Identities = 77/214 (35%), Positives = 121/214 (56%), Gaps = 7/214 (3%)
Query: 560 SETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTK 619
S+ + ++ + + + L TNNF + ++G G FG VYKG L DG K
Sbjct: 6 SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65
Query: 620 IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS 679
+A+KR S +G+ EF++EI L+ RH HLV+L+G C + NE +L+++YM G L
Sbjct: 66 VALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 680 RHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 739
RH++ ++ + W +RL I + ARG+ YLH ++ IHRD+K NILL ++ K
Sbjct: 124 RHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPK 179
Query: 740 VADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYA 772
+ DFG+ + E + + T + GT GY+ PEY
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYF 213
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 1e-86
Identities = 80/187 (42%), Positives = 115/187 (61%), Gaps = 2/187 (1%)
Query: 588 LRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
L+ ++NFS +NILGRGGFG VYKG L DGT +AVKR++ G G +F++E+ +++
Sbjct: 25 LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISM 83
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
HR+L+ L G C+ E+LLV+ YM G+++ + E PL+W +R IAL AR
Sbjct: 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKRQRIALGSAR 142
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
G+ YLH IHRD+K +NILL ++ A V DFGL +L + T + GT G++
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 202
Query: 768 APEYAVH 774
APEY
Sbjct: 203 APEYLST 209
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 5e-60
Identities = 103/444 (23%), Positives = 179/444 (40%), Gaps = 49/444 (11%)
Query: 20 SILFVSASGDDGDAAVMLALKKSLNPPESL-GWS-DTDPCKWNHVVCIEDKRITRIQIGH 77
S + + +++ K L L WS + +PC ++ V C D ++T I +
Sbjct: 1 SFQASPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTC-RDDKVTSIDLSS 59
Query: 78 QNLQ---GTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFT-SVPSD 133
+ L + S+L +LT LE L L + I+G + ASL + LS N + V +
Sbjct: 60 KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTL 119
Query: 134 F-FTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP-SFFGPDEFPG 191
S L+ + + +N + L+ ++ +I+G + D
Sbjct: 120 TSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE 179
Query: 192 LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251
L L ++ N++ G + S ++ L V+ N GI + + ++L+ + + N
Sbjct: 180 LKHLAISGNKISGDVDVS-RCVNLEFLDVSSNN----FSTGIPFLGDCSALQHLDISGNK 234
Query: 252 FSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS- 309
SG S +L+ L++ N F GP+P L+SL+ +++ N G +P+F
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 310 ----VSLDMAKGSNNF--CLPSP-GACDPRLNAL-LSVVKLMGY-PQRFAENWKGNDPCS 360
LD+ N+F +P G+C L +L LS G P +
Sbjct: 293 CDTLTGLDL--SGNHFYGAVPPFFGSC-SLLESLALSSNNFSGELPMDTLLKMR------ 343
Query: 361 DWIGVTCTKGNITVINFQKMNLTGTISPEFASFK-SLQRLILADNNLSGMIPEGL--SVL 417
+ V++ +G + + SL L L+ NN SG I L +
Sbjct: 344 ----------GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393
Query: 418 GALKELDVSNNQLYGKIPSFKSNA 441
L+EL + NN GKIP SN
Sbjct: 394 NTLQELYLQNNGFTGKIPPTLSNC 417
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 1e-57
Identities = 102/399 (25%), Positives = 166/399 (41%), Gaps = 40/399 (10%)
Query: 68 KRITRIQIGHQNLQGTLP-SNLQNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSN 124
+ + + N G LP L + L+ L+L +N SG LP N ASL + LS+
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 125 NQFT-SVPSDFF-TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQI 180
N F+ + + ++LQ + + NN F+ +IP +L N S L + S N ++G I
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFT-GKIPPTLSNCSELVSLHLSFN--YLSGTI 434
Query: 181 PSFFGPDEFPGLTILHLAFNQLIGGLPASFS-GSQIQSLWVNGQNGNAKLGGGI-DVIQN 238
PS G L L L N L G +P +++L ++ N L G I + N
Sbjct: 435 PSSLG--SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF---N-DLTGEIPSGLSN 488
Query: 239 MTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
T+L I L +N +G +P ++ L L L +N F+G +P L SL +++ N
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL---LSVVKLMG-YPQRFAE-- 351
L G +P S +A D ++++ G ++
Sbjct: 549 LFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608
Query: 352 ----------NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLIL 401
+ G+ ++ ++ L+G I E S L L L
Sbjct: 609 TRNPCNITSRVYGGHTS--PTFD-NNG--SMMFLDMSYNMLSGYIPKEIGSMPYLFILNL 663
Query: 402 ADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN 440
N++SG IP+ + L L LD+S+N+L G+IP S
Sbjct: 664 GHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA 702
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 6e-52
Identities = 88/384 (22%), Positives = 147/384 (38%), Gaps = 57/384 (14%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQ---NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSN 124
+ + + ++ G +L+ L + N ISG + +LE + +S+
Sbjct: 151 NSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSR-CVNLEFLDVSS 209
Query: 125 NQFT-SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSF 183
N F+ +P S+LQ ++I N S + +++ + L+ + +S G IP
Sbjct: 210 NNFSTGIPF--LGDCSALQHLDISGNKLSG-DFSRAISTCTELKLLNISSNQFVGPIPPL 266
Query: 184 FGPDEFPGLTILHLAFNQLIGGLPASFSG--SQIQSLWVNGQNGNAKLGGGI-DVIQNMT 240
L L LA N+ G +P SG + L + G + + +
Sbjct: 267 ----PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDL----SGNHFYGAVPPFFGSCS 318
Query: 241 SLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKL-ESLKIVNMTNN 297
L+ + L SN FSG LP ++ L+ L L N F+G +P+SL L SL +++++N
Sbjct: 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSN 378
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGN 356
GP+ L L L G
Sbjct: 379 NFSGPILPNLCQNPK------------------NTLQELYLQNNGFTG------------ 408
Query: 357 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV 416
+ C+ + ++ L+GTI S L+ L L N L G IP+ L
Sbjct: 409 -KIPPTLS-NCS--ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464
Query: 417 LGALKELDVSNNQLYGKIPSFKSN 440
+ L+ L + N L G+IPS SN
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSN 488
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-51
Identities = 87/383 (22%), Positives = 150/383 (39%), Gaps = 79/383 (20%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127
+ + I L G + T+L+ L + N GP+P L L SL+ + L+ N+F
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP-LKSLQYLSLAENKF 281
Query: 128 T-SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP-SFFG 185
T +P +L +++ N F +P + S L++ + +S N +G++P
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGNHFYG-AVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340
Query: 186 PDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMT-SLKE 244
+ GL +L L+FN+ G LP S + N++ SL
Sbjct: 341 --KMRGLKVLDLSFNEFSGELPESLT--------------------------NLSASLLT 372
Query: 245 IWLHSNAFSGPLPDFSGV---KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301
+ L SN FSGP+ L+ L L++N FTG +P +L L ++++ N L G
Sbjct: 373 LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSG 432
Query: 302 PVP----EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 357
+P + L + N +G
Sbjct: 433 TIPSSLGSLSKLRDLKL--WLNML--------------------------------EGEI 458
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL 417
P + + + +LTG I ++ +L + L++N L+G IP+ + L
Sbjct: 459 P--QELMYVK---TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 513
Query: 418 GALKELDVSNNQLYGKIPSFKSN 440
L L +SNN G IP+ +
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGD 536
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 2e-49
Identities = 79/382 (20%), Positives = 133/382 (34%), Gaps = 79/382 (20%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQ-NLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNN 125
K + + + G +P L L L+L N G +P + LE + LS+N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 126 QFT-SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASG-LQNFSANSANITGQIPSF 183
F+ +P D + L+ +++ N FS E+P+SL N S L +S N +G I
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSG-ELPESLTNLSASLLTLDLSSNNFSGPILPN 387
Query: 184 FGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLK 243
+ L L+L N G +P + S N + L
Sbjct: 388 LCQNPKNTLQELYLQNNGFTGKIPPTLS--------------------------NCSELV 421
Query: 244 EIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302
+ L N SG +P + +L L L N G +P L+ +++L+ + + N L G
Sbjct: 422 SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGE 481
Query: 303 VPEFDRS----VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDP 358
+P + + + +N
Sbjct: 482 IPSGLSNCTNLNWISL--SNNRL----------------------------------TGE 505
Query: 359 CSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG 418
WIG N+ ++ + +G I E +SL L L N +G IP +
Sbjct: 506 IPKWIG---RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ- 561
Query: 419 ALKELDVSNNQLYGKIPSFKSN 440
++ N + GK + N
Sbjct: 562 ---SGKIAANFIAGKRYVYIKN 580
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 5e-47
Identities = 92/382 (24%), Positives = 145/382 (37%), Gaps = 84/382 (21%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQ 126
+ + + N +P L + + L+ L++ N +SG +++ L+++ +S+NQ
Sbjct: 200 VNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQ 258
Query: 127 FT-SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLR-NASGLQNFSANSANITGQIPSFF 184
F +P L SLQ + + N F+ EIP L L + + G +P FF
Sbjct: 259 FVGPIPP---LPLKSLQYLSLAENKFTG-EIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314
Query: 185 GPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKE 244
G L L L+ N G LP + M LK
Sbjct: 315 G--SCSLLESLALSSNNFSGELPMDT-------------------------LLKMRGLKV 347
Query: 245 IWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVK--LESLKIVNMTNNLLQ 300
+ L N FSG LP+ + L +L L N F+GP+ +L + +L+ + + NN
Sbjct: 348 LDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 407
Query: 301 GPVPEFDRSVS----LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGY-PQRFAENWKG 355
G +P + S L + S N L G P
Sbjct: 408 GKIPPTLSNCSELVSLHL---SFN--------------------YLSGTIPSSLGSL--- 441
Query: 356 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLS 415
+ + L G I E K+L+ LIL N+L+G IP GLS
Sbjct: 442 --------------SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487
Query: 416 VLGALKELDVSNNQLYGKIPSF 437
L + +SNN+L G+IP +
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKW 509
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-45
Identities = 89/379 (23%), Positives = 148/379 (39%), Gaps = 64/379 (16%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFT 128
+ + + + G +P L N ++L L L +N +SG +P SL L+ L + L N
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
Query: 129 -SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
+P + + +L+++ +D N + EIP L N + L S ++ +TG+IP + G
Sbjct: 456 GEIPQELMY-VKTLETLILDFNDLT-GEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG-- 511
Query: 188 EFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEI 245
L IL L+ N G +PA + L +N N G I + +
Sbjct: 512 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT---N-LFNGTIPAAMFKQSGK--- 564
Query: 246 WLHSNAFSGPLP-DFSGVKQLESLSLRDNF--FTGPVPDSLVKLESLKIVNMTNNLLQGP 302
+ +N +G + N F G + L +L + N+T+ + G
Sbjct: 565 -IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGH 623
Query: 303 VPEFDRS----VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGY-PQRFAENWKGND 357
+ + LDM S N L GY P+
Sbjct: 624 TSPTFDNNGSMMFLDM---SYN--------------------MLSGYIPKEIGS------ 654
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL 417
+ ++N +++G+I E + L L L+ N L G IP+ +S L
Sbjct: 655 -MP----------YLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSAL 703
Query: 418 GALKELDVSNNQLYGKIPS 436
L E+D+SNN L G IP
Sbjct: 704 TMLTEIDLSNNNLSGPIPE 722
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-22
Identities = 41/209 (19%), Positives = 74/209 (35%), Gaps = 15/209 (7%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGL 138
+ G +P+ L + L L+L N +G +P+ + ++ N +
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA--AMFKQSG-KIAANFIAGKRYVYIKND 581
Query: 139 SSLQSIEIDNNPFS-SWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHL 197
+ N + L S + S G F + L +
Sbjct: 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFD--NNGSMMFLDM 639
Query: 198 AFNQLIGGLPASFSG-SQIQSLWVN-GQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSG 254
++N L G +P + L N G N + G I D + ++ L + L SN G
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFIL--NLGHN---DISGSIPDEVGDLRGLNILDLSSNKLDG 694
Query: 255 PLPD-FSGVKQLESLSLRDNFFTGPVPDS 282
+P S + L + L +N +GP+P+
Sbjct: 695 RIPQAMSALTMLTEIDLSNNNLSGPIPEM 723
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 1e-56
Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 22/212 (10%)
Query: 583 ISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEI 642
+ + L + + RG FG V+K + +AVK + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW---QNEYEV 69
Query: 643 AVLTKVRHRHLVALLGHCLDGN----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR 698
L ++H +++ +G G + L+ + +G+LS + + WN
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA------NVVSWNEL 123
Query: 699 LTIALDVARGVEYLH-------GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751
IA +ARG+ YLH + HRD+K N+LL +++ A +ADFGL
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 752 GKGSIET-RIAGTFGYLAPEYAVHTRWSSCSY 782
GK + +T GT Y+APE
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDA 215
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 5e-55
Identities = 59/180 (32%), Positives = 96/180 (53%), Gaps = 8/180 (4%)
Query: 594 NFSE---ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
+ + + +G G FGTV++ E H G+ +AVK + + + EF E+A++ ++RH
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
++V +G +V EY+ +G+L R + + L+ RRL++A DVA+G+
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMAYDVAKGMN 151
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
YLH + +HR+LK N+L+ KV DFGL RL S AGT ++APE
Sbjct: 152 YLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS-KSAAGTPEWMAPE 209
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 9e-50
Identities = 56/179 (31%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
E ++GRG FG V K + +A+K++E S F E+ L++V H +
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIE----SESERKAFIVELRQLSRVNHPN 62
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V L G CL N LV EY G+L + E L ++ L ++GV YL
Sbjct: 63 IVKLYGACL--NPVCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMR-AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
H + ++ IHRDLKP N+LL K+ DFG + T G+ ++APE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPE 173
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 9e-50
Identities = 79/306 (25%), Positives = 144/306 (47%), Gaps = 22/306 (7%)
Query: 32 DAAVMLALKKSLNPPESL-GWSDTDPC---KWNHVVCIED---KRITRIQIGHQNLQGT- 83
D +L +KK L P +L W T C W V+C D R+ + + NL
Sbjct: 7 DKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY 66
Query: 84 -LPSNLQNLTKLERLELQ-WNSISGPLP-SLNGLASLEVVMLSNNQFT-SVPSDFFTGLS 139
+PS+L NL L L + N++ GP+P ++ L L + +++ + ++P F + +
Sbjct: 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD-FLSQIK 125
Query: 140 SLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGL-TILHLA 198
+L +++ N S +P S+ + L + + I+G IP +G F L T + ++
Sbjct: 126 TLVTLDFSYNALSG-TLPPSISSLPNLVGITFDGNRISGAIPDSYG--SFSKLFTSMTIS 182
Query: 199 FNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLP 257
N+L G +P +F+ + + + +N L G + + + ++I L N+ + L
Sbjct: 183 RNRLTGKIPPTFANLNLAFVDL-SRN---MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
Query: 258 DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKG 317
K L L LR+N G +P L +L+ L +N++ N L G +P+ D++
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
Query: 318 SNNFCL 323
+NN CL
Sbjct: 299 ANNKCL 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 68/319 (21%), Positives = 108/319 (33%), Gaps = 69/319 (21%)
Query: 122 LSNNQFTSVPSDFFTGLSSLQSIEIDNNPFS-SWEIPQSLRNASGLQNFS-ANSANITGQ 179
N + V D T + ++++ + IP SL N L N+ G
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 180 IPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNM 239
IP + L L++ + G +P S +
Sbjct: 93 IPPAIA--KLTQLHYLYITHTNVSGAIPDFLS--------------------------QI 124
Query: 240 TSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV-NMTNN 297
+L + NA SG LP S + L ++ N +G +PDS L ++ N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 357
L G +P +++L S N L G
Sbjct: 185 RLTGKIPPTFANLNLAFVDLSRN--------------------MLEG------------- 211
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL 417
S G + N I+ K +L + + K+L L L +N + G +P+GL+ L
Sbjct: 212 DASVLFG-SDK--NTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267
Query: 418 GALKELDVSNNQLYGKIPS 436
L L+VS N L G+IP
Sbjct: 268 KFLHSLNVSFNNLCGEIPQ 286
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 62/297 (20%), Positives = 114/297 (38%), Gaps = 60/297 (20%)
Query: 155 EIPQSLRNASGLQNFSANS----ANITGQIPSFFGPDEFPGLTILHLAFNQLIG--GLPA 208
+I + L N + L ++ + G + + + L L+ L +P+
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDT--QTYRVNNLDLSGLNLPKPYPIPS 70
Query: 209 SFSG-SQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLPDF-SGVKQL 265
S + + L++ G N L G I I +T L +++ SG +PDF S +K L
Sbjct: 71 SLANLPYLNFLYIGGIN---NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPV-PEFDR----SVSLDMAKGSNN 320
+L N +G +P S+ L +L + N + G + + S+ + S N
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI---SRN 184
Query: 321 FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKM 380
L+ G P + N+ ++ +
Sbjct: 185 R---------------LT----------------GKIPPT--FA----NLNLAFVDLSRN 207
Query: 381 NLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF 437
L G S F S K+ Q++ LA N+L+ + + + + L LD+ NN++YG +P
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQG 263
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 32/117 (27%), Positives = 50/117 (42%), Gaps = 10/117 (8%)
Query: 333 LNALLSVVKLMGYPQRFAENWKGNDPCSD--WIGVTCTK----GNITVINFQKMNLTGT- 385
ALL + K +G P + +W C + W+GV C + ++ +NL
Sbjct: 8 KQALLQIKKDLGNPTTLS-SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY 66
Query: 386 -ISPEFASFKSLQRLILAD-NNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN 440
I A+ L L + NNL G IP ++ L L L +++ + G IP F S
Sbjct: 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 4e-49
Identities = 38/182 (20%), Positives = 73/182 (40%), Gaps = 16/182 (8%)
Query: 594 NFSE---ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
+F + L G ++KG G I VK ++ S + +F E L H
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 651 RHLVALLGHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
+++ +LG C + +MP G+L + E ++ ++ + ALD+ARG
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL---HEGTNFVVDQSQAVKFALDMARG 123
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 768
+ +LH L L ++++ +DM A+++ + ++A
Sbjct: 124 MAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVA 176
Query: 769 PE 770
PE
Sbjct: 177 PE 178
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-49
Identities = 58/190 (30%), Positives = 90/190 (47%), Gaps = 23/190 (12%)
Query: 594 NFSE---ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS--GKGLTEFKSEIAVLTKV 648
+F+E E I+G GGFG VY+ G ++AVK + + + E + +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
+H +++AL G CL LV E+ G L+R + K + + + A+ +ARG
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARG 117
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMR--------AKVADFGLVRLAPEGKGSIETRI 760
+ YLH A IHRDLK SNIL+ + K+ DFGL R + +
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSA 174
Query: 761 AGTFGYLAPE 770
AG + ++APE
Sbjct: 175 AGAYAWMAPE 184
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-48
Identities = 44/184 (23%), Positives = 82/184 (44%), Gaps = 17/184 (9%)
Query: 594 NFSE---ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
F + ++G+G FG VY G H ++A++ ++ + L FK E+ + RH
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
++V +G C+ ++ TL + + L+ N+ IA ++ +G+
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMG 144
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE----TRIAGTFGY 766
YLH + +H+DLK N+ D+ + + DFGL ++ + G +
Sbjct: 145 YLHA---KGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 767 LAPE 770
LAPE
Sbjct: 201 LAPE 204
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-48
Identities = 57/189 (30%), Positives = 98/189 (51%), Gaps = 22/189 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKG-----LTEFKSEIAVLT 646
N E +G+GGFG V+KG + D + +A+K + G G+ EF+ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
+ H ++V L G + +V E++P G L + + A P++W+ +L + LD+A
Sbjct: 79 NLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIA 132
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILL-----GDDMRAKVADFGLVRLAPEGKGSIETRIA 761
G+EY+ + +HRDL+ NI L + AKVADFGL + + + +
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV----SGLL 187
Query: 762 GTFGYLAPE 770
G F ++APE
Sbjct: 188 GNFQWMAPE 196
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 4e-48
Identities = 57/171 (33%), Positives = 90/171 (52%), Gaps = 11/171 (6%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC 660
+G G FGTVYKG+ H +AVK + + + L FK+E+ VL K RH +++ +G+
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720
+V ++ +L H+ E + + IA ARG++YLH +S
Sbjct: 90 TAPQ-LAIVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 721 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE-TRIAGTFGYLAPE 770
IHRDLK +NI L +D K+ DFGL GS + +++G+ ++APE
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 9e-48
Identities = 51/200 (25%), Positives = 78/200 (39%), Gaps = 32/200 (16%)
Query: 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAV--LTKVR 649
+N ++GRG +G VYKG L +AVK S F +E + + +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVF-----SFANRQNFINEKNIYRVPLME 65
Query: 650 HRHLVALLGHCLDGN-----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALD 704
H ++ + E LLV EY P G+L +++ +W +A
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHS 119
Query: 705 VARGVEYLH------GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE- 757
V RG+ YLH + HRDL N+L+ +D ++DFGL +
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 758 ------TRIAGTFGYLAPEY 771
GT Y+APE
Sbjct: 180 EEDNAAISEVGTIRYMAPEV 199
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 45/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 587 VLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSE--IAV 644
+ R V + + +G+G +G V++G G +AVK + S + + E +
Sbjct: 2 MQRTVARDITLLECVGKGRYGEVWRGSWQ-GENVAVK-----IFSSRDEKSWFRETELYN 55
Query: 645 LTKVRHRHLVALLGHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT 700
+RH +++ + + L+ Y G+L ++ L+ L
Sbjct: 56 TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLR 109
Query: 701 IALDVARGVEYLHGLAHQSF-----IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755
I L +A G+ +LH + HRDLK NIL+ + + +AD GL + +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 756 IE---TRIAGTFGYLAPE 770
++ GT Y+APE
Sbjct: 170 LDVGNNPRVGTKRYMAPE 187
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-43
Identities = 49/187 (26%), Positives = 80/187 (42%), Gaps = 23/187 (12%)
Query: 598 ENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
+LG+G FG K + G + +K + + F E+ V+ + H +++
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+G + EY+ GTL I + W++R++ A D+A G+ YLH
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLH--- 125
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR-------------IAGT 763
+ IHRDL N L+ ++ VADFGL RL + K E + G
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 764 FGYLAPE 770
++APE
Sbjct: 186 PYWMAPE 192
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-43
Identities = 43/187 (22%), Positives = 73/187 (39%), Gaps = 26/187 (13%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSE--IAVLTKVRHRHLVA 655
+G+G +G V+ G+ G K+AVK V + E I +RH +++
Sbjct: 42 VKQIGKGRYGEVWMGKWR-GEKVAVK-----VFFTTEEASWFRETEIYQTVLMRHENILG 95
Query: 656 LLGHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
+ + G L+ +Y G+L ++ + L+ L +A G+ +
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCH 149
Query: 712 LHGLAHQSF-----IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE---TRIAGT 763
LH + HRDLK NIL+ + +AD GL ++ GT
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 764 FGYLAPE 770
Y+ PE
Sbjct: 210 KRYMPPE 216
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 7e-41
Identities = 71/404 (17%), Positives = 131/404 (32%), Gaps = 66/404 (16%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQF 127
++T + +G + P Q L L+ L LQ N +S + +L + L +N
Sbjct: 50 QLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSI 109
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFG 185
+ ++ F +L ++++ +N SS + LQ S N I
Sbjct: 110 QKIKNNPFVKQKNLITLDLSHNGLSS-TKLGTQVQLENLQELLLSNN--KIQALKSEELD 166
Query: 186 PDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKE 244
L L L+ NQ+ P F ++ L++N L + + TS++
Sbjct: 167 IFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRN 226
Query: 245 IWLHSNAFSGPLPD-FSGVK--QLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301
+ L ++ S F G+K L L L N DS L L+ + N +Q
Sbjct: 227 LSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286
Query: 302 PVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS 360
++ +F +S+ L + K
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSF-----------TKQSISLASLPKIDDFSFQWLK------ 329
Query: 361 DWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQ----------------------- 397
+ +N + ++ G S F +L+
Sbjct: 330 ----------CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379
Query: 398 -----RLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436
L L N +S + + S LG L+ LD+ N++ ++
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-39
Identities = 67/408 (16%), Positives = 139/408 (34%), Gaps = 63/408 (15%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNN-- 125
+T + + + NL + L +LE L++N+I SL+GL ++ + L +
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFT 308
Query: 126 -------QFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANI 176
+ F L L+ + +++N L+ + S + ++
Sbjct: 309 KQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG-IKSNMFTGLINLKYLSLSNSFTSL 367
Query: 177 TGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGI-- 233
F L IL+L N++ +FS ++ L + N ++G +
Sbjct: 368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGL---N-EIGQELTG 423
Query: 234 DVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTG--PVPDSLVKLESLK 290
+ + ++ EI+L N + + F+ V L+ L LR P L +L
Sbjct: 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483
Query: 291 IVNMTNNLLQGPVPEFDRSVS----LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYP 346
I++++NN + + + LD+ +N L L G
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDL---QHN-----------NLARLWKHANPGGPI 529
Query: 347 QRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNL 406
++ ++N + F L+ + L NNL
Sbjct: 530 YFLKGL-----------------SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNL 572
Query: 407 SGMIPEGLSVLGALKELDVSNNQLYGKIPS-----FKSNAIVNTDGNP 449
+ + + +LK L++ N + F++ ++ NP
Sbjct: 573 NTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNP 620
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-38
Identities = 60/390 (15%), Positives = 125/390 (32%), Gaps = 59/390 (15%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQ 126
+T + + ++Q + L L+L N +S L + L +L+ ++LSNN+
Sbjct: 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156
Query: 127 FTSVPSDFFT--GLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP-SF 183
++ S+ SSL+ +E+ +N P L N+ + +
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQIKE-FSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
Query: 184 FGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLK 243
+ L L+ +QL +F G T+L
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGL------------------------KWTNLT 251
Query: 244 EIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302
+ L N + D F+ + QLE L N SL L +++ +N+ + +
Sbjct: 252 MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS 311
Query: 303 VPEFDRSVSLDMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLMGYPQRF---------- 349
+ + + L L + + G
Sbjct: 312 IS-------------LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYL 358
Query: 350 --AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLS 407
+ ++ ++ V+ + ++N K ++ S F+ L+ L L N +
Sbjct: 359 SLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIG 418
Query: 408 GMIPEG-LSVLGALKELDVSNNQLYGKIPS 436
+ L + E+ +S N+ +
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRN 448
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-37
Identities = 58/376 (15%), Positives = 128/376 (34%), Gaps = 52/376 (13%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFT 128
IT + + H L+ +N ++L L++ +N+IS P L L+V+ L +N+ +
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 129 SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDE 188
+ F ++L + + +N L + ++
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ-- 143
Query: 189 FPGLTILHLAFNQLIGGLPASFSG---SQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKE 244
L L L+ N++ S ++ L ++ N ++ + L
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS-N---QIKEFSPGCFHAIGRLFG 199
Query: 245 IWLHSNAFSGPLPD----FSGVKQLESLSLRDNFFTGPVPDSLVKLE--SLKIVNMTNNL 298
++L++ L + + +LSL ++ + + + L+ +L +++++ N
Sbjct: 200 LFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNN 259
Query: 299 LQGPVPE----FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 354
L + + + NN + L+ L +V L
Sbjct: 260 LNVVGNDSFAWLPQLEYFFL--EYNNIQHLFSHS----LHGLFNVRYLNLK--------- 304
Query: 355 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 414
+ T + +L F K L+ L + DN++ G+
Sbjct: 305 ---------------RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMF 349
Query: 415 SVLGALKELDVSNNQL 430
+ L LK L +SN+
Sbjct: 350 TGLINLKYLSLSNSFT 365
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-35
Identities = 56/364 (15%), Positives = 106/364 (29%), Gaps = 68/364 (18%)
Query: 77 HQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFF 135
H L +P +L T + L L N + + + L + + N + + +
Sbjct: 13 HLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELC 69
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL 195
L L+ + + +N S ++ + L S +I + F L L
Sbjct: 70 QKLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK--QKNLITL 126
Query: 196 HLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG- 254
L+ N L + + +L+E+ L +N
Sbjct: 127 DLSHNGLSSTKLGTQV--------------------------QLENLQELLLSNNKIQAL 160
Query: 255 PLPDFSGVK--QLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSL 312
+ L+ L L N P + L + + N L + E
Sbjct: 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTE------- 213
Query: 313 DMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGN 371
CL + L LS +L + + N
Sbjct: 214 -------KLCLELAN---TSIRNLSLSNSQL----STTSNTTFLGLKWT----------N 249
Query: 372 ITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 431
+T+++ NL + FA L+ L NN+ + L L ++ L++ +
Sbjct: 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309
Query: 432 GKIP 435
I
Sbjct: 310 QSIS 313
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-29
Identities = 74/391 (18%), Positives = 131/391 (33%), Gaps = 59/391 (15%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLP----------SLNGLASLEVVMLSNNQFT 128
N+Q +L L + L L+ + + S L LE + + +N
Sbjct: 283 NIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP 342
Query: 129 SVPSDFFTGLSSLQSIEIDNNPFSSWEIP----QSLRNASGLQ--NFSANSANITGQIPS 182
+ S+ FTGL +L+ + + N+ S + SL + S L N + N I+
Sbjct: 343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAH-SPLHILNLTKN--KISKIESD 399
Query: 183 FFGPDEFPGLTILHLAFNQLIGGLPAS-FSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMT 240
F L +L L N++ L + G I ++++ N L + +
Sbjct: 400 AFS--WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY---NKYLQLTRNSFALVP 454
Query: 241 SLKEIWLHSNAFSG---PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
SL+ + L A F ++ L L L +N D L LE L+I+++ +N
Sbjct: 455 SLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHN 514
Query: 298 LLQGPVPEFDRSVSLDMAKG----------SNNFCLPSPGACD--PRLNAL-LSVVKLMG 344
L + + KG SN F L + L + L
Sbjct: 515 NLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNT 574
Query: 345 YPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFA-SFKSLQRLILAD 403
P N + ++ +N QK +T F +F++L L +
Sbjct: 575 LPASVFNN----------------QVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618
Query: 404 NNLSGMIPEGLSVLGALKELDVSNNQLYGKI 434
N + + E + +L
Sbjct: 619 NPFDCTCESIAWFVNWINETHTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-29
Identities = 67/333 (20%), Positives = 117/333 (35%), Gaps = 59/333 (17%)
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
S EV S+ + T VP D T ++ + + +N + S L +
Sbjct: 5 SHEVADCSHLKLTQVPDDLPT---NITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNT 60
Query: 176 ITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDV 235
I+ P P L +L+L N+L +F+
Sbjct: 61 ISKLEPELCQK--LPMLKVLNLQHNELSQLSDKTFA------------------------ 94
Query: 236 IQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 294
T+L E+ L SN+ + F K L +L L N + + V+LE+L+ + +
Sbjct: 95 --FCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLL 152
Query: 295 TNNLLQGPVPEFDRS------VSLDMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLMGY 345
+NN +Q E L+++ SN SPG RL L L+ V+L
Sbjct: 153 SNNKIQALKSEELDIFANSSLKKLELS--SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPS 210
Query: 346 PQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFK--SLQRLILAD 403
+ + +I ++ L+ T + F K +L L L+
Sbjct: 211 LTE-------------KLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSY 257
Query: 404 NNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436
NNL+ + + + L L+ + N +
Sbjct: 258 NNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH 290
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-22
Identities = 42/239 (17%), Positives = 78/239 (32%), Gaps = 50/239 (20%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG---PLPSLNGLASLEVVMLSN 124
+ I I + + ++ + L+RL L+ ++ L +L ++ LSN
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 125 NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFF 184
N ++ D GL L+ +++ +N L ++ G F
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNN---------------LARLWKHA--NPGGPIYFL 532
Query: 185 GPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKE 244
L IL+L N +P +V +++ LK
Sbjct: 533 K--GLSHLHILNLESNG-FDEIPV-------------------------EVFKDLFELKI 564
Query: 245 IWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSL-VKLESLKIVNMTNNLLQG 301
I L N + F+ L+SL+L+ N T +L ++M N
Sbjct: 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 30/195 (15%), Positives = 57/195 (29%), Gaps = 45/195 (23%)
Query: 240 TSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
S + + +PD + L+L N + + L +++ N +
Sbjct: 4 VSHEVADCSHLKLTQ-VPDDLP-TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 300 QGPVPEFDRSVS----LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 355
PE + + L++ N S ++ +L N
Sbjct: 62 SKLEPELCQKLPMLKVLNLQ--HNELSQLSDKT----FAFCTNLTEL-----HLMSN--- 107
Query: 356 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLS 415
++ + F K+L L L+ N LS
Sbjct: 108 -------------------------SIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQV 142
Query: 416 VLGALKELDVSNNQL 430
L L+EL +SNN++
Sbjct: 143 QLENLQELLLSNNKI 157
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-40
Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 26/187 (13%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSE--IAVLTKVRHRHLVA 655
+ +G+G FG V++G+ G ++AVK + S + + E I +RH +++
Sbjct: 47 QESIGKGRFGEVWRGKWR-GEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILG 100
Query: 656 LLGHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
+ N LV +Y G+L ++ + + +AL A G+ +
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAH 154
Query: 712 LHGLAHQS-----FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE---TRIAGT 763
LH + HRDLK NIL+ + +AD GL +I+ GT
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 764 FGYLAPE 770
Y+APE
Sbjct: 215 KRYMAPE 221
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-37
Identities = 59/370 (15%), Positives = 119/370 (32%), Gaps = 30/370 (8%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTG 137
+ L N LE L L N IS LP L+V+ NN + + +
Sbjct: 116 GISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSS 175
Query: 138 LSSLQSIEID--NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL 195
L ++ ++ N + I +++ Q+ + I L +
Sbjct: 176 LQQATNLSLNLNGNDIAG--IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLG 233
Query: 196 HLAFNQLIGGLPASFSG---SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252
PA F G ++S+ + + + + L+E+ L +
Sbjct: 234 TFEDMDDEDISPAVFEGLCEMSVESINL---QKHYFFNISSNTFHCFSGLQELDLTATHL 290
Query: 253 SGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE--FDRSV 310
S G+ L+ L L N F S SL +++ N + + +
Sbjct: 291 SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350
Query: 311 SL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTC 367
+L D+ S++ + + C+ +L L + L + N + +
Sbjct: 351 NLRELDL---SHD-DIETSDCCNLQLRNLSHLQSL-----NLSYNEPLSLKTEAFKECP- 400
Query: 368 TKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVS 426
+ +++ L + F + L+ L L+ + L + L AL+ L++
Sbjct: 401 ---QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457
Query: 427 NNQLYGKIPS 436
N
Sbjct: 458 GNHFPKGNIQ 467
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 71/388 (18%), Positives = 129/388 (33%), Gaps = 54/388 (13%)
Query: 74 QIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSD 133
Q +G S +Q+L ++ IS + S+E + L + F ++ S+
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272
Query: 134 FFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLT 193
F S LQ +++ S +P L S L+ ++ FP LT
Sbjct: 273 TFHCFSGLQELDLTATHLSE--LPSGLVGLSTLKKLVLSANKFENLCQISAS--NFPSLT 328
Query: 194 ILHLAFNQLIGGL-PASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251
L + N L ++ L ++ + ++N++ L+ + L N
Sbjct: 329 HLSIKGNTKRLELGTGCLENLENLRELDLSH-DDIETSDCCNLQLRNLSHLQSLNLSYNE 387
Query: 252 FSG-PLPDFSGVKQLESLSLRDNFFTGPVPDS-LVKLESLKIVNMTNNLLQGPVPE-FDR 308
F QLE L L S L LK++N++++LL + FD
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG 447
Query: 309 SVS---LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGV 365
+ L++ N L L
Sbjct: 448 LPALQHLNL---QGNHFPKGNIQKTNSLQTL----------------------------- 475
Query: 366 TCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDV 425
G + ++ +L+ F S K + + L+ N L+ E LS L + L++
Sbjct: 476 ----GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNL 530
Query: 426 SNNQLYGKIPS----FKSNAIVNTDGNP 449
++N + +PS +N NP
Sbjct: 531 ASNHISIILPSLLPILSQQRTINLRQNP 558
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-31
Identities = 63/381 (16%), Positives = 125/381 (32%), Gaps = 37/381 (9%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFT 128
+T + + + Q+ +L+ L L N + +L+G +L+ + +
Sbjct: 59 LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118
Query: 129 SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFGP 186
S+ +L+S+ + +N SS L+ +F N I
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISS-IKLPKGFPTEKLKVLDFQNN--AIHYLSKEDMSS 175
Query: 187 DEFPGLTI--LHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKE 244
T L+L N + G P +F + QSL G N + + SL
Sbjct: 176 --LQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGG-TQNLLVIFKGLKNSTIQSLWL 232
Query: 245 IWLHSNAFSGPLPD-FSGVK--QLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301
P F G+ +ES++L+ ++F ++ L+ +++T L
Sbjct: 233 GTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE 292
Query: 302 PVPEFDRSVS---LDMAKGSNNFCLPSPGACD--PRLNALLSVVKLMGYPQRFAENWKGN 356
+ L + +N F + P L L N K
Sbjct: 293 LPSGLVGLSTLKKLVL--SANKFENLCQISASNFPSLTHL-----------SIKGNTKRL 339
Query: 357 DPCSDWIGVTCTKGNITVINFQKMNLT--GTISPEFASFKSLQRLILADNNLSGMIPEGL 414
+ + + N+ ++ ++ + + + LQ L L+ N + E
Sbjct: 340 ELGTGCLENL---ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF 396
Query: 415 SVLGALKELDVSNNQLYGKIP 435
L+ LD++ +L K
Sbjct: 397 KECPQLELLDLAFTRLKVKDA 417
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-29
Identities = 65/371 (17%), Positives = 106/371 (28%), Gaps = 69/371 (18%)
Query: 64 CIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVML 122
CIE + + L +P L E LE +N + + + L +L + L
Sbjct: 8 CIEKEVNKTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDL 64
Query: 123 SNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPS 182
+ Q + D F L ++ + NP +L L++ I+
Sbjct: 65 TRCQIYWIHEDTFQSQHRLDTLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSIDFI 123
Query: 183 FFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
L L+L N + L
Sbjct: 124 PLHN--QKTLESLYLGSNHISSIKLPKG--------------------------FPTEKL 155
Query: 243 KEIWLHSNAFSG-PLPDFSGVKQLE--SLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
K + +NA D S ++Q SL+L N G + + +N
Sbjct: 156 KVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQN 214
Query: 300 QGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPC 359
+ + G N + S +
Sbjct: 215 LLVIFK-----------GLKNSTIQSLWLGTFEDMDDEDI-------------------- 243
Query: 360 SDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGA 419
S + + ++ IN QK S F F LQ L L +LS +P GL L
Sbjct: 244 SPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLST 302
Query: 420 LKELDVSNNQL 430
LK+L +S N+
Sbjct: 303 LKKLVLSANKF 313
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-28
Identities = 60/367 (16%), Positives = 114/367 (31%), Gaps = 67/367 (18%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFT 128
+ I + + + L+ L+L +S L GL++L+ ++LS N+F
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFE 314
Query: 129 SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFGP 186
++ + SL + I N L N L+ + S + +I
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD--DIETSDCCNLQL 372
Query: 187 DEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIW 246
L L+L++N+ +++ + + L+ +
Sbjct: 373 RNLSHLQSLNLSYNEP----------LSLKT----------------EAFKECPQLELLD 406
Query: 247 LHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304
L F + L+ L+L + L +L+ +N+ N
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF----- 461
Query: 305 EFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWI 363
N S RL L LS L Q +
Sbjct: 462 -----------PKGNIQKTNSLQTL-GRLEILVLSFCDLSSIDQHAFTS----------- 498
Query: 364 GVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKEL 423
+ ++ LT + S E S L LA N++S ++P L +L + +
Sbjct: 499 -----LKMMNHVDLSHNRLT-SSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTI 552
Query: 424 DVSNNQL 430
++ N L
Sbjct: 553 NLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-27
Identities = 71/374 (18%), Positives = 111/374 (29%), Gaps = 58/374 (15%)
Query: 78 QNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFT--SVPSDFF 135
L S+LQ T L L L N I+G P A + + Q
Sbjct: 166 HYLSKEDMSSLQQATNLS-LNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN 224
Query: 136 TGLSSLQSIEIDNNPFS--SWEIPQSLRNASGLQ-NFSANSANITGQIPSFFGPDEFPGL 192
+ + SL ++ S + + L S N + + F F GL
Sbjct: 225 STIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKH--YFFNISSNTFHC--FSGL 280
Query: 193 TILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251
L L + LP+ G S ++ L ++ N L N SL + + N
Sbjct: 281 QELDLTATH-LSELPSGLVGLSTLKKLVLSA-NKFENLCQI--SASNFPSLTHLSIKGNT 336
Query: 252 FSGPLPD--FSGVKQLESLSLRDNFFT--GPVPDSLVKLESLKIVNMTNNLLQGPVPE-F 306
L ++ L L L + L L L+ +N++ N E F
Sbjct: 337 KRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF 396
Query: 307 DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVT 366
L+ L+ L+ +L K D S + +
Sbjct: 397 KECPQLE------------------LLD--LAFTRL-----------KVKDAQSPFQNLH 425
Query: 367 CTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI---PEGLSVLGALKEL 423
+ V+N L + F +LQ L L N+ L LG L+ L
Sbjct: 426 ----LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481
Query: 424 DVSNNQLYGKIPSF 437
+S L
Sbjct: 482 VLSFCDLSSIDQHA 495
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 40/232 (17%), Positives = 83/232 (35%), Gaps = 15/232 (6%)
Query: 79 NLQGTLPSN-LQNLTKLERLELQWNSISG---PLPSLNGLASLEVVMLSNNQFTSVPSDF 134
+ L + L+NL L L+L + I L L+ L+ + LS N+ S+ ++
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395
Query: 135 FTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTI 194
F L+ +++ + +N L+ + + + + F P L
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD--GLPALQH 453
Query: 195 LHLAFNQL---IGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
L+L N S +++ L ++ ++ + + L N
Sbjct: 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF---CDLSSIDQHAFTSLKMMNHVDLSHN 510
Query: 251 AFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301
+ + S +K + L+L N + +P L L + +N+ N L
Sbjct: 511 RLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-17
Identities = 31/140 (22%), Positives = 58/140 (41%), Gaps = 10/140 (7%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG----PLPSLNGLASLEVVMLS 123
+ + + H L + L L+ L LQ N SL L LE+++LS
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484
Query: 124 NNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ-NFSANSANITGQIPS 182
+S+ FT L + +++ +N +S ++L + G+ N ++N +I+ +PS
Sbjct: 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTS-SSIEALSHLKGIYLNLASN--HISIILPS 541
Query: 183 FFGPDEFPGLTILHLAFNQL 202
++L N L
Sbjct: 542 LLPI--LSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 10/66 (15%), Positives = 21/66 (31%)
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+ + F L + F+ +L L L + + + L L ++ N L
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 431 YGKIPS 436
+
Sbjct: 94 IFMAET 99
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 16/72 (22%), Positives = 25/72 (34%), Gaps = 4/72 (5%)
Query: 359 CSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG 418
S + N T N + + L I S + L + N L + S L
Sbjct: 2 TSSDQKCIEKEVNKTY-NCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLI 57
Query: 419 ALKELDVSNNQL 430
L LD++ Q+
Sbjct: 58 NLTFLDLTRCQI 69
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-35
Identities = 56/388 (14%), Positives = 116/388 (29%), Gaps = 59/388 (15%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFT 128
+ + I Q ++ + + K ++ N+I+ ++ L L + N+ F
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 129 SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDE 188
+ + + + N L + + ++P+F
Sbjct: 220 AENICEAWENENSEYAQQYKT------EDLKWDNLKDLTDVEVYNCPNLTKLPTFLK--A 271
Query: 189 FPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQ------NGNAKLGGGI-DVIQNMTS 241
P + ++++A N+ I G + V + N + +Q M
Sbjct: 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKK 331
Query: 242 LKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301
L + N G LP F +L SL+L N T + E ++ ++ +N L+
Sbjct: 332 LGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY 391
Query: 302 PVPEFDRS-----VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN 356
FD ++D S N ++
Sbjct: 392 IPNIFDAKSVSVMSAIDF---SYN--------------------EIGSVD----GKNFDP 424
Query: 357 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGM------- 409
+ N++ IN ++ F++ L + L N L+ +
Sbjct: 425 LDPT-----PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 410 IPEGLSVLGALKELDVSNNQLYGKIPSF 437
E L +D+ N+L F
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTKLSDDF 507
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-33
Identities = 60/440 (13%), Positives = 118/440 (26%), Gaps = 87/440 (19%)
Query: 20 SILFVSASGDDGDAAVMLALKKSLNPPE--SLGWSDTDPCKWNH------------VVCI 65
I + D + + +LN G+ WN V
Sbjct: 19 PIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLN 78
Query: 66 EDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGP-----LPSLNGLASLEVV 120
+ R+T + + G +P + LT+LE L L + ++ S E
Sbjct: 79 SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138
Query: 121 MLSNNQFT--SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITG 178
+ V D S L I+++P I +S R S NIT
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQK-SIKKSSRITLKDTQIGQLSNNITF 197
Query: 179 QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQN 238
+ L ++ + + + ++ Q N
Sbjct: 198 -VSKAVM--RLTKLRQFYMGNSPFVAENICEAW--ENENSEYAQQYKT-----EDLKWDN 247
Query: 239 MTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+ L ++ +++ LP + +++ +++ N
Sbjct: 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK- 306
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFC-LPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN 356
+Q + + G NN P
Sbjct: 307 -IQ----------IIYI--GYNNLKTFPVE------------------------------ 323
Query: 357 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV 416
+ + ++ L G + P F S L L LA N ++ +
Sbjct: 324 ----TSLQ-KMK--KLGMLECLYNQLEGKL-PAFGSEIKLASLNLAYNQITEIPANFCGF 375
Query: 417 LGALKELDVSNNQLYGKIPS 436
++ L ++N+L IP+
Sbjct: 376 TEQVENLSFAHNKLKY-IPN 394
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-32
Identities = 54/258 (20%), Positives = 100/258 (38%), Gaps = 22/258 (8%)
Query: 68 KRITRIQIGHQNLQ-GTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQ 126
++I I IG+ NL+ + ++LQ + KL LE +N + G LP+ L + L+ NQ
Sbjct: 305 EKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQ 364
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGP 186
T +P++F ++++ +N ++ S + + I F P
Sbjct: 365 ITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
Query: 187 -----DEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNG----QNGNAKLGGGIDVI 236
+ ++ ++L+ NQ+ FS S + S+ + G + L +
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484
Query: 237 QNMTSLKEIWLHSNAFSGPLPD---FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 293
+N L I L N + L D + + L + L N F+ P + +LK
Sbjct: 485 KNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFG 542
Query: 294 MTNNL------LQGPVPE 305
+ N PE
Sbjct: 543 IRNQRDAQGNRTLREWPE 560
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 50/363 (13%), Positives = 108/363 (29%), Gaps = 91/363 (25%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNG-LASLEVVMLSNNQFTSVPSDFFTG 137
L+G LP+ + KL L L +N I+ + G +E + ++N+ +P+ F
Sbjct: 341 QLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAK 399
Query: 138 -LSSLQSIEIDNNPFSS------WEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFP 190
+S + +I+ N S + + + + + ++ I+ F
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS--TGS 457
Query: 191 GLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
L+ ++L N L +P + + ++ +N L I L N
Sbjct: 458 PLSSINLMGNML-TEIPKNSLKDENEN------------------FKNTYLLTSIDLRFN 498
Query: 251 AFSGPLPD---FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFD 307
+ L D + + L + L N F+ P + +LK F
Sbjct: 499 KLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLK--------------GFG 542
Query: 308 RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTC 367
D N P + I C
Sbjct: 543 IRNQRDAQ--GNRTL--------------------------------REWP--EGIT-LC 565
Query: 368 TKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSN 427
++T + ++ ++ + ++ L + DN + + +
Sbjct: 566 P--SLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFY 620
Query: 428 NQL 430
++
Sbjct: 621 DKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-19
Identities = 32/242 (13%), Positives = 64/242 (26%), Gaps = 59/242 (24%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG--------PLPSLNGLASLEV 119
++ I + + + + L + L N ++ + L
Sbjct: 433 INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492
Query: 120 VMLSNNQFTSVPSDF-FTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITG 178
+ L N+ T + DF T L L I++ N FS P N+S L+ F +
Sbjct: 493 IDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK--FPTQPLNSSTLKGFGIRN----- 545
Query: 179 QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQN 238
N+ + P +
Sbjct: 546 ---------------QRDAQGNRTLREWPEGIT--------------------------L 564
Query: 239 MTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 298
SL ++ + SN + + L ++DN + + + +
Sbjct: 565 CPSLTQLQIGSNDIRKVNEKIT--PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
Query: 299 LQ 300
Q
Sbjct: 623 TQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 11/89 (12%), Positives = 26/89 (29%), Gaps = 8/89 (8%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGL 138
P + L +L++ N I + ++ V+ + +N S+ +
Sbjct: 553 RTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI--TPNISVLDIKDNPNISIDLSYVCPY 610
Query: 139 SSLQSIEIDNNPFSSWEIPQSLRNASGLQ 167
+ + Q +R L
Sbjct: 611 IEAGMYMLFYDK------TQDIRGCDALD 633
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 16/96 (16%), Positives = 26/96 (27%), Gaps = 26/96 (27%)
Query: 352 NWKGNDPCSDW---IGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG 408
NW N W GV+ + + L L SG
Sbjct: 59 NWNFNKELDMWGAQPGVSL--NSNG---------------------RVTGLSLEGFGASG 95
Query: 409 MIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAIVN 444
+P+ + L L+ L + ++ F I
Sbjct: 96 RVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISA 131
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-35
Identities = 64/390 (16%), Positives = 136/390 (34%), Gaps = 48/390 (12%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQ 126
+ + + +Q Q+L+ L L L N I L + +GL+SL+ ++
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFF 184
S+ + L +L+ + + +N S+++P+ N + L+ + S+N I +
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN--KIQSIYCTDL 169
Query: 185 GPDEFPGLTI----LHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGI--DVIQN 238
+ + L L+ N + P +F ++ L + N + IQ
Sbjct: 170 RV--LHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR----NNFDSLNVMKTCIQG 223
Query: 239 MTSLKEIWLHSNAFSG----PLPDFSGVKQLESLSLRDN------FFTGPVPDSLVKLES 288
+ L+ L F D S ++ L +L++ + ++ + D L +
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
Query: 289 LKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQR 348
+ ++ + ++ V +F + + N P L L
Sbjct: 284 VSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL-----------T 331
Query: 349 FAENWKGNDPCSDWIGVTCTKGNITVINFQ--KMNLTGTISPEFASFKSLQRLILADNNL 406
F N GN + ++ ++ ++ G S SL+ L L+ N +
Sbjct: 332 FTSNKGGNAFSEVDL------PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
Query: 407 SGMIPEGLSVLGALKELDVSNNQLYGKIPS 436
+ L L+ LD ++ L
Sbjct: 386 IT-MSSNFLGLEQLEHLDFQHSNLKQMSEF 414
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-34
Identities = 70/374 (18%), Positives = 125/374 (33%), Gaps = 37/374 (9%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISG--PLPSLNGLASLEVVMLSNNQFTSVPSDFFT 136
NL + +L L+ L + N I + L +LE + LS+N+ S+
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 137 GLSSLQ----SIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGL 192
L + S+++ NP + P + + L + + + + GL
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIR-LHKLTLRNNFDSLNVMKTCI-QGLAGL 227
Query: 193 TILHLAFNQLIG-GLPASFSGSQIQSLWV------NGQNGNAKLGGGIDVIQNMTSLKEI 245
+ L + G F S ++ L + L ID+ +T++
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 246 WLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305
L S + DFS + L L + F L L+ L T+N E
Sbjct: 288 SLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL---TFTSNKGGNAFSE 343
Query: 306 FDRS--VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWI 363
D LD+ S N L G C S+ L + N S+++
Sbjct: 344 VDLPSLEFLDL---SRNG-LSFKGCCSQSDFGTTSLKYL-----DLSFNGVITMS-SNFL 393
Query: 364 GVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKE 422
G+ + ++FQ NL F S ++L L ++ + + L +L+
Sbjct: 394 GLE----QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 449
Query: 423 LDVSNNQLYGKIPS 436
L ++ N
Sbjct: 450 LKMAGNSFQENFLP 463
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-33
Identities = 64/410 (15%), Positives = 118/410 (28%), Gaps = 73/410 (17%)
Query: 64 CIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVML 122
C+E Q N +P NL + L+L +N + S L+V+ L
Sbjct: 3 CVEVVPNITYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 123 SNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPS 182
S + ++ + LS L ++ + NP S + S LQ A N+
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 183 FFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
G L L++A N + + N+T+L
Sbjct: 119 PIGH--LKTLKELNVAHNLIQSFKLPEY-------------------------FSNLTNL 151
Query: 243 KEIWLHSNAFSGPLP-DFSGVKQLE----SLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+ + L SN D + Q+ SL L N P + ++ L + + NN
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNN 210
Query: 298 LLQGPVPE--FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 355
V + L++ + +AL + L
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL------------- 257
Query: 356 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGL 414
I ++ + F ++ L + +
Sbjct: 258 ---------------TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--F 300
Query: 415 SVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGNPDIGKEKSSSFQGSPS 464
S + L++ N + G+ P+ K ++ + S PS
Sbjct: 301 SYNFGWQHLELVNCKF-GQFPTLKLKSLKRLTFT-SNKGGNAFSEVDLPS 348
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-31
Identities = 67/395 (16%), Positives = 116/395 (29%), Gaps = 85/395 (21%)
Query: 82 GTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVM----LSNNQFTSVPSDFFT 136
LP NLT LE L+L N I L L + ++ LS N + F
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 137 GLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFGPDEFPGLTI 194
+ L + + NN S + ++ +GL+ G + F GL
Sbjct: 199 EIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD-KSALEGLCN 256
Query: 195 LHLAFNQL------IGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWL 247
L + +L + + F+ + + S + + + + L
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-----RVKDFSYNFGWQHLEL 311
Query: 248 HSNAFSG--------------------PLPDFSGVKQLESLSLRDNF--FTGPVPDSLVK 285
+ F + LE L L N F G S
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 286 LESLKIVNMTNNLLQGPVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKL 342
SLK ++++ N + F L D ++
Sbjct: 372 TTSLKYLDLSFNGVITMSSNFLGLEQLEHLDF---QHS---------------------- 406
Query: 343 MGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILA 402
N K S ++ + N+ ++ + + F SL+ L +A
Sbjct: 407 ---------NLKQMSEFSVFLSLR----NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453
Query: 403 DNNLSGMI-PEGLSVLGALKELDVSNNQLYGKIPS 436
N+ P+ + L L LD+S QL P+
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-29
Identities = 78/388 (20%), Positives = 122/388 (31%), Gaps = 86/388 (22%)
Query: 76 GHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP----SLNGLASLEVVMLSNNQFTSVP 131
NL+ S L+ L L E + + L N L ++ L + V
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298
Query: 132 SDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG 191
F+ Q +E+ N F L++ L F++N S P
Sbjct: 299 D--FSYNFGWQHLELVNCKFGQ-FPTLKLKSLKRL-TFTSNKGGN---AFSEVD---LPS 348
Query: 192 LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251
L L L+ N L SF G QS + TSLK + L N
Sbjct: 349 LEFLDLSRNGL------SFKGCCSQSDF------------------GTTSLKYLDLSFNG 384
Query: 252 FSGPLPDFSGVKQLESLSLRDNFFTGPVPDS-LVKLESLKIVNMTNNLLQGPVPE-FDRS 309
+F G++QLE L + + S + L +L +++++ + F+
Sbjct: 385 VITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444
Query: 310 VSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVT 366
SL MA N+F P + L
Sbjct: 445 SSLEVLKMA--GNSFQENFL----PDIFTELR---------------------------- 470
Query: 367 CTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVS 426
N+T ++ + L F S SLQ L ++ NN + L +L+ LD S
Sbjct: 471 ----NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 526
Query: 427 NNQLYGKIPS-----FKSNAIVNTDGNP 449
N + S A +N N
Sbjct: 527 LNHIMTSKKQELQHFPSSLAFLNLTQND 554
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-29
Identities = 43/233 (18%), Positives = 79/233 (33%), Gaps = 19/233 (8%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSIS--GPLP-SLNGLASLEVVMLSNNQFTSVPSDFF 135
+ +G + +L LE L+L N +S G S G SL+ + LS N ++ S+F
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFL 393
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFGPDEFPGLT 193
GL L+ ++ ++ + L + S + F L
Sbjct: 394 -GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT--HTRVAFNGIFN--GLSSLE 448
Query: 194 ILHLAFNQLIGGLPASFSG--SQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSN 250
+L +A N + L ++ +L +++SL+ + + N
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQ---C-QLEQLSPTAFNSLSSLQVLNMSHN 504
Query: 251 AFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLE-SLKIVNMTNNLLQG 301
F + + L+ L N L SL +N+T N
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-27
Identities = 63/381 (16%), Positives = 118/381 (30%), Gaps = 71/381 (18%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLP--SLNGLASLEVVMLSNNQFTS------V 130
+ P + + +L +L L+ N S + + GLA LEV L +F +
Sbjct: 188 PMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 131 PSDFFTGLSSLQSIEIDNN--PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDE 188
GL +L E + +I + + +FS S I +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY---- 302
Query: 189 FPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH 248
G L L + G P S ++ L G ++ SL+ + L
Sbjct: 303 NFGWQHLELVNCKF-GQFPTLKLKS-LKRLTFTSNKGG-----NAFSEVDLPSLEFLDLS 355
Query: 249 SNA--FSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305
N F G G L+ L L N + + + LE L+ ++ ++ L+
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF 414
Query: 306 --FDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS 360
F +L D++ + + G
Sbjct: 415 SVFLSLRNLIYLDIS--HTHTRVAFNGIF-------------------------NGLS-- 445
Query: 361 DWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGA 419
++ V+ + P+ F ++L L L+ L + P + L +
Sbjct: 446 ----------SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495
Query: 420 LKELDVSNNQLYGKIPSFKSN 440
L+ L++S+N +
Sbjct: 496 LQVLNMSHNNFFSLDTFPYKC 516
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 16/80 (20%), Positives = 26/80 (32%), Gaps = 10/80 (12%)
Query: 357 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV 416
+PC NIT ++N I S + L L+ N L +
Sbjct: 1 EPC------VEVVPNITY-QCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFS 50
Query: 417 LGALKELDVSNNQLYGKIPS 436
L+ LD+S ++
Sbjct: 51 FPELQVLDLSRCEIQTIEDG 70
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 53/190 (27%), Positives = 85/190 (44%), Gaps = 19/190 (10%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
++ LG GGF V E LHDG A+KR+ + E + E + H +
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNHPN 87
Query: 653 LVALLGHCLD----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
++ L+ +CL +E L+ + +GTL I ++ L ++ L + L + RG
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLLLGICRG 146
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA------- 761
+E +H + + HRDLKP+NILLGD+ + + D G + A +
Sbjct: 147 LEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 762 -GTFGYLAPE 770
T Y APE
Sbjct: 204 RCTISYRAPE 213
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 54/160 (33%), Positives = 87/160 (54%), Gaps = 13/160 (8%)
Query: 598 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
ILG G FG+V +G L K+AVK M+ S + + EF SE A + H ++
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 654 VALLGHCLDGN-----EKLLVFEYMPQGTLSRHI-FNWAEEGLKPLEWNRRLTIALDVAR 707
+ LLG C++ + + +++ +M G L ++ ++ E G K + L +D+A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
G+EYL ++++F+HRDL N +L DDM VADFGL +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 55/189 (29%), Positives = 80/189 (42%), Gaps = 16/189 (8%)
Query: 598 ENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
+GRG FG V+ G L D T +AVK + +F E +L + H ++V L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+G C +V E + G + EG L L + D A G+EYL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL---RTEG-ARLRVKTLLQMVGDAAAGMEYLES-- 231
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY----LAPEYA 772
+ IHRDL N L+ + K++DFG+ R +G + G APE
Sbjct: 232 -KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAPEAL 287
Query: 773 VHTRWSSCS 781
+ R+SS S
Sbjct: 288 NYGRYSSES 296
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 53/193 (27%), Positives = 95/193 (49%), Gaps = 18/193 (9%)
Query: 598 ENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
LG+G FG+V G +AVK+++ + + L +F+ EI +L ++H +
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDN 103
Query: 653 LVALLGHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+V G C + L+ EY+P G+L ++ E ++ + L + +G+E
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGME 159
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLA 768
YL + +IHRDL NIL+ ++ R K+ DFGL ++ P+ K + + G + A
Sbjct: 160 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 216
Query: 769 PEYAVHTRWSSCS 781
PE +++S S
Sbjct: 217 PESLTESKFSVAS 229
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 57/165 (34%), Positives = 80/165 (48%), Gaps = 19/165 (11%)
Query: 598 ENILGRGGFGTVYKGELHDG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHL 653
++++G G FG V K + A+KRM+ S +F E+ VL K+ H ++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNI 88
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTL-----------SRHIFNWAEEGLKPLEWNRRLTIA 702
+ LLG C L EY P G L + F A L + L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
DVARG++YL + + FIHRDL NIL+G++ AK+ADFGL R
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 52/193 (26%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 598 ENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
LG+G FG+V G +AVK+++ + + L +F+ EI +L ++H +
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDN 72
Query: 653 LVALLGHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+V G C + L+ EY+P G+L ++ ++ + ++ + L + +G+E
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQICKGME 128
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLA 768
YL + +IHRDL NIL+ ++ R K+ DFGL ++ P+ K + + G + A
Sbjct: 129 YLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 769 PEYAVHTRWSSCS 781
PE +++S S
Sbjct: 186 PESLTESKFSVAS 198
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 58/187 (31%), Positives = 85/187 (45%), Gaps = 16/187 (8%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+G G FG V+ G + K+A+K + G +S + +F E V+ K+ H LV L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLY 69
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
G CL+ LV E+M G L ++ L + LDV G+ YL
Sbjct: 70 GVCLEQAPICLVTEFMEHGCL----SDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EE 122
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLAPEYAVH 774
IHRDL N L+G++ KV+DFG+ R + T GT + +PE
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWASPEVFSF 179
Query: 775 TRWSSCS 781
+R+SS S
Sbjct: 180 SRYSSKS 186
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 14/161 (8%)
Query: 598 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
+LG+G FG+V + +L K+AVK ++A +I+ + EF E A + + H H+
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 654 VALLGHCLDGNEK------LLVFEYMPQGTLSRHI-FNWAEEGLKPLEWNRRLTIALDVA 706
L+G L K +++ +M G L + + E L + +D+A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
G+EYL + ++FIHRDL N +L +DM VADFGL R
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 5e-34
Identities = 50/175 (28%), Positives = 75/175 (42%), Gaps = 29/175 (16%)
Query: 598 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
LG G FG V K T +AVK ++ S L + SE VL +V H
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHP 86
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTL-------------------SRHIFNWAEEGLKP 692
H++ L G C LL+ EY G+L SR+ + +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 693 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
L ++ A +++G++Y LA +HRDL NIL+ + + K++DFGL R
Sbjct: 147 LTMGDLISFAWQISQGMQY---LAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 15/160 (9%)
Query: 599 NILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
LG+G FG VY+G T++A+K + S + EF +E +V+ + H
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHH 89
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+V LLG G L++ E M +G L S L P ++ + +A ++A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
G+ YL F+HRDL N ++ +D K+ DFG+ R
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-34
Identities = 45/193 (23%), Positives = 86/193 (44%), Gaps = 17/193 (8%)
Query: 598 ENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
LG G FG V G ++AVK ++ G + + K EI +L + H +
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHEN 84
Query: 653 LVALLGHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+V G C + L+ E++P G+L ++ + + ++L A+ + +G++
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGMD 140
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLA 768
YL + ++HRDL N+L+ + + K+ DFGL + K + + A
Sbjct: 141 YL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197
Query: 769 PEYAVHTRWSSCS 781
PE + +++ S
Sbjct: 198 PECLMQSKFYIAS 210
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 24/170 (14%)
Query: 598 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV- 648
LG G FG V E +AVK ++ + K L++ SE+ ++ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIG 98
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----------SRHIFNWAEEGLKPLEWNR 697
+H++++ LLG C ++ EY +G L + ++ + + +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
++ +ARG+EY LA Q IHRDL N+L+ ++ K+ADFGL R
Sbjct: 159 LVSCTYQLARGMEY---LASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 24/170 (14%)
Query: 598 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV- 648
LG G FG V E +AVK ++ + K L++ SE+ ++ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIG 144
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----------SRHIFNWAEEGLKPLEWNR 697
+H++++ LLG C ++ EY +G L + ++ + + +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
++ +ARG+EY LA Q IHRDL N+L+ ++ K+ADFGL R
Sbjct: 205 LVSCTYQLARGMEY---LASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 51/170 (30%), Positives = 82/170 (48%), Gaps = 24/170 (14%)
Query: 598 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV- 648
LG G FG V E TK+AVK +++ + K L++ SE+ ++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIG 132
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----------SRHIFNWAEEGLKPLEWNR 697
+H++++ LLG C ++ EY +G L + +N + + L
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
++ A VARG+EYL A + IHRDL N+L+ +D K+ADFGL R
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 597 EENILGRGGFGTVYKGELHDG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
E+ LG G FGTV KG +AVK ++ E +E V+ ++ + ++
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVAR 707
V ++G C +LV E G L K L+ NR + + V+
Sbjct: 81 VRMIGICE-AESWMLVMEMAELGPL-----------NKYLQQNRHVKDKNIIELVHQVSM 128
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--G 765
G++YL +F+HRDL N+LL AK++DFGL + + + + G +
Sbjct: 129 GMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 766 YLAPEYAVHTRWSSCS 781
+ APE + ++SS S
Sbjct: 186 WYAPECINYYKFSSKS 201
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 58/187 (31%), Positives = 82/187 (43%), Gaps = 16/187 (8%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
LG G FG V G+ +AVK ++ G +S EF E + K+ H LV
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFY 69
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
G C +V EY+ G L N+ K LE ++ L + DV G+ +L
Sbjct: 70 GVCSKEYPIYIVTEYISNGCLL----NYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ES 122
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLAPEYAVH 774
FIHRDL N L+ D+ KV+DFG+ R + GT + APE +
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD---DQYVSSVGTKFPVKWSAPEVFHY 179
Query: 775 TRWSSCS 781
++SS S
Sbjct: 180 FKYSSKS 186
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 51/175 (29%), Positives = 74/175 (42%), Gaps = 24/175 (13%)
Query: 593 NNFSEENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
N S LG G FG V + + +AVK ++ SE+ VL+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLS 81
Query: 647 KV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTL-------------SRHIFNWAEEGLKP 692
+ H ++V LLG C G L++ EY G L S+ E+
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 693 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
L+ L+ + VA+G+ +L A ++ IHRDL NILL K+ DFGL R
Sbjct: 142 LDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 56/189 (29%), Positives = 81/189 (42%), Gaps = 20/189 (10%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
LG G FG V G+ +A+K ++ G +S EF E V+ + H LV L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLY 85
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
G C ++ EYM G L N+ E + + L + DV +EYL
Sbjct: 86 GVCTKQRPIFIITEYMANGCL----LNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ES 138
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL-----APEYA 772
+ F+HRDL N L+ D KV+DFGL R + T G PE
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVG--SKFPVRWSPPEVL 193
Query: 773 VHTRWSSCS 781
+++++SS S
Sbjct: 194 MYSKFSSKS 202
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 20/166 (12%)
Query: 598 ENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RH 650
LG G FG V + K+AVK +++ SE+ +++ + +H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQH 109
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTL---------SRHIFNWAEEGLKPLEWNRRLTI 701
++V LLG C G L++ EY G L L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ VA+G+ +L A ++ IHRD+ N+LL + AK+ DFGL R
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 51/167 (30%), Positives = 80/167 (47%), Gaps = 22/167 (13%)
Query: 598 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+ LG G FG V+ E ++ +AVK ++ + +F+ E +LT ++H
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHE 77
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTL-----------SRHIFNWAEEGLKPLEWNRRLT 700
H+V G C DG+ ++VFEYM G L + + L ++ L
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
IA +A G+ YL A Q F+HRDL N L+G ++ K+ DFG+ R
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 14/190 (7%)
Query: 598 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
E I+G G G V G L +A+K ++AG + +F SE +++ + H ++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE-RQRRDFLSEASIMGQFDHPNI 112
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
+ L G G ++V EYM G+L + + + + V G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSL----DTFLRTHDGQFTIMQLVGMLRGVGAGMRYL- 167
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL--APEY 771
+ ++HRDL N+L+ ++ KV+DFGL R+ + + T G APE
Sbjct: 168 --SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 772 AVHTRWSSCS 781
+SS S
Sbjct: 226 IAFRTFSSAS 235
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 8e-33
Identities = 53/175 (30%), Positives = 78/175 (44%), Gaps = 29/175 (16%)
Query: 598 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+G G FG V++ T +AVK ++ S +F+ E A++ + +
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNP 110
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTL-------------------SRHIFNWAEEGLKP 692
++V LLG C G L+FEYM G L + G P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 693 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
L +L IA VA G+ Y L+ + F+HRDL N L+G++M K+ADFGL R
Sbjct: 171 LSCAEQLCIARQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 51/191 (26%), Positives = 92/191 (48%), Gaps = 15/191 (7%)
Query: 598 ENILGRGGFGTVYKGELHDGT-----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ ++G G FG VYKG L + +A+K ++AG + K +F E ++ + H +
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHN 107
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
++ L G +++ EYM G L + E + + + +A G++YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGAL----DKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY--LAPE 770
A+ +++HRDL NIL+ ++ KV+DFGL R+ + + T G APE
Sbjct: 164 ---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 771 YAVHTRWSSCS 781
+ +++S S
Sbjct: 221 AISYRKFTSAS 231
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 53/166 (31%), Positives = 80/166 (48%), Gaps = 21/166 (12%)
Query: 598 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+ LG G FG V+ E H+ +AVK ++ S +F+ E +LT ++H+
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQ 103
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTL----------SRHIFNWAEEGLKPLEWNRRLTI 701
H+V G C +G L+VFEYM G L ++ + + PL + L +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
A VA G+ YL A F+HRDL N L+G + K+ DFG+ R
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 23/168 (13%)
Query: 599 NILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHR 651
LGRG FG V + + +AVK ++ G + SE+ +L + H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHL 91
Query: 652 HLVALLGHCLDGNEKLLV-FEYMPQGTL------SRHIFNWAEEGL-----KPLEWNRRL 699
++V LLG C L+V E+ G L R+ F + L +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 700 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ VA+G+E+L A + IHRDL NILL + K+ DFGL R
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 53/191 (27%), Positives = 80/191 (41%), Gaps = 15/191 (7%)
Query: 598 ENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISG-KGLTEFKSEIAVLTKVRHRH 652
LG G FG V +GE +AVK ++ V+S + + +F E+ + + HR+
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
L+ L G L +V E P G+L + + A+ VA G+ YL
Sbjct: 83 LIRLYGVVL-TPPMKMVTELAPLGSLLDRL----RKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY--LAPE 770
+ FIHRDL N+LL K+ DFGL+R P+ + + APE
Sbjct: 138 ---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 771 YAVHTRWSSCS 781
+S S
Sbjct: 195 SLKTRTFSHAS 205
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-32
Identities = 54/185 (29%), Positives = 90/185 (48%), Gaps = 10/185 (5%)
Query: 598 ENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
++ LG G +G VY+G +AVK ++ + + EF E AV+ +++H +LV L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQL 281
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
LG C ++ E+M G L ++ E + + L +A ++ +EYL
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL---E 335
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR 776
++FIHR+L N L+G++ KVADFGL RL + + APE + +
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 777 WSSCS 781
+S S
Sbjct: 396 FSIKS 400
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 57/190 (30%), Positives = 91/190 (47%), Gaps = 20/190 (10%)
Query: 598 ENILGRGGFGTVYKGELHDG-TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
++ LG G +G VY+G +AVK ++ + + EF E AV+ +++H +LV L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQL 74
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
LG C ++ E+M G L ++ E + + L +A ++ +EYL
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL---E 128
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL-----APEY 771
++FIHRDL N L+G++ KVADFGL RL +T A APE
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-----DTYTAHAGAKFPIKWTAPES 183
Query: 772 AVHTRWSSCS 781
+ ++S S
Sbjct: 184 LAYNKFSIKS 193
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 50/175 (28%), Positives = 74/175 (42%), Gaps = 29/175 (16%)
Query: 598 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RH 650
+LG G FG V + ++AVK ++ SE+ ++T++ H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSH 108
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTL------SRHIFNWA------------EEGLKP 692
++V LLG C L+FEY G L R F+ EE L
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 693 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
L + L A VA+G+E+L +S +HRDL N+L+ K+ DFGL R
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 42/167 (25%), Positives = 68/167 (40%), Gaps = 21/167 (12%)
Query: 598 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
LG FG VYKG L +A+K ++ G EF+ E + +++H
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHP 72
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTL-----------SRHIFNWAEEGLKPLEWNRRLT 700
++V LLG ++F Y G L + LE +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ +A G+EYL + +H+DL N+L+ D + K++D GL R
Sbjct: 133 LVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 53/151 (35%), Positives = 83/151 (54%), Gaps = 12/151 (7%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+G+G FG V G+ G K+AVK ++ + F +E +V+T++RH +LV LL
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLL 80
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
G ++ L +V EYM +G+L ++ G L + L +LDV +EYL
Sbjct: 81 GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYL---E 134
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+F+HRDL N+L+ +D AKV+DFGL +
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 59/197 (29%), Positives = 83/197 (42%), Gaps = 27/197 (13%)
Query: 598 ENILGRGGFGTVYKGELHD-----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
LG G FG V G +AVK ++A + + +K EI +L + H H
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEH 94
Query: 653 LVALLGHCLDGNEK--LLVFEYMPQGTL----SRHIFNWAEEGLKPLEWNRRLTIALDVA 706
++ G C D LV EY+P G+L RH + + L A +
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----------SIGLAQLLLFAQQIC 144
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF-- 764
G+ YLH Q +IHRDL N+LL +D K+ DFGL + PEG R G
Sbjct: 145 EGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 201
Query: 765 GYLAPEYAVHTRWSSCS 781
+ APE ++ S
Sbjct: 202 FWYAPECLKEYKFYYAS 218
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 55/202 (27%), Positives = 80/202 (39%), Gaps = 30/202 (14%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+F LGRGGFG V++ + D A+KR+ + E+ L K+ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHP 63
Query: 652 HLVALLGHCLDGNEKL------------LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 699
+V L+ N + + + L + ++ E + L
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG--RCTIEERERSVCL 121
Query: 700 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-----------L 748
I L +A VE+LH + +HRDLKPSNI D KV DFGLV L
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 749 APEGKGSIETRIAGTFGYLAPE 770
P + T GT Y++PE
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPE 200
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 50/190 (26%), Positives = 86/190 (45%), Gaps = 14/190 (7%)
Query: 597 EENILGRGGFGTVYKGELHDG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
+ LG G FG+V +G +A+K ++ G E E ++ ++ + ++
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYI 72
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
V L+G C +LV E G L + + EE + + + V+ G++YL
Sbjct: 73 VRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYL- 126
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLAPEY 771
++F+HRDL N+LL + AK++DFGL + R AG + + APE
Sbjct: 127 --EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 184
Query: 772 AVHTRWSSCS 781
++SS S
Sbjct: 185 INFRKFSSRS 194
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 53/193 (27%), Positives = 83/193 (43%), Gaps = 18/193 (9%)
Query: 598 ENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ LG+G FG+V G +AVK+++ +F+ EI +L +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDF 85
Query: 653 LVALLGHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+V G + LV EY+P G L + + L+ +R L + + +G+E
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGME 141
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF--GYLA 768
YL + +HRDL NIL+ + K+ADFGL +L P K R G + A
Sbjct: 142 YLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
Query: 769 PEYAVHTRWSSCS 781
PE +S S
Sbjct: 199 PESLSDNIFSRQS 211
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-31
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 29/213 (13%)
Query: 566 PSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRM 625
PS E D + +V I F +++LG G GT+ + D +AVKR
Sbjct: 5 PSLEQDDGDEETSVVIVGKIS--------FCPKDVLGHGAEGTIVYRGMFDNRDVAVKR- 55
Query: 626 EAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN 684
I + + E+ +L + H +++ D + + E TL ++
Sbjct: 56 ----ILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV-- 108
Query: 685 WAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-----DMRAK 739
E+ +T+ G+ +LH + +HRDLKP NIL+ ++A
Sbjct: 109 --EQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAM 163
Query: 740 VADFGLVRLAPEGKGSIETR--IAGTFGYLAPE 770
++DFGL + G+ S R + GT G++APE
Sbjct: 164 ISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 50/155 (32%), Positives = 71/155 (45%), Gaps = 13/155 (8%)
Query: 598 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
++GRG FG VY G L D AVK + +++F +E ++ H ++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNV 88
Query: 654 VALLGHCLDGNEKLL-VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
++LLG CL L V YM G L I + L VA+G++YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
A + F+HRDL N +L + KVADFGL R
Sbjct: 145 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-31
Identities = 53/151 (35%), Positives = 83/151 (54%), Gaps = 12/151 (7%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+G+G FG V G+ G K+AVK ++ + F +E +V+T++RH +LV LL
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA----QAFLAEASVMTQLRHSNLVQLL 252
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
G ++ L +V EYM +G+L ++ G L + L +LDV +EYL
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYL---E 306
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+F+HRDL N+L+ +D AKV+DFGL +
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 47/162 (29%), Positives = 72/162 (44%), Gaps = 17/162 (10%)
Query: 598 ENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
LG G FG VY+G++ ++AVK + S + +F E +++K H+
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQ 93
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLKPLEWNRRLTIALDVARG 708
++V +G L + ++ E M G L R + L L +A D+A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQP-SSLAMLDLLHVARDIACG 152
Query: 709 VEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVR 747
+Y L FIHRD+ N LL G AK+ DFG+ R
Sbjct: 153 CQY---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 45/183 (24%), Positives = 80/183 (43%), Gaps = 7/183 (3%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
++ +G G +G K DG + K ++ G ++ SE+ +L +++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 652 HLVALLGHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
++V +D L V EY G L+ I +E + L+ L + + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLAL 124
Query: 710 EYLH--GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
+ H + +HRDLKP+N+ L K+ DFGL R+ +T + GT Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYM 183
Query: 768 APE 770
+PE
Sbjct: 184 SPE 186
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 13/157 (8%)
Query: 597 EENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ ++G+G FG VY GE D + A+K + + + F E ++ + H +
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPN 83
Query: 653 LVALLGHCLDGNE-KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
++AL+G L ++ YM G L + I + ++ L VARG+EY
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLISFGLQVARGMEY 139
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748
L A Q F+HRDL N +L + KVADFGL R
Sbjct: 140 L---AEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 47/190 (24%), Positives = 90/190 (47%), Gaps = 14/190 (7%)
Query: 598 ENILGRGGFGTVYKGELHDGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
+ ++G G FG V G L +K +A+K ++ G K +F E +++ + H ++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE-KQRRDFLGEASIMGQFDHPNI 108
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
+ L G ++V EYM G+L ++ + + + + +A G++YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLD----SFLRKHDAQFTVIQLVGMLRGIASGMKYL- 163
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL--APEY 771
+ ++HRDL NIL+ ++ KV+DFGL R+ + + T G +PE
Sbjct: 164 --SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 772 AVHTRWSSCS 781
+ +++S S
Sbjct: 222 IAYRKFTSAS 231
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 56/187 (29%), Positives = 92/187 (49%), Gaps = 16/187 (8%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
LG G FG V+ G + TK+AVK ++ G +S F +E ++ +++H+ LV L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLY 74
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
++ EYM G+L F G L N+ L +A +A G+ ++
Sbjct: 75 AVVT-QEPIYIITEYMENGSLVD--FLKTPSG-IKLTINKLLDMAAQIAEGMAFI---EE 127
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLAPEYAVH 774
+++IHRDL+ +NIL+ D + K+ADFGL RL + + T G + APE +
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINY 184
Query: 775 TRWSSCS 781
++ S
Sbjct: 185 GTFTIKS 191
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-31
Identities = 57/406 (14%), Positives = 122/406 (30%), Gaps = 88/406 (21%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG--PLPSLNGLASLEVVMLSNNQ 126
R + L + K++ + +N++ SL + L ++ +N+
Sbjct: 526 RGISAAQLKADW-TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNK 584
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSL-RNASGLQNFSANSANITGQIPSFFG 185
+ + F L +++D N EIP+ ++ + + IP+ F
Sbjct: 585 VRHLEA--FGTNVKLTDLKLDYNQIE--EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFN 639
Query: 186 PDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEI 245
+ + ++N+ IG + S S + +
Sbjct: 640 AKSVYVMGSVDFSYNK-IGSEGRNISCSM--------------------DDYKGINASTV 678
Query: 246 WLHSNAFSGPLPD-FSGVKQLESLSLRDNFFT-------GPVPDSLVKLESLKIVNMTNN 297
L N + F+ + ++ L +N T P + L +++ N
Sbjct: 679 TLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFN 738
Query: 298 LLQGPVPEFDRS-----VSLDMAKGSNNF-CLPSPGACDPRLNALLSVVKLMGYPQRFAE 351
L +F + ++D++ N F P+ L+ +L + R
Sbjct: 739 KLTSLSDDFRATTLPYLSNMDVS--YNCFSSFPT---------QPLNSSQLKAFGIRHQR 787
Query: 352 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 411
+ +GN + + SL +L + N++ +
Sbjct: 788 DAEGN------------------------RILRQWPTGITTCPSLIQLQIGSNDIRK-VD 822
Query: 412 EGLSVLGALKELDVSNNQL-YGKIPSFKSNAIVNT-----DGNPDI 451
E L L LD+++N + S D DI
Sbjct: 823 EKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI 866
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-30
Identities = 61/465 (13%), Positives = 127/465 (27%), Gaps = 73/465 (15%)
Query: 21 ILFVSASGDDGDAAVMLALKKSLN-------------PPESLGWS-DTDPCKWNH---VV 63
I + D + A+ ++L+ SL W+ + + W V
Sbjct: 259 IQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVD 318
Query: 64 CIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG--PLPSLNGLASLEVVM 121
+ R+T + + +G +P + LT+L+ L +S + L L
Sbjct: 319 LDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEE 378
Query: 122 LSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGL---QNFSANSANITG 178
+ F L ++ + + + ++ S + N N
Sbjct: 379 RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT 438
Query: 179 QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQN 238
I L I++ A + + S + + N
Sbjct: 439 FISKAIQ--RLTKLQIIYFANSPF-TYDNIAVDWEDANS------DYAKQYENEELSWSN 489
Query: 239 MTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGP---------VPDSLVKLES 288
+ L ++ L++ LPD + +L+SL++ N + D
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
Query: 289 LKIVNMTNNLLQGPVPEFDRS-----VSLDMAKGSNNF-CLPSPGACDPRLNAL-LSVVK 341
++I M N L+ LD N L + G +L L L +
Sbjct: 550 IQIFYMGYNNLEEFPASASLQKMVKLGLLDC--VHNKVRHLEAFGTN-VKLTDLKLDYNQ 606
Query: 342 LMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTG-TISPEFASFKSLQRLI 400
+ P+ F + + F L S + +
Sbjct: 607 IEEIPEDFCAFTD----------------QVEGLGFSHNKLKYIPNIFNAKSVYVMGSVD 650
Query: 401 LADNNLSGMIPEGLSVLGA-----LKELDVSNNQLYGKIPSFKSN 440
+ N + + + +S N++ +
Sbjct: 651 FSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFAT 695
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-29
Identities = 50/388 (12%), Positives = 118/388 (30%), Gaps = 48/388 (12%)
Query: 67 DKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLA-SLEVVMLSNN 125
++R RI++ ++ + L L+ + + P+ + ++ + N
Sbjct: 377 EERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEM-KPIKKDSRISLKDTQIGNLTN 435
Query: 126 QFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFG 185
+ T + L+ LQ I N+PF+ I +A+ +
Sbjct: 436 RITFISKAIQ-RLTKLQIIYFANSPFTYDNIAVDWEDANSDYA------KQYENEELSWS 488
Query: 186 PDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNG------QNGNAKLGGGIDVIQN 238
LT + L + LP ++QSL + A D
Sbjct: 489 --NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDT 546
Query: 239 MTSLKEIWLHSNAFSG--PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 296
++ ++ N + +L L N ++ L + +
Sbjct: 547 GPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDY 604
Query: 297 NLLQGPVPE--FDRSVSLDMAKGSNNF--CLPSPGACD--PRLNAL-LSVVKLMGYPQRF 349
N ++ +PE + ++ S+N +P+ + ++ S K+ +
Sbjct: 605 NQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNI 663
Query: 350 AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLS-- 407
+ + N + + + + FA+ + +IL++N ++
Sbjct: 664 SCSMD-----------DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSI 712
Query: 408 -----GMIPEGLSVLGALKELDVSNNQL 430
L +D+ N+L
Sbjct: 713 PENSLKPKDGNYKNTYLLTTIDLRFNKL 740
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-29
Identities = 59/387 (15%), Positives = 117/387 (30%), Gaps = 74/387 (19%)
Query: 76 GHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFF 135
N + +Q LTKL+ + + + +++ + + +
Sbjct: 432 NLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN----SDYAKQYENEELSW 487
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFG----PDEF 189
+ L L +E+ N P + ++P L + LQ N + N D+
Sbjct: 488 SNLKDLTDVELYNCPNMT-QLPDFLYDLPELQSLNIACN--RGISAAQLKADWTRLADDE 544
Query: 190 ---PGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIW 246
P + I ++ +N L PAS S ++ L + N K+ ++ L ++
Sbjct: 545 DTGPKIQIFYMGYNNL-EEFPASASLQKMVKLGLLDCVHN-KVRH-LEAFGTNVKLTDLK 601
Query: 247 LHSNAFSGPLPD--FSGVKQLESLSLRDNFFTG-PVPDSLVKLESLKIVNMTNNLLQGPV 303
L N +P+ + Q+E L N P + + + V+ + N +
Sbjct: 602 LDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEG 660
Query: 304 PEFDRS---------VSLDMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLMGYPQRFAE 351
S ++ + N ++ + LS
Sbjct: 661 RNISCSMDDYKGINASTVTL--SYNEIQKFPTELFATGSPISTIILS------------- 705
Query: 352 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 411
N +T I N + + L + L N L+ +
Sbjct: 706 ---NN--------------LMTSIPE---NSLKPKDGNYKNTYLLTTIDLRFNKLTS-LS 744
Query: 412 EGLSV--LGALKELDVSNNQLYGKIPS 436
+ L L +DVS N P+
Sbjct: 745 DDFRATTLPYLSNMDVSYNCF-SSFPT 770
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-29
Identities = 49/395 (12%), Positives = 113/395 (28%), Gaps = 88/395 (22%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPL----------PSLNGLASL 117
K +T +++ + LP L +L +L+ L + N + +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 118 EVVMLSNNQFTSVP-SDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANI 176
++ + N P S + L ++ +N + + L + + I
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH--LE-AFGTNVKLTDLKLDYNQI 607
Query: 177 TGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVI 236
+IP F + L + N+L +P F+
Sbjct: 608 E-EIPEDFCAF-TDQVEGLGFSHNKL-KYIPNIFN------------------------A 640
Query: 237 QNMTSLKEIWLHSNAFSGPLPDFSG------VKQLESLSLRDNFFTGPVPDSLVKLESLK 290
+++ + + N + S +++L N + +
Sbjct: 641 KSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPIS 700
Query: 291 IVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLMGYPQ 347
+ ++NNL+ +PE N P G L + L KL
Sbjct: 701 TIILSNNLMTS-IPE--------------NSLKPKDGNYKNTYLLTTIDLRFNKLTSLSD 745
Query: 348 RFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADN--- 404
F T ++ ++ + + + + L+ +
Sbjct: 746 DFRA---------------TTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDA 789
Query: 405 ---NLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436
+ P G++ +L +L + +N + K+
Sbjct: 790 EGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDE 823
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 5e-18
Identities = 35/199 (17%), Positives = 63/199 (31%), Gaps = 36/199 (18%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSIS--------GPLPSLNGLASLEV 119
+ + + + +Q + + + L N ++ + L
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTT 732
Query: 120 VMLSNNQFTSVPSDF-FTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ------NFSAN 172
+ L N+ TS+ DF T L L ++++ N FSS P N+S L+ A
Sbjct: 733 IDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS--FPTQPLNSSQLKAFGIRHQRDAE 790
Query: 173 SANITGQIPSFFG------------------PDE-FPGLTILHLAFNQLIGGLPASFSGS 213
I Q P+ ++ P L IL +A N I S
Sbjct: 791 GNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLYILDIADNPNISIDVTSVCPY 850
Query: 214 QIQSLWVNGQNGNAKLGGG 232
++V + + G
Sbjct: 851 IEAGMYVLLYDKTQDIRGC 869
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 48/206 (23%), Positives = 80/206 (38%), Gaps = 37/206 (17%)
Query: 592 TNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
++F E +LG+G FG V K D A+K++ + + L+ SE+ +L + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNH 61
Query: 651 RHLVALLGHCLDGNEKL-------------LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR 697
+++V L+ + + EY GTL ++ + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDE 117
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL--------- 748
+ + + Y+H Q IHRDLKP NI + + K+ DFGL +
Sbjct: 118 YWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 749 ----APEGKGSIETRIAGTFGYLAPE 770
G T GT Y+A E
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATE 200
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 21/193 (10%)
Query: 598 ENILGRGGFGTVYKGELHDG-----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+LG G FGTVYKG +A+K + S K E E V+ V + H
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPH 78
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTIALDVARGVEY 711
+ LLG CL + L+ + MP G L ++ + G + L L + +A+G+ Y
Sbjct: 79 VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNY 132
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLA 768
L + +HRDL N+L+ K+ DFGL +L E G ++A
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMA 187
Query: 769 PEYAVHTRWSSCS 781
E +H ++ S
Sbjct: 188 LESILHRIYTHQS 200
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 37/181 (20%), Positives = 72/181 (39%), Gaps = 13/181 (7%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH-- 650
+S +G GG V++ A+K + + L +++EIA L K++
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
++ L + + +V E L+ + ++ + ++ V
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKS--YWKNMLEAVH 141
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAP 769
+H +H DLKP+N L+ D K+ DFG+ + P+ ++ GT Y+ P
Sbjct: 142 TIH---QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 770 E 770
E
Sbjct: 198 E 198
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 60/240 (25%), Positives = 94/240 (39%), Gaps = 20/240 (8%)
Query: 518 QKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLE 577
R ++ A I I +++ A SE + I +
Sbjct: 11 HHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSA 70
Query: 578 AGNMVISIQVLRNVTNNFSEENI-----LGRGGFGTVYKGELHDG----TKIAVKRMEAG 628
++ Q +++V S + +GRG FG VY G L D AVK +
Sbjct: 71 LNPELV--QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 128
Query: 629 VISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL-VFEYMPQGTLSRHIFNWAE 687
+++F +E ++ H ++++LLG CL L V YM G L I
Sbjct: 129 T-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----R 183
Query: 688 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ L VA+G+++L A + F+HRDL N +L + KVADFGL R
Sbjct: 184 NETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 6e-31
Identities = 58/184 (31%), Positives = 97/184 (52%), Gaps = 10/184 (5%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
E LG+G FG V+ G + T++A+K ++ G +S F E V+ K+RH LV L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLY 245
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
+ +V EYM +G+L + E K L + + +A +A G+ Y+
Sbjct: 246 AVVSE-EPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYV---ER 298
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRW 777
+++HRDL+ +NIL+G+++ KVADFGL RL + + + + APE A++ R+
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 778 SSCS 781
+ S
Sbjct: 359 TIKS 362
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-31
Identities = 45/241 (18%), Positives = 89/241 (36%), Gaps = 18/241 (7%)
Query: 533 HPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVT 592
H H S + + + + D + + N IS++
Sbjct: 1 HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG----- 55
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH-- 650
+S +G GG V++ A+K + + L +++EIA L K++
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
++ L + + +V E L+ + + K ++ R + ++ V
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVH 169
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAP 769
+H +H DLKP+N L+ D K+ DFG+ + P+ ++ G Y+ P
Sbjct: 170 TIH---QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 770 E 770
E
Sbjct: 226 E 226
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 42/179 (23%), Positives = 77/179 (43%), Gaps = 8/179 (4%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+ +G G FG + DG + +K + +S K E + E+AVL ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
++V + +V +Y G L + I + + ++ L + + +++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICLALKH 140
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+H + +HRD+K NI L D ++ DFG+ R+ I GT YL+PE
Sbjct: 141 VH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPE 195
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 8e-31
Identities = 53/243 (21%), Positives = 90/243 (37%), Gaps = 29/243 (11%)
Query: 517 KQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQML 576
+ + + S K++ ++ + + + +
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLK 66
Query: 577 EAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDG------TKIAVKRMEAGVI 630
E V R N + LG G FG VY+G++ ++AVK +
Sbjct: 67 E---------VPRK---NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC- 113
Query: 631 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAE 687
S + +F E +++K H+++V +G L + ++ E M G L R
Sbjct: 114 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS 173
Query: 688 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFG 744
+ L L +A D+A G +Y L FIHRD+ N LL G AK+ DFG
Sbjct: 174 QP-SSLAMLDLLHVARDIACGCQY---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229
Query: 745 LVR 747
+ R
Sbjct: 230 MAR 232
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-30
Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 14/186 (7%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
E LG G FG V+ + TK+AVK M+ G +S + F +E V+ ++H LV L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLH 249
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
++ E+M +G+L + + +EG + + + +A G+ ++
Sbjct: 250 AVVT-KEPIYIITEFMAKGSLLDFLKS--DEG-SKQPLPKLIDFSAQIAEGMAFI---EQ 302
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY--LAPEYAVHT 775
+++IHRDL+ +NIL+ + K+ADFGL R+ + + R F APE
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFG 360
Query: 776 RWSSCS 781
++ S
Sbjct: 361 SFTIKS 366
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 14/189 (7%)
Query: 598 ENILGRGGFGTVYKGELHDG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV 654
+ LG G FG+V +G +A+K ++ G E E ++ ++ + ++V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIV 399
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
L+G C +LV E G L + + EE + + + V+ G++YL
Sbjct: 400 RLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYL-- 452
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY--LAPEYA 772
++F+HR+L N+LL + AK++DFGL + R AG + APE
Sbjct: 453 -EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 773 VHTRWSSCS 781
++SS S
Sbjct: 512 NFRKFSSRS 520
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 61/373 (16%), Positives = 123/373 (32%), Gaps = 64/373 (17%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127
R + ++ T + L + +L + ++ + + L +LE + L+ NQ
Sbjct: 22 AEGIRAVLQKASV--TDVVTQEELESITKLVVAGEKVAS-IQGIEYLTNLEYLNLNGNQI 78
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
T + + L L ++ I N + +L+N + L+ N NI+ I
Sbjct: 79 TDISP--LSNLVKLTNLYIGTNKITD---ISALQNLTNLRELYLNEDNISD-ISPL---A 129
Query: 188 EFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIW 246
+ L+L N + + S + + L V +K+ + I N+T L +
Sbjct: 130 NLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVT----ESKV-KDVTPIANLTDLYSLS 183
Query: 247 LHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 306
L+ N + + + L + N T + + L + + NN + +
Sbjct: 184 LNYNQIED-ISPLASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITD-LSPL 239
Query: 307 DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVT 366
L + N +++ + +V L
Sbjct: 240 ANLSQLTWLEIGTN-----------QISDINAVKDL------------------------ 264
Query: 367 CTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVS 426
+ ++N ++ IS + L L L +N L E + L L L +S
Sbjct: 265 ---TKLKMLNVGSNQISD-ISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLS 319
Query: 427 NNQLYGKIPSFKS 439
N + I S
Sbjct: 320 QNHITD-IRPLAS 331
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 57/368 (15%), Positives = 128/368 (34%), Gaps = 71/368 (19%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127
+ IT++ + + + ++ LT LE L L N I+ + L+ L L + + N+
Sbjct: 44 ESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKI 100
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
T + + L++L+ + ++ + S L N + + + + + + +
Sbjct: 101 TDISA--LQNLTNLRELYLNEDNISD---ISPLANLTKMYSLNLGANHNLSDLSPLSN-- 153
Query: 188 EFPGLTILHLAFNQL-----IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
GL L + +++ I L + SL +N N ++ I + ++TSL
Sbjct: 154 -MTGLNYLTVTESKVKDVTPIANLT------DLYSLSLNY---N-QIED-ISPLASLTSL 201
Query: 243 KEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302
+ N + + + + +L SL + +N T L L L + + N +
Sbjct: 202 HYFTAYVNQITD-ITPVANMTRLNSLKIGNNKITDL--SPLANLSQLTWLEIGTNQISD- 257
Query: 303 VPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW 362
+ L M +N +++ + + L
Sbjct: 258 INAVKDLTKLKMLNVGSN-----------QISDISVLNNL-------------------- 286
Query: 363 IGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKE 422
+ + L +L L L+ N+++ + P L+ L +
Sbjct: 287 -------SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDS 337
Query: 423 LDVSNNQL 430
D +N +
Sbjct: 338 ADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 52/354 (14%), Positives = 109/354 (30%), Gaps = 84/354 (23%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+L + R LQ S++ + + L S+ ++++ + S+ L++L+ +
Sbjct: 16 FPDADLAEGIRAVLQKASVTD-VVTQEELESITKLVVAGEKVASIQG--IEYLTNLEYLN 72
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205
++ N + L N L N + IT I + L L+L + +
Sbjct: 73 LNGNQITD---ISPLSNLVKLTNLYIGTNKIT-DISAL---QNLTNLRELYLNEDNI--- 122
Query: 206 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 265
I + N+T + + L +N L S + L
Sbjct: 123 -------------------------SDISPLANLTKMYSLNLGANHNLSDLSPLSNMTGL 157
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPS 325
L++ ++ P + L L +++ N ++ + SL N
Sbjct: 158 NYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVN----- 209
Query: 326 PGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT 385
++ + V + + + +T
Sbjct: 210 ------QITDITPVANM---------------------------TRLNSLKIGNNKITD- 235
Query: 386 ISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS 439
A+ L L + N +S + L LK L+V +NQ+ I +
Sbjct: 236 -LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI-SDISVLNN 285
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 7e-12
Identities = 39/303 (12%), Positives = 86/303 (28%), Gaps = 84/303 (27%)
Query: 137 GLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILH 196
G ++L ++ P + L A++T + +E +T L
Sbjct: 1 GAATLATL---PAPINQIFPDADLAE---GIRAVLQKASVTDVVT----QEELESITKLV 50
Query: 197 LAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL 256
+A ++ I I+ +T+L+ + L+ N + +
Sbjct: 51 VAGEKV----------------------------ASIQGIEYLTNLEYLNLNGNQITD-I 81
Query: 257 PDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAK 316
S + +L +L + N T +L L +L+ + + + + + +
Sbjct: 82 SPLSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISD-ISPLANLTKMY--- 135
Query: 317 GSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVIN 376
LN L + + + +
Sbjct: 136 ---------------SLN--LGANHNLSDLSPLSNM-----------------TGLNYLT 161
Query: 377 FQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436
+ + A+ L L L N + + P L+ L +L NQ+ I
Sbjct: 162 VTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD-ITP 216
Query: 437 FKS 439
+
Sbjct: 217 VAN 219
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 4e-11
Identities = 26/110 (23%), Positives = 53/110 (48%), Gaps = 6/110 (5%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127
++T ++IG + + +++LTKL+ L + N IS + LN L+ L + L+NNQ
Sbjct: 243 SQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQL 299
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANIT 177
+ + GL++L ++ + N + L + S + + + I
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITDIR---PLASLSKMDSADFANQVIK 346
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 33/196 (16%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+F E ++G GGFG V+K + DG +KR++ + + E+ L K+ H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDHV 64
Query: 652 HLVALLGHCLDGNEKL----------------LVFEYMPQGTLSRHIFNWAEEGLKPLEW 695
++V G + + E+ +GTL + I + + L+
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGEKLDK 121
Query: 696 NRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKG 754
L + + +GV+Y+H + I+RDLKPSNI L D + K+ DFGLV L +GK
Sbjct: 122 VLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 755 SIETRIAGTFGYLAPE 770
TR GT Y++PE
Sbjct: 179 ---TRSKGTLRYMSPE 191
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-30
Identities = 55/201 (27%), Positives = 84/201 (41%), Gaps = 28/201 (13%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+++ N E ILG G GTV G +AVKRM EI +LT+
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTES 65
Query: 649 -RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI--FNWAEEGLKPLEWNRRLTIALDV 705
H +++ + E L + N ++E LK + +++ +
Sbjct: 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILL-------------GDDMRAKVADFGLVRLAPEG 752
A GV +LH IHRDLKP NIL+ +++R ++DFGL + G
Sbjct: 125 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 753 KGSIETR---IAGTFGYLAPE 770
+ S T +GT G+ APE
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPE 202
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 49/193 (25%), Positives = 82/193 (42%), Gaps = 21/193 (10%)
Query: 598 ENILGRGGFGTVYKGELHDG-----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+LG G FGTV+KG + +K +E + + + + H H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAH 76
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTIALDVARGVEY 711
+V LLG C G+ LV +Y+P G+L H+ G + L L + +A+G+ Y
Sbjct: 77 IVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWGVQIAKGMYY 130
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLA 768
L +HR+L N+LL + +VADFG+ L P + + ++A
Sbjct: 131 L---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP--DDKQLLYSEAKTPIKWMA 185
Query: 769 PEYAVHTRWSSCS 781
E +++ S
Sbjct: 186 LESIHFGKYTHQS 198
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 46/180 (25%), Positives = 88/180 (48%), Gaps = 7/180 (3%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
NF E +GRG F VY+ L DG +A+K+++ ++ K + EI +L ++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+++ ++ NE +V E G LSR I ++ ++ + + + + +E
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTVWKYFVQLCSALE 150
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
++H + +HRD+KP+N+ + K+ D GL R + + + GT Y++PE
Sbjct: 151 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 206
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-30
Identities = 58/184 (31%), Positives = 97/184 (52%), Gaps = 10/184 (5%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
E LG+G FG V+ G + T++A+K ++ G +S F E V+ K+RH LV L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLY 328
Query: 658 GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAH 717
+ +V EYM +G+L + E K L + + +A +A G+ Y+
Sbjct: 329 AVVSE-EPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYV---ER 381
Query: 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRW 777
+++HRDL+ +NIL+G+++ KVADFGL RL + + + + APE A++ R+
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 778 SSCS 781
+ S
Sbjct: 442 TIKS 445
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 41/188 (21%), Positives = 78/188 (41%), Gaps = 24/188 (12%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVK---------------RMEAGVISGKGLTEFKSEIAVL 645
L +G F + E D A+K + +FK+E+ ++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI---FNWAEEGLKPLEWNRRLTIA 702
T +++ + + G + +E +++EYM ++ + F + + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG 762
V Y+H ++ HRD+KPSNIL+ + R K++DFG + K I+ G
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK--IKG-SRG 212
Query: 763 TFGYLAPE 770
T+ ++ PE
Sbjct: 213 TYEFMPPE 220
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 38/175 (21%), Positives = 73/175 (41%), Gaps = 13/175 (7%)
Query: 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--RHLVAL 656
+G GG V++ A+K + + L +++EIA L K++ ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+ + +V E L+ + + K ++ R + ++ V +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIH--- 125
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAPE 770
+H DLKP+N L+ D K+ DFG+ + P+ ++ GT Y+ PE
Sbjct: 126 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 60/397 (15%), Positives = 130/397 (32%), Gaps = 35/397 (8%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQF 127
R ++ +L+ L S Q+ ++ L+L N +S L LE++ LS+N
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
LS+L++++++NN + S+ L + + N NI+ ++
Sbjct: 71 YETLD--LESLSTLRTLDLNNNYVQELLVGPSIET---L-HAANN--NIS-RVS----CS 117
Query: 188 EFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIW 246
G ++LA N++ S++Q L + N + ++ + +L+ +
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL-NEIDTVNFA-ELAASSDTLEHLN 175
Query: 247 LHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 306
L N + +L++L L N + + +++ NN L
Sbjct: 176 LQYNFIYD-VKGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKAL 233
Query: 307 DRSVSLDMAKGSNN----FCLPSPGACDPRL-----NALLSVVKLMGYPQRFAENWKGND 357
S +L+ N L + + R+ + +
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293
Query: 358 PCSDWI------GVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 411
C + + + K + + + T + E + + + +I
Sbjct: 294 YCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVID 353
Query: 412 EGLSVLGALKELDVSNNQLYGKIPSFKSNAIVNTDGN 448
+ A L+ L + S A DG
Sbjct: 354 QVTLRKQAKITLEQKKKALD-EQVSNGRRAHAELDGT 389
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 18/127 (14%), Positives = 32/127 (25%), Gaps = 6/127 (4%)
Query: 78 QNLQGTLPSNLQNLT--KLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFF 135
++L L L + L Q + A + Q+ +V
Sbjct: 297 EDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVT 356
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL 195
+ ++E E + R A GQI +E L +L
Sbjct: 357 LRKQAKITLEQKKKALD--EQVSNGRRA--HAELDGTLQQAVGQIELQHATEEQSPLQLL 412
Query: 196 HLAFNQL 202
+
Sbjct: 413 RAIVKRY 419
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 53/180 (29%), Positives = 75/180 (41%), Gaps = 14/180 (7%)
Query: 594 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHR 651
+F + LG G +G V+K DG AVKR + K +E+ KV +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
V L +G L E +L +H E L + D + +
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHC----EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAPE 770
LH Q +H D+KP+NI LG R K+ DFGL+ L G G ++ G Y+APE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPE 226
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 21/193 (10%)
Query: 598 ENILGRGGFGTVYKGELHDG-----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+LG G FGTVYKG +A+K + S K E E V+ V + H
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPH 78
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTIALDVARGVEY 711
+ LLG CL + L+ + MP G L ++ + G + L L + +A+G+ Y
Sbjct: 79 VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNY 132
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT---FGYLA 768
L + +HRDL N+L+ K+ DFGL +L E G ++A
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMA 187
Query: 769 PEYAVHTRWSSCS 781
E +H ++ S
Sbjct: 188 LESILHRIYTHQS 200
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 41/155 (26%), Positives = 67/155 (43%), Gaps = 13/155 (8%)
Query: 598 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
ILG G FG VY+G + +AVK + + +F SE ++ + H H+
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHI 75
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
V L+G ++ E P G L ++ E L+ + +L + + + YL
Sbjct: 76 VKLIGIIE-EEPTWIIMELYPYGELGHYL----ERNKNSLKVLTLVLYSLQICKAMAYL- 129
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748
+ +HRD+ NIL+ K+ DFGL R
Sbjct: 130 --ESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 54/172 (31%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 658
LG+G FG VY E +A+K + + G+ + E+ + + +RH +++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
+ D L+ EY P GT+ R + L + R T ++A + Y H +
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCH---SK 128
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
IHRD+KP N+LLG K+ADFG AP + T + GT YL PE
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPPE 177
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 37/167 (22%), Positives = 76/167 (45%), Gaps = 25/167 (14%)
Query: 598 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 649
LG+G F ++KG + T++ +K ++ + F ++++K+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFFEAASMMSKLS 70
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
H+HLV G C+ G+E +LV E++ G+L ++ ++ + +L +A +A +
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL----KKNKNCINILWKLEVAKQLAAAM 126
Query: 710 EYLHGLAHQSFIHRDLKPSNILL--------GDDMRAKVADFGLVRL 748
+ L + IH ++ NILL G+ K++D G+
Sbjct: 127 HF---LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 36/155 (23%), Positives = 64/155 (41%), Gaps = 13/155 (8%)
Query: 598 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
+G G FG V++G +A+K + S +F E + + H H+
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHI 78
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
V L+G N ++ E G L ++ + L+ + A ++ + YL
Sbjct: 79 VKLIGVIT-ENPVWIIMELCTLGEL----RSFLQVRKYSLDLASLILYAYQLSTALAYL- 132
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748
+ F+HRD+ N+L+ + K+ DFGL R
Sbjct: 133 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-29
Identities = 63/392 (16%), Positives = 131/392 (33%), Gaps = 39/392 (9%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQ 126
+ + + +Q Q+L+ L L L N I L + +GL+SL+ ++
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFF 184
S+ + L +L+ + + +N S+++P+ N + L+ + S+N I +
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN--KIQSIYCTDL 169
Query: 185 GPDEFPGLTI----LHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMT 240
+ + L L+ N + P +F ++ L + + + IQ +
Sbjct: 170 RV--LHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKT--CIQGLA 225
Query: 241 SLKEIWLHSNAFSG-------PLPDFSGVKQLESLSLR---DNFFTGPVPDSLVKLESLK 290
L+ L F G+ L R +++ + D L ++
Sbjct: 226 GLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVS 285
Query: 291 IVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRF 349
++ + ++ V +F + + N P L L + K
Sbjct: 286 SFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 344
Query: 350 ----------AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRL 399
+ N C T ++ ++ + T+S F + L+ L
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTT--SLKYLDLSFNGVI-TMSSNFLGLEQLEHL 401
Query: 400 ILADNNLSGMIPEG-LSVLGALKELDVSNNQL 430
+NL M L L LD+S+
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 71/382 (18%), Positives = 121/382 (31%), Gaps = 49/382 (12%)
Query: 64 CIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVML 122
C+E Q N +P NL + L+L +N + S L+V+ L
Sbjct: 3 CVEVVPNITYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 123 SNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPS 182
S + ++ + LS L ++ + NP S + S LQ A N+
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 183 FFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
G L L++A N IQS + + N+T+L
Sbjct: 119 PIGH--LKTLKELNVAHN-------------LIQSFKLP------------EYFSNLTNL 151
Query: 243 KEIWLHSNAFSG-PLPDFSGVKQLE----SLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+ + L SN D + Q+ SL L N + K L + + NN
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNN 210
Query: 298 LLQGPVPE--FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 355
V + L++ + +AL + L R A
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL--- 267
Query: 356 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLS 415
+ D I + N++ + + + +F+ Q L L + L
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 416 VLGALKELDVSNNQLYGKIPSF 437
+LK L ++N+ G S
Sbjct: 326 ---SLKRLTFTSNKG-GNAFSE 343
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 70/375 (18%), Positives = 123/375 (32%), Gaps = 39/375 (10%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSI-SGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFT 136
NL + +L L+ L + N I S LP + L +LE + LS+N+ S+
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 137 GLSSLQ----SIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGL 192
L + S+++ NP + I L + + + + GL
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNF--IQPGAFKEIRLHKLTLRNNFDSLNVMKTC-IQGLAGL 227
Query: 193 TILHLA------FNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEI 245
+ L L ++ G + + L ID+ +T++
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 246 WLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305
L S + DFS + L L + F L L+ L T+N
Sbjct: 288 SLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL---TFTSNKGGN-AFS 342
Query: 306 FDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW 362
SL D+ S N L G C S+ L + N S++
Sbjct: 343 EVDLPSLEFLDL---SRN-GLSFKGCCSQSDFGTTSLKYL-----DLSFN-GVITMSSNF 392
Query: 363 IGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALK 421
+G+ + ++FQ NL F S ++L L ++ + + L +L+
Sbjct: 393 LGLE----QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 422 ELDVSNNQLYGKIPS 436
L ++ N
Sbjct: 449 VLKMAGNSFQENFLP 463
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-21
Identities = 50/242 (20%), Positives = 91/242 (37%), Gaps = 18/242 (7%)
Query: 78 QNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTG 137
++ + + LEL P+L L SL+ + ++N+ + S
Sbjct: 290 VSVTIERVKDFSYNFGWQHLELVNCKFGQ-FPTLK-LKSLKRLTFTSNKGGNAFS--EVD 345
Query: 138 LSSLQSIEIDNNPFSSWEI-PQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILH 196
L SL+ +++ N S QS + L+ + + +F G L L
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG---LEQLEHLD 402
Query: 197 LAFNQLIGGLPAS-FSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG 254
+ L S F + L ++ G + ++SL+ + + N+F
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISH-THTRVAFNG--IFNGLSSLEVLKMAGNSFQE 459
Query: 255 PLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE--FDRSV 310
F+ ++ L L L P + L SL+++NM +N L+ VP+ FDR
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS-VPDGIFDRLT 518
Query: 311 SL 312
SL
Sbjct: 519 SL 520
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-21
Identities = 45/248 (18%), Positives = 82/248 (33%), Gaps = 40/248 (16%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG---PLPSLNG 113
CK+ ++ K + R+ N G S +L LE L+L N +S S G
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTS-NKGGNAFS-EVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 114 LASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSA 171
SL+ + LS N ++ S+F GL L+ ++ ++ + L + S
Sbjct: 372 TTSLKYLDLSFNGVITMSSNFL-GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 172 NSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGG 231
+ F + L +L +A N
Sbjct: 431 T--HTRVAFNGIF--NGLSSLEVLKMAGNSFQENFLP----------------------- 463
Query: 232 GIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESL 289
D+ + +L + L L F+ + L+ L++ N +L SL
Sbjct: 464 --DIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSL 520
Query: 290 KIVNMTNN 297
+ + + N
Sbjct: 521 QKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-20
Identities = 68/390 (17%), Positives = 126/390 (32%), Gaps = 74/390 (18%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPS--LNGLASLEVVML------SNNQFTSVPSDF 134
+ +L +L L+ N S + + GLA LEV L +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 135 FTGLSSLQSIEIDNN--PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGL 192
GL +L E + +I + + +FS S I ++ F + L
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHL 309
Query: 193 TILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252
+++ F Q +++SL N GG ++ SL+ + L N
Sbjct: 310 ELVNCKFGQF--------PTLKLKSLKRLTFTSN--KGGNAFSEVDLPSLEFLDLSRNGL 359
Query: 253 SG---PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG--PVPEFD 307
S G L+ L L N + + + LE L+ ++ ++ L+ F
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 308 RSVS---LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIG 364
+ LD+ + + G + L++L
Sbjct: 419 SLRNLIYLDI--SHTHTRVAFNGIFN-GLSSL---------------------------- 447
Query: 365 VTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKEL 423
V+ + P+ F ++L L L+ L + P + L +L+ L
Sbjct: 448 --------EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 424 DVSNNQLY----GKIPSFKSNAIVNTDGNP 449
++++NQL G S + NP
Sbjct: 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNP 529
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-15
Identities = 39/179 (21%), Positives = 69/179 (38%), Gaps = 34/179 (18%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISG--PLPSLNGLASLEVVMLSNNQFTSVPSDFFT 136
N T+ SN L +LE L+ Q +++ L +L + +S+ + F
Sbjct: 383 NGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 137 GLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFGPDEFPGLTI 194
GLSSL+ +++ N F +P L + S + P+ F + L +
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC--QLEQLSPTAF--NSLSSLQV 498
Query: 195 LHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253
L++A NQL + + +TSL++IWLH+N +
Sbjct: 499 LNMASNQL----------KSVPD----------------GIFDRLTSLQKIWLHTNPWD 531
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 45/193 (23%), Positives = 73/193 (37%), Gaps = 25/193 (12%)
Query: 598 ENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVA 655
+L GGF VY+ + + G + A+KR+ + E+ + K+ H ++V
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90
Query: 656 LLGHCL-------DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
G + L+ + +G L + G PL + L I R
Sbjct: 91 FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG--PLSCDTVLKIFYQTCRA 148
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA---------PEGKGSIETR 759
V+++H IHRDLK N+LL + K+ DFG + + +E
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 760 IA--GTFGYLAPE 770
I T Y PE
Sbjct: 208 ITRNTTPMYRTPE 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 48/180 (26%), Positives = 73/180 (40%), Gaps = 27/180 (15%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 658
LG+GGF ++ + A K + ++ E EI++ + H+H+V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVE 710
D + +V E + +L + LT AR G +
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKR-----------RKALT--EPEARYYLRQIVLGCQ 129
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
YLH IHRDLK N+ L +D+ K+ DFGL E G + + GT Y+APE
Sbjct: 130 YLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKVLCGTPNYIAPE 185
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-28
Identities = 55/385 (14%), Positives = 121/385 (31%), Gaps = 41/385 (10%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQ 126
+ + + ++ L L L L N I S +GL SLE ++ +
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFF 184
S+ S L +L+ + + +N S ++P N + L + S N I +
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN--YIQTITVNDL 173
Query: 185 GP--DEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
+ L ++ N + +F G ++ L + G ++ + +QN+ L
Sbjct: 174 QFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTC--LQNLAGL 231
Query: 243 KEIWLHSNAFSG-------PLPDFSGVKQL--ESLSLRDNFFTGPVPDSLVKLESLKIVN 293
L F G+ + + L L ++ ++
Sbjct: 232 HVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMS 291
Query: 294 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFAEN 352
+ ++ + + + P P L +L L++ K +
Sbjct: 292 LAGVSIKY-LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGS-ISFKKVAL 349
Query: 353 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFK--SLQRLILADNNLSGMI 410
+++ ++ + L+ + ++ SL+ L L+ N +
Sbjct: 350 -----------------PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-M 391
Query: 411 PEGLSVLGALKELDVSNNQLYGKIP 435
L L+ LD ++ L
Sbjct: 392 SANFMGLEELQHLDFQHSTLKRVTE 416
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-27
Identities = 58/376 (15%), Positives = 119/376 (31%), Gaps = 51/376 (13%)
Query: 64 CIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVML 122
CIE Q Q L +P ++ + + ++L +N + S + + L+ + L
Sbjct: 7 CIEVVPNITYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDL 63
Query: 123 SNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPS 182
S + ++ + GL L ++ + NP S P S + L+N A +
Sbjct: 64 SRCEIETIEDKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVETKLASLESF 122
Query: 183 FFGPDEFPGLTILHLAFNQLIG-GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTS 241
G L L++A N + LPA FS N+T+
Sbjct: 123 PIGQ--LITLKKLNVAHNFIHSCKLPAYFS--------------------------NLTN 154
Query: 242 LKEIWLHSNAFSG-PLPDFSGVKQL----ESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 296
L + L N + D +++ SL + N + D + L + +
Sbjct: 155 LVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRG 213
Query: 297 NLLQGPVPE--FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 354
N + + L + + + + + + R
Sbjct: 214 NFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTND 273
Query: 355 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 414
+D + + N++ ++ +++ + Q L + L L
Sbjct: 274 FSDDIVKFHCLA----NVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLKQFPTLDL 327
Query: 415 SVLGALKELDVSNNQL 430
LK L ++ N+
Sbjct: 328 P---FLKSLTLTMNKG 340
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-27
Identities = 63/392 (16%), Positives = 120/392 (30%), Gaps = 66/392 (16%)
Query: 76 GHQNLQGTLPSNLQNLTKLERLELQWNSISG-------PLPSLNGLASLEVVML--SNNQ 126
G+ N + + LQNL L L + GL + + +
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGP 186
S F L+++ ++ + + + Q+ S + Q P+
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIKY---LEDVPKHFKWQSLSIIRCQLK-QFPTLD-- 326
Query: 187 DEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIW 246
P L L L N+ + + L ++ N + G SL+ +
Sbjct: 327 --LPFLKSLTLTMNK-GSISFKKVALPSLSYLDLSR-NALSFSGCCSYSDLGTNSLRHLD 382
Query: 247 LHSNAFSGPLPDFSGVKQLESLSLRDNFFTG-PVPDSLVKLESLKIVNMTNNLLQGPVPE 305
L N +F G+++L+ L + + + + LE L ++++ +
Sbjct: 383 LSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDG 442
Query: 306 -FDRSVS---LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD 361
F S L M + N ++K N +
Sbjct: 443 IFLGLTSLNTLKM---AGN-------------------------------SFKDNTLSNV 468
Query: 362 WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALK 421
+ T N+T ++ K L F + LQ L ++ NNL + + L +L
Sbjct: 469 FANTT----NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLS 524
Query: 422 ELDVSNNQLYGKIPSFKSNA----IVNTDGNP 449
LD S N++ + N N
Sbjct: 525 TLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 53/357 (14%), Positives = 93/357 (26%), Gaps = 76/357 (21%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGL 138
N L + + L SI L + + + + Q P L
Sbjct: 272 NDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRCQLKQFP---TLDL 327
Query: 139 SSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFGPDEFPGLTILH 196
L+S+ + N S I L + S N ++ + L L
Sbjct: 328 PFLKSLTLTMNKGS---ISFKKVALPSLSYLDLSRN--ALSFSGCCSYSDLGTNSLRHLD 382
Query: 197 LAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-- 254
L+FN I + A+F + L+ + +
Sbjct: 383 LSFNGAII-MSANFM--------------------------GLEELQHLDFQHSTLKRVT 415
Query: 255 PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDM 314
F +++L L + + L SL + M N +
Sbjct: 416 EFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL---------- 465
Query: 315 AKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNIT 373
SN F L L LS +L + +
Sbjct: 466 ---SNVFANT------TNLTFLDLSKCQLEQISWGVFDTLH----------------RLQ 500
Query: 374 VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
++N NL S + SL L + N + +L +++NN +
Sbjct: 501 LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-22
Identities = 63/337 (18%), Positives = 109/337 (32%), Gaps = 31/337 (9%)
Query: 106 GPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASG 165
G L + + + + VP D SS ++I++ NP S N S
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLSKVPDDIP---SSTKNIDLSFNPLKI-LKSYSFSNFSE 57
Query: 166 LQ--NFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNG 222
LQ + S I + L+ L L N + P SFSG + +++L
Sbjct: 58 LQWLDLSRC--EIETIEDKAWHG--LHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVE 113
Query: 223 QNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-PLPD-FSGVKQLESLSLRDNFFTGPVP 280
A L I + +LK++ + N LP FS + L + L N+
Sbjct: 114 -TKLASLESF--PIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV 170
Query: 281 DSLVKLESLKIVNMTNNLLQGPVPEFDRSV-------SLDMAKGSNNFCLPSPGACDPRL 333
+ L L VN++ ++ P+ L + NF + +
Sbjct: 171 NDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTL---RGNFNSSNIMKTCLQN 227
Query: 334 NALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASF 393
A L V +L F + + C I N +F
Sbjct: 228 LAGLHVHRL--ILGEFKDERNLEIFEPSIMEGLC-DVTIDEFRLTYTNDFSDDIVKFHCL 284
Query: 394 KSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
++ + LA ++ + E + + L + QL
Sbjct: 285 ANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQL 319
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 15/76 (19%), Positives = 26/76 (34%), Gaps = 1/76 (1%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTG 137
L+ L +L+ L + N++ N L SL + S N+ +
Sbjct: 484 QLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHF 543
Query: 138 LSSLQSIEIDNNPFSS 153
SL + NN +
Sbjct: 544 PKSLAFFNLTNNSVAC 559
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 14/66 (21%), Positives = 25/66 (37%)
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+ I+ L S F++F LQ L L+ + + + L L L ++ N +
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 431 YGKIPS 436
P
Sbjct: 93 QSFSPG 98
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 15/71 (21%), Positives = 36/71 (50%), Gaps = 1/71 (1%)
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+++ + + F+ SL+ L+ + L+ + + L LK+L+V++N +
Sbjct: 81 HLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
Query: 431 YG-KIPSFKSN 440
+ K+P++ SN
Sbjct: 141 HSCKLPAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 11/66 (16%), Positives = 21/66 (31%)
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+ ++ + + + L LIL N + P S L +L+ L +L
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 431 YGKIPS 436
Sbjct: 117 ASLESF 122
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 10/172 (5%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 658
LG+G F VY+ +H G ++A+K ++ + G+ + ++E+ + +++H ++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
+ D N LV E G ++R++ + +KP N + G+ YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYL----KNRVKPFSENEARHFMHQIITGMLYLH---SH 131
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+HRDL SN+LL +M K+ADFGL T + GT Y++PE
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE 182
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 51/221 (23%), Positives = 81/221 (36%), Gaps = 27/221 (12%)
Query: 560 SETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGT 618
+ + PG + + V + LG+GGF ++ +
Sbjct: 8 GKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKE 67
Query: 619 KIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGT 677
A K + ++ E EI++ + H+H+V G D + +V E + +
Sbjct: 68 VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 127
Query: 678 LSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVEYLHGLAHQSFIHRDLKPSN 729
L + LT AR G +YLH IHRDLK N
Sbjct: 128 LLELHKR-----------RKALT--EPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGN 171
Query: 730 ILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+ L +D+ K+ DFGL E G + + GT Y+APE
Sbjct: 172 LFLNEDLEVKIGDFGLATK-VEYDGERKKVLCGTPNYIAPE 211
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 15/178 (8%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
+GRG F TVYKG + ++A ++ ++ FK E +L ++H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 659 HCLDG--NEKLLVF--EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
+K +V E M GTL ++ + K ++ + + +G+++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 715 LAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
IHRDLK NI + G K+ D G LA + S + GT ++APE
Sbjct: 148 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLG---LATLKRASFAKAVIGTPEFMAPEM 201
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 71/366 (19%), Positives = 132/366 (36%), Gaps = 64/366 (17%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+ L NLT L L L N I+ + L L +L + LS+N + + + +GL+SLQ +
Sbjct: 106 TPLANLTNLTGLTLFNNQITD-IDPLKNLTNLNRLELSSNTISDISA--LSGLTSLQQLS 162
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205
N + L N + L+ +S ++ I + L L NQ I
Sbjct: 163 FGNQVTD----LKPLANLTTLERLDISSNKVSD-ISVL---AKLTNLESLIATNNQ-ISD 213
Query: 206 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 265
+ + + L +NG I + ++T+L ++ L +N S L SG+ +L
Sbjct: 214 ITPLGILTNLDELSLNGNQLK-----DIGTLASLTNLTDLDLANNQISN-LAPLSGLTKL 267
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPS 325
L L N + L L +L + + N L+ + +L N
Sbjct: 268 TELKLGANQISNI--SPLAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFN----- 319
Query: 326 PGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT 385
++ + V L + + F ++
Sbjct: 320 ------NISDISPVSSL---------------------------TKLQRLFFYNNKVSD- 345
Query: 386 ISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN-AIVN 444
A+ ++ L N +S + P L+ L + +L +++ ++K+N +I N
Sbjct: 346 -VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPN 402
Query: 445 TDGNPD 450
T N
Sbjct: 403 TVKNVT 408
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-27
Identities = 65/374 (17%), Positives = 136/374 (36%), Gaps = 68/374 (18%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127
++T +Q ++ ++ L L ++ N ++ + L L L ++++NNQ
Sbjct: 46 DQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQI 102
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
+ L++L + + NN + + ++L N L +S I+ I + G
Sbjct: 103 ADITP--LANLTNLTGLTLFNNQITDIDPLKNLTN---LNRLELSSNTISD-ISALSG-- 154
Query: 188 EFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIW 246
L L NQ+ P + + ++ L ++ + I V+ +T+L+ +
Sbjct: 155 -LTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVS-----DISVLAKLTNLESLI 205
Query: 247 LHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 306
+N S + + L+ LSL N +L L +L +++ NN + +
Sbjct: 206 ATNNQISD-ITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISN-LAPL 261
Query: 307 DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVT 366
L K N +++ + + L
Sbjct: 262 SGLTKLTELKLGAN-----------QISNISPLAGL------------------------ 286
Query: 367 CTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVS 426
+T + + L ++ K+L L L NN+S + P +S L L+ L
Sbjct: 287 ---TALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFY 339
Query: 427 NNQLYGKIPSFKSN 440
NN++ + S +
Sbjct: 340 NNKVSD-VSSLANL 352
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 79/386 (20%), Positives = 135/386 (34%), Gaps = 57/386 (14%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127
+ +G N+ T+ +L ++ L+ I + + L +L + SNNQ
Sbjct: 24 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQL 80
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
T + L+ L I ++NN + L N + L + + IT I
Sbjct: 81 TDITP--LKNLTKLVDILMNNNQIAD---ITPLANLTNLTGLTLFNNQITD-IDPL---K 131
Query: 188 EFPGLTILHLAFNQLIGGLPASFSGSQIQSLWV-NGQNGNAKLGG--------------- 231
L L L+ N I + A + +Q L N L
Sbjct: 132 NLTNLNRLELSSNT-ISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 190
Query: 232 GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 291
I V+ +T+L+ + +N S + + L+ LSL N +L L +L
Sbjct: 191 DISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTD 247
Query: 292 VNMTNNLLQGPVPEFDRSVSLDMAK-GSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRF 349
+++ NN + + L K G+N SP A L L L+ +L
Sbjct: 248 LDLANNQISN-LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQL------- 299
Query: 350 AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGM 409
D ++ K N+T + N++ +S LQRL +N +S
Sbjct: 300 ----------EDISPISNLK-NLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKVSD- 345
Query: 410 IPEGLSVLGALKELDVSNNQLYGKIP 435
L+ L + L +NQ+ P
Sbjct: 346 -VSSLANLTNINWLSAGHNQISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 47/222 (21%), Positives = 85/222 (38%), Gaps = 27/222 (12%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+ L LT L+ L L N + + +L L +L + L+NNQ +++ +GL+ L ++
Sbjct: 215 TPLGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 271
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL--- 202
+ N S+ L + L N N + I LT L L FN +
Sbjct: 272 LGANQISNIS---PLAGLTALTNLELNENQLED-ISPI---SNLKNLTYLTLYFNNISDI 324
Query: 203 --IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFS 260
+ L ++Q L+ N K+ + + N+T++ + N S L +
Sbjct: 325 SPVSSLT------KLQRLFFY----NNKVSD-VSSLANLTNINWLSAGHNQISD-LTPLA 372
Query: 261 GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302
+ ++ L L D +T + + V L P
Sbjct: 373 NLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAP 414
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 64/350 (18%), Positives = 119/350 (34%), Gaps = 63/350 (18%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
L + + L +++ S L + + S+ L++L I
Sbjct: 18 FTDTALAEKMKTVLGKTNVTD-TVSQTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQIN 74
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205
NN + I L+N + L + N+ I I LT L L NQ I
Sbjct: 75 FSNNQLTD--IT-PLKNLTKLVDILMNNNQIAD-ITPL---ANLTNLTGLTLFNNQ-ITD 126
Query: 206 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 265
+ + + + L ++ + I + +TSL+++ N + P + + L
Sbjct: 127 IDPLKNLTNLNRLELSSNTIS-----DISALSGLTSLQQLSF-GNQVTDLKP-LANLTTL 179
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPS 325
E L + N + L KL +L+ + TNN + + +LD + N
Sbjct: 180 ERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGN----- 231
Query: 326 PGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT 385
+L + ++ L N+T ++ ++
Sbjct: 232 ------QLKDIGTLASLT---------------------------NLTDLDLANNQISN- 257
Query: 386 ISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 435
+ L L L N +S + P L+ L AL L+++ NQL P
Sbjct: 258 -LAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-22
Identities = 65/346 (18%), Positives = 123/346 (35%), Gaps = 63/346 (18%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
L+NLT L RLEL N+IS + +L+GL SL+ + N P L++L+ ++
Sbjct: 128 DPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLSFGNQVTDLKP---LANLTTLERLD 183
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205
I +N S + L N L++ A + I+ I L L L NQL
Sbjct: 184 ISSNKVSDISVLAKLTN---LESLIATNNQISD-ITPL---GILTNLDELSLNGNQLKD- 235
Query: 206 LPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQ 264
+ + + + L + N ++ + + +T L E+ L +N S + +G+
Sbjct: 236 -IGTLASLTNLTDLDLA----NNQISN-LAPLSGLTKLTELKLGANQISN-ISPLAGLTA 288
Query: 265 LESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLP 324
L +L L +N P + L++L + + N + + L NN
Sbjct: 289 LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD-ISPVSSLTKLQRLFFYNN---- 341
Query: 325 SPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTG 384
+++ + S+ L NI ++ ++
Sbjct: 342 -------KVSDVSSLANL---------------------------TNINWLSAGHNQISD 367
Query: 385 TISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
A+ + +L L D + + + + L
Sbjct: 368 --LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 9e-14
Identities = 56/338 (16%), Positives = 108/338 (31%), Gaps = 108/338 (31%)
Query: 102 NSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLR 161
I+ + + LA +L T S T L + +++ D ++
Sbjct: 12 TPINQ-IFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL---------GIK 59
Query: 162 NASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVN 221
+ G++ + LT ++ + NQL
Sbjct: 60 SIDGVEYLNN--------------------LTQINFSNNQL------------------- 80
Query: 222 GQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPD 281
I ++N+T L +I +++N + + + + L L+L +N T D
Sbjct: 81 ---------TDITPLKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITDI--D 128
Query: 282 SLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVK 341
L L +L + +++N + + SL N P L L ++ +
Sbjct: 129 PLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLSFGNQVTDLKP------LANLTTLER 181
Query: 342 LMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLIL 401
L + ++ I A +L+ LI
Sbjct: 182 L-----------------------DISSNKVSDI------------SVLAKLTNLESLIA 206
Query: 402 ADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS 439
+N +S + P L +L L EL ++ NQL I + S
Sbjct: 207 TNNQISDITP--LGILTNLDELSLNGNQL-KDIGTLAS 241
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-12
Identities = 41/261 (15%), Positives = 88/261 (33%), Gaps = 55/261 (21%)
Query: 172 NSANITG--QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKL 229
SA IT I F L + + Q+ +L +
Sbjct: 4 GSATITQDTPINQIFTDTALAEKMKTVLGKTN-VTDTVSQTDLDQVTTLQADRLGIK--- 59
Query: 230 GGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESL 289
ID ++ + +L +I +N + + + +L + + +N P L L +L
Sbjct: 60 --SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITP--LANLTNL 114
Query: 290 KIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRF 349
+ + NN + + +L+ + S+N ++ + ++ L
Sbjct: 115 TGLTLFNNQITD-IDPLKNLTNLNRLELSSN-----------TISDISALSGL------- 155
Query: 350 AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGM 409
++ ++F +T A+ +L+RL ++ N +S
Sbjct: 156 --------------------TSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD- 191
Query: 410 IPEGLSVLGALKELDVSNNQL 430
L+ L L+ L +NNQ+
Sbjct: 192 -ISVLAKLTNLESLIATNNQI 211
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 27/138 (19%), Positives = 53/138 (38%), Gaps = 19/138 (13%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQ 142
+ S+L NLT + L N IS L L L + + L++ +T+ P ++ +S
Sbjct: 344 SDVSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPN 402
Query: 143 SIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFGPDEFPGLTILHLAFN 200
+++ + P ++ + + + N + T ++ F
Sbjct: 403 TVKNVTGALIA---PATISDGGSYTEPDITWNLPSYTNEVSYTFS-------------QP 446
Query: 201 QLIGGLPASFSGSQIQSL 218
IG +FSG+ Q L
Sbjct: 447 VTIGKGTTTFSGTVTQPL 464
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 45/226 (19%), Positives = 73/226 (32%), Gaps = 29/226 (12%)
Query: 566 PSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGE------LHDGTK 619
SS P + + + + ++LG G F VY+ + K
Sbjct: 38 VSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQK 97
Query: 620 IAVKRMEAGVISGKGLTEF---KSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676
+K V EF + L + L N +LV E G
Sbjct: 98 FVLK-----VQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYG 152
Query: 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736
TL I + K + ++ A+ + +E +H IH D+KP N +LG+
Sbjct: 153 TLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGF 209
Query: 737 RA-----------KVADFGL-VRLAPEGKGSIETRIAGTFGYLAPE 770
+ D G + + KG+I T T G+ E
Sbjct: 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE 255
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 49/172 (28%), Positives = 83/172 (48%), Gaps = 13/172 (7%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 658
LG+G FG VY E + +A+K + + +G+ + EI + + +RH +++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ 718
+ D L+ E+ P+G L + + + G E + ++A + Y H +
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKEL---QKHGRFD-EQRSATFME-ELADALHYCHE---R 133
Query: 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
IHRD+KP N+L+G K+ADFG AP + T + GT YL PE
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--RRT-MCGTLDYLPPE 182
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 63/365 (17%), Positives = 144/365 (39%), Gaps = 43/365 (11%)
Query: 77 HQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFF 135
++ ++PS L ++ L+L +N I+ L A+L+V++L +++ ++ D F
Sbjct: 14 SRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF 70
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL 195
L SL+ +++ +N SS + S+FGP L L
Sbjct: 71 YSLGSLEHLDLSDNHLSS--LS-----------------------SSWFGP--LSSLKYL 103
Query: 196 HLAFNQLIG-GLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253
+L N G+ + F + +Q+L + +++ +TSL E+ + + +
Sbjct: 104 NLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI--DFAGLTSLNELEIKALSLR 161
Query: 254 G-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG--PVPEFDRSV 310
++ + L+L + + L S++ + + + L P V
Sbjct: 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEV 221
Query: 311 SLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYP-QRFAENWKGNDPCSDWIGVTCTK 369
S M K + + + + + L L +++L N G+ S+ V+
Sbjct: 222 SSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG 281
Query: 370 G----NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDV 425
I ++ + L +S ++ + ++R+ + ++ + + L +L+ LD+
Sbjct: 282 KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDL 341
Query: 426 SNNQL 430
S N +
Sbjct: 342 SENLM 346
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-24
Identities = 66/380 (17%), Positives = 117/380 (30%), Gaps = 53/380 (13%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFT 128
+ + + + +L+ L+ L L+ + I+ + L SLE + LS+N +
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87
Query: 129 SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP-SFFGPD 187
S+ S +F LSSL+ + + NP+ + + N + LQ + +I F
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG- 146
Query: 188 EFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWL 247
L L + L QS ++++ + + L
Sbjct: 147 -LTSLNELEIKALSL----------RNYQS----------------QSLKSIRDIHHLTL 179
Query: 248 HSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE- 305
H + + L + + L LRD L E + E
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239
Query: 306 FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK----------- 354
F+ + L L D LN L +E K
Sbjct: 240 FNELLKLL----RYILELSEVEFDDCTLNGLGDFNPS--ESDVVSELGKVETVTIRRLHI 293
Query: 355 -GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEG 413
D V + I + + KSL+ L L++N + +
Sbjct: 294 PQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKN 353
Query: 414 LSVLGA---LKELDVSNNQL 430
+ GA L+ L +S N L
Sbjct: 354 SACKGAWPSLQTLVLSQNHL 373
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-23
Identities = 51/372 (13%), Positives = 118/372 (31%), Gaps = 66/372 (17%)
Query: 85 PSNLQNLTKLERLELQWNSIS--GPLPSLNGLASLEVVMLS-NNQFTSVPSDFFTGLSSL 141
S L+ L+ L L N G L +L+ + + F+ + F GL+SL
Sbjct: 91 SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL 150
Query: 142 QSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQ 201
+EI +++ QSL++ + + + + + + F D + L L
Sbjct: 151 NELEIKALSLRNYQ-SQSLKSIRDIHHLTLHLSESAFLLEIFA--DILSSVRYLELRDTN 207
Query: 202 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGG-----IDVIQNMTSLKEIWLHSNAFSG-- 254
L + ++ S + L + +++ + L E+ +G
Sbjct: 208 LARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLG 267
Query: 255 -----PLPDFSGVKQLESLSLR-----DNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PV 303
S + ++E++++R + + LE +K + + N+ + P
Sbjct: 268 DFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPC 327
Query: 304 PEFDRSVS---LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS 360
S LD+ S N + +
Sbjct: 328 SFSQHLKSLEFLDL---SEN-LMVEEYLKNSACKGAWP---------------------- 361
Query: 361 DWIGVTCTKGNITVINFQKMNLT--GTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG 418
++ + + +L + K+L L ++ N +P+
Sbjct: 362 ----------SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPE 410
Query: 419 ALKELDVSNNQL 430
++ L++S+ +
Sbjct: 411 KMRFLNLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 49/258 (18%), Positives = 90/258 (34%), Gaps = 24/258 (9%)
Query: 51 WSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLP 109
++ ++ + + +E I R+ I L L + L K++R+ ++ + + P
Sbjct: 269 FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCS 328
Query: 110 SLNGLASLEVVMLSNNQFTSVP---SDFFTGLSSLQSIEIDNNPFSS-WEIPQSLRNASG 165
L SLE + LS N S SLQ++ + N S + + L
Sbjct: 329 FSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388
Query: 166 LQ--NFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQ 223
L + S N S P + L+L+ + Q+L V
Sbjct: 389 LTSLDISRN--TFHPMPDSCQWP---EKMRFLNLSSTGI-----RVVKTCIPQTLEVLDV 438
Query: 224 NGNAKLGGGIDVI-QNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDS 282
+ N +D + L+E+++ N LPD S L + + N
Sbjct: 439 SNN-----NLDSFSLFLPRLQELYISRNKLKT-LPDASLFPVLLVMKISRNQLKSVPDGI 492
Query: 283 LVKLESLKIVNMTNNLLQ 300
+L SL+ + + N
Sbjct: 493 FDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-21
Identities = 50/379 (13%), Positives = 126/379 (33%), Gaps = 61/379 (16%)
Query: 71 TRIQIGHQNLQGTLPSN-LQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFT 128
++IG+ + LT L LE++ S+ SL + + + L ++
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 129 SVPSDFFTGLSSLQSIEIDNNPFSS--WEIPQSLRNASGLQNFSANSANITGQIPSFFGP 186
+ F LSS++ +E+ + + + +S ++ + + +T
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT--------D 237
Query: 187 DEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIW 246
+ F L L +L + + + + + ++LG +++ +
Sbjct: 238 ESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGK-----VETVTIRRLH 292
Query: 247 LHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305
+ L +S +++++ +++ ++ L+SL+ ++++ NL+
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV----- 347
Query: 306 FDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LS---VVKLMGYPQRFAENWKGNDPCSD 361
+ P L L LS + + +
Sbjct: 348 ------------EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL--------- 386
Query: 362 WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALK 421
N+T ++ + N + + ++ L L+ + ++ + L+
Sbjct: 387 --------KNLTSLDISR-NTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLE 434
Query: 422 ELDVSNNQLYGKIPSFKSN 440
LDVSNN L F
Sbjct: 435 VLDVSNNNL-DSFSLFLPR 452
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-18
Identities = 52/392 (13%), Positives = 120/392 (30%), Gaps = 57/392 (14%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQ 126
+ ++I +L+ +L+++ + L L + + L + L+S+ + L +
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN 207
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSW------EIPQSLRNASGLQNFSANSANITGQI 180
++ S E+ + LR L + + G
Sbjct: 208 LARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLG 267
Query: 181 PSFFGPDEFPG---------LTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLG 230
+ + LH+ L L +S +++ + V + +
Sbjct: 268 DFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN-SKVFLVP 326
Query: 231 GGIDVIQNMTSLKEIWLHSNAFS----GPLPDFSGVKQLESLSLRDNFFT--GPVPDSLV 284
Q++ SL+ + L N L++L L N + L+
Sbjct: 327 CS--FSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL 384
Query: 285 KLESLKIVNMTNNLLQGPVPEFDRSVS---LDMAKGSNNFCLPSPGACDP-RLNAL-LSV 339
L++L ++++ N L++ S+ + C P L L +S
Sbjct: 385 TLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNL---SSTG-IRVVKTCIPQTLEVLDVSN 440
Query: 340 VKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRL 399
L + + + + L T+ P+ + F L +
Sbjct: 441 NNLDSFSLFL--------------------PRLQELYISRNKLK-TL-PDASLFPVLLVM 478
Query: 400 ILADNNLSGMIPEGLSVLGALKELDVSNNQLY 431
++ N L + L +L+++ + N
Sbjct: 479 KISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 44/188 (23%), Positives = 74/188 (39%), Gaps = 15/188 (7%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+ + +ILG+G V++G G A+K + E VL K+
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLKKL 64
Query: 649 RHRHLVALLG--HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
H+++V L K+L+ E+ P G+L + L + L + DV
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE--EPSNAYGLPESEFLIVLRDVV 122
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLG----DDMRAKVADFGLVRLAPEGKGSIETRIAG 762
G+ +L +HR++KP NI+ K+ DFG R + + + G
Sbjct: 123 GGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLY-G 177
Query: 763 TFGYLAPE 770
T YL P+
Sbjct: 178 TEEYLHPD 185
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 22/201 (10%), Positives = 41/201 (20%), Gaps = 38/201 (18%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALL 657
L G V+ ++ A+K G S L ++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 658 GHC--------------------------LDGNEKLLVFEYMPQGTLSRHI--FNWAEEG 689
LL+ L ++
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVF 187
Query: 690 LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749
+ + R L + +H P N+ + D R + D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 750 PEGKGSIETRIAGTFGYLAPE 770
G+ + Y E
Sbjct: 245 ----GTRGPASSVPVTYAPRE 261
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 48/177 (27%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 601 LGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVAL 656
LG GG TVY D K+A+K + + + F+ E+ +++ H+++V++
Sbjct: 19 LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+ + + LV EY+ TLS +I G PL + + + G+++ A
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI---ESHG--PLSVDTAINFTNQILDGIKH----A 127
Query: 717 HQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
H +HRD+KP NIL+ + K+ DFG+ + E + + GT Y +PE A
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 43/282 (15%), Positives = 84/282 (29%), Gaps = 54/282 (19%)
Query: 533 HPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLR--- 589
H H S E++ G V + + + M A + ++S +
Sbjct: 3 HHHHH-SSGRENLYFQGPGDVV-IEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQ 60
Query: 590 --NVTNNFSEE-------NILGRGGFGTVYKG-ELHDGTKIAVK--------------RM 625
V + E +LG+ + + G V +M
Sbjct: 61 PFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQM 120
Query: 626 EAGVISGKGLTEFKSEIAVLTKVR------------HRHLVALLGHCLDGNEKLLVFEYM 673
+ V+ + L K++ +R + ++ + D F Y
Sbjct: 121 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 180
Query: 674 ----PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSN 729
T + + + K L + RL + L V R + LH H +H L+P +
Sbjct: 181 RMQSNLQTFGEVLLSHSSTH-KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVD 236
Query: 730 ILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
I+L + F + + + + G+ PE
Sbjct: 237 IVLDQRGGVFLTGFEHLV-----RDGARVVSSVSRGFEPPEL 273
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-26
Identities = 36/155 (23%), Positives = 64/155 (41%), Gaps = 13/155 (8%)
Query: 598 ENILGRGGFGTVYKGELHDG----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
+G G FG V++G +A+K + S +F E + + H H+
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHI 453
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
V L+G + N ++ E G L + + L+ + A ++ + YL
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKFSLDLASLILYAYQLSTALAYL- 507
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748
+ F+HRD+ N+L+ + K+ DFGL R
Sbjct: 508 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 45/192 (23%), Positives = 76/192 (39%), Gaps = 28/192 (14%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
++N+ + LG+G F V + G + A K + +S + + + E + K+
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLT------I 701
+H ++V L + + LVF+ + G L F +
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVARE--------FYSEADASHC 110
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIET 758
+ + Y H +HR+LKP N+LL K+ADFGL + +
Sbjct: 111 IQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWH 165
Query: 759 RIAGTFGYLAPE 770
AGT GYL+PE
Sbjct: 166 GFAGTPGYLSPE 177
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-26
Identities = 60/374 (16%), Positives = 117/374 (31%), Gaps = 86/374 (22%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQF 127
+ +G ++ + LE LEL N +S + N L +L + L +N+
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPS--FFG 185
+P FTGLS+L ++I N ++ L++ ++ I F G
Sbjct: 93 KLIPLGVFTGLSNLTKLDISENKIVILL-DYMFQDLYNLKSLEVGDNDLV-YISHRAFSG 150
Query: 186 PDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEI 245
L L L L + I + + + ++ L +
Sbjct: 151 ---LNSLEQLTLEKCNL----------TSIPT----------------EALSHLHGLIVL 181
Query: 246 WLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPV 303
L + + D F + +L+ L + + + + + +L +++T+ L V
Sbjct: 182 RLRHLNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-V 239
Query: 304 PE--FDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDP 358
P V L ++ N E
Sbjct: 240 PYLAVRHLVYLRFLNL--SYNPISTIEGSM--------------------LHEL------ 271
Query: 359 CSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGL-SV 416
+ I L + P F L+ L ++ N L+ + E +
Sbjct: 272 -----------LRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
Query: 417 LGALKELDVSNNQL 430
+G L+ L + +N L
Sbjct: 319 VGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 41/222 (18%), Positives = 86/222 (38%), Gaps = 15/222 (6%)
Query: 85 PSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQS 143
Q+L L+ LE+ N + + +GL SLE + L TS+P++ + L L
Sbjct: 121 DYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIV 180
Query: 144 IEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG--LTILHLAFNQ 201
+ + + ++ S + L+ + + P+ G LT L +
Sbjct: 181 LRLRHLNINAIR-DYSFKRLYRLKVLEISHWPYLDTMT----PNCLYGLNLTSLSITHCN 235
Query: 202 LIGGLPA-SFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-PLPD 258
+ +P + ++ L ++ N + + G + + + L+EI L +
Sbjct: 236 -LTAVPYLAVRHLVYLRFLNLSY-NPISTIEGSM--LHELLRLQEIQLVGGQLAVVEPYA 291
Query: 259 FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300
F G+ L L++ N T + +L+ + + +N L
Sbjct: 292 FRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 6e-19
Identities = 63/373 (16%), Positives = 117/373 (31%), Gaps = 101/373 (27%)
Query: 64 CIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVML 122
C + + + +P + T+ L+L N I LE + L
Sbjct: 7 CECSAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELEL 63
Query: 123 SNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPS 182
+ N ++V F L +L+++ + +N IP + +GL N
Sbjct: 64 NENIVSAVEPGAFNNLFNLRTLGLRSNRLKL--IPLGVF--TGLSN-------------- 105
Query: 183 FFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
LT L ++ N++ + + Q++ +L
Sbjct: 106 ---------LTKLDISENKI----------VILLD----------------YMFQDLYNL 130
Query: 243 KEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300
K + + N + FSG+ LE L+L T ++L L L ++ + + +
Sbjct: 131 KSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN 189
Query: 301 G-PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPC 359
F R L + + S+ L + P L++ L
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTM---TPNCLYGLNLTSL----------------- 229
Query: 360 SDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEG-LSVL 417
+ NLT + L+ L L+ N +S I L L
Sbjct: 230 ----------------SITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHEL 271
Query: 418 GALKELDVSNNQL 430
L+E+ + QL
Sbjct: 272 LRLQEIQLVGGQL 284
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-15
Identities = 66/343 (19%), Positives = 106/343 (30%), Gaps = 80/343 (23%)
Query: 119 VVMLSNNQFTSVPSDF---------------------FTGLSSLQSIEIDNNPFSSWEIP 157
V+ +F +VP F L+ +E++ N S+ E P
Sbjct: 15 AVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE-P 73
Query: 158 QSLRNASGLQNFSANSANITGQIPSFFGPDEFPG---LTILHLAFNQLIGGLPASFSG-S 213
+ N L+ S + IP F G LT L ++ N+++ L F
Sbjct: 74 GAFNNLFNLRTLGLRSNRLK-LIP----LGVFTGLSNLTKLDISENKIVILLDYMFQDLY 128
Query: 214 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRD 272
++SL V N + + SL+++ L + P S + L L LR
Sbjct: 129 NLKSLEVGD-NDLVYISHR--AFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRH 185
Query: 273 NFFTGPVPDSLVKLESLKIVNMT-NNLLQGPVPEFDRSVSL-DMAKGSNNFCLPSPGACD 330
S +L LK++ ++ L P ++L ++ N A
Sbjct: 186 LNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVR 245
Query: 331 --PRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS 387
L L LS N I+ I
Sbjct: 246 HLVYLRFLNLS----------------YN--------------PISTIE------GSM-- 267
Query: 388 PEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
LQ + L L+ + P L L+ L+VS NQL
Sbjct: 268 --LHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQL 308
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 31/181 (17%), Positives = 63/181 (34%), Gaps = 35/181 (19%)
Query: 77 HQNLQGTLPSN-LQNLTKLERLELQ-WNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDF 134
+ + L +L+ LE+ W + P+ +L + +++ T+VP
Sbjct: 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLA 243
Query: 135 FTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPS--FFGPDEFPGL 192
L L+ + + NP S+ E L LQ + + F G L
Sbjct: 244 VRHLVYLRFLNLSYNPISTIE-GSMLHELLRLQEIQLVGGQLA-VVEPYAFRG---LNYL 298
Query: 193 TILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252
+L+++ NQL + ++ V ++ +L+ + L SN
Sbjct: 299 RVLNVSGNQL----------TTLEE----------------SVFHSVGNLETLILDSNPL 332
Query: 253 S 253
+
Sbjct: 333 A 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 18/86 (20%), Positives = 42/86 (48%), Gaps = 1/86 (1%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQ 126
+ + + + + S L L +L+ ++L ++ + GL L V+ +S NQ
Sbjct: 248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ 307
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFS 152
T++ F + +L+++ +D+NP +
Sbjct: 308 LTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 38/203 (18%), Positives = 74/203 (36%), Gaps = 22/203 (10%)
Query: 240 TSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 298
T + + L N +F+ LE L L +N + P + L +L+ + + +N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 299 LQG-PVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 354
L+ P+ F +L D++ N + L ++ L +N
Sbjct: 92 LKLIPLGVFTGLSNLTKLDIS--ENKIVILLDYM----FQDLYNLKSL-----EVGDNDL 140
Query: 355 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEG 413
+ G+ ++ + +K NLT +I E + L L L N++ +
Sbjct: 141 VYISHRAFSGLN----SLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYS 195
Query: 414 LSVLGALKELDVSNNQLYGKIPS 436
L LK L++S+ +
Sbjct: 196 FKRLYRLKVLEISHWPYLDTMTP 218
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-26
Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 18/190 (9%)
Query: 591 VTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 649
+ + LG GGFG V + G ++A+K+ + K + EI ++ K+
Sbjct: 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP-KNRERWCLEIQIMKKLN 70
Query: 650 HRHLVALL------GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
H ++V+ + LL EY G L +++ E L+ T+
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN--QFENCCGLKEGPIRTLLS 128
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRI 760
D++ + YLH IHRDLKP NI+L + K+ D G + +G+ +
Sbjct: 129 DISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFV 184
Query: 761 AGTFGYLAPE 770
GT YLAPE
Sbjct: 185 -GTLQYLAPE 193
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-26
Identities = 58/181 (32%), Positives = 90/181 (49%), Gaps = 9/181 (4%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
+ F + +LGRGGFG V+ ++ K+ A K++ + KG E +L KV
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
R +V+L + + L LV M G + HI+N E+ E A + G+
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGL 302
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
E+LH ++ I+RDLKP N+LL DD +++D GL G+ + AGT G++AP
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AGTPGFMAP 358
Query: 770 E 770
E
Sbjct: 359 E 359
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 43/234 (18%), Positives = 92/234 (39%), Gaps = 19/234 (8%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQ 126
R ++ +L+ L S Q+ ++ L+L N +S L LE++ LS+N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGP 186
LS+L++++++NN + S+ L + + N NI+ ++
Sbjct: 70 LYETLD--LESLSTLRTLDLNNNYVQELLVGPSIET---L-HAANN--NIS-RVS----C 116
Query: 187 DEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEI 245
G ++LA N++ S++Q L + N + ++ + +L+ +
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL-NEIDTVNFA-ELAASSDTLEHL 174
Query: 246 WLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
L N + +L++L L N + + +++ NN L
Sbjct: 175 NLQYNFIYD-VKGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL 226
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 46/255 (18%), Positives = 79/255 (30%), Gaps = 41/255 (16%)
Query: 86 SNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSI 144
L +E L N+IS G ++ L+NN+ T + S +Q +
Sbjct: 93 QELLVGPSIETLHAANNNISRVSCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQYL 149
Query: 145 EIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIG 204
++ N + + ++ L++ + I + F L L L+ N+L
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV---FAKLKTLDLSSNKLA- 204
Query: 205 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVK 263
+ F + + I L +N + +
Sbjct: 205 FMGPEFQ--------------------------SAAGVTWISLRNNKLVL-IEKALRFSQ 237
Query: 264 QLESLSLRDN-FFTGPVPDSLVKLESLK-IVNMTNNLLQGPVPEFDRSVSLDMAKGSNNF 321
LE LR N F G + D K + ++ + T L G E +L
Sbjct: 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG--HYGAYC 295
Query: 322 CLPSPGACDPRLNAL 336
C P RL AL
Sbjct: 296 CEDLPAPFADRLIAL 310
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 37/245 (15%), Positives = 83/245 (33%), Gaps = 36/245 (14%)
Query: 192 LTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
I + + L L + ++ L ++G N +++ + T L+ + L SN
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSG-NPLSQISAA--DLAPFTKLELLNLSSN 68
Query: 251 AFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRS 309
D + L +L L +N+ L+ S++ ++ NN +
Sbjct: 69 VLYE-TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGK 122
Query: 310 VSLDMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLMGYPQR-FAENWKGNDPCSDWIGV 365
++ +A +N + R+ L L + ++ A +
Sbjct: 123 KNIYLA--NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD----------- 169
Query: 366 TCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDV 425
+ +N Q + + + F L+ L L+ N L+ + + + +
Sbjct: 170 -----TLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221
Query: 426 SNNQL 430
NN+L
Sbjct: 222 RNNKL 226
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 25/198 (12%), Positives = 63/198 (31%), Gaps = 46/198 (23%)
Query: 234 DVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 292
++ QN K + ++ L ++ L L N + L L+++
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 293 NMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 352
N+++N+L + + +L +NN + LL +
Sbjct: 64 NLSSNVLYE-TLDLESLSTLRTLDLNNN-----------YVQELLVGPSI---------- 101
Query: 353 WKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 412
++ N++ +S + + + LA+N ++ +
Sbjct: 102 --------------------ETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITMLRDL 138
Query: 413 GLSVLGALKELDVSNNQL 430
++ LD+ N++
Sbjct: 139 DEGCRSRVQYLDLKLNEI 156
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 14/67 (20%), Positives = 29/67 (43%), Gaps = 1/67 (1%)
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+ +L ++ S +++ L L+ N LS + L+ L+ L++S+N L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 431 YGKIPSF 437
Y +
Sbjct: 71 Y-ETLDL 76
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 13/80 (16%), Positives = 28/80 (35%), Gaps = 1/80 (1%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVP-SDFFTGLSSL 141
+ Q+ + + L+ N + +L +LE L N F DFF+ +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 142 QSIEIDNNPFSSWEIPQSLR 161
Q++ + + +
Sbjct: 265 QTVAKQTVKKLTGQNEEECT 284
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 44/188 (23%), Positives = 74/188 (39%), Gaps = 15/188 (7%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+ + +ILG+G V++G G A+K + E VL K+
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLKKL 64
Query: 649 RHRHLVALLG--HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
H+++V L K+L+ E+ P G+L + L + L + DV
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE--EPSNAYGLPESEFLIVLRDVV 122
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLG----DDMRAKVADFGLVRLAPEGKGSIETRIAG 762
G+ +L +HR++KP NI+ K+ DFG R + + + G
Sbjct: 123 GGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLY-G 177
Query: 763 TFGYLAPE 770
T YL P+
Sbjct: 178 TEEYLHPD 185
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 18/177 (10%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLG 658
+LG+G +G VY G +L + +IA+K + + EIA+ ++H+++V LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 659 HCLDGNEKLLVF-EYMPQGTLSRHIFNWAEEGLKPLEWNRRLT--IALDVARGVEYLHGL 715
+ + +F E +P G+LS + PL+ N + + G++YLH
Sbjct: 87 SFSENG-FIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKYLHD- 140
Query: 716 AHQSFIHRDLKPSNILLGDDM-RAKVADFGL-VRLAPEGKGSIETRIAGTFGYLAPE 770
+HRD+K N+L+ K++DFG RLA G GT Y+APE
Sbjct: 141 --NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA--GINPCTETFTGTLQYMAPE 193
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 52/199 (26%), Positives = 80/199 (40%), Gaps = 35/199 (17%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE------FKSE 641
+ + + + LG G G V E K+A+K + + E ++E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 642 IAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLT 700
I +L K+ H ++ + D + +V E M G L F+ RL
Sbjct: 66 IEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNK--------RLK 112
Query: 701 ------IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPE 751
+ V+YLH IHRDLKP N+LL +D K+ DFG ++
Sbjct: 113 EATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--L 167
Query: 752 GKGSIETRIAGTFGYLAPE 770
G+ S+ + GT YLAPE
Sbjct: 168 GETSLMRTLCGTPTYLAPE 186
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 53/197 (26%), Positives = 76/197 (38%), Gaps = 33/197 (16%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK-------RMEAGVISGKGLTEFKSE 641
N+ + ILGRG V + + AVK + + E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 642 IAVLTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRL 699
+ +L KV H +++ L LVF+ M +G L F++ E+ L
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKV--------TL 121
Query: 700 T------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753
+ I + + LH + +HRDLKP NILL DDM K+ DFG
Sbjct: 122 SEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-- 176
Query: 754 GSIETRIAGTFGYLAPE 770
G + GT YLAPE
Sbjct: 177 GEKLREVCGTPSYLAPE 193
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 79/398 (19%), Positives = 135/398 (33%), Gaps = 42/398 (10%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS---LNGLASLEVVMLSN 124
+ + +G + P Q L L L L + +S + L +L + LS
Sbjct: 73 PNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSK 132
Query: 125 NQFTSVP-SDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASG--LQNFSANSANITGQIP 181
NQ S+ F L+SL+SI+ +N L G L FS + ++ ++
Sbjct: 133 NQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC-EHELEPLQGKTLSFFSLAANSLYSRVS 191
Query: 182 SFF----GPDEFPGLTILHLAFNQLIGGLPASF----SGSQIQSLWVNGQNGNAKLGG-G 232
+ P L IL ++ N + +F S SQ SL + A G
Sbjct: 192 VDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251
Query: 233 IDVIQNMT-------SLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLV 284
I T S++ + L F +K L+ L+L N ++
Sbjct: 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFY 311
Query: 285 KLESLKIVNMTNNLLQGPVPEFDRSVS----LDMAKGSNNFCLPSPGACD--PRLNAL-L 337
L++L+++N++ NLL + +D+ N+ + +L L L
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQ--KNHIAIIQDQTFKFLEKLQTLDL 369
Query: 338 SV---VKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTG-TISPEFASF 393
+ P GN + +I+ + L I
Sbjct: 370 RDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTA----NLIHLSENRLENLDILYFLLRV 425
Query: 394 KSLQRLILADNNLSGMIPEGL-SVLGALKELDVSNNQL 430
LQ LIL N S + S +L++L + N L
Sbjct: 426 PHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENML 463
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-24
Identities = 59/369 (15%), Positives = 115/369 (31%), Gaps = 76/369 (20%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP--SLNGLASLEVVMLSNNQF 127
R+ + ++ S+ L +L+ LEL + + L +L ++ L +++
Sbjct: 26 TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
+ D F GL L + + S + +F
Sbjct: 86 YFLHPDAFQGLFHLFELRLYFCGLSDAVLK-----------------------DGYFRN- 121
Query: 188 EFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWL 247
LT L L+ N QI+SL+++ + SLK I
Sbjct: 122 -LKALTRLDLSKN-------------QIRSLYLHP------------SFGKLNSLKSIDF 155
Query: 248 HSNAFSG-PLPDFSGVKQ--LESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304
SN + ++ L SL N SL S+ N
Sbjct: 156 SSNQIFLVCEHELEPLQGKTLSFFSLAAN--------SLYSRVSVDWGKCMNPF------ 201
Query: 305 EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND--PCSDW 362
R++ L++ S N + L+ + ++
Sbjct: 202 ---RNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258
Query: 363 IGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALK 421
+ ++ ++ + +++ F + K L+ L LA N ++ + E L L+
Sbjct: 259 TFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQ 317
Query: 422 ELDVSNNQL 430
L++S N L
Sbjct: 318 VLNLSYNLL 326
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-23
Identities = 64/394 (16%), Positives = 130/394 (32%), Gaps = 55/394 (13%)
Query: 68 KRITRIQIGHQNLQG-TLPSNLQNLTKLERLELQWNSISG-PLPSLNGLA--SLEVVMLS 123
K +TR+ + ++ L + L L+ ++ N I L L +L L+
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182
Query: 124 NNQFTSVPSDFFTGLS------SLQSIEIDNNPFS-----------SWEIPQSLRNASGL 166
N S S + L+ +++ N ++ S SL A +
Sbjct: 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242
Query: 167 QNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNG 225
NI + F + L L+ + F ++ L + N
Sbjct: 243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAY-NK 301
Query: 226 NAKLGGGIDVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLV 284
K+ + +L+ + L N +F G+ ++ + L+ N +
Sbjct: 302 INKIADEA--FYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFK 359
Query: 285 KLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMG 344
LE L+ +++ +N L S+ S N L + + N +
Sbjct: 360 FLEKLQTLDLRDNALT----TIHFIPSIPDIFLSGNK-LVTLPKINLTANLI-------- 406
Query: 345 YPQRFAENW-KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE--FASFKSLQRLIL 401
+EN + D + V ++ ++ + + + S + + SL++L L
Sbjct: 407 ---HLSENRLENLDILYFLLRVP----HLQILILNQNRFS-SCSGDQTPSENPSLEQLFL 458
Query: 402 ADNNLSGMIPEGLSV-----LGALKELDVSNNQL 430
+N L L L L+ L +++N L
Sbjct: 459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-21
Identities = 54/293 (18%), Positives = 113/293 (38%), Gaps = 28/293 (9%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQ 126
K + + + + + L L+ L L +N + + GL + + L N
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQN---------FSANSANIT 177
+ F L LQ++++ +N ++ S+ + N +AN +++
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLS 409
Query: 178 G----QIPSFFGPDEFPGLTILHLAFNQLIGGLP-ASFSG-SQIQSLWVNGQNGNAKLGG 231
+ + P L IL L N+ + S ++ L++
Sbjct: 410 ENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWET 469
Query: 232 GI--DVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLES 288
+ DV + ++ L+ ++L+ N + P FS + L LSL N T + L +
Sbjct: 470 ELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PAN 527
Query: 289 LKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVK 341
L+I++++ N L P P+ VSL + ++N C+ L+ ++ +
Sbjct: 528 LEILDISRNQLLAPNPDV--FVSLSVLDITHN-----KFICECELSTFINWLN 573
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-18
Identities = 66/394 (16%), Positives = 119/394 (30%), Gaps = 87/394 (22%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTK--LERLELQWNSISGPLPS-LNGLASLEVVMLSN 124
I G N++ + L + + L+L + L L+V+ L+
Sbjct: 240 HHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAY 299
Query: 125 NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQ-SLRNASGLQNFSANSANITGQIPSF 183
N+ + + F GL +LQ + + N E+ + + +I
Sbjct: 300 NKINKIADEAFYGLDNLQVLNLSYNLLG--ELYSSNFYGLPKVAYIDLQKNHIAIIQDQT 357
Query: 184 FGPDEFPGLTILHLAFNQL--IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMT- 240
F L L L N L I +P I ++++G + + +
Sbjct: 358 FKF--LEKLQTLDLRDNALTTIHFIP------SIPDIFLSGNK--------LVTLPKINL 401
Query: 241 SLKEIWLHSNAFSG--PLPDFSGVKQLESLSLRDNFFTG-PVPDSLVKLESLKIVNMTNN 297
+ I L N L V L+ L L N F+ + + SL+ + +
Sbjct: 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGE- 460
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 357
N L + LS
Sbjct: 461 ---------------------NMLQLAWETELCWDVFEGLS------------------- 480
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSV 416
++ V+ L ++ P F+ +L+ L L N L+ + L
Sbjct: 481 -------------HLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLTVLSHNDL-- 524
Query: 417 LGALKELDVSNNQLYGKIPS-FKSNAIVNTDGNP 449
L+ LD+S NQL P F S ++++ N
Sbjct: 525 PANLEILDISRNQLLAPNPDVFVSLSVLDITHNK 558
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 1e-12
Identities = 46/264 (17%), Positives = 89/264 (33%), Gaps = 24/264 (9%)
Query: 186 PDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKE 244
P L L+FN + +SF Q+Q L + Q + + +N+ +L+
Sbjct: 20 PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK--EAFRNLPNLRI 77
Query: 245 IWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPV--PDSLVKLESLKIVNMTNNLLQ- 300
+ L S+ PD F G+ L L L + V L++L ++++ N ++
Sbjct: 78 LDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRS 137
Query: 301 -GPVPEFDRSVSL---DMAKGSNNFCLPSPGACD----PRLNAL-LSVVKLMGYPQRFAE 351
P F + SL D SN L + L+ L+ L
Sbjct: 138 LYLHPSFGKLNSLKSIDF--SSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWG 195
Query: 352 NWKGNDPCSDWIGVTCTKGNITVI---NFQKMNLTGTISPEFASFKSLQRLILADNNLSG 408
+ + TV NF ++ + + + +N+
Sbjct: 196 KCMNPFRNMVLEILDVSGNGWTVDITGNFSN-AISKSQAFSLILAHHIMGAGFGFHNIKD 254
Query: 409 MIPEGLSVLG--ALKELDVSNNQL 430
+ L +++ LD+S+ +
Sbjct: 255 PDQNTFAGLARSSVRHLDLSHGFV 278
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 33/202 (16%), Positives = 57/202 (28%), Gaps = 35/202 (17%)
Query: 600 ILGRGGFGTVYKGE-LHDGTKIAVKRMEAG-VISGKGLTEFKSEIAVLTKVR-------- 649
+LG+ + G V + + K E+ L +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 650 --HRHLVALLGHCLDGNEKLLV--------------FEYMPQ-----GTLSRHIFNWAEE 688
H + D +K ++ F P+ T + + +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 689 GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748
K L + RL + L V R + LH H +H L+P +I+L + F +
Sbjct: 205 H-KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 749 APEGKGSIETRIAGTFGYLAPE 770
S R A
Sbjct: 261 DGASAVSPIGRGFAPPETTAER 282
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 51/190 (26%), Positives = 75/190 (39%), Gaps = 24/190 (12%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
++ +LG+G FG V K + + AVK + K + E+ +L K+
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIAL 703
H +++ L D + +V E G L R F+ E I
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS--EHDAA--------RIIK 128
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRI 760
V G+ Y+H + +HRDLKP NILL D K+ DFGL +
Sbjct: 129 QVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDR 183
Query: 761 AGTFGYLAPE 770
GT Y+APE
Sbjct: 184 IGTAYYIAPE 193
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 34/218 (15%)
Query: 566 PSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKR 624
+S G QM +++ ++N+ + LG+G F V + G + A K
Sbjct: 4 MASMTGGQQMGRGSEFMMNAS--TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 625 MEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----S 679
+ +S + + + E + K++H ++V L + + LVF+ + G L +
Sbjct: 62 INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA 121
Query: 680 RHIFNWAEEGLKPLEWNRRLTIALDVAR----GVEYLHGLAHQSFIHRDLKPSNILL--- 732
R ++ A+ A + + Y H +HR+LKP N+LL
Sbjct: 122 REFYSEAD--------------ASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASK 164
Query: 733 GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
K+ADFGL + + AGT GYL+PE
Sbjct: 165 AKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPE 200
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 40/194 (20%), Positives = 71/194 (36%), Gaps = 33/194 (17%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE--FKSEIAVL 645
+ + + LGRG FG V++ E K + KG + K EI++L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK-----FVKVKGTDQVLVKKEISIL 55
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
RHR+++ L E +++FE++ + I + E ++
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERI---NTSAFELNE--------REI 104
Query: 706 AR-------GVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPEGKGSI 756
+++LH + H D++P NI+ K+ +FG R G
Sbjct: 105 VSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N 159
Query: 757 ETRIAGTFGYLAPE 770
+ Y APE
Sbjct: 160 FRLLFTAPEYYAPE 173
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 56/275 (20%), Positives = 104/275 (37%), Gaps = 33/275 (12%)
Query: 511 FCLCKKKQKRFSRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEP 570
K++++ ++ + R + + A +++ +
Sbjct: 13 NKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENL 72
Query: 571 GDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK-----R 624
M + + + ++++GRG V + G + AVK
Sbjct: 73 YFQSMGPEDELPDWAAA-KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTA 131
Query: 625 MEAGVISGKGLTE-FKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI 682
+ + E + E +L +V H H++ L+ + LVF+ M +G L
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL---- 187
Query: 683 FNW-AEEGLKPLEWNRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735
F++ E+ L+ I + V +LH + +HRDLKP NILL D+
Sbjct: 188 FDYLTEKV--------ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDN 236
Query: 736 MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
M+ +++DFG G+ + GT GYLAPE
Sbjct: 237 MQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPE 269
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 57/241 (23%), Positives = 96/241 (39%), Gaps = 23/241 (9%)
Query: 537 SGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFS 596
SGS +S + + ++ + + +L + R + +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61
Query: 597 EENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-EIAVLTKVRHRHLV 654
+ +GRG FG V++ + G + AVK++ L F+ E+ + +V
Sbjct: 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLSSPRIV 113
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
L G +G + E + G+L + I L +R L G+EYLH
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHT 168
Query: 715 LAHQSFIHRDLKPSNILLGDD-MRAKVADFGL-VRLAPEGKGSIETR---IAGTFGYLAP 769
+ +H D+K N+LL D RA + DFG + L P+G G I GT ++AP
Sbjct: 169 ---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 770 E 770
E
Sbjct: 226 E 226
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 24/184 (13%)
Query: 601 LGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVAL 656
LG GG V+ D +AVK + A + F+ E + H +VA+
Sbjct: 20 LGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 657 L--GHCLDGNEKL--LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
G L +V EY+ TL + EG P+ R + + D + + +
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEG--PMTPKRAIEVIADACQALNF- 131
Query: 713 HGLAHQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR---IAGTFGYLA 768
+HQ+ IHRD+KP+NI++ KV DFG+ R + S+ T+ + GT YL+
Sbjct: 132 ---SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGTAQYLS 187
Query: 769 PEYA 772
PE A
Sbjct: 188 PEQA 191
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 43/177 (24%), Positives = 72/177 (40%), Gaps = 16/177 (9%)
Query: 601 LGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVAL 656
+GRGG G VY+ D +A+K M + S + E +++ H+V +
Sbjct: 42 VGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
+ + + L+ + +G PL R + I + ++ A
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML---RRQG--PLAPPRAVAIVRQIGSALDA----A 150
Query: 717 HQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
H + HRD+KP NIL+ D A + DFG+ + K + GT Y+APE
Sbjct: 151 HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-25
Identities = 52/186 (27%), Positives = 78/186 (41%), Gaps = 33/186 (17%)
Query: 601 LGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE------FKSEIAVLTKVRHRHL 653
LG G G V E K+A++ + + E ++EI +L K+ H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVAR 707
+ + D + +V E M G L F+ N+RL +
Sbjct: 203 IKIKNFF-DAEDYYIVLELMEGGEL----FDKVVG-------NKRLKEATCKLYFYQMLL 250
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTF 764
V+YLH IHRDLKP N+LL +D K+ DFG ++ G+ S+ + GT
Sbjct: 251 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTP 305
Query: 765 GYLAPE 770
YLAPE
Sbjct: 306 TYLAPE 311
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 52/385 (13%), Positives = 119/385 (30%), Gaps = 68/385 (17%)
Query: 73 IQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVP 131
+ I Q L + + + +++ P L+ +E++ L++ Q +
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 85
Query: 132 SDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG 191
+ F ++Q + + N P +N L +++ +P F
Sbjct: 86 TYAFAYAHTIQKLYMGFNAIRYLP-PHVFQNVPLLTVLVLERNDLS-SLP----RGIFHN 139
Query: 192 LT---ILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH 248
L ++ N L +I+ D Q TSL+ + L
Sbjct: 140 TPKLTTLSMSNNNL----------ERIED----------------DTFQATTSLQNLQLS 173
Query: 249 SNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFD 307
SN + + S + L ++ N + +L +++ ++ ++N + P
Sbjct: 174 SNRLTH-VD-LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNV 226
Query: 308 RSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVT 366
L + NN + P L + LS +L +
Sbjct: 227 ELTILKLQ--HNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ------------ 272
Query: 367 CTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVS 426
+ + L ++ +L+ L L+ N+L + L+ L +
Sbjct: 273 ----RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD 326
Query: 427 NNQLYGKIP--SFKSNAIVNTDGNP 449
+N + + + + + N
Sbjct: 327 HNSI-VTLKLSTHHTLKNLTLSHND 350
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 63/353 (17%), Positives = 116/353 (32%), Gaps = 65/353 (18%)
Query: 83 TLPSN-LQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSS 140
LP+ L + ++E L L I + +++ + + N +P F +
Sbjct: 59 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL 118
Query: 141 LQSIEIDNNPFSSWEIPQSL-RNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAF 199
L + ++ N S +P+ + N L S ++ N+ F L L L+
Sbjct: 119 LTVLVLERNDLS--SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA--TTSLQNLQLSS 174
Query: 200 NQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-PLPD 258
N+L S I SL+ + N + + +++E+ N+ + P
Sbjct: 175 NRL-----THVDLSLIPSLFHANVSYNL-----LSTLAIPIAVEELDASHNSINVVRGPV 224
Query: 259 FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAKG 317
+L L L+ N T L+ L V+++ N L+ F + L+
Sbjct: 225 NV---ELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 279
Query: 318 SNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINF 377
SNN RL AL + V++
Sbjct: 280 SNN-----------RLVAL---------NLYGQPI-----------------PTLKVLDL 302
Query: 378 QKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+L + F L+ L L N++ + LK L +S+N
Sbjct: 303 SHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 9e-20
Identities = 62/353 (17%), Positives = 113/353 (32%), Gaps = 85/353 (24%)
Query: 83 TLPSNLQNLTKLERLEL--QWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSS 140
+ SNLQ + + Q + + L + ++V N+ +P+
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDIT-LNNQKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 141 LQSIEIDNNPFSSWEIPQ-SLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAF 199
++ + +++ EI + A +Q I P F P LT+L L
Sbjct: 71 VELLNLNDLQIE--EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF--QNVPLLTVLVLER 126
Query: 200 NQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD- 258
N L S + + N L + + +N + D
Sbjct: 127 NDL----------SSLPR----------------GIFHNTPKLTTLSMSNNNLER-IEDD 159
Query: 259 -FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKG 317
F L++L L N T V SL + SL N++ NLL ++++
Sbjct: 160 TFQATTSLQNLQLSSNRLTH-VDLSL--IPSLFHANVSYNLLS----TLAIPIAVEELDA 212
Query: 318 SNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINF 377
S+N +N + +T++
Sbjct: 213 SHN-----------SINVV--------RGPVNV--------------------ELTILKL 233
Query: 378 QKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
Q NLT T ++ L + L+ N L ++ + L+ L +SNN+L
Sbjct: 234 QHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 284
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 63/349 (18%), Positives = 116/349 (33%), Gaps = 64/349 (18%)
Query: 98 ELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIP 157
+ ++ I L + + M + + + L++ + + N+ +P
Sbjct: 7 QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFE---DITLNNQKIVTFKNSTMRK--LP 61
Query: 158 QS-LRNASGLQNFSANSANITGQIPSFFGPDEFPG---LTILHLAFNQLIGGLPASFSG- 212
+ L + ++ + N I +I F + L++ FN + P F
Sbjct: 62 AALLDSFRQVELLNLNDLQIE-EID----TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV 116
Query: 213 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSL 270
+ L + N + L GI N L + + +N + D F L++L L
Sbjct: 117 PLLTVLVLER-NDLSSLPRGI--FHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQL 172
Query: 271 RDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAKGSNNFCLPSPGAC 329
N T V SL + SL N++ NLL +P + N+ +
Sbjct: 173 SSNRLTH-VDLSL--IPSLFHANVSYNLLSTLAIPIAVEELDAS----HNSINVVRGPVN 225
Query: 330 DPRL-------NALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNL 382
L N L L+ YP + ++ L
Sbjct: 226 -VELTILKLQHNNLTDTAWLLNYP------------------------GLVEVDLSYNEL 260
Query: 383 TGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
I F + L+RL +++N L + + LK LD+S+N L
Sbjct: 261 E-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 307
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 32/296 (10%), Positives = 85/296 (28%), Gaps = 74/296 (25%)
Query: 156 IPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQI 215
I +L+ + + T + F I+ + + ++
Sbjct: 13 IDSNLQYDCVFYDVHID--MQTQDVYFGFEDITLNNQKIVTFKNSTM----------RKL 60
Query: 216 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDN 273
+ ++ + ++ + L+ + F+ ++ L + N
Sbjct: 61 PA----------------ALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFN 103
Query: 274 FFTGPVPDSLVKLESLKIVNMT-NNLLQGPVPEFDRSVSL---DMAKGSNNFCLPSPGAC 329
P + L ++ + N+L P F + L M+ +NN
Sbjct: 104 AIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS--NNNLERIEDDT- 160
Query: 330 DPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINF------QKMNLT 383
A S+ L + + N +T ++ N++
Sbjct: 161 ---FQATTSLQNL-----QLSSN------------------RLTHVDLSLIPSLFHANVS 194
Query: 384 GTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKS 439
+ A +++ L + N+++ ++ + L L + +N L +
Sbjct: 195 YNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL-TDTAWLLN 246
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 47/235 (20%), Positives = 77/235 (32%), Gaps = 47/235 (20%)
Query: 580 NMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK---RMEAGVISGKGL 635
N+ L + + + +G+G +G V E A+K + + I+ K +
Sbjct: 13 NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV 72
Query: 636 TEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI------------- 682
K+E+ ++ K+ H ++ L D LV E G L +
Sbjct: 73 ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 683 ----------------FNWAEEGLKPLEWNRRLT------IALDVARGVEYLHGLAHQSF 720
+ I + + YLH +Q
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGI 189
Query: 721 IHRDLKPSNILLGDDMRA--KVADFGL---VRLAPEGKGSIETRIAGTFGYLAPE 770
HRD+KP N L + K+ DFGL G+ T AGT ++APE
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 52/197 (26%), Positives = 82/197 (41%), Gaps = 33/197 (16%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK----RMEAGVISGKGLTEFKSEIAV 644
V +++ LG G F V K + G + A K R + G E + E+ +
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 645 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLT--- 700
L ++RH +++ L + + +L+ E + G L F++ AE+ LT
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKE--------SLTEDE 109
Query: 701 ---IALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPEGK 753
+ GV YLH + H DLKP NI+L + R K+ DFG+ G
Sbjct: 110 ATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166
Query: 754 GSIETRIAGTFGYLAPE 770
I GT ++APE
Sbjct: 167 --EFKNIFGTPEFVAPE 181
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 48/194 (24%), Positives = 80/194 (41%), Gaps = 15/194 (7%)
Query: 552 SNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYK 611
+ V +E S Q A MV+ + +G G G V
Sbjct: 7 HSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQG---DPRLLLDSYVKIGEGSTGIVCL 63
Query: 612 G-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670
E H G ++AVK M+ + + +E+ ++ +H ++V + L G E ++
Sbjct: 64 AREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM 121
Query: 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNI 730
E++ G L+ + L + T+ V + + YLH Q IHRD+K +I
Sbjct: 122 EFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSI 172
Query: 731 LLGDDMRAKVADFG 744
LL D R K++DFG
Sbjct: 173 LLTLDGRVKLSDFG 186
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 47/202 (23%), Positives = 74/202 (36%), Gaps = 30/202 (14%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
T F E +G G FG+V+K + DG A+KR + + E+ +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 649 -RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+H H+V + + L+ EY G+L+ I + + L V R
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIM-SYFKEAELKDLLLQVGR 126
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDD-------------------MRAKVADFGLVRL 748
G+ Y+H S +H D+KPSNI + + K+ D G V
Sbjct: 127 GLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 749 APEGKGSIETRIAGTFGYLAPE 770
S + G +LA E
Sbjct: 184 I----SSPQVEE-GDSRFLANE 200
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 54/195 (27%), Positives = 80/195 (41%), Gaps = 37/195 (18%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE---FKSEIAVL 645
N+ F +LG G F V+ + G A+K I ++EIAVL
Sbjct: 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALK-----CIKKSPAFRDSSLENEIAVL 60
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLT---- 700
K++H ++V L LV + + G L F+ E G T
Sbjct: 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERG--------VYTEKDA 108
Query: 701 --IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGS 755
+ V V+YLH +HRDLKP N+L ++ + + DFGL ++ G
Sbjct: 109 SLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-- 163
Query: 756 IETRIAGTFGYLAPE 770
+ T GT GY+APE
Sbjct: 164 MST-ACGTPGYVAPE 177
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 44/194 (22%), Positives = 77/194 (39%), Gaps = 31/194 (15%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
T + LG+G F V + ++ G + A + +S + + + E + +
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIAL 703
+H ++V L + L+F+ + G L +R ++ A+ A
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD--------------AS 113
Query: 704 DVAR----GVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSI 756
+ V + H +HR+LKP N+LL K+ADFGL + +
Sbjct: 114 HCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170
Query: 757 ETRIAGTFGYLAPE 770
AGT GYL+PE
Sbjct: 171 FG-FAGTPGYLSPE 183
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 48/184 (26%), Positives = 67/184 (36%), Gaps = 31/184 (16%)
Query: 598 ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVA 655
+ LG G F K AVK +IS + + EI L H ++V
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVK-----IISKRMEANTQKEITALKLCEGHPNIVK 70
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IALDVARGV 709
L D LV E + G L I + + I + V
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKK-----------KKHFSETEASYIMRKLVSAV 119
Query: 710 EYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 766
++H +HRDLKP N+L D++ K+ DFG RL P ++T T Y
Sbjct: 120 SHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHY 175
Query: 767 LAPE 770
APE
Sbjct: 176 AAPE 179
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 51/191 (26%), Positives = 75/191 (39%), Gaps = 24/191 (12%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
++ +LG+G FG V K + + AVK + K + E+ +L K
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIA 702
+ H +++ L D + +V E G L R F+ E I
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS--EHDAA--------RII 127
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETR 759
V G+ Y+H + +HRDLKP NILL D K+ DFGL +
Sbjct: 128 KQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKD 182
Query: 760 IAGTFGYLAPE 770
GT Y+APE
Sbjct: 183 RIGTAYYIAPE 193
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 62/181 (34%), Positives = 94/181 (51%), Gaps = 12/181 (6%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
N F + +LG+GGFG V ++ K+ A K++E + KG +E +L KV
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
R +V+L + + + L LV M G L HI++ + G E A ++ G+
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP--EARAVFYAA-EICCGL 299
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
E LH + ++RDLKP NILL D +++D GL PEG+ +I+ R GT GY+AP
Sbjct: 300 EDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGR-VGTVGYMAP 354
Query: 770 E 770
E
Sbjct: 355 E 355
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 41/161 (25%), Positives = 69/161 (42%), Gaps = 10/161 (6%)
Query: 585 IQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIA 643
++ + + LG G FG VYK G A K +E S + L ++ EI
Sbjct: 11 VRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIE 68
Query: 644 VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
+L H ++V LLG + ++ E+ P G + E + L + +
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD----AIMLELDRGLTEPQIQVVCR 124
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744
+ + +LH + IHRDLK N+L+ + ++ADFG
Sbjct: 125 QMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFG 162
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 51/191 (26%), Positives = 78/191 (40%), Gaps = 19/191 (9%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK----RMEAGVISGKGLTEFKSEIA 643
+ V + + LG G F V K E G + A K R G E + E++
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 644 VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
+L +V H +++ L + + +L+ E + G L F++ + E I
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFI-K 122
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPEGKGSIETR 759
+ GV YLH + H DLKP NI+L K+ DFGL +G
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKN 177
Query: 760 IAGTFGYLAPE 770
I GT ++APE
Sbjct: 178 IFGTPEFVAPE 188
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 58/183 (31%), Positives = 85/183 (46%), Gaps = 20/183 (10%)
Query: 594 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLT---EFKSEIAVLTKVR 649
S+ ILG G FG V+K E G K+A K +I +G+ E K+EI+V+ ++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAK-----IIKTRGMKDKEEVKNEISVMNQLD 144
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
H +L+ L N+ +LV EY+ G L I +E E + L + + G+
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRI---IDESYNLTELDTILFM-KQICEGI 200
Query: 710 EYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
++H +H DLKP NIL D + K+ DFGL R GT +L
Sbjct: 201 RHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLKVNFGTPEFL 255
Query: 768 APE 770
APE
Sbjct: 256 APE 258
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-24
Identities = 42/181 (23%), Positives = 71/181 (39%), Gaps = 28/181 (15%)
Query: 601 LGRGGFGTVYKGELH--DGTKIAVKRMEAGVISG--KGLTEFKSEIAVLTKVRHRHLVAL 656
+ GG G +Y +G + +K + SG + +E L +V H +V +
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVH---SGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 657 L--GHCLDGNEKL---LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
D + +V EY+ +L R + L + L++ + Y
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSY 197
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
LH ++ DLKP NI+L ++ + K+ D G V G + GT G+ APE
Sbjct: 198 LH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGY----LYGTPGFQAPEI 248
Query: 772 A 772
Sbjct: 249 V 249
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 56/222 (25%), Positives = 84/222 (37%), Gaps = 29/222 (13%)
Query: 563 HTVPSSEPGDIQMLEAGNMVISIQVL-----RNVTNNFSEENILGRGGFGTVYKG-ELHD 616
H G + G++ + + +++ + LG G +G V +
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 617 GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQG 676
+ A+K + +S ++ E+AVL + H +++ L D LV E G
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121
Query: 677 TL-----SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731
L R FN E I V GV YLH + +HRDLKP N+L
Sbjct: 122 ELFDEIIHRMKFN--EVDAA--------VIIKQVLSGVTYLH---KHNIVHRDLKPENLL 168
Query: 732 L---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
L D K+ DFGL + K GT Y+APE
Sbjct: 169 LESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPE 208
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 51/197 (25%), Positives = 78/197 (39%), Gaps = 33/197 (16%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK----RMEAGVISGKGLTEFKSEIAV 644
V + + LG G F V K E G + A K R G E + E+++
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 645 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLT--- 700
L +V H +++ L + + +L+ E + G L F++ A++ L+
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKE--------SLSEEE 116
Query: 701 ---IALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPEGK 753
+ GV YLH + H DLKP NI+L K+ DFGL
Sbjct: 117 ATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IED 171
Query: 754 GSIETRIAGTFGYLAPE 770
G I GT ++APE
Sbjct: 172 GVEFKNIFGTPEFVAPE 188
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 20/222 (9%)
Query: 88 LQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147
L KLERL L N + LP +L+ + + N+ T V F GL+ + +E+
Sbjct: 96 FAPLVKLERLYLSKNQLKE-LPE-KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELG 153
Query: 148 NNPFSSWEIP-QSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGL 206
NP S I + + L NIT IP P LT LHL N+ I +
Sbjct: 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIP----QGLPPSLTELHLDGNK-ITKV 207
Query: 207 PA-SFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQ 264
A S G + + L ++ N + + G + N L+E+ L++N + K
Sbjct: 208 DAASLKGLNNLAKLGLSF-NSISAVDNG--SLANTPHLRELHLNNNKLVKVPGGLADHKY 264
Query: 265 LESLSLRDNFFTG------PVPDSLVKLESLKIVNMTNNLLQ 300
++ + L +N + P K S V++ +N +Q
Sbjct: 265 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 54/254 (21%), Positives = 92/254 (36%), Gaps = 41/254 (16%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLA 115
C V C D + ++ P +L T L+LQ N I+ L
Sbjct: 31 CHLRVVQC-SDLGLEKV-----------PKDLPPDTA--LLDLQNNKITEIKDGDFKNLK 76
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
+L ++L NN+ + + F L L+ + + N E+P+ + LQ +
Sbjct: 77 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK--ELPEKM--PKTLQELRVHENE 132
Query: 176 ITGQIPSFFGPDEFPG---LTILHLAFNQL-IGGLPA-SFSG-SQIQSLWVNGQNGNAKL 229
IT ++ F G + ++ L N L G+ +F G ++ + + N
Sbjct: 133 IT-KVR----KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN----- 182
Query: 230 GGGIDVIQN--MTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKL 286
I I SL E+ L N + G+ L L L N + SL
Sbjct: 183 ---ITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 239
Query: 287 ESLKIVNMTNNLLQ 300
L+ +++ NN L
Sbjct: 240 PHLRELHLNNNKLV 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 37/232 (15%), Positives = 72/232 (31%), Gaps = 61/232 (26%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSIS---------GPLPSLNGL----- 114
IT+++ S L ++ +EL N + + L+ +
Sbjct: 132 EITKVR----------KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181
Query: 115 ----------ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNAS 164
SL + L N+ T V + GL++L + + N S+ + SL N
Sbjct: 182 NITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD-NGSLANTP 240
Query: 165 GLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQN 224
L+ N+ + ++P + + +++L N + S I S
Sbjct: 241 HLRELHLNNNKLV-KVPGGL--ADHKYIQVVYLHNNNI----------SAIGSNDFCPPG 287
Query: 225 GNAKLGGGIDVIQNMTSLKEIWLHSNAFS-GPLPD--FSGVKQLESLSLRDN 273
S + L SN + F V ++ L +
Sbjct: 288 ----------YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 17/106 (16%), Positives = 40/106 (37%), Gaps = 16/106 (15%)
Query: 59 WNHVVCIED------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSIS------- 105
+N + +++ + + + + L +P L + ++ + L N+IS
Sbjct: 225 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 283
Query: 106 GPLPSLNGLASLEVVMLSNN--QFTSVPSDFFTGLSSLQSIEIDNN 149
P AS V L +N Q+ + F + ++++ N
Sbjct: 284 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 51/329 (15%), Positives = 90/329 (27%), Gaps = 111/329 (33%)
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
L VV S+ VP D + L ++ NN + I
Sbjct: 32 HLRVVQCSDLGLEKVPKDLPPDTALL---DLQNNKITE--IKDG---------------- 70
Query: 176 ITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDV 235
F L L L N++ S+I
Sbjct: 71 ------DFKN---LKNLHTLILINNKI----------SKISP----------------GA 95
Query: 236 IQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 294
+ L+ ++L N P L+ L + +N T L + +V +
Sbjct: 96 FAPLVKLERLYLSKNQLKELPEKMPKT---LQELRVHENEITKVRKSVFNGLNQMIVVEL 152
Query: 295 -TNNLLQGPVPE--FDRSVS---LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQR 348
TN L + F + +A N G
Sbjct: 153 GTNPLKSSGIENGAFQGMKKLSYIRIA--DTNITTIPQGL-------------------- 190
Query: 349 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLS 407
++T ++ +T + +L +L L+ N++S
Sbjct: 191 PP--------------------SLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS 229
Query: 408 GMIPEGLSVLGALKELDVSNNQLYGKIPS 436
+ L+ L+EL ++NN+L K+P
Sbjct: 230 AVDNGSLANTPHLRELHLNNNKLV-KVPG 257
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 48/191 (25%), Positives = 78/191 (40%), Gaps = 28/191 (14%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE---FKSEIAVL 645
+V + + LG G FG V++ E G K I+ + K+EI+++
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK-----FINTPYPLDKYTVKNEISIM 102
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
++ H L+ L D E +L+ E++ G L I A E K E ++
Sbjct: 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSE-----AEVINY 154
Query: 706 AR----GVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPEGKGSIETR 759
R G++++H S +H D+KP NI+ K+ DFGL + I
Sbjct: 155 MRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKV 209
Query: 760 IAGTFGYLAPE 770
T + APE
Sbjct: 210 TTATAEFAAPE 220
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 41/180 (22%), Positives = 71/180 (39%), Gaps = 16/180 (8%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE---FKSEIAVLTKVRHRHLVA 655
++G+G F V + G + AVK ++ + K E ++ ++H H+V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL--DVARGVEYLH 713
LL +VFE+M L I + ++ + + + Y H
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEI---VKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 714 GLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+ IHRD+KP +LL + K+ FG+ E G + GT ++APE
Sbjct: 148 ---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES-GLVAGGRVGTPHFMAPE 203
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 49/193 (25%), Positives = 76/193 (39%), Gaps = 32/193 (16%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE---FKSEIAVL 645
++ ++ EN +GRG +G V + + A K I + + FK EI ++
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAK-----KIPKYFVEDVDRFKQEIEIM 60
Query: 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLT 700
+ H +++ L D + LV E G L + +F ++
Sbjct: 61 KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA----------R 110
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIE 757
I DV V Y H + HRDLKP N L D K+ DFGL GK +
Sbjct: 111 IMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MM 165
Query: 758 TRIAGTFGYLAPE 770
GT Y++P+
Sbjct: 166 RTKVGTPYYVSPQ 178
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 6e-24
Identities = 54/387 (13%), Positives = 121/387 (31%), Gaps = 72/387 (18%)
Query: 73 IQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVP 131
+ I Q L + + + +++ P L+ +E++ L++ Q +
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 91
Query: 132 SDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG 191
+ F ++Q + + N P +N L +++ +P F
Sbjct: 92 TYAFAYAHTIQKLYMGFNAIRYLP-PHVFQNVPLLTVLVLERNDLS-SLP----RGIFHN 145
Query: 192 ---LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH 248
LT L ++ N L +I+ D Q TSL+ + L
Sbjct: 146 TPKLTTLSMSNNNL----------ERIED----------------DTFQATTSLQNLQLS 179
Query: 249 SNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFD 307
SN + + S + L ++ N + +L +++ ++ ++N + P
Sbjct: 180 SNRLTH-VD-LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNV 232
Query: 308 RSVSLDMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIG 364
L + +N L P L + LS +L +
Sbjct: 233 ELTILKL---QHNN-LTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ---------- 278
Query: 365 VTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELD 424
+ + L ++ +L+ L L+ N+L + L+ L
Sbjct: 279 ------RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330
Query: 425 VSNNQLYGKIP--SFKSNAIVNTDGNP 449
+ +N + + + + + N
Sbjct: 331 LDHNSI-VTLKLSTHHTLKNLTLSHND 356
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 1e-19
Identities = 60/358 (16%), Positives = 114/358 (31%), Gaps = 87/358 (24%)
Query: 77 HQNLQGTLPSN-LQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDF 134
+ + + +++L + +N+I P + L V++L N +S+P
Sbjct: 83 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGI 142
Query: 135 FTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTI 194
F L ++ + NN E + + + LQN +S +T + P L
Sbjct: 143 FHNTPKLTTLSMSNNNLERIE-DDTFQATTSLQNLQLSSNRLT-HVD----LSLIPSLFH 196
Query: 195 LHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG 254
++++N L + +++E+ N+ +
Sbjct: 197 ANVSYNLL-------------------------------STLAIPIAVEELDASHNSINV 225
Query: 255 -PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSL 312
P +L L L+ N T L+ L V+++ N L+ F + L
Sbjct: 226 VRGPVNV---ELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 280
Query: 313 DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNI 372
+ SNN RL AL +
Sbjct: 281 ERLYISNN-----------RLVAL---------NLYGQPI-----------------PTL 303
Query: 373 TVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
V++ +L + F L+ L L N++ + LS LK L +S+N
Sbjct: 304 KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 1e-19
Identities = 40/256 (15%), Positives = 87/256 (33%), Gaps = 38/256 (14%)
Query: 68 KRITRIQIGHQNLQGTLPSN-LQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNN 125
+ + ++ LP+ L + ++E L L I + +++ + + N
Sbjct: 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 109
Query: 126 QFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSL-RNASGLQNFSANSANITGQIP--- 181
+P F + L + ++ N SS +P+ + N L S ++ N+ +I
Sbjct: 110 AIRYLPPHVFQNVPLLTVLVLERNDLSS--LPRGIFHNTPKLTTLSMSNNNLE-RIEDDT 166
Query: 182 -----------------SFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQN 224
+ P L ++++N L L + ++ L + N
Sbjct: 167 FQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLL-STLAIPIA---VEELDASH-N 221
Query: 225 GNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLV 284
+ G + L + L N + L + L N + V
Sbjct: 222 SINVVRGPV-----NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMYHPFV 275
Query: 285 KLESLKIVNMTNNLLQ 300
K++ L+ + ++NN L
Sbjct: 276 KMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 1e-19
Identities = 60/356 (16%), Positives = 108/356 (30%), Gaps = 91/356 (25%)
Query: 83 TLPSNLQNLTKLERLELQWNS--ISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSS 140
+ SNLQ + + + + + L + ++V N+ +P+
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDIT-LNNQKIVTFKNSTMRKLPAALLDSFRQ 76
Query: 141 LQSIEIDNNPFSSWEIPQ-SLRNASGLQ--NFSANSANITGQIPSFFGPDEFPGLTILHL 197
++ + +++ EI + A +Q N I P F P LT+L L
Sbjct: 77 VELLNLNDLQIE--EIDTYAFAYAHTIQKLYMGFN--AIRYLPPHVF--QNVPLLTVLVL 130
Query: 198 AFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP 257
N L S + + N L + + +N +
Sbjct: 131 ERNDL----------SSLPR----------------GIFHNTPKLTTLSMSNNNLER-IE 163
Query: 258 D--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDM 314
D F L++L L N T V SL + SL N++ NLL +P +
Sbjct: 164 DDTFQATTSLQNLQLSSNRLTH-VDLSL--IPSLFHANVSYNLLSTLAIPIAVEELDAS- 219
Query: 315 AKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITV 374
N+ + L L + N N+T
Sbjct: 220 ---HNSINVVRGPVN-VELTIL---------------KLQHN--------------NLTD 246
Query: 375 INFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
++ L + L+ N L ++ + L+ L +SNN+L
Sbjct: 247 T------------AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 290
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 3e-17
Identities = 45/273 (16%), Positives = 103/273 (37%), Gaps = 31/273 (11%)
Query: 83 TLPSN-LQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSL 141
+ + Q T L+ L+L N ++ + L+ + SL +S N +++ ++
Sbjct: 161 RIEDDTFQATTSLQNLQLSSNRLTH-VD-LSLIPSLFHANVSYNLLSTLA-----IPIAV 213
Query: 142 QSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQ 201
+ ++ +N + + + L N+T +PGL + L++N+
Sbjct: 214 EELDASHNSINV--VRGPV--NVELTILKLQHNNLT-DTAWLLN---YPGLVEVDLSYNE 265
Query: 202 LIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFS 260
L + F +++ L+++ N +L Q + +LK + L N +
Sbjct: 266 LEKIMYHPFVKMQRLERLYISN---N-RLVALNLYGQPIPTLKVLDLSHNHLLHVERNQP 321
Query: 261 GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN----------MTNNLLQGPVPEFDRSV 310
+LE+L L N + L++L + + + N+ + V + D+
Sbjct: 322 QFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHC 381
Query: 311 SLDMAKGSNNFCLPSPGACDPRLNALLSVVKLM 343
+D C S RL +++ ++
Sbjct: 382 KIDYQLEHGLCCKESDKPYLDRLLQYIALTSVV 414
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 3e-15
Identities = 65/361 (18%), Positives = 118/361 (32%), Gaps = 65/361 (18%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
Q R + ++ I L + + M + + + L++ + +
Sbjct: 2 GGQQRYNVKPR-QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFE---DITLNNQKIVT 57
Query: 146 IDNNPFSSWEIPQS-LRNASGLQNFSANSANITGQIPSFFGPDEFPG---LTILHLAFNQ 201
N+ +P + L + ++ + N I +I F + L++ FN
Sbjct: 58 FKNSTMRK--LPAALLDSFRQVELLNLNDLQIE-EID----TYAFAYAHTIQKLYMGFNA 110
Query: 202 LIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-- 258
+ P F + L + N + L GI N L + + +N + D
Sbjct: 111 IRYLPPHVFQNVPLLTVLVLER-NDLSSLPRGI--FHNTPKLTTLSMSNNNLER-IEDDT 166
Query: 259 FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAKG 317
F L++L L N T V SL + SL N++ NLL +P +
Sbjct: 167 FQATTSLQNLQLSSNRLTH-VDLSL--IPSLFHANVSYNLLSTLAIPIAVEELDAS---- 219
Query: 318 SNNFCLPSPGACDPRL-------NALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKG 370
N+ + L N L L+ YP
Sbjct: 220 HNSINVVRGPVN-VELTILKLQHNNLTDTAWLLNYP------------------------ 254
Query: 371 NITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ 429
+ ++ L I F + L+RL +++N L + + LK LD+S+N
Sbjct: 255 GLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 312
Query: 430 L 430
L
Sbjct: 313 L 313
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 16/137 (11%), Positives = 40/137 (29%), Gaps = 8/137 (5%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQ 142
L Q + L+ L+L N + + LE + L +N ++ L +L
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLT 351
Query: 143 SIEIDNNPFSSWEIPQSLRN-----ASGLQNFSANSANITGQIPSFFGPDEFPGLTILHL 197
+ +N + + RN + + + + ++
Sbjct: 352 ---LSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYI 408
Query: 198 AFNQLIGGLPASFSGSQ 214
A ++ + +
Sbjct: 409 ALTSVVEKVQRAQGRCS 425
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-24
Identities = 59/258 (22%), Positives = 104/258 (40%), Gaps = 28/258 (10%)
Query: 60 NHVVCIEDKRITRIQIG----------HQNLQGTLPSN-LQNLTKLERLELQWNSISGPL 108
+ V+C K + + G H+N + N ++L LE L+L N I
Sbjct: 46 SKVIC-VRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIE 104
Query: 109 P-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIP-QSLRNASGL 166
+ NGLA+L + L +N+ T++P+ F LS L+ + + NNP S IP + L
Sbjct: 105 IGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES--IPSYAFNRIPSL 162
Query: 167 QNFSANSANITGQIPSFFGPDEFPG---LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQ 223
+ I F G L L+LA L +P ++ L ++G
Sbjct: 163 RRLDLGELKRLSYIS----EGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSG- 216
Query: 224 NGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDS 282
N + + G Q + L+++W+ + F ++ L ++L N T D
Sbjct: 217 NHLSAIRPG--SFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDL 274
Query: 283 LVKLESLKIVNMTNNLLQ 300
L L+ +++ +N
Sbjct: 275 FTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 54/325 (16%), Positives = 104/325 (32%), Gaps = 87/325 (26%)
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
V+ VP T + + + + N + S ++ L+ + +
Sbjct: 44 QFSKVICVRKNLREVPDGIST---NTRLLNLHENQIQIIK-VNSFKHLRHLEILQLSRNH 99
Query: 176 ITGQIP--SFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGI 233
I I +F G L L L N+L + I +
Sbjct: 100 IR-TIEIGAFNG---LANLNTLELFDNRL----------TTIPN---------------- 129
Query: 234 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRD-NFFTGPVPDSLVKLESLK 290
++ LKE+WL +N +P F+ + L L L + + + L +L+
Sbjct: 130 GAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLR 188
Query: 291 IVNMTNNLLQGPVPEFDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQ 347
+N+ L+ +P + L D+ N+ PG+ L+ + KL
Sbjct: 189 YLNLAMCNLRE-IPNLTPLIKLDELDL--SGNHLSAIRPGS----FQGLMHLQKL----- 236
Query: 348 RFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNL 406
+ + I F + +SL + LA NNL
Sbjct: 237 ----------------------------WMIQSQIQ-VIERNAFDNLQSLVEINLAHNNL 267
Query: 407 SGMIPEG-LSVLGALKELDVSNNQL 430
+ ++P + L L+ + + +N
Sbjct: 268 T-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 28/126 (22%), Positives = 50/126 (39%), Gaps = 23/126 (18%)
Query: 323 LPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPC-------SDWIGVTCTKGNITVI 375
LPSPG L +LLSV+ + + C + + V C + N+ +
Sbjct: 4 LPSPGMPALLLVSLLSVLLMGCVAE-----TGSAQTCPSVCSCSNQFSKVICVRKNLREV 58
Query: 376 ------NFQKMNLTG----TISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELD 424
N + +NL I F + L+ L L+ N++ + + L L L+
Sbjct: 59 PDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLE 118
Query: 425 VSNNQL 430
+ +N+L
Sbjct: 119 LFDNRL 124
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 13/70 (18%), Positives = 27/70 (38%), Gaps = 5/70 (7%)
Query: 385 TISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL----YGKIPSFKS 439
I P F LQ+L + + + + L +L E+++++N L +
Sbjct: 221 AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280
Query: 440 NAIVNTDGNP 449
++ NP
Sbjct: 281 LERIHLHHNP 290
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 53/196 (27%), Positives = 79/196 (40%), Gaps = 31/196 (15%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK----RMEAGVISGKGLTEFKSEIAV 644
NV + + LG G F V K E G + A K R G + + E+++
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 645 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT---- 700
L +++H +++ L + + +L+ E + G L + AE+ LT
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKE--------SLTEEEA 116
Query: 701 --IALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRLAPEGKG 754
+ GV YLH L H DLKP NI+L R K+ DFGL G
Sbjct: 117 TEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN- 172
Query: 755 SIETRIAGTFGYLAPE 770
I GT ++APE
Sbjct: 173 -EFKNIFGTPEFVAPE 187
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 52/190 (27%), Positives = 76/190 (40%), Gaps = 29/190 (15%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
+F ILG G F TV ++ A+K +E +I + E V++++ H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-- 707
V L D +EKL Y G L ++I + + R
Sbjct: 90 PFFVKLYFTFQD-DEKLYFGLSYAKNGELLKYI-------------RKIGSFDETCTRFY 135
Query: 708 ------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR-I 760
+EYLHG IHRDLKP NILL +DM ++ DFG ++
Sbjct: 136 TAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 761 AGTFGYLAPE 770
GT Y++PE
Sbjct: 193 VGTAQYVSPE 202
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 49/202 (24%), Positives = 79/202 (39%), Gaps = 37/202 (18%)
Query: 585 IQVLRNVTNNFSEE----NILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFK 639
+Q L + F++ +G G + + + AVK +I K +
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK-----IID-KSKRDPT 63
Query: 640 SEIAVLTK-VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR 698
EI +L + +H +++ L DG +V E M G L I +
Sbjct: 64 EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR-----------QKF 112
Query: 699 LT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFGLVRL 748
+ + + + VEYLH Q +HRDLKPSNIL G+ ++ DFG +
Sbjct: 113 FSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 749 APEGKGSIETRIAGTFGYLAPE 770
G + T T ++APE
Sbjct: 170 LRAENGLLMT-PCYTANFVAPE 190
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 60/205 (29%), Positives = 85/205 (41%), Gaps = 53/205 (25%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVK-----------------------RMEAGVISGKGLT 636
+G+G +G V +D T A+K G I +G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 637 EF-KSEIAVLTKVRHRHLVALLGHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPL 693
E EIA+L K+ H ++V L+ D NE L VFE + QG +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK---- 132
Query: 694 EWNRRLTIALDVAR--------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745
L+ D AR G+EYLH +Q IHRD+KPSN+L+G+D K+ADFG+
Sbjct: 133 ----PLSE--DQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 746 VRLAPEGKGSIETRIAGTFGYLAPE 770
+ GT ++APE
Sbjct: 184 SNEFKGSDALLSNT-VGTPAFMAPE 207
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 44/174 (25%), Positives = 85/174 (48%), Gaps = 15/174 (8%)
Query: 572 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI 630
D ++LE ++S+ + ++ +G+G GTVY ++ G ++A+++M +
Sbjct: 2 DEEILEKLRSIVSV---GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQ 56
Query: 631 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 690
+EI V+ + ++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------ 110
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744
++ + + + + +E+LH IHRD+K NILLG D K+ DFG
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFG 161
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 51/192 (26%), Positives = 75/192 (39%), Gaps = 25/192 (13%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLT 646
++ + + +LG+G FG V + G + AVK + V E+ +L
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTI 701
++ H +++ L D LV E G L SR F+ E I
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS--EVDAA--------RI 131
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIET 758
V G+ Y+H +HRDLKP N+LL D ++ DFGL K
Sbjct: 132 IRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMK 186
Query: 759 RIAGTFGYLAPE 770
GT Y+APE
Sbjct: 187 DKIGTAYYIAPE 198
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 61/264 (23%), Positives = 108/264 (40%), Gaps = 32/264 (12%)
Query: 57 CKWN--HVVCIEDKRITRIQIG----------HQNLQGTLPSN-LQNLTKLERLELQWNS 103
C VVC + ++ + G +N + ++ ++L LE L+L NS
Sbjct: 52 CSNQFSKVVC-TRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 104 ISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIP-QSLR 161
I + + NGLASL + L +N T +PS F LS L+ + + NNP S IP +
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIES--IPSYAFN 168
Query: 162 NASGLQNFSANSANITGQIPSFFGPDEFPGLT---ILHLAFNQLIGGLPASFSG-SQIQS 217
L ++ + F GL L+L + +P + ++
Sbjct: 169 RVPSLMRLDLGELK---KL-EYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEE 222
Query: 218 LWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFT 276
L ++G N ++ G ++SLK++W+ ++ S F G+ L L+L N +
Sbjct: 223 LEMSG-NHFPEIRPG--SFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
Query: 277 GPVPDSLVKLESLKIVNMTNNLLQ 300
D L L +++ +N
Sbjct: 280 SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 61/324 (18%), Positives = 101/324 (31%), Gaps = 104/324 (32%)
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174
++ + L N + +D F L L+ +++ N E + +GL +
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIE-VGAF---NGLAS------ 124
Query: 175 NITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGID 234
L L L N L + I S
Sbjct: 125 -----------------LNTLELFDNWL----------TVIPS----------------G 141
Query: 235 VIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRD-NFFTGPVPDSLVKLESLKI 291
+ ++ L+E+WL +N +P F+ V L L L + + L +LK
Sbjct: 142 AFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKY 200
Query: 292 VNMTNNLLQGPVPEFDRSVS---LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQR 348
+N+ ++ +P V L+M N+F PG+ + L S+ KL
Sbjct: 201 LNLGMCNIKD-MPNLTPLVGLEELEM--SGNHFPEIRPGS----FHGLSSLKKL------ 247
Query: 349 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLS 407
++ I F SL L LA NNLS
Sbjct: 248 ---------------------------WVMNSQVS-LIERNAFDGLASLVELNLAHNNLS 279
Query: 408 GMIPEG-LSVLGALKELDVSNNQL 430
+P + L L EL + +N
Sbjct: 280 -SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 48/283 (16%), Positives = 88/283 (31%), Gaps = 77/283 (27%)
Query: 189 FPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH 248
L+L N + +F ++ L+ + L
Sbjct: 74 PSNTRYLNLMENNIQMIQADTFR--------------------------HLHHLEVLQLG 107
Query: 249 SNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM-TNNLLQGPVPE 305
N+ + F+G+ L +L L DN+ T + L L+ + + N + P
Sbjct: 108 RNSIRQ-IEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYA 166
Query: 306 FDRSVSL---DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW 362
F+R SL D+ S GA L ++ L
Sbjct: 167 FNRVPSLMRLDLG-ELKKLEYISEGA----FEGLFNLKYL-----NLGMC---------- 206
Query: 363 IGVTCTKGNITVI-NFQKM-NLT---------GTISPE-FASFKSLQRLILADNNLSGMI 410
NI + N + L I P F SL++L + ++ +S +
Sbjct: 207 --------NIKDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIE 258
Query: 411 PEGLSVLGALKELDVSNNQL----YGKIPSFKSNAIVNTDGNP 449
L +L EL++++N L + + ++ NP
Sbjct: 259 RNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNP 301
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 19/78 (24%), Positives = 34/78 (43%), Gaps = 13/78 (16%)
Query: 365 VTCTKGNITVI------NFQKMNLTG----TISPE-FASFKSLQRLILADNNLSGMIPEG 413
V CT+ ++ + N + +NL I + F L+ L L N++ I G
Sbjct: 59 VVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVG 117
Query: 414 -LSVLGALKELDVSNNQL 430
+ L +L L++ +N L
Sbjct: 118 AFNGLASLNTLELFDNWL 135
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 51/254 (20%), Positives = 90/254 (35%), Gaps = 19/254 (7%)
Query: 522 SRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNM 581
QS P + + + + T + +
Sbjct: 87 KHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQ 146
Query: 582 VISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS 640
+ I+ +V +++ LG G FG V++ E G A K + +
Sbjct: 147 PVEIKH-DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM--TPHESDKETVRK 203
Query: 641 EIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT 700
EI ++ +RH LV L D NE ++++E+M G L + E + +
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHN----KMSEDEA 257
Query: 701 IAL--DVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPEGKGSI 756
+ V +G+ ++H +++H DLKP NI+ K+ DFGL +
Sbjct: 258 VEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S 312
Query: 757 ETRIAGTFGYLAPE 770
GT + APE
Sbjct: 313 VKVTTGTAEFAAPE 326
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 61/250 (24%), Positives = 91/250 (36%), Gaps = 44/250 (17%)
Query: 533 HPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVT 592
H H S + S SV A + T I ++
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDA----------LS 52
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRH 650
+ F E+ LGRG VY+ + A+K V+ + ++EI VL ++ H
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALK-----VLKKTVDKKIVRTEIGVLLRLSH 107
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-AEEGLKPLEWNRRLT------IAL 703
+++ L E LV E + G L F+ E+G +
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKG--------YYSERDAADAVK 155
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRI 760
+ V YLH +HRDLKP N+L D K+ADFGL ++ + +
Sbjct: 156 QILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTV 210
Query: 761 AGTFGYLAPE 770
GT GY APE
Sbjct: 211 CGTPGYCAPE 220
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 19/189 (10%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTE----FKSEIAV 644
+ + F + LG G FG V+ E G + +K I+ ++EI V
Sbjct: 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIK-----TINKDRSQVPMEQIEAEIEV 73
Query: 645 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALD 704
L + H +++ + D + +V E G L I + G E +
Sbjct: 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-ELMKQ 132
Query: 705 VARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIA 761
+ + Y H Q +H+DLKP NIL K+ DFGL L + T A
Sbjct: 133 MMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAA 187
Query: 762 GTFGYLAPE 770
GT Y+APE
Sbjct: 188 GTALYMAPE 196
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-23
Identities = 75/349 (21%), Positives = 127/349 (36%), Gaps = 85/349 (24%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQ 142
LP Q+L L ++S LP LE + +SNNQ +P S L+
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSD-LPP-----LLEYLGVSNNQLEKLPE--LQNSSFLK 156
Query: 143 SIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL 202
I++DNN +P + L+ +A + + ++P P LT ++ N L
Sbjct: 157 IIDVDNNSLKK--LPDLPPS---LEFIAAGNNQLE-ELPELQ---NLPFLTAIYADNNSL 207
Query: 203 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGV 262
LP ++S+ N L + +QN+ L I+ +N LPD
Sbjct: 208 K-KLPDLP--LSLESIVAGN-N---IL-EELPELQNLPFLTTIYADNNLLKT-LPDLPP- 257
Query: 263 KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSV-SLDMAKGSNNF 321
LE+L++RDN+ T +P+ L L + + L E ++ L+ S+N
Sbjct: 258 -SLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGL----SELPPNLYYLNA---SSN- 307
Query: 322 CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 381
+ +L + ++ +N
Sbjct: 308 ----------EIRSLCDLPP-----------------------------SLEELNVSNNK 328
Query: 382 LTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
L + L+RLI + N+L+ +PE LK+L V N L
Sbjct: 329 LI-ELPALPPR---LERLIASFNHLA-EVPEL---PQNLKQLHVEYNPL 369
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-21
Identities = 70/365 (19%), Positives = 125/365 (34%), Gaps = 77/365 (21%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPSLNG--------------LASLEVVMLSNNQFT 128
+P +N+ W+ P NG + L+N +
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 129 SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDE 188
S+P L+S+ N + +P+ ++ L + N ++ P
Sbjct: 85 SLPEL----PPHLESLVASCNSLTE--LPELPQSLKSLLVDNNNLKALSDLPPL------ 132
Query: 189 FPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH 248
L L ++ NQL LP + S ++ + V+ N L + SL+ I
Sbjct: 133 ---LEYLGVSNNQLE-KLPELQNSSFLKIIDVDN-N---SL---KKLPDLPPSLEFIAAG 181
Query: 249 SNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDR 308
+N LP+ + L ++ +N +PD + LES+ NN+L+ PE
Sbjct: 182 NNQLEE-LPELQNLPFLTAIYADNNSLKK-LPDLPLSLESI---VAGNNILEEL-PELQN 235
Query: 309 SVSLDMAKGSNNF--CLPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGV 365
L NN LP P L AL + L P+
Sbjct: 236 LPFLTTIYADNNLLKTLPDLP---PSLEALNVRDNYLTDLPELP---------------- 276
Query: 366 TCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDV 425
++T ++ + + +S +L L + N + + +L+EL+V
Sbjct: 277 ----QSLTFLDVSENIFS-GLS---ELPPNLYYLNASSNEIRSLCDL----PPSLEELNV 324
Query: 426 SNNQL 430
SNN+L
Sbjct: 325 SNNKL 329
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 61/348 (17%), Positives = 108/348 (31%), Gaps = 82/348 (23%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQ 142
LP LQNL L + NS+ LP L SLE ++ NN +P L L
Sbjct: 187 ELP-ELQNLPFLTAIYADNNSLKK-LPDL--PLSLESIVAGNNILEELPE--LQNLPFLT 240
Query: 143 SIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL 202
+I DNN + +P + L+ + +T P+ LT L ++ N
Sbjct: 241 TIYADNNLLKT--LPDLPPS---LEALNVRDNYLTD------LPELPQSLTFLDVSENIF 289
Query: 203 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGV 262
G L + L + + ++ + SL+E+ + +N LP
Sbjct: 290 SG-LSELPP--NLYYLNAS----SNEIR---SLCDLPPSLEELNVSNNKLIE-LPALPP- 337
Query: 263 KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFC 322
+LE L N VP+ L+ L ++ N L+ + L M
Sbjct: 338 -RLERLIASFNHLAE-VPELPQNLKQL---HVEYNPLREFPDIPESVEDLRM-------- 384
Query: 323 LPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNL 382
+ L V +L N+ ++ + L
Sbjct: 385 ----------NSHLAEVPELPQ--------------------------NLKQLHVETNPL 408
Query: 383 TGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+S++ L + + L++ ++
Sbjct: 409 R-EFPDIP---ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 41/221 (18%), Positives = 79/221 (35%), Gaps = 35/221 (15%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGL 138
N LP Q+LT L+ E ++ +S P+L L S+N+ S+
Sbjct: 267 NYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYL------NASSNEIRSLCDL----P 316
Query: 139 SSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLA 198
SL+ + + NN +P L+ A+ ++ ++P L LH+
Sbjct: 317 PSLEELNVSNNKLIE--LPALPPR---LERLIASFNHLA-EVPE-----LPQNLKQLHVE 365
Query: 199 FNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD 258
+N L P ++ L +N +V + +LK++ + +N PD
Sbjct: 366 YNPLR-EFPDIP--ESVEDLRMNSH--------LAEVPELPQNLKQLHVETNPLRE-FPD 413
Query: 259 FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
+E L + P + + L+ ++
Sbjct: 414 IPE--SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 62/349 (17%), Positives = 107/349 (30%), Gaps = 71/349 (20%)
Query: 109 PSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQN 168
P L+ + ++ T +P + + S + + P +
Sbjct: 5 PRNVSNTFLQEPLRHSSNLTEMPVEAEN-VKSKTEYYNAWSEWER-NAPPGNGEQREMAV 62
Query: 169 FSANSANITG---------QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLW 219
+ S P+ P L L + N L LP ++SL
Sbjct: 63 SRLRDCLDRQAHELELNNLGLSSL--PELPPHLESLVASCNSLT-ELPELP--QSLKSLL 117
Query: 220 VNGQNGNAKLGG----------------GIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVK 263
V+ N L + +QN + LK I + +N+ LPD
Sbjct: 118 VDNNNLK-ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK-LPDL--PP 173
Query: 264 QLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNF-C 322
LE ++ +N L L L + NN L+ S+ G+N
Sbjct: 174 SLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVA--GNNILEE 229
Query: 323 LPSPGACDPRLNAL-LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 381
LP P L + L P D ++ +N +
Sbjct: 230 LPELQNL-PFLTTIYADNNLLKTLP--------------DLP------PSLEALNVRDNY 268
Query: 382 LTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
LT + +SL L +++N SG + E + L L+ S+N++
Sbjct: 269 LT-DLPEL---PQSLTFLDVSENIFSG-LSE---LPPNLYYLNASSNEI 309
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 33/216 (15%), Positives = 65/216 (30%), Gaps = 68/216 (31%)
Query: 236 IQNMTSLKEIWLHSNAFSGPLPDFSG--------------VKQLESLSLRDNFFTGPVPD 281
+N+ S E + + + P +G +Q L L + + +P+
Sbjct: 30 AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPE 88
Query: 282 SLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVK 341
LESL N+L + P SL + + L+ L
Sbjct: 89 LPPHLESLVASC--NSLTELP-ELPQSLKSLLVDNNNLK-----------ALSDLPP--- 131
Query: 342 LMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLIL 401
+ + L + PE + L+ + +
Sbjct: 132 -----------------------------LLEYLGVSNNQLE-KL-PELQNSSFLKIIDV 160
Query: 402 ADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF 437
+N+L +P+ +L+ + NNQL ++P
Sbjct: 161 DNNSLK-KLPDL---PPSLEFIAAGNNQL-EELPEL 191
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 8e-04
Identities = 10/74 (13%), Positives = 27/74 (36%), Gaps = 6/74 (8%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGL 138
+ +P QNL +L ++ N + P + S+E + +++ +
Sbjct: 386 SHLAEVPELPQNLKQLH---VETNPLRE-FPDI--PESVEDLRMNSERVVDPYEFAHETT 439
Query: 139 SSLQSIEIDNNPFS 152
L+ +++
Sbjct: 440 DKLEDDVFEHHHHH 453
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 54/189 (28%), Positives = 75/189 (39%), Gaps = 18/189 (9%)
Query: 590 NVTNNFS-EENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
N N + LGRG F V + G + A K ++ E EIAVL
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 648 VRHR-HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL--D 704
+ ++ L + +E +L+ EY G + E + + + I L
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC---LPELAEMV--SENDVIRLIKQ 139
Query: 705 VARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIA 761
+ GV YLH + +H DLKP NILL K+ DFG+ R G I
Sbjct: 140 ILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIM 194
Query: 762 GTFGYLAPE 770
GT YLAPE
Sbjct: 195 GTPEYLAPE 203
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 50/191 (26%), Positives = 85/191 (44%), Gaps = 16/191 (8%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRM--EAGVISGKGLTEFKSEIAVLT 646
+++ + ++G G V K+A+KR+ E + E EI ++
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK---CQTSMDELLKEIQAMS 68
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLKPLEWNRRLTIAL 703
+ H ++V+ + +E LV + + G++ +HI E L+ + TI
Sbjct: 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPEGKGSIETR 759
+V G+EYLH IHRD+K NILLG+D ++ADFG L + +
Sbjct: 129 EVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 760 IAGTFGYLAPE 770
GT ++APE
Sbjct: 186 FVGTPCWMAPE 196
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 2e-22
Identities = 60/288 (20%), Positives = 103/288 (35%), Gaps = 36/288 (12%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFT 128
+ + + + + S+LQ L+ L L N I+ S + L SLE + LS N +
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113
Query: 129 SVPSDFFTGLSSLQSIEIDNNPFSS---WEIPQSLRNASGLQNFSANSANITGQIPSFFG 185
++ S +F LSSL + + NP+ + + L L+ N T +I
Sbjct: 114 NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV--GNMDTFT-KIQ---- 166
Query: 186 PDEFPGLT---ILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTS 241
+F GLT L + + L P S + L ++ + L + +S
Sbjct: 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHM-KQHILLLEI--FVDVTSS 223
Query: 242 LKEIWLHSNAF---------SGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 292
++ + L +G ++ + D V L ++ L +
Sbjct: 224 VECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLEL 282
Query: 293 NMTNNLLQGPVPE--FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLS 338
+ N L+ VP+ FDR SL N P C LS
Sbjct: 283 EFSRNQLKS-VPDGIFDRLTSLQKIWLHTN-----PWDCSCPRIDYLS 324
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 51/352 (14%), Positives = 111/352 (31%), Gaps = 111/352 (31%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLSS 140
++PS L ++ L+L N I+ + + L +L+ ++L++N ++ D F+ L S
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGS 101
Query: 141 LQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFN 200
L+ +++ N S+ + S+F LT L+L N
Sbjct: 102 LEHLDLSYNYLSN--LS-----------------------SSWF--KPLSSLTFLNLLGN 134
Query: 201 QLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-- 258
S ++T L+ + + + +
Sbjct: 135 PYKTLGETSLF-------------------------SHLTKLQILRVGNMDTFTKIQRKD 169
Query: 259 FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGS 318
F+G+ LE L + + P SL ++++ + +
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHM---------------------- 207
Query: 319 NNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQ 378
L D + + ++L + + F
Sbjct: 208 KQHILLLEIFVDVTSS--VECLEL---------------------------RDTDLDTFH 238
Query: 379 KMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
L+ + + + + + D +L + + L+ + L EL+ S NQL
Sbjct: 239 FSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 20/83 (24%), Positives = 34/83 (40%), Gaps = 2/83 (2%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFT 128
+ L ++L +++ S+ + LN ++ L + S NQ
Sbjct: 233 DLDTFHF--SELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK 290
Query: 129 SVPSDFFTGLSSLQSIEIDNNPF 151
SVP F L+SLQ I + NP+
Sbjct: 291 SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 45/180 (25%), Positives = 78/180 (43%), Gaps = 29/180 (16%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
+G+G F V + G ++A+K ++ ++ L + E+ ++ + H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF-E 81
Query: 660 CLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVE 710
++ + L L+ EY G + ++ + R+ AR V+
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVA-----------HGRMKE--KEARSKFRQIVSAVQ 128
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
Y H + +HRDLK N+LL DM K+ADFG G G ++ G Y APE
Sbjct: 129 YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAF-CGAPPYAAPE 183
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 10/158 (6%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLT 646
+ FS+ +G G FG VY ++ + +A+K+M +G S + + E+ L
Sbjct: 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
K+RH + + G L + LV EY G+ S + E KPL+ +
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAVTHGAL 164
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744
+G+ YLH + IHRD+K NILL + K+ DFG
Sbjct: 165 QGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFG 199
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 50/192 (26%), Positives = 76/192 (39%), Gaps = 37/192 (19%)
Query: 598 ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVR-HRH 652
E++LG G V L + AVK +I G + E+ +L + + HR+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVK-----IIEKQPGHIRSRVFREVEMLYQCQGHRN 72
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHI-----FNWAEEGLKPLEWNRRLTIALDVAR 707
++ L+ + + LVFE M G++ HI FN E + DVA
Sbjct: 73 VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS----------VVVQDVAS 122
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETR----- 759
+++LH ++ HRDLKP NIL K+ DF L
Sbjct: 123 ALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 760 -IAGTFGYLAPE 770
G+ Y+APE
Sbjct: 180 TPCGSAEYMAPE 191
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 12/162 (7%)
Query: 584 SIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEI 642
+ + F LG G +G+VYK G +A+K++ L E EI
Sbjct: 20 EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEI 75
Query: 643 AVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIA 702
+++ + H+V G + +V EY G++S I K L + TI
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII----RLRNKTLTEDEIATIL 131
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744
+G+EYLH IHRD+K NILL + AK+ADFG
Sbjct: 132 QSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFG 170
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-22
Identities = 53/230 (23%), Positives = 85/230 (36%), Gaps = 35/230 (15%)
Query: 561 ETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTK 619
H E Q + + + + ++ + LG G +G V E + ++
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 620 IAVK-----------RMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668
A+K + K E +EI++L + H +++ L D L
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123
Query: 669 VFEYMPQGTL-----SRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHR 723
V E+ G L +RH F+ E I + G+ YLH + +HR
Sbjct: 124 VTEFYEGGELFEQIINRHKFD--ECDAA--------NIMKQILSGICYLH---KHNIVHR 170
Query: 724 DLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
D+KP NILL + K+ DFGL + GT Y+APE
Sbjct: 171 DIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPE 218
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 41/228 (17%), Positives = 80/228 (35%), Gaps = 20/228 (8%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSL 141
P L+ L+ + + + LP ++ A LE + L+ N ++P+ L+ L
Sbjct: 95 QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLRALPASI-ASLNRL 152
Query: 142 QSIEIDNNP--------FSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLT 193
+ + I P +S + + LQ+ I +P+ L
Sbjct: 153 RELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA--NLQNLK 209
Query: 194 ILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252
L + + L L + +++ L + G + LK + L +
Sbjct: 210 SLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNY---PPIFGGRAPLKRLILKDCSN 265
Query: 253 SGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
LP + QLE L LR +P + +L + I+ + +L
Sbjct: 266 LLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 33/223 (14%), Positives = 80/223 (35%), Gaps = 18/223 (8%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTG-LSSL 141
L + + + + N + ++ + +
Sbjct: 27 PYHDVLSQWQRHYNADRNRWHSAWRQANSN---NPQIETRTGRALKATADLLEDATQPGR 83
Query: 142 QSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQ 201
++E+ + P P S LQ+ + ++A + ++P +F GL L LA N
Sbjct: 84 VALELRSVPLPQ--FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQ--QFAGLETLTLARNP 138
Query: 202 LIGGLPASFSG-SQIQSLWVNGQNGNAKL------GGGIDVIQNMTSLKEIWLHSNAFSG 254
L LPAS + ++++ L + +L Q + +L+ + L
Sbjct: 139 LR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS 197
Query: 255 PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+ ++ L+SL +R++ + + ++ L L+ +++
Sbjct: 198 LPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGC 239
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 38/225 (16%), Positives = 76/225 (33%), Gaps = 41/225 (18%)
Query: 83 TLPSNLQNLT--KLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLS 139
L++ T LEL+ + P L+ L+ + + +P +
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLMELPDTM-QQFA 127
Query: 140 SLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG-------L 192
L+++ + NP + +P S+ + + L+ S + ++P + G L
Sbjct: 128 GLETLTLARNPLRA--LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
Query: 193 TILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252
L L + + LPAS + N+ +LK + + ++
Sbjct: 186 QSLRLEWTGIRS-LPASIA--------------------------NLQNLKSLKIRNSPL 218
Query: 253 SGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
S P + +LE L LR P LK + + +
Sbjct: 219 SALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC 263
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 43/324 (13%), Positives = 78/324 (24%), Gaps = 75/324 (23%)
Query: 114 LASLEVVMLSN-NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSAN 172
+ E + LS Q + + W N++ Q +
Sbjct: 11 SSGRENLYFQGSTALRPYHD----VLSQWQRHYNADR--NRWHSAWRQANSNNPQIETRT 64
Query: 173 SANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGG 232
+ PG L L +
Sbjct: 65 GRALK-ATADLLEDATQPGRVALEL-------------RSVPLPQFP------------- 97
Query: 233 IDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 291
D ++ L+ + + + LPD LE+L+L N +P S+ L L+
Sbjct: 98 -DQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRE 154
Query: 292 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL----LSVVKLMGYPQ 347
+++ +PE L L L + P
Sbjct: 155 LSIRACPELTELPE--------------PLASTDASGEHQGLVNLQSLRLEWTGIRSLPA 200
Query: 348 RFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLS 407
N + N+ + + L+ + P L+ L L
Sbjct: 201 SI-ANLQ----------------NLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTAL 242
Query: 408 GMIPEGLSVLGALKELDVSN-NQL 430
P LK L + + + L
Sbjct: 243 RNYPPIFGGRAPLKRLILKDCSNL 266
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 22/139 (15%), Positives = 47/139 (33%), Gaps = 8/139 (5%)
Query: 81 QGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSS 140
Q L L+ L L+W I S+ L +L+ + + N+ +++ L
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALGPA-IHHLPK 230
Query: 141 LQSIEI-DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAF 199
L+ +++ + P + L+ + +P L L L
Sbjct: 231 LEELDLRGCTALRN--YPPIFGGRAPLKRLILKDCSNLLTLPLDIH--RLTQLEKLDLRG 286
Query: 200 NQLIGGLPASFSGSQIQSL 218
+ LP+ +Q+ +
Sbjct: 287 CVNLSRLPSLI--AQLPAN 303
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 16/77 (20%), Positives = 27/77 (35%), Gaps = 3/77 (3%)
Query: 75 IGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNN-QFTSVPS 132
+ P L+RL L+ S LP ++ L LE + L + +PS
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
Query: 133 DFFTGLSSLQSIEIDNN 149
L + I + +
Sbjct: 296 L-IAQLPANCIILVPPH 311
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 5e-22
Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 40/228 (17%)
Query: 560 SETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTK 619
+ P D + + ++ ++G G FG V++ +L + +
Sbjct: 7 NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE 66
Query: 620 IAVKRMEAGVISGKGLTEFKS-EIAVLTKVRHRHLVALL------GHCLDGNEKLLVFEY 672
+A+K++ FK+ E+ ++ V+H ++V L G D LV EY
Sbjct: 67 VAIKKVLQD-------KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL------DVARGVEYLHGLAHQSFIHRDLK 726
+P+ T+ R ++A+ + + + L + R + Y+H + HRD+K
Sbjct: 120 VPE-TVYRASRHYAKL-------KQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIK 168
Query: 727 PSNILL-GDDMRAKVADFGLVRLAPEGKGSIE---TRIAGTFGYLAPE 770
P N+LL K+ DFG ++ G+ ++ +R Y APE
Sbjct: 169 PQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPE 211
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 5e-22
Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 18/161 (11%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RMEA---GVISGKGLTEFKSEIAVLT 646
NF + +G G +G VYK G +A+K R++ GV S T + EI++L
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS----TAIR-EISLLK 57
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
++ H ++V LL N+ LVFE++ Q L + + A G+ + L
Sbjct: 58 ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL-IKSYLFQL--L 113
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+G+ + H +HRDLKP N+L+ + K+ADFGL R
Sbjct: 114 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 6e-22
Identities = 48/160 (30%), Positives = 81/160 (50%), Gaps = 18/160 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVK--RMEA---GVISGKGLTEFKSEIAVLTK 647
+ + +G G +G VYK + G +A+K R++A G+ S T + EI++L +
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPS----TAIR-EISLLKE 75
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+ H ++V+L+ LVFE+M + L + + +E L+ ++ + R
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL----DENKTGLQDSQIKIYLYQLLR 130
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
GV + H +HRDLKP N+L+ D K+ADFGL R
Sbjct: 131 GVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 7e-22
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 583 ISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSE 641
I + LR+ F ++G G +G VYKG + G A+K M+ ++G E K E
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQE 70
Query: 642 IAVLTKV-RHRHLVALLG-----HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLE 694
I +L K HR++ G + +++L LV E+ G+++ + +K +
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT--------DLIKNTK 122
Query: 695 WNRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748
L I ++ RG+ +LH IHRD+K N+LL ++ K+ DFG+
Sbjct: 123 -GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWSSCSY 782
G T I GT ++APE +Y
Sbjct: 179 LDRTVGRRNTFI-GTPYWMAPEVIACDENPDATY 211
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 7e-22
Identities = 54/375 (14%), Positives = 112/375 (29%), Gaps = 85/375 (22%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQF 127
+ + + ++ ++ L L+ L+++ + + + GL+SL ++ L NQF
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
+ + F GL++L+ + + + +FF
Sbjct: 92 LQLETGAFNGLANLEVLTLTQCNLDGAVLS-----------------------GNFF--K 126
Query: 188 EFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWL 247
L +L L N I+ + NM + L
Sbjct: 127 PLTSLEMLVLRDNN-------------IKKIQPAS------------FFLNMRRFHVLDL 161
Query: 248 HSNAFSG-PLPDFSG--VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304
N D K L L L+ + L
Sbjct: 162 TFNKVKSICEEDLLNFQGKHFTLLRLSSI-----------TLQDMN----EYWLGWEKCG 206
Query: 305 EFDRSVSLDMAKGSNNF--CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW 362
++ S+ S N + D ++ K+ + N + +++
Sbjct: 207 NPFKNTSITTLDLSGNGFKESMAKRFFD-----AIAGTKIQSLILSNSYNMGSSFGHTNF 261
Query: 363 IGVT-CTKGNITVINFQKMNLTG----TISPE-FASFKSLQRLILADNNLSGMIPEG-LS 415
T + + +L+ + F+ F L++L LA N ++ I +
Sbjct: 262 KDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFW 320
Query: 416 VLGALKELDVSNNQL 430
L L +L++S N L
Sbjct: 321 GLTHLLKLNLSQNFL 335
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 4e-16
Identities = 39/246 (15%), Positives = 82/246 (33%), Gaps = 32/246 (13%)
Query: 83 TLPSNL-QNLTKLERLELQWNSIS--GPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLS 139
L N + LT LE L L+ N+I P + V+ L+ N+ S+ +
Sbjct: 119 VLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQ 178
Query: 140 S--LQSIEIDNNPFSS-------WEIPQSLRNASGLQNFSANSANITGQIPS-FFGPDEF 189
+ + + WE + + + + + FF
Sbjct: 179 GKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAG 238
Query: 190 PGLTILHL-------------AFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVI 236
+ L L F S +++ ++ ++ L +
Sbjct: 239 TKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLS-KSKIFALLKSV--F 295
Query: 237 QNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 294
+ T L+++ L N + + D F G+ L L+L NF L+ L+++++
Sbjct: 296 SHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354
Query: 295 TNNLLQ 300
+ N ++
Sbjct: 355 SYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 54/372 (14%), Positives = 113/372 (30%), Gaps = 81/372 (21%)
Query: 83 TLPSN-LQNLTKLERLELQWNSI-SGPLP--SLNGLASLEVVMLSNNQFTSV-PSDFFTG 137
L + L LE L L ++ L L SLE+++L +N + P+ FF
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN 152
Query: 138 LSSLQSIEIDNNPFSSWEIP---------QSLRNASGLQNFSANSANITGQIPSFFGPDE 188
+ +++ N S I + + P +
Sbjct: 153 MRRFHVLDLTFNKVKS--ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 189 FPGLTILHLAFNQLIGGLPASF----SGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKE 244
+T L L+ N + F +G++IQSL ++ + N G ++ +
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS-NSYNMGSSFGHTNFKDPDNFTF 269
Query: 245 IWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304
L ++ +++ L + + L+ + + N + +
Sbjct: 270 KGLEAS-------------GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KID 315
Query: 305 E--FDRSVSLDMAKGSNNF--CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS 360
+ F L S NF + + L
Sbjct: 316 DNAFWGLTHLLKLNLSQNFLGSID-SRMFE----------NL------------------ 346
Query: 361 DWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEG-LSVLG 418
+ V++ ++ + + F +L+ L L N L +P+G L
Sbjct: 347 ---------DKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLT 395
Query: 419 ALKELDVSNNQL 430
+L+++ + N
Sbjct: 396 SLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 65/387 (16%), Positives = 133/387 (34%), Gaps = 87/387 (22%)
Query: 71 TRIQIGHQNLQGTLPSNL-QNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQF 127
+++ Q + +N + L+ L L+L +N L + NGLA+LEV+ L+
Sbjct: 57 QFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ-LETGAFNGLANLEVLTLTQCNL 115
Query: 128 TS--VPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSF 183
+ +FF L+SL+ + + +N + N + + N +
Sbjct: 116 DGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN--KVKSICEED 173
Query: 184 FGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLK 243
+ T+L L+ L + + + TS+
Sbjct: 174 LLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF------------------KNTSIT 215
Query: 244 EIWLHSNAF----SGPLPDFSGVKQLESLSLRDNF----------FTGPVPDSLVKLE-- 287
+ L N F + D +++SL L +++ F P + LE
Sbjct: 216 TLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS 275
Query: 288 SLKIVNMTNNLLQGPVPE--FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGY 345
+K +++ + + + + F L+ + N +N +
Sbjct: 276 GVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQN-----------EINKI--------- 314
Query: 346 PQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADN 404
+ + G+T ++ +N + N G+I F + L+ L L+ N
Sbjct: 315 ------------DDNAFWGLT----HLLKLNLSQ-NFLGSIDSRMFENLDKLEVLDLSYN 357
Query: 405 NLSGMIPEGL-SVLGALKELDVSNNQL 430
++ + + L LKEL + NQL
Sbjct: 358 HIR-ALGDQSFLGLPNLKELALDTNQL 383
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-15
Identities = 50/271 (18%), Positives = 101/271 (37%), Gaps = 34/271 (12%)
Query: 79 NLQGTLPSNL-QNLTKLERLELQWNSIS----GPLPSLNG-------LASLEVVMLSNNQ 126
N++ P++ N+ + L+L +N + L + G L+S+ + ++
Sbjct: 140 NIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYW 199
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSW--EIPQSLRNASGLQNFSANSANITGQIPSF- 183
+S+ ++++ N F + + +Q+ +++ G
Sbjct: 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259
Query: 184 ---------FGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGI 233
F E G+ L+ +++ L + FS + ++ L + QN K+
Sbjct: 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLA-QNEINKIDDN- 317
Query: 234 DVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 291
+T L ++ L N + F + +LE L L N S + L +LK
Sbjct: 318 -AFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKE 375
Query: 292 VNMTNNLLQGPVPE--FDRSVSLDMAKGSNN 320
+ + N L+ VP+ FDR SL N
Sbjct: 376 LALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 31/77 (40%), Positives = 43/77 (55%), Gaps = 2/77 (2%)
Query: 77 HQNLQGTLPSNL-QNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDF 134
QN G++ S + +NL KLE L+L +N I S GL +L+ + L NQ SVP
Sbjct: 331 SQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGI 390
Query: 135 FTGLSSLQSIEIDNNPF 151
F L+SLQ I + NP+
Sbjct: 391 FDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 36/248 (14%), Positives = 75/248 (30%), Gaps = 72/248 (29%)
Query: 68 KRITRIQIGHQNLQGTLPS---NLQNLTKLERLELQWNSISGPLPSLNGL---------- 114
IT + + + ++ + TK++ L L + G
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271
Query: 115 ---ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSA 171
+ ++ LS ++ ++ F+ + L+ + + N + I
Sbjct: 272 LEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK--ID-------------- 315
Query: 172 NSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGG 231
+ F L L+L+ N L G + +
Sbjct: 316 ---------DNAF--WGLTHLLKLNLSQNFL-GSIDS----------------------- 340
Query: 232 GIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESL 289
+ +N+ L+ + L N L D F G+ L+ L+L N +L SL
Sbjct: 341 --RMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSL 397
Query: 290 KIVNMTNN 297
+ + + N
Sbjct: 398 QKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 45/219 (20%), Positives = 74/219 (33%), Gaps = 58/219 (26%)
Query: 37 LALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNL-QNLTKLE 95
L L S N S G ++ +E + + + L ++ + T LE
Sbjct: 244 LILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLE 302
Query: 96 RLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSS 153
+L L N I+ + GL L + LS N S+ S F L L+ +++ N +
Sbjct: 303 QLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA 361
Query: 154 WEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGS 213
+ F P L L L NQL
Sbjct: 362 --LG-----------------------DQSF--LGLPNLKELALDTNQL----------- 383
Query: 214 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252
+S+ +G + +TSL++IWLH+N +
Sbjct: 384 --KSV----PDG---------IFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 47/282 (16%), Positives = 89/282 (31%), Gaps = 41/282 (14%)
Query: 186 PDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKE 244
P+ + + L+ N + SFS +Q L V Q + + ++SL
Sbjct: 26 PELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNN--TFRGLSSLII 83
Query: 245 IWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPV--PDSLVKLESLKIVNMTNNLLQ 300
+ L N F L F+G+ LE L+L G V + L SL+++ + +N ++
Sbjct: 84 LKLDYNQFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142
Query: 301 --GPVPEFDRSVSLDMAKGSNN--FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGN 356
P F + + N + ++++L
Sbjct: 143 KIQPASFFLNMRRFHVLDLTFNKVKSIC-EEDLLNFQGKHFTLLRL-------------- 187
Query: 357 DPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV 416
+IT+ + + L S+ L L+ N + +
Sbjct: 188 -------------SSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFD 234
Query: 417 LGALKEL-DVSNNQLYGKIPSFKSNAIVNTDGNPDIGKEKSS 457
A ++ + + Y SF + D G E S
Sbjct: 235 AIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASG 276
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 44/186 (23%), Positives = 73/186 (39%), Gaps = 33/186 (17%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFK--SEIAVLTKVRHRHLVALL 657
LG G +G V + + AVK ++ + E EI +L ++RH++++ L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 658 GHCLDGNEKL---LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR------- 707
L EK +V EY G + + E R + A
Sbjct: 73 -DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK--------RFPV--CQAHGYFCQLI 119
Query: 708 -GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK--GSIETRIAGTF 764
G+EYLH Q +H+D+KP N+LL K++ G+ + T G+
Sbjct: 120 DGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSP 175
Query: 765 GYLAPE 770
+ PE
Sbjct: 176 AFQPPE 181
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 8e-22
Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 19/163 (11%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RMEA--GVISGKGLTEFKSEIAVLTK 647
+ F + LG G + TVYKG G +A+K ++++ G S T + EI+++ +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS----TAIR-EISLMKE 59
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQ---GTLSRHIFNWAEEGLKPLEWNRRLTIALD 704
++H ++V L N+ LVFE+M + GL+
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNL---VKYFQWQ 116
Query: 705 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ +G+ + H +HRDLKP N+L+ + K+ DFGL R
Sbjct: 117 LLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 9e-22
Identities = 55/184 (29%), Positives = 89/184 (48%), Gaps = 18/184 (9%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKV-- 648
N+FS I+GRGGFG VY D K+ A+K ++ + +G T +E +L+ V
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 649 -RHRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
+V + + +KL + + M G L H+ G+ E + R A ++
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFS-EADMRFYAA-EII 302
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGY 766
G+E++H ++RDLKP+NILL + +++D GL + K GT GY
Sbjct: 303 LGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--AS-VGTHGY 356
Query: 767 LAPE 770
+APE
Sbjct: 357 MAPE 360
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 21/173 (12%)
Query: 583 ISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RMEAGVISGKGLTEFK 639
+++ V + + + LG G F TVYK + + +A+K ++ + G
Sbjct: 1 MALDVKSRA-KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDG---IN 56
Query: 640 S----EIAVLTKVRHRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLE 694
EI +L ++ H +++ LL + LVF++M L I ++ L
Sbjct: 57 RTALREIKLLQELSHPNIIGLLD-AFGHKSNISLVFDFMETD-LEVII----KDNSLVLT 110
Query: 695 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ L +G+EYLH +HRDLKP+N+LL ++ K+ADFGL +
Sbjct: 111 PSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 41/161 (25%), Positives = 78/161 (48%), Gaps = 19/161 (11%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RMEA---GVISGKGLTEFKSEIAVLT 646
+ + +G G +GTV+K +A+K R++ GV S + + EI +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS----SALR-EICLLK 56
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
+++H+++V L + LVFE+ Q L ++ + L+ + +
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF----DSCNGDLDPEIVKSFLFQLL 111
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+G+ + H ++ +HRDLKP N+L+ + K+A+FGL R
Sbjct: 112 KGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 56/241 (23%), Positives = 99/241 (41%), Gaps = 41/241 (17%)
Query: 548 TVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFG 607
+ A S V S ++ S D + R ++++ ++G G FG
Sbjct: 9 SFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFG 68
Query: 608 TVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKS-EIAVLTKVRHRHLVALLGHCLDGNE 665
VY+ +L D G +A+K++ FK+ E+ ++ K+ H ++V L E
Sbjct: 69 VVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 121
Query: 666 KL------LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL------DVARGVEYLH 713
K LV +Y+P+ T+ R +++ + L + + R + Y+H
Sbjct: 122 KKDEVYLNLVLDYVPE-TVYRVARHYSRA-------KQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRA-KVADFGLVRLAPEGKGSIE---TRIAGTFGYLAP 769
HRD+KP N+LL D K+ DFG + G+ ++ +R Y AP
Sbjct: 174 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 225
Query: 770 E 770
E
Sbjct: 226 E 226
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 25/164 (15%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS--------EIA 643
+ + +G G +G V+K G +A+K+ +E EI
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL--------ESEDDPVIKKIALREIR 54
Query: 644 VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
+L +++H +LV LL LVFEY T+ + + + + + +I
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL----DRYQRGVPEHLVKSITW 109
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ V + H + IHRD+KP NIL+ K+ DFG R
Sbjct: 110 QTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 40/157 (25%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
+ F++ +G+G FG V+KG + +A+K ++ + + + + EI VL++
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQ 76
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
++ G L + ++ EY+ G+ + PL+ + TI ++ +
Sbjct: 77 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILK 130
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744
G++YLH + IHRD+K +N+LL + K+ADFG
Sbjct: 131 GLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFG 164
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 48/186 (25%), Positives = 78/186 (41%), Gaps = 20/186 (10%)
Query: 593 NNFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK-VR 649
+ + +GRG +G+V K +H G +AVKR+ + V + + ++ V+ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKM-VHKPSGQIMAVKRIRSTVDEKE-QKQLLMDLDVVMRSSD 79
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
++V G + + E M + + + I L + +
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPEGKGSI-ETRIAGTF 764
+L + IHRD+KPSNILL K+ DFG LV SI +TR AG
Sbjct: 139 NHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD-------SIAKTRDAGCR 189
Query: 765 GYLAPE 770
Y+APE
Sbjct: 190 PYMAPE 195
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 2e-21
Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 601 LGRGGFGTVYKG---ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+GRG +G VYK + D A+K++E IS EIA+L +++H ++++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPNVISLQ 84
Query: 658 GHCLDGNEKL--LVFEYMPQ---GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
L ++ L+F+Y + H + A + L ++ + G+ YL
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRA----KVADFGLVRL--APEGKGSIETRIAGTFGY 766
H +HRDLKP+NIL+ + K+AD G RL +P + + TF Y
Sbjct: 145 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 767 LAPE 770
APE
Sbjct: 202 RAPE 205
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 3e-21
Identities = 68/285 (23%), Positives = 97/285 (34%), Gaps = 44/285 (15%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQ 142
+LP L +L + LPS GL L + NQ TS+P LQ
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHLP-ALPS--GLCKLW---IFGNQLTSLPVL----PPGLQ 144
Query: 143 SIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL 202
+ + +N +S +P L A + +T + P GL L ++ NQL
Sbjct: 145 ELSVSDNQLAS--LPALPSE---LCKLWAYNNQLT-SL-----PMLPSGLQELSVSDNQL 193
Query: 203 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGI------DVIQN--------MTSLKEIWLH 248
LP S++ LW N L V N + LKE+ +
Sbjct: 194 A-SLPTLP--SELYKLWAY-NNRLTSLPALPSGLKELIVSGNRLTSLPVLPSELKELMVS 249
Query: 249 SNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDR 308
N + LP L SLS+ N T +P+SL+ L S VN+ N L + R
Sbjct: 250 GNRLTS-LPMLPS--GLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALR 305
Query: 309 S-VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 352
S G + + AL P R E
Sbjct: 306 EITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEP 350
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 3e-19
Identities = 67/360 (18%), Positives = 119/360 (33%), Gaps = 86/360 (23%)
Query: 74 QIGHQNLQGTLPSNLQN--LTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVP 131
+ + ++ L + + ++ LP A + +++ +N TS+P
Sbjct: 20 PAEESRGRAAVVQKMRACLNNGNAVLNVGESGLTT-LPD-CLPAHITTLVIPDNNLTSLP 77
Query: 132 SDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG 191
+ L+++E+ N +S +P L FS ++ P G
Sbjct: 78 A----LPPELRTLEVSGNQLTS--LPVLPPGLLELSIFSNPLTHL---------PALPSG 122
Query: 192 LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251
L L + NQL LP +Q L V+ N A L + L ++W ++N
Sbjct: 123 LCKLWIFGNQLTS-LPVLPP--GLQELSVSD-NQLASLPALP------SELCKLWAYNNQ 172
Query: 252 FSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSV- 310
+ LP L+ LS+ DN +P +L L N N L +P +
Sbjct: 173 LTS-LPM--LPSGLQELSVSDNQLAS-LPTLPSELYKLWAYN--NRLTS--LPALPSGLK 224
Query: 311 SLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKG 370
L + S N RL +L P
Sbjct: 225 ELIV---SGN-----------RLTSL---------------------PVL--------PS 241
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+ + LT ++ + L L + N L+ +PE L L + +++ N L
Sbjct: 242 ELKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 55/343 (16%), Positives = 96/343 (27%), Gaps = 94/343 (27%)
Query: 116 SLEVVMLSNNQFTSVPSDFFTGL-----------------SSLQSIEIDNNPFSSWEIPQ 158
V+ + + T++P + L+++E+ N +S +P
Sbjct: 41 GNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLTSLPALPPELRTLEVSGNQLTS--LPV 98
Query: 159 SLRNASGLQNFSANSANITGQIPSFFG-----------PDEFPGLTILHLAFNQLIGGLP 207
L FS ++ P PGL L ++ NQL LP
Sbjct: 99 LPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQL-ASLP 157
Query: 208 ASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLES 267
A S++ LW N L + L+E+ + N + LP +L
Sbjct: 158 ALP--SELCKLWAYN-NQLTSLPMLP------SGLQELSVSDNQLAS-LPT--LPSELYK 205
Query: 268 LSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPG 327
L +N T +P L+ L ++ N L L + S N
Sbjct: 206 LWAYNNRLT-SLPALPSGLKEL---IVSGNRLTSLPVLPSELKELMV---SGN------- 251
Query: 328 ACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS 387
RL +L + ++ + LT +
Sbjct: 252 ----RLTSL-----------------------PMLP------SGLLSLSVYRNQLT-RLP 277
Query: 388 PEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
S + L N LS + L + + +
Sbjct: 278 ESLIHLSSETTVNLEGNPLSERTLQ---ALREITSAPGYSGPI 317
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 4e-21
Identities = 34/188 (18%), Positives = 71/188 (37%), Gaps = 15/188 (7%)
Query: 592 TNNFSEENILGRG--GFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+ ++G+G TV G + V+R+ S + +T + E+ V
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
H ++V + NE +V +M G+ + + + I V +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMD--GMNELAIAYILQGVLKA 140
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG-LVRLAPEGK-----GSIETRIAG 762
++Y+H H ++HR +K S+IL+ D + ++ + + G+
Sbjct: 141 LDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 763 TFGYLAPE 770
+L+PE
Sbjct: 198 VLPWLSPE 205
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 50/170 (29%), Positives = 75/170 (44%), Gaps = 25/170 (14%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RMEAGVISGKGLTEFKS----EIAVL 645
+ + +G G +GTVYK + H G +A+K R+ G G E+A+L
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---GGGGGGGLPISTVREVALL 65
Query: 646 ---TKVRHRHLVALL----GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR 697
H ++V L+ D K+ LVFE++ Q L ++ GL
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA---ET 121
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ RG+++LH +HRDLKP NIL+ K+ADFGL R
Sbjct: 122 IKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 46/186 (24%), Positives = 80/186 (43%), Gaps = 21/186 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK-VR 649
++ LGRG +G V K H G +AVKR+ A ++ + ++ + + V
Sbjct: 7 DDLEPIMELGRGAYGVVEKM-RHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDISMRTVD 64
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
V G + + E M +L + + + + + + IA+ + + +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMD-TSLDK-FYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPEGKGSI-ETRIAGTF 764
E+LH IHRD+KPSN+L+ + K+ DFG LV + + AG
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD-------DVAKDIDAGCK 173
Query: 765 GYLAPE 770
Y+APE
Sbjct: 174 PYMAPE 179
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 6e-21
Identities = 48/181 (26%), Positives = 69/181 (38%), Gaps = 29/181 (16%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
LG G +G V +AVK ++ K EI + + H ++V GH
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGH 73
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVEY 711
+GN + L EY G L I + + A+ GV Y
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPE--PDAQRFFHQLMAGVVY 120
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK--GSIETRIAGTFGYLAP 769
LH HRD+KP N+LL + K++DFGL + + GT Y+AP
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAP 176
Query: 770 E 770
E
Sbjct: 177 E 177
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 7e-21
Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 28/187 (14%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
++F + + LG G G V+K H + +A K + + + E+ VL +
Sbjct: 33 DDFEKISELGAGNGGVVFKV-SHKPSGLVMARKLIHLEIKPAI-RNQIIRELQVLHECNS 90
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLS---RHIFNWAEEGLKPLEWNRRLTIALDVAR 707
++V G E + E+M G+L + E+ L +++ V +
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG--------KVSIAVIK 142
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLAPEGKGSIETRIAGT 763
G+ YL +HRD+KPSNIL+ K+ DFG L+ S+ GT
Sbjct: 143 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------SMANSFVGT 193
Query: 764 FGYLAPE 770
Y++PE
Sbjct: 194 RSYMSPE 200
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 8e-21
Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 18/160 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVK--RMEA---GVISGKGLTEFKSEIAVLTK 647
+ +G G +G VYK + + G A+K R+E G+ S T + EI++L +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS----TTIR-EISILKE 56
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
++H ++V L +LVFE++ Q L + + + LE + L +
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL----DVCEGGLESVTAKSFLLQLLN 111
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
G+ Y H + +HRDLKP N+L+ + K+ADFGL R
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 8e-21
Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 25/164 (15%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS--------EIA 643
+ ++G G +G V K G +A+K+ ++ EI
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL--------ESDDDKMVKKIAMREIK 76
Query: 644 VLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
+L ++RH +LV LL C LVFE++ T+ + E L++
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL----ELFPNGLDYQVVQKYLF 131
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ G+ + H + IHRD+KP NIL+ K+ DFG R
Sbjct: 132 QIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 50/222 (22%), Positives = 88/222 (39%), Gaps = 21/222 (9%)
Query: 88 LQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147
L KL++L + N + +P N +SL + + +N+ VP F+GL ++ IE+
Sbjct: 98 FSPLRKLQKLYISKNHLVE-IPP-NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMG 155
Query: 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLP 207
NP + + L + A +T IP D L LHL N+ I +
Sbjct: 156 GNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIP----KDLPETLNELHLDHNK-IQAIE 209
Query: 208 A-SFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 265
S++ L + N + G + + +L+E+ L +N S +K L
Sbjct: 210 LEDLLRYSKLYRLGLGH-NQIRMIENG--SLSFLPTLRELHLDNNKLSRVPAGLPDLKLL 266
Query: 266 ESLSLRDNFFTGPVPDS-------LVKLESLKIVNMTNNLLQ 300
+ + L N T V + VK +++ NN +
Sbjct: 267 QVVYLHTNNITK-VGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 55/253 (21%), Positives = 88/253 (34%), Gaps = 40/253 (15%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLA 115
C V C D + + + + L+LQ N IS GL
Sbjct: 33 CHLRVVQC-SDLGLKAVPKE-------ISPDTT------LLDLQNNDISELRKDDFKGLQ 78
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
L ++L NN+ + + F+ L LQ + I N IP +L S L +
Sbjct: 79 HLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE--IPPNL--PSSLVELRIHDNR 134
Query: 176 ITGQIPSFFGPDEFPG---LTILHLAFNQLIGGL--PASFSGSQIQSLWVNGQNGNAKLG 230
I ++P F G + + + N L P +F G ++ L ++
Sbjct: 135 IR-KVP----KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK------ 183
Query: 231 GGIDVIQNM--TSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLE 287
+ I +L E+ L N L D +L L L N SL L
Sbjct: 184 --LTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLP 241
Query: 288 SLKIVNMTNNLLQ 300
+L+ +++ NN L
Sbjct: 242 TLRELHLDNNKLS 254
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 30/195 (15%), Positives = 53/195 (27%), Gaps = 54/195 (27%)
Query: 83 TLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSL 141
+P +L L L L N I L L + L + L +NQ + + + L +L
Sbjct: 186 GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTL 243
Query: 142 QSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQ 201
+ + +DNN S +P L + L +++L N
Sbjct: 244 RELHLDNNKLSR--VPAGLPD--------------------------LKLLQVVYLHTNN 275
Query: 202 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS-GPLPD-- 258
+ F I L +N +
Sbjct: 276 ITKVGVNDFCPVGFGV--------------------KRAYYNGISLFNNPVPYWEVQPAT 315
Query: 259 FSGVKQLESLSLRDN 273
F V ++ +
Sbjct: 316 FRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 61/334 (18%), Positives = 98/334 (29%), Gaps = 122/334 (36%)
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
L VV S+ +VP + + L ++ NN S + +
Sbjct: 34 HLRVVQCSDLGLKAVPKEISPDTTLL---DLQNNDISE--LRKD---------------- 72
Query: 176 ITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDV 235
F G L L L N++ S+I
Sbjct: 73 ------DFKG---LQHLYALVLVNNKI----------SKIHE----------------KA 97
Query: 236 IQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 294
+ L+++++ N P S L L + DN L ++ + M
Sbjct: 98 FSPLRKLQKLYISKNHLVEIPPNLPSS---LVELRIHDNRIRKVPKGVFSGLRNMNCIEM 154
Query: 295 TNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 354
N L+ + PGA D L + L R +E
Sbjct: 155 GGNPLE--------NSGF------------EPGAFDG-----LKLNYL-----RISEA-- 182
Query: 355 GNDPCSDWIGVTCTKGNITVI------NFQKMNLTG----TISPE-FASFKSLQRLILAD 403
+T I +++L I E + L RL L
Sbjct: 183 ----------------KLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGH 226
Query: 404 NNLSGMIPEG-LSVLGALKELDVSNNQLYGKIPS 436
N + MI G LS L L+EL + NN+L ++P+
Sbjct: 227 NQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPA 258
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 23/160 (14%), Positives = 51/160 (31%), Gaps = 20/160 (12%)
Query: 601 LGRGGFGTVYKGELHD---GTKIAVKRMEA-GVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
G ++ D ++A+ ++ GV+ L E S L+++ + +
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 657 LGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
L L+V E++ G+L + P+ + +A + A
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPV---GAIRAMQSLAAAADA----A 145
Query: 717 HQS-FIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755
H++ PS + + D +A +
Sbjct: 146 HRAGVALSIDHPSRVRVSIDGDVVLAYPAT--MPDANPQD 183
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 45/211 (21%), Positives = 79/211 (37%), Gaps = 42/211 (19%)
Query: 580 NMVISIQVLRNVTNNFSE-----ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGK 633
+ + Q ++ + +LG G G V + G K A+K ++
Sbjct: 11 GLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK-----LLYDS 65
Query: 634 GLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEE 688
+ E+ + H+V +L + + L++ E M G L I E
Sbjct: 66 PK--ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI---QER 120
Query: 689 GLKPLEWNRRLT------IALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAK 739
G ++ T I D+ +++LH + HRD+KP N+L D K
Sbjct: 121 G------DQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLK 171
Query: 740 VADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+ DFG + + ++T T Y+APE
Sbjct: 172 LTDFGFAKETTQNA--LQT-PCYTPYYVAPE 199
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 46/250 (18%), Positives = 95/250 (38%), Gaps = 34/250 (13%)
Query: 60 NHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLE 118
C + + + P + +R+ L N IS P S +L
Sbjct: 14 VTTSC-PQQGLQAV-----------PVGI--PAASQRIFLHGNRISHVPAASFRACRNLT 59
Query: 119 VVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQS-LRNASGLQNFSANSANIT 177
++ L +N + + FTGL+ L+ +++ +N + + L + +
Sbjct: 60 ILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR-SVDPATFHGLGRLHTLHLDRCGLQ 118
Query: 178 GQIPSFFGPDEFPGLT---ILHLAFNQLIGGLPA-SFSG-SQIQSLWVNGQNGNAKLGGG 232
++ P F GL L+L N + LP +F + L+++G N + +
Sbjct: 119 -ELG----PGLFRGLAALQYLYLQDNA-LQALPDDTFRDLGNLTHLFLHG-NRISSVPER 171
Query: 233 IDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLK 290
+ + SL + LH N + + F + +L +L L N + ++L L +L+
Sbjct: 172 --AFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228
Query: 291 IVNMTNNLLQ 300
+ + +N
Sbjct: 229 YLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 31/139 (22%), Positives = 54/139 (38%), Gaps = 27/139 (19%)
Query: 77 HQNLQGTLPSN-LQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDF 134
H N ++P + L L+RL L N ++ + L L + L N +++P++
Sbjct: 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220
Query: 135 FTGLSSLQSIEIDNNP---------FSSWEIPQSLRNASGLQNFSANSANITGQIPSFFG 185
L +LQ + +++NP +W LQ F +S+ +
Sbjct: 221 LAPLRALQYLRLNDNPWVCDCRARPLWAW-----------LQKFRGSSSEVPCS-----L 264
Query: 186 PDEFPGLTILHLAFNQLIG 204
P G + LA N L G
Sbjct: 265 PQRLAGRDLKRLAANDLQG 283
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 58/181 (32%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 658
LG G FG V GE G K+AVK + I + K EI L RH H++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY- 77
Query: 659 HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GV 709
+ +V EY+ G L +I + R+ AR V
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICK-----------HGRVEE--MEARRLFQQILSAV 124
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
+Y H +HRDLKP N+LL M AK+ADFGL + +G + T G+ Y AP
Sbjct: 125 DYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS-CGSPNYAAP 179
Query: 770 E 770
E
Sbjct: 180 E 180
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-20
Identities = 51/205 (24%), Positives = 78/205 (38%), Gaps = 45/205 (21%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFK----SEIA 643
R + F E + G+G FGTV G E G +A+K+ VI F+ +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK----VIQDP---RFRNRELQIMQ 71
Query: 644 VLTKVRHRHLVALLGHCL------DGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEW 695
L + H ++V L D + +V EY+P TL R N+
Sbjct: 72 DLAVLHHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR------- 122
Query: 696 NRRLTIAL------DVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRL 748
L + R + LH + HRD+KP N+L+ D K+ DFG +
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181
Query: 749 APEGKGSIE---TRIAGTFGYLAPE 770
+ ++ +R Y APE
Sbjct: 182 LSPSEPNVAYICSRY-----YRAPE 201
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 51/229 (22%), Positives = 84/229 (36%), Gaps = 36/229 (15%)
Query: 560 SETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGE-LHDGT 618
+ VP + + + + + +LG GGFG+VY G + D
Sbjct: 10 HSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 69
Query: 619 KIAVKRMEAGVISGKGLTEF----KSEIAVLTKVRHR--HLVALLGHCLDGNEKLLVFEY 672
+A+K +E IS G E+ +L KV ++ LL + +L+ E
Sbjct: 70 PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 129
Query: 673 -MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVEYLHGLAHQSFIHR 723
P L F++ + L ++AR V + H + +HR
Sbjct: 130 PEPVQDL----FDF-------ITERGALQ--EELARSFFWQVLEAVRHCH---NCGVLHR 173
Query: 724 DLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
D+K NIL+ + K+ DFG L + GT Y PE+
Sbjct: 174 DIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDF-DGTRVYSPPEW 219
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 48/181 (26%), Positives = 69/181 (38%), Gaps = 29/181 (16%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
LG G +G V +AVK ++ K EI + + H ++V GH
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGH 73
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVEY 711
+GN + L EY G L I + + A+ GV Y
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPE--PDAQRFFHQLMAGVVY 120
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK--GSIETRIAGTFGYLAP 769
LH HRD+KP N+LL + K++DFGL + + GT Y+AP
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAP 176
Query: 770 E 770
E
Sbjct: 177 E 177
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 44/237 (18%), Positives = 84/237 (35%), Gaps = 36/237 (15%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG---PLPSLNGLASLEVVMLSNNQ 126
TR+++ LQ LT+L +L L N +S S G SL+ + LS N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGP 186
++ S+F GL L+ ++ ++ + + S F
Sbjct: 90 VITMSSNF-LGLEQLEHLDFQHSNLKQ--MSE----------------------FSVF-- 122
Query: 187 DEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEI 245
L L ++ F+G S ++ L + G + + + +L +
Sbjct: 123 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD--IFTELRNLTFL 180
Query: 246 WLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300
L L F+ + L+ L++ N F L SL++++ + N +
Sbjct: 181 DLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 45/249 (18%), Positives = 78/249 (31%), Gaps = 73/249 (29%)
Query: 69 RITRIQIGHQNLQG---------------TLPSNLQNLTKLERLELQWNSIS--GPLPSL 111
++ Q+ G T+ SN L +LE L+ Q +++
Sbjct: 63 GLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 122
Query: 112 NGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSA 171
L +L + +S+ + F GLSSL+ +++ N F +P L+N
Sbjct: 123 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT---ELRN--- 176
Query: 172 NSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGG 231
LT L L+ QL Q+
Sbjct: 177 --------------------LTFLDLSQCQL----------EQLSP-------------- 192
Query: 232 GIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKL-ES 288
+++SL+ + + N F L + + L+ L N L S
Sbjct: 193 --TAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 249
Query: 289 LKIVNMTNN 297
L +N+T N
Sbjct: 250 LAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 35/192 (18%), Positives = 71/192 (36%), Gaps = 13/192 (6%)
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEI-PQSLRNASGLQNFSANS 173
+S + L +N+ S+P F L+ L + + +N S QS + L+ +
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS--FSG-SQIQSLWVNGQNGNAKLG 230
+ + S F L L + + + F + L ++
Sbjct: 88 NGVI-TMSSNF--LGLEQLEHLDFQHSN-LKQMSEFSVFLSLRNLIYLDISH-THTRVAF 142
Query: 231 GGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLES 288
G + ++SL+ + + N+F F+ ++ L L L P + L S
Sbjct: 143 NG--IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 200
Query: 289 LKIVNMTNNLLQ 300
L+++NM++N
Sbjct: 201 LQVLNMSHNNFF 212
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 30/182 (16%), Positives = 59/182 (32%), Gaps = 34/182 (18%)
Query: 77 HQNLQGTLPSN--LQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQF-TSVPS 132
+ + +L L L++ NGL+SLEV+ ++ N F +
Sbjct: 109 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 168
Query: 133 DFFTGLSSLQSIEIDNNPFSSWEIPQ-SLRNASGLQNFSANSANITGQIPSFFGPDEFPG 191
D FT L +L +++ + + + S LQ + + N +
Sbjct: 169 DIFTELRNLTFLDLSQCQLEQ--LSPTAFNSLSSLQVLNMSHNNFFSLDTFPY--KCLNS 224
Query: 192 LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251
L +L + N + + ++Q +SL + L N
Sbjct: 225 LQVLDYSLNHI-----MTSKKQELQHFP--------------------SSLAFLNLTQND 259
Query: 252 FS 253
F+
Sbjct: 260 FA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 51/250 (20%), Positives = 88/250 (35%), Gaps = 42/250 (16%)
Query: 186 PDEFP-GLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLK 243
P P T L L N+L F +Q+ L ++ NG + G TSLK
Sbjct: 23 PTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLS-SNGLSFKGCCSQSDFGTTSLK 81
Query: 244 EIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTG-PVPDSLVKLESLKIVNMTNNLLQG- 301
+ L N +F G++QLE L + + + L +L +++++ +
Sbjct: 82 YLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 141
Query: 302 PVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD 361
F+ SL++ K + N + + + L
Sbjct: 142 FNGIFNGLSSLEVLKMAGNSFQENFLP-----DIFTELRNL------------------- 177
Query: 362 WIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGAL 420
T ++ + L +SP F S SLQ L ++ NN + L +L
Sbjct: 178 -----------TFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 225
Query: 421 KELDVSNNQL 430
+ LD S N +
Sbjct: 226 QVLDYSLNHI 235
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-20
Identities = 48/189 (25%), Positives = 78/189 (41%), Gaps = 30/189 (15%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
++F +G+G FG V + +D K+ A+K M + + E+ ++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-- 707
LV L D E + +V + + G L H L+ N + +
Sbjct: 75 PFLVNLWYSFQD-EEDMFMVVDLLLGGDLRYH-----------LQQNVHFKE--ETVKLF 120
Query: 708 ------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 761
++YL Q IHRD+KP NILL + + DF + + P T +A
Sbjct: 121 ICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMA 175
Query: 762 GTFGYLAPE 770
GT Y+APE
Sbjct: 176 GTKPYMAPE 184
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 47/197 (23%), Positives = 82/197 (41%), Gaps = 25/197 (12%)
Query: 562 THTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKI 620
H + Q G+M +S + + LG G +G VYK + +
Sbjct: 3 HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETV 62
Query: 621 AVK--RMEA---GVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675
A+K R+E GV T + E+++L +++HR+++ L + L+FEY
Sbjct: 63 AIKRIRLEHEEEGVPG----TAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117
Query: 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL--- 732
L +++ + + + + GV + H + +HRDLKP N+LL
Sbjct: 118 -DLKKYM-----DKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVS 168
Query: 733 --GDDMRAKVADFGLVR 747
+ K+ DFGL R
Sbjct: 169 DASETPVLKIGDFGLAR 185
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 48/202 (23%), Positives = 76/202 (37%), Gaps = 24/202 (11%)
Query: 577 EAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKG 634
+ G + I Q + N+ +G G G V+K T IAVK+M +
Sbjct: 9 QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKM-RFRKTGHVIAVKQMRRSGNKEE- 66
Query: 635 LTEFKSEIAVLTK-VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPL 693
++ V+ K ++V G + + + E M P+
Sbjct: 67 NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK-----RMQGPI 121
Query: 694 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG----LVRLA 749
+ + + + + YL IHRD+KPSNILL + + K+ DFG LV
Sbjct: 122 PERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-- 177
Query: 750 PEGKGSI-ETRIAGTFGYLAPE 770
+ R AG Y+APE
Sbjct: 178 -----DKAKDRSAGCAAYMAPE 194
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 9e-20
Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGELHD-GTKIAVK--RMEA--GVISGKGLTEFKSEIAVLTK 647
+ + + LG G + TVYKG+ +A+K R+E G T + E+++L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC----TAIR-EVSLLKD 56
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
++H ++V L LVFEY+ + L +++ ++ + + + R
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL----DDCGNIINMHNVKLFLFQLLR 111
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
G+ Y H Q +HRDLKP N+L+ + K+ADFGL R
Sbjct: 112 GLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 51/211 (24%), Positives = 83/211 (39%), Gaps = 40/211 (18%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
++ ++GRG FG V K+ A+K + +I F E ++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-- 707
+V L + + L +V EYMP G L + + AR
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM--------------SNYDVPEKWARFY 173
Query: 708 ------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRI 760
++ +H + FIHRD+KP N+LL K+ADFG +++ EG +T
Sbjct: 174 TAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-A 229
Query: 761 AGTFGYLAPE-------YAVHTRWSSCSYWA 784
GT Y++PE + R C +W+
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGR--ECDWWS 258
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 50/186 (26%), Positives = 78/186 (41%), Gaps = 21/186 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRH 650
++F ++GRG F V ++ ++ A+K M + +G F+ E VL
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR----RLTIALDV 705
R + L L LV EY G L + P E R + +A+
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAI-- 175
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL-VRLAPEGKGSIETRIAGTF 764
+ +H L ++HRD+KP NILL ++ADFG ++L +G GT
Sbjct: 176 ----DSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTP 227
Query: 765 GYLAPE 770
YL+PE
Sbjct: 228 DYLSPE 233
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 58/181 (32%), Positives = 79/181 (43%), Gaps = 30/181 (16%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 658
LG G FG V G+ G K+AVK + I + + EI L RH H++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY- 82
Query: 659 HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GV 709
+ + +V EY+ G L +I N RL +R GV
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICK-----------NGRLDE--KESRRLFQQILSGV 129
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
+Y H +HRDLKP N+LL M AK+ADFGL + +G + T G+ Y AP
Sbjct: 130 DYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS-CGSPNYAAP 184
Query: 770 E 770
E
Sbjct: 185 E 185
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 48/193 (24%), Positives = 70/193 (36%), Gaps = 48/193 (24%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRM------EAGVISGKGLTEFKSEIAVLTKVRHRHL 653
LG G FG V+ ++ VK + E I L + EIA+L++V H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 654 VALLGHCLDGNEKL-LVFEYMPQG---------------TLSRHIFNWAEEGLKPLEWNR 697
+ +L + LV E G L+ +IF
Sbjct: 92 IKVL-DIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR------------- 137
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 757
+ V YL + IHRD+K NI++ +D K+ DFG G
Sbjct: 138 ------QLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFY 187
Query: 758 TRIAGTFGYLAPE 770
T GT Y APE
Sbjct: 188 T-FCGTIEYCAPE 199
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 47/189 (24%), Positives = 74/189 (39%), Gaps = 36/189 (19%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRME----AGVISGKGLTEFKSEIAVLTKVR----HR 651
LG+GGFGTV+ G L D ++A+K + G E+A+L KV H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR---- 707
++ LL +LV E + +F++ + L +R
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPA---QDLFDY-------ITEKGPLG--EGPSRCFFG 146
Query: 708 ----GVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIETRIAG 762
+++ H + +HRD+K NIL+ AK+ DFG L + G
Sbjct: 147 QVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTD-FDG 200
Query: 763 TFGYLAPEY 771
T Y PE+
Sbjct: 201 TRVYSPPEW 209
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 27/170 (15%)
Query: 593 NNFSEENILGRGGFGTVYKG--ELHDGTKIAVK--RMEA---GVISGKGLTEFKSEIAVL 645
+ +G G +G V+K + G +A+K R++ G+ + + E+AVL
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL----STIR-EVAVL 65
Query: 646 ---TKVRHRHLVALL----GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR 697
H ++V L D KL LVFE++ Q L+ ++ E G+
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT---ET 121
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ + RG+++LH +HRDLKP NIL+ + K+ADFGL R
Sbjct: 122 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-19
Identities = 52/186 (27%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKVRH 650
+F ++GRG FG V +L + K+ A+K + + + T F+ E VL
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR----RLTIALDV 705
+ + L D + L LV +Y G L + + E P E R + IA+
Sbjct: 134 KWITTLHYAFQD-DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAI-- 188
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA-GTF 764
+ +H L ++HRD+KP NIL+ + ++ADFG E G++++ +A GT
Sbjct: 189 ----DSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTP 240
Query: 765 GYLAPE 770
Y++PE
Sbjct: 241 DYISPE 246
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 4e-19
Identities = 39/159 (24%), Positives = 60/159 (37%), Gaps = 16/159 (10%)
Query: 623 KRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI 682
+ + + S + +I + ++ V L + + + L +
Sbjct: 93 ESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM 152
Query: 683 FNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742
L+ E L I + +A VE+LH + +HRDLKPSNI D KV D
Sbjct: 153 NR--RCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD 207
Query: 743 FGLVR-----------LAPEGKGSIETRIAGTFGYLAPE 770
FGLV L P + T GT Y++PE
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 5e-19
Identities = 47/264 (17%), Positives = 91/264 (34%), Gaps = 39/264 (14%)
Query: 57 CKWNHVVCIEDKRITRIQIG----------HQNLQGTLPSN-LQNLTKLERLELQWNSIS 105
C +C ++ ++T I + LE++E+ N +
Sbjct: 9 CSNRVFLC-QESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 67
Query: 106 GPLPS--LNGLASLEVVMLSN-NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRN 162
+ + + L L + + N + + F L +LQ + I N +P +
Sbjct: 68 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH--LP-DVHK 124
Query: 163 ASGLQNFS---ANSANITGQIPSFFGPDEFPGLT----ILHLAFNQLIGGLPASFSGSQI 215
LQ ++ NI I + F GL+ IL L N + ++F+G+Q+
Sbjct: 125 IHSLQKVLLDIQDNINIH-TIE----RNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQL 179
Query: 216 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDN 273
L ++ N +L + + + + LP +K+L + S N
Sbjct: 180 DELNLSDNNNLEELPNDV--FHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTY-N 235
Query: 274 FFTGPVPDSLVKLESLKIVNMTNN 297
P + LV L ++T
Sbjct: 236 LKKLPTLEKLVALMEA---SLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 28/193 (14%), Positives = 56/193 (29%), Gaps = 14/193 (7%)
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174
+ + + + F+G L+ IEI N N L A
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 175 NITGQIPSFFGPDEF---PGLTILHLAFNQLIGGLPASFSGS-QIQSLWVNGQNGNAKLG 230
N + + P+ F P L L ++ + S Q L + +
Sbjct: 90 N---NL-LYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 145
Query: 231 GGIDVIQNMTS-LKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLE 287
++ +WL+ N + + F+G + E +N D
Sbjct: 146 RN--SFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGAS 202
Query: 288 SLKIVNMTNNLLQ 300
I++++ +
Sbjct: 203 GPVILDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 36/200 (18%), Positives = 64/200 (32%), Gaps = 24/200 (12%)
Query: 240 TSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVP----DSLVKLESLKIVNM 294
+ E+ FSG LE + + N + +L KL ++I
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK- 88
Query: 295 TNNLLQGPVPEFDRSVSLDMAKGSNN--FCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 352
NNLL F +L SN LP L ++ + +N
Sbjct: 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLP-DVHKIHSLQ--KVLLDI-------QDN 138
Query: 353 WKGND-PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 411
+ + ++G++ ++ K + I + L L L+DNN +P
Sbjct: 139 INIHTIERNSFVGLS---FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELP 194
Query: 412 EG-LSVLGALKELDVSNNQL 430
LD+S ++
Sbjct: 195 NDVFHGASGPVILDISRTRI 214
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-19
Identities = 62/237 (26%), Positives = 100/237 (42%), Gaps = 12/237 (5%)
Query: 537 SGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFS 596
+ E E ++ + S P D E + ++ R N F
Sbjct: 92 TPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFE 151
Query: 597 EENILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKVRHRHLV 654
+LG+G FG V + + A+K ++ VI K +E VL RH L
Sbjct: 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 655 ALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
AL + +++L V EY G L H+ + E + E R A ++ ++YLH
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGGELFFHL---SRERVFS-EDRARFYGA-EIVSALDYLH 265
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
++ ++RDLK N++L D K+ DFGL + + +++T GT YLAPE
Sbjct: 266 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPE 319
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 90.2 bits (223), Expect = 8e-19
Identities = 40/223 (17%), Positives = 85/223 (38%), Gaps = 23/223 (10%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+ + L+ S++ + N L S++ ++ +N+ SV L ++ +
Sbjct: 15 FPDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLF 71
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL--I 203
++ N + + +L+N L N +I + L L L N + I
Sbjct: 72 LNGNKLTDIKPLTNLKNLGWL-FLDEN------KIKDLSSLKDLKKLKSLSLEHNGISDI 124
Query: 204 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVK 263
GL Q++SL++ I V+ +T L + L N S + +G+
Sbjct: 125 NGLVHL---PQLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQISD-IVPLAGLT 175
Query: 264 QLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 306
+L++L L N + +L L++L ++ + +
Sbjct: 176 KLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINH 216
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 77.1 bits (189), Expect = 8e-15
Identities = 42/226 (18%), Positives = 76/226 (33%), Gaps = 57/226 (25%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+Q L + +L L N ++ + L L +L + L N+ + L L+S+
Sbjct: 59 QGIQYLPNVTKLFLNGNKLTD-IKPLTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLS 115
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL--- 202
+++N + + +GL + P L L+L N++
Sbjct: 116 LEHNG---------ISDINGLVH--------------------LPQLESLYLGNNKITDI 146
Query: 203 --IGGLPA----SFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL 256
+ L S +QI I + +T L+ ++L N S L
Sbjct: 147 TVLSRLTKLDTLSLEDNQISD---------------IVPLAGLTKLQNLYLSKNHIS-DL 190
Query: 257 PDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302
+G+K L+ L L + L V T+ L P
Sbjct: 191 RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 236
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 6e-06
Identities = 50/287 (17%), Positives = 103/287 (35%), Gaps = 65/287 (22%)
Query: 179 QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQN 238
I F D F +L + + I + N + + G IQ
Sbjct: 10 PIKQIFPDDAFAETIKDNLKKKS-VTDAVTQNELNSIDQIIANN-SDIKSVQG----IQY 63
Query: 239 MTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPD--SLVKLESLKIVNMTN 296
+ ++ +++L+ N + + + +K L L L +N + D SL L+ LK +++ +
Sbjct: 64 LPNVTKLFLNGNKLTD-IKPLTNLKNLGWLFLDEN----KIKDLSSLKDLKKLKSLSLEH 118
Query: 297 NLLQ--GPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 354
N + + + SL + NN ++ + + +L
Sbjct: 119 NGISDINGLVHLPQLESLYL---GNN-----------KITDITVLSRLT----------- 153
Query: 355 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 414
+ ++ + ++ I P A LQ L L+ N++S + L
Sbjct: 154 ----------------KLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISDL--RAL 193
Query: 415 SVLGALKELDVSNNQLYGKIPSFKS-----NAIVNTDGNPDIGKEKS 456
+ L L L++ + + K + +S N + NTDG+ + S
Sbjct: 194 AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 7e-04
Identities = 29/193 (15%), Positives = 57/193 (29%), Gaps = 54/193 (27%)
Query: 242 LKEIWLHSNAFS--GPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
+ E S P F + +L+ T V +L S+ + N+ +
Sbjct: 1 MGETITVSTPIKQIFPDDAF---AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI 55
Query: 300 Q--GPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 357
+ + L + + N +L + + L
Sbjct: 56 KSVQGIQYLPNVTKLFL---NGN-----------KLTDIKPLTNL--------------- 86
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL 417
N+ + + + +S K L+ L L N +S + GL L
Sbjct: 87 ------------KNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISDI--NGLVHL 130
Query: 418 GALKELDVSNNQL 430
L+ L + NN++
Sbjct: 131 PQLESLYLGNNKI 143
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 31/181 (17%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRHRHLVALLG 658
LG G FG V K+A+K + ++ + + EI+ L +RH H++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY- 75
Query: 659 HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GV 709
+ + +V EY G L +I +R+T D R +
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVE-----------KKRMTE--DEGRRFFQQIICAI 121
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
EY H +HRDLKP N+LL D++ K+ADFGL + +G ++T G+ Y AP
Sbjct: 122 EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTS-CGSPNYAAP 176
Query: 770 E 770
E
Sbjct: 177 E 177
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 62/361 (17%), Positives = 122/361 (33%), Gaps = 47/361 (13%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGL 138
+Q T + + L L L+ +SI+ + + L L ++ ++N T++ +
Sbjct: 29 EMQATDTISEEQLATLTSLDCHNSSITD-MTGIEKLTGLTKLICTSNNITTLD---LSQN 84
Query: 139 SSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLA 198
++L + D+N ++ + + + L + ++ +T + P LT L+ A
Sbjct: 85 TNLTYLACDSNKLTN--LD--VTPLTKLTYLNCDTNKLTK-----LDVSQNPLLTYLNCA 135
Query: 199 FNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD 258
N L S L + N K+ + T L + N + D
Sbjct: 136 RNTL-----TEIDVSHNTQLTELDCHLNKKI--TKLDVTPQTQLTTLDCSFNKITE--LD 186
Query: 259 FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGS 318
S K L L+ N T + ++L L + N L + V + D S
Sbjct: 187 VSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSS--NKLTEIDVTPLTQLTYFDC---S 241
Query: 319 NNFCLPSPGACDPRLNAL---------LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTK 369
N + +L L + + AE + + VT
Sbjct: 242 VNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKE----LDVTHNT 297
Query: 370 GNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ 429
+ +++ Q +T + + L L L + L+ + +S LK L N
Sbjct: 298 -QLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAH 350
Query: 430 L 430
+
Sbjct: 351 I 351
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 39/233 (16%), Positives = 74/233 (31%), Gaps = 42/233 (18%)
Query: 87 NLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146
++ + T+L L+ N L + L + S N+ T + + L +
Sbjct: 143 DVSHNTQLTELDCHLNKKITKLD-VTPQTQLTTLDCSFNKITELD---VSQNKLLNRLNC 198
Query: 147 DNNPFSSWEIPQ-----------------SLRNASGLQNFSANSANITGQIPSFFGPDEF 189
D N + ++ Q + + L F + +T S
Sbjct: 199 DTNNITKLDLNQNIQLTFLDCSSNKLTEIDVTPLTQLTYFDCSVNPLTELDVS-----TL 253
Query: 190 PGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS 249
LT LH L+ + + + +Q+ G +L + + T L + +
Sbjct: 254 SKLTTLHCIQTDLL-EIDLTHN-TQLIYFQAEGCRKIKELD-----VTHNTQLYLLDCQA 306
Query: 250 NAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSL--VKLESLKIVNMTNNLLQ 300
+ L D S +L L L + T L LK ++ N +Q
Sbjct: 307 AGIT-EL-DLSQNPKLVYLYLNNTELT-----ELDVSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 28/226 (12%), Positives = 63/226 (27%), Gaps = 49/226 (21%)
Query: 87 NLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146
+L +L L+ N ++ + + L L S N T + + LS L ++
Sbjct: 207 DLNQNIQLTFLDCSSNKLTE-ID-VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHC 261
Query: 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL---- 202
++ + + L F A ++ L +L +
Sbjct: 262 IQTDLLEIDLTHNTQ----LIYFQAEGCRKIKELDV----THNTQLYLLDCQAAGITELD 313
Query: 203 IGGLPA----SFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD 258
+ P + +++ L + + T LK + +
Sbjct: 314 LSQNPKLVYLYLNNTELTEL----------------DVSHNTKLKSLSCVNAHIQD-FSS 356
Query: 259 FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304
+ L + + + ++ +TNN L V
Sbjct: 357 VGKIPALNNNFEAEG-----------QTITMPKETLTNNSLTIAVS 391
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 34/219 (15%), Positives = 69/219 (31%), Gaps = 41/219 (18%)
Query: 89 QNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148
N + + S LA+L + N+ T + L+ L + +
Sbjct: 18 DNFASEVAAAFEMQATD--TISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTS 73
Query: 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL----IG 204
N ++ + L + L + +S +T + LT L+ N+L +
Sbjct: 74 NNITT--LD--LSQNTNLTYLACDSNKLT-NLD----VTPLTKLTYLNCDTNKLTKLDVS 124
Query: 205 GLPA----SFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFS 260
P + + + + + + + T L E+ H N D +
Sbjct: 125 QNPLLTYLNCARNTLTEI----------------DVSHNTQLTELDCHLNKKI-TKLDVT 167
Query: 261 GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299
QL +L N T + + + L +N N +
Sbjct: 168 PQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNI 203
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 47/262 (17%), Positives = 81/262 (30%), Gaps = 39/262 (14%)
Query: 170 SANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAK 228
+ A T +F D F S + + SL + +
Sbjct: 1 NTLKAGQTQSFNDWFPDDNFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITD- 56
Query: 229 LGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLES 288
+ I+ +T L ++ SN + D S L L+ N T L KL
Sbjct: 57 ----MTGIEKLTGLTKLICTSNNITTL--DLSQNTNLTYLACDSNKLTNLDVTPLTKLTY 110
Query: 289 LKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQR 348
L N L + V + L+ + N L+ + + Q
Sbjct: 111 LNCDT--NKLTKLDVSQNPLLTYLNC---ARN---------------TLTEIDVSHNTQL 150
Query: 349 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG 408
+ N + T +T ++ +T + + K L RL NN++
Sbjct: 151 TELDCHLNKKITKLDVTPQT--QLTTLDCSFNKIT---ELDVSQNKLLNRLNCDTNNIT- 204
Query: 409 MIPEGLSVLGALKELDVSNNQL 430
+ L+ L LD S+N+L
Sbjct: 205 KLD--LNQNIQLTFLDCSSNKL 224
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 17/99 (17%), Positives = 34/99 (34%), Gaps = 8/99 (8%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGL 138
+ ++ + T+L L+ Q I+ L L+ L + L+N + T + +
Sbjct: 284 GCRKIKELDVTHNTQLYLLDCQAAGIT-ELD-LSQNPKLVYLYLNNTELTELD---VSHN 338
Query: 139 SSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANIT 177
+ L+S+ N S+ L N
Sbjct: 339 TKLKSLSCVNAHIQD--FS-SVGKIPALNNNFEAEGQTI 374
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 45/176 (25%), Positives = 74/176 (42%), Gaps = 41/176 (23%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVK--RMEAGVISGKGLTE---FKS----EI 642
+ + + +G+G FG V+K G K+A+K ME E F EI
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME---------NEKEGFPITALREI 67
Query: 643 AVLTKVRHRHLVALLGHCLDGNEKL--------LVFEYMPQ---GTLSRHIFNWAEEGLK 691
+L ++H ++V L+ C LVF++ G LS + + +K
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 127
Query: 692 PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
+ + G+ Y+H +HRD+K +N+L+ D K+ADFGL R
Sbjct: 128 --------RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR 172
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 2e-18
Identities = 41/268 (15%), Positives = 84/268 (31%), Gaps = 43/268 (16%)
Query: 84 LPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQS 143
S K N L + + L+ +S+P + +
Sbjct: 29 YFSAWDKWEKQALPGENRNEAVSLLKECL-INQFSELQLNRLNLSSLPDNLP---PQITV 84
Query: 144 IEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFG---------------PDE 188
+EI N S +P+ + L+ A ++ +P P+
Sbjct: 85 LEITQNALIS--LPELPAS---LEYLDACDNRLS-TLPELPASLKHLDVDNNQLTMLPEL 138
Query: 189 FPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH 248
L ++ NQL LP + ++ L V N +L + + SL+ + +
Sbjct: 139 PALLEYINADNNQL-TMLPELPT--SLEVLSVR----NNQLT---FLPELPESLEALDVS 188
Query: 249 SNAFSGPLPDFSG-----VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN-LLQGP 302
+N LP + R+N T +P++++ L+ + + +N L
Sbjct: 189 TNLLES-LPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRI 246
Query: 303 VPEFDRSVSLDMAKGSNNFCLPSPGACD 330
+ + G + S G +
Sbjct: 247 RESLSQQTAQPDYHGPRIYFSMSDGQQN 274
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 3e-16
Identities = 49/271 (18%), Positives = 103/271 (38%), Gaps = 28/271 (10%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127
+ + +Q+ NL +LP NL ++ LE+ N++ LP L ASLE + +N+
Sbjct: 59 NQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPEL--PASLEYLDACDNRL 112
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
+++P +SL+ +++DNN + +P+ L+ +A++ +T +P +
Sbjct: 113 STLPEL----PASLKHLDVDNNQLTM--LPELPAL---LEYINADNNQLT-MLP-----E 157
Query: 188 EFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL-KEIW 246
L +L + NQL LP +++L V+ N L +
Sbjct: 158 LPTSLEVLSVRNNQL-TFLPELPE--SLEALDVST-NLLESLPAVPVRNHHSEETEIFFR 213
Query: 247 LHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305
N + +P+ + ++ L DN + + +SL + + + +
Sbjct: 214 CRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272
Query: 306 FDRSVSLDMAKGSNNFCLPSPGACDPRLNAL 336
+ + F +A
Sbjct: 273 QNTLHRPLADAVTAWFPENKQSDVSQIWHAF 303
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 49/241 (20%), Positives = 80/241 (33%), Gaps = 61/241 (25%)
Query: 192 LTILHLAFNQLIGGLPASFSG--SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS 249
++ +F I G A + + + + G+N N + + + + E+ L+
Sbjct: 11 FSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNR 68
Query: 250 NAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS 309
S LPD Q+ L + N +P+ LE L + N L P
Sbjct: 69 LNLSS-LPDNLP-PQITVLEITQNALI-SLPELPASLEYLDACD--NRLSTLP-ELPASL 122
Query: 310 VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTK 369
LD+ NN +L L +
Sbjct: 123 KHLDV---DNN-----------QLTMLPELP----------------------------- 139
Query: 370 GNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ 429
+ IN LT PE SL+ L + +N L+ +PE + +L+ LDVS N
Sbjct: 140 ALLEYINADNNQLTML--PE--LPTSLEVLSVRNNQLTF-LPE---LPESLEALDVSTNL 191
Query: 430 L 430
L
Sbjct: 192 L 192
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 55/189 (29%), Positives = 74/189 (39%), Gaps = 32/189 (16%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
+ F LG G FG V + + A+K ++ V+ K + +E +L V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-- 707
LV L D N L +V EY+ G + H L R + AR
Sbjct: 101 PFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSH-----------LRRIGRFSE--PHARFY 146
Query: 708 ------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 761
EYLH I+RDLKP N+L+ +V DFG A KG T +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFG---FAKRVKGRTWT-LC 199
Query: 762 GTFGYLAPE 770
GT LAPE
Sbjct: 200 GTPEALAPE 208
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 48/181 (26%), Positives = 67/181 (37%), Gaps = 32/181 (17%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659
+G G FG +AVK +E G + + + EI +RH ++V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV---QREIINHRSLRHPNIVRFKEV 84
Query: 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GVEY 711
L ++ EY G L I N R + D AR GV Y
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICN-----------AGRFSE--DEARFFFQQLLSGVSY 131
Query: 712 LHGLAHQSFIHRDLKPSNILL--GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
H HRDLK N LL R K+ DFG + + ++ + GT Y+AP
Sbjct: 132 CH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAP 186
Query: 770 E 770
E
Sbjct: 187 E 187
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 43/251 (17%), Positives = 84/251 (33%), Gaps = 40/251 (15%)
Query: 539 SENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSE- 597
+ +S + + P ++P + + + +
Sbjct: 4 NSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDY 63
Query: 598 ---ENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRH 652
+LG G G V + K A+K ++ + + E+ + + + H
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDC--PKARREVELHWRASQCPH 116
Query: 653 LVALLGHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IA 702
+V ++ + L+V E + G L I + G ++ T I
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ---DRG------DQAFTEREASEIM 167
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETR 759
+ ++YLH + HRD+KP N+L + K+ DFG + + T
Sbjct: 168 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTT- 222
Query: 760 IAGTFGYLAPE 770
T Y+APE
Sbjct: 223 PCYTPYYVAPE 233
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 38/217 (17%), Positives = 86/217 (39%), Gaps = 29/217 (13%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+ + + L+ S++ + N L S++ ++ +N+ SV L ++ +
Sbjct: 18 FSDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLF 74
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL--- 202
++ N + + +L+N L N ++ + L L L N +
Sbjct: 75 LNGNKLTDIKPLANLKNLGWL-FLDEN------KVKDLSSLKDLKKLKSLSLEHNGISDI 127
Query: 203 --IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFS 260
+ LP Q++SL++ I V+ +T L + L N S + +
Sbjct: 128 NGLVHLP------QLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQISD-IVPLA 175
Query: 261 GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
G+ +L++L L N + +L L++L ++ + +
Sbjct: 176 GLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQ 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 31/118 (26%), Positives = 56/118 (47%), Gaps = 10/118 (8%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
S+L++L KL+ L L+ N IS + L L LE + L NN+ T + + L+ L ++
Sbjct: 106 SSLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLS 162
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI 203
+++N S I L + LQN + +I+ + + L +L L + +
Sbjct: 163 LEDNQISD--IV-PLAGLTKLQNLYLSKNHIS-DLRAL---AGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 31/135 (22%), Positives = 54/135 (40%), Gaps = 19/135 (14%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
L LTKL+ L L N IS L +L GL +L+V+ L + + + P + + L +++
Sbjct: 172 VPLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 230
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI-- 203
+ + P+ + + + N+ +P F + F Q +
Sbjct: 231 NTDGSLVT---PEIISDDGDYEK-----PNVKWHLPEFTN--------EVSFIFYQPVTI 274
Query: 204 GGLPASFSGSQIQSL 218
G A F G Q L
Sbjct: 275 GKAKARFHGRVTQPL 289
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 7e-18
Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 25/180 (13%)
Query: 601 LGRGGFGTVY---KGELHDGTKI-AVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
LG+G FG V+ K D ++ A+K ++ + + K E +L +V H +V L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 657 LGH-CLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR----RLTIALDVARGVE 710
H KL L+ +++ G L + ++E + E + L +AL +
Sbjct: 92 --HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALAL------D 140
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+LH L I+RDLKP NILL ++ K+ DFGL + + + + + GT Y+APE
Sbjct: 141 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPE 196
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 8e-18
Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 32/189 (16%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKI-AVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
+F LG G FG V+ + A+K ++ V+ K + E +L+ V H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 651 RHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR-- 707
++ + G D +++ ++ +Y+ G L L ++R VA+
Sbjct: 66 PFIIRMWGTFQD-AQQIFMIMDYIEGGELFSL-----------LRKSQRFPN--PVAKFY 111
Query: 708 ------GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA 761
+EYLH + I+RDLKP NILL + K+ DFG A T +
Sbjct: 112 AAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFG---FAKYVPDVTYT-LC 164
Query: 762 GTFGYLAPE 770
GT Y+APE
Sbjct: 165 GTPDYIAPE 173
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 42/254 (16%), Positives = 90/254 (35%), Gaps = 39/254 (15%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127
+I G N+ T +L + L ++ + + L +L + L +NQ
Sbjct: 19 ANAIKIAAGKSNV--TDTVTQADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQI 75
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187
T + L+ + +E+ NP + L++ ++ S IT +
Sbjct: 76 TDLAP--LKNLTKITELELSGNPLKNVSAIAGLQS---IKTLDLTSTQIT-DVTPL---A 126
Query: 188 EFPGLTILHLAFNQL-----IGGLPA----SFSGSQIQSLWVNGQNGNAKLGGGIDVIQN 238
L +L+L NQ+ + GL S +Q+ + + N
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD---------------LTPLAN 171
Query: 239 MTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 298
++ L + N S + + + L + L++N + L +L IV +TN
Sbjct: 172 LSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQIS--DVSPLANTSNLFIVTLTNQT 228
Query: 299 LQGPVPEFDRSVSL 312
+ ++ ++ +
Sbjct: 229 ITNQPVFYNNNLVV 242
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 43/224 (19%), Positives = 83/224 (37%), Gaps = 30/224 (13%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+Q L L LEL+ N I+ L L L + + LS N +V + GL S+++++
Sbjct: 57 EGVQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLD 113
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL--- 202
+ + + L S LQ + IT I L L + Q+
Sbjct: 114 LTSTQITDVT---PLAGLSNLQVLYLDLNQIT-NISPL---AGLTNLQYLSIGNAQVSDL 166
Query: 203 --IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFS 260
+ L ++ +L + N + I + ++ +L E+ L +N S + +
Sbjct: 167 TPLANLS------KLTTLKADD-NKISD----ISPLASLPNLIEVHLKNNQISD-VSPLA 214
Query: 261 GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304
L ++L + T + +L + N+ P+
Sbjct: 215 NTSNLFIVTLTNQTITNQ---PVFYNNNLVVPNVVKGPSGAPIA 255
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 33/212 (15%), Positives = 77/212 (36%), Gaps = 19/212 (8%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
L ++ ++++ + L + + T++ L++L +E
Sbjct: 13 FPDPALANAIKIAAGKSNVTD-TVTQADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLE 69
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205
+ +N + L+N + + + + + + L L Q I
Sbjct: 70 LKDNQITD---LAPLKNLTKITELELSGNPLK----NVSAIAGLQSIKTLDLTSTQ-ITD 121
Query: 206 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 265
+ S +Q L+++ N I + +T+L+ + + + S L + + +L
Sbjct: 122 VTPLAGLSNLQVLYLDL-NQITN----ISPLAGLTNLQYLSIGNAQVSD-LTPLANLSKL 175
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+L DN + P L L +L V++ NN
Sbjct: 176 TTLKADDNKISDISP--LASLPNLIEVHLKNN 205
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 47/236 (19%), Positives = 83/236 (35%), Gaps = 42/236 (17%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
S + L ++ L+L I+ + L GL++L+V+ L NQ T++ GL++LQ +
Sbjct: 101 SAIAGLQSIKTLDLTSTQITD-VTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLS 157
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205
I N S L N S L A+ I+ I P L +HL NQ+
Sbjct: 158 IGNAQVSDLT---PLANLSKLTTLKADDNKIS-DISPL---ASLPNLIEVHLKNNQIS-- 208
Query: 206 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 265
+ + N ++L + L + + P F +
Sbjct: 209 --------------------------DVSPLANTSNLFIVTLTNQTITN-QPVFYNNNLV 241
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP---VPEFDRSVSLDMAKGS 318
++ P ++ + N+T NL F++SV+
Sbjct: 242 VPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVP 297
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 47/351 (13%), Positives = 102/351 (29%), Gaps = 107/351 (30%)
Query: 102 NSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLR 161
+I+ P LA+ + + T + L + ++ +
Sbjct: 7 TAINVIFP-DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGT---------GVT 54
Query: 162 NASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVN 221
G+Q L L L NQ+
Sbjct: 55 TIEGVQYL--------------------NNLIGLELKDNQITD----------------- 77
Query: 222 GQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPD 281
+ ++N+T + E+ L N + +G++ +++L L T P
Sbjct: 78 -----------LAPLKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITDVTP- 124
Query: 282 SLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVK 341
L L +L+++ + N + + +L N +++ L +
Sbjct: 125 -LAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNA-----------QVSDLTPLAN 171
Query: 342 LMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLIL 401
L +T + ++ ISP AS +L + L
Sbjct: 172 L---------------------------SKLTTLKADDNKIS-DISP-LASLPNLIEVHL 202
Query: 402 ADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN-AIVNTDGNPDI 451
+N +S + L+ L + ++N + + + +N + N P
Sbjct: 203 KNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSG 251
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 44/198 (22%), Positives = 73/198 (36%), Gaps = 30/198 (15%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKS--------- 640
+ + ++ + + G +G V G +G +A+KR+ V G+ +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 641 EIAVLTKVRHRHLVALL-----GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEW 695
EI +L H +++ L ++ LV E M + L++ I + +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVI----HDQRIVISP 133
Query: 696 NRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755
+ G+ LH A +HRDL P NILL D+ + DF L R
Sbjct: 134 QHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 756 IE---TRIAGTFGYLAPE 770
R Y APE
Sbjct: 191 THYVTHRW-----YRAPE 203
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 54/375 (14%), Positives = 103/375 (27%), Gaps = 51/375 (13%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFT 128
T + I + S++ +L+KL L + N I + LE + LS+N+
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 129 SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDE 188
+ +L+ +++ N F + +P I F
Sbjct: 83 KISCH---PTVNLKHLDLSFNAFDA--LP----------------------ICKEF--GN 113
Query: 189 FPGLTILHLAFNQLIGGLPASFSGSQIQSLWVN-GQNGNAKLGGGIDVIQNMTSLKEIWL 247
L L L+ L + I + + G+ K N SL ++
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173
Query: 248 HSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLE-----------SLKIVNMT 295
+ F L V LE +++ L L +L + T
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233
Query: 296 NNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 355
N + + + + L + +
Sbjct: 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSI--------HQVVS 285
Query: 356 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLS 415
+ + N+ + NF + L ++N L+ + E
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG 345
Query: 416 VLGALKELDVSNNQL 430
L L+ L + NQL
Sbjct: 346 HLTELETLILQMNQL 360
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 7e-17
Identities = 48/371 (12%), Positives = 110/371 (29%), Gaps = 43/371 (11%)
Query: 83 TLPSNLQNLTKLERLELQWNSIS--GPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSS 140
+ L+ L+L +N+ ++ L+ + LS L+
Sbjct: 83 KISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNI 140
Query: 141 LQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFN 200
+ + + + E P+ L++ + N L + ++
Sbjct: 141 SKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200
Query: 201 QLIGGLPASFS-------GSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253
S ++ +L +N I + T++ + +
Sbjct: 201 LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260
Query: 254 GPLP------DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEF 306
G L + +K L + + F P ++ I N T + + +
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320
Query: 307 DRSVS---LDMAKGSNNFCLPSPGACD--PRLNAL-LSVVKLMGYPQRFAENWKGNDPCS 360
+ LD +N C L L L + +L +
Sbjct: 321 SKISPFLHLDF--SNNLLTDTVFENCGHLTELETLILQMNQLKELSKIA----------- 367
Query: 361 DWIGVTCTKGNITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGA 419
+T ++ ++ + +++ + KSL L ++ N L+ I L
Sbjct: 368 ---EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR-- 422
Query: 420 LKELDVSNNQL 430
+K LD+ +N++
Sbjct: 423 IKVLDLHSNKI 433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 5e-16
Identities = 32/214 (14%), Positives = 75/214 (35%), Gaps = 15/214 (7%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSI-SGPLPSLNGLASLEVVMLSNNQ 126
K ++ Q+ + + + + + + ++ + SNN
Sbjct: 276 KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNL 335
Query: 127 FTSVPSDFFTGLSSLQSIEIDNNPFSS-WEIPQSLRNASGLQ--NFSANSANITGQIPSF 183
T + L+ L+++ + N +I + LQ + S NS + +
Sbjct: 336 LTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDC 395
Query: 184 FGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLK 243
L L+++ N L + +I+ L ++ N + + + +L+
Sbjct: 396 SWT---KSLLSLNMSSNILTDTIFRCLP-PRIKVLDLH-SNKIKSIPKQVV---KLEALQ 447
Query: 244 EIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFF 275
E+ + SN +PD F + L+ + L N +
Sbjct: 448 ELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 44/321 (13%), Positives = 85/321 (26%), Gaps = 43/321 (13%)
Query: 119 VVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITG 178
+V S N VP D + I N S + + S L+ + I
Sbjct: 4 LVDRSKNGLIHVPKDLSQ---KTTILNISQNYISELW-TSDILSLSKLRILIISHNRIQY 59
Query: 179 QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQN 238
S F L L L+ N+L +
Sbjct: 60 LDISVF--KFNQELEYLDLSHNKL-VKIS----------------------------CHP 88
Query: 239 MTSLKEIWLHSNAFS--GPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV-NMT 295
+LK + L NAF +F + QL+ L L + L K++ +
Sbjct: 89 TVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLG 148
Query: 296 NNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 355
+ PE + + + D + + ++
Sbjct: 149 ETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY 208
Query: 356 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL- 414
+ N+T+ N + + + ++ +++ L G +
Sbjct: 209 FLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDF 268
Query: 415 ----SVLGALKELDVSNNQLY 431
+ L AL V ++
Sbjct: 269 DYSGTSLKALSIHQVVSDVFG 289
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 58/386 (15%), Positives = 125/386 (32%), Gaps = 43/386 (11%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERL--ELQWNSISGPLPSLNGLA--SLEVVMLS 123
++ + + +L+ + + +L + L + L SL +V +
Sbjct: 115 SQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174
Query: 124 NNQFTSVPSDFFTGLSSLQSIEIDNNPF-----SSWEIPQSLRNASGLQNFSANSANITG 178
N +F + +++L+ I I L+ L N + N+ T
Sbjct: 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTW 234
Query: 179 ----QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGID 234
+I +I ++ + +SG+ +++L ++ +
Sbjct: 235 NSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSY 294
Query: 235 VIQNMTSLKEIWLH-SNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 293
+ + +++ S + S + L +N T V ++ L L+ +
Sbjct: 295 IYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLI 354
Query: 294 MTNNLLQ---GPVPEFDRSVSLDMAKGSNNF--CLPSPGACD--PRLNAL-LSVVKLMGY 345
+ N L+ + SL S N G C L +L +S L
Sbjct: 355 LQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDT 414
Query: 346 PQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNN 405
R C I V++ + +I + ++LQ L +A N
Sbjct: 415 IFR------------------CLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQ 455
Query: 406 LSGMIPEG-LSVLGALKELDVSNNQL 430
L +P+G L +L+++ + N
Sbjct: 456 LK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 42/234 (17%), Positives = 83/234 (35%), Gaps = 79/234 (33%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS----EIAV 644
+ +S LG G FG V + ++ G + A+K+ + + E+ +
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK----------VLQDPRYKNRELDI 53
Query: 645 LTKVRHRHLVALLGHCLDGNEKL------------------------------------- 667
+ + H +++ L+ + ++
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 668 -LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL------DVARGVEYLHGLAHQSF 720
++ EY+P TL + + ++ R + + L + R V ++H L
Sbjct: 114 NVIMEYVPD-TLHKVLKSFIRS-------GRSIPMNLISIYIYQLFRAVGFIHSL---GI 162
Query: 721 IHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIE---TRIAGTFGYLAPE 770
HRD+KP N+L+ D K+ DFG + + S+ +R Y APE
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE 211
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 38/207 (18%)
Query: 586 QVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS---- 640
+++ N++++F +++LG G +G V G +A+K++E F
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----------FDKPLFA 53
Query: 641 -----EIAVLTKVRHRHLVALL-----GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 690
EI +L +H +++ + + NE ++ E M Q L R I
Sbjct: 54 LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST------ 106
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750
+ L + R V+ LHG ++ IHRDLKPSN+L+ + KV DFGL R+
Sbjct: 107 QMLSDDHIQYFIYQTLRAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163
Query: 751 EGKGSIETRIAGTFGYLAPEYAVHTRW 777
E + G + E+ V TRW
Sbjct: 164 ESAAD-NSEPTGQQSGM-VEF-VATRW 187
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-17
Identities = 54/181 (29%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 601 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKVRHRHLVALLG 658
LG+G FG V + A+K + VI K +E VL RH L AL
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 659 HCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR--------GV 709
+ +++L V EY G L H L R T + AR +
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFH-----------LSRERVFT--EERARFYGAEIVSAL 118
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
EYLH ++RD+K N++L D K+ DFGL + +++T GT YLAP
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAP 174
Query: 770 E 770
E
Sbjct: 175 E 175
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.0 bits (202), Expect = 3e-16
Identities = 60/273 (21%), Positives = 96/273 (35%), Gaps = 26/273 (9%)
Query: 522 SRVQSPNAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHTVPSSEPGDIQMLEAGNM 581
S +Q S E + + + G E
Sbjct: 265 SELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTAN 324
Query: 582 VISIQVLRNVTNNFSEEN-----ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGL 635
IS + + +LG+G FG V E ++ AVK ++ V+
Sbjct: 325 TISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD 384
Query: 636 TEF-KSEIAVLTKV-RHRHLVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKP 692
E E VL + L L C ++L V EY+ G L HI + G
Sbjct: 385 VECTMVEKRVLALPGKPPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFK 440
Query: 693 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752
A ++A G+ +L + I+RDLK N++L + K+ADFG+ +
Sbjct: 441 EPHAV--FYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495
Query: 753 KGSIETRIAGTFGYLAPE---YAVHTR----WS 778
+ +T GT Y+APE Y + + W+
Sbjct: 496 GVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWA 527
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 4e-16
Identities = 53/182 (29%), Positives = 81/182 (44%), Gaps = 27/182 (14%)
Query: 601 LGRGGFGTVY---KGELHDGTKI-AVKRMEAGVISGKG--LTEFKSEIAVLTKVRHRHLV 654
LG+GG+G V+ K + KI A+K ++ +I K+E +L +V+H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 655 ALLGH-CLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNR----RLTIALDVARG 708
L KL L+ EY+ G L + EG+ + +++AL
Sbjct: 85 DL--IYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMAL----- 134
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 768
+LH I+RDLKP NI+L K+ DFGL + + T GT Y+A
Sbjct: 135 -GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMA 189
Query: 769 PE 770
PE
Sbjct: 190 PE 191
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 47/260 (18%), Positives = 79/260 (30%), Gaps = 57/260 (21%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQG---------TLPSN-LQNLTKLERLELQWNSISG 106
C + K I RI + Q T+PS+ NL + R+ + +
Sbjct: 10 CHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ 69
Query: 107 PLPS--LNGLASLEVVMLSNNQF-TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNA 163
L S L+ + + + N + T + D L L+ + I N
Sbjct: 70 QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM---------- 119
Query: 164 SGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPA-SFSG--SQIQSLWV 220
P IL + N + +P +F G ++ +L +
Sbjct: 120 ----------------FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163
Query: 221 NGQNGNAKLGGGIDVIQ----NMTSLKEIWLHSNAFSGPLPD--FSGVKQ-LESLSLRDN 273
N G +Q N T L ++L+ N + + F GV L +
Sbjct: 164 YN-N-------GFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQT 215
Query: 274 FFTGPVPDSLVKLESLKIVN 293
T L L+ L N
Sbjct: 216 SVTALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 40/205 (19%), Positives = 78/205 (38%), Gaps = 24/205 (11%)
Query: 108 LPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID-NNPFSSWEIPQSLRNASGL 166
+PSL S + + L ++PS F+ L ++ I + + E S N S +
Sbjct: 26 IPSL--PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLE-SHSFYNLSKV 82
Query: 167 QNFS-ANSANITGQIPSFFGPDEF---PGLTILHLAFNQL--IGGLPASFSGSQIQSLWV 220
+ N+ N+T I PD P L L + L L +S L +
Sbjct: 83 THIEIRNTRNLT-YID----PDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEI 137
Query: 221 NGQNGNAKLGGGIDVIQNMTS-LKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDN-FFT 276
+ Q + + + L++N F+ + F+G K L+++ L N + T
Sbjct: 138 TDNPYMTSIPVN--AFQGLCNETLTLKLYNNGFTS-VQGYAFNGTK-LDAVYLNKNKYLT 193
Query: 277 GPVPDSLVKLES-LKIVNMTNNLLQ 300
D+ + S +++++ +
Sbjct: 194 VIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 48/278 (17%), Positives = 79/278 (28%), Gaps = 82/278 (29%)
Query: 164 SGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQ 223
++F +I +IPS P P L L L I S
Sbjct: 11 HQEEDFRVTCKDIQ-RIPSL--P---PSTQTLKLIETHL----------RTIPS------ 48
Query: 224 NGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDN-FFTGPVP 280
N+ ++ I++ + L F + ++ + +R+ T P
Sbjct: 49 ----------HAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP 98
Query: 281 DSLVKLESLKIVNMTNNLLQGPVPEF------DRSVSLDMAKGSNNFCLPSPGACDPRLN 334
D+L +L LK + + N L+ P+ D L++ +P A L
Sbjct: 99 DALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIP-VNAFQ-GLC 155
Query: 335 ALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFK 394
+KL N T + Q GT
Sbjct: 156 NETLTLKLYN-----------N--------------GFTSV--QGYAFNGT--------- 179
Query: 395 SLQRLILADNNLSGMIPEGL--SVLGALKELDVSNNQL 430
L + L N +I + V LDVS +
Sbjct: 180 KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV 217
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 13/89 (14%), Positives = 30/89 (33%), Gaps = 11/89 (12%)
Query: 359 CSDWIGVTCTKGNITVI-----NFQKMNLTG----TISPE-FASFKSLQRLILADNNLSG 408
C T +I I + Q + L TI F++ ++ R+ ++ +
Sbjct: 10 CHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ 69
Query: 409 MIPEGL-SVLGALKELDVSNNQLYGKIPS 436
+ L + +++ N + I
Sbjct: 70 QLESHSFYNLSKVTHIEIRNTRNLTYIDP 98
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 52/273 (19%), Positives = 90/273 (32%), Gaps = 69/273 (25%)
Query: 55 DPCK----WNHVVCIEDKRITRIQIG----------HQNLQGTLPSN-LQNLTKLERLEL 99
+PC C + +I N L S + +L+ L+L
Sbjct: 1 EPCVEVVPNITYQC-MELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 100 QWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIP 157
I + L+ L ++L+ N S+ F+GLSSLQ + +S +
Sbjct: 60 SRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS--LE 116
Query: 158 ----QSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLT---ILHLAFNQLIGGLPASF 210
L+ L N + N I SF P+ F LT L L+ N
Sbjct: 117 NFPIGHLKTLKEL-NVAHN------LIQSFKLPEYFSNLTNLEHLDLSSN---------- 159
Query: 211 SGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLK----EIWLHSNAFSGPLPD--FSGVKQ 264
+IQS+ ++ + + + L N + + F + +
Sbjct: 160 ---KIQSI----YCT---------DLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEI-R 201
Query: 265 LESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
L+ L+L N +L SL+ + + N
Sbjct: 202 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 22/76 (28%), Positives = 35/76 (46%), Gaps = 3/76 (3%)
Query: 78 QNLQGTLPSNLQNLTKLE-RLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFF 135
Q++ T L + L L+L N ++ + + L+ + L NQ SVP F
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIF 220
Query: 136 TGLSSLQSIEIDNNPF 151
L+SLQ I + NP+
Sbjct: 221 DRLTSLQKIWLHTNPW 236
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 47/292 (16%), Positives = 76/292 (26%), Gaps = 74/292 (25%)
Query: 205 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGV 262
LP S ++L ++ N LG + L+ + L + D + +
Sbjct: 25 NLPFS-----TKNLDLSF-NPLRHLGSY--SFFSFPELQVLDLSRCEIQT-IEDGAYQSL 75
Query: 263 KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAKGSNNF 321
L +L L N + L SL+ + L +L ++N
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 322 --CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQK 379
P L L ++
Sbjct: 136 IQSFKLPEYFS-NLTNL------------------------------------EHLDLSS 158
Query: 380 MNLTGTISPE-FASFKSLQ----RLILADNNLSGMIPEGLSVLGALKELDVSNNQL---- 430
+ +I + L L+ N ++ I G LKEL + NQL
Sbjct: 159 NKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVP 216
Query: 431 YGKIPSFKSNAIVNTDGNP------DIG------KEKSSSFQGSPSGSPTGT 470
G S + NP I + S QGS S +G
Sbjct: 217 DGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSAKCSGSGK 268
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 62/255 (24%), Positives = 94/255 (36%), Gaps = 69/255 (27%)
Query: 57 CKWNHVVCIEDKRITRIQIG----------HQNLQGTLPSN-LQNLTKLERLELQWNSIS 105
N V C K++T I N +LPS LTKL L L N +
Sbjct: 16 NNKNSVDC-SSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ 74
Query: 106 GPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNA 163
LP+ L +LE + +++N+ ++P F L +L + +D N S +P
Sbjct: 75 T-LPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS--LP------ 125
Query: 164 SGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQ 223
P F D LT L L +N+L QSL
Sbjct: 126 -----------------PRVF--DSLTKLTYLSLGYNEL-------------QSLPKG-- 151
Query: 224 NGNAKLGGGIDVIQNMTSLKEIWLHSNAF-SGPLPDFSGVKQLESLSLRDNFFTGPVPDS 282
V +TSLKE+ L++N P F + +L++L L +N +
Sbjct: 152 -----------VFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGA 200
Query: 283 LVKLESLKIVNMTNN 297
LE LK++ + N
Sbjct: 201 FDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 25/78 (32%), Positives = 38/78 (48%), Gaps = 4/78 (5%)
Query: 77 HQN-LQGTLPSNL-QNLTKLERLELQWNSI-SGPLPSLNGLASLEVVMLSNNQFTSVPSD 133
N LQ +LP + LT L+ L L N + P + + L L+ + L NNQ VP
Sbjct: 141 GYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEG 199
Query: 134 FFTGLSSLQSIEIDNNPF 151
F L L+ +++ NP+
Sbjct: 200 AFDSLEKLKMLQLQENPW 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 35/161 (21%), Positives = 62/161 (38%), Gaps = 25/161 (15%)
Query: 600 ILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALL 657
+LG G G V + K A+K ++ + + E+ + + + H+V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALK-----MLQDC--PKARREVELHWRASQCPHIVRIV 77
Query: 658 GHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
+ L+V E + G L I + G + I + ++YLH
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 714 GLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPE 751
+ HRD+KP N+L + K+ DFG A E
Sbjct: 135 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFG---FAKE 169
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-16
Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 27/226 (11%)
Query: 560 SETHTVPSSEPGDIQMLEAGNMVISIQVLRNVT----NNFSEENILGRGGFGTVY---KG 612
T G Q+L + + + + + NF +LG G +G V+ K
Sbjct: 17 GAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKI 76
Query: 613 ELHDGTKI-AVKRME-AGVISGKGLTEF-KSEIAVLTKVRHRHLVALLGHCLDGNEKL-L 668
HD K+ A+K ++ A ++ TE ++E VL +R + L + KL L
Sbjct: 77 SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL 136
Query: 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNR----RLTIALDVARGVEYLHGLAHQSFIHRD 724
+ +Y+ G L H+ ++ + + +AL E+LH L I+RD
Sbjct: 137 ILDYINGGELFTHL---SQRERFTEHEVQIYVGEIVLAL------EHLHKL---GIIYRD 184
Query: 725 LKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+K NILL + + DFGL + + GT Y+AP+
Sbjct: 185 IKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 8e-16
Identities = 44/218 (20%), Positives = 77/218 (35%), Gaps = 49/218 (22%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 640
+ + + +++G G +G V + + + +A+K++ F+
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL---------RVFEDLIDCKRIL 100
Query: 641 -EIAVLTKVRHRHLVALL-----GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLE 694
EIA+L ++ H H+V +L +E +V E + L
Sbjct: 101 REIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLF-----RTPVYLT 154
Query: 695 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754
T+ ++ GV+Y+H +HRDLKP+N L+ D KV DFGL R +
Sbjct: 155 ELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 755 SIETRIAGTFGYLAP---------------EYAVHTRW 777
+ V TRW
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGH-VVTRW 248
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 8e-16
Identities = 46/356 (12%), Positives = 104/356 (29%), Gaps = 45/356 (12%)
Query: 85 PSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQS 143
++ L++L L L N I LE + +S+N+ ++ ++SL+
Sbjct: 69 MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC---PMASLRH 125
Query: 144 IEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI 203
+++ N F +P + F LT L L+ +
Sbjct: 126 LDLSFNDFDV--LP----------------------VCKEF--GNLTKLTFLGLSAAKFR 159
Query: 204 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA-FSGPLPD-FSG 261
+ + + ++ + + K G + T++ + H N+ FS + +
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNA 219
Query: 262 VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGS--- 318
+ L+ +++ N + + + + L
Sbjct: 220 LGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279
Query: 319 ----NNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITV 374
N + + + ++ LM E+ K + + +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLM------IEHVKNQVFLFSKEALYSVFAEMNI 333
Query: 375 INFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+ S S L N + + +G S L L+ L + N L
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 5e-14
Identities = 66/378 (17%), Positives = 107/378 (28%), Gaps = 45/378 (11%)
Query: 77 HQNLQGTLPSN--LQNLTKLERLELQWNSI-SGPLPSLNGLASLEVVMLSNNQFTSVPSD 133
N LP NLTKL L L L + L +L + +
Sbjct: 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL--HLSCILLDLVSYHIKGG 186
Query: 134 FFTGLSSLQ----SIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEF 189
L + N S ++ S+ LQ + + Q F +
Sbjct: 187 ETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELT 246
Query: 190 PGLTILHLAFNQLIGGLPASFSGSQIQSLWV--------NGQNGNAKLGGGIDVIQNMTS 241
G T+L++ + S Q + S
Sbjct: 247 RGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKS 306
Query: 242 LKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDN---FFTGPVPDSLVKLESLKIVNMTNN 297
L + + F +S ++ L + F P S L N T N
Sbjct: 307 LMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFL---NFTQN 363
Query: 298 LLQG-PVPEFDRSVSLDMAKGSNNFC--LPSPGACDPRLNAL-LSVVKLMGYPQRFAENW 353
+ L N +++L V L
Sbjct: 364 VFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLN------S 417
Query: 354 KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASF-KSLQRLILADNNLSGMIPE 412
D W +I V+N LTG++ F ++ L L +N + IP+
Sbjct: 418 HAYDRTCAW------AESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRIMS-IPK 467
Query: 413 GLSVLGALKELDVSNNQL 430
++ L AL+EL+V++NQL
Sbjct: 468 DVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 33/205 (16%), Positives = 75/205 (36%), Gaps = 9/205 (4%)
Query: 74 QIGHQNLQGTLPSNLQNLTKLERLELQWNSI-SGPLPSLNGLASLEVVMLSNNQFTSVPS 132
+ +Q + + ++ L + + +S + + N FT
Sbjct: 311 HVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVF 370
Query: 133 DFFTGLSSLQSIEIDNNPFSSWE-IPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG 191
+ L LQ++ + N ++ + +N S L+ S N
Sbjct: 371 QGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLD-VSLNSLNSHAYDRTCAWAES 429
Query: 192 LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251
+ +L+L+ N L G + +++ L ++ N + + ++ +L+E+ + SN
Sbjct: 430 ILVLNLSSNMLTGSVFRCLP-PKVKVLDLH-NNRIMSIPKDVT---HLQALQELNVASNQ 484
Query: 252 F-SGPLPDFSGVKQLESLSLRDNFF 275
S P F + L+ + L DN +
Sbjct: 485 LKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 52/288 (18%), Positives = 103/288 (35%), Gaps = 22/288 (7%)
Query: 48 SLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPS-----NLQNLTKLERLELQWN 102
++ +D + + + + T + + Q+++ T +E L +
Sbjct: 227 NIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNL 286
Query: 103 SISGPLP------SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN--PFSSW 154
+I+ + S L SL + + N F ++ + + + + PF
Sbjct: 287 TITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHM 346
Query: 155 EIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQ 214
P S + + L NF+ N T + L L L N L +
Sbjct: 347 VCPPSPSSFTFL-NFTQNV--FTDSVFQGC--STLKRLQTLILQRNGLKNFFKVALMTKN 401
Query: 215 IQSLWVNGQNGNAKLGGGIDVI-QNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDN 273
+ SL + N+ D S+ + L SN +G + +++ L L +N
Sbjct: 402 MSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR-CLPPKVKVLDLHNN 460
Query: 274 FFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAKGSNN 320
+P + L++L+ +N+ +N L+ P FDR SL +N
Sbjct: 461 RIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 49/322 (15%), Positives = 96/322 (29%), Gaps = 19/322 (5%)
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
+V SN T VP D +++ + N S + S L+ +
Sbjct: 32 LESMVDYSNRNLTHVPKDL---PPRTKALSLSQNSISELR-MPDISFLSELRVLRLSHNR 87
Query: 176 ITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDV 235
I F L L ++ N+L + + ++ L ++ N L
Sbjct: 88 IRSLDFHVF--LFNQDLEYLDVSHNRL-QNISCC-PMASLRHLDLSF-NDFDVLPVC-KE 141
Query: 236 IQNMTSLKEIWLHSNAF-SGPLPDFSGVK-QLESLSLRDNFFTGPVPDSLVKLESLKIVN 293
N+T L + L + F L + + L L G +SL + +
Sbjct: 142 FGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHL 201
Query: 294 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENW 353
+ + V +L + SN C + L + + ++
Sbjct: 202 VFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN--CQRLMTFLSELTRGPTLLNVTLQHI 259
Query: 354 KGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG----M 409
+ CS + + +N + +T I E ++ L ++
Sbjct: 260 ETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLF 319
Query: 410 IPEGL-SVLGALKELDVSNNQL 430
E L SV + +S +
Sbjct: 320 SKEALYSVFAEMNIKMLSISDT 341
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 22/101 (21%), Positives = 41/101 (40%), Gaps = 16/101 (15%)
Query: 67 DKRITRIQIGHQNLQGTLPSNLQNL----------------TKLERLELQWNSISGPLPS 110
D + + + ++ L K++ L+L N I
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKD 468
Query: 111 LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF 151
+ L +L+ + +++NQ SVP F L+SLQ I + +NP+
Sbjct: 469 VTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 50/216 (23%), Positives = 85/216 (39%), Gaps = 50/216 (23%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 640
+V +N+ ++++GRG +G VY + + +A+K++ F+
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---------MFEDLIDCKRIL 73
Query: 641 -EIAVLTKVRHRHLVALL-----GHCLDGNEKLLVFEYMPQGT-LSRHIFNWAEEGLKPL 693
EI +L +++ +++ L L +E +V E + L + + L
Sbjct: 74 REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLF-----KTPIFL 126
Query: 694 EWNRRLTIALDVARGVEYLH--GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751
TI ++ G ++H G+ IHRDLKP+N LL D KV DFGL R
Sbjct: 127 TEEHIKTILYNLLLGENFIHESGI-----IHRDLKPANCLLNQDCSVKVCDFGLARTINS 181
Query: 752 GKGSIETRIAGTFGYLAP----------EYAVHTRW 777
K + P + V TRW
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSH-VVTRW 216
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 49/216 (22%), Positives = 82/216 (37%), Gaps = 20/216 (9%)
Query: 110 SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNF 169
++ +AS V T++P D + + N ++ +L + L
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLPK---DTTILHLSENLLYTFS-LATLMPYTRLTQL 60
Query: 170 SANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAK 228
+ + A +T ++ P L L L+ NQL LP + L V+ N
Sbjct: 61 NLDRAELT-KLQVD---GTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVS-FNRLTS 114
Query: 229 LGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKL 286
L G ++ + L+E++L N LP + +LE LSL +N T L L
Sbjct: 115 LPLG--ALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171
Query: 287 ESLKIVNMTNNLLQGPVPE--FDRSVSLDMAKGSNN 320
E+L + + N L +P+ F L A N
Sbjct: 172 ENLDTLLLQENSLYT-IPKGFFGSH-LLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 45/254 (17%), Positives = 81/254 (31%), Gaps = 71/254 (27%)
Query: 57 CKWNHVVCIEDKRITRIQIG----------HQNLQGTLPSN-LQNLTKLERLELQWNSIS 105
V C + + +T + +NL T L T+L +L L ++
Sbjct: 10 ASHLEVNC-DKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 106 GPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASG 165
L L L + LS+NQ S+P L +L +++ N +S +P
Sbjct: 69 K-LQVDGTLPVLGTLDLSHNQLQSLPL-LGQTLPALTVLDVSFNRLTS--LP-------- 116
Query: 166 LQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNG 225
L L+L N+L LP
Sbjct: 117 ---------------LGAL--RGLGELQELYLKGNEL-KTLPP----------------- 141
Query: 226 NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSL 283
++ L+++ L +N + LP +G++ L++L L++N +P
Sbjct: 142 --------GLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLYT-IPKGF 191
Query: 284 VKLESLKIVNMTNN 297
L + N
Sbjct: 192 FGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 26/77 (33%), Positives = 38/77 (49%), Gaps = 3/77 (3%)
Query: 77 HQNLQGTLPSNL-QNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDF 134
N TLP L KLE+L L N+++ P LNGL +L+ ++L N ++P F
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGF 191
Query: 135 FTGLSSLQSIEIDNNPF 151
F G L + NP+
Sbjct: 192 F-GSHLLPFAFLHGNPW 207
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 38/228 (16%), Positives = 64/228 (28%), Gaps = 54/228 (23%)
Query: 205 GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQ 264
LP L ++ N + T L ++ L + L +
Sbjct: 28 DLPKD-----TTILHLSE-NLLYTFSLA--TLMPYTRLTQLNLDRAELTK-LQVDGTLPV 78
Query: 265 LESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAKGSNN--F 321
L +L L N +P L +L +++++ N L P+ L N
Sbjct: 79 LGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK 137
Query: 322 CLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMN 381
LP PG L ++ N
Sbjct: 138 TLP-PGLLT-PTPKL------------------------------------EKLSLANNN 159
Query: 382 LTGTISPE-FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNN 428
LT + ++L L+L +N+L IP+G L + N
Sbjct: 160 LT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-15
Identities = 65/266 (24%), Positives = 102/266 (38%), Gaps = 58/266 (21%)
Query: 530 MVIHPRHSGSENSESVKITVA---GSNVSVGAISETHTVPSSEPGDIQMLEAGNMVISIQ 586
M +H + SE + VKI V V I++ H S D Q S++
Sbjct: 1 MSLHFLYYCSEPTLDVKIAFCQGFDKQVDVSYIAK-HYNMSKSKVDNQF-------YSVE 52
Query: 587 VLRN---VTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-- 640
V + V + +G G G V + +A+K++ F++
Sbjct: 53 VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR---------PFQNQT 103
Query: 641 -------EIAVLTKVRHRHLVALL------GHCLDGNEKLLVFEYMPQGTLSRHIFNWAE 687
E+ ++ V H+++++LL + + LV E M L + I
Sbjct: 104 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI----- 157
Query: 688 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
L+ R + + G+++LH A IHRDLKPSNI++ D K+ DFGL R
Sbjct: 158 --QMELDHERMSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 212
Query: 748 LAPEGKGSIE---TRIAGTFGYLAPE 770
A TR Y APE
Sbjct: 213 TAGTSFMMTPYVVTRY-----YRAPE 233
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 46/203 (22%), Positives = 84/203 (41%), Gaps = 45/203 (22%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 640
+V ++ + +G G +G V + + ++A+K++ F+
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----------FEHQTYCQRTL 73
Query: 641 -EIAVLTKVRHRHLVALL-----GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLE 694
EI +L + RH +++ + + +V + M + L + + + L
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT------QHLS 126
Query: 695 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG 754
+ + RG++Y+H + +HRDLKPSN+LL K+ DFGL R+A
Sbjct: 127 NDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD-- 181
Query: 755 SIETRIAGTFGYLAPEYAVHTRW 777
G+L EY V TRW
Sbjct: 182 ------HDHTGFL-TEY-VATRW 196
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 48/200 (24%), Positives = 77/200 (38%), Gaps = 44/200 (22%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 640
V + +G G G V + +A+K++ F++
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR---------PFQNQTHAKRAY 72
Query: 641 -EIAVLTKVRHRHLVALL------GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPL 693
E+ ++ V H++++ LL + + +V E M L + I L
Sbjct: 73 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-------QMEL 124
Query: 694 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753
+ R + + G+++LH A IHRDLKPSNI++ D K+ DFGL R A
Sbjct: 125 DHERMSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 754 GSIE---TRIAGTFGYLAPE 770
TR Y APE
Sbjct: 182 MMTPYVVTRY-----YRAPE 196
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 62/214 (28%), Positives = 84/214 (39%), Gaps = 31/214 (14%)
Query: 566 PSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKI-AVKR 624
P + I + + N +F ++G+G FG V AVK
Sbjct: 18 PPAPSQQINLGPSSNPHAKPS-------DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKV 70
Query: 625 MEAGVISGKGLTEF-KSEIAVLTK-VRHRHLVALLGH-CLDGNEKL-LVFEYMPQGTLSR 680
++ I K + SE VL K V+H LV L H +KL V +Y+ G L
Sbjct: 71 LQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL--HFSFQTADKLYFVLDYINGGELFY 128
Query: 681 HIFNWAEEGLKPLEWNR----RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736
H+ E R + AL YLH L + ++RDLKP NILL
Sbjct: 129 HL---QRERCFLEPRARFYAAEIASAL------GYLHSL---NIVYRDLKPENILLDSQG 176
Query: 737 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+ DFGL + E + T GT YLAPE
Sbjct: 177 HIVLTDFGLCKENIEHNSTTST-FCGTPEYLAPE 209
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 9e-15
Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 14/175 (8%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKV-RHRHLVAL 656
++GRG + V L +I A+K ++ +++ ++ ++E V + H LV L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 657 LGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
C +L V EY+ G L H+ + P E R A +++ + YLH
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHAR-FYSA-EISLALNYLHE- 128
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+ I+RDLK N+LL + K+ D+G+ + + T GT Y+APE
Sbjct: 129 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPE 180
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 9e-15
Identities = 52/189 (27%), Positives = 81/189 (42%), Gaps = 21/189 (11%)
Query: 601 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKV-RHRHLVALL 657
LG+G FG V E ++ AVK ++ V+ E E VL + L L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
C ++L V EY+ G L HI + G A ++A G+ +L
Sbjct: 88 -SCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAV--FYAAEIAIGLFFLQS-- 139
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE---YAV 773
+ I+RDLK N++L + K+ADFG+ + + +T GT Y+APE Y
Sbjct: 140 -KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQP 197
Query: 774 HTR----WS 778
+ + W+
Sbjct: 198 YGKSVDWWA 206
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 14/175 (8%)
Query: 600 ILGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKV-RHRHLVAL 656
++GRG + V L +I A++ ++ +++ ++ ++E V + H LV L
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 657 LGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL 715
C +L V EY+ G L H+ + P E R A +++ + YLH
Sbjct: 119 HS-CFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHAR-FYSA-EISLALNYLHE- 171
Query: 716 AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
+ I+RDLK N+LL + K+ D+G+ + + T GT Y+APE
Sbjct: 172 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPE 223
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 29/152 (19%), Positives = 59/152 (38%), Gaps = 10/152 (6%)
Query: 67 DKRITRIQIGHQNLQGTLPSN--LQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLS 123
+ + H NL L + LT L L L N ++ + + +L + LS
Sbjct: 38 PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96
Query: 124 NNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQ-SLRNASGLQNFSANSANITGQIPS 182
+N ++ F+ L +L+ + + NN + + + + + LQ + I+ + P
Sbjct: 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVV--VDRNAFEDMAQLQKLYLSQNQIS-RFPV 153
Query: 183 --FFGPDEFPGLTILHLAFNQLIGGLPASFSG 212
++ P L +L L+ N+L
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQK 185
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 46/293 (15%), Positives = 91/293 (31%), Gaps = 109/293 (37%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSIS--GPLPSLNGL 114
C N + C +++ + P +L + T L+L N++S + L
Sbjct: 18 CASNILSCS-KQQLPNV-----------PQSLPSYT--ALLDLSHNNLSRLRAEWTPTRL 63
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174
+L ++LS+N + S+ F + +
Sbjct: 64 TNLHSLLLSHNHLNFISSEAFVPVPN---------------------------------- 89
Query: 175 NITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGID 234
L L L+ N L +
Sbjct: 90 -----------------LRYLDLSSNHL----------HTLDE----------------F 106
Query: 235 VIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVP----DSLVKLES 288
+ ++ +L+ + L++N + F + QL+ L L N + P KL
Sbjct: 107 LFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPK 164
Query: 289 LKIVNMTNNLLQG-PVPEFDRSVSLDMAKGS--NNFCLPSPGACDPRLNALLS 338
L ++++++N L+ P+ + + + NN P CD +L L S
Sbjct: 165 LMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN-----PLECDCKLYQLFS 212
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 15/63 (23%), Positives = 29/63 (46%), Gaps = 5/63 (7%)
Query: 371 NITVINFQKMNLTGTISPE--FASFKSLQRLILADNNLSGMIPEG-LSVLGALKELDVSN 427
+++ NL+ + E +L L+L+ N+L+ I + L+ LD+S+
Sbjct: 40 YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97
Query: 428 NQL 430
N L
Sbjct: 98 NHL 100
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 21/189 (11%)
Query: 601 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTEF-KSEIAVLTKV-RHRHLVALL 657
LG+G FG V + + + AVK ++ VI E +E +L+ H L L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
C ++L V E++ G L HI + R A ++ + +LH
Sbjct: 91 -CCFQTPDRLFFVMEFVNGGDLMFHI---QKSRRFDEARAR--FYAAEIISALMFLHD-- 142
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE---YAV 773
+ I+RDLK N+LL + K+ADFG+ + + T GT Y+APE +
Sbjct: 143 -KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAPEILQEML 200
Query: 774 HTR----WS 778
+ W+
Sbjct: 201 YGPAVDWWA 209
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 22/185 (11%), Positives = 60/185 (32%), Gaps = 15/185 (8%)
Query: 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
L +S + + + SL + L+N T + +++ + I+N
Sbjct: 21 TFKAYLNGLLGQSSTANITEA--QMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNI 76
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209
+++ + S L+ ++T LT+L ++ + +
Sbjct: 77 HATNYN---PISGLSNLERLRIMGKDVTSDKIPNLS--GLTSLTLLDISHSAHDDSILTK 131
Query: 210 FSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESL 268
+ ++ S+ + + N + I ++ + LK + + + +L L
Sbjct: 132 INTLPKVNSIDL---SYNGAI-TDIMPLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQL 186
Query: 269 SLRDN 273
Sbjct: 187 YAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-14
Identities = 27/165 (16%), Positives = 68/165 (41%), Gaps = 11/165 (6%)
Query: 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
+ L + L +++ L + +++ + ++N T+ + +GLS+L+ + I
Sbjct: 42 QMNSLTYITLANINVTD-LTGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGK 98
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209
+S +IP +L + L + + I + P + + L++N I +
Sbjct: 99 DVTSDKIP-NLSGLTSLTLLDISHSAHDDSILTKIN--TLPKVNSIDLSYNGAITDIMPL 155
Query: 210 FSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG 254
+ +++SL + +G I++ L +++ S G
Sbjct: 156 KTLPELKSLNIQF-DGVHD----YRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 9e-10
Identities = 11/88 (12%), Positives = 29/88 (32%), Gaps = 2/88 (2%)
Query: 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQF 127
+T + I H ++ + + L K+ ++L +N + L L L+ + + +
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGV 171
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWE 155
L + + +
Sbjct: 172 HDY--RGIEDFPKLNQLYAFSQTIGGKK 197
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 15/163 (9%), Positives = 50/163 (30%), Gaps = 37/163 (22%)
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL 195
+ + + + + + I ++ + L + + N+T G + + L
Sbjct: 20 STFKAYLNGLLGQSSTA--NITEA--QMNSLTYITLANINVT----DLTGIEYAHNIKDL 71
Query: 196 HLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG- 254
+ + I +++L+ + + +
Sbjct: 72 TINNIHA----------------------------TNYNPISGLSNLERLRIMGKDVTSD 103
Query: 255 PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+P+ SG+ L L + + + + L + ++++ N
Sbjct: 104 KIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN 146
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 12/73 (16%), Positives = 33/73 (45%), Gaps = 1/73 (1%)
Query: 233 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 292
+ I+ ++K++ +++ + SG+ LE L + T +L L SL ++
Sbjct: 59 LTGIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 293 NMTNNLLQGPVPE 305
+++++ +
Sbjct: 118 DISHSAHDDSILT 130
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 15/70 (21%), Positives = 32/70 (45%), Gaps = 2/70 (2%)
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
NI + ++ T +P + +L+RL + +++ LS L +L LD+S++
Sbjct: 67 NIKDLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
Query: 431 YGKIPSFKSN 440
I + +
Sbjct: 125 DDSILTKINT 134
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 13/70 (18%), Positives = 27/70 (38%)
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
N+ + ++T P + SL L ++ + I ++ L + +D+S N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 431 YGKIPSFKSN 440
I K+
Sbjct: 149 ITDIMPLKTL 158
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 53/174 (30%), Positives = 74/174 (42%), Gaps = 14/174 (8%)
Query: 601 LGRGGFGTVYKGELHDGTKI-AVKRMEAGVISGKGLTE-FKSEIAVLTKV-RHRHLVALL 657
LG+G FG V+ E + A+K ++ V+ E E VL+ H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 658 GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA 716
E L V EY+ G L HI L R A ++ G+++LH
Sbjct: 85 C-TFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLS--RATFYAAEIILGLQFLHSK- 137
Query: 717 HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
++RDLK NILL D K+ADFG+ + G T GT Y+APE
Sbjct: 138 --GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPE 188
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 47/198 (23%), Positives = 81/198 (40%), Gaps = 42/198 (21%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 640
+ + +G G +G+V + G K+A+K++ F+S
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---------PFQSEIFAKRAY 71
Query: 641 -EIAVLTKVRHRHLVALL-----GHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPL 693
E+ +L ++H +++ LL L LV +M Q L + +
Sbjct: 72 RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM-------GLKF 123
Query: 694 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEG 752
+ + + +G++Y+H +HRDLKP N+ + +D K+ DFGL R A E
Sbjct: 124 SEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
Query: 753 KGSIETRIAGTFGYLAPE 770
G + TR Y APE
Sbjct: 181 TGYVVTRW-----YRAPE 193
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 47/208 (22%), Positives = 85/208 (40%), Gaps = 46/208 (22%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS---EIAVL 645
++ + + + LG GG G V+ + ++A+K+ I K EI ++
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK-----IVLTDPQSVKHALREIKII 62
Query: 646 TKVRHRHLVALL--------------GHCLDGNEKLLVFEYMPQGT-LSRHIFNWAEEGL 690
++ H ++V + G + N +V EYM T L+ +
Sbjct: 63 RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQ------ 114
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLA 749
PL + RG++Y+H + +HRDLKP+N+ + +D+ K+ DFGL R+
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 750 PEGKGSIETRIAGTFGYLAPEYAVHTRW 777
G+L E + T+W
Sbjct: 172 DPHYSHK--------GHL-SEG-LVTKW 189
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 9e-14
Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 44/215 (20%)
Query: 586 QVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS---- 640
+V R+V + LG+G +G V+K + G +AVK++ F++
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA---------FQNSTDA 52
Query: 641 -----EIAVLTKVR-HRHLVALLGHCL---DGNEKLLVFEYMPQGTLSRHIFNWAEEGLK 691
EI +LT++ H ++V LL + L + + LVF+YM + L I
Sbjct: 53 QRTFREIMILTELSGHENIVNLL-NVLRADNDRDVYLVFDYM-ETDLHAVIRA------N 104
Query: 692 PLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751
LE + + + + ++YLH +HRD+KPSNILL + KVADFGL R
Sbjct: 105 ILEPVHKQYVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161
Query: 752 GKGSIETRIAGTFGYLAP---------EYAVHTRW 777
+ +Y V TRW
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTDY-VATRW 195
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 41/198 (20%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 640
V + + +G G +G V + G K+A+K++ F+S
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---------PFQSELFAKRAY 72
Query: 641 -EIAVLTKVRHRHLVALL------GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPL 693
E+ +L +RH +++ LL D + LV +M L + + + + L
Sbjct: 73 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH------EKL 125
Query: 694 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA-PEG 752
+R + + +G+ Y+H IHRDLKP N+ + +D K+ DFGL R A E
Sbjct: 126 GEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182
Query: 753 KGSIETRIAGTFGYLAPE 770
G + TR Y APE
Sbjct: 183 TGYVVTRW-----YRAPE 195
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 41/198 (20%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKS-------- 640
V + + +G G +G+V + G ++AVK K F+S
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---------KLSRPFQSIIHAKRTY 76
Query: 641 -EIAVLTKVRHRHLVALL------GHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPL 693
E+ +L ++H +++ LL + N+ LV M L+ + + L
Sbjct: 77 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC------QKL 129
Query: 694 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEG 752
+ + + RG++Y+H IHRDLKPSN+ + +D K+ DFGL R A E
Sbjct: 130 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 753 KGSIETRIAGTFGYLAPE 770
G + TR Y APE
Sbjct: 187 TGYVATRW-----YRAPE 199
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 34/248 (13%), Positives = 64/248 (25%), Gaps = 46/248 (18%)
Query: 69 RITRIQIGHQNLQGTLPSNLQNLT--KLERLELQWNSISGPLPSLNGL-----ASLEVVM 121
+ + + + + GT P L T L L L+ S + L L L+V+
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155
Query: 122 LSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWE------IPQSLRNASGLQNFSANS-A 174
++ + + +L ++++ +NP P L
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVL-ALRNAGME 214
Query: 175 NITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGID 234
+G + L L L+ N L A
Sbjct: 215 TPSGVCSALAA--ARVQLQGLDLSHNSLRDAAGAPSC----------------------- 249
Query: 235 VIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 294
+ L + L +L L L N P +L + +++
Sbjct: 250 --DWPSQLNSLNLSFTGLKQVPKGLP--AKLSVLDLSYNRLDR-NPSPD-ELPQVGNLSL 303
Query: 295 TNNLLQGP 302
N
Sbjct: 304 KGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 41/258 (15%), Positives = 79/258 (30%), Gaps = 42/258 (16%)
Query: 69 RITRIQIGHQNLQGTLPSN---LQNLTKLERLELQWNSISGPLPS---LNGLASLEVVML 122
+ R+ + + + + ++ L+ L L+ ++G P L ++ L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 123 SNNQFTSVPSD----FFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSANSANI 176
N + + + L+ + I ++ Q +R L + S N
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ-VRVFPALSTLDLSDNPELG 187
Query: 177 TGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVI 236
+ S P +FP L +L L + + SG
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGM-----ETPSGVCSALA------------------ 224
Query: 237 QNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 294
L+ + L N+ QL SL+L VP L L ++++
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDL 281
Query: 295 TNNLLQGPVPEFDRSVSL 312
+ N L P D +
Sbjct: 282 SYNRLDR-NPSPDELPQV 298
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 47/324 (14%), Positives = 89/324 (27%), Gaps = 68/324 (20%)
Query: 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQ-IPSFFGP 186
+ + + G SL+ + + + + + L+ + +A I + +
Sbjct: 32 GAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRV 91
Query: 187 DEFPGLTILHLAFNQLIGGLP---ASFSGSQIQSLWVNGQNGNAKLGGGIDVIQN--MTS 241
GL L L ++ G P +G + L + A + +Q
Sbjct: 92 LGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR-NVSWATRDAWLAELQQWLKPG 150
Query: 242 LKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVP----DSLVKLESLKIVNMTN 296
LK + + L +L L DN G +K +L+++ + N
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210
Query: 297 NLLQGPVPEFDRSV-------SLDMAKGSNNF-CLPSPGACD--PRLNALLSVVKLMGYP 346
++ P LD++ N+ +CD +LN+L
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLS--HNSLRDAAGAPSCDWPSQLNSL---------- 258
Query: 347 QRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNL 406
N L + L L L+ N L
Sbjct: 259 -----NLSFT------------------------GLK-QVPKG--LPAKLSVLDLSYNRL 286
Query: 407 SGMIPEGLSVLGALKELDVSNNQL 430
P L + L + N
Sbjct: 287 DR-NPSPDE-LPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 33/213 (15%), Positives = 62/213 (29%), Gaps = 46/213 (21%)
Query: 238 NMTSLKEIWLHSNAFSGPLPD----FSGVKQLESLSLRDNFFTGPVPDSLVKL--ESLKI 291
SLK + + + + G+ L+ L+L + TG P L++ L I
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 292 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-LSVVKLMGYPQRFA 350
+N+ N P L L ++ + +
Sbjct: 126 LNLRNVSWATRDAWLAELQQW----------------LKPGLKVLSIAQAHSLNFSCEQV 169
Query: 351 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFA----SFKSLQRLILADNN- 405
+ ++ ++ G A F +LQ L L +
Sbjct: 170 RVFP----------------ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213
Query: 406 --LSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436
SG+ + L+ LD+S+N L +
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 32/212 (15%), Positives = 69/212 (32%), Gaps = 42/212 (19%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
L + L S++ L S L+ ++ N+ S+ ++L+ +
Sbjct: 13 FPDPGLANAVKQNLGKQSVTD-LVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELH 69
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205
+ +N S + L L+ S N + + L+ L L N+L
Sbjct: 70 LSHNQISDLSPLKDLTK---LEELSVNRNRLK-NLN----GIPSACLSRLFLDNNELR-- 119
Query: 206 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 265
D + ++ +L+ + + +N + + +L
Sbjct: 120 --------------------------DTDSLIHLKNLEILSIRNNKLKS-IVMLGFLSKL 152
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
E L L N T L +L+ + +++T
Sbjct: 153 EVLDLHGNEIT--NTGGLTRLKKVNWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 28/118 (23%), Positives = 45/118 (38%), Gaps = 11/118 (9%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
S L++LTKLE L + N + L + L + L NN+ S L +L+ +
Sbjct: 79 SPLKDLTKLEELSVNRNRLKN-LNGIPSA-CLSRLFLDNNELRDTDS--LIHLKNLEILS 134
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI 203
I NN S L S L+ + IT + G + + L + +
Sbjct: 135 IRNNKLKSIV---MLGFLSKLEVLDLHGNEIT----NTGGLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 27/151 (17%), Positives = 55/151 (36%), Gaps = 29/151 (19%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+L +L LE L ++ N + + L L+ LEV+ L N+ T+ T L + I+
Sbjct: 122 DSLIHLKNLEILSIRNNKLKS-IVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWID 178
Query: 146 IDNNPFSSWE--------IPQSLRNASGLQ--------NFSANSANITGQIPSFFGPDEF 189
+ + I ++++ G S + ++P +
Sbjct: 179 LTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVY------ 232
Query: 190 PGLTILHLAFNQL--IGGLPASFSGSQIQSL 218
+ F++ +G A F G+ Q +
Sbjct: 233 --TDEVSYKFSEYINVGETEAIFDGTVTQPI 261
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 36/217 (16%), Positives = 68/217 (31%), Gaps = 62/217 (28%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+ +Q T L+ L L N IS L L L LE + ++ N+ ++ + L +
Sbjct: 57 AGMQFFTNLKELHLSHNQISD-LSPLKDLTKLEELSVNRNRLKNLN---GIPSACLSRLF 112
Query: 146 IDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205
+DNN LR+ L + L IL + N
Sbjct: 113 LDNN---------ELRDTDSLIH--------------------LKNLEILSIRNN----- 138
Query: 206 LPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL 265
+++S I ++ ++ L+ + LH N + + +K++
Sbjct: 139 --------KLKS---------------IVMLGFLSKLEVLDLHGNEITN-TGGLTRLKKV 174
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302
+ L +L V + P
Sbjct: 175 NWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISP 211
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 39/193 (20%), Positives = 78/193 (40%), Gaps = 37/193 (19%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+++ LGRG + V++ + + K+ VK ++ + K EI +L +
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVK-----ILKPVKKKKIKREIKILENL 87
Query: 649 R-HRHLVALLGHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
R +++ L D + LVFE++ + + LT D+
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--------------QTLTDY-DI 132
Query: 706 A-------RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA-KVADFGLVRLAPEGKGSIE 757
+ ++Y H +HRD+KP N+++ + R ++ D+GL G+
Sbjct: 133 RFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189
Query: 758 TRIAGTFGYLAPE 770
R+A + + PE
Sbjct: 190 -RVA-SRYFKGPE 200
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 5e-12
Identities = 33/237 (13%), Positives = 59/237 (24%), Gaps = 55/237 (23%)
Query: 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRM------EAGVISGKGLTEFKSEIAVL 645
T +G G FG V++ D T +A+K + K E EI +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 646 TKV---------RHRHLVALLGHCL------------------------------DGNEK 666
++ R + L ++
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLK 726
+V E+ G + K +I + + F HRDL
Sbjct: 138 FIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 727 PSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWSSCSYW 783
N+LL K+ + + ++ I + E + S
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI-IDYTLSRLERDGIVVFCDVSMD 245
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 32/210 (15%), Positives = 68/210 (32%), Gaps = 69/210 (32%)
Query: 57 CKWNHVVCIEDKRITRIQIG----------HQNLQGTLPSN--LQNLTKLERLELQWNSI 104
C+ V C ++++ +I + N L + + L +L ++ N I
Sbjct: 11 CEGTTVDC-SNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI 69
Query: 105 SGPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRN 162
+ + G + + ++L++N+ +V F GL SL+++ + +N + +
Sbjct: 70 TD-IEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITC--VG----- 121
Query: 163 ASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNG 222
F + +L L NQ+ P +F
Sbjct: 122 ------------------NDSF--IGLSSVRLLSLYDNQITTVAPGAFD----------- 150
Query: 223 QNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252
+ SL + L +N F
Sbjct: 151 ---------------TLHSLSTLNLLANPF 165
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 37/161 (22%), Positives = 62/161 (38%), Gaps = 14/161 (8%)
Query: 95 ERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSS 153
E+L+LQ ++ + GL L + L NQ ++ + F L+ L ++ + NN +S
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 154 WE--IPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS-F 210
+ L L + F D L L L NQL +PA F
Sbjct: 98 LPLGVFDHLTQ---LDKLYLGGNQLKSLPSGVF--DRLTKLKELRLNTNQL-QSIPAGAF 151
Query: 211 SG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
+ +Q+L ++ + G D + L+ I L N
Sbjct: 152 DKLTNLQTLSLSTNQLQSVPHGAFD---RLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 24/63 (38%), Positives = 34/63 (53%), Gaps = 3/63 (4%)
Query: 91 LTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148
LTKL+ L L N + +P+ + L +L+ + LS NQ SVP F L LQ+I +
Sbjct: 130 LTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFG 188
Query: 149 NPF 151
N F
Sbjct: 189 NQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 39/187 (20%), Positives = 66/187 (35%), Gaps = 36/187 (19%)
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWE--IPQSLRNASGLQNFSAN 172
A E + L + ++ F GL+ L + +D N + + L L
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTE---LGTLGLA 91
Query: 173 SANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGG 232
+ + F D L L+L NQL +SL +G
Sbjct: 92 NNQLASLPLGVF--DHLTQLDKLYLGGNQL-------------KSL----PSG------- 125
Query: 233 IDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLK 290
V +T LKE+ L++N +P F + L++LSL N + +L L+
Sbjct: 126 --VFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQ 182
Query: 291 IVNMTNN 297
+ + N
Sbjct: 183 TITLFGN 189
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 34/151 (22%), Positives = 57/151 (37%), Gaps = 26/151 (17%)
Query: 595 FSEENI-----LGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIA 643
F + + LGRG FG V + + +AVK ++ G + SE+
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELK 77
Query: 644 VLTKV-RHRHLVALLGHCLDGNEKLLV-FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTI 701
+L + H ++V LLG C L+V E+ G LS ++ ++R
Sbjct: 78 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL------------RSKRNEF 125
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732
+G + G + I DLK +
Sbjct: 126 VPYKTKGARFRQGKDYVGAIPVDLKRRLDSI 156
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 22/57 (38%), Positives = 30/57 (52%), Gaps = 3/57 (5%)
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
L + + VA+G+E+L A + IHRDL NILL + K+ DFGL R
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 42/200 (21%), Positives = 69/200 (34%), Gaps = 50/200 (25%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS--LNGL 114
C N V C K +T I LP + + L+ N+I +P +
Sbjct: 11 CSNNIVDC-RGKGLTEIPTN-------LPETIT------EIRLEQNTIKV-IPPGAFSPY 55
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174
L + LSNNQ + + D F GL SL S+ + N + +P
Sbjct: 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE--LP----------------- 96
Query: 175 NITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPA-SFSG-SQIQSLWVNGQNGNAKLGGG 232
S F + L +L L N++ L +F + L + N + G
Sbjct: 97 ------KSLF--EGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLY-DNKLQTIAKG 146
Query: 233 IDVIQNMTSLKEIWLHSNAF 252
+ +++ + L N F
Sbjct: 147 T--FSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 31/185 (16%), Positives = 58/185 (31%), Gaps = 56/185 (30%)
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174
++ + L N +P F+ L+ I++ NN S +
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE--LA----------------- 72
Query: 175 NITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGID 234
P F L L L N++ LP
Sbjct: 73 ------PDAF--QGLRSLNSLVLYGNKI-TELPK-------------------------S 98
Query: 235 VIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 292
+ + + SL+ + L++N + L F + L LSL DN + L +++ +
Sbjct: 99 LFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTM 157
Query: 293 NMTNN 297
++ N
Sbjct: 158 HLAQN 162
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 28/171 (16%)
Query: 91 LTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNP 150
L + L L N + + +L L +L ++L+ NQ S+P+ F L++L+ + + N
Sbjct: 62 LPNVRYLALGGNKLH-DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQ 120
Query: 151 FSSWE--IPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPA 208
S + L N L + + F D+ LT L L++NQL LP
Sbjct: 121 LQSLPDGVFDKLTN---LTYLNLAHNQLQSLPKGVF--DKLTNLTELDLSYNQL-QSLPE 174
Query: 209 SFSG-----SQIQSLWVNGQNGNAKL----GGGIDVIQNMTSLKEIWLHSN 250
G +Q++ L + +L G D +TSL+ IWLH N
Sbjct: 175 ---GVFDKLTQLKDLRLY----QNQLKSVPDGVFD---RLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 54/238 (22%), Positives = 86/238 (36%), Gaps = 50/238 (21%)
Query: 92 TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF 151
+ + L+ S++ + N L S++ ++ +N+ SV L +++ + + N
Sbjct: 19 AETIKANLKKKSVTD-AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKL 75
Query: 152 SSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS-F 210
I + E LT L L NQL LP F
Sbjct: 76 HD--------------------------ISAL---KELTNLTYLILTGNQL-QSLPNGVF 105
Query: 211 SG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLES 267
+ ++ L + N L G V +T+L + L N LP F + L
Sbjct: 106 DKLTNLKELVLVE-NQLQSLPDG--VFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTE 161
Query: 268 LSLRDNFFTG-P--VPDSLVKLESLKIVNMTNNLLQGPVPE--FDRSVSLDMAKGSNN 320
L L N P V D L +L+ L + N L+ VP+ FDR SL +N
Sbjct: 162 LDLSYNQLQSLPEGVFDKLTQLKDL---RLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 26/65 (40%), Positives = 33/65 (50%), Gaps = 9/65 (13%)
Query: 91 LTKLERLELQWNSISGPLPSL-NG----LASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
LT L L+L +N L SL G L L+ + L NQ SVP F L+SLQ I
Sbjct: 156 LTNLTELDLSYNQ----LQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 211
Query: 146 IDNNP 150
+ +NP
Sbjct: 212 LHDNP 216
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 39/168 (23%), Positives = 73/168 (43%), Gaps = 29/168 (17%)
Query: 591 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 649
V N + +G G FG +Y G + G ++A+K +E L E + ++
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQL---HIESKIYKMMQ 62
Query: 650 H-RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IA 702
+ + +G+ ++V E + G +FN+ +R+ + +A
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFC---------SRKFSLKTVLLLA 111
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK---VADFGLVR 747
+ +EY+H ++FIHRD+KP N L+G + + DFGL +
Sbjct: 112 DQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 26/174 (14%), Positives = 58/174 (33%), Gaps = 41/174 (23%)
Query: 601 LGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL--- 657
+G+GGFG +Y +++ + + +E+ + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 658 --------------GHCLDGNEK--LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT- 700
G + ++ + G+ + I+ +R +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEAN---------AKRFSR 151
Query: 701 -----IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV--ADFGLVR 747
++L + +EY+H ++H D+K SN+LL +V D+GL
Sbjct: 152 KTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 31/202 (15%), Positives = 67/202 (33%), Gaps = 66/202 (32%)
Query: 586 QVLRNVT-NNFSEENILGRGGFGTVYKGE---------LHDGTKIAVKRMEAGVISGKGL 635
VL + + + ++ R G +Y+ K ++K ++A G+
Sbjct: 34 TVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDA--KDGRLF 90
Query: 636 TEFKS--------EIAVLTKV-------------------RHRHLV-ALLGHCLDGNEKL 667
E ++ K+ ++R LV LG L +
Sbjct: 91 NEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSL---QSA 147
Query: 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKP 727
+ P+ LS + + L +A + +E+LH ++H ++
Sbjct: 148 --LDVSPKHVLS----------ERSV-----LQVACRLLDALEFLH---ENEYVHGNVTA 187
Query: 728 SNILLGDDMRAKV--ADFGLVR 747
NI + + +++V A +G
Sbjct: 188 ENIFVDPEDQSQVTLAGYGFAF 209
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.1 bits (150), Expect = 5e-10
Identities = 25/97 (25%), Positives = 39/97 (40%), Gaps = 4/97 (4%)
Query: 78 QNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTG 137
+ T+ +L+ L + L+L N + P+L L LEV+ S+N +V
Sbjct: 449 AHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG--VAN 506
Query: 138 LSSLQSIEIDNNPFSSWEIPQSLRNASGLQ--NFSAN 172
L LQ + + NN Q L + L N N
Sbjct: 507 LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 3e-09
Identities = 18/99 (18%), Positives = 36/99 (36%), Gaps = 7/99 (7%)
Query: 60 NHVVCIED----KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLA 115
+ + +T + + H L+ LP L L LE L+ N++ + + L
Sbjct: 451 KDLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLP 508
Query: 116 SLEVVMLSNNQFTSVPS-DFFTGLSSLQSIEIDNNPFSS 153
L+ ++L NN+ + L + + N
Sbjct: 509 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 33/258 (12%), Positives = 79/258 (30%), Gaps = 23/258 (8%)
Query: 49 LGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPL 108
+ + V + + ++ + +L R EL +
Sbjct: 306 AASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQ 365
Query: 109 PSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQN 168
L L+ + N T + +++++ + + +L+ ++
Sbjct: 366 SELESCKELQELEPENKWCL------LTIILLMRALDPLLYEKETLQYFSTLKAVDPMRA 419
Query: 169 FSANSANITGQIPSFFGPDEFPGLTILHLAFNQL-----IGGLPASFSGSQIQSLWVNGQ 223
+ + + E+ + +LHLA L + L + L ++
Sbjct: 420 AYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLL------LVTHLDLSH- 472
Query: 224 NGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTG-PVPDS 282
N L + + L+ + NA + + + +L+ L L +N
Sbjct: 473 NRLRALPPALA---ALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQP 528
Query: 283 LVKLESLKIVNMTNNLLQ 300
LV L ++N+ N L
Sbjct: 529 LVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 52.1 bits (124), Expect = 6e-07
Identities = 35/269 (13%), Positives = 76/269 (28%), Gaps = 26/269 (9%)
Query: 37 LALKKSLNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLER 96
L L P + + +HV + + Q+ + + + +
Sbjct: 274 LLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVL 333
Query: 97 LELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF--SSW 154
L+ + + L E LS + T + S LQ +E +N +
Sbjct: 334 LKDRPECWCRDSATDEQLFRCE---LSVEKSTVLQS-ELESCKELQELEPENKWCLLTII 389
Query: 155 EIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPA---SFS 211
+ ++L + + + P + L + +
Sbjct: 390 LLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLA 449
Query: 212 GSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLR 271
+ + ++ + + + L N P + ++ LE L
Sbjct: 450 HKDLTV---------------LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQAS 494
Query: 272 DNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300
DN D + L L+ + + NN LQ
Sbjct: 495 DNALE--NVDGVANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 2e-05
Identities = 25/160 (15%), Positives = 51/160 (31%), Gaps = 12/160 (7%)
Query: 280 PDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPS---------PGACD 330
E L ++ E + L + N +CL + P +
Sbjct: 342 CRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYE 401
Query: 331 PRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEF 390
S +K + + + + + + ++ V++ +LT +
Sbjct: 402 KETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VL-CHL 459
Query: 391 ASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+ L L+ N L +P L+ L L+ L S+N L
Sbjct: 460 EQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNAL 498
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 8e-05
Identities = 21/84 (25%), Positives = 39/84 (46%), Gaps = 8/84 (9%)
Query: 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430
+T ++ L + P A+ + L+ L +DN L + +G++ L L+EL + NN+L
Sbjct: 464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRL 520
Query: 431 -----YGKIPSFKSNAIVNTDGNP 449
+ S ++N GN
Sbjct: 521 QQSAAIQPLVSCPRLVLLNLQGNS 544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 33/170 (19%), Positives = 66/170 (38%), Gaps = 31/170 (18%)
Query: 591 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 649
V ++ +G G FG +++G L + ++A+K E L + E +
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDAPQL---RDEYRTYKLLA 63
Query: 650 H-RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IA 702
+ + +G +LV + + +L + + R+ + A
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLC---------GRKFSVKTVAMAA 112
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK-----VADFGLVR 747
+ V+ +H +S ++RD+KP N L+G V DFG+V+
Sbjct: 113 KQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 39/177 (22%), Positives = 68/177 (38%), Gaps = 32/177 (18%)
Query: 584 SIQVLRNVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEI 642
S+ VL V NF +G G FG + G+ L+ +A+K +E L E
Sbjct: 1 SMGVLM-VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQL---HLEY 55
Query: 643 AVLTKVRH-RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT- 700
++ + + G +V E + G +F+ +R +
Sbjct: 56 RFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLC---------DRTFSL 104
Query: 701 -----IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK-----VADFGLVR 747
IA+ + +EY+H ++ I+RD+KP N L+G + DF L +
Sbjct: 105 KTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 35/172 (20%), Positives = 62/172 (36%), Gaps = 40/172 (23%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGL-TEFK-----SEIAVLTKVRHRHL 653
+G GGFG +Y + K A ++ L +E K ++ + K R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 654 VALLG----------HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT--- 700
+ LG + + +V E + G + I N
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQ----------NGTFKKST 152
Query: 701 ---IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV--ADFGLVR 747
+ + + +EY+H ++H D+K +N+LLG +V AD+GL
Sbjct: 153 VLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 55/203 (27%)
Query: 600 ILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVI-SGKGLTE-FKSEIAVLTKVR------- 649
LG G F TV+ + + + T +A+K ++ K TE + EI +L +V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 650 ----HRHLVALLGH-----------CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLE 694
H++ LL H + VFE + + L I + G+ PL
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVM-------VFEVLGE-NLLALIKKYEHRGI-PLI 131
Query: 695 WNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA------KVADFGLVRL 748
+ ++ I+ + G++Y+H IH D+KP N+L+ K+AD G
Sbjct: 132 YVKQ--ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 749 APEGKGS-IETRIAGTFGYLAPE 770
E + I+TR Y +PE
Sbjct: 188 YDEHYTNSIQTRE-----YRSPE 205
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 15/95 (15%), Positives = 35/95 (36%), Gaps = 1/95 (1%)
Query: 76 GHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFF 135
++ +G L +LE L ++ + +L L L+ + LS+N+ +
Sbjct: 26 NSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSDNRVSGGLEVLA 84
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFS 170
+L + + N + L+ L++
Sbjct: 85 EKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 15/88 (17%), Positives = 37/88 (42%), Gaps = 3/88 (3%)
Query: 213 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRD 272
S ++ L ++ N G + L+ + + + + + + +L+ L L D
Sbjct: 17 SDVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSD 73
Query: 273 NFFTGPVPDSLVKLESLKIVNMTNNLLQ 300
N +G + K +L +N++ N ++
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 27/87 (31%), Positives = 43/87 (49%), Gaps = 5/87 (5%)
Query: 68 KRITRIQIGHQNLQGTLPSNL-QNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSN 124
K +T I + + + TL + N+T+L L L +N + +P +GL SL ++ L
Sbjct: 54 KHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLSLHG 111
Query: 125 NQFTSVPSDFFTGLSSLQSIEIDNNPF 151
N + VP F LS+L + I NP
Sbjct: 112 NDISVVPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 23/84 (27%), Positives = 38/84 (45%), Gaps = 5/84 (5%)
Query: 77 HQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSDF 134
N +P L N L ++L N IS L + + + L ++LS N+ +P
Sbjct: 39 DGNQFTLVPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNRLRCIPPRT 97
Query: 135 FTGLSSLQSIEIDNNPFSSWEIPQ 158
F GL SL+ + + N S +P+
Sbjct: 98 FDGLKSLRLLSLHGNDISV--VPE 119
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 24/156 (15%), Positives = 49/156 (31%), Gaps = 53/156 (33%)
Query: 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSW 154
L L N + L+ L ++ LSNN+ +++ + F+ ++ L ++ + N
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC- 92
Query: 155 EIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQ 214
IP P F D L +L L N +
Sbjct: 93 -IP-----------------------PRTF--DGLKSLRLLSLHGNDI------------ 114
Query: 215 IQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
+ G ++++L + + +N
Sbjct: 115 -SVV-PEG------------AFNDLSALSHLAIGAN 136
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 1e-08
Identities = 16/115 (13%), Positives = 27/115 (23%), Gaps = 15/115 (13%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP--SLNGL 114
+ + +L L L ++ L L GL
Sbjct: 7 PHGSSGLRCTRDGALDS-----------LHHLPGAENLTELYIENQQHLQHLELRDLRGL 55
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNF 169
L + + + V D F L + + N S + LQ
Sbjct: 56 GELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES--LSWKTVQGLSLQEL 108
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 4e-05
Identities = 19/116 (16%), Positives = 37/116 (31%), Gaps = 30/116 (25%)
Query: 186 PDEFPG---LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
PG LT L++ Q + L ++ + L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLEL-------------------------RDLRGLGEL 58
Query: 243 KEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+ + + + PD F +L L+L N + V+ SL+ + ++ N
Sbjct: 59 RNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 20/104 (19%), Positives = 40/104 (38%), Gaps = 9/104 (8%)
Query: 123 SNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIP-QSLRNASGLQNFSANSANITGQIP 181
+ + G +L + I+N + + LR L+N + + + +
Sbjct: 16 TRDGALDSLHHL-PGAENLTELYIENQQ-HLQHLELRDLRGLGELRNLTIVKSGLR-FVA 72
Query: 182 --SFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQ 223
+F P L+ L+L+FN L + G +Q L ++G
Sbjct: 73 PDAFHF---TPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 21/129 (16%), Positives = 44/129 (34%), Gaps = 12/129 (9%)
Query: 236 IQNMTSLKEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 293
+ +L E+++ + L G+ +L +L++ + PD+ L +N
Sbjct: 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86
Query: 294 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENW 353
++ N L+ + + +SL S N P C L L + +
Sbjct: 87 LSFNALESLSWKTVQGLSLQELVLSGN-----PLHCSCALRWLQRWEE-----EGLGGVP 136
Query: 354 KGNDPCSDW 362
+ C
Sbjct: 137 EQKLQCHGQ 145
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 41.3 bits (96), Expect = 9e-04
Identities = 14/86 (16%), Positives = 27/86 (31%), Gaps = 14/86 (16%)
Query: 359 CSDWIGVTCTK-------------GNITVINFQKMNLTGTISPE-FASFKSLQRLILADN 404
G+ CT+ N+T + + + L+ L + +
Sbjct: 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 405 NLSGMIPEGLSVLGALKELDVSNNQL 430
L + P+ L L++S N L
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNAL 92
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 29/168 (17%)
Query: 591 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 649
V N F +G G FG +Y G + ++A+K +E L E + ++
Sbjct: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQL---LYESKIYRILQ 60
Query: 650 -HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLT------IA 702
+ + ++G+ +LV + + +L +FN+ +R+L+ +A
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFC---------SRKLSLKTVLMLA 109
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK---VADFGLVR 747
+ VE++H +SF+HRD+KP N L+G RA + DFGL +
Sbjct: 110 DQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 39/166 (23%)
Query: 599 NILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEF----KSEIAVLTKVRHR-- 651
+++G+G FG V K + +A+K +I K F + E+ +L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIK-----II--KNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 652 ----HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLK-------PLEWNRRLT 700
++V L H + N LVFE LS +++ + L+ L R+
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEM-----LSYNLY----DLLRNTNFRGVSLNLTRK-- 161
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA--KVADFG 744
A + + +L S IH DLKP NILL + R+ K+ DFG
Sbjct: 162 FAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 39/166 (23%), Positives = 66/166 (39%), Gaps = 43/166 (25%)
Query: 600 ILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEF----KSEIAVLTKVRHR--- 651
++G+G FG V K +A+K ++ + F EI +L +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALK-----MV--RNEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 652 ---HLVALL------GH-CLDGNEKLLVFEYMPQGTLSRHIFNWAEEG-LKPLEWNRRLT 700
+++ +L H C+ FE LS +++ ++ +
Sbjct: 157 NTMNVIHMLENFTFRNHICM-------TFEL-----LSMNLYELIKKNKFQGFSLPLVRK 204
Query: 701 IALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA--KVADFG 744
A + + ++ LH IH DLKP NILL R+ KV DFG
Sbjct: 205 FAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 7e-08
Identities = 16/93 (17%), Positives = 32/93 (34%), Gaps = 1/93 (1%)
Query: 76 GHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFF 135
++ G + LE L L + + +L L L+ + LS N+
Sbjct: 33 NCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSENRIFGGLDMLA 91
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQN 168
L +L + + N + L+ L++
Sbjct: 92 EKLPNLTHLNLSGNKLKDISTLEPLKKLECLKS 124
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 24/101 (23%), Positives = 45/101 (44%), Gaps = 5/101 (4%)
Query: 60 NHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTK---LERLELQWNSISGPLPSL-NGLA 115
++ IE + + +L ++ NL K L++LEL N I G L L L
Sbjct: 36 SNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLP 95
Query: 116 SLEVVMLSNNQFTSVPS-DFFTGLSSLQSIEIDNNPFSSWE 155
+L + LS N+ + + + L L+S+++ N ++
Sbjct: 96 NLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 20/72 (27%), Positives = 36/72 (50%), Gaps = 4/72 (5%)
Query: 83 TLPSNL-QNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLS 139
+ N + + ++ L+L N I + + GL L+ + L +NQ + V F L+
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN 126
Query: 140 SLQSIEIDNNPF 151
SL S+ + +NPF
Sbjct: 127 SLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 36/200 (18%), Positives = 56/200 (28%), Gaps = 73/200 (36%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG--PLPSLNGL 114
C+ V C + + I P ++ T L L N + L
Sbjct: 8 CEGTTVDC-TGRGLKEI-----------PRDIPLHT--TELLLNDNELGRISSDGLFGRL 53
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174
L + L NQ T + + F G S +Q +++ N
Sbjct: 54 PHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE--------------------- 92
Query: 175 NITGQIPS--FFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGG 232
I + F L L+L NQ+ +P SF
Sbjct: 93 -----ISNKMF---LGLHQLKTLNLYDNQISCVMPGSFE--------------------- 123
Query: 233 IDVIQNMTSLKEIWLHSNAF 252
++ SL + L SN F
Sbjct: 124 -----HLNSLTSLNLASNPF 138
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 17/94 (18%), Positives = 35/94 (37%), Gaps = 5/94 (5%)
Query: 79 NLQGTLPSNLQNL----TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDF 134
+L+G ++NL + + ++ N I L L L+ ++++NN+ +
Sbjct: 25 DLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGL 83
Query: 135 FTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQN 168
L L + + NN L + L
Sbjct: 84 DQALPDLTELILTNNSLVELGDLDPLASLKSLTY 117
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 7e-05
Identities = 25/129 (19%), Positives = 44/129 (34%), Gaps = 14/129 (10%)
Query: 173 SANITGQIPSFFGPDEFPGLTILHLAFNQL--IGGLPASFSGSQIQSLWVNGQNGNAKLG 230
+A + Q + L L ++ I L A+ Q ++ + N KL
Sbjct: 5 TAELIEQAAQY---TNAVRDRELDLRGYKIPVIENLGATLD--QFDAIDFSD-NEIRKLD 58
Query: 231 GGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVP-DSLVKLES 288
G + LK + +++N + L L L +N D L L+S
Sbjct: 59 G----FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS 114
Query: 289 LKIVNMTNN 297
L + + N
Sbjct: 115 LTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 23/101 (22%), Positives = 36/101 (35%), Gaps = 5/101 (4%)
Query: 60 NHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLE---LQWNSISGPLPSL-NGLA 115
+ IE+ T Q + L L RL+ + N I L L
Sbjct: 29 YKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88
Query: 116 SLEVVMLSNNQFTSVPS-DFFTGLSSLQSIEIDNNPFSSWE 155
L ++L+NN + D L SL + I NP ++ +
Sbjct: 89 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 129
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 31/161 (19%), Positives = 57/161 (35%), Gaps = 33/161 (20%)
Query: 92 TKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNP 150
T + L L N I+ + L +L+ + L +NQ ++P F L+ L +++ N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99
Query: 151 FSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASF 210
+ +P + F D L L + N+L LP
Sbjct: 100 LTV--LP-----------------------SAVF--DRLVHLKELFMCCNKL-TELPRGI 131
Query: 211 -SGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
+ + L ++ + G D ++SL +L N
Sbjct: 132 ERLTHLTHLALDQNQLKSIPHGAFD---RLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 20/64 (31%), Positives = 25/64 (39%), Gaps = 8/64 (12%)
Query: 91 LTKLERLELQWNSISGPLPSL----NGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146
L L+ L + N L L L L + L NQ S+P F LSSL +
Sbjct: 111 LVHLKELFMCCNK----LTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYL 166
Query: 147 DNNP 150
NP
Sbjct: 167 FGNP 170
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 45/156 (28%), Positives = 63/156 (40%), Gaps = 38/156 (24%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEF-KSEIAVLTKVR--------H 650
LG G F TV+ + +A+K V S + TE EI +L VR
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKV----VKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 651 RHLVALLGH-----------CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 699
+V LL C+ VFE + L + I +GL PL ++
Sbjct: 101 EMVVQLLDDFKISGVNGTHICM-------VFEVL-GHHLLKWIIKSNYQGL-PLPCVKK- 150
Query: 700 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735
I V +G++YLH IH D+KP NILL +
Sbjct: 151 -IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVN 183
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 31/168 (18%), Positives = 63/168 (37%), Gaps = 39/168 (23%)
Query: 87 NLQNLTKLERLEL--QWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSI 144
T+ E++EL I +L+ L + + + LS N + +G+ +L+ +
Sbjct: 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRIL 75
Query: 145 EIDNNPFSSWEIPQSLRNASGLQ--NFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL 202
+ N E ++ + L+ S N QI S G ++ L +L+++ N
Sbjct: 76 SLGRNLIKKIENLDAVADT--LEELWISYN------QIASLSGIEKLVNLRVLYMSNN-- 125
Query: 203 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
+I + G ID + + L+++ L N
Sbjct: 126 -----------KITNW------------GEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 22/84 (26%), Positives = 40/84 (47%), Gaps = 4/84 (4%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLA-SLEVVMLSNNQFTSVPSDFFTGLSSLQSI 144
S+L + L L L N I + +L+ +A +LE + +S NQ S+ L +L+ +
Sbjct: 64 SSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASLSG--IEKLVNLRVL 120
Query: 145 EIDNNPFSSWEIPQSLRNASGLQN 168
+ NN ++W L L++
Sbjct: 121 YMSNNKITNWGEIDKLAALDKLED 144
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 34/172 (19%), Positives = 59/172 (34%), Gaps = 40/172 (23%)
Query: 600 ILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEF----KSEIAVLTKVRHR--- 651
+G G FG V + + + AVK V+ + + ++ K E +L K+++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVK-----VV--RNIKKYTRSAKIEADILKKIQNDDIN 94
Query: 652 --HLVALL------GH-CLDGNEKLLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTI 701
++V H CL +FE L ++
Sbjct: 95 NNNIVKYHGKFMYYDHMCL-------IFE-----PLGPSLYEIITRNNYNGFHIEDIKLY 142
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753
+++ + + YL + S H DLKP NILL D K +
Sbjct: 143 CIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 28/65 (43%), Positives = 32/65 (49%), Gaps = 9/65 (13%)
Query: 91 LTKLERLELQWNSISGPLPSL-NG----LASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
LTKL L L N L SL NG L L+ + L NQ SVP F L+SLQ I
Sbjct: 75 LTKLTILYLHENK----LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIW 130
Query: 146 IDNNP 150
+ NP
Sbjct: 131 LHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 40/161 (24%), Positives = 58/161 (36%), Gaps = 56/161 (34%)
Query: 92 TKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
+ RLEL+ N + LP + L L + LS NQ S+P F L+ L + + N
Sbjct: 28 SSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209
S +P + F D+ L L L NQL
Sbjct: 87 KLQS--LPNGV--------F-----------------DKLTQLKELALDTNQL------- 112
Query: 210 FSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
+S+ G D +TSL++IWLH+N
Sbjct: 113 ------KSV----------PDGIFD---RLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 24/80 (30%), Positives = 38/80 (47%), Gaps = 4/80 (5%)
Query: 77 HQNLQGTLPSNL-QNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSD 133
N +LP + LT+L +L L N I LP + L L ++ L N+ S+P+
Sbjct: 36 ESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKLQSLPNG 94
Query: 134 FFTGLSSLQSIEIDNNPFSS 153
F L+ L+ + +D N S
Sbjct: 95 VFDKLTQLKELALDTNQLKS 114
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 26/66 (39%), Positives = 35/66 (53%), Gaps = 9/66 (13%)
Query: 91 LTKLERLELQWNSISGPLPSL-NG----LASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
LT+L+ L L N L SL +G L L+ + L NQ SVP F L+SLQ I
Sbjct: 99 LTQLKELALNTNQ----LQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 154
Query: 146 IDNNPF 151
+ +NP+
Sbjct: 155 LHDNPW 160
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 44/172 (25%), Positives = 66/172 (38%), Gaps = 42/172 (24%)
Query: 85 PSNLQNLTKLERLELQWNSISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQS 143
P+ + T L+L+ NS+ P + L SL + L N+ S+P+ F L+SL
Sbjct: 23 PTGIPAQT--TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTY 80
Query: 144 IEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI 203
+ + N S +P F D+ L L L NQL
Sbjct: 81 LNLSTNQLQS--LP-----------------------NGVF--DKLTQLKELALNTNQL- 112
Query: 204 GGLPASFSG-----SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250
LP G +Q++ L + + G D +TSL+ IWLH N
Sbjct: 113 QSLPD---GVFDKLTQLKDLRLYQNQLKSVPDGVFD---RLTSLQYIWLHDN 158
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 6e-06
Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 4/77 (5%)
Query: 77 HQNLQGTLPSNL-QNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSD 133
+ N L + LT+L RL+L N ++ LP+ + L L + L++NQ S+P
Sbjct: 38 YDNQITKLEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLTQLTQLSLNDNQLKSIPRG 96
Query: 134 FFTGLSSLQSIEIDNNP 150
F L SL I + NNP
Sbjct: 97 AFDNLKSLTHIWLLNNP 113
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 9e-06
Identities = 38/176 (21%), Positives = 65/176 (36%), Gaps = 42/176 (23%)
Query: 600 ILGRGGFGTVYKGELHDGTK--IAVKRMEAGVISGKGLTEF----KSEIAVLTKVRHR-- 651
LG G FG V + H K +A+K +I + + ++ + EI VL K++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALK-----II--RNVGKYREAARLEINVLKKIKEKDK 78
Query: 652 ----HLVALL------GH-CLDGNEKLLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRL 699
V + GH C+ FE L ++ F + +E +P
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCI-------AFE-----LLGKNTFEFLKENNFQPYPLPHVR 126
Query: 700 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755
+A + + +LH H DLKP NIL + + + K +
Sbjct: 127 HMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 19/62 (30%), Positives = 31/62 (50%), Gaps = 3/62 (4%)
Query: 91 LTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148
L L++L N ++ +P+ + L L + L++N S+P F L SL I + N
Sbjct: 56 LVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYN 114
Query: 149 NP 150
NP
Sbjct: 115 NP 116
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-05
Identities = 8/37 (21%), Positives = 18/37 (48%)
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF 151
++L+ N T++P L +L++ + NP+
Sbjct: 31 VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 3e-05
Identities = 68/429 (15%), Positives = 131/429 (30%), Gaps = 96/429 (22%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLAS 116
C V C D +I + + + N T+ LQ L L +++ W S S ++
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL--LYQIDPNWTSRSDHSSNI----- 223
Query: 117 LEVVMLSNNQFTSVPSDFFTGLSSLQSIEI-DNNPFSSWEIPQSL----------RNASG 165
L + + + + N + + + R
Sbjct: 224 ----KLRIHSIQAELRRLLKSKPYENCLLVLLN--VQNAKAWNAFNLSCKILLTTRFKQ- 276
Query: 166 LQNFSANSANITGQIPSF-----FGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWV 220
SA T I PDE ++L + LP ++ +
Sbjct: 277 --VTDFLSAATTTHISLDHHSMTLTPDE--VKSLLLKYLDCRPQDLP-----REVLT--- 324
Query: 221 NGQNGNAKLGGGI-DVIQNMTSLKEIWLHSN--AFSGPLPDFSGVKQLESLSLRDNF--- 274
N + I + I++ + + W H N + + + LE R F
Sbjct: 325 ----TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS--LNVLEPAEYRKMFDRL 378
Query: 275 --FTGPVPDSLVKLESLKIV--NMTNNLLQGPVPEFDRSVSLDMAKGSNNFC--LPS--- 325
F P P + + L ++ ++ + + V + + SL + K +PS
Sbjct: 379 SVF--P-PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKY-SL-VEKQPKESTISIPSIYL 433
Query: 326 ----PGACDPRLNALLSVVKLMGY-PQRFAENWKGNDPCSD--W---IGVTCTKGNITVI 375
+ L+ + + Y + ++ P D + IG
Sbjct: 434 ELKVKLENEYALHRSI----VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIE---- 485
Query: 376 NFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALK-------ELDVSNN 428
+ ++M L + F F+ L++ I D+ L+ L LK + D
Sbjct: 486 HPERMTLFRMV---FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYE 542
Query: 429 QLYGKIPSF 437
+L I F
Sbjct: 543 RLVNAILDF 551
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 3e-04
Identities = 67/512 (13%), Positives = 138/512 (26%), Gaps = 151/512 (29%)
Query: 303 VPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYP----QRFAE------- 351
V + +S+ ++K + + S D L L+ Q+F E
Sbjct: 38 VQDMPKSI---LSKEEIDHIIMSK---DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY 91
Query: 352 NW-------KGNDPCSDWIGVTCTKGNI--TVINFQKMNLTGTISPEFASFKS-LQRLIL 401
+ + P + + F K N++ + + L L
Sbjct: 92 KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS--RLQPYLKLRQALLELRP 149
Query: 402 ADN-NLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSNAI----VNTDGNPD--IGKE 454
A N + G++ G + + DV + K+ I + +P+ +
Sbjct: 150 AKNVLIDGVLGSGKTWVAL----DVCLSY---KVQCKMDFKIFWLNLKNCNSPETVLEML 202
Query: 455 KSSSFQGSPSGSPTGTGSGNASSTENGVKNSSALITVILFCVIGGAFVISLTGVLVFCLC 514
+ +Q P+ + S N + ++ L +L
Sbjct: 203 QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE-------------------LRRLL----- 238
Query: 515 KKKQKRFSR-------VQSP---NAMVIHPRHSGSENSESVKITVAGSNVSVGAISETHT 564
K K + VQ+ NA + + + +T V+ + T T
Sbjct: 239 --KSKPYENCLLVLLNVQNAKAWNAFNLSCK---------ILLTTRFKQVTDFLSAATTT 287
Query: 565 VPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEE----NILGRGGFGTVYKGELHDGT-- 618
S + + + + ++ L + E N + DG
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAE----SIRDGLAT 343
Query: 619 -----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE-- 671
+ ++ T +S + VL +R + ++L VF
Sbjct: 344 WDNWKHVNCDKLT---------TIIESSLNVLEPAEYRKMF----------DRLSVFPPS 384
Query: 672 -YMPQGTLSRHIFNWA-------EEGLKPLEWNRRLTIALDVARGVEYLHGLA------- 716
++P LS + W + L L + + +
Sbjct: 385 AHIPTILLS--LI-WFDVIKSDVMVVVNKLH-KYSL-VEKQPKESTISIPSIYLELKVKL 439
Query: 717 ------HQSFIHRDLKPSNILLGDDMRAKVAD 742
H+S + P DD+ D
Sbjct: 440 ENEYALHRSIVDHYNIPKT-FDSDDLIPPYLD 470
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 5e-04
Identities = 45/319 (14%), Positives = 88/319 (27%), Gaps = 70/319 (21%)
Query: 503 ISLTGVLVFCLCKKKQ---KRF-SRVQSPN----AMVIHPRHSGSENSESVKITVAGSNV 554
+S T L + L K++ ++F V N I + I
Sbjct: 61 VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY 120
Query: 555 SVGAISETHTVPSSEPGDIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFG-TVYKGE 613
+ + + V +P L+ ++ ++ +NV I G G G T +
Sbjct: 121 NDNQVFAKYNVSRLQP----YLKLRQALLELRPAKNVL-------IDGVLGSGKTWVALD 169
Query: 614 LHDGTKIAVKRMEAGV--ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671
+ K+ +M+ + ++ L S VL L LL + +D N +
Sbjct: 170 VCLSYKV-QCKMDFKIFWLN---LKNCNSPETVL-----EMLQKLL-YQIDPN-----WT 214
Query: 672 YMPQGTLS-RHIFNWAEEGLKPLEWNRRLTIALDVARGV---EYLHGLAHQS---FIHRD 724
+ + + + + L+ L ++ L V V + + R
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRF 274
Query: 725 LKPSNILLGDDMR--------------------AKVADFGLVRLAPEGKGSIETRIAGTF 764
+ ++ L K D L E + R
Sbjct: 275 KQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVL-TTNPRRLSII 333
Query: 765 GYLAPEYAVHTRWSSCSYW 783
+ W W
Sbjct: 334 AESIRDGL--ATW---DNW 347
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 42/182 (23%), Positives = 64/182 (35%), Gaps = 54/182 (29%)
Query: 600 ILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEF----KSEIAVLTKVRHR-- 651
LG G FG V + H G +AVK ++ K + + +SEI VL +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVK-----IV--KNVDRYCEAARSEIQVLEHLNTTDP 73
Query: 652 ----HLVALL------GH-CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLK-------PL 693
V +L GH C+ VFE L + + +K L
Sbjct: 74 NSTFRCVQMLEWFEHHGHICI-------VFE-----LLGLSTY----DFIKENGFLPFRL 117
Query: 694 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753
+ R+ +A + + V +LH H DLKP NIL + + + R
Sbjct: 118 DHIRK--MAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172
Query: 754 GS 755
Sbjct: 173 NP 174
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 42/260 (16%), Positives = 83/260 (31%), Gaps = 53/260 (20%)
Query: 84 LPSNLQNLTKLERLELQWNSISGP--------LPSLNGLASLEVVMLSNNQFTSVP---- 131
+ S L+ L L L+ N + L + + ++ + L N T
Sbjct: 48 ISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS--CKIQKLSLQNCCLTGAGCGVL 105
Query: 132 SDFFTGLSSLQSIEIDNNPFSSWEIPQ----SLRNASGLQNFSANSANITGQIPSFFGP- 186
S L +LQ + + +N + L L+ +++
Sbjct: 106 SSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165
Query: 187 -DEFPGLTILHLAFNQLIG-GLPA-----SFSGSQIQSLWVN----GQNGNAKLGGGIDV 235
P L ++ N + G+ S Q+++L + + L +
Sbjct: 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC---GI 222
Query: 236 IQNMTSLKEIWLHSNAFSGPLPDFSGVK-----------QLESLSLRDNFFTGP----VP 280
+ + SL+E+ L SN G+ +L +L + + T +
Sbjct: 223 VASKASLRELALGSNKLGD-----VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC 277
Query: 281 DSLVKLESLKIVNMTNNLLQ 300
L ESLK +++ N L
Sbjct: 278 RVLRAKESLKELSLAGNELG 297
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 787 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.98 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.98 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.98 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.98 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.98 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.98 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.98 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.98 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.97 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.97 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.97 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.97 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.97 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.97 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.97 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.97 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.97 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.97 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.97 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.97 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.97 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.97 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.97 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.97 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.97 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.97 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.96 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.96 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.96 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.96 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.96 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.96 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.96 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.96 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.96 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.96 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.96 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.96 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.96 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.96 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.96 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.96 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.96 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.96 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.96 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.96 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.96 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.96 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.96 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.96 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.96 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.96 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.96 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.96 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.96 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.96 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.96 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.96 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.96 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.96 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.96 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.96 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.96 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.96 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.96 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.96 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.96 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.96 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.96 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.96 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.96 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.96 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.96 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.96 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.96 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.96 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.96 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.96 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.96 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.96 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.96 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.96 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.96 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.96 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.96 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.96 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.96 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.96 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.96 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.96 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.96 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.96 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.96 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.96 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.96 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.96 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.96 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.96 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.96 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.96 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.96 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.96 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.96 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.96 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.96 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.96 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.96 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.96 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.96 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.96 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.96 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.96 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.96 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.96 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.96 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.96 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.96 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.96 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.96 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.95 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.95 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.95 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.95 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.95 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.95 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.95 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.95 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.95 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.95 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.95 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.95 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.95 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.95 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.95 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.95 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.95 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.95 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.95 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.95 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.95 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.95 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.95 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.95 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.95 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.95 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.95 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.94 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.94 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.94 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.92 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.92 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.89 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.87 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.84 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.84 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.83 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.83 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.79 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.71 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.68 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.54 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.53 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.53 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.5 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.45 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.34 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.28 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.27 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.23 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.04 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.04 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.97 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.95 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.87 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.83 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.71 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.71 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.62 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.57 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.57 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.57 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.5 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.43 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.26 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.23 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.21 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.09 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.06 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.94 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.76 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.72 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.65 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.47 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.42 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.38 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.38 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.36 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.34 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.2 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.13 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.04 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.99 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.93 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.91 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.63 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.59 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.3 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.75 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.09 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.81 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.71 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=470.14 Aligned_cols=96 Identities=28% Similarity=0.430 Sum_probs=80.8
Q ss_pred ccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCC---CCCCce
Q 003911 366 TCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS---FKSNAI 442 (787)
Q Consensus 366 ~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~---~~~~~~ 442 (787)
+..++.|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..++.+++|++|||++|+|+|.||. |..+..
T Consensus 652 l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~ 731 (768)
T 3rgz_A 652 IGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPP 731 (768)
T ss_dssp GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCG
T ss_pred HhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCH
Confidence 44556788888888888888888888899999999999999999999999999999999999999999996 555667
Q ss_pred eecCCCCCCCCCCCCCCCCC
Q 003911 443 VNTDGNPDIGKEKSSSFQGS 462 (787)
Q Consensus 443 ~~~~gn~~~~~~~~~~~~~~ 462 (787)
..+.|||++|+.|.. .|..
T Consensus 732 ~~~~gN~~Lcg~~l~-~C~~ 750 (768)
T 3rgz_A 732 AKFLNNPGLCGYPLP-RCDP 750 (768)
T ss_dssp GGGCSCTEEESTTSC-CCCS
T ss_pred HHhcCCchhcCCCCc-CCCC
Confidence 789999999998875 6643
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=436.44 Aligned_cols=403 Identities=19% Similarity=0.237 Sum_probs=289.8
Q ss_pred ChhHHHHHHHHHHhcCCCCC----------CCCC-CCCCCCc---ccEEEcCCCCEEEEEeCCCCccccCCCCCCCCCCC
Q 003911 29 DDGDAAVMLALKKSLNPPES----------LGWS-DTDPCKW---NHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKL 94 (787)
Q Consensus 29 ~~~d~~~l~~~k~~~~~~~~----------~~w~-~~~~C~w---~gv~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L 94 (787)
...|++||.+|+++++++.. .+|+ ++|||.| .||+|+..+||+.|+|++++++|.+|++|++|++|
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~L 107 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTEL 107 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTTC
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCccc
Confidence 34699999999999976532 2696 5689999 99999988999999999999999999999999999
Q ss_pred cEEEeecCC-----------------------------------------------------------------------
Q 003911 95 ERLELQWNS----------------------------------------------------------------------- 103 (787)
Q Consensus 95 ~~L~L~~N~----------------------------------------------------------------------- 103 (787)
++|+|++|.
T Consensus 108 ~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~ 187 (636)
T 4eco_A 108 EVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ 187 (636)
T ss_dssp CEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTT
T ss_pred eEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhh
Confidence 999999884
Q ss_pred -------CCCCCCCCCCCCCCcEEEcccccCCcC-----------------CCcccc--CCCCCcEEEccCCCCCCCCCC
Q 003911 104 -------ISGPLPSLNGLASLEVVMLSNNQFTSV-----------------PSDFFT--GLSSLQSIEIDNNPFSSWEIP 157 (787)
Q Consensus 104 -------l~~~~~~~~~l~~L~~L~L~~N~l~~~-----------------~~~~~~--~l~~L~~L~L~~N~l~~~~~p 157 (787)
|+++++.|+++++|++|+|++|+|++. .|..++ ++++|++|+|++|++.+ .+|
T Consensus 188 l~~~~n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~-~~p 266 (636)
T 4eco_A 188 IGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT-KLP 266 (636)
T ss_dssp TTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCS-SCC
T ss_pred hccccCCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCc-cCh
Confidence 345333699999999999999999993 445577 99999999999999988 899
Q ss_pred hhhhcCCCCCEEeccCce-ecc-cCCCCCCCCCC------CCCcEEeccccccccCCCc--Cccc-ccccceeeccCCCC
Q 003911 158 QSLRNASGLQNFSANSAN-ITG-QIPSFFGPDEF------PGLTILHLAFNQLIGGLPA--SFSG-SQIQSLWVNGQNGN 226 (787)
Q Consensus 158 ~~~~~l~~L~~L~l~~n~-l~~-~~p~~~~~~~l------~~L~~L~L~~N~l~~~~p~--~~~~-~~l~~L~~~~~~~~ 226 (787)
..++++++|++|++++|+ ++| .+|..++ .+ ++|++|+|++|+++ .+|. .+.. .+|+.|++.++.
T Consensus 267 ~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~--~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~-- 341 (636)
T 4eco_A 267 TFLKALPEMQLINVACNRGISGEQLKDDWQ--ALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQ-- 341 (636)
T ss_dssp TTTTTCSSCCEEECTTCTTSCHHHHHHHHH--HHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCC--
T ss_pred HHHhcCCCCCEEECcCCCCCccccchHHHH--hhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCc--
Confidence 999999999999999998 998 7887765 54 88999999999998 7887 6654 456666665433
Q ss_pred CcCCCCccccccCccCceEeccccccccCCCCCCCCCC-CCEEecCCCcccccCCccccCCC--CCCEEEccCCcccccC
Q 003911 227 AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQ-LESLSLRDNFFTGPVPDSLVKLE--SLKIVNMTNNLLQGPV 303 (787)
Q Consensus 227 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~l~~l~--~L~~L~Ls~N~l~~~~ 303 (787)
..+..| .++++++|++|+|++|+++..+..+..+++ |++|+|++|+++ .+|..+..++ +|++|+|++|++++.+
T Consensus 342 -l~g~ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~ 418 (636)
T 4eco_A 342 -LEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVD 418 (636)
T ss_dssp -CEEECC-CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTT
T ss_pred -Cccchh-hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcc
Confidence 222334 677888888888888888866667888888 888888888888 7888777655 7888888888888876
Q ss_pred CC-CC-------CceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCcccc---ccCCCce
Q 003911 304 PE-FD-------RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGV---TCTKGNI 372 (787)
Q Consensus 304 p~-~~-------~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~L 372 (787)
|. +. .+.+|+.+++++|.+..+|.........+ ..+ .+..+.....|.....+. .....+|
T Consensus 419 p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L---~~L-----~Ls~N~l~~i~~~~~~~~~~~~~~l~~L 490 (636)
T 4eco_A 419 GKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPL---SSI-----NLMGNMLTEIPKNSLKDENENFKNTYLL 490 (636)
T ss_dssp TCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCC---SEE-----ECCSSCCSBCCSSSSEETTEECTTGGGC
T ss_pred hhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCC---CEE-----ECCCCCCCCcCHHHhccccccccccCCc
Confidence 64 44 55678888888887776553211100000 000 000000001111100000 0011256
Q ss_pred EEEEccCCcccccCchhhc--CCCCCCEEecccccccccCCccCcCCCCCCeeec------cCCcccccCCC----CCCC
Q 003911 373 TVINFQKMNLTGTISPEFA--SFKSLQRLILADNNLSGMIPEGLSVLGALKELDV------SNNQLYGKIPS----FKSN 440 (787)
Q Consensus 373 ~~L~Ls~N~l~g~~p~~~~--~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~L------s~N~l~g~iP~----~~~~ 440 (787)
+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|++|+| ++|++.+.+|. +..+
T Consensus 491 ~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L 568 (636)
T 4eco_A 491 TSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSL 568 (636)
T ss_dssp CEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSC
T ss_pred cEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCC
Confidence 66666666666 5666665 66666666666666665 6666666666666666 34556666664 4455
Q ss_pred ceeecCCCCC
Q 003911 441 AIVNTDGNPD 450 (787)
Q Consensus 441 ~~~~~~gn~~ 450 (787)
..+.+.+|..
T Consensus 569 ~~L~Ls~N~l 578 (636)
T 4eco_A 569 TQLQIGSNDI 578 (636)
T ss_dssp CEEECCSSCC
T ss_pred CEEECCCCcC
Confidence 5666666654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=446.12 Aligned_cols=402 Identities=18% Similarity=0.244 Sum_probs=310.0
Q ss_pred CCChhHHHHHHHHHHhcCCCCCCCCCC------CCC--CCc------------ccEEEcCCCCEEEEEeCCCCccccCCC
Q 003911 27 SGDDGDAAVMLALKKSLNPPESLGWSD------TDP--CKW------------NHVVCIEDKRITRIQIGHQNLQGTLPS 86 (787)
Q Consensus 27 ~~~~~d~~~l~~~k~~~~~~~~~~w~~------~~~--C~w------------~gv~C~~~~~v~~L~l~~~~l~~~~~~ 86 (787)
++...|++||++||+++.+| +|+. .+| |.| .||+|+..+||+.|+|+++++.|.+|+
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK---NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECG
T ss_pred ccchHHHHHHHHHHHHcCCC---CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCch
Confidence 34467999999999999877 6742 356 999 999999889999999999999999999
Q ss_pred CCCCCCCCcEEEe-ecCCCCCC----------------------------------------------------------
Q 003911 87 NLQNLTKLERLEL-QWNSISGP---------------------------------------------------------- 107 (787)
Q Consensus 87 ~~~~l~~L~~L~L-~~N~l~~~---------------------------------------------------------- 107 (787)
+|++|++|++|+| ++|.++|.
T Consensus 342 ~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~ 421 (876)
T 4ecn_A 342 AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421 (876)
T ss_dssp GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCC
T ss_pred HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccc
Confidence 9999999999999 77754333
Q ss_pred ------------------CC-CCCCCCCCcEEEcccccCCc------------------CCCcccc--CCCCCcEEEccC
Q 003911 108 ------------------LP-SLNGLASLEVVMLSNNQFTS------------------VPSDFFT--GLSSLQSIEIDN 148 (787)
Q Consensus 108 ------------------~~-~~~~l~~L~~L~L~~N~l~~------------------~~~~~~~--~l~~L~~L~L~~ 148 (787)
+| .|.+|++|++|+|++|+|++ +|+. ++ ++++|++|+|++
T Consensus 422 ~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~-l~f~~L~~L~~L~Ls~ 500 (876)
T 4ecn_A 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE-LSWSNLKDLTDVELYN 500 (876)
T ss_dssp CCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEES
T ss_pred ccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChh-hhhccCCCCCEEECcC
Confidence 45 68899999999999999999 5554 55 999999999999
Q ss_pred CCCCCCCCChhhhcCCCCCEEeccCce-ecc-cCCCCCC-----CCCCCCCcEEeccccccccCCCc--Cccc-ccccce
Q 003911 149 NPFSSWEIPQSLRNASGLQNFSANSAN-ITG-QIPSFFG-----PDEFPGLTILHLAFNQLIGGLPA--SFSG-SQIQSL 218 (787)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~-l~~-~~p~~~~-----~~~l~~L~~L~L~~N~l~~~~p~--~~~~-~~l~~L 218 (787)
|++.+ .+|..|.++++|+.|++++|+ ++| .+|..++ ...+++|++|+|++|+++ .+|. .+.. .+|+.|
T Consensus 501 N~l~~-~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L 578 (876)
T 4ecn_A 501 CPNMT-QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLL 578 (876)
T ss_dssp CTTCC-SCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEE
T ss_pred CCCCc-cChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEE
Confidence 99887 899999999999999999998 998 7776543 014569999999999999 8887 6764 567777
Q ss_pred eeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCC-CCEEecCCCcccccCCccccCCCC--CCEEEcc
Q 003911 219 WVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQ-LESLSLRDNFFTGPVPDSLVKLES--LKIVNMT 295 (787)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~Ls 295 (787)
++.++... ..| .|+++++|+.|+|++|+++..++.+..+++ |+.|+|++|+|+ .+|..+..++. |+.|+|+
T Consensus 579 ~Ls~N~l~----~lp-~~~~L~~L~~L~Ls~N~l~~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls 652 (876)
T 4ecn_A 579 DCVHNKVR----HLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFS 652 (876)
T ss_dssp ECTTSCCC----BCC-CCCTTSEESEEECCSSCCSCCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECC
T ss_pred ECCCCCcc----cch-hhcCCCcceEEECcCCccccchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECc
Confidence 77655433 334 788999999999999999966667888998 999999999999 88988887765 9999999
Q ss_pred CCcccccCCCCC------CceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCcccc---c
Q 003911 296 NNLLQGPVPEFD------RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGV---T 366 (787)
Q Consensus 296 ~N~l~~~~p~~~------~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 366 (787)
+|++++.+|.+. ...+|+.+++++|.+..+|.........+ .. + .+..+.....|.....+. .
T Consensus 653 ~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L---~~-L----~Ls~N~L~~ip~~~~~~~~~~l 724 (876)
T 4ecn_A 653 YNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI---ST-I----ILSNNLMTSIPENSLKPKDGNY 724 (876)
T ss_dssp SSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCC---SE-E----ECCSCCCSCCCTTSSSCTTSCC
T ss_pred CCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCC---CE-E----ECCCCcCCccChHHhccccccc
Confidence 999999887654 44578899999998886653211000000 00 0 000010111111111110 0
Q ss_pred cCCCceEEEEccCCcccccCchhhc--CCCCCCEEecccccccccCCccCcCCCCCCeeeccC------CcccccCCC--
Q 003911 367 CTKGNITVINFQKMNLTGTISPEFA--SFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSN------NQLYGKIPS-- 436 (787)
Q Consensus 367 ~~~~~L~~L~Ls~N~l~g~~p~~~~--~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~------N~l~g~iP~-- 436 (787)
..+++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+|++ |++.+.+|.
T Consensus 725 ~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l 802 (876)
T 4ecn_A 725 KNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802 (876)
T ss_dssp TTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTG
T ss_pred cccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHH
Confidence 11237888888888888 7787776 88888888888888886 788888888888888866 777888885
Q ss_pred --CCCCceeecCCCCC
Q 003911 437 --FKSNAIVNTDGNPD 450 (787)
Q Consensus 437 --~~~~~~~~~~gn~~ 450 (787)
+..+..+.+.+|..
T Consensus 803 ~~L~~L~~L~Ls~N~L 818 (876)
T 4ecn_A 803 TTCPSLIQLQIGSNDI 818 (876)
T ss_dssp GGCSSCCEEECCSSCC
T ss_pred hcCCCCCEEECCCCCC
Confidence 55667778888765
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=379.68 Aligned_cols=292 Identities=25% Similarity=0.477 Sum_probs=215.7
Q ss_pred CCChhHHHHHHHHHHhcCCCCC-CCCC-CCCCCC--cccEEEcCC---CCEEEEEeCCCCccc--cCCCCCCCCCCCcEE
Q 003911 27 SGDDGDAAVMLALKKSLNPPES-LGWS-DTDPCK--WNHVVCIED---KRITRIQIGHQNLQG--TLPSNLQNLTKLERL 97 (787)
Q Consensus 27 ~~~~~d~~~l~~~k~~~~~~~~-~~w~-~~~~C~--w~gv~C~~~---~~v~~L~l~~~~l~~--~~~~~~~~l~~L~~L 97 (787)
.|.++|++||++||+++.+|.. .+|. ++|||. |.||+|+.. ++|+.|+|++++++| .+|+.|+++++|++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L 81 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCee
Confidence 5889999999999999987753 3896 468998 999999864 799999999999999 899999999999999
Q ss_pred Eeec-CCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCce
Q 003911 98 ELQW-NSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175 (787)
Q Consensus 98 ~L~~-N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~ 175 (787)
+|++ |++.+.+| .|.++++|++|+|++|++++..|..|.++++|++|+|++|++++ .+|..+..+++|++|++++|+
T Consensus 82 ~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG-TLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEES-CCCGGGGGCTTCCEEECCSSC
T ss_pred eCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCC-cCChHHhcCCCCCeEECcCCc
Confidence 9995 99988777 68889999999999999887777778888888888888877775 566677666666666666666
Q ss_pred ecccCCCCCCCCCCC-CCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEecccccccc
Q 003911 176 ITGQIPSFFGPDEFP-GLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG 254 (787)
Q Consensus 176 l~~~~p~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 254 (787)
+++.+|..++ .++ +|++|+|++|++++.+|..+
T Consensus 161 l~~~~p~~l~--~l~~~L~~L~L~~N~l~~~~~~~~-------------------------------------------- 194 (313)
T 1ogq_A 161 ISGAIPDSYG--SFSKLFTSMTISRNRLTGKIPPTF-------------------------------------------- 194 (313)
T ss_dssp CEEECCGGGG--CCCTTCCEEECCSSEEEEECCGGG--------------------------------------------
T ss_pred ccCcCCHHHh--hhhhcCcEEECcCCeeeccCChHH--------------------------------------------
Confidence 6666666554 444 55666666666555555443
Q ss_pred CCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhh
Q 003911 255 PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLN 334 (787)
Q Consensus 255 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~ 334 (787)
..++ |+.|+|++|++++.+|..|..+++|++|+|++|++++.+|.+.
T Consensus 195 -----~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~--------------------------- 241 (313)
T 1ogq_A 195 -----ANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG--------------------------- 241 (313)
T ss_dssp -----GGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCC---------------------------
T ss_pred -----hCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCccc---------------------------
Confidence 3333 6677777777776677777777777777777777765544311
Q ss_pred HHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccC
Q 003911 335 ALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 414 (787)
Q Consensus 335 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l 414 (787)
..++|+.|+|++|++++.+|..|..+++|+.|+|++|+++|.+|..
T Consensus 242 ---------------------------------~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~- 287 (313)
T 1ogq_A 242 ---------------------------------LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG- 287 (313)
T ss_dssp ---------------------------------CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-
T ss_pred ---------------------------------ccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-
Confidence 1125556666666666666667777777777777777777777765
Q ss_pred cCCCCCCeeeccCCc-ccc
Q 003911 415 SVLGALKELDVSNNQ-LYG 432 (787)
Q Consensus 415 ~~l~~L~~L~Ls~N~-l~g 432 (787)
..+++|+.|++++|+ ++|
T Consensus 288 ~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 288 GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp TTGGGSCGGGTCSSSEEES
T ss_pred ccccccChHHhcCCCCccC
Confidence 667777777777665 444
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=360.98 Aligned_cols=186 Identities=23% Similarity=0.407 Sum_probs=160.3
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|+||+||+|+.. +|+.||||++..........+++.+|++++++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999875 79999999998766666677899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
||+||+|.+++.. .....+++.+++.|+.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~---~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHH---cCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 9999999999954 223467899999999999999999998 8999999999999999999999999999987643
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.. ......+||+.|||||++.+..|+ ++||||.
T Consensus 178 ~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSl 211 (350)
T 4b9d_A 178 TV-ELARACIGTPYYLSPEICENKPYNNKSDIWAL 211 (350)
T ss_dssp HH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHH
T ss_pred Cc-ccccccCCCccccCHHHHCCCCCCcHHHHHHH
Confidence 21 122346799999999999999999 9999983
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=351.19 Aligned_cols=185 Identities=28% Similarity=0.446 Sum_probs=164.9
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||+||+|+.. +++.||||++.+... .....+.+.+|++++++++|||||++++++++.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999875 799999999986433 2345678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||++||+|.+++.. .+.+++.++..++.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+...
T Consensus 112 Ey~~gG~L~~~i~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 112 SYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 99999999999954 2468999999999999999999998 899999999999999999999999999999875
Q ss_pred CCCC-ceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... ......+||+.|||||++.+..|+ ++||||.
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl 220 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 220 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHH
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHH
Confidence 4332 233457899999999999999999 8999983
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.50 Aligned_cols=182 Identities=24% Similarity=0.420 Sum_probs=162.4
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.+.|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 356999999999999999999875 79999999997643 233456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
|||++|+|.+++.. ..+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 151 Ey~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 151 EFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 221 (346)
T ss_dssp CCCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecC
Confidence 99999999998853 368999999999999999999998 899999999999999999999999999999875
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... .....+||+.|||||++.+..|+ ++||||.
T Consensus 222 ~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl 256 (346)
T 4fih_A 222 KEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSL 256 (346)
T ss_dssp SSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred CCCC-cccccccCcCcCCHHHHCCCCCCcHHHHHHH
Confidence 4432 33457899999999999999998 8999983
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=346.47 Aligned_cols=187 Identities=29% Similarity=0.543 Sum_probs=160.0
Q ss_pred CCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
++|.+.+.||+|+||+||+|++. ++..||||+++.. .....++|.+|++++++++|||||+++|+|.+++..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 56888999999999999999864 4788999999753 445668899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhh--------hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcE
Q 003911 667 LLVFEYMPQGTLSRHIFNWA--------EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 738 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 738 (787)
|||||||++|+|.++++... ......++|.+++.|+.||++||+|||+ ++||||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcE
Confidence 99999999999999997532 1233579999999999999999999998 899999999999999999999
Q ss_pred EEeecccceecCCCCCce-eeeeccccCcccccccccCCcC-cceeec
Q 003911 739 KVADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 739 kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
||+|||+|+......... .....||+.|||||++.++.|+ ++||||
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS 215 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 215 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHH
Confidence 999999998764433221 2235699999999999999999 999998
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=353.38 Aligned_cols=182 Identities=24% Similarity=0.420 Sum_probs=162.7
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.+.|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 357999999999999999999875 79999999997643 233467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
|||+||+|.+++.. ..+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 228 Ey~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 228 EFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp ECCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred eCCCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 99999999998843 358999999999999999999998 899999999999999999999999999999875
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... .....+||+.|||||++.+..|+ ++||||.
T Consensus 299 ~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl 333 (423)
T 4fie_A 299 KEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSL 333 (423)
T ss_dssp SSCC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHH
T ss_pred CCCc-cccccccCcCcCCHHHHCCCCCCcHHHHHHH
Confidence 5432 33457899999999999999999 8999983
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=386.43 Aligned_cols=391 Identities=18% Similarity=0.219 Sum_probs=271.6
Q ss_pred CCcccEEEcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCC-C-CCCCCCCCcEEEcccccCCcCCCcc
Q 003911 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPL-P-SLNGLASLEVVMLSNNQFTSVPSDF 134 (787)
Q Consensus 57 C~w~gv~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~-~~~~l~~L~~L~L~~N~l~~~~~~~ 134 (787)
|.|..|.+ -..+++.|||++|.+++..|..|.++++|++|+|++|.+.+.+ | .|.++++|++|+|++|+|++++|+.
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 45666665 4578999999999999888889999999999999999766544 4 6899999999999999999998888
Q ss_pred ccCCCCCcEEEccCCCCCCCCCChh--hhcCCCCCEEeccCceecccCC-CCCCCCCCCCCcEEeccccccccCCCcCcc
Q 003911 135 FTGLSSLQSIEIDNNPFSSWEIPQS--LRNASGLQNFSANSANITGQIP-SFFGPDEFPGLTILHLAFNQLIGGLPASFS 211 (787)
Q Consensus 135 ~~~l~~L~~L~L~~N~l~~~~~p~~--~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 211 (787)
|+++++|++|+|++|.+++ .+|.. +.++++|++|++++|.+++..+ ..|+ ++++|++|+|++|++++..|..+.
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~-~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~--~L~~L~~L~Ls~N~i~~~~~~~l~ 169 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSD-AVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFG--KLNSLKSIDFSSNQIFLVCEHELE 169 (844)
T ss_dssp SCSCSSCCCEECTTCCCSS-CCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGG--TCSSCCEEEEESSCCCCCCSGGGH
T ss_pred ccCCcccCEeeCcCCCCCc-ccccCccccccCCCCEEECCCCcccccccchhHh--hCCCCCEEECCCCcCCeeCHHHcc
Confidence 9999999999999999886 45544 8889999999999999887765 4565 788888888888888777665543
Q ss_pred c---cc------------------------------ccceeeccCCC---------------------------------
Q 003911 212 G---SQ------------------------------IQSLWVNGQNG--------------------------------- 225 (787)
Q Consensus 212 ~---~~------------------------------l~~L~~~~~~~--------------------------------- 225 (787)
. .+ ++.|++.++..
T Consensus 170 ~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~ 249 (844)
T 3j0a_A 170 PLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGF 249 (844)
T ss_dssp HHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSC
T ss_pred cccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccc
Confidence 2 12 34444433310
Q ss_pred --------------------------CCcCCCCccccccCccCceEeccccccccCCC-CCCCCCCCCEEecCCCccccc
Q 003911 226 --------------------------NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGP 278 (787)
Q Consensus 226 --------------------------~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~ 278 (787)
+......+..+..+++|+.|+|++|++++.++ .|.++++|++|+|++|++++.
T Consensus 250 ~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 329 (844)
T 3j0a_A 250 HNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGEL 329 (844)
T ss_dssp SSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCC
T ss_pred cccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCcc
Confidence 00111123345667777777777777777655 477777777777777777766
Q ss_pred CCccccCCCCCCEEEccCCcccccCCC-CCCceeeeccccCCCccCCCCCCCCchhhHH-------H-------------
Q 003911 279 VPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNAL-------L------------- 337 (787)
Q Consensus 279 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l-------~------------- 337 (787)
.|..|..+++|++|+|++|++++.++. +..+.+|+.+++++|.+..++.. +.+..+ .
T Consensus 330 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~--~~L~~L~l~~N~l~~l~~~~~~l~~L~ 407 (844)
T 3j0a_A 330 YSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFI--PSIPDIFLSGNKLVTLPKINLTANLIH 407 (844)
T ss_dssp CSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSC--CSCSEEEEESCCCCCCCCCCTTCCEEE
T ss_pred CHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCC--CCcchhccCCCCcccccccccccceee
Confidence 677777777777777777777766664 55566777777777765543320 000000 0
Q ss_pred ----------HHHHHhCCChh----hhcccCC--------------------CCCC------CCccccccCCCceEEEEc
Q 003911 338 ----------SVVKLMGYPQR----FAENWKG--------------------NDPC------SDWIGVTCTKGNITVINF 377 (787)
Q Consensus 338 ----------~~~~~~~~~~~----~~~~~~~--------------------~~~~------~~~~~~~~~~~~L~~L~L 377 (787)
........+.. +..+... .... ......+..+++|+.|+|
T Consensus 408 ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~L 487 (844)
T 3j0a_A 408 LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL 487 (844)
T ss_dssp CCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCC
T ss_pred cccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEEC
Confidence 00000000000 0000000 0000 000112334578888999
Q ss_pred cCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCC-CCCCceeecCCCCCCCCCC
Q 003911 378 QKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS-FKSNAIVNTDGNPDIGKEK 455 (787)
Q Consensus 378 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~-~~~~~~~~~~gn~~~~~~~ 455 (787)
++|++++..|..|..+++|+.|+|++|+|++..|..+. ++|++|||++|+|+|.+|. +..+..+.+.|||+.|..+
T Consensus 488 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 488 NHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECE 564 (844)
T ss_dssp CHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSS
T ss_pred CCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccccc
Confidence 99999988888889999999999999999876666665 7899999999999998886 6677889999999999654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=335.02 Aligned_cols=182 Identities=28% Similarity=0.477 Sum_probs=146.4
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.... ....+++.+|++++++++|||||++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999865 7999999999865433 344568999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+ +|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 6899998854 2479999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCceeeeeccccCcccccccccCCcC--cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS--SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~DiWS~ 785 (787)
... .....+||+.|||||++.+..|. ++||||.
T Consensus 164 ~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSl 198 (275)
T 3hyh_A 164 DGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 198 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHH
T ss_pred CCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHH
Confidence 432 23447899999999999998764 7999984
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=347.33 Aligned_cols=184 Identities=24% Similarity=0.370 Sum_probs=155.2
Q ss_pred CCCcccceeccccceEEEEEEEe----CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
++|++.+.||+|+||+||+|+.. +++.||||++++.........++.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 47999999999999999999763 47899999998755544455678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||++||+|.+++.. ...+++.++..++.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 9999999999999954 2468999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
...... .....+||+.|||||++.+..|+ ++||||.
T Consensus 176 ~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl 212 (304)
T 3ubd_A 176 SIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSF 212 (304)
T ss_dssp -----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHH
T ss_pred ccCCCc-cccccccCcccCCHHHhccCCCCCCCcccch
Confidence 644332 23347899999999999999998 8999983
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=346.06 Aligned_cols=187 Identities=32% Similarity=0.572 Sum_probs=154.5
Q ss_pred CCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
++|.+.+.||+|+||+||+|+++ +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+.+..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46788899999999999999864 4789999999753 455668899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhh----------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC
Q 003911 667 LLVFEYMPQGTLSRHIFNWAE----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 736 (787)
|||||||++|+|.++++.... ....+++|.+++.|+.||++||+|||+ ++||||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCC
Confidence 999999999999999975321 123469999999999999999999998 8999999999999999999
Q ss_pred cEEEeecccceecCCCCC-ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 737 RAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 737 ~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.+||+|||+|+....... ......+||+.|||||++.+..|+ ++||||
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS 245 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWS 245 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccc
Confidence 999999999987644332 223446799999999999999999 999998
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=340.35 Aligned_cols=183 Identities=28% Similarity=0.504 Sum_probs=153.7
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.+++++.+.||+|+||+||+|+++ ..||||+++....+....++|.+|++++++++|||||+++|++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 357888999999999999999865 369999998655566677899999999999999999999998864 56899999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
||++|+|.++++. ....+++.++..|+.|||.||+|||+ ++||||||||+|||+++++.+||+|||+|+....
T Consensus 112 y~~gGsL~~~l~~----~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 112 WCEGSSLYKHLHV----QETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp CCSSCBHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred cCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999854 23469999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCC-ceeeeeccccCcccccccccC---CcC-cceeec
Q 003911 752 GKG-SIETRIAGTFGYLAPEYAVHT---RWS-SCSYWA 784 (787)
Q Consensus 752 ~~~-~~~~~~~gt~~y~aPE~~~~~---~~~-~~DiWS 784 (787)
... ......+||+.|||||++.+. .|+ ++||||
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS 222 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYS 222 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHH
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHh
Confidence 322 223456899999999999643 577 899998
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=365.91 Aligned_cols=375 Identities=20% Similarity=0.203 Sum_probs=248.8
Q ss_pred CCCcccEEEcCC------------CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEc
Q 003911 56 PCKWNHVVCIED------------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVML 122 (787)
Q Consensus 56 ~C~w~gv~C~~~------------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L 122 (787)
.|.|.|| |+.. .+++.|+|++|++++..|..|+++++|++|+|++|+|++.+| .|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4999998 8632 379999999999998889999999999999999999999887 7999999999999
Q ss_pred ccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCC-CCCCCCCCCCCcEEeccccc
Q 003911 123 SNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP-SFFGPDEFPGLTILHLAFNQ 201 (787)
Q Consensus 123 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~L~~N~ 201 (787)
++|+++++++..|+++++|++|+|++|+++...+|..+.++++|++|++++|.+.+.+| ..|. .+++|++|++++|+
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~--~l~~L~~L~L~~n~ 159 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA--GLTSLNELEIKALS 159 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTT--TCCEEEEEEEEETT
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhh--cccccCeeeccCCc
Confidence 99999999999999999999999999999976678899999999999999998544444 5675 88999999999999
Q ss_pred cccCCCcCccc-------------------------ccccceeeccCCCCCcCCCCc-----------------------
Q 003911 202 LIGGLPASFSG-------------------------SQIQSLWVNGQNGNAKLGGGI----------------------- 233 (787)
Q Consensus 202 l~~~~p~~~~~-------------------------~~l~~L~~~~~~~~~~~~~~~----------------------- 233 (787)
+++.+|..+.. .+++.|++.++..........
T Consensus 160 l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 239 (549)
T 2z81_A 160 LRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239 (549)
T ss_dssp CCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHH
T ss_pred ccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhH
Confidence 99888877653 233334433322111000000
Q ss_pred --------------------------------------cc--------------------------cccCccCceEeccc
Q 003911 234 --------------------------------------DV--------------------------IQNMTSLKEIWLHS 249 (787)
Q Consensus 234 --------------------------------------~~--------------------------~~~l~~L~~L~L~~ 249 (787)
.. +...++|+.|++++
T Consensus 240 ~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~ 319 (549)
T 2z81_A 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN 319 (549)
T ss_dssp HHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEES
T ss_pred HHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEecc
Confidence 00 00011222233333
Q ss_pred cccccCCCCC-CCCCCCCEEecCCCcccccCCc---cccCCCCCCEEEccCCcccccCC---CCCCceeeeccccCCCcc
Q 003911 250 NAFSGPLPDF-SGVKQLESLSLRDNFFTGPVPD---SLVKLESLKIVNMTNNLLQGPVP---EFDRSVSLDMAKGSNNFC 322 (787)
Q Consensus 250 N~l~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~---~l~~l~~L~~L~Ls~N~l~~~~p---~~~~~~~L~~l~~~~n~~ 322 (787)
|+++..+..+ ..+++|++|+|++|++++.+|. .+..+++|++|+|++|++++.++ .+..+.+|+.+++++|.+
T Consensus 320 n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l 399 (549)
T 2z81_A 320 SKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF 399 (549)
T ss_dssp SCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred CccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCC
Confidence 3322211111 2344555555555555544322 24444555555555555544321 133344444445555544
Q ss_pred CCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecc
Q 003911 323 LPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILA 402 (787)
Q Consensus 323 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 402 (787)
..+|..... .. .+..............+ +..++|+.|+|++|++++.+ ..+++|++|+|+
T Consensus 400 ~~lp~~~~~-~~-------------~L~~L~Ls~N~l~~l~~--~~~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls 459 (549)
T 2z81_A 400 HPMPDSCQW-PE-------------KMRFLNLSSTGIRVVKT--CIPQTLEVLDVSNNNLDSFS----LFLPRLQELYIS 459 (549)
T ss_dssp CCCCSCCCC-CT-------------TCCEEECTTSCCSCCCT--TSCTTCSEEECCSSCCSCCC----CCCTTCCEEECC
T ss_pred ccCChhhcc-cc-------------cccEEECCCCCcccccc--hhcCCceEEECCCCChhhhc----ccCChhcEEECC
Confidence 433321110 00 00000000000000000 01147899999999999753 578999999999
Q ss_pred cccccccCCccCcCCCCCCeeeccCCcccccCCC----CCCCceeecCCCCCCCCCC
Q 003911 403 DNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDIGKEK 455 (787)
Q Consensus 403 ~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~----~~~~~~~~~~gn~~~~~~~ 455 (787)
+|+|+ .+|. ...+++|++|||++|++++.+|. +..+..+.+.+|++.|..+
T Consensus 460 ~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 460 RNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp SSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 99999 7887 57799999999999999998885 5567789999999988764
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=357.77 Aligned_cols=337 Identities=17% Similarity=0.218 Sum_probs=230.4
Q ss_pred CCCCccc--EEEcCC---------CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCC-C-CCCCCCCCcEEE
Q 003911 55 DPCKWNH--VVCIED---------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPL-P-SLNGLASLEVVM 121 (787)
Q Consensus 55 ~~C~w~g--v~C~~~---------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~-~~~~l~~L~~L~ 121 (787)
+.|.|.+ |.|+.. .+++.|+|++|++++..|..|+++++|++|+|++|.+.+.+ + .|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 4566665 888643 47999999999999988999999999999999999998754 3 699999999999
Q ss_pred cccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChh--hhcCCCCCEEeccCceecccCCCC-CCCCCCCCCcEEecc
Q 003911 122 LSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQS--LRNASGLQNFSANSANITGQIPSF-FGPDEFPGLTILHLA 198 (787)
Q Consensus 122 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~--~~~l~~L~~L~l~~n~l~~~~p~~-~~~~~l~~L~~L~L~ 198 (787)
|++|+++++++..|+++++|++|+|++|++++ .+|.. +..+++|++|++++|++++..|.. +. .+++|++|+|+
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~--~l~~L~~L~L~ 162 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDG-AVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL--NMRRFHVLDLT 162 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBT-HHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGG--GCTTCCEEECT
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCc-cccCcccccCcccCCEEECCCCccCccCcccccC--CCCcccEEeCC
Confidence 99999999999999999999999999999985 44444 999999999999999999998876 65 89999999999
Q ss_pred ccccccCCCcCcccc---cccceeeccCCCCCcCCCCc-----cccccCccCceEeccccccccCCCC-CC---C-----
Q 003911 199 FNQLIGGLPASFSGS---QIQSLWVNGQNGNAKLGGGI-----DVIQNMTSLKEIWLHSNAFSGPLPD-FS---G----- 261 (787)
Q Consensus 199 ~N~l~~~~p~~~~~~---~l~~L~~~~~~~~~~~~~~~-----~~~~~l~~L~~L~L~~N~l~~~~~~-~~---~----- 261 (787)
+|++++..|..+... .++.|++.++.......... ..+..+++|++|+|++|++++.++. +. .
T Consensus 163 ~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~ 242 (455)
T 3v47_A 163 FNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQ 242 (455)
T ss_dssp TCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEE
T ss_pred CCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhcccccccee
Confidence 999999999888653 45555554433222211111 1234567889999999988764332 11 1
Q ss_pred -------------------------------CCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCC-CCCc
Q 003911 262 -------------------------------VKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRS 309 (787)
Q Consensus 262 -------------------------------l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~ 309 (787)
.++|+.|++++|++++.+|..+..+++|++|+|++|++++.+|. +..+
T Consensus 243 ~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 322 (455)
T 3v47_A 243 SLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGL 322 (455)
T ss_dssp EEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred eEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCc
Confidence 13555566666666555555555566666666666665555442 3334
Q ss_pred eeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchh
Q 003911 310 VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE 389 (787)
Q Consensus 310 ~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~ 389 (787)
. +|+.|+|++|++++..|..
T Consensus 323 ~------------------------------------------------------------~L~~L~Ls~N~l~~~~~~~ 342 (455)
T 3v47_A 323 T------------------------------------------------------------HLLKLNLSQNFLGSIDSRM 342 (455)
T ss_dssp T------------------------------------------------------------TCCEEECCSSCCCEECGGG
T ss_pred c------------------------------------------------------------cCCEEECCCCccCCcChhH
Confidence 4 4555555555555444555
Q ss_pred hcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCC----CCCCceeecCCCCCCCCC
Q 003911 390 FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDIGKE 454 (787)
Q Consensus 390 ~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~----~~~~~~~~~~gn~~~~~~ 454 (787)
|+.+++|++|+|++|++++..|..|..+++|++|+|++|++++.++. +..+..+.+.+|++.|..
T Consensus 343 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 411 (455)
T 3v47_A 343 FENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 411 (455)
T ss_dssp GTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred hcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCC
Confidence 55555555555555555544455555555555555555555543332 233444555555554443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=343.02 Aligned_cols=188 Identities=25% Similarity=0.435 Sum_probs=160.0
Q ss_pred CCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
.++++.+.||+|+||+||+|++. +++.||||+++.. ......++|.+|+.++++++|||||+++|+|.+++..
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC--CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc-cChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 34677889999999999999863 5688999999753 3445567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 735 (787)
+||||||++|+|.+++...... ....++|.++++|+.|||+||+|||+ ++||||||||+|||++++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCC
Confidence 9999999999999999653211 12468999999999999999999998 899999999999999999
Q ss_pred CcEEEeecccceecCCCCC-ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 736 MRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 736 ~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+.+||+|||+|+....... ......+||++|||||++.++.|+ ++||||
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwS 232 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWS 232 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhh
Confidence 9999999999987643322 223346799999999999999999 999998
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=339.87 Aligned_cols=187 Identities=29% Similarity=0.436 Sum_probs=149.5
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC-------
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN------- 664 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 664 (787)
++|++.+.||+|+||+||+|+.. +|+.||||+++... .....+++.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 46999999999999999999875 79999999997643 3445678999999999999999999999987544
Q ss_pred -----eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEE
Q 003911 665 -----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 739 (787)
Q Consensus 665 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 739 (787)
..|+|||||++|+|.+++.... .....++..++.|+.||+.||+|||+ ++||||||||+|||++.++.+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEE
Confidence 3689999999999999996421 12345667788999999999999998 8999999999999999999999
Q ss_pred EeecccceecCCCCCc-----------eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 740 VADFGLVRLAPEGKGS-----------IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 740 l~DFG~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|+|||+|+........ ..+..+||+.|||||++.+..|+ ++||||.
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl 216 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSL 216 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHH
Confidence 9999999876543211 12345799999999999999998 8999983
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=334.38 Aligned_cols=179 Identities=26% Similarity=0.408 Sum_probs=154.9
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe----CCeeEEE
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEKLLV 669 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv 669 (787)
|++.+.||+|+||+||+|.+. +++.||+|++..........++|.+|++++++++|||||++++++.+ .+..|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 366788999999999999875 68999999998766666677889999999999999999999999875 3457999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCEEEC-CCCcEEEeecccc
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLG-DDMRAKVADFGLV 746 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DFG~a 746 (787)
||||++|+|.+++.. ...+++..+..|+.||+.||+|||+ ++ ||||||||+|||++ +++.+||+|||+|
T Consensus 108 mEy~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 999999999999954 2468999999999999999999997 55 99999999999998 4789999999999
Q ss_pred eecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+..... .....+||+.|||||++.+ +|+ ++||||.
T Consensus 180 ~~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSl 215 (290)
T 3fpq_A 180 TLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAF 215 (290)
T ss_dssp GGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHH
T ss_pred EeCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHH
Confidence 865332 2345789999999999876 477 9999983
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.92 Aligned_cols=178 Identities=26% Similarity=0.376 Sum_probs=153.8
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
+.|++.++||+|+||+||+|+.. +|+.||||+++.+.. ..+|++++++++|||||++++++.+++..|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46888899999999999999875 799999999976432 2469999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC-cEEEeecccceecC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVRLAP 750 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~ 750 (787)
||+||+|.+++... +.+++.++..|+.||+.||+|||+ ++||||||||+|||++.++ ++||+|||+|+...
T Consensus 131 y~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 131 LLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred ccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999542 468999999999999999999997 8999999999999999887 69999999999875
Q ss_pred CCCCc----eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGS----IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... .....+||+.|||||++.+..|+ ++||||.
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl 242 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSS 242 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHH
Confidence 43211 11235799999999999999998 8999984
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=360.65 Aligned_cols=372 Identities=20% Similarity=0.170 Sum_probs=266.0
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (787)
.+++.|+|++|++++..+..|.++++|++|+|++|+|++.+| .|.++++|++|+|++|++++++|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 468888888888887777788888888888888888888766 6888888888888888888888888888888888888
Q ss_pred cCCCCCCCCCChhhhcCCCCCEEeccCceecc-cCCCCCCCCCCCCCcEEeccccccccCCCcCccc-------------
Q 003911 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITG-QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG------------- 212 (787)
Q Consensus 147 ~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~------------- 212 (787)
++|++.. ..|..++++++|++|++++|.+++ .+|..|+ .+++|++|+|++|++++..|..+..
T Consensus 112 ~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~--~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l 188 (606)
T 3vq2_A 112 VETKLAS-LESFPIGQLITLKKLNVAHNFIHSCKLPAYFS--NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188 (606)
T ss_dssp TTSCCCC-SSSSCCTTCTTCCEEECCSSCCCCCCCCGGGG--TCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEEC
T ss_pred cCCcccc-ccccccCCCCCCCEEeCCCCcccceechHhHh--hcCCCCEEEccCCcceecChhhhhhhhccccccceeec
Confidence 8888875 334667788888888888888775 4577775 7778888888777777666554432
Q ss_pred ---------------ccccceeeccCCCC---------------------------------------------------
Q 003911 213 ---------------SQIQSLWVNGQNGN--------------------------------------------------- 226 (787)
Q Consensus 213 ---------------~~l~~L~~~~~~~~--------------------------------------------------- 226 (787)
.+++.|++.++...
T Consensus 189 ~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l 268 (606)
T 3vq2_A 189 SLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268 (606)
T ss_dssp TTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEE
T ss_pred cCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheec
Confidence 12333333222100
Q ss_pred ---C---------------------------------------------cCCCC--------------------cccccc
Q 003911 227 ---A---------------------------------------------KLGGG--------------------IDVIQN 238 (787)
Q Consensus 227 ---~---------------------------------------------~~~~~--------------------~~~~~~ 238 (787)
+ .++.. ...+..
T Consensus 269 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~ 348 (606)
T 3vq2_A 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVA 348 (606)
T ss_dssp CCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCC
T ss_pred cccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhcc
Confidence 0 00000 012345
Q ss_pred CccCceEeccccccccC---CCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCC--CCCCceeee
Q 003911 239 MTSLKEIWLHSNAFSGP---LPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP--EFDRSVSLD 313 (787)
Q Consensus 239 l~~L~~L~L~~N~l~~~---~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~~~L~ 313 (787)
+++|++|+|++|++++. +..+..+++|++|+|++|+++ .+|..+..+++|++|++++|++++.+| .+..+.+|+
T Consensus 349 l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 427 (606)
T 3vq2_A 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427 (606)
T ss_dssp CTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCC
T ss_pred CCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCC
Confidence 66777777777777765 234677888888889888888 467888888888888888888888776 467778888
Q ss_pred ccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCC--ccccccCCCceEEEEccCCcccccCchhhc
Q 003911 314 MAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD--WIGVTCTKGNITVINFQKMNLTGTISPEFA 391 (787)
Q Consensus 314 ~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~ 391 (787)
.+++++|.+.............+. ..........+ ....+...++|+.|+|++|++++.+|..|+
T Consensus 428 ~L~l~~n~l~~~~~~~~~~l~~L~-------------~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 494 (606)
T 3vq2_A 428 YLDISYTNTKIDFDGIFLGLTSLN-------------TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494 (606)
T ss_dssp EEECTTSCCEECCTTTTTTCTTCC-------------EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred EEECcCCCCCccchhhhcCCCCCC-------------EEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhc
Confidence 888888876654332211111000 00000000000 122344567999999999999999999999
Q ss_pred CCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCC---CC-CCceeecCCCCCCCCCCC
Q 003911 392 SFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS---FK-SNAIVNTDGNPDIGKEKS 456 (787)
Q Consensus 392 ~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~---~~-~~~~~~~~gn~~~~~~~~ 456 (787)
.+++|+.|+|++|++++.+|..+..+++|++|||++|+++...+. +. .+..+.+.|||+.|..+.
T Consensus 495 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp TCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred ccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 999999999999999998999999999999999999999953333 33 467889999999987764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=331.82 Aligned_cols=183 Identities=25% Similarity=0.368 Sum_probs=148.7
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC----eeE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----EKL 667 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~ 667 (787)
.++|.+.+.||+|+||+||+|++ +|+.||||+++... .....++.|+..+.+++|||||++++++.+++ ..|
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 35688899999999999999987 58999999986532 22233455666677889999999999998654 579
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEcCCCCCCEEECCCCcEEEee
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL-----AHQSFIHRDLKPSNILLGDDMRAKVAD 742 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~D 742 (787)
||||||++|+|.++++. ..++|+.+.+++.|++.||+|||+. ++++||||||||+|||+++++++||+|
T Consensus 78 lV~Ey~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EEecCCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 99999999999999954 3689999999999999999999973 124999999999999999999999999
Q ss_pred cccceecCCCCCce---eeeeccccCcccccccccC------CcC-cceeec
Q 003911 743 FGLVRLAPEGKGSI---ETRIAGTFGYLAPEYAVHT------RWS-SCSYWA 784 (787)
Q Consensus 743 FG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~-~~DiWS 784 (787)
||+|+......... ....+||+.|||||++.+. .++ ++||||
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS 203 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 203 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHH
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhh
Confidence 99998775543322 2346799999999999765 355 899998
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=351.94 Aligned_cols=374 Identities=18% Similarity=0.135 Sum_probs=234.5
Q ss_pred cccEEEcCC----------CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccC
Q 003911 59 WNHVVCIED----------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQF 127 (787)
Q Consensus 59 w~gv~C~~~----------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l 127 (787)
+..|.|... ..++.|+|++|++++..|..|+++++|++|+|++|+|++..| .|.++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 455778532 479999999999998889999999999999999999999877 699999999999999999
Q ss_pred CcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCC
Q 003911 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLP 207 (787)
Q Consensus 128 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p 207 (787)
+++++..|+++++|++|+|++|+++. ..|..+.++++|++|++++|.+++..++.+. .+++|++|+|++|++++..|
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~-l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~~ 170 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGF--PTEKLKVLDFQNNAIHYLSK 170 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSC-GGGSCCTTCTTCCEEECCSSCCCCCCCCTTC--CCTTCCEEECCSSCCCEECH
T ss_pred cccChhhhcccccccEeeccccCccc-CCcchhccCCcccEEECCCCcccccCccccc--CCcccCEEEcccCcccccCh
Confidence 99999999999999999999999995 3367789999999999999999985544443 58888999998888887766
Q ss_pred cCccc-cccc--ceeeccCCCCCcCCC----------------------------------------------Ccccccc
Q 003911 208 ASFSG-SQIQ--SLWVNGQNGNAKLGG----------------------------------------------GIDVIQN 238 (787)
Q Consensus 208 ~~~~~-~~l~--~L~~~~~~~~~~~~~----------------------------------------------~~~~~~~ 238 (787)
..+.. .+++ .|++.++........ ....+..
T Consensus 171 ~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~ 250 (606)
T 3t6q_A 171 EDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250 (606)
T ss_dssp HHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGG
T ss_pred hhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhch
Confidence 66554 3344 444443322111100 0011111
Q ss_pred Cc--cCceEeccccccccCCCC-CCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCC-CCCCceeeec
Q 003911 239 MT--SLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP-EFDRSVSLDM 314 (787)
Q Consensus 239 l~--~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~~~L~~ 314 (787)
+. +|+.|++++|.+++.++. |..+++|++|+|++|+++ .+|..+..+++|++|++++|++++.+| .+..+.+|+.
T Consensus 251 l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 329 (606)
T 3t6q_A 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329 (606)
T ss_dssp GGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSE
T ss_pred hhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCE
Confidence 11 566666666666665554 666666666666666666 566666666666666666666666544 3445556666
Q ss_pred cccCCCccC-CCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCc---cccccCCCceEEEEccCCcccccCchhh
Q 003911 315 AKGSNNFCL-PSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW---IGVTCTKGNITVINFQKMNLTGTISPEF 390 (787)
Q Consensus 315 l~~~~n~~~-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~L~~L~Ls~N~l~g~~p~~~ 390 (787)
+++++|.+. .++.........+ ............. ...+...++|+.|++++|++.+..|..|
T Consensus 330 L~l~~n~~~~~~~~~~~~~l~~L-------------~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 396 (606)
T 3t6q_A 330 LSIKGNTKRLELGTGCLENLENL-------------RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF 396 (606)
T ss_dssp EECCSCSSCCBCCSSTTTTCTTC-------------CEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTT
T ss_pred EECCCCCcccccchhhhhccCcC-------------CEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHh
Confidence 666665443 1211110000000 0000000000000 0112233455555555555555555555
Q ss_pred cCCCCCCEEecccccccccCCcc-CcCCCCCCeeeccCCcccccCCC----CCCCceeecCCCC
Q 003911 391 ASFKSLQRLILADNNLSGMIPEG-LSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNP 449 (787)
Q Consensus 391 ~~l~~L~~L~Ls~N~l~g~ip~~-l~~l~~L~~L~Ls~N~l~g~iP~----~~~~~~~~~~gn~ 449 (787)
..+++|+.|+|++|++++..|.. +..+++|++|++++|++++.+|. +..+..+.+.+|+
T Consensus 397 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 460 (606)
T 3t6q_A 397 KECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNH 460 (606)
T ss_dssp TTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCB
T ss_pred cCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCC
Confidence 55555555555555555444433 55555555555555555554443 2334445555543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=332.59 Aligned_cols=194 Identities=26% Similarity=0.421 Sum_probs=163.8
Q ss_pred HHHhhcCCCcccceeccccceEEEEEEEeC------CcEEEEEEeecccccchhHHHHHHHHHHHHhcCC-CccceEEeE
Q 003911 587 VLRNVTNNFSEENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH-RHLVALLGH 659 (787)
Q Consensus 587 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~ 659 (787)
..+...++|++.+.||+|+||+||+|++.. ++.||||+++... .....++|.+|++++++++| ||||+++|+
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 344456789999999999999999998652 3679999997633 34456789999999999965 899999999
Q ss_pred EEeC-CeeEEEEEecCCCCHHHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 003911 660 CLDG-NEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKP 727 (787)
Q Consensus 660 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 727 (787)
|... +..++|||||++|+|.++++..... ....+++.++..|+.|||+||+|||+ ++||||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCc
Confidence 9764 5689999999999999999764321 12458999999999999999999998 8999999999
Q ss_pred CCEEECCCCcEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeec
Q 003911 728 SNILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 728 ~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+|||+++++.+||+|||+|+........ ......||+.|||||++.++.|+ ++||||
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS 272 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 272 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEee
Confidence 9999999999999999999977554332 23346799999999999999999 999998
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=343.94 Aligned_cols=311 Identities=18% Similarity=0.209 Sum_probs=180.5
Q ss_pred cccEEEcCC----------CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccC
Q 003911 59 WNHVVCIED----------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQF 127 (787)
Q Consensus 59 w~gv~C~~~----------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l 127 (787)
|..|.|... .+++.|+|++|++++..+..|.++++|++|+|++|.|++..| .|.++++|++|+|++|++
T Consensus 13 ~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l 92 (477)
T 2id5_A 13 DRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92 (477)
T ss_dssp TTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcC
Confidence 567777532 246666666666666666666666666666666666666554 566666666666666666
Q ss_pred CcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCC
Q 003911 128 TSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLP 207 (787)
Q Consensus 128 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p 207 (787)
+.+++..|.++++|++|+|++|++.. ..|..|..+++|++|++++|.+++..+..|. .+++|++|+|++|++++..+
T Consensus 93 ~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~ 169 (477)
T 2id5_A 93 KLIPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDLYNLKSLEVGDNDLVYISHRAFS--GLNSLEQLTLEKCNLTSIPT 169 (477)
T ss_dssp CSCCTTSSTTCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEEECCTTCCEECTTSST--TCTTCCEEEEESCCCSSCCH
T ss_pred CccCcccccCCCCCCEEECCCCcccc-CChhHccccccCCEEECCCCccceeChhhcc--CCCCCCEEECCCCcCcccCh
Confidence 66666666666666666666666664 4455666666666666666666666666664 66666666666666664433
Q ss_pred cCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCC-CCCCCCCCCEEecCCCcccccCCccccCC
Q 003911 208 ASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKL 286 (787)
Q Consensus 208 ~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 286 (787)
..| .++++|+.|+|++|.+++.++ .|..+++|+.|++++|.+.+.+|..+...
T Consensus 170 ~~l--------------------------~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~ 223 (477)
T 2id5_A 170 EAL--------------------------SHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG 223 (477)
T ss_dssp HHH--------------------------TTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTT
T ss_pred hHh--------------------------cccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccC
Confidence 333 355555666666665555444 35555556666666555555555555555
Q ss_pred CCCCEEEccCCcccccCC-CCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCcccc
Q 003911 287 ESLKIVNMTNNLLQGPVP-EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGV 365 (787)
Q Consensus 287 ~~L~~L~Ls~N~l~~~~p-~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (787)
.+|++|+|++|++++.++ .+..+.+|+.+++++|.+..++.. .
T Consensus 224 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~------------------------------------~ 267 (477)
T 2id5_A 224 LNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGS------------------------------------M 267 (477)
T ss_dssp CCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTT------------------------------------S
T ss_pred ccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChh------------------------------------h
Confidence 556666666655554332 133333344444444433222110 0
Q ss_pred ccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccC
Q 003911 366 TCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKI 434 (787)
Q Consensus 366 ~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~i 434 (787)
+...++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++++..
T Consensus 268 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 268 LHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp CTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred ccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCcc
Confidence 112235566666666666666666666666666666666666544445566666666666666665543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=348.46 Aligned_cols=371 Identities=18% Similarity=0.193 Sum_probs=219.2
Q ss_pred CEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEcc
Q 003911 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (787)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 147 (787)
+++.|++++|++++..+.+|.++++|++|+|++|+|++.++ .|.++++|++|+|++|+++++++..|+++++|++|+|+
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 46666666666665555566666666666666666666554 45666666666666666666666556666666666666
Q ss_pred CCCCCCCCCC-hhhhcCCCCCEEeccCceecc-cCCCCCCCCCCCCCcEEeccccccccCC-------------------
Q 003911 148 NNPFSSWEIP-QSLRNASGLQNFSANSANITG-QIPSFFGPDEFPGLTILHLAFNQLIGGL------------------- 206 (787)
Q Consensus 148 ~N~l~~~~~p-~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~~~l~~L~~L~L~~N~l~~~~------------------- 206 (787)
+|+++. +| ..++++++|++|++++|.+++ .+|..|+ .+++|++|++++|++++..
T Consensus 109 ~n~l~~--l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l 184 (570)
T 2z63_A 109 ETNLAS--LENFPIGHLKTLKELNVAHNLIQSFKLPEYFS--NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184 (570)
T ss_dssp TSCCCC--STTCSCTTCTTCCEEECCSSCCCCCCCCGGGG--GCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEEC
T ss_pred cccccc--CCCccccccccccEEecCCCccceecChhhhc--ccCCCCEEeCcCCccceecHHHccchhccchhhhhccc
Confidence 665553 22 245555555566665555554 2455554 5555555555555555443
Q ss_pred ---------CcCcccccccceeeccCCCC---------------------------------------------------
Q 003911 207 ---------PASFSGSQIQSLWVNGQNGN--------------------------------------------------- 226 (787)
Q Consensus 207 ---------p~~~~~~~l~~L~~~~~~~~--------------------------------------------------- 226 (787)
|..+....++.|++.++...
T Consensus 185 ~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l 264 (570)
T 2z63_A 185 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264 (570)
T ss_dssp TTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEE
T ss_pred CCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhh
Confidence 43333333444433322000
Q ss_pred ----CcCCCCccccccCccCceEeccccccccCCCCC------------------------------------------C
Q 003911 227 ----AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDF------------------------------------------S 260 (787)
Q Consensus 227 ----~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~------------------------------------------~ 260 (787)
......++.+..+++|+.|++++|.+++.++.+ .
T Consensus 265 ~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~ 344 (570)
T 2z63_A 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 344 (570)
T ss_dssp EETTEEESCSTTTTGGGTTCSEEEEESCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCC
T ss_pred hcchhhhhhchhhhcCcCcccEEEecCccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccc
Confidence 111122334555566666666666665433322 3
Q ss_pred CCCCCCEEecCCCcccccC--CccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCC-CCCchhhHHH
Q 003911 261 GVKQLESLSLRDNFFTGPV--PDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPG-ACDPRLNALL 337 (787)
Q Consensus 261 ~l~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~-~~~~~~~~l~ 337 (787)
.+++|++|++++|++++.. |..+..+++|++|++++|.+++.++.+..+.+|+.+++++|.+...+. ........+.
T Consensus 345 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 424 (570)
T 2z63_A 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424 (570)
T ss_dssp BCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCC
T ss_pred cCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCC
Confidence 4566666666666666443 566667777777777777777666656666667777777766554322 1111100000
Q ss_pred HHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCccc-ccCchhhcCCCCCCEEecccccccccCCccCcC
Q 003911 338 SVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLT-GTISPEFASFKSLQRLILADNNLSGMIPEGLSV 416 (787)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~ 416 (787)
......+.........+...++|+.|++++|+++ +.+|..|..+++|+.|+|++|++++..|..+..
T Consensus 425 ------------~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 492 (570)
T 2z63_A 425 ------------YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492 (570)
T ss_dssp ------------EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred ------------EEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhc
Confidence 0000000000111223445578888888888887 578888888888888888888888888888888
Q ss_pred CCCCCeeeccCCcccccCCC----CCCCceeecCCCCCCCCCC
Q 003911 417 LGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDIGKEK 455 (787)
Q Consensus 417 l~~L~~L~Ls~N~l~g~iP~----~~~~~~~~~~gn~~~~~~~ 455 (787)
+++|++|+|++|++++.+|. +..+..+.+.+|++.|..+
T Consensus 493 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 493 LSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp CTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 88888888888888887764 4556778888888877654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=346.78 Aligned_cols=147 Identities=21% Similarity=0.325 Sum_probs=133.2
Q ss_pred EEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCC
Q 003911 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNP 150 (787)
Q Consensus 72 ~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 150 (787)
.++.++++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+++++++.+|.++++|++|+|++|+
T Consensus 15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~ 91 (606)
T 3vq2_A 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence 5788888898 7888776 899999999999999888 79999999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEecccccccc-CCCcCccc-ccccceeeccCC
Q 003911 151 FSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIG-GLPASFSG-SQIQSLWVNGQN 224 (787)
Q Consensus 151 l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~-~~l~~L~~~~~~ 224 (787)
++. ..|..|.++++|++|++++|.+++..+..++ .+++|++|+|++|++++ .+|..|.+ .+|+.|++.++.
T Consensus 92 l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~ 164 (606)
T 3vq2_A 92 IQS-FSPGSFSGLTSLENLVAVETKLASLESFPIG--QLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY 164 (606)
T ss_dssp CCC-CCTTSSTTCTTCCEEECTTSCCCCSSSSCCT--TCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSC
T ss_pred ccc-cChhhcCCcccCCEEEccCCccccccccccC--CCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCc
Confidence 996 5689999999999999999999998888886 99999999999999987 57888875 568888877654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=359.74 Aligned_cols=323 Identities=27% Similarity=0.402 Sum_probs=268.8
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCC-CCcEEEeecCCCCCCCC-CCCC--CCCCcEEEcccccCCcCCCccccCCCCCcE
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLT-KLERLELQWNSISGPLP-SLNG--LASLEVVMLSNNQFTSVPSDFFTGLSSLQS 143 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~-~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 143 (787)
.+++.|++++|.++|.+|..+.+++ +|++|+|++|++++.+| .+.. +++|++|+|++|++++..|..|.++++|++
T Consensus 343 ~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 422 (768)
T 3rgz_A 343 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 422 (768)
T ss_dssp TTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCE
T ss_pred CCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCE
Confidence 5788999999999999999888887 89999999999988555 5555 788999999999999888888999999999
Q ss_pred EEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCccc-ccccceeecc
Q 003911 144 IEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNG 222 (787)
Q Consensus 144 L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~L~~~~ 222 (787)
|+|++|++++ .+|..+..+++|+.|++++|.+++.+|..+. .+++|++|+|++|++++.+|..+.. .+|+.|++.+
T Consensus 423 L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 499 (768)
T 3rgz_A 423 LHLSFNYLSG-TIPSSLGSLSKLRDLKLWLNMLEGEIPQELM--YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499 (768)
T ss_dssp EECCSSEEES-CCCGGGGGCTTCCEEECCSSCCCSCCCGGGG--GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCS
T ss_pred EECcCCcccC-cccHHHhcCCCCCEEECCCCcccCcCCHHHc--CCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccC
Confidence 9999999887 7888899999999999999999988888886 8889999999999999888888864 4566666654
Q ss_pred CCCCCcCCCCccccccCccCceEeccccccccCCC-CCCCCCCCCEEecCCCcccccCCcccc-----------------
Q 003911 223 QNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLV----------------- 284 (787)
Q Consensus 223 ~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~----------------- 284 (787)
|...+..|..++++++|++|+|++|++++.+| .+..+++|+.|+|++|+++|.+|..+.
T Consensus 500 ---N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~ 576 (768)
T 3rgz_A 500 ---NRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYV 576 (768)
T ss_dssp ---SCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEE
T ss_pred ---CccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccc
Confidence 44445667788889999999999999988776 488889999999999998888776543
Q ss_pred -----------------------------------------------------CCCCCCEEEccCCcccccCCC-CCCce
Q 003911 285 -----------------------------------------------------KLESLKIVNMTNNLLQGPVPE-FDRSV 310 (787)
Q Consensus 285 -----------------------------------------------------~l~~L~~L~Ls~N~l~~~~p~-~~~~~ 310 (787)
.+++|++|||++|+++|.+|. +..+.
T Consensus 577 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~ 656 (768)
T 3rgz_A 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMP 656 (768)
T ss_dssp EEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCT
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccc
Confidence 357799999999999998885 77888
Q ss_pred eeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhh
Q 003911 311 SLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEF 390 (787)
Q Consensus 311 ~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~ 390 (787)
.|+.+++++|.+....+ ..+..+.+|+.|||++|+++|.+|..+
T Consensus 657 ~L~~L~Ls~N~l~g~ip------------------------------------~~l~~L~~L~~LdLs~N~l~g~ip~~l 700 (768)
T 3rgz_A 657 YLFILNLGHNDISGSIP------------------------------------DEVGDLRGLNILDLSSNKLDGRIPQAM 700 (768)
T ss_dssp TCCEEECCSSCCCSCCC------------------------------------GGGGGCTTCCEEECCSSCCEECCCGGG
T ss_pred cCCEEeCcCCccCCCCC------------------------------------hHHhCCCCCCEEECCCCcccCcCChHH
Confidence 89999999998763221 123345689999999999999999999
Q ss_pred cCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCc-cccc
Q 003911 391 ASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ-LYGK 433 (787)
Q Consensus 391 ~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~-l~g~ 433 (787)
+.+++|++|||++|+|+|.||.. +.+..+....+.+|+ |.|.
T Consensus 701 ~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 701 SALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp GGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEEST
T ss_pred hCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcCC
Confidence 99999999999999999999965 456667777788885 6764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=338.70 Aligned_cols=341 Identities=18% Similarity=0.169 Sum_probs=259.1
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (787)
.+++.|+|++|++++..|..|.++++|++|+|++|+|++..| .|.++++|++|+|++|+|+.++.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC---PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC---CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc---ccccCCEEEC
Confidence 579999999999998777899999999999999999999877 699999999999999999998876 8999999999
Q ss_pred cCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCC--cEEecccccc--ccCCCcCcccccccceee--
Q 003911 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGL--TILHLAFNQL--IGGLPASFSGSQIQSLWV-- 220 (787)
Q Consensus 147 ~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~~~l~~L~~-- 220 (787)
++|+++.+.+|..|.++++|++|++++|++++. .+. .+++| ++|+|++|++ ++..|..+.....+.+.+
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~--~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l 203 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLL--PVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVF 203 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTG--GGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEE
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccC---chh--hhhhceeeEEEeecccccccccCcccccccCcceEEEEe
Confidence 999999766778999999999999999999863 232 55566 9999999999 888887776532111111
Q ss_pred ----------------------ccCCCCC----cCCCCccccc---------------------------cCccCceEec
Q 003911 221 ----------------------NGQNGNA----KLGGGIDVIQ---------------------------NMTSLKEIWL 247 (787)
Q Consensus 221 ----------------------~~~~~~~----~~~~~~~~~~---------------------------~l~~L~~L~L 247 (787)
.+...+. .+.+.+..+. ..++|++|++
T Consensus 204 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l 283 (562)
T 3a79_B 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283 (562)
T ss_dssp CSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEE
T ss_pred cCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEE
Confidence 1111110 0000000000 1125666666
Q ss_pred cccccccCCCC-C-----------------------------------------------------CCCCCCCEEecCCC
Q 003911 248 HSNAFSGPLPD-F-----------------------------------------------------SGVKQLESLSLRDN 273 (787)
Q Consensus 248 ~~N~l~~~~~~-~-----------------------------------------------------~~l~~L~~L~L~~N 273 (787)
++|.++|.+|. + ..+++|++|+|++|
T Consensus 284 ~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n 363 (562)
T 3a79_B 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQN 363 (562)
T ss_dssp EEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSS
T ss_pred eccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCC
Confidence 66666654432 2 56788888888888
Q ss_pred cccccCCccccCCCCCCEEEccCCcccccC--C-CCCCceeeeccccCCCccCC-CCCCCCchhhHHHHHHHHhCCChhh
Q 003911 274 FFTGPVPDSLVKLESLKIVNMTNNLLQGPV--P-EFDRSVSLDMAKGSNNFCLP-SPGACDPRLNALLSVVKLMGYPQRF 349 (787)
Q Consensus 274 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~--p-~~~~~~~L~~l~~~~n~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~ 349 (787)
++++.+|..+..+++|++|+|++|++++.. | .+..+.+|+.+++++|.+.. +|..
T Consensus 364 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~--------------------- 422 (562)
T 3a79_B 364 VFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDR--------------------- 422 (562)
T ss_dssp CCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSC---------------------
T ss_pred ccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChh---------------------
Confidence 888878888888888888888888888643 2 46677788888888887654 3321
Q ss_pred hcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCc
Q 003911 350 AENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ 429 (787)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~ 429 (787)
.+...++|+.|++++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|++|+
T Consensus 423 ---------------~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~ 484 (562)
T 3a79_B 423 ---------------TCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQ 484 (562)
T ss_dssp ---------------CCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSC
T ss_pred ---------------hhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCC
Confidence 122346899999999999988887665 78999999999999 899988899999999999999
Q ss_pred ccccCCC----CCCCceeecCCCCCCCCCC
Q 003911 430 LYGKIPS----FKSNAIVNTDGNPDIGKEK 455 (787)
Q Consensus 430 l~g~iP~----~~~~~~~~~~gn~~~~~~~ 455 (787)
|++..+. +..+..+.+.+||+.|..+
T Consensus 485 l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 485 LKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp CCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred CCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 9954333 4456778999999988764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=329.92 Aligned_cols=186 Identities=24% Similarity=0.423 Sum_probs=158.2
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe------C
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD------G 663 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~ 663 (787)
+.++|++.+.||+|+||+||+|+.. +|+.||||+++.........+++.+|+++|++++|||||++++++.. .
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 3468999999999999999999875 79999999998755555666788999999999999999999998764 3
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
+..|||||||+ |+|.+++.. .+.+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+||
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DF 202 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDF 202 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCC
T ss_pred CEEEEEEeCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeec
Confidence 57899999995 689888843 3579999999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCC---CceeeeeccccCcccccccccCC-cC-cceeecC
Q 003911 744 GLVRLAPEGK---GSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS~ 785 (787)
|+|+...... .......+||+.|||||++.+.. |+ ++||||.
T Consensus 203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSl 249 (398)
T 4b99_A 203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSV 249 (398)
T ss_dssp TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehh
Confidence 9998764321 12234578999999999998864 46 8999984
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=336.02 Aligned_cols=324 Identities=19% Similarity=0.203 Sum_probs=283.7
Q ss_pred cEEEcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCC
Q 003911 61 HVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLS 139 (787)
Q Consensus 61 gv~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 139 (787)
+-.|.... +.++.++++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+++++.+..|.+++
T Consensus 6 ~C~C~~~~--~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~ 80 (477)
T 2id5_A 6 RCECSAQD--RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLF 80 (477)
T ss_dssp TCEEETTT--TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred CCeECCCC--CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCc
Confidence 33575433 46888999998 7888775 689999999999999877 799999999999999999999999999999
Q ss_pred CCcEEEccCCCCCCCCCC-hhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccce
Q 003911 140 SLQSIEIDNNPFSSWEIP-QSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSL 218 (787)
Q Consensus 140 ~L~~L~L~~N~l~~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L 218 (787)
+|++|+|++|+++. +| ..|.++++|++|++++|.+++..|..|. .+++|++|+|++|++++..|..|.
T Consensus 81 ~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~------- 149 (477)
T 2id5_A 81 NLRTLGLRSNRLKL--IPLGVFTGLSNLTKLDISENKIVILLDYMFQ--DLYNLKSLEVGDNDLVYISHRAFS------- 149 (477)
T ss_dssp TCCEEECCSSCCCS--CCTTSSTTCTTCCEEECTTSCCCEECTTTTT--TCTTCCEEEECCTTCCEECTTSST-------
T ss_pred cCCEEECCCCcCCc--cCcccccCCCCCCEEECCCCccccCChhHcc--ccccCCEEECCCCccceeChhhcc-------
Confidence 99999999999994 55 5689999999999999999999999986 899999999999999987777654
Q ss_pred eeccCCCCCcCCCCccccccCccCceEeccccccccCCCC-CCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCC
Q 003911 219 WVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297 (787)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 297 (787)
++++|++|+|++|++++.++. +..+++|+.|+|++|++++..+..|..+++|++|++++|
T Consensus 150 -------------------~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~ 210 (477)
T 2id5_A 150 -------------------GLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210 (477)
T ss_dssp -------------------TCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECC
T ss_pred -------------------CCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCC
Confidence 799999999999999987764 889999999999999999888889999999999999999
Q ss_pred cccccCC-CCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEE
Q 003911 298 LLQGPVP-EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVIN 376 (787)
Q Consensus 298 ~l~~~~p-~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~ 376 (787)
++.+.+| ......+|+.+++++|.+..++.. .+...++|+.|+
T Consensus 211 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~------------------------------------~~~~l~~L~~L~ 254 (477)
T 2id5_A 211 PYLDTMTPNCLYGLNLTSLSITHCNLTAVPYL------------------------------------AVRHLVYLRFLN 254 (477)
T ss_dssp TTCCEECTTTTTTCCCSEEEEESSCCCSCCHH------------------------------------HHTTCTTCCEEE
T ss_pred ccccccCcccccCccccEEECcCCcccccCHH------------------------------------HhcCccccCeeE
Confidence 8776554 466666889999999877654311 123346899999
Q ss_pred ccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCC----CCCCceeecCCCCCCC
Q 003911 377 FQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDIG 452 (787)
Q Consensus 377 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~----~~~~~~~~~~gn~~~~ 452 (787)
|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|+|++..+. +..+..+.+.+||+.|
T Consensus 255 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 255 LSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC 334 (477)
T ss_dssp CCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred CCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence 999999999999999999999999999999999999999999999999999999986654 4567889999999998
Q ss_pred CCC
Q 003911 453 KEK 455 (787)
Q Consensus 453 ~~~ 455 (787)
..+
T Consensus 335 ~c~ 337 (477)
T 2id5_A 335 DCR 337 (477)
T ss_dssp SGG
T ss_pred ccc
Confidence 754
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=346.68 Aligned_cols=367 Identities=19% Similarity=0.204 Sum_probs=255.4
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCc--EEEcccccCCcCCCccccCC------
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLE--VVMLSNNQFTSVPSDFFTGL------ 138 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~--~L~L~~N~l~~~~~~~~~~l------ 138 (787)
.+++.|++++|.+++...+.+..+++|++|+|++|++++..+ .|..+++|+ +|++++|+++++++..|...
T Consensus 129 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~ 208 (606)
T 3t6q_A 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLN 208 (606)
T ss_dssp TTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEE
T ss_pred CcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccc
Confidence 468888888888886444455558888888888888887766 577777777 78888888877776655431
Q ss_pred ---------------------------------------------CCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccC
Q 003911 139 ---------------------------------------------SSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173 (787)
Q Consensus 139 ---------------------------------------------~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~ 173 (787)
.+|++|++++|.++. ..+..|..+++|++|++++
T Consensus 209 l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~ 287 (606)
T 3t6q_A 209 FGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN-ISSNTFHCFSGLQELDLTA 287 (606)
T ss_dssp CTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSS-CCTTTTTTCTTCSEEECTT
T ss_pred cCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCc-cCHHHhccccCCCEEeccC
Confidence 156677777777764 3345577777777777777
Q ss_pred ceecccCCCCCCCCCCCCCcEEeccccccccCCCcCccc-ccccceeeccCCCCCcCCCC-ccccccCccCceEeccccc
Q 003911 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGG-IDVIQNMTSLKEIWLHSNA 251 (787)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~L~~~~~~~~~~~~~~-~~~~~~l~~L~~L~L~~N~ 251 (787)
|+++ .+|..+. .+++|++|++++|++++..|..+.. .+|+.|++.++. ..... +..+.++++|++|++++|.
T Consensus 288 n~l~-~lp~~l~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~---~~~~~~~~~~~~l~~L~~L~l~~n~ 361 (606)
T 3t6q_A 288 THLS-ELPSGLV--GLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNT---KRLELGTGCLENLENLRELDLSHDD 361 (606)
T ss_dssp SCCS-CCCSSCC--SCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCS---SCCBCCSSTTTTCTTCCEEECCSSC
T ss_pred CccC-CCChhhc--ccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCC---cccccchhhhhccCcCCEEECCCCc
Confidence 7776 4555554 6777777777777777666666654 445555555432 22122 2346677777777777777
Q ss_pred cccCC---CCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCC--CCCceeeeccccCCCccCCCC
Q 003911 252 FSGPL---PDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE--FDRSVSLDMAKGSNNFCLPSP 326 (787)
Q Consensus 252 l~~~~---~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~--~~~~~~L~~l~~~~n~~~~~~ 326 (787)
+++.. ..+..+++|++|++++|++++..|..|..+++|++|++++|++++..+. +..+.+|+.+++++|.+...+
T Consensus 362 l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 441 (606)
T 3t6q_A 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISS 441 (606)
T ss_dssp CCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTC
T ss_pred cccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcC
Confidence 77653 3467777777777777777777777777777777777777777765443 556667777777777665543
Q ss_pred CCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCC----ccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecc
Q 003911 327 GACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD----WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILA 402 (787)
Q Consensus 327 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 402 (787)
.........+ ............ ....+...++|+.|++++|++++..|..|+.+++|+.|+|+
T Consensus 442 ~~~~~~l~~L-------------~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 508 (606)
T 3t6q_A 442 EQLFDGLPAL-------------QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLS 508 (606)
T ss_dssp TTTTTTCTTC-------------CEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred HHHHhCCCCC-------------CEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECC
Confidence 3221111100 000000000000 01224456799999999999999999999999999999999
Q ss_pred cccccccCCccCcCCCCCCeeeccCCcccccCCC----CCCCceeecCCCCCCCCCC
Q 003911 403 DNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDIGKEK 455 (787)
Q Consensus 403 ~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~----~~~~~~~~~~gn~~~~~~~ 455 (787)
+|++++.+|..+..++.| +|||++|++++.+|. +..+..+.+.|||+.|..+
T Consensus 509 ~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 509 HNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp SSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred CCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 999999999999999999 999999999998876 4567889999999988664
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=343.78 Aligned_cols=372 Identities=19% Similarity=0.170 Sum_probs=264.8
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (787)
..++.|||++|+|++..+.+|.++++|++|+|++|+|+++++ +|.+|++|++|+|++|+|+++++++|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 368999999999997777899999999999999999999888 6999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCChhhhcCCCCCEEeccCceeccc-CCCCCCCCCCCCCcEEeccccccccCCCcCcccc------------
Q 003911 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQ-IPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGS------------ 213 (787)
Q Consensus 147 ~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~-~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~------------ 213 (787)
++|+++. ..+..|+++++|++|++++|.+++. +|..++ .+++|++|+|++|+|++..|..+...
T Consensus 132 s~N~l~~-l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~l 208 (635)
T 4g8a_A 132 VETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFS--NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 208 (635)
T ss_dssp TTSCCCC-STTCCCTTCTTCCEEECCSSCCCCCCCCGGGG--GCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEEC
T ss_pred CCCcCCC-CChhhhhcCcccCeeccccCccccCCCchhhc--cchhhhhhcccCccccccccccccchhhhhhhhhhhhc
Confidence 9999995 3345799999999999999999864 567775 89999999999999987766554320
Q ss_pred ----------------cccceeeccCC-----------------------------------------------------
Q 003911 214 ----------------QIQSLWVNGQN----------------------------------------------------- 224 (787)
Q Consensus 214 ----------------~l~~L~~~~~~----------------------------------------------------- 224 (787)
.+..+.+.++.
T Consensus 209 s~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~ 288 (635)
T 4g8a_A 209 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 288 (635)
T ss_dssp TTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEE
T ss_pred ccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhh
Confidence 00011110000
Q ss_pred ---------------------------------------------------CCCcC----------------CCCccccc
Q 003911 225 ---------------------------------------------------GNAKL----------------GGGIDVIQ 237 (787)
Q Consensus 225 ---------------------------------------------------~~~~~----------------~~~~~~~~ 237 (787)
..... ...+....
T Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~ 368 (635)
T 4g8a_A 289 AYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 368 (635)
T ss_dssp ECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCC
T ss_pred hhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccc
Confidence 00000 00001122
Q ss_pred cCccCceEeccccccccC--CC-CCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCC--CCCCceee
Q 003911 238 NMTSLKEIWLHSNAFSGP--LP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP--EFDRSVSL 312 (787)
Q Consensus 238 ~l~~L~~L~L~~N~l~~~--~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~~~L 312 (787)
.+++|+.|++++|.+... .+ .+..+.+|+.|++..|.+. .++..+..+++|+.+++++|++....+ .+..+..+
T Consensus 369 ~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l 447 (635)
T 4g8a_A 369 DLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 447 (635)
T ss_dssp BCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTC
T ss_pred cccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhcccccccccccccccccc
Confidence 467788888888887542 22 2344566666666666665 344455566666666666665554433 24444555
Q ss_pred eccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCC-CccccccCCCceEEEEccCCcccccCchhhc
Q 003911 313 DMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS-DWIGVTCTKGNITVINFQKMNLTGTISPEFA 391 (787)
Q Consensus 313 ~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~ 391 (787)
..++++.|.+...+.........+.. ....++.... .....+...++|+.|+|++|++++.+|..|.
T Consensus 448 ~~l~ls~n~l~~~~~~~~~~~~~L~~------------L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~ 515 (635)
T 4g8a_A 448 IYLDISHTHTRVAFNGIFNGLSSLEV------------LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 515 (635)
T ss_dssp CEEECTTSCCEECCTTTTTTCTTCCE------------EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred ccccccccccccccccccccchhhhh------------hhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHc
Confidence 55555555544333221111000000 0000000000 0112344567999999999999999999999
Q ss_pred CCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCC----C-CCCceeecCCCCCCCCCC
Q 003911 392 SFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS----F-KSNAIVNTDGNPDIGKEK 455 (787)
Q Consensus 392 ~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~----~-~~~~~~~~~gn~~~~~~~ 455 (787)
++++|++|+|++|+|++..|..|..+++|++|||++|+|++.+|. + .++..+.+.|||+.|.+.
T Consensus 516 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 516 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 999999999999999998899999999999999999999999886 2 456789999999999865
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=346.03 Aligned_cols=379 Identities=16% Similarity=0.155 Sum_probs=251.7
Q ss_pred CCcccEEEcC----------CCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccc
Q 003911 57 CKWNHVVCIE----------DKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNN 125 (787)
Q Consensus 57 C~w~gv~C~~----------~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N 125 (787)
|.+..|.|.. ..+++.|+|++|++++..+..|+++++|++|+|++|.+++.+| .|.++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 4455567753 2479999999999998777789999999999999999999888 5899999999999999
Q ss_pred cCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccC
Q 003911 126 QFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205 (787)
Q Consensus 126 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~ 205 (787)
+++++++..|+++++|++|+|++|++.. ..|..|.++++|++|++++|.+++.+|..++ .+++|++|+|++|++++.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~ 160 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQV--QLENLQELLLSNNKIQAL 160 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCC-CCSCTTTTCTTCCEEECCSSCCSCCCCCSSS--CCTTCCEEECCSSCCCCB
T ss_pred ccCccChhhhccCCCCCEEECCCCccCc-cChhHccccCCCCEEECCCCcccccCchhhc--ccccCCEEEccCCccccc
Confidence 9999999999999999999999999985 4457899999999999999999999998886 899999999999999988
Q ss_pred CCcCccc---ccccceeeccCCCCCcCCCCccccccC---------------------------ccCceEeccccccccC
Q 003911 206 LPASFSG---SQIQSLWVNGQNGNAKLGGGIDVIQNM---------------------------TSLKEIWLHSNAFSGP 255 (787)
Q Consensus 206 ~p~~~~~---~~l~~L~~~~~~~~~~~~~~~~~~~~l---------------------------~~L~~L~L~~N~l~~~ 255 (787)
.+..+.. .+|+.|++.++..... .+..+..+ ++|+.|++++|.+++.
T Consensus 161 ~~~~~~~~~~~~L~~L~L~~n~l~~~---~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~ 237 (680)
T 1ziw_A 161 KSEELDIFANSSLKKLELSSNQIKEF---SPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT 237 (680)
T ss_dssp CHHHHGGGTTCEESEEECTTCCCCCB---CTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEE
T ss_pred CHHHhhccccccccEEECCCCccccc---ChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCccccc
Confidence 7766543 4567776665433222 22222221 4556666666666665
Q ss_pred CCC-CCCCCC--CCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCC-CCCceeeeccccCCC-----------
Q 003911 256 LPD-FSGVKQ--LESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNN----------- 320 (787)
Q Consensus 256 ~~~-~~~l~~--L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~L~~l~~~~n----------- 320 (787)
++. +.+++. |+.|+|++|++++..|..|..+++|++|+|++|++++.+|. +..+.+|+.+++++|
T Consensus 238 ~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~l 317 (680)
T 1ziw_A 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASL 317 (680)
T ss_dssp CTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------C
T ss_pred ChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccc
Confidence 543 544433 66666666666666666666666666666666666665543 444445555555444
Q ss_pred ----------------------ccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEcc
Q 003911 321 ----------------------FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQ 378 (787)
Q Consensus 321 ----------------------~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls 378 (787)
.+...+.........+..+ .+..+...........-.......|+.|+++
T Consensus 318 p~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L--------~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~ 389 (680)
T 1ziw_A 318 PKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYL--------SLSNSFTSLRTLTNETFVSLAHSPLHILNLT 389 (680)
T ss_dssp CEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEE--------ECTTCBSCCCEECTTTTGGGTTSCCCEEECT
T ss_pred cccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEE--------ECCCCchhhhhcchhhhcccccCcCceEECC
Confidence 3333221111100000000 0000000000000000000112367777777
Q ss_pred CCcccccCchhhcCCCCCCEEecccccccccCC-ccCcCCCCCCeeeccCCcccccCCC----CCCCceeecCCCC
Q 003911 379 KMNLTGTISPEFASFKSLQRLILADNNLSGMIP-EGLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNP 449 (787)
Q Consensus 379 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip-~~l~~l~~L~~L~Ls~N~l~g~iP~----~~~~~~~~~~gn~ 449 (787)
+|++++..|..|..+++|+.|+|++|++++.+| ..+..+++|++|++++|++++..|. ++.+..+.+.+|.
T Consensus 390 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~ 465 (680)
T 1ziw_A 390 KNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA 465 (680)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSC
T ss_pred CCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccc
Confidence 777777777777777777777777777776665 5677777777777777777665443 3444555555554
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=321.99 Aligned_cols=183 Identities=22% Similarity=0.376 Sum_probs=155.3
Q ss_pred HHhhcCCCcccceeccccceEEEEEEEe----CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEe
Q 003911 588 LRNVTNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 662 (787)
Q Consensus 588 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 662 (787)
+..+.++|++.+.||+|+||+||+|+.+ +++.||+|++... ....++.+|+++++.+ +||||+++++++.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 3456788999999999999999999764 4688999998653 2345788999999998 69999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC-CcEEEe
Q 003911 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVA 741 (787)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~ 741 (787)
.+..|+||||+++|+|.+++ +.+++.++..++.|++.||+|||+ ++||||||||+|||++.+ +.+||+
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~--------~~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~ 160 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDIL--------NSLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALV 160 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHH--------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred CCEEEEEEeCCCcccHHHHH--------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEEC
Confidence 99999999999999999988 248899999999999999999998 899999999999999876 799999
Q ss_pred ecccceecCCCCC---------------------------ceeeeeccccCcccccccccCC-cC-cceeecC
Q 003911 742 DFGLVRLAPEGKG---------------------------SIETRIAGTFGYLAPEYAVHTR-WS-SCSYWAG 785 (787)
Q Consensus 742 DFG~a~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS~ 785 (787)
|||+|+...+... ......+||+.|||||++.+.. |+ ++||||.
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSl 233 (361)
T 4f9c_A 161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSA 233 (361)
T ss_dssp CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhh
Confidence 9999986543221 1112357999999999998764 66 7899984
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=336.34 Aligned_cols=341 Identities=19% Similarity=0.171 Sum_probs=236.8
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (787)
.+++.|+|++|++++..|..|.++++|++|+|++|+|++..| .|.++++|++|+|++|+|+.+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH---PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC---CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc---ccCCccEEec
Confidence 589999999999998777889999999999999999999876 799999999999999999988776 8999999999
Q ss_pred cCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCC--cEEecccccc--ccCCCcCccccc--------
Q 003911 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGL--TILHLAFNQL--IGGLPASFSGSQ-------- 214 (787)
Q Consensus 147 ~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~~~-------- 214 (787)
++|+++++.+|..|+++++|++|++++|.+++. .+. .+++| ++|+|++|++ .+..|..+....
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~---~~~--~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l 172 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS---SVL--PIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVF 172 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG---GGG--GGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEEC
T ss_pred cCCccccccchhhhccCCcceEEEecCcccchh---hcc--ccccceeeEEEeecccccccccccccccccccceEEEEe
Confidence 999998766889999999999999999999873 343 67777 9999999999 777787776522
Q ss_pred ----------------ccceeeccCCCCC------cCCCCcccccc---------------------------CccCceE
Q 003911 215 ----------------IQSLWVNGQNGNA------KLGGGIDVIQN---------------------------MTSLKEI 245 (787)
Q Consensus 215 ----------------l~~L~~~~~~~~~------~~~~~~~~~~~---------------------------l~~L~~L 245 (787)
+..|...+...+. ...+.+..++. +++|++|
T Consensus 173 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L 252 (520)
T 2z7x_B 173 PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYF 252 (520)
T ss_dssp CSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEE
T ss_pred ccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEE
Confidence 1112111111110 00000001111 1245555
Q ss_pred eccccccccCCCC-C-----------------------------------------------------CCCCCCCEEecC
Q 003911 246 WLHSNAFSGPLPD-F-----------------------------------------------------SGVKQLESLSLR 271 (787)
Q Consensus 246 ~L~~N~l~~~~~~-~-----------------------------------------------------~~l~~L~~L~L~ 271 (787)
++++|+++|.+|. + ..+++|++|+|+
T Consensus 253 ~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls 332 (520)
T 2z7x_B 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS 332 (520)
T ss_dssp EEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECC
T ss_pred EeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeE
Confidence 5555555543332 2 334455555555
Q ss_pred CCcccccCCccccCCCCCCEEEccCCcccc--cCC-CCCCceeeeccccCCCccCC-CCCCCCchhhHHHHHHHHhCCCh
Q 003911 272 DNFFTGPVPDSLVKLESLKIVNMTNNLLQG--PVP-EFDRSVSLDMAKGSNNFCLP-SPGACDPRLNALLSVVKLMGYPQ 347 (787)
Q Consensus 272 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~--~~p-~~~~~~~L~~l~~~~n~~~~-~~~~~~~~~~~l~~~~~~~~~~~ 347 (787)
+|++++.+|..+..+++|++|+|++|++++ .+| .+..+.+|+.+++++|.+.. +|.
T Consensus 333 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~-------------------- 392 (520)
T 2z7x_B 333 NNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK-------------------- 392 (520)
T ss_dssp SSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGG--------------------
T ss_pred CCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCccccc--------------------
Confidence 555554455555555555555555555553 111 23344444555555544332 210
Q ss_pred hhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccC
Q 003911 348 RFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSN 427 (787)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~ 427 (787)
+.+...++|+.|++++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|++
T Consensus 393 ----------------~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~ 453 (520)
T 2z7x_B 393 ----------------GDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVAS 453 (520)
T ss_dssp ----------------CSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCS
T ss_pred ----------------chhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCC
Confidence 1123446899999999999988887765 78999999999999 8999888999999999999
Q ss_pred CcccccCCC----CCCCceeecCCCCCCCCCC
Q 003911 428 NQLYGKIPS----FKSNAIVNTDGNPDIGKEK 455 (787)
Q Consensus 428 N~l~g~iP~----~~~~~~~~~~gn~~~~~~~ 455 (787)
|++++..+. +..+..+.+.+|++.|..+
T Consensus 454 N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 454 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence 999953332 4566788999999988654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=342.73 Aligned_cols=339 Identities=19% Similarity=0.269 Sum_probs=289.7
Q ss_pred CCEEEEEeCCCCcccc-----------------CCCCCC--CCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEccccc-
Q 003911 68 KRITRIQIGHQNLQGT-----------------LPSNLQ--NLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQ- 126 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~-----------------~~~~~~--~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~- 126 (787)
.+++.|+|++|.++|. +|+.++ ++++|++|+|++|++.+.+| .|.++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~ 285 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCC
Confidence 6899999999999996 999999 99999999999999999887 79999999999999998
Q ss_pred CCc-CCCccccCC------CCCcEEEccCCCCCCCCCCh--hhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEec
Q 003911 127 FTS-VPSDFFTGL------SSLQSIEIDNNPFSSWEIPQ--SLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHL 197 (787)
Q Consensus 127 l~~-~~~~~~~~l------~~L~~L~L~~N~l~~~~~p~--~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L 197 (787)
+++ ..|..++.+ ++|++|+|++|+++ .+|. .+.++++|++|++++|+++|.+| .++ .+++|++|+|
T Consensus 286 l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~--~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~--~l~~L~~L~L 360 (636)
T 4eco_A 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK--TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFG--SEIKLASLNL 360 (636)
T ss_dssp SCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS--SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCE--EEEEESEEEC
T ss_pred CccccchHHHHhhhccccCCCCCEEECCCCcCC--ccCchhhhccCCCCCEEeCcCCcCccchh-hhC--CCCCCCEEEC
Confidence 998 555667766 99999999999999 7898 99999999999999999999999 775 8999999999
Q ss_pred cccccccCCCcCccc-cc-ccceeeccCCCCCcCCCCccccccCc--cCceEeccccccccCCCC-CC-------CCCCC
Q 003911 198 AFNQLIGGLPASFSG-SQ-IQSLWVNGQNGNAKLGGGIDVIQNMT--SLKEIWLHSNAFSGPLPD-FS-------GVKQL 265 (787)
Q Consensus 198 ~~N~l~~~~p~~~~~-~~-l~~L~~~~~~~~~~~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~-~~-------~l~~L 265 (787)
++|+++ .+|..+.. .+ |+.|++.++... ..|..+..++ +|+.|+|++|++++.+|. +. .+++|
T Consensus 361 ~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~----~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L 435 (636)
T 4eco_A 361 AYNQIT-EIPANFCGFTEQVENLSFAHNKLK----YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435 (636)
T ss_dssp CSSEEE-ECCTTSEEECTTCCEEECCSSCCS----SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCE
T ss_pred CCCccc-cccHhhhhhcccCcEEEccCCcCc----ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCC
Confidence 999999 78888775 45 888888765433 4556666654 899999999999997764 66 77899
Q ss_pred CEEecCCCcccccCCcc-ccCCCCCCEEEccCCcccccCCCCCCce--------eeeccccCCCccCCCCCCCCchhhHH
Q 003911 266 ESLSLRDNFFTGPVPDS-LVKLESLKIVNMTNNLLQGPVPEFDRSV--------SLDMAKGSNNFCLPSPGACDPRLNAL 336 (787)
Q Consensus 266 ~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~~--------~L~~l~~~~n~~~~~~~~~~~~~~~l 336 (787)
++|+|++|+|+ .+|.. +..+++|++|+|++|+++..++.++... +|+.+++++|.+..+|....
T Consensus 436 ~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~------ 508 (636)
T 4eco_A 436 SSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFR------ 508 (636)
T ss_dssp EEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCCBCCGGGS------
T ss_pred CEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCCccChhhh------
Confidence 99999999999 55554 5669999999999999996555554433 78899999998775542110
Q ss_pred HHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEec------ccccccccC
Q 003911 337 LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLIL------ADNNLSGMI 410 (787)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L------s~N~l~g~i 410 (787)
....++|+.|+|++|++++ +|..++.+++|+.|+| ++|++.+.+
T Consensus 509 -----------------------------~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~ 558 (636)
T 4eco_A 509 -----------------------------ATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREW 558 (636)
T ss_dssp -----------------------------TTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCC
T ss_pred -----------------------------hccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccC
Confidence 0134689999999999998 9999999999999999 568899999
Q ss_pred CccCcCCCCCCeeeccCCcccccCCC--CCCCceeecCCCCCCCCC
Q 003911 411 PEGLSVLGALKELDVSNNQLYGKIPS--FKSNAIVNTDGNPDIGKE 454 (787)
Q Consensus 411 p~~l~~l~~L~~L~Ls~N~l~g~iP~--~~~~~~~~~~gn~~~~~~ 454 (787)
|..+..+++|++|+|++|++ +.||. +..+..+.+.+|+..|-.
T Consensus 559 p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 559 PEGITLCPSLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNISID 603 (636)
T ss_dssp CTTGGGCSSCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCEEE
T ss_pred hHHHhcCCCCCEEECCCCcC-CccCHhHhCcCCEEECcCCCCcccc
Confidence 99999999999999999999 78886 567788999999988743
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=338.66 Aligned_cols=328 Identities=18% Similarity=0.172 Sum_probs=257.9
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (787)
.+++.++++++.+....+..|.++++|++|+|++|.|++.+| .|.++++|++|+|++|.|+++++..|+++++|++|+|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 357889999999986555568899999999999999999887 7999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCh-hhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCC
Q 003911 147 DNNPFSSWEIPQ-SLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNG 225 (787)
Q Consensus 147 ~~N~l~~~~~p~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~ 225 (787)
++|.++. +|. .|.++++|++|++++|.+++.+|..|+ .+++|++|+|++|++++..+..+ ..++.|++.++..
T Consensus 131 ~~n~l~~--l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~l--~~L~~L~l~~n~l 204 (597)
T 3oja_B 131 ERNDLSS--LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ--ATTSLQNLQLSSNRLTHVDLSLI--PSLFHANVSYNLL 204 (597)
T ss_dssp CSSCCCC--CCTTTTTTCTTCCEEECCSSCCCBCCTTTTT--TCTTCCEEECTTSCCSBCCGGGC--TTCSEEECCSSCC
T ss_pred eCCCCCC--CCHHHhccCCCCCEEEeeCCcCCCCChhhhh--cCCcCcEEECcCCCCCCcChhhh--hhhhhhhcccCcc
Confidence 9999994 554 479999999999999999999999887 89999999999999997654444 4566666654322
Q ss_pred CCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCC
Q 003911 226 NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305 (787)
Q Consensus 226 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 305 (787)
..+...++|+.|++++|.++..++.+. ++|+.|+|++|++++ +..+..+++|+.|+|++|.+++.+|.
T Consensus 205 --------~~l~~~~~L~~L~ls~n~l~~~~~~~~--~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~ 272 (597)
T 3oja_B 205 --------STLAIPIAVEELDASHNSINVVRGPVN--VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYH 272 (597)
T ss_dssp --------SEEECCTTCSEEECCSSCCCEEECSCC--SCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESG
T ss_pred --------ccccCCchhheeeccCCcccccccccC--CCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHH
Confidence 223456789999999999987766543 689999999999985 47789999999999999999988764
Q ss_pred -CCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccc
Q 003911 306 -FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTG 384 (787)
Q Consensus 306 -~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g 384 (787)
+..+.+|+.+++++|.+..++.. ....++|+.|+|++|+++
T Consensus 273 ~~~~l~~L~~L~Ls~N~l~~l~~~-------------------------------------~~~l~~L~~L~Ls~N~l~- 314 (597)
T 3oja_B 273 PFVKMQRLERLYISNNRLVALNLY-------------------------------------GQPIPTLKVLDLSHNHLL- 314 (597)
T ss_dssp GGTTCSSCCEEECTTSCCCEEECS-------------------------------------SSCCTTCCEEECCSSCCC-
T ss_pred HhcCccCCCEEECCCCCCCCCCcc-------------------------------------cccCCCCcEEECCCCCCC-
Confidence 66677777777777765543211 112357788888888887
Q ss_pred cCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCC--CCCCceeecCCCCCCCCC
Q 003911 385 TISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS--FKSNAIVNTDGNPDIGKE 454 (787)
Q Consensus 385 ~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~--~~~~~~~~~~gn~~~~~~ 454 (787)
.+|..++.+++|+.|+|++|+|++. | +..+++|+.|+|++|++++..+. +.......+.+++..|+.
T Consensus 315 ~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 315 HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 383 (597)
T ss_dssp CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCCCCCT
T ss_pred ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHHHHHHHHhhhccccccccCCc
Confidence 5677777788888888888888743 3 66677888888888888765332 333333445566666654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=338.83 Aligned_cols=380 Identities=18% Similarity=0.184 Sum_probs=245.1
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCC--CcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEE
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTK--LERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSI 144 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 144 (787)
..++.|++++|.+++..|..|.+++. |++|+|++|++++.+| .|..+++|++|+|++|+++++++..|.++++|++|
T Consensus 222 ~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 301 (680)
T 1ziw_A 222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301 (680)
T ss_dssp SCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEE
T ss_pred ccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEE
Confidence 45778888888888888888877754 8888888888888766 58888888888888888888888888888888888
Q ss_pred EccCCCCCC----CCCCh----hhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccC--CCcCccc--
Q 003911 145 EIDNNPFSS----WEIPQ----SLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGG--LPASFSG-- 212 (787)
Q Consensus 145 ~L~~N~l~~----~~~p~----~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~-- 212 (787)
+|++|.... ..+|. .|..+++|++|++++|++++..+..|. .+++|++|++++|.+++. .+..|..
T Consensus 302 ~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~ 379 (680)
T 1ziw_A 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFT--GLINLKYLSLSNSFTSLRTLTNETFVSLA 379 (680)
T ss_dssp ECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTT--TCTTCCEEECTTCBSCCCEECTTTTGGGT
T ss_pred eccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhc--cccCCcEEECCCCchhhhhcchhhhcccc
Confidence 888765442 02332 677788888888888888887777775 777777777777764322 1222221
Q ss_pred -ccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCC--CCCCCCCCCEEecCCCcccccCCccccCCCCC
Q 003911 213 -SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP--DFSGVKQLESLSLRDNFFTGPVPDSLVKLESL 289 (787)
Q Consensus 213 -~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 289 (787)
..++.|++.++ ......+..+..+++|+.|+|++|.+++.++ .+.++++|++|++++|++++..+..|..+++|
T Consensus 380 ~~~L~~L~L~~n---~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L 456 (680)
T 1ziw_A 380 HSPLHILNLTKN---KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSL 456 (680)
T ss_dssp TSCCCEEECTTS---CCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTC
T ss_pred cCcCceEECCCC---CCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCccc
Confidence 23444444433 2223334455666666666666666665443 35566666666666666665555555555555
Q ss_pred CEEEccCCccc--ccCC-CCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccc
Q 003911 290 KIVNMTNNLLQ--GPVP-EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVT 366 (787)
Q Consensus 290 ~~L~Ls~N~l~--~~~p-~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (787)
+.|++++|.++ +.+| .+..+.+|+.+++++|.+..++.........+.. +.-....+...+....|- .....+
T Consensus 457 ~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~---L~Ls~N~l~~~~~~~~~~-~~~~~~ 532 (680)
T 1ziw_A 457 QRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEI---LDLQHNNLARLWKHANPG-GPIYFL 532 (680)
T ss_dssp CEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE---EECCSSCCGGGGSTTSTT-SCCCTT
T ss_pred ccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCE---EeCCCCCccccchhhccC-Ccchhh
Confidence 55555555554 2222 2444455555555555555444322111110000 000000000000000000 000123
Q ss_pred cCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCC-----CCCCc
Q 003911 367 CTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS-----FKSNA 441 (787)
Q Consensus 367 ~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~-----~~~~~ 441 (787)
...++|+.|+|++|+++...+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++.+|. +..+.
T Consensus 533 ~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~ 612 (680)
T 1ziw_A 533 KGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLT 612 (680)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCS
T ss_pred cCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccC
Confidence 4557999999999999955556799999999999999999976667789999999999999999998774 56788
Q ss_pred eeecCCCCCCCCCCC
Q 003911 442 IVNTDGNPDIGKEKS 456 (787)
Q Consensus 442 ~~~~~gn~~~~~~~~ 456 (787)
.+.+.|||+.|..+.
T Consensus 613 ~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 613 ELDMRFNPFDCTCES 627 (680)
T ss_dssp EEECTTCCCCBCCCC
T ss_pred EEEccCCCcccCCcc
Confidence 999999999998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=335.77 Aligned_cols=183 Identities=26% Similarity=0.407 Sum_probs=156.0
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHH---HHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEF---KSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
.++|++.+.||+|+||+||+|+.. +|+.||||++.+.... ......+ +.++++++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999876 7999999999764332 1222233 3446667777999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
|+||||++||+|.+++.. ...+++..+..|+.||+.||+|||+ ++||||||||+|||++.+|.+||+|||+|
T Consensus 268 ylVmEy~~GGdL~~~l~~-----~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp EEEECCCCSCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEeccccee
Confidence 999999999999999954 2468999999999999999999997 89999999999999999999999999999
Q ss_pred eecCCCCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
+...... ....+||+.|||||++.+ ..|+ ++|+||.
T Consensus 340 ~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSL 377 (689)
T 3v5w_A 340 CDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSL 377 (689)
T ss_dssp EECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHH
T ss_pred eecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHH
Confidence 9875443 234689999999999975 5677 8999983
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.96 Aligned_cols=327 Identities=18% Similarity=0.173 Sum_probs=245.1
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (787)
.+++.|+++++.++...+..|..+++|++|+|++|.|++.++ .|.++++|++|+|++|+++++++..|+++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 468889999999885444457899999999999999999877 7999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCChh-hhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCC
Q 003911 147 DNNPFSSWEIPQS-LRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNG 225 (787)
Q Consensus 147 ~~N~l~~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~ 225 (787)
++|+++ .+|.. |.++++|++|++++|.+++..|..+. .+++|++|++++|++++.....+ .+++.|++.++..
T Consensus 125 ~~n~l~--~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~l--~~L~~L~l~~n~l 198 (390)
T 3o6n_A 125 ERNDLS--SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ--ATTSLQNLQLSSNRLTHVDLSLI--PSLFHANVSYNLL 198 (390)
T ss_dssp CSSCCC--CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTS--SCTTCCEEECCSSCCSBCCGGGC--TTCSEEECCSSCC
T ss_pred CCCccC--cCCHHHhcCCCCCcEEECCCCccCccChhhcc--CCCCCCEEECCCCcCCccccccc--cccceeecccccc
Confidence 999999 56655 68999999999999999999888886 89999999999999997643333 4566666654321
Q ss_pred CCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCC
Q 003911 226 NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305 (787)
Q Consensus 226 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 305 (787)
..+...++|++|++++|.++..+... .++|+.|+|++|++++. ..+..+++|++|+|++|.+++.+|.
T Consensus 199 --------~~~~~~~~L~~L~l~~n~l~~~~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~ 266 (390)
T 3o6n_A 199 --------STLAIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYH 266 (390)
T ss_dssp --------SEEECCSSCSEEECCSSCCCEEECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESG
T ss_pred --------cccCCCCcceEEECCCCeeeeccccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChh
Confidence 22345568999999999988765543 47899999999999853 5788899999999999999887664
Q ss_pred -CCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccc
Q 003911 306 -FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTG 384 (787)
Q Consensus 306 -~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g 384 (787)
+..+.+|+.+++++|.+..++.. ....++|+.|+|++|+++
T Consensus 267 ~~~~l~~L~~L~L~~n~l~~~~~~-------------------------------------~~~l~~L~~L~L~~n~l~- 308 (390)
T 3o6n_A 267 PFVKMQRLERLYISNNRLVALNLY-------------------------------------GQPIPTLKVLDLSHNHLL- 308 (390)
T ss_dssp GGTTCSSCCEEECCSSCCCEEECS-------------------------------------SSCCTTCCEEECCSSCCC-
T ss_pred HccccccCCEEECCCCcCcccCcc-------------------------------------cCCCCCCCEEECCCCcce-
Confidence 55666677777776655433211 112346777777777776
Q ss_pred cCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCC--CCCCceeecCCCCCCCC
Q 003911 385 TISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS--FKSNAIVNTDGNPDIGK 453 (787)
Q Consensus 385 ~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~--~~~~~~~~~~gn~~~~~ 453 (787)
.+|..+..+++|+.|+|++|+++. +| +..+++|++|++++|++++.-.. +.......+.+++..|.
T Consensus 309 ~~~~~~~~l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~c~ 376 (390)
T 3o6n_A 309 HVERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCK 376 (390)
T ss_dssp CCGGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCSCCC
T ss_pred ecCccccccCcCCEEECCCCccce-eC--chhhccCCEEEcCCCCccchhHHHHHHHHHhhcccccCceec
Confidence 456666777777777777777763 33 56667777777777777653221 22223333445554444
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=341.61 Aligned_cols=336 Identities=17% Similarity=0.194 Sum_probs=285.5
Q ss_pred CCEEEEEeCCCCccc-----------------cCCCCCC--CCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEccccc-
Q 003911 68 KRITRIQIGHQNLQG-----------------TLPSNLQ--NLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQ- 126 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~-----------------~~~~~~~--~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~- 126 (787)
.+++.|+|++|+++| .+|+.++ ++++|++|+|++|++.+.+| .|.++++|++|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ 527 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence 689999999999998 4999988 99999999999999999888 69999999999999998
Q ss_pred CCc-CCCcccc-------CCCCCcEEEccCCCCCCCCCCh--hhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEe
Q 003911 127 FTS-VPSDFFT-------GLSSLQSIEIDNNPFSSWEIPQ--SLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILH 196 (787)
Q Consensus 127 l~~-~~~~~~~-------~l~~L~~L~L~~N~l~~~~~p~--~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~ 196 (787)
+++ ..|..|+ .+++|++|+|++|+++ .+|. .+.++++|+.|++++|+++ .+| .|+ .+++|++|+
T Consensus 528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~--~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~--~L~~L~~L~ 601 (876)
T 4ecn_A 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE--EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFG--TNVKLTDLK 601 (876)
T ss_dssp SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC--BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCC--TTSEESEEE
T ss_pred cccccchHHHHhhhhcccccCCccEEEeeCCcCC--ccCChhhhhcCCCCCEEECCCCCcc-cch-hhc--CCCcceEEE
Confidence 998 4444444 4559999999999999 7898 9999999999999999999 777 675 899999999
Q ss_pred ccccccccCCCcCccc-cc-ccceeeccCCCCCcCCCCccccccCcc--CceEeccccccccCCCCCC------CCCCCC
Q 003911 197 LAFNQLIGGLPASFSG-SQ-IQSLWVNGQNGNAKLGGGIDVIQNMTS--LKEIWLHSNAFSGPLPDFS------GVKQLE 266 (787)
Q Consensus 197 L~~N~l~~~~p~~~~~-~~-l~~L~~~~~~~~~~~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~------~l~~L~ 266 (787)
|++|+++ .+|..+.. .+ |+.|++.++... ..|..+..++. |+.|+|++|++++.+|.+. .+++|+
T Consensus 602 Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~----~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~ 676 (876)
T 4ecn_A 602 LDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK----YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAS 676 (876)
T ss_dssp CCSSCCS-CCCTTSCEECTTCCEEECCSSCCC----SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEE
T ss_pred CcCCccc-cchHHHhhccccCCEEECcCCCCC----cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcC
Confidence 9999999 88888765 45 888888765433 45666666654 9999999999999887654 456899
Q ss_pred EEecCCCcccccCCcccc-CCCCCCEEEccCCcccccCCCCCCce--------eeeccccCCCccCCCCCCCCchhhHHH
Q 003911 267 SLSLRDNFFTGPVPDSLV-KLESLKIVNMTNNLLQGPVPEFDRSV--------SLDMAKGSNNFCLPSPGACDPRLNALL 337 (787)
Q Consensus 267 ~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~~--------~L~~l~~~~n~~~~~~~~~~~~~~~l~ 337 (787)
.|+|++|+|+ .+|..+. .+++|+.|+|++|+|+..++.++... +|+.+++++|.+..+|....
T Consensus 677 ~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~~lp~~l~------- 748 (876)
T 4ecn_A 677 TVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFR------- 748 (876)
T ss_dssp EEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCCCCCGGGS-------
T ss_pred EEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCccchHHhh-------
Confidence 9999999999 6777654 89999999999999996666555433 89999999998775542210
Q ss_pred HHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEeccc------ccccccCC
Q 003911 338 SVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILAD------NNLSGMIP 411 (787)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~------N~l~g~ip 411 (787)
...+++|+.|+|++|++++ +|..++.+++|+.|+|++ |++.+.+|
T Consensus 749 ----------------------------~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip 799 (876)
T 4ecn_A 749 ----------------------------ATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWP 799 (876)
T ss_dssp ----------------------------TTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCC
T ss_pred ----------------------------hccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccCh
Confidence 0134689999999999998 899999999999999977 88999999
Q ss_pred ccCcCCCCCCeeeccCCcccccCCC--CCCCceeecCCCCCCC
Q 003911 412 EGLSVLGALKELDVSNNQLYGKIPS--FKSNAIVNTDGNPDIG 452 (787)
Q Consensus 412 ~~l~~l~~L~~L~Ls~N~l~g~iP~--~~~~~~~~~~gn~~~~ 452 (787)
..|..+++|++|+|++|++ +.||. +..+..+.+.+|+...
T Consensus 800 ~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l~~ 841 (876)
T 4ecn_A 800 TGITTCPSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNIS 841 (876)
T ss_dssp TTGGGCSSCCEEECCSSCC-CBCCSCCCSSSCEEECCSCTTCE
T ss_pred HHHhcCCCCCEEECCCCCC-CccCHhhcCCCCEEECCCCCCCc
Confidence 9999999999999999999 88886 5567889999998754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.55 Aligned_cols=252 Identities=26% Similarity=0.431 Sum_probs=187.5
Q ss_pred CCCcEEEeecCCCCC--CCC-CCCCCCCCcEEEccc-ccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCC
Q 003911 92 TKLERLELQWNSISG--PLP-SLNGLASLEVVMLSN-NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ 167 (787)
Q Consensus 92 ~~L~~L~L~~N~l~~--~~~-~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~ 167 (787)
.++++|+|++|++++ .+| .|.++++|++|+|++ |++.+..|..|+++++|++|+|++|++++ .+|..|.++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~-~~p~~~~~l---- 124 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG-AIPDFLSQI---- 124 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEE-ECCGGGGGC----
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCC-cCCHHHhCC----
Confidence 467777777777776 444 566667777777763 66666555556666666666666665553 444455444
Q ss_pred EEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEec
Q 003911 168 NFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWL 247 (787)
Q Consensus 168 ~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L 247 (787)
++|++|+|++|++++.+|..+. ++++|++|+|
T Consensus 125 ----------------------~~L~~L~Ls~N~l~~~~p~~~~--------------------------~l~~L~~L~L 156 (313)
T 1ogq_A 125 ----------------------KTLVTLDFSYNALSGTLPPSIS--------------------------SLPNLVGITF 156 (313)
T ss_dssp ----------------------TTCCEEECCSSEEESCCCGGGG--------------------------GCTTCCEEEC
T ss_pred ----------------------CCCCEEeCCCCccCCcCChHHh--------------------------cCCCCCeEEC
Confidence 4555555555555544444332 4555666666
Q ss_pred cccccccCCC-CCCCCC-CCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCC
Q 003911 248 HSNAFSGPLP-DFSGVK-QLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPS 325 (787)
Q Consensus 248 ~~N~l~~~~~-~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~ 325 (787)
++|++++.+| .+..++ +|++|+|++|++++.+|..+..++ |++|+|++|++++.+|..
T Consensus 157 ~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~------------------- 216 (313)
T 1ogq_A 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVL------------------- 216 (313)
T ss_dssp CSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGG-------------------
T ss_pred cCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHH-------------------
Confidence 6666654444 355665 899999999999999999999998 999999999999876641
Q ss_pred CCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEeccccc
Q 003911 326 PGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNN 405 (787)
Q Consensus 326 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 405 (787)
+...++|+.|+|++|++++.+|. +..+++|++|+|++|+
T Consensus 217 ----------------------------------------~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~ 255 (313)
T 1ogq_A 217 ----------------------------------------FGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNR 255 (313)
T ss_dssp ----------------------------------------CCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSC
T ss_pred ----------------------------------------HhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCc
Confidence 11234899999999999988776 8899999999999999
Q ss_pred ccccCCccCcCCCCCCeeeccCCcccccCCC---CCCCceeecCCCCCCCCCCCC
Q 003911 406 LSGMIPEGLSVLGALKELDVSNNQLYGKIPS---FKSNAIVNTDGNPDIGKEKSS 457 (787)
Q Consensus 406 l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~---~~~~~~~~~~gn~~~~~~~~~ 457 (787)
+++.+|..+..+++|++|+|++|+++|.+|. +..+..+.+.||+++|+.|..
T Consensus 256 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~ 310 (313)
T 1ogq_A 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp CEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred ccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC
Confidence 9999999999999999999999999999997 455677889999999998764
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=331.88 Aligned_cols=319 Identities=17% Similarity=0.187 Sum_probs=257.0
Q ss_pred CCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcC-CCccccCCCCCcEEE
Q 003911 67 DKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSV-PSDFFTGLSSLQSIE 145 (787)
Q Consensus 67 ~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~ 145 (787)
-.+++.|+|++|++++..|..|+++++|++|+|++|+|+.+++. .+++|++|+|++|+++++ .|..|+++++|++|+
T Consensus 44 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~ 121 (520)
T 2z7x_B 44 LSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121 (520)
T ss_dssp CTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEE
T ss_pred cccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEE
Confidence 36899999999999998899999999999999999999965545 899999999999999986 467899999999999
Q ss_pred ccCCCCCCCCCChhhhcCCCC--CEEeccCcee--cccCCCCCCCCCC--------------------------------
Q 003911 146 IDNNPFSSWEIPQSLRNASGL--QNFSANSANI--TGQIPSFFGPDEF-------------------------------- 189 (787)
Q Consensus 146 L~~N~l~~~~~p~~~~~l~~L--~~L~l~~n~l--~~~~p~~~~~~~l-------------------------------- 189 (787)
|++|++.+ ..+..+++| +.|++++|.+ .+..|..+. .+
T Consensus 122 L~~n~l~~----~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~--~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L 195 (520)
T 2z7x_B 122 LSTTHLEK----SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQ--DFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195 (520)
T ss_dssp EEESSCCG----GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTT--TCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEEC
T ss_pred ecCcccch----hhccccccceeeEEEeeccccccccccccccc--ccccceEEEEeccCcchhhhhhhhhhcccceeec
Confidence 99999974 467777888 9999999988 677776664 32
Q ss_pred ---------------------------------------------------CCCcEEeccccccccCCCcCc-----cc-
Q 003911 190 ---------------------------------------------------PGLTILHLAFNQLIGGLPASF-----SG- 212 (787)
Q Consensus 190 ---------------------------------------------------~~L~~L~L~~N~l~~~~p~~~-----~~- 212 (787)
++|++|++++|+++|.+|..+ ..
T Consensus 196 ~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l 275 (520)
T 2z7x_B 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSL 275 (520)
T ss_dssp CEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCC
T ss_pred cccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccC
Confidence 267888888888888888776 21
Q ss_pred ccccceeeccCCC-----------------------CCcCCCCccccccCccCceEeccccccccCCC-CCCCCCCCCEE
Q 003911 213 SQIQSLWVNGQNG-----------------------NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESL 268 (787)
Q Consensus 213 ~~l~~L~~~~~~~-----------------------~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L 268 (787)
..++.+++..+.. +.. .. ...+..+++|++|+|++|++++.+| .+..+++|++|
T Consensus 276 ~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l-~~-~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 353 (520)
T 2z7x_B 276 KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM-VH-MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETL 353 (520)
T ss_dssp CEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCC-CC-CCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEE
T ss_pred ceeEeccccccceecchhhhhcccccCceeEEEcCCCcc-cc-ccchhhCCcccEEEeECCccChhhhhhhccCCCCCEE
Confidence 2222222222111 000 00 0112688999999999999999555 68999999999
Q ss_pred ecCCCcccc--cCCccccCCCCCCEEEccCCcccccCC-C-CCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhC
Q 003911 269 SLRDNFFTG--PVPDSLVKLESLKIVNMTNNLLQGPVP-E-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMG 344 (787)
Q Consensus 269 ~L~~N~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~-~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~ 344 (787)
+|++|+|++ .+|..+..+++|++|+|++|++++.+| . +..+.+|+.+++++|.+......
T Consensus 354 ~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~---------------- 417 (520)
T 2z7x_B 354 ILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR---------------- 417 (520)
T ss_dssp ECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGG----------------
T ss_pred EccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhh----------------
Confidence 999999997 567889999999999999999998444 3 66778899999999876421100
Q ss_pred CChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCcc-CcCCCCCCee
Q 003911 345 YPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEG-LSVLGALKEL 423 (787)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~-l~~l~~L~~L 423 (787)
...++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|+ .+|.. +..+++|++|
T Consensus 418 ----------------------~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L 473 (520)
T 2z7x_B 418 ----------------------CLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKI 473 (520)
T ss_dssp ----------------------SCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred ----------------------hhcccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEE
Confidence 00148999999999999 89998889999999999999999 67776 9999999999
Q ss_pred eccCCcccccCC
Q 003911 424 DVSNNQLYGKIP 435 (787)
Q Consensus 424 ~Ls~N~l~g~iP 435 (787)
+|++|++++..+
T Consensus 474 ~l~~N~~~c~c~ 485 (520)
T 2z7x_B 474 WLHTNPWDCSCP 485 (520)
T ss_dssp ECCSSCBCCCHH
T ss_pred ECcCCCCcccCC
Confidence 999999998765
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=321.85 Aligned_cols=311 Identities=18% Similarity=0.223 Sum_probs=246.9
Q ss_pred CCEEEEEeCCCCccccCC-CCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCc--CCCccccCCCCCcE
Q 003911 68 KRITRIQIGHQNLQGTLP-SNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTS--VPSDFFTGLSSLQS 143 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~ 143 (787)
.+++.|++++|.+.+.++ ..|.++++|++|+|++|++++.+| .|.++++|++|+|++|++++ +....|.++++|++
T Consensus 54 ~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~ 133 (455)
T 3v47_A 54 QDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM 133 (455)
T ss_dssp TTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCE
T ss_pred ccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCE
Confidence 579999999999987774 679999999999999999999866 79999999999999999998 34455999999999
Q ss_pred EEccCCCCCCCCCChh-hhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccc---------------------
Q 003911 144 IEIDNNPFSSWEIPQS-LRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQ--------------------- 201 (787)
Q Consensus 144 L~L~~N~l~~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~--------------------- 201 (787)
|+|++|++.+ ..|.. +.++++|++|++++|.+++..|..+......+|+.|++++|.
T Consensus 134 L~L~~n~l~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~ 212 (455)
T 3v47_A 134 LVLRDNNIKK-IQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212 (455)
T ss_dssp EECCSSBCCS-CCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTC
T ss_pred EECCCCccCc-cCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccc
Confidence 9999999996 44655 899999999999999999998887751111344444444444
Q ss_pred -----------cccCCCcCccc----ccccceeeccCCCCC-------cCCCCcccccc--CccCceEeccccccccCCC
Q 003911 202 -----------LIGGLPASFSG----SQIQSLWVNGQNGNA-------KLGGGIDVIQN--MTSLKEIWLHSNAFSGPLP 257 (787)
Q Consensus 202 -----------l~~~~p~~~~~----~~l~~L~~~~~~~~~-------~~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~ 257 (787)
+++.+|..+.. .+++.|++.++.... ........+.. .++|+.|+|++|++++.+|
T Consensus 213 ~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 292 (455)
T 3v47_A 213 SITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLK 292 (455)
T ss_dssp EEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECT
T ss_pred eeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccch
Confidence 44444433321 233344333221110 00011112222 3689999999999999877
Q ss_pred C-CCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHH
Q 003911 258 D-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL 336 (787)
Q Consensus 258 ~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l 336 (787)
. +..+++|++|+|++|++++..|..|..+++|++|+|++|++++.+|..
T Consensus 293 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~------------------------------ 342 (455)
T 3v47_A 293 SVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRM------------------------------ 342 (455)
T ss_dssp TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGG------------------------------
T ss_pred hhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhH------------------------------
Confidence 5 889999999999999999888999999999999999999998766531
Q ss_pred HHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcC
Q 003911 337 LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV 416 (787)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~ 416 (787)
+...++|+.|+|++|++++..|..|..+++|++|+|++|+|++..+..+..
T Consensus 343 -----------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 393 (455)
T 3v47_A 343 -----------------------------FENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDR 393 (455)
T ss_dssp -----------------------------GTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTT
T ss_pred -----------------------------hcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhcc
Confidence 123358999999999999999999999999999999999999766777899
Q ss_pred CCCCCeeeccCCcccccCCCCC
Q 003911 417 LGALKELDVSNNQLYGKIPSFK 438 (787)
Q Consensus 417 l~~L~~L~Ls~N~l~g~iP~~~ 438 (787)
+++|++|+|++|++++.+|.+.
T Consensus 394 l~~L~~L~l~~N~l~~~~~~~~ 415 (455)
T 3v47_A 394 LTSLQKIWLHTNPWDCSCPRID 415 (455)
T ss_dssp CTTCCEEECCSSCBCCCTTTTH
T ss_pred CCcccEEEccCCCcccCCCcch
Confidence 9999999999999999999643
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=332.05 Aligned_cols=319 Identities=17% Similarity=0.190 Sum_probs=258.5
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCC-CccccCCCCCcEEEc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVP-SDFFTGLSSLQSIEI 146 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L 146 (787)
.+++.|+|++|++++..|..|+++++|++|+|++|+|+..++. .+++|++|+|++|++++++ |..|+++++|++|+|
T Consensus 76 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L 153 (562)
T 3a79_B 76 SELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGL 153 (562)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEE
T ss_pred CCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEec
Confidence 5899999999999998899999999999999999999965555 8999999999999999976 578999999999999
Q ss_pred cCCCCCCCCCChhhhcCCCC--CEEeccCcee--cccCCCCCCCCCCC--------------------------------
Q 003911 147 DNNPFSSWEIPQSLRNASGL--QNFSANSANI--TGQIPSFFGPDEFP-------------------------------- 190 (787)
Q Consensus 147 ~~N~l~~~~~p~~~~~l~~L--~~L~l~~n~l--~~~~p~~~~~~~l~-------------------------------- 190 (787)
++|++.. ..+..+++| +.|++++|.+ ++..|..+. .+.
T Consensus 154 ~~n~l~~----~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~--~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~ 227 (562)
T 3a79_B 154 SAAKFRQ----LDLLPVAHLHLSCILLDLVSYHIKGGETESLQ--IPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSN 227 (562)
T ss_dssp ECSBCCT----TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEE--ECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEE
T ss_pred CCCcccc----CchhhhhhceeeEEEeecccccccccCccccc--ccCcceEEEEecCccchhhhhhhcccccceEEEec
Confidence 9999985 345556666 9999999999 777776654 222
Q ss_pred -------------------------------------------------CCcEEeccccccccCCCcCccc---ccccce
Q 003911 191 -------------------------------------------------GLTILHLAFNQLIGGLPASFSG---SQIQSL 218 (787)
Q Consensus 191 -------------------------------------------------~L~~L~L~~N~l~~~~p~~~~~---~~l~~L 218 (787)
+|++|++++|+++|.+|..+.. ..++.|
T Consensus 228 l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L 307 (562)
T 3a79_B 228 IKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSL 307 (562)
T ss_dssp EECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEE
T ss_pred ccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchhe
Confidence 7888888888898888877621 233333
Q ss_pred eeccCCCCCc-------------------------CCCCccccccCccCceEeccccccccCCC-CCCCCCCCCEEecCC
Q 003911 219 WVNGQNGNAK-------------------------LGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRD 272 (787)
Q Consensus 219 ~~~~~~~~~~-------------------------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~ 272 (787)
.+.++..+.. +.. ......+++|++|+|++|++++.+| .+.++++|++|+|++
T Consensus 308 ~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 386 (562)
T 3a79_B 308 MIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIH-MVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQR 386 (562)
T ss_dssp EEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCC-CCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCS
T ss_pred ehhhcccceeecChhhhhhhhccCcceEEEccCCCccc-ccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCC
Confidence 3333222211 000 0112688999999999999999665 689999999999999
Q ss_pred Ccccc--cCCccccCCCCCCEEEccCCcccccCC-C-CCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChh
Q 003911 273 NFFTG--PVPDSLVKLESLKIVNMTNNLLQGPVP-E-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQR 348 (787)
Q Consensus 273 N~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~-~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 348 (787)
|++++ .+|..+..+++|++|+|++|++++.+| . +..+.+|+.+++++|.+....
T Consensus 387 N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~---------------------- 444 (562)
T 3a79_B 387 NGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV---------------------- 444 (562)
T ss_dssp SCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGG----------------------
T ss_pred CCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcch----------------------
Confidence 99996 335779999999999999999998444 3 667788999999998764211
Q ss_pred hhcccCCCCCCCCccccccCC-CceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCcc-CcCCCCCCeeecc
Q 003911 349 FAENWKGNDPCSDWIGVTCTK-GNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEG-LSVLGALKELDVS 426 (787)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~-~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~-l~~l~~L~~L~Ls 426 (787)
+... ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|+ .+|.. +..+++|++|+|+
T Consensus 445 -----------------~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~ 505 (562)
T 3a79_B 445 -----------------FRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLH 505 (562)
T ss_dssp -----------------GSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECC
T ss_pred -----------------hhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEec
Confidence 0111 48999999999999 78888889999999999999999 67776 9999999999999
Q ss_pred CCcccccCCC
Q 003911 427 NNQLYGKIPS 436 (787)
Q Consensus 427 ~N~l~g~iP~ 436 (787)
+|++++..|.
T Consensus 506 ~N~~~c~c~~ 515 (562)
T 3a79_B 506 DNPWDCTCPG 515 (562)
T ss_dssp SCCBCCCHHH
T ss_pred CCCcCCCcch
Confidence 9999998763
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=314.04 Aligned_cols=275 Identities=17% Similarity=0.217 Sum_probs=160.7
Q ss_pred CCChhHHHHHHHHHHhc-CCCCCC--CCC-----CCCCCCcccEEEcC---------CCCEEEEEeCCCCccccCCCCCC
Q 003911 27 SGDDGDAAVMLALKKSL-NPPESL--GWS-----DTDPCKWNHVVCIE---------DKRITRIQIGHQNLQGTLPSNLQ 89 (787)
Q Consensus 27 ~~~~~d~~~l~~~k~~~-~~~~~~--~w~-----~~~~C~w~gv~C~~---------~~~v~~L~l~~~~l~~~~~~~~~ 89 (787)
++..+|++||++||+++ .++..+ +|. ..++|.|.|+.|.. ..+|+.|+|++|+++ .+|+.++
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~ 101 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF 101 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGG
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhh
Confidence 34567999999999998 455443 683 45789999999952 246666666666666 5666666
Q ss_pred CCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEE
Q 003911 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNF 169 (787)
Q Consensus 90 ~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L 169 (787)
++++|++|+|++|.|+..+..+.++++|++|+|++|+++.+| ..|.++++|++|+|++|++.+ .+|..+...
T Consensus 102 ~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~lp-~~l~~l~~L~~L~L~~n~~~~-~~p~~~~~~------ 173 (328)
T 4fcg_A 102 RLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALP-ASIASLNRLRELSIRACPELT-ELPEPLAST------ 173 (328)
T ss_dssp GGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCCC-GGGGGCTTCCEEEEEEETTCC-CCCSCSEEE------
T ss_pred hCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccCc-HHHhcCcCCCEEECCCCCCcc-ccChhHhhc------
Confidence 666666666666666633334555555555555555555432 234455555555555544333 333322210
Q ss_pred eccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccc
Q 003911 170 SANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS 249 (787)
Q Consensus 170 ~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~ 249 (787)
..+..|. .+++|++|+|++|+++ .+|..+. ++++|++|+|++
T Consensus 174 ---------~~~~~~~--~l~~L~~L~L~~n~l~-~lp~~l~--------------------------~l~~L~~L~L~~ 215 (328)
T 4fcg_A 174 ---------DASGEHQ--GLVNLQSLRLEWTGIR-SLPASIA--------------------------NLQNLKSLKIRN 215 (328)
T ss_dssp ---------C-CCCEE--ESTTCCEEEEEEECCC-CCCGGGG--------------------------GCTTCCEEEEES
T ss_pred ---------cchhhhc--cCCCCCEEECcCCCcC-cchHhhc--------------------------CCCCCCEEEccC
Confidence 0001111 3455555555555554 3443322 444555555555
Q ss_pred cccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCC
Q 003911 250 NAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGAC 329 (787)
Q Consensus 250 N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~ 329 (787)
|++++.++.+..+++|++|+|++|++.+.+|..+..+++|
T Consensus 216 N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L---------------------------------------- 255 (328)
T 4fcg_A 216 SPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL---------------------------------------- 255 (328)
T ss_dssp SCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCC----------------------------------------
T ss_pred CCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCC----------------------------------------
Confidence 5555444444445555555555555544455444444444
Q ss_pred CchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEeccccccccc
Q 003911 330 DPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGM 409 (787)
Q Consensus 330 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ 409 (787)
+.|+|++|++.+.+|..++.+++|+.|+|++|++.+.
T Consensus 256 -------------------------------------------~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~ 292 (328)
T 4fcg_A 256 -------------------------------------------KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292 (328)
T ss_dssp -------------------------------------------CEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCC
T ss_pred -------------------------------------------CEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhh
Confidence 4445555555556666777888888888888888888
Q ss_pred CCccCcCCCCCCeeeccCCccc
Q 003911 410 IPEGLSVLGALKELDVSNNQLY 431 (787)
Q Consensus 410 ip~~l~~l~~L~~L~Ls~N~l~ 431 (787)
+|..++.+++|+.+++..|.+.
T Consensus 293 iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 293 LPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCGGGGGSCTTCEEECCGGGSC
T ss_pred ccHHHhhccCceEEeCCHHHHH
Confidence 8888888888888888876554
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=329.31 Aligned_cols=183 Identities=25% Similarity=0.396 Sum_probs=162.3
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||+||+|..+ +|+.||+|++.... ....+.+.+|+++|+.++|||||++++++.+.+..||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 468999999999999999999875 79999999997632 344578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC--CcEEEeeccccee
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD--MRAKVADFGLVRL 748 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DFG~a~~ 748 (787)
|||+||+|.+++.. ....+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 234 E~~~gg~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 234 EFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp ECCCCCBHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred eecCCCcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 99999999998843 23468999999999999999999998 899999999999999854 8999999999998
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... .....+||+.|||||++.+..|+ ++||||.
T Consensus 307 ~~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSl 342 (573)
T 3uto_A 307 LDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 342 (573)
T ss_dssp CCTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred ccCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHH
Confidence 75543 33457899999999999999999 8999983
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=328.01 Aligned_cols=343 Identities=17% Similarity=0.169 Sum_probs=270.8
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCC-CCCCCCCcEEEcccccCCcCC-CccccCCCCCcEEE
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS-LNGLASLEVVMLSNNQFTSVP-SDFFTGLSSLQSIE 145 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~ 145 (787)
.+++.|++++|++++..|..|+++++|++|+|++|+|++.+|. |.++++|++|+|++|++++++ +..|+++++|++|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 129 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence 5799999999999988889999999999999999999998884 999999999999999999753 46799999999999
Q ss_pred ccCCCCCCCCCC-hhhhcCCCCCEEeccCceecccCCCCCCC----------------------CCCCCCcEEecccccc
Q 003911 146 IDNNPFSSWEIP-QSLRNASGLQNFSANSANITGQIPSFFGP----------------------DEFPGLTILHLAFNQL 202 (787)
Q Consensus 146 L~~N~l~~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~----------------------~~l~~L~~L~L~~N~l 202 (787)
|++|++.+ .+| ..+.++++|++|++++|.+++.+|..++. ..+++|++|++++|++
T Consensus 130 L~~n~~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l 208 (549)
T 2z81_A 130 IGNVETFS-EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208 (549)
T ss_dssp EEESSSCC-EECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBC
T ss_pred CCCCcccc-ccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCcc
Confidence 99998544 555 68999999999999999999988887751 1367888888888888
Q ss_pred ccCC--CcCcc--ccc----------------------------------------------------------------
Q 003911 203 IGGL--PASFS--GSQ---------------------------------------------------------------- 214 (787)
Q Consensus 203 ~~~~--p~~~~--~~~---------------------------------------------------------------- 214 (787)
++.. |..+. ...
T Consensus 209 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l 288 (549)
T 2z81_A 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTI 288 (549)
T ss_dssp TTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEE
T ss_pred ccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccc
Confidence 8642 11110 011
Q ss_pred -----------------------ccceeeccCCCCCcCCCCcccc-ccCccCceEeccccccccCCC----CCCCCCCCC
Q 003911 215 -----------------------IQSLWVNGQNGNAKLGGGIDVI-QNMTSLKEIWLHSNAFSGPLP----DFSGVKQLE 266 (787)
Q Consensus 215 -----------------------l~~L~~~~~~~~~~~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~----~~~~l~~L~ 266 (787)
++.|++.+ +.+...|..+ .++++|++|+|++|++++.+| .+..+++|+
T Consensus 289 ~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~----n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~ 364 (549)
T 2z81_A 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVEN----SKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364 (549)
T ss_dssp ESCBCSCGGGSCCCCHHHHHSTTCCEEEEES----SCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCC
T ss_pred cccccchhhhcccchhhhhhcccceEEEecc----CccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCc
Confidence 11122211 1223345444 579999999999999998643 377899999
Q ss_pred EEecCCCcccccCC--ccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhC
Q 003911 267 SLSLRDNFFTGPVP--DSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMG 344 (787)
Q Consensus 267 ~L~L~~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~ 344 (787)
+|+|++|+|++..+ ..+..+++|++|+|++|++++.++.+..+.+|+.+++++|.+..++......+..+
T Consensus 365 ~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L-------- 436 (549)
T 2z81_A 365 TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVL-------- 436 (549)
T ss_dssp EEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEE--------
T ss_pred EEEccCCcccccccchhhhhcCCCCCEEECCCCCCccCChhhcccccccEEECCCCCcccccchhcCCceEE--------
Confidence 99999999995433 56899999999999999999777778888899999999999887765443221110
Q ss_pred CChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeee
Q 003911 345 YPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELD 424 (787)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~ 424 (787)
...+... .+.....++|+.|+|++|+++ .+|. ...+++|+.|+|++|+|++.+|..+..+++|++|+
T Consensus 437 --------~Ls~N~l---~~~~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 503 (549)
T 2z81_A 437 --------DVSNNNL---DSFSLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIW 503 (549)
T ss_dssp --------ECCSSCC---SCCCCCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEE
T ss_pred --------ECCCCCh---hhhcccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEE
Confidence 0011111 112235679999999999999 6776 57899999999999999999899999999999999
Q ss_pred ccCCcccccCCC
Q 003911 425 VSNNQLYGKIPS 436 (787)
Q Consensus 425 Ls~N~l~g~iP~ 436 (787)
|++|+++|.+|.
T Consensus 504 l~~N~~~~~~~~ 515 (549)
T 2z81_A 504 LHTNPWDCSCPR 515 (549)
T ss_dssp CCSSCBCCCHHH
T ss_pred ecCCCccCCCcc
Confidence 999999999884
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=318.23 Aligned_cols=355 Identities=17% Similarity=0.124 Sum_probs=260.2
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (787)
.+++.|+|++|++++..|..|+++++|++|+|++|++++.+| .|.++++|++|+|++|+++++++..|+++++|++|+|
T Consensus 52 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 131 (570)
T 2z63_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (570)
T ss_dssp SSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEEC
T ss_pred CCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEec
Confidence 578999999999998778889999999999999999998776 6899999999999999999998878999999999999
Q ss_pred cCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCC-----------------------------------------
Q 003911 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFG----------------------------------------- 185 (787)
Q Consensus 147 ~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~----------------------------------------- 185 (787)
++|.+..+.+|..|.++++|++|++++|++++..|..++
T Consensus 132 ~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~ 211 (570)
T 2z63_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF 211 (570)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCC
T ss_pred CCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEeccccc
Confidence 999998766899999999999999998887665443221
Q ss_pred ------------------------------------------------------------------CCCCCCCcEEeccc
Q 003911 186 ------------------------------------------------------------------PDEFPGLTILHLAF 199 (787)
Q Consensus 186 ------------------------------------------------------------------~~~l~~L~~L~L~~ 199 (787)
...+++|++|++++
T Consensus 212 ~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~ 291 (570)
T 2z63_A 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291 (570)
T ss_dssp SCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEES
T ss_pred ccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecC
Confidence 00235566666666
Q ss_pred cccccCCCcCcccccccceeeccCCCCCcCCCC----------------ccccccCccCceEeccccccccCC---CCCC
Q 003911 200 NQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGG----------------IDVIQNMTSLKEIWLHSNAFSGPL---PDFS 260 (787)
Q Consensus 200 N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~----------------~~~~~~l~~L~~L~L~~N~l~~~~---~~~~ 260 (787)
|.++ .+|..+....++.|++.++......... ......+++|++|++++|++++.. ..+.
T Consensus 292 ~~l~-~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~ 370 (570)
T 2z63_A 292 VTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370 (570)
T ss_dssp CEEC-SCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHH
T ss_pred ccch-hhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCcccccccccc
Confidence 6665 3555444345555555443322110000 000146778888888888887653 3467
Q ss_pred CCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCC--CCCCceeeeccccCCCccCCCCCCCCchhhHHHH
Q 003911 261 GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP--EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLS 338 (787)
Q Consensus 261 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~ 338 (787)
.+++|++|++++|++++ +|..+..+++|++|++++|++++.+| .+..+.+|+.+++++|.+...+.........+.
T Consensus 371 ~~~~L~~L~l~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~- 448 (570)
T 2z63_A 371 GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE- 448 (570)
T ss_dssp TCSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC-
T ss_pred ccCccCEEECCCCcccc-ccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCc-
Confidence 78888888888888884 44448888888888888888887765 466777888888888876554332211111000
Q ss_pred HHHHhCCChhhhcccCCCCCCC--CccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcC
Q 003911 339 VVKLMGYPQRFAENWKGNDPCS--DWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV 416 (787)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~ 416 (787)
.......... .....+...++|+.|++++|++++..|..|..+++|+.|+|++|++++..|..+..
T Consensus 449 ------------~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 516 (570)
T 2z63_A 449 ------------VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDR 516 (570)
T ss_dssp ------------EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTT
T ss_pred ------------EEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhc
Confidence 0000000000 01123445679999999999999999999999999999999999999888889999
Q ss_pred CCCCCeeeccCCcccccCCCC
Q 003911 417 LGALKELDVSNNQLYGKIPSF 437 (787)
Q Consensus 417 l~~L~~L~Ls~N~l~g~iP~~ 437 (787)
+++|++|++++|+++|.+|..
T Consensus 517 l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 517 LTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp CTTCCEEECCSSCBCCCTTTT
T ss_pred ccCCcEEEecCCcccCCCcch
Confidence 999999999999999999973
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=299.37 Aligned_cols=283 Identities=19% Similarity=0.271 Sum_probs=237.1
Q ss_pred CCCCCCcccEEEcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCC
Q 003911 53 DTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVP 131 (787)
Q Consensus 53 ~~~~C~w~gv~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~ 131 (787)
...+|.|.|+ |+ +++++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|++++++
T Consensus 26 ~~~~C~~~~~-c~---------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 92 (353)
T 2z80_A 26 ASLSCDRNGI-CK---------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIE 92 (353)
T ss_dssp -CCEECTTSE-EE---------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEEC
T ss_pred cCCCCCCCeE-ee---------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccC
Confidence 3567999988 64 4667787 7787776 589999999999999877 7999999999999999999999
Q ss_pred CccccCCCCCcEEEccCCCCCCCCCChh-hhcCCCCCEEeccCceecccCC-CCCCCCCCCCCcEEeccccc-cccCCCc
Q 003911 132 SDFFTGLSSLQSIEIDNNPFSSWEIPQS-LRNASGLQNFSANSANITGQIP-SFFGPDEFPGLTILHLAFNQ-LIGGLPA 208 (787)
Q Consensus 132 ~~~~~~l~~L~~L~L~~N~l~~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~L~~N~-l~~~~p~ 208 (787)
+..|.++++|++|+|++|+++ .+|.. +.++++|++|++++|++++..+ ..+. .+++|++|++++|+ +.+..|.
T Consensus 93 ~~~~~~l~~L~~L~Ls~n~l~--~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~--~l~~L~~L~l~~n~~~~~~~~~ 168 (353)
T 2z80_A 93 EDSFSSLGSLEHLDLSYNYLS--NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFS--HLTKLQILRVGNMDTFTKIQRK 168 (353)
T ss_dssp TTTTTTCTTCCEEECCSSCCS--SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCT--TCTTCCEEEEEESSSCCEECTT
T ss_pred HhhcCCCCCCCEEECCCCcCC--cCCHhHhCCCccCCEEECCCCCCcccCchhhhc--cCCCCcEEECCCCccccccCHH
Confidence 999999999999999999999 46655 8999999999999999997655 4665 89999999999995 6655555
Q ss_pred CcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCC-CCCCCCCCCEEecCCCcccccCCc-cccCC
Q 003911 209 SFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPD-SLVKL 286 (787)
Q Consensus 209 ~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~-~l~~l 286 (787)
.| .++++|++|++++|++++.+| .+..+++|++|++++|+++ .+|. .+..+
T Consensus 169 ~~--------------------------~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~ 221 (353)
T 2z80_A 169 DF--------------------------AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVT 221 (353)
T ss_dssp TT--------------------------TTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHT
T ss_pred Hc--------------------------cCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhc
Confidence 54 378999999999999999866 5899999999999999998 4554 45569
Q ss_pred CCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccc
Q 003911 287 ESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVT 366 (787)
Q Consensus 287 ~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (787)
++|++|+|++|++++..+..... .
T Consensus 222 ~~L~~L~L~~n~l~~~~~~~l~~--------------------------------------------------------~ 245 (353)
T 2z80_A 222 SSVECLELRDTDLDTFHFSELST--------------------------------------------------------G 245 (353)
T ss_dssp TTEEEEEEESCBCTTCCCC-------------------------------------------------------------
T ss_pred ccccEEECCCCcccccccccccc--------------------------------------------------------c
Confidence 99999999999999765431000 0
Q ss_pred cCCCceEEEEccCCcccc----cCchhhcCCCCCCEEecccccccccCCcc-CcCCCCCCeeeccCCcccccCCC
Q 003911 367 CTKGNITVINFQKMNLTG----TISPEFASFKSLQRLILADNNLSGMIPEG-LSVLGALKELDVSNNQLYGKIPS 436 (787)
Q Consensus 367 ~~~~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~-l~~l~~L~~L~Ls~N~l~g~iP~ 436 (787)
.....++.++|+++.+.+ .+|..+..+++|+.|+|++|+|+ .+|.. |..+++|++|+|++|++++.+|.
T Consensus 246 ~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 246 ETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp -CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred cccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 011356778888888887 57889999999999999999999 67776 58999999999999999998874
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-32 Score=304.83 Aligned_cols=318 Identities=22% Similarity=0.309 Sum_probs=181.0
Q ss_pred CEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccC
Q 003911 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (787)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 148 (787)
+++.|++++|.+++..+ ++++++|++|+|++|++++.++ +.++++|++|+|++|+++++++ +.++++|++|+|++
T Consensus 69 ~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~ 143 (466)
T 1o6v_A 69 NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSS 143 (466)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEE
T ss_pred CCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh-hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCC
Confidence 44455555555443222 4455555555555555544443 4445555555555555554433 44455555555555
Q ss_pred CCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCccc-ccccceeeccCCCCC
Q 003911 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNA 227 (787)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~L~~~~~~~~~ 227 (787)
|++.. ++ .+..+++|+.|+++ |.+.+..+ +. .+++|++|++++|++++. +. +.. .+|+.|++.++...
T Consensus 144 n~l~~--~~-~~~~l~~L~~L~l~-~~~~~~~~--~~--~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~- 212 (466)
T 1o6v_A 144 NTISD--IS-ALSGLTSLQQLSFG-NQVTDLKP--LA--NLTTLERLDISSNKVSDI-SV-LAKLTNLESLIATNNQIS- 212 (466)
T ss_dssp EEECC--CG-GGTTCTTCSEEEEE-ESCCCCGG--GT--TCTTCCEEECCSSCCCCC-GG-GGGCTTCSEEECCSSCCC-
T ss_pred CccCC--Ch-hhccCCcccEeecC-CcccCchh--hc--cCCCCCEEECcCCcCCCC-hh-hccCCCCCEEEecCCccc-
Confidence 54442 22 24444455555443 23332222 32 556666666666665532 21 221 34445544433211
Q ss_pred cCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCC
Q 003911 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFD 307 (787)
Q Consensus 228 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 307 (787)
+.+ .++.+++|++|++++|++++. +.+..+++|+.|++++|++++..| +..+++|++|++++|++++.++ +.
T Consensus 213 ---~~~-~~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~ 284 (466)
T 1o6v_A 213 ---DIT-PLGILTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LA 284 (466)
T ss_dssp ---CCG-GGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GT
T ss_pred ---ccc-cccccCCCCEEECCCCCcccc-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-cc
Confidence 111 145566666666666666543 345556666666666666664333 5666666666666666665444 55
Q ss_pred CceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCc
Q 003911 308 RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS 387 (787)
Q Consensus 308 ~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p 387 (787)
.+..|+.+++++|.+...+ .+...++|+.|+|++|++++..|
T Consensus 285 ~l~~L~~L~L~~n~l~~~~--------------------------------------~~~~l~~L~~L~L~~n~l~~~~~ 326 (466)
T 1o6v_A 285 GLTALTNLELNENQLEDIS--------------------------------------PISNLKNLTYLTLYFNNISDISP 326 (466)
T ss_dssp TCTTCSEEECCSSCCSCCG--------------------------------------GGGGCTTCSEEECCSSCCSCCGG
T ss_pred CCCccCeEEcCCCcccCch--------------------------------------hhcCCCCCCEEECcCCcCCCchh
Confidence 5555666666665544322 12344688899999999888766
Q ss_pred hhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCC--CCCCceeecCCCCCCC
Q 003911 388 PEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS--FKSNAIVNTDGNPDIG 452 (787)
Q Consensus 388 ~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~--~~~~~~~~~~gn~~~~ 452 (787)
+..+++|+.|++++|++++. ..+..+++|++|++++|++++.+|- +..+..+.+.+|++.+
T Consensus 327 --~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 327 --VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp --GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGGGTTCTTCCEEECCCEEEEC
T ss_pred --hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccchhhcCCCCCEEeccCCcccC
Confidence 78888999999999988864 4788889999999999999887772 4556677777776643
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-32 Score=293.12 Aligned_cols=232 Identities=20% Similarity=0.311 Sum_probs=158.2
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEcc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 147 (787)
.+++.|+++++++. .++ .+..+++|++|+|++|++++.++ +.++++|++|+|++|+++.++ .|.++++|++|+|+
T Consensus 44 ~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~~~-~~~l~~L~~L~L~~n~i~~~~--~~~~l~~L~~L~l~ 118 (347)
T 4fmz_A 44 ESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP-LSNLVKLTNLYIGTNKITDIS--ALQNLTNLRELYLN 118 (347)
T ss_dssp TTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEECT
T ss_pred ccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccchh-hhcCCcCCEEEccCCcccCch--HHcCCCcCCEEECc
Confidence 57999999999998 455 48899999999999999998766 999999999999999999874 59999999999999
Q ss_pred CCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCccc-ccccceeeccCCCC
Q 003911 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGN 226 (787)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~L~~~~~~~~ 226 (787)
+|++.. ++. +..+++|+.|++++|.....++. +. .+++|++|++++|.+.+..+ +.. .+++.|++.++...
T Consensus 119 ~n~i~~--~~~-~~~l~~L~~L~l~~n~~~~~~~~-~~--~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~ 190 (347)
T 4fmz_A 119 EDNISD--ISP-LANLTKMYSLNLGANHNLSDLSP-LS--NMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIE 190 (347)
T ss_dssp TSCCCC--CGG-GTTCTTCCEEECTTCTTCCCCGG-GT--TCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCC
T ss_pred CCcccC--chh-hccCCceeEEECCCCCCcccccc-hh--hCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccc
Confidence 999984 454 88999999999999976655555 44 89999999999999885443 321 33444444332211
Q ss_pred CcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCC
Q 003911 227 AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 306 (787)
Q Consensus 227 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 306 (787)
..+ .+..+++|+.|++++|.+++..+ +..+++|++|++++|++++ +|. +..+++|++|++++|.+++. +.+
T Consensus 191 ----~~~-~~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~-~~~ 261 (347)
T 4fmz_A 191 ----DIS-PLASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISDI-NAV 261 (347)
T ss_dssp ----CCG-GGGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GGG
T ss_pred ----ccc-cccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCCC-hhH
Confidence 111 14455555555555555554433 4455555555555555553 222 55555555555555555542 333
Q ss_pred CCceeeeccccCCCc
Q 003911 307 DRSVSLDMAKGSNNF 321 (787)
Q Consensus 307 ~~~~~L~~l~~~~n~ 321 (787)
..+.+|+.+++++|.
T Consensus 262 ~~l~~L~~L~l~~n~ 276 (347)
T 4fmz_A 262 KDLTKLKMLNVGSNQ 276 (347)
T ss_dssp TTCTTCCEEECCSSC
T ss_pred hcCCCcCEEEccCCc
Confidence 444444444444443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-32 Score=323.45 Aligned_cols=333 Identities=18% Similarity=0.199 Sum_probs=258.2
Q ss_pred EEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEccccc-CCcCCCccccCCCCCcEEEccC
Q 003911 71 TRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQ-FTSVPSDFFTGLSSLQSIEIDN 148 (787)
Q Consensus 71 ~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~ 148 (787)
...|.++++++ .+|. -.++|++|+|++|+|++..| .|.++++|++|+|++|. +..+++..|.++++|++|+|++
T Consensus 7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~ 82 (844)
T 3j0a_A 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82 (844)
T ss_dssp EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence 34566788888 6776 45899999999999999877 79999999999999995 5567789999999999999999
Q ss_pred CCCCCCCCChhhhcCCCCCEEeccCceecccCCCC--CCCCCCCCCcEEeccccccccCCC-cCccc-ccccceeeccCC
Q 003911 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSF--FGPDEFPGLTILHLAFNQLIGGLP-ASFSG-SQIQSLWVNGQN 224 (787)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~--~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~-~~l~~L~~~~~~ 224 (787)
|++.. ..|..|.++++|++|+|++|.+++.+|.. |+ .+++|++|+|++|.+++..| ..|.+ .+|+.|++.++.
T Consensus 83 N~l~~-~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~--~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~ 159 (844)
T 3j0a_A 83 SKIYF-LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR--NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQ 159 (844)
T ss_dssp CCCCE-ECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCS--SCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSC
T ss_pred CcCcc-cCHhHccCCcccCEeeCcCCCCCcccccCcccc--ccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCc
Confidence 99996 56999999999999999999999877665 65 89999999999999998765 45654 567777776543
Q ss_pred CCCcCCCCccccccC--ccCceEeccccccccCCC-CCCCCCC------CCEEecCCCcccccCCccccCC---------
Q 003911 225 GNAKLGGGIDVIQNM--TSLKEIWLHSNAFSGPLP-DFSGVKQ------LESLSLRDNFFTGPVPDSLVKL--------- 286 (787)
Q Consensus 225 ~~~~~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~-~~~~l~~------L~~L~L~~N~l~~~~p~~l~~l--------- 286 (787)
.....+..+..+ ++|+.|+|++|.+.+..+ .+..+++ |+.|+|++|++++.+|..+...
T Consensus 160 ---i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L 236 (844)
T 3j0a_A 160 ---IFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSL 236 (844)
T ss_dssp ---CCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEE
T ss_pred ---CCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccce
Confidence 333345556666 789999999999888665 3544444 8899999988887766655432
Q ss_pred -----------------------------CCCCEEEccCCcccccCCC-CCCceeeeccccCCCccCCCCCCCCchhhHH
Q 003911 287 -----------------------------ESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNAL 336 (787)
Q Consensus 287 -----------------------------~~L~~L~Ls~N~l~~~~p~-~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l 336 (787)
++|+.|+|++|.+++.+|. +..+.+|+.+++++|.+...+..
T Consensus 237 ~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~-------- 308 (844)
T 3j0a_A 237 ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADE-------- 308 (844)
T ss_dssp ECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTT--------
T ss_pred ecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChH--------
Confidence 5788888888888877665 55677788888888776543211
Q ss_pred HHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcC
Q 003911 337 LSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSV 416 (787)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~ 416 (787)
.+...++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..|..
T Consensus 309 ----------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~ 360 (844)
T 3j0a_A 309 ----------------------------AFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360 (844)
T ss_dssp ----------------------------TTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCS
T ss_pred ----------------------------HhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcC
Confidence 1233457888888888888888888888888888888888888777777888
Q ss_pred CCCCCeeeccCCcccccCCCCCCCceeecCCCCC
Q 003911 417 LGALKELDVSNNQLYGKIPSFKSNAIVNTDGNPD 450 (787)
Q Consensus 417 l~~L~~L~Ls~N~l~g~iP~~~~~~~~~~~gn~~ 450 (787)
+++|++|+|++|++++ +|.+..+..+.+.+|..
T Consensus 361 l~~L~~L~Ls~N~l~~-i~~~~~L~~L~l~~N~l 393 (844)
T 3j0a_A 361 LEKLQTLDLRDNALTT-IHFIPSIPDIFLSGNKL 393 (844)
T ss_dssp CCCCCEEEEETCCSCC-CSSCCSCSEEEEESCCC
T ss_pred CCCCCEEECCCCCCCc-ccCCCCcchhccCCCCc
Confidence 8888888888888875 34455555556655543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-32 Score=289.44 Aligned_cols=194 Identities=23% Similarity=0.341 Sum_probs=126.5
Q ss_pred EEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCC
Q 003911 71 TRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (787)
Q Consensus 71 ~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 149 (787)
+.+++++++++ .+|..+. ++|++|+|++|+|++.+| .|.++++|++|+|++|+++++++..|.++++|++|+|++|
T Consensus 36 ~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 36 RVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred CEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 34556666666 6666664 578888888888887666 6788888888888888888887777888888888888888
Q ss_pred CCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccc--cCCCcCcccccccceeeccCCCCC
Q 003911 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI--GGLPASFSGSQIQSLWVNGQNGNA 227 (787)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~~~l~~L~~~~~~~~~ 227 (787)
+++ .+|..+. ++|++|++++|++++..+..|. .+++|++|++++|+++ +..|..+.
T Consensus 113 ~l~--~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~~---------------- 170 (332)
T 2ft3_A 113 HLV--EIPPNLP--SSLVELRIHDNRIRKVPKGVFS--GLRNMNCIEMGGNPLENSGFEPGAFD---------------- 170 (332)
T ss_dssp CCC--SCCSSCC--TTCCEEECCSSCCCCCCSGGGS--SCSSCCEEECCSCCCBGGGSCTTSSC----------------
T ss_pred cCC--ccCcccc--ccCCEEECCCCccCccCHhHhC--CCccCCEEECCCCccccCCCCccccc----------------
Confidence 887 5666555 6788888888888776666665 7788888888888875 35555554
Q ss_pred cCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCccccc
Q 003911 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302 (787)
Q Consensus 228 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 302 (787)
.+ +|+.|++++|++++.+..+. ++|++|+|++|++++..|..+..+++|++|+|++|++++.
T Consensus 171 ----------~l-~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~ 232 (332)
T 2ft3_A 171 ----------GL-KLNYLRISEAKLTGIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMI 232 (332)
T ss_dssp ----------SC-CCSCCBCCSSBCSSCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCC
T ss_pred ----------CC-ccCEEECcCCCCCccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcC
Confidence 23 44444555554444333322 4444455555555444444444445555555555544443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-33 Score=296.09 Aligned_cols=186 Identities=23% Similarity=0.385 Sum_probs=165.1
Q ss_pred hhcCCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
...++|++.+.||+|+||.||+|+. .+|+.||||++..........+++.+|+++++.++||||+++++++.+.+..|+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3456899999999999999999987 489999999998766666667889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 92 v~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNE 163 (328)
T ss_dssp EECCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred EEECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence 99999999999998542 368999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC--cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS--SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~DiWS~ 785 (787)
..... .....+||+.|+|||++.+..+. ++||||.
T Consensus 164 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 200 (328)
T 3fe3_A 164 FTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSL 200 (328)
T ss_dssp GSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHH
T ss_pred cCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhh
Confidence 65432 23346799999999999988875 7999983
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-31 Score=287.01 Aligned_cols=263 Identities=20% Similarity=0.282 Sum_probs=199.0
Q ss_pred EEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCC
Q 003911 71 TRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (787)
Q Consensus 71 ~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 149 (787)
+.+++++++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+++++.+..|.++++|++|+|++|
T Consensus 34 ~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (330)
T 1xku_A 34 RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110 (330)
T ss_dssp TEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred eEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCC
Confidence 34556666666 5676665 688899999999988777 6888999999999999999988888999999999999999
Q ss_pred CCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEecccccccc--CCCcCcccccccceeeccCCCCC
Q 003911 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIG--GLPASFSGSQIQSLWVNGQNGNA 227 (787)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~~~l~~L~~~~~~~~~ 227 (787)
+++ .+|..+. ++|++|++++|.+++..+..|. .+++|++|++++|++.. ..+..
T Consensus 111 ~l~--~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~------------------ 166 (330)
T 1xku_A 111 QLK--ELPEKMP--KTLQELRVHENEITKVRKSVFN--GLNQMIVVELGTNPLKSSGIENGA------------------ 166 (330)
T ss_dssp CCS--BCCSSCC--TTCCEEECCSSCCCBBCHHHHT--TCTTCCEEECCSSCCCGGGBCTTG------------------
T ss_pred cCC--ccChhhc--ccccEEECCCCcccccCHhHhc--CCccccEEECCCCcCCccCcChhh------------------
Confidence 988 5676654 7899999999999888777775 78899999999998863 44443
Q ss_pred cCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCC-C
Q 003911 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-F 306 (787)
Q Consensus 228 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~ 306 (787)
+.++++|++|++++|+++..+..+. ++|++|+|++|++++..|..|..+++|++|+|++|++++.++. +
T Consensus 167 --------~~~l~~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 236 (330)
T 1xku_A 167 --------FQGMKKLSYIRIADTNITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL 236 (330)
T ss_dssp --------GGGCTTCCEEECCSSCCCSCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTG
T ss_pred --------ccCCCCcCEEECCCCccccCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhc
Confidence 3478888899999988887665544 7888999999998887788888888999999999888876653 2
Q ss_pred CCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccC
Q 003911 307 DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTI 386 (787)
Q Consensus 307 ~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~ 386 (787)
.. .++|+.|+|++|+++ .+
T Consensus 237 ~~------------------------------------------------------------l~~L~~L~L~~N~l~-~l 255 (330)
T 1xku_A 237 AN------------------------------------------------------------TPHLRELHLNNNKLV-KV 255 (330)
T ss_dssp GG------------------------------------------------------------STTCCEEECCSSCCS-SC
T ss_pred cC------------------------------------------------------------CCCCCEEECCCCcCc-cC
Confidence 22 235666666666666 56
Q ss_pred chhhcCCCCCCEEecccccccccCCccCcC------CCCCCeeeccCCccc
Q 003911 387 SPEFASFKSLQRLILADNNLSGMIPEGLSV------LGALKELDVSNNQLY 431 (787)
Q Consensus 387 p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~------l~~L~~L~Ls~N~l~ 431 (787)
|..+..+++|++|+|++|+|++..+..|.. ...|+.|++++|++.
T Consensus 256 p~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~ 306 (330)
T 1xku_A 256 PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306 (330)
T ss_dssp CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred ChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccc
Confidence 666666666777777777666554445533 255666677776664
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-31 Score=287.63 Aligned_cols=277 Identities=19% Similarity=0.262 Sum_probs=237.3
Q ss_pred CCcccEEEcCC----------CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccc
Q 003911 57 CKWNHVVCIED----------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNN 125 (787)
Q Consensus 57 C~w~gv~C~~~----------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N 125 (787)
|.|..+.|... .+++.|++++|++++..|..|.++++|++|+|++|+|++..| .|.++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 78999999642 378999999999998888899999999999999999999877 7999999999999999
Q ss_pred cCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceec--ccCCCCCCCCCCCCCcEEeccccccc
Q 003911 126 QFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANIT--GQIPSFFGPDEFPGLTILHLAFNQLI 203 (787)
Q Consensus 126 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~--~~~p~~~~~~~l~~L~~L~L~~N~l~ 203 (787)
+++.+++..+ ++|++|+|++|++.. ..+..|..+++|+.|++++|.++ +..|..+. .+ +|++|++++|+++
T Consensus 113 ~l~~l~~~~~---~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~--~l-~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 113 HLVEIPPNLP---SSLVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD--GL-KLNYLRISEAKLT 185 (332)
T ss_dssp CCCSCCSSCC---TTCCEEECCSSCCCC-CCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSC--SC-CCSCCBCCSSBCS
T ss_pred cCCccCcccc---ccCCEEECCCCccCc-cCHhHhCCCccCCEEECCCCccccCCCCccccc--CC-ccCEEECcCCCCC
Confidence 9999988755 899999999999995 34567999999999999999996 47777775 66 9999999999998
Q ss_pred cCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCC-CCCCCCCCCEEecCCCcccccCCcc
Q 003911 204 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDS 282 (787)
Q Consensus 204 ~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~ 282 (787)
+ +|..+ .++|++|+|++|.+++.++ .+..+++|+.|+|++|+|++..|..
T Consensus 186 ~-l~~~~----------------------------~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 236 (332)
T 2ft3_A 186 G-IPKDL----------------------------PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGS 236 (332)
T ss_dssp S-CCSSS----------------------------CSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTG
T ss_pred c-cCccc----------------------------cCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhH
Confidence 5 55543 2689999999999999876 5899999999999999999888889
Q ss_pred ccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCc
Q 003911 283 LVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW 362 (787)
Q Consensus 283 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (787)
+..+++|++|+|++|+++..++.+
T Consensus 237 ~~~l~~L~~L~L~~N~l~~lp~~l-------------------------------------------------------- 260 (332)
T 2ft3_A 237 LSFLPTLRELHLDNNKLSRVPAGL-------------------------------------------------------- 260 (332)
T ss_dssp GGGCTTCCEEECCSSCCCBCCTTG--------------------------------------------------------
T ss_pred hhCCCCCCEEECCCCcCeecChhh--------------------------------------------------------
Confidence 999999999999999998443321
Q ss_pred cccccCCCceEEEEccCCcccccCchhhcCC------CCCCEEeccccccc--ccCCccCcCCCCCCeeeccCCc
Q 003911 363 IGVTCTKGNITVINFQKMNLTGTISPEFASF------KSLQRLILADNNLS--GMIPEGLSVLGALKELDVSNNQ 429 (787)
Q Consensus 363 ~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l------~~L~~L~Ls~N~l~--g~ip~~l~~l~~L~~L~Ls~N~ 429 (787)
...++|+.|++++|++++..+..|... ..|+.|+|++|.+. +..|..|..+++|+.|++++|+
T Consensus 261 ----~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 261 ----PDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp ----GGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ----hcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 123488999999999998877777653 67999999999997 6778889999999999999985
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.9e-33 Score=305.63 Aligned_cols=195 Identities=24% Similarity=0.372 Sum_probs=166.4
Q ss_pred eHHHHHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEE
Q 003911 584 SIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCL 661 (787)
Q Consensus 584 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 661 (787)
..+..+...++|++.+.||+|+||+||+|+.. +++.||+|++++.... ......+.+|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34555666789999999999999999999876 5889999999763221 223345889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEe
Q 003911 662 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 741 (787)
Q Consensus 662 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 741 (787)
+.+..|+||||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+||||||||+|||++.++.+||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEc
Confidence 999999999999999999998542 2468999999999999999999998 899999999999999999999999
Q ss_pred ecccceecCCCCCceeeeeccccCcccccccc-----cCCcC-cceeecC
Q 003911 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV-----HTRWS-SCSYWAG 785 (787)
Q Consensus 742 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~-~~DiWS~ 785 (787)
|||+|+.............+||+.|||||++. +..++ ++|+||.
T Consensus 218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSl 267 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267 (437)
T ss_dssp CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHH
T ss_pred chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHH
Confidence 99999877655443344468999999999997 45677 8999983
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-31 Score=300.62 Aligned_cols=302 Identities=22% Similarity=0.332 Sum_probs=255.7
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEcc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 147 (787)
.+++.|++++|.+++..+ ++++++|++|+|++|++++.++ +.++++|++|+|++|++++++ .+.++++|++|+++
T Consensus 90 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~ 164 (466)
T 1o6v_A 90 TKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSFG 164 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE
T ss_pred ccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH-HcCCCCCCEEECCCCccCCCh--hhccCCcccEeecC
Confidence 589999999999996554 9999999999999999998765 999999999999999999976 38999999999997
Q ss_pred CCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcc-cccccceeeccCCCC
Q 003911 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFS-GSQIQSLWVNGQNGN 226 (787)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~~~l~~L~~~~~~~~ 226 (787)
|.+.. ++ .+.++++|+.|++++|.+++.. .+. .+++|++|++++|++++..| +. ..+|+.|++.++...
T Consensus 165 -~~~~~--~~-~~~~l~~L~~L~l~~n~l~~~~--~l~--~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~ 234 (466)
T 1o6v_A 165 -NQVTD--LK-PLANLTTLERLDISSNKVSDIS--VLA--KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK 234 (466)
T ss_dssp -ESCCC--CG-GGTTCTTCCEEECCSSCCCCCG--GGG--GCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred -CcccC--ch-hhccCCCCCEEECcCCcCCCCh--hhc--cCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcc
Confidence 55553 23 4899999999999999998653 344 89999999999999997766 32 256777777665432
Q ss_pred CcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCC
Q 003911 227 AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 306 (787)
Q Consensus 227 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 306 (787)
. ...+..+++|+.|++++|.+++.++ +..+++|+.|++++|++++..| +..+++|++|+|++|++++.++ +
T Consensus 235 ~-----~~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~ 305 (466)
T 1o6v_A 235 D-----IGTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP-I 305 (466)
T ss_dssp C-----CGGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG-G
T ss_pred c-----chhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh-h
Confidence 2 2468899999999999999998776 8889999999999999996544 8999999999999999998766 7
Q ss_pred CCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccC
Q 003911 307 DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTI 386 (787)
Q Consensus 307 ~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~ 386 (787)
..+.+|+.+++++|.+...+. +...++|+.|++++|++++.
T Consensus 306 ~~l~~L~~L~L~~n~l~~~~~--------------------------------------~~~l~~L~~L~l~~n~l~~~- 346 (466)
T 1o6v_A 306 SNLKNLTYLTLYFNNISDISP--------------------------------------VSSLTKLQRLFFYNNKVSDV- 346 (466)
T ss_dssp GGCTTCSEEECCSSCCSCCGG--------------------------------------GGGCTTCCEEECCSSCCCCC-
T ss_pred cCCCCCCEEECcCCcCCCchh--------------------------------------hccCccCCEeECCCCccCCc-
Confidence 778889999999997664421 12346899999999999986
Q ss_pred chhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCC
Q 003911 387 SPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP 435 (787)
Q Consensus 387 p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP 435 (787)
..+..+++|+.|+|++|++++..| +..+++|+.|++++|++++.+.
T Consensus 347 -~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~p~ 392 (466)
T 1o6v_A 347 -SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPV 392 (466)
T ss_dssp -GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECCCB
T ss_pred -hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCCch
Confidence 579999999999999999998877 8999999999999999998533
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.9e-33 Score=302.82 Aligned_cols=192 Identities=25% Similarity=0.364 Sum_probs=164.5
Q ss_pred HHHHHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEe
Q 003911 585 IQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 662 (787)
Q Consensus 585 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 662 (787)
.+.++...++|++.+.||+|+||.||+|+.. +++.||+|++++... .....+.+.+|+++++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455556789999999999999999999876 689999999976322 12233468899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEee
Q 003911 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (787)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 742 (787)
.+..|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEec
Confidence 9999999999999999998853 258899999999999999999998 8999999999999999999999999
Q ss_pred cccceecCCCCCceeeeeccccCcccccccccCC----cC-cceeecC
Q 003911 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR----WS-SCSYWAG 785 (787)
Q Consensus 743 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~-~~DiWS~ 785 (787)
||+|+.............+||+.|+|||++.+.. ++ ++|+||.
T Consensus 212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSl 259 (410)
T 3v8s_A 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 259 (410)
T ss_dssp CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHH
T ss_pred cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecc
Confidence 9999887554333334578999999999998765 66 8999983
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-32 Score=291.64 Aligned_cols=184 Identities=28% Similarity=0.419 Sum_probs=161.3
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|+.. +|+.||+|++++... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57999999999999999999876 699999999976432 2345677899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 85 E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 85 EYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999998854 1368999999999999999999998 899999999999999999999999999998643
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... ......+||+.|+|||++.+..++ ++|+||.
T Consensus 157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 191 (337)
T 1o6l_A 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHH
T ss_pred cCC-CcccccccChhhCChhhhcCCCCCchhhcccc
Confidence 322 223446799999999999998888 8999983
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.98 E-value=5e-31 Score=293.71 Aligned_cols=308 Identities=17% Similarity=0.125 Sum_probs=237.5
Q ss_pred CCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEc
Q 003911 67 DKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (787)
Q Consensus 67 ~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (787)
-.+++.|++++|++++. | .++.+++|++|+|++|+|++. | +..+++|++|+|++|+|++++ |+++++|++|+|
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~-~~~l~~L~~L~Ls~N~l~~~~---~~~l~~L~~L~L 113 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D-LSQNTNLTYLACDSNKLTNLD---VTPLTKLTYLNC 113 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C-CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEEC
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c-cccCCCCCEEECcCCCCceee---cCCCCcCCEEEC
Confidence 36899999999999964 5 799999999999999999986 3 899999999999999999985 899999999999
Q ss_pred cCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCccc-ccccceeeccCCC
Q 003911 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNG 225 (787)
Q Consensus 147 ~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~L~~~~~~~ 225 (787)
++|++++ +| +..+++|++|++++|++++. + ++ .+++|++|++++|+..+.++ +.. .+++.|++.++..
T Consensus 114 ~~N~l~~--l~--~~~l~~L~~L~l~~N~l~~l-~--l~--~l~~L~~L~l~~n~~~~~~~--~~~l~~L~~L~ls~n~l 182 (457)
T 3bz5_A 114 DTNKLTK--LD--VSQNPLLTYLNCARNTLTEI-D--VS--HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI 182 (457)
T ss_dssp CSSCCSC--CC--CTTCTTCCEEECTTSCCSCC-C--CT--TCTTCCEEECTTCSCCCCCC--CTTCTTCCEEECCSSCC
T ss_pred CCCcCCe--ec--CCCCCcCCEEECCCCcccee-c--cc--cCCcCCEEECCCCCcccccc--cccCCcCCEEECCCCcc
Confidence 9999995 45 89999999999999999985 3 54 89999999999997666663 322 5577777665432
Q ss_pred CCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCC
Q 003911 226 NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305 (787)
Q Consensus 226 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 305 (787)
. +.+ +..+++|+.|++++|++++. .+..+++|+.|+|++|+|++ +| +..+++|++|++++|++++.++.
T Consensus 183 ~----~l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~ 251 (457)
T 3bz5_A 183 T----ELD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVS 251 (457)
T ss_dssp C----CCC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCT
T ss_pred c----eec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHH
Confidence 2 222 77888899999999998876 47888899999999999986 66 88889999999999999886543
Q ss_pred CCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCccccc
Q 003911 306 FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT 385 (787)
Q Consensus 306 ~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~ 385 (787)
.+..|+.+++++|.+..+.-.... ..+..| ....++|+.|++++|.+.+.
T Consensus 252 --~l~~L~~L~l~~n~L~~L~l~~n~---------------------~~~~~~-------~~~l~~L~~L~Ls~n~~l~~ 301 (457)
T 3bz5_A 252 --TLSKLTTLHCIQTDLLEIDLTHNT---------------------QLIYFQ-------AEGCRKIKELDVTHNTQLYL 301 (457)
T ss_dssp --TCTTCCEEECTTCCCSCCCCTTCT---------------------TCCEEE-------CTTCTTCCCCCCTTCTTCCE
T ss_pred --HCCCCCEEeccCCCCCEEECCCCc---------------------cCCccc-------ccccccCCEEECCCCcccce
Confidence 333444444444433322110000 000000 12336889999999988887
Q ss_pred Cchh--------hcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCCC
Q 003911 386 ISPE--------FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSF 437 (787)
Q Consensus 386 ~p~~--------~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~~ 437 (787)
+|.. +..+++|+.|+|++|+|++ +| ++.+++|++||+++|+|+| +|.+
T Consensus 302 l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~-l~~L 357 (457)
T 3bz5_A 302 LDCQAAGITELDLSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD-FSSV 357 (457)
T ss_dssp EECTTCCCSCCCCTTCTTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB-CTTG
T ss_pred eccCCCcceEechhhcccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC-cccc
Confidence 7753 5566789999999999997 43 8899999999999999998 4543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.4e-32 Score=283.81 Aligned_cols=182 Identities=25% Similarity=0.457 Sum_probs=161.3
Q ss_pred cCCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 46899999999999999999985 478999999997643 233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 97 e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp ECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999998854 358899999999999999999998 899999999999999999999999999998775
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... ......||+.|+|||++.+..++ ++||||.
T Consensus 168 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 202 (297)
T 3fxz_A 168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202 (297)
T ss_dssp STTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHH
T ss_pred Cccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHH
Confidence 5432 23346799999999999999888 8999983
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=294.83 Aligned_cols=346 Identities=14% Similarity=0.080 Sum_probs=259.1
Q ss_pred CCCCC-CCCC-cccEEEcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCC-CCCCCCCcEEEccccc
Q 003911 50 GWSDT-DPCK-WNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS-LNGLASLEVVMLSNNQ 126 (787)
Q Consensus 50 ~w~~~-~~C~-w~gv~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~ 126 (787)
+|... +||. |.+..|.... +.+............-..+++|+.|++++|.++..++. |.++++|++|+|++|+
T Consensus 5 ~~~~~~~C~~~~~~~~c~~~~----~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~ 80 (390)
T 3o6n_A 5 PRQPEYKCIDSNLQYDCVFYD----VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 80 (390)
T ss_dssp --CCEECBCC------EEEES----CEECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSC
T ss_pred CCCCccceehhhhhhccceee----eeeecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCc
Confidence 67654 6654 5555554211 12222222212222234578999999999999987774 7899999999999999
Q ss_pred CCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCC
Q 003911 127 FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGL 206 (787)
Q Consensus 127 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~ 206 (787)
++++++..|.++++|++|+|++|+++. ..|..|.++++|++|++++|.++..++..|. .+++|++|+|++|++++..
T Consensus 81 i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~--~l~~L~~L~L~~n~l~~~~ 157 (390)
T 3o6n_A 81 IEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFH--NTPKLTTLSMSNNNLERIE 157 (390)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCCBCC
T ss_pred ccccChhhccCCCCcCEEECCCCCCCc-CCHHHhcCCCCCCEEECCCCccCcCCHHHhc--CCCCCcEEECCCCccCccC
Confidence 999999999999999999999999996 5577899999999999999999977777676 8999999999999999888
Q ss_pred CcCccc-ccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccC
Q 003911 207 PASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVK 285 (787)
Q Consensus 207 p~~~~~-~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 285 (787)
|..+.. .+|+.|++.++..... .+..+++|+.|++++|.+++. ...++|+.|++++|+++. +|..+
T Consensus 158 ~~~~~~l~~L~~L~l~~n~l~~~------~~~~l~~L~~L~l~~n~l~~~----~~~~~L~~L~l~~n~l~~-~~~~~-- 224 (390)
T 3o6n_A 158 DDTFQATTSLQNLQLSSNRLTHV------DLSLIPSLFHANVSYNLLSTL----AIPIAVEELDASHNSINV-VRGPV-- 224 (390)
T ss_dssp TTTTSSCTTCCEEECCSSCCSBC------CGGGCTTCSEEECCSSCCSEE----ECCSSCSEEECCSSCCCE-EECCC--
T ss_pred hhhccCCCCCCEEECCCCcCCcc------ccccccccceeeccccccccc----CCCCcceEEECCCCeeee-ccccc--
Confidence 887765 5677777765433221 255678888888888887753 234578888888888884 44433
Q ss_pred CCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCcccc
Q 003911 286 LESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGV 365 (787)
Q Consensus 286 l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (787)
.++|+.|++++|++++. +.+..+..|+.+++++|.+...+. ..
T Consensus 225 ~~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~~------------------------------------~~ 267 (390)
T 3o6n_A 225 NVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMY------------------------------------HP 267 (390)
T ss_dssp CSSCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEES------------------------------------GG
T ss_pred cccccEEECCCCCCccc-HHHcCCCCccEEECCCCcCCCcCh------------------------------------hH
Confidence 47888888888888864 556677778888888886553311 12
Q ss_pred ccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCC-CCCCCceee
Q 003911 366 TCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP-SFKSNAIVN 444 (787)
Q Consensus 366 ~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP-~~~~~~~~~ 444 (787)
+...++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|+++.... .+..+..+.
T Consensus 268 ~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~L~~L~ 345 (390)
T 3o6n_A 268 FVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLT 345 (390)
T ss_dssp GTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEE
T ss_pred ccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeCchhhccCCEEE
Confidence 3345689999999999986 5667788899999999999998 678888889999999999999986533 366778889
Q ss_pred cCCCCCCCCC
Q 003911 445 TDGNPDIGKE 454 (787)
Q Consensus 445 ~~gn~~~~~~ 454 (787)
+.||++.|..
T Consensus 346 l~~N~~~~~~ 355 (390)
T 3o6n_A 346 LSHNDWDCNS 355 (390)
T ss_dssp CCSSCEEHHH
T ss_pred cCCCCccchh
Confidence 9999988753
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=287.22 Aligned_cols=281 Identities=19% Similarity=0.314 Sum_probs=236.8
Q ss_pred CCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEc
Q 003911 67 DKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (787)
Q Consensus 67 ~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (787)
-.+++.|++++|++++ +++ +..+++|++|+|++|.++.. +.+.++++|++|+|++|+++++++ +..+++|++|++
T Consensus 65 ~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~~-~~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l 139 (347)
T 4fmz_A 65 LTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITDI-SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNL 139 (347)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEEC
T ss_pred cCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccCc-hHHcCCCcCCEEECcCCcccCchh--hccCCceeEEEC
Confidence 3589999999999995 444 99999999999999999974 679999999999999999999876 899999999999
Q ss_pred cCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCccc-ccccceeeccCCC
Q 003911 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNG 225 (787)
Q Consensus 147 ~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~L~~~~~~~ 225 (787)
++|.... .+..+..+++|++|++++|.+.+..+ +. .+++|++|++++|++.+..+ +.. .+++.|++.++..
T Consensus 140 ~~n~~~~--~~~~~~~l~~L~~L~l~~~~~~~~~~--~~--~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l 211 (347)
T 4fmz_A 140 GANHNLS--DLSPLSNMTGLNYLTVTESKVKDVTP--IA--NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQI 211 (347)
T ss_dssp TTCTTCC--CCGGGTTCTTCCEEECCSSCCCCCGG--GG--GCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred CCCCCcc--cccchhhCCCCcEEEecCCCcCCchh--hc--cCCCCCEEEccCCccccccc--ccCCCccceeecccCCC
Confidence 9997663 35559999999999999999987665 54 89999999999999986443 332 5566666655432
Q ss_pred CCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCC
Q 003911 226 NAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305 (787)
Q Consensus 226 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 305 (787)
. ..+ .+..+++|++|++++|++++.++ +..+++|++|++++|++++ + +.+..+++|++|++++|++++. +.
T Consensus 212 ~----~~~-~~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~ 282 (347)
T 4fmz_A 212 T----DIT-PVANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SV 282 (347)
T ss_dssp C----CCG-GGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GG
T ss_pred C----CCc-hhhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hh
Confidence 2 222 27899999999999999998776 8899999999999999995 4 5699999999999999999864 21
Q ss_pred CCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCccccc
Q 003911 306 FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT 385 (787)
Q Consensus 306 ~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~ 385 (787)
+ ...++|+.|++++|++++.
T Consensus 283 ~------------------------------------------------------------~~l~~L~~L~L~~n~l~~~ 302 (347)
T 4fmz_A 283 L------------------------------------------------------------NNLSQLNSLFLNNNQLGNE 302 (347)
T ss_dssp G------------------------------------------------------------GGCTTCSEEECCSSCCCGG
T ss_pred h------------------------------------------------------------cCCCCCCEEECcCCcCCCc
Confidence 1 1234899999999999999
Q ss_pred CchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCccc
Q 003911 386 ISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 431 (787)
Q Consensus 386 ~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~ 431 (787)
.|..|+.+++|+.|+|++|++++..| +..+++|++||+++|+++
T Consensus 303 ~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 303 DMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp GHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred ChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 99999999999999999999997666 889999999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=300.25 Aligned_cols=195 Identities=25% Similarity=0.358 Sum_probs=166.2
Q ss_pred eHHHHHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEE
Q 003911 584 SIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCL 661 (787)
Q Consensus 584 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 661 (787)
.+++.+...++|++.+.||+|+||.||+|+.. +++.||||++++... .....+.+.+|.+++.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34555566789999999999999999999875 799999999976322 2233456889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEe
Q 003911 662 DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 741 (787)
Q Consensus 662 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 741 (787)
+.+..|+||||+++|+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEe
Confidence 999999999999999999998542 1368999999999999999999998 899999999999999999999999
Q ss_pred ecccceecCCCCCceeeeeccccCcccccccc-------cCCcC-cceeecC
Q 003911 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV-------HTRWS-SCSYWAG 785 (787)
Q Consensus 742 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~-~~DiWS~ 785 (787)
|||+++.............+||+.|+|||++. +..++ ++|+||.
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSl 256 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWAL 256 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHH
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHH
Confidence 99999887554433333468999999999997 35666 8999983
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=285.92 Aligned_cols=187 Identities=25% Similarity=0.407 Sum_probs=157.4
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
+.++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+++.+|++++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 4578999999999999999999865 789999999865432 34456789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 89 v~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred EEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 99999999999998542 368999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.............||+.|+|||++.+..++ ++|+||.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 198 (294)
T 4eqm_A 161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSI 198 (294)
T ss_dssp C-------------CCSSCCHHHHHTCCCCTTHHHHHH
T ss_pred cccccccccCccccCccccCHhHhcCCCCCchHhHHHH
Confidence 654433333446799999999999998888 8999983
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=292.67 Aligned_cols=204 Identities=40% Similarity=0.698 Sum_probs=175.3
Q ss_pred ceeeeHHHHHhhcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeE
Q 003911 580 NMVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659 (787)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 659 (787)
...++.+++....++|++.+.||+|+||.||+|+..+++.||||++..... .....++.+|++++++++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEE
Confidence 456788899999999999999999999999999887899999999976432 2233478999999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEE
Q 003911 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAK 739 (787)
Q Consensus 660 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 739 (787)
+.+.+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+..+|+||||||+||++++++.+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999865332 234589999999999999999999983223999999999999999999999
Q ss_pred EeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 740 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 740 l~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|+|||+++..............||+.|+|||++.+..++ ++||||.
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 221 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 221 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHH
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhH
Confidence 999999998765555555556799999999999988888 9999983
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=284.69 Aligned_cols=185 Identities=26% Similarity=0.451 Sum_probs=160.2
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|... +++.||+|++.. ......+.+.+|++++++++||||+++++++.+++..++||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 357999999999999999999875 689999998854 34556778999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ....+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 87 e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 87 EYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp ECCTTCBHHHHHHH----CCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 99999999999854 23468999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCce-------------eeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSI-------------ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
...... .....||+.|+|||++.+..++ ++||||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 208 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF 208 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHH
Confidence 432211 1145799999999999999888 8999983
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=289.85 Aligned_cols=185 Identities=26% Similarity=0.379 Sum_probs=162.3
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccc----hhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
+.++|++.+.||+|+||.||+|+.. +|+.||+|+++...... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4578999999999999999999876 69999999998754321 235789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC----cEEEe
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 741 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~ 741 (787)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||++++++ .+||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence 9999999999999999843 3468999999999999999999998 8999999999999998776 79999
Q ss_pred ecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 742 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|||+++...... .....+||+.|+|||++.+..++ ++|+||.
T Consensus 162 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 204 (361)
T 2yab_A 162 DFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 204 (361)
T ss_dssp CCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred ecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHH
Confidence 999998875533 22346799999999999998888 8999983
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=293.77 Aligned_cols=185 Identities=27% Similarity=0.431 Sum_probs=157.1
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (787)
.++|++.+.||+|+||.||+|+.. +++.||||++++... .....+.+.+|.++++.+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999876 689999999986432 234556788999999998 69999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 102 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999988542 468999999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... ......+||+.|+|||++.+..++ ++|+||.
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 210 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAM 210 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHH
T ss_pred cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcc
Confidence 43322 223446899999999999998888 8999983
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=295.41 Aligned_cols=185 Identities=23% Similarity=0.402 Sum_probs=159.8
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (787)
.++|++.+.||+|+||.||+|+.. +++.||+|++++.... ....+.+.+|..+++++ +||||+++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357999999999999999999876 6889999999875433 33445688999999887 89999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 131 V~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999988542 468999999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... ......+||+.|+|||++.+..++ ++|+||.
T Consensus 203 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~Diwsl 239 (396)
T 4dc2_A 203 GLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 239 (396)
T ss_dssp CCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred cccCC-CccccccCCcccCCchhhcCCCCChHHHHHHH
Confidence 43322 233457899999999999999998 8999983
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=293.04 Aligned_cols=186 Identities=23% Similarity=0.322 Sum_probs=160.9
Q ss_pred cCCCcccceeccccceEEEEEE------EeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcC---CCccceEEeEEEe
Q 003911 592 TNNFSEENILGRGGFGTVYKGE------LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR---HRHLVALLGHCLD 662 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 662 (787)
.++|++.+.||+|+||.||+|. ..+++.||||+++.. ...++.+|++++++++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 4679999999999999999993 447899999998653 3457888899998887 9999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC--------
Q 003911 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-------- 734 (787)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------- 734 (787)
.+..++||||+++|+|.+++..........+++..++.|+.||+.||+|||+ .+||||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999976554445679999999999999999999997 89999999999999998
Q ss_pred ---CCcEEEeecccceecCCC-CCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 735 ---DMRAKVADFGLVRLAPEG-KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 735 ---~~~~kl~DFG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++.+||+|||+|+..... ........+||+.|||||++.+..++ ++||||.
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 271 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHH
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHH
Confidence 899999999999865422 22334456799999999999999888 8999983
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-31 Score=292.09 Aligned_cols=308 Identities=15% Similarity=0.132 Sum_probs=239.0
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEcc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 147 (787)
.+++.|++++|++++. | ++.+++|++|+|++|+|++. + +.++++|++|+|++|++++++ ++.+++|++|+++
T Consensus 64 ~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~-~~~l~~L~~L~L~~N~l~~l~---~~~l~~L~~L~l~ 135 (457)
T 3bz5_A 64 TGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D-VTPLTKLTYLNCDTNKLTKLD---VSQNPLLTYLNCA 135 (457)
T ss_dssp TTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C-CTTCTTCCEEECCSSCCSCCC---CTTCTTCCEEECT
T ss_pred CCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e-cCCCCcCCEEECCCCcCCeec---CCCCCcCCEEECC
Confidence 6899999999999974 4 99999999999999999986 3 899999999999999999985 8999999999999
Q ss_pred CCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCccc-ccccceeeccCCCC
Q 003911 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGN 226 (787)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~L~~~~~~~~ 226 (787)
+|++++ ++ ++.+++|++|++++|+..+.++ ++ .+++|++|++++|++++. | +.. ..++.|++.++...
T Consensus 136 ~N~l~~--l~--l~~l~~L~~L~l~~n~~~~~~~--~~--~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~ 204 (457)
T 3bz5_A 136 RNTLTE--ID--VSHNTQLTELDCHLNKKITKLD--VT--PQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNIT 204 (457)
T ss_dssp TSCCSC--CC--CTTCTTCCEEECTTCSCCCCCC--CT--TCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCS
T ss_pred CCccce--ec--cccCCcCCEEECCCCCcccccc--cc--cCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCC
Confidence 999996 33 8899999999999997666663 44 899999999999999974 4 332 56777777655433
Q ss_pred CcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCC-------CCCEEEccCCcc
Q 003911 227 AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLE-------SLKIVNMTNNLL 299 (787)
Q Consensus 227 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-------~L~~L~Ls~N~l 299 (787)
.. .++.+++|+.|+|++|++++. | +..+++|+.|++++|+|++..+..+.+++ +|+.|++++|++
T Consensus 205 ~~------~l~~l~~L~~L~Ls~N~l~~i-p-~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~ 276 (457)
T 3bz5_A 205 KL------DLNQNIQLTFLDCSSNKLTEI-D-VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQ 276 (457)
T ss_dssp CC------CCTTCTTCSEEECCSSCCSCC-C-CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTT
T ss_pred ee------ccccCCCCCEEECcCCccccc-C-ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCcc
Confidence 22 378899999999999999995 4 88999999999999999987655555554 566677777776
Q ss_pred cccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccC
Q 003911 300 QGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQK 379 (787)
Q Consensus 300 ~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~ 379 (787)
.+.+| +..+.+|+.+++++|............+ ... .+...++|+.|++++
T Consensus 277 ~~~~~-~~~l~~L~~L~Ls~n~~l~~l~~~~~~L--------------------------~~L--~l~~~~~L~~L~L~~ 327 (457)
T 3bz5_A 277 LIYFQ-AEGCRKIKELDVTHNTQLYLLDCQAAGI--------------------------TEL--DLSQNPKLVYLYLNN 327 (457)
T ss_dssp CCEEE-CTTCTTCCCCCCTTCTTCCEEECTTCCC--------------------------SCC--CCTTCTTCCEEECTT
T ss_pred CCccc-ccccccCCEEECCCCcccceeccCCCcc--------------------------eEe--chhhcccCCEEECCC
Confidence 66666 4566788888988886432211000000 000 022336899999999
Q ss_pred CcccccCchhhcCCCCCCEEecccccccccCCccCc-------------CCCCCCeeeccCCcccccCCC
Q 003911 380 MNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLS-------------VLGALKELDVSNNQLYGKIPS 436 (787)
Q Consensus 380 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~-------------~l~~L~~L~Ls~N~l~g~iP~ 436 (787)
|++++. + ++.+++|+.|+|++|+|++ +| .+. .+..|+.+++++|+|+|.||.
T Consensus 328 N~l~~l-~--l~~l~~L~~L~l~~N~l~~-l~-~L~~L~l~~n~l~g~~~~~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 328 TELTEL-D--VSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp CCCSCC-C--CTTCTTCSEEECCSSCCCB-CT-TGGGSSGGGTSEEEEEEEEECCCBCCBTTBEEEECCT
T ss_pred Cccccc-c--cccCCcCcEEECCCCCCCC-cc-ccccccccCCcEEecceeeecCccccccCcEEEEcCh
Confidence 999984 3 9999999999999999996 32 111 123456667777777777765
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-31 Score=307.66 Aligned_cols=332 Identities=16% Similarity=0.157 Sum_probs=253.7
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (787)
.+++.|+|++|+|++..|.+|.+|++|++|+|++|+|++.++ .|.+|++|++|+|++|+|+++++..|+++++|++|+|
T Consensus 76 ~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~L 155 (635)
T 4g8a_A 76 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 155 (635)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeecc
Confidence 479999999999998778899999999999999999999887 6999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCC----------------------------------------
Q 003911 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGP---------------------------------------- 186 (787)
Q Consensus 147 ~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~---------------------------------------- 186 (787)
++|+++.+.+|..+..+++|++|++++|+|++..|..|..
T Consensus 156 s~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~ 235 (635)
T 4g8a_A 156 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF 235 (635)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCC
T ss_pred ccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhccc
Confidence 9999998778999999999999999999988766543310
Q ss_pred --------------------------------------------------------------------------------
Q 003911 187 -------------------------------------------------------------------------------- 186 (787)
Q Consensus 187 -------------------------------------------------------------------------------- 186 (787)
T Consensus 236 ~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~ 315 (635)
T 4g8a_A 236 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVS 315 (635)
T ss_dssp SSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEES
T ss_pred ccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccc
Confidence
Q ss_pred ---------CCCCCCcEEeccccccccCCCcCcc--------------------cccccceeeccCCCC-----------
Q 003911 187 ---------DEFPGLTILHLAFNQLIGGLPASFS--------------------GSQIQSLWVNGQNGN----------- 226 (787)
Q Consensus 187 ---------~~l~~L~~L~L~~N~l~~~~p~~~~--------------------~~~l~~L~~~~~~~~----------- 226 (787)
.....|+.|++.+|++.+..+..+. ...++.|++..+...
T Consensus 316 ~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~ 395 (635)
T 4g8a_A 316 VTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 395 (635)
T ss_dssp CEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHS
T ss_pred cccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchhh
Confidence 0001233333333333322211110 012222322222110
Q ss_pred -----------CcCCCCccccccCccCceEeccccccccCCC--CCCCCCCCCEEecCCCcccccCCccccCCCCCCEEE
Q 003911 227 -----------AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP--DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 293 (787)
Q Consensus 227 -----------~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 293 (787)
+.....+..+..+++|+.++++.|.+....+ .+..+++|+.+++++|++++..|..+..+++|+.|+
T Consensus 396 ~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~ 475 (635)
T 4g8a_A 396 TISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 475 (635)
T ss_dssp CSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred hhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhh
Confidence 0011112345566777777777777766554 377788888888888988888888888889999999
Q ss_pred ccCCccc-ccCCC-CCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCc
Q 003911 294 MTNNLLQ-GPVPE-FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGN 371 (787)
Q Consensus 294 Ls~N~l~-~~~p~-~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (787)
|++|++. +.+|. +..+.+|+.+++++|.+..++.. .+..+++
T Consensus 476 Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~------------------------------------~f~~l~~ 519 (635)
T 4g8a_A 476 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT------------------------------------AFNSLSS 519 (635)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT------------------------------------TTTTCTT
T ss_pred hhhcccccccCchhhhhccccCEEECCCCccCCcChH------------------------------------HHcCCCC
Confidence 9988754 34454 66777888888888876654322 2334568
Q ss_pred eEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCC-CCCCeeeccCCcccccCC
Q 003911 372 ITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL-GALKELDVSNNQLYGKIP 435 (787)
Q Consensus 372 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l-~~L~~L~Ls~N~l~g~iP 435 (787)
|+.|+|++|+|++..|..|..+++|++|+|++|+|++..|..+..+ ++|++|+|++|++++.-.
T Consensus 520 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 520 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 9999999999999999999999999999999999999999999998 689999999999987543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-32 Score=290.69 Aligned_cols=186 Identities=26% Similarity=0.440 Sum_probs=163.5
Q ss_pred hhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
.+.++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34568999999999999999999875 68999999998766666667889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC---CcEEEeeccc
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVADFGL 745 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFG~ 745 (787)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.+ +.+||+|||+
T Consensus 106 v~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EECCCCSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 9999999999988843 3468999999999999999999998 899999999999999864 4599999999
Q ss_pred ceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++...... ......||+.|+|||++.+..++ ++||||.
T Consensus 178 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 216 (362)
T 2bdw_A 178 AIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 216 (362)
T ss_dssp CBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHH
T ss_pred ceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHH
Confidence 98775433 22346799999999999998888 8999983
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=285.68 Aligned_cols=182 Identities=27% Similarity=0.459 Sum_probs=160.9
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||.||+|+.. +|+.||+|++++... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357999999999999999999875 799999999976432 234457788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 85 MDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp ECCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceec
Confidence 999999999999854 2468999999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... ....+||+.|+|||++.+..++ ++|+||.
T Consensus 157 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 189 (318)
T 1fot_A 157 PDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSF 189 (318)
T ss_dssp SSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHH
T ss_pred CCc----cccccCCccccCHhHhcCCCCCcccchhhh
Confidence 432 2346799999999999998888 8999983
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=309.57 Aligned_cols=310 Identities=15% Similarity=0.101 Sum_probs=256.6
Q ss_pred CCCCCcEEEeecCCCCCCCCC-CCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCE
Q 003911 90 NLTKLERLELQWNSISGPLPS-LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQN 168 (787)
Q Consensus 90 ~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~ 168 (787)
.+++++.|++++|.++..++. |.++++|++|+|++|.|+++++..|+++++|++|+|++|.+++ ..|..|+++++|++
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~ 127 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTV 127 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCC-CCHHHHcCCCCCCE
Confidence 478999999999999988884 7889999999999999999999999999999999999999997 55778899999999
Q ss_pred EeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCccc-ccccceeeccCCCCCcCCCCccccccCccCceEec
Q 003911 169 FSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWL 247 (787)
Q Consensus 169 L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L 247 (787)
|++++|.|++.++..|+ .+++|++|+|++|.+++..|..|.. .+|+.|++.++..... .++.+++|+.|++
T Consensus 128 L~L~~n~l~~l~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~------~~~~l~~L~~L~l 199 (597)
T 3oja_B 128 LVLERNDLSSLPRGIFH--NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV------DLSLIPSLFHANV 199 (597)
T ss_dssp EECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC------CGGGCTTCSEEEC
T ss_pred EEeeCCCCCCCCHHHhc--cCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc------Chhhhhhhhhhhc
Confidence 99999999988887776 8999999999999999998888865 5677777765433221 2556788888888
Q ss_pred cccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCC
Q 003911 248 HSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPG 327 (787)
Q Consensus 248 ~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~ 327 (787)
++|.+++. ...++|+.|++++|.++. +|..+ .++|+.|+|++|.+++. +.+..+..|+.+++++|.+...+.
T Consensus 200 ~~n~l~~l----~~~~~L~~L~ls~n~l~~-~~~~~--~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~ 271 (597)
T 3oja_B 200 SYNLLSTL----AIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMY 271 (597)
T ss_dssp CSSCCSEE----ECCTTCSEEECCSSCCCE-EECSC--CSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEES
T ss_pred ccCccccc----cCCchhheeeccCCcccc-ccccc--CCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCH
Confidence 88888753 334678899999999884 44333 26899999999998874 567777788888888887654321
Q ss_pred CCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEeccccccc
Q 003911 328 ACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLS 407 (787)
Q Consensus 328 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 407 (787)
..+..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++
T Consensus 272 ------------------------------------~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~ 314 (597)
T 3oja_B 272 ------------------------------------HPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL 314 (597)
T ss_dssp ------------------------------------GGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC
T ss_pred ------------------------------------HHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC
Confidence 123345689999999999997 5777888999999999999999
Q ss_pred ccCCccCcCCCCCCeeeccCCcccccCCC-CCCCceeecCCCCCCCCC
Q 003911 408 GMIPEGLSVLGALKELDVSNNQLYGKIPS-FKSNAIVNTDGNPDIGKE 454 (787)
Q Consensus 408 g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~-~~~~~~~~~~gn~~~~~~ 454 (787)
.+|..+..+++|++|+|++|++++..+. +..+..+.+.||++.|..
T Consensus 315 -~i~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~~~~~~ 361 (597)
T 3oja_B 315 -HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNS 361 (597)
T ss_dssp -CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCEEHHH
T ss_pred -ccCcccccCCCCCEEECCCCCCCCcChhhcCCCCEEEeeCCCCCChh
Confidence 7898999999999999999999876443 777888999999998854
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=283.69 Aligned_cols=183 Identities=23% Similarity=0.341 Sum_probs=161.4
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+.++|++.+.||+|+||.||+|... +++.||+|++... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 4578999999999999999999876 6889999998752 34456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC--CCcEEEeecccce
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD--DMRAKVADFGLVR 747 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~ 747 (787)
|||+++|+|.+++.. ....+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++
T Consensus 80 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 80 FEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp ECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEeCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 999999999998843 22468999999999999999999998 89999999999999987 7899999999998
Q ss_pred ecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 748 LAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
...... ......||+.|+|||++.+..++ ++|+||.
T Consensus 153 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 189 (321)
T 1tki_A 153 QLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSL 189 (321)
T ss_dssp ECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHH
T ss_pred ECCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHH
Confidence 875443 33446799999999999998888 8999983
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-32 Score=297.97 Aligned_cols=187 Identities=24% Similarity=0.354 Sum_probs=163.1
Q ss_pred hhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
.+.++|++.+.||+|+||.||+|... +|+.||+|++..........+.+.+|++++++++||||+++++++.+.+..|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 35678999999999999999999765 78999999998766556667789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC---CCCcEEEeeccc
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGL 745 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG~ 745 (787)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++ +++.+||+|||+
T Consensus 88 v~E~~~gg~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EECCCBCCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 9999999999998854 2468999999999999999999998 8999999999999998 567899999999
Q ss_pred ceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++....... ......||+.|+|||++.+..++ ++||||.
T Consensus 160 a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSl 199 (444)
T 3soa_A 160 AIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWAC 199 (444)
T ss_dssp CBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred eEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHH
Confidence 987654432 22346799999999999998888 8999983
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-32 Score=288.90 Aligned_cols=186 Identities=27% Similarity=0.484 Sum_probs=161.2
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 667 (787)
..++|++.+.||+|+||.||+|+.+ +++.||||+++.... .....+.+..|.++++.+ +||||+++++++.+.+..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 3578999999999999999999876 689999999986432 233456788999999987 8999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 95 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999998542 368999999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 748 LAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
....... .....+||+.|+|||++.+..++ ++|+||.
T Consensus 167 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 204 (345)
T 1xjd_A 167 ENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSF 204 (345)
T ss_dssp CCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred hcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHH
Confidence 6533322 23446899999999999998888 8999983
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-32 Score=285.10 Aligned_cols=188 Identities=30% Similarity=0.508 Sum_probs=154.4
Q ss_pred hcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
..++|++.+.||+|+||.||+|+. +++.||||++..........+++.+|++++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 346899999999999999999987 5899999999876656666788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||+++|+|.+++..... ...+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||+++.
T Consensus 114 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp ECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred ecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 99999999999854221 1248899999999999999999997 77 99999999999999999999999999986
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... .......||+.|+|||++.+..++ ++||||.
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 225 (309)
T 3p86_A 189 KASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSF 225 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHH
T ss_pred ccccc-cccccCCCCccccChhhhcCCCCCchhhHHHH
Confidence 54332 122346799999999999998888 8999983
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=288.00 Aligned_cols=184 Identities=24% Similarity=0.408 Sum_probs=161.2
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 669 (787)
++|++.+.||+|+||.||+|+.. +++.||+|++++.... ....+.+.+|.++++++ +||||+++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999876 6899999999875433 34556788999999998 899999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999988542 368999999999999999999998 89999999999999999999999999999864
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... ......+||+.|+|||++.+..++ ++|+||.
T Consensus 161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 196 (345)
T 3a8x_A 161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 196 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred cCCC-CcccccCCCccccCccccCCCCCChHHhHHHH
Confidence 3322 223446899999999999998888 8999983
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=288.58 Aligned_cols=190 Identities=23% Similarity=0.373 Sum_probs=162.0
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc---chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS---GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
+.++|++.+.||+|+||.||+|... +++.||||++...... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3457999999999999999999875 7899999999753221 22467899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc---EEEeec
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVADF 743 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DF 743 (787)
|+||||+++++|.+++...... ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++. +||+||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEeCCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecC
Confidence 9999999999999888654332 2468999999999999999999998 89999999999999986554 999999
Q ss_pred ccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|+++...... ......+||+.|+|||++.+..++ ++||||.
T Consensus 178 g~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 219 (351)
T 3c0i_A 178 GVAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGC 219 (351)
T ss_dssp TTCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred cceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHH
Confidence 9998875533 223346799999999999998888 8999983
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=286.47 Aligned_cols=189 Identities=28% Similarity=0.425 Sum_probs=157.6
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC-----
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----- 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 664 (787)
+.++|++.+.||+|+||.||+|+.. +++.||||+++... .....+.+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 3467999999999999999999886 79999999997643 3445678999999999999999999999986543
Q ss_pred ----------------------------------------------------eeEEEEEecCCCCHHHHHHhhhhcCCCC
Q 003911 665 ----------------------------------------------------EKLLVFEYMPQGTLSRHIFNWAEEGLKP 692 (787)
Q Consensus 665 ----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~ 692 (787)
..++||||+++|+|.+++.... ....
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~ 160 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLED 160 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGG
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--Cccc
Confidence 2799999999999999986532 2234
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCC-----------ceeeeec
Q 003911 693 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG-----------SIETRIA 761 (787)
Q Consensus 693 l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-----------~~~~~~~ 761 (787)
.++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... .......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 5677889999999999999998 8999999999999999999999999999988765421 1123356
Q ss_pred cccCcccccccccCCcC-cceeecC
Q 003911 762 GTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 762 gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
||+.|+|||++.+..++ ++|+||.
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~sl 262 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSL 262 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHH
T ss_pred CCcCccChHHhcCCCCcchhhHHHH
Confidence 99999999999998888 8999983
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=283.69 Aligned_cols=187 Identities=27% Similarity=0.397 Sum_probs=157.3
Q ss_pred hhcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.+.++|++.+.||+|+||.||+|+..+++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 35578999999999999999999988899999999976544445567889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||++ ++|.+++.. ....+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 98 ~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 98 FEFME-KDLKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp EECCS-EEHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred EcCCC-CCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence 99997 588877743 23468999999999999999999998 89999999999999999999999999999877
Q ss_pred CCCCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
..... ......||+.|+|||++.+ ..++ ++|+||.
T Consensus 170 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 206 (311)
T 3niz_A 170 GIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSI 206 (311)
T ss_dssp TSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHH
T ss_pred CCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHH
Confidence 54332 2234578999999999977 4566 8999983
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=281.22 Aligned_cols=251 Identities=20% Similarity=0.278 Sum_probs=183.1
Q ss_pred CCcccEEEcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCC-CCCCCCCcEEEcccccCCcCC--Cc
Q 003911 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS-LNGLASLEVVMLSNNQFTSVP--SD 133 (787)
Q Consensus 57 C~w~gv~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~--~~ 133 (787)
|.|.+|.|+. ++++ .+|..+. ++|++|+|++|+|+..++. |.++++|++|+|++|+++.+. +.
T Consensus 7 C~~~~l~c~~-----------~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 72 (306)
T 2z66_A 7 CSGTEIRCNS-----------KGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ 72 (306)
T ss_dssp EETTEEECCS-----------SCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEH
T ss_pred eCCCEEEcCC-----------CCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCccc
Confidence 6788777754 3455 5666554 6899999999999977764 789999999999999998653 45
Q ss_pred cccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCC-CCCCCCCCCCCcEEeccccccccCCCcCccc
Q 003911 134 FFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP-SFFGPDEFPGLTILHLAFNQLIGGLPASFSG 212 (787)
Q Consensus 134 ~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 212 (787)
.+..+++|++|+|++|.+. .+|..+..+++|++|++++|++++..+ ..+. .+++|++|++++|++.+..|..+.
T Consensus 73 ~~~~~~~L~~L~Ls~n~i~--~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~- 147 (306)
T 2z66_A 73 SDFGTTSLKYLDLSFNGVI--TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL--SLRNLIYLDISHTHTRVAFNGIFN- 147 (306)
T ss_dssp HHHSCSCCCEEECCSCSEE--EEEEEEETCTTCCEEECTTSEEESSTTTTTTT--TCTTCCEEECTTSCCEECSTTTTT-
T ss_pred ccccccccCEEECCCCccc--cChhhcCCCCCCCEEECCCCcccccccchhhh--hccCCCEEECCCCcCCccchhhcc-
Confidence 5677889999999999887 577778888888888888888887665 4554 777888888888887766665543
Q ss_pred ccccceeeccCCCCCcCCCCccccccCccCceEecccccccc--CCCCCCCCCCCCEEecCCCcccccCCccccCCCCCC
Q 003911 213 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG--PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLK 290 (787)
Q Consensus 213 ~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 290 (787)
++++|++|+|++|.+++ .+..+..+++|++|+|++|+|++..|..+..+++|+
T Consensus 148 -------------------------~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 202 (306)
T 2z66_A 148 -------------------------GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 202 (306)
T ss_dssp -------------------------TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred -------------------------cCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCC
Confidence 66777777777777765 333566777777777777777766667777777777
Q ss_pred EEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCC
Q 003911 291 IVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKG 370 (787)
Q Consensus 291 ~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (787)
+|+|++|++++.
T Consensus 203 ~L~L~~N~l~~~-------------------------------------------------------------------- 214 (306)
T 2z66_A 203 VLNMSHNNFFSL-------------------------------------------------------------------- 214 (306)
T ss_dssp EEECTTSCCSBC--------------------------------------------------------------------
T ss_pred EEECCCCccCcc--------------------------------------------------------------------
Confidence 777777766543
Q ss_pred ceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCC-CCCeeeccCCcccccC
Q 003911 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG-ALKELDVSNNQLYGKI 434 (787)
Q Consensus 371 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~-~L~~L~Ls~N~l~g~i 434 (787)
.+..+..+++|+.|+|++|++++..|..+..++ +|++|+|++|++++..
T Consensus 215 ---------------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 215 ---------------DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp ---------------CSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred ---------------ChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 333456667777777777777777777777763 7777777777777653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=289.73 Aligned_cols=248 Identities=21% Similarity=0.295 Sum_probs=198.2
Q ss_pred EEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCC
Q 003911 71 TRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (787)
Q Consensus 71 ~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 149 (787)
..++.++++++ .+|..+. ++++.|+|++|+|++..+ .|.++++|++|+|++|+|+++++..|.++++|++|+|++|
T Consensus 46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 35566667777 7888776 789999999999999776 7999999999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcC
Q 003911 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKL 229 (787)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~ 229 (787)
+++. ..+..|..+++|++|++++|.|+...+..|. .+++|++|+|++|+..+.++..
T Consensus 123 ~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~l~~~~~l~~i~~~-------------------- 179 (440)
T 3zyj_A 123 RLTT-IPNGAFVYLSKLKELWLRNNPIESIPSYAFN--RIPSLRRLDLGELKRLSYISEG-------------------- 179 (440)
T ss_dssp CCSS-CCTTTSCSCSSCCEEECCSCCCCEECTTTTT--TCTTCCEEECCCCTTCCEECTT--------------------
T ss_pred cCCe-eCHhHhhccccCceeeCCCCcccccCHHHhh--hCcccCEeCCCCCCCcceeCcc--------------------
Confidence 9995 3345788999999999999999988877776 8899999999885544344432
Q ss_pred CCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCc
Q 003911 230 GGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS 309 (787)
Q Consensus 230 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 309 (787)
.|.++++|++|+|++|+++. +|.+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..+
T Consensus 180 -----~~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~----- 248 (440)
T 3zyj_A 180 -----AFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIER----- 248 (440)
T ss_dssp -----TTTTCSSCCEEECTTSCCSS-CCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECT-----
T ss_pred -----hhhcccccCeecCCCCcCcc-ccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEECh-----
Confidence 13478888888888888884 4567778888888888888887778888888888888887777765433
Q ss_pred eeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchh
Q 003911 310 VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPE 389 (787)
Q Consensus 310 ~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~ 389 (787)
..
T Consensus 249 ------------------------------------------------------------------------------~~ 250 (440)
T 3zyj_A 249 ------------------------------------------------------------------------------NA 250 (440)
T ss_dssp ------------------------------------------------------------------------------TS
T ss_pred ------------------------------------------------------------------------------hh
Confidence 34
Q ss_pred hcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCccccc
Q 003911 390 FASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGK 433 (787)
Q Consensus 390 ~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ 433 (787)
|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++...
T Consensus 251 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp STTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred hcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence 66677788888888888866666777788888888888877653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=289.97 Aligned_cols=183 Identities=25% Similarity=0.421 Sum_probs=160.0
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57999999999999999999876 688999999976432 2345678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+...
T Consensus 95 e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp CCCTTEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999998843 3468999999999999999999998 899999999999999999999999999998775
Q ss_pred CCCCceeeeeccccCccccccccc---CCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVH---TRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~-~~DiWS~ 785 (787)
... .....+||+.|+|||++.+ ..++ ++|+||.
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSl 203 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSL 203 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHH
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeech
Confidence 432 2344679999999999974 3466 8999983
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=278.75 Aligned_cols=184 Identities=24% Similarity=0.382 Sum_probs=159.2
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|+||+||+|+.. +++.||||++..........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999875 68999999998765555566789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++ ++.+.+.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~-~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9975 66665533 23568999999999999999999998 8999999999999999999999999999987754
Q ss_pred CCCceeeeeccccCcccccccccCC-cC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS~ 785 (787)
... ......||+.|+|||++.+.. ++ ++||||.
T Consensus 154 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 188 (292)
T 3o0g_A 154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred ccc-cccCCccccCCcChHHHcCCCCcCchHHHHHH
Confidence 332 233457899999999998765 56 8999983
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=289.56 Aligned_cols=190 Identities=26% Similarity=0.449 Sum_probs=161.3
Q ss_pred cCCCcccceeccccceEEEEEEEe--------CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEe
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 662 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 662 (787)
.++|++.+.||+|+||.||+|+.. ++..||||+++.. ......+++.+|+++++++ +||||+++++++.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 467999999999999999999763 3567999999764 3445567899999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 003911 663 GNEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (787)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 731 (787)
.+..|+||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+ ++|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEE
Confidence 99999999999999999999653211 12358899999999999999999998 89999999999999
Q ss_pred ECCCCcEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 732 LGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 732 l~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++.++.+||+|||+++........ ......||+.|+|||++.+..++ ++|+||.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvwsl 291 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 291 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHH
Confidence 999999999999999876543321 12234578899999999999888 8999983
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-31 Score=291.23 Aligned_cols=323 Identities=20% Similarity=0.215 Sum_probs=176.7
Q ss_pred CEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCC---------------------------------
Q 003911 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGL--------------------------------- 114 (787)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l--------------------------------- 114 (787)
++++|++++|++ |.+|++|+++++|++|+|++|+++|.+| +++++
T Consensus 12 ~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~~ 90 (454)
T 1jl5_A 12 FLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPELP 90 (454)
T ss_dssp -----------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSCC
T ss_pred cchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCCc
Confidence 455555555555 4555555555555555555555554433 34443
Q ss_pred CCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcE
Q 003911 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTI 194 (787)
Q Consensus 115 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~ 194 (787)
++|++|+|++|++++++. .+++|++|++++|++++ +|.. .++|++|++++|++++ +| .|+ .+++|++
T Consensus 91 ~~L~~L~l~~n~l~~lp~----~~~~L~~L~l~~n~l~~--l~~~---~~~L~~L~L~~n~l~~-lp-~~~--~l~~L~~ 157 (454)
T 1jl5_A 91 PHLESLVASCNSLTELPE----LPQSLKSLLVDNNNLKA--LSDL---PPLLEYLGVSNNQLEK-LP-ELQ--NSSFLKI 157 (454)
T ss_dssp TTCSEEECCSSCCSSCCC----CCTTCCEEECCSSCCSC--CCSC---CTTCCEEECCSSCCSS-CC-CCT--TCTTCCE
T ss_pred CCCCEEEccCCcCCcccc----ccCCCcEEECCCCccCc--ccCC---CCCCCEEECcCCCCCC-Cc-ccC--CCCCCCE
Confidence 345555555555555442 13566666666666653 3321 1578888888888876 55 354 7888888
Q ss_pred EeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCc
Q 003911 195 LHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNF 274 (787)
Q Consensus 195 L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~ 274 (787)
|++++|++++ +|..+ .+++.|++.++.. .+.+ .++++++|++|++++|++++.+... ++|++|++++|+
T Consensus 158 L~l~~N~l~~-lp~~~--~~L~~L~L~~n~l----~~l~-~~~~l~~L~~L~l~~N~l~~l~~~~---~~L~~L~l~~n~ 226 (454)
T 1jl5_A 158 IDVDNNSLKK-LPDLP--PSLEFIAAGNNQL----EELP-ELQNLPFLTAIYADNNSLKKLPDLP---LSLESIVAGNNI 226 (454)
T ss_dssp EECCSSCCSC-CCCCC--TTCCEEECCSSCC----SSCC-CCTTCTTCCEEECCSSCCSSCCCCC---TTCCEEECCSSC
T ss_pred EECCCCcCcc-cCCCc--ccccEEECcCCcC----CcCc-cccCCCCCCEEECCCCcCCcCCCCc---CcccEEECcCCc
Confidence 8888888875 55544 3677777765432 2233 4778888888888888888643322 578888888888
Q ss_pred ccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccC
Q 003911 275 FTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 354 (787)
Q Consensus 275 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 354 (787)
++ .+|. +..+++|++|++++|++++.++.. .+|+.+++++|.+..+|... ..+.. ...
T Consensus 227 l~-~lp~-~~~l~~L~~L~l~~N~l~~l~~~~---~~L~~L~l~~N~l~~l~~~~-~~L~~----------------L~l 284 (454)
T 1jl5_A 227 LE-ELPE-LQNLPFLTTIYADNNLLKTLPDLP---PSLEALNVRDNYLTDLPELP-QSLTF----------------LDV 284 (454)
T ss_dssp CS-SCCC-CTTCTTCCEEECCSSCCSSCCSCC---TTCCEEECCSSCCSCCCCCC-TTCCE----------------EEC
T ss_pred CC-cccc-cCCCCCCCEEECCCCcCCcccccc---cccCEEECCCCcccccCccc-CcCCE----------------EEC
Confidence 88 6774 788888888888888888744322 45666777777766654321 10000 000
Q ss_pred CCCCCCCccccccCCCceEEEEccCCcccccCchhhcCC-CCCCEEecccccccccCCccCcCCCCCCeeeccCCccccc
Q 003911 355 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASF-KSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGK 433 (787)
Q Consensus 355 ~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l-~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ 433 (787)
...... +.....++|+.|++++|++++. ..+ ++|+.|+|++|++++ +|.. +++|++|++++|++++
T Consensus 285 s~N~l~---~l~~~~~~L~~L~l~~N~l~~i-----~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~- 351 (454)
T 1jl5_A 285 SENIFS---GLSELPPNLYYLNASSNEIRSL-----CDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE- 351 (454)
T ss_dssp CSSCCS---EESCCCTTCCEEECCSSCCSEE-----CCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-
T ss_pred cCCccC---cccCcCCcCCEEECcCCcCCcc-----cCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-
Confidence 000000 0001113566666666666541 122 366777777777764 5543 4667777777777764
Q ss_pred CCC-CCCCceeecCCCCCC
Q 003911 434 IPS-FKSNAIVNTDGNPDI 451 (787)
Q Consensus 434 iP~-~~~~~~~~~~gn~~~ 451 (787)
+|. +..+..+.+.+|+..
T Consensus 352 lp~~l~~L~~L~L~~N~l~ 370 (454)
T 1jl5_A 352 VPELPQNLKQLHVEYNPLR 370 (454)
T ss_dssp CCCCCTTCCEEECCSSCCS
T ss_pred ccchhhhccEEECCCCCCC
Confidence 333 344556666666543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=287.27 Aligned_cols=181 Identities=27% Similarity=0.394 Sum_probs=160.9
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|+.. +|+.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999876 799999999976432 2345678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 121 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999998542 358999999999999999999998 899999999999999999999999999998764
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.. ....+||+.|+|||++.+..++ ++|+||.
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 224 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWAL 224 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred CC----cccccCCccccCHHHhcCCCCCCcCCEecc
Confidence 43 2346799999999999998888 8999983
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=287.61 Aligned_cols=185 Identities=26% Similarity=0.371 Sum_probs=160.9
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (787)
.++|++.+.||+|+||.||+|+.. +++.||||+++.... .....+.+..|.++++.+ +||+|+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 468999999999999999999876 588999999986432 234456788999999988 79999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 99 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999998542 368999999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... ......+||+.|+|||++.+..++ ++|+||.
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 207 (353)
T 2i0e_A 171 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 207 (353)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHH
T ss_pred cccCC-cccccccCCccccChhhhcCCCcCCcccccch
Confidence 43322 223446799999999999998888 8999983
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-32 Score=287.29 Aligned_cols=196 Identities=39% Similarity=0.749 Sum_probs=167.3
Q ss_pred eHHHHHhhcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC
Q 003911 584 SIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG 663 (787)
Q Consensus 584 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 663 (787)
+..++....++|++.+.||+|+||.||+|+.++++.||||++... .....+++.+|++++++++||||+++++++.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 334455677899999999999999999999888999999988753 334567899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
+..++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CeEEEEEEcCCCCcHHHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999999999998854221 12358999999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCC-ceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 744 GLVRLAPEGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|+++....... .......||+.|+|||++.+..++ ++||||.
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 227 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHH
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhH
Confidence 99987543322 222345689999999999888888 8999983
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-31 Score=281.34 Aligned_cols=185 Identities=25% Similarity=0.387 Sum_probs=161.3
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccc----hhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
+.++|++.+.||+|+||.||+|... +++.||+|++....... ...+++.+|++++++++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3457999999999999999999876 68999999997643321 246789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC----cEEEe
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 741 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~ 741 (787)
.++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 9999999999999999843 3468999999999999999999998 8999999999999999877 89999
Q ss_pred ecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 742 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|||+++...... ......||+.|+|||++.+..++ ++|+||.
T Consensus 161 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 203 (326)
T 2y0a_A 161 DFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 203 (326)
T ss_dssp CCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHH
T ss_pred ECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHH
Confidence 999998775432 22345799999999999988888 8999983
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-30 Score=274.73 Aligned_cols=278 Identities=19% Similarity=0.266 Sum_probs=228.0
Q ss_pred CCcccEEEcCC----------CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccc
Q 003911 57 CKWNHVVCIED----------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNN 125 (787)
Q Consensus 57 C~w~gv~C~~~----------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N 125 (787)
|.|..+.|... ..++.|++++|++++..+..|+++++|++|+|++|+|++..| .|.++++|++|+|++|
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCC
Confidence 78999999642 468999999999998777799999999999999999999866 7999999999999999
Q ss_pred cCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecc--cCCCCCCCCCCCCCcEEeccccccc
Q 003911 126 QFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITG--QIPSFFGPDEFPGLTILHLAFNQLI 203 (787)
Q Consensus 126 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~--~~p~~~~~~~l~~L~~L~L~~N~l~ 203 (787)
+++.++...+ ++|++|++++|+++. ..+..+.++++|+.|++++|.++. ..+..+. .+++|++|++++|+++
T Consensus 111 ~l~~l~~~~~---~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~--~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 111 QLKELPEKMP---KTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ--GMKKLSYIRIADTNIT 184 (330)
T ss_dssp CCSBCCSSCC---TTCCEEECCSSCCCB-BCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGG--GCTTCCEEECCSSCCC
T ss_pred cCCccChhhc---ccccEEECCCCcccc-cCHhHhcCCccccEEECCCCcCCccCcChhhcc--CCCCcCEEECCCCccc
Confidence 9999887755 799999999999995 445679999999999999999964 6777776 8999999999999998
Q ss_pred cCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCC-CCCCCCCCCEEecCCCcccccCCcc
Q 003911 204 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDS 282 (787)
Q Consensus 204 ~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~ 282 (787)
. +|..+ .++|++|+|++|++++.++ .+..+++|+.|+|++|++++..+..
T Consensus 185 ~-l~~~~----------------------------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 235 (330)
T 1xku_A 185 T-IPQGL----------------------------PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 235 (330)
T ss_dssp S-CCSSC----------------------------CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTT
T ss_pred c-CCccc----------------------------cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhh
Confidence 4 55443 2688899999999988765 4888899999999999998777778
Q ss_pred ccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCc
Q 003911 283 LVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW 362 (787)
Q Consensus 283 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (787)
+..+++|++|+|++|+++..+..+..
T Consensus 236 ~~~l~~L~~L~L~~N~l~~lp~~l~~------------------------------------------------------ 261 (330)
T 1xku_A 236 LANTPHLRELHLNNNKLVKVPGGLAD------------------------------------------------------ 261 (330)
T ss_dssp GGGSTTCCEEECCSSCCSSCCTTTTT------------------------------------------------------
T ss_pred ccCCCCCCEEECCCCcCccCChhhcc------------------------------------------------------
Confidence 88899999999999988844433322
Q ss_pred cccccCCCceEEEEccCCcccccCchhhcC------CCCCCEEecccccccc--cCCccCcCCCCCCeeeccCCc
Q 003911 363 IGVTCTKGNITVINFQKMNLTGTISPEFAS------FKSLQRLILADNNLSG--MIPEGLSVLGALKELDVSNNQ 429 (787)
Q Consensus 363 ~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~------l~~L~~L~Ls~N~l~g--~ip~~l~~l~~L~~L~Ls~N~ 429 (787)
.++|+.|++++|++++..+..|.. .+.|+.|+|++|.+.. ..|..|..+..|+.++|++|+
T Consensus 262 ------l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 262 ------HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp ------CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred ------CCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 236777777777777766666643 3678889999998863 567788889999999999885
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-30 Score=288.32 Aligned_cols=248 Identities=23% Similarity=0.274 Sum_probs=199.9
Q ss_pred EEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCC
Q 003911 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNP 150 (787)
Q Consensus 72 ~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 150 (787)
.++.++.+++ .+|..+. ++|++|+|++|+|++..+ .|.++++|++|+|++|+|+++++..|.++++|++|+|++|+
T Consensus 58 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 58 KVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 3445555666 6777665 689999999999999877 79999999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCC
Q 003911 151 FSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLG 230 (787)
Q Consensus 151 l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~ 230 (787)
++. ..+..|..+++|++|++++|+|+...+..|. .+++|++|+|++|+..+.+|..
T Consensus 135 l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~l~~~~~l~~i~~~--------------------- 190 (452)
T 3zyi_A 135 LTV-IPSGAFEYLSKLRELWLRNNPIESIPSYAFN--RVPSLMRLDLGELKKLEYISEG--------------------- 190 (452)
T ss_dssp CSB-CCTTTSSSCTTCCEEECCSCCCCEECTTTTT--TCTTCCEEECCCCTTCCEECTT---------------------
T ss_pred CCc-cChhhhcccCCCCEEECCCCCcceeCHhHHh--cCCcccEEeCCCCCCccccChh---------------------
Confidence 995 3345688899999999999999988777776 8999999999985544444432
Q ss_pred CCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCce
Q 003911 231 GGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSV 310 (787)
Q Consensus 231 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 310 (787)
.|.++++|++|+|++|++++. |.+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+
T Consensus 191 ----~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~------ 259 (452)
T 3zyi_A 191 ----AFEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIER------ 259 (452)
T ss_dssp ----TTTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECT------
T ss_pred ----hccCCCCCCEEECCCCccccc-ccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECH------
Confidence 134788899999999988865 578888888888888888888888888888888888888887765433
Q ss_pred eeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhh
Q 003911 311 SLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEF 390 (787)
Q Consensus 311 ~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~ 390 (787)
..|
T Consensus 260 -----------------------------------------------------------------------------~~~ 262 (452)
T 3zyi_A 260 -----------------------------------------------------------------------------NAF 262 (452)
T ss_dssp -----------------------------------------------------------------------------TTT
T ss_pred -----------------------------------------------------------------------------HHh
Confidence 346
Q ss_pred cCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccC
Q 003911 391 ASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKI 434 (787)
Q Consensus 391 ~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~i 434 (787)
..+++|+.|+|++|+|++..+..+..+++|++|+|++|++....
T Consensus 263 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 263 DGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred cCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCC
Confidence 67778888888888888666667788888888888888876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-31 Score=279.72 Aligned_cols=179 Identities=25% Similarity=0.405 Sum_probs=158.4
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEec
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYM 673 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (787)
|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 677789999999999999876 79999999997633 334577899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCC
Q 003911 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753 (787)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 753 (787)
++++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 125 ~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 125 QGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp CSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc
Confidence 99999998732 368999999999999999999998 899999999999999999999999999998775433
Q ss_pred CceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 754 GSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 754 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
. ......||+.|+|||++.+..++ ++|+||.
T Consensus 196 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl 227 (321)
T 2c30_A 196 P-KRKSLVGTPYWMAPEVISRSLYATEVDIWSL 227 (321)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred c-ccccccCCccccCHhhhcCCCCCchhhHHHH
Confidence 2 22346799999999999998888 8999983
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=274.58 Aligned_cols=184 Identities=29% Similarity=0.441 Sum_probs=161.3
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.++|++.+.||+|+||.||+|+..++..||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 467999999999999999999988888999999976432 34678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.++....
T Consensus 84 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 84 YISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp CCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ccCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 99999999998653 2358999999999999999999998 8999999999999999999999999999987755
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..........||+.|+|||++.+..++ ++|+||.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 191 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAF 191 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHH
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHH
Confidence 443333334567789999999988888 9999983
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=298.34 Aligned_cols=186 Identities=34% Similarity=0.540 Sum_probs=162.8
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... .......+.+|++++++++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999875 799999999976432 233456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++|+|.+++... +...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+..
T Consensus 263 mEy~~gg~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999988542 23458999999999999999999998 89999999999999999999999999999887
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... .....+||+.|+|||++.+..++ ++|+||.
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSL 371 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWAL 371 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHH
T ss_pred ccCc--cccccCCCccccCHHHHcCCCCCccchHHHH
Confidence 5443 23346899999999999998888 8999983
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=283.99 Aligned_cols=185 Identities=26% Similarity=0.461 Sum_probs=149.7
Q ss_pred cCCCcccceeccccceEEEEEEE----eCCcEEEEEEeeccccc--chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 592 TNNFSEENILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVIS--GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
.++|++.+.||+|+||.||+|+. .+++.||+|+++..... ......+.+|++++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35799999999999999999987 47899999999764322 2345668899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999988541 368899999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++...... .......||+.|+|||++.+..++ ++|+||.
T Consensus 168 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 207 (327)
T 3a62_A 168 CKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSL 207 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHH
T ss_pred ccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhH
Confidence 97653322 122345799999999999988888 8999983
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=277.43 Aligned_cols=183 Identities=31% Similarity=0.498 Sum_probs=159.7
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
++|++.+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 57999999999999999999988899999999976432 346799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 87 MEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHHh----cCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 999999999854 23468999999999999999999998 89999999999999999999999999999866443
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.........||+.|+|||++.+..++ ++|+||.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 193 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHH
Confidence 22222334567889999999988888 8999983
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-29 Score=282.32 Aligned_cols=309 Identities=23% Similarity=0.278 Sum_probs=190.0
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEcc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 147 (787)
.+++.|++++|.+++ +|+. +++|++|++++|++++.+.. .++|++|+|++|+++++| .|+++++|++|+++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~~---~~~L~~L~L~~n~l~~lp--~~~~l~~L~~L~l~ 161 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSDL---PPLLEYLGVSNNQLEKLP--ELQNSSFLKIIDVD 161 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCSC---CTTCCEEECCSSCCSSCC--CCTTCTTCCEEECC
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccCC---CCCCCEEECcCCCCCCCc--ccCCCCCCCEEECC
Confidence 468888888888886 6653 37788888888888864331 168888888888888876 38888889999998
Q ss_pred CCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCC
Q 003911 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (787)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~ 227 (787)
+|++++ +|..+ .+|++|++++|++++ +| .++ .+++|++|++++|++++ +|... .+++.|++.++...
T Consensus 162 ~N~l~~--lp~~~---~~L~~L~L~~n~l~~-l~-~~~--~l~~L~~L~l~~N~l~~-l~~~~--~~L~~L~l~~n~l~- 228 (454)
T 1jl5_A 162 NNSLKK--LPDLP---PSLEFIAAGNNQLEE-LP-ELQ--NLPFLTAIYADNNSLKK-LPDLP--LSLESIVAGNNILE- 228 (454)
T ss_dssp SSCCSC--CCCCC---TTCCEEECCSSCCSS-CC-CCT--TCTTCCEEECCSSCCSS-CCCCC--TTCCEEECCSSCCS-
T ss_pred CCcCcc--cCCCc---ccccEEECcCCcCCc-Cc-ccc--CCCCCCEEECCCCcCCc-CCCCc--CcccEEECcCCcCC-
Confidence 888884 56543 488888898888887 45 454 78889999999998885 45433 36777777654332
Q ss_pred cCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCC
Q 003911 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFD 307 (787)
Q Consensus 228 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 307 (787)
..| .++.+++|++|++++|++++.++. +++|+.|++++|++++ +|.. +++|++|++++|++++.+. +.
T Consensus 229 ---~lp-~~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~-~~ 296 (454)
T 1jl5_A 229 ---ELP-ELQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSE-LP 296 (454)
T ss_dssp ---SCC-CCTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESC-CC
T ss_pred ---ccc-ccCCCCCCCEEECCCCcCCccccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccC-cC
Confidence 333 377888888888888888875432 3788888888888884 6654 3788888888888887432 11
Q ss_pred CceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCc
Q 003911 308 RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS 387 (787)
Q Consensus 308 ~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p 387 (787)
.+|+.+++++|.+..++.. ...+. .......... +.....++|+.|++++|+++ .+|
T Consensus 297 --~~L~~L~l~~N~l~~i~~~-~~~L~----------------~L~Ls~N~l~---~lp~~~~~L~~L~L~~N~l~-~lp 353 (454)
T 1jl5_A 297 --PNLYYLNASSNEIRSLCDL-PPSLE----------------ELNVSNNKLI---ELPALPPRLERLIASFNHLA-EVP 353 (454)
T ss_dssp --TTCCEEECCSSCCSEECCC-CTTCC----------------EEECCSSCCS---CCCCCCTTCCEEECCSSCCS-CCC
T ss_pred --CcCCEEECcCCcCCcccCC-cCcCC----------------EEECCCCccc---cccccCCcCCEEECCCCccc-ccc
Confidence 3456666777765543211 00000 0000000000 01111245666666666666 344
Q ss_pred hhhcCCCCCCEEecccccccc--cCCccCcCC-------------CCCCeeeccCCcccc--cCCC
Q 003911 388 PEFASFKSLQRLILADNNLSG--MIPEGLSVL-------------GALKELDVSNNQLYG--KIPS 436 (787)
Q Consensus 388 ~~~~~l~~L~~L~Ls~N~l~g--~ip~~l~~l-------------~~L~~L~Ls~N~l~g--~iP~ 436 (787)
. .+++|++|+|++|++++ .+|.++..+ ++|++||+++|+++| .+|.
T Consensus 354 ~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~ 416 (454)
T 1jl5_A 354 E---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPE 416 (454)
T ss_dssp C---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC------------------------------
T ss_pred c---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchh
Confidence 4 35666666666666666 566666555 566666666666665 4553
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=282.11 Aligned_cols=186 Identities=26% Similarity=0.430 Sum_probs=157.7
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+.++|++.+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4578999999999999999999876 789999999975432 23346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++|+|.+++. ....+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 84 LEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (323)
T ss_dssp EECCTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeecccee
Confidence 99999999998873 23468999999999999999999998 89999999999999999999999999999866
Q ss_pred CCCCC-ceeeeeccccCcccccccccCCc-C-cceeecC
Q 003911 750 PEGKG-SIETRIAGTFGYLAPEYAVHTRW-S-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~-~~DiWS~ 785 (787)
..... .......||+.|+|||++.+..+ + ++||||.
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 194 (323)
T 3tki_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194 (323)
T ss_dssp EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHH
T ss_pred ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHH
Confidence 43221 22234679999999999988876 4 7999983
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=278.38 Aligned_cols=184 Identities=27% Similarity=0.401 Sum_probs=155.3
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
++|++.+.||+|+||.||+|+..+++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999888899999999976544444557889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++ +|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 82 LDQ-DLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CSE-EHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred cCC-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 975 89888743 23468999999999999999999998 89999999999999999999999999999876433
Q ss_pred CCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
.. ......||+.|+|||++.+. .++ ++|+||.
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 187 (288)
T 1ob3_A 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV 187 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHH
T ss_pred cc-ccccccccccccCchheeCCCCCCcHHHHHHH
Confidence 21 22335789999999999764 466 8999983
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-31 Score=281.20 Aligned_cols=186 Identities=26% Similarity=0.453 Sum_probs=157.6
Q ss_pred cCCCcccceeccccceEEEEEEEe----CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
.++|++.+.||+|+||.||+|+.. .+..||||+++.. ......+++.+|++++++++||||+++++++.+.+..+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 457999999999999999999874 3556999999763 34455678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+||||+++|+|.+++.. ....+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 127 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEeeCCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999999853 23468999999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCCce--eeeeccccCcccccccccCCcC-cceeecC
Q 003911 748 LAPEGKGSI--ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
......... .....+|+.|+|||++.+..++ ++||||.
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 240 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSF 240 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHH
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHH
Confidence 775543221 2223467889999999988888 8999983
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=296.09 Aligned_cols=189 Identities=31% Similarity=0.493 Sum_probs=164.2
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.+.... ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999875 6999999999764332 33457789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++|+|.+++..... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 264 mE~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999999999865322 13468999999999999999999998 89999999999999999999999999999887
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... .....+||+.|+|||++.+..++ ++|+||.
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSl 375 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHH
T ss_pred cCCCc-ccccccCCccccChhhhcCCCCChHHhcCcc
Confidence 54432 22345899999999999998888 8999983
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=287.99 Aligned_cols=185 Identities=29% Similarity=0.430 Sum_probs=151.2
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHH-HHhcCCCccceEEeEEEeCCeeEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAV-LTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
.++|++.+.||+|+||.||+|+.+ +++.||||++++.... ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357999999999999999999876 6889999999875432 3334566677776 567899999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 117 v~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 9999999999998854 1368899999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... ......+||+.|+|||++.+..++ ++|+||.
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 225 (373)
T 2r5t_A 189 NIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 225 (373)
T ss_dssp GBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHH
T ss_pred cccCC-CccccccCCccccCHHHhCCCCCCchhhhHHH
Confidence 43332 223446899999999999999888 8999983
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=282.83 Aligned_cols=183 Identities=27% Similarity=0.457 Sum_probs=159.0
Q ss_pred cCCCcccceeccccceEEEEEEE-eCCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||.||+|+. .+++.||||++...... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999987 47899999999764322 23346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+ +|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 88 ~E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp ECCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 9999 78999888542 468999999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCceeeeeccccCcccccccccCCc-C-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRW-S-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~-~~DiWS~ 785 (787)
.... .....+||+.|+|||++.+..+ + ++||||.
T Consensus 159 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 194 (336)
T 3h4j_B 159 TDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSC 194 (336)
T ss_dssp TTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHH
T ss_pred cCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHH
Confidence 5432 2234679999999999998877 4 8999983
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=285.21 Aligned_cols=188 Identities=18% Similarity=0.263 Sum_probs=162.4
Q ss_pred cCCCcccceeccc--cceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 592 TNNFSEENILGRG--GFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 592 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
.++|++.+.||+| +||.||+|+.. +++.||||++..........+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3579999999999 99999999876 79999999998766566667889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++|+|.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+..
T Consensus 104 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999998652 22468999999999999999999998 8999999999999999999999999999865
Q ss_pred cCCCCC------ceeeeeccccCccccccccc--CCcC-cceeecC
Q 003911 749 APEGKG------SIETRIAGTFGYLAPEYAVH--TRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~-~~DiWS~ 785 (787)
...... .......||+.|+|||++.+ ..++ ++||||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 223 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 223 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHH
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHH
Confidence 432211 11122478999999999988 5677 8999983
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=282.14 Aligned_cols=184 Identities=23% Similarity=0.339 Sum_probs=160.1
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 3468999999999999999999875 78999999987632 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC--CCcEEEeecccce
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD--DMRAKVADFGLVR 747 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~ 747 (787)
|||+++|+|.+++.. ....+++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 127 ~E~~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~ 199 (387)
T 1kob_A 127 LEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199 (387)
T ss_dssp EECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEcCCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccce
Confidence 999999999988843 22468999999999999999999998 89999999999999974 5789999999999
Q ss_pred ecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 748 LAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
...... ......||+.|+|||++.+..++ ++||||.
T Consensus 200 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 236 (387)
T 1kob_A 200 KLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAI 236 (387)
T ss_dssp ECCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred ecCCCc--ceeeeccCCCccCchhccCCCCCCcccEeeH
Confidence 875433 23345799999999999998888 8999983
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-31 Score=275.58 Aligned_cols=184 Identities=32% Similarity=0.489 Sum_probs=152.2
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccc------------------------hhHHHHHHHHHHHH
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG------------------------KGLTEFKSEIAVLT 646 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~l~ 646 (787)
.++|++.+.||+|+||.||+|+.. +++.||||++....... ...+++.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 368999999999999999999865 68999999997643211 12356899999999
Q ss_pred hcCCCccceEEeEEEe--CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcC
Q 003911 647 KVRHRHLVALLGHCLD--GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRD 724 (787)
Q Consensus 647 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 724 (787)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++.++..++.|++.||+|||+ .+|+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~D 162 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP------TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRD 162 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS------CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccC
Confidence 9999999999999987 56789999999999997754 22478999999999999999999998 8999999
Q ss_pred CCCCCEEECCCCcEEEeecccceecCCCCCceeeeeccccCcccccccccCCc---C-cceeecC
Q 003911 725 LKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRW---S-SCSYWAG 785 (787)
Q Consensus 725 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~-~~DiWS~ 785 (787)
|||+||+++.++.+||+|||+++....... ......||+.|+|||++.+... + ++|+||.
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 226 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAM 226 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHH
T ss_pred CCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhH
Confidence 999999999999999999999987754432 2334679999999999987653 4 7899983
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=295.44 Aligned_cols=186 Identities=25% Similarity=0.390 Sum_probs=146.0
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC-----C
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----N 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 664 (787)
+.++|++.+.||+|+||.||+|... +++.||||++..........+++.+|++++++++||||+++++++... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3478999999999999999999765 789999999976555556678899999999999999999999999543 5
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..|+||||+ +++|.+++.. ...+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFG 201 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFG 201 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecc-ccchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccc
Confidence 689999998 5789888843 3468999999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCC--------------------------ceeeeeccccCccccccc-ccCCcC-cceeecC
Q 003911 745 LVRLAPEGKG--------------------------SIETRIAGTFGYLAPEYA-VHTRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~-~~DiWS~ 785 (787)
+|+....... ...+..+||+.|+|||++ .+..|+ ++||||.
T Consensus 202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSl 270 (458)
T 3rp9_A 202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI 270 (458)
T ss_dssp TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHH
Confidence 9987643211 122346789999999986 455677 8999983
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=286.03 Aligned_cols=186 Identities=32% Similarity=0.476 Sum_probs=149.0
Q ss_pred hhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCC--e
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGN--E 665 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~ 665 (787)
.+.++|++.+.||+|+||.||+|... +++.||||++..........+++.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45678999999999999999999865 7899999999765555666778899999999997 999999999998654 6
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.|+||||++ ++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 899999997 689888853 368899999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCC--------------------CceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 746 VRLAPEGK--------------------GSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
|+...... .......+||+.|+|||++.+ ..++ ++||||.
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 217 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSL 217 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHH
Confidence 98764311 112234679999999999987 5677 8999983
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=271.47 Aligned_cols=185 Identities=26% Similarity=0.451 Sum_probs=163.3
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+.++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4678999999999999999999875 689999999987666666678899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc---EEEeecccc
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVADFGLV 746 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFG~a 746 (787)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||.+
T Consensus 84 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 9999999998888542 468999999999999999999998 89999999999999986655 999999999
Q ss_pred eecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
........ .....||+.|+|||++.+..++ ++|+||.
T Consensus 156 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (284)
T 3kk8_A 156 IEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 193 (284)
T ss_dssp EECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred EEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHH
Confidence 87754332 2345799999999999998888 8999983
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-31 Score=280.79 Aligned_cols=180 Identities=29% Similarity=0.436 Sum_probs=152.9
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC----eeEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----EKLL 668 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~l 668 (787)
++|++.+.||+|+||.||+|+.. ++.||||++... .......++|+.++++++||||+++++++.... ..++
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 57999999999999999999875 899999999653 334456677999999999999999999998754 3699
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC----------CeEEcCCCCCCEEECCCCcE
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ----------SFIHRDLKPSNILLGDDMRA 738 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~----------~ivH~Dlkp~NIll~~~~~~ 738 (787)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+
T Consensus 100 v~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred EEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 9999999999999854 358999999999999999999997 6 99999999999999999999
Q ss_pred EEeecccceecCCCCCc-eeeeeccccCcccccccccC-----CcC-cceeecC
Q 003911 739 KVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHT-----RWS-SCSYWAG 785 (787)
Q Consensus 739 kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~-~~DiWS~ 785 (787)
||+|||+++........ ......||+.|+|||++.+. .++ ++||||.
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl 224 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHH
Confidence 99999999876544322 22335799999999999873 444 7899983
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=289.88 Aligned_cols=178 Identities=19% Similarity=0.220 Sum_probs=148.3
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccc------cchhHHHHHHHHHHHHhcC---------CCccceE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVI------SGKGLTEFKSEIAVLTKVR---------HRHLVAL 656 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~niv~~ 656 (787)
.++|++.+.||+|+||+||+|+. +|+.||||++..... .....+.+.+|++++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35789999999999999999987 689999999986532 2334578999999999986 6666666
Q ss_pred EeEE-----------------Ee-------------CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHH
Q 003911 657 LGHC-----------------LD-------------GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706 (787)
Q Consensus 657 ~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~ 706 (787)
.+.+ .+ .+..|+||||+++|++.+.+.+ ..+++.++..++.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 6654 32 6789999999999977666522 4679999999999999
Q ss_pred HHHHHHH-hCCCCCeEEcCCCCCCEEECCCC--------------------cEEEeecccceecCCCCCceeeeeccccC
Q 003911 707 RGVEYLH-GLAHQSFIHRDLKPSNILLGDDM--------------------RAKVADFGLVRLAPEGKGSIETRIAGTFG 765 (787)
Q Consensus 707 ~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DFG~a~~~~~~~~~~~~~~~gt~~ 765 (787)
.||+||| + .+|+||||||+|||++.++ .+||+|||+|+..... ..+||+.
T Consensus 172 ~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 7 8999999999999999887 8999999999877532 2479999
Q ss_pred cccccccccCCcCcceeecC
Q 003911 766 YLAPEYAVHTRWSSCSYWAG 785 (787)
Q Consensus 766 y~aPE~~~~~~~~~~DiWS~ 785 (787)
|||||++.+....++||||.
T Consensus 243 y~aPE~~~g~~~~~~Diwsl 262 (336)
T 2vuw_A 243 SMDEDLFTGDGDYQFDIYRL 262 (336)
T ss_dssp TTCSGGGCCCSSHHHHHHHH
T ss_pred ccChhhhcCCCccceehhhh
Confidence 99999999877339999984
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=275.77 Aligned_cols=183 Identities=27% Similarity=0.346 Sum_probs=153.7
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||+||+|+.. +++.||||++...........++..|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357999999999999999999876 799999999876544445555666677666666 899999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+ +++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 136 ~e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred Eecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999 77998888542 2468999999999999999999998 89999999999999999999999999999877
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... ......||+.|+|||++.+ .++ ++||||.
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~Diwsl 241 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSL 241 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHH
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHH
Confidence 5432 2233569999999999887 455 9999983
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=275.93 Aligned_cols=188 Identities=27% Similarity=0.414 Sum_probs=145.9
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|... +++.||+|+++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 467999999999999999999865 68999999997643 2334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 671 EYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
||++ |+|.+++...... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9997 6999988654322 22458999999999999999999998 89999999999999999999999999999877
Q ss_pred CCCCCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
..... ......||+.|+|||++.+. .++ ++||||.
T Consensus 159 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 195 (317)
T 2pmi_A 159 GIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSC 195 (317)
T ss_dssp TSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred CCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHH
Confidence 54322 22345789999999999874 466 8999983
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=289.02 Aligned_cols=186 Identities=27% Similarity=0.411 Sum_probs=156.1
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC-----C
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----N 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 664 (787)
+.++|++.+.||+|+||.||+|... +++.||||++..........+++.+|++++++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4578999999999999999999875 688999999987555556678899999999999999999999999776 5
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..|+||||++ ++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCC
Confidence 6899999995 699988843 3468999999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCCc---------------------eeeeeccccCccccccc-ccCCcC-cceeecC
Q 003911 745 LVRLAPEGKGS---------------------IETRIAGTFGYLAPEYA-VHTRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~-~~DiWS~ 785 (787)
+|+........ .....+||+.|+|||++ .+..++ ++||||.
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSl 238 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWST 238 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchH
Confidence 99876543211 12456899999999986 455677 8999983
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-30 Score=275.33 Aligned_cols=186 Identities=24% Similarity=0.391 Sum_probs=158.4
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC--eeEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN--EKLL 668 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l 668 (787)
.++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+.+|++++++++||||+++++++.... ..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 467999999999999999999876 58999999997633 2334677889999999999999999999998765 6799
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE----CCCCcEEEeecc
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 744 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFG 744 (787)
||||+++++|.+++..... ...+++.+++.++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||
T Consensus 87 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEECCTTCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEeCCCCCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 9999999999999965322 2348999999999999999999998 899999999999999 778889999999
Q ss_pred cceecCCCCCceeeeeccccCcccccccc--------cCCcC-cceeecC
Q 003911 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAV--------HTRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~-~~DiWS~ 785 (787)
+++....... .....||+.|+|||++. +..++ ++||||.
T Consensus 162 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diwsl 209 (319)
T 4euu_A 162 AARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209 (319)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHH
T ss_pred CceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHH
Confidence 9988755432 23457999999999986 46666 8999983
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=275.77 Aligned_cols=184 Identities=28% Similarity=0.459 Sum_probs=157.0
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.++|++.+.||+|+||.||+|+..++..||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 457999999999999999999998888999999976432 34678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++... ...+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 100 YMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCTTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred ccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999998542 2358999999999999999999998 8999999999999999999999999999986644
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..........||+.|+|||++.+..++ ++|+||.
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 207 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 207 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHH
Confidence 322222234567889999999988888 8999983
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-30 Score=293.30 Aligned_cols=281 Identities=23% Similarity=0.256 Sum_probs=211.7
Q ss_pred CCC-CCCCCCcccEEE------cC-CCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEE
Q 003911 50 GWS-DTDPCKWNHVVC------IE-DKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVM 121 (787)
Q Consensus 50 ~w~-~~~~C~w~gv~C------~~-~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ 121 (787)
.|. ..+||.|.|..| .. ..+++.|++++++|+ .+|..+. ++|++|+|++|+|+.+++ .+++|++|+
T Consensus 14 ~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~---~l~~L~~L~ 87 (622)
T 3g06_A 14 AWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA---LPPELRTLE 87 (622)
T ss_dssp HHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC---CCTTCCEEE
T ss_pred HHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC---cCCCCCEEE
Confidence 464 457889977532 11 246899999999999 8898887 899999999999997665 679999999
Q ss_pred cccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccc
Q 003911 122 LSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQ 201 (787)
Q Consensus 122 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~ 201 (787)
|++|+|+.++. .+++|++|+|++|+++. +|. .+++|+.|++++|+|++. |. .+++|++|+|++|+
T Consensus 88 Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~~--l~~---~l~~L~~L~L~~N~l~~l-p~-----~l~~L~~L~Ls~N~ 152 (622)
T 3g06_A 88 VSGNQLTSLPV----LPPGLLELSIFSNPLTH--LPA---LPSGLCKLWIFGNQLTSL-PV-----LPPGLQELSVSDNQ 152 (622)
T ss_dssp ECSCCCSCCCC----CCTTCCEEEECSCCCCC--CCC---CCTTCCEEECCSSCCSCC-CC-----CCTTCCEEECCSSC
T ss_pred cCCCcCCcCCC----CCCCCCEEECcCCcCCC--CCC---CCCCcCEEECCCCCCCcC-CC-----CCCCCCEEECcCCc
Confidence 99999999887 78999999999999994 666 678999999999999874 43 35899999999999
Q ss_pred cccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCc
Q 003911 202 LIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPD 281 (787)
Q Consensus 202 l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 281 (787)
+++ +|.. +++|+.|++++|.|++.+ ..+++|+.|+|++|+|++ +|.
T Consensus 153 l~~-l~~~-----------------------------~~~L~~L~L~~N~l~~l~---~~~~~L~~L~Ls~N~l~~-l~~ 198 (622)
T 3g06_A 153 LAS-LPAL-----------------------------PSELCKLWAYNNQLTSLP---MLPSGLQELSVSDNQLAS-LPT 198 (622)
T ss_dssp CSC-CCCC-----------------------------CTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCSC-CCC
T ss_pred CCC-cCCc-----------------------------cCCCCEEECCCCCCCCCc---ccCCCCcEEECCCCCCCC-CCC
Confidence 985 4432 245666666666666543 334566666666666663 443
Q ss_pred cccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCC
Q 003911 282 SLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSD 361 (787)
Q Consensus 282 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (787)
. +++|+.|++++|.++..++.+ .+|+.+++++|.+..+|.
T Consensus 199 ~---~~~L~~L~L~~N~l~~l~~~~---~~L~~L~Ls~N~L~~lp~---------------------------------- 238 (622)
T 3g06_A 199 L---PSELYKLWAYNNRLTSLPALP---SGLKELIVSGNRLTSLPV---------------------------------- 238 (622)
T ss_dssp C---CTTCCEEECCSSCCSSCCCCC---TTCCEEECCSSCCSCCCC----------------------------------
T ss_pred c---cchhhEEECcCCcccccCCCC---CCCCEEEccCCccCcCCC----------------------------------
Confidence 2 355666666666666433321 344555555555444331
Q ss_pred ccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCC
Q 003911 362 WIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPS 436 (787)
Q Consensus 362 ~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~ 436 (787)
..++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++|.+|.
T Consensus 239 ------~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 239 ------LPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp ------CCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred ------CCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 1247899999999999 4665 6789999999999999 8899999999999999999999998775
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-31 Score=283.82 Aligned_cols=194 Identities=32% Similarity=0.517 Sum_probs=162.6
Q ss_pred HHhhcCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEE
Q 003911 588 LRNVTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCL 661 (787)
Q Consensus 588 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 661 (787)
.....++|++.+.||+|+||.||+|+.. +++.||||+++... .....+++.+|++++++++||||+++++++.
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 3445678999999999999999999875 34889999997632 3455678999999999999999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHHHhhhhc-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 003911 662 DGNEKLLVFEYMPQGTLSRHIFNWAEE-------------------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIH 722 (787)
Q Consensus 662 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH 722 (787)
+.+..++||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+ .+|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence 999999999999999999999653211 12568999999999999999999998 89999
Q ss_pred cCCCCCCEEECCCCcEEEeecccceecCCCCC-ceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 723 RDLKPSNILLGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 723 ~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++ ++|+||.
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 262 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 262 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHH
Confidence 99999999999999999999999976543221 122335689999999999988888 9999983
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=281.46 Aligned_cols=187 Identities=25% Similarity=0.391 Sum_probs=152.6
Q ss_pred hcCCCcccceeccccceEEEEEEE-eCCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe---
Q 003911 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE--- 665 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 665 (787)
+.++|++.+.||+|+||.||+|+. .+++.||||+++..... ......+.+|++++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 457899999999999999999986 47899999999765332 3445689999999999999999999999876543
Q ss_pred -eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 666 -KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 666 -~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
.|+||||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred ccEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeecc
Confidence 49999999999999998541 368999999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCCc--eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 745 LVRLAPEGKGS--IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+++........ ......||+.|+|||++.+..++ ++||||.
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 205 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205 (311)
T ss_dssp CC------------------CCTTCCHHHHHTCCCCHHHHHHHH
T ss_pred CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHH
Confidence 99876543221 22335699999999999998888 8999983
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=280.87 Aligned_cols=190 Identities=26% Similarity=0.346 Sum_probs=163.8
Q ss_pred eeeHHHHHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-----CCccce
Q 003911 582 VISIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-----HRHLVA 655 (787)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~ 655 (787)
.++++....+.++|++.+.||+|+||.||+|+.. +++.||||+++. .......+..|++++++++ ||||++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 3445555667789999999999999999999874 789999999864 2344567888999999996 999999
Q ss_pred EEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC-
Q 003911 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD- 734 (787)
Q Consensus 656 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~- 734 (787)
+++++...+..++||||+ +++|.+++... ....+++.++..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDP 173 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCT
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccc
Confidence 999999999999999999 99999998652 23458999999999999999999998 89999999999999975
Q ss_pred ------------------------CCcEEEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 735 ------------------------DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 735 ------------------------~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++.+||+|||+|+...... ....||+.|+|||++.+..++ ++||||.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 245 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSF 245 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHH
Confidence 7899999999998764432 335789999999999999888 9999983
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=274.18 Aligned_cols=185 Identities=26% Similarity=0.358 Sum_probs=154.3
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|+.. +++.||||++..........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 368999999999999999999876 6899999999775555555678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 82 e~~~~~~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 82 EYCDHTVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp ECCSEEHHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeCCCchHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 99999999887632 3468999999999999999999998 899999999999999999999999999998775
Q ss_pred CCCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
.... ......||+.|+|||++.+ ..++ ++|+||.
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 189 (311)
T 4agu_A 154 GPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAI 189 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHH
T ss_pred Cccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHH
Confidence 4332 2234578999999999976 4566 8999983
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=289.63 Aligned_cols=184 Identities=30% Similarity=0.491 Sum_probs=161.4
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|.+.+.||+|+||.||+|+.. +|+.||||++...... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999876 7999999999764322 23456899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 95 ~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 95 MEYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 999999999998842 3468999999999999999999997 89999999999999999999999999999887
Q ss_pred CCCCCceeeeeccccCcccccccccCCc-C-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRW-S-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~-~~DiWS~ 785 (787)
.... .....+||+.|+|||++.+..+ + ++|+||.
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 202 (476)
T 2y94_A 167 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSS 202 (476)
T ss_dssp CTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHH
T ss_pred cccc--cccccCCCcCeEChhhccCCCCCCCcceehhh
Confidence 5433 2334679999999999998876 4 8999983
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-31 Score=285.00 Aligned_cols=185 Identities=24% Similarity=0.464 Sum_probs=148.7
Q ss_pred CCCcccceeccccceEEEEEEEe----CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
++|++.+.||+|+||.||+|+.. ++..||||+++... .....+++.+|++++++++||||+++++++.+.+..++
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 57999999999999999999865 57789999997632 44556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 124 v~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999854 23468999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCce--eeeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSI--ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
........ .....+|+.|+|||++.+..++ ++||||.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~Sl 236 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSY 236 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHH
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHH
Confidence 65432211 1123457889999999998888 8999983
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=279.96 Aligned_cols=181 Identities=28% Similarity=0.440 Sum_probs=143.6
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+.++|++.+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 4578999999999999999999876 68899999997632 346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC---CCcEEEeecccc
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGLV 746 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~a 746 (787)
|||+++|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++
T Consensus 127 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 127 LELVTGGELFDRIVE-----KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp ECCCCSCBHHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred EEeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 999999999998843 3468999999999999999999998 89999999999999975 889999999999
Q ss_pred eecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+...... ......||+.|+|||++.+..++ ++||||.
T Consensus 199 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 236 (349)
T 2w4o_A 199 KIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSV 236 (349)
T ss_dssp ----------------CGGGSCHHHHTTCCCCTHHHHHHH
T ss_pred cccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHH
Confidence 8764332 22346799999999999998888 8999983
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-31 Score=280.09 Aligned_cols=186 Identities=26% Similarity=0.385 Sum_probs=160.4
Q ss_pred hhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccc------hhHHHHHHHHHHHHhcCCCccceEEeEEEe
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG------KGLTEFKSEIAVLTKVRHRHLVALLGHCLD 662 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 662 (787)
...++|++.+.||+|+||.||+|+.. +++.||||++....... ...+.+.+|++++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 34578999999999999999999864 78999999998653221 234567889999999999999999999999
Q ss_pred CCeeEEEEEecCCC-CHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEe
Q 003911 663 GNEKLLVFEYMPQG-TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 741 (787)
Q Consensus 663 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 741 (787)
.+..++||||+.+| +|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEe
Confidence 99999999999777 99888843 3468999999999999999999998 899999999999999999999999
Q ss_pred ecccceecCCCCCceeeeeccccCcccccccccCCc-C-cceeecC
Q 003911 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRW-S-SCSYWAG 785 (787)
Q Consensus 742 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~-~~DiWS~ 785 (787)
|||+++...... ......||+.|+|||++.+..+ + ++||||.
T Consensus 173 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 216 (335)
T 3dls_A 173 DFGSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSL 216 (335)
T ss_dssp CCTTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHH
T ss_pred ecccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhH
Confidence 999998875543 2234679999999999998877 5 7999983
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-30 Score=268.55 Aligned_cols=186 Identities=25% Similarity=0.367 Sum_probs=160.5
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (787)
..++|++.+.||+|+||.||+|... +++.||+|++...........++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567999999999999999999876 799999999987655556677889999999999 99999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC-------------
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD------------- 735 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------------- 735 (787)
||||+++++|.+++...... ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC---------------
T ss_pred EEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999764332 2468999999999999999999998 899999999999999844
Q ss_pred ------CcEEEeecccceecCCCCCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 736 ------MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 736 ------~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
..+||+|||.+....... ...||+.|+|||++.+. .++ ++||||.
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 217 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFAL 217 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHH
T ss_pred cccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHH
Confidence 479999999998775432 23589999999999876 444 8999983
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=291.47 Aligned_cols=182 Identities=26% Similarity=0.382 Sum_probs=152.1
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC------
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------ 663 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 663 (787)
..++|++.+.||+|+||.||+|... +++.||||++..........+++.+|+++++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999765 689999999987655566678899999999999999999999999754
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
...|+||||+++ ++.+.+. ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DF 208 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 208 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred CeEEEEEeCCCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEE
Confidence 357999999975 5666652 248899999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|+|+...... .....+||+.|+|||++.+..|+ ++||||.
T Consensus 209 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 249 (464)
T 3ttj_A 209 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249 (464)
T ss_dssp CCC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred EeeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHH
Confidence 9998765432 23446899999999999999998 9999983
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=282.81 Aligned_cols=190 Identities=28% Similarity=0.447 Sum_probs=161.7
Q ss_pred cCCCcccceeccccceEEEEEEEe--------CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEe
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 662 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 662 (787)
.++|++.+.||+|+||.||+|+.. ++..||||+++.. ......+++.+|+++++++ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 468999999999999999999863 2357999999764 3455567899999999999 99999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 003911 663 GNEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (787)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 731 (787)
.+..++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ .+|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence 99999999999999999999764321 12458999999999999999999998 89999999999999
Q ss_pred ECCCCcEEEeecccceecCCCCC-ceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 732 LGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 732 l~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+++++.+||+|||+++....... .......||+.|+|||++.+..++ ++||||.
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl 279 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 279 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHH
Confidence 99999999999999987654322 122334578999999999999888 8999983
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-31 Score=286.88 Aligned_cols=185 Identities=28% Similarity=0.435 Sum_probs=158.3
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|+.. +++.||||+++.. ......+++.+|++++++++||||+++++++...+..++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 357899999999999999999886 7899999998753 23444567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++... ...+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 192 e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp ECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 999999999998642 1358899999999999999999998 899999999999999999999999999998754
Q ss_pred CCCCcee-eeeccccCcccccccccCCcC-cceeec
Q 003911 751 EGKGSIE-TRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
....... ....+++.|+|||++.+..++ ++||||
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 300 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWS 300 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHH
Confidence 3221111 112357789999999988888 899998
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=273.05 Aligned_cols=183 Identities=25% Similarity=0.421 Sum_probs=151.4
Q ss_pred hcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHh--cCCCccceEEeEEEeC----C
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK--VRHRHLVALLGHCLDG----N 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~ 664 (787)
..++|++.+.||+|+||.||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++... .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 457899999999999999999987 6999999998652 34556677777777 7999999999987653 4
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEcCCCCCCEEECCCCcEE
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL-----AHQSFIHRDLKPSNILLGDDMRAK 739 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~k 739 (787)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. ++.+|+||||||+|||++.++.+|
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred eeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 57899999999999999832 4689999999999999999999921 028999999999999999999999
Q ss_pred EeecccceecCCCCCce---eeeeccccCcccccccccC------CcC-cceeecC
Q 003911 740 VADFGLVRLAPEGKGSI---ETRIAGTFGYLAPEYAVHT------RWS-SCSYWAG 785 (787)
Q Consensus 740 l~DFG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~-~~DiWS~ 785 (787)
|+|||+|+......... .....||+.|+|||++.+. .++ ++||||.
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvwsl 209 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAF 209 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHH
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHH
Confidence 99999998765543322 1234799999999999887 444 8999983
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-31 Score=273.87 Aligned_cols=186 Identities=22% Similarity=0.366 Sum_probs=146.6
Q ss_pred hcCCCcccceeccccceEEEEEEEe----CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
..++|++.+.||+|+||.||+|... .+..||+|+++.. ......+.+.+|+.++++++||||+++++++. .+..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 3468999999999999999999864 3557999998653 23455678999999999999999999999984 5678
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
++||||+++++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp EEEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred EEEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccc
Confidence 999999999999999854 22468999999999999999999998 89999999999999999999999999999
Q ss_pred eecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+..............+|+.|+|||++.+..++ ++|+||.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 203 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 203 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHH
Confidence 87755433333344578899999999988888 8999983
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=277.74 Aligned_cols=182 Identities=20% Similarity=0.251 Sum_probs=157.8
Q ss_pred cCCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+|+++++++ +||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 46899999999999999999986 4799999999875322 24688999999999 999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc-----EEEeecc
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-----AKVADFG 744 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DFG 744 (787)
|||+ +++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||
T Consensus 84 ~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred EEeC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 9999 99999998542 3478999999999999999999998 89999999999999998887 9999999
Q ss_pred cceecCCCCCce------eeeeccccCcccccccccCCcC-cceeecC
Q 003911 745 LVRLAPEGKGSI------ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+++......... .....||+.|+|||++.+..++ ++|+||.
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 203 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEAL 203 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHH
Confidence 998765443211 2346799999999999999888 8999983
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=281.04 Aligned_cols=181 Identities=24% Similarity=0.348 Sum_probs=149.4
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST---TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc---cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 468999999999999999999876 78999999997633 23367889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc--EEEeeccccee
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--AKVADFGLVRL 748 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFG~a~~ 748 (787)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||+++.
T Consensus 96 e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 96 EYASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp ECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 99999999998854 1368999999999999999999998 89999999999999987665 99999999975
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC--cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS--SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~DiWS~ 785 (787)
..... ......||+.|+|||++.+..++ ++||||.
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 204 (361)
T 3uc3_A 168 SVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSC 204 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHH
T ss_pred ccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehh
Confidence 43322 22345799999999999888876 4899983
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-30 Score=273.99 Aligned_cols=185 Identities=26% Similarity=0.388 Sum_probs=161.6
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccc----hhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
+.++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+++.+|++++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467999999999999999999876 68999999997643321 246789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC----cEEEe
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 741 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~ 741 (787)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 9999999999999999843 3468999999999999999999998 8999999999999999887 79999
Q ss_pred ecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 742 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|||+++....... .....||+.|+|||++.+..++ ++|+||.
T Consensus 162 Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 204 (321)
T 2a2a_A 162 DFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSI 204 (321)
T ss_dssp CCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred cCccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHH
Confidence 9999987755332 2345699999999999988888 8999983
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=278.51 Aligned_cols=194 Identities=29% Similarity=0.472 Sum_probs=146.6
Q ss_pred HhhcCCCcccceeccccceEEEEEEEeC-C---cEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC
Q 003911 589 RNVTNNFSEENILGRGGFGTVYKGELHD-G---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN 664 (787)
Q Consensus 589 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 664 (787)
....++|++.+.||+|+||.||+|+... + ..||||+++.........+++.+|++++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3345689999999999999999997653 3 27999999876555666788999999999999999999999998876
Q ss_pred ee------EEEEEecCCCCHHHHHHhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc
Q 003911 665 EK------LLVFEYMPQGTLSRHIFNWAEE-GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (787)
Q Consensus 665 ~~------~lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 737 (787)
.. ++||||+++|+|.+++...... ....+++.++..++.|++.||+|||+ .+|+||||||+||++++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCC
Confidence 55 9999999999999998654322 22358999999999999999999998 89999999999999999999
Q ss_pred EEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 738 AKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 738 ~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+||+|||+++........ ......+|+.|+|||++.+..++ ++||||.
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 225 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAF 225 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhH
Confidence 999999999876443321 22234578899999999999888 9999983
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=275.36 Aligned_cols=173 Identities=28% Similarity=0.410 Sum_probs=134.8
Q ss_pred cceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCeeEEEEEecCC
Q 003911 598 ENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
.+.||+|+||.||+|... +++.||||++... ....+.+|+++++++. ||||+++++++.+....|+||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 378999999999999875 6899999998652 3467889999999997 99999999999999999999999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC---cEEEeecccceecCCC
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKVADFGLVRLAPEG 752 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a~~~~~~ 752 (787)
|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||+++.....
T Consensus 91 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 91 GELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 999999854 2468999999999999999999998 8999999999999998665 8999999999876544
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.. .....+||+.|+|||++.+..++ ++||||
T Consensus 163 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Diws 194 (325)
T 3kn6_A 163 NQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWS 194 (325)
T ss_dssp ----------------------CCCCHHHHHHH
T ss_pred CC-cccccCCCcCccCHHHhcCCCCCCccchHH
Confidence 32 22345789999999999999888 899998
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=283.24 Aligned_cols=197 Identities=25% Similarity=0.405 Sum_probs=163.2
Q ss_pred HHHHHhhcCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEE
Q 003911 585 IQVLRNVTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALL 657 (787)
Q Consensus 585 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 657 (787)
........++|++.+.||+|+||.||+|++. +++.||||+++.. ......+.+.+|+++++++ +||||++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 4445556789999999999999999999743 4578999999763 3344567899999999999 799999999
Q ss_pred eEEEeCCe-eEEEEEecCCCCHHHHHHhhhhcC-----------------------------------------------
Q 003911 658 GHCLDGNE-KLLVFEYMPQGTLSRHIFNWAEEG----------------------------------------------- 689 (787)
Q Consensus 658 ~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~----------------------------------------------- 689 (787)
+++.+.+. .++||||+++|+|.+++.......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99987654 899999999999999997543210
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCC-
Q 003911 690 --------------LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG- 754 (787)
Q Consensus 690 --------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 754 (787)
...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 1228899999999999999999998 8999999999999999999999999999987644332
Q ss_pred ceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 755 SIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 755 ~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.......||+.|+|||++.+..++ ++||||.
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 281 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 281 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhH
Confidence 223345689999999999999888 9999983
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=275.02 Aligned_cols=185 Identities=28% Similarity=0.546 Sum_probs=153.6
Q ss_pred cCCCcccceeccccceEEEEEEE-----eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC--C
Q 003911 592 TNNFSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--N 664 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~ 664 (787)
.++|++.+.||+|+||.||+|++ .+++.||||++... .....+++.+|++++++++||||+++++++... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 46799999999999999999985 26899999998753 345567899999999999999999999998654 4
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..++||||+++|+|.+++... ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred ceEEEEEeCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCc
Confidence 589999999999999998542 2358999999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCCc--eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 745 LVRLAPEGKGS--IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+++........ ......||..|+|||++.+..++ ++||||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 203 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSF 203 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHH
Confidence 99876543221 12234577889999999999888 9999983
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-31 Score=294.30 Aligned_cols=186 Identities=27% Similarity=0.417 Sum_probs=150.7
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||.||+|+.. +++.||||+++.... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999865 789999999976432 234456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ..+|+||||||+|||++.++.+||+|||+|+..
T Consensus 227 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999998854 1368999999999999999999995 268999999999999999999999999999864
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... ......+||+.|+|||++.+..++ ++|+||.
T Consensus 300 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 335 (446)
T 4ejn_A 300 IKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 335 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHH
T ss_pred cCCC-cccccccCCccccCHhhcCCCCCCCccchhhh
Confidence 3332 223346799999999999999888 8999983
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=293.55 Aligned_cols=184 Identities=29% Similarity=0.485 Sum_probs=160.2
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|.+. ++..||||+++... ...++|.+|++++++++||||+++++++...+..++||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 457889999999999999999887 48899999997632 34678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++...
T Consensus 296 E~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 296 EFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp ECCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EccCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999642 23468999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
...........+++.|+|||++.+..++ ++||||
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS 404 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 404 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHH
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHh
Confidence 4332222234467889999999998888 999998
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-31 Score=283.78 Aligned_cols=190 Identities=26% Similarity=0.398 Sum_probs=159.0
Q ss_pred cCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
.++|++.+.||+|+||.||+|++. +++.||||+++. ........++.+|+.++++++||||+++++++.+...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCS-SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccc-ccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 467999999999999999999843 467899999975 3345556689999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC---cEEE
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAE--EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM---RAKV 740 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 740 (787)
.++||||+++|+|.+++..... .....+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999976432 122458999999999999999999998 8999999999999999554 5999
Q ss_pred eecccceecCCCC-CceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 741 ADFGLVRLAPEGK-GSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 741 ~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+|||+|+...... ........||+.|+|||++.+..++ ++||||.
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvwsl 272 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 272 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHH
Confidence 9999997543221 1122335689999999999998888 8999983
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=268.54 Aligned_cols=200 Identities=40% Similarity=0.655 Sum_probs=169.5
Q ss_pred ceeeeHHHHHhhcCCCccc------ceeccccceEEEEEEEeCCcEEEEEEeeccc--ccchhHHHHHHHHHHHHhcCCC
Q 003911 580 NMVISIQVLRNVTNNFSEE------NILGRGGFGTVYKGELHDGTKIAVKRMEAGV--ISGKGLTEFKSEIAVLTKVRHR 651 (787)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~ 651 (787)
...++..++..++++|... +.||+|+||.||+|.. +++.||||++.... ......+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3567888888998888776 8999999999999986 58899999987532 2234567899999999999999
Q ss_pred ccceEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 003911 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (787)
Q Consensus 652 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 731 (787)
||+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+||+
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil 165 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL 165 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence 99999999999999999999999999999986532 23468999999999999999999998 89999999999999
Q ss_pred ECCCCcEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcCcceeecC
Q 003911 732 LGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWSSCSYWAG 785 (787)
Q Consensus 732 l~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~DiWS~ 785 (787)
+++++.+||+|||+++........ ......||+.|+|||++.+....++|+||.
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~sl 220 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSF 220 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHH
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHH
Confidence 999999999999999876543322 223457999999999987653338999983
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-30 Score=268.97 Aligned_cols=186 Identities=28% Similarity=0.439 Sum_probs=155.4
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... .....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 457999999999999999999875 68999999997643 3445678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---CCCCcEEEeecccce
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVR 747 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~ 747 (787)
||+++|+|.+++....... ..+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||+++
T Consensus 100 e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARG-KALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999986644332 568999999999999999999998 899999999999999 456789999999998
Q ss_pred ecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 748 LAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
...... ......||+.|+|||++.+. ++ ++|+||.
T Consensus 176 ~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~sl 211 (285)
T 3is5_A 176 LFKSDE--HSTNAAGTALYMAPEVFKRD-VTFKCDIWSA 211 (285)
T ss_dssp C------------CTTGGGCCHHHHTTC-CCHHHHHHHH
T ss_pred ecCCcc--cCcCcccccCcCChHHhccC-CCcccCeehH
Confidence 764432 22345799999999998654 55 9999983
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=278.84 Aligned_cols=184 Identities=22% Similarity=0.337 Sum_probs=153.9
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCC--CccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--RHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||.||+|...+++.||||++..........+.+.+|++++++++| |||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45799999999999999999988889999999998766566667889999999999976 9999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
||+ .+++|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+|||++ ++.+||+|||+++..
T Consensus 88 ~e~-~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp ECC-CSEEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EeC-CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 994 58899999854 2468999999999999999999998 8999999999999997 578999999999876
Q ss_pred CCCCCc-eeeeeccccCccccccccc-----------CCcC-cceeecC
Q 003911 750 PEGKGS-IETRIAGTFGYLAPEYAVH-----------TRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~-~~DiWS~ 785 (787)
...... .....+||+.|+|||++.+ ..++ ++||||.
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diwsl 206 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHH
Confidence 543322 2234679999999999975 5666 8999983
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=273.64 Aligned_cols=186 Identities=30% Similarity=0.466 Sum_probs=163.1
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
..++|++.+.||+|+||.||+|... ++..||+|++... ....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 4567999999999999999999876 5889999999753 34567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|.+++.. .....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.++..
T Consensus 88 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EECCTTEEHHHHHHH---CCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEcCCCCcHHHHHHh---cccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999999854 233568999999999999999999998 89999999999999999999999999999877
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
............||+.|+|||++.+..++ ++|+||.
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 198 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 198 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHH
Confidence 65443334445678899999999988888 8999983
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=290.82 Aligned_cols=185 Identities=25% Similarity=0.443 Sum_probs=158.4
Q ss_pred hcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
..++|++.+.||+|+||.||+|.+.++..||||+++... ...+++.+|++++++++||||+++++++. .+..++||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 346789999999999999999999888999999997633 34678999999999999999999999986 56789999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 262 e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp CCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred eecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999965322 257889999999999999999998 899999999999999999999999999998764
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
...........+|+.|+|||++.+..++ ++||||.
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 371 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 371 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhH
Confidence 3221112233467889999999988888 9999983
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-30 Score=278.48 Aligned_cols=179 Identities=32% Similarity=0.418 Sum_probs=150.4
Q ss_pred cccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecC
Q 003911 596 SEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMP 674 (787)
Q Consensus 596 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (787)
...+.||+|+||.||+|... +|+.||+|+++... ....+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 33678999999999999875 78999999997632 3456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE--CCCCcEEEeecccceecCCC
Q 003911 675 QGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL--GDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 170 ~~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 170 GGELFDRIIDE----SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp TCEEHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred CCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 99999888542 2358899999999999999999998 899999999999999 56789999999999987544
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.. .....||+.|+|||++.+..++ ++|+||.
T Consensus 243 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 274 (373)
T 2x4f_A 243 EK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSV 274 (373)
T ss_dssp CB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHH
T ss_pred cc--cccccCCCcEeChhhccCCCCCcHHhHHHH
Confidence 32 2335699999999999988888 8999983
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-30 Score=270.92 Aligned_cols=186 Identities=28% Similarity=0.443 Sum_probs=153.1
Q ss_pred hcCCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccc---cchhHHHHHHHHHHHHhcC---CCccceEEeEEEeC
Q 003911 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVI---SGKGLTEFKSEIAVLTKVR---HRHLVALLGHCLDG 663 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 663 (787)
..++|++.+.||+|+||+||+|+. .+++.||||++..... .......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999986 4789999999975332 1222356777888777764 99999999999876
Q ss_pred C-----eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcE
Q 003911 664 N-----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 738 (787)
Q Consensus 664 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 738 (787)
. ..++||||++ ++|.+++.. .....+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDK---APPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHT---CCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCE
Confidence 5 4789999996 699998854 222348999999999999999999998 899999999999999999999
Q ss_pred EEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 739 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 739 kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
||+|||+++...... ......||+.|+|||++.+..++ ++||||.
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 205 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSV 205 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHH
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHH
Confidence 999999998764432 22346799999999999998888 8999983
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-30 Score=266.82 Aligned_cols=186 Identities=28% Similarity=0.491 Sum_probs=141.7
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 457999999999999999999874 7999999999764322 23357899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|.+++.. ....+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EECCTTEEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 999999999998853 23568999999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... ......||+.|+|||++.+..++ ++|+||.
T Consensus 163 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 198 (278)
T 3cok_A 163 KMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSL 198 (278)
T ss_dssp C-----------------------------CTHHHHH
T ss_pred cCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHH
Confidence 54322 12235689999999999988888 8999983
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-30 Score=273.52 Aligned_cols=190 Identities=27% Similarity=0.449 Sum_probs=161.2
Q ss_pred cCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
.++|++.+.||+|+||.||+|... +++.||||+++.. ......+++.+|++++++++||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 467999999999999999999762 4578999999753 344556789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhc-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEE-------------------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLK 726 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 726 (787)
.++||||+++++|.+++...... ....+++.+++.++.|++.||+|||+ .+|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence 99999999999999999753321 12348899999999999999999998 899999999
Q ss_pred CCCEEECCCCcEEEeecccceecCCCCCce-eeeeccccCcccccccccCCcC-cceeecC
Q 003911 727 PSNILLGDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 727 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|+||++++++.+||+|||+++......... .....||+.|+|||++.+..++ ++||||.
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 238 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHH
Confidence 999999999999999999998775443221 2234578899999999998888 8999983
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=279.26 Aligned_cols=195 Identities=24% Similarity=0.346 Sum_probs=157.2
Q ss_pred HHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc---cchhHHHHHHHHHHHHhcCCCccceEEeEEEeC
Q 003911 588 LRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI---SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG 663 (787)
Q Consensus 588 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 663 (787)
+..+.++|++.+.||+|+||.||+|... +++.||+|++..... .....+++.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3456678999999999999999999875 788999999976422 345567899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhc-----------------------------------CCCCCCHHHHHHHHHHHHHH
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEE-----------------------------------GLKPLEWNRRLTIALDVARG 708 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~qi~~~ 708 (787)
+..++||||+++|+|.+++...... ....+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999988421111 01123577788999999999
Q ss_pred HHHHHhCCCCCeEEcCCCCCCEEECCCC--cEEEeecccceecCCCCC---ceeeeeccccCccccccccc--CCcC-cc
Q 003911 709 VEYLHGLAHQSFIHRDLKPSNILLGDDM--RAKVADFGLVRLAPEGKG---SIETRIAGTFGYLAPEYAVH--TRWS-SC 780 (787)
Q Consensus 709 L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~-~~ 780 (787)
|+|||+ .+|+||||||+||+++.++ .+||+|||+++....... .......||+.|+|||++.+ ..++ ++
T Consensus 181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999998 8999999999999998766 899999999987643221 12234679999999999976 5666 89
Q ss_pred eeecC
Q 003911 781 SYWAG 785 (787)
Q Consensus 781 DiWS~ 785 (787)
||||.
T Consensus 258 Diwsl 262 (345)
T 3hko_A 258 DAWSA 262 (345)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99983
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=278.03 Aligned_cols=186 Identities=25% Similarity=0.379 Sum_probs=147.5
Q ss_pred hhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
...++|++.+.||+|+||.||+|... +++.||||+++.........+.+.+|++++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34568999999999999999999865 78999999997655444556678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE-----CCCCcEEEeec
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL-----GDDMRAKVADF 743 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~DF 743 (787)
||||++ |+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++ ++.+.+||+||
T Consensus 111 v~e~~~-~~L~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDK-----NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEECCS-EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEecCC-CCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 999997 599988853 2358999999999999999999998 899999999999999 45556999999
Q ss_pred ccceecCCCCCceeeeeccccCcccccccccCC-cC-cceeecC
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS~ 785 (787)
|+++....... ......||+.|+|||++.+.. ++ ++||||.
T Consensus 182 g~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 224 (329)
T 3gbz_A 182 GLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSI 224 (329)
T ss_dssp THHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred CCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHH
Confidence 99987643322 223457899999999998754 66 8999983
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=274.73 Aligned_cols=195 Identities=28% Similarity=0.351 Sum_probs=164.3
Q ss_pred eeHHHHHhhcCCCccc-ceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeE
Q 003911 583 ISIQVLRNVTNNFSEE-NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGH 659 (787)
Q Consensus 583 ~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 659 (787)
..++..+.+.++|.+. +.||+|+||.||+|... +++.||+|+++..........++.+|+.+++++ .||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4455566777888887 89999999999999876 689999999987655555678899999999999 46999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC---CC
Q 003911 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DM 736 (787)
Q Consensus 660 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~ 736 (787)
+.+.+..++||||+++|+|.+++.. .....+++.+++.++.|++.||+|||+ .+|+||||||+||+++. ++
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCC
Confidence 9999999999999999999988743 223568999999999999999999998 89999999999999997 78
Q ss_pred cEEEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 737 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 737 ~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.+||+|||+++...... ......||+.|+|||++.+..++ ++|+||.
T Consensus 172 ~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 219 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNI 219 (327)
T ss_dssp CEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred cEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHH
Confidence 99999999998775432 22345799999999999998888 8999983
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-30 Score=299.77 Aligned_cols=185 Identities=26% Similarity=0.371 Sum_probs=161.7
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (787)
.++|++.+.||+|+||.||+|+.. +++.||||++++... .....+.+..|.+++..+ +||+|+++++++.+.+..|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 468999999999999999999876 688999999986432 234556788999999988 79999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+|+.
T Consensus 420 V~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999998542 368999999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... ......+||+.|||||++.+..|+ ++|+||.
T Consensus 492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSl 528 (674)
T 3pfq_A 492 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 528 (674)
T ss_dssp CCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHH
T ss_pred cccCC-cccccccCCCcccCHhhhcCCCCCccceEech
Confidence 54332 223457899999999999999998 8999983
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-30 Score=278.72 Aligned_cols=181 Identities=27% Similarity=0.447 Sum_probs=151.9
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC-----
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----- 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 664 (787)
+.++|++.+.||+|+||.||+|... +|+.||||++..........+++.+|++++++++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3578999999999999999999874 7999999999765545556678999999999999999999999998653
Q ss_pred -eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 665 -EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 665 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
..|+||||+ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEee
Confidence 459999999 8899998853 368899999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
|+++..... ....+||+.|+|||++.+ ..++ ++|+||.
T Consensus 173 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 212 (367)
T 1cm8_A 173 GLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSV 212 (367)
T ss_dssp TTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHH
T ss_pred ecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHH
Confidence 999876432 234678999999999987 5677 8999983
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=277.57 Aligned_cols=180 Identities=26% Similarity=0.441 Sum_probs=154.4
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (787)
+.++|++.+.||+|+||.||+|... +++.||||++..... ...+|++++.++ +||||+++++++.+.+..|+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 4567999999999999999999876 689999999976432 235688888888 79999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC----CcEEEeecc
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAKVADFG 744 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFG 744 (787)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||++.++ +.+||+|||
T Consensus 94 v~E~~~gg~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 94 VTELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EECCCCSCBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 9999999999998843 2468999999999999999999998 899999999999998543 359999999
Q ss_pred cceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+++....... .....+||+.|+|||++.+..++ ++|+||.
T Consensus 166 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 206 (342)
T 2qr7_A 166 FAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSL 206 (342)
T ss_dssp TCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHH
T ss_pred CcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeH
Confidence 9987755432 22346789999999999988888 8999983
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=281.91 Aligned_cols=185 Identities=24% Similarity=0.366 Sum_probs=157.5
Q ss_pred CCCcccceeccccceEEEEEEE----eCCcEEEEEEeecccc--cchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCe
Q 003911 593 NNFSEENILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNE 665 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 665 (787)
++|++.+.||+|+||.||+|+. .+++.||||+++.... .....+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999987 3789999999875432 123445678899999999 69999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred EEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999998542 368899999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCCceeeeeccccCcccccccccC--CcC-cceeecC
Q 003911 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVHT--RWS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~~DiWS~ 785 (787)
++.............+||+.|+|||++.+. .++ ++||||.
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dvwsl 248 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 248 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHH
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHH
Confidence 987654333333446799999999999864 355 8999983
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-30 Score=264.92 Aligned_cols=182 Identities=27% Similarity=0.430 Sum_probs=158.1
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+.++|++.+.||+|+||.||+|... ++..||+|++.... ....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 4567999999999999999999876 57899999997643 23467899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---CCCCcEEEeecccc
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLV 746 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a 746 (787)
|||+++++|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 85 MELCTGGELFERVVH-----KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EeccCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 999999999998854 1358999999999999999999998 899999999999999 78899999999999
Q ss_pred eecCCCCCceeeeeccccCcccccccccCCcCcceeec
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTRWSSCSYWA 784 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiWS 784 (787)
....... ......||+.|+|||++.+....++|+||
T Consensus 157 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~Di~s 192 (277)
T 3f3z_A 157 ARFKPGK--MMRTKVGTPYYVSPQVLEGLYGPECDEWS 192 (277)
T ss_dssp EECCTTS--CBCCCCSCTTTCCHHHHTTCBCTTHHHHH
T ss_pred eeccCcc--chhccCCCCCccChHHhcccCCchhhehh
Confidence 8775433 22345799999999998776333999998
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-30 Score=268.35 Aligned_cols=183 Identities=30% Similarity=0.481 Sum_probs=159.0
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
++|++.+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 57899999999999999999988889999999976432 346899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++++|.+++.. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 85 MEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CTTCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHhh----CcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 999999999854 22468899999999999999999998 89999999999999999999999999999866432
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.........||+.|+|||++.+..++ ++|+||.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 191 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 191 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cccccccccccccccChhhhcCCCccchhchhhh
Confidence 21122234578899999999988888 8999983
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=271.08 Aligned_cols=185 Identities=25% Similarity=0.518 Sum_probs=156.6
Q ss_pred CCCcccceeccccceEEEEEEE-----eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC--Ce
Q 003911 593 NNFSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NE 665 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 665 (787)
++|++.+.||+|+||.||+|++ .+++.||||++.... .....+++.+|++++++++||||+++++++.+. ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4688999999999999999984 368999999997643 344567899999999999999999999999876 56
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccc
Confidence 89999999999999998542 2468999999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCCc--eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 746 VRLAPEGKGS--IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++........ ......||..|+|||++.+..++ ++|+||.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 215 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF 215 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHH
Confidence 9887654321 12235688899999999998888 8999983
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=266.27 Aligned_cols=185 Identities=24% Similarity=0.377 Sum_probs=161.5
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999876 688999999976543 244567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.++..
T Consensus 94 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 94 LELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EECCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 999999999998743 1368999999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... ......||+.|+|||++.+..++ ++|+||.
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 201 (294)
T 2rku_A 166 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI 201 (294)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHH
T ss_pred ccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHH
Confidence 53322 22345789999999999988888 8999983
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.96 E-value=8.4e-30 Score=279.30 Aligned_cols=179 Identities=23% Similarity=0.368 Sum_probs=145.0
Q ss_pred cCCCccc-ceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEe----CC
Q 003911 592 TNNFSEE-NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD----GN 664 (787)
Q Consensus 592 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~ 664 (787)
.++|.+. +.||+|+||.||+|... +++.||||++.. ...+.+|++++.++ +||||+++++++.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 4567776 78999999999999875 689999999864 24577888887554 89999999999875 56
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC---CCcEEEe
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVA 741 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 741 (787)
..|+||||+++|+|.+++... ....+++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEEEeCCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEE
Confidence 689999999999999998542 22468999999999999999999998 89999999999999997 7899999
Q ss_pred ecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 742 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|||+++...... .....+||+.|+|||++.+..++ ++||||.
T Consensus 207 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 249 (400)
T 1nxk_A 207 DFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 249 (400)
T ss_dssp CCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHH
T ss_pred ecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHH
Confidence 999998765432 22346789999999999988888 8999983
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-30 Score=270.93 Aligned_cols=186 Identities=23% Similarity=0.313 Sum_probs=150.6
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999875 7899999999764332 33457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 113 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999998542 368999999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
............||+.|+|||++.+..++ ++|+||.
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 221 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYAL 221 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHH
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHH
Confidence 55433333446799999999999988888 8999983
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-30 Score=267.68 Aligned_cols=183 Identities=29% Similarity=0.515 Sum_probs=156.2
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||.||+|... +++.||+|++...... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467999999999999999999876 6789999999764322 23356789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999988542 358999999999999999999997 89999999999999999999999999998655
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... .....||+.|+|||++.+..++ ++|+||.
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (279)
T 3fdn_A 160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSL 193 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred Cccc---ccccCCCCCccCHhHhccCCCCccchhHhH
Confidence 3322 2345789999999999988888 8999983
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-30 Score=266.46 Aligned_cols=184 Identities=28% Similarity=0.476 Sum_probs=158.0
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.++|++.+.||+|+||.||+|...++..||||++.... ...+.+.+|++++++++||||+++++++. .+..++|||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 46799999999999999999998888899999997633 23578999999999999999999999986 456899999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++++|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||.++....
T Consensus 88 ~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 9999999999854221 258899999999999999999998 8999999999999999999999999999988755
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..........+++.|+|||++.+..++ ++|+||.
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 196 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHH
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHH
Confidence 432222334578899999999988888 8999983
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-30 Score=275.46 Aligned_cols=191 Identities=27% Similarity=0.441 Sum_probs=158.1
Q ss_pred hcCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeC
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG 663 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 663 (787)
..++|++.+.||+|+||.||+|+.. ++..||||++.... .....+.+.+|+++++++ +||||+++++++...
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3468999999999999999999862 45689999997532 334557899999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhc------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEE------------------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDL 725 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl 725 (787)
+..++||||+++|+|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCC
Confidence 9999999999999999999653211 11347899999999999999999998 89999999
Q ss_pred CCCCEEECCCCcEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 726 KPSNILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 726 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++ ++||||.
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 260 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 260 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHH
Confidence 999999999999999999999876544322 22335678899999999988888 8999983
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=280.62 Aligned_cols=183 Identities=22% Similarity=0.334 Sum_probs=153.9
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcC--CCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR--HRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|...+++.||||++..........+.+.+|++++++++ ||||+++++++...+..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999998888999999999876555666788999999999996 599999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
| +.+++|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++...
T Consensus 136 E-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp E-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred e-cCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9 568899999854 2368889999999999999999997 8999999999999995 5789999999998765
Q ss_pred CCCCc-eeeeeccccCccccccccc-----------CCcC-cceeecC
Q 003911 751 EGKGS-IETRIAGTFGYLAPEYAVH-----------TRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~-~~DiWS~ 785 (787)
..... .....+||+.|+|||++.+ ..++ ++||||.
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSl 253 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHH
Confidence 43322 2234679999999999976 3566 8999983
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=271.94 Aligned_cols=185 Identities=24% Similarity=0.378 Sum_probs=161.8
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|.+.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999876 588999999976533 344567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp ECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 9999999999987541 468999999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... ......||+.|+|||++.+..++ ++|+||.
T Consensus 192 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 227 (335)
T 2owb_A 192 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI 227 (335)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHH
T ss_pred ccCcc-cccccCCCccccCHHHhccCCCCchhhHHHH
Confidence 53322 22346799999999999988888 8999983
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-30 Score=287.54 Aligned_cols=183 Identities=31% Similarity=0.536 Sum_probs=152.5
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.++|++.+.||+|+||.||+|.+..+..||||+++... ...+++.+|++++++++||||+++++++.+ +..++|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 46789999999999999999999878889999997643 235689999999999999999999999876 67899999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++|+|.+++..... ..+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 259 ~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999964221 358899999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..........+++.|+|||++.+..++ ++||||
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws 366 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHH
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHh
Confidence 332223334578899999999988888 999998
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=282.76 Aligned_cols=178 Identities=33% Similarity=0.554 Sum_probs=154.2
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC-eeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-EKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|... ++.||||+++... ..+++.+|++++++++||||+++++++...+ ..++||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 467899999999999999999875 8899999997632 4578999999999999999999999987765 789999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++... +...+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++...
T Consensus 267 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp ECCTTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999652 23357899999999999999999998 899999999999999999999999999998653
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
... ....+++.|+|||++.+..++ ++||||
T Consensus 341 ~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvws 371 (450)
T 1k9a_A 341 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWS 371 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHH
T ss_pred ccc----cCCCCCcceeCHHHhcCCCCCcHHHHHH
Confidence 321 223578899999999999888 999998
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=262.71 Aligned_cols=209 Identities=23% Similarity=0.348 Sum_probs=168.6
Q ss_pred EEEcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCC
Q 003911 62 VVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSS 140 (787)
Q Consensus 62 v~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 140 (787)
-.|.... .+.++.++++++ .+|..+ .++|++|+|++|+|++.++ .|.++++|++|+|++|+++++.+..|.++++
T Consensus 6 C~C~~~~-~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 81 (285)
T 1ozn_A 6 CVCYNEP-KVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81 (285)
T ss_dssp CEEECSS-SCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred ceECCCC-CeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccC
Confidence 3454332 367888888888 667655 4789999999999999776 6899999999999999999998889999999
Q ss_pred CcEEEccCCC-CCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCccccccccee
Q 003911 141 LQSIEIDNNP-FSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLW 219 (787)
Q Consensus 141 L~~L~L~~N~-l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~ 219 (787)
|++|+|++|+ +.. ..|..+..+++|++|++++|.+++..|..+. .+++|++|+|++|++++..+..|.
T Consensus 82 L~~L~l~~n~~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~-------- 150 (285)
T 1ozn_A 82 LEQLDLSDNAQLRS-VDPATFHGLGRLHTLHLDRCGLQELGPGLFR--GLAALQYLYLQDNALQALPDDTFR-------- 150 (285)
T ss_dssp CCEEECCSCTTCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTT--TCTTCCEEECCSSCCCCCCTTTTT--------
T ss_pred CCEEeCCCCCCccc-cCHHHhcCCcCCCEEECCCCcCCEECHhHhh--CCcCCCEEECCCCcccccCHhHhc--------
Confidence 9999999997 764 4477888888999999999988888888776 788888888888888865554443
Q ss_pred eccCCCCCcCCCCccccccCccCceEeccccccccCCCC-CCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCc
Q 003911 220 VNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 298 (787)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 298 (787)
++++|++|+|++|++++.++. +..+++|+.|+|++|++++..|..|..+++|++|+|++|+
T Consensus 151 ------------------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 212 (285)
T 1ozn_A 151 ------------------DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212 (285)
T ss_dssp ------------------TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred ------------------cCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCc
Confidence 678888888888888877664 7778888888888888887778888888888888888887
Q ss_pred ccccC
Q 003911 299 LQGPV 303 (787)
Q Consensus 299 l~~~~ 303 (787)
+++.+
T Consensus 213 l~~~~ 217 (285)
T 1ozn_A 213 LSALP 217 (285)
T ss_dssp CSCCC
T ss_pred CCcCC
Confidence 76543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=265.02 Aligned_cols=184 Identities=26% Similarity=0.419 Sum_probs=157.7
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccc----hhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
.++|++.+.||+|+||.||+|+.. +++.||+|+++...... ...+++.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999876 68999999998654321 2467899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC----cEEEee
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVAD 742 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~D 742 (787)
++||||+++++|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE-----KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEeecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 999999999999999854 1368999999999999999999998 8999999999999998877 899999
Q ss_pred cccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 743 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
||.+....... ......||+.|+|||++.+..++ ++|+||.
T Consensus 156 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 197 (283)
T 3bhy_A 156 FGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 197 (283)
T ss_dssp CTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred cccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhH
Confidence 99998765432 22345689999999999988888 8999983
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=272.32 Aligned_cols=190 Identities=26% Similarity=0.458 Sum_probs=159.2
Q ss_pred cCCCcccceeccccceEEEEEEE--------eCCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEe
Q 003911 592 TNNFSEENILGRGGFGTVYKGEL--------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 662 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 662 (787)
.++|++.+.||+|+||.||+|+. .++..||||+++.. ......+++.+|+++++++ +||||+++++++.+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 46899999999999999999986 35678999999763 2445567899999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 003911 663 GNEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (787)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 731 (787)
.+..++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ .+|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEE
Confidence 99999999999999999999653211 11348899999999999999999998 89999999999999
Q ss_pred ECCCCcEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 732 LGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 732 l~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++.++.+||+|||+++........ ......+|+.|+|||++.+..++ ++||||.
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 245 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHH
Confidence 999999999999999877544321 12234578899999999988888 8999983
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=290.05 Aligned_cols=184 Identities=28% Similarity=0.435 Sum_probs=153.9
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+.++|++.+.||+|+||.||+|+.. ++..||+|++............+.+|++++++++||||+++++++.+....|+|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999876 789999999987655555567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC---CCcEEEeecccc
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVADFGLV 746 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~a 746 (787)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 115 ~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999888542 468999999999999999999998 89999999999999975 455999999999
Q ss_pred eecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+...... .....+||+.|+|||++.+ .++ ++||||.
T Consensus 187 ~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~Diwsl 223 (494)
T 3lij_A 187 AVFENQK--KMKERLGTAYYIAPEVLRK-KYDEKCDVWSI 223 (494)
T ss_dssp EECBTTB--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHH
T ss_pred eECCCCc--cccccCCCcCeeCHHHHcc-cCCCchhHHHH
Confidence 8875433 2334679999999999875 465 9999983
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-30 Score=289.20 Aligned_cols=184 Identities=29% Similarity=0.454 Sum_probs=158.9
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+.++|++.+.||+|+||.||+|... +++.||||++............+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567999999999999999999875 789999999976544455667899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC---CCCcEEEeecccc
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGLV 746 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG~a 746 (787)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++ .++.+||+|||++
T Consensus 100 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999988542 468999999999999999999998 8999999999999995 5567999999999
Q ss_pred eecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+...... .....+||+.|+|||++.+. ++ ++||||.
T Consensus 172 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~Diwsl 208 (486)
T 3mwu_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSA 208 (486)
T ss_dssp TTBCCC------CCTTGGGGCCGGGGGSC-CCHHHHHHHH
T ss_pred eECCCCC--ccCCCcCCCCCCCHHHhCCC-CCchhhHHHH
Confidence 8664432 22346799999999999875 66 9999983
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-30 Score=271.04 Aligned_cols=190 Identities=27% Similarity=0.442 Sum_probs=161.3
Q ss_pred cCCCcccceeccccceEEEEEEE------eCCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCC
Q 003911 592 TNNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 664 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 664 (787)
.++|++.+.||+|+||.||+|+. .+++.||||+++... .....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 46799999999999999999975 246889999997632 334567899999999999 9999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhhhh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAE-------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 731 (787)
..++||||+++|+|.+++..... .....+++.+++.++.|++.||+|||+ .+|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence 99999999999999999865321 112358999999999999999999998 89999999999999
Q ss_pred ECCCCcEEEeecccceecCCCCCce-eeeeccccCcccccccccCCcC-cceeecC
Q 003911 732 LGDDMRAKVADFGLVRLAPEGKGSI-ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 732 l~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++.++.+||+|||+++......... .....||+.|+|||++.+..++ ++||||.
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 233 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHH
Confidence 9999999999999998775543322 2234578899999999998888 8999983
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-30 Score=272.75 Aligned_cols=185 Identities=26% Similarity=0.418 Sum_probs=155.0
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|+.. +++.||||++..........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357999999999999999999876 5899999999775555555677899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 104 e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 104 EFVDHTILDDLEL-----FPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp ECCSEEHHHHHHH-----STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecCCcchHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 9999988887653 23468999999999999999999998 899999999999999999999999999998764
Q ss_pred CCCCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
.... ......||+.|+|||++.+. .++ ++||||.
T Consensus 176 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~sl 211 (331)
T 4aaa_A 176 APGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAI 211 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHH
T ss_pred CCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHH
Confidence 4322 22345789999999999876 566 8999983
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=268.66 Aligned_cols=183 Identities=30% Similarity=0.524 Sum_probs=156.6
Q ss_pred CCC-cccceeccccceEEEEEEEe-----CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC--C
Q 003911 593 NNF-SEENILGRGGFGTVYKGELH-----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--N 664 (787)
Q Consensus 593 ~~~-~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~ 664 (787)
++| ++.+.||+|+||.||++.+. +++.||||+++.. ......+.+.+|++++++++||||+++++++.+. .
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 345 89999999999999988653 6889999999764 3445567899999999999999999999999874 5
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..++||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred eEEEEEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcc
Confidence 78999999999999999843 348999999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCCc--eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 745 LVRLAPEGKGS--IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+++........ ......||+.|+|||++.+..++ ++||||.
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 223 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 223 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHH
Confidence 99987654321 12334578899999999998888 8999983
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-30 Score=273.65 Aligned_cols=184 Identities=29% Similarity=0.493 Sum_probs=148.8
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcE----EEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
++|++.+.||+|+||.||+|++. +++. ||+|.+... ......+++.+|++++++++||||+++++++.+.. .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 57999999999999999999864 4443 577777542 23445678999999999999999999999998765 78
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+|+||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+
T Consensus 93 ~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEECCTTCBHHHHHHH----STTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCccee
Confidence 99999999999999854 23468999999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCCc-eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 748 LAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
........ ......||+.|+|||++.+..++ ++||||.
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 205 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhh
Confidence 76544322 22234578899999999999998 9999983
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=266.72 Aligned_cols=189 Identities=23% Similarity=0.419 Sum_probs=159.9
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe--CCeeEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNEKLL 668 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 668 (787)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+.+|++++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999875 78999999998765556667889999999999999999999998864 567899
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEEcCCCCCCEEECCCCcEEEeec
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS-----FIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
||||+++++|.+++..... ....+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 9999999999999976433 23468999999999999999999998 56 999999999999999999999999
Q ss_pred ccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|.++....... ......||+.|+|||++.+..++ ++|+||.
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 202 (279)
T 2w5a_A 161 GLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSL 202 (279)
T ss_dssp CHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHH
T ss_pred chheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHH
Confidence 99987644321 12235689999999999998888 8999983
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=285.55 Aligned_cols=184 Identities=27% Similarity=0.436 Sum_probs=155.7
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccc-----------hhHHHHHHHHHHHHhcCCCccceEEe
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-----------KGLTEFKSEIAVLTKVRHRHLVALLG 658 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~~~~ 658 (787)
+.++|++.+.||+|+||.||+|+.. +++.||||++....... ...+++.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4678999999999999999999876 68899999997643221 34578999999999999999999999
Q ss_pred EEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC--
Q 003911 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-- 736 (787)
Q Consensus 659 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 736 (787)
++.+....++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999988542 468999999999999999999998 8999999999999998765
Q ss_pred -cEEEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 737 -RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 737 -~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.+||+|||+++...... ......||+.|+|||++.+. ++ ++||||.
T Consensus 186 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~Diwsl 233 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKKK-YNEKCDVWSC 233 (504)
T ss_dssp SSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTTC-BCTHHHHHHH
T ss_pred ccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhccC-CCchHHHHHH
Confidence 69999999998875443 22346799999999998754 55 9999983
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=274.79 Aligned_cols=182 Identities=26% Similarity=0.379 Sum_probs=148.8
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC-----
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----- 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 664 (787)
..++|++.+.||+|+||.||+|... +++.||||++..........+++.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3478999999999999999999865 6899999999875555556678999999999999999999999998665
Q ss_pred -eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 665 -EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 665 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
..++||||++ ++|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cceEEEEEcCC-CCHHHHHh-------hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEe
Confidence 6899999996 57877773 258899999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|+++...... ......||+.|+|||++.+..++ ++||||.
T Consensus 172 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 212 (371)
T 2xrw_A 172 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 212 (371)
T ss_dssp CC------------------CTTCCHHHHTTCCCCTTHHHHHH
T ss_pred eccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHH
Confidence 9998764332 22346799999999999998888 8999983
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=270.79 Aligned_cols=188 Identities=23% Similarity=0.391 Sum_probs=152.1
Q ss_pred HHHHHhhcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhc--CCCccceEEeEEEe
Q 003911 585 IQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV--RHRHLVALLGHCLD 662 (787)
Q Consensus 585 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~ 662 (787)
......+.++|++.+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++... +||||+++++++..
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 3344556678999999999999999999875 899999998652 234455566666555 89999999999988
Q ss_pred C----CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEcCCCCCCEEEC
Q 003911 663 G----NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA-----HQSFIHRDLKPSNILLG 733 (787)
Q Consensus 663 ~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~ 733 (787)
. ...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.. +.+|+||||||+||+++
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 7 678999999999999999854 35899999999999999999999710 12999999999999999
Q ss_pred CCCcEEEeecccceecCCCCCce---eeeeccccCcccccccccCCcC-c------ceeec
Q 003911 734 DDMRAKVADFGLVRLAPEGKGSI---ETRIAGTFGYLAPEYAVHTRWS-S------CSYWA 784 (787)
Q Consensus 734 ~~~~~kl~DFG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~-~------~DiWS 784 (787)
.++.+||+|||+++......... .....||+.|+|||++.+..+. . +||||
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diws 237 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHH
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHH
Confidence 99999999999998765433221 1235799999999999887665 3 89998
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-30 Score=273.04 Aligned_cols=193 Identities=26% Similarity=0.449 Sum_probs=162.0
Q ss_pred HhhcCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe
Q 003911 589 RNVTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 662 (787)
Q Consensus 589 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 662 (787)
+...++|++.+.||+|+||.||+|... +++.||||++... .......++.+|++++++++||||+++++++.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 344578999999999999999999754 4788999999753 234456679999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHhhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc
Q 003911 663 GNEKLLVFEYMPQGTLSRHIFNWAEE-----GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (787)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 737 (787)
.+..++||||+++|+|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCe
Confidence 99999999999999999998764321 12457899999999999999999998 89999999999999999999
Q ss_pred EEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 738 AKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 738 ~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+||+|||+++........ ......||+.|+|||++.+..++ ++|+||.
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 226 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHH
Confidence 999999999865433211 11224578899999999988888 8999983
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=272.92 Aligned_cols=185 Identities=25% Similarity=0.412 Sum_probs=156.2
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC--------
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-------- 663 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------- 663 (787)
++|++.+.||+|+||.||+|+.. +++.||||++............+.+|++++++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57999999999999999999874 789999999977555555567888999999999999999999999873
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
+..++||||+++ +|.+.+.. ....+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCC-CHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 468999999974 77777643 23468999999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCC---ceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 744 GLVRLAPEGKG---SIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
|+++....... .......||+.|+|||++.+. .++ ++||||.
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 215 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 215 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHH
Confidence 99987653221 122345789999999999774 456 8999983
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=280.08 Aligned_cols=185 Identities=26% Similarity=0.426 Sum_probs=146.8
Q ss_pred hhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc------chhHHHHHHHHHHHHhcCCCccceEEeEEEe
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS------GKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 662 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 662 (787)
...++|.+.+.||+|+||.||+|... +++.||||++...... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45678999999999999999999865 6899999999764322 112235889999999999999999999975
Q ss_pred CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC---CcEE
Q 003911 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAK 739 (787)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~k 739 (787)
.+..++||||+++|+|.+++. ....+++.++..++.|++.||+|||+ .+|+||||||+|||++.+ ..+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS-----SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred cCceEEEEEcCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEE
Confidence 456899999999999988773 23568999999999999999999998 899999999999999754 4599
Q ss_pred EeecccceecCCCCCceeeeeccccCccccccccc---CCcC-cceeecC
Q 003911 740 VADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVH---TRWS-SCSYWAG 785 (787)
Q Consensus 740 l~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~-~~DiWS~ 785 (787)
|+|||+|+...... .....+||+.|+|||++.+ ..++ ++|+||.
T Consensus 283 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl 330 (419)
T 3i6u_A 283 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHH
T ss_pred EeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhH
Confidence 99999998765432 2334679999999999864 4566 8999983
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=264.89 Aligned_cols=183 Identities=19% Similarity=0.274 Sum_probs=158.0
Q ss_pred hcCCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (787)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++++++ +|++++++++++.+....++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 356899999999999999999986 479999999986532 234678999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc-----EEEeec
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-----AKVADF 743 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DF 743 (787)
||||+ +++|.+++... ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++. +||+||
T Consensus 84 v~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 155 (298)
T ss_dssp EEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred EEEec-CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence 99999 99999998542 2468999999999999999999997 89999999999999987766 999999
Q ss_pred ccceecCCCCCc------eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 744 GLVRLAPEGKGS------IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|+++........ ......||+.|+|||++.+..++ ++||||.
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 204 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEAL 204 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHH
Confidence 999877654321 12346799999999999998888 8999983
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=263.87 Aligned_cols=183 Identities=25% Similarity=0.466 Sum_probs=161.2
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.+.|++.+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 357999999999999999999865 68999999997643 2345678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 100 e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 100 EYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp ECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecC
Confidence 99999999998832 468999999999999999999998 899999999999999999999999999998775
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... ......||+.|+|||++.+..++ ++|+||.
T Consensus 171 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 205 (303)
T 3a7i_A 171 DTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 205 (303)
T ss_dssp TTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred cccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHH
Confidence 4332 22345789999999999988888 8999983
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=264.41 Aligned_cols=183 Identities=26% Similarity=0.483 Sum_probs=159.6
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357999999999999999999876 6889999999764322 23356799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 93 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999988542 358899999999999999999997 89999999999999999999999999999766
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... .....||+.|+|||++.+..++ ++|+||.
T Consensus 165 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 198 (284)
T 2vgo_A 165 PSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCA 198 (284)
T ss_dssp SSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHH
T ss_pred cccc---cccccCCCCcCCHHHhccCCCCcccchhhH
Confidence 4432 2335789999999999998888 8999983
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=263.34 Aligned_cols=181 Identities=31% Similarity=0.538 Sum_probs=145.3
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeeccccc--chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS--GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||.||+|... ++.||||+++..... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 367999999999999999999875 899999998764322 23457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEEcCCCCCCEEECC--------CCcE
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS---FIHRDLKPSNILLGD--------DMRA 738 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~---ivH~Dlkp~NIll~~--------~~~~ 738 (787)
|||+++++|.+++. ...+++..+..++.|++.||+|||+ .+ |+||||||+||+++. ++.+
T Consensus 85 ~e~~~~~~L~~~~~------~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 85 MEFARGGPLNRVLS------GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp EECCTTEEHHHHHT------SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EEcCCCCCHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcce
Confidence 99999999998883 2468999999999999999999998 56 999999999999986 6789
Q ss_pred EEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 739 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 739 kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
||+|||+++...... .....||+.|+|||++.+..++ ++|+||.
T Consensus 156 kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (271)
T 3dtc_A 156 KITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSY 200 (271)
T ss_dssp EECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHH
T ss_pred EEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHH
Confidence 999999998664432 2235689999999999998888 8999983
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.6e-30 Score=264.28 Aligned_cols=180 Identities=21% Similarity=0.333 Sum_probs=157.0
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC--CeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG--NEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|+.. ++.||||+++.........+++.+|++++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57999999999999999999985 89999999987665666678899999999999999999999999887 7789999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||+++|+|.+++.. .....+++.+++.++.|++.||+|||+ .+ |+||||||+||++++++.++|+|||++..
T Consensus 89 e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 89 HWMPYGSLYNVLHE---GTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp ECCTTCBHHHHHHS---CSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred cccCCCcHHHHHhh---cccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999999999954 222358999999999999999999997 67 99999999999999999999999998765
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC----cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS----SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~DiWS~ 785 (787)
.... ...||+.|+|||++.+..++ ++||||.
T Consensus 163 ~~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~sl 197 (271)
T 3kmu_A 163 FQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSF 197 (271)
T ss_dssp TSCT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHH
T ss_pred eccc------CccCCccccChhhhccCCCCCCCchhhHHHH
Confidence 4322 24689999999999887655 5999983
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=254.84 Aligned_cols=218 Identities=22% Similarity=0.383 Sum_probs=196.2
Q ss_pred CCCCCcccEEEcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCC
Q 003911 54 TDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPS 132 (787)
Q Consensus 54 ~~~C~w~gv~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~ 132 (787)
.|.|.|.|+.|....+++.+++++++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+++.+++
T Consensus 2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~ 78 (270)
T 2o6q_A 2 EALCKKDGGVCSCNNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPA 78 (270)
T ss_dssp CCCBGGGTCSBEEETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCT
T ss_pred CccCCCCCCCCEeCCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeCh
Confidence 4789999999987677889999999999 6887776 689999999999999887 79999999999999999999999
Q ss_pred ccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCccc
Q 003911 133 DFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG 212 (787)
Q Consensus 133 ~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 212 (787)
..|.++++|++|+|++|+++. ..+..|..+++|++|++++|++++..+..|. .+++|++|+|++|++++..+..|.
T Consensus 79 ~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~Ls~n~l~~~~~~~~~- 154 (270)
T 2o6q_A 79 GIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFD--SLTKLTYLSLGYNELQSLPKGVFD- 154 (270)
T ss_dssp TTTSSCTTCCEEECCSSCCCC-CCTTTTTTCSSCCEEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCCCCCTTTTT-
T ss_pred hhhcCCCCCCEEECCCCcCCc-CCHhHcccccCCCEEECCCCccCeeCHHHhC--cCcCCCEEECCCCcCCccCHhHcc-
Confidence 999999999999999999995 3456789999999999999999999988886 899999999999999966555443
Q ss_pred ccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCCC-CCCCCCCCEEecCCCcccccCCccccCCCCCCE
Q 003911 213 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 291 (787)
Q Consensus 213 ~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 291 (787)
.+++|++|+|++|++++.++. |..+++|++|+|++|+|++..+..|..+++|+.
T Consensus 155 -------------------------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 209 (270)
T 2o6q_A 155 -------------------------KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKM 209 (270)
T ss_dssp -------------------------TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred -------------------------CCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCE
Confidence 789999999999999998875 888999999999999999766777999999999
Q ss_pred EEccCCcccccC
Q 003911 292 VNMTNNLLQGPV 303 (787)
Q Consensus 292 L~Ls~N~l~~~~ 303 (787)
|+|++|++....
T Consensus 210 L~l~~N~~~c~c 221 (270)
T 2o6q_A 210 LQLQENPWDCTC 221 (270)
T ss_dssp EECCSSCBCCSS
T ss_pred EEecCCCeeCCC
Confidence 999999987543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=272.57 Aligned_cols=192 Identities=28% Similarity=0.457 Sum_probs=163.3
Q ss_pred eHHHHHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc------chhHHHHHHHHHHHHhc-CCCccce
Q 003911 584 SIQVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS------GKGLTEFKSEIAVLTKV-RHRHLVA 655 (787)
Q Consensus 584 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l-~h~niv~ 655 (787)
.......+.++|++.+.||+|+||.||+|... +|+.||||++...... ....+.+.+|+++++++ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34455666788999999999999999999886 7999999999764321 12245688999999999 7999999
Q ss_pred EEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC
Q 003911 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD 735 (787)
Q Consensus 656 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 735 (787)
+++++......++||||+++++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++++
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~ 236 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTE-----KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDN 236 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTT
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCC
Confidence 99999999999999999999999999854 1368999999999999999999998 899999999999999999
Q ss_pred CcEEEeecccceecCCCCCceeeeeccccCcccccccccC------CcC-cceeecC
Q 003911 736 MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHT------RWS-SCSYWAG 785 (787)
Q Consensus 736 ~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~-~~DiWS~ 785 (787)
+.+||+|||++....... ......||+.|+|||++.+. .++ ++||||.
T Consensus 237 ~~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 291 (365)
T 2y7j_A 237 MQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291 (365)
T ss_dssp CCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHH
T ss_pred CCEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhH
Confidence 999999999998775443 22346799999999998643 456 8999983
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-30 Score=267.57 Aligned_cols=180 Identities=22% Similarity=0.385 Sum_probs=154.9
Q ss_pred cCCCcccceeccccceEEEEEEEe-CC-------cEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DG-------TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG 663 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 663 (787)
.++|++.+.||+|+||.||+|+.. ++ ..||+|++... .....+++.+|++++++++||||+++++++.++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 357999999999999999999765 33 57999998653 344567899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc------
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR------ 737 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~------ 737 (787)
+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred CCCEEEEECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccc
Confidence 9999999999999999998642 2348899999999999999999998 89999999999999998877
Q ss_pred --EEEeecccceecCCCCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 738 --AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 738 --~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
+||+|||.+...... ....||+.|+|||++.+ ..++ ++||||.
T Consensus 158 ~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 204 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSF 204 (289)
T ss_dssp CEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHH
T ss_pred ceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHH
Confidence 999999998755322 23468999999999987 5677 8999983
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=270.99 Aligned_cols=180 Identities=28% Similarity=0.462 Sum_probs=155.1
Q ss_pred CCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
+.|++.+.||+|+||.||+|+. .+++.||||++..... .....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588999999999999999986 4799999999976432 2344567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||++ |++.+++... ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 134 e~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp ECCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred ecCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 9996 6888877432 2468999999999999999999998 899999999999999999999999999998764
Q ss_pred CCCCceeeeeccccCcccccccc---cCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAV---HTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~-~~DiWS~ 785 (787)
.. ....||+.|+|||++. +..++ ++||||.
T Consensus 206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl 239 (348)
T 1u5q_A 206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 239 (348)
T ss_dssp SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHH
T ss_pred CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHH
Confidence 32 2357999999999985 45666 8999983
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=265.88 Aligned_cols=189 Identities=24% Similarity=0.431 Sum_probs=151.8
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccc-ccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||.||+|... +++.||||++.... ......+++.+|++++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 457999999999999999999864 79999999997633 2345567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|.+++..... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 111 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999865443 23568999999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... ......||+.|+|||++.+..++ ++|+||.
T Consensus 187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 222 (310)
T 2wqm_A 187 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSL 222 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHH
T ss_pred cCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHH
Confidence 44322 22335689999999999998888 8999983
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=261.76 Aligned_cols=186 Identities=26% Similarity=0.434 Sum_probs=160.1
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+.++|++.+.||+|+||.||+|... +++.||||++.... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 3467999999999999999999876 78999999997643 234567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+...
T Consensus 84 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 84 LEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp EECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 999999999988732 3468999999999999999999998 89999999999999999999999999999866
Q ss_pred CCCCC-ceeeeeccccCcccccccccCCc-C-cceeecC
Q 003911 750 PEGKG-SIETRIAGTFGYLAPEYAVHTRW-S-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~-~~DiWS~ 785 (787)
..... .......||+.|+|||++.+..+ + ++|+||.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 194 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHH
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHH
Confidence 43221 12234578999999999988776 4 7999983
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-30 Score=279.77 Aligned_cols=186 Identities=24% Similarity=0.388 Sum_probs=157.5
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC--eeEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN--EKLL 668 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l 668 (787)
.++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 457999999999999999999876 58999999997633 2334677889999999999999999999998765 6799
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE----CCCCcEEEeecc
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMRAKVADFG 744 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFG 744 (787)
||||+++|+|.+++..... ...+++..++.++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||
T Consensus 87 v~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EECCCTTEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEecCCCCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 9999999999999855322 2348999999999999999999998 899999999999999 777889999999
Q ss_pred cceecCCCCCceeeeeccccCccccccccc--------CCcC-cceeecC
Q 003911 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVH--------TRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~-~~DiWS~ 785 (787)
+++...... ......||+.|+|||++.+ ..++ ++||||.
T Consensus 162 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSl 209 (396)
T 4eut_A 162 AARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209 (396)
T ss_dssp GCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHH
T ss_pred CceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHH
Confidence 998775432 2234579999999999875 4566 8999983
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=264.84 Aligned_cols=181 Identities=30% Similarity=0.510 Sum_probs=156.7
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe-------
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD------- 662 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------- 662 (787)
+.++|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 4567999999999999999999876 79999999997632 356789999999999999999998864
Q ss_pred ---------CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC
Q 003911 663 ---------GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG 733 (787)
Q Consensus 663 ---------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 733 (787)
....++||||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLV 156 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEc
Confidence 345799999999999999996532 2468999999999999999999998 8999999999999999
Q ss_pred CCCcEEEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 734 DDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 734 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+++.+||+|||+++....... .....||+.|+|||++.+..++ ++|+||.
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYAL 207 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHH
T ss_pred CCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHH
Confidence 999999999999987755432 2335689999999999988888 8999983
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=262.65 Aligned_cols=181 Identities=26% Similarity=0.389 Sum_probs=156.0
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe----CCeeE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEKL 667 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~ 667 (787)
..|++.+.||+|+||.||+|... ++..||+|++..........+.+.+|++++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 35788899999999999999875 68899999998766666677889999999999999999999999875 35589
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCEEEC-CCCcEEEeecc
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLG-DDMRAKVADFG 744 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DFG 744 (787)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+ |+||||||+||+++ +++.+||+|||
T Consensus 106 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 999999999999998542 468899999999999999999997 66 99999999999998 78999999999
Q ss_pred cceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++....... .....||+.|+|||++.+. ++ ++|+||.
T Consensus 178 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~sl 215 (290)
T 1t4h_A 178 LATLKRASF---AKAVIGTPEFMAPEMYEEK-YDESVDVYAF 215 (290)
T ss_dssp GGGGCCTTS---BEESCSSCCCCCGGGGGTC-CCTHHHHHHH
T ss_pred Ccccccccc---cccccCCcCcCCHHHHhcc-CCCcchHHHH
Confidence 997554332 2345799999999988765 55 9999983
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-30 Score=267.93 Aligned_cols=185 Identities=31% Similarity=0.533 Sum_probs=146.4
Q ss_pred hcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
..++|++.+.||+|+||.||+|+.. ..||+|+++.........+.+.+|++++++++||||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3468999999999999999999754 4699999987655666678899999999999999999999965 456689999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 99 e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 99 QWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp ECCCEEEHHHHHTT----C---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EecCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccc
Confidence 99999999998843 23468999999999999999999998 899999999999999999999999999998654
Q ss_pred CCCC-ceeeeeccccCcccccccc---cCCcC-cceeecC
Q 003911 751 EGKG-SIETRIAGTFGYLAPEYAV---HTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~-~~DiWS~ 785 (787)
.... .......||+.|+|||++. +..++ ++||||.
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 211 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAF 211 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHH
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHH
Confidence 3221 2223457999999999987 55666 8999983
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-30 Score=272.81 Aligned_cols=183 Identities=26% Similarity=0.410 Sum_probs=147.7
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|+||.||+|+.. +++.||||++.... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc-ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 57999999999999999999876 78999999986532 12222245679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|++ |+|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 81 YLD-KDLKQYLDD----CGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CCS-EEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred ccc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 996 589888754 23468999999999999999999998 8999999999999999999999999999986643
Q ss_pred CCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
... ......||+.|+|||++.+ ..++ ++||||.
T Consensus 153 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 187 (324)
T 3mtl_A 153 PTK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGV 187 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred Ccc-ccccccCcccccChhhhcCCCCCCcHHHHHHH
Confidence 322 2234578999999999987 4566 8999983
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-30 Score=272.32 Aligned_cols=184 Identities=27% Similarity=0.496 Sum_probs=151.7
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcE----EEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
++|++.+.||+|+||.||+|.+. +++. ||+|++.... .....+++.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 57999999999999999999865 4444 7777775432 2333456789999999999999999999886 45688
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 91 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCccc
Confidence 999999999999998542 2468889999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCCc-eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 748 LAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
........ ......||+.|+|||++.+..++ ++|+||.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 203 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSY 203 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHh
Confidence 77544322 23345688899999999988888 9999983
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=269.15 Aligned_cols=196 Identities=31% Similarity=0.472 Sum_probs=152.6
Q ss_pred HHHhhcCCCcccceeccccceEEEEEEEe----CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe
Q 003911 587 VLRNVTNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 662 (787)
Q Consensus 587 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 662 (787)
......++|++.+.||+|+||.||+|... +++.||+|+++.........+++.+|++++++++||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 33344578999999999999999999764 34589999998765556667889999999999999999999999987
Q ss_pred CCe-----eEEEEEecCCCCHHHHHHhhh-hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC
Q 003911 663 GNE-----KLLVFEYMPQGTLSRHIFNWA-EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736 (787)
Q Consensus 663 ~~~-----~~lv~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 736 (787)
.+. .++||||+++|+|.+++.... ......+++..++.++.|++.||+|||+ .+|+||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCC
Confidence 653 499999999999999985432 1234578999999999999999999997 8999999999999999999
Q ss_pred cEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 737 RAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 737 ~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.+||+|||+++........ ......+++.|+|||++.+..++ ++|+||.
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 235 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF 235 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHH
Confidence 9999999999876443221 12234578899999999998888 8999983
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=280.62 Aligned_cols=185 Identities=17% Similarity=0.230 Sum_probs=150.5
Q ss_pred cCCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccc-cchhHHHHHHHH---HHHHhcCCCccceEE-------eE
Q 003911 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVI-SGKGLTEFKSEI---AVLTKVRHRHLVALL-------GH 659 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~---~~l~~l~h~niv~~~-------~~ 659 (787)
.++|++.+.||+|+||.||+|+. .+|+.||||++..... .....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999985 4799999999986432 344567899999 455556899999998 66
Q ss_pred EEeCCe-----------------eEEEEEecCCCCHHHHHHhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 003911 660 CLDGNE-----------------KLLVFEYMPQGTLSRHIFNWAEEG--LKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720 (787)
Q Consensus 660 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i 720 (787)
+.+.+. .|+||||+ +|+|.+++.....-. ...+++..++.|+.||+.||+|||+ .+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 665532 78999999 689999997532211 1234468888999999999999998 899
Q ss_pred EEcCCCCCCEEECCCCcEEEeecccceecCCCCCceeeeeccccCcccccccccC-----------CcC-cceeecC
Q 003911 721 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHT-----------RWS-SCSYWAG 785 (787)
Q Consensus 721 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~-~~DiWS~ 785 (787)
+||||||+|||++.++.+||+|||+|+.... ......| +.|+|||++.+. .++ ++||||.
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 9999999999999999999999999986432 3344678 999999999887 788 8999983
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=286.14 Aligned_cols=184 Identities=28% Similarity=0.447 Sum_probs=160.1
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
+.++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4467999999999999999999876 7999999999765433 4456789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---CCCCcEEEeeccc
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL 745 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~ 745 (787)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||+
T Consensus 104 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EECCCCSCBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 9999999999998843 3468999999999999999999998 899999999999999 5678999999999
Q ss_pred ceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++...... .....+||+.|+|||++.+. ++ ++||||.
T Consensus 176 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~Diwsl 213 (484)
T 3nyv_A 176 STHFEASK--KMKDKIGTAYYIAPEVLHGT-YDEKCDVWST 213 (484)
T ss_dssp HHHBCCCC--SHHHHTTGGGTCCHHHHHTC-CCTHHHHHHH
T ss_pred eEEccccc--ccccCCCCccccCceeecCC-CCCcceeHHH
Confidence 98775443 22345799999999999874 55 9999983
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=271.91 Aligned_cols=187 Identities=29% Similarity=0.397 Sum_probs=150.3
Q ss_pred hhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccc---hhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG---KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
...++|++.+.||+|+||.||+|... +|+.||||++....... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999875 68999999997533221 123468899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.++||||+++ +|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred eEEEEEcCCC-CHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 9999999975 88887743 33468889999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
++....... ......||+.|+|||++.+. .++ ++||||.
T Consensus 159 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 199 (346)
T 1ua2_A 159 AKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAV 199 (346)
T ss_dssp GSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHH
T ss_pred ceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhH
Confidence 987654332 23345789999999999765 466 8999983
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=263.47 Aligned_cols=185 Identities=24% Similarity=0.408 Sum_probs=153.5
Q ss_pred cCCCcccceeccccceEEEEEEEeC----CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
.++|++.+.||+|+||.||+|.... +..||+|++.... .....+++.+|++++++++||||+++++++.+ +..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 4679999999999999999997652 3469999987642 34456789999999999999999999999865 4568
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 89 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 999999999999998542 2458899999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 748 LAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..............+|+.|+|||++.+..++ ++|+||.
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMF 200 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHH
Confidence 7655433333345578899999999988888 8999983
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=268.04 Aligned_cols=185 Identities=25% Similarity=0.392 Sum_probs=151.1
Q ss_pred hcCCCccc-ceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeE
Q 003911 591 VTNNFSEE-NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 591 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 667 (787)
+.+.|++. +.||+|+||.||+|... +++.||||++.... ....+.+.+|++++.++ +||||+++++++.+.+..+
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 34678884 78999999999999854 79999999997642 33467889999999995 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc---EEEeecc
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVADFG 744 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFG 744 (787)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||
T Consensus 88 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred EEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 999999999999998542 368999999999999999999998 89999999999999998765 9999999
Q ss_pred cceecCCCCC------ceeeeeccccCccccccccc-----CCcC-cceeecC
Q 003911 745 LVRLAPEGKG------SIETRIAGTFGYLAPEYAVH-----TRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~-~~DiWS~ 785 (787)
+++....... ......+||+.|+|||++.+ ..++ ++||||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl 212 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSL 212 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHH
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhH
Confidence 9876542211 11123469999999999975 4456 8999983
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=261.61 Aligned_cols=181 Identities=32% Similarity=0.614 Sum_probs=152.1
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchh-----HHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKG-----LTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
.++|++.+.||+|+||.||+|+.. +++.||+|++......... .+++.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 368999999999999999999875 7899999998764332221 268999999999999999999999987654
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCEEECCCCc-----E
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMR-----A 738 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~ 738 (787)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+ .+ |+||||||+||+++.++. +
T Consensus 97 -~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred -eEEEEecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeE
Confidence 799999999999888843 23478999999999999999999997 67 999999999999988776 9
Q ss_pred EEeecccceecCCCCCceeeeeccccCcccccccc--cCCcC-cceeecC
Q 003911 739 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV--HTRWS-SCSYWAG 785 (787)
Q Consensus 739 kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~-~~DiWS~ 785 (787)
||+|||+++.... ......||+.|+|||++. +..++ ++|+||.
T Consensus 169 kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~sl 214 (287)
T 4f0f_A 169 KVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSF 214 (287)
T ss_dssp EECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHH
T ss_pred EeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHH
Confidence 9999999985433 233467999999999984 44556 8999983
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=267.99 Aligned_cols=184 Identities=28% Similarity=0.465 Sum_probs=158.1
Q ss_pred CCCcccceeccccceEEEEEEE-----eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe--CCe
Q 003911 593 NNFSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNE 665 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 665 (787)
++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 5799999999999999999985 36889999998763 34456779999999999999999999999874 456
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred EEEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccc
Confidence 899999999999999986532 358999999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCCce--eeeeccccCcccccccccCCcC-cceeecC
Q 003911 746 VRLAPEGKGSI--ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++......... .....||+.|+|||++.+..++ ++||||.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 216 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 216 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHH
Confidence 98775443221 1234588889999999998888 9999983
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-30 Score=276.23 Aligned_cols=183 Identities=25% Similarity=0.390 Sum_probs=158.8
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|... +++.||+|++... ......+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 467999999999999999999876 7899999999764 24455678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++... ..+++..+..++.|++.||+|||+ +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 111 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred ECCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999998542 358899999999999999999997 2389999999999999999999999999987553
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... .....||+.|+|||++.+..++ ++||||.
T Consensus 184 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 216 (360)
T 3eqc_A 184 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSM 216 (360)
T ss_dssp HHC-------CCCCTTCCHHHHTTCCCSHHHHHHHH
T ss_pred ccc---ccCCCCCCCeECHHHHcCCCCCchhhHHHH
Confidence 221 2335789999999999999888 8999983
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=261.73 Aligned_cols=184 Identities=24% Similarity=0.442 Sum_probs=155.9
Q ss_pred CCCcccc-eeccccceEEEEEEEe---CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 593 NNFSEEN-ILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 593 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
++|.+.+ .||+|+||.||+|... ++..||||+++.. ......+++.+|++++++++||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 4566666 9999999999999753 6788999999764 2345567899999999999999999999999 4566899
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++++|.+++.. ....+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 87 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 9999999999998843 23468999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCce--eeeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSI--ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
........ .....||+.|+|||++.+..++ ++|+||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 199 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 199 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHH
Confidence 75443221 1223468899999999988888 8999983
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=272.91 Aligned_cols=183 Identities=22% Similarity=0.381 Sum_probs=151.3
Q ss_pred hhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC-----
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG----- 663 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 663 (787)
...++|++.+.||+|+||.||+|... +|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 35678999999999999999999864 799999999875321 234799999999999999999998543
Q ss_pred ---------------------------------CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 003911 664 ---------------------------------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710 (787)
Q Consensus 664 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~ 710 (787)
...++||||++ |+|.+.+....... ..+++..+..++.|++.||+
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~-~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSG-RSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTT-CCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHH
Confidence 33789999997 58888887654433 57899999999999999999
Q ss_pred HHHhCCCCCeEEcCCCCCCEEEC-CCCcEEEeecccceecCCCCCceeeeeccccCcccccccccCC-cC-cceeecC
Q 003911 711 YLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWAG 785 (787)
Q Consensus 711 ~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS~ 785 (787)
|||+ .+|+||||||+||+++ +++.+||+|||+|+....... .....||+.|+|||++.+.. ++ ++||||.
T Consensus 156 ~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (383)
T 3eb0_A 156 FIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSI 228 (383)
T ss_dssp HHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence 9997 8999999999999998 688999999999987754432 23457899999999988754 66 8999984
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=275.61 Aligned_cols=186 Identities=17% Similarity=0.225 Sum_probs=149.8
Q ss_pred hcCCCcccceeccccceEEEEEEEeC------CcEEEEEEeecccccc---------hhHHHHHHHHHHHHhcCCCccce
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISG---------KGLTEFKSEIAVLTKVRHRHLVA 655 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~ 655 (787)
..++|++.+.||+|+||.||+|.+.. ++.||||++....... .....+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998764 4789999987642110 01122345566677788999999
Q ss_pred EEeEEEeC----CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 003911 656 LLGHCLDG----NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (787)
Q Consensus 656 ~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 731 (787)
+++++... ...++||||+ +++|.+++.. ....+++.+++.++.||+.||+|||+ .+|+||||||+|||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nil 184 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLL 184 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEE
Confidence 99999764 4579999999 9999999854 23569999999999999999999998 89999999999999
Q ss_pred EC--CCCcEEEeecccceecCCCCCc------eeeeeccccCcccccccccCCcC-cceeec
Q 003911 732 LG--DDMRAKVADFGLVRLAPEGKGS------IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 732 l~--~~~~~kl~DFG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
++ .++.+||+|||+++........ ......||+.|+|||++.+..++ ++||||
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 246 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEI 246 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHH
Confidence 99 8899999999999876433211 11235599999999999999888 899998
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=267.73 Aligned_cols=180 Identities=31% Similarity=0.526 Sum_probs=146.9
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
++|++.+.||+|+||.||+|+.. ++.||||++.. ....+.+.+|++++++++||||+++++++.+ ..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 57899999999999999999875 88999999864 2345789999999999999999999998863 47999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc-EEEeecccceecCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR-AKVADFGLVRLAPE 751 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DFG~a~~~~~ 751 (787)
+++|+|.+++.... ....+++..++.++.|+++||+|||+.+.++|+||||||+||+++.++. +||+|||+++....
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 81 AEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CTTCBHHHHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCCHHHHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999985421 1234788999999999999999999754468999999999999998876 79999999976543
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.. ....||+.|+|||++.+..++ ++||||.
T Consensus 159 ~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 189 (307)
T 2eva_A 159 HM----TNNKGSAAWMAPEVFEGSNYSEKCDVFSW 189 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHH
T ss_pred cc----ccCCCCCceEChhhhCCCCCCcHHHHHHH
Confidence 21 234689999999999998888 8999983
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=275.04 Aligned_cols=181 Identities=27% Similarity=0.442 Sum_probs=140.5
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC------
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------ 663 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 663 (787)
+.++|++.+.||+|+||.||+|... +|+.||||++..........+++.+|+++++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3578999999999999999999764 789999999976554555677889999999999999999999999754
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
...++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-
T ss_pred CeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeec
Confidence 5579999999 7899888743 468999999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
|+++..... ....+||+.|+|||++.+ ..++ ++||||.
T Consensus 177 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 216 (367)
T 2fst_X 177 GLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 216 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHH
T ss_pred ccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHH
Confidence 999875432 234679999999999987 5666 8999983
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=264.98 Aligned_cols=185 Identities=26% Similarity=0.426 Sum_probs=151.3
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe-------
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD------- 662 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------- 662 (787)
+.++|++.+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 4567999999999999999999875 799999999965 23456789999999999999999999998865
Q ss_pred ------CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC
Q 003911 663 ------GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM 736 (787)
Q Consensus 663 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 736 (787)
.+..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHS----ENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESR 153 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHH----SCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTS
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhc----cccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCC
Confidence 3467999999999999999854 22457888999999999999999998 8999999999999999999
Q ss_pred cEEEeecccceecCCCC-------------CceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 737 RAKVADFGLVRLAPEGK-------------GSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 737 ~~kl~DFG~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
.+||+|||+++...... ........||+.|+|||++.+. .++ ++|+||.
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 217 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSL 217 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHH
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHH
Confidence 99999999998664321 1112345689999999999865 566 8999983
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=269.86 Aligned_cols=191 Identities=26% Similarity=0.414 Sum_probs=160.8
Q ss_pred hcCCCcccceeccccceEEEEEEEe-C-----CcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeC
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-D-----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG 663 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 663 (787)
..++|++.+.||+|+||.||+|... + ...||+|++.... .....+.+.+|+++++++ +||||+++++++.+.
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 3578999999999999999999864 2 2479999997632 344567899999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhc---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEE---------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 734 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 734 (787)
+..++||||+++|+|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECC
Confidence 9999999999999999998754321 12357899999999999999999998 89999999999999999
Q ss_pred CCcEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 735 DMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 735 ~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++.+||+|||+++........ ......||+.|+|||++.+..++ ++||||.
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 252 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 252 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHH
Confidence 999999999999866443322 22234578899999999998888 8999983
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=267.91 Aligned_cols=186 Identities=25% Similarity=0.471 Sum_probs=151.8
Q ss_pred cCCCcccceeccccceEEEEEEEeC-----CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHD-----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
.++|++.+.||+|+||.||+|.... +..||||+++... ......++.+|++++++++||||+++++++.+.+..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 3578889999999999999997652 2469999997632 445566899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
++||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 122 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 122 MIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp EEEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 999999999999999854 23468999999999999999999998 89999999999999999999999999999
Q ss_pred eecCCCCCc--eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 747 RLAPEGKGS--IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+........ ......+|+.|+|||++.+..++ ++||||.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 236 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF 236 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHH
Confidence 876543221 11223467899999999988888 8999983
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-30 Score=290.51 Aligned_cols=185 Identities=30% Similarity=0.518 Sum_probs=157.8
Q ss_pred hcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
..++|++.+.||+|+||.||+|.+..+..||||+++... ...++|.+|++++++++||||+++++++.+ +..++||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 346789999999999999999999888889999997643 235689999999999999999999999876 6789999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++..... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++...
T Consensus 341 e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp CCCTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred ehhcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 99999999999964322 358899999999999999999998 899999999999999999999999999998664
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
...........++..|+|||++.+..++ ++||||.
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSl 450 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 450 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHH
Confidence 3211111224467889999999998888 9999983
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=263.17 Aligned_cols=185 Identities=26% Similarity=0.404 Sum_probs=154.4
Q ss_pred cCCCcccc-eeccccceEEEEEEEe---CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 592 TNNFSEEN-ILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 592 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
.++|++.+ .||+|+||.||+|.+. +++.||||+++.........+++.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35788888 9999999999999653 468899999987554455578899999999999999999999999 566789
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 94 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEeCCCCCHHHHHHh-----CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 99999999999999854 2458999999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCCcee--eeeccccCcccccccccCCcC-cceeecC
Q 003911 748 LAPEGKGSIE--TRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.......... ....||+.|+|||++.+..++ ++|+||.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 206 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 206 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHH
Confidence 7755433221 223467899999999988888 8999983
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=263.69 Aligned_cols=187 Identities=26% Similarity=0.353 Sum_probs=144.6
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|+.. +++.||+|+++.........+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 468999999999999999999874 7899999999765433444445555666688889999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
||++ |+|.+++...... ...+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9997 5888887654433 3579999999999999999999998 6 9999999999999999999999999999876
Q ss_pred CCCCCceeeeeccccCccccccc----ccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYA----VHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~-~~DiWS~ 785 (787)
..... .....||+.|+|||++ .+..++ ++|+||.
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~sl 199 (290)
T 3fme_A 161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSL 199 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHH
T ss_pred ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHH
Confidence 54322 2234689999999996 455666 8999983
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=272.11 Aligned_cols=192 Identities=23% Similarity=0.355 Sum_probs=153.9
Q ss_pred eHHHHHhhcCCCcccceeccccceEEEEEEEeCCcEEEEEEeeccccc---------chhHHHHHHHHHHHHhcCCCccc
Q 003911 584 SIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS---------GKGLTEFKSEIAVLTKVRHRHLV 654 (787)
Q Consensus 584 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~E~~~l~~l~h~niv 654 (787)
..+++....++|++.+.||+|+||.||+|...+++.||||++...... ....+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456778889999999999999999999998888999999998653322 12247899999999999999999
Q ss_pred eEEeEEEeC-----CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 003911 655 ALLGHCLDG-----NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSN 729 (787)
Q Consensus 655 ~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 729 (787)
++++++... ...++||||++ |+|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~N 164 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGN 164 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGG
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHH
Confidence 999998643 35799999997 688888753 23468999999999999999999998 899999999999
Q ss_pred EEECCCCcEEEeecccceecCCCCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 730 ILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 730 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
|+++.++.+||+|||+++...... ......||+.|+|||++.+ ..++ ++|+||.
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 220 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSA 220 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHH
T ss_pred EEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhH
Confidence 999999999999999998554332 2234578999999999887 5666 8999983
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=264.37 Aligned_cols=185 Identities=29% Similarity=0.486 Sum_probs=153.6
Q ss_pred CCCcccceeccccceEEEEEEEeC----CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEE-eCCeeE
Q 003911 593 NNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCL-DGNEKL 667 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~ 667 (787)
.+|++.+.||+|+||.||+|...+ ...||+|++.. .......+++.+|++++++++||||+++++++. ..+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc-CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 468899999999999999997542 33689998875 234455678999999999999999999999865 456789
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+||||+++|+|.+++.. ....+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 104 ~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp EEEECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred EEEeCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccc
Confidence 99999999999999853 23467899999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCC---ceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 748 LAPEGKG---SIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
....... .......||+.|+|||++.+..++ ++|+||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 218 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 218 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHH
Confidence 6644321 112335678899999999998888 8999983
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=260.95 Aligned_cols=185 Identities=31% Similarity=0.474 Sum_probs=152.8
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
..++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3468999999999999999999876 799999999976432 23345689999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 89 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred EEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccc
Confidence 99999999999998542 358899999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCceeeeeccccCcccccccccCCc-C-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRW-S-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~-~~DiWS~ 785 (787)
..... ......||+.|+|||++.+..+ + ++|+||.
T Consensus 161 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 197 (276)
T 2h6d_A 161 MSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSC 197 (276)
T ss_dssp CCC---------------CCTGGGTTSCCCHHHHHHHHH
T ss_pred cCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHH
Confidence 65432 2233568999999999988776 3 8999983
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=265.38 Aligned_cols=182 Identities=27% Similarity=0.471 Sum_probs=156.4
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+.++|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 4567999999999999999999875 79999999997632 22346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---CCCCcEEEeecccc
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLV 746 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a 746 (787)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++ ++++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 85 MQLVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp ECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred EEcCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 9999999999988542 368899999999999999999998 899999999999999 78889999999999
Q ss_pred eecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+...... .....||+.|+|||++.+..++ ++|+||.
T Consensus 157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (304)
T 2jam_A 157 KMEQNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSI 193 (304)
T ss_dssp CCCCCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHH
T ss_pred eecCCCc---cccccCCCCccChHHhccCCCCchhhHHHH
Confidence 7654321 2335689999999999998888 8999983
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=267.94 Aligned_cols=196 Identities=26% Similarity=0.407 Sum_probs=162.1
Q ss_pred HHHHhhcCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEe
Q 003911 586 QVLRNVTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLG 658 (787)
Q Consensus 586 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 658 (787)
.......++|++.+.||+|+||.||+|+.. +++.||||+++.. ......+.+.+|+++++++ +||||+++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 344445678999999999999999999752 4688999999764 2344557899999999999 7999999999
Q ss_pred EEEeCC-eeEEEEEecCCCCHHHHHHhhhhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 003911 659 HCLDGN-EKLLVFEYMPQGTLSRHIFNWAEEG-----------LKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLK 726 (787)
Q Consensus 659 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 726 (787)
++...+ ..++||||+++|+|.+++....... ...+++..+..++.|++.||+|||+ .+|+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCc
Confidence 998755 4899999999999999996532210 1237899999999999999999998 899999999
Q ss_pred CCCEEECCCCcEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 727 PSNILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 727 p~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++ ++||||.
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 236 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHH
Confidence 99999999999999999999876544322 22335688999999999998888 9999983
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-29 Score=267.26 Aligned_cols=189 Identities=24% Similarity=0.385 Sum_probs=157.8
Q ss_pred HHHHHhhcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHh--cCCCccceEEeEEEe
Q 003911 585 IQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK--VRHRHLVALLGHCLD 662 (787)
Q Consensus 585 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~ 662 (787)
......+.++|++.+.||+|+||.||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++..
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 344455678899999999999999999987 5999999998642 34677889999988 689999999999988
Q ss_pred CC----eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEcCCCCCCEEEC
Q 003911 663 GN----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL-----AHQSFIHRDLKPSNILLG 733 (787)
Q Consensus 663 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~ 733 (787)
.. ..++||||+++|+|.+++.. ..+++.+++.++.|++.||+|||.. +..+|+||||||+||+++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC
Confidence 76 78999999999999999854 3589999999999999999999921 017999999999999999
Q ss_pred CCCcEEEeecccceecCCCCCc---eeeeeccccCcccccccccC------CcC-cceeecC
Q 003911 734 DDMRAKVADFGLVRLAPEGKGS---IETRIAGTFGYLAPEYAVHT------RWS-SCSYWAG 785 (787)
Q Consensus 734 ~~~~~kl~DFG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~-~~DiWS~ 785 (787)
.++.+||+|||+++........ ......||+.|+|||++.+. .++ ++||||.
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 243 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 243 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHH
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHH
Confidence 9999999999999877554322 12335799999999999876 233 7999983
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-29 Score=263.40 Aligned_cols=184 Identities=29% Similarity=0.451 Sum_probs=155.1
Q ss_pred hhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
...++|++.+.||+|+||.||+|... +|+.||+|++.... ..+++.+|++++++++||||+++++++...+..++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 34578999999999999999999876 68999999997632 34678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.+..
T Consensus 102 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 102 VMEYCGAGSVSDIIRL----RNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEECCTTEEHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EeecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 9999999999998853 12468999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
...... ......||+.|+|||++.+..++ ++|+||.
T Consensus 175 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 211 (314)
T 3com_A 175 LTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSL 211 (314)
T ss_dssp CBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHH
T ss_pred hhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHH
Confidence 654322 22345789999999999998888 8999983
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-29 Score=274.83 Aligned_cols=181 Identities=24% Similarity=0.326 Sum_probs=155.8
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc------CCCccceEEeEEEeC
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV------RHRHLVALLGHCLDG 663 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~ 663 (787)
+..+|++.+.||+|+||.||+|... +++.||||+++.. .....++.+|+++++.+ .|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 4568999999999999999999765 6899999999752 33456788899888887 577999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc--EEEe
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR--AKVA 741 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~ 741 (787)
+..++||||+. ++|.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~ 244 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKN---KFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVI 244 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred CeEEEEEeccC-CCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEe
Confidence 99999999995 6999988552 23458999999999999999999998 79999999999999999887 9999
Q ss_pred ecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 742 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|||+|+...... ...+||+.|+|||++.+..++ ++||||.
T Consensus 245 DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 285 (429)
T 3kvw_A 245 DFGSSCYEHQRV----YTYIQSRFYRAPEVILGARYGMPIDMWSL 285 (429)
T ss_dssp CCTTCEETTCCC----CSSCSCGGGCCHHHHHTBCCCTHHHHHHH
T ss_pred ecccceecCCcc----cccCCCCCccChHHHhCCCCCchHHHHhH
Confidence 999998764332 235789999999999999888 8999983
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=273.77 Aligned_cols=184 Identities=29% Similarity=0.487 Sum_probs=145.0
Q ss_pred CCcccceeccccceEEEEEEEeC----CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe-CCeeEE
Q 003911 594 NFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNEKLL 668 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l 668 (787)
.|++.+.||+|+||.||+|...+ +..||||.++. .......+++.+|+.++++++||||+++++++.. .+..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCS-CSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCC-CCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 47788999999999999997642 24689998865 2344566889999999999999999999998764 457899
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++|+|.+++.. ....+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.
T Consensus 169 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EEECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEECCCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccc
Confidence 9999999999999853 23457899999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCc---eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGS---IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
....... ......+|+.|+|||++.+..++ ++||||.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 282 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 282 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHH
Confidence 6433211 12334578899999999999888 8999983
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=269.90 Aligned_cols=272 Identities=17% Similarity=0.200 Sum_probs=224.8
Q ss_pred CCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEecc
Q 003911 93 KLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSAN 172 (787)
Q Consensus 93 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~ 172 (787)
.....++++|.++.++..+. ++|++|+|++|+++++++..|.++++|++|+|++|++++ ..|..|.++++|++|+++
T Consensus 32 ~~~~c~~~~~~l~~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls 108 (353)
T 2z80_A 32 RNGICKGSSGSLNSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLS 108 (353)
T ss_dssp TTSEEECCSTTCSSCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECC
T ss_pred CCeEeeCCCCCccccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCc-cCHhhcCCCCCCCEEECC
Confidence 33457899999998777665 589999999999999999899999999999999999996 457789999999999999
Q ss_pred CceecccCCCCCCCCCCCCCcEEeccccccccCCC-cCcccccccceeeccCCCCCcCCCCccccccCccCceEecccc-
Q 003911 173 SANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLP-ASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN- 250 (787)
Q Consensus 173 ~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N- 250 (787)
+|++++..+..|. .+++|++|+|++|++++..+ .. +.++++|++|++++|
T Consensus 109 ~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~l~~~~~--------------------------~~~l~~L~~L~l~~n~ 160 (353)
T 2z80_A 109 YNYLSNLSSSWFK--PLSSLTFLNLLGNPYKTLGETSL--------------------------FSHLTKLQILRVGNMD 160 (353)
T ss_dssp SSCCSSCCHHHHT--TCTTCSEEECTTCCCSSSCSSCS--------------------------CTTCTTCCEEEEEESS
T ss_pred CCcCCcCCHhHhC--CCccCCEEECCCCCCcccCchhh--------------------------hccCCCCcEEECCCCc
Confidence 9999987666675 89999999999999984333 23 347899999999999
Q ss_pred ccccCCC-CCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCC
Q 003911 251 AFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGAC 329 (787)
Q Consensus 251 ~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~ 329 (787)
.++..++ .+.++++|++|++++|++++..|..+..+++|++|++++|+++..++.+
T Consensus 161 ~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~----------------------- 217 (353)
T 2z80_A 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIF----------------------- 217 (353)
T ss_dssp SCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHH-----------------------
T ss_pred cccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhh-----------------------
Confidence 4777655 5888999999999999999888999999999999999999886432210
Q ss_pred CchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhc---CCCCCCEEecccccc
Q 003911 330 DPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFA---SFKSLQRLILADNNL 406 (787)
Q Consensus 330 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~---~l~~L~~L~Ls~N~l 406 (787)
....++|+.|++++|++++..+..+. ....++.++|++|.+
T Consensus 218 ------------------------------------~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l 261 (353)
T 2z80_A 218 ------------------------------------VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261 (353)
T ss_dssp ------------------------------------HHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBC
T ss_pred ------------------------------------hhhcccccEEECCCCccccccccccccccccchhhccccccccc
Confidence 11234899999999999987766554 467789999999998
Q ss_pred cc----cCCccCcCCCCCCeeeccCCcccccCCC-----CCCCceeecCCCCCCCCCC
Q 003911 407 SG----MIPEGLSVLGALKELDVSNNQLYGKIPS-----FKSNAIVNTDGNPDIGKEK 455 (787)
Q Consensus 407 ~g----~ip~~l~~l~~L~~L~Ls~N~l~g~iP~-----~~~~~~~~~~gn~~~~~~~ 455 (787)
++ .+|..+..+++|++|||++|+++. +|. +..+..+.+.+|++.|..+
T Consensus 262 ~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 262 TDESLFQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CHHHHHHHHHHHHTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCcchhhhHHHHhcccCCCEEECCCCCCCc-cCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 86 478889999999999999999994 553 4567789999999988654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=270.48 Aligned_cols=182 Identities=29% Similarity=0.453 Sum_probs=143.8
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHH--HHhcCCCccceEEeEEEe-----CC
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAV--LTKVRHRHLVALLGHCLD-----GN 664 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~-----~~ 664 (787)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 46899999999999999999976 68999999987522 2344444444 445899999999986643 23
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEEcCCCCCCEEECCCCcE
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA------HQSFIHRDLKPSNILLGDDMRA 738 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~ 738 (787)
..++||||+++|+|.+++.. ...++..+..++.|++.||+|||+.. +.+|+||||||+|||++.++.+
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred eEEEEEecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 56899999999999999854 24588999999999999999999720 1199999999999999999999
Q ss_pred EEeecccceecCCCCC-------ceeeeeccccCccccccccc-------CCcC-cceeecC
Q 003911 739 KVADFGLVRLAPEGKG-------SIETRIAGTFGYLAPEYAVH-------TRWS-SCSYWAG 785 (787)
Q Consensus 739 kl~DFG~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~-~~DiWS~ 785 (787)
||+|||+++....... .......||+.|+|||++.+ ..++ ++||||.
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 221 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYAL 221 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHH
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHH
Confidence 9999999987654321 11223569999999999987 3444 7999983
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-29 Score=267.17 Aligned_cols=187 Identities=33% Similarity=0.529 Sum_probs=153.3
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEE--EEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKI--AVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~v--avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (787)
++|++.+.||+|+||.||+|+.. ++..+ |+|+++.. ......+++.+|+++++++ +||||+++++++.+.+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 57999999999999999999765 56644 99988752 2344556799999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc
Q 003911 669 VFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 737 (787)
||||+++|+|.+++..... .....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence 9999999999999865320 122468999999999999999999998 89999999999999999999
Q ss_pred EEEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 738 AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 738 ~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+||+|||+++...... ......+++.|+|||++.+..++ ++|+||.
T Consensus 181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 227 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 227 (327)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHH
T ss_pred EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHH
Confidence 9999999997543221 11224578899999999988888 8999983
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-28 Score=267.12 Aligned_cols=246 Identities=16% Similarity=0.190 Sum_probs=180.4
Q ss_pred CcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccC
Q 003911 94 LERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173 (787)
Q Consensus 94 L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~ 173 (787)
.+.++.+++.++.++..+. +++++|+|++|+|+++++..|.++++|++|+|++|+++. ..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~-i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT-IEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCSSCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCE-ECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcCcCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCc-cChhhccCCccCCEEECCC
Confidence 4578999999998777665 789999999999999999999999999999999999985 3346777777777777777
Q ss_pred ceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccc-c
Q 003911 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA-F 252 (787)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~-l 252 (787)
|+|++..+..|. .+++|++|+|++|++++..+..|. ++++|++|+|++|. +
T Consensus 122 n~l~~~~~~~~~--~l~~L~~L~L~~N~i~~~~~~~~~--------------------------~l~~L~~L~l~~~~~l 173 (440)
T 3zyj_A 122 NRLTTIPNGAFV--YLSKLKELWLRNNPIESIPSYAFN--------------------------RIPSLRRLDLGELKRL 173 (440)
T ss_dssp SCCSSCCTTTSC--SCSSCCEEECCSCCCCEECTTTTT--------------------------TCTTCCEEECCCCTTC
T ss_pred CcCCeeCHhHhh--ccccCceeeCCCCcccccCHHHhh--------------------------hCcccCEeCCCCCCCc
Confidence 777766666664 666677777766666644443332 45555555555532 2
Q ss_pred ccCCC-CCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCc
Q 003911 253 SGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDP 331 (787)
Q Consensus 253 ~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~ 331 (787)
...++ .|.++++|++|+|++|+|+ .+|. +..++
T Consensus 174 ~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~-~~~l~-------------------------------------------- 207 (440)
T 3zyj_A 174 SYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLI-------------------------------------------- 207 (440)
T ss_dssp CEECTTTTTTCSSCCEEECTTSCCS-SCCC-CTTCS--------------------------------------------
T ss_pred ceeCcchhhcccccCeecCCCCcCc-cccc-cCCCc--------------------------------------------
Confidence 22222 2444455555555555444 2331 33333
Q ss_pred hhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCC
Q 003911 332 RLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 411 (787)
Q Consensus 332 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip 411 (787)
+|+.|+|++|++++..|..|..+++|+.|+|++|+|++..|
T Consensus 208 ---------------------------------------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 248 (440)
T 3zyj_A 208 ---------------------------------------KLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIER 248 (440)
T ss_dssp ---------------------------------------SCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECT
T ss_pred ---------------------------------------ccCEEECCCCccCccChhhhccCccCCEEECCCCceeEECh
Confidence 45566666666666667788999999999999999999999
Q ss_pred ccCcCCCCCCeeeccCCcccccCCC----CCCCceeecCCCCCCCCCC
Q 003911 412 EGLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDIGKEK 455 (787)
Q Consensus 412 ~~l~~l~~L~~L~Ls~N~l~g~iP~----~~~~~~~~~~gn~~~~~~~ 455 (787)
..|..+++|++|||++|+|++..+. +..+..+.+.+||+.|...
T Consensus 249 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 249 NAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp TSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred hhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCC
Confidence 9999999999999999999987664 4567889999999999764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-29 Score=269.04 Aligned_cols=184 Identities=24% Similarity=0.415 Sum_probs=154.9
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC-----C
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----N 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 664 (787)
+.++|++.+.||+|+||.||+|... +++.||||++... ......+.+.+|++++++++||||+++++++... .
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 3468999999999999999999865 7889999999752 2344557899999999999999999999999765 3
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..++||||++ |+|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg 173 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFG 173 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCc
Confidence 6899999996 599888843 358999999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCCce--eeeeccccCcccccccccC-CcC-cceeecC
Q 003911 745 LVRLAPEGKGSI--ETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
+++......... .....||+.|+|||++.+. .++ ++||||.
T Consensus 174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 218 (364)
T 3qyz_A 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218 (364)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHH
T ss_pred ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHH
Confidence 998765432211 2345799999999987654 466 8999983
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=266.73 Aligned_cols=189 Identities=29% Similarity=0.463 Sum_probs=152.6
Q ss_pred HHHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEe--
Q 003911 587 VLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD-- 662 (787)
Q Consensus 587 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-- 662 (787)
.+....++|++.+.||+|+||.||+|+.. +++.||||++.... ...+++.+|+++++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 34445688999999999999999999874 78999999997532 3456889999999999 79999999999987
Q ss_pred ----CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcE
Q 003911 663 ----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 738 (787)
Q Consensus 663 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 738 (787)
.+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCE
Confidence 467899999999999999986532 2468899999999999999999998 899999999999999999999
Q ss_pred EEeecccceecCCCCCceeeeeccccCcccccccc-----cCCcC-cceeecC
Q 003911 739 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV-----HTRWS-SCSYWAG 785 (787)
Q Consensus 739 kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~-~~DiWS~ 785 (787)
||+|||++........ ......||+.|+|||++. +..++ ++|+||.
T Consensus 169 kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 220 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSL 220 (326)
T ss_dssp EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHH
T ss_pred EEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHH
Confidence 9999999987643322 223357899999999987 45566 8999983
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=263.98 Aligned_cols=175 Identities=21% Similarity=0.387 Sum_probs=152.4
Q ss_pred CCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEe--CCeeEE
Q 003911 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLD--GNEKLL 668 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~l 668 (787)
++|++.+.||+|+||.||+|.. .+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.+ ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 6799999999999999999976 47899999998642 2467899999999997 9999999999998 567899
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC-cEEEeecccce
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVR 747 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~ 747 (787)
||||+++++|.+++. .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||+++
T Consensus 111 v~e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 999999999988872 47889999999999999999998 8999999999999999766 89999999998
Q ss_pred ecCCCCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 748 LAPEGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
....... .....||+.|+|||++.+ ..++ ++||||.
T Consensus 180 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 217 (330)
T 3nsz_A 180 FYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSL 217 (330)
T ss_dssp ECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred EcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHH
Confidence 7754432 233578999999999987 5566 8999983
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=266.20 Aligned_cols=184 Identities=26% Similarity=0.416 Sum_probs=150.6
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc------chhHHHHHHHHHHHHhcCCCccceEEeEEEeC
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS------GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG 663 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 663 (787)
..++|++.+.||+|+||.||+|... +++.||||++...... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4567999999999999999999875 6899999998754321 12234688999999999999999999998765
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc---EEE
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKV 740 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl 740 (787)
. .++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred c-eEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEE
Confidence 5 8999999999999988842 3468999999999999999999998 89999999999999987654 999
Q ss_pred eecccceecCCCCCceeeeeccccCcccccccc---cCCcC-cceeecC
Q 003911 741 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV---HTRWS-SCSYWAG 785 (787)
Q Consensus 741 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~-~~DiWS~ 785 (787)
+|||+++...... ......||+.|+|||++. +..++ ++|+||.
T Consensus 159 ~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 205 (322)
T 2ycf_A 159 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 205 (322)
T ss_dssp CCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHH
T ss_pred ccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHH
Confidence 9999998774432 223356899999999974 45566 8999983
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-29 Score=261.85 Aligned_cols=184 Identities=27% Similarity=0.441 Sum_probs=154.5
Q ss_pred CCcccceeccccceEEEEEEEe-CC---cEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee-EE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK-LL 668 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~l 668 (787)
.|...+.||+|+||.||+|+.. ++ ..||+|++.. .......+.+.+|++++++++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc-cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 4666799999999999999764 22 3799999875 23345567899999999999999999999999876665 99
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+.+|+|.+++.. ....+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.
T Consensus 101 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EECCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 9999999999999853 23568899999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCC---CceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGK---GSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... ........||+.|+|||.+.+..++ ++|+||.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 214 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSF 214 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHH
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhH
Confidence 54321 1122335678999999999998888 8999983
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=267.24 Aligned_cols=185 Identities=29% Similarity=0.490 Sum_probs=148.4
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcE----EEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTK----IAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK 666 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (787)
.++|++.+.||+|+||.||+|++. +++. ||+|.+... ......+++.+|++++++++||||+++++++.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 367999999999999999999864 4554 567766542 23455678999999999999999999999998765 7
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
++|+||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~v~~~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEECCCSSCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred eEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 899999999999999854 23468999999999999999999998 89999999999999999999999999999
Q ss_pred eecCCCCCc-eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 747 RLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+........ ......||+.|+|||++.+..++ ++||||.
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 205 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHH
Confidence 876443221 22234578899999999999988 9999983
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=259.13 Aligned_cols=186 Identities=29% Similarity=0.388 Sum_probs=158.6
Q ss_pred hhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc---c----chhHHHHHHHHHHHHhcC-CCccceEEeEE
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI---S----GKGLTEFKSEIAVLTKVR-HRHLVALLGHC 660 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~----~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 660 (787)
...++|++.+.||+|+||.||+|... +++.||||++..... . ....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45678999999999999999999875 689999999976431 1 223467889999999995 99999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEE
Q 003911 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 740 (787)
Q Consensus 661 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 740 (787)
...+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEE
Confidence 9999999999999999999998541 368999999999999999999998 89999999999999999999999
Q ss_pred eecccceecCCCCCceeeeeccccCcccccccc------cCCcC-cceeecC
Q 003911 741 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAV------HTRWS-SCSYWAG 785 (787)
Q Consensus 741 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~-~~DiWS~ 785 (787)
+|||.+....... ......||+.|+|||++. ...++ ++|+||.
T Consensus 166 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 215 (298)
T 1phk_A 166 TDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215 (298)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHH
T ss_pred ecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhH
Confidence 9999998775433 223457899999999985 34555 8999983
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-29 Score=263.78 Aligned_cols=188 Identities=28% Similarity=0.388 Sum_probs=154.9
Q ss_pred cCCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe----CCee
Q 003911 592 TNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEK 666 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~ 666 (787)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++.. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 46799999999999999999987 47999999998653 34556789999999999999999999999873 3467
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
++||||+++|+|.+++...... ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 8999999999999998764432 3578999999999999999999998 89999999999999999999999999998
Q ss_pred eecCCCCCc--------eeeeeccccCcccccccccCC---cC-cceeecC
Q 003911 747 RLAPEGKGS--------IETRIAGTFGYLAPEYAVHTR---WS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~-~~DiWS~ 785 (787)
+........ ......||+.|+|||++.+.. ++ ++||||.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 232 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSL 232 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHH
Confidence 765321110 011245799999999987654 45 8999983
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-29 Score=270.01 Aligned_cols=180 Identities=24% Similarity=0.421 Sum_probs=152.9
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCee---
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEK--- 666 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--- 666 (787)
..++|.+.+.||+|+||.||+|... +|+.||||++..........+++.+|++++++++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4578999999999999999999865 789999999987555556678899999999999999999999999877654
Q ss_pred ---EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 667 ---LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 667 ---~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
++||||++ ++|.+++. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECST
T ss_pred eeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEec
Confidence 99999996 68877762 358999999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
|+++..... .....||+.|+|||++.+ ..++ ++|+||.
T Consensus 189 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (371)
T 4exu_A 189 GLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSV 228 (371)
T ss_dssp TCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHH
T ss_pred CcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHH
Confidence 999866432 234578999999999987 5666 8999983
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=270.50 Aligned_cols=185 Identities=17% Similarity=0.194 Sum_probs=148.6
Q ss_pred cCCCcccceeccccceEEEEEEEe----CCcEEEEEEeecccccc---------hhHHHHHHHHHHHHhcCCCccceEEe
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISG---------KGLTEFKSEIAVLTKVRHRHLVALLG 658 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~ 658 (787)
.++|++.+.||+|+||.||+|... ++..||||++....... .....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999875 57889999987642210 11234678889999999999999999
Q ss_pred EEEe----CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC
Q 003911 659 HCLD----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD 734 (787)
Q Consensus 659 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 734 (787)
++.. ....++||||+ +++|.+++... ..+++.+++.++.||+.||+|||+ .+|+||||||+||+++.
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEES
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEcc
Confidence 9988 67889999999 99999988431 268999999999999999999998 89999999999999998
Q ss_pred CC--cEEEeecccceecCCCCC------ceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 735 DM--RAKVADFGLVRLAPEGKG------SIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 735 ~~--~~kl~DFG~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++ .+||+|||+++....... .......||+.|+|||++.+..++ ++||||.
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 246 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEIL 246 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHH
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHH
Confidence 77 999999999987643221 111345799999999999999888 9999983
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-29 Score=265.08 Aligned_cols=185 Identities=28% Similarity=0.539 Sum_probs=157.2
Q ss_pred cCCCcccceeccccceEEEEEEE-----eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC--
Q 003911 592 TNNFSEENILGRGGFGTVYKGEL-----HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN-- 664 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 664 (787)
.++|++.+.||+|+||.||+|++ .+++.||||++... .....+++.+|++++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 45789999999999999999984 36899999998763 3455678999999999999999999999987654
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHH----STTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ceEEEEECCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCc
Confidence 67999999999999999854 22468999999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCCce--eeeeccccCcccccccccCCcC-cceeecC
Q 003911 745 LVRLAPEGKGSI--ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+++......... .....++..|+|||++.+..++ ++|+||.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 234 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSF 234 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHH
Confidence 998875543221 1224577889999999988888 8999983
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=275.61 Aligned_cols=57 Identities=19% Similarity=0.276 Sum_probs=37.3
Q ss_pred ceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccc
Q 003911 371 NITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 432 (787)
Q Consensus 371 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g 432 (787)
+|+.|+|++|+++ .+|..+. ++|+.|+|++|+|++. |. +..+++|++|+|++|++++
T Consensus 254 ~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 254 QLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp TCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred CCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 4555555555555 5555554 6677777777777744 55 7777777777777777765
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-28 Score=259.02 Aligned_cols=201 Identities=22% Similarity=0.315 Sum_probs=177.0
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCcccc---------CC
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFT---------GL 138 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---------~l 138 (787)
.+++.|+|++|+++ .+|..++++++|++|+|++|+|+..++.+.++++|++|+|++|++.+..|..+. ++
T Consensus 104 ~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l 182 (328)
T 4fcg_A 104 SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182 (328)
T ss_dssp TTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEES
T ss_pred CCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccC
Confidence 47999999999999 999999999999999999999996655899999999999999888776665554 49
Q ss_pred CCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccce
Q 003911 139 SSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSL 218 (787)
Q Consensus 139 ~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L 218 (787)
++|++|+|++|+++ .+|..+..+++|++|++++|.+++. |..++ .+++|++|+|++|++.+.+|..+.
T Consensus 183 ~~L~~L~L~~n~l~--~lp~~l~~l~~L~~L~L~~N~l~~l-~~~l~--~l~~L~~L~Ls~n~~~~~~p~~~~------- 250 (328)
T 4fcg_A 183 VNLQSLRLEWTGIR--SLPASIANLQNLKSLKIRNSPLSAL-GPAIH--HLPKLEELDLRGCTALRNYPPIFG------- 250 (328)
T ss_dssp TTCCEEEEEEECCC--CCCGGGGGCTTCCEEEEESSCCCCC-CGGGG--GCTTCCEEECTTCTTCCBCCCCTT-------
T ss_pred CCCCEEECcCCCcC--cchHhhcCCCCCCEEEccCCCCCcC-chhhc--cCCCCCEEECcCCcchhhhHHHhc-------
Confidence 99999999999998 7899999999999999999999964 44565 889999999999999988887764
Q ss_pred eeccCCCCCcCCCCccccccCccCceEeccccccccCCC-CCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCC
Q 003911 219 WVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297 (787)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 297 (787)
++++|++|+|++|.+.+.+| .+..+++|++|+|++|++.+.+|+.+.++++|+.+++..|
T Consensus 251 -------------------~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~ 311 (328)
T 4fcg_A 251 -------------------GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311 (328)
T ss_dssp -------------------CCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGG
T ss_pred -------------------CCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHH
Confidence 78899999999998888777 5888999999999999999999999999999999999877
Q ss_pred ccc
Q 003911 298 LLQ 300 (787)
Q Consensus 298 ~l~ 300 (787)
.+.
T Consensus 312 ~~~ 314 (328)
T 4fcg_A 312 LQA 314 (328)
T ss_dssp GSC
T ss_pred HHH
Confidence 665
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-29 Score=286.97 Aligned_cols=184 Identities=24% Similarity=0.431 Sum_probs=150.6
Q ss_pred CCCcccc-eeccccceEEEEEEEe---CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 593 NNFSEEN-ILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 593 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
+++.+.+ .||+|+||.||+|.+. ++..||||+++.. ......+++.+|++++++++||||+++++++.. +..++
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 3444445 7999999999999765 4667999999764 234457889999999999999999999999976 56899
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++|+|.+++.. ....+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.
T Consensus 413 v~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp EEECCTTCBHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred EEEeCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 9999999999999843 23468999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCcee--eeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSIE--TRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
......... ....+|+.|+|||++.+..++ ++||||.
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSl 525 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 525 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHH
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHH
Confidence 644322111 123456899999999988888 9999983
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-29 Score=288.42 Aligned_cols=178 Identities=26% Similarity=0.402 Sum_probs=149.4
Q ss_pred ceeccccceEEEEEEEe---CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.||+|+||.||+|.+. +++.||||+++.........+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999654 46789999998765555667899999999999999999999999964 558899999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|+|.+++.. ...+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+........
T Consensus 454 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999843 2468999999999999999999998 89999999999999999999999999999876543321
Q ss_pred --eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 756 --IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 756 --~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
......||+.|+|||++.+..++ ++||||.
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSl 558 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 558 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHH
Confidence 22234568899999999998898 9999983
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=253.42 Aligned_cols=247 Identities=20% Similarity=0.225 Sum_probs=171.5
Q ss_pred cEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCC-CCChhhhcCCCCCEEeccC
Q 003911 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSW-EIPQSLRNASGLQNFSANS 173 (787)
Q Consensus 95 ~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~p~~~~~l~~L~~L~l~~ 173 (787)
+.++++++.++..+..+. ++|++|+|++|+++.+++..|.++++|++|+|++|+++.. ..|..+..+++|++|++++
T Consensus 10 ~~l~c~~~~l~~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~ 87 (306)
T 2z66_A 10 TEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87 (306)
T ss_dssp TEEECCSSCCSSCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred CEEEcCCCCcccCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence 478888888887766554 6889999999999998888889999999999999988731 1245666666666666666
Q ss_pred ceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccc
Q 003911 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253 (787)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (787)
|.++.. |..+. .+++|++|++++|+++
T Consensus 88 n~i~~l-~~~~~--~l~~L~~L~l~~n~l~-------------------------------------------------- 114 (306)
T 2z66_A 88 NGVITM-SSNFL--GLEQLEHLDFQHSNLK-------------------------------------------------- 114 (306)
T ss_dssp CSEEEE-EEEEE--TCTTCCEEECTTSEEE--------------------------------------------------
T ss_pred CccccC-hhhcC--CCCCCCEEECCCCccc--------------------------------------------------
Confidence 666532 22232 4555555555555554
Q ss_pred cCCC--CCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccc-cCCCCCCceeeeccccCCCccCCCCCCCC
Q 003911 254 GPLP--DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG-PVPEFDRSVSLDMAKGSNNFCLPSPGACD 330 (787)
Q Consensus 254 ~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~p~~~~~~~L~~l~~~~n~~~~~~~~~~ 330 (787)
+.++ .+..+++|++|++++|++++..|..+..+++|++|+|++|.+++ .+|..
T Consensus 115 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~------------------------ 170 (306)
T 2z66_A 115 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI------------------------ 170 (306)
T ss_dssp SSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSC------------------------
T ss_pred ccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhH------------------------
Confidence 4332 34445555555555555555555555555666666666665554 22221
Q ss_pred chhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccC
Q 003911 331 PRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI 410 (787)
Q Consensus 331 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i 410 (787)
+...++|+.|+|++|++++..|..|..+++|+.|+|++|++++..
T Consensus 171 -----------------------------------~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 215 (306)
T 2z66_A 171 -----------------------------------FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 215 (306)
T ss_dssp -----------------------------------CTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCC
T ss_pred -----------------------------------HhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccC
Confidence 011235566666666666666778889999999999999999887
Q ss_pred CccCcCCCCCCeeeccCCcccccCCC----C-CCCceeecCCCCCCCCCC
Q 003911 411 PEGLSVLGALKELDVSNNQLYGKIPS----F-KSNAIVNTDGNPDIGKEK 455 (787)
Q Consensus 411 p~~l~~l~~L~~L~Ls~N~l~g~iP~----~-~~~~~~~~~gn~~~~~~~ 455 (787)
+..+..+++|++|||++|++++.+|. + ..+..+.+.||++.|...
T Consensus 216 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 216 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp SGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred hhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 88899999999999999999998875 3 367789999999887653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.95 E-value=8.9e-29 Score=264.15 Aligned_cols=186 Identities=26% Similarity=0.419 Sum_probs=154.9
Q ss_pred hcCCCcccceeccccceEEEEEEE--eCCcEEEEEEeecccccchhHHHHHHHHHHHHhc---CCCccceEEeEEE----
Q 003911 591 VTNNFSEENILGRGGFGTVYKGEL--HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV---RHRHLVALLGHCL---- 661 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~---- 661 (787)
..++|++.+.||+|+||.||+|+. .+++.||+|++............+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 3688999999976443333334566788777766 8999999999987
Q ss_pred -eCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEE
Q 003911 662 -DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 740 (787)
Q Consensus 662 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 740 (787)
.....++||||++ |+|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEE
Confidence 4567899999997 6999988542 22358999999999999999999998 89999999999999999999999
Q ss_pred eecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 741 ADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 741 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+|||+++...... ......||+.|+|||++.+..++ ++|+||.
T Consensus 162 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 205 (326)
T 1blx_A 162 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 205 (326)
T ss_dssp CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred ecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHH
Confidence 9999998664322 22345789999999999988888 8999983
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-29 Score=269.74 Aligned_cols=181 Identities=12% Similarity=0.102 Sum_probs=137.9
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhc--CCCccceEE-------eEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKV--RHRHLVALL-------GHCL 661 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~~ 661 (787)
.+|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+.+|+++++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45889999999999999999875 789999999987543 334566788886555555 699988755 4444
Q ss_pred eC-----------------CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 003911 662 DG-----------------NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRR------LTIALDVARGVEYLHGLAHQ 718 (787)
Q Consensus 662 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~qi~~~L~~LH~~~~~ 718 (787)
.. ...|+||||++ |+|.+++..... .+++..+ ..++.||+.||+|||+ +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~ 213 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQS---K 213 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence 33 33799999998 899999976422 3455555 7888999999999998 8
Q ss_pred CeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCceeeeeccccCccccccccc--CCcC-cceeecC
Q 003911 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVH--TRWS-SCSYWAG 785 (787)
Q Consensus 719 ~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~-~~DiWS~ 785 (787)
+|+||||||+|||++.++.+||+|||+|+..... .....||+.|+|||++.+ ..++ ++||||.
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl 279 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQL 279 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHH
Confidence 9999999999999999999999999999876432 223567899999999987 6777 8999983
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-30 Score=275.69 Aligned_cols=267 Identities=21% Similarity=0.229 Sum_probs=194.2
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (787)
.+++.++++.+++...+...+..+++|++|+|++|+|++.+| .|.++++|++|+|++|+++++++ |..+++|++|+|
T Consensus 10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L 87 (317)
T 3o53_A 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL 87 (317)
T ss_dssp TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence 456777788888875555566677788899999998888776 68888888999998888887765 888888888888
Q ss_pred cCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCC
Q 003911 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGN 226 (787)
Q Consensus 147 ~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~ 226 (787)
++|++++ +| ..++|++|++++|++++..+. .+++|++|+|++|++++..|..+.
T Consensus 88 s~n~l~~--l~----~~~~L~~L~l~~n~l~~~~~~-----~~~~L~~L~l~~N~l~~~~~~~~~--------------- 141 (317)
T 3o53_A 88 NNNYVQE--LL----VGPSIETLHAANNNISRVSCS-----RGQGKKNIYLANNKITMLRDLDEG--------------- 141 (317)
T ss_dssp CSSEEEE--EE----ECTTCCEEECCSSCCSEEEEC-----CCSSCEEEECCSSCCCSGGGBCTG---------------
T ss_pred cCCcccc--cc----CCCCcCEEECCCCccCCcCcc-----ccCCCCEEECCCCCCCCccchhhh---------------
Confidence 8888773 22 347888888888888776654 346788888888888765555443
Q ss_pred CcCCCCccccccCccCceEeccccccccCCCC-C-CCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCC
Q 003911 227 AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-F-SGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304 (787)
Q Consensus 227 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~-~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 304 (787)
.+++|++|+|++|.+++.++. + ..+++|++|+|++|+|++. |. ...+++|++|+|++|++++.++
T Consensus 142 -----------~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~ 208 (317)
T 3o53_A 142 -----------CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGP 208 (317)
T ss_dssp -----------GGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECG
T ss_pred -----------ccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcchh
Confidence 677788888888888776543 4 3577788888888888744 32 3347778888888887776544
Q ss_pred CCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccc
Q 003911 305 EFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTG 384 (787)
Q Consensus 305 ~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g 384 (787)
.+. ..++|+.|+|++|+++
T Consensus 209 ~~~------------------------------------------------------------~l~~L~~L~L~~N~l~- 227 (317)
T 3o53_A 209 EFQ------------------------------------------------------------SAAGVTWISLRNNKLV- 227 (317)
T ss_dssp GGG------------------------------------------------------------GGTTCSEEECTTSCCC-
T ss_pred hhc------------------------------------------------------------ccCcccEEECcCCccc-
Confidence 321 1236777777777777
Q ss_pred cCchhhcCCCCCCEEeccccccc-ccCCccCcCCCCCCeeecc-CCcccccCCC
Q 003911 385 TISPEFASFKSLQRLILADNNLS-GMIPEGLSVLGALKELDVS-NNQLYGKIPS 436 (787)
Q Consensus 385 ~~p~~~~~l~~L~~L~Ls~N~l~-g~ip~~l~~l~~L~~L~Ls-~N~l~g~iP~ 436 (787)
.+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|+++ .+.++|..|.
T Consensus 228 ~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 45667777778888888888877 6777777777778888777 4556665553
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=271.28 Aligned_cols=180 Identities=25% Similarity=0.445 Sum_probs=147.6
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC----C--e
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG----N--E 665 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~--~ 665 (787)
.+|++.+.||+|+||.||+|+.. +++.||||++.... ....+|++++++++||||+++++++... + .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 46899999999999999999885 69999999986532 1234799999999999999999998642 2 3
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC-CcEEEeecc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-MRAKVADFG 744 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG 744 (787)
.++||||+++ ++.+.+..... ....+++..+..++.||++||+|||+ .+|+||||||+|||++.+ +.+||+|||
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEeehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccch
Confidence 5799999975 77776654433 23578999999999999999999997 899999999999999955 678999999
Q ss_pred cceecCCCCCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
+++....... ....+||+.|+|||++.+. .++ ++||||.
T Consensus 203 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 243 (420)
T 1j1b_A 203 SAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSA 243 (420)
T ss_dssp TCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHH
T ss_pred hhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHH
Confidence 9987654332 2346789999999999775 667 8999983
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=258.40 Aligned_cols=184 Identities=21% Similarity=0.342 Sum_probs=150.7
Q ss_pred hhcCCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEE-EeCCeeE
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC-LDGNEKL 667 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~ 667 (787)
.+.++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+|++++++++|++++..++++ ...+..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 3457899999999999999999986 4789999998765322 23578899999999988877666655 6677889
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---CCCCcEEEeecc
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFG 744 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG 744 (787)
+||||+ +++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||++ ++++.+||+|||
T Consensus 82 lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEECC-CCBHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEcc-CCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 999999 9999998853 22468999999999999999999998 899999999999999 788999999999
Q ss_pred cceecCCCCCc------eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 745 LVRLAPEGKGS------IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+++........ ......||+.|+|||++.+..++ ++||||.
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 201 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL 201 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHH
Confidence 99877554321 12345799999999999999888 9999983
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=256.55 Aligned_cols=185 Identities=24% Similarity=0.411 Sum_probs=153.1
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|.....||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 34555679999999999999864 6889999999764 23445789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC-CCcEEEeecccceecC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVADFGLVRLAP 750 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~ 750 (787)
|+++++|.+++.... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++...
T Consensus 100 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 100 QVPGGSLSALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp CCSEEEHHHHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred eCCCCCHHHHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 999999999986521 22356788999999999999999998 89999999999999987 8999999999998765
Q ss_pred CCCCceeeeeccccCcccccccccCC--cC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTR--WS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~-~~DiWS~ 785 (787)
.... ......||+.|+|||++.+.. ++ ++|+||.
T Consensus 175 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl 211 (295)
T 2clq_A 175 GINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSL 211 (295)
T ss_dssp C------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHH
T ss_pred CCCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHH
Confidence 4322 223457899999999997754 56 8999983
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-29 Score=265.47 Aligned_cols=190 Identities=26% Similarity=0.391 Sum_probs=154.8
Q ss_pred cCCCcccceeccccceEEEEEEE------eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 592 TNNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
.++|++.+.||+|+||.||+|+. .+++.||||++... .......++.+|+.++++++||||+++++++.+.+.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 46899999999999999999973 35788999999753 344556789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC---CCcEEE
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEE--GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKV 740 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 740 (787)
.++||||+++++|.+++...... ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999653321 12458899999999999999999998 89999999999999984 446999
Q ss_pred eecccceecCCCCC-ceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 741 ADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 741 ~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+|||+++....... .......||+.|+|||++.+..++ ++||||.
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 231 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 231 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHH
Confidence 99999975533221 112235679999999999988888 9999983
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=265.51 Aligned_cols=247 Identities=15% Similarity=0.162 Sum_probs=175.4
Q ss_pred CcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccC
Q 003911 94 LERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173 (787)
Q Consensus 94 L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~ 173 (787)
...++.+++.++.++..+. ++|++|+|++|+|+++++..|.++++|++|+|++|+|+. ..|..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcCccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCC-cChhhccCcccCCEEECCC
Confidence 4578888899987766554 688999999999999988889999999999998888875 3345666666666666666
Q ss_pred ceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccc
Q 003911 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253 (787)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (787)
|+|++..+..|. .+++|++|+|++|++++..+..
T Consensus 133 n~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~-------------------------------------------- 166 (452)
T 3zyi_A 133 NWLTVIPSGAFE--YLSKLRELWLRNNPIESIPSYA-------------------------------------------- 166 (452)
T ss_dssp SCCSBCCTTTSS--SCTTCCEEECCSCCCCEECTTT--------------------------------------------
T ss_pred CcCCccChhhhc--ccCCCCEEECCCCCcceeCHhH--------------------------------------------
Confidence 666655555553 5555555555555555333322
Q ss_pred cCCCCCCCCCCCCEEecCC-CcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCch
Q 003911 254 GPLPDFSGVKQLESLSLRD-NFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPR 332 (787)
Q Consensus 254 ~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~ 332 (787)
|..+++|+.|+|++ |.+....+..|..+++|++|+|++|++++. |.+.
T Consensus 167 -----~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~------------------------- 215 (452)
T 3zyi_A 167 -----FNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNLT------------------------- 215 (452)
T ss_dssp -----TTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCCT-------------------------
T ss_pred -----HhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-cccc-------------------------
Confidence 44445555555555 233322223455566666666666655533 2111
Q ss_pred hhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCc
Q 003911 333 LNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 412 (787)
Q Consensus 333 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~ 412 (787)
...+|+.|+|++|++++..|..|..+++|+.|+|++|++++..|.
T Consensus 216 -----------------------------------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 260 (452)
T 3zyi_A 216 -----------------------------------PLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERN 260 (452)
T ss_dssp -----------------------------------TCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTT
T ss_pred -----------------------------------ccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHH
Confidence 113566777777777777788899999999999999999999999
Q ss_pred cCcCCCCCCeeeccCCcccccCCC----CCCCceeecCCCCCCCCCC
Q 003911 413 GLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDIGKEK 455 (787)
Q Consensus 413 ~l~~l~~L~~L~Ls~N~l~g~iP~----~~~~~~~~~~gn~~~~~~~ 455 (787)
.|..+++|++|||++|+|++.++. +..+..+.+.+||+.|...
T Consensus 261 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 261 AFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred HhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence 999999999999999999977664 5667889999999998765
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-29 Score=267.67 Aligned_cols=189 Identities=22% Similarity=0.398 Sum_probs=160.0
Q ss_pred hcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccch---------------hHHHHHHHHHHHHhcCCCccce
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK---------------GLTEFKSEIAVLTKVRHRHLVA 655 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~ 655 (787)
..++|++.+.||+|+||.||+|+. +++.||||++........ ..+.+.+|++++++++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999999988 899999999976432211 1278999999999999999999
Q ss_pred EEeEEEeCCeeEEEEEecCCCCHHHHHHhh---hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 003911 656 LLGHCLDGNEKLLVFEYMPQGTLSRHIFNW---AEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (787)
Q Consensus 656 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 732 (787)
+++++.+.+..++||||+++|+|.+++... .......+++..+..++.|++.||+|||+ ..+|+||||||+||++
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILM 185 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEE
Confidence 999999999999999999999998873210 11124578999999999999999999996 3799999999999999
Q ss_pred CCCCcEEEeecccceecCCCCCceeeeeccccCcccccccccC-CcC--cceeecC
Q 003911 733 GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHT-RWS--SCSYWAG 785 (787)
Q Consensus 733 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~--~~DiWS~ 785 (787)
+.++.+||+|||.+...... ......||+.|+|||++.+. .++ ++|+||.
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl 238 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSL 238 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHH
Confidence 99999999999999876443 23346789999999999887 554 7999983
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-29 Score=274.13 Aligned_cols=186 Identities=29% Similarity=0.432 Sum_probs=139.3
Q ss_pred cCCCcc-cceeccccceEEEEEEEe---CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe--CCe
Q 003911 592 TNNFSE-ENILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNE 665 (787)
Q Consensus 592 ~~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 665 (787)
.+.|++ .++||+|+||.||+|+.. +++.||||++..... ...+.+|++++++++||||+++++++.. ...
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 345665 458999999999999875 578999999975322 3468899999999999999999999965 668
Q ss_pred eEEEEEecCCCCHHHHHHhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE----CCCCc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEE----GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL----GDDMR 737 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~ 737 (787)
.++||||++ |+|.+++...... ....+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCc
Confidence 899999996 5888887543322 12358999999999999999999998 899999999999999 67789
Q ss_pred EEEeecccceecCCCCC--ceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 738 AKVADFGLVRLAPEGKG--SIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 738 ~kl~DFG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
+||+|||+|+....... ......+||+.|+|||++.+. .++ ++||||.
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 222 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 222 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHH
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHH
Confidence 99999999987654321 122346799999999999875 477 8999983
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=258.27 Aligned_cols=186 Identities=28% Similarity=0.424 Sum_probs=160.0
Q ss_pred hhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
.+.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 45578999999999999999999876 78999999998765555667889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC---CcEEEeeccc
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD---MRAKVADFGL 745 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFG~ 745 (787)
||||+++++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.+ +.+||+|||+
T Consensus 99 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 99999999999888542 368999999999999999999998 899999999999999754 4799999999
Q ss_pred ceecCCCCCceeeeeccccCcccccccccCCcCcceeecC
Q 003911 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWSSCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiWS~ 785 (787)
+........ .....||+.|+|||++.+....++|+||.
T Consensus 171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~Di~sl 208 (287)
T 2wei_A 171 STCFQQNTK--MKDRIGTAYYIAPEVLRGTYDEKCDVWSA 208 (287)
T ss_dssp GGTBCCCSS--CSCHHHHHTTCCHHHHTTCCCTHHHHHHH
T ss_pred ceeecCCCc--cccccCcccccChHHhcCCCCCchhhHhH
Confidence 986644322 22346899999999988763338999983
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-29 Score=265.24 Aligned_cols=190 Identities=25% Similarity=0.433 Sum_probs=141.1
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|... +++.||||++.... .....+++.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 568999999999999999999754 78999999986532 2334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 671 EYMPQGTLSRHIFNWAEE---GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
||+++++|.+++...... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998654322 23468999999999999999999998 899999999999999999999999999987
Q ss_pred ecCCCCC----ceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 748 LAPEGKG----SIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
....... .......||+.|+|||++.+ ..++ ++|+||.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 213 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSF 213 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHH
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHH
Confidence 6543221 11233579999999999876 4556 8999983
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=268.38 Aligned_cols=181 Identities=23% Similarity=0.420 Sum_probs=148.0
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe------
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE------ 665 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 665 (787)
..+|++.+.||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+.
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 457999999999999999999987777799998865321 22379999999999999999999965433
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC-CCCcEEEeecc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFG 744 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG 744 (787)
.++||||+++ ++.+.+..... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||
T Consensus 113 ~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 113 LNLVLEYVPE-TVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEECCSE-EHHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEeeccCc-cHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 7899999976 45444433322 23578999999999999999999998 8999999999999999 79999999999
Q ss_pred cceecCCCCCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
+|+....... .....||+.|+|||++.+. .++ ++||||.
T Consensus 188 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 228 (394)
T 4e7w_A 188 SAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWST 228 (394)
T ss_dssp TCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred CcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHH
Confidence 9987754432 2345789999999999775 466 8999983
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=262.03 Aligned_cols=181 Identities=28% Similarity=0.454 Sum_probs=156.0
Q ss_pred hcCCCcccceeccccceEEEEEEE-e-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCc------cceEEeEEEe
Q 003911 591 VTNNFSEENILGRGGFGTVYKGEL-H-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH------LVALLGHCLD 662 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~ 662 (787)
+.++|++.+.||+|+||.||+|.. . +++.||||+++.. ....+.+.+|+++++.++|++ |+++++++..
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 457899999999999999999986 3 6889999998652 345677899999999987654 9999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC--------
Q 003911 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-------- 734 (787)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------- 734 (787)
.+..++||||+ +++|.+++.. .....+++.++..++.|++.||+|||+ .+|+||||||+||+++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKE---NGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC
T ss_pred CCcEEEEEcCC-CCCHHHHHHh---cCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999 8999998854 223468899999999999999999998 89999999999999987
Q ss_pred -----------CCcEEEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 735 -----------DMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 735 -----------~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++.+||+|||+++...... ....||+.|+|||++.+..++ ++|+||.
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 220 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSI 220 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHH
T ss_pred CccccccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHH
Confidence 6689999999998764332 335789999999999998888 8999983
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=264.60 Aligned_cols=184 Identities=28% Similarity=0.449 Sum_probs=153.6
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC-----C
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----N 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 664 (787)
+.++|++.+.||+|+||.||+|... +|+.||||++... .......++.+|++++++++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 4578999999999999999999876 6899999999652 2344566788999999999999999999988754 6
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecc
Confidence 7899999996 689888743 368999999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCCc---------eeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 745 LVRLAPEGKGS---------IETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
+++........ ......||+.|+|||++.+ ..++ ++|+||.
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 209 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSC 209 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHH
Confidence 99876533211 1123578999999998765 5667 8999983
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=270.36 Aligned_cols=181 Identities=26% Similarity=0.356 Sum_probs=153.6
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC--------CCccceEEeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR--------HRHLVALLGHCL 661 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~ 661 (787)
+.++|++.+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|++++++++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 3578999999999999999999765 6899999999752 344578899999999995 788999999988
Q ss_pred ----eCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEcCCCCCCEEECCCC
Q 003911 662 ----DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDM 736 (787)
Q Consensus 662 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~ 736 (787)
.....++||||+ ++++.+++.. .....+++..++.++.||+.||+|||+ + +|+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIK---SNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccc
Confidence 456789999999 6677776644 223468999999999999999999998 6 999999999999999775
Q ss_pred -------------------------------------------------cEEEeecccceecCCCCCceeeeeccccCcc
Q 003911 737 -------------------------------------------------RAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767 (787)
Q Consensus 737 -------------------------------------------------~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~ 767 (787)
.+||+|||+++..... ....+||+.|+
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~ 260 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYR 260 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGC
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCccc
Confidence 7999999999876543 23357899999
Q ss_pred cccccccCCcC-cceeecC
Q 003911 768 APEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 768 aPE~~~~~~~~-~~DiWS~ 785 (787)
|||++.+..++ ++||||.
T Consensus 261 aPE~~~~~~~~~~~Diwsl 279 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWST 279 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHH
T ss_pred CChhhcCCCCCcHHHHHHH
Confidence 99999998888 8999983
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-29 Score=269.92 Aligned_cols=180 Identities=13% Similarity=0.191 Sum_probs=152.1
Q ss_pred cCCCcccceeccccceEEEEEEEeC---------CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccce-------
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHD---------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVA------- 655 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 655 (787)
.++|++.+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 3689999999999999999998753 789999998753 36789999999999999998
Q ss_pred --------EEeEEEe-CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 003911 656 --------LLGHCLD-GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLK 726 (787)
Q Consensus 656 --------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 726 (787)
+++++.. .+..++||||+ +++|.+++.... ...+++.+++.++.|++.||+|||+ .+|+|||||
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dik 186 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVT 186 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCC
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCC
Confidence 6777776 67889999999 999999996531 2468999999999999999999998 899999999
Q ss_pred CCCEEECCCC--cEEEeecccceecCCCCCc------eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 727 PSNILLGDDM--RAKVADFGLVRLAPEGKGS------IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 727 p~NIll~~~~--~~kl~DFG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|+||+++.++ .+||+|||+++........ ......||+.|+|||++.+..++ ++||||.
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 254 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSL 254 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHH
Confidence 9999999988 8999999999866432211 11334799999999999998888 9999983
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=258.17 Aligned_cols=188 Identities=22% Similarity=0.355 Sum_probs=153.6
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc--chhHHHHHHHHHHHHhcCCCccceEEeEEE--eCCe
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS--GKGLTEFKSEIAVLTKVRHRHLVALLGHCL--DGNE 665 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~ 665 (787)
..++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|++++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4578999999999999999999864 6899999999764322 244678999999999999999999999985 4457
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.++||||++++ +.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEehhccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccc
Confidence 89999999876 77776442 23468999999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCC-ceeeeeccccCcccccccccCCc--C-cceeecC
Q 003911 746 VRLAPEGKG-SIETRIAGTFGYLAPEYAVHTRW--S-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~--~-~~DiWS~ 785 (787)
+........ .......||+.|+|||++.+... + ++|+||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl 199 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSA 199 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHH
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHH
Confidence 987654322 22234568999999999987543 4 8999983
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=256.68 Aligned_cols=183 Identities=21% Similarity=0.344 Sum_probs=154.4
Q ss_pred hcCCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEE-EeCCeeEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHC-LDGNEKLL 668 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~l 668 (787)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+|++++++++|++++..+.++ ...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 457899999999999999999986 4799999999876332 24688999999999988876666555 56777899
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---CCCCcEEEeeccc
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL 745 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~ 745 (787)
||||+ +++|.+++.. ....+++.++..++.|++.||+|||+ .+|+||||||+||++ ++++.+||+|||+
T Consensus 83 v~e~~-~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 99999 9999999853 22468999999999999999999998 899999999999999 4888999999999
Q ss_pred ceecCCCCCc------eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 746 VRLAPEGKGS------IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++........ ......||+.|+|||++.+..++ ++||||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 201 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL 201 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHH
Confidence 9877654321 12345799999999999998888 9999983
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=248.93 Aligned_cols=177 Identities=18% Similarity=0.221 Sum_probs=121.5
Q ss_pred cEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCc
Q 003911 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174 (787)
Q Consensus 95 ~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n 174 (787)
+.++.+++.++.++..+ .++|++|+|++|+++++++..|.++++|++|+|++|+++. ..|..|..+++|++|++++|
T Consensus 14 ~~~~c~~~~l~~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-IDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCSSCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcccCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccce-eCHhhcCCccCCCEEeCCCC
Confidence 67888888888765544 3678888888888888888888888888888888888875 34667777777777777777
Q ss_pred e-ecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccc
Q 003911 175 N-ITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253 (787)
Q Consensus 175 ~-l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (787)
. ++...|..|. .+++|++|+|++|++++..|..+. ++++|++|+|++|+++
T Consensus 91 ~~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~--------------------------~l~~L~~L~l~~n~l~ 142 (285)
T 1ozn_A 91 AQLRSVDPATFH--GLGRLHTLHLDRCGLQELGPGLFR--------------------------GLAALQYLYLQDNALQ 142 (285)
T ss_dssp TTCCCCCTTTTT--TCTTCCEEECTTSCCCCCCTTTTT--------------------------TCTTCCEEECCSSCCC
T ss_pred CCccccCHHHhc--CCcCCCEEECCCCcCCEECHhHhh--------------------------CCcCCCEEECCCCccc
Confidence 5 6665566664 667777777777777655554433 5666666666666666
Q ss_pred cCCCC-CCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCccccc
Q 003911 254 GPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302 (787)
Q Consensus 254 ~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 302 (787)
+.++. +..+++|++|+|++|+|++..+..|..+++|++|+|++|++++.
T Consensus 143 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 192 (285)
T 1ozn_A 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (285)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred ccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccccc
Confidence 65553 55666666666666666644444566666666666666655544
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-29 Score=262.50 Aligned_cols=185 Identities=25% Similarity=0.433 Sum_probs=152.5
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
..++|++.+.||+|+||.||+|+.. +++.||+|++... .....+++.+|++++++++||||+++++++...+..++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 4568999999999999999999876 6899999998753 234567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 95 ~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp EECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred EEeCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 9999999999888542 2468999999999999999999998 89999999999999999999999999987543
Q ss_pred CCCCCceeeeeccccCcccccccc-----cCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAV-----HTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~-~~DiWS~ 785 (787)
.... .......||+.|+|||++. +..++ ++|+||.
T Consensus 168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 208 (302)
T 2j7t_A 168 LKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL 208 (302)
T ss_dssp HHHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHH
T ss_pred cccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHH
Confidence 2111 1112356899999999984 55666 8999983
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.3e-29 Score=258.03 Aligned_cols=179 Identities=32% Similarity=0.533 Sum_probs=147.3
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC-CeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-NEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|+.. ++.||||+++.. ...+++.+|++++++++||||+++++++... +..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 357999999999999999999874 899999998753 2457899999999999999999999997654 4689999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 95 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ecCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 99999999999865322 247889999999999999999998 899999999999999999999999999998654
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... ....+++.|+|||++.+..++ ++|+||.
T Consensus 169 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (278)
T 1byg_A 169 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSF 200 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred ccc----cCCCccccccCHHHhCCCCCCchhcHHHH
Confidence 322 223578999999999988888 8999983
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=265.60 Aligned_cols=189 Identities=24% Similarity=0.346 Sum_probs=143.9
Q ss_pred HHHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 587 VLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 587 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
......++|++.+.||+|+||.||+|+.. +++.||||++.... ....++.+|++.++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 34556689999999999999999999875 68999999986532 223456778888999999999999999976433
Q ss_pred -------eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEEcCCCCCCEEECC-C
Q 003911 666 -------KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH--GLAHQSFIHRDLKPSNILLGD-D 735 (787)
Q Consensus 666 -------~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~~~~ivH~Dlkp~NIll~~-~ 735 (787)
.++||||+++ +|.+.+..... ....+++..+..++.|++.||+||| + .+|+||||||+|||++. +
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCC
Confidence 7899999975 66665544332 2356889999999999999999999 6 89999999999999996 8
Q ss_pred CcEEEeecccceecCCCCCceeeeeccccCcccccccccCC-cC-cceeecC
Q 003911 736 MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWAG 785 (787)
Q Consensus 736 ~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS~ 785 (787)
+.+||+|||+++....... .....||+.|+|||++.+.. ++ ++||||.
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 218 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSV 218 (360)
T ss_dssp TEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred CcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHH
Confidence 9999999999987754332 23457899999999987654 66 8999983
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=265.19 Aligned_cols=180 Identities=24% Similarity=0.417 Sum_probs=151.9
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe----
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE---- 665 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 665 (787)
+.++|.+.+.||+|+||.||+|... +|+.||||++..........+++.+|+.++++++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 3568999999999999999999875 79999999997755455566789999999999999999999999987654
Q ss_pred --eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 666 --KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 666 --~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
.++||||++ ++|.+++. ..+++.++..++.||+.||+|||+ .+|+||||||+||++++++.+||+||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Df 170 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDF 170 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECST
T ss_pred eeEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeec
Confidence 499999996 68877652 258999999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
|+++..... .....||+.|+|||++.+ ..++ ++|+||.
T Consensus 171 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~sl 210 (353)
T 3coi_A 171 GLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSV 210 (353)
T ss_dssp TCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHH
T ss_pred ccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHH
Confidence 999865432 234578999999999987 5666 8999983
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-30 Score=272.51 Aligned_cols=263 Identities=16% Similarity=0.194 Sum_probs=210.9
Q ss_pred CCCCC-CCCCcccEEEc-CCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCC-CCCC-CCC-------CCCCCc
Q 003911 50 GWSDT-DPCKWNHVVCI-EDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSIS-GPLP-SLN-------GLASLE 118 (787)
Q Consensus 50 ~w~~~-~~C~w~gv~C~-~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~-~~~-------~l~~L~ 118 (787)
+|... .|+.+..+... ...+++.|++++|++ .+|..+... |++|+|++|+|+ +.+| .+. ++++|+
T Consensus 23 ~~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~ 98 (312)
T 1wwl_A 23 DWSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98 (312)
T ss_dssp CGGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCC
T ss_pred chHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCcc
Confidence 56543 45566655432 234688899999999 788777655 999999999994 4455 343 699999
Q ss_pred EEEcccccCCcCCCccc--cCCCCCcEEEccCCCCCCCCCChhhhcC-----CCCCEEeccCceecccCCCCCCCCCCCC
Q 003911 119 VVMLSNNQFTSVPSDFF--TGLSSLQSIEIDNNPFSSWEIPQSLRNA-----SGLQNFSANSANITGQIPSFFGPDEFPG 191 (787)
Q Consensus 119 ~L~L~~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~p~~~~~l-----~~L~~L~l~~n~l~~~~p~~~~~~~l~~ 191 (787)
+|+|++|++++..|..+ ..+++|++|+|++|++++ +|..+..+ ++|++|++++|++++..|..|+ .+++
T Consensus 99 ~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~--~l~~ 174 (312)
T 1wwl_A 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT--RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVR--VFPA 174 (312)
T ss_dssp EEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSS--SSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCC--CCSS
T ss_pred EEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcc--hhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhc--cCCC
Confidence 99999999997666654 899999999999999995 48888887 9999999999999999989887 8999
Q ss_pred CcEEeccccccccCC--CcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCC---C-CCCCCCC
Q 003911 192 LTILHLAFNQLIGGL--PASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP---D-FSGVKQL 265 (787)
Q Consensus 192 L~~L~L~~N~l~~~~--p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~---~-~~~l~~L 265 (787)
|++|+|++|++.+.+ |..+. ++++++|++|+|++|+|++.+. . +..+++|
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L 230 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALC------------------------PLKFPTLQVLALRNAGMETPSGVCSALAAARVQL 230 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSC------------------------TTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCC
T ss_pred CCEEECCCCCcCcchHHHHHHH------------------------hccCCCCCEEECCCCcCcchHHHHHHHHhcCCCC
Confidence 999999999987642 22221 2478999999999999984322 2 4578999
Q ss_pred CEEecCCCcccccCC-ccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhC
Q 003911 266 ESLSLRDNFFTGPVP-DSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMG 344 (787)
Q Consensus 266 ~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~ 344 (787)
++|+|++|+|++.+| ..+..+++|++|+|++|+|+..++.+.
T Consensus 231 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~------------------------------------- 273 (312)
T 1wwl_A 231 QGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP------------------------------------- 273 (312)
T ss_dssp SEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSCCSSCC-------------------------------------
T ss_pred CEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChhhhhcc-------------------------------------
Confidence 999999999998775 556778999999999999984333211
Q ss_pred CChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccc
Q 003911 345 YPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG 408 (787)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 408 (787)
++|+.|+|++|++++. |. +..+++|++|+|++|++++
T Consensus 274 -------------------------~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 274 -------------------------AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp -------------------------SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred -------------------------CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 3799999999999987 65 9999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-29 Score=263.03 Aligned_cols=189 Identities=22% Similarity=0.321 Sum_probs=154.8
Q ss_pred HHHhhcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcC--CCccceEEeEEEeCC
Q 003911 587 VLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR--HRHLVALLGHCLDGN 664 (787)
Q Consensus 587 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 664 (787)
.+....++|++.+.||+|+||.||+|...+++.||||++..........+.+.+|++++++++ ||||+++++++...+
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 333445679999999999999999998888999999999876555666788999999999997 599999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..++||| +.+++|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||++++ +.+||+|||
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred EEEEEEe-cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecc
Confidence 9999999 558899999854 2468899999999999999999998 89999999999999965 899999999
Q ss_pred cceecCCCCCc-eeeeeccccCccccccccc-----------CCcC-cceeecC
Q 003911 745 LVRLAPEGKGS-IETRIAGTFGYLAPEYAVH-----------TRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~-~~DiWS~ 785 (787)
+++........ ......||+.|+|||++.+ ..++ ++||||.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~sl 225 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHH
Confidence 99876543221 1234568999999999876 3566 8999983
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=284.95 Aligned_cols=187 Identities=22% Similarity=0.358 Sum_probs=154.6
Q ss_pred hhcCCCcccceeccccceEEEEEEEe----CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 590 NVTNNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 590 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
...++|++.+.||+|+||.||+|.+. .+..||+|+++.. ......+.+.+|+.++++++||||+++++++. .+.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 34568999999999999999999874 2567999988653 23445678999999999999999999999985 456
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 465 ~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp CEEEEECCTTCBHHHHHHH----TTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred eEEEEEcCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCC
Confidence 8999999999999999854 22468999999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++..............||+.|+|||++.+..++ ++||||.
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 578 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 578 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHH
Confidence 987755433333345578899999999988888 8999983
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=261.47 Aligned_cols=186 Identities=26% Similarity=0.342 Sum_probs=141.4
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEe-------
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLD------- 662 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~------- 662 (787)
..+|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++++. ||||+++++++..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 357999999999999999999875 7899999998653 3445678899999999996 9999999999952
Q ss_pred -CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCEEECCCCcEE
Q 003911 663 -GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLGDDMRAK 739 (787)
Q Consensus 663 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~k 739 (787)
....++||||++ |+|.+++..... ...+++.+++.++.|++.||+|||+ .+ |+||||||+||+++.++.+|
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEE
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEE
Confidence 345789999995 799998865433 3468999999999999999999997 67 99999999999999999999
Q ss_pred EeecccceecCCCCCce-----------eeeeccccCccccccc---ccCCcC-cceeecC
Q 003911 740 VADFGLVRLAPEGKGSI-----------ETRIAGTFGYLAPEYA---VHTRWS-SCSYWAG 785 (787)
Q Consensus 740 l~DFG~a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~-~~DiWS~ 785 (787)
|+|||+++......... .....||+.|+|||++ .+..++ ++||||.
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~sl 239 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWAL 239 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHH
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHH
Confidence 99999998765432211 1134689999999998 556677 8999983
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=260.80 Aligned_cols=187 Identities=24% Similarity=0.356 Sum_probs=136.8
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHH-HHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIA-VLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||.||+|... +++.||||++.... ......++..|+. +++.++||||+++++++.+.+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 368999999999999999999875 78999999997643 2334455566665 66777999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
|||+++ +|.+++..........+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999975 88888765443334678999999999999999999998 6 999999999999999999999999999987
Q ss_pred cCCCCCceeeeeccccCccccccc----ccCCcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYA----VHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~-~~DiWS~ 785 (787)
..... ......||+.|+|||++ .+..++ ++||||.
T Consensus 176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~sl 215 (327)
T 3aln_A 176 LVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSL 215 (327)
T ss_dssp --------------------------------CCSHHHHHHH
T ss_pred ccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHH
Confidence 64432 22334689999999998 455566 8999983
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=258.24 Aligned_cols=185 Identities=29% Similarity=0.495 Sum_probs=146.9
Q ss_pred CCCcccceeccccceEEEEEEEe--CCc--EEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH--DGT--KIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
++|++.+.||+|+||.||+|++. +++ .||||+++.... .....+++.+|++++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 57999999999999999999864 233 689999876433 2455678999999999999999999999998765 88
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 97 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccc
Confidence 9999999999999986532 358899999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCCce--eeeeccccCcccccccccCCcC-cceeecC
Q 003911 748 LAPEGKGSI--ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
......... .....+|+.|+|||++.+..++ ++|+||.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 210 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMF 210 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHH
Confidence 875543221 1234578899999999988888 8999983
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=280.64 Aligned_cols=174 Identities=20% Similarity=0.221 Sum_probs=126.8
Q ss_pred eeccccceEEEEEE-EeCCcEEEEEEeecccc--------cchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEE
Q 003911 600 ILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVI--------SGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 600 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 669 (787)
..+.|+.|.+..++ ...|+.||||++.+... .....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677777777764 44799999999976421 123456799999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||++|++|.+++.. ..+++.. +|+.||+.||+|+|+ +|||||||||+|||+++++++||+|||+|+..
T Consensus 321 MEyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 999999999999953 2356654 588999999999998 89999999999999999999999999999877
Q ss_pred CCCCCceeeeeccccCcccccccccCCcCcceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWSSCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiWS~ 785 (787)
..... .....+||+.|||||++.+....++|+||.
T Consensus 390 ~~~~~-~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~ 424 (569)
T 4azs_A 390 PQDCS-WPTNLVQSFFVFVNELFAENKSWNGFWRSA 424 (569)
T ss_dssp C---C-CSHHHHHHHHHHHHHHC-------------
T ss_pred CCCCc-cccCceechhhccHHHhCCCCCCccccccc
Confidence 54432 234478999999999998876668999984
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=264.13 Aligned_cols=186 Identities=24% Similarity=0.313 Sum_probs=156.3
Q ss_pred HHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CC-----ccceEEeEE
Q 003911 588 LRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HR-----HLVALLGHC 660 (787)
Q Consensus 588 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~ 660 (787)
...+.++|++.+.||+|+||.||+|... +++.||||+++.. .....++..|+++++.++ |+ +|+++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 3445679999999999999999999876 6889999999752 334567888999998885 55 499999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC--CCCcE
Q 003911 661 LDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRA 738 (787)
Q Consensus 661 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~ 738 (787)
...+..++||||++ |+|.+++... ....+++..+..++.|++.||+|||+. +.+|+||||||+|||++ .++.+
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~ 200 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI 200 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCE
T ss_pred ccCCceEEEEecCC-CCHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcE
Confidence 99999999999995 5999988652 224589999999999999999999952 37999999999999995 57789
Q ss_pred EEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 739 KVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 739 kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
||+|||+|+...... ....||+.|+|||++.+..++ ++||||.
T Consensus 201 kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 244 (382)
T 2vx3_A 201 KIVDFGSSCQLGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSL 244 (382)
T ss_dssp EECCCTTCEETTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred EEEeccCceeccccc----ccccCCccccChHHHcCCCCCcHHHHHHH
Confidence 999999998875432 335789999999999999888 8999983
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=261.18 Aligned_cols=189 Identities=27% Similarity=0.370 Sum_probs=158.1
Q ss_pred HHHHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccc----hhHHHHHHHHHHHHhcC--CCccceEEe
Q 003911 586 QVLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVR--HRHLVALLG 658 (787)
Q Consensus 586 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~~~~ 658 (787)
+......++|++.+.||+|+||.||+|... +++.||||++....... ...+.+.+|++++++++ ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 344556788999999999999999999864 78999999997654322 22356778999999996 599999999
Q ss_pred EEEeCCeeEEEEEecCC-CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC-CCC
Q 003911 659 HCLDGNEKLLVFEYMPQ-GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DDM 736 (787)
Q Consensus 659 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~ 736 (787)
++...+..++||||+.+ ++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++ +++
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTT
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCC
Confidence 99999999999999976 899998854 2468899999999999999999998 8999999999999999 788
Q ss_pred cEEEeecccceecCCCCCceeeeeccccCcccccccccCCc-C-cceeecC
Q 003911 737 RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRW-S-SCSYWAG 785 (787)
Q Consensus 737 ~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~-~~DiWS~ 785 (787)
.+||+|||+++...... .....||+.|+|||++.+..+ + ++|+||.
T Consensus 188 ~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 235 (320)
T 3a99_A 188 ELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 235 (320)
T ss_dssp EEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHH
T ss_pred CEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhH
Confidence 99999999998775432 233569999999999988776 4 7899983
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=286.86 Aligned_cols=178 Identities=22% Similarity=0.350 Sum_probs=151.8
Q ss_pred hcCCCcccceeccccceEEEEEEEe--CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe---
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH--DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE--- 665 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 665 (787)
+.++|++.+.||+|+||.||+|.+. +++.||||++... ........+.+|++++++++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 3478999999999999999999875 5899999998653 234456788999999999999999999999987655
Q ss_pred --eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 666 --KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 666 --~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
.|+||||+++++|.+++. ..+++.+++.++.||+.||+|||+ .+||||||||+|||++++ .+||+||
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DF 225 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDL 225 (681)
T ss_dssp EEEEEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCC
T ss_pred ceeEEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEec
Confidence 699999999999988762 268999999999999999999998 899999999999999875 8999999
Q ss_pred ccceecCCCCCceeeeeccccCcccccccccCCcCcceeecC
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWSSCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiWS~ 785 (787)
|+++..... ....||+.|+|||++.+....++||||-
T Consensus 226 G~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~sDi~sl 262 (681)
T 2pzi_A 226 GAVSRINSF-----GYLYGTPGFQAPEIVRTGPTVATDIYTV 262 (681)
T ss_dssp TTCEETTCC-----SCCCCCTTTSCTTHHHHCSCHHHHHHHH
T ss_pred ccchhcccC-----CccCCCccccCHHHHcCCCCCceehhhh
Confidence 999877543 2356999999999998776449999983
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-28 Score=257.74 Aligned_cols=183 Identities=23% Similarity=0.421 Sum_probs=146.5
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEE--------
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCL-------- 661 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-------- 661 (787)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+++.+|++++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 3578999999999999999999876 5899999998753 3455678999999999999999999999874
Q ss_pred ------eCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC-C
Q 003911 662 ------DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-D 734 (787)
Q Consensus 662 ------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~ 734 (787)
+....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++ +
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~ 156 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTE 156 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETT
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCC
Confidence 3467899999997 699988832 468899999999999999999998 8999999999999997 5
Q ss_pred CCcEEEeecccceecCCCCC--ceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 735 DMRAKVADFGLVRLAPEGKG--SIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 735 ~~~~kl~DFG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
++.+||+|||+++....... .......||+.|+|||++.+ ..++ ++|+||.
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 211 (320)
T 2i6l_A 157 DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 211 (320)
T ss_dssp TTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHH
T ss_pred CCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhH
Confidence 67999999999987643221 11223467999999998876 5666 8999983
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=267.00 Aligned_cols=183 Identities=21% Similarity=0.326 Sum_probs=154.7
Q ss_pred hcCCCcccceeccccceEEEEEEE-eCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCC-CccceEEeEEEeCCeeEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH-RHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~l 668 (787)
+.++|++.+.||+|+||.||+|+. .+++.||||++..... ..++.+|+++++.++| ++|..+..++...+..++
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 457899999999999999999986 4799999998875432 2357899999999976 566667777778888999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---CCCCcEEEeeccc
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGL 745 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~ 745 (787)
||||+ +++|.+++... ...+++.+++.|+.||+.||+|||+ .+||||||||+|||+ ++++.+||+|||+
T Consensus 81 vme~~-g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp EEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEECC-CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 99999 99999998532 2468999999999999999999998 899999999999999 5889999999999
Q ss_pred ceecCCCCCce------eeeeccccCcccccccccCCcC-cceeecC
Q 003911 746 VRLAPEGKGSI------ETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++......... .....||+.|+|||++.+..++ ++||||.
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSl 199 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESL 199 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHH
Confidence 98776543211 1246799999999999999998 8999983
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=260.47 Aligned_cols=188 Identities=27% Similarity=0.388 Sum_probs=148.8
Q ss_pred HHHhhcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccc----hhHHHHHHHHHHHHhc----CCCccceEE
Q 003911 587 VLRNVTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKV----RHRHLVALL 657 (787)
Q Consensus 587 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~niv~~~ 657 (787)
+.....++|++.+.||+|+||.||+|+.. +++.||||++....... .....+.+|+++++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34456678999999999999999999764 78999999997643221 1233466899999999 899999999
Q ss_pred eEEEeCCeeEEEEEe-cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC-CC
Q 003911 658 GHCLDGNEKLLVFEY-MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG-DD 735 (787)
Q Consensus 658 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~ 735 (787)
+++...+..++|||| +++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++ ++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCC
Confidence 999999999999999 7899999998541 358999999999999999999998 8999999999999999 88
Q ss_pred CcEEEeecccceecCCCCCceeeeeccccCcccccccccCCcC--cceeecC
Q 003911 736 MRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS--SCSYWAG 785 (787)
Q Consensus 736 ~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~DiWS~ 785 (787)
+.+||+|||+++...... .....||+.|+|||++.+..+. ++|+||.
T Consensus 177 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 225 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSL 225 (312)
T ss_dssp TEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHH
T ss_pred CeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHH
Confidence 999999999998775432 2345689999999999877764 7999983
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=258.34 Aligned_cols=181 Identities=26% Similarity=0.438 Sum_probs=154.2
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CC-cEEEEEEeecccccchhHHHHHHHHHHHHhcCCCc------cceEEeEEEe
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DG-TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH------LVALLGHCLD 662 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~ 662 (787)
+.++|++.+.||+|+||.||+|... ++ +.||+|+++. .....+.+.+|++++++++|++ ++.+++++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 4578999999999999999999875 44 7899999865 2344577889999999997766 9999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE----------
Q 003911 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL---------- 732 (787)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---------- 732 (787)
.+..++||||+ ++++.+++.. .....+++.++..++.||+.||+|||+ .+|+||||||+|||+
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKE---NNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEEC
T ss_pred CCeEEEEEecc-CCChHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccc
Confidence 99999999999 6777777754 223468999999999999999999997 899999999999999
Q ss_pred ---------CCCCcEEEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 733 ---------GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 733 ---------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+.++.+||+|||+++...... ....||+.|+|||++.+..++ ++|+||.
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 225 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSI 225 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred ccccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHH
Confidence 567899999999998754332 335799999999999998888 8999983
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=256.83 Aligned_cols=180 Identities=25% Similarity=0.372 Sum_probs=130.5
Q ss_pred hcCCCcccc-eeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe----CC
Q 003911 591 VTNNFSEEN-ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GN 664 (787)
Q Consensus 591 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 664 (787)
+.++|++.+ .||+|+||.||+|... +++.||||++... . ....+....++.++||||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 456898854 6999999999999876 7999999998652 1 122223334566799999999999976 44
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC---CCcEEEe
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVA 741 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 741 (787)
..++||||+++|+|.+++.. .....+++.+++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQE---RGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHT---C-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred eEEEEEeccCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEe
Confidence 57999999999999999864 222468999999999999999999998 89999999999999976 4559999
Q ss_pred ecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 742 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|||+++...... .....||+.|+|||++.+..++ ++||||.
T Consensus 174 Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 215 (336)
T 3fhr_A 174 DFGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSL 215 (336)
T ss_dssp CCTTCEEC-------------------------CHHHHHHHHHHH
T ss_pred ccccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHH
Confidence 999998765332 2335689999999999888888 8999983
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.6e-29 Score=278.22 Aligned_cols=218 Identities=21% Similarity=0.240 Sum_probs=126.0
Q ss_pred CCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEe
Q 003911 92 TKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFS 170 (787)
Q Consensus 92 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~ 170 (787)
++|++|+|++|.|++.+| .|.++++|++|+|++|.++++++ |..+++|++|+|++|.|+
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~------------------ 93 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ------------------ 93 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEE------------------
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCC------------------
Confidence 355555555555555544 45555555555555555555443 555555555555555544
Q ss_pred ccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEecccc
Q 003911 171 ANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250 (787)
Q Consensus 171 l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N 250 (787)
+..+ .++|++|+|++|++++..+. .+++|+.|+|++|
T Consensus 94 -------~l~~-------~~~L~~L~L~~N~l~~~~~~-----------------------------~l~~L~~L~L~~N 130 (487)
T 3oja_A 94 -------ELLV-------GPSIETLHAANNNISRVSCS-----------------------------RGQGKKNIYLANN 130 (487)
T ss_dssp -------EEEE-------CTTCCEEECCSSCCCCEEEC-----------------------------CCSSCEEEECCSS
T ss_pred -------CCCC-------CCCcCEEECcCCcCCCCCcc-----------------------------ccCCCCEEECCCC
Confidence 3221 24455555555555543322 2345555666666
Q ss_pred ccccCCC-CCCCCCCCCEEecCCCcccccCCcccc-CCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCC
Q 003911 251 AFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLV-KLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGA 328 (787)
Q Consensus 251 ~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~ 328 (787)
.+++.+| .+..+++|++|+|++|+|++.+|..+. .+++|++|+|++|.|++.++..
T Consensus 131 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~---------------------- 188 (487)
T 3oja_A 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQV---------------------- 188 (487)
T ss_dssp CCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCC----------------------
T ss_pred CCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccc----------------------
Confidence 6655544 355566666666666666666666654 5666666666666666543210
Q ss_pred CCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccc
Q 003911 329 CDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSG 408 (787)
Q Consensus 329 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 408 (787)
..++|+.|+|++|++++..| .|..+++|+.|+|++|+|++
T Consensus 189 ---------------------------------------~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~ 228 (487)
T 3oja_A 189 ---------------------------------------VFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL 228 (487)
T ss_dssp ---------------------------------------CCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE
T ss_pred ---------------------------------------cCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc
Confidence 11356666666666665433 36777777777777777773
Q ss_pred cCCccCcCCCCCCeeeccCCccc-ccCC
Q 003911 409 MIPEGLSVLGALKELDVSNNQLY-GKIP 435 (787)
Q Consensus 409 ~ip~~l~~l~~L~~L~Ls~N~l~-g~iP 435 (787)
+|..+..+++|+.|++++|+++ +.+|
T Consensus 229 -lp~~l~~l~~L~~L~l~~N~l~c~~~~ 255 (487)
T 3oja_A 229 -IEKALRFSQNLEHFDLRGNGFHCGTLR 255 (487)
T ss_dssp -ECTTCCCCTTCCEEECTTCCBCHHHHH
T ss_pred -cchhhccCCCCCEEEcCCCCCcCcchH
Confidence 6667777777777777777776 4444
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-28 Score=267.20 Aligned_cols=184 Identities=29% Similarity=0.334 Sum_probs=141.1
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 671 (787)
+.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 456677899999999998776678999999998652 235678999999987 89999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCC-------------C
Q 003911 672 YMPQGTLSRHIFNWAEEGL--KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDD-------------M 736 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~ 736 (787)
|++ |+|.+++........ ....+..++.++.||+.||+|||+ .+|+||||||+|||++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCce
Confidence 995 699999865321111 112334567899999999999998 899999999999999754 4
Q ss_pred cEEEeecccceecCCCCCc---eeeeeccccCccccccccc-------CCcC-cceeecC
Q 003911 737 RAKVADFGLVRLAPEGKGS---IETRIAGTFGYLAPEYAVH-------TRWS-SCSYWAG 785 (787)
Q Consensus 737 ~~kl~DFG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~-~~DiWS~ 785 (787)
.+||+|||+++........ ......||+.|+|||++.+ ..++ ++||||.
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSl 225 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSM 225 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHH
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhH
Confidence 8999999999987654322 1224579999999999976 4566 8999983
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.6e-29 Score=262.90 Aligned_cols=249 Identities=19% Similarity=0.192 Sum_probs=213.7
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEcc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 147 (787)
.+++.|+|++|++++..|..|.++++|++|+|++|+|++.++ +..+++|++|+|++|+|+++++ .++|++|+++
T Consensus 34 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~Ls~n~l~~l~~-----~~~L~~L~l~ 107 (317)
T 3o53_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (317)
T ss_dssp GGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE-ETTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh-hhhcCCCCEEECcCCccccccC-----CCCcCEEECC
Confidence 379999999999998877899999999999999999998776 9999999999999999998763 4899999999
Q ss_pred CCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCC
Q 003911 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (787)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~ 227 (787)
+|+++. ++. ..+++|+.|++++|++++..+..++ .+++|++|+|++|++++..|..+.
T Consensus 108 ~n~l~~--~~~--~~~~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~---------------- 165 (317)
T 3o53_A 108 NNNISR--VSC--SRGQGKKNIYLANNKITMLRDLDEG--CRSRVQYLDLKLNEIDTVNFAELA---------------- 165 (317)
T ss_dssp SSCCSE--EEE--CCCSSCEEEECCSSCCCSGGGBCTG--GGSSEEEEECTTSCCCEEEGGGGG----------------
T ss_pred CCccCC--cCc--cccCCCCEEECCCCCCCCccchhhh--ccCCCCEEECCCCCCCcccHHHHh----------------
Confidence 999985 332 2368899999999999998888886 899999999999999987666542
Q ss_pred cCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCC
Q 003911 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFD 307 (787)
Q Consensus 228 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 307 (787)
..+++|++|+|++|.+++. +....+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++.++.+.
T Consensus 166 ---------~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~~l~~~~~ 234 (317)
T 3o53_A 166 ---------ASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALR 234 (317)
T ss_dssp ---------GGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCCEECTTCC
T ss_pred ---------hccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCcccchhhHhh
Confidence 3689999999999999987 44456899999999999999 466669999999999999999996544321
Q ss_pred CceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCccc-ccC
Q 003911 308 RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLT-GTI 386 (787)
Q Consensus 308 ~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-g~~ 386 (787)
..++|+.|++++|.+. +.+
T Consensus 235 ------------------------------------------------------------~l~~L~~L~l~~N~~~~~~~ 254 (317)
T 3o53_A 235 ------------------------------------------------------------FSQNLEHFDLRGNGFHCGTL 254 (317)
T ss_dssp ------------------------------------------------------------CCTTCCEEECTTCCCBHHHH
T ss_pred ------------------------------------------------------------cCCCCCEEEccCCCccCcCH
Confidence 2247899999999999 889
Q ss_pred chhhcCCCCCCEEecc-cccccccCCccCc
Q 003911 387 SPEFASFKSLQRLILA-DNNLSGMIPEGLS 415 (787)
Q Consensus 387 p~~~~~l~~L~~L~Ls-~N~l~g~ip~~l~ 415 (787)
|..+..+++|+.|+++ .+.++|..|....
T Consensus 255 ~~~~~~~~~L~~l~l~~~~~l~~~~~~~~~ 284 (317)
T 3o53_A 255 RDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284 (317)
T ss_dssp HHHHHTCHHHHHHHHHHHHHHHSSSSCCCS
T ss_pred HHHHhccccceEEECCCchhccCCchhccC
Confidence 9999999999999999 5567777665443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=262.29 Aligned_cols=188 Identities=23% Similarity=0.415 Sum_probs=152.7
Q ss_pred HHhhcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 588 LRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 588 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
.....++|++.+.||+|+||.||+|+... .||+|+++.........+.+.+|++++++++||||+++++++.+.+..+
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 33446789999999999999999998753 4999999765444445567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+||||+++++|.+++.. ....+++.++..++.|++.||+|||+ .+|+||||||+||+++ ++.+||+|||+++
T Consensus 106 iv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp EECBCCCSEEHHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred EEeecccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 99999999999998843 23468899999999999999999998 8999999999999998 6799999999987
Q ss_pred ecCCCC----CceeeeeccccCccccccccc---------CCcC-cceeecC
Q 003911 748 LAPEGK----GSIETRIAGTFGYLAPEYAVH---------TRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~-~~DiWS~ 785 (787)
...... ........||+.|+|||++.+ ..++ ++||||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~sl 229 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHH
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHH
Confidence 653211 111223468999999999975 3456 8999983
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.94 E-value=9.7e-28 Score=261.25 Aligned_cols=180 Identities=25% Similarity=0.399 Sum_probs=153.0
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-----------CCccceEEeE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-----------HRHLVALLGH 659 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~ 659 (787)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++ ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 358999999999999999999864 7899999998752 334567889999999886 8999999999
Q ss_pred EEeCC----eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEcCCCCCCEEEC-
Q 003911 660 CLDGN----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQ-SFIHRDLKPSNILLG- 733 (787)
Q Consensus 660 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~ivH~Dlkp~NIll~- 733 (787)
+...+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+ + +|+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEI 167 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEE
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEec
Confidence 98654 689999999 899999986532 2458999999999999999999998 6 999999999999994
Q ss_pred -----CCCcEEEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 734 -----DDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 734 -----~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..+.+||+|||+++...... ....||+.|+|||++.+..++ ++||||.
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 221 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWST 221 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHH
T ss_pred cCCCcCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHH
Confidence 44589999999998775432 235789999999999998888 8999983
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=263.81 Aligned_cols=180 Identities=24% Similarity=0.386 Sum_probs=141.7
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.+|.+.+.||+|+||+||.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+....|+|||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 46888999999999997766566899999999865332 2356899999999 79999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC-----CCcEEEeecccc
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-----DMRAKVADFGLV 746 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DFG~a 746 (787)
|++ |+|.+++... .....+..+..++.||+.||+|||+ .+|+||||||+||+++. ...+||+|||+|
T Consensus 99 ~~~-g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 99 LCA-ATLQEYVEQK----DFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp CCS-EEHHHHHHSS----SCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred CCC-CCHHHHHHhc----CCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 995 6999988542 2234455677899999999999998 89999999999999953 336889999999
Q ss_pred eecCCCCC--ceeeeeccccCccccccccc---CCcC-cceeecC
Q 003911 747 RLAPEGKG--SIETRIAGTFGYLAPEYAVH---TRWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~-~~DiWS~ 785 (787)
+....... .......||+.|+|||++.+ ..++ ++||||.
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSl 215 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSA 215 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHH
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHH
Confidence 87754322 12234679999999999974 4555 8999983
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-28 Score=275.98 Aligned_cols=186 Identities=28% Similarity=0.481 Sum_probs=156.6
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe------CC
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD------GN 664 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~ 664 (787)
.++|++.+.||+|+||.||+|... +|+.||||++... ......+++.+|++++++++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 368999999999999999999764 6899999998763 345566789999999999999999999998765 66
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc---EEEe
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR---AKVA 741 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~ 741 (787)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred eEEEEEEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEc
Confidence 7899999999999999986422 22358889999999999999999998 89999999999999997665 9999
Q ss_pred ecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 742 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|||.++...... ......||+.|+|||++.+..++ ++||||.
T Consensus 167 DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSL 209 (676)
T 3qa8_A 167 DLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSF 209 (676)
T ss_dssp SCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHH
T ss_pred cccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHH
Confidence 999998775443 22346799999999999998888 9999983
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=252.79 Aligned_cols=185 Identities=24% Similarity=0.362 Sum_probs=136.1
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|+.. +++.||||++..........+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467999999999999999999875 7899999999875433333445556666788889999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+ ++.+..+... ....+++..+..++.|++.||+|||+ +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 104 e~~-~~~~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR----MQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 5555444422 12468999999999999999999997 1399999999999999999999999999997664
Q ss_pred CCCCceeeeeccccCcccccccc-----cCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAV-----HTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~-~~DiWS~ 785 (787)
... ......||+.|+|||++. +..++ ++||||.
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 215 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSL 215 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHH
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhH
Confidence 432 223356899999999995 44556 8999983
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-25 Score=254.94 Aligned_cols=255 Identities=23% Similarity=0.274 Sum_probs=212.5
Q ss_pred CCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEec
Q 003911 92 TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSA 171 (787)
Q Consensus 92 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l 171 (787)
.+++.|++++|.|+.+++.+. ++|++|+|++|+|+.++. .+++|++|+|++|+|+ .+|. .+++|++|++
T Consensus 40 ~~l~~L~ls~n~L~~lp~~l~--~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~--~lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLTTLPDCLP--AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLT--SLPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCSCCCSCCC--TTCSEEEECSCCCSCCCC----CCTTCCEEEECSCCCS--CCCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcCccChhhC--CCCcEEEecCCCCCCCCC----cCCCCCEEEcCCCcCC--cCCC---CCCCCCEEEC
Confidence 468999999999997666665 899999999999999887 5799999999999999 5676 7899999999
Q ss_pred cCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccc
Q 003911 172 NSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251 (787)
Q Consensus 172 ~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 251 (787)
++|+|++..+ .+++|++|+|++|+|++ +|. .+++|++|+|++|+
T Consensus 109 s~N~l~~l~~------~l~~L~~L~L~~N~l~~-lp~-----------------------------~l~~L~~L~Ls~N~ 152 (622)
T 3g06_A 109 FSNPLTHLPA------LPSGLCKLWIFGNQLTS-LPV-----------------------------LPPGLQELSVSDNQ 152 (622)
T ss_dssp CSCCCCCCCC------CCTTCCEEECCSSCCSC-CCC-----------------------------CCTTCCEEECCSSC
T ss_pred cCCcCCCCCC------CCCCcCEEECCCCCCCc-CCC-----------------------------CCCCCCEEECcCCc
Confidence 9999987543 36789999999999985 443 24789999999999
Q ss_pred cccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCc
Q 003911 252 FSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDP 331 (787)
Q Consensus 252 l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~ 331 (787)
+++.++ .+++|+.|++++|+|+ .+| ..+++|+.|+|++|+|++.++.+ .+|..+++++|.+..++..
T Consensus 153 l~~l~~---~~~~L~~L~L~~N~l~-~l~---~~~~~L~~L~Ls~N~l~~l~~~~---~~L~~L~L~~N~l~~l~~~--- 219 (622)
T 3g06_A 153 LASLPA---LPSELCKLWAYNNQLT-SLP---MLPSGLQELSVSDNQLASLPTLP---SELYKLWAYNNRLTSLPAL--- 219 (622)
T ss_dssp CSCCCC---CCTTCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCSSCCCC---
T ss_pred CCCcCC---ccCCCCEEECCCCCCC-CCc---ccCCCCcEEECCCCCCCCCCCcc---chhhEEECcCCcccccCCC---
Confidence 997654 3478999999999999 577 55789999999999999865543 4566777888877655421
Q ss_pred hhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCC
Q 003911 332 RLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 411 (787)
Q Consensus 332 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip 411 (787)
.++|+.|+|++|++++ +| ..+++|+.|+|++|+|+ .+|
T Consensus 220 -------------------------------------~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp 257 (622)
T 3g06_A 220 -------------------------------------PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLP 257 (622)
T ss_dssp -------------------------------------CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCC
T ss_pred -------------------------------------CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCC
Confidence 1489999999999997 66 56789999999999999 677
Q ss_pred ccCcCCCCCCeeeccCCcccccCCC----CCCCceeecCCCCCCC
Q 003911 412 EGLSVLGALKELDVSNNQLYGKIPS----FKSNAIVNTDGNPDIG 452 (787)
Q Consensus 412 ~~l~~l~~L~~L~Ls~N~l~g~iP~----~~~~~~~~~~gn~~~~ 452 (787)
. .+++|+.|+|++|+|+ .||. +..+..+.+.+|+..+
T Consensus 258 ~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~ 298 (622)
T 3g06_A 258 M---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE 298 (622)
T ss_dssp C---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCH
T ss_pred c---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCC
Confidence 7 6789999999999999 6664 5667889999998754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=269.44 Aligned_cols=195 Identities=20% Similarity=0.199 Sum_probs=158.4
Q ss_pred CEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccC
Q 003911 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (787)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 148 (787)
+++.|+|++|++++..|..|+.+++|++|+|++|.|++.+| |..+++|++|+|++|.|+++++. ++|++|+|++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~~~-----~~L~~L~L~~ 108 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLVG-----PSIETLHAAN 108 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEEEEEC-----TTCCEEECCS
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCCCCCC-----CCcCEEECcC
Confidence 79999999999998888899999999999999999998777 99999999999999999987743 8999999999
Q ss_pred CCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCc
Q 003911 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAK 228 (787)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~ 228 (787)
|.+++ ++. ..+++|+.|++++|.+++.+|..++ .+++|++|+|++|++++.+|..+.
T Consensus 109 N~l~~--~~~--~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~l~----------------- 165 (487)
T 3oja_A 109 NNISR--VSC--SRGQGKKNIYLANNKITMLRDLDEG--CRSRVQYLDLKLNEIDTVNFAELA----------------- 165 (487)
T ss_dssp SCCCC--EEE--CCCSSCEEEECCSSCCCSGGGBCGG--GGSSEEEEECTTSCCCEEEGGGGG-----------------
T ss_pred CcCCC--CCc--cccCCCCEEECCCCCCCCCCchhhc--CCCCCCEEECCCCCCCCcChHHHh-----------------
Confidence 99985 222 2457788888888888888787775 788888888888888877666542
Q ss_pred CCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCccccc
Q 003911 229 LGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302 (787)
Q Consensus 229 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 302 (787)
..+++|+.|+|++|.|++.+ .+..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|+|++.
T Consensus 166 --------~~l~~L~~L~Ls~N~l~~~~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~l 229 (487)
T 3oja_A 166 --------ASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLI 229 (487)
T ss_dssp --------GGTTTCCEEECTTSCCCEEE-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEE
T ss_pred --------hhCCcccEEecCCCcccccc-ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCccc
Confidence 25778888888888888763 34457788888888888885 444577777788888777777653
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-26 Score=236.32 Aligned_cols=208 Identities=18% Similarity=0.233 Sum_probs=165.8
Q ss_pred CEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEcc
Q 003911 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (787)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 147 (787)
.++.|++++|++++..+..|.++++|++|+|++|+|++.++ .|.++++|++|+|++|+++++++..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 57888888888887666688888888888888888887766 68888888888888888888888888888888888888
Q ss_pred CCCCCCCCCChhhhcCCCCCEEeccCceeccc-CCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCC
Q 003911 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQ-IPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGN 226 (787)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~-~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~ 226 (787)
+|++.. ..+..+..+++|++|++++|.+++. +|..+. .+++|++|+|++|++++..+..+.
T Consensus 109 ~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~--------------- 170 (276)
T 2z62_A 109 ETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFS--NLTNLEHLDLSSNKIQSIYCTDLR--------------- 170 (276)
T ss_dssp TSCCCC-STTCCCTTCTTCCEEECCSSCCCCCCCCGGGG--GCTTCCEEECCSSCCCEECGGGGH---------------
T ss_pred CCCccc-cCchhcccCCCCCEEECcCCccceecCchhhc--cCCCCCEEECCCCCCCcCCHHHhh---------------
Confidence 888875 3344688888888888888888764 477775 788888888888888866655543
Q ss_pred CcCCCCccccccCccCc----eEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCccccc
Q 003911 227 AKLGGGIDVIQNMTSLK----EIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302 (787)
Q Consensus 227 ~~~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 302 (787)
.+++|+ .|++++|.+++.++......+|+.|+|++|+|++..+..|..+++|+.|+|++|++++.
T Consensus 171 -----------~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 239 (276)
T 2z62_A 171 -----------VLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 239 (276)
T ss_dssp -----------HHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred -----------hhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence 444444 89999999998888766666899999999999966666778899999999999999876
Q ss_pred CCC
Q 003911 303 VPE 305 (787)
Q Consensus 303 ~p~ 305 (787)
.|.
T Consensus 240 c~~ 242 (276)
T 2z62_A 240 CPR 242 (276)
T ss_dssp TTT
T ss_pred CCc
Confidence 553
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=232.93 Aligned_cols=76 Identities=24% Similarity=0.377 Sum_probs=53.4
Q ss_pred eCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCC
Q 003911 75 IGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSS 153 (787)
Q Consensus 75 l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 153 (787)
..+.++. .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+++++++..|.++++|++|+|++|+++.
T Consensus 14 c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 90 (276)
T 2z62_A 14 CMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90 (276)
T ss_dssp CTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred ecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCc
Confidence 3344454 5666554 567888888888877666 67777778888887777777777777777777777777776653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.93 E-value=9.2e-29 Score=277.46 Aligned_cols=330 Identities=19% Similarity=0.184 Sum_probs=191.5
Q ss_pred CEEEEEeCCCCccc----cCCCCCCCCCCCcEEEeecCCCCCCCC-C-CCCCC----CCcEEEcccccCCc----CCCcc
Q 003911 69 RITRIQIGHQNLQG----TLPSNLQNLTKLERLELQWNSISGPLP-S-LNGLA----SLEVVMLSNNQFTS----VPSDF 134 (787)
Q Consensus 69 ~v~~L~l~~~~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~-~-~~~l~----~L~~L~L~~N~l~~----~~~~~ 134 (787)
+++.|++++|+++. .++..+..+++|++|+|++|.|++..+ . +..++ +|++|+|++|+++. ..+..
T Consensus 29 ~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 108 (461)
T 1z7x_W 29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 108 (461)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHH
Confidence 56666666666653 344555666666666666666654222 1 12233 56666666666663 23455
Q ss_pred ccCCCCCcEEEccCCCCCCCCCChhhh-----cCCCCCEEeccCceecccC----CCCCCCCCCCCCcEEeccccccccC
Q 003911 135 FTGLSSLQSIEIDNNPFSSWEIPQSLR-----NASGLQNFSANSANITGQI----PSFFGPDEFPGLTILHLAFNQLIGG 205 (787)
Q Consensus 135 ~~~l~~L~~L~L~~N~l~~~~~p~~~~-----~l~~L~~L~l~~n~l~~~~----p~~~~~~~l~~L~~L~L~~N~l~~~ 205 (787)
|..+++|++|+|++|.+.. ..+..+. ..++|++|++++|++++.. +..+. .+++|++|+|++|.++..
T Consensus 109 l~~~~~L~~L~Ls~n~i~~-~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~--~~~~L~~L~L~~n~i~~~ 185 (461)
T 1z7x_W 109 LRTLPTLQELHLSDNLLGD-AGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLR--AKPDFKELTVSNNDINEA 185 (461)
T ss_dssp TTSCTTCCEEECCSSBCHH-HHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHH--HCTTCCEEECCSSBCHHH
T ss_pred HccCCceeEEECCCCcCch-HHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHh--hCCCCCEEECcCCCcchH
Confidence 6666666666666666553 2222222 1345666666666666532 33332 456677777777766544
Q ss_pred CCcCccc------ccccceeeccCCCCCcC-CCCccccccCccCceEeccccccccCC-----CC-CCCCCCCCEEecCC
Q 003911 206 LPASFSG------SQIQSLWVNGQNGNAKL-GGGIDVIQNMTSLKEIWLHSNAFSGPL-----PD-FSGVKQLESLSLRD 272 (787)
Q Consensus 206 ~p~~~~~------~~l~~L~~~~~~~~~~~-~~~~~~~~~l~~L~~L~L~~N~l~~~~-----~~-~~~l~~L~~L~L~~ 272 (787)
.+..+.. .+++.|++.++...... ...+..+..+++|++|+|++|.++... +. +..+++|++|+|++
T Consensus 186 ~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~ 265 (461)
T 1z7x_W 186 GVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265 (461)
T ss_dssp HHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred HHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcC
Confidence 3333321 25556655544221100 002344556777777777777776531 22 33467777777777
Q ss_pred Cccccc----CCccccCCCCCCEEEccCCcccccCCC-C----C-CceeeeccccCCCccCCCCCCCCchhhHHHHHHHH
Q 003911 273 NFFTGP----VPDSLVKLESLKIVNMTNNLLQGPVPE-F----D-RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKL 342 (787)
Q Consensus 273 N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~----~-~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~ 342 (787)
|++++. ++..+..+++|++|+|++|.+++..+. + . ...+|+.+++++|.+.... ...+
T Consensus 266 n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~------~~~l------ 333 (461)
T 1z7x_W 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAAC------CSHF------ 333 (461)
T ss_dssp SCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG------HHHH------
T ss_pred CCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHH------HHHH------
Confidence 777743 566677777777777777777643221 1 1 1135566666666543210 0000
Q ss_pred hCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcC-----CCCCCEEecccccccc----cCCcc
Q 003911 343 MGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFAS-----FKSLQRLILADNNLSG----MIPEG 413 (787)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~-----l~~L~~L~Ls~N~l~g----~ip~~ 413 (787)
...+...++|+.|+|++|++++..+..+.. .++|+.|+|++|++++ .+|..
T Consensus 334 --------------------~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 393 (461)
T 1z7x_W 334 --------------------SSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 393 (461)
T ss_dssp --------------------HHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred --------------------HHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHH
Confidence 011122357888888888888766665553 6788888888888876 67777
Q ss_pred CcCCCCCCeeeccCCccccc
Q 003911 414 LSVLGALKELDVSNNQLYGK 433 (787)
Q Consensus 414 l~~l~~L~~L~Ls~N~l~g~ 433 (787)
+..+++|++|||++|++++.
T Consensus 394 l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 394 LLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp HHHCCCCCEEECCSSSCCHH
T ss_pred HHhCCCccEEECCCCCCCHH
Confidence 88888888888888888753
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-25 Score=231.00 Aligned_cols=179 Identities=20% Similarity=0.279 Sum_probs=83.5
Q ss_pred CCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCE
Q 003911 89 QNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQN 168 (787)
Q Consensus 89 ~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~ 168 (787)
..+++|+.|++++|.++. ++.+..+++|++|+|++|++++++ .+.++++|++|+|++|++++ ..+..+..+++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~~-~~~l~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~ 113 (272)
T 3rfs_A 38 NELNSIDQIIANNSDIKS-VQGIQYLPNVRYLALGGNKLHDIS--ALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKE 113 (272)
T ss_dssp HHHTTCCEEECTTSCCCC-CTTGGGCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCE
T ss_pred ccccceeeeeeCCCCccc-ccccccCCCCcEEECCCCCCCCch--hhcCCCCCCEEECCCCccCc-cChhHhcCCcCCCE
Confidence 344455555555555543 233445555555555555555432 34455555555555555543 22333444444444
Q ss_pred EeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEecc
Q 003911 169 FSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH 248 (787)
Q Consensus 169 L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~ 248 (787)
|++++|++++..+..|+ .+++|++|+|++|++++..+..|. ++++|+.|+|+
T Consensus 114 L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~--------------------------~l~~L~~L~l~ 165 (272)
T 3rfs_A 114 LVLVENQLQSLPDGVFD--KLTNLTYLNLAHNQLQSLPKGVFD--------------------------KLTNLTELDLS 165 (272)
T ss_dssp EECTTSCCCCCCTTTTT--TCTTCCEEECCSSCCCCCCTTTTT--------------------------TCTTCCEEECC
T ss_pred EECCCCcCCccCHHHhc--cCCCCCEEECCCCccCccCHHHhc--------------------------cCccCCEEECC
Confidence 44444444444444443 444555555555544433332221 34444445555
Q ss_pred ccccccCCCC-CCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcc
Q 003911 249 SNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299 (787)
Q Consensus 249 ~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 299 (787)
+|++++.++. +..+++|++|+|++|+|++..|..+..+++|++|+|++|++
T Consensus 166 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 217 (272)
T 3rfs_A 166 YNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPW 217 (272)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred CCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCc
Confidence 4444444433 34444555555555555444444444444444444444443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=234.01 Aligned_cols=143 Identities=13% Similarity=0.040 Sum_probs=126.6
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ....+++.+|++++++++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999876 5899999999865433 34557899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
|||+++++|.+++.. .....++.+++.|++.||+|||+ .+|+||||||+||++++++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~-------~~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA 174 (286)
T ss_dssp EECCCEEEHHHHHTT-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred EEecCCCCHHHHHhc-------CCChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc
Confidence 999999999999832 13556788999999999999998 899999999999999999999998554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.5e-27 Score=263.71 Aligned_cols=171 Identities=18% Similarity=0.218 Sum_probs=133.2
Q ss_pred cccceeccccceEEEEEEEeCCcEEEEEEeecccccch------hHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 596 SEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK------GLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 596 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
...+.||+|+||.||+|+. .++.+++|+......... ..+++.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999954 578899998755333211 245689999999999999999776677778888999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++++|.+++.. +..++.|+++||+|||+ ++|+||||||+|||+++ .+||+|||+|+..
T Consensus 418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999999998843 45799999999999998 89999999999999998 9999999999987
Q ss_pred CCCCCce------eeeeccccCccccccccc--CCcC-cceeecC
Q 003911 750 PEGKGSI------ETRIAGTFGYLAPEYAVH--TRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~-~~DiWS~ 785 (787)
....... .....||+.|||||++.+ ..|+ .+|+||.
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~ 524 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEI 524 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHH
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHH
Confidence 5532211 134679999999999987 5566 7899973
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=9.2e-25 Score=228.24 Aligned_cols=201 Identities=18% Similarity=0.218 Sum_probs=174.4
Q ss_pred EcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCc
Q 003911 64 CIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQ 142 (787)
Q Consensus 64 C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 142 (787)
|..-.+++.+++++++++ .+|..+. ++|+.|+|++|+|++..+ .|.++++|++|+|++|+|+++++. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 445567889999999998 6777775 689999999999998776 689999999999999999988764 7899999
Q ss_pred EEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeecc
Q 003911 143 SIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNG 222 (787)
Q Consensus 143 ~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~ 222 (787)
+|+|++|+++ .+|..+..+++|++|++++|+|++..|..|. .+++|++|+|++|+|++..+..|.
T Consensus 81 ~L~Ls~N~l~--~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~----------- 145 (290)
T 1p9a_G 81 TLDLSHNQLQ--SLPLLGQTLPALTVLDVSFNRLTSLPLGALR--GLGELQELYLKGNELKTLPPGLLT----------- 145 (290)
T ss_dssp EEECCSSCCS--SCCCCTTTCTTCCEEECCSSCCCCCCSSTTT--TCTTCCEEECTTSCCCCCCTTTTT-----------
T ss_pred EEECCCCcCC--cCchhhccCCCCCEEECCCCcCcccCHHHHc--CCCCCCEEECCCCCCCccChhhcc-----------
Confidence 9999999998 6888889999999999999999988888886 899999999999999866665543
Q ss_pred CCCCCcCCCCccccccCccCceEeccccccccCCCC-CCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCccc
Q 003911 223 QNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300 (787)
Q Consensus 223 ~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 300 (787)
.+++|+.|+|++|+|++.++. |..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++.
T Consensus 146 ---------------~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 146 ---------------PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp ---------------TCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ---------------cccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 788999999999999987775 677999999999999999 78888888899999999999876
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-26 Score=251.39 Aligned_cols=184 Identities=18% Similarity=0.231 Sum_probs=137.9
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccc-ccchhHHHHHHHHHHHHhcCC-Cccce--------------
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV-ISGKGLTEFKSEIAVLTKVRH-RHLVA-------------- 655 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h-~niv~-------------- 655 (787)
..|...+.||+|+||.||+|++. +|+.||||++.... ......+.+++|+.+++.++| ++...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45778899999999999999864 79999999987432 223446789999999999987 22111
Q ss_pred -------EEeEEEe-----CCeeEEEEEecCCCCHHHHHHhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 003911 656 -------LLGHCLD-----GNEKLLVFEYMPQGTLSRHIFNWAE--EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFI 721 (787)
Q Consensus 656 -------~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 721 (787)
+..++.. ....+++|+++ +++|.+++..... .....+++..++.++.|++.||+|||+ ++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcc
Confidence 1111111 12356777765 7899998853321 223457788999999999999999998 8999
Q ss_pred EcCCCCCCEEECCCCcEEEeecccceecCCCCCceeeeeccccCccccccc----------ccCCcC-cceeecC
Q 003911 722 HRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA----------VHTRWS-SCSYWAG 785 (787)
Q Consensus 722 H~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~-~~DiWS~ 785 (787)
||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++ ++||||.
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 9999999999999999999999999875432 334578 999999999 555677 8999983
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.92 E-value=9.4e-25 Score=223.51 Aligned_cols=192 Identities=20% Similarity=0.308 Sum_probs=134.2
Q ss_pred CCCCcccEEEcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCc
Q 003911 55 DPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSD 133 (787)
Q Consensus 55 ~~C~w~gv~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~ 133 (787)
+||.|.|++|.. ..+.+++++++++ .+|..+. ++|+.|+|++|+|++..+ .|.++++|++|+|++|+|+++++.
T Consensus 3 ~Cp~~~gC~C~~--~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 77 (251)
T 3m19_A 3 TCETVTGCTCNE--GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAG 77 (251)
T ss_dssp -CHHHHSSEEEG--GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT
T ss_pred cCCCCCceEcCC--CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHh
Confidence 578999999964 3457889999998 7777776 688999999999988777 688888899999999988888888
Q ss_pred cccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccc
Q 003911 134 FFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGS 213 (787)
Q Consensus 134 ~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 213 (787)
.|.++++|++|+|++|+++. ..+..|..+++|++|++++|+|++..+..|.
T Consensus 78 ~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---------------------------- 128 (251)
T 3m19_A 78 VFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFD---------------------------- 128 (251)
T ss_dssp TTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT----------------------------
T ss_pred HhccCCcCCEEECCCCcccc-cChhHhcccCCCCEEEcCCCcCCCcChhHhc----------------------------
Confidence 88888888888888888774 2233444444444444444444443333332
Q ss_pred cccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCC-CCCCCCCCCEEecCCCcccccCCccccCCCCCCEE
Q 003911 214 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 292 (787)
Q Consensus 214 ~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 292 (787)
++++|++|+|++|+|++.++ .|..+++|++|+|++|+|++..+..|..+++|++|
T Consensus 129 ------------------------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 184 (251)
T 3m19_A 129 ------------------------RLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184 (251)
T ss_dssp ------------------------TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred ------------------------cCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence 45556666666666665555 35666677777777777775555667777777777
Q ss_pred EccCCcccccCC
Q 003911 293 NMTNNLLQGPVP 304 (787)
Q Consensus 293 ~Ls~N~l~~~~p 304 (787)
+|++|++++...
T Consensus 185 ~l~~N~~~c~~~ 196 (251)
T 3m19_A 185 TLFGNQFDCSRC 196 (251)
T ss_dssp ECCSCCBCTTST
T ss_pred EeeCCceeCCcc
Confidence 777777765533
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-29 Score=279.06 Aligned_cols=349 Identities=15% Similarity=0.128 Sum_probs=240.6
Q ss_pred CCEEEEEeCCCCccccCCCC-CCCCCCCcEEEeecCCCCCC----CC-CCCCCCCCcEEEcccccCCcCCCc-cccCCC-
Q 003911 68 KRITRIQIGHQNLQGTLPSN-LQNLTKLERLELQWNSISGP----LP-SLNGLASLEVVMLSNNQFTSVPSD-FFTGLS- 139 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~----~~-~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~- 139 (787)
.+++.|+|++++++...... +..+++|++|+|++|+++.. ++ .+..+++|++|+|++|+++..... .+..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 36899999999998654333 78899999999999999853 23 578899999999999999875433 334566
Q ss_pred ---CCcEEEccCCCCCCC---CCChhhhcCCCCCEEeccCceecccCCCCCC---CCCCCCCcEEeccccccccCCCc--
Q 003911 140 ---SLQSIEIDNNPFSSW---EIPQSLRNASGLQNFSANSANITGQIPSFFG---PDEFPGLTILHLAFNQLIGGLPA-- 208 (787)
Q Consensus 140 ---~L~~L~L~~N~l~~~---~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~---~~~l~~L~~L~L~~N~l~~~~p~-- 208 (787)
+|++|+|++|+++.. .++..+..+++|++|++++|.+++..+..+. ....++|++|+|++|++++..+.
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 799999999998841 3578899999999999999999865444322 01356899999999999875433
Q ss_pred --Cccc-ccccceeeccCCCCCcCCCCccccc-----cCccCceEeccccccccC-----CCCCCCCCCCCEEecCCCcc
Q 003911 209 --SFSG-SQIQSLWVNGQNGNAKLGGGIDVIQ-----NMTSLKEIWLHSNAFSGP-----LPDFSGVKQLESLSLRDNFF 275 (787)
Q Consensus 209 --~~~~-~~l~~L~~~~~~~~~~~~~~~~~~~-----~l~~L~~L~L~~N~l~~~-----~~~~~~l~~L~~L~L~~N~l 275 (787)
.+.. .+|+.|++.++. .....+..+. ..++|++|+|++|.++.. +..+..+++|++|+|++|++
T Consensus 163 ~~~l~~~~~L~~L~L~~n~---i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l 239 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNND---INEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239 (461)
T ss_dssp HHHHHHCTTCCEEECCSSB---CHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBC
T ss_pred HHHHhhCCCCCEEECcCCC---cchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcC
Confidence 2222 456666665433 1111122222 245788888888877763 22355677788888888877
Q ss_pred cccC-----CccccCCCCCCEEEccCCccccc-----CCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCC
Q 003911 276 TGPV-----PDSLVKLESLKIVNMTNNLLQGP-----VPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGY 345 (787)
Q Consensus 276 ~~~~-----p~~l~~l~~L~~L~Ls~N~l~~~-----~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~ 345 (787)
++.. +..+..+++|++|+|++|++++. +..+..+.+|+.+++++|.+... ....+....
T Consensus 240 ~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~---------~~~~l~~~l-- 308 (461)
T 1z7x_W 240 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE---------GARLLCETL-- 308 (461)
T ss_dssp HHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHH---------HHHHHHHHH--
T ss_pred ChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchH---------HHHHHHHHh--
Confidence 7432 22223577888888888877762 22233455666777777654211 000111100
Q ss_pred ChhhhcccCCCCCCCCccccccCCCceEEEEccCCccccc----CchhhcCCCCCCEEecccccccccCCccCcC-----
Q 003911 346 PQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT----ISPEFASFKSLQRLILADNNLSGMIPEGLSV----- 416 (787)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~----- 416 (787)
....++|+.|+|++|++++. +|..+..+++|+.|+|++|++++..+..+..
T Consensus 309 --------------------~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~ 368 (461)
T 1z7x_W 309 --------------------LEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQP 368 (461)
T ss_dssp --------------------TSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTST
T ss_pred --------------------ccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCC
Confidence 01124899999999999876 6777888899999999999998766655543
Q ss_pred CCCCCeeeccCCcccc----cCCC----CCCCceeecCCCCC
Q 003911 417 LGALKELDVSNNQLYG----KIPS----FKSNAIVNTDGNPD 450 (787)
Q Consensus 417 l~~L~~L~Ls~N~l~g----~iP~----~~~~~~~~~~gn~~ 450 (787)
.++|++|+|++|++++ .+|. .+.+..+.+.+|+.
T Consensus 369 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i 410 (461)
T 1z7x_W 369 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410 (461)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSC
T ss_pred CCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCC
Confidence 6799999999999986 5553 56677888888754
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.7e-24 Score=219.71 Aligned_cols=178 Identities=21% Similarity=0.308 Sum_probs=135.4
Q ss_pred CCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCC-hhhhcCCCCCEEec
Q 003911 93 KLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIP-QSLRNASGLQNFSA 171 (787)
Q Consensus 93 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p-~~~~~l~~L~~L~l 171 (787)
+++.+++++|+++.++..+. ++|++|+|++|+++++++..|.++++|++|+|++|+++. +| ..|..+++|++|++
T Consensus 17 ~~~~l~~~~~~l~~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~--i~~~~~~~l~~L~~L~l 92 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT--LPAGIFKELKNLETLWV 92 (270)
T ss_dssp TTTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSC--CCTTTTSSCTTCCEEEC
T ss_pred CCCEEEccCCCCCccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCe--eChhhhcCCCCCCEEEC
Confidence 57889999999997665554 689999999999999998889999999999999999884 44 44577888888888
Q ss_pred cCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccc
Q 003911 172 NSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251 (787)
Q Consensus 172 ~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 251 (787)
++|.+++..+..|. .+++|++|+|++|++++..|..|. ++++|++|+|++|+
T Consensus 93 ~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~--------------------------~l~~L~~L~Ls~n~ 144 (270)
T 2o6q_A 93 TDNKLQALPIGVFD--QLVNLAELRLDRNQLKSLPPRVFD--------------------------SLTKLTYLSLGYNE 144 (270)
T ss_dssp CSSCCCCCCTTTTT--TCSSCCEEECCSSCCCCCCTTTTT--------------------------TCTTCCEEECCSSC
T ss_pred CCCcCCcCCHhHcc--cccCCCEEECCCCccCeeCHHHhC--------------------------cCcCCCEEECCCCc
Confidence 88888877766665 777888888888887765555443 67777777777777
Q ss_pred cccCCCC-CCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCccccc
Q 003911 252 FSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302 (787)
Q Consensus 252 l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 302 (787)
+++.++. |..+++|+.|+|++|+|++..+..|..+++|++|+|++|++++.
T Consensus 145 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 196 (270)
T 2o6q_A 145 LQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRV 196 (270)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcC
Confidence 7766654 66677777777777777755555667777777777777766643
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-24 Score=224.11 Aligned_cols=201 Identities=21% Similarity=0.317 Sum_probs=180.4
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEcc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 147 (787)
.+++.|++++++++. + +.+..+++|++|+|++|++++. +.+.++++|++|+|++|+++++++..|.++++|++|+|+
T Consensus 41 ~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 117 (272)
T 3rfs_A 41 NSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLV 117 (272)
T ss_dssp TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred cceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECC
Confidence 579999999999883 3 3589999999999999999984 589999999999999999999999999999999999999
Q ss_pred CCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCC
Q 003911 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (787)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~ 227 (787)
+|+++. ..+..+..+++|++|++++|++++..+..|. .+++|++|+|++|++++..+..|.
T Consensus 118 ~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~---------------- 178 (272)
T 3rfs_A 118 ENQLQS-LPDGVFDKLTNLTYLNLAHNQLQSLPKGVFD--KLTNLTELDLSYNQLQSLPEGVFD---------------- 178 (272)
T ss_dssp TSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCCCCCTTTTT----------------
T ss_pred CCcCCc-cCHHHhccCCCCCEEECCCCccCccCHHHhc--cCccCCEEECCCCCcCccCHHHhc----------------
Confidence 999996 4566689999999999999999998888886 899999999999999977665543
Q ss_pred cCCCCccccccCccCceEeccccccccCCCC-CCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCC
Q 003911 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 306 (787)
Q Consensus 228 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 306 (787)
++++|++|+|++|++++.++. +..+++|+.|+|++|.+.+. +++|+.|+++.|+++|.+|..
T Consensus 179 ----------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 179 ----------KLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp ----------TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred ----------CCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence 789999999999999998886 78899999999999999864 557999999999999988864
Q ss_pred C
Q 003911 307 D 307 (787)
Q Consensus 307 ~ 307 (787)
.
T Consensus 242 ~ 242 (272)
T 3rfs_A 242 A 242 (272)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=228.59 Aligned_cols=146 Identities=23% Similarity=0.374 Sum_probs=126.6
Q ss_pred cCCCccc-ceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHH-HhcCCCccceEEeEEEe----CC
Q 003911 592 TNNFSEE-NILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVL-TKVRHRHLVALLGHCLD----GN 664 (787)
Q Consensus 592 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~ 664 (787)
.++|.+. +.||+|+||.||+|... +++.||+|+++. ...+.+|++++ +..+||||+++++++.. ..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 4567776 78999999999999874 789999999864 24677888888 55589999999999987 66
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC---CCcEEEe
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVA 741 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 741 (787)
..++||||+++|+|.+++.. .....+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred eEEEEEeecCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 78999999999999999865 222468999999999999999999998 89999999999999997 7889999
Q ss_pred ecccceecC
Q 003911 742 DFGLVRLAP 750 (787)
Q Consensus 742 DFG~a~~~~ 750 (787)
|||++....
T Consensus 163 Dfg~a~~~~ 171 (299)
T 3m2w_A 163 DFGFAKETT 171 (299)
T ss_dssp CCTTCEECT
T ss_pred ccccccccc
Confidence 999997654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.1e-24 Score=222.55 Aligned_cols=204 Identities=22% Similarity=0.253 Sum_probs=118.9
Q ss_pred CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCC
Q 003911 110 SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEF 189 (787)
Q Consensus 110 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l 189 (787)
.+.++++|+++++++|+++.+|+..+ ++|++|+|++|+++. ..|..|..+++|++|++++|.|++..+. + .+
T Consensus 5 ~~~~l~~l~~l~~~~~~l~~ip~~~~---~~l~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~--~l 76 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELTKLQVD--G--TL 76 (290)
T ss_dssp EEECSTTCCEEECTTSCCSSCCSCCC---TTCCEEECTTSCCSE-EEGGGGTTCTTCCEEECTTSCCCEEECC--S--CC
T ss_pred cccccCCccEEECCCCCCCcCCCCCC---CCCCEEEcCCCcCCc-cCHHHhhcCCCCCEEECCCCccCcccCC--C--CC
Confidence 35667777777777777777776533 566777777777664 3345566666666666666665544332 1 45
Q ss_pred CCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCCC-CCCCCCCCEE
Q 003911 190 PGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESL 268 (787)
Q Consensus 190 ~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L 268 (787)
++|++|+|++|+++ .+|..+ .++++|++|+|++|+|++.++. |.++++|++|
T Consensus 77 ~~L~~L~Ls~N~l~-~l~~~~--------------------------~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L 129 (290)
T 1p9a_G 77 PVLGTLDLSHNQLQ-SLPLLG--------------------------QTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129 (290)
T ss_dssp TTCCEEECCSSCCS-SCCCCT--------------------------TTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEE
T ss_pred CcCCEEECCCCcCC-cCchhh--------------------------ccCCCCCEEECCCCcCcccCHHHHcCCCCCCEE
Confidence 55555555555554 233222 1344444444444444444432 4444444444
Q ss_pred ecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChh
Q 003911 269 SLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQR 348 (787)
Q Consensus 269 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 348 (787)
+|++|+|++..+..|..+++|+.
T Consensus 130 ~L~~N~l~~~~~~~~~~l~~L~~--------------------------------------------------------- 152 (290)
T 1p9a_G 130 YLKGNELKTLPPGLLTPTPKLEK--------------------------------------------------------- 152 (290)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCE---------------------------------------------------------
T ss_pred ECCCCCCCccChhhcccccCCCE---------------------------------------------------------
Confidence 44444444333333444444444
Q ss_pred hhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCC
Q 003911 349 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNN 428 (787)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N 428 (787)
|+|++|++++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|
T Consensus 153 --------------------------L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~N 205 (290)
T 1p9a_G 153 --------------------------LSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205 (290)
T ss_dssp --------------------------EECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSC
T ss_pred --------------------------EECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCC
Confidence 444444444333445677888888888888888 78888888888888888887
Q ss_pred cccc
Q 003911 429 QLYG 432 (787)
Q Consensus 429 ~l~g 432 (787)
++..
T Consensus 206 p~~C 209 (290)
T 1p9a_G 206 PWLC 209 (290)
T ss_dssp CBCC
T ss_pred CccC
Confidence 7754
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-24 Score=217.44 Aligned_cols=189 Identities=16% Similarity=0.203 Sum_probs=122.5
Q ss_pred cCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEccccc-CCcCCCccccCCCCCcEEEccC-CCCCCCCCChh
Q 003911 83 TLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQ-FTSVPSDFFTGLSSLQSIEIDN-NPFSSWEIPQS 159 (787)
Q Consensus 83 ~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~p~~ 159 (787)
.+|. +. ++|++|+|++|+|++.++ .|.++++|++|+|++|+ ++.+++..|.++++|++|+|++ |+++. ..+..
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~-i~~~~ 100 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY-IDPDA 100 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCE-ECTTS
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeE-cCHHH
Confidence 4555 33 367777777777776665 56677777777777775 7777776677777777777776 77763 22355
Q ss_pred hhcCCCCCEEeccCceecccCCCCCCCCCCCCCc---EEecccc-ccccCCCcCcccccccceeeccCCCCCcCCCCccc
Q 003911 160 LRNASGLQNFSANSANITGQIPSFFGPDEFPGLT---ILHLAFN-QLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDV 235 (787)
Q Consensus 160 ~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~ 235 (787)
|.++++|++|++++|.+++ +|. |. .+++|+ +|++++| ++++..+..|.
T Consensus 101 f~~l~~L~~L~l~~n~l~~-lp~-~~--~l~~L~~L~~L~l~~N~~l~~i~~~~~~------------------------ 152 (239)
T 2xwt_C 101 LKELPLLKFLGIFNTGLKM-FPD-LT--KVYSTDIFFILEITDNPYMTSIPVNAFQ------------------------ 152 (239)
T ss_dssp EECCTTCCEEEEEEECCCS-CCC-CT--TCCBCCSEEEEEEESCTTCCEECTTTTT------------------------
T ss_pred hCCCCCCCEEeCCCCCCcc-ccc-cc--cccccccccEEECCCCcchhhcCccccc------------------------
Confidence 6677777777777777766 444 43 566666 7777777 66654444443
Q ss_pred cccCccCc-eEeccccccccCCCCCCCCCCCCEEecCCCc-ccccCCccccCC-CCCCEEEccCCcccccCCC
Q 003911 236 IQNMTSLK-EIWLHSNAFSGPLPDFSGVKQLESLSLRDNF-FTGPVPDSLVKL-ESLKIVNMTNNLLQGPVPE 305 (787)
Q Consensus 236 ~~~l~~L~-~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~ 305 (787)
++++|+ +|+|++|+++..++.....++|+.|+|++|+ +++..+..|..+ ++|++|+|++|++++.++.
T Consensus 153 --~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~ 223 (239)
T 2xwt_C 153 --GLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK 223 (239)
T ss_dssp --TTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT
T ss_pred --chhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh
Confidence 566777 7777777777555443233677777777774 765555666677 7777777777777765544
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.9e-25 Score=232.56 Aligned_cols=227 Identities=18% Similarity=0.208 Sum_probs=124.4
Q ss_pred CCcEEEeecCCCCCC-C---CCCCCCCCCcEEEcccccCCcCCCccc--cCCCCCcEEEccCCCCCCCCCC----hhhhc
Q 003911 93 KLERLELQWNSISGP-L---PSLNGLASLEVVMLSNNQFTSVPSDFF--TGLSSLQSIEIDNNPFSSWEIP----QSLRN 162 (787)
Q Consensus 93 ~L~~L~L~~N~l~~~-~---~~~~~l~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~p----~~~~~ 162 (787)
.++.|.+.++.++.. . ..+..+++|++|+|++|++++..+..+ ..+++|++|+|++|++.+ ..+ ..+..
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~-~~~~~~~~~~~~ 143 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWAT-GRSWLAELQQWL 143 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSS-TTSSHHHHHTTB
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccc-hhhhhHHHHhhh
Confidence 456667766666431 1 122334557777777777776666555 667777777777776664 222 22334
Q ss_pred CCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccC
Q 003911 163 ASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242 (787)
Q Consensus 163 l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L 242 (787)
+++|++|++++|.+++.+|..|+ .+++|++|+|++|++.+..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~------------------------------------ 185 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVR--AFPALTSLDLSDNPGLGER------------------------------------ 185 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCC--CCTTCCEEECCSCTTCHHH------------------------------------
T ss_pred ccCCCEEEeeCCCcchhhHHHhc--cCCCCCEEECCCCCCccch------------------------------------
Confidence 55555555555555544444443 4445555555555443210
Q ss_pred ceEeccccccccCCCC--CCCCCCCCEEecCCCcccccCCc----cccCCCCCCEEEccCCcccccCCC-CCCceeeecc
Q 003911 243 KEIWLHSNAFSGPLPD--FSGVKQLESLSLRDNFFTGPVPD----SLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMA 315 (787)
Q Consensus 243 ~~L~L~~N~l~~~~~~--~~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~L~~l 315 (787)
+.++. +..+++|++|+|++|+|+ .+|. .+..+++|++|+|++|++++..|. +..+.
T Consensus 186 -----------~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~----- 248 (310)
T 4glp_A 186 -----------GLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM----- 248 (310)
T ss_dssp -----------HHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC-----
T ss_pred -----------hhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc-----
Confidence 01111 234555555555555554 2222 134555666666666665554332 11110
Q ss_pred ccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCC
Q 003911 316 KGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKS 395 (787)
Q Consensus 316 ~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~ 395 (787)
..++|+.|+|++|+++ .+|..+. ++
T Consensus 249 ----------------------------------------------------~~~~L~~L~Ls~N~l~-~lp~~~~--~~ 273 (310)
T 4glp_A 249 ----------------------------------------------------WSSALNSLNLSFAGLE-QVPKGLP--AK 273 (310)
T ss_dssp ----------------------------------------------------CCTTCCCEECCSSCCC-SCCSCCC--SC
T ss_pred ----------------------------------------------------CcCcCCEEECCCCCCC-chhhhhc--CC
Confidence 0125556666666666 4555553 67
Q ss_pred CCEEecccccccccCCccCcCCCCCCeeeccCCcccc
Q 003911 396 LQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 432 (787)
Q Consensus 396 L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g 432 (787)
|+.|+|++|+|++ +|. +..+++|++|+|++|+|+.
T Consensus 274 L~~L~Ls~N~l~~-~~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 274 LRVLDLSSNRLNR-APQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CSCEECCSCCCCS-CCC-TTSCCCCSCEECSSTTTSC
T ss_pred CCEEECCCCcCCC-Cch-hhhCCCccEEECcCCCCCC
Confidence 8888888888885 343 6777888888888888864
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-26 Score=247.20 Aligned_cols=259 Identities=16% Similarity=0.221 Sum_probs=142.1
Q ss_pred EEeecCCCCCCCCCCCCC-CCCcEEEcccccCCcCCC----ccccCCC-CCcEEEccCCCCCCCCCChhhhcC-----CC
Q 003911 97 LELQWNSISGPLPSLNGL-ASLEVVMLSNNQFTSVPS----DFFTGLS-SLQSIEIDNNPFSSWEIPQSLRNA-----SG 165 (787)
Q Consensus 97 L~L~~N~l~~~~~~~~~l-~~L~~L~L~~N~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~p~~~~~l-----~~ 165 (787)
++|++|++++.+|.+..+ ++|++|+|++|+|++.++ ..|.+++ +|++|+|++|++.. ..+..+..+ ++
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~-~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGF-KNSDELVQILAAIPAN 81 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGG-SCHHHHHHHHHTSCTT
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCH-HHHHHHHHHHhccCCC
Confidence 445555555555543322 225555555555555554 4455555 55555555555553 334444443 55
Q ss_pred CCEEeccCceecccCCCCCCC--CCC-CCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCcccccc-Ccc
Q 003911 166 LQNFSANSANITGQIPSFFGP--DEF-PGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQN-MTS 241 (787)
Q Consensus 166 L~~L~l~~n~l~~~~p~~~~~--~~l-~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~-l~~ 241 (787)
|++|++++|.+++..+..+.. ..+ ++|++|+|++|++++..+..+. ..+.. .++
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~----------------------~~l~~~~~~ 139 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFK----------------------QAFSNLPAS 139 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH----------------------HHHTTSCTT
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHH----------------------HHHHhCCCc
Confidence 666666666655544432210 022 5666666666666654443332 11223 246
Q ss_pred CceEeccccccccCCC-----CCCCCC-CCCEEecCCCcccccCCcccc----CC-CCCCEEEccCCcccccCCCCCCce
Q 003911 242 LKEIWLHSNAFSGPLP-----DFSGVK-QLESLSLRDNFFTGPVPDSLV----KL-ESLKIVNMTNNLLQGPVPEFDRSV 310 (787)
Q Consensus 242 L~~L~L~~N~l~~~~~-----~~~~l~-~L~~L~L~~N~l~~~~p~~l~----~l-~~L~~L~Ls~N~l~~~~p~~~~~~ 310 (787)
|++|+|++|+++.... .+..++ +|++|+|++|+|++..+..+. .+ ++|++|+|++|++++....
T Consensus 140 L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~----- 214 (362)
T 3goz_A 140 ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYA----- 214 (362)
T ss_dssp CCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHH-----
T ss_pred eeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHH-----
Confidence 6677777776664322 123333 677777777777765554443 33 4777777777776642110
Q ss_pred eeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccC-CCceEEEEccCCcccccCc--
Q 003911 311 SLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCT-KGNITVINFQKMNLTGTIS-- 387 (787)
Q Consensus 311 ~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~L~Ls~N~l~g~~p-- 387 (787)
.+.. .+.. .++|+.|+|++|++++..+
T Consensus 215 ------------------------~l~~--------------------------~l~~~~~~L~~L~Ls~N~l~~~~~~~ 244 (362)
T 3goz_A 215 ------------------------ELAY--------------------------IFSSIPNHVVSLNLCLNCLHGPSLEN 244 (362)
T ss_dssp ------------------------HHHH--------------------------HHHHSCTTCCEEECCSSCCCCCCHHH
T ss_pred ------------------------HHHH--------------------------HHhcCCCCceEEECcCCCCCcHHHHH
Confidence 0000 0001 1367777777777776544
Q ss_pred --hhhcCCCCCCEEeccccccccc-------CCccCcCCCCCCeeeccCCccccc
Q 003911 388 --PEFASFKSLQRLILADNNLSGM-------IPEGLSVLGALKELDVSNNQLYGK 433 (787)
Q Consensus 388 --~~~~~l~~L~~L~Ls~N~l~g~-------ip~~l~~l~~L~~L~Ls~N~l~g~ 433 (787)
..+..+++|+.|+|++|++.+. ++..+..+++|++||+++|++.+.
T Consensus 245 l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 245 LKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 3345677888888888885432 344677788888888888888765
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=4e-24 Score=217.16 Aligned_cols=195 Identities=20% Similarity=0.240 Sum_probs=173.0
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCC-CCCCCC-CCCCCCCCcEEEccc-ccCCcCCCccccCCCCCcEE
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNS-ISGPLP-SLNGLASLEVVMLSN-NQFTSVPSDFFTGLSSLQSI 144 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~-~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L 144 (787)
..++.|++++|++++..+..|.++++|++|+|++|+ ++++++ .|.++++|++|+|++ |+++++++..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 479999999999997777799999999999999997 988777 799999999999999 99999999999999999999
Q ss_pred EccCCCCCCCCCChhhhcCCCCC---EEeccCc-eecccCCCCCCCCCCCCCc-EEeccccccccCCCcCccccccccee
Q 003911 145 EIDNNPFSSWEIPQSLRNASGLQ---NFSANSA-NITGQIPSFFGPDEFPGLT-ILHLAFNQLIGGLPASFSGSQIQSLW 219 (787)
Q Consensus 145 ~L~~N~l~~~~~p~~~~~l~~L~---~L~l~~n-~l~~~~p~~~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~~~l~~L~ 219 (787)
+|++|+++ .+|. +..+++|+ +|++++| ++++..+..|. .+++|+ +|+|++|+++...+..|
T Consensus 111 ~l~~n~l~--~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~--~l~~L~~~L~l~~n~l~~i~~~~~--------- 176 (239)
T 2xwt_C 111 GIFNTGLK--MFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQ--GLCNETLTLKLYNNGFTSVQGYAF--------- 176 (239)
T ss_dssp EEEEECCC--SCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTT--TTBSSEEEEECCSCCCCEECTTTT---------
T ss_pred eCCCCCCc--cccc-cccccccccccEEECCCCcchhhcCccccc--chhcceeEEEcCCCCCcccCHhhc---------
Confidence 99999999 4776 88888888 9999999 99988888886 899999 99999999984333333
Q ss_pred eccCCCCCcCCCCccccccCccCceEeccccc-cccCCCC-CCCC-CCCCEEecCCCcccccCCccccCCCCCCEEEccC
Q 003911 220 VNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA-FSGPLPD-FSGV-KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 296 (787)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~-~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 296 (787)
..++|++|+|++|+ +++.++. |.++ ++|+.|+|++|+|+ .+|.. .+++|+.|++++
T Consensus 177 ------------------~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~ 235 (239)
T 2xwt_C 177 ------------------NGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARN 235 (239)
T ss_dssp ------------------TTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECTT
T ss_pred ------------------CCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeeccC
Confidence 23799999999995 9987764 8889 99999999999999 56654 688999999987
Q ss_pred C
Q 003911 297 N 297 (787)
Q Consensus 297 N 297 (787)
+
T Consensus 236 ~ 236 (239)
T 2xwt_C 236 T 236 (239)
T ss_dssp C
T ss_pred c
Confidence 6
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-24 Score=227.79 Aligned_cols=226 Identities=19% Similarity=0.227 Sum_probs=117.0
Q ss_pred CEEEEEeCCCCccccCC---CCCCCCCCCcEEEeecCCCCCCCC-CC--CCCCCCcEEEcccccCCcCCC----ccccCC
Q 003911 69 RITRIQIGHQNLQGTLP---SNLQNLTKLERLELQWNSISGPLP-SL--NGLASLEVVMLSNNQFTSVPS----DFFTGL 138 (787)
Q Consensus 69 ~v~~L~l~~~~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~-~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l 138 (787)
+++.+.+.+..++...- ..+..+++|++|+|++|.+++..| .+ ..+++|++|+|++|++++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 35555565555542100 011223446666666666665554 34 556666666666666665333 233456
Q ss_pred CCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecc---cCCCCCCCCCCCCCcEEeccccccccCCCcCcccccc
Q 003911 139 SSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITG---QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQI 215 (787)
Q Consensus 139 ~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~---~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l 215 (787)
++|++|+|++|++.. ..|..+..+++|++|++++|++.+ ..+..+ ...+++|++|+|++|+++. +|....
T Consensus 145 ~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~---- 217 (310)
T 4glp_A 145 PGLKVLSIAQAHSPA-FSCEQVRAFPALTSLDLSDNPGLGERGLMAALC-PHKFPAIQNLALRNTGMET-PTGVCA---- 217 (310)
T ss_dssp SCCCEEEEECCSSCC-CCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSC-TTSSCCCCSCBCCSSCCCC-HHHHHH----
T ss_pred cCCCEEEeeCCCcch-hhHHHhccCCCCCEEECCCCCCccchhhhHHHh-hhcCCCCCEEECCCCCCCc-hHHHHH----
Confidence 666666666666654 344556666666666666666543 222221 1255666666666666641 111000
Q ss_pred cceeeccCCCCCcCCCCccccccCccCceEeccccccccCC-CCCCCC---CCCCEEecCCCcccccCCccccCCCCCCE
Q 003911 216 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL-PDFSGV---KQLESLSLRDNFFTGPVPDSLVKLESLKI 291 (787)
Q Consensus 216 ~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~l---~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 291 (787)
..++++++|++|+|++|++++.. +.+..+ ++|++|+|++|+|+ .+|..+. ++|++
T Consensus 218 ------------------~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~ 276 (310)
T 4glp_A 218 ------------------ALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRV 276 (310)
T ss_dssp ------------------HHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSC
T ss_pred ------------------HHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCE
Confidence 00234556666666666666552 233333 46666666666666 4555543 56666
Q ss_pred EEccCCcccccCCCCCCceeeeccccCCCccC
Q 003911 292 VNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCL 323 (787)
Q Consensus 292 L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~ 323 (787)
|+|++|+|++. |.+..+.+|+.+++++|.+.
T Consensus 277 L~Ls~N~l~~~-~~~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 277 LDLSSNRLNRA-PQPDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp EECCSCCCCSC-CCTTSCCCCSCEECSSTTTS
T ss_pred EECCCCcCCCC-chhhhCCCccEEECcCCCCC
Confidence 66666666653 22444555555666655543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=220.87 Aligned_cols=190 Identities=24% Similarity=0.349 Sum_probs=101.1
Q ss_pred CEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccC
Q 003911 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (787)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 148 (787)
+++.|++++++++. +| .+..+++|++|+|++|+|++.++ +.++++|++|+|++|++++++ .+..+++|++|+|++
T Consensus 42 ~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~l~~ 116 (308)
T 1h6u_A 42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVS--AIAGLQSIKTLDLTS 116 (308)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCG--GGTTCTTCCEEECTT
T ss_pred CcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCch--hhcCCCCCCEEECCC
Confidence 45566666665552 33 45555666666666666655444 555666666666666665543 355566666666666
Q ss_pred CCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCc
Q 003911 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAK 228 (787)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~ 228 (787)
|+++. ++. +..+++|++|++++|.+++..+ +. .+++|++|+|++|++++..+ +
T Consensus 117 n~l~~--~~~-l~~l~~L~~L~l~~n~l~~~~~--l~--~l~~L~~L~l~~n~l~~~~~--l------------------ 169 (308)
T 1h6u_A 117 TQITD--VTP-LAGLSNLQVLYLDLNQITNISP--LA--GLTNLQYLSIGNAQVSDLTP--L------------------ 169 (308)
T ss_dssp SCCCC--CGG-GTTCTTCCEEECCSSCCCCCGG--GG--GCTTCCEEECCSSCCCCCGG--G------------------
T ss_pred CCCCC--chh-hcCCCCCCEEECCCCccCcCcc--cc--CCCCccEEEccCCcCCCChh--h------------------
Confidence 65553 222 5555555555555555554433 32 45555555555555543211 1
Q ss_pred CCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccc
Q 003911 229 LGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301 (787)
Q Consensus 229 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 301 (787)
..+++|+.|+|++|++++.++ +..+++|++|+|++|++++.. .+..+++|+.|+|++|++++
T Consensus 170 --------~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 170 --------ANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp --------TTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred --------cCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 245555555555555554333 445555555555555555322 15555555555555555543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=9.4e-23 Score=208.59 Aligned_cols=177 Identities=23% Similarity=0.281 Sum_probs=131.7
Q ss_pred CCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEecc
Q 003911 93 KLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSAN 172 (787)
Q Consensus 93 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~ 172 (787)
..++++++++.++..++.+. ++|++|+|++|+++++++..|.++++|++|+|++|+++
T Consensus 15 ~~~~l~~~~~~l~~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-------------------- 72 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-------------------- 72 (251)
T ss_dssp GGTEEECTTCCCSSCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC--------------------
T ss_pred CCeEEecCCCCccccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCC--------------------
Confidence 34566666666665554443 45666666666666666655666666666666666555
Q ss_pred CceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEecccccc
Q 003911 173 SANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252 (787)
Q Consensus 173 ~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 252 (787)
+..+..|. .+++|++|+|++|++++..+..|. .+++|++|+|++|+|
T Consensus 73 -----~~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~--------------------------~l~~L~~L~L~~N~l 119 (251)
T 3m19_A 73 -----TLSAGVFD--DLTELGTLGLANNQLASLPLGVFD--------------------------HLTQLDKLYLGGNQL 119 (251)
T ss_dssp -----CCCTTTTT--TCTTCCEEECTTSCCCCCCTTTTT--------------------------TCTTCCEEECCSSCC
T ss_pred -----ccCHhHhc--cCCcCCEEECCCCcccccChhHhc--------------------------ccCCCCEEEcCCCcC
Confidence 44555554 677777777777777755554443 678888999999999
Q ss_pred ccCCCC-CCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCC-CCCceeeeccccCCCccCC
Q 003911 253 SGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDMAKGSNNFCLP 324 (787)
Q Consensus 253 ~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~L~~l~~~~n~~~~ 324 (787)
++.++. |..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++.++. +..+.+|+.+++++|.+.-
T Consensus 120 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 120 KSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred CCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 887775 78899999999999999977777899999999999999999998884 6678889999999997653
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4e-26 Score=244.66 Aligned_cols=211 Identities=13% Similarity=0.210 Sum_probs=147.9
Q ss_pred CCCCcccEEEcCCCCEEEEEeCCCCccccCCCCCCCC--CCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcC-C
Q 003911 55 DPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNL--TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSV-P 131 (787)
Q Consensus 55 ~~C~w~gv~C~~~~~v~~L~l~~~~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~-~ 131 (787)
-|.+|.++.|+ ...++.++++++++. +..+..+ ++++.|++++|.+++.++.+.++++|++|+|++|.+++. .
T Consensus 35 vc~~W~~~~~~-~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~ 110 (336)
T 2ast_B 35 VCKRWYRLASD-ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 110 (336)
T ss_dssp SCHHHHHHHTC-STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHH
T ss_pred HHHHHHHHhcC-chhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHH
Confidence 34479998875 345788999998877 4556666 889999999999999888888899999999999988864 5
Q ss_pred CccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCc-eeccc-CCCCCCCCCCCCCcEEecccc-ccccC-CC
Q 003911 132 SDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA-NITGQ-IPSFFGPDEFPGLTILHLAFN-QLIGG-LP 207 (787)
Q Consensus 132 ~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n-~l~~~-~p~~~~~~~l~~L~~L~L~~N-~l~~~-~p 207 (787)
+..+.++++|++|+|++|++++ ..|..+..+++|++|++++| .+++. ++..+. .+++|++|+|++| ++++. ++
T Consensus 111 ~~~~~~~~~L~~L~L~~~~l~~-~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~--~~~~L~~L~l~~~~~l~~~~~~ 187 (336)
T 2ast_B 111 HGILSQCSKLQNLSLEGLRLSD-PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS--SCSRLDELNLSWCFDFTEKHVQ 187 (336)
T ss_dssp HHHHTTBCCCSEEECTTCBCCH-HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHH--HCTTCCEEECCCCTTCCHHHHH
T ss_pred HHHHhhCCCCCEEeCcCcccCH-HHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHh--cCCCCCEEcCCCCCCcChHHHH
Confidence 5668888888888888888775 56777777888888888887 56642 444443 5677777777777 66532 22
Q ss_pred cCcccccccceeeccCCCCCcCCCCccccccCc-cCceEeccccc--cc-c-CCCCCCCCCCCCEEecCCCc-ccccCCc
Q 003911 208 ASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMT-SLKEIWLHSNA--FS-G-PLPDFSGVKQLESLSLRDNF-FTGPVPD 281 (787)
Q Consensus 208 ~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~-~L~~L~L~~N~--l~-~-~~~~~~~l~~L~~L~L~~N~-l~~~~p~ 281 (787)
.. +..++ +|++|+|++|. ++ + .+..+..+++|+.|+|++|. +++..+.
T Consensus 188 ~~--------------------------~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~ 241 (336)
T 2ast_B 188 VA--------------------------VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ 241 (336)
T ss_dssp HH--------------------------HHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGG
T ss_pred HH--------------------------HHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHH
Confidence 22 33566 67777777763 33 1 22234456666666666666 5555566
Q ss_pred cccCCCCCCEEEccCCc
Q 003911 282 SLVKLESLKIVNMTNNL 298 (787)
Q Consensus 282 ~l~~l~~L~~L~Ls~N~ 298 (787)
.+..+++|++|+|++|.
T Consensus 242 ~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 242 EFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp GGGGCTTCCEEECTTCT
T ss_pred HHhCCCCCCEeeCCCCC
Confidence 66666666666666664
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=3.1e-23 Score=218.79 Aligned_cols=198 Identities=20% Similarity=0.325 Sum_probs=174.3
Q ss_pred CCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCC
Q 003911 88 LQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ 167 (787)
Q Consensus 88 ~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~ 167 (787)
+.++++|++|++++|.++.. +.+..+++|++|+|++|+++++++ +.++++|++|+|++|+++. + ..+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~l-~~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~--~-~~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN--V-SAIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC--C-GGGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccCc-hhhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC--c-hhhcCCCCCC
Confidence 45688999999999999875 579999999999999999999887 9999999999999999985 3 3799999999
Q ss_pred EEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEec
Q 003911 168 NFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWL 247 (787)
Q Consensus 168 ~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L 247 (787)
+|++++|++++..+ +. .+++|++|+|++|++++..+ +..+++|+.|+|
T Consensus 111 ~L~l~~n~l~~~~~--l~--~l~~L~~L~l~~n~l~~~~~----------------------------l~~l~~L~~L~l 158 (308)
T 1h6u_A 111 TLDLTSTQITDVTP--LA--GLSNLQVLYLDLNQITNISP----------------------------LAGLTNLQYLSI 158 (308)
T ss_dssp EEECTTSCCCCCGG--GT--TCTTCCEEECCSSCCCCCGG----------------------------GGGCTTCCEEEC
T ss_pred EEECCCCCCCCchh--hc--CCCCCCEEECCCCccCcCcc----------------------------ccCCCCccEEEc
Confidence 99999999997543 54 89999999999999985433 337899999999
Q ss_pred cccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCC
Q 003911 248 HSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPG 327 (787)
Q Consensus 248 ~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~ 327 (787)
++|++++.++ +..+++|+.|+|++|++++. +. +..+++|++|+|++|++++.++ +..+.+|+.+++++|.+...|.
T Consensus 159 ~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~l~~N~i~~~~~ 234 (308)
T 1h6u_A 159 GNAQVSDLTP-LANLSKLTTLKADDNKISDI-SP-LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTITNQPV 234 (308)
T ss_dssp CSSCCCCCGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEEEEEECCCE
T ss_pred cCCcCCCChh-hcCCCCCCEEECCCCccCcC-hh-hcCCCCCCEEEccCCccCcccc-ccCCCCCCEEEccCCeeecCCe
Confidence 9999998666 88999999999999999954 43 8999999999999999998775 7888899999999998877654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-25 Score=241.13 Aligned_cols=266 Identities=13% Similarity=0.135 Sum_probs=203.1
Q ss_pred EEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-----CCCCCC-CCcEEEcccccCCcCCCccccCC-----CC
Q 003911 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-----SLNGLA-SLEVVMLSNNQFTSVPSDFFTGL-----SS 140 (787)
Q Consensus 72 ~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-----~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~ 140 (787)
..++++++++|.+|..+...++|++|+|++|.|++..+ .|.+++ +|++|+|++|+|++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46789999999999888888889999999999998764 477888 89999999999999888777775 99
Q ss_pred CcEEEccCCCCCCCCCChhh----hcC-CCCCEEeccCceecccCCCCCCC--CC-CCCCcEEeccccccccCCCcCccc
Q 003911 141 LQSIEIDNNPFSSWEIPQSL----RNA-SGLQNFSANSANITGQIPSFFGP--DE-FPGLTILHLAFNQLIGGLPASFSG 212 (787)
Q Consensus 141 L~~L~L~~N~l~~~~~p~~~----~~l-~~L~~L~l~~n~l~~~~p~~~~~--~~-l~~L~~L~L~~N~l~~~~p~~~~~ 212 (787)
|++|+|++|+++. ..+..+ ..+ ++|++|++++|.+++..+..+.. .. .++|++|+|++|++++..+..+.
T Consensus 82 L~~L~Ls~n~l~~-~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~- 159 (362)
T 3goz_A 82 VTSLNLSGNFLSY-KSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELI- 159 (362)
T ss_dssp CCEEECCSSCGGG-SCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHH-
T ss_pred ccEEECcCCcCCh-HHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHH-
Confidence 9999999999986 445544 444 89999999999998876654320 12 36999999999999865554432
Q ss_pred ccccceeeccCCCCCcCCCCccccccCc-cCceEeccccccccCCCC-----CCCC-CCCCEEecCCCccccc----CCc
Q 003911 213 SQIQSLWVNGQNGNAKLGGGIDVIQNMT-SLKEIWLHSNAFSGPLPD-----FSGV-KQLESLSLRDNFFTGP----VPD 281 (787)
Q Consensus 213 ~~l~~L~~~~~~~~~~~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~-----~~~l-~~L~~L~L~~N~l~~~----~p~ 281 (787)
..+..++ +|++|+|++|++++..+. +..+ ++|++|+|++|+|++. ++.
T Consensus 160 ---------------------~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~ 218 (362)
T 3goz_A 160 ---------------------QILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAY 218 (362)
T ss_dssp ---------------------HHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred ---------------------HHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHH
Confidence 2233455 899999999999887652 4445 5999999999999963 566
Q ss_pred cccC-CCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCC
Q 003911 282 SLVK-LESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCS 360 (787)
Q Consensus 282 ~l~~-l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 360 (787)
.+.. .++|++|+|++|++++..+.. +
T Consensus 219 ~l~~~~~~L~~L~Ls~N~l~~~~~~~-----------------------------l------------------------ 245 (362)
T 3goz_A 219 IFSSIPNHVVSLNLCLNCLHGPSLEN-----------------------------L------------------------ 245 (362)
T ss_dssp HHHHSCTTCCEEECCSSCCCCCCHHH-----------------------------H------------------------
T ss_pred HHhcCCCCceEEECcCCCCCcHHHHH-----------------------------H------------------------
Confidence 6666 459999999999988643310 0
Q ss_pred CccccccCCCceEEEEccCCccccc-------CchhhcCCCCCCEEecccccccccCCccCc
Q 003911 361 DWIGVTCTKGNITVINFQKMNLTGT-------ISPEFASFKSLQRLILADNNLSGMIPEGLS 415 (787)
Q Consensus 361 ~~~~~~~~~~~L~~L~Ls~N~l~g~-------~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~ 415 (787)
.......++|+.|+|++|.+.+. ++..+..+++|+.|||++|++.+..|..+.
T Consensus 246 --~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~~ 305 (362)
T 3goz_A 246 --KLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPIS 305 (362)
T ss_dssp --HHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHHHH
T ss_pred --HHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHHHH
Confidence 00112234788999999985543 334567888899999999999876555443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=9.3e-23 Score=219.47 Aligned_cols=204 Identities=18% Similarity=0.233 Sum_probs=155.5
Q ss_pred CCcccEEEcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCc-CCCcc
Q 003911 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTS-VPSDF 134 (787)
Q Consensus 57 C~w~gv~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~-~~~~~ 134 (787)
|+|..|.|+ +++++ .+|..+. +++++|+|++|+|+.+++ +|.++++|++|+|++|++.+ +++.+
T Consensus 9 C~~~~v~C~-----------~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~ 74 (350)
T 4ay9_X 9 CSNRVFLCQ-----------ESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 74 (350)
T ss_dssp EETTEEEEE-----------STTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTS
T ss_pred eeCCEEEec-----------CCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhH
Confidence 566666664 45666 6787764 689999999999998777 68999999999999999855 77788
Q ss_pred ccCCCCCcE-EEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccc-cccccCCCcCccc
Q 003911 135 FTGLSSLQS-IEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAF-NQLIGGLPASFSG 212 (787)
Q Consensus 135 ~~~l~~L~~-L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~ 212 (787)
|.++++|++ ++++.|+++. ..|..|..+++|++|++++|+|++..+..+. ...++..|++.+ |++....+..|.
T Consensus 75 f~~L~~l~~~l~~~~N~l~~-l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~--~~~~l~~l~l~~~~~i~~l~~~~f~- 150 (350)
T 4ay9_X 75 FSNLPKLHEIRIEKANNLLY-INPEAFQNLPNLQYLLISNTGIKHLPDVHKI--HSLQKVLLDIQDNINIHTIERNSFV- 150 (350)
T ss_dssp BCSCTTCCEEEEEEETTCCE-ECTTSBCCCTTCCEEEEEEECCSSCCCCTTC--CBSSCEEEEEESCTTCCEECTTSST-
T ss_pred hhcchhhhhhhcccCCcccc-cCchhhhhccccccccccccccccCCchhhc--ccchhhhhhhccccccccccccchh-
Confidence 999988775 6677788885 3467788899999999999988877766654 666778888865 556544444442
Q ss_pred ccccceeeccCCCCCcCCCCccccccC-ccCceEeccccccccCCCCCCCCCCCCEEecCC-CcccccCC-ccccCCCCC
Q 003911 213 SQIQSLWVNGQNGNAKLGGGIDVIQNM-TSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRD-NFFTGPVP-DSLVKLESL 289 (787)
Q Consensus 213 ~~l~~L~~~~~~~~~~~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~-N~l~~~~p-~~l~~l~~L 289 (787)
.+ ..++.|+|++|+|+.+++......+|+.|++++ |.++ .+| ..|..+++|
T Consensus 151 -------------------------~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L 204 (350)
T 4ay9_X 151 -------------------------GLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGP 204 (350)
T ss_dssp -------------------------TSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECC
T ss_pred -------------------------hcchhhhhhccccccccCCChhhccccchhHHhhccCCccc-CCCHHHhccCccc
Confidence 33 457888999999988777766677888888875 6666 555 567888889
Q ss_pred CEEEccCCcccccCC
Q 003911 290 KIVNMTNNLLQGPVP 304 (787)
Q Consensus 290 ~~L~Ls~N~l~~~~p 304 (787)
++|||++|+|+..++
T Consensus 205 ~~LdLs~N~l~~lp~ 219 (350)
T 4ay9_X 205 VILDISRTRIHSLPS 219 (350)
T ss_dssp SEEECTTSCCCCCCS
T ss_pred chhhcCCCCcCccCh
Confidence 999999888886554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.4e-23 Score=234.37 Aligned_cols=200 Identities=24% Similarity=0.389 Sum_probs=169.8
Q ss_pred CCC-CCCCC-----CcccE-EEcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEc
Q 003911 50 GWS-DTDPC-----KWNHV-VCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVML 122 (787)
Q Consensus 50 ~w~-~~~~C-----~w~gv-~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L 122 (787)
+|. +.++| .|.|+ .|.. ++++.|+|++|+|++ +|..+. ++|++|+|++|+|+.++ ..+++|++|+|
T Consensus 35 ~W~~~~~~~~~~~~~~~~l~~C~~-~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~ip---~~l~~L~~L~L 107 (571)
T 3cvr_A 35 KWEKQALPGENRNEAVSLLKECLI-NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALISLP---ELPASLEYLDA 107 (571)
T ss_dssp HHHTTCCTTCCHHHHHHHHHHHHH-TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSCCC---CCCTTCCEEEC
T ss_pred HHhccCCccccccchhhhcccccc-CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcccc---cccCCCCEEEc
Confidence 353 45678 69999 7864 589999999999996 888774 89999999999999644 56899999999
Q ss_pred ccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEecccccc
Q 003911 123 SNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQL 202 (787)
Q Consensus 123 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l 202 (787)
++|+|+++|. |.+ +|++|+|++|+|++ +|. .+++|+.|++++|.|++ +|. .+++|++|+|++|+|
T Consensus 108 s~N~l~~ip~--l~~--~L~~L~Ls~N~l~~--lp~---~l~~L~~L~Ls~N~l~~-lp~-----~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 108 CDNRLSTLPE--LPA--SLKHLDVDNNQLTM--LPE---LPALLEYINADNNQLTM-LPE-----LPTSLEVLSVRNNQL 172 (571)
T ss_dssp CSSCCSCCCC--CCT--TCCEEECCSSCCSC--CCC---CCTTCCEEECCSSCCSC-CCC-----CCTTCCEEECCSSCC
T ss_pred cCCCCCCcch--hhc--CCCEEECCCCcCCC--CCC---cCccccEEeCCCCccCc-CCC-----cCCCcCEEECCCCCC
Confidence 9999999877 655 99999999999995 677 68999999999999997 454 368999999999999
Q ss_pred ccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCC-------CEEecCCCcc
Q 003911 203 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL-------ESLSLRDNFF 275 (787)
Q Consensus 203 ~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L-------~~L~L~~N~l 275 (787)
++ +|. | . ++|+.|+|++|+|+..++ +.. +| +.|+|++|+|
T Consensus 173 ~~-lp~-l---------------------------~-~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l 219 (571)
T 3cvr_A 173 TF-LPE-L---------------------------P-ESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCRENRI 219 (571)
T ss_dssp SC-CCC-C---------------------------C-TTCCEEECCSSCCSSCCC-CC----------CCEEEECCSSCC
T ss_pred CC-cch-h---------------------------h-CCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCCcc
Confidence 96 665 4 2 789999999999996665 654 77 9999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcccccCCC
Q 003911 276 TGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305 (787)
Q Consensus 276 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 305 (787)
+ .+|..+..+++|+.|+|++|+|++.+|.
T Consensus 220 ~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~ 248 (571)
T 3cvr_A 220 T-HIPENILSLDPTCTIILEDNPLSSRIRE 248 (571)
T ss_dssp C-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred e-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence 9 7999999999999999999999987664
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-25 Score=246.33 Aligned_cols=251 Identities=18% Similarity=0.224 Sum_probs=161.6
Q ss_pred cCCCCCCCCCCCcEEEeecCCCCCCCC-----CCCCCCCCcEEEcccccCC---cCCCcc-------ccCCCCCcEEEcc
Q 003911 83 TLPSNLQNLTKLERLELQWNSISGPLP-----SLNGLASLEVVMLSNNQFT---SVPSDF-------FTGLSSLQSIEID 147 (787)
Q Consensus 83 ~~~~~~~~l~~L~~L~L~~N~l~~~~~-----~~~~l~~L~~L~L~~N~l~---~~~~~~-------~~~l~~L~~L~L~ 147 (787)
.++..+..+++|++|+|++|+|+...+ .+..+++|++|+|++|.+. +..|.. |..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 455667777888888888888876422 4677888888888886544 322322 3677888888888
Q ss_pred CCCCCCC---CCChhhhcCCCCCEEeccCceecccCCCCCCC--CCC---------CCCcEEeccccccc-cCCCcCccc
Q 003911 148 NNPFSSW---EIPQSLRNASGLQNFSANSANITGQIPSFFGP--DEF---------PGLTILHLAFNQLI-GGLPASFSG 212 (787)
Q Consensus 148 ~N~l~~~---~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~--~~l---------~~L~~L~L~~N~l~-~~~p~~~~~ 212 (787)
+|++... .+|..+..+++|++|++++|.++...+..+.. ..+ ++|++|+|++|+++ +.+|. +
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~-l-- 179 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE-W-- 179 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHH-H--
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHH-H--
Confidence 8888741 15667778888888888888876544433320 012 67777777777765 22221 0
Q ss_pred ccccceeeccCCCCCcCCCCccccccCccCceEeccccccc--c---CCC-CCCCCCCCCEEecCCCccc----ccCCcc
Q 003911 213 SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS--G---PLP-DFSGVKQLESLSLRDNFFT----GPVPDS 282 (787)
Q Consensus 213 ~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~--~---~~~-~~~~l~~L~~L~L~~N~l~----~~~p~~ 282 (787)
...+..+++|++|+|++|+++ | ..+ .+..+++|+.|+|++|+|+ +.+|..
T Consensus 180 --------------------~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~ 239 (386)
T 2ca6_A 180 --------------------AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239 (386)
T ss_dssp --------------------HHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred --------------------HHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHH
Confidence 012345667777777777766 2 233 5666667777777777764 456666
Q ss_pred ccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCc
Q 003911 283 LVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDW 362 (787)
Q Consensus 283 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (787)
+..+++|++|+|++|++++....
T Consensus 240 l~~~~~L~~L~L~~n~i~~~~~~--------------------------------------------------------- 262 (386)
T 2ca6_A 240 LKSWPNLRELGLNDCLLSARGAA--------------------------------------------------------- 262 (386)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHH---------------------------------------------------------
T ss_pred HccCCCcCEEECCCCCCchhhHH---------------------------------------------------------
Confidence 66666666666666665532100
Q ss_pred cccccCCCceEEEEccCCcccccCchhh--cCCCCCCEEecccccccc----cCCccC-cCCCCCCeeeccCCcccccCC
Q 003911 363 IGVTCTKGNITVINFQKMNLTGTISPEF--ASFKSLQRLILADNNLSG----MIPEGL-SVLGALKELDVSNNQLYGKIP 435 (787)
Q Consensus 363 ~~~~~~~~~L~~L~Ls~N~l~g~~p~~~--~~l~~L~~L~Ls~N~l~g----~ip~~l-~~l~~L~~L~Ls~N~l~g~iP 435 (787)
.+|..+ +.+++|+.|+|++|++++ .+|..+ .++++|++|+|++|++++..|
T Consensus 263 ----------------------~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 263 ----------------------AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp ----------------------HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred ----------------------HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 134455 337788888888888876 477776 557888888888888876654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-23 Score=216.45 Aligned_cols=156 Identities=15% Similarity=0.088 Sum_probs=123.3
Q ss_pred HHHHHhhcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccc----------------hhHHHHHHHHHHHHhc
Q 003911 585 IQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISG----------------KGLTEFKSEIAVLTKV 648 (787)
Q Consensus 585 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l 648 (787)
+..+......|.+.+.||+|+||.||+|...+|+.||+|+++...... .....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 344445556788889999999999999988779999999996432111 2356789999999999
Q ss_pred CCCccceEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 003911 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPS 728 (787)
Q Consensus 649 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 728 (787)
+| +++.+++.. +..++||||+++++|.+ +. ......++.|++.||+|||+ .+|+||||||+
T Consensus 162 ~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-----------~~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~ 222 (282)
T 1zar_A 162 QG---LAVPKVYAW-EGNAVLMELIDAKELYR-VR-----------VENPDEVLDMILEEVAKFYH---RGIVHGDLSQY 222 (282)
T ss_dssp TT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-----------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTT
T ss_pred cC---CCcCeEEec-cceEEEEEecCCCcHHH-cc-----------hhhHHHHHHHHHHHHHHHHH---CCCEeCCCCHH
Confidence 94 555554433 55699999999999987 41 12345799999999999998 89999999999
Q ss_pred CEEECCCCcEEEeecccceecCCCCCceeeeeccccCccccccccc
Q 003911 729 NILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVH 774 (787)
Q Consensus 729 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 774 (787)
|||++ ++.+||+|||+|+. +..|+|||++..
T Consensus 223 NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp SEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred HEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 99999 99999999999863 345789998864
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=9.1e-23 Score=202.35 Aligned_cols=183 Identities=25% Similarity=0.362 Sum_probs=147.0
Q ss_pred CCcccEEEcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccc
Q 003911 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFF 135 (787)
Q Consensus 57 C~w~gv~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~ 135 (787)
|.|.+|.|... +++ .+|..+ .++|++|+|++|+|++.++ .|.++++|++|+|++|+++++++..|
T Consensus 7 C~~~~v~c~~~-----------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 72 (208)
T 2o6s_A 7 CSGTTVECYSQ-----------GRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF 72 (208)
T ss_dssp EETTEEECCSS-----------CCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT
T ss_pred ECCCEEEecCC-----------Ccc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhc
Confidence 78999999643 333 456554 3689999999999998777 47899999999999999999999999
Q ss_pred cCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccc
Q 003911 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQI 215 (787)
Q Consensus 136 ~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l 215 (787)
.++++|++|+|++|+++. ..+..|..+++|++|++++|++++..+..|. .+++|++|+|++|++++..+..+.
T Consensus 73 ~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~l~~N~l~~~~~~~~~---- 145 (208)
T 2o6s_A 73 NKLTSLTYLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQLQSLPDGVFD--KLTQLKDLRLYQNQLKSVPDGVFD---- 145 (208)
T ss_dssp TTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTT--TCTTCCEEECCSSCCSCCCTTTTT----
T ss_pred CCCCCcCEEECCCCcCCc-cCHhHhcCccCCCEEEcCCCcCcccCHhHhc--cCCcCCEEECCCCccceeCHHHhc----
Confidence 999999999999999985 3345578888999999999988887777775 788888888888888865554443
Q ss_pred cceeeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCC
Q 003911 216 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLES 288 (787)
Q Consensus 216 ~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 288 (787)
.+++|+.|+|++|.+.+. +++|++|+++.|+++|.+|.+++.++.
T Consensus 146 ----------------------~l~~L~~L~l~~N~~~~~------~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 146 ----------------------RLTSLQYIWLHDNPWDCT------CPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ----------------------TCTTCCEEECCSCCBCCC------TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ----------------------cCCCccEEEecCCCeecC------CCCHHHHHHHHHhCCceeeccCccccC
Confidence 678888888888877643 457788888888888888887776654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.8e-22 Score=215.70 Aligned_cols=177 Identities=16% Similarity=0.126 Sum_probs=130.2
Q ss_pred cEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCC-hhhhcCCCCCE-Eecc
Q 003911 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIP-QSLRNASGLQN-FSAN 172 (787)
Q Consensus 95 ~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p-~~~~~l~~L~~-L~l~ 172 (787)
+.++.++|+|+.+|..+. +++++|+|++|+|+.+++++|.++++|++|+|++|++.+ .+| ..|.++++|+. +.++
T Consensus 12 ~~v~C~~~~Lt~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~-~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE-VIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCCSCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCC-EECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCCccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCC-ccChhHhhcchhhhhhhccc
Confidence 578899999998766663 689999999999999999999999999999999999875 444 46778887765 6666
Q ss_pred CceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccc-cc
Q 003911 173 SANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS-NA 251 (787)
Q Consensus 173 ~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~-N~ 251 (787)
.|+|+...|..|. .+++|++|++++|++++..+..+. ...++..|++.+ |+
T Consensus 89 ~N~l~~l~~~~f~--~l~~L~~L~l~~n~l~~~~~~~~~--------------------------~~~~l~~l~l~~~~~ 140 (350)
T 4ay9_X 89 ANNLLYINPEAFQ--NLPNLQYLLISNTGIKHLPDVHKI--------------------------HSLQKVLLDIQDNIN 140 (350)
T ss_dssp ETTCCEECTTSBC--CCTTCCEEEEEEECCSSCCCCTTC--------------------------CBSSCEEEEEESCTT
T ss_pred CCcccccCchhhh--hccccccccccccccccCCchhhc--------------------------ccchhhhhhhccccc
Confidence 7888888888886 788888888888888755554432 445666777754 55
Q ss_pred cccCCC-CCCCC-CCCCEEecCCCcccccCCccccCCCCCCEEEccC-CcccccC
Q 003911 252 FSGPLP-DFSGV-KQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN-NLLQGPV 303 (787)
Q Consensus 252 l~~~~~-~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~ 303 (787)
+...++ .|..+ ..|+.|+|++|+|+ .+|.......+|++|++++ |.++..+
T Consensus 141 i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~ 194 (350)
T 4ay9_X 141 IHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELP 194 (350)
T ss_dssp CCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCC
T ss_pred cccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCC
Confidence 665554 35554 35777777777777 4555555566777777764 4454433
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.87 E-value=5.8e-22 Score=224.27 Aligned_cols=196 Identities=25% Similarity=0.315 Sum_probs=126.1
Q ss_pred CCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEE
Q 003911 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL 195 (787)
Q Consensus 116 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L 195 (787)
+|++|+|++|+|+++|+..+ ++|++|+|++|+|+ .+| ..+++|++|++++|+|++ +|. +. . +|++|
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l~---~~L~~L~Ls~N~l~--~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~--~--~L~~L 125 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNLP---PQITVLEITQNALI--SLP---ELPASLEYLDACDNRLST-LPE-LP--A--SLKHL 125 (571)
T ss_dssp TCSEEECCSSCCSCCCSCCC---TTCSEEECCSSCCS--CCC---CCCTTCCEEECCSSCCSC-CCC-CC--T--TCCEE
T ss_pred CccEEEeCCCCCCccCHhHc---CCCCEEECcCCCCc--ccc---cccCCCCEEEccCCCCCC-cch-hh--c--CCCEE
Confidence 45555555555555444322 45555555555555 344 334556666666666665 444 43 2 67777
Q ss_pred eccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcc
Q 003911 196 HLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFF 275 (787)
Q Consensus 196 ~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l 275 (787)
+|++|+|++ +|. .+++|+.|+|++|+|++.++ .+++|+.|+|++|+|
T Consensus 126 ~Ls~N~l~~-lp~-----------------------------~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 126 DVDNNQLTM-LPE-----------------------------LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQL 172 (571)
T ss_dssp ECCSSCCSC-CCC-----------------------------CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCC
T ss_pred ECCCCcCCC-CCC-----------------------------cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCC
Confidence 777777775 443 24677788888888877443 567888888888888
Q ss_pred cccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCC
Q 003911 276 TGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 355 (787)
Q Consensus 276 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 355 (787)
++ +|. |. ++|++|+|++|+|+..++ +.. +|
T Consensus 173 ~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~--~L------------------------------------------- 202 (571)
T 3cvr_A 173 TF-LPE-LP--ESLEALDVSTNLLESLPA-VPV--RN------------------------------------------- 202 (571)
T ss_dssp SC-CCC-CC--TTCCEEECCSSCCSSCCC-CC------------------------------------------------
T ss_pred CC-cch-hh--CCCCEEECcCCCCCchhh-HHH--hh-------------------------------------------
Confidence 85 666 55 788888888888874333 221 10
Q ss_pred CCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCC
Q 003911 356 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGA 419 (787)
Q Consensus 356 ~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~ 419 (787)
......|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..+..
T Consensus 203 ----------~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 203 ----------HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp ---------------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred ----------hcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 001124588888888888 57888888888888888888888888888776543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.86 E-value=6.4e-23 Score=240.85 Aligned_cols=225 Identities=16% Similarity=0.180 Sum_probs=107.8
Q ss_pred CChhHHHHHHHHHHhcCCCC---CCCCCC--CCCCCcccEEEcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecC
Q 003911 28 GDDGDAAVMLALKKSLNPPE---SLGWSD--TDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWN 102 (787)
Q Consensus 28 ~~~~d~~~l~~~k~~~~~~~---~~~w~~--~~~C~w~gv~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N 102 (787)
..+.++++|+++..++..+. ...|.. +.+++|.++.++. .+++.|+|.++++.. ++. ..|+.++|+.|
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~ 201 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST-PLTPKIELFANGKDE-ANQ-----ALLQHKKLSQY 201 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC-CccceEEeeCCCCCc-chh-----hHhhcCccCcc
Confidence 34568899999998874322 235743 3457899998865 689999999999885 333 34566677777
Q ss_pred CCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCC
Q 003911 103 SISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPS 182 (787)
Q Consensus 103 ~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~ 182 (787)
.|.+ ++++.|++. ++++.|..+++|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|.
T Consensus 202 ~i~~-------------~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~--~l~~~~~~l~~L~~L~Ls~N~l~-~lp~ 264 (727)
T 4b8c_D 202 SIDE-------------DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF--NISANIFKYDFLTRLYLNGNSLT-ELPA 264 (727)
T ss_dssp ----------------------------------CCCCCCEEECTTSCCS--CCCGGGGGCCSCSCCBCTTSCCS-CCCG
T ss_pred cccC-------------cccccccee-cChhhhccCCCCcEEECCCCCCC--CCChhhcCCCCCCEEEeeCCcCc-ccCh
Confidence 6654 344556655 55666777777777777777777 56777767777777777777777 5666
Q ss_pred CCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCC
Q 003911 183 FFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGV 262 (787)
Q Consensus 183 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l 262 (787)
.|+ .+++|++|+|++|+|+ .+|..|. ++++|++|+|++|.|+.++..|..+
T Consensus 265 ~~~--~l~~L~~L~Ls~N~l~-~lp~~~~--------------------------~l~~L~~L~L~~N~l~~lp~~~~~l 315 (727)
T 4b8c_D 265 EIK--NLSNLRVLDLSHNRLT-SLPAELG--------------------------SCFQLKYFYFFDNMVTTLPWEFGNL 315 (727)
T ss_dssp GGG--GGTTCCEEECTTSCCS-SCCSSGG--------------------------GGTTCSEEECCSSCCCCCCSSTTSC
T ss_pred hhh--CCCCCCEEeCcCCcCC-ccChhhc--------------------------CCCCCCEEECCCCCCCccChhhhcC
Confidence 664 6777777777777777 5565543 6777777777777777655567777
Q ss_pred CCCCEEecCCCcccccCCccccCCCC-CCEEEccCCcccccCCC
Q 003911 263 KQLESLSLRDNFFTGPVPDSLVKLES-LKIVNMTNNLLQGPVPE 305 (787)
Q Consensus 263 ~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~p~ 305 (787)
++|++|+|++|+|++.+|..+..+.. +..|+|++|.+++.+|.
T Consensus 316 ~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 316 CNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp TTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred CCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 77777777777777777776654322 22356777777766654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.8e-21 Score=191.59 Aligned_cols=104 Identities=19% Similarity=0.235 Sum_probs=60.1
Q ss_pred cEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCc
Q 003911 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174 (787)
Q Consensus 95 ~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n 174 (787)
+.++++++.++..+..+ .++|++|+|++|+++++++..|.++++|++|+|++|+++. ..+..|..+++|++|++++|
T Consensus 10 ~~v~c~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCc-cChhhcCCCCCcCEEECCCC
Confidence 46677777777655444 2467777777777777777777777777777777777663 22233444555555555555
Q ss_pred eecccCCCCCCCCCCCCCcEEeccccccc
Q 003911 175 NITGQIPSFFGPDEFPGLTILHLAFNQLI 203 (787)
Q Consensus 175 ~l~~~~p~~~~~~~l~~L~~L~L~~N~l~ 203 (787)
++++..+..|. .+++|++|+|++|+++
T Consensus 87 ~l~~~~~~~~~--~l~~L~~L~L~~N~l~ 113 (208)
T 2o6s_A 87 QLQSLPNGVFD--KLTQLKELALNTNQLQ 113 (208)
T ss_dssp CCCCCCTTTTT--TCTTCCEEECCSSCCC
T ss_pred cCCccCHhHhc--CccCCCEEEcCCCcCc
Confidence 55444443333 4444444444444444
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.84 E-value=4e-23 Score=225.72 Aligned_cols=205 Identities=20% Similarity=0.277 Sum_probs=162.6
Q ss_pred CCEEEEEeCCCCcccc----CCCCCCCCCCCcEEEeecCCC---CCCCC-CC-------CCCCCCcEEEcccccCCc---
Q 003911 68 KRITRIQIGHQNLQGT----LPSNLQNLTKLERLELQWNSI---SGPLP-SL-------NGLASLEVVMLSNNQFTS--- 129 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~----~~~~~~~l~~L~~L~L~~N~l---~~~~~-~~-------~~l~~L~~L~L~~N~l~~--- 129 (787)
.+++.|+|++|++++. ++..|..+++|++|+|++|.+ ++.+| .+ ..+++|++|+|++|+++.
T Consensus 32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~ 111 (386)
T 2ca6_A 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111 (386)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence 5799999999999876 445688999999999999755 44444 33 789999999999999998
Q ss_pred -CCCccccCCCCCcEEEccCCCCCCCCC----ChhhhcC---------CCCCEEeccCceec-ccCC---CCCCCCCCCC
Q 003911 130 -VPSDFFTGLSSLQSIEIDNNPFSSWEI----PQSLRNA---------SGLQNFSANSANIT-GQIP---SFFGPDEFPG 191 (787)
Q Consensus 130 -~~~~~~~~l~~L~~L~L~~N~l~~~~~----p~~~~~l---------~~L~~L~l~~n~l~-~~~p---~~~~~~~l~~ 191 (787)
..+..+.++++|++|+|++|.+.. .. +..+..+ ++|++|++++|+++ +.++ ..+. .+++
T Consensus 112 ~~l~~~l~~~~~L~~L~L~~n~l~~-~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~--~~~~ 188 (386)
T 2ca6_A 112 EPLIDFLSKHTPLEHLYLHNNGLGP-QAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ--SHRL 188 (386)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHH-HHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH--HCTT
T ss_pred HHHHHHHHhCCCCCEEECcCCCCCH-HHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHH--hCCC
Confidence 355678999999999999999863 22 3334444 99999999999998 4444 3443 6789
Q ss_pred CcEEecccccccc-----CCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccc----cCC-CCCCC
Q 003911 192 LTILHLAFNQLIG-----GLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS----GPL-PDFSG 261 (787)
Q Consensus 192 L~~L~L~~N~l~~-----~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~----~~~-~~~~~ 261 (787)
|++|+|++|+++. ..|.. +..+++|+.|+|++|.++ +.+ ..+..
T Consensus 189 L~~L~L~~n~l~~~g~~~l~~~~--------------------------l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~ 242 (386)
T 2ca6_A 189 LHTVKMVQNGIRPEGIEHLLLEG--------------------------LAYCQELKVLDLQDNTFTHLGSSALAIALKS 242 (386)
T ss_dssp CCEEECCSSCCCHHHHHHHHHTT--------------------------GGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred cCEEECcCCCCCHhHHHHHHHHH--------------------------hhcCCCccEEECcCCCCCcHHHHHHHHHHcc
Confidence 9999999999872 22223 448899999999999995 333 35788
Q ss_pred CCCCCEEecCCCccccc----CCccccC--CCCCCEEEccCCcccc
Q 003911 262 VKQLESLSLRDNFFTGP----VPDSLVK--LESLKIVNMTNNLLQG 301 (787)
Q Consensus 262 l~~L~~L~L~~N~l~~~----~p~~l~~--l~~L~~L~Ls~N~l~~ 301 (787)
+++|++|+|++|+|++. +|..+.. +++|++|+|++|++++
T Consensus 243 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~ 288 (386)
T 2ca6_A 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288 (386)
T ss_dssp CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred CCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCH
Confidence 99999999999999976 5677743 8888888888888764
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-20 Score=189.49 Aligned_cols=154 Identities=19% Similarity=0.262 Sum_probs=139.7
Q ss_pred CCCCCCCCCcccEEEcCC----------CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCc
Q 003911 50 GWSDTDPCKWNHVVCIED----------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLE 118 (787)
Q Consensus 50 ~w~~~~~C~w~gv~C~~~----------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~ 118 (787)
.|.+.+.|+|.+|.|... .+++.|+|++|++++..|..|.++++|++|+|++|+|+..++ .|.++++|+
T Consensus 12 ~~~~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~ 91 (229)
T 3e6j_A 12 ACPSQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91 (229)
T ss_dssp CCCTTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred cCCCCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcC
Confidence 345677899999999742 468999999999999889999999999999999999988877 589999999
Q ss_pred EEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEecc
Q 003911 119 VVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLA 198 (787)
Q Consensus 119 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~ 198 (787)
+|+|++|+|+++++..|..+++|++|+|++|+|+ .+|..+..+++|+.|++++|+|++..+..|. .+++|++|+|+
T Consensus 92 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~--~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~l~ 167 (229)
T 3e6j_A 92 VLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT--ELPRGIERLTHLTHLALDQNQLKSIPHGAFD--RLSSLTHAYLF 167 (229)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC--SCCTTGGGCTTCSEEECCSSCCCCCCTTTTT--TCTTCCEEECT
T ss_pred EEECCCCcCCccChhHhCcchhhCeEeccCCccc--ccCcccccCCCCCEEECCCCcCCccCHHHHh--CCCCCCEEEee
Confidence 9999999999999999999999999999999999 7899999999999999999999988887786 89999999999
Q ss_pred ccccccCCC
Q 003911 199 FNQLIGGLP 207 (787)
Q Consensus 199 ~N~l~~~~p 207 (787)
+|.+.+..+
T Consensus 168 ~N~~~c~c~ 176 (229)
T 3e6j_A 168 GNPWDCECR 176 (229)
T ss_dssp TSCBCTTBG
T ss_pred CCCccCCcc
Confidence 999986544
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.5e-20 Score=196.39 Aligned_cols=175 Identities=19% Similarity=0.331 Sum_probs=135.1
Q ss_pred CCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCE
Q 003911 89 QNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQN 168 (787)
Q Consensus 89 ~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~ 168 (787)
..+++|++|++++|.++.. +.+..+++|++|+|++|+++++++ +.++++|++|+|++|+++. +| .+..+++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~~~-~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~--~~-~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD--LS-SLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC--GG-GGTTCTTCCE
T ss_pred hhcCcccEEEccCCCcccC-hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC--Ch-hhccCCCCCE
Confidence 4567777777777777755 457777778888888888777766 7777888888888887773 33 3777788888
Q ss_pred EeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEecc
Q 003911 169 FSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH 248 (787)
Q Consensus 169 L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~ 248 (787)
|++++|++++. +.+. .+++|++|+|++|++++. .. +..+++|+.|+|+
T Consensus 117 L~L~~n~i~~~--~~l~--~l~~L~~L~l~~n~l~~~--~~--------------------------l~~l~~L~~L~L~ 164 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLV--HLPQLESLYLGNNKITDI--TV--------------------------LSRLTKLDTLSLE 164 (291)
T ss_dssp EECTTSCCCCC--GGGG--GCTTCCEEECCSSCCCCC--GG--------------------------GGGCTTCSEEECC
T ss_pred EECCCCcCCCC--hhhc--CCCCCCEEEccCCcCCcc--hh--------------------------hccCCCCCEEEcc
Confidence 88888887764 2343 788888888888888753 22 3478899999999
Q ss_pred ccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCC
Q 003911 249 SNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP 304 (787)
Q Consensus 249 ~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 304 (787)
+|++++.++ +..+++|+.|+|++|+|++ +| .+..+++|+.|++++|+++..+.
T Consensus 165 ~N~l~~~~~-l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~~~ 217 (291)
T 1h6t_A 165 DNQISDIVP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNKPI 217 (291)
T ss_dssp SSCCCCCGG-GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECCCE
T ss_pred CCccccchh-hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCCcc
Confidence 999988766 8889999999999999984 55 48899999999999999986443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.5e-22 Score=216.77 Aligned_cols=201 Identities=15% Similarity=0.198 Sum_probs=165.9
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCC-CC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEE
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGP-LP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 145 (787)
.+++.|++++|.+.+..+. +..+++|++|+|++|.+++. ++ .+.++++|++|+|++|++++..+..|+.+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 6799999999999977665 67899999999999999874 55 588999999999999999987778899999999999
Q ss_pred ccCC-CCCCCCCChhhhcCCCCCEEeccCc-eeccc-CCCCCCCCCCC-CCcEEeccccc--cc-cCCCcCcccccccce
Q 003911 146 IDNN-PFSSWEIPQSLRNASGLQNFSANSA-NITGQ-IPSFFGPDEFP-GLTILHLAFNQ--LI-GGLPASFSGSQIQSL 218 (787)
Q Consensus 146 L~~N-~l~~~~~p~~~~~l~~L~~L~l~~n-~l~~~-~p~~~~~~~l~-~L~~L~L~~N~--l~-~~~p~~~~~~~l~~L 218 (787)
|++| .+++..++..+..+++|++|++++| .+++. ++..+. .++ +|++|+|++|. ++ +.+|..
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~--~l~~~L~~L~l~~~~~~~~~~~l~~~--------- 217 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVA--HVSETITQLNLSGYRKNLQKSDLSTL--------- 217 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHH--HSCTTCCEEECCSCGGGSCHHHHHHH---------
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHH--hcccCCCEEEeCCCcccCCHHHHHHH---------
Confidence 9999 6774236778999999999999999 99864 455564 789 99999999994 44 233332
Q ss_pred eeccCCCCCcCCCCccccccCccCceEeccccc-ccc-CCCCCCCCCCCCEEecCCCc-ccccCCccccCCCCCCEEEcc
Q 003911 219 WVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA-FSG-PLPDFSGVKQLESLSLRDNF-FTGPVPDSLVKLESLKIVNMT 295 (787)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~Ls 295 (787)
+.++++|++|+|++|. +++ .++.+..+++|++|+|++|. ++......+..+++|++|+|+
T Consensus 218 -----------------~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~ 280 (336)
T 2ast_B 218 -----------------VRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 280 (336)
T ss_dssp -----------------HHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECT
T ss_pred -----------------HhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEecc
Confidence 4478999999999999 664 44568889999999999996 332222367888899999988
Q ss_pred CC
Q 003911 296 NN 297 (787)
Q Consensus 296 ~N 297 (787)
+|
T Consensus 281 ~~ 282 (336)
T 2ast_B 281 GI 282 (336)
T ss_dssp TS
T ss_pred Cc
Confidence 88
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.7e-20 Score=214.73 Aligned_cols=189 Identities=19% Similarity=0.326 Sum_probs=151.4
Q ss_pred EeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCC
Q 003911 74 QIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSS 153 (787)
Q Consensus 74 ~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 153 (787)
.+..+.+...++ +..|++|+.|+|++|.|... +.+..|++|+.|+|++|+|+++++ |..+++|++|+|++|++..
T Consensus 27 ~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~ 101 (605)
T 1m9s_A 27 NLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD 101 (605)
T ss_dssp HTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-TTGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred hccCCCcccccc--hhcCCCCCEEECcCCCCCCC-hHHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC
Confidence 344444443333 45678888888888888765 468888888888888888888876 8888889999999888884
Q ss_pred CCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCc
Q 003911 154 WEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGI 233 (787)
Q Consensus 154 ~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~ 233 (787)
+| .+..+++|+.|+|++|.|++. + .+. .+++|+.|+|++|+|++. ..
T Consensus 102 --l~-~l~~l~~L~~L~Ls~N~l~~l-~-~l~--~l~~L~~L~Ls~N~l~~l--~~------------------------ 148 (605)
T 1m9s_A 102 --LS-SLKDLKKLKSLSLEHNGISDI-N-GLV--HLPQLESLYLGNNKITDI--TV------------------------ 148 (605)
T ss_dssp --CT-TSTTCTTCCEEECTTSCCCCC-G-GGG--GCTTCSEEECCSSCCCCC--GG------------------------
T ss_pred --Ch-hhccCCCCCEEEecCCCCCCC-c-ccc--CCCccCEEECCCCccCCc--hh------------------------
Confidence 34 688888899999999888864 3 344 789999999999998854 22
Q ss_pred cccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCC
Q 003911 234 DVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305 (787)
Q Consensus 234 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 305 (787)
+..+++|+.|+|++|+|++.+| +..+++|+.|+|++|+|++ + +.+..+++|+.|+|++|++++.+..
T Consensus 149 --l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~-l-~~l~~l~~L~~L~L~~N~l~~~p~~ 215 (605)
T 1m9s_A 149 --LSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD-L-RALAGLKNLDVLELFSQECLNKPIN 215 (605)
T ss_dssp --GGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB-C-GGGTTCTTCSEEECCSEEEECCCCC
T ss_pred --hcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCC-C-hHHccCCCCCEEEccCCcCcCCccc
Confidence 4478999999999999998877 8889999999999999995 4 4689999999999999999876543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=9.3e-20 Score=182.03 Aligned_cols=152 Identities=22% Similarity=0.299 Sum_probs=133.9
Q ss_pred EEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC--CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCC
Q 003911 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP--SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (787)
Q Consensus 72 ~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 149 (787)
.+++++++++ .+|..+. ..+++|+|++|+|++.++ .|.++++|++|+|++|+|+++++..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 6778888888 5787775 457899999999999865 4899999999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcC
Q 003911 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKL 229 (787)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~ 229 (787)
+++. ..+..|..+++|++|++++|+|++..|..|. .+++|++|+|++|+|++..|..|.
T Consensus 92 ~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~------------------ 150 (220)
T 2v70_A 92 RLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFI--GLSSVRLLSLYDNQITTVAPGAFD------------------ 150 (220)
T ss_dssp CCCC-CCGGGGTTCSSCCEEECTTSCCCCBCTTSST--TCTTCSEEECTTSCCCCBCTTTTT------------------
T ss_pred ccCc-cCHhHhcCCcCCCEEECCCCcCCeECHhHcC--CCccCCEEECCCCcCCEECHHHhc------------------
Confidence 9996 4566799999999999999999999999987 899999999999999988887764
Q ss_pred CCCccccccCccCceEeccccccccC
Q 003911 230 GGGIDVIQNMTSLKEIWLHSNAFSGP 255 (787)
Q Consensus 230 ~~~~~~~~~l~~L~~L~L~~N~l~~~ 255 (787)
.+++|+.|+|++|.+...
T Consensus 151 --------~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 151 --------TLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp --------TCTTCCEEECCSCCEECS
T ss_pred --------CCCCCCEEEecCcCCcCC
Confidence 678888888888877754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.8e-20 Score=199.89 Aligned_cols=173 Identities=20% Similarity=0.226 Sum_probs=120.1
Q ss_pred EEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCC-CCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCC
Q 003911 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLN-GLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (787)
Q Consensus 72 ~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 149 (787)
.+++++++|+ .+|..+. ..++.|+|++|+|++.++ .|. ++++|++|+|++|+|+++++..|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 5677778887 5777665 458889999999888777 465 8888888888888888888888888888888888888
Q ss_pred CCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcC
Q 003911 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKL 229 (787)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~ 229 (787)
+|+. ..+..|..+++|+.|+|++|+|++..|..|. .+++|++|+|++|
T Consensus 99 ~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~L~~N----------------------------- 146 (361)
T 2xot_A 99 HLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFE--DMAQLQKLYLSQN----------------------------- 146 (361)
T ss_dssp CCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTT--TCTTCCEEECCSS-----------------------------
T ss_pred cCCc-CCHHHhCCCcCCCEEECCCCcccEECHHHhC--CcccCCEEECCCC-----------------------------
Confidence 8774 2233455555555555555555555555443 4444555555444
Q ss_pred CCCccccccCccCceEeccccccccCCCC-C---CCCCCCCEEecCCCcccccCCccccCCCC--CCEEEccCCccc
Q 003911 230 GGGIDVIQNMTSLKEIWLHSNAFSGPLPD-F---SGVKQLESLSLRDNFFTGPVPDSLVKLES--LKIVNMTNNLLQ 300 (787)
Q Consensus 230 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~---~~l~~L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~Ls~N~l~ 300 (787)
+|++.++. | ..+++|+.|+|++|+|++..+..+..++. |+.|+|++|++.
T Consensus 147 ---------------------~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 147 ---------------------QISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp ---------------------CCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred ---------------------cCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 44443333 2 45778888888888888555567777776 478899999886
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.9e-20 Score=214.40 Aligned_cols=181 Identities=20% Similarity=0.302 Sum_probs=142.1
Q ss_pred CCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEe
Q 003911 91 LTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFS 170 (787)
Q Consensus 91 l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~ 170 (787)
+..+..++|..+.+...+ .+..|++|+.|+|++|.|+.++ .|..+++|++|+|++|+|.+ ++. +..+++|+.|+
T Consensus 20 l~~l~~l~l~~~~i~~~~-~~~~L~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~Ls~N~l~~--~~~-l~~l~~L~~L~ 93 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD--IKP-LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHHTTCSCTTSEE-CHHHHTTCCCCBCTTCCCCCCT--TGGGCTTCCEEECTTSCCCC--CGG-GGGCTTCCEEE
T ss_pred HHHHHHHhccCCCccccc-chhcCCCCCEEECcCCCCCCCh--HHccCCCCCEEEeeCCCCCC--Chh-hccCCCCCEEE
Confidence 344566677777777654 3667888999999999999886 38899999999999999985 444 88999999999
Q ss_pred ccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEecccc
Q 003911 171 ANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250 (787)
Q Consensus 171 l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N 250 (787)
|++|.|++. | .+. .+++|++|+|++|+|++. + . +..+++|+.|+|++|
T Consensus 94 Ls~N~l~~l-~-~l~--~l~~L~~L~Ls~N~l~~l-~-~--------------------------l~~l~~L~~L~Ls~N 141 (605)
T 1m9s_A 94 LDENKIKDL-S-SLK--DLKKLKSLSLEHNGISDI-N-G--------------------------LVHLPQLESLYLGNN 141 (605)
T ss_dssp CCSSCCCCC-T-TST--TCTTCCEEECTTSCCCCC-G-G--------------------------GGGCTTCSEEECCSS
T ss_pred CcCCCCCCC-h-hhc--cCCCCCEEEecCCCCCCC-c-c--------------------------ccCCCccCEEECCCC
Confidence 999999863 3 454 789999999999998852 2 2 347889999999999
Q ss_pred ccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeee
Q 003911 251 AFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLD 313 (787)
Q Consensus 251 ~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~ 313 (787)
+|++. +.+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|++. |.+..+.+|+
T Consensus 142 ~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~ 200 (605)
T 1m9s_A 142 KITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLD 200 (605)
T ss_dssp CCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCS
T ss_pred ccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCC
Confidence 99876 678888999999999999986655 88899999999999988764 3333333333
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.9e-19 Score=178.43 Aligned_cols=153 Identities=24% Similarity=0.300 Sum_probs=100.8
Q ss_pred cEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCC-ccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccC
Q 003911 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPS-DFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173 (787)
Q Consensus 95 ~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~ 173 (787)
+.+++++|.++.+++.+. ..+++|+|++|+|+++++ ..|.++++|++|+|++|+|+
T Consensus 14 ~~l~~s~n~l~~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~--------------------- 70 (220)
T 2v70_A 14 TTVDCSNQKLNKIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT--------------------- 70 (220)
T ss_dssp TEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCC---------------------
T ss_pred CEeEeCCCCcccCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCC---------------------
Confidence 366666666665544443 234566666666666532 34555555555555555554
Q ss_pred ceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccc
Q 003911 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253 (787)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (787)
+..+..|. .+++|++|+|++|++++..|..|. ++++|++|+|++|+|+
T Consensus 71 ----~i~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~--------------------------~l~~L~~L~Ls~N~l~ 118 (220)
T 2v70_A 71 ----DIEEGAFE--GASGVNEILLTSNRLENVQHKMFK--------------------------GLESLKTLMLRSNRIT 118 (220)
T ss_dssp ----EECTTTTT--TCTTCCEEECCSSCCCCCCGGGGT--------------------------TCSSCCEEECTTSCCC
T ss_pred ----EECHHHhC--CCCCCCEEECCCCccCccCHhHhc--------------------------CCcCCCEEECCCCcCC
Confidence 44555554 666677777777776655554433 6677777777777777
Q ss_pred cCCC-CCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCccccc
Q 003911 254 GPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302 (787)
Q Consensus 254 ~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 302 (787)
+.+| .|.++++|++|+|++|+|++..|..|..+++|++|+|++|++++.
T Consensus 119 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 119 CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp CBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred eECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 7655 477788888888888888877788888888888888888888754
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=3.7e-19 Score=177.68 Aligned_cols=77 Identities=29% Similarity=0.460 Sum_probs=56.7
Q ss_pred EEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCC
Q 003911 73 IQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF 151 (787)
Q Consensus 73 L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 151 (787)
+++++++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+|+++.+..|.++++|++|+|++|+|
T Consensus 16 v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 92 (220)
T 2v9t_B 16 VDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92 (220)
T ss_dssp EECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred EEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence 444556666 5676665 678888888888887666 577788888888888888877777777777777777777776
Q ss_pred C
Q 003911 152 S 152 (787)
Q Consensus 152 ~ 152 (787)
+
T Consensus 93 ~ 93 (220)
T 2v9t_B 93 T 93 (220)
T ss_dssp C
T ss_pred C
Confidence 6
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=3.7e-19 Score=177.68 Aligned_cols=145 Identities=27% Similarity=0.428 Sum_probs=128.6
Q ss_pred CCcccEEEcCC----------CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccc
Q 003911 57 CKWNHVVCIED----------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNN 125 (787)
Q Consensus 57 C~w~gv~C~~~----------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N 125 (787)
|.|..|.|... ..++.|++++|+|++..+..|..+++|++|+|++|+|++..| .|.++++|++|+|++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 78999999643 369999999999998777899999999999999999999877 7999999999999999
Q ss_pred cCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEecccccccc
Q 003911 126 QFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIG 204 (787)
Q Consensus 126 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~ 204 (787)
+|+.+++..|.++++|++|+|++|+|+. ..|..|..+++|+.|++++|+|++..+..|. .+++|++|+|++|.+..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS--PLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTT--TCTTCCEEECCSSCEEC
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCE-eCHHHcCCCCCCCEEECCCCcCCEECHHHHh--CCCCCCEEEeCCCCcCC
Confidence 9999999999999999999999999996 5577888888888888888888888777775 77888888888888764
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=7.3e-20 Score=191.19 Aligned_cols=169 Identities=24% Similarity=0.384 Sum_probs=150.6
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEcc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 147 (787)
.+++.|++++|++.. ++ .+..+++|++|+|++|+|++.++ +.++++|++|+|++|++++++. +..+++|++|+|+
T Consensus 46 ~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~ 120 (291)
T 1h6t_A 46 NSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLE 120 (291)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCGGG--GTTCTTCCEEECT
T ss_pred CcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCCChh--hccCCCCCEEECC
Confidence 479999999999984 44 58999999999999999999877 9999999999999999999764 9999999999999
Q ss_pred CCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCC
Q 003911 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (787)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~ 227 (787)
+|+++. + ..+..+++|+.|++++|++++. ..+. .+++|++|+|++|++++..| +
T Consensus 121 ~n~i~~--~-~~l~~l~~L~~L~l~~n~l~~~--~~l~--~l~~L~~L~L~~N~l~~~~~--l----------------- 174 (291)
T 1h6t_A 121 HNGISD--I-NGLVHLPQLESLYLGNNKITDI--TVLS--RLTKLDTLSLEDNQISDIVP--L----------------- 174 (291)
T ss_dssp TSCCCC--C-GGGGGCTTCCEEECCSSCCCCC--GGGG--GCTTCSEEECCSSCCCCCGG--G-----------------
T ss_pred CCcCCC--C-hhhcCCCCCCEEEccCCcCCcc--hhhc--cCCCCCEEEccCCccccchh--h-----------------
Confidence 999995 3 5799999999999999999976 4554 89999999999999986544 3
Q ss_pred cCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccc
Q 003911 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTG 277 (787)
Q Consensus 228 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~ 277 (787)
..+++|+.|+|++|.+++. +.+..+++|+.|++++|+++.
T Consensus 175 ---------~~l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 175 ---------AGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp ---------TTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEEEC
T ss_pred ---------cCCCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCcccC
Confidence 3789999999999999975 568999999999999999984
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=9.3e-20 Score=196.81 Aligned_cols=148 Identities=20% Similarity=0.272 Sum_probs=126.7
Q ss_pred CCcccEEEcCC----------CCEEEEEeCCCCccccCCCCCC-CCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEccc
Q 003911 57 CKWNHVVCIED----------KRITRIQIGHQNLQGTLPSNLQ-NLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSN 124 (787)
Q Consensus 57 C~w~gv~C~~~----------~~v~~L~l~~~~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~ 124 (787)
|.|..|.|... ..++.|+|++|+|++..+..+. ++++|++|+|++|+|++.++ .|.++++|++|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 67888999642 3588999999999988788887 99999999999999999887 699999999999999
Q ss_pred ccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCC-CCCCCCcEEeccccccc
Q 003911 125 NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGP-DEFPGLTILHLAFNQLI 203 (787)
Q Consensus 125 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~-~~l~~L~~L~L~~N~l~ 203 (787)
|+|+.+++..|.++++|++|+|++|+|+. ..|..|..+++|+.|+|++|+|++..+..|.. ..+++|++|+|++|+|+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccE-ECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 99999999999999999999999999996 45789999999999999999999866655520 14667777777777776
Q ss_pred cC
Q 003911 204 GG 205 (787)
Q Consensus 204 ~~ 205 (787)
+.
T Consensus 177 ~l 178 (361)
T 2xot_A 177 KL 178 (361)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.4e-19 Score=185.35 Aligned_cols=141 Identities=20% Similarity=0.175 Sum_probs=109.0
Q ss_pred CCcccceeccccceEEEEEEE-eCCcE--EEEEEeecccccc----------------------hhHHHHHHHHHHHHhc
Q 003911 594 NFSEENILGRGGFGTVYKGEL-HDGTK--IAVKRMEAGVISG----------------------KGLTEFKSEIAVLTKV 648 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l 648 (787)
-|++.+.||+|+||.||+|.. .+|+. ||||+++...... .....+.+|+++++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999987 68999 9999975432110 1123688999999999
Q ss_pred CCCcc--ceEEeEEEeCCeeEEEEEecCC-C----CHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCe
Q 003911 649 RHRHL--VALLGHCLDGNEKLLVFEYMPQ-G----TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH-GLAHQSF 720 (787)
Q Consensus 649 ~h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~i 720 (787)
.|+++ +.++++ +..++||||+.+ | +|.+.... .++..+..++.|++.||.||| + .+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~---~gi 192 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQE---AEL 192 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHT---SCE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHH---CCE
Confidence 88764 444432 356899999942 4 66655421 224567789999999999999 7 899
Q ss_pred EEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 721 IHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 721 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
+||||||+|||+++ .++|+|||+|.....
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEETTS
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccCCC
Confidence 99999999999988 999999999987643
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.6e-22 Score=231.18 Aligned_cols=324 Identities=15% Similarity=0.076 Sum_probs=214.6
Q ss_pred CCEEEEEeCCCCcccc----CCCCCCCCCCCcEEEeecCCCCCCCC-----CCCCCCCCcEEEcccccCCcCCCccccCC
Q 003911 68 KRITRIQIGHQNLQGT----LPSNLQNLTKLERLELQWNSISGPLP-----SLNGLASLEVVMLSNNQFTSVPSDFFTGL 138 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~-----~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 138 (787)
.+++.|+|++|.+++. ++..+..+++|++|+|++|.+++... .+.++++|++|+|++|.+.+++ ..+.++
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~-~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV-GFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGH-HHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHH-HHHhhh
Confidence 5799999999998765 44456778999999999999985332 3567899999999999999976 668999
Q ss_pred CCCcEEEccCCCCC--CCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcC-cc-ccc
Q 003911 139 SSLQSIEIDNNPFS--SWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS-FS-GSQ 214 (787)
Q Consensus 139 ~~L~~L~L~~N~l~--~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~-~~~ 214 (787)
++|++|+++.+... ....+..+..+++|+.|+++++. .+.+|..+. .+++|++|+|++|.+++..... +. ..+
T Consensus 243 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~--~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~ 319 (592)
T 3ogk_B 243 ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFP--FAAQIRKLDLLYALLETEDHCTLIQKCPN 319 (592)
T ss_dssp TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGG--GGGGCCEEEETTCCCCHHHHHHHHTTCTT
T ss_pred hHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHh--hcCCCcEEecCCCcCCHHHHHHHHHhCcC
Confidence 99999999864322 11345677788889999888753 345566554 7888999999998876543321 11 145
Q ss_pred ccceeeccCCCCCcCCCCccccccCccCceEecc-----------ccccccC-CCC-CCCCCCCCEEecCCCcccccCCc
Q 003911 215 IQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH-----------SNAFSGP-LPD-FSGVKQLESLSLRDNFFTGPVPD 281 (787)
Q Consensus 215 l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~-----------~N~l~~~-~~~-~~~l~~L~~L~L~~N~l~~~~p~ 281 (787)
|+.|++.+. ....+.+..+..+++|++|+|+ .|.+++. ++. ...+++|++|+++.|++++..+.
T Consensus 320 L~~L~L~~~---~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~ 396 (592)
T 3ogk_B 320 LEVLETRNV---IGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLE 396 (592)
T ss_dssp CCEEEEEGG---GHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHH
T ss_pred CCEEeccCc---cCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHH
Confidence 666666521 1111112233567888888888 3555532 112 33477888888888888877777
Q ss_pred cccC-CCCCCEEEcc----CCcccccCCC------CCCceeeeccccCCCc--cCCCCCCCCchhhHHHHHHHHhCCChh
Q 003911 282 SLVK-LESLKIVNMT----NNLLQGPVPE------FDRSVSLDMAKGSNNF--CLPSPGACDPRLNALLSVVKLMGYPQR 348 (787)
Q Consensus 282 ~l~~-l~~L~~L~Ls----~N~l~~~~p~------~~~~~~L~~l~~~~n~--~~~~~~~~~~~~~~l~~~~~~~~~~~~ 348 (787)
.+.. +++|+.|+|+ .|.+++.+.+ +..+.+|+.++++.+. +.. ..+..
T Consensus 397 ~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~---------~~~~~---------- 457 (592)
T 3ogk_B 397 SIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTD---------LGLSY---------- 457 (592)
T ss_dssp HHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCH---------HHHHH----------
T ss_pred HHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccH---------HHHHH----------
Confidence 7765 8888888886 6677654221 2223344444443210 000 00000
Q ss_pred hhcccCCCCCCCCccccccCCCceEEEEccCCcccc-cCchhhcCCCCCCEEeccccccccc-CCccCcCCCCCCeeecc
Q 003911 349 FAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTG-TISPEFASFKSLQRLILADNNLSGM-IPEGLSVLGALKELDVS 426 (787)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~g~-ip~~l~~l~~L~~L~Ls 426 (787)
.....++|+.|+|++|++++ .++..+..+++|++|+|++|++++. ++..+..+++|++|+|+
T Consensus 458 ----------------~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls 521 (592)
T 3ogk_B 458 ----------------IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQ 521 (592)
T ss_dssp ----------------HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEE
T ss_pred ----------------HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECc
Confidence 00123478888888888876 3555567788888888888887654 34445677888888888
Q ss_pred CCccccc
Q 003911 427 NNQLYGK 433 (787)
Q Consensus 427 ~N~l~g~ 433 (787)
+|++++.
T Consensus 522 ~n~it~~ 528 (592)
T 3ogk_B 522 GYRASMT 528 (592)
T ss_dssp SCBCCTT
T ss_pred CCcCCHH
Confidence 8887754
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.79 E-value=4e-22 Score=230.81 Aligned_cols=225 Identities=13% Similarity=0.138 Sum_probs=131.5
Q ss_pred CCEEEEEeCCCCc---cccCCCCCC------------CCCCCcEEEeecCCCCCCCC-CCCC-CC-CCcEEEccccc-CC
Q 003911 68 KRITRIQIGHQNL---QGTLPSNLQ------------NLTKLERLELQWNSISGPLP-SLNG-LA-SLEVVMLSNNQ-FT 128 (787)
Q Consensus 68 ~~v~~L~l~~~~l---~~~~~~~~~------------~l~~L~~L~L~~N~l~~~~~-~~~~-l~-~L~~L~L~~N~-l~ 128 (787)
.+++.|+|+++.. .+.+|..++ .+++|++|+|++|.+++..+ .+.. ++ +|++|+|++|. ++
T Consensus 73 ~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~ 152 (592)
T 3ogk_B 73 PNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFT 152 (592)
T ss_dssp TTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEE
T ss_pred CCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcC
Confidence 3466777766432 134444444 57778888888777765433 3443 23 37777777765 22
Q ss_pred cC-CCccccCCCCCcEEEccCCCCCCCC---CChhhhcCCCCCEEeccCceec----ccCCCCCCCCCCCCCcEEecccc
Q 003911 129 SV-PSDFFTGLSSLQSIEIDNNPFSSWE---IPQSLRNASGLQNFSANSANIT----GQIPSFFGPDEFPGLTILHLAFN 200 (787)
Q Consensus 129 ~~-~~~~~~~l~~L~~L~L~~N~l~~~~---~p~~~~~l~~L~~L~l~~n~l~----~~~p~~~~~~~l~~L~~L~L~~N 200 (787)
.. .+....++++|++|+|++|.+.+.. ++..+..+++|++|++++|.++ +.++..+. .+++|++|+|++|
T Consensus 153 ~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~--~~~~L~~L~L~~~ 230 (592)
T 3ogk_B 153 TDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR--NCRSLVSVKVGDF 230 (592)
T ss_dssp HHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHH--HCTTCCEEECSSC
T ss_pred HHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHh--hCCCCcEEeccCc
Confidence 10 1112346777778888777765411 3345566777777777777776 23333332 5677777887777
Q ss_pred ccccCCCcCccc-ccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccC
Q 003911 201 QLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPV 279 (787)
Q Consensus 201 ~l~~~~p~~~~~-~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~ 279 (787)
.+.+ +|..+.. .+|+.|.+...............+..+++|+.|+++++.....+..+..+++|++|+|++|.+++..
T Consensus 231 ~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~ 309 (592)
T 3ogk_B 231 EILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETED 309 (592)
T ss_dssp BGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHH
T ss_pred cHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHH
Confidence 7765 3444432 4566666654333322333344556667777777776544433334555677777777777765443
Q ss_pred C-ccccCCCCCCEEEcc
Q 003911 280 P-DSLVKLESLKIVNMT 295 (787)
Q Consensus 280 p-~~l~~l~~L~~L~Ls 295 (787)
. ..+..+++|++|+|+
T Consensus 310 ~~~~~~~~~~L~~L~L~ 326 (592)
T 3ogk_B 310 HCTLIQKCPNLEVLETR 326 (592)
T ss_dssp HHHHHTTCTTCCEEEEE
T ss_pred HHHHHHhCcCCCEEecc
Confidence 3 335667777777777
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.4e-18 Score=174.62 Aligned_cols=152 Identities=16% Similarity=0.267 Sum_probs=90.7
Q ss_pred cEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCC-hhhhcCCCCCEEeccC
Q 003911 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIP-QSLRNASGLQNFSANS 173 (787)
Q Consensus 95 ~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p-~~~~~l~~L~~L~l~~ 173 (787)
+.++.++++++.++..+. ++|++|+|++|+|+++++..|.++++|++|+|++|+|.. +| ..|..+++|+.|+|++
T Consensus 22 ~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~--i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 22 TTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA--LPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC--CCTTTTTTCTTCCEEECCS
T ss_pred CEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCC--cChhhcccCCCcCEEECCC
Confidence 457777777766555443 667777777777777776667777777777777777653 32 3344444455444444
Q ss_pred ceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccc
Q 003911 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253 (787)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (787)
|+|++..+..|. .+++|++|+|++|+|+
T Consensus 98 N~l~~l~~~~~~----------------------------------------------------~l~~L~~L~Ls~N~l~ 125 (229)
T 3e6j_A 98 NQLTVLPSAVFD----------------------------------------------------RLVHLKELFMCCNKLT 125 (229)
T ss_dssp SCCCCCCTTTTT----------------------------------------------------TCTTCCEEECCSSCCC
T ss_pred CcCCccChhHhC----------------------------------------------------cchhhCeEeccCCccc
Confidence 444444443332 4555555555555555
Q ss_pred cCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCccccc
Q 003911 254 GPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302 (787)
Q Consensus 254 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 302 (787)
..+..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++.
T Consensus 126 ~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 126 ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 4444455566666666666666654445566666666666666666543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.6e-19 Score=185.53 Aligned_cols=174 Identities=18% Similarity=0.243 Sum_probs=132.2
Q ss_pred CCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEE
Q 003911 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNF 169 (787)
Q Consensus 90 ~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L 169 (787)
++.+++.+++++|.+++.+ .+..+++|++|++++|+++.++ .+..+++|++|+|++|++++ +|. +..+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~L~~N~i~~--~~~-l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQSLA--GMQFFTNLKELHLSHNQISD--LSP-LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC--CGG-GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc-chhhcCcCcEEECcCCCcccch--HHhhCCCCCEEECCCCccCC--Chh-hccCCCCCEE
Confidence 4556677777777777654 5677778888888888887776 47777888888888888774 444 7778888888
Q ss_pred eccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccc
Q 003911 170 SANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS 249 (787)
Q Consensus 170 ~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~ 249 (787)
++++|++++. |... . ++|++|+|++|++++. + . +..+++|+.|+|++
T Consensus 91 ~L~~N~l~~l-~~~~---~-~~L~~L~L~~N~l~~~-~-~--------------------------l~~l~~L~~L~Ls~ 137 (263)
T 1xeu_A 91 SVNRNRLKNL-NGIP---S-ACLSRLFLDNNELRDT-D-S--------------------------LIHLKNLEILSIRN 137 (263)
T ss_dssp ECCSSCCSCC-TTCC---C-SSCCEEECCSSCCSBS-G-G--------------------------GTTCTTCCEEECTT
T ss_pred ECCCCccCCc-Cccc---c-CcccEEEccCCccCCC-h-h--------------------------hcCcccccEEECCC
Confidence 8888888764 3322 3 7888888888888753 2 2 34788899999999
Q ss_pred cccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCC
Q 003911 250 NAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE 305 (787)
Q Consensus 250 N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 305 (787)
|++++. +.+..+++|+.|+|++|+|++. ..+..+++|+.|++++|++++.+..
T Consensus 138 N~i~~~-~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~~~ 190 (263)
T 1xeu_A 138 NKLKSI-VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEPVK 190 (263)
T ss_dssp SCCCBC-GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECCCEE
T ss_pred CcCCCC-hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCCccc
Confidence 998876 4678889999999999999865 6788899999999999998876443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=5.5e-19 Score=173.29 Aligned_cols=155 Identities=14% Similarity=0.180 Sum_probs=98.5
Q ss_pred CCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCC
Q 003911 112 NGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG 191 (787)
Q Consensus 112 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~ 191 (787)
..+++|++|++++|.++.++ .+..+++|++|++++|.+.. +..+..+++|++|++++|.+++..|..++ .+++
T Consensus 41 ~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~~n~~~~---~~~l~~l~~L~~L~l~~n~l~~~~~~~l~--~l~~ 113 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDLT--GIEYAHNIKDLTINNIHATN---YNPISGLSNLERLRIMGKDVTSDKIPNLS--GLTS 113 (197)
T ss_dssp HHHHTCCEEEEESSCCSCCT--TGGGCTTCSEEEEESCCCSC---CGGGTTCTTCCEEEEECTTCBGGGSCCCT--TCTT
T ss_pred hhcCCccEEeccCCCccChH--HHhcCCCCCEEEccCCCCCc---chhhhcCCCCCEEEeECCccCcccChhhc--CCCC
Confidence 34455555555555555444 25555566666666664432 33556666666666666666666666665 6777
Q ss_pred CcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecC
Q 003911 192 LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLR 271 (787)
Q Consensus 192 L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~ 271 (787)
|++|+|++|++++..|..+ +.+++|++|+|++|.+.+.++.+..+++|+.|+++
T Consensus 114 L~~L~Ls~n~i~~~~~~~l--------------------------~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~ 167 (197)
T 4ezg_A 114 LTLLDISHSAHDDSILTKI--------------------------NTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQ 167 (197)
T ss_dssp CCEEECCSSBCBGGGHHHH--------------------------TTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECT
T ss_pred CCEEEecCCccCcHhHHHH--------------------------hhCCCCCEEEccCCCCccccHhhcCCCCCCEEECC
Confidence 7777777777775555443 36777888888887733334567777888888888
Q ss_pred CCcccccCCccccCCCCCCEEEccCCcccc
Q 003911 272 DNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301 (787)
Q Consensus 272 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 301 (787)
+|++++ ++ .+..+++|++|++++|++.+
T Consensus 168 ~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 168 FDGVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp TBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred CCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 888874 44 67788888888888888754
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.3e-21 Score=222.74 Aligned_cols=59 Identities=17% Similarity=0.330 Sum_probs=40.9
Q ss_pred cCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccc
Q 003911 241 SLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301 (787)
Q Consensus 241 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 301 (787)
.|+.|+|++|+|++.+ .+..+++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++
T Consensus 442 ~L~~L~Ls~n~l~~lp-~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~ 500 (567)
T 1dce_A 442 DVRVLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN 500 (567)
T ss_dssp TCSEEECTTSCCSSCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC
T ss_pred CceEEEecCCCCCCCc-CccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC
Confidence 4667777777777643 3666777777777777777 667777777777777777776664
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.77 E-value=4.3e-22 Score=230.65 Aligned_cols=364 Identities=14% Similarity=0.100 Sum_probs=180.2
Q ss_pred CCEEEEEeCCCCccccCCCCCC-CCCCCcEEEeecC-CCCCC-CCC-CCCCCCCcEEEcccccCCcCCCcccc----CCC
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQ-NLTKLERLELQWN-SISGP-LPS-LNGLASLEVVMLSNNQFTSVPSDFFT----GLS 139 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~-~l~~L~~L~L~~N-~l~~~-~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~----~l~ 139 (787)
.+++.|+|+++.+++..+..+. .+++|++|+|++| .++.. ++. +.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4688888888887776666664 5778888888887 44431 333 34678888888888887765544433 566
Q ss_pred CCcEEEccCCC--CCCCCCChhhhcCCCCCEEeccCc-eecccCCCCCCCCCCCCCcEEeccccc-------cccCCCcC
Q 003911 140 SLQSIEIDNNP--FSSWEIPQSLRNASGLQNFSANSA-NITGQIPSFFGPDEFPGLTILHLAFNQ-------LIGGLPAS 209 (787)
Q Consensus 140 ~L~~L~L~~N~--l~~~~~p~~~~~l~~L~~L~l~~n-~l~~~~p~~~~~~~l~~L~~L~L~~N~-------l~~~~p~~ 209 (787)
+|++|+|++|. +....++..+..+++|++|++++| .+++ +|..+. .+++|++|+++.+. +.+. +..
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~--~~~~L~~L~l~~~~~~~~~~~~~~l-~~~ 260 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQ--RAPQLEELGTGGYTAEVRPDVYSGL-SVA 260 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHH--HCTTCSEEECSBCCCCCCHHHHHHH-HHH
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHh--cCCcceEcccccccCccchhhHHHH-HHH
Confidence 88888888886 221011222345688888888877 4443 555554 67777777754432 2221 111
Q ss_pred ccc-ccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCC-C-CCCCCCCCEEecCCCccccc-CCccccC
Q 003911 210 FSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-D-FSGVKQLESLSLRDNFFTGP-VPDSLVK 285 (787)
Q Consensus 210 ~~~-~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~-~~~l~~L~~L~L~~N~l~~~-~p~~l~~ 285 (787)
+.+ .+|+.|. +... ......+..+..+++|++|+|++|.+++... . +..+++|+.|++++| ++.. ++.....
T Consensus 261 l~~~~~L~~Ls--~~~~-~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~ 336 (594)
T 2p1m_B 261 LSGCKELRCLS--GFWD-AVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLAST 336 (594)
T ss_dssp HHTCTTCCEEE--CCBT-CCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHH
T ss_pred HhcCCCccccc--CCcc-cchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHh
Confidence 111 1222221 0000 0011112223345666666666666543211 1 334556666666655 3321 1222223
Q ss_pred CCCCCEEEcc---------CCcccccCC-CCC-CceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccC
Q 003911 286 LESLKIVNMT---------NNLLQGPVP-EFD-RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 354 (787)
Q Consensus 286 l~~L~~L~Ls---------~N~l~~~~p-~~~-~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 354 (787)
+++|++|+|+ .|.+++... .+. .+.+|+.+....|.+.. ..+..+.........+...+.
T Consensus 337 ~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~---------~~~~~l~~~~~~L~~L~L~~~ 407 (594)
T 2p1m_B 337 CKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTN---------AALITIARNRPNMTRFRLCII 407 (594)
T ss_dssp CTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCH---------HHHHHHHHHCTTCCEEEEEES
T ss_pred CCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCH---------HHHHHHHhhCCCcceeEeecc
Confidence 5555555552 233332100 000 01122222222222110 000000000000000000000
Q ss_pred C--------CCCCC-CccccccCCCceEEEEccCCcccccCchhhcC-CCCCCEEecccccccccCCccC-cCCCCCCee
Q 003911 355 G--------NDPCS-DWIGVTCTKGNITVINFQKMNLTGTISPEFAS-FKSLQRLILADNNLSGMIPEGL-SVLGALKEL 423 (787)
Q Consensus 355 ~--------~~~~~-~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~-l~~L~~L~Ls~N~l~g~ip~~l-~~l~~L~~L 423 (787)
+ ..+.. .........++|+.|+|++ ++++..+..++. +++|+.|+|++|.+++..+..+ ..+++|++|
T Consensus 408 ~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L 486 (594)
T 2p1m_B 408 EPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKL 486 (594)
T ss_dssp STTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEE
T ss_pred cCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEE
Confidence 0 00000 0001122335778888866 666666666665 7778888888888766555444 557788888
Q ss_pred eccCCcccccCC-----CCCCCceeecCCCC
Q 003911 424 DVSNNQLYGKIP-----SFKSNAIVNTDGNP 449 (787)
Q Consensus 424 ~Ls~N~l~g~iP-----~~~~~~~~~~~gn~ 449 (787)
+|++|++++..+ .++.+..+.+.+|+
T Consensus 487 ~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~ 517 (594)
T 2p1m_B 487 EIRDCPFGDKALLANASKLETMRSLWMSSCS 517 (594)
T ss_dssp EEESCSCCHHHHHHTGGGGGGSSEEEEESSC
T ss_pred ECcCCCCcHHHHHHHHHhCCCCCEEeeeCCC
Confidence 888888754322 14455666666653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2e-21 Score=221.22 Aligned_cols=183 Identities=17% Similarity=0.190 Sum_probs=117.0
Q ss_pred CCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEccccc-------------CCcCCCccccCCCCCcEEE-ccCCCCCCC
Q 003911 89 QNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQ-------------FTSVPSDFFTGLSSLQSIE-IDNNPFSSW 154 (787)
Q Consensus 89 ~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~~~l~~L~~L~-L~~N~l~~~ 154 (787)
..+++|+.|+|++|+|+.++++++.+++|+.|++++|. +.+.++..++++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH--
T ss_pred ccCccceeccCChhhHHhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc--
Confidence 56778888888888887655577888888888887665 5566666777777777777 5555443
Q ss_pred CCCh------hhhc--CCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCC
Q 003911 155 EIPQ------SLRN--ASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGN 226 (787)
Q Consensus 155 ~~p~------~~~~--l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~ 226 (787)
.++. .+.. ...|+.|++++|.|++ +|. ++ .+++|++|+|++|+|+ .+|..++
T Consensus 424 ~L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~--~l~~L~~L~Ls~N~l~-~lp~~~~--------------- 483 (567)
T 1dce_A 424 DLRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LE--QLLLVTHLDLSHNRLR-ALPPALA--------------- 483 (567)
T ss_dssp HHHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GG--GGTTCCEEECCSSCCC-CCCGGGG---------------
T ss_pred hhhhhhhhcccccccCccCceEEEecCCCCCC-CcC-cc--ccccCcEeecCccccc-ccchhhh---------------
Confidence 1111 1111 1246666666666665 343 43 5666666666666666 4554433
Q ss_pred CcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccC-CccccCCCCCCEEEccCCcccccCCC
Q 003911 227 AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPV-PDSLVKLESLKIVNMTNNLLQGPVPE 305 (787)
Q Consensus 227 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~ 305 (787)
++++|+.|+|++|+|++. |.+..+++|+.|+|++|+|++.. |..|..+++|+.|+|++|+|++.+|.
T Consensus 484 -----------~l~~L~~L~Ls~N~l~~l-p~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 484 -----------ALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp -----------GCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred -----------cCCCCCEEECCCCCCCCC-cccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 566677777777777663 36666667777777777776554 66666777777777777766665553
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=9.5e-19 Score=171.61 Aligned_cols=154 Identities=14% Similarity=0.203 Sum_probs=92.6
Q ss_pred CCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCE
Q 003911 89 QNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQN 168 (787)
Q Consensus 89 ~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~ 168 (787)
+.+++|++|++++|.|+..+ .+..+++|++|++++|.++.++ .+..+++|++|+|++|+++. ..|..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~l~~n~l~~-~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATNYN--PISGLSNLERLRIMGKDVTS-DKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCSCCG--GGTTCTTCCEEEEECTTCBG-GGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCCcch--hhhcCCCCCEEEeECCccCc-ccChhhcCCCCCCE
Confidence 34455666666666665332 5556666666666666554443 35566666666666666654 34555666666666
Q ss_pred EeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEecc
Q 003911 169 FSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH 248 (787)
Q Consensus 169 L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~ 248 (787)
|++++|.+++..|..++ .+++|++|+|++|++.+.+| . +..+++|++|+++
T Consensus 117 L~Ls~n~i~~~~~~~l~--~l~~L~~L~L~~n~~i~~~~-~--------------------------l~~l~~L~~L~l~ 167 (197)
T 4ezg_A 117 LDISHSAHDDSILTKIN--TLPKVNSIDLSYNGAITDIM-P--------------------------LKTLPELKSLNIQ 167 (197)
T ss_dssp EECCSSBCBGGGHHHHT--TCSSCCEEECCSCTBCCCCG-G--------------------------GGGCSSCCEEECT
T ss_pred EEecCCccCcHhHHHHh--hCCCCCEEEccCCCCccccH-h--------------------------hcCCCCCCEEECC
Confidence 66666666665555554 66777777777776222333 2 3366777777777
Q ss_pred ccccccCCCCCCCCCCCCEEecCCCccc
Q 003911 249 SNAFSGPLPDFSGVKQLESLSLRDNFFT 276 (787)
Q Consensus 249 ~N~l~~~~~~~~~l~~L~~L~L~~N~l~ 276 (787)
+|++++.. .+..+++|+.|++++|+|.
T Consensus 168 ~n~i~~~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 168 FDGVHDYR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp TBCCCCCT-TGGGCSSCCEEEECBC---
T ss_pred CCCCcChH-HhccCCCCCEEEeeCcccC
Confidence 77777543 6667777777777777765
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-18 Score=178.99 Aligned_cols=167 Identities=14% Similarity=0.246 Sum_probs=141.0
Q ss_pred EEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCC
Q 003911 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (787)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 149 (787)
++.++++++++++.. .+..+++|++|++++|+|+... .+..+++|++|+|++|+|+++++ |.++++|++|+|++|
T Consensus 21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N 95 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRN 95 (263)
T ss_dssp HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSS
T ss_pred HHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCC
Confidence 455667778877443 5788999999999999998654 78899999999999999999887 899999999999999
Q ss_pred CCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcC
Q 003911 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKL 229 (787)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~ 229 (787)
+++. +|.... ++|+.|++++|++++. + .+. .+++|++|+|++|++++. | .
T Consensus 96 ~l~~--l~~~~~--~~L~~L~L~~N~l~~~-~-~l~--~l~~L~~L~Ls~N~i~~~-~-~-------------------- 145 (263)
T 1xeu_A 96 RLKN--LNGIPS--ACLSRLFLDNNELRDT-D-SLI--HLKNLEILSIRNNKLKSI-V-M-------------------- 145 (263)
T ss_dssp CCSC--CTTCCC--SSCCEEECCSSCCSBS-G-GGT--TCTTCCEEECTTSCCCBC-G-G--------------------
T ss_pred ccCC--cCcccc--CcccEEEccCCccCCC-h-hhc--CcccccEEECCCCcCCCC-h-H--------------------
Confidence 9984 554333 8999999999999875 3 354 899999999999999854 2 2
Q ss_pred CCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCccccc
Q 003911 230 GGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGP 278 (787)
Q Consensus 230 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~ 278 (787)
+..+++|+.|+|++|++++. +.+..+++|+.|++++|++++.
T Consensus 146 ------l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 146 ------LGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp ------GGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred ------HccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 34789999999999999987 7789999999999999999954
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=8.3e-20 Score=214.43 Aligned_cols=225 Identities=18% Similarity=0.126 Sum_probs=114.2
Q ss_pred CCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEec
Q 003911 92 TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSA 171 (787)
Q Consensus 92 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l 171 (787)
+.++.|+|.+|.+..... ..|+.++|++|.|.++ +++.|++. ..|..+..++.|+.|+|
T Consensus 173 ~~~~~l~L~~n~~~~~~~-----~~l~~l~Ls~~~i~~~--------------~~~~n~~~--~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 173 PLTPKIELFANGKDEANQ-----ALLQHKKLSQYSIDED--------------DDIENRMV--MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CccceEEeeCCCCCcchh-----hHhhcCccCcccccCc--------------ccccccee--cChhhhccCCCCcEEEC
Confidence 557888888888876433 3356677777776543 45567766 56888999999999999
Q ss_pred cCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccc
Q 003911 172 NSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251 (787)
Q Consensus 172 ~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 251 (787)
++|.+. .+|..+. .+++|++|+|++|+|+ .+|..|. ++++|+.|+|++|+
T Consensus 232 s~n~l~-~l~~~~~--~l~~L~~L~Ls~N~l~-~lp~~~~--------------------------~l~~L~~L~Ls~N~ 281 (727)
T 4b8c_D 232 SNLQIF-NISANIF--KYDFLTRLYLNGNSLT-ELPAEIK--------------------------NLSNLRVLDLSHNR 281 (727)
T ss_dssp TTSCCS-CCCGGGG--GCCSCSCCBCTTSCCS-CCCGGGG--------------------------GGTTCCEEECTTSC
T ss_pred CCCCCC-CCChhhc--CCCCCCEEEeeCCcCc-ccChhhh--------------------------CCCCCCEEeCcCCc
Confidence 999998 4555444 7999999999999999 7776654 89999999999999
Q ss_pred cccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCc
Q 003911 252 FSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDP 331 (787)
Q Consensus 252 l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~ 331 (787)
|+.++..|.++++|++|+|++|.|+ .+|..|..+++|++|+|++|+|++.+|.......+
T Consensus 282 l~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~------------------- 341 (727)
T 4b8c_D 282 LTSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSV------------------- 341 (727)
T ss_dssp CSSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHH-------------------
T ss_pred CCccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcch-------------------
Confidence 9976667999999999999999998 88989999999999999999999877752111100
Q ss_pred hhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccc-------
Q 003911 332 RLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADN------- 404 (787)
Q Consensus 332 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N------- 404 (787)
....|+|++|.++|.+|.. |+.|++++|
T Consensus 342 ---------------------------------------~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~ 376 (727)
T 4b8c_D 342 ---------------------------------------TGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREY 376 (727)
T ss_dssp ---------------------------------------HHHHHHHHHCCCCCCCCCC----------------------
T ss_pred ---------------------------------------hhhHHhhccCcccCcCccc------cceeEeeccccccccc
Confidence 1112556777777777754 345556655
Q ss_pred -cccccCCccCcCCCCCCeeeccCCcccc
Q 003911 405 -NLSGMIPEGLSVLGALKELDVSNNQLYG 432 (787)
Q Consensus 405 -~l~g~ip~~l~~l~~L~~L~Ls~N~l~g 432 (787)
.|.+.++..+..+..+....+++|-+.+
T Consensus 377 ~~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 377 DSLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp -------------------------CCCG
T ss_pred CCccccccchhhcccccceeeeecccccc
Confidence 4444455555666667777777777654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=9.7e-18 Score=163.54 Aligned_cols=131 Identities=21% Similarity=0.285 Sum_probs=108.4
Q ss_pred EEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCC--CCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccC
Q 003911 71 TRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS--LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (787)
Q Consensus 71 ~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 148 (787)
+.+++++++++ .+|..+.. +|++|+|++|+|++.++. |.++++|++|+|++|+|+++++..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 35677777885 78877764 899999999999988773 88999999999999999999888899999999999999
Q ss_pred CCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCC
Q 003911 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLP 207 (787)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p 207 (787)
|+|++ ..|..|..+++|++|++++|+|++.+|..|. .+++|++|+|++|.+++..+
T Consensus 88 N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFE--HLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCE-ECSSSSTTCTTCCEEECCSSCCCEECTTSST--TCTTCCEEECTTCCBCCSGG
T ss_pred CcCCc-cCHHHhcCCCCCCEEECCCCcCCeeCHHHhh--cCCCCCEEEeCCCCccCcCc
Confidence 99986 4456688888888888888888888888776 78888888888888876544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=3.7e-17 Score=159.38 Aligned_cols=124 Identities=21% Similarity=0.403 Sum_probs=108.8
Q ss_pred CCcccEEEcCC----------CCEEEEEeCCCCccccCCC-CCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEccc
Q 003911 57 CKWNHVVCIED----------KRITRIQIGHQNLQGTLPS-NLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSN 124 (787)
Q Consensus 57 C~w~gv~C~~~----------~~v~~L~l~~~~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~ 124 (787)
|.|..+.|... .+++.|++++|++++..+. .|+.+++|++|+|++|+|++.+| .|.++++|++|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 78999999643 3788999999999876664 48999999999999999999877 699999999999999
Q ss_pred ccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCC
Q 003911 125 NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP 181 (787)
Q Consensus 125 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p 181 (787)
|+|+++++..|.++++|++|+|++|+|++ ..|..+..+++|++|++++|.+++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCE-ECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCe-eCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 99999999999999999999999999997 668889999999999999999987654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.71 E-value=2e-20 Score=216.64 Aligned_cols=321 Identities=14% Similarity=0.133 Sum_probs=188.9
Q ss_pred CCEEEEEeCCC-Ccccc-CCCCCCCCCCCcEEEeecCCCCCCCC----C-CCCCCCCcEEEcccccCCcCCCcc----cc
Q 003911 68 KRITRIQIGHQ-NLQGT-LPSNLQNLTKLERLELQWNSISGPLP----S-LNGLASLEVVMLSNNQFTSVPSDF----FT 136 (787)
Q Consensus 68 ~~v~~L~l~~~-~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~----~-~~~l~~L~~L~L~~N~l~~~~~~~----~~ 136 (787)
.+++.|+|+++ .++.. ++..+.++++|++|+|++|.+++..+ . ...+++|++|+|++|. ..+.... +.
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~ 208 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALERLVT 208 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHHHHHH
Confidence 58999999998 55543 44445589999999999999877443 2 3367899999999997 3333333 34
Q ss_pred CCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCce-------eccc-----------------------CCCCCCC
Q 003911 137 GLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN-------ITGQ-----------------------IPSFFGP 186 (787)
Q Consensus 137 ~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~-------l~~~-----------------------~p~~~~~ 186 (787)
++++|++|+|++|.... .+|..+..+++|+.|++..+. +.+. ++..+.
T Consensus 209 ~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~- 286 (594)
T 2p1m_B 209 RCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYS- 286 (594)
T ss_dssp HCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHH-
T ss_pred hCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHH-
Confidence 56999999999983222 467778888888888865442 2211 111111
Q ss_pred CCCCCCcEEeccccccccCCCcC-cc-cccccceeeccCCCCCcCCCCccccccCccCceEeccc---------cccccC
Q 003911 187 DEFPGLTILHLAFNQLIGGLPAS-FS-GSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHS---------NAFSGP 255 (787)
Q Consensus 187 ~~l~~L~~L~L~~N~l~~~~p~~-~~-~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~---------N~l~~~ 255 (787)
.+++|++|+|++|.+++..... +. ..+|+.|++.++. ...+.......+++|++|+|++ |.+++.
T Consensus 287 -~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~~---~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~ 362 (594)
T 2p1m_B 287 -VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYI---EDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQ 362 (594)
T ss_dssp -HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGGG---HHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHH
T ss_pred -hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCcc---CHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHH
Confidence 3456666666666654322111 11 1345555554330 0001111122355666666522 233321
Q ss_pred CC-CC-CCCCCCCEEecCCCcccccCCcccc-CCCCCCEEEcc--C----CcccccCCC------CCCceeeeccccCCC
Q 003911 256 LP-DF-SGVKQLESLSLRDNFFTGPVPDSLV-KLESLKIVNMT--N----NLLQGPVPE------FDRSVSLDMAKGSNN 320 (787)
Q Consensus 256 ~~-~~-~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls--~----N~l~~~~p~------~~~~~~L~~l~~~~n 320 (787)
.. .+ .++++|+.|+++.|++++..+..+. .+++|+.|+|+ + |.+++.+.. +..+.+|+.++++++
T Consensus 363 ~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~~ 442 (594)
T 2p1m_B 363 GLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGL 442 (594)
T ss_dssp HHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCSS
T ss_pred HHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecCc
Confidence 10 11 1255666666666666655444444 36666666666 3 344421110 112223333443331
Q ss_pred ccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCcccccc-CCCceEEEEccCCcccccCchhh-cCCCCCCE
Q 003911 321 FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTC-TKGNITVINFQKMNLTGTISPEF-ASFKSLQR 398 (787)
Q Consensus 321 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~ 398 (787)
. .. . ...... ..++|+.|+|++|.+++..+..+ ..+++|+.
T Consensus 443 l-~~---------~---------------------------~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~ 485 (594)
T 2p1m_B 443 L-TD---------K---------------------------VFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRK 485 (594)
T ss_dssp C-CH---------H---------------------------HHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCE
T ss_pred c-cH---------H---------------------------HHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCE
Confidence 0 00 0 000011 14589999999999988766666 77999999
Q ss_pred EecccccccccCCc-cCcCCCCCCeeeccCCcccc
Q 003911 399 LILADNNLSGMIPE-GLSVLGALKELDVSNNQLYG 432 (787)
Q Consensus 399 L~Ls~N~l~g~ip~-~l~~l~~L~~L~Ls~N~l~g 432 (787)
|+|++|++++..+. .+..+++|++|++++|+++.
T Consensus 486 L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 486 LEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp EEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred EECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 99999999765544 44568999999999999853
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.69 E-value=3.6e-17 Score=155.87 Aligned_cols=137 Identities=18% Similarity=0.191 Sum_probs=123.0
Q ss_pred CCEEEEEeCCCCcc-ccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEc
Q 003911 68 KRITRIQIGHQNLQ-GTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (787)
Q Consensus 68 ~~v~~L~l~~~~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (787)
.+++.|++++|+++ +.+|..+..+++|++|+|++|.|++. +.+..+++|++|+|++|++++.++..+.++++|++|+|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 57999999999998 88999999999999999999999988 88999999999999999999988888888999999999
Q ss_pred cCCCCCCCCCChhhhcCCCCCEEeccCceecccCC---CCCCCCCCCCCcEEeccccccccCCCc
Q 003911 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP---SFFGPDEFPGLTILHLAFNQLIGGLPA 208 (787)
Q Consensus 147 ~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p---~~~~~~~l~~L~~L~L~~N~l~~~~p~ 208 (787)
++|+++++..+..+..+++|+.|++++|.+++..+ ..+. .+++|++|++++|.+. .+|.
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~--~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFK--LLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHT--TCSSCCEETTEETTSC-BCCS
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHH--hCccCcEecCCCCChh-hccc
Confidence 99999953333789999999999999999998766 4665 8999999999999987 4443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.6e-16 Score=152.78 Aligned_cols=134 Identities=21% Similarity=0.356 Sum_probs=115.2
Q ss_pred CCcccEEEcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccc
Q 003911 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFF 135 (787)
Q Consensus 57 C~w~gv~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~ 135 (787)
|.|.+|.|.. ++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+|+++++..|
T Consensus 7 C~~~~l~~~~-----------~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 72 (177)
T 2o6r_A 7 CSGTEIRCNS-----------KGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVF 72 (177)
T ss_dssp EETTEEECCS-----------SCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT
T ss_pred eCCCEEEecC-----------CCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHc
Confidence 6787777753 4455 4565544 789999999999998877 57999999999999999999999999
Q ss_pred cCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCC
Q 003911 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLP 207 (787)
Q Consensus 136 ~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p 207 (787)
.++++|++|+|++|+++. ..+..+..+++|++|++++|++++.++..+. .+++|++|+|++|.+.+..|
T Consensus 73 ~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 73 DKLTKLTILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFD--RLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTT--TCTTCCEEECCSSCBCCCHH
T ss_pred cCCCccCEEECCCCCccc-cCHHHhhCCcccCEEECcCCcceEeCHHHhc--CCcccCEEEecCCCeeccCc
Confidence 999999999999999995 4455688999999999999999988777775 89999999999999997655
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.9e-17 Score=175.63 Aligned_cols=150 Identities=13% Similarity=0.122 Sum_probs=105.9
Q ss_pred HHHHhhcCCCcccceeccccceEEEEEEEeCCcEEEEEEeeccccc------------chhHH--------HHHHHHHHH
Q 003911 586 QVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS------------GKGLT--------EFKSEIAVL 645 (787)
Q Consensus 586 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~~--------~~~~E~~~l 645 (787)
..+..-..-|++.+.||+|++|.||+|...+|+.||||+++..... ..... ...+|...+
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 3333333449999999999999999999889999999987642111 00111 124566777
Q ss_pred HhcCCCccceEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC
Q 003911 646 TKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDL 725 (787)
Q Consensus 646 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl 725 (787)
.++.+.++....-+... ..++||||++|++|.++. ..+....++.|++.+|.|||. .|||||||
T Consensus 168 ~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~-----------~~~~~~~l~~qll~~l~~lH~---~gIVHrDL 231 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVS-----------SVPDPASLYADLIALILRLAK---HGLIHGDF 231 (397)
T ss_dssp HHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCC-----------CCSCHHHHHHHHHHHHHHHHH---TTEECSCC
T ss_pred HHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhc-----------ccHHHHHHHHHHHHHHHHHHH---CCCcCCCC
Confidence 77754444322222222 247999999998885432 112345688999999999997 89999999
Q ss_pred CCCCEEECCCC----------cEEEeecccceecCC
Q 003911 726 KPSNILLGDDM----------RAKVADFGLVRLAPE 751 (787)
Q Consensus 726 kp~NIll~~~~----------~~kl~DFG~a~~~~~ 751 (787)
||.|||+++++ .+.|+||+-+.....
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccCCC
Confidence 99999998776 389999998765543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=4e-16 Score=152.01 Aligned_cols=127 Identities=19% Similarity=0.315 Sum_probs=114.9
Q ss_pred EEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCC
Q 003911 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF 151 (787)
Q Consensus 72 ~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 151 (787)
.+++++++++ .+|..+. ++|++|+|++|+|+.+++.|.++++|++|+|++|+|+++++..|.++++|++|+|++|+|
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 5677788888 7787665 689999999999997666899999999999999999999999999999999999999999
Q ss_pred CCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEecccccccc
Q 003911 152 SSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIG 204 (787)
Q Consensus 152 ~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~ 204 (787)
+. ..|..|..+++|++|+|++|+|++..+..|. .+++|++|+|++|.+..
T Consensus 91 ~~-i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 91 RC-IPPRTFDGLKSLRLLSLHGNDISVVPEGAFN--DLSALSHLAIGANPLYC 140 (193)
T ss_dssp CB-CCTTTTTTCTTCCEEECCSSCCCBCCTTTTT--TCTTCCEEECCSSCEEC
T ss_pred CE-eCHHHhCCCCCCCEEECCCCCCCeeChhhhh--cCccccEEEeCCCCeec
Confidence 96 4567899999999999999999988887886 89999999999999975
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.8e-16 Score=150.94 Aligned_cols=136 Identities=18% Similarity=0.178 Sum_probs=88.2
Q ss_pred CCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccce
Q 003911 139 SSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSL 218 (787)
Q Consensus 139 ~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L 218 (787)
++|++|+|++|+++...+|..+..+++|+.|++++|.+++. ..+. .+++|++|+|++|++++.+|..+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~--~l~~L~~L~Ls~N~l~~~~~~~~-------- 91 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLP--KLPKLKKLELSENRIFGGLDMLA-------- 91 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCC--CCSSCCEEEEESCCCCSCCCHHH--------
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhc--cCCCCCEEECcCCcCchHHHHHH--------
Confidence 34444444444444223444445555555555555555544 3443 67777777777777776555443
Q ss_pred eeccCCCCCcCCCCccccccCccCceEeccccccccCC--CCCCCCCCCCEEecCCCcccccCC---ccccCCCCCCEEE
Q 003911 219 WVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL--PDFSGVKQLESLSLRDNFFTGPVP---DSLVKLESLKIVN 293 (787)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~l~~L~~L~L~~N~l~~~~p---~~l~~l~~L~~L~ 293 (787)
.++++|+.|+|++|.+++.+ +.+..+++|+.|++++|++++..+ ..+..+++|++|+
T Consensus 92 ------------------~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~ 153 (168)
T 2ell_A 92 ------------------EKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153 (168)
T ss_dssp ------------------HHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEET
T ss_pred ------------------hhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEec
Confidence 25778888888888887754 467778888888888888885444 4788888888888
Q ss_pred ccCCcccccCC
Q 003911 294 MTNNLLQGPVP 304 (787)
Q Consensus 294 Ls~N~l~~~~p 304 (787)
+++|.+...+.
T Consensus 154 l~~n~~~~~~~ 164 (168)
T 2ell_A 154 GYDREDQEAPD 164 (168)
T ss_dssp TEETTSCBCCS
T ss_pred CCCCChhhccc
Confidence 88888775543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.65 E-value=6.5e-17 Score=150.74 Aligned_cols=129 Identities=16% Similarity=0.204 Sum_probs=110.5
Q ss_pred CCEEEEEeCCCCcc-ccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEc
Q 003911 68 KRITRIQIGHQNLQ-GTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (787)
Q Consensus 68 ~~v~~L~l~~~~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (787)
.+++.|++++|+++ +.+|..+..+++|++|+|++|+|++. +.+.++++|++|+|++|++++..+..+.++++|++|+|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 46889999999998 88898889999999999999999887 77889999999999999999977777888999999999
Q ss_pred cCCCCCCCCCChhhhcCCCCCEEeccCceecccCC---CCCCCCCCCCCcEEeccc
Q 003911 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP---SFFGPDEFPGLTILHLAF 199 (787)
Q Consensus 147 ~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p---~~~~~~~l~~L~~L~L~~ 199 (787)
++|++++...+..+..+++|++|++++|.+++..+ ..+. .+++|++|++++
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~--~l~~L~~L~l~d 149 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFK--LLPQLTYLDGYD 149 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHH--HCTTCCEETTBC
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHH--HCCCcccccCCC
Confidence 99999853234788999999999999999987766 4564 788999998863
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.8e-15 Score=147.45 Aligned_cols=84 Identities=24% Similarity=0.327 Sum_probs=47.3
Q ss_pred cEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEec
Q 003911 118 EVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHL 197 (787)
Q Consensus 118 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L 197 (787)
+++++++|+++.+|...+ ++|++|+|++|+|+ .+|..|..+++|+.|++++|.|++..+..|. .+++|++|+|
T Consensus 13 ~~l~~~~~~l~~ip~~~~---~~l~~L~L~~n~i~--~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~--~l~~L~~L~L 85 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP---RDVTELYLDGNQFT--LVPKELSNYKHLTLIDLSNNRISTLSNQSFS--NMTQLLTLIL 85 (193)
T ss_dssp TEEECTTSCCSSCCSCCC---TTCCEEECCSSCCC--SCCGGGGGCTTCCEEECCSSCCCCCCTTTTT--TCTTCCEEEC
T ss_pred CEEEcCCCCCCcCCCCCC---CCCCEEECCCCcCc--hhHHHhhcccCCCEEECCCCcCCEeCHhHcc--CCCCCCEEEC
Confidence 455566666665554422 35666666666665 4555566565666666655555555555554 5555555555
Q ss_pred cccccccCCCc
Q 003911 198 AFNQLIGGLPA 208 (787)
Q Consensus 198 ~~N~l~~~~p~ 208 (787)
++|+|++..|.
T Consensus 86 s~N~l~~i~~~ 96 (193)
T 2wfh_A 86 SYNRLRCIPPR 96 (193)
T ss_dssp CSSCCCBCCTT
T ss_pred CCCccCEeCHH
Confidence 55555544443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.9e-15 Score=145.25 Aligned_cols=133 Identities=21% Similarity=0.322 Sum_probs=111.0
Q ss_pred CcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccC
Q 003911 94 LERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173 (787)
Q Consensus 94 L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~ 173 (787)
.+.+++++|+++..+..+. ++|++|+|++|+++++++..|.++++|++|+|++|+++. ..+..+..+++|++|++++
T Consensus 9 ~~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceE-eChhHccCCCccCEEECCC
Confidence 4789999999998765543 789999999999999999999999999999999999995 3445678999999999999
Q ss_pred ceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccc
Q 003911 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253 (787)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (787)
|+|++.++..|. .+++|++|+|++|++++..+..+. .+++|++|+|++|.+.
T Consensus 86 N~l~~~~~~~~~--~l~~L~~L~l~~N~l~~~~~~~~~--------------------------~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 86 NKLQSLPNGVFD--KLTQLKELALDTNQLKSVPDGIFD--------------------------RLTSLQKIWLHTNPWD 137 (177)
T ss_dssp SCCCCCCTTTTT--TCTTCCEEECCSSCCSCCCTTTTT--------------------------TCTTCCEEECCSSCBC
T ss_pred CCccccCHHHhh--CCcccCEEECcCCcceEeCHHHhc--------------------------CCcccCEEEecCCCee
Confidence 999988888776 899999999999999865554433 6777777777777776
Q ss_pred cCCC
Q 003911 254 GPLP 257 (787)
Q Consensus 254 ~~~~ 257 (787)
+..+
T Consensus 138 ~~~~ 141 (177)
T 2o6r_A 138 CSCP 141 (177)
T ss_dssp CCHH
T ss_pred ccCc
Confidence 5443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.62 E-value=2.4e-16 Score=167.81 Aligned_cols=229 Identities=11% Similarity=0.098 Sum_probs=122.6
Q ss_pred cCCCccccC--------CCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEecccc
Q 003911 129 SVPSDFFTG--------LSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFN 200 (787)
Q Consensus 129 ~~~~~~~~~--------l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N 200 (787)
.+++.+|.+ +++|++|+|.+ .++. .-+.+|.++++|+.|++.+|.++...+..|. ...++..+.+..+
T Consensus 83 ~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~-I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~--~~~~l~~l~~~~~ 158 (329)
T 3sb4_A 83 FVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKN-IEDAAFKGCDNLKICQIRKKTAPNLLPEALA--DSVTAIFIPLGSS 158 (329)
T ss_dssp EECTTTTEEEETTEEEECTTCCC-CBCT-TCCE-ECTTTTTTCTTCCEEEBCCSSCCEECTTSSC--TTTCEEEECTTCT
T ss_pred ccCHHHhcccccccccccCCCcEEECCc-cccc-hhHHHhhcCcccceEEcCCCCccccchhhhc--CCCceEEecCcch
Confidence 445556666 66666666666 5553 2234566666666666666666655555554 4555555554442
Q ss_pred cc----ccCCCcCccc-cccc-ceeeccCCCCCcCCCCc-cccccCccCceEeccccccccCCCCC-CCCCCCCEEecCC
Q 003911 201 QL----IGGLPASFSG-SQIQ-SLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSNAFSGPLPDF-SGVKQLESLSLRD 272 (787)
Q Consensus 201 ~l----~~~~p~~~~~-~~l~-~L~~~~~~~~~~~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~-~~l~~L~~L~L~~ 272 (787)
.. .......|.+ ..++ .+.+.. ...+.... ..--...+++.+.+.++-.......+ ..+++|+.|+|++
T Consensus 159 ~~~~~~~~i~~~~f~~~~~L~~~i~~~~---~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~ 235 (329)
T 3sb4_A 159 DAYRFKNRWEHFAFIEGEPLETTIQVGA---MGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISK 235 (329)
T ss_dssp HHHHTSTTTTTSCEEESCCCEEEEEECT---TCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTT
T ss_pred hhhhccccccccccccccccceeEEecC---CCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCC
Confidence 21 1111111211 0011 000000 00000000 00001233344444333111111111 1257788888888
Q ss_pred CcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcc
Q 003911 273 NFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAEN 352 (787)
Q Consensus 273 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 352 (787)
|+++...+..|.++++|+.|+|++| ++...+.
T Consensus 236 n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~----------------------------------------------- 267 (329)
T 3sb4_A 236 TNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQR----------------------------------------------- 267 (329)
T ss_dssp BCCCEECTTTTTTCTTCCEEECCTT-CCEECTT-----------------------------------------------
T ss_pred CCcceecHhhhhCCCCCCEEECCcc-cceehHH-----------------------------------------------
Confidence 8887555566788888888888777 5433322
Q ss_pred cCCCCCCCCccccccCCCceE-EEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeec
Q 003911 353 WKGNDPCSDWIGVTCTKGNIT-VINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDV 425 (787)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~L~-~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~L 425 (787)
.+....+|+ .|++.+ +++..-+..|.++++|+.|+|+.|+++..-+..|.++++|+.++.
T Consensus 268 ------------aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 268 ------------VFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp ------------TTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred ------------HhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 122233666 777776 666666778888888888888888888666678888888888763
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=7.6e-16 Score=143.43 Aligned_cols=129 Identities=16% Similarity=0.152 Sum_probs=111.7
Q ss_pred CCCCCcEEEeecCCCC-CCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCC
Q 003911 90 NLTKLERLELQWNSIS-GPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ 167 (787)
Q Consensus 90 ~l~~L~~L~L~~N~l~-~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~ 167 (787)
..++|++|++++|.++ +.+| .+..+++|++|+|++|+++++ ..|.++++|++|+|++|++++ .+|..+..+++|+
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~ 91 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSG-GLEVLAEKCPNLT 91 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCS-CTHHHHHHCTTCC
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccc-hHHHHhhhCCCCC
Confidence 3478999999999998 5555 689999999999999999998 669999999999999999996 4888888999999
Q ss_pred EEeccCceeccc-CCCCCCCCCCCCCcEEeccccccccCCC---cCcccccccceeeccCCCCCcCCCCccccccCccCc
Q 003911 168 NFSANSANITGQ-IPSFFGPDEFPGLTILHLAFNQLIGGLP---ASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLK 243 (787)
Q Consensus 168 ~L~l~~n~l~~~-~p~~~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~ 243 (787)
+|++++|.+++. .+..+. .+++|++|++++|++++..+ .. +..+++|+
T Consensus 92 ~L~ls~N~i~~~~~~~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~--------------------------~~~l~~L~ 143 (149)
T 2je0_A 92 HLNLSGNKIKDLSTIEPLK--KLENLKSLDLFNCEVTNLNDYRENV--------------------------FKLLPQLT 143 (149)
T ss_dssp EEECTTSCCCSHHHHGGGG--GCTTCCEEECTTCGGGGSTTHHHHH--------------------------HHHCTTCC
T ss_pred EEECCCCcCCChHHHHHHh--hCCCCCEEeCcCCcccchHHHHHHH--------------------------HHHCCCcc
Confidence 999999999985 346665 89999999999999997655 23 44788999
Q ss_pred eEeccc
Q 003911 244 EIWLHS 249 (787)
Q Consensus 244 ~L~L~~ 249 (787)
.|++++
T Consensus 144 ~L~l~d 149 (149)
T 2je0_A 144 YLDGYD 149 (149)
T ss_dssp EETTBC
T ss_pred cccCCC
Confidence 998864
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=2.8e-15 Score=143.91 Aligned_cols=130 Identities=15% Similarity=0.250 Sum_probs=113.8
Q ss_pred CCCEEEEEeCCCCccccCCCCCCCCC-CCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEE
Q 003911 67 DKRITRIQIGHQNLQGTLPSNLQNLT-KLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145 (787)
Q Consensus 67 ~~~v~~L~l~~~~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 145 (787)
..+++.|++++|+++ .+|. +..+. +|++|+|++|+|++. +.|.++++|++|+|++|+|+++++..|..+++|++|+
T Consensus 18 ~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 18 AVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred cCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 357999999999999 4554 55555 999999999999987 7899999999999999999999988889999999999
Q ss_pred ccCCCCCCCCCCh--hhhcCCCCCEEeccCceecccCCCC----CCCCCCCCCcEEecccccccc
Q 003911 146 IDNNPFSSWEIPQ--SLRNASGLQNFSANSANITGQIPSF----FGPDEFPGLTILHLAFNQLIG 204 (787)
Q Consensus 146 L~~N~l~~~~~p~--~~~~l~~L~~L~l~~n~l~~~~p~~----~~~~~l~~L~~L~L~~N~l~~ 204 (787)
|++|+|. .+|. .+..+++|+.|++++|.++.. |.. +. .+++|++|+++.|.+..
T Consensus 95 L~~N~i~--~~~~~~~l~~l~~L~~L~l~~N~i~~~-~~~~~~~~~--~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 95 LTNNSLV--ELGDLDPLASLKSLTYLCILRNPVTNK-KHYRLYVIY--KVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CCSCCCC--CGGGGGGGGGCTTCCEEECCSSGGGGS-TTHHHHHHH--HCTTCSEETTEECCHHH
T ss_pred CCCCcCC--cchhhHhhhcCCCCCEEEecCCCCCCc-HhHHHHHHH--HCCccceeCCCcCCHHH
Confidence 9999997 5676 899999999999999999854 543 54 79999999999998763
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=4.2e-15 Score=142.65 Aligned_cols=134 Identities=14% Similarity=0.134 Sum_probs=94.2
Q ss_pred ccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCccccc
Q 003911 135 FTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQ 214 (787)
Q Consensus 135 ~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~ 214 (787)
+.++++|++|+|++|+++ .+|......++|++|++++|.|++. ..+. .+++|++|+|++|+|++..|..
T Consensus 15 ~~~~~~L~~L~l~~n~l~--~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~--~l~~L~~L~Ls~N~l~~~~~~~----- 83 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEIRKL--DGFP--LLRRLKTLLVNNNRICRIGEGL----- 83 (176)
T ss_dssp EECTTSCEEEECTTSCCC--SCCCGGGGTTCCSEEECCSSCCCEE--CCCC--CCSSCCEEECCSSCCCEECSCH-----
T ss_pred cCCcCCceEEEeeCCCCc--hhHHhhhcCCCCCEEECCCCCCCcc--cccc--cCCCCCEEECCCCcccccCcch-----
Confidence 445556666666666665 2343222223666666666666654 3444 7788888888888887543332
Q ss_pred ccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCC--CCCCCCCCCEEecCCCcccccCCcc----ccCCCC
Q 003911 215 IQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP--DFSGVKQLESLSLRDNFFTGPVPDS----LVKLES 288 (787)
Q Consensus 215 l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~----l~~l~~ 288 (787)
+..+++|+.|+|++|+|+..++ .+..+++|+.|++++|+++ .+|.. +..+++
T Consensus 84 ---------------------~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~ 141 (176)
T 1a9n_A 84 ---------------------DQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQ 141 (176)
T ss_dssp ---------------------HHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTT
T ss_pred ---------------------hhcCCCCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCc
Confidence 2378888888888888876555 5778899999999999998 56764 889999
Q ss_pred CCEEEccCCcccc
Q 003911 289 LKIVNMTNNLLQG 301 (787)
Q Consensus 289 L~~L~Ls~N~l~~ 301 (787)
|++||+++|.+..
T Consensus 142 L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 142 VRVLDFQKVKLKE 154 (176)
T ss_dssp CSEETTEECCHHH
T ss_pred cceeCCCcCCHHH
Confidence 9999999998764
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.54 E-value=2.6e-13 Score=147.54 Aligned_cols=169 Identities=17% Similarity=0.147 Sum_probs=82.3
Q ss_pred CCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEe
Q 003911 92 TKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFS 170 (787)
Q Consensus 92 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~ 170 (787)
..++.+.+.+ .++.+.+ +|.+. +|+.+.|.+| ++.+...+|.+. +|+.++|.+ .+.. .-+..|.++++|+.++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~-I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQ-LKEDIFYYCYNLKKAD 186 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCE-ECSSTTTTCTTCCEEE
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccE-ehHHHhhCcccCCeee
Confidence 4444555432 2333333 45543 4666665544 555555555553 466666554 3332 1234555566666666
Q ss_pred ccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEecccc
Q 003911 171 ANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSN 250 (787)
Q Consensus 171 l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N 250 (787)
+.+|+++......|. ..+|+.+.|..| ++......| .++++|+.++|..|
T Consensus 187 l~~n~l~~I~~~aF~---~~~L~~l~lp~~-l~~I~~~aF--------------------------~~~~~L~~l~l~~~ 236 (401)
T 4fdw_A 187 LSKTKITKLPASTFV---YAGIEEVLLPVT-LKEIGSQAF--------------------------LKTSQLKTIEIPEN 236 (401)
T ss_dssp CTTSCCSEECTTTTT---TCCCSEEECCTT-CCEECTTTT--------------------------TTCTTCCCEECCTT
T ss_pred cCCCcceEechhhEe---ecccCEEEeCCc-hheehhhHh--------------------------hCCCCCCEEecCCC
Confidence 665555555555552 355666655532 332223222 24555555555543
Q ss_pred ccccCCC-CCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcc
Q 003911 251 AFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLL 299 (787)
Q Consensus 251 ~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 299 (787)
++.... .|.+ .+|+.+.| .|.++...+..|.++++|+.+++.+|.+
T Consensus 237 -l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~ 283 (401)
T 4fdw_A 237 -VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTF 283 (401)
T ss_dssp -CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCC
T ss_pred -ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccc
Confidence 332222 2444 45555555 3334434445555555555555555544
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.53 E-value=4.5e-17 Score=159.74 Aligned_cols=131 Identities=19% Similarity=0.302 Sum_probs=76.8
Q ss_pred cccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccc
Q 003911 134 FFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGS 213 (787)
Q Consensus 134 ~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 213 (787)
.|..+++|++|+|++|+++. +| .+..+++|++|++++|.++ .+|..+. .+++|++|+|++|++++ +| .
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~--l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~~~L~~L~L~~N~l~~-l~-~---- 110 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK--IS-SLSGMENLRILSLGRNLIK-KIENLDA--VADTLEELWISYNQIAS-LS-G---- 110 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC--CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH--HHHHCSEEEEEEEECCC-HH-H----
T ss_pred HHhcCCCCCEEECCCCCCcc--cc-ccccCCCCCEEECCCCCcc-cccchhh--cCCcCCEEECcCCcCCc-CC-c----
Confidence 34444445555555554442 33 4445555555555555554 2333332 34566666666666653 22 1
Q ss_pred cccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCC--CCCCCCCCCEEecCCCcccccCCcc---------
Q 003911 214 QIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP--DFSGVKQLESLSLRDNFFTGPVPDS--------- 282 (787)
Q Consensus 214 ~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~--------- 282 (787)
+..+++|+.|+|++|++++.++ .+..+++|++|++++|++++.+|..
T Consensus 111 ----------------------~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 168 (198)
T 1ds9_A 111 ----------------------IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE 168 (198)
T ss_dssp ----------------------HHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred ----------------------cccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence 2356777777777777775433 4667778888888888887665543
Q ss_pred -ccCCCCCCEEEccCCccc
Q 003911 283 -LVKLESLKIVNMTNNLLQ 300 (787)
Q Consensus 283 -l~~l~~L~~L~Ls~N~l~ 300 (787)
+..+++|+.|| +|.++
T Consensus 169 ~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 169 VVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHCSSCSEEC--CGGGT
T ss_pred HHHhCCCcEEEC--CcccC
Confidence 77788888876 66665
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.5e-14 Score=152.16 Aligned_cols=98 Identities=20% Similarity=0.186 Sum_probs=62.1
Q ss_pred CCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCC-CCCCCCCCC-
Q 003911 189 FPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLE- 266 (787)
Q Consensus 189 l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~- 266 (787)
+++|+.|+|++|+++...+..|. ++++|++|+|.+| ++.+.+ .|.++++|+
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~--------------------------~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~ 277 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFA--------------------------QKKYLLKIKLPHN-LKTIGQRVFSNCGRLAG 277 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTT--------------------------TCTTCCEEECCTT-CCEECTTTTTTCTTCCE
T ss_pred cCCCeEEECCCCCcceecHhhhh--------------------------CCCCCCEEECCcc-cceehHHHhhCChhccE
Confidence 56788888888777754444443 6667777777766 554444 366677777
Q ss_pred EEecCCCcccccCCccccCCCCCCEEEccCCcccccCCC-CCCceeeec
Q 003911 267 SLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-FDRSVSLDM 314 (787)
Q Consensus 267 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~L~~ 314 (787)
.|++.+ +++...+.+|.++++|+.|++++|+++...+. |..+.+|+.
T Consensus 278 ~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ 325 (329)
T 3sb4_A 278 TLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKL 325 (329)
T ss_dssp EEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCE
T ss_pred EEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhh
Confidence 777766 56645556677777777777777777665553 444444443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.51 E-value=4.8e-17 Score=159.53 Aligned_cols=134 Identities=22% Similarity=0.286 Sum_probs=115.6
Q ss_pred CCEEEEEeCCCCccccCCC------CCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCC
Q 003911 68 KRITRIQIGHQNLQGTLPS------NLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSL 141 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 141 (787)
.+++.++++.+++.|.+|. .|..+++|++|+|++|+|++. |.+.++++|++|+|++|+|+.++. .+..+++|
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l-~~~~~l~~L~~L~l~~n~l~~l~~-~~~~~~~L 95 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIKKIEN-LDAVADTL 95 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCC-CCHHHHTTCCEEEEEEEEECSCSS-HHHHHHHC
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCccc-cccccCCCCCEEECCCCCcccccc-hhhcCCcC
Confidence 4677778888888888776 899999999999999999985 489999999999999999998764 57788999
Q ss_pred cEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCC-CCCCCCCCCCCcEEeccccccccCCCc
Q 003911 142 QSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP-SFFGPDEFPGLTILHLAFNQLIGGLPA 208 (787)
Q Consensus 142 ~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~L~~N~l~~~~p~ 208 (787)
++|+|++|++++ +| .+..+++|+.|++++|++++..+ ..+. .+++|++|++++|.+++.+|.
T Consensus 96 ~~L~L~~N~l~~--l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~--~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 96 EELWISYNQIAS--LS-GIEKLVNLRVLYMSNNKITNWGEIDKLA--ALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SEEEEEEEECCC--HH-HHHHHHHSSEEEESEEECCCHHHHHHHT--TTTTCSEEEECSCHHHHHHHT
T ss_pred CEEECcCCcCCc--CC-ccccCCCCCEEECCCCcCCchhHHHHHh--cCCCCCEEEecCCcccccccc
Confidence 999999999995 55 68999999999999999987543 4554 899999999999999877664
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.50 E-value=7e-14 Score=133.07 Aligned_cols=105 Identities=23% Similarity=0.318 Sum_probs=81.5
Q ss_pred EEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCC
Q 003911 71 TRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (787)
Q Consensus 71 ~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 149 (787)
+.+++++++++ .+|..+. ++|++|+|++|+|++.+| .|.++++|++|+|++|+|+++++..|.++++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 35677778887 5777664 788999999999998877 5888999999999999999988888888888888888888
Q ss_pred CCCCCCCChhhhcCCCCCEEeccCceeccc
Q 003911 150 PFSSWEIPQSLRNASGLQNFSANSANITGQ 179 (787)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~ 179 (787)
+|+. ..+..|..+++|++|++++|.++..
T Consensus 89 ~l~~-~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 89 QLKS-IPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CCCC-CCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred ccCE-eCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 8884 2234466666666666666666543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.2e-13 Score=131.94 Aligned_cols=103 Identities=23% Similarity=0.426 Sum_probs=83.2
Q ss_pred EEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCC
Q 003911 71 TRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (787)
Q Consensus 71 ~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 149 (787)
+.+++++++++ .+|..+. ++|++|+|++|+|++.+| .|.++++|++|+|++|+|+++++..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 57888999886 7887775 889999999999998877 6888999999999999999998888888999999999998
Q ss_pred CCCCCCCCh-hhhcCCCCCEEeccCceecc
Q 003911 150 PFSSWEIPQ-SLRNASGLQNFSANSANITG 178 (787)
Q Consensus 150 ~l~~~~~p~-~~~~l~~L~~L~l~~n~l~~ 178 (787)
+|+. +|. .|..+++|++|++++|.+..
T Consensus 92 ~l~~--l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKS--IPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCC--CCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccce--eCHHHhccccCCCEEEeCCCCccc
Confidence 8884 343 46666666666666666653
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.49 E-value=1.1e-13 Score=131.71 Aligned_cols=109 Identities=18% Similarity=0.239 Sum_probs=98.0
Q ss_pred CcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccC
Q 003911 94 LERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173 (787)
Q Consensus 94 L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~ 173 (787)
.+.|++++|+|+.++..+. ++|++|+|++|+|+++++..|.++++|++|+|++|+|+. ..+..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCc-cChhhccCCCCCCEEECCC
Confidence 5789999999998776664 899999999999999999999999999999999999995 4455679999999999999
Q ss_pred ceecccCCCCCCCCCCCCCcEEeccccccccCCC
Q 003911 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLP 207 (787)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p 207 (787)
|+|++..+..|. .+++|++|+|++|.+++..+
T Consensus 88 N~l~~~~~~~~~--~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFD--NLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTT--TCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhc--CCCCCCEEEeCCCCCCCCch
Confidence 999998888886 89999999999999986544
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=3e-13 Score=129.14 Aligned_cols=105 Identities=19% Similarity=0.242 Sum_probs=95.2
Q ss_pred cEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCCh-hhhcCCCCCEEeccC
Q 003911 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQ-SLRNASGLQNFSANS 173 (787)
Q Consensus 95 ~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~-~~~~l~~L~~L~l~~ 173 (787)
+.+++++|+|+.+++.+. ++|++|+|++|+|+++++..|.++++|++|+|++|+|+. +|. .|.++++|++|+|++
T Consensus 15 ~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA--IPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC--CCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc--cChhHhCCcchhhEEECCC
Confidence 789999999987776665 899999999999999999999999999999999999995 554 578999999999999
Q ss_pred ceecccCCCCCCCCCCCCCcEEeccccccccC
Q 003911 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGG 205 (787)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~ 205 (787)
|+|++.++..|. .+++|++|+|++|.+...
T Consensus 91 N~l~~l~~~~~~--~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 91 NHLKSIPRGAFD--NLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp SCCCCCCTTTTT--TCTTCSEEECCSSCBCTT
T ss_pred CccceeCHHHhc--cccCCCEEEeCCCCcccc
Confidence 999988887786 899999999999999854
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.45 E-value=2.1e-12 Score=140.40 Aligned_cols=261 Identities=10% Similarity=0.121 Sum_probs=175.7
Q ss_pred EEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccC
Q 003911 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (787)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 148 (787)
++.+.+.+ +++..-..+|.+. +|+.++|..| ++.+.. +|.+ .+|+.+.|.+ .++.+...+|.++++|+.++|++
T Consensus 115 l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~ 189 (401)
T 4fdw_A 115 YNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSK 189 (401)
T ss_dssp CSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTT
T ss_pred ccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCC
Confidence 34444443 4553445677775 7999999877 776655 6888 4799999986 89999999999999999999999
Q ss_pred CCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCc
Q 003911 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAK 228 (787)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~ 228 (787)
|+++ .+|.......+|+.+.+..+ ++.+....|. ++++|+.+++..| ++.....+|.+
T Consensus 190 n~l~--~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~--~~~~L~~l~l~~~-l~~I~~~aF~~---------------- 247 (401)
T 4fdw_A 190 TKIT--KLPASTFVYAGIEEVLLPVT-LKEIGSQAFL--KTSQLKTIEIPEN-VSTIGQEAFRE---------------- 247 (401)
T ss_dssp SCCS--EECTTTTTTCCCSEEECCTT-CCEECTTTTT--TCTTCCCEECCTT-CCEECTTTTTT----------------
T ss_pred Ccce--EechhhEeecccCEEEeCCc-hheehhhHhh--CCCCCCEEecCCC-ccCcccccccc----------------
Confidence 9999 56665555799999999854 7777778886 8999999999875 55455555543
Q ss_pred CCCCccccccCccCceEeccccccccCCC-CCCCCCCCCEEecCCCccc-----ccCCccccCCCCCCEEEccCCccccc
Q 003911 229 LGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFT-----GPVPDSLVKLESLKIVNMTNNLLQGP 302 (787)
Q Consensus 229 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~-----~~~p~~l~~l~~L~~L~Ls~N~l~~~ 302 (787)
.+|+.+.| .|.++.... .|.++++|+.+++.+|.+. ...+..|.++++|+.++|.+ .++..
T Consensus 248 -----------~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I 314 (401)
T 4fdw_A 248 -----------SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRIL 314 (401)
T ss_dssp -----------CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEE
T ss_pred -----------CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEE
Confidence 45555555 333443333 3566666666666665553 24445566666666666653 23322
Q ss_pred CCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcc
Q 003911 303 VPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNL 382 (787)
Q Consensus 303 ~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l 382 (787)
... .+....+|+.|+|..| +
T Consensus 315 ~~~-----------------------------------------------------------aF~~c~~L~~l~lp~~-l 334 (401)
T 4fdw_A 315 GQG-----------------------------------------------------------LLGGNRKVTQLTIPAN-V 334 (401)
T ss_dssp CTT-----------------------------------------------------------TTTTCCSCCEEEECTT-C
T ss_pred hhh-----------------------------------------------------------hhcCCCCccEEEECcc-c
Confidence 211 1111224555555332 4
Q ss_pred cccCchhhcCCCCCCEEecccccccccCCccCcCCC-CCCeeeccCCccc
Q 003911 383 TGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG-ALKELDVSNNQLY 431 (787)
Q Consensus 383 ~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~-~L~~L~Ls~N~l~ 431 (787)
+..-+..|.++ +|+.|++++|.+....+..|..++ .++.|++..|.+.
T Consensus 335 ~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 335 TQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred cEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 44455667788 888888888888755566677774 6788888777654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.34 E-value=1e-12 Score=140.80 Aligned_cols=84 Identities=19% Similarity=0.256 Sum_probs=69.2
Q ss_pred CCcccEEEcCCCCEEEEEeCCC-CccccCCCCCCCCCCCcEEEeec-CCCCCCCC-CCCCCCCCcEEEcccccCCcCCCc
Q 003911 57 CKWNHVVCIEDKRITRIQIGHQ-NLQGTLPSNLQNLTKLERLELQW-NSISGPLP-SLNGLASLEVVMLSNNQFTSVPSD 133 (787)
Q Consensus 57 C~w~gv~C~~~~~v~~L~l~~~-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~ 133 (787)
|.|.+|.|. ++ +|+ .+|. |..+++|++|+|++ |+|+++++ .|.+|++|++|+|++|+|+++++.
T Consensus 8 C~~~~v~~~-----------~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRCT-----------RDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEECC-----------SSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEcC-----------CCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 777777664 33 566 4788 99999999999986 99988876 688899999999999999998888
Q ss_pred cccCCCCCcEEEccCCCCCC
Q 003911 134 FFTGLSSLQSIEIDNNPFSS 153 (787)
Q Consensus 134 ~~~~l~~L~~L~L~~N~l~~ 153 (787)
.|.+|++|++|+|++|+|+.
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~ 94 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALES 94 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSC
T ss_pred HhcCCcCCCEEeCCCCccce
Confidence 88888888888888888874
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=5.8e-12 Score=129.18 Aligned_cols=148 Identities=15% Similarity=0.073 Sum_probs=116.0
Q ss_pred HhhcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCeeE
Q 003911 589 RNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 589 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 667 (787)
......|++...++.|+.+.||++... ++.+++|+...... ....++.+|+++++.+. +..++++++++.+.+..|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 345567988899999999999999754 78999999875321 12346899999999994 677889999999988999
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA------------------------------- 716 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------- 716 (787)
+||||++|.++.+.+. +......++.++++++..||+..
T Consensus 87 lv~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred EEEEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 9999999999876531 11223468889999999999721
Q ss_pred -------------------------CCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 717 -------------------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 717 -------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
...++|+|++|.||+++++..+.|+||+.+...
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 145899999999999987656679999987643
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.28 E-value=7.2e-12 Score=134.15 Aligned_cols=105 Identities=15% Similarity=0.168 Sum_probs=95.2
Q ss_pred cEEEeecC-CCCCCCCCCCCCCCCcEEEccc-ccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEecc
Q 003911 95 ERLELQWN-SISGPLPSLNGLASLEVVMLSN-NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSAN 172 (787)
Q Consensus 95 ~~L~L~~N-~l~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~ 172 (787)
..++++++ +|+++++ |..+++|++|+|++ |+|+++++..|.+|++|++|+|++|+|++ ..|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF-VAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE-ECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccce-eCHHHhcCCcCCCEEeCC
Confidence 35799998 9998777 99999999999996 99999999999999999999999999997 567889999999999999
Q ss_pred CceecccCCCCCCCCCCCCCcEEecccccccc
Q 003911 173 SANITGQIPSFFGPDEFPGLTILHLAFNQLIG 204 (787)
Q Consensus 173 ~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~ 204 (787)
+|+|++.++..|. .++ |++|+|.+|.|..
T Consensus 89 ~N~l~~~~~~~~~--~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 89 FNALESLSWKTVQ--GLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SSCCSCCCSTTTC--SCC-CCEEECCSSCCCC
T ss_pred CCccceeCHHHcc--cCC-ceEEEeeCCCccC
Confidence 9999988888775 455 9999999999984
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=4e-14 Score=152.42 Aligned_cols=65 Identities=17% Similarity=0.159 Sum_probs=46.1
Q ss_pred ccCccCceEeccccccccCC-----CCCCCCCCCCEEecCCCccccc----CCccccCCCCCCEEEccCCcccc
Q 003911 237 QNMTSLKEIWLHSNAFSGPL-----PDFSGVKQLESLSLRDNFFTGP----VPDSLVKLESLKIVNMTNNLLQG 301 (787)
Q Consensus 237 ~~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~ 301 (787)
..+++|++|+|++|.|+... ..+...++|+.|+|++|.|+.. ++..+...++|++|+|++|.|+.
T Consensus 180 ~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 45677888888888776422 2355567888888888888743 34455567888888888888864
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=3.6e-14 Score=152.76 Aligned_cols=39 Identities=21% Similarity=0.210 Sum_probs=23.5
Q ss_pred CCCCCEEecCCCcccc----cCCccccCCCCCCEEEccCCccc
Q 003911 262 VKQLESLSLRDNFFTG----PVPDSLVKLESLKIVNMTNNLLQ 300 (787)
Q Consensus 262 l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~ 300 (787)
.++|+.|+|++|.|+. .++..+..+++|++|+|++|.|+
T Consensus 154 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 154 QCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG 196 (372)
T ss_dssp TCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCH
T ss_pred CCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCC
Confidence 4556666666666653 23444456666777777777665
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=1.7e-11 Score=125.51 Aligned_cols=140 Identities=19% Similarity=0.162 Sum_probs=103.0
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCc--cceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH--LVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv 669 (787)
...|.+....+.|..+.||++...+|+.+++|+.... ....+.+|+++++.+.+.+ +++++++...++..++|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 3455554444466679999998777888999987542 2246788999999985444 56788888888889999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA--------------------------------- 716 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--------------------------------- 716 (787)
|||++|.++. . . ..+ ...++.++++.+..||+..
T Consensus 94 ~e~i~G~~l~--~-~-------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 94 LGEVPGQDLL--S-S-------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp EECCSSEETT--T-S-------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred EEecCCcccC--c-C-------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 9999998873 2 0 111 1256777788888888632
Q ss_pred ----------------------CCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 717 ----------------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 717 ----------------------~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
...++|+|++|.||++++++.+.|+|||.+...
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999987766779999998754
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.18 E-value=1e-09 Score=119.44 Aligned_cols=289 Identities=15% Similarity=0.096 Sum_probs=153.5
Q ss_pred CCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCC--------------
Q 003911 86 SNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNP-------------- 150 (787)
Q Consensus 86 ~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-------------- 150 (787)
.+|.++++|+.+.|.. .++.+.. +|.++++|+.++|.++ ++.+...+|.++++|+.+.+..+-
T Consensus 65 ~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~~ 142 (394)
T 4fs7_A 65 AAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDFK 142 (394)
T ss_dssp TTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCCS
T ss_pred HHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeeccccc
Confidence 3455555555555542 2443333 4555555555555433 444555555555555544443221
Q ss_pred -------CCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCccc-ccccceeecc
Q 003911 151 -------FSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNG 222 (787)
Q Consensus 151 -------l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~L~~~~ 222 (787)
+.. .-...|.++++|+.+.+.++. .......|. .+.+|+.+++..| ++......|.+ ..|+.+.+..
T Consensus 143 ~~~~~~~~~~-i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~--~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~ 217 (394)
T 4fs7_A 143 EITIPEGVTV-IGDEAFATCESLEYVSLPDSM-ETLHNGLFS--GCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPN 217 (394)
T ss_dssp EEECCTTCCE-ECTTTTTTCTTCCEEECCTTC-CEECTTTTT--TCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCT
T ss_pred ccccCccccc-cchhhhcccCCCcEEecCCcc-ceecccccc--CCCCceEEEcCCC-ceEeCchhhccccccceeecCC
Confidence 110 113457777888888886553 334445554 6777888877665 44333344433 2333333221
Q ss_pred CCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCccccc
Q 003911 223 QNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302 (787)
Q Consensus 223 ~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 302 (787)
.. ....+......+|+.+.+..+.-.-....+.++..|+.+.+..+..+ .....|..+..|+.+.+..+.+..
T Consensus 218 ~~-----~~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~- 290 (394)
T 4fs7_A 218 SL-----YYLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPE- 290 (394)
T ss_dssp TC-----CEECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECT-
T ss_pred Cc-----eEeehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeecc-
Confidence 10 00111223456677777754432211224667777888887777655 566677777777777776654321
Q ss_pred CCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcc
Q 003911 303 VPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNL 382 (787)
Q Consensus 303 ~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l 382 (787)
..+..+.+|+.+.+.++. ..+. ...+....+|+.++|..+ +
T Consensus 291 -~~F~~~~~L~~i~l~~~i-~~I~------------------------------------~~aF~~c~~L~~i~lp~~-v 331 (394)
T 4fs7_A 291 -KTFYGCSSLTEVKLLDSV-KFIG------------------------------------EEAFESCTSLVSIDLPYL-V 331 (394)
T ss_dssp -TTTTTCTTCCEEEECTTC-CEEC------------------------------------TTTTTTCTTCCEECCCTT-C
T ss_pred -cccccccccccccccccc-ceec------------------------------------hhhhcCCCCCCEEEeCCc-c
Confidence 113333333333332221 0000 011223346777777643 6
Q ss_pred cccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCC
Q 003911 383 TGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNN 428 (787)
Q Consensus 383 ~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N 428 (787)
+..-...|.++++|+.++|..| ++..-...|.++.+|+.+++..|
T Consensus 332 ~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 332 EEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred cEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 6555667888888888888776 66455667888888888888654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.04 E-value=5.5e-10 Score=120.03 Aligned_cols=144 Identities=15% Similarity=0.226 Sum_probs=107.8
Q ss_pred ccceeccccceEEEEEEEeCCcEEEEEEee--cccccchhHHHHHHHHHHHHhcC--CCccceEEeEEEeC---CeeEEE
Q 003911 597 EENILGRGGFGTVYKGELHDGTKIAVKRME--AGVISGKGLTEFKSEIAVLTKVR--HRHLVALLGHCLDG---NEKLLV 669 (787)
Q Consensus 597 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv 669 (787)
..+.++.|.++.||+++.. +..+++|+.. .... ......+.+|.++++.+. +..+++++.++.+. +..|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4577999999999998875 4678888775 3211 123457889999999996 45688899888776 458999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA--------------------------------- 716 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--------------------------------- 716 (787)
|||++|..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 120 me~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 9999998774311 234677888899999999999999731
Q ss_pred ----------------------CCCeEEcCCCCCCEEECCCCc--EEEeecccceec
Q 003911 717 ----------------------HQSFIHRDLKPSNILLGDDMR--AKVADFGLVRLA 749 (787)
Q Consensus 717 ----------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DFG~a~~~ 749 (787)
...++|+|++|.||+++.++. +.|+||+.+..-
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999997653 689999998753
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.04 E-value=5.2e-09 Score=113.85 Aligned_cols=272 Identities=12% Similarity=0.027 Sum_probs=161.3
Q ss_pred CCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCce-------
Q 003911 104 ISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN------- 175 (787)
Q Consensus 104 l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~------- 175 (787)
++.+.. +|.++++|+.+.|.. .++.+...+|.++++|+.++|.+| ++. .-...|.++.+|+.+.+..+-
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~-I~~~aF~~c~~L~~i~~p~~l~~i~~~a 135 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKM-IGRCTFSGCYALKSILLPLMLKSIGVEA 135 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCE-ECTTTTTTCTTCCCCCCCTTCCEECTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceE-ccchhhcccccchhhcccCceeeeccee
Confidence 343334 799999999999975 599999999999999999999866 542 224567778888777665431
Q ss_pred --------------ecccCCCCCCCCCCCCCcEEeccccccccCCCcCccc-ccccceeeccCCCCCcCCCCccccccCc
Q 003911 176 --------------ITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMT 240 (787)
Q Consensus 176 --------------l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~L~~~~~~~~~~~~~~~~~~~~l~ 240 (787)
+.......|. .+++|+.+.+..+. .......|.+ .+|+.+.+... .......++.+++
T Consensus 136 F~~~~~~~~~~~~~~~~i~~~aF~--~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~----~~~I~~~~F~~~~ 208 (394)
T 4fs7_A 136 FKGCDFKEITIPEGVTVIGDEAFA--TCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN----LKIIRDYCFAECI 208 (394)
T ss_dssp TTTCCCSEEECCTTCCEECTTTTT--TCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT----CCEECTTTTTTCT
T ss_pred eecccccccccCccccccchhhhc--ccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC----ceEeCchhhcccc
Confidence 1111123343 77899999997654 3244444543 33444443211 1111123455666
Q ss_pred cCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCC
Q 003911 241 SLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNN 320 (787)
Q Consensus 241 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n 320 (787)
.|+.+.+..+...- .........|+.+.+..+. +......+..+..|+.+.+..+..+-....+..+..+.......+
T Consensus 209 ~L~~i~~~~~~~~i-~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~ 286 (394)
T 4fs7_A 209 LLENMEFPNSLYYL-GDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSV 286 (394)
T ss_dssp TCCBCCCCTTCCEE-CTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSS
T ss_pred ccceeecCCCceEe-ehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcceeeccccccccccceeccCce
Confidence 66666665554331 1223334566666665433 324455666777777777766644322222333333222222111
Q ss_pred ccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEe
Q 003911 321 FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLI 400 (787)
Q Consensus 321 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 400 (787)
.+. ...+....+|+.+.+..+ ++..-...|.++++|+.++
T Consensus 287 ~i~---------------------------------------~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~ 326 (394)
T 4fs7_A 287 IVP---------------------------------------EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSID 326 (394)
T ss_dssp EEC---------------------------------------TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEEC
T ss_pred eec---------------------------------------cccccccccccccccccc-cceechhhhcCCCCCCEEE
Confidence 100 011223357788888654 6655667788899999999
Q ss_pred cccccccccCCccCcCCCCCCeeeccCC
Q 003911 401 LADNNLSGMIPEGLSVLGALKELDVSNN 428 (787)
Q Consensus 401 Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N 428 (787)
|.++ ++..-...|.++.+|+.+++..|
T Consensus 327 lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 327 LPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp CCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred eCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 9754 66445678888999999988766
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.97 E-value=3.3e-08 Score=107.53 Aligned_cols=36 Identities=14% Similarity=0.287 Sum_probs=23.9
Q ss_pred CCCCCCCCEEecCCCcccccCCccccCCCCCCEEEcc
Q 003911 259 FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 295 (787)
Q Consensus 259 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 295 (787)
|.++..|+.+.+.++..+ .....|.++++|+.+.+.
T Consensus 261 F~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~ 296 (394)
T 4gt6_A 261 FDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS 296 (394)
T ss_dssp TTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC
T ss_pred eeecccccEEecccccce-ecCcccccccccccccCC
Confidence 666677777777665544 555667777777777764
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.95 E-value=9.3e-11 Score=125.02 Aligned_cols=102 Identities=16% Similarity=0.215 Sum_probs=59.1
Q ss_pred CCCEEEEEeCCCCccc-c-------CCCCCCCCCCCcEEEeecCCCCC---------CCC-CCCCCCCCcEEEcccccCC
Q 003911 67 DKRITRIQIGHQNLQG-T-------LPSNLQNLTKLERLELQWNSISG---------PLP-SLNGLASLEVVMLSNNQFT 128 (787)
Q Consensus 67 ~~~v~~L~l~~~~l~~-~-------~~~~~~~l~~L~~L~L~~N~l~~---------~~~-~~~~l~~L~~L~L~~N~l~ 128 (787)
..+|+.|.+...+..| . +.+++..+++|+.|.+..+.... .+. .+..+++|+.|+|++|.-.
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 3578888888666553 2 23446677899999887654321 111 2455677777777776311
Q ss_pred cCCCccccCCCCCcEEEccCCCCCCCCCChhhh--cCCCCCEEecc
Q 003911 129 SVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLR--NASGLQNFSAN 172 (787)
Q Consensus 129 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~--~l~~L~~L~l~ 172 (787)
.+++ +. +++|++|+|..+.+.. .....+. .+++|+.|+|+
T Consensus 186 ~l~~--~~-~~~L~~L~L~~~~l~~-~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 186 SIGK--KP-RPNLKSLEIISGGLPD-SVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp BCCS--CB-CTTCSEEEEECSBCCH-HHHHHHHHSBCTTCCEEEEE
T ss_pred eecc--cc-CCCCcEEEEecCCCCh-HHHHHHHHccCCCCcEEEEe
Confidence 2222 32 6777777777766542 1112232 46666666664
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.87 E-value=1.7e-07 Score=101.83 Aligned_cols=294 Identities=14% Similarity=0.168 Sum_probs=170.7
Q ss_pred CCCCCCC-CCcEEEeecCCCCCCCC-CCCCCCCCcEEEccccc---CCcCCCccccCCCCCcEEEccCCCCCCCCCChhh
Q 003911 86 SNLQNLT-KLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQ---FTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSL 160 (787)
Q Consensus 86 ~~~~~l~-~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~---l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~ 160 (787)
.+|.+.. .|+.+.+..+ ++.+-. +|.++++|+.+.+..|. ++.+...+|.++.+|+.+.+..+ ++. .-...|
T Consensus 57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~-I~~~aF 133 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTE-IDSEAF 133 (394)
T ss_dssp TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSE-ECTTTT
T ss_pred hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cce-ehhhhh
Confidence 4566663 5777777643 555444 67788888888887764 66677777888888877777655 331 223556
Q ss_pred hcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCc
Q 003911 161 RNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMT 240 (787)
Q Consensus 161 ~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~ 240 (787)
..+.+|+.+.+..+ ++......|. ....|+.+.+..+ ++......|.+..|+.+.+... .......++.++.
T Consensus 134 ~~c~~L~~i~lp~~-~~~I~~~~F~--~c~~L~~i~~~~~-~~~I~~~aF~~~~l~~i~ip~~----~~~i~~~af~~c~ 205 (394)
T 4gt6_A 134 HHCEELDTVTIPEG-VTSVADGMFS--YCYSLHTVTLPDS-VTAIEERAFTGTALTQIHIPAK----VTRIGTNAFSECF 205 (394)
T ss_dssp TTCTTCCEEECCTT-CCEECTTTTT--TCTTCCEEECCTT-CCEECTTTTTTCCCSEEEECTT----CCEECTTTTTTCT
T ss_pred hhhcccccccccce-eeeeccccee--cccccccccccce-eeEeccccccccceeEEEECCc----ccccccchhhhcc
Confidence 77777887777543 3334444554 6677777777654 4434455555555665555321 1111223455667
Q ss_pred cCceEeccccccccCCC--------------CCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCC
Q 003911 241 SLKEIWLHSNAFSGPLP--------------DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEF 306 (787)
Q Consensus 241 ~L~~L~L~~N~l~~~~~--------------~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 306 (787)
+|+......+....... .+.....+..+.+.+ .++.....+|.++.+|+.+.+.++..+-....+
T Consensus 206 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~I~~~aF 284 (394)
T 4gt6_A 206 ALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVVSIGTGAF 284 (394)
T ss_dssp TCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCCEECTTTT
T ss_pred ccceecccccccccccceeecccccccccccccccccccceEEcCC-cceEcccceeeecccccEEecccccceecCccc
Confidence 77776665554432111 122233455555543 344355667888888888888766543222234
Q ss_pred CCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccC
Q 003911 307 DRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTI 386 (787)
Q Consensus 307 ~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~ 386 (787)
..+..|+.+.+.++. ..++ ...+....+|+.++|..+ ++..-
T Consensus 285 ~~c~~L~~i~l~~~i-~~I~------------------------------------~~aF~~c~~L~~i~lp~~-v~~I~ 326 (394)
T 4gt6_A 285 MNCPALQDIEFSSRI-TELP------------------------------------ESVFAGCISLKSIDIPEG-ITQIL 326 (394)
T ss_dssp TTCTTCCEEECCTTC-CEEC------------------------------------TTTTTTCTTCCEEECCTT-CCEEC
T ss_pred ccccccccccCCCcc-cccC------------------------------------ceeecCCCCcCEEEeCCc-ccEeh
Confidence 444444444433221 1111 112223347777777653 55455
Q ss_pred chhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcc
Q 003911 387 SPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQL 430 (787)
Q Consensus 387 p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l 430 (787)
...|.++++|+.+.|..+ ++..-...|.++++|+.+++.+|..
T Consensus 327 ~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 327 DDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp TTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred HhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 667888888888888654 5534456788888888888887754
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.83 E-value=5e-10 Score=119.33 Aligned_cols=57 Identities=23% Similarity=0.281 Sum_probs=28.9
Q ss_pred ceEEEEccCCccccc----CchhhcCCCCCCEEecccccccccCCccCcC-CCCCCeeeccCCc
Q 003911 371 NITVINFQKMNLTGT----ISPEFASFKSLQRLILADNNLSGMIPEGLSV-LGALKELDVSNNQ 429 (787)
Q Consensus 371 ~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~-l~~L~~L~Ls~N~ 429 (787)
+|+.|+|+.|.+.+. ++..+..+++|+.|+|++|.|+...-..+.. + ...+|+++|+
T Consensus 280 ~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 280 QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp GCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred CCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 455555555555442 2233345567777777777665432222222 1 2446666665
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.71 E-value=1.3e-10 Score=117.39 Aligned_cols=23 Identities=17% Similarity=0.037 Sum_probs=16.0
Q ss_pred CCCCcccEEEcCC-CCEEEEEeCC
Q 003911 55 DPCKWNHVVCIED-KRITRIQIGH 77 (787)
Q Consensus 55 ~~C~w~gv~C~~~-~~v~~L~l~~ 77 (787)
..|+|.|+.|+.+ .+|+.+-..+
T Consensus 76 ~l~~~~g~i~~~~~~ki~~~v~~~ 99 (267)
T 3rw6_A 76 ALKAVNYKILDRENRRISIIINSS 99 (267)
T ss_dssp HHHHTTSSCBCTTSCBCCCEEEEC
T ss_pred HHHhcCcEEECCCCCEEEEEEecC
Confidence 3589999999865 3666555544
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.62 E-value=9.3e-08 Score=99.88 Aligned_cols=137 Identities=19% Similarity=0.273 Sum_probs=100.4
Q ss_pred cceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCc--cceEEeEEEeCC---eeEEEEE
Q 003911 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRH--LVALLGHCLDGN---EKLLVFE 671 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~~~~~~~~~~---~~~lv~e 671 (787)
.+.++.|....||++. ..+++|+... ......+.+|.++++.+ .+.. +.+++......+ ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4568999999999863 5688898643 23457899999999988 3433 445555443333 3489999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA----------------------------------- 716 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----------------------------------- 716 (787)
+++|.++.+... ..++.+++..++.+++..++.||+..
T Consensus 97 ~i~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 97 KIKGVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp CCCCEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred ccCCeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 999988865432 24667777888888888888888521
Q ss_pred --------------------CCCeEEcCCCCCCEEECC--CCcEEEeecccceec
Q 003911 717 --------------------HQSFIHRDLKPSNILLGD--DMRAKVADFGLVRLA 749 (787)
Q Consensus 717 --------------------~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~~~ 749 (787)
...++|+|++|.||++++ ...+.|+||+.+...
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 135899999999999998 456789999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=4e-07 Score=93.28 Aligned_cols=136 Identities=16% Similarity=0.154 Sum_probs=99.6
Q ss_pred eeccccce-EEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCeeEEEEEecCCC
Q 003911 600 ILGRGGFG-TVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLLVFEYMPQG 676 (787)
Q Consensus 600 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (787)
.+..|..+ .||+.... ++..+++|+-.. ....++.+|.+.++.+. +--+.++++++.+.+..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 45556555 69988755 467799998654 23467889999999884 444778999999999999999999998
Q ss_pred CHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 003911 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA---------------------------------------- 716 (787)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------------- 716 (787)
++.+.... .......++.+++..|..||+..
T Consensus 106 ~~~~~~~~---------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 106 TAFQVLEE---------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp EHHHHHHH---------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred cccccccC---------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 88765422 11223456667777777777421
Q ss_pred ---------------CCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 717 ---------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 717 ---------------~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
...++|+|+.+.||++++++.+-|+||+.+...
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 113899999999999998777789999998754
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.57 E-value=3.8e-06 Score=90.52 Aligned_cols=296 Identities=11% Similarity=0.068 Sum_probs=145.0
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (787)
.+++.+.+.. +++..-..+|.++++|+.++|..+ ++.+.. +|.+. +|+.+.+.. +++.+...+|.+. +|+.+++
T Consensus 46 ~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~-~l~~I~~~aF~~~-~L~~i~l 120 (379)
T 4h09_A 46 DRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGME-RVKKFGDYVFQGT-DLDDFEF 120 (379)
T ss_dssp GGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECT-TCCEECTTTTTTC-CCSEEEC
T ss_pred cCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCc-eeeEeccceeccC-CcccccC
Confidence 3566666653 455344456777888888888643 554444 57665 577776654 4667777777664 6788877
Q ss_pred cCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCC
Q 003911 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGN 226 (787)
Q Consensus 147 ~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~ 226 (787)
..+-. .+......-.+|+.+.+..+ ++......|. ...+|+.+.+..+.........+.....
T Consensus 121 p~~~~---~i~~~~F~~~~l~~~~~~~~-v~~i~~~~f~--~~~~l~~~~~~~~~~~~~~~~~~~~~~~----------- 183 (379)
T 4h09_A 121 PGATT---EIGNYIFYNSSVKRIVIPKS-VTTIKDGIGY--KAENLEKIEVSSNNKNYVAENYVLYNKN----------- 183 (379)
T ss_dssp CTTCC---EECTTTTTTCCCCEEEECTT-CCEECSCTTT--TCTTCCEEEECTTCSSEEEETTEEEETT-----------
T ss_pred CCccc---cccccccccceeeeeeccce-eeccccchhc--ccccccccccccccceeecccceecccc-----------
Confidence 66532 23333222335555555433 3333334443 5666776666554432111110000000
Q ss_pred CcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCC-
Q 003911 227 AKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE- 305 (787)
Q Consensus 227 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~- 305 (787)
......+....++..+.+..+.-.-....+....+|+.+.+..+ ++......+.++..|+.+.+..+ ++.....
T Consensus 184 ---~~~~~~~~~~~~~~~~~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~a 258 (379)
T 4h09_A 184 ---KTILESYPAAKTGTEFTIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFL 258 (379)
T ss_dssp ---SSEEEECCTTCCCSEEECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTT
T ss_pred ---cceeccccccccccccccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccc
Confidence 00001122233333333332222212222344444444444433 22233344444455555544433 2211111
Q ss_pred CCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCccccc
Q 003911 306 FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT 385 (787)
Q Consensus 306 ~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~ 385 (787)
+..+..|..+.+..+. ..+ ....+....+|+.+++.++.++..
T Consensus 259 F~~~~~l~~i~l~~~i-~~i------------------------------------~~~aF~~c~~L~~i~l~~~~i~~I 301 (379)
T 4h09_A 259 LQNCTALKTLNFYAKV-KTV------------------------------------PYLLCSGCSNLTKVVMDNSAIETL 301 (379)
T ss_dssp TTTCTTCCEEEECCCC-SEE------------------------------------CTTTTTTCTTCCEEEECCTTCCEE
T ss_pred cceeehhccccccccc-eec------------------------------------ccccccccccccccccccccccee
Confidence 1112222211111110 000 001222334788888888888766
Q ss_pred CchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCC
Q 003911 386 ISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNN 428 (787)
Q Consensus 386 ~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N 428 (787)
-...|.++.+|+.++|..+ ++-.-...|.++.+|+.+.+..+
T Consensus 302 ~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 302 EPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred hhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 6777888888988888754 65344567888888888877543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=5.8e-07 Score=93.81 Aligned_cols=137 Identities=17% Similarity=0.180 Sum_probs=95.8
Q ss_pred cceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCC---ccceEEeEEE-eCCeeEEEEEec
Q 003911 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR---HLVALLGHCL-DGNEKLLVFEYM 673 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~ 673 (787)
.+.++.|....||+. +..+++|+... ......+.+|.++++.+.+. .+.+++.++. ..+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456888998999988 56788887432 23456899999999999642 3667777775 445678999999
Q ss_pred CCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 003911 674 PQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL-------------------------------------- 715 (787)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-------------------------------------- 715 (787)
+|..+.+... ..++..+...++.++++.|..||+.
T Consensus 96 ~G~~l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 96 QGQILGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CSEECHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred CCeECchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9988865321 1233444444555555555555532
Q ss_pred -------------------CCCCeEEcCCCCCCEEECC---CCc-EEEeecccceec
Q 003911 716 -------------------AHQSFIHRDLKPSNILLGD---DMR-AKVADFGLVRLA 749 (787)
Q Consensus 716 -------------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DFG~a~~~ 749 (787)
....++|+|++|.||+++. ++. +.|+||+.+..-
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1246799999999999987 455 489999988754
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.28 E-value=7.3e-08 Score=92.50 Aligned_cols=70 Identities=19% Similarity=0.209 Sum_probs=42.5
Q ss_pred cCCCCCCCCCCCcEEEeecC-CCCCC-----CCCCCCCCCCcEEEcccccCCcCC----CccccCCCCCcEEEccCCCCC
Q 003911 83 TLPSNLQNLTKLERLELQWN-SISGP-----LPSLNGLASLEVVMLSNNQFTSVP----SDFFTGLSSLQSIEIDNNPFS 152 (787)
Q Consensus 83 ~~~~~~~~l~~L~~L~L~~N-~l~~~-----~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~ 152 (787)
.+...+...+.|++|+|++| .|... ...+...++|++|+|++|+|+... ...+...++|++|+|++|.|.
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 34445666777888888887 77642 113555667777777777776421 223444556666666666665
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=1.5e-06 Score=92.88 Aligned_cols=82 Identities=10% Similarity=-0.013 Sum_probs=56.7
Q ss_pred ccee-ccccceEEEEEEEe-------CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcC-C--CccceEEeEEEeC--
Q 003911 598 ENIL-GRGGFGTVYKGELH-------DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVR-H--RHLVALLGHCLDG-- 663 (787)
Q Consensus 598 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~-- 663 (787)
.+.| +.|....+|+.+.. +++.+++|+...... .......+.+|.++++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88989999998764 267889997654220 0001246788888888884 3 3577888887655
Q ss_pred -CeeEEEEEecCCCCHH
Q 003911 664 -NEKLLVFEYMPQGTLS 679 (787)
Q Consensus 664 -~~~~lv~e~~~~gsL~ 679 (787)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.23 E-value=7.1e-08 Score=92.57 Aligned_cols=64 Identities=17% Similarity=0.168 Sum_probs=45.8
Q ss_pred ccCccCceEeccccccccC-----CCCCCCCCCCCEEec--CCCccccc----CCccccCCCCCCEEEccCCccc
Q 003911 237 QNMTSLKEIWLHSNAFSGP-----LPDFSGVKQLESLSL--RDNFFTGP----VPDSLVKLESLKIVNMTNNLLQ 300 (787)
Q Consensus 237 ~~l~~L~~L~L~~N~l~~~-----~~~~~~l~~L~~L~L--~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 300 (787)
...++|++|+|++|.|... ...+...+.|++|+| ++|.|+.. +...+...+.|++|+|++|.+.
T Consensus 90 ~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 90 KVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3456777777777777652 223566678888888 78888754 3455666788999999999876
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.21 E-value=6.6e-07 Score=90.22 Aligned_cols=104 Identities=19% Similarity=0.243 Sum_probs=61.1
Q ss_pred CCCCCCCcE--EEeecCCCCCC---CC-CCCCCCCCcEEEcccccCCcCC--CccccCCCCCcEEEccCCCCCCCCCChh
Q 003911 88 LQNLTKLER--LELQWNSISGP---LP-SLNGLASLEVVMLSNNQFTSVP--SDFFTGLSSLQSIEIDNNPFSSWEIPQS 159 (787)
Q Consensus 88 ~~~l~~L~~--L~L~~N~l~~~---~~-~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~p~~ 159 (787)
|...+.|+. ++++.|+.... .+ ...++++|++|+|++|+|++++ +..+..+++|++|+|++|+|+++ ..
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~---~~ 213 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE---RE 213 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG---GG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc---hh
Confidence 333444444 55566643221 11 1245677777777777777754 24556777777777777777752 33
Q ss_pred hhcCC--CCCEEeccCceecccCCC-------CCCCCCCCCCcEEe
Q 003911 160 LRNAS--GLQNFSANSANITGQIPS-------FFGPDEFPGLTILH 196 (787)
Q Consensus 160 ~~~l~--~L~~L~l~~n~l~~~~p~-------~~~~~~l~~L~~L~ 196 (787)
+..++ +|++|+|++|.+.+.+|. .+. .+++|+.||
T Consensus 214 l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~--~~P~L~~LD 257 (267)
T 3rw6_A 214 LDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRE--RFPKLLRLD 257 (267)
T ss_dssp GGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHH--HCTTCCEES
T ss_pred hhhcccCCcceEEccCCcCccccCcchhHHHHHHH--HCcccCeEC
Confidence 34343 777777777777765552 122 577777776
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.09 E-value=0.00013 Score=78.41 Aligned_cols=265 Identities=12% Similarity=0.096 Sum_probs=151.3
Q ss_pred CCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCC
Q 003911 87 NLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASG 165 (787)
Q Consensus 87 ~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~ 165 (787)
++....+|+.+.+.. .++.+.. +|.++.+|+.++|..+ ++.+...+|.+. +|+.+.+..+ +. .++.......+
T Consensus 41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~--~I~~~aF~~~~ 114 (379)
T 4h09_A 41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VK--KFGDYVFQGTD 114 (379)
T ss_dssp TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CC--EECTTTTTTCC
T ss_pred ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-ee--EeccceeccCC
Confidence 345556777777753 3554444 6888888888888643 777777788776 5777776544 33 33333333346
Q ss_pred CCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceE
Q 003911 166 LQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEI 245 (787)
Q Consensus 166 L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L 245 (787)
|+.+.+..+ ++......|. -.+|+.+.+..+ ++.... ..+.++.+++.+
T Consensus 115 L~~i~lp~~-~~~i~~~~F~---~~~l~~~~~~~~-v~~i~~--------------------------~~f~~~~~l~~~ 163 (379)
T 4h09_A 115 LDDFEFPGA-TTEIGNYIFY---NSSVKRIVIPKS-VTTIKD--------------------------GIGYKAENLEKI 163 (379)
T ss_dssp CSEEECCTT-CCEECTTTTT---TCCCCEEEECTT-CCEECS--------------------------CTTTTCTTCCEE
T ss_pred cccccCCCc-cccccccccc---cceeeeeeccce-eecccc--------------------------chhccccccccc
Confidence 777776544 2223233332 123444433322 111111 224456666666
Q ss_pred eccccccccC-------------CCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCC-CCCCcee
Q 003911 246 WLHSNAFSGP-------------LPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVP-EFDRSVS 311 (787)
Q Consensus 246 ~L~~N~l~~~-------------~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~~~ 311 (787)
.+..+..... ...+.....+..+.+..+.-. .....+..+.+|+.+.+..+- +.... .+..+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~~-~~i~~~~f~~~~~ 241 (379)
T 4h09_A 164 EVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSGV-TTLGDGAFYGMKA 241 (379)
T ss_dssp EECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTTC-CEECTTTTTTCSS
T ss_pred ccccccceeecccceecccccceeccccccccccccccccceeE-Eeecccccccccceeeeccce-eEEccccccCCcc
Confidence 6655433211 112445566777776655444 566777888889988886652 22222 2344444
Q ss_pred eeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhc
Q 003911 312 LDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFA 391 (787)
Q Consensus 312 L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~ 391 (787)
|+.+.+..+. ..+. ...+....+|+.+.+.. ++.......|.
T Consensus 242 L~~i~lp~~v-~~I~------------------------------------~~aF~~~~~l~~i~l~~-~i~~i~~~aF~ 283 (379)
T 4h09_A 242 LDEIAIPKNV-TSIG------------------------------------SFLLQNCTALKTLNFYA-KVKTVPYLLCS 283 (379)
T ss_dssp CCEEEECTTC-CEEC------------------------------------TTTTTTCTTCCEEEECC-CCSEECTTTTT
T ss_pred ceEEEcCCCc-cEeC------------------------------------ccccceeehhccccccc-cceeccccccc
Confidence 4443332221 0000 01122334677777754 35555566788
Q ss_pred CCCCCCEEecccccccccCCccCcCCCCCCeeeccCC
Q 003911 392 SFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNN 428 (787)
Q Consensus 392 ~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N 428 (787)
++++|+.+++.++.++..-...|.++.+|+.++|..+
T Consensus 284 ~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 284 GCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp TCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred cccccccccccccccceehhhhhcCCCCCCEEEcCcc
Confidence 9999999999998888555678899999999998654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.06 E-value=3.4e-05 Score=81.72 Aligned_cols=145 Identities=16% Similarity=0.194 Sum_probs=82.3
Q ss_pred cceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcC--CCccceEEe------EEEeCCeeEEE
Q 003911 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR--HRHLVALLG------HCLDGNEKLLV 669 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~------~~~~~~~~~lv 669 (787)
.+.|+.|..+.||++...+| .+++|+.... ..++..|.++++.+. .-.+++++. +....+..+++
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 34566677899999987644 5899988651 133445555555552 112333332 22346678999
Q ss_pred EEecCCCCHH-----------H---HHHhhhhcC--C-------CCCCHHHH----------------------------
Q 003911 670 FEYMPQGTLS-----------R---HIFNWAEEG--L-------KPLEWNRR---------------------------- 698 (787)
Q Consensus 670 ~e~~~~gsL~-----------~---~l~~~~~~~--~-------~~l~~~~~---------------------------- 698 (787)
|||++|..+. + .++...... . ....|...
T Consensus 110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 189 (346)
T 2q83_A 110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL 189 (346)
T ss_dssp EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence 9999986542 1 112111110 0 00122110
Q ss_pred ---HHHHHHHHHHHHHHHh----------CCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 699 ---LTIALDVARGVEYLHG----------LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 699 ---~~i~~qi~~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
..+..++..++++|+. .....++|+|+++.||+++.++.+.|+||+.+..-
T Consensus 190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 1111234445666652 02478999999999999987888999999988643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=2.8e-05 Score=84.33 Aligned_cols=77 Identities=12% Similarity=0.094 Sum_probs=50.9
Q ss_pred cceeccccceEEEEEEEe-CCcEEEEEEeecccc--c---chhHHHHHHHHHHHHhcCC--C-ccceEEeEEEeCCeeEE
Q 003911 598 ENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI--S---GKGLTEFKSEIAVLTKVRH--R-HLVALLGHCLDGNEKLL 668 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~---~~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~l 668 (787)
.+.+|.|.++.||+++.. +++.++||....... . ....+++..|.++++.+.. | .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999654 468899998653211 0 1123567789999988742 3 34456544 4455689
Q ss_pred EEEecCCC
Q 003911 669 VFEYMPQG 676 (787)
Q Consensus 669 v~e~~~~g 676 (787)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=8.6e-05 Score=76.99 Aligned_cols=141 Identities=15% Similarity=0.155 Sum_probs=93.7
Q ss_pred ccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcC---CCccceEEeEEEeCCeeEEEEEec
Q 003911 597 EENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR---HRHLVALLGHCLDGNEKLLVFEYM 673 (787)
Q Consensus 597 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~ 673 (787)
..+.|+.|....+|+.+. ++..+++|+.... ....+..|.+.++.+. ...++++++++...+..++||||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 356789999999999876 4678899987542 3567899999998883 367889999988888899999999
Q ss_pred CCCCHH--------HH---HHhhhh-cCC----------------CCCCHHHHH---HHHH----------------HHH
Q 003911 674 PQGTLS--------RH---IFNWAE-EGL----------------KPLEWNRRL---TIAL----------------DVA 706 (787)
Q Consensus 674 ~~gsL~--------~~---l~~~~~-~~~----------------~~l~~~~~~---~i~~----------------qi~ 706 (787)
++..+. +. ++.... ... -.-+|.... ++.. +++
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 987652 11 222111 000 012354322 1111 111
Q ss_pred HH-HHHHHh-CCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 707 RG-VEYLHG-LAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 707 ~~-L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
.. ...|.. ..+..+||+|+.+.|++++.++ +.|+||.
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 123321 1246899999999999999887 8999984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00016 Score=74.41 Aligned_cols=79 Identities=19% Similarity=0.196 Sum_probs=57.9
Q ss_pred CCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-C--CccceEEeEEEeCCeeEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-H--RHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~lv~ 670 (787)
...-.+.+|.|..+.||+.+..+|+.|++|+..... ......|+.|.+.|+.+. . -.+++++++. ..++||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 455567899999999999999999999999865432 222346889999999884 2 2345555542 347899
Q ss_pred EecCCCCH
Q 003911 671 EYMPQGTL 678 (787)
Q Consensus 671 e~~~~gsL 678 (787)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00019 Score=78.22 Aligned_cols=75 Identities=13% Similarity=0.158 Sum_probs=47.3
Q ss_pred cceeccccceEEEEEEEeCCcEEEEEEeecccc--cc-----hhHHHHHHHHHHHHh-cCCCccceEEeEEEeCCeeEEE
Q 003911 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVI--SG-----KGLTEFKSEIAVLTK-VRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~-----~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv 669 (787)
.+.+|.|....||++.. +++.++||....... .. .....++.|+..+.. .....+++++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 56789999999999964 467899995432110 11 123344444443332 2335667777665 5667999
Q ss_pred EEec-CC
Q 003911 670 FEYM-PQ 675 (787)
Q Consensus 670 ~e~~-~~ 675 (787)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00033 Score=73.33 Aligned_cols=159 Identities=13% Similarity=0.148 Sum_probs=87.0
Q ss_pred HHHHHhhcCCCcc-----cceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCc--cceEE
Q 003911 585 IQVLRNVTNNFSE-----ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH--LVALL 657 (787)
Q Consensus 585 ~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~ 657 (787)
.+++..+...|.+ .+.|+.|....+|+....+| .+++|+.... ...+++..|.++++.+.... +++++
T Consensus 9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 3444444444543 34567788899999987655 6889988652 12235667777777763212 33333
Q ss_pred eE------EEeCCeeEEEEEecCCCCHHH-----------H---HHhhhhc-CCC---CC---CHHHHHH----------
Q 003911 658 GH------CLDGNEKLLVFEYMPQGTLSR-----------H---IFNWAEE-GLK---PL---EWNRRLT---------- 700 (787)
Q Consensus 658 ~~------~~~~~~~~lv~e~~~~gsL~~-----------~---l~~~~~~-~~~---~l---~~~~~~~---------- 700 (787)
.. ....+..+++|+|++|..+.. . ++..... ... .. .|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 223456789999998865321 1 1111100 000 00 1211100
Q ss_pred --HHHHHHHHHHHHHhC----CCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 701 --IALDVARGVEYLHGL----AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 701 --i~~qi~~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
+...+...+++++.. .+.+++|+|+++.||+++++..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455555531 135799999999999998876568999998764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.47 E-value=3e-05 Score=72.35 Aligned_cols=58 Identities=17% Similarity=0.200 Sum_probs=30.1
Q ss_pred CCCcEEEeecCCCCC-CCCCCCCCCCCcEEEcccc-cCCcCCCccccCC----CCCcEEEccCC
Q 003911 92 TKLERLELQWNSISG-PLPSLNGLASLEVVMLSNN-QFTSVPSDFFTGL----SSLQSIEIDNN 149 (787)
Q Consensus 92 ~~L~~L~L~~N~l~~-~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l----~~L~~L~L~~N 149 (787)
.+|++|||+++.|+. .+..+.++++|++|+|++| +|+.-.-..++.+ ++|++|+|+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C 124 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISC 124 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESC
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCC
Confidence 356666666666544 2224555666666666665 3544332333333 24666666655
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00031 Score=73.92 Aligned_cols=144 Identities=15% Similarity=0.116 Sum_probs=74.9
Q ss_pred ceeccccceE-EEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-C-CccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRGGFGT-VYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-H-RHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.|+.|.... +|+....++..+++|...... ..++..|+++++.+. + -.+++++.+....+ +++||++.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~-----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE-----GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT-----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC-----CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 4566665554 667765446778887654321 123456677777663 2 23566776643333 789999977
Q ss_pred CCHHHHHHhhh------------------hc---CCCCCCHHHHH-------H-------------HHHHHHHHHHHHH-
Q 003911 676 GTLSRHIFNWA------------------EE---GLKPLEWNRRL-------T-------------IALDVARGVEYLH- 713 (787)
Q Consensus 676 gsL~~~l~~~~------------------~~---~~~~l~~~~~~-------~-------------i~~qi~~~L~~LH- 713 (787)
..+.+++.... .. ....++..... . ....+...++.+.
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 66654442110 00 01112211100 0 0011112222221
Q ss_pred --hCCCCCeEEcCCCCCCEEECCC----CcEEEeecccceec
Q 003911 714 --GLAHQSFIHRDLKPSNILLGDD----MRAKVADFGLVRLA 749 (787)
Q Consensus 714 --~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFG~a~~~ 749 (787)
......++|||+.+.||+++.+ +.+.|+||+.+..-
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1124689999999999999874 68999999988754
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00026 Score=62.99 Aligned_cols=55 Identities=15% Similarity=0.376 Sum_probs=38.4
Q ss_pred EEEeecCCCC--CCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCC
Q 003911 96 RLELQWNSIS--GPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFS 152 (787)
Q Consensus 96 ~L~L~~N~l~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 152 (787)
.++.+++.++ .++..+. ++|++|+|++|+|+.++++.|..+++|++|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555555555 3332322 35778888888888888888888888888888888765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00087 Score=70.23 Aligned_cols=145 Identities=13% Similarity=0.049 Sum_probs=83.3
Q ss_pred ceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCC--ccceEEeE-----EEeCCeeEEEEE
Q 003911 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR--HLVALLGH-----CLDGNEKLLVFE 671 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e 671 (787)
+.++ |....||++...+|+.+++|+...... ...++..|.++++.+... .+++++.. ....+..+++||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 888899998776777899999864322 235677788888877421 24444443 223456688999
Q ss_pred ecCCCCHH----H-------H---HHhhhhcC----CCCCCHHHH----HH---------------HHHHHHHHHHHHHh
Q 003911 672 YMPQGTLS----R-------H---IFNWAEEG----LKPLEWNRR----LT---------------IALDVARGVEYLHG 714 (787)
Q Consensus 672 ~~~~gsL~----~-------~---l~~~~~~~----~~~l~~~~~----~~---------------i~~qi~~~L~~LH~ 714 (787)
|++|..+. + . ++...... ....++... .. +...+...++.+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99875432 1 1 11111100 011222111 00 11111122333321
Q ss_pred C----CCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 715 L----AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 715 ~----~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
. ....++|+|+++.||+++ + .+.|+||+.+..-
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 1 235689999999999998 4 8999999887643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0004 Score=71.87 Aligned_cols=141 Identities=16% Similarity=0.105 Sum_probs=76.8
Q ss_pred cceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCcc-ceEEeEEEeCCeeEEEEEec-CC
Q 003911 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL-VALLGHCLDGNEKLLVFEYM-PQ 675 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~ 675 (787)
.+.|+.|....+|+. ..+++|+...... ......+|.++++.+....+ .+++++ +.+.-++++||+ ++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 678999999999998 5688888764211 11223567777777742222 455544 344457899999 66
Q ss_pred CCHHHH---------------HHhhhhcCC---CCCC-HHHHHHHHH--------------HHHHHHH----HHHh-CCC
Q 003911 676 GTLSRH---------------IFNWAEEGL---KPLE-WNRRLTIAL--------------DVARGVE----YLHG-LAH 717 (787)
Q Consensus 676 gsL~~~---------------l~~~~~~~~---~~l~-~~~~~~i~~--------------qi~~~L~----~LH~-~~~ 717 (787)
.++... +........ .... +.....+.. .+.+.+. .+.. ...
T Consensus 93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~ 172 (301)
T 3dxq_A 93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP 172 (301)
T ss_dssp EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence 544321 101000000 0011 111111110 0111111 1111 123
Q ss_pred CCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 718 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
..++|+|+.|.||+ .+++.+.++||..+..-
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 46899999999999 56667899999988754
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.34 E-value=3.8e-05 Score=71.71 Aligned_cols=83 Identities=16% Similarity=0.144 Sum_probs=66.2
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCC-CCC-CCCCCCCC----CCCcEEEcccc-cCCcCCCccccCCCC
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNS-ISG-PLPSLNGL----ASLEVVMLSNN-QFTSVPSDFFTGLSS 140 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~l----~~L~~L~L~~N-~l~~~~~~~~~~l~~ 140 (787)
-+++.||++++.++..--..+..+++|++|+|+++. |+. .+..+..+ ++|++|+|++| +|+.---..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999886555668899999999999995 665 22345554 47999999998 588654456788999
Q ss_pred CcEEEccCCC
Q 003911 141 LQSIEIDNNP 150 (787)
Q Consensus 141 L~~L~L~~N~ 150 (787)
|++|+|++..
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 9999999885
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00061 Score=74.24 Aligned_cols=73 Identities=15% Similarity=0.129 Sum_probs=49.8
Q ss_pred cceeccccceEEEEEEEeC--------CcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCeeEE
Q 003911 598 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 668 (787)
.+.|+.|-...||++...+ ++.+++|+..... ..+.+.+|..+++.+. +.-.+++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 4678888899999998753 5789999874311 1145557999888884 3333667765432 38
Q ss_pred EEEecCCCCH
Q 003911 669 VFEYMPQGTL 678 (787)
Q Consensus 669 v~e~~~~gsL 678 (787)
|+||++|.++
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00096 Score=71.03 Aligned_cols=144 Identities=15% Similarity=0.157 Sum_probs=84.2
Q ss_pred cceeccccceEEEEEEEe--------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCeeEE
Q 003911 598 ENILGRGGFGTVYKGELH--------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 668 (787)
.+.+..|-...+|++... +++.+++|+.... ......+.+|.++++.+. +.-..++++++.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 356777888899998764 2478999986331 123456678999998884 3334667666543 28
Q ss_pred EEEecCCCCHHH--------------HHHhhhhcC---CCCC--CHHHHHHHHHHHHH-------------------HHH
Q 003911 669 VFEYMPQGTLSR--------------HIFNWAEEG---LKPL--EWNRRLTIALDVAR-------------------GVE 710 (787)
Q Consensus 669 v~e~~~~gsL~~--------------~l~~~~~~~---~~~l--~~~~~~~i~~qi~~-------------------~L~ 710 (787)
||||++|.++.. .+...-... .+.. -+.++.++..++.. .++
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999999865531 111111110 1112 23455555544322 233
Q ss_pred HHH----h-CCCCCeEEcCCCCCCEEECCC----CcEEEeeccccee
Q 003911 711 YLH----G-LAHQSFIHRDLKPSNILLGDD----MRAKVADFGLVRL 748 (787)
Q Consensus 711 ~LH----~-~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFG~a~~ 748 (787)
+|. . .....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 1 123568999999999999876 7899999998864
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.00096 Score=59.21 Aligned_cols=56 Identities=18% Similarity=0.168 Sum_probs=47.6
Q ss_pred ceEeccccccc--cCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCccc
Q 003911 243 KEIWLHSNAFS--GPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300 (787)
Q Consensus 243 ~~L~L~~N~l~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 300 (787)
..++.+++.++ .+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 47899999998 6665554 67999999999999666677899999999999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0035 Score=68.55 Aligned_cols=74 Identities=12% Similarity=0.065 Sum_probs=48.4
Q ss_pred cceeccccceEEEEEEEeC-CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCcc-ceEEeEEEeCCeeEEEEEecCC
Q 003911 598 ENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL-VALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~ 675 (787)
.+.|+.|-...+|++...+ +..+++|+..... . ...+..+|..+++.+...++ +++++++. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--D-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--C-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--h-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4678888899999998764 4788999875421 1 11122688999999864444 56776662 2 359999987
Q ss_pred CCH
Q 003911 676 GTL 678 (787)
Q Consensus 676 gsL 678 (787)
.++
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0012 Score=70.52 Aligned_cols=74 Identities=16% Similarity=0.138 Sum_probs=45.1
Q ss_pred cceeccccceEEEEEEEeC---------CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCc-cceEEeEEEeCCeeE
Q 003911 598 ENILGRGGFGTVYKGELHD---------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH-LVALLGHCLDGNEKL 667 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~ 667 (787)
.+.++.|....+|++...+ +..+++|+..... ....+...|.++++.+...+ ++++++.. . -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 3567888888999998754 2688899875421 11123467888888874323 45666544 2 37
Q ss_pred EEEEecCCCCH
Q 003911 668 LVFEYMPQGTL 678 (787)
Q Consensus 668 lv~e~~~~gsL 678 (787)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0049 Score=64.82 Aligned_cols=32 Identities=25% Similarity=0.446 Sum_probs=28.5
Q ss_pred CCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 718 QSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 718 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
..++|+|+.+.||++++++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 57999999999999998888999999887654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.63 E-value=0.00024 Score=67.54 Aligned_cols=65 Identities=15% Similarity=0.138 Sum_probs=43.5
Q ss_pred cccCccCceEeccccccccCC-----CCCCCCCCCCEEecCCCc---ccc----cCCccccCCCCCCEEEccCCccc
Q 003911 236 IQNMTSLKEIWLHSNAFSGPL-----PDFSGVKQLESLSLRDNF---FTG----PVPDSLVKLESLKIVNMTNNLLQ 300 (787)
Q Consensus 236 ~~~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~L~~N~---l~~----~~p~~l~~l~~L~~L~Ls~N~l~ 300 (787)
+..-+.|++|+|++|.|...- ..+..-+.|+.|+|++|. +.. .+.+.+..-+.|+.|+++.|.+.
T Consensus 94 L~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 94 IETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 345567888888888886422 135556778899998653 332 24455666788999999887654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.59 E-value=0.00036 Score=66.36 Aligned_cols=112 Identities=14% Similarity=0.213 Sum_probs=49.0
Q ss_pred CCCCCCcEEEeecC-CCCCC-----CCCCCCCCCCcEEEcccccCCcCC----CccccCCCCCcEEEccCCCCCCC---C
Q 003911 89 QNLTKLERLELQWN-SISGP-----LPSLNGLASLEVVMLSNNQFTSVP----SDFFTGLSSLQSIEIDNNPFSSW---E 155 (787)
Q Consensus 89 ~~l~~L~~L~L~~N-~l~~~-----~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~---~ 155 (787)
.+-+.|++|+|++| +|... -.++..-+.|+.|+|++|+|...- .+++..-+.|++|+|++|.|... .
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a 117 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 117 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence 33445555555553 44321 012333445555555555555321 22233445555555555555420 0
Q ss_pred CChhhhcCCCCCEEeccCc---eeccc----CCCCCCCCCCCCCcEEecccccc
Q 003911 156 IPQSLRNASGLQNFSANSA---NITGQ----IPSFFGPDEFPGLTILHLAFNQL 202 (787)
Q Consensus 156 ~p~~~~~l~~L~~L~l~~n---~l~~~----~p~~~~~~~l~~L~~L~L~~N~l 202 (787)
+-+.+..-+.|+.|+|++| .+... +...+. .-+.|+.|+++.|.+
T Consensus 118 la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~--~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 118 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIE--ENESLLRVGISFASM 169 (197)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHH--HCSSCCEEECCCCCH
T ss_pred HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHH--hCCCcCeEeccCCCc
Confidence 1122333344666666543 22211 111121 335667777766654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.75 E-value=0.027 Score=60.64 Aligned_cols=143 Identities=13% Similarity=0.173 Sum_probs=85.2
Q ss_pred cceeccccceEEEEEEEeC--------CcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCeeEE
Q 003911 598 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 668 (787)
.+.+..|-...+|+....+ ++.+++|+..... ....+.++|.++++.+. +.-..++++.+ . -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence 4567778889999998753 5789999865421 11223467888888874 33345666533 2 278
Q ss_pred EEEecCCCCHHH--------------H---HHhhhh-----c---CCCCCCHHHHHHHHHHH------------------
Q 003911 669 VFEYMPQGTLSR--------------H---IFNWAE-----E---GLKPLEWNRRLTIALDV------------------ 705 (787)
Q Consensus 669 v~e~~~~gsL~~--------------~---l~~~~~-----~---~~~~l~~~~~~~i~~qi------------------ 705 (787)
||||++|..+.. . ++.... . ...+.-+.++.++..++
T Consensus 148 I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 227 (424)
T 3mes_A 148 IEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSK 227 (424)
T ss_dssp EEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHH
T ss_pred EEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHH
Confidence 999999865421 0 111111 0 11111244443333222
Q ss_pred -HHHHHHHHh---------------------CCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 706 -ARGVEYLHG---------------------LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 706 -~~~L~~LH~---------------------~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
...+++|.. ..+..++|+|+.+.||+ ++++.+.++||..|..
T Consensus 228 l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 228 ILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 222333321 11346899999999999 7888999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.09 E-value=0.26 Score=52.81 Aligned_cols=30 Identities=30% Similarity=0.501 Sum_probs=25.4
Q ss_pred CeEEcCCCCCCEEE------CCCCcEEEeeccccee
Q 003911 719 SFIHRDLKPSNILL------GDDMRAKVADFGLVRL 748 (787)
Q Consensus 719 ~ivH~Dlkp~NIll------~~~~~~kl~DFG~a~~ 748 (787)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.81 E-value=2 Score=41.00 Aligned_cols=86 Identities=10% Similarity=0.048 Sum_probs=63.0
Q ss_pred CCCccceEEeEEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEEcCCCC
Q 003911 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE-YLHGLAHQSFIHRDLKP 727 (787)
Q Consensus 649 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~-~LH~~~~~~ivH~Dlkp 727 (787)
.||++ -..+-.+.+...+.++.-+++.=...+ ..++...+++++..|+...+ +++ .-+|--+.|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeC
Confidence 57888 444556777777777765443222333 24778889999999888776 555 358889999
Q ss_pred CCEEECCCCcEEEeecccceec
Q 003911 728 SNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 728 ~NIll~~~~~~kl~DFG~a~~~ 749 (787)
+||+++.++.+++.-.|+-..+
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~l 134 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKESL 134 (219)
T ss_dssp GGEEECTTCCEEESCCEETTTB
T ss_pred ceEEEeCCCcEEEEEcCCcccC
Confidence 9999999999999998875444
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.71 E-value=0.14 Score=55.94 Aligned_cols=64 Identities=9% Similarity=0.055 Sum_probs=18.7
Q ss_pred cccceeccccceEEEEEEEeC-CcEEEE------EEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe
Q 003911 596 SEENILGRGGFGTVYKGELHD-GTKIAV------KRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD 662 (787)
Q Consensus 596 ~~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 662 (787)
.+.+.+| ||.||+|.+.. ..+||| |..+...........+.+|..+++..+|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3456676 99999998753 367888 7766544445555678889999999999999999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 787 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-49 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-45 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-44 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-41 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-32 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-31 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-25 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.002 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-11 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.004 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-51
Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ +G G FGTVYKG+ H +AVK + + + L FK+E+ VL K RH +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
++ +G+ + +V ++ +L H+ E + + IA A+G++YL
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYL 120
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE-TRIAGTFGYLAPEY 771
H +S IHRDLK +NI L +D+ K+ DFGL + GS + +++G+ ++APE
Sbjct: 121 H---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 772 AVHTRWSSCSY 782
+ S+
Sbjct: 178 IRMQDKNPYSF 188
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 2e-49
Identities = 52/189 (27%), Positives = 90/189 (47%), Gaps = 10/189 (5%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
LG G FG V+ G + TK+AVK ++ G +S F +E ++ +++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQR 69
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
LV L ++ EYM G+L + L N+ L +A +A G+ ++
Sbjct: 70 LVRLYAVVTQEP-IYIITEYMENGSLVDFLKT---PSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
+++IHRDL+ +NIL+ D + K+ADFGL RL + + + + APE
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 773 VHTRWSSCS 781
+ ++ S
Sbjct: 183 NYGTFTIKS 191
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 3e-48
Identities = 48/195 (24%), Positives = 82/195 (42%), Gaps = 13/195 (6%)
Query: 592 TNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH 650
++F + + LG G G V+K G +A K + I + E+ VL +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNS 63
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
++V G E + E+M G+L + + + +++ V +G+
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLT 118
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
YL +HRD+KPSNIL+ K+ DFG+ + S+ GT Y++PE
Sbjct: 119 YLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPE 173
Query: 771 YAVHTRWSSCS-YWA 784
T +S S W+
Sbjct: 174 RLQGTHYSVQSDIWS 188
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-47
Identities = 52/191 (27%), Positives = 83/191 (43%), Gaps = 10/191 (5%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ + LG G FG V G+ +A+K ++ G +S EF E V+ + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEK 60
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
LV L G C ++ EYM G L ++ + + L + DV +EYL
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYL 116
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
+ F+HRDL N L+ D KV+DFGL R + + + + PE
Sbjct: 117 E---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 773 VHTRWSSCSYW 783
+++++SS S
Sbjct: 174 MYSKFSSKSDI 184
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-47
Identities = 58/191 (30%), Positives = 89/191 (46%), Gaps = 10/191 (5%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ + +G G FG V+ G + K+A+K + G +S + +F E V+ K+ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPK 61
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
LV L G CL+ LVFE+M G LS ++ L + LDV G+ YL
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYL 117
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
IHRDL N L+G++ KV+DFG+ R + + + T + +PE
Sbjct: 118 E---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 773 VHTRWSSCSYW 783
+R+SS S
Sbjct: 175 SFSRYSSKSDV 185
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (425), Expect = 4e-47
Identities = 49/184 (26%), Positives = 77/184 (41%), Gaps = 15/184 (8%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTK 647
+ FS+ +G G FG VY + + +A+K+M +G S + + E+ L K
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+RH + + G L + LV EY + KPL+ + +
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQ 126
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
G+ YLH + IHRD+K NILL + K+ DFG + GT ++
Sbjct: 127 GLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWM 178
Query: 768 APEY 771
APE
Sbjct: 179 APEV 182
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-46
Identities = 54/195 (27%), Positives = 84/195 (43%), Gaps = 14/195 (7%)
Query: 593 NNFSEENILGRGGFGTVYKGEL-HDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTKVRH 650
+F LG+G FG VY +A+K + + G+ + E+ + + +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+++ L G+ D L+ EY P GT+ R + + R T ++A +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALS 120
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
Y H + IHRD+KP N+LLG K+ADFG AP + T + GT YL PE
Sbjct: 121 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPE 174
Query: 771 YAVHTRWS-SCSYWA 784
W+
Sbjct: 175 MIEGRMHDEKVDLWS 189
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-45
Identities = 59/193 (30%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ E LG+G FG V+ G + T++A+K ++ G +S + F E V+ K+RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 73
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
LV L +V EYM +G+L + E K L + + +A +A G+ Y+
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
+++HRDL+ +NIL+G+++ KVADFGL RL + + + + APE A
Sbjct: 130 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 773 VHTRWSSCS-YWA 784
++ R++ S W+
Sbjct: 187 LYGRFTIKSDVWS 199
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-45
Identities = 46/197 (23%), Positives = 82/197 (41%), Gaps = 8/197 (4%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
++ +G G +G K DG + K ++ G ++ SE+ +L +++H +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 653 LVALLGHCLDGNEKLL--VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
+V +D L V EY G L+ I +E + L+ L + + ++
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALK 123
Query: 711 YLH--GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 768
H + +HRDLKP+N+ L K+ DFGL R+ S GT Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMS 182
Query: 769 PEYAVHTRWS-SCSYWA 784
PE ++ W+
Sbjct: 183 PEQMNRMSYNEKSDIWS 199
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-45
Identities = 48/192 (25%), Positives = 88/192 (45%), Gaps = 14/192 (7%)
Query: 597 EENILGRGGFGTVYKGELHD---GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL 653
E+ LG G FGTV KG +AVK ++ E +E V+ ++ + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 654 VALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
V ++G C + +LV E G L++++ + ++ + + V+ G++YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE 124
Query: 714 GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFGYLAPEY 771
+F+HRDL N+LL AK++DFGL + + + + + APE
Sbjct: 125 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 772 AVHTRWSSCSYW 783
+ ++SS S
Sbjct: 182 INYYKFSSKSDV 193
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 5e-45
Identities = 49/194 (25%), Positives = 76/194 (39%), Gaps = 11/194 (5%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
N + + LG G FG VYK + + A K ++ S + L ++ EI +L
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASC 66
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
H ++V LL N ++ E+ G + + +PL ++ +
Sbjct: 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDA 122
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 768
+ YLH IHRDLK NIL D K+ADFG+ GT ++A
Sbjct: 123 LNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMA 178
Query: 769 PEYAVHTRWSSCSY 782
PE + Y
Sbjct: 179 PEVVMCETSKDRPY 192
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 9e-45
Identities = 60/192 (31%), Positives = 97/192 (50%), Gaps = 16/192 (8%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+G+G FG V G+ + G K+AVK ++ + F +E +V+T++RH +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSN 61
Query: 653 LVALLGHCLDGNEKL-LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
LV LLG ++ L +V EYM +G+L ++ + G L + L +LDV +EY
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
L +F+HRDL N+L+ +D AKV+DFGL + A S + + APE
Sbjct: 119 LE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEA 171
Query: 772 AVHTRWSSCSYW 783
++S+ S
Sbjct: 172 LREKKFSTKSDV 183
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 160 bits (405), Expect = 1e-44
Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 10/192 (5%)
Query: 593 NNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+ + ++ LG G +G VY+G +AVK ++ + + EF E AV+ +++H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHP 73
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
+LV LLG C ++ E+M G L ++ E + + L +A ++ +EY
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLR---ECNRQEVSAVVLLYMATQISSAMEY 130
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
L ++FIHRDL N L+G++ KVADFGL RL + + APE
Sbjct: 131 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 772 AVHTRWSSCSYW 783
+ ++S S
Sbjct: 188 LAYNKFSIKSDV 199
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 49/193 (25%), Positives = 82/193 (42%), Gaps = 15/193 (7%)
Query: 598 ENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVAL 656
+ +GRG F TVYKG + ++A ++ ++ FK E +L ++H ++V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 657 LGHCLD----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+LV E M GTL ++ + K ++ + + +G+++L
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFL 128
Query: 713 HGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
H IHRDLK NI + G K+ D GL L + S + GT ++APE
Sbjct: 129 H-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM 184
Query: 772 AVHTRWSSCSYWA 784
S +A
Sbjct: 185 YEEKYDESVDVYA 197
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 4e-44
Identities = 54/217 (24%), Positives = 86/217 (39%), Gaps = 30/217 (13%)
Query: 593 NNFSEENILGRGGFGTVYKGELHD------GTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
N +LG G FG V + ++AVK ++ S + SE+ ++T
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-REALMSELKMMT 95
Query: 647 KV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN------------------WAE 687
++ H ++V LLG C L+FEY G L ++ + E
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 688 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
E L L + L A VA+G+E+L +S +HRDL N+L+ K+ DFGL R
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 748 LAPEGKG-SIETRIAGTFGYLAPEYAVHTRWSSCSYW 783
+ ++APE ++ S
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (402), Expect = 4e-44
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 30/217 (13%)
Query: 593 NNFSEENILGRGGFGTVYKGEL------HDGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
NN +G G FG V++ T +AVK ++ S +F+ E A++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMA 71
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN-------------------WAE 687
+ + ++V LLG C G L+FEYM G L+ + + +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 688 EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
G PL +L IA VA G+ YL + F+HRDL N L+G++M K+ADFGL R
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR 188
Query: 748 LAPEGKGS-IETRIAGTFGYLAPEYAVHTRWSSCSYW 783
+ A ++ PE + R+++ S
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-43
Identities = 47/181 (25%), Positives = 71/181 (39%), Gaps = 11/181 (6%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
++ LG G +G V +AVK ++ K EI + + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHE 63
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
++V GH +GN + L EY G L I + + GV Y
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVY 118
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIETRIAGTFGYLAPE 770
LH HRD+KP N+LL + K++DFGL + + ++ GT Y+APE
Sbjct: 119 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 771 Y 771
Sbjct: 176 L 176
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-43
Identities = 48/198 (24%), Positives = 85/198 (42%), Gaps = 15/198 (7%)
Query: 592 TNNFSEENI-LGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
+N +I LG G FG+V +G +A+K ++ G E E ++ +
Sbjct: 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQ 65
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+ + ++V L+G C +LV E G L + + + + + + V+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSM 120
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETR--IAGTFG 765
G++YL ++F+HRDL N+LL + AK++DFGL + R
Sbjct: 121 GMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 766 YLAPEYAVHTRWSSCSYW 783
+ APE ++SS S
Sbjct: 178 WYAPECINFRKFSSRSDV 195
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-43
Identities = 53/212 (25%), Positives = 84/212 (39%), Gaps = 25/212 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
N S LG G FG V + + +AVK ++ + SE+ VL+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-REALMSELKVLS 81
Query: 647 KV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFN-------------WAEEGLKP 692
+ H ++V LLG C G L++ EY G L + E+
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 693 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752
L+ L+ + VA+G+ +L ++ IHRDL NILL K+ DFGL R
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 753 KGS-IETRIAGTFGYLAPEYAVHTRWSSCSYW 783
++ ++APE + ++ S
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDV 230
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (388), Expect = 3e-42
Identities = 47/219 (21%), Positives = 92/219 (42%), Gaps = 26/219 (11%)
Query: 584 SIQVLRNVTNNFSEE---------NILGRGGFGTVYKGELHDGTK----IAVKRMEAGVI 630
+ + F++E ++G G FG V G L K +A+K +++G
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY- 66
Query: 631 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 690
+ K +F SE +++ + H +++ L G +++ E+M G+L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND---- 122
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750
+ + + +A G++YL +++HRDL NIL+ ++ KV+DFGL R
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 751 EGKGSIETR----IAGTFGYLAPEYAVHTR-WSSCSYWA 784
+ + APE + + S+ W+
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWS 218
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 5e-42
Identities = 48/196 (24%), Positives = 92/196 (46%), Gaps = 15/196 (7%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGT-----KIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
+ + + ++G G FG VYKG L + +A+K ++AG K +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQ 65
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
H +++ L G +++ EYM G L + + + + + +A
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAA 121
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIA--GTFG 765
G++YL + +++HRDL NIL+ ++ KV+DFGL R+ + + T
Sbjct: 122 GMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 766 YLAPEYAVHTRWSSCS 781
+ APE + +++S S
Sbjct: 179 WTAPEAISYRKFTSAS 194
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 5e-42
Identities = 45/186 (24%), Positives = 78/186 (41%), Gaps = 22/186 (11%)
Query: 598 ENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALL 657
+ +G+G FG V++G+ G ++AVK + + ++EI +RH +++ +
Sbjct: 8 QESIGKGRFGEVWRGK-WRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 63
Query: 658 GHCLDGNEKL----LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH 713
N LV +Y G+L ++ + + +AL A G+ +LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLH 117
Query: 714 -----GLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE---TRIAGTFG 765
+ HRDLK NIL+ + +AD GL +I+ GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 766 YLAPEY 771
Y+APE
Sbjct: 178 YMAPEV 183
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 585 IQVLRNVTNNFSEENILGRGGFGTVYKGELHD-----GTKIAVKRMEAGVISGKGLTEFK 639
+++L+ F + +LG G FGTVYKG +A+K + S K E
Sbjct: 3 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEIL 59
Query: 640 SEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRL 699
E V+ V + H+ LLG CL +L+ + MP G L ++ E + L
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL----LDYVREHKDNIGSQYLL 114
Query: 700 TIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR-LAPEGKGSIET 758
+ +A+G+ YL + +HRDL N+L+ K+ DFGL + L E K
Sbjct: 115 NWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
Query: 759 RIAGTFGYLAPEYAVHTRWSSCSYW 783
++A E +H ++ S
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDV 196
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-41
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKV- 648
N+ ++++G G FG V K + A+KRM+ S +F E+ VL K+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLG 68
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHI-----------FNWAEEGLKPLEWNR 697
H +++ LLG C L EY P G L + F A L +
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 698 RLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE 757
L A DVARG++YL + FIHRDL NIL+G++ AK+ADFGL R
Sbjct: 129 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-- 183
Query: 758 TRIAGTFGYLAPEYAVHTRWSSCS 781
T ++A E ++ +++ S
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNS 207
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 55/195 (28%), Positives = 82/195 (42%), Gaps = 12/195 (6%)
Query: 594 NFSEENILGRGGFGTVYKG-ELHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRHR 651
+F ILG G F TV EL + A+K +E +I + E V++++ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
V L D + Y G L ++I + ++ +EY
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEY 123
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL-APEGKGSIETRIAGTFGYLAPE 770
LH + IHRDLKP NILL +DM ++ DFG ++ +PE K + GT Y++PE
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 771 YAVHTRWS-SCSYWA 784
S WA
Sbjct: 181 LLTEKSACKSSDLWA 195
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 7e-41
Identities = 50/213 (23%), Positives = 96/213 (45%), Gaps = 16/213 (7%)
Query: 572 DIQMLEAGNMVISIQVLRNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI 630
D ++LE ++S+ + ++ +G+G GTVY ++ G ++A+++M
Sbjct: 2 DEEILEKLRSIVSV---GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-- 56
Query: 631 SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL 690
+EI V+ + ++ ++V L L G+E +V EY+ G+L+ +
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------ 110
Query: 691 KPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750
++ + + + + +E+LH IHRD+K NILLG D K+ DFG
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI- 166
Query: 751 EGKGSIETRIAGTFGYLAPEYAVHTRWSSCSYW 783
+ S + + GT ++APE +
Sbjct: 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-40
Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
+ LG+G FG VY+G T++A+K + S + EF +E +V+
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMK 78
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNW-----AEEGLKPLEWNRRLTI 701
+ H+V LLG G L++ E M +G L ++ + L P ++ + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE-TRI 760
A ++A G+ YL+ F+HRDL N ++ +D K+ DFG+ R E + +
Sbjct: 139 AGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 761 AGTFGYLAPEYAVHTRWSSCSYW 783
+++PE +++ S
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDV 218
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-39
Identities = 55/198 (27%), Positives = 84/198 (42%), Gaps = 15/198 (7%)
Query: 593 NNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTK 647
+ LG G FG V +GE +AVK ++ V+S + + +F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+ HR+L+ L G L K+ V E P G+L + + A+ VA
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS--IETRIAGTFG 765
G+ YL + FIHRDL N+LL K+ DFGL+R P+ ++ F
Sbjct: 123 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 766 YLAPEYAVHTRWSSCSYW 783
+ APE +S S
Sbjct: 180 WCAPESLKTRTFSHASDT 197
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 145 bits (368), Expect = 5e-39
Identities = 49/186 (26%), Positives = 81/186 (43%), Gaps = 14/186 (7%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+V +++ LG G FG V++ E G A K + S K + EI ++ +
Sbjct: 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVL 80
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
RH LV L D NE ++++E+M G L + + + + + V +G
Sbjct: 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKG 136
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDM--RAKVADFGLVRLAPEGKGSIETRIAGTFGY 766
+ ++H +++H DLKP NI+ K+ DFGL + T GT +
Sbjct: 137 LCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEF 191
Query: 767 LAPEYA 772
APE A
Sbjct: 192 AAPEVA 197
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-38
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVL 645
++ +F+E ++GRG FG VY G L D AVK + G+ +++F +E ++
Sbjct: 26 SLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIM 82
Query: 646 TKVRHRHLVALLGHCLDG-NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALD 704
H ++++LLG CL L+V YM G L I N + L
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQ 138
Query: 705 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG---SIETRIA 761
VA+G+++L + F+HRDL N +L + KVADFGL R + + +T
Sbjct: 139 VAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 762 GTFGYLAPEYAVHTRWSSCSYW 783
++A E ++++ S
Sbjct: 196 LPVKWMALESLQTQKFTTKSDV 217
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 6e-38
Identities = 41/193 (21%), Positives = 75/193 (38%), Gaps = 13/193 (6%)
Query: 593 NNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+G G FG V++G +A+K + S +F E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQF 65
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
H H+V L+G + ++ E G L + L+ + A ++
Sbjct: 66 DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTA 120
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 768
+ YL + F+HRD+ N+L+ + K+ DFGL R + ++ ++A
Sbjct: 121 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 769 PEYAVHTRWSSCS 781
PE R++S S
Sbjct: 178 PESINFRRFTSAS 190
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 141 bits (357), Expect = 1e-37
Identities = 43/198 (21%), Positives = 72/198 (36%), Gaps = 14/198 (7%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
+V + + LG G FG V++ E G K + K K+EI+++ +
Sbjct: 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQ 82
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+ H L+ L D E +L+ E++ G L I + +
Sbjct: 83 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACE 138
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILL--GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 765
G++++H S +H D+KP NI+ K+ DFGL I T
Sbjct: 139 GLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAE 193
Query: 766 YLAPEYAVHTRWSSCSYW 783
+ APE +
Sbjct: 194 FAAPEIVDREPVGFYTDM 211
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-37
Identities = 42/195 (21%), Positives = 83/195 (42%), Gaps = 9/195 (4%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+V ++ + +G G +G V + + ++A+K++ EI +L +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLREIKILLRF 63
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
RH +++ + + + Y+ + ++ + L + + RG
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRG 121
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE--TRIAGTFGY 766
++Y+H + +HRDLKPSN+LL K+ DFGL R+A T T Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 767 LAPEYAVHTRWSSCS 781
APE ++++ + S
Sbjct: 179 RAPEIMLNSKGYTKS 193
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 139 bits (350), Expect = 3e-37
Identities = 52/187 (27%), Positives = 74/187 (39%), Gaps = 19/187 (10%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTE-------FKSEIAVL 645
N+ + ILGRG V + + AVK ++ E E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 646 TKVR-HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALD 704
KV H +++ L LVF+ M +G L ++ L I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRA 118
Query: 705 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF 764
+ + LH + +HRDLKP NILL DDM K+ DFG G+ + GT
Sbjct: 119 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTP 173
Query: 765 GYLAPEY 771
YLAPE
Sbjct: 174 SYLAPEI 180
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (349), Expect = 7e-37
Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 16/200 (8%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
++ + + ++LG G F V E +A+K + + GK ++EIAVL K+
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKI 64
Query: 649 RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
+H ++VAL G L+ + + G L I + V
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDA 119
Query: 709 VEYLHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 765
V+YLH +HRDLKP N+L +D + ++DFGL ++ E GS+ + GT G
Sbjct: 120 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPG 174
Query: 766 YLAPEYAVHTRWS-SCSYWA 784
Y+APE +S + W+
Sbjct: 175 YVAPEVLAQKPYSKAVDCWS 194
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 140 bits (353), Expect = 8e-37
Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 18/199 (9%)
Query: 593 NNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKG----LTEFKSEIAVLTK 647
N+FS I+GRGGFG VY D G A+K ++ I K + +++++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
+V + ++ + + M G L H+ A ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 118
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYL 767
G+E++H ++ ++RDLKP+NILL + +++D GL + K GT GY+
Sbjct: 119 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYM 172
Query: 768 APEYAVHTRW--SSCSYWA 784
APE SS +++
Sbjct: 173 APEVLQKGVAYDSSADWFS 191
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 136 bits (343), Expect = 2e-36
Identities = 49/202 (24%), Positives = 81/202 (40%), Gaps = 16/202 (7%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTE-FKSEIAVLTK 647
++++ + ILG GG V+ L +AVK + A + F+ E
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 648 VRHRHLVALLGHCLD----GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
+ H +VA+ G +V EY+ TL + P+ R + +
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIA 118
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIE--TRIA 761
D + + + H IHRD+KP+NI++ KV DFG+ R + S+ +
Sbjct: 119 DACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 762 GTFGYLAPEYAVHTRWSSCSYW 783
GT YL+PE A + S
Sbjct: 176 GTAQYLSPEQARGDSVDARSDV 197
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGEL--------HDGTKIAVKRMEAGVISGKGLTEFKSEIAV 644
+ LG G FG V E + TK+AVK +++ K L++ SE+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEM 71
Query: 645 LTKV-RHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGL-----------KP 692
+ + +H++++ LLG C ++ EY +G L ++ GL +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 693 LEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752
L ++ A VARG+EYL + IHRDL N+L+ +D K+ADFGL R
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 753 KGSIET-RIAGTFGYLAPEYAVHTRWSSCS 781
+T ++APE ++ S
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQS 218
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 1e-35
Identities = 47/211 (22%), Positives = 79/211 (37%), Gaps = 24/211 (11%)
Query: 593 NNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLT 646
+ LGRG FG V + + +AVK ++ G + SE+ +L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-HRALMSELKILI 71
Query: 647 KVRHRHLVALLGHCL--DGNEKLLVFEYMPQGTLSRHIFN-----------WAEEGLKPL 693
+ H V L G +++ E+ G LS ++ + + L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 694 EWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGK 753
+ + VA+G+E+L + IHRDL NILL + K+ DFGL R +
Sbjct: 132 TLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 754 GSIE-TRIAGTFGYLAPEYAVHTRWSSCSYW 783
+ ++APE ++ S
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDV 219
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 133 bits (336), Expect = 4e-35
Identities = 49/193 (25%), Positives = 83/193 (43%), Gaps = 14/193 (7%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRH 650
+F LG G FG V+ H+G A+K ++ ++ K + E +L+ V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
++ + G D + ++ +Y+ G L + + A +V +E
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALE 118
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
YLH + I+RDLKP NILL + K+ DFG + P+ + + GT Y+APE
Sbjct: 119 YLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPE 171
Query: 771 YAVHTRWSSCSYW 783
++ W
Sbjct: 172 VVSTKPYNKSIDW 184
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 5e-35
Identities = 51/196 (26%), Positives = 85/196 (43%), Gaps = 13/196 (6%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGK-GLTEFKSEIAVLTKV-R 649
+F +LG+G FG V+ E A+K ++ V+ + E VL+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 650 HRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGV 709
H L + V EY+ G L HI + + +R A ++ G+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGL 116
Query: 710 EYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAP 769
++LH + ++RDLK NILL D K+ADFG+ + G + GT Y+AP
Sbjct: 117 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNTFCGTPDYIAP 172
Query: 770 EYAVHTRWS-SCSYWA 784
E + +++ S +W+
Sbjct: 173 EILLGQKYNHSVDWWS 188
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 131 bits (330), Expect = 1e-34
Identities = 43/191 (22%), Positives = 75/191 (39%), Gaps = 8/191 (4%)
Query: 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
+ +G G +G VYK + + G A+K++ + EI++L +++H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V L +LVFE++ Q LE + L + G+ Y
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYC 116
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
H + +HRDLKP N+L+ + K+ADFGL R I +
Sbjct: 117 H---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 773 VHTRWSSCSYW 783
++S+
Sbjct: 174 GSKKYSTTIDI 184
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 7e-34
Identities = 49/189 (25%), Positives = 83/189 (43%), Gaps = 9/189 (4%)
Query: 594 NFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRH 652
NF + +G G +G VYK G +A+K++ + + EI++L ++ H +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 653 LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYL 712
+V LL N+ LVFE++ Q + L + + + +G+ +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFC 118
Query: 713 HGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYA 772
H +HRDLKP N+L+ + K+ADFGL R T T Y APE
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEIL 174
Query: 773 VHTRWSSCS 781
+ ++ S +
Sbjct: 175 LGCKYYSTA 183
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-33
Identities = 52/187 (27%), Positives = 79/187 (42%), Gaps = 13/187 (6%)
Query: 599 NILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKG---LTEFKSEIAVLTKVRHRHLV 654
+ LG G F TVYK + +A+K+++ G S EI +L ++ H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 655 ALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHG 714
LL + LVF++M N L + L +G+EYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLH- 117
Query: 715 LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVH 774
+HRDLKP+N+LL ++ K+ADFGL + + T T Y APE
Sbjct: 118 --QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFG 174
Query: 775 TRWSSCS 781
R
Sbjct: 175 ARMYGVG 181
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 4e-33
Identities = 49/199 (24%), Positives = 79/199 (39%), Gaps = 18/199 (9%)
Query: 593 NNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKG----LTEFKSEIAVLTK 647
+ + +LG GGFG+VY G + D +A+K +E IS G T E+ +L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 648 VRHRH--LVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
V ++ LL + +L+ E L+ + V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQV 119
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIETRIAGTF 764
V + H + +HRD+K NIL+ + K+ DFG L + ++ T GT
Sbjct: 120 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTR 173
Query: 765 GYLAPEYAVHTRWSSCSYW 783
Y PE+ + R+ S
Sbjct: 174 VYSPPEWIRYHRYHGRSAA 192
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 5e-33
Identities = 43/200 (21%), Positives = 76/200 (38%), Gaps = 16/200 (8%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
+ + + LGRG FG V++ E K ++ + G K EI++L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNI 57
Query: 648 VRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVAR 707
RHR+++ L E +++FE++ + I L ++ V
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCE 113
Query: 708 GVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 765
+++LH + H D++P NI+ K+ +FG R G +
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPE 168
Query: 766 YLAPEYAVHTRWS-SCSYWA 784
Y APE H S + W+
Sbjct: 169 YYAPEVHQHDVVSTATDMWS 188
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 5e-33
Identities = 49/203 (24%), Positives = 80/203 (39%), Gaps = 19/203 (9%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVI----SGKGLTEFKSEIAV 644
NV + + LG G F V K E G + A K ++ G + + E+++
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 645 LTKVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALD 704
L +++H +++ L + + +L+ E + G L + + L
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQ 121
Query: 705 VARGVEYLHGLAHQSFIHRDLKPSNILLGDD----MRAKVADFGLVRLAPEGKGSIETRI 760
+ GV YLH H DLKP NI+L D R K+ DFGL G+ I
Sbjct: 122 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNI 176
Query: 761 AGTFGYLAPEYAVHTRWSSCSYW 783
GT ++APE + +
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADM 199
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 3e-32
Identities = 46/201 (22%), Positives = 81/201 (40%), Gaps = 21/201 (10%)
Query: 589 RNVTNNFSEENILGRGGFGTVYKGELHD-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTK 647
R ++++ ++G G FG VY+ +L D G +A+K++ + E+ ++ K
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRK 69
Query: 648 VRHRHLVALLGHCLDGNEK------LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTI 701
+ H ++V L EK LV +Y+P+ + L
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ--TLPVIYVKLY 127
Query: 702 ALDVARGVEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGKGSIETRI 760
+ R + Y+H HRD+KP N+LL D K+ DFG + G+ ++
Sbjct: 128 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 761 AGTFGYLAPEYAVHTRWSSCS 781
+ Y APE + S
Sbjct: 185 --SRYYRAPELIFGATDYTSS 203
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 5e-32
Identities = 44/198 (22%), Positives = 80/198 (40%), Gaps = 11/198 (5%)
Query: 592 TNNFSEENILGRGGFGTVYKGE--LHDGTKIAVKRMEAGVISGKGLTEFKSEIAV---LT 646
+ +G G +G V+K + G +A+KR+ E+AV L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 647 KVRHRHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKP-LEWNRRLTIALDV 705
H ++V L C + + + + + ++ +P + + +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 765
RG+++LH +HRDLKP NIL+ + K+ADFGL R+ T + T
Sbjct: 126 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLW 180
Query: 766 YLAPEYAVHTRWSSCSYW 783
Y APE + + +++
Sbjct: 181 YRAPEVLLQSSYATPVDL 198
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-31
Identities = 38/195 (19%), Positives = 69/195 (35%), Gaps = 24/195 (12%)
Query: 598 ENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVA 655
+LG G G V + K A+K + + + + E+ + + + H+V
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVR 69
Query: 656 LLGHCLDGNEK----LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
++ + L+V E + G L I + G + I + ++Y
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 712 LHGLAHQSFIHRDLKPSNILL---GDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLA 768
LH + HRD+KP N+L + K+ DFG + T Y+A
Sbjct: 127 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVA 181
Query: 769 PEYAVHTRWSSCSYW 783
PE ++
Sbjct: 182 PEVLGPEKYDKSCDM 196
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-31
Identities = 42/190 (22%), Positives = 78/190 (41%), Gaps = 10/190 (5%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+ + +G G +GTV+K + +A+KR+ + EI +L +++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 652 HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEY 711
++V L + LVFE+ Q L+ + + +G+ +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGF 116
Query: 712 LHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEY 771
H ++ +HRDLKP N+L+ + K+A+FGL R + T Y P+
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDV 172
Query: 772 AVHTRWSSCS 781
+ S S
Sbjct: 173 LFGAKLYSTS 182
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 3e-31
Identities = 53/193 (27%), Positives = 76/193 (39%), Gaps = 11/193 (5%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGK-GLTEFKSEIAVLTKVRH 650
N+F +LG+G FG V G A+K + VI K + +E VL RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
L AL + V EY G L H+ + R ++ +E
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALE 119
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
YLH + ++RD+K N++L D K+ DFGL + G+ GT YLAPE
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGTPEYLAPE 175
Query: 771 YAVHTRWSSCSYW 783
+ W
Sbjct: 176 VLEDNDYGRAVDW 188
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (305), Expect = 4e-31
Identities = 39/204 (19%), Positives = 72/204 (35%), Gaps = 23/204 (11%)
Query: 591 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 649
V N + +G G FG +Y G + G ++A+K + E + ++
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE----CVKTKHPQLHIESKIYKMMQ 60
Query: 650 HRHLVALLGHCL-DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
+ + C +G+ ++V E + F + L +A +
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-----RKFSLKTVLLLADQMISR 115
Query: 709 VEYLHGLAHQSFIHRDLKPSNIL---LGDDMRAKVADFGLVRLAPEGKGSIE------TR 759
+EY+H ++FIHRD+KP N L + DFGL + + +
Sbjct: 116 IEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 760 IAGTFGYLAPEYAVHTRWSSCSYW 783
+ GT Y + + S
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDL 196
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 8e-31
Identities = 45/196 (22%), Positives = 75/196 (38%), Gaps = 20/196 (10%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHR 651
+ + + +G+G FG V+K G K+A+K++ EI +L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 652 HLVALLGHCLDGNEK--------LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
++V L+ C LVF++ L + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQ 124
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS---IETRI 760
+ G L+ + +HRD+K +N+L+ D K+ADFGL R K S T
Sbjct: 125 MLLNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 761 AGTFGYLAPEYAVHTR 776
T Y PE + R
Sbjct: 182 VVTLWYRPPELLLGER 197
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 120 bits (302), Expect = 9e-31
Identities = 34/208 (16%), Positives = 70/208 (33%), Gaps = 26/208 (12%)
Query: 591 VTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR 649
V ++ +G G FG +++G L + ++A+K + + E +
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLA 58
Query: 650 HR-HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
+ + +G +LV + + + A +
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-----RKFSVKTVAMAAKQMLAR 113
Query: 709 VEYLHGLAHQSFIHRDLKPSNILLGDDM-----RAKVADFGLVRLAPEGKGSIE------ 757
V+ +H +S ++RD+KP N L+G V DFG+V+ +
Sbjct: 114 VQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 758 TRIAGTFGYLAPEYAVHTRWSSCS-YWA 784
++GT Y++ + S A
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEA 198
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-30
Identities = 49/199 (24%), Positives = 82/199 (41%), Gaps = 21/199 (10%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
V + + +G G +G V + G K+A+K++ S E+ +L +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 649 RHRHLVALLGHCLDGN------EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIA 702
RH +++ LL + LV +M GT + + L +R +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH-----EKLGEDRIQFLV 127
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG 762
+ +G+ Y+H IHRDLKP N+ + +D K+ DFGL R A S T
Sbjct: 128 YQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVV 180
Query: 763 TFGYLAPEYAVHTRWSSCS 781
T Y APE ++ + +
Sbjct: 181 TRWYRAPEVILNWMRYTQT 199
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 7e-30
Identities = 45/196 (22%), Positives = 74/196 (37%), Gaps = 20/196 (10%)
Query: 590 NVTNNFSEENILGRGGFGTVYKG-ELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
V + +G G G V + +A+K++ + E+ ++ V
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 649 RHRHLVALLGHCL------DGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIA 702
H+++++LL + + LV E M E R +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE--------RMSYLL 125
Query: 703 LDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAG 762
+ G+++LH IHRDLKPSNI++ D K+ DFGL R G + T
Sbjct: 126 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVV 180
Query: 763 TFGYLAPEYAVHTRWS 778
T Y APE + +
Sbjct: 181 TRYYRAPEVILGMGYK 196
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (292), Expect = 5e-29
Identities = 48/193 (24%), Positives = 73/193 (37%), Gaps = 14/193 (7%)
Query: 593 NNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRME-AGVISGKGLTEFKSEIAVLTKVRH 650
+ F LG G FG V + G A+K ++ V+ K + +E +L V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 651 RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVE 710
LV L D + +V EY+ G + H+ + A + E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFE 155
Query: 711 YLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPE 770
YLH I+RDLKP N+L+ +V DFG + + GT LAPE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPE 208
Query: 771 YAVHTRWSSCSYW 783
+ ++ W
Sbjct: 209 IILSKGYNKAVDW 221
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 113 bits (282), Expect = 7e-28
Identities = 36/197 (18%), Positives = 77/197 (39%), Gaps = 23/197 (11%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
+++ LGRG + V++ + + K+ VK ++ + K EI +L +
Sbjct: 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVK-----ILKPVKKKKIKREIKILENL 86
Query: 649 R-HRHLVALLGHCLDGNEKL--LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
R +++ L D + LVFE++ + + L ++
Sbjct: 87 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEI 138
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLG-DDMRAKVADFGLVRLAPEGKGSIETRIAGTF 764
+ ++Y H +HRD+KP N+++ + + ++ D+GL G+ +
Sbjct: 139 LKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASR 193
Query: 765 GYLAPEYAVHTRWSSCS 781
+ PE V + S
Sbjct: 194 YFKGPELLVDYQMYDYS 210
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 6e-26
Identities = 43/198 (21%), Positives = 80/198 (40%), Gaps = 19/198 (9%)
Query: 590 NVTNNFSEENILGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV 648
V + + +G G +G+V G ++AVK++ S E+ +L +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 649 RHRHLVALLGHCLDGN-----EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIAL 703
+H +++ LL + + ++ L+ + + L + +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIY 128
Query: 704 DVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGT 763
+ RG++Y+H IHRDLKPSN+ + +D K+ DFGL R T T
Sbjct: 129 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTGYVAT 181
Query: 764 FGYLAPEYAVHTRWSSCS 781
Y APE ++ + +
Sbjct: 182 RWYRAPEIMLNWMHYNQT 199
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 6e-26
Identities = 44/186 (23%), Positives = 72/186 (38%), Gaps = 15/186 (8%)
Query: 593 NNFSEENILGRGGFGTVYKGEL----HDGTKIAVKRMEAGVISG--KGLTEFKSEIAVLT 646
NF +LG G +G V+ G A+K ++ I K ++E VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 647 KVRHR-HLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDV 705
+R LV L + L+ +Y+ G L H+ + + ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEI 138
Query: 706 ARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFG 765
+E+LH I+RD+K NILL + + DFGL + + GT
Sbjct: 139 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 766 YLAPEY 771
Y+AP+
Sbjct: 196 YMAPDI 201
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 101 bits (253), Expect = 2e-25
Identities = 27/161 (16%), Positives = 46/161 (28%), Gaps = 28/161 (17%)
Query: 599 NILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGK--------GLTEFKSEIAVLTKVRH 650
++G G V+ + VK + G S K G F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 651 RHLVALLG----HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVA 706
R L L G ++ E + L R +E + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDE------------VLDMIL 113
Query: 707 RGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747
V + H+ +H DL N+L+ + + DF
Sbjct: 114 EEVAKFY---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 93.7 bits (231), Expect = 2e-21
Identities = 75/306 (24%), Positives = 134/306 (43%), Gaps = 16/306 (5%)
Query: 29 DDGDAAVMLALKKSLNPPESLG--WSDTDPC--KWNHVVCIED---KRITRIQIGHQNLQ 81
+ D +L +KK L P +L TD C W V+C D R+ + + NL
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 82 G--TLPSNLQNLTKLERLELQ--WNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTG 137
+PS+L NL L L + N + P++ L L + +++ + DF +
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 138 LSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHL 197
+ +L +++ N S +P S+ + L + + I+G IP +G T + +
Sbjct: 124 IKTLVTLDFSYNALS-GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF-SKLFTSMTI 181
Query: 198 AFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP 257
+ N+L G +P +F +L + N G + + + ++I L N+ + L
Sbjct: 182 SRNRLTGKIPPTF---ANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
Query: 258 DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKG 317
K L L LR+N G +P L +L+ L +N++ N L G +P+ D++
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
Query: 318 SNNFCL 323
+NN CL
Sbjct: 299 ANNKCL 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 64.0 bits (154), Expect = 2e-11
Identities = 56/250 (22%), Positives = 88/250 (35%), Gaps = 14/250 (5%)
Query: 192 LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGI-DVIQNMTSLKEIWLHSN 250
+ L L+ L P S + + L G L G I I +T L +++
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 251 AFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRS 309
SG +PD S +K L +L N +G +P S+ L +L + N + G +P+
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD---- 167
Query: 310 VSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTK 369
S + N L + A + V
Sbjct: 168 --------SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGS 219
Query: 370 GNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQ 429
T N + K+L L L +N + G +P+GL+ L L L+VS N
Sbjct: 220 DKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 430 LYGKIPSFKS 439
L G+IP +
Sbjct: 280 LCGEIPQGGN 289
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.1 bits (131), Expect = 1e-08
Identities = 28/110 (25%), Positives = 46/110 (41%), Gaps = 9/110 (8%)
Query: 329 CDPR-LNALLSVVKLMGYPQRFAENWKGNDPCSD-WIGVTCTKGN----ITVINFQKMNL 382
C+P+ ALL + K +G P + D C+ W+GV C + ++ +NL
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 383 TG--TISPEFASFKSLQRLILADN-NLSGMIPEGLSVLGALKELDVSNNQ 429
I A+ L L + NL G IP ++ L L L +++
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN 112
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 38.6 bits (88), Expect = 0.002
Identities = 42/257 (16%), Positives = 71/257 (27%), Gaps = 17/257 (6%)
Query: 168 NFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227
+ S + IPS P L L++ + G +++ L
Sbjct: 56 DLSGLNLPKPYPIPSSLA--NLPYLNFLYIGGINNLVGPIPPAI-AKLTQLHYLYITHTN 112
Query: 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKL 286
G D + + +L + NA SG LP S + L ++ N +G +PDS
Sbjct: 113 VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF 172
Query: 287 ESLKIVNMT--NNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMG 344
L N L P F + N + N +
Sbjct: 173 SKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232
Query: 345 YPQRFAENWKGNDPCSDWIGVTCTKGNI----------TVINFQKMNLTGTISPEFASFK 394
+ + + G + +N NL G I P+ + +
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQ 291
Query: 395 SLQRLILADNNLSGMIP 411
A+N P
Sbjct: 292 RFDVSAYANNKCLCGSP 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 93.6 bits (231), Expect = 5e-21
Identities = 36/197 (18%), Positives = 70/197 (35%), Gaps = 19/197 (9%)
Query: 601 LGRGGFGTVYKGE-LHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH--------- 650
LG G F TV+ + + + T +A+K + + + + EI +L +V
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNTKEDSM 77
Query: 651 --RHLVALLGHCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARG 708
H++ LL H + + + + + + + I+ + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 709 VEYLHGLAHQSFIHRDLKPSNILL-GDDMRAKVADFGLVRLAPEGK-GSIETRIAGTFGY 766
++Y+H IH D+KP N+L+ D + + L T T Y
Sbjct: 138 LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 767 LAPEYAVHTRWSSCSYW 783
+PE + W +
Sbjct: 196 RSPEVLLGAPWGCGADI 212
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 86.6 bits (213), Expect = 1e-18
Identities = 65/372 (17%), Positives = 112/372 (30%), Gaps = 37/372 (9%)
Query: 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVP 131
+ +G N+ T+ +L ++ L+ I + + L +L + SNNQ T +
Sbjct: 26 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDIT 82
Query: 132 SDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG 191
L+ L I ++NN + +L N +GL F+ +I
Sbjct: 83 P--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELS 140
Query: 192 LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLH--- 248
+ S + N I + L
Sbjct: 141 SNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLE 200
Query: 249 -----SNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPV 303
+N S P + L+ LSL N +L L +L +++ NN +
Sbjct: 201 SLIATNNQISDITPLGI-LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA 257
Query: 304 PEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWI 363
P L K N + ++ L G N
Sbjct: 258 P-LSGLTKLTELKLGANQ--------------ISNISPLAGLTALTNLELNENQLEDISP 302
Query: 364 GVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKEL 423
N+T + N++ +S LQRL A+N +S L+ L + L
Sbjct: 303 ISNLK--NLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD--VSSLANLTNINWL 356
Query: 424 DVSNNQLYGKIP 435
+NQ+ P
Sbjct: 357 SAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 61.2 bits (147), Expect = 2e-10
Identities = 41/189 (21%), Positives = 75/189 (39%), Gaps = 20/189 (10%)
Query: 64 CIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLS 123
+ + + L+ L +LT L L+L N IS L L+GL L + L
Sbjct: 215 LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLG 271
Query: 124 NNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSF 183
NQ +++ GL++L ++E++ N +L+N + L N NI+ P
Sbjct: 272 ANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYL-TLYFN--NISDISP-- 324
Query: 184 FGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGIDVIQNMTSL 242
L L A N++ +S + + I L + + + N+T +
Sbjct: 325 --VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQIS-----DLTPLANLTRI 375
Query: 243 KEIWLHSNA 251
++ L+ A
Sbjct: 376 TQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 60.8 bits (146), Expect = 3e-10
Identities = 18/99 (18%), Positives = 40/99 (40%), Gaps = 5/99 (5%)
Query: 51 WSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS 110
+ + K +T + + N+ P + +LTKL+RL N +S S
Sbjct: 290 LELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV-SS 346
Query: 111 LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
L L ++ + +NQ + + L+ + + +++
Sbjct: 347 LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 5e-06
Identities = 36/265 (13%), Positives = 84/265 (31%), Gaps = 11/265 (4%)
Query: 173 SANITGQIP--SFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLG 230
SA IT P F L + + + Q+ +L + G +
Sbjct: 3 SATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT-DLDQVTTLQADR-LGIKSID 60
Query: 231 GGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLK 290
G ++ + +L +I +N + + + +L + + +N P + + +
Sbjct: 61 G----VEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGL 115
Query: 291 IVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFA 350
+ P+ L+++ + + G + + + V +
Sbjct: 116 TLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLT 175
Query: 351 ENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMI 410
+ + + ++ + + N + +L L L N L
Sbjct: 176 TLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD-- 233
Query: 411 PEGLSVLGALKELDVSNNQLYGKIP 435
L+ L L +LD++NNQ+ P
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP 258
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 81.6 bits (200), Expect = 2e-17
Identities = 61/283 (21%), Positives = 98/283 (34%), Gaps = 46/283 (16%)
Query: 57 CKWNHVVCIE----------DKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISG 106
C V C + + + + + + +NL L L L N IS
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 107 PLP-SLNGLASLEVVMLSNNQFTSVPSDF---------------------FTGLSSLQSI 144
P + L LE + LS NQ +P F GL+ + +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129
Query: 145 EIDNNPF-SSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI 203
E+ NP SS + + L NIT IP P LT LHL N++
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL----PPSLTELHLDGNKIT 184
Query: 204 GGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVK 263
AS G + +L G + N+ + N L+E+ L++N + K
Sbjct: 185 KVDAASLKG--LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHK 242
Query: 264 QLESLSLRDNFFTG------PVPDSLVKLESLKIVNMTNNLLQ 300
++ + L +N + P K S V++ +N +Q
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 68.9 bits (167), Expect = 3e-13
Identities = 36/222 (16%), Positives = 64/222 (28%), Gaps = 8/222 (3%)
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174
++ L NN+ T + F L +L ++ + NN S P + L+ +
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI-SPGAFAPLVKLERLYLSKN 89
Query: 175 NITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGID 234
+ + L + N++ + F+G + G N G
Sbjct: 90 QLKELPEKMPKTLQE-----LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 144
Query: 235 VIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 294
Q M L I + + L L L N T SL L +L + +
Sbjct: 145 AFQGMKKLSYIRIADTNITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGL 202
Query: 295 TNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNAL 336
+ N + + NN L +
Sbjct: 203 SFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYI 244
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.1 bits (139), Expect = 1e-09
Identities = 31/199 (15%), Positives = 62/199 (31%), Gaps = 16/199 (8%)
Query: 240 TSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNL 298
+ L +N + DF +K L +L L +N + P + L L+ + ++ N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 299 LQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDP 358
L+ + +++ + + ++ +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL------------GTNPLKS 138
Query: 359 CSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLG 418
G ++ I N+T TI SL L L N ++ + L L
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLN 195
Query: 419 ALKELDVSNNQLYGKIPSF 437
L +L +S N +
Sbjct: 196 NLAKLGLSFNSISAVDNGS 214
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.5 bits (127), Expect = 4e-08
Identities = 37/232 (15%), Positives = 71/232 (30%), Gaps = 31/232 (13%)
Query: 44 NPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQ--GTLPSNLQNLTKLERLELQW 101
+ L + + K V ++ +++G L+ G Q + KL + +
Sbjct: 100 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 159
Query: 102 NSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLR 161
+I+ L SL + L N+ T V + GL++L + + N S+ SL
Sbjct: 160 TNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV-DNGSLA 216
Query: 162 NASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVN 221
N L+ N+ + + +++L N + F
Sbjct: 217 NTPHLRELHLNNNKLVKVPGGLAD---HKYIQVVYLHNNNISAIGSNDFCPPGY------ 267
Query: 222 GQNGNAKLGGGIDVIQNMTSLKEIWLHSN---AFSGPLPDFSGVKQLESLSL 270
S + L SN + F V ++ L
Sbjct: 268 --------------NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 60.4 bits (145), Expect = 9e-11
Identities = 26/216 (12%), Positives = 68/216 (31%), Gaps = 15/216 (6%)
Query: 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
L ++ ++++ + + L + + T++ L++L +E+ +N
Sbjct: 17 ALANAIKIAAGKSNVTDTV-TQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDN 73
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDE---------FPGLTILHLAFN 200
+ ++L + L+ N++ L L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 201 QLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFS 260
+ + + + + + N++ L + N S + +
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLA 192
Query: 261 GVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 296
+ L + L++N + P L +L IV +TN
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 1e-07
Identities = 28/195 (14%), Positives = 59/195 (30%), Gaps = 12/195 (6%)
Query: 238 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
++ + + + + + L L L+DN T P L + + ++ N
Sbjct: 39 DLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQITDLAPLK--NLTKITELELSGN 95
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 357
L+ + S +P A L L + + A
Sbjct: 96 PLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQY 155
Query: 358 PCSDWIGVTCT-----KGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 412
V+ +T + ++ AS +L + L +N +S + P
Sbjct: 156 LSIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP- 212
Query: 413 GLSVLGALKELDVSN 427
L+ L + ++N
Sbjct: 213 -LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.6 bits (109), Expect = 4e-06
Identities = 27/201 (13%), Positives = 63/201 (31%), Gaps = 8/201 (3%)
Query: 238 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+ + +I + + + + + + +LS T + + L +L + + +N
Sbjct: 17 ALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 298 LLQGPVPE---FDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWK 354
+ P + N + L+ + + + +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 355 GNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 414
+ ++ G + N + A+ L L DN +S + P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 415 SVLGALKELDVSNNQLYGKIP 435
+ L L E+ + NNQ+ P
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 23/92 (25%), Positives = 35/92 (38%), Gaps = 3/92 (3%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLAS 116
+ + N Q + + L NL+KL L+ N IS + L L +
Sbjct: 138 LNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLASLPN 196
Query: 117 LEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148
L V L NNQ + V S+L + + N
Sbjct: 197 LIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.5 bits (137), Expect = 2e-09
Identities = 49/226 (21%), Positives = 84/226 (37%), Gaps = 11/226 (4%)
Query: 115 ASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174
A+ + + L N+ + VP+ F +L + + +N + + A Q +++A
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 175 NITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGID 234
+ P+ F L LHL L P F + +L NA D
Sbjct: 92 QLRSVDPATFHG--LGRLHTLHLDRCGLQELGPGLF--RGLAALQYLYLQDNALQALPDD 147
Query: 235 VIQNMTSLKEIWLHSNAFSG-PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVN 293
+++ +L ++LH N S P F G+ L+ L L N P + L L +
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207
Query: 294 MTNN-LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLS 338
+ N L P +L + ++N P CD R L +
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDN-----PWVCDCRARPLWA 248
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.6 bits (132), Expect = 6e-09
Identities = 36/187 (19%), Positives = 63/187 (33%), Gaps = 32/187 (17%)
Query: 43 LNPPESLGWSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWN 102
L +L + + + + + LQ ++L L L L N
Sbjct: 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163
Query: 103 SISG-PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLS---------------------- 139
IS P + GL SL+ ++L N+ V F L
Sbjct: 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223
Query: 140 --SLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHL 197
+LQ + +++NP+ ++ + LQ F +S+ + +P G + L
Sbjct: 224 LRALQYLRLNDNPWVC--DCRARPLWAWLQKFRGSSSEVPCSLPQ-----RLAGRDLKRL 276
Query: 198 AFNQLIG 204
A N L G
Sbjct: 277 AANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.6 bits (132), Expect = 6e-09
Identities = 37/315 (11%), Positives = 76/315 (24%), Gaps = 47/315 (14%)
Query: 119 VVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITG 178
+VP + Q I + N S S R L +S +
Sbjct: 15 TTSCPQQGLQAVPVGIPA---ASQRIFLHGNRISHV-PAASFRACRNLTILWLHSNVLAR 70
Query: 179 QIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQN 238
+ F L ++ +L ++ G + +
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL---GPGLFRG 127
Query: 239 MTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+ +L+ ++L NA D F + L L L N + + L SL + + N
Sbjct: 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 357
+ P + N+
Sbjct: 188 RVAHVHPHA-----------------------------------FRDLGRLMTLYLFANN 212
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVL 417
+ + + + LQ+ + + + +P+ L+
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLA-- 269
Query: 418 GALKELDVSNNQLYG 432
++ N L G
Sbjct: 270 -GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.8 bits (130), Expect = 1e-08
Identities = 53/260 (20%), Positives = 99/260 (38%), Gaps = 10/260 (3%)
Query: 63 VCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVM 121
VC + ++T Q LQ +P + + +R+ L N IS S +L ++
Sbjct: 7 VCYNEPKVT-TSCPQQGLQ-AVPVGIPAAS--QRIFLHGNRISHVPAASFRACRNLTILW 62
Query: 122 LSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIP 181
L +N + + FTGL+ L+ +++ +N P + L + + P
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122
Query: 182 SFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTS 241
F L L+L N L +F + +L +GN + + S
Sbjct: 123 GLF--RGLAALQYLYLQDNALQALPDDTF--RDLGNLTHLFLHGNRISSVPERAFRGLHS 178
Query: 242 LKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300
L + LH N + P F + +L +L L N + ++L L +L+ + + +N
Sbjct: 179 LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
Query: 301 GPVPEFDRSVSLDMAKGSNN 320
L +GS++
Sbjct: 239 CDCRARPLWAWLQKFRGSSS 258
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.3 bits (126), Expect = 4e-08
Identities = 38/258 (14%), Positives = 77/258 (29%), Gaps = 34/258 (13%)
Query: 70 ITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-------------------- 109
RI + + ++ + L L L N ++
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 110 ------SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNA 163
+ +GL L + L + F GL++LQ + + +N + + R+
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQAL-PDDTFRDL 152
Query: 164 SGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQ 223
L + + I+ F L L L N++ P +F
Sbjct: 153 GNLTHLFLHGNRISSVPERAF--RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 224 NGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSL 283
N + L + + + +L+ + L+ N + L+ + +P
Sbjct: 211 NNLSALP--TEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQR- 267
Query: 284 VKLESLKIVNMTNNLLQG 301
L + + N LQG
Sbjct: 268 --LAGRDLKRLAANDLQG 283
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (134), Expect = 3e-09
Identities = 32/205 (15%), Positives = 61/205 (29%), Gaps = 13/205 (6%)
Query: 236 IQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 295
+ + S E+ + PD K L L +N +L+ L +N+
Sbjct: 6 VSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 296 NN----------LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGY 345
L + + + + L + L G
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 346 PQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNN 405
+ KGN+ + G+ + ++ NLT + ++L L+L +N+
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 406 LSGMIPEGLSVLGALKELDVSNNQL 430
L IP+G L + N
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 4e-08
Identities = 26/208 (12%), Positives = 62/208 (29%), Gaps = 10/208 (4%)
Query: 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
+ + +++ LP + ++ LS N + + L + +D
Sbjct: 8 KVASHLEVNCDKRNLTA-LPP-DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPAS 209
+ ++ +L L ++ + ++FN+L +
Sbjct: 66 ELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL------DVSFNRLTSLPLGA 119
Query: 210 FSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLS 269
G N L G+ + ++N P +G++ L++L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA-NNNLTELPAGLLNGLENLDTLL 178
Query: 270 LRDNFFTGPVPDSLVKLESLKIVNMTNN 297
L++N +P L + N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.003
Identities = 14/77 (18%), Positives = 25/77 (32%)
Query: 51 WSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS 110
+ + ++ ++ + + NL L L L+ L LQ NS+
Sbjct: 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKG 190
Query: 111 LNGLASLEVVMLSNNQF 127
G L L N +
Sbjct: 191 FFGSHLLPFAFLHGNPW 207
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.0 bits (133), Expect = 8e-09
Identities = 20/113 (17%), Positives = 39/113 (34%), Gaps = 8/113 (7%)
Query: 51 WSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPS 110
+ + + + S LE L + N + LP+
Sbjct: 243 PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPA 301
Query: 111 LNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSW-EIPQSLRN 162
L LE ++ S N VP +L+ + ++ NP + +IP+S+ +
Sbjct: 302 L--PPRLERLIASFNHLAEVPEL----PQNLKQLHVEYNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.9 bits (125), Expect = 7e-08
Identities = 47/325 (14%), Positives = 94/325 (28%), Gaps = 18/325 (5%)
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
+ L+N +S+P L+S+ N + E+P+ ++ L + N
Sbjct: 39 QAHELELNNLGLSSLPEL----PPHLESLVASCNSLT--ELPELPQSLKSLLVDNNNLKA 92
Query: 176 ITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDV 235
++ P + ++ L + G +
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 236 IQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 295
+ +L + L S+ L L L +
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 296 NNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKG 355
NNLL+ +L++ P + + L P +
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNL---YYL 269
Query: 356 NDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLS 415
N ++ + ++ +N L + A L+RLI + N+L+ +PE
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLAE-VPE--- 321
Query: 416 VLGALKELDVSNNQLYGKIPSFKSN 440
+ LK+L V N L + P +
Sbjct: 322 LPQNLKQLHVEYNPLR-EFPDIPES 345
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 3e-04
Identities = 18/108 (16%), Positives = 34/108 (31%), Gaps = 6/108 (5%)
Query: 343 MGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILA 402
Y E + + + + + I SL+ L ++
Sbjct: 233 DNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVS 292
Query: 403 DNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFKSN-AIVNTDGNP 449
+N L +P L+ L S N L ++P N ++ + NP
Sbjct: 293 NNKLIE-LPAL---PPRLERLIASFNHL-AEVPELPQNLKQLHVEYNP 335
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 7e-04
Identities = 17/84 (20%), Positives = 32/84 (38%), Gaps = 15/84 (17%)
Query: 114 LASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173
SLE + +SNN+ +P+ L+ + N + +P+ +N L + N
Sbjct: 283 PPSLEELNVSNNKLIELPA----LPPRLERLIASFNHLAE--VPELPQNLKQL-HVEYN- 334
Query: 174 ANITGQIPSFFGPDEFPGLTILHL 197
+ F PD + L +
Sbjct: 335 -----PLREF--PDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.004
Identities = 20/69 (28%), Positives = 29/69 (42%), Gaps = 7/69 (10%)
Query: 92 TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF 151
+ LEL +S LP L LE ++ S N T +P SL+S+ +DNN
Sbjct: 38 RQAHELELNNLGLSS-LPEL--PPHLESLVASCNSLTELPE----LPQSLKSLLVDNNNL 90
Query: 152 SSWEIPQSL 160
+ L
Sbjct: 91 KALSDLPPL 99
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 3e-07
Identities = 22/96 (22%), Positives = 38/96 (39%), Gaps = 2/96 (2%)
Query: 83 TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQ 142
T+ +L+ L + L+L N + P+L L LEV+ S+N +V LQ
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANL--PRLQ 68
Query: 143 SIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITG 178
+ + NN Q L + L + ++
Sbjct: 69 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.8 bits (82), Expect = 0.004
Identities = 14/103 (13%), Positives = 30/103 (29%), Gaps = 23/103 (22%)
Query: 233 IDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQL----------------------ESLSL 270
+ ++ + + + L N P + ++ L + L L
Sbjct: 13 LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLL 72
Query: 271 RDNFFTG-PVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSL 312
+N LV L ++N+ N L +R +
Sbjct: 73 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 5e-07
Identities = 35/247 (14%), Positives = 80/247 (32%), Gaps = 10/247 (4%)
Query: 71 TRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFT-S 129
+ + +NL + L + + + + PL ++ + LSN+ S
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 130 VPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEF 189
+ S LQ++ ++ S I +L S L + + + +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSD-PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 190 PGLTIL----HLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEI 245
L L F + + + I L ++G N + +++ +L +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 246 WLHSNAFSGPL--PDFSGVKQLESLSLRD-NFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302
L + +F + L+ LSL L ++ +LK + + + G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 303 VPEFDRS 309
+ +
Sbjct: 241 LQLLKEA 247
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 5e-05
Identities = 23/222 (10%), Positives = 61/222 (27%), Gaps = 8/222 (3%)
Query: 78 QNLQGTLPSNLQNLTKLERLELQWNSIS--GPLPSLNGLASLEVVMLSNNQFTSVPSDFF 135
++ + + +++ ++L + I L+ + L+ + L + + +
Sbjct: 32 RSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTL 91
Query: 136 TGLSSLQSIEIDNNPFSSWEIPQS----LRNASGLQNFSANSANITGQIPSFFGPDEFPG 191
S+L + + S Q+ L + E
Sbjct: 92 AKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETIT 151
Query: 192 LTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251
L L ++ + ++ + + L+ + L
Sbjct: 152 QLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 211
Query: 252 FSGP--LPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKI 291
P L + + L++L + G + L L+I
Sbjct: 212 DIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 253
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 9e-06
Identities = 17/65 (26%), Positives = 28/65 (43%), Gaps = 5/65 (7%)
Query: 371 NITVINFQKMNLTGTISPE-FASFKSLQRLILADNNLSGM----IPEGLSVLGALKELDV 425
+I ++ Q L+ E + Q + L D L+ I L V AL EL++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 426 SNNQL 430
+N+L
Sbjct: 63 RSNEL 67
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 15/80 (18%), Positives = 28/80 (35%), Gaps = 9/80 (11%)
Query: 94 LERLELQWNSIS--GPLPSLNGLASLEVVMLSNNQFTSVP----SDFFTGLSSLQSIEID 147
++ L++Q +S L L +VV L + T S +L + +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 148 NNPFSS---WEIPQSLRNAS 164
+N + Q L+ S
Sbjct: 64 SNELGDVGVHCVLQGLQTPS 83
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.002
Identities = 13/103 (12%), Positives = 34/103 (33%), Gaps = 15/103 (14%)
Query: 347 QRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT----ISPEFASFKSLQRLILA 402
Q + G+ + V+ +++ + ++ + SL+ L L+
Sbjct: 346 QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLS 405
Query: 403 DNNLSGMIPEGLSVLG--------ALKELDVSNNQLYGKIPSF 437
+N L G+ L L++L + + ++
Sbjct: 406 NNCLG---DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR 445
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (103), Expect = 1e-05
Identities = 18/138 (13%), Positives = 36/138 (26%), Gaps = 4/138 (2%)
Query: 108 LPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ 167
+ L + + + L +I+ +N + LR L+
Sbjct: 11 AAQYTNAVRDRELDLRGYKIPVIE-NLGATLDQFDAIDFSDNEIRKLDGFPLLRR---LK 66
Query: 168 NFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227
N+ I IL +G L S + L +
Sbjct: 67 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 126
Query: 228 KLGGGIDVIQNMTSLKEI 245
K + VI + ++ +
Sbjct: 127 KKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 12/69 (17%), Positives = 26/69 (37%), Gaps = 2/69 (2%)
Query: 86 SNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIE 145
+ N + L+L+ I L + + S+N+ + F L L+++
Sbjct: 12 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD--GFPLLRRLKTLL 69
Query: 146 IDNNPFSSW 154
++NN
Sbjct: 70 VNNNRICRI 78
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.003
Identities = 9/55 (16%), Positives = 23/55 (41%), Gaps = 4/55 (7%)
Query: 380 MNLTGTI---SPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLY 431
+ LT + + ++ + + L L + +I + L +D S+N++
Sbjct: 1 VKLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR 54
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 2e-05
Identities = 27/189 (14%), Positives = 61/189 (32%), Gaps = 15/189 (7%)
Query: 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
L + + L +++ S L + + S+ L++L I NN
Sbjct: 16 ALAEKMKTVLGKTNVTDT-VSQTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNN 72
Query: 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPG----------LTILHLAF 199
+ ++L + + A+IT + +L
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 200 NQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDF 259
+L + S + + ++ + + N+T+L+ + + SN S +
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQV-TDLKPLANLTTLERLDISSNKVSD-ISVL 190
Query: 260 SGVKQLESL 268
+ + LESL
Sbjct: 191 AKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 31/189 (16%), Positives = 65/189 (34%), Gaps = 8/189 (4%)
Query: 238 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+ + L + + + + Q+ +L D + L +L +N +NN
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 357
L P + + +D+ +N +P A L L + N
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTG---TISPEFASFKSLQRLILADNNLSGMIPEGL 414
++ + + Q++N + T A+ +L+RL ++ N +S L
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVL 190
Query: 415 SVLGALKEL 423
+ L L+ L
Sbjct: 191 AKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 28/186 (15%), Positives = 54/186 (29%), Gaps = 11/186 (5%)
Query: 113 GLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGL---QNF 169
LA +L T S T L + +++ D S + + L N + + N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQ 73
Query: 170 SANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKL 229
+ + + + N F+ + +L
Sbjct: 74 LTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL 133
Query: 230 GGGIDVIQNMTSLKEIWLHSNAFSGP-----LPDFSGVKQLESLSLRDNFFTG-PVPDSL 283
+ I ++++L + L + + LE L + N + V L
Sbjct: 134 ELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 193
Query: 284 VKLESL 289
LESL
Sbjct: 194 TNLESL 199
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 3e-05
Identities = 22/193 (11%), Positives = 56/193 (29%), Gaps = 8/193 (4%)
Query: 238 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297
+ L + + + + + ++ + ++ + L ++ + + N
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQ-NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 298 LLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGND 357
L P + + N S +L +L + +
Sbjct: 79 KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138
Query: 358 PCSDWIGVTCTKGNITVINFQKMNLTGTI---SPEFASFKSLQRLILADNNLSGMIPEGL 414
+T + ++L A LQ L L+ N++S + L
Sbjct: 139 LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL--RAL 196
Query: 415 SVLGALKELDVSN 427
+ L L L++ +
Sbjct: 197 AGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 6e-04
Identities = 33/211 (15%), Positives = 66/211 (31%), Gaps = 23/211 (10%)
Query: 102 NSISGPLP-----SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEI 156
+I+ P P S + A L T + L+S+ I +N+ S +
Sbjct: 6 ETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG 63
Query: 157 PQSLRNASGLQNFSANSANITG--------QIPSFFGPDEFPGLTILHLAFNQLIGGLPA 208
Q L N + N +T + F + +L
Sbjct: 64 IQYLPN---VTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLE 120
Query: 209 SFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMT---SLKEIWLHSNAFSGPLPDFSGVKQL 265
S I L Q + LG + + + + + +G+ +L
Sbjct: 121 HNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKL 180
Query: 266 ESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 296
++L L N + +L L++L ++ + +
Sbjct: 181 QNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.004
Identities = 11/49 (22%), Positives = 23/49 (46%), Gaps = 2/49 (4%)
Query: 100 QWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148
++ + L GL L+ + LS N + + + GL +L +E+ +
Sbjct: 163 LEDNQISDIVPLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFS 209
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 3e-05
Identities = 16/78 (20%), Positives = 31/78 (39%), Gaps = 3/78 (3%)
Query: 79 NLQGTLPSNLQNLTKLERLELQWNSISGPLP---SLNGLASLEVVMLSNNQFTSVPSDFF 135
++ TL +N+ +L L L N + + +L+++ LS N+ S
Sbjct: 52 SMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDK 111
Query: 136 TGLSSLQSIEIDNNPFSS 153
L+ + +D N S
Sbjct: 112 IKGLKLEELWLDGNSLSD 129
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 5e-05
Identities = 9/43 (20%), Positives = 18/43 (41%)
Query: 107 PLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149
P +G + ++ +S + S+PS L L++ N
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 6e-05
Identities = 30/242 (12%), Positives = 58/242 (23%), Gaps = 15/242 (6%)
Query: 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLA 115
C +C ++ ++T I PS+L L + + +G
Sbjct: 8 CSNRVFLC-QESKVTEI-----------PSDL--PRNAIELRFVLTKLRVIQKGAFSGFG 53
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
LE + +S N V + I + S
Sbjct: 54 DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT 113
Query: 176 ITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDV 235
+P + + + SF G +S+ + +
Sbjct: 114 GIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF 173
Query: 236 IQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 295
+ ++N P F G L + L L+ L+ +
Sbjct: 174 NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
Query: 296 NN 297
N
Sbjct: 234 NL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 2e-04
Identities = 12/85 (14%), Positives = 22/85 (25%), Gaps = 3/85 (3%)
Query: 352 NWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 411
N + NL + F L ++ + +
Sbjct: 159 WLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 218
Query: 412 EGLSVLGALKELDVSNNQLYGKIPS 436
GL L L+ N + K+P+
Sbjct: 219 YGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 7e-04
Identities = 13/84 (15%), Positives = 27/84 (32%), Gaps = 4/84 (4%)
Query: 51 WSDTDPCKWNHVVCIEDKRITRIQIGHQNLQGTLPSN-LQNLTKLERLELQWNSISG-PL 108
W + + + H ++ + + N LP++ + L++ I P
Sbjct: 159 WLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 218
Query: 109 PSLNGLASLEVVMLSNNQFTSVPS 132
L L L S +P+
Sbjct: 219 YGLENLKKLRA--RSTYNLKKLPT 240
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.5 bits (98), Expect = 6e-05
Identities = 27/185 (14%), Positives = 55/185 (29%), Gaps = 12/185 (6%)
Query: 116 SLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175
V + +P D + +++N L
Sbjct: 9 EGTTVDCTGRGLKEIPRDIPL---HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 176 ITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNAKLGGGID 234
+TG P+ F L + I F G Q+++L + + + G
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIKEI--SNKMFLGLHQLKTLNLYDNQISCVMPG--- 120
Query: 235 VIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNM 294
+++ SL + L SN F+ + L SL P + ++I ++
Sbjct: 121 SFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDL 177
Query: 295 TNNLL 299
++
Sbjct: 178 PHSEF 182
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 4e-04
Identities = 14/95 (14%), Positives = 32/95 (33%), Gaps = 6/95 (6%)
Query: 65 IEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPL-----PSLNGLASLEV 119
IE K + I ++ + ++ + L ++ + L N+I ++ LE+
Sbjct: 5 IEGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 120 VMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSW 154
S+ V + L L + +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTV 98
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 38.1 bits (87), Expect = 0.002
Identities = 24/161 (14%), Positives = 50/161 (31%), Gaps = 24/161 (14%)
Query: 58 KWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASL 117
+ VV E +++ G + + L L + L L N+I + SL+G+ +L
Sbjct: 16 ERKSVVATEAEKVELH--GMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENL 72
Query: 118 EVVML---------------------SNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEI 156
++ L + L +L+ + + NN ++W
Sbjct: 73 RILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGE 132
Query: 157 PQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHL 197
L L++ + E+ + L
Sbjct: 133 IDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL 173
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 787 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.98 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.98 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.98 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.98 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.97 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.97 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.97 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.97 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.79 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.79 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.79 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.78 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.57 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.55 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.54 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.5 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.49 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.47 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.39 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.37 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.35 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.34 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.31 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.3 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.29 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.6 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.31 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.28 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.19 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.72 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.34 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.26 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.2 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.94 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.68 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.46 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.17 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=7.8e-44 Score=376.07 Aligned_cols=293 Identities=25% Similarity=0.467 Sum_probs=228.2
Q ss_pred CCChhHHHHHHHHHHhcCCCCC-CCCC-CCCCC--CcccEEEcCC---CCEEEEEeCCCCccc--cCCCCCCCCCCCcEE
Q 003911 27 SGDDGDAAVMLALKKSLNPPES-LGWS-DTDPC--KWNHVVCIED---KRITRIQIGHQNLQG--TLPSNLQNLTKLERL 97 (787)
Q Consensus 27 ~~~~~d~~~l~~~k~~~~~~~~-~~w~-~~~~C--~w~gv~C~~~---~~v~~L~l~~~~l~~--~~~~~~~~l~~L~~L 97 (787)
-|.++|++||++||+++.+|.. .+|. ++||| .|.||+|+.. .||+.|+|++++++| .+|++|++|++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L 81 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccc
Confidence 3789999999999999988765 4896 67999 4999999864 389999999999998 589999999999999
Q ss_pred Eeec-CCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCce
Q 003911 98 ELQW-NSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSAN 175 (787)
Q Consensus 98 ~L~~-N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~ 175 (787)
+|++ |+++|.+| +|++|++|++|+|++|+|.++++..+..+.+|+++++++|++.. .+|..+.++++|+.+++++|.
T Consensus 82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~-~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG-TLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEES-CCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccc-cCchhhccCcccceeeccccc
Confidence 9986 89998777 79999999999999999999998888889999999998888776 677777777777777777777
Q ss_pred ecccCCCCCCCCCCCCC-cEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEecccccccc
Q 003911 176 ITGQIPSFFGPDEFPGL-TILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSG 254 (787)
Q Consensus 176 l~~~~p~~~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 254 (787)
+++.+|..+. .+..+ +.+++++|++++..|..+.
T Consensus 161 l~~~ip~~~~--~l~~l~~~l~~~~n~l~~~~~~~~~------------------------------------------- 195 (313)
T d1ogqa_ 161 ISGAIPDSYG--SFSKLFTSMTISRNRLTGKIPPTFA------------------------------------------- 195 (313)
T ss_dssp CEEECCGGGG--CCCTTCCEEECCSSEEEEECCGGGG-------------------------------------------
T ss_pred cccccccccc--ccccccccccccccccccccccccc-------------------------------------------
Confidence 7777776664 44443 5566666666655554432
Q ss_pred CCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhh
Q 003911 255 PLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLN 334 (787)
Q Consensus 255 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~ 334 (787)
.+ .+..+++++|.+.|.+|..+..+++|+.+++++|.+++.+|.+..
T Consensus 196 ------~l-~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~-------------------------- 242 (313)
T d1ogqa_ 196 ------NL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGL-------------------------- 242 (313)
T ss_dssp ------GC-CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCC--------------------------
T ss_pred ------cc-ccccccccccccccccccccccccccccccccccccccccccccc--------------------------
Confidence 22 234567777777777777777777777777777777765554211
Q ss_pred HHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccC
Q 003911 335 ALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGL 414 (787)
Q Consensus 335 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l 414 (787)
.++|+.|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|+ +
T Consensus 243 ----------------------------------~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~ 287 (313)
T d1ogqa_ 243 ----------------------------------SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-G 287 (313)
T ss_dssp ----------------------------------CTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-S
T ss_pred ----------------------------------ccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-c
Confidence 12566777777777777888888888888888888888888884 5
Q ss_pred cCCCCCCeeeccCCc-cccc
Q 003911 415 SVLGALKELDVSNNQ-LYGK 433 (787)
Q Consensus 415 ~~l~~L~~L~Ls~N~-l~g~ 433 (787)
+++++|+.+++++|+ ++|.
T Consensus 288 ~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 288 GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp TTGGGSCGGGTCSSSEEEST
T ss_pred ccCCCCCHHHhCCCccccCC
Confidence 778888888888886 5553
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=333.10 Aligned_cols=184 Identities=27% Similarity=0.439 Sum_probs=158.4
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... ....+++.+|++++++++||||+++++++.+++..|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 468999999999999999999875 799999999976432 234467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+...
T Consensus 83 Ey~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 83 EYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp ECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred eccCCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 99999999998832 3579999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCC-ceeeeeccccCcccccccccCCc-C-cceeec
Q 003911 751 EGKG-SIETRIAGTFGYLAPEYAVHTRW-S-SCSYWA 784 (787)
Q Consensus 751 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~-~~DiWS 784 (787)
.... ......+||+.|||||++.+..+ + ++||||
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwS 191 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 191 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHH
T ss_pred cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeH
Confidence 4322 22345689999999999998876 4 699998
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-39 Score=330.32 Aligned_cols=181 Identities=25% Similarity=0.455 Sum_probs=161.4
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 57999999999999999999864 799999999976432 345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++|+|.+++.. ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 98 y~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 98 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp CCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999987743 368999999999999999999998 8999999999999999999999999999998754
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... .....+||+.|||||++.+..|+ ++||||.
T Consensus 169 ~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 202 (293)
T d1yhwa1 169 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202 (293)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHH
T ss_pred ccc-cccccccCCCccChhhhcCCCCCchhceehH
Confidence 432 23446799999999999999888 8999983
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=331.47 Aligned_cols=192 Identities=23% Similarity=0.413 Sum_probs=153.9
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe--CCeeEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--GNEKLL 668 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 668 (787)
.++|++.+.||+|+||+||+|+.. +|+.||||++..........+.+.+|++++++++|||||++++++.+ .+..|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 367999999999999999999875 78999999998766666667889999999999999999999999975 456899
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCEEECCCCcEEEeecccc
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA--HQSFIHRDLKPSNILLGDDMRAKVADFGLV 746 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 746 (787)
||||+++|+|.+++...... ...+++..++.++.|++.||+|||+.. ..+||||||||+|||++.++.+||+|||+|
T Consensus 83 vmEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999998765443 357999999999999999999999731 124999999999999999999999999999
Q ss_pred eecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+....... .....+||+.|||||++.+..|+ ++||||.
T Consensus 162 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSl 200 (269)
T d2java1 162 RILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 200 (269)
T ss_dssp HHC------------CCCSCCCHHHHTTCCCCHHHHHHHH
T ss_pred eecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhh
Confidence 88754332 23447899999999999999998 9999983
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-39 Score=327.53 Aligned_cols=182 Identities=30% Similarity=0.529 Sum_probs=161.9
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||+||+|+.+ +++.||+|++.+.... ....+++.+|++++++++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999875 7899999999764322 344678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+...
T Consensus 86 Ey~~~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred eecCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 99999999999854 2468999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... .....||+.|||||++.+..|+ ++||||.
T Consensus 158 ~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSl 190 (263)
T d2j4za1 158 SSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSL 190 (263)
T ss_dssp CCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred CCc---ccccCCCCcccCHHHHcCCCCCchhhhhhH
Confidence 432 3446799999999999999888 9999983
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-39 Score=326.94 Aligned_cols=182 Identities=31% Similarity=0.503 Sum_probs=151.6
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
++|++.+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++||||++++|++.+++..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 5789999999999999999999888999999997633 3356899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++|+|.+++.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 82 ~~~g~L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 82 MEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp CTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred cCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCC
Confidence 999999998854 23468899999999999999999998 89999999999999999999999999999877655
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.........||+.|||||++.+..|+ ++||||
T Consensus 155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS 187 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHH
T ss_pred CceeecceecCcccCChHHhcCCCCCchhhhcc
Confidence 44444456799999999999999999 999998
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-38 Score=329.50 Aligned_cols=185 Identities=28% Similarity=0.446 Sum_probs=160.3
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||+||+|+.. +++.||||++.+... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999875 799999999976432 2345678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||+ ++||||||||+|||+++++.+||+|||+|+...
T Consensus 88 Ey~~gg~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecc
Confidence 99999999998754 2468999999999999999999998 899999999999999999999999999999875
Q ss_pred CCCC-ceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.... ......+||+.|||||++.+..|+ ++||||.
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSl 196 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 196 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHH
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehh
Confidence 4332 223446799999999999999998 8999984
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-39 Score=332.48 Aligned_cols=184 Identities=30% Similarity=0.484 Sum_probs=163.5
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|++++++++|||||++++++.+++..++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 457889999999999999999876 6889999998763 234578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. .....+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+...
T Consensus 93 E~~~~g~l~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 93 EFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp ECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred ecccCcchHHHhhh---ccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999854 234578999999999999999999998 899999999999999999999999999998776
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
...........||+.|||||++.+..|+ ++||||
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS 201 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 201 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHH
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhh
Confidence 5544444445689999999999999999 999998
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-38 Score=324.39 Aligned_cols=183 Identities=28% Similarity=0.492 Sum_probs=160.2
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.++|++.+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||++++++.+ +..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 35789999999999999999999888999999997633 345689999999999999999999998754 56799999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++|+|.+++..... ..+++.+++.|+.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+....
T Consensus 88 y~~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eCCCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccC
Confidence 9999999998754322 358999999999999999999998 8999999999999999999999999999998765
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
..........||+.|||||++.++.++ ++||||
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS 195 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHH
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhh
Confidence 543334446789999999999999898 999998
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-39 Score=337.48 Aligned_cols=183 Identities=25% Similarity=0.390 Sum_probs=161.0
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++.. ......+++.+|++++++++|||||++++++.+.+..|+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECC-CCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChh-hCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 568999999999999999999875 7899999999764 23445678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.+. ..+++..+..++.|++.||+|||+ +.+|+||||||+|||+++++++||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999998542 368999999999999999999997 2489999999999999999999999999998764
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+.. ....+||+.|||||++.+..|+ ++||||.
T Consensus 157 ~~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSl 189 (322)
T d1s9ja_ 157 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSM 189 (322)
T ss_dssp HHT---C---CCSSCCCCHHHHHCSCCCTTHHHHHH
T ss_pred CCc---cccccCCccccCchHHcCCCCCcHHHHHHH
Confidence 322 2346899999999999999998 9999984
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-38 Score=324.99 Aligned_cols=183 Identities=26% Similarity=0.429 Sum_probs=158.4
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
+.|++.+.||+|+||+||+|+.. +++.||||+++.. .....+++.+|++++++++|||||++++++.+++..|+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 56899999999999999999875 7899999999764 34456788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++|+|.+++.+. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 90 y~~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 90 FCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp CCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred cCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999999987542 2468999999999999999999998 8999999999999999999999999999986543
Q ss_pred CCCceeeeeccccCcccccccc-----cCCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAV-----HTRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~-~~DiWS~ 785 (787)
.. .......||+.|||||++. +..|+ ++||||.
T Consensus 163 ~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSl 201 (288)
T d2jfla1 163 TI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 201 (288)
T ss_dssp HH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHH
T ss_pred Cc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHH
Confidence 21 1123467999999999984 44566 8999983
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-38 Score=322.44 Aligned_cols=183 Identities=31% Similarity=0.536 Sum_probs=153.5
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.++|++.+.||+|+||+||+|+++ ..||||+++.........++|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467999999999999999999764 469999998766666778899999999999999999999998754 56899999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++|+|.+++.. ....+++.++..++.||++||+|||+ ++||||||||+|||+++++.+||+|||+|+....
T Consensus 84 y~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 84 WCEGSSLYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CCCEEEHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred cCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 9999999999853 23468999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCC-ceeeeeccccCcccccccccC---CcC-cceeec
Q 003911 752 GKG-SIETRIAGTFGYLAPEYAVHT---RWS-SCSYWA 784 (787)
Q Consensus 752 ~~~-~~~~~~~gt~~y~aPE~~~~~---~~~-~~DiWS 784 (787)
... .......||+.|||||++.+. .|+ ++||||
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS 194 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYA 194 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHH
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhh
Confidence 332 223446799999999999754 466 899998
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=327.91 Aligned_cols=184 Identities=28% Similarity=0.419 Sum_probs=163.3
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|+.+ +|+.||||++++... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999875 799999999986532 2345678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++||||||||+|||++++|.+||+|||+|+...
T Consensus 85 ey~~gg~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 85 EYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eccCCCchhhhhhc-----ccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999998854 2468999999999999999999998 899999999999999999999999999998764
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... ......+||+.|||||++.+..|+ ++|+||.
T Consensus 157 ~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSl 191 (337)
T d1o6la_ 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHH
T ss_pred cCC-cccccceeCHHHhhhhhccCCCCChhhcccch
Confidence 433 233457899999999999999999 9999983
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-38 Score=328.31 Aligned_cols=184 Identities=28% Similarity=0.474 Sum_probs=145.3
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+.+.|++.+.||+|+||+||+|+.. +++.||||++...... ...+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4577999999999999999999875 7899999999864432 3346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC---CCCcEEEeecccc
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGLV 746 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG~a 746 (787)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||+ ++||||||||+||++. +++.+||+|||+|
T Consensus 86 mE~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp ECCCCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EeccCCCcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEecccee
Confidence 999999999999843 3579999999999999999999998 8999999999999995 5789999999999
Q ss_pred eecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+...... .....+||+.|||||++.+..|+ ++||||.
T Consensus 158 ~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSl 195 (307)
T d1a06a_ 158 KMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 195 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHH
T ss_pred EEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhh
Confidence 8765432 23346799999999999999888 9999983
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-37 Score=315.80 Aligned_cols=183 Identities=28% Similarity=0.449 Sum_probs=163.5
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
++|++.+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++||||++++|++.+++..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 5799999999999999999999888899999998643 2356899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++|+|.+++.. ....+++..+.+++.|+++||+|||+ ++|+||||||+||++++++.+||+|||+|+.....
T Consensus 81 ~~~g~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 81 MANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp CTTEEHHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred cCCCcHHHhhhc----cccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 999999988744 22468899999999999999999998 89999999999999999999999999999877655
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.........||+.|+|||++.+..++ ++||||.
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~ 187 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 187 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeeccc
Confidence 44444456799999999999999999 9999983
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-37 Score=315.48 Aligned_cols=179 Identities=26% Similarity=0.406 Sum_probs=154.2
Q ss_pred CcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe----CCeeEEE
Q 003911 595 FSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD----GNEKLLV 669 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv 669 (787)
|++.+.||+|+||+||+|... +++.||+|++..........+++.+|++++++++|||||++++++.+ ....|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366778999999999999875 68899999998766666667889999999999999999999999875 3457999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCEEEC-CCCcEEEeecccc
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQS--FIHRDLKPSNILLG-DDMRAKVADFGLV 746 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DFG~a 746 (787)
|||+++|+|.+++... ..+++..+..++.||++||+|||+ ++ |+||||||+|||++ +++.+||+|||+|
T Consensus 91 mE~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EeCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 9999999999998542 468999999999999999999997 55 99999999999996 5789999999999
Q ss_pred eecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 747 RLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 747 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+..... .....+||+.|||||++.+. ++ ++||||.
T Consensus 163 ~~~~~~---~~~~~~GT~~Y~aPE~~~~~-~~~~~DIwSl 198 (270)
T d1t4ha_ 163 TLKRAS---FAKAVIGTPEFMAPEMYEEK-YDESVDVYAF 198 (270)
T ss_dssp GGCCTT---SBEESCSSCCCCCGGGGGTC-CCTHHHHHHH
T ss_pred eeccCC---ccCCcccCccccCHHHhCCC-CCCcCchhhH
Confidence 865332 23456899999999998765 66 9999983
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-37 Score=324.43 Aligned_cols=181 Identities=27% Similarity=0.465 Sum_probs=161.2
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||+||+|+.+ +|+.||||++++... .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999875 799999999976432 2345678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||++||++..++.. ...+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCccccccccc-----cccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 99999999888743 2467888999999999999999997 899999999999999999999999999999875
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... ...+||+.|||||++.+..|+ ++||||.
T Consensus 156 ~~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSl 187 (316)
T d1fota_ 156 DVT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSF 187 (316)
T ss_dssp SCB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHH
T ss_pred ccc----ccccCcccccCHHHHcCCCCCchhhcccc
Confidence 432 346799999999999999898 8999983
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.5e-37 Score=324.79 Aligned_cols=183 Identities=25% Similarity=0.396 Sum_probs=161.8
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 468999999999999999999875 79999999997632 344578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC--CCCcEEEeeccccee
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRL 748 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFG~a~~ 748 (787)
||+++|+|.+++.. ....+++..+..|+.||+.||+|||+ ++||||||||+|||++ .++.+||+|||+|+.
T Consensus 103 E~~~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 103 EFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp CCCCSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EcCCCCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 99999999998843 23469999999999999999999998 8999999999999996 467899999999998
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... ......||+.|||||++.+..|+ ++||||.
T Consensus 176 ~~~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSl 211 (350)
T d1koaa2 176 LDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 211 (350)
T ss_dssp CCTTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHH
T ss_pred ccccc--ccceecCcccccCHHHHcCCCCChhHhhhhh
Confidence 75543 23446899999999999999998 8999984
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-37 Score=317.51 Aligned_cols=185 Identities=26% Similarity=0.396 Sum_probs=162.4
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc----chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS----GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
+.++|++.+.||+|+||+||+|+.. +|+.||||++++.... ....+.+.+|++++++++|||||++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4568999999999999999999875 7999999999764332 2246789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC----cEEEe
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM----RAKVA 741 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~ 741 (787)
.|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+|++
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEec
Confidence 99999999999999998542 468999999999999999999998 8999999999999998776 59999
Q ss_pred ecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 742 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|||+|+...... ......||+.|||||++.+..++ ++||||.
T Consensus 160 DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSl 202 (293)
T d1jksa_ 160 DFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 202 (293)
T ss_dssp CCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred chhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhh
Confidence 999998875443 23346799999999999998888 9999983
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-37 Score=321.31 Aligned_cols=179 Identities=27% Similarity=0.434 Sum_probs=156.2
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
.|+..+.||+|+||+||+|+.. +++.||||++...... ....+++.+|++++++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4899999999999999999865 7899999999865433 4455779999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
||++|++..++.. ...+++.++..++.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp CCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999998765532 2478999999999999999999998 8999999999999999999999999999986643
Q ss_pred CCCceeeeeccccCccccccccc---CCcC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVH---TRWS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~-~~DiWS~ 785 (787)
. ....||+.|||||++.+ ..|+ ++||||.
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSl 200 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHH
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhH
Confidence 2 23579999999999865 3566 8999983
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-36 Score=322.10 Aligned_cols=183 Identities=23% Similarity=0.336 Sum_probs=161.6
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
.++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 467999999999999999999875 79999999997643 334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC--CCCcEEEeeccccee
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG--DDMRAKVADFGLVRL 748 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFG~a~~ 748 (787)
||+++|+|.+++.. ....+++.++..|+.||+.||+|||+ ++||||||||+|||++ .++.+||+|||+|+.
T Consensus 106 E~~~gg~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 106 EFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp ECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EcCCCChHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeeccccee
Confidence 99999999887632 23468999999999999999999998 8999999999999998 678999999999998
Q ss_pred cCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 749 APEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 749 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... ......||+.|||||++.+..|+ ++||||.
T Consensus 179 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 214 (352)
T d1koba_ 179 LNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAI 214 (352)
T ss_dssp CCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred cCCCC--ceeeccCcccccCHHHHcCCCCCCccchHHH
Confidence 76543 33446799999999999999998 9999983
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-37 Score=320.61 Aligned_cols=184 Identities=24% Similarity=0.465 Sum_probs=147.7
Q ss_pred CCCcccceeccccceEEEEEEEe-CC---cEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DG---TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
++|++.+.||+|+||+||+|+++ ++ ..||||++... ......++|.+|++++++++|||||+++|++.+++..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888999999999999999875 23 35889988653 344556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++|+|.+++.. ....+++.++..++.||++||+|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 105 v~Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEecCCCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceE
Confidence 9999999999998743 23468999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCce----eeeeccccCcccccccccCCcC-cceeec
Q 003911 749 APEGKGSI----ETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 749 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
........ .....||+.|||||++.++.++ ++||||
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS 218 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWS 218 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHH
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCccccccc
Confidence 65432211 1224579999999999999998 899998
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-37 Score=314.07 Aligned_cols=177 Identities=27% Similarity=0.414 Sum_probs=149.9
Q ss_pred ceeccccceEEEEEEEe---CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEecCC
Q 003911 599 NILGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEYMPQ 675 (787)
Q Consensus 599 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (787)
+.||+|+||+||+|.++ +++.||||+++.........++|.+|++++++++|||||++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999865 35689999997655555667789999999999999999999999865 457899999999
Q ss_pred CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCCCCc
Q 003911 676 GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGS 755 (787)
Q Consensus 676 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 755 (787)
|+|.+++.. ...+++.+++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+........
T Consensus 92 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 999998853 2468999999999999999999998 89999999999999999999999999999987554332
Q ss_pred ee--eeeccccCcccccccccCCcC-cceeec
Q 003911 756 IE--TRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 756 ~~--~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.. ....||+.|||||++.+..++ ++||||
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS 195 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWS 195 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHH
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhcc
Confidence 22 235689999999999999998 999998
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=313.55 Aligned_cols=183 Identities=25% Similarity=0.458 Sum_probs=156.4
Q ss_pred CCCcccce-eccccceEEEEEEEe---CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEE
Q 003911 593 NNFSEENI-LGRGGFGTVYKGELH---DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 593 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (787)
++|.+.+. ||+|+||+||+|.++ ++..||||+++.. ......++|.+|++++++++|||||+++|++.+ +..|+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 45777775 999999999999764 4567999999763 345567889999999999999999999999865 56899
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
||||+++|+|.+++.. ....+++.++..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+|+.
T Consensus 86 vmE~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhc
Confidence 9999999999998743 23468999999999999999999998 8999999999999999999999999999998
Q ss_pred cCCCCCce--eeeeccccCcccccccccCCcC-cceeec
Q 003911 749 APEGKGSI--ETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 749 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
........ .....||+.|||||++.++.++ ++||||
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS 197 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWS 197 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHH
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhc
Confidence 76543222 2234689999999999999999 999998
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-37 Score=317.34 Aligned_cols=182 Identities=31% Similarity=0.533 Sum_probs=152.9
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
++|++.+.||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++|||||++++++. .+..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence 5799999999999999999999888899999997533 33578999999999999999999999985 4568999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++|+|..++..... ..++|.+++.++.||+.||+|||+ .+|+||||||+|||+++++++||+|||+|+.....
T Consensus 93 ~~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 93 MSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred cCCCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 999999988865322 358999999999999999999998 89999999999999999999999999999877554
Q ss_pred CCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.........||+.|+|||++.++.++ ++||||
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S 199 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 199 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHH
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhc
Confidence 44444456799999999999999999 999998
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-36 Score=313.85 Aligned_cols=184 Identities=25% Similarity=0.488 Sum_probs=151.9
Q ss_pred CCCcccceeccccceEEEEEEEeCC-----cEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDG-----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
+.|++.++||+|+||+||+|.++.. ..||||+++.. .......+|.+|++++++++|||||+++|++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4688899999999999999987632 47999999753 34455678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+||||+.++++.+++.. ....+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEecccCcchhhhhc----ccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhh
Confidence 99999999999887743 33578999999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCCc--eeeeeccccCcccccccccCCcC-cceeec
Q 003911 748 LAPEGKGS--IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 748 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
........ ......||+.|||||++.++.++ ++||||
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S 198 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWS 198 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHH
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccc
Confidence 76543221 22335689999999999999998 999998
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-36 Score=322.51 Aligned_cols=181 Identities=27% Similarity=0.394 Sum_probs=161.7
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVF 670 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (787)
++|++.+.||+|+||.||+|+.+ +|+.||||++.+... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999875 799999999976432 2345678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecC
Q 003911 671 EYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAP 750 (787)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 750 (787)
||+.+|+|.+++... +.+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 121 e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 999999999988542 368999999999999999999998 899999999999999999999999999999875
Q ss_pred CCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 751 EGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 751 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
... ....||+.|||||++.+..|+ ++||||.
T Consensus 193 ~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSl 224 (350)
T d1rdqe_ 193 GRT----WTLCGTPEALAPEIILSKGYNKAVDWWAL 224 (350)
T ss_dssp SCB----CCCEECGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred ccc----ccccCccccCCHHHHcCCCCCccccccch
Confidence 432 346799999999999999898 8999983
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-36 Score=319.19 Aligned_cols=189 Identities=28% Similarity=0.465 Sum_probs=157.2
Q ss_pred cCCCcccceeccccceEEEEEEEeC-C-----cEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCC
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHD-G-----TKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 664 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 664 (787)
.++|++.+.||+|+||+||+|++.. + ..||||++.... .......+.+|+.+++++ +|||||++++++.+.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 3679999999999999999998752 2 369999886532 344557899999999998 8999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhhhh------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAE------------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLK 726 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 726 (787)
..++||||+++|+|.++++.... .....+++..++.++.||++||+|||+ ++|||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCc
Confidence 99999999999999999965321 112358999999999999999999998 899999999
Q ss_pred CCCEEECCCCcEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeec
Q 003911 727 PSNILLGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 727 p~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
|+||+++.++.+||+|||+|+........ ......||+.|||||++.++.++ ++||||
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS 251 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWS 251 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccc
Confidence 99999999999999999999876554432 22346689999999999999999 899998
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-35 Score=310.78 Aligned_cols=183 Identities=23% Similarity=0.341 Sum_probs=160.6
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (787)
+.++|++.+.||+|+||+||+|... +++.||||+++.. ......+.+|++++++++||||+++++++.+++..|+|
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999875 7899999999763 23345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC--CCcEEEeecccce
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD--DMRAKVADFGLVR 747 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~ 747 (787)
||||++|+|.+++.. ....+++.++..++.||+.||+|||+ ++|+||||||+|||++. ...+||+|||+++
T Consensus 80 mE~~~gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 80 FEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp ECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhh
Confidence 999999999998843 22368999999999999999999998 89999999999999984 4589999999998
Q ss_pred ecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 748 LAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
...... ......||+.|+|||.+.+..|+ ++||||.
T Consensus 153 ~~~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSl 189 (321)
T d1tkia_ 153 QLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSL 189 (321)
T ss_dssp ECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHH
T ss_pred ccccCC--cccccccccccccchhccCCCCCchhhcccH
Confidence 875433 33446799999999999999998 8999983
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-36 Score=313.10 Aligned_cols=184 Identities=28% Similarity=0.491 Sum_probs=159.6
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccc-cchhHHHHHHHHHHHH-hcCCCccceEEeEEEeCCeeEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVI-SGKGLTEFKSEIAVLT-KVRHRHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv 669 (787)
++|++.+.||+|+||+||+|+.. +++.||||++++... .....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999875 799999999976432 2344566777777765 68999999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
|||+++|+|.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+..
T Consensus 82 mEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhc
Confidence 9999999999998542 368899999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 750 PEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 750 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..... ......||+.|+|||++.+..|+ ++||||.
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 189 (320)
T d1xjda_ 154 MLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSF 189 (320)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred ccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhh
Confidence 54332 33446799999999999999999 8999983
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-35 Score=306.96 Aligned_cols=187 Identities=24% Similarity=0.369 Sum_probs=154.0
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCccceEEeEEEeCC----
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN---- 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 664 (787)
..++|++.+.||+|+||+||+|+.. +|+.||||+++..... ....+++.+|++++++++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 3578999999999999999999864 7999999999875443 445668999999999999999999999998654
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..|+||||+++++|.+++.. .+.+++.+++.++.||+.||+|||+ ++||||||||+|||++.++.++++|||
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCT
T ss_pred eEEEEEECCCCCEehhhhcc-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhh
Confidence 37899999999999988744 2468999999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCC--ceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 745 LVRLAPEGKG--SIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.++....... ......+||+.|||||++.+..++ ++||||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSl 200 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 200 (277)
T ss_dssp TCEECC----------------TTCCHHHHTTCCCCHHHHHHHH
T ss_pred hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccc
Confidence 9876543322 223446799999999999999898 9999983
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.4e-35 Score=302.55 Aligned_cols=184 Identities=28% Similarity=0.383 Sum_probs=159.5
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccc-------hhHHHHHHHHHHHHhcC-CCccceEEeEEEe
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG-------KGLTEFKSEIAVLTKVR-HRHLVALLGHCLD 662 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 662 (787)
.++|++.+.||+|+||+||+|+.. +|+.||||+++...... ...+++.+|++++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999874 78999999997654321 22346889999999997 9999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEee
Q 003911 663 GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVAD 742 (787)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 742 (787)
++..||||||+++|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred CcceEEEEEcCCCchHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEcc
Confidence 9999999999999999999954 2468999999999999999999998 8999999999999999999999999
Q ss_pred cccceecCCCCCceeeeeccccCcccccccccC------CcC-cceeecC
Q 003911 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHT------RWS-SCSYWAG 785 (787)
Q Consensus 743 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~-~~DiWS~ 785 (787)
||+|+...... .....+||+.|+|||++.+. .++ ++||||.
T Consensus 154 FG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~Diwsl 201 (277)
T d1phka_ 154 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 201 (277)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHH
T ss_pred chheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEccc
Confidence 99999876543 23446799999999999743 345 7999983
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-35 Score=317.57 Aligned_cols=182 Identities=26% Similarity=0.401 Sum_probs=154.3
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeeccccc-chhHHHHH---HHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVIS-GKGLTEFK---SEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
++|++.+.||+|+||.||+|+.. +|+.||||++.+.... ......+. +|+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999875 7999999999754322 12223333 4466777778999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+
T Consensus 84 ivmE~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHh-----cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceee
Confidence 99999999999999854 2467899999999999999999998 899999999999999999999999999999
Q ss_pred ecCCCCCceeeeeccccCccccccccc-CCcC-cceeecC
Q 003911 748 LAPEGKGSIETRIAGTFGYLAPEYAVH-TRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiWS~ 785 (787)
...... ....+||+.|||||++.+ ..|+ ++||||.
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSl 192 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSL 192 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHH
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHH
Confidence 775443 234679999999999975 4577 8999983
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.4e-36 Score=310.78 Aligned_cols=195 Identities=32% Similarity=0.513 Sum_probs=164.0
Q ss_pred HHHHhhcCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeE
Q 003911 586 QVLRNVTNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGH 659 (787)
Q Consensus 586 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 659 (787)
.+++...++|++.+.||+|+||+||+|+++ +++.||||+++.. ......++|.+|++++++++||||++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 344555678999999999999999999875 3578999998753 344556789999999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHHHhhhh-------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 003911 660 CLDGNEKLLVFEYMPQGTLSRHIFNWAE-------------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSF 720 (787)
Q Consensus 660 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i 720 (787)
+.+.+..++||||+++|+|.++++.... .....+++.+++.|+.|++.||+|||+ ++|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCe
Confidence 9999999999999999999999865321 122358899999999999999999998 899
Q ss_pred EEcCCCCCCEEECCCCcEEEeecccceecCCCCC-ceeeeeccccCcccccccccCCcC-cceeec
Q 003911 721 IHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKG-SIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 721 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
|||||||+|||++.++.+||+|||+|+....... .......||+.|||||++.+..|+ ++||||
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS 227 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 227 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhcc
Confidence 9999999999999999999999999986644322 222346789999999999999999 999998
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-35 Score=304.70 Aligned_cols=185 Identities=22% Similarity=0.373 Sum_probs=146.6
Q ss_pred cCCCcccceeccccceEEEEEEEeC----CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
.++|++.+.||+|+||.||+|.+.. +..||||+++.. ......+.+.+|++++++++||||+++++++. .+..|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 3579999999999999999997642 456889988652 34455678999999999999999999999986 46789
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+||||+++|++.+++.. ....+++..++.++.||++||+|||+ ++||||||||+||++++++.+||+|||+|+
T Consensus 84 iv~E~~~~g~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEeccCCcHHhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhhe
Confidence 99999999999988743 23468999999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 748 LAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
..............||+.|+|||++.+..++ ++||||.
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSl 195 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 195 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccc
Confidence 7765444444556789999999999999999 8999983
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-35 Score=309.14 Aligned_cols=179 Identities=23% Similarity=0.376 Sum_probs=153.1
Q ss_pred cCCCcccc-eeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEe----CC
Q 003911 592 TNNFSEEN-ILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD----GN 664 (787)
Q Consensus 592 ~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~ 664 (787)
.++|++.+ .||+|+||.||+|+.. +++.||||+++. ...+.+|++++.++ +|||||++++++.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 46898865 6999999999999874 799999999865 24678899987665 89999999999876 35
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC---CCcEEEe
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD---DMRAKVA 741 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 741 (787)
..|+|||||+||+|.+++.. .+...+++.++..|+.||+.||+|||+ .+|+||||||+|||+++ .+.+||+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~---~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHS---CSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEEECCCCCcHHHHHHh---cCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccc
Confidence 68999999999999999954 233579999999999999999999998 89999999999999985 5679999
Q ss_pred ecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 742 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|||+|+....... ....+||+.|||||++.+..|+ ++||||.
T Consensus 157 DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSl 199 (335)
T d2ozaa1 157 DFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 199 (335)
T ss_dssp CCTTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHH
T ss_pred ccceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhh
Confidence 9999987755432 2346799999999999999998 8999983
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-35 Score=307.74 Aligned_cols=183 Identities=28% Similarity=0.498 Sum_probs=151.3
Q ss_pred CCCcccceeccccceEEEEEEEe-CCc----EEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGT----KIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
.+|++.+.||+|+||+||+|.+. +|+ +||+|+++.. ......++|.+|++++++++|||||+++|++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 46999999999999999999864 444 5888888653 3445577899999999999999999999999865 567
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
++|||+.+|+|.+++.. ....+++..++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 87 ~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEECCTTCBHHHHHHH----TSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred EEEEeccCCcccccccc----cccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccce
Confidence 88999999999988754 34578999999999999999999998 899999999999999999999999999998
Q ss_pred ecCCCCCce-eeeeccccCcccccccccCCcC-cceeec
Q 003911 748 LAPEGKGSI-ETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 748 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
......... .....||+.|||||++.++.++ ++||||
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS 198 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 198 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHH
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhh
Confidence 775543322 2335689999999999999998 899998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-35 Score=305.17 Aligned_cols=185 Identities=28% Similarity=0.445 Sum_probs=154.4
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|+||+||+|+.. +|+.||||+++.........+++.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999874 79999999997654444556789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+.+ ++.+++.. .....+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||.|+....
T Consensus 82 ~~~~-~~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSE-EHHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCC-chhhhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccC
Confidence 9965 44444432 233568999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCceeeeeccccCcccccccccCCc-C-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRW-S-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~-~~DiWS~ 785 (787)
... ......||+.|+|||++....+ + ++|+||.
T Consensus 155 ~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSl 189 (298)
T d1gz8a_ 155 PVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189 (298)
T ss_dssp CSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHH
T ss_pred Ccc-cceeecccceeeehhhhccccCCCcccccccc
Confidence 332 2334579999999999877765 4 8999984
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-35 Score=304.68 Aligned_cols=190 Identities=26% Similarity=0.435 Sum_probs=150.5
Q ss_pred cCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeC-
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDG- 663 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~- 663 (787)
.++|++.+.||+|+||.||+|++. +++.||||+++... .....+++.+|.+++.++ +|+||+.+++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 468999999999999999999864 34689999987533 344556788888888887 689999999998765
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEE-----------GLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILL 732 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 732 (787)
...++||||+++|+|.++++..... ....+++.++..++.||++||+|||+ ++||||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeE
Confidence 4689999999999999999764321 12358899999999999999999998 899999999999999
Q ss_pred CCCCcEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 733 GDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 733 ~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++++.+||+|||+|+........ ......||+.|||||++.++.++ ++||||.
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~ 222 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 222 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeeh
Confidence 99999999999999876544322 23346799999999999999998 9999983
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-35 Score=298.73 Aligned_cols=177 Identities=33% Similarity=0.549 Sum_probs=147.4
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe-CCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 671 (787)
++|++.+.||+|+||.||+|+++ |+.||||+++.. ...+++.+|++++++++||||++++|++.+ .+..++|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 46888999999999999999985 889999999753 344789999999999999999999999865 456899999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
|+++|+|.+++..... ..+++..+++++.||+.||+|||+ .+|+||||||+||+++.++.+|++|||+++....
T Consensus 82 y~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999965332 258999999999999999999998 8999999999999999999999999999987643
Q ss_pred CCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
.. ....+|+.|+|||++.++.++ ++||||
T Consensus 156 ~~----~~~~~~~~y~aPE~l~~~~~t~~sDIwS 185 (262)
T d1byga_ 156 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWS 185 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHH
T ss_pred CC----ccccccccCCChHHHhCCCCChHHHHHh
Confidence 32 234679999999999999998 999998
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-35 Score=305.21 Aligned_cols=180 Identities=29% Similarity=0.383 Sum_probs=148.6
Q ss_pred ccceeccccceEEEEEEEe-CCcEEEEEEeecccccc---hhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 597 EENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG---KGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 597 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
.+++||+|+||+||+|+.. +|+.||||+++...... ...+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999865 69999999997643221 2235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
++++++.... .....+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~-----~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 82 METDLEVIIK-----DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp CSEEHHHHHT-----TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred hcchHHhhhh-----hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCC
Confidence 9887765554 233568899999999999999999998 89999999999999999999999999999876554
Q ss_pred CCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
... ....+||+.|||||++.+. .|+ ++||||.
T Consensus 154 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 187 (299)
T d1ua2a_ 154 NRA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAV 187 (299)
T ss_dssp CCC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHH
T ss_pred ccc-ccceecChhhccHHHHccCCCCChhhhhhhc
Confidence 322 2346799999999998765 566 8999983
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-35 Score=300.07 Aligned_cols=183 Identities=28% Similarity=0.372 Sum_probs=154.8
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccc----hhHHHHHHHHHHHHhcC--CCccceEEeEEEeCC
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISG----KGLTEFKSEIAVLTKVR--HRHLVALLGHCLDGN 664 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 664 (787)
.++|++.+.||+|+||+||+|+.. +|+.||||+++...... ....++.+|++++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999875 79999999997643321 12345778999999996 899999999999999
Q ss_pred eeEEEEEecCC-CCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC-CCcEEEee
Q 003911 665 EKLLVFEYMPQ-GTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-DMRAKVAD 742 (787)
Q Consensus 665 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~D 742 (787)
..++||||+.+ +++.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEEEeccCcchHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECc
Confidence 99999999976 577777643 2468999999999999999999998 89999999999999985 57999999
Q ss_pred cccceecCCCCCceeeeeccccCcccccccccCCcC--cceeecC
Q 003911 743 FGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS--SCSYWAG 785 (787)
Q Consensus 743 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~DiWS~ 785 (787)
||+|+...... .....||+.|||||++.+..+. ++||||.
T Consensus 155 FG~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSl 196 (273)
T d1xwsa_ 155 FGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 196 (273)
T ss_dssp CTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHH
T ss_pred cccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccc
Confidence 99998764432 3346799999999999887764 6899983
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-34 Score=301.37 Aligned_cols=183 Identities=25% Similarity=0.363 Sum_probs=148.7
Q ss_pred cCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC----eeE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----EKL 667 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~ 667 (787)
.++|.+.+.||+|+||.||+|++ +|+.||||+++... ......+.|+..+.+++||||+++++++.+.+ ..|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 35688899999999999999986 58999999986522 22223344555666789999999999998654 579
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEcCCCCCCEEECCCCcEEEee
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGL-----AHQSFIHRDLKPSNILLGDDMRAKVAD 742 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~D 742 (787)
+||||+++|+|.+++++ ..++|.+++.++.|++.||+|+|+. .+++||||||||+||||++++.+||+|
T Consensus 78 lv~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 99999999999999954 3589999999999999999999963 236999999999999999999999999
Q ss_pred cccceecCCCCCce---eeeeccccCcccccccccCC------cC-cceeec
Q 003911 743 FGLVRLAPEGKGSI---ETRIAGTFGYLAPEYAVHTR------WS-SCSYWA 784 (787)
Q Consensus 743 FG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~~-~~DiWS 784 (787)
||+++......... ....+||+.|||||++.+.. ++ ++||||
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S 203 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 203 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHH
T ss_pred cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhh
Confidence 99998775543322 23467999999999987653 44 799998
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-34 Score=301.53 Aligned_cols=186 Identities=33% Similarity=0.535 Sum_probs=154.6
Q ss_pred CCCcccceeccccceEEEEEEEe-CCc--EEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCCeeEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGT--KIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (787)
++|++.+.||+|+||+||+|+++ ++. .||||+++.. ......+++.+|+++++++ +|||||++++++.+.+..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc-cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 57899999999999999999876 444 4778887642 2344566899999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHHHhhh-----------hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCc
Q 003911 669 VFEYMPQGTLSRHIFNWA-----------EEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMR 737 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 737 (787)
||||+++|+|.++++... ......+++.++.+++.||+.||.|+|+ ++|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCc
Confidence 999999999999986431 1234579999999999999999999998 89999999999999999999
Q ss_pred EEEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeec
Q 003911 738 AKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 738 ~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+||+|||+|+....... .....||+.|+|||.+.++.++ ++||||
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwS 211 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWS 211 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHH
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeeh
Confidence 99999999986543322 1235689999999999999998 899998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-34 Score=295.01 Aligned_cols=184 Identities=29% Similarity=0.504 Sum_probs=146.6
Q ss_pred CCCcccceeccccceEEEEEEEeC--C--cEEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeE
Q 003911 593 NNFSEENILGRGGFGTVYKGELHD--G--TKIAVKRMEAGVI-SGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKL 667 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (787)
++|++.+.||+|+||+||+|++.. + ..||||+++.... .....++|.+|++++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 569999999999999999998642 2 3789999876543 34456789999999999999999999999976 4678
Q ss_pred EEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccce
Q 003911 668 LVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVR 747 (787)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 747 (787)
+||||+++|++.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhh
Confidence 999999999999887542 2468999999999999999999998 899999999999999999999999999999
Q ss_pred ecCCCCCce--eeeeccccCcccccccccCCcC-cceeec
Q 003911 748 LAPEGKGSI--ETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 748 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
......... .....||..|+|||++.+..++ ++||||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S 199 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWM 199 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHH
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhh
Confidence 875543322 2234578899999999999999 799998
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2e-34 Score=298.86 Aligned_cols=184 Identities=26% Similarity=0.376 Sum_probs=156.4
Q ss_pred CCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEEe
Q 003911 593 NNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFEY 672 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (787)
++|++.+.||+|+||+||+|+.++|+.||||+++.........+++.+|+.++++++||||+++++++.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 58999999999999999999998999999999977555555568899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+.++.+..+. .....+++.++..++.||+.||+|||+ .+||||||||+|||++.++.+|++|||.|......
T Consensus 82 ~~~~~~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLD-----VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHH-----TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHH-----hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9876665554 233579999999999999999999998 89999999999999999999999999999876543
Q ss_pred CCceeeeeccccCcccccccccCC-cC-cceeecC
Q 003911 753 KGSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWAG 785 (787)
Q Consensus 753 ~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS~ 785 (787)
.. ......|++.|+|||.+.+.. ++ ++||||.
T Consensus 154 ~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~Diwsl 187 (286)
T d1ob3a_ 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV 187 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHH
T ss_pred cc-ccceecccchhhhHHHHhCCCCCCcceeehhc
Confidence 32 223356899999999997654 45 8999983
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-34 Score=299.17 Aligned_cols=190 Identities=27% Similarity=0.437 Sum_probs=162.9
Q ss_pred cCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEeCC
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLDGN 664 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 664 (787)
.++|++.+.||+|+||.||+|++. +++.||||+++... ......++.+|+.+++++ +|||||++++++.+.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 367899999999999999999863 45789999997643 344566899999999999 6999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHHhhhh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAE-------------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 731 (787)
..++||||+++|+|.++++.... .....+++..+..++.||++||+|||+ +++|||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccc
Confidence 99999999999999999976432 123468999999999999999999998 89999999999999
Q ss_pred ECCCCcEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 732 LGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 732 l~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
++.++.+|++|||.++........ ......||+.|+|||++.++.++ ++||||-
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~ 233 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccch
Confidence 999999999999999977654432 23346799999999999999888 8999983
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-34 Score=297.92 Aligned_cols=189 Identities=26% Similarity=0.469 Sum_probs=161.8
Q ss_pred cCCCcccceeccccceEEEEEEEe------CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCe
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH------DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNE 665 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (787)
.++|++.+.||+|+||+||+|.+. +++.||||+++.. ........|.+|++++++++||||+++++++...+.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 367889999999999999999763 3578999999753 344556789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhh-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEE
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAE-----EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKV 740 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 740 (787)
.++||||+++|+|.+++..... .....+++..+.+++.|+++||.|||+ ++|+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEE
Confidence 9999999999999999865322 223457899999999999999999998 89999999999999999999999
Q ss_pred eecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeec
Q 003911 741 ADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 741 ~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
+|||+|+........ ......||+.|+|||.+.+..++ ++|+||
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S 220 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWS 220 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCccccccc
Confidence 999999876543322 12334689999999999999998 899998
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-33 Score=294.48 Aligned_cols=179 Identities=30% Similarity=0.522 Sum_probs=152.6
Q ss_pred cceeccccceEEEEEEEeC----CcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe-CCeeEEEEEe
Q 003911 598 ENILGRGGFGTVYKGELHD----GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD-GNEKLLVFEY 672 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 672 (787)
.++||+|+||+||+|++.+ ...||||+++. .......++|.+|++++++++||||++++|++.. ++..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 5789999999999998753 23689999875 3345567889999999999999999999999876 4578999999
Q ss_pred cCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCCC
Q 003911 673 MPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEG 752 (787)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 752 (787)
+++|+|.+++.. .....++..+++++.|+++||.|+|+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 111 ~~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 111 MKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp CTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 999999998753 33467788999999999999999998 89999999999999999999999999999876543
Q ss_pred CCc---eeeeeccccCcccccccccCCcC-cceeec
Q 003911 753 KGS---IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 753 ~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
... ......||+.|+|||.+.+..++ ++||||
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S 219 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 219 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHH
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhh
Confidence 221 22235689999999999999999 999998
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-34 Score=295.86 Aligned_cols=189 Identities=29% Similarity=0.458 Sum_probs=156.3
Q ss_pred cCCCcccceeccccceEEEEEEEeC--------CcEEEEEEeecccccchhHHHHHHHHHHHHhc-CCCccceEEeEEEe
Q 003911 592 TNNFSEENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV-RHRHLVALLGHCLD 662 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 662 (787)
.++|++.+.||+|+||.||+|+... +..||||+++.. .......++.+|...+.++ +|||||++++++.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc-cChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3679999999999999999997542 247999999764 3455567889999999998 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHHhhhh-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 003911 663 GNEKLLVFEYMPQGTLSRHIFNWAE-----------EGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNIL 731 (787)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 731 (787)
++..++||||+++|+|.+++..... .....+++.+++.++.||+.||+|||+ .+||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeeccccee
Confidence 9999999999999999999965321 123468999999999999999999998 89999999999999
Q ss_pred ECCCCcEEEeecccceecCCCCCc-eeeeeccccCcccccccccCCcC-cceeec
Q 003911 732 LGDDMRAKVADFGLVRLAPEGKGS-IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 732 l~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
++.++.+||+|||+++........ ......||+.|+|||++.++.|+ ++||||
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS 222 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 222 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHH
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHH
Confidence 999999999999999876544322 22345789999999999999999 999998
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-34 Score=297.00 Aligned_cols=185 Identities=26% Similarity=0.397 Sum_probs=152.3
Q ss_pred cCCCcccceeccccceEEEEEEEe-C-CcEEEEEEeecccccchhHHHHHHHHHHHHhc---CCCccceEEeEEEe----
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-D-GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKV---RHRHLVALLGHCLD---- 662 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~---- 662 (787)
.++|++.+.||+|+||+||+|+.. + ++.||||+++...........+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999874 4 66799999976544444444566788777766 79999999999863
Q ss_pred -CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEe
Q 003911 663 -GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 741 (787)
Q Consensus 663 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 741 (787)
....+++|||++++.+..... .....+++..+..++.|++.||+|||+ ++||||||||+|||+++++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH----SCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhhh----ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeec
Confidence 246789999998876654332 234568999999999999999999998 899999999999999999999999
Q ss_pred ecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 742 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 742 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
|||+++...... ......||+.|||||++.+..|+ ++||||.
T Consensus 159 dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSl 201 (305)
T d1blxa_ 159 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 201 (305)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred chhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhch
Confidence 999988654322 23446799999999999999998 9999984
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4.2e-33 Score=297.06 Aligned_cols=181 Identities=27% Similarity=0.431 Sum_probs=151.5
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC-----
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----- 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 664 (787)
+.++|++.+.||+|+||+||+|... +|+.||||+++.........+.+.+|++++++++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4578999999999999999999875 7999999999876556666788999999999999999999999998654
Q ss_pred -eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 665 -EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 665 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
..|+||||+ +.+|..+++. ..+++..++.++.||+.||+|||+ ++||||||||+|||++.++.+|++||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccc
Confidence 469999999 6677776632 469999999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCCceeeeeccccCcccccccccCC-cC-cceeecC
Q 003911 744 GLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS~ 785 (787)
|+|+...... +...||+.|+|||++.+.. ++ ++||||.
T Consensus 166 g~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 205 (346)
T d1cm8a_ 166 GLARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSV 205 (346)
T ss_dssp TTCEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHH
T ss_pred cceeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcc
Confidence 9998775432 3467999999999998754 45 8999984
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=6.8e-33 Score=292.04 Aligned_cols=185 Identities=24% Similarity=0.389 Sum_probs=151.9
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEe--------C
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLD--------G 663 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~ 663 (787)
++|++.+.||+|+||+||+|+.. +|+.||||++..........+++.+|++++++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 68999999999999999999875 79999999997765555667889999999999999999999999865 3
Q ss_pred CeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeec
Q 003911 664 NEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADF 743 (787)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 743 (787)
+..|+||||++++.+.... .....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~-----~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS-----NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT-----CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCCCccchhh-----hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeec
Confidence 4579999999877665433 334578899999999999999999998 89999999999999999999999999
Q ss_pred ccceecCCCCC---ceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 744 GLVRLAPEGKG---SIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 744 G~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
|+++....... ......+||+.|+|||++.+. .++ ++||||.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSl 208 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 208 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccC
Confidence 99987654321 122235799999999999876 566 8999983
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.98 E-value=1.5e-32 Score=285.03 Aligned_cols=182 Identities=18% Similarity=0.266 Sum_probs=155.0
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCC-CccceEEeEEEeCCeeEEE
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRH-RHLVALLGHCLDGNEKLLV 669 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv 669 (787)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+++|+++++.++| +|++.+++++......++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 468999999999999999999875 78999999886532 22457889999999965 8999999999999999999
Q ss_pred EEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECC-----CCcEEEeecc
Q 003911 670 FEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGD-----DMRAKVADFG 744 (787)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DFG 744 (787)
|||+ +++|.+++.. ....+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||
T Consensus 80 me~~-~~~l~~~~~~----~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 80 IDLL-GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEec-CCCHHHHHHh----hccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccc
Confidence 9999 7899888744 22468999999999999999999997 89999999999999974 5789999999
Q ss_pred cceecCCCCCc------eeeeeccccCcccccccccCCcC-cceeecC
Q 003911 745 LVRLAPEGKGS------IETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+|+........ .....+||+.|||||++.+..++ ++||||-
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSl 199 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEAL 199 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHh
Confidence 99987543221 12346799999999999999998 8999983
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.2e-32 Score=293.07 Aligned_cols=185 Identities=23% Similarity=0.404 Sum_probs=150.9
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCC----e
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGN----E 665 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~ 665 (787)
+..+|++.+.||+|+||+||+|... +|+.||||++.... .....+++.+|++++++++||||+++++++.... .
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 3468999999999999999999764 89999999997532 3445678899999999999999999999997653 2
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.+++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 85 ~~~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp CEEEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCc
Confidence 3455566779999999853 368999999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCCc--eeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 746 VRLAPEGKGS--IETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
|+........ .....+||+.|+|||++... .++ ++||||.
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSl 199 (345)
T d1pmea_ 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 199 (345)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHH
T ss_pred eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhcc
Confidence 9876443221 22346799999999998554 455 7899983
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3e-32 Score=283.75 Aligned_cols=184 Identities=23% Similarity=0.360 Sum_probs=160.8
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeCCeeEEEEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDGNEKLLVFE 671 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (787)
++|++.+.||+|+||+||+|+.. +++.||||+++.........+++.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999875 78999999998765556667899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecccceecCC
Q 003911 672 YMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPE 751 (787)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 751 (787)
++.++++..++.. .+.+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||.|+....
T Consensus 82 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecccccccccccc-----ccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 9999888776632 3578899999999999999999998 8999999999999999999999999999998755
Q ss_pred CCCceeeeeccccCcccccccccCC-cC-cceeecC
Q 003911 752 GKGSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWAG 785 (787)
Q Consensus 752 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS~ 785 (787)
.... .....+++.|+|||++.+.. ++ ++||||.
T Consensus 154 ~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSl 188 (292)
T d1unla_ 154 PVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188 (292)
T ss_dssp CCSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred CCcc-ceeeccccchhhhhHhccCCCCCchhhcccc
Confidence 4322 23346788999999988775 45 8999983
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.97 E-value=1.8e-32 Score=290.06 Aligned_cols=175 Identities=21% Similarity=0.390 Sum_probs=150.3
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeC--CeeEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDG--NEKLL 668 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~l 668 (787)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. ..+++.+|++++++++ ||||+++++++... ...++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 57999999999999999999874 7999999998652 2467899999999995 99999999999854 46899
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC-cEEEeecccce
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGLVR 747 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~ 747 (787)
||||+++++|.... +.+++..+..++.||+.||+|||+ ++||||||||+|||++.++ .+||+|||+|+
T Consensus 110 v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 110 VFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred EEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccce
Confidence 99999999986553 468999999999999999999998 8999999999999998654 69999999998
Q ss_pred ecCCCCCceeeeeccccCcccccccccCC-cC-cceeecC
Q 003911 748 LAPEGKGSIETRIAGTFGYLAPEYAVHTR-WS-SCSYWAG 785 (787)
Q Consensus 748 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~DiWS~ 785 (787)
....... ....+||+.|+|||.+.+.. ++ ++|+||.
T Consensus 179 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 216 (328)
T d3bqca1 179 FYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSL 216 (328)
T ss_dssp ECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred eccCCCc--ccccccCccccCcccccCCCCCCcccchhhh
Confidence 8755432 33467899999999988764 56 8999984
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.9e-32 Score=288.75 Aligned_cols=179 Identities=25% Similarity=0.433 Sum_probs=146.6
Q ss_pred CCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC------Cee
Q 003911 594 NFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------NEK 666 (787)
Q Consensus 594 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~ 666 (787)
+|+..++||+|+||+||+|+.. +|+.||||++..... ...+|++++++++||||+++++++... ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 5888899999999999999875 799999999976432 234799999999999999999998643 246
Q ss_pred EEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC-cEEEeeccc
Q 003911 667 LLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-RAKVADFGL 745 (787)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~ 745 (787)
++||||++++ +.+.+..... ....+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 95 ~lv~Ey~~~~-~~~~l~~~~~-~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 95 NLVLDYVPET-VYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEECCSEE-HHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEeccCCc-cHHHHHhhhh-ccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccc
Confidence 8999999765 4444433222 33579999999999999999999997 8999999999999999765 899999999
Q ss_pred ceecCCCCCceeeeeccccCcccccccccC-CcC-cceeecC
Q 003911 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVHT-RWS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~DiWS~ 785 (787)
|+....... ....+||+.|+|||.+.+. .|+ ++||||.
T Consensus 170 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSl 209 (350)
T d1q5ka_ 170 AKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSA 209 (350)
T ss_dssp CEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHH
T ss_pred hhhccCCcc--cccccccccccChHHhhcccCCCcceeeccc
Confidence 987755432 2346799999999998764 566 8999983
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.4e-33 Score=289.81 Aligned_cols=185 Identities=24% Similarity=0.371 Sum_probs=158.1
Q ss_pred CCCcccceeccccceEEEEEEEe----CCcEEEEEEeecccc--cchhHHHHHHHHHHHHhcCC-CccceEEeEEEeCCe
Q 003911 593 NNFSEENILGRGGFGTVYKGELH----DGTKIAVKRMEAGVI--SGKGLTEFKSEIAVLTKVRH-RHLVALLGHCLDGNE 665 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~ 665 (787)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 57999999999999999999752 588999999876432 23345678899999999976 899999999999999
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeeccc
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 745 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 745 (787)
.++||||+.+|+|.+++... ..+++..+..++.|++.||+|+|+ .+||||||||+||+++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999998542 356788999999999999999998 8999999999999999999999999999
Q ss_pred ceecCCCCCceeeeeccccCcccccccccCC--cC-cceeecC
Q 003911 746 VRLAPEGKGSIETRIAGTFGYLAPEYAVHTR--WS-SCSYWAG 785 (787)
Q Consensus 746 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~-~~DiWS~ 785 (787)
|+..............|++.|+|||.+.+.. ++ ++||||.
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSl 218 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHH
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHH
Confidence 9877554444444567999999999997653 45 7999984
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.8e-32 Score=290.24 Aligned_cols=181 Identities=26% Similarity=0.378 Sum_probs=146.5
Q ss_pred cCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC------C
Q 003911 592 TNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG------N 664 (787)
Q Consensus 592 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~ 664 (787)
.++|++.+.||+|+||+||+|++. +|+.||||+++..........++.+|+.++++++||||+++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999876 799999999987666666677899999999999999999999999643 5
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..|+||||+.++ +.+.+. ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+|++|||
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred eeEEEEeccchH-HHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechh
Confidence 789999999665 444441 358999999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
+++...... .....+||+.|+|||++.+..++ ++||||.
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSl 204 (355)
T d2b1pa1 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 204 (355)
T ss_dssp C-----------------CCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred hhhcccccc--ccccccccccccChhhhcCCCCCCCcccccc
Confidence 988665433 23446799999999999998888 8999983
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=7.7e-32 Score=281.20 Aligned_cols=182 Identities=21% Similarity=0.335 Sum_probs=149.5
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccc-eEEeEEEeCCeeEE
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLV-ALLGHCLDGNEKLL 668 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~l 668 (787)
+.++|++.+.||+|+||+||+|+.. +|+.||||++.... ..+++.+|++++++++|++++ .+.+++.+.+..++
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 3468999999999999999999874 78999999987632 224578999999999877655 55566677888999
Q ss_pred EEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEC---CCCcEEEeeccc
Q 003911 669 VFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLG---DDMRAKVADFGL 745 (787)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG~ 745 (787)
||||+ ++++.+.+.. ....+++..+..++.|++.||+|||+ ++||||||||+|||++ .+..+||+|||+
T Consensus 81 vme~~-~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~ 152 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152 (299)
T ss_dssp EEECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred EEEEc-CCchhhhhhh----ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCc
Confidence 99999 5677666533 23578999999999999999999998 8999999999999986 355799999999
Q ss_pred ceecCCCCCc------eeeeeccccCcccccccccCCcC-cceeec
Q 003911 746 VRLAPEGKGS------IETRIAGTFGYLAPEYAVHTRWS-SCSYWA 784 (787)
Q Consensus 746 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS 784 (787)
|+........ ......||+.|||||++.+..++ ++||||
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 198 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLES 198 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHH
T ss_pred ceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEe
Confidence 9987654321 12346799999999999999898 899998
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=9.7e-32 Score=282.80 Aligned_cols=252 Identities=27% Similarity=0.448 Sum_probs=181.8
Q ss_pred CCCcEEEeecCCCCCC--CC-CCCCCCCCcEEEccc-ccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCC
Q 003911 92 TKLERLELQWNSISGP--LP-SLNGLASLEVVMLSN-NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQ 167 (787)
Q Consensus 92 ~~L~~L~L~~N~l~~~--~~-~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~ 167 (787)
.+++.|+|++|.++|. +| ++++|++|++|+|++ |+++|..|..|++|++|++|+|++|++.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~--------------- 114 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS--------------- 114 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCE---------------
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhcccccc---------------
Confidence 4677788888777763 33 566666666666664 5565544444555555555555555554
Q ss_pred EEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEec
Q 003911 168 NFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWL 247 (787)
Q Consensus 168 ~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L 247 (787)
+.++..+. .+.+|+++++++|++.+.+|..+. ++++|+.+++
T Consensus 115 ----------~~~~~~~~--~~~~L~~l~l~~N~~~~~~p~~l~--------------------------~l~~L~~l~l 156 (313)
T d1ogqa_ 115 ----------GAIPDFLS--QIKTLVTLDFSYNALSGTLPPSIS--------------------------SLPNLVGITF 156 (313)
T ss_dssp ----------EECCGGGG--GCTTCCEEECCSSEEESCCCGGGG--------------------------GCTTCCEEEC
T ss_pred ----------cccccccc--chhhhcccccccccccccCchhhc--------------------------cCcccceeec
Confidence 44444443 455555555555555555554433 5566666666
Q ss_pred cccccccCCCC-CCCCCCC-CEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCC
Q 003911 248 HSNAFSGPLPD-FSGVKQL-ESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPS 325 (787)
Q Consensus 248 ~~N~l~~~~~~-~~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~ 325 (787)
++|.+++.+|. +..+..+ +.+++++|+++|..|..+..+..+ .+++++|.+.+.+|....
T Consensus 157 ~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~----------------- 218 (313)
T d1ogqa_ 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFG----------------- 218 (313)
T ss_dssp CSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCC-----------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccc-----------------
Confidence 66666655543 4455454 889999999999999999888655 799999999987775211
Q ss_pred CCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEeccccc
Q 003911 326 PGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNN 405 (787)
Q Consensus 326 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 405 (787)
...+++.+++++|++.+.+| .++.+++|+.|+|++|+
T Consensus 219 ------------------------------------------~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~ 255 (313)
T d1ogqa_ 219 ------------------------------------------SDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNR 255 (313)
T ss_dssp ------------------------------------------TTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSC
T ss_pred ------------------------------------------cccccccccccccccccccc-ccccccccccccCccCe
Confidence 22478899999999998766 68999999999999999
Q ss_pred ccccCCccCcCCCCCCeeeccCCcccccCCCC---CCCceeecCCCCCCCCCCCC
Q 003911 406 LSGMIPEGLSVLGALKELDVSNNQLYGKIPSF---KSNAIVNTDGNPDIGKEKSS 457 (787)
Q Consensus 406 l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~~---~~~~~~~~~gn~~~~~~~~~ 457 (787)
|+|.+|..|+++++|++|||++|+|+|.||++ ..+..+.+.||+.+|+.|.+
T Consensus 256 l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp 310 (313)
T d1ogqa_ 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp CEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred ecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCC
Confidence 99999999999999999999999999999985 45567788999999998764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.4e-32 Score=287.96 Aligned_cols=182 Identities=24% Similarity=0.393 Sum_probs=152.6
Q ss_pred hcCCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCccceEEeEEEeC-----C
Q 003911 591 VTNNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHLVALLGHCLDG-----N 664 (787)
Q Consensus 591 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 664 (787)
+.++|++.+.||+|+||+||+|+.. +|+.||||+++.........+++.+|++++++++||||+++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3578999999999999999999864 799999999987655666677899999999999999999999998643 3
Q ss_pred eeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcEEEeecc
Q 003911 665 EKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFG 744 (787)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 744 (787)
..+++|+|+.+|+|.+++.. +.+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred ceEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccc
Confidence 34677788889999998832 469999999999999999999998 899999999999999999999999999
Q ss_pred cceecCCCCCceeeeeccccCcccccccccCCc-C-cceeecC
Q 003911 745 LVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRW-S-SCSYWAG 785 (787)
Q Consensus 745 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~-~~DiWS~ 785 (787)
.|...... .....||+.|+|||+..+..+ + ++||||.
T Consensus 167 ~a~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSl 205 (348)
T d2gfsa1 167 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 205 (348)
T ss_dssp ---CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHH
T ss_pred hhcccCcc----cccccccccccCchhhcCCccCCcccchhhh
Confidence 99765332 233578999999999877654 5 8999983
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=1.2e-26 Score=242.52 Aligned_cols=273 Identities=20% Similarity=0.282 Sum_probs=215.7
Q ss_pred CCcccEEEcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccc
Q 003911 57 CKWNHVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFF 135 (787)
Q Consensus 57 C~w~gv~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~ 135 (787)
|.|.+|.|.. ++++ .+|..+. +++++|+|++|+|+.+++ +|.++++|++|++++|.+..+++..|
T Consensus 10 c~~~~~~C~~-----------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f 75 (305)
T d1xkua_ 10 CHLRVVQCSD-----------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75 (305)
T ss_dssp EETTEEECTT-----------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTT
T ss_pred ecCCEEEecC-----------CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhh
Confidence 5677777753 4566 7788775 689999999999999887 69999999999999999999999999
Q ss_pred cCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccc
Q 003911 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQI 215 (787)
Q Consensus 136 ~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l 215 (787)
.++++|++|++++|+++ .+|..+ ...|..|++.+|.+.+..+..+. ....+..++...|.......
T Consensus 76 ~~l~~L~~L~l~~n~l~--~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~--~~~~~~~l~~~~n~~~~~~~-------- 141 (305)
T d1xkua_ 76 APLVKLERLYLSKNQLK--ELPEKM--PKTLQELRVHENEITKVRKSVFN--GLNQMIVVELGTNPLKSSGI-------- 141 (305)
T ss_dssp TTCTTCCEEECCSSCCS--BCCSSC--CTTCCEEECCSSCCCBBCHHHHT--TCTTCCEEECCSSCCCGGGB--------
T ss_pred hCCCccCEecccCCccC--cCccch--hhhhhhhhccccchhhhhhhhhh--ccccccccccccccccccCC--------
Confidence 99999999999999998 566543 35788888888888876665554 56677778877775432111
Q ss_pred cceeeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEcc
Q 003911 216 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMT 295 (787)
Q Consensus 216 ~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 295 (787)
....+..+++|+.+++++|.++..+..+ +++|+.|++++|.+++..+..|..++.+++|+++
T Consensus 142 ----------------~~~~~~~l~~L~~l~l~~n~l~~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s 203 (305)
T d1xkua_ 142 ----------------ENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203 (305)
T ss_dssp ----------------CTTGGGGCTTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECC
T ss_pred ----------------CccccccccccCccccccCCccccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccc
Confidence 1123557899999999999998655443 5899999999999999999999999999999999
Q ss_pred CCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEE
Q 003911 296 NNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVI 375 (787)
Q Consensus 296 ~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L 375 (787)
+|.+++..+.. +...++|+.|
T Consensus 204 ~n~l~~~~~~~-----------------------------------------------------------~~~l~~L~~L 224 (305)
T d1xkua_ 204 FNSISAVDNGS-----------------------------------------------------------LANTPHLREL 224 (305)
T ss_dssp SSCCCEECTTT-----------------------------------------------------------GGGSTTCCEE
T ss_pred ccccccccccc-----------------------------------------------------------ccccccceee
Confidence 99998766542 1123478899
Q ss_pred EccCCcccccCchhhcCCCCCCEEecccccccccCCcc------CcCCCCCCeeeccCCccc-ccCC
Q 003911 376 NFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEG------LSVLGALKELDVSNNQLY-GKIP 435 (787)
Q Consensus 376 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~------l~~l~~L~~L~Ls~N~l~-g~iP 435 (787)
+|++|+|+ .+|..|..+++|++|+|++|+|+..-... +..+.+|+.|+|++|+++ +.+|
T Consensus 225 ~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~ 290 (305)
T d1xkua_ 225 HLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 290 (305)
T ss_dssp ECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSC
T ss_pred eccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCC
Confidence 99999888 56888999999999999999998432222 346778889999999885 4454
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=7.2e-27 Score=252.66 Aligned_cols=320 Identities=18% Similarity=0.269 Sum_probs=188.0
Q ss_pred CCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEc
Q 003911 67 DKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEI 146 (787)
Q Consensus 67 ~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 146 (787)
-..+++|++++++|+. + +.+..|++|++|+|++|+|++.++ +.++++|++|++++|+++++++ ++++++|+.|++
T Consensus 43 l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~-l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~ 117 (384)
T d2omza2 43 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 117 (384)
T ss_dssp HTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred hCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCcc-ccCCcccccccccccccccccc--cccccccccccc
Confidence 3579999999999884 4 468889999999999999998654 8899999999999999998765 889999999999
Q ss_pred cCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEE-------------------eccccccccCCC
Q 003911 147 DNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTIL-------------------HLAFNQLIGGLP 207 (787)
Q Consensus 147 ~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L-------------------~L~~N~l~~~~p 207 (787)
++|.+++ + ........+..+....|.+....+.... ........ ....|.... ..
T Consensus 118 ~~~~~~~--~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 191 (384)
T d2omza2 118 FNNQITD--I-DPLKNLTNLNRLELSSNTISDISALSGL--TSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD-IS 191 (384)
T ss_dssp CSSCCCC--C-GGGTTCTTCSEEEEEEEEECCCGGGTTC--TTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCC-CG
T ss_pred ccccccc--c-cccccccccccccccccccccccccccc--ccccccccccccchhhhhcccccccccccccccccc-cc
Confidence 9998885 2 2344556677777777766543332211 11111111 111111110 00
Q ss_pred cCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCC
Q 003911 208 ASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLE 287 (787)
Q Consensus 208 ~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 287 (787)
.......+..+++.++.. ... ..+..+++|++|++++|+++. ++.+..+++|+.|++++|++++..+ +..++
T Consensus 192 ~~~~l~~~~~l~l~~n~i----~~~-~~~~~~~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~ 263 (384)
T d2omza2 192 VLAKLTNLESLIATNNQI----SDI-TPLGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP--LSGLT 263 (384)
T ss_dssp GGGGCTTCSEEECCSSCC----CCC-GGGGGCTTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCCCGG--GTTCT
T ss_pred ccccccccceeeccCCcc----CCC-CcccccCCCCEEECCCCCCCC-cchhhcccccchhccccCccCCCCc--ccccc
Confidence 000001111111111100 000 012234445555555555443 2234444555555555555543221 44455
Q ss_pred CCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCcccccc
Q 003911 288 SLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTC 367 (787)
Q Consensus 288 ~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (787)
+|++|++++|++++..+ +..+..+..+....|.+..+ ....
T Consensus 264 ~L~~L~l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~~--------------------------------------~~~~ 304 (384)
T d2omza2 264 KLTELKLGANQISNISP-LAGLTALTNLELNENQLEDI--------------------------------------SPIS 304 (384)
T ss_dssp TCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCC--------------------------------------GGGG
T ss_pred cCCEeeccCcccCCCCc-cccccccccccccccccccc--------------------------------------cccc
Confidence 55555555555543322 22233333333333322211 1233
Q ss_pred CCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCC--CCCCCceeec
Q 003911 368 TKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIP--SFKSNAIVNT 445 (787)
Q Consensus 368 ~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP--~~~~~~~~~~ 445 (787)
..++++.|++++|++++..| +..+++|++|+|++|+|++ +| .++.+++|++|++++|++++.+| .+.++..+.+
T Consensus 305 ~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L 380 (384)
T d2omza2 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGL 380 (384)
T ss_dssp GCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEEC
T ss_pred hhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeC
Confidence 44678889999999987543 8889999999999999884 55 68889999999999999987655 2445566666
Q ss_pred CCC
Q 003911 446 DGN 448 (787)
Q Consensus 446 ~gn 448 (787)
++|
T Consensus 381 ~~N 383 (384)
T d2omza2 381 NDQ 383 (384)
T ss_dssp CCE
T ss_pred CCC
Confidence 665
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.3e-26 Score=239.47 Aligned_cols=211 Identities=23% Similarity=0.350 Sum_probs=169.7
Q ss_pred cEEEcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCC
Q 003911 61 HVVCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLS 139 (787)
Q Consensus 61 gv~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 139 (787)
+-.|..... ..++.++++++ .+|..+. +.+++|+|++|+|+.+++ +|.++++|++|++++|++..+++..+.+++
T Consensus 5 ~C~C~~~~~-~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~ 80 (284)
T d1ozna_ 5 ACVCYNEPK-VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA 80 (284)
T ss_dssp TCEEECSSS-CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred CCEEcCCCC-eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccc
Confidence 445643322 33467777888 7787765 678999999999998777 699999999999999999999999999999
Q ss_pred CCcEEEcc-CCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccce
Q 003911 140 SLQSIEID-NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSL 218 (787)
Q Consensus 140 ~L~~L~L~-~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L 218 (787)
.++.++.. .|.++. ..|..|.++++|++|++++|.+....+..+. .+++|+.+++++|+|++..+..|.
T Consensus 81 ~~~~l~~~~~~~~~~-l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~--~~~~L~~l~l~~N~l~~i~~~~f~------- 150 (284)
T d1ozna_ 81 LLEQLDLSDNAQLRS-VDPATFHGLGRLHTLHLDRCGLQELGPGLFR--GLAALQYLYLQDNALQALPDDTFR------- 150 (284)
T ss_dssp TCCEEECCSCTTCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTT--TCTTCCEEECCSSCCCCCCTTTTT-------
T ss_pred ccccccccccccccc-ccchhhcccccCCEEecCCcccccccccccc--hhcccchhhhccccccccChhHhc-------
Confidence 99999875 555664 4477888999999999999998877777775 788899999999999866665553
Q ss_pred eeccCCCCCcCCCCccccccCccCceEeccccccccCCC-CCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCC
Q 003911 219 WVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLP-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNN 297 (787)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 297 (787)
.+++|++|+|++|+|++.++ .|.++++|+.|++++|++++..|..|..+++|++|++++|
T Consensus 151 -------------------~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 211 (284)
T d1ozna_ 151 -------------------DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211 (284)
T ss_dssp -------------------TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred -------------------cccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccc
Confidence 67788888888888887766 4778888888888888888888888888888888888888
Q ss_pred cccccCC
Q 003911 298 LLQGPVP 304 (787)
Q Consensus 298 ~l~~~~p 304 (787)
++++.++
T Consensus 212 ~i~~~~~ 218 (284)
T d1ozna_ 212 NLSALPT 218 (284)
T ss_dssp CCSCCCH
T ss_pred ccccccc
Confidence 8876554
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.93 E-value=6e-27 Score=251.17 Aligned_cols=182 Identities=24% Similarity=0.335 Sum_probs=145.9
Q ss_pred CCCcccceeccccceEEEEEEEe-CCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-----------CCccceEEeEE
Q 003911 593 NNFSEENILGRGGFGTVYKGELH-DGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-----------HRHLVALLGHC 660 (787)
Q Consensus 593 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~ 660 (787)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|++++++++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 35999999999999999999874 7999999999763 233467788999888875 57899999888
Q ss_pred Ee--CCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCC--
Q 003911 661 LD--GNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDM-- 736 (787)
Q Consensus 661 ~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 736 (787)
.. ....+++|+++..+........ ......+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETT
T ss_pred eeccccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcc
Confidence 64 3556777777766554333322 2334578899999999999999999997 47899999999999998654
Q ss_pred ----cEEEeecccceecCCCCCceeeeeccccCcccccccccCCcC-cceeecC
Q 003911 737 ----RAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVHTRWS-SCSYWAG 785 (787)
Q Consensus 737 ----~~kl~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~DiWS~ 785 (787)
.++++|||.|....... ...+||+.|+|||++.+..++ ++|+||.
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 215 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWST 215 (362)
T ss_dssp TTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHH
T ss_pred cccceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccch
Confidence 39999999998664332 346799999999999998888 8999984
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=1.1e-24 Score=227.44 Aligned_cols=263 Identities=18% Similarity=0.202 Sum_probs=216.5
Q ss_pred CCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEecc
Q 003911 93 KLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSAN 172 (787)
Q Consensus 93 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~ 172 (787)
.++.+|-++++++.+|+.+. +++++|+|++|+|+.+++..|.++++|++|++++|.+.. ..|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~-i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCCccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccc-cchhhhhCCCccCEeccc
Confidence 56788999999998877764 689999999999999999999999999999999999996 457889999999999999
Q ss_pred CceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEecccccc
Q 003911 173 SANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAF 252 (787)
Q Consensus 173 ~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 252 (787)
+|+++.. |..+ ...|..|++..|.+.+..+..+ .....+..++...|..
T Consensus 88 ~n~l~~l-~~~~----~~~l~~L~~~~n~l~~l~~~~~--------------------------~~~~~~~~l~~~~n~~ 136 (305)
T d1xkua_ 88 KNQLKEL-PEKM----PKTLQELRVHENEITKVRKSVF--------------------------NGLNQMIVVELGTNPL 136 (305)
T ss_dssp SSCCSBC-CSSC----CTTCCEEECCSSCCCBBCHHHH--------------------------TTCTTCCEEECCSSCC
T ss_pred CCccCcC-ccch----hhhhhhhhccccchhhhhhhhh--------------------------hccccccccccccccc
Confidence 9999865 4433 4688999999999986554433 2566778888888865
Q ss_pred ccCC--C-CCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCC
Q 003911 253 SGPL--P-DFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGAC 329 (787)
Q Consensus 253 ~~~~--~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~ 329 (787)
.... + .+..+++|+.+++++|+++ .+|..+ +++|+.|++++|..++.++..
T Consensus 137 ~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~----------------------- 190 (305)
T d1xkua_ 137 KSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAAS----------------------- 190 (305)
T ss_dssp CGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGG-----------------------
T ss_pred cccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhH-----------------------
Confidence 4422 2 4778899999999999998 677654 689999999999988765531
Q ss_pred CchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEeccccccccc
Q 003911 330 DPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGM 409 (787)
Q Consensus 330 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ 409 (787)
+.....++.|++++|++.+..+..|..+++|++|+|++|+|+ .
T Consensus 191 ------------------------------------~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~ 233 (305)
T d1xkua_ 191 ------------------------------------LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-K 233 (305)
T ss_dssp ------------------------------------GTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-S
T ss_pred ------------------------------------hhccccccccccccccccccccccccccccceeeeccccccc-c
Confidence 112247889999999999999999999999999999999999 7
Q ss_pred CCccCcCCCCCCeeeccCCcccccCC----------CCCCCceeecCCCCCCC
Q 003911 410 IPEGLSVLGALKELDVSNNQLYGKIP----------SFKSNAIVNTDGNPDIG 452 (787)
Q Consensus 410 ip~~l~~l~~L~~L~Ls~N~l~g~iP----------~~~~~~~~~~~gn~~~~ 452 (787)
+|..|..+++|++|+|++|+|+..-+ .......+.+.|||+.+
T Consensus 234 lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 234 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred cccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 89999999999999999999985321 12345678899999865
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=6.3e-25 Score=224.21 Aligned_cols=202 Identities=17% Similarity=0.199 Sum_probs=180.0
Q ss_pred EEcCCCCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCC
Q 003911 63 VCIEDKRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSL 141 (787)
Q Consensus 63 ~C~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 141 (787)
.|.......++|.++++|+ .+|+.+. ++|++|+|++|+|+++++ .|.++++|++|+|++|+|+.+++ ++.+++|
T Consensus 5 ~~~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~--~~~l~~L 79 (266)
T d1p9ag_ 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVL 79 (266)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTC
T ss_pred EEcccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc--ccccccc
Confidence 3555556677899999999 6898876 689999999999999876 69999999999999999998875 6789999
Q ss_pred cEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeec
Q 003911 142 QSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVN 221 (787)
Q Consensus 142 ~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~ 221 (787)
++|+|++|+++ .++..+..+++|+.|++++|.+.+..+..+. .+.+|++|++++|.++...+..+.
T Consensus 80 ~~L~Ls~N~l~--~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~--~l~~l~~L~l~~n~l~~l~~~~~~---------- 145 (266)
T d1p9ag_ 80 GTLDLSHNQLQ--SLPLLGQTLPALTVLDVSFNRLTSLPLGALR--GLGELQELYLKGNELKTLPPGLLT---------- 145 (266)
T ss_dssp CEEECCSSCCS--SCCCCTTTCTTCCEEECCSSCCCCCCSSTTT--TCTTCCEEECTTSCCCCCCTTTTT----------
T ss_pred ccccccccccc--ccccccccccccccccccccccceeeccccc--cccccccccccccccceecccccc----------
Confidence 99999999998 5788999999999999999999988888875 899999999999999966655543
Q ss_pred cCCCCCcCCCCccccccCccCceEeccccccccCCCC-CCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCccc
Q 003911 222 GQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300 (787)
Q Consensus 222 ~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 300 (787)
.+++|+.|++++|+|++.++. |..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|++.
T Consensus 146 ----------------~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 146 ----------------PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp ----------------TCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ----------------ccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 789999999999999998875 888999999999999999 89999999999999999999875
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.7e-24 Score=221.92 Aligned_cols=227 Identities=21% Similarity=0.256 Sum_probs=133.4
Q ss_pred cEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEecc-C
Q 003911 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSAN-S 173 (787)
Q Consensus 95 ~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~-~ 173 (787)
..++.++++++.+|..+. +.+++|+|++|+|+.+++.+|.++++|++|++++|++.. ..+..+..+..++.+... .
T Consensus 14 ~~v~c~~~~L~~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~-i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 14 VTTSCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-IDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp CEEECCSSCCSSCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCCCCCCccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccc-cccccccccccccccccccc
Confidence 345677777776554443 567888888888888888888888888888888888774 334445555555555443 3
Q ss_pred ceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccc
Q 003911 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253 (787)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (787)
|.++...+..|. ++++|++|++++|.+....+..+. .+++|+.+++++|+|+
T Consensus 91 ~~~~~l~~~~~~--~l~~L~~L~l~~n~~~~~~~~~~~--------------------------~~~~L~~l~l~~N~l~ 142 (284)
T d1ozna_ 91 AQLRSVDPATFH--GLGRLHTLHLDRCGLQELGPGLFR--------------------------GLAALQYLYLQDNALQ 142 (284)
T ss_dssp TTCCCCCTTTTT--TCTTCCEEECTTSCCCCCCTTTTT--------------------------TCTTCCEEECCSSCCC
T ss_pred cccccccchhhc--ccccCCEEecCCcccccccccccc--------------------------hhcccchhhhcccccc
Confidence 444444444443 455555555555555433332221 3444455555555554
Q ss_pred cCCCC-CCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCch
Q 003911 254 GPLPD-FSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPR 332 (787)
Q Consensus 254 ~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~ 332 (787)
+.++. |..+++|+.|+|++|+|++..+..|.++++|+
T Consensus 143 ~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~------------------------------------------ 180 (284)
T d1ozna_ 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD------------------------------------------ 180 (284)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC------------------------------------------
T ss_pred ccChhHhccccchhhcccccCcccccchhhhccccccc------------------------------------------
Confidence 44332 44444444455555444444444444444444
Q ss_pred hhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCc
Q 003911 333 LNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPE 412 (787)
Q Consensus 333 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~ 412 (787)
.+++++|++++..|..|..+++|+.|++++|++.+..|.
T Consensus 181 -----------------------------------------~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~ 219 (284)
T d1ozna_ 181 -----------------------------------------RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219 (284)
T ss_dssp -----------------------------------------EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHH
T ss_pred -----------------------------------------hhhhhhccccccChhHhhhhhhccccccccccccccccc
Confidence 445555555555555666677777777777777766666
Q ss_pred cCcCCCCCCeeeccCCcccccCC
Q 003911 413 GLSVLGALKELDVSNNQLYGKIP 435 (787)
Q Consensus 413 ~l~~l~~L~~L~Ls~N~l~g~iP 435 (787)
.|..+++|++|+|++|++.+..+
T Consensus 220 ~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 220 ALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp HHTTCTTCCEEECCSSCEECSGG
T ss_pred ccccccccCEEEecCCCCCCCcc
Confidence 67777777777777777665433
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.92 E-value=2.6e-24 Score=232.32 Aligned_cols=278 Identities=23% Similarity=0.303 Sum_probs=199.5
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEcc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 147 (787)
.++++|+|++|+|++ +| .|+++++|++|+|++|+|++.. .+.++++|+.|++++|.++++... .....+..+...
T Consensus 66 ~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i~-~l~~l~~L~~L~~~~~~~~~~~~~--~~~~~~~~~~~~ 140 (384)
T d2omza2 66 NNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQITDIDPL--KNLTNLNRLELS 140 (384)
T ss_dssp TTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCCGGG--TTCTTCSEEEEE
T ss_pred CCCCEEeCcCCcCCC-Cc-cccCCccccccccccccccccc-cccccccccccccccccccccccc--cccccccccccc
Confidence 579999999999995 44 3999999999999999999754 488999999999999999987653 344566666665
Q ss_pred CCCCCCC----------------------------------------CCChhhhcCCCCCEEeccCceecccCCCCCCCC
Q 003911 148 NNPFSSW----------------------------------------EIPQSLRNASGLQNFSANSANITGQIPSFFGPD 187 (787)
Q Consensus 148 ~N~l~~~----------------------------------------~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~ 187 (787)
.|.+... .....+..+++++.+++++|.+++..|..
T Consensus 141 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~~~---- 216 (384)
T d2omza2 141 SNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG---- 216 (384)
T ss_dssp EEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGGGG----
T ss_pred cccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccccceeeccCCccCCCCccc----
Confidence 5554321 11233444445555555555554433321
Q ss_pred CCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccCCCCCCCCCCCCE
Q 003911 188 EFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLES 267 (787)
Q Consensus 188 ~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~ 267 (787)
..++|++|++++|+++. ++.+..+++|+.|++++|++++.+ .+..+++|+.
T Consensus 217 ~~~~L~~L~l~~n~l~~----------------------------~~~l~~l~~L~~L~l~~n~l~~~~-~~~~~~~L~~ 267 (384)
T d2omza2 217 ILTNLDELSLNGNQLKD----------------------------IGTLASLTNLTDLDLANNQISNLA-PLSGLTKLTE 267 (384)
T ss_dssp GCTTCCEEECCSSCCCC----------------------------CGGGGGCTTCSEEECCSSCCCCCG-GGTTCTTCSE
T ss_pred ccCCCCEEECCCCCCCC----------------------------cchhhcccccchhccccCccCCCC-cccccccCCE
Confidence 23445555555554442 123557788888888888888654 3677788888
Q ss_pred EecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCCh
Q 003911 268 LSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQ 347 (787)
Q Consensus 268 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~ 347 (787)
|++++|++++.. .+..++.++.+++++|++++. +.+..+..++.+++++|.+..++
T Consensus 268 L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~-~~~~~~~~l~~L~ls~n~l~~l~--------------------- 323 (384)
T d2omza2 268 LKLGANQISNIS--PLAGLTALTNLELNENQLEDI-SPISNLKNLTYLTLYFNNISDIS--------------------- 323 (384)
T ss_dssp EECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC-GGGGGCTTCSEEECCSSCCSCCG---------------------
T ss_pred eeccCcccCCCC--ccccccccccccccccccccc-cccchhcccCeEECCCCCCCCCc---------------------
Confidence 888888887433 367788888888888888763 34555566677777777655432
Q ss_pred hhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccC
Q 003911 348 RFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSN 427 (787)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~ 427 (787)
.+..+++|+.|++++|++++ +| .|+.+++|++|+|++|+|++..| +.++++|++|+|++
T Consensus 324 -----------------~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~ 382 (384)
T d2omza2 324 -----------------PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382 (384)
T ss_dssp -----------------GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCC
T ss_pred -----------------ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCC
Confidence 12234689999999999985 44 69999999999999999997654 89999999999999
Q ss_pred C
Q 003911 428 N 428 (787)
Q Consensus 428 N 428 (787)
|
T Consensus 383 N 383 (384)
T d2omza2 383 Q 383 (384)
T ss_dssp E
T ss_pred C
Confidence 8
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.4e-23 Score=212.35 Aligned_cols=135 Identities=19% Similarity=0.157 Sum_probs=91.2
Q ss_pred cCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeecccc
Q 003911 238 NMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKG 317 (787)
Q Consensus 238 ~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~ 317 (787)
.+++|++|+|++|+++..++.+..+++|+.|++++|++.+..+..+..+.++++|++++|.++..++....
T Consensus 75 ~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~--------- 145 (266)
T d1p9ag_ 75 TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLT--------- 145 (266)
T ss_dssp CCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTT---------
T ss_pred ccccccccccccccccccccccccccccccccccccccceeeccccccccccccccccccccceecccccc---------
Confidence 45556666666666665555566666666666666666655556666666666666666666654443111
Q ss_pred CCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCC
Q 003911 318 SNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQ 397 (787)
Q Consensus 318 ~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 397 (787)
..++++.|++++|++++..+..|..+++|+
T Consensus 146 --------------------------------------------------~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~ 175 (266)
T d1p9ag_ 146 --------------------------------------------------PTPKLEKLSLANNNLTELPAGLLNGLENLD 175 (266)
T ss_dssp --------------------------------------------------TCTTCCEEECTTSCCSCCCTTTTTTCTTCC
T ss_pred --------------------------------------------------ccccchhcccccccccccCccccccccccc
Confidence 123566666666666666666788888899
Q ss_pred EEecccccccccCCccCcCCCCCCeeeccCCcccc
Q 003911 398 RLILADNNLSGMIPEGLSVLGALKELDVSNNQLYG 432 (787)
Q Consensus 398 ~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g 432 (787)
+|+|++|+|+ .+|..+..+++|+.|+|++|++..
T Consensus 176 ~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp EEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred eeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 9999999988 888888888888888888776653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=9.5e-24 Score=203.73 Aligned_cols=138 Identities=15% Similarity=0.151 Sum_probs=108.6
Q ss_pred CcccceeccccceEEEEEEEeCCcEEEEEEeeccccc----------------chhHHHHHHHHHHHHhcCCCccceEEe
Q 003911 595 FSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVIS----------------GKGLTEFKSEIAVLTKVRHRHLVALLG 658 (787)
Q Consensus 595 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~niv~~~~ 658 (787)
+.+.++||+|+||+||+|+..+|+.||||+++..... ........+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3567899999999999999889999999987532111 111234567899999999999999876
Q ss_pred EEEeCCeeEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEECCCCcE
Q 003911 659 HCLDGNEKLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRA 738 (787)
Q Consensus 659 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 738 (787)
+. ..+++|||+++..+. .++...+..++.|++.+++|||+ .+|+||||||+|||++++ .+
T Consensus 82 ~~----~~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 82 WE----GNAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EE----TTEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EE
T ss_pred ec----CCEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CE
Confidence 53 237999999875542 23445567899999999999998 899999999999999865 58
Q ss_pred EEeecccceecCCC
Q 003911 739 KVADFGLVRLAPEG 752 (787)
Q Consensus 739 kl~DFG~a~~~~~~ 752 (787)
+|+|||.|.....+
T Consensus 142 ~liDFG~a~~~~~~ 155 (191)
T d1zara2 142 WIIDFPQSVEVGEE 155 (191)
T ss_dssp EECCCTTCEETTST
T ss_pred EEEECCCcccCCCC
Confidence 99999999876543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=4.7e-19 Score=187.95 Aligned_cols=304 Identities=20% Similarity=0.251 Sum_probs=173.0
Q ss_pred CEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccC
Q 003911 69 RITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDN 148 (787)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 148 (787)
++++|||++++|+ .+|+. +++|++|+|++|+|+..+.. +.+|+.|++++|+++.++. + .+.|++|+|++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~~l~~--l--p~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLKALSD--L--PPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCCCS--C--CTTCCEEECCS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcccccc---hhhhhhhhhhhcccchhhh--h--ccccccccccc
Confidence 6789999999998 68864 46899999999999965433 4589999999999987753 1 24699999999
Q ss_pred CCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCccc-ccccceeeccCCCCC
Q 003911 149 NPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSG-SQIQSLWVNGQNGNA 227 (787)
Q Consensus 149 N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~L~~~~~~~~~ 227 (787)
|.+. .+|. ++.+++|+.|++++|.+..... ....+..+.+..+..... ..+.. ..++.+.+..+....
T Consensus 108 n~l~--~lp~-~~~l~~L~~L~l~~~~~~~~~~------~~~~l~~l~~~~~~~~~~--~~l~~l~~l~~L~l~~n~~~~ 176 (353)
T d1jl5a_ 108 NQLE--KLPE-LQNSSFLKIIDVDNNSLKKLPD------LPPSLEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSLKK 176 (353)
T ss_dssp SCCS--SCCC-CTTCTTCCEEECCSSCCSCCCC------CCTTCCEEECCSSCCSSC--CCCTTCTTCCEEECCSSCCSS
T ss_pred cccc--cccc-hhhhccceeecccccccccccc------ccccccchhhcccccccc--ccccccccceecccccccccc
Confidence 9998 5664 5789999999999998875433 234566666665554321 11111 122222222211110
Q ss_pred cCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCC
Q 003911 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFD 307 (787)
Q Consensus 228 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 307 (787)
.. ......+.+.++.+.+. .++.+..++.|+.+++++|... .+|.. ..++..+.+.+|.+...+....
T Consensus 177 ~~-------~~~~~~~~l~~~~~~~~-~~~~~~~l~~L~~l~l~~n~~~-~~~~~---~~~l~~~~~~~~~~~~~~~~~~ 244 (353)
T d1jl5a_ 177 LP-------DLPLSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRDNYLTDLPELPQ 244 (353)
T ss_dssp CC-------CCCTTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCS-SCCSC---CTTCCEEECCSSCCSCCCCCCT
T ss_pred cc-------ccccccccccccccccc-cccccccccccccccccccccc-ccccc---cccccccccccccccccccccc
Confidence 00 01112223333333332 2334444555555555555554 33322 2345555555555544332222
Q ss_pred CceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCc
Q 003911 308 RSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTIS 387 (787)
Q Consensus 308 ~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p 387 (787)
.+..........+.+...+.... ... .......+.....++|+.|+|++|+++ .+|
T Consensus 245 ~l~~~~~~~~~~~~l~~l~~~~~-------------------~~~----~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp 300 (353)
T d1jl5a_ 245 SLTFLDVSENIFSGLSELPPNLY-------------------YLN----ASSNEIRSLCDLPPSLEELNVSNNKLI-ELP 300 (353)
T ss_dssp TCCEEECCSSCCSEESCCCTTCC-------------------EEE----CCSSCCSEECCCCTTCCEEECCSSCCS-CCC
T ss_pred cccccccccccccccccccchhc-------------------ccc----cccCccccccccCCCCCEEECCCCccC-ccc
Confidence 22211111111111111110000 000 000011122223468999999999988 566
Q ss_pred hhhcCCCCCCEEecccccccccCCccCcCCCCCCeeeccCCcccccCCCCC
Q 003911 388 PEFASFKSLQRLILADNNLSGMIPEGLSVLGALKELDVSNNQLYGKIPSFK 438 (787)
Q Consensus 388 ~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~iP~~~ 438 (787)
.. +++|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|.++
T Consensus 301 ~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~ 343 (353)
T d1jl5a_ 301 AL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP 343 (353)
T ss_dssp CC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCC
T ss_pred cc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccc
Confidence 43 578889999999998 67754 467899999999987 566543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=1.7e-19 Score=178.88 Aligned_cols=184 Identities=21% Similarity=0.356 Sum_probs=103.0
Q ss_pred EeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCC
Q 003911 74 QIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSS 153 (787)
Q Consensus 74 ~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 153 (787)
+++.+++++.+ .+..|.+|+.|++++|+|+.. +.+.++++|++|+|++|+++++.+ |.++++|++|++++|.++.
T Consensus 25 ~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~ 99 (227)
T d1h6ua2 25 AAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN 99 (227)
T ss_dssp HTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC
T ss_pred HhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc
Confidence 34444444332 234556667777777766654 456667777777777777666554 6666777777777766653
Q ss_pred CCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCc
Q 003911 154 WEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGI 233 (787)
Q Consensus 154 ~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~ 233 (787)
+ ..+..+++|+.++++++...+..+ +. ..+.+..+.++.+.+....+
T Consensus 100 --i-~~l~~l~~L~~l~l~~~~~~~~~~--~~--~~~~~~~l~~~~~~~~~~~~-------------------------- 146 (227)
T d1h6ua2 100 --V-SAIAGLQSIKTLDLTSTQITDVTP--LA--GLSNLQVLYLDLNQITNISP-------------------------- 146 (227)
T ss_dssp --C-GGGTTCTTCCEEECTTSCCCCCGG--GT--TCTTCCEEECCSSCCCCCGG--------------------------
T ss_pred --c-ccccccccccccccccccccccch--hc--cccchhhhhchhhhhchhhh--------------------------
Confidence 2 245566666666666665554322 11 34556666666655542221
Q ss_pred cccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCccc
Q 003911 234 DVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQ 300 (787)
Q Consensus 234 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 300 (787)
+.++++|++|++++|.++... .+.++++|+.|+|++|++++ +|. +.++++|++|+|++|+++
T Consensus 147 --~~~~~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 147 --LAGLTNLQYLSIGNAQVSDLT-PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp --GGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCC
T ss_pred --hccccccccccccccccccch-hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCC
Confidence 224555666666666555332 25555666666666666653 322 555555555555555554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1.2e-18 Score=174.45 Aligned_cols=218 Identities=16% Similarity=0.158 Sum_probs=165.1
Q ss_pred EEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCc-CCCccccCCCCCcEEEccC-C
Q 003911 73 IQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTS-VPSDFFTGLSSLQSIEIDN-N 149 (787)
Q Consensus 73 L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~-N 149 (787)
++.++.+++ .+|+.+. +++++|+|++|+|+.+++ .|.++++|++|+|++|.+.. +++.+|.+++++++|++.. |
T Consensus 13 i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n 89 (242)
T d1xwdc1 13 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 89 (242)
T ss_dssp EEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCT
T ss_pred EEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccc
Confidence 444556777 7887665 588999999999998777 68999999999999998876 6778899999999999864 6
Q ss_pred CCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcC
Q 003911 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKL 229 (787)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~ 229 (787)
++.. ..+..|.++++|+.|++++|.+....+..+. ..+..|..+..+++++....+..|.
T Consensus 90 ~l~~-~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~-~~l~~l~~~~~~n~~l~~i~~~~~~------------------ 149 (242)
T d1xwdc1 90 NLLY-INPEAFQNLPNLQYLLISNTGIKHLPDVHKI-HSLQKVLLDIQDNINIHTIERNSFV------------------ 149 (242)
T ss_dssp TCCE-ECTTSEECCTTCCEEEEESCCCCSCCCCTTT-CBSSCEEEEEESCTTCCEECTTSST------------------
T ss_pred cccc-cccccccccccccccccchhhhccccccccc-ccccccccccccccccccccccccc------------------
Confidence 6664 5567789999999999999998755443321 3566777777777777755555443
Q ss_pred CCCccccccC-ccCceEeccccccccCCCCCCCCCCCCEE-ecCCCcccccCCccccCCCCCCEEEccCCcccccCCC-C
Q 003911 230 GGGIDVIQNM-TSLKEIWLHSNAFSGPLPDFSGVKQLESL-SLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPE-F 306 (787)
Q Consensus 230 ~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~l~~L~~L-~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~ 306 (787)
++ ..++.|++++|+++...+.....++++.+ ++++|+|+...+..|.++++|++|+|++|+|+..++. +
T Consensus 150 --------~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~ 221 (242)
T d1xwdc1 150 --------GLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL 221 (242)
T ss_dssp --------TSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSC
T ss_pred --------cccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHH
Confidence 33 37888999999999877765555665544 6788889844455688899999999999999976664 6
Q ss_pred CCceeeeccccCCCc
Q 003911 307 DRSVSLDMAKGSNNF 321 (787)
Q Consensus 307 ~~~~~L~~l~~~~n~ 321 (787)
..+..|+.++..+..
T Consensus 222 ~~l~~L~~l~~~~l~ 236 (242)
T d1xwdc1 222 ENLKKLRARSTYNLK 236 (242)
T ss_dssp TTCCEEESSSEESSS
T ss_pred cCCcccccCcCCCCC
Confidence 677788887766543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.79 E-value=2.4e-19 Score=175.16 Aligned_cols=179 Identities=18% Similarity=0.330 Sum_probs=131.2
Q ss_pred eCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCC
Q 003911 75 IGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSW 154 (787)
Q Consensus 75 l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 154 (787)
++.+.+++.++. ..+.+|++|++++|.|+... .+..+++|++|+|++|+|+++++ ++.+++|++|++++|+++
T Consensus 31 l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~-~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~-- 103 (210)
T d1h6ta2 31 LKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-- 103 (210)
T ss_dssp TTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC--
T ss_pred hCcCccCCccCH--HHhcCccEEECcCCCCCCch-hHhhCCCCCEEeCCCccccCccc--cccCcccccccccccccc--
Confidence 334444444332 24567778888888887543 47778888888888888887664 677888888888888877
Q ss_pred CCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCcc
Q 003911 155 EIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGID 234 (787)
Q Consensus 155 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~ 234 (787)
.+| .+..+++|+.|++++|.+... + .+. .++.|+.+++++|.+++.. .
T Consensus 104 ~l~-~l~~l~~L~~L~l~~~~~~~~-~-~l~--~l~~l~~l~~~~n~l~~~~--~------------------------- 151 (210)
T d1h6ta2 104 DLS-SLKDLKKLKSLSLEHNGISDI-N-GLV--HLPQLESLYLGNNKITDIT--V------------------------- 151 (210)
T ss_dssp CGG-GGTTCTTCCEEECTTSCCCCC-G-GGG--GCTTCCEEECCSSCCCCCG--G-------------------------
T ss_pred ccc-ccccccccccccccccccccc-c-ccc--ccccccccccccccccccc--c-------------------------
Confidence 344 477788888888888877542 2 233 6788888888888876422 1
Q ss_pred ccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccC
Q 003911 235 VIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 296 (787)
Q Consensus 235 ~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 296 (787)
+..+++|+.+++++|++++. +.+.++++|+.|+|++|+|+ .+| .+.++++|++|+|++
T Consensus 152 -~~~l~~L~~l~l~~n~l~~i-~~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 152 -LSRLTKLDTLSLEDNQISDI-VPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp -GGGCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred -cccccccccccccccccccc-ccccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence 23688899999999999864 45888999999999999998 565 589999999999874
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.79 E-value=1.7e-19 Score=173.66 Aligned_cols=129 Identities=20% Similarity=0.284 Sum_probs=112.4
Q ss_pred EEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC--CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCC
Q 003911 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP--SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNN 149 (787)
Q Consensus 72 ~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 149 (787)
.++.++++++ .+|+.+. +++++|+|++|+|++.++ .|.++++|++|+|++|++..++++.|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4566677888 7888775 789999999999987554 6899999999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCC
Q 003911 150 PFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGL 206 (787)
Q Consensus 150 ~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~ 206 (787)
+|+. ..|..|.++++|++|+|++|+|++..|..|. .+++|++|+|++|.+....
T Consensus 89 ~l~~-l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~--~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 89 KIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFE--HLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCE-ECSSSSTTCTTCCEEECCSSCCCEECTTSST--TCTTCCEEECTTCCBCCSG
T ss_pred cccc-cCHHHHhCCCcccccccCCccccccCHHHhc--CCccccccccccccccccc
Confidence 9995 4466789999999999999999998888886 8899999999999887543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.78 E-value=2.7e-17 Score=174.21 Aligned_cols=299 Identities=20% Similarity=0.185 Sum_probs=201.1
Q ss_pred CCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEec
Q 003911 92 TKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSA 171 (787)
Q Consensus 92 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l 171 (787)
.+|++|||++|.|+..++. +++|++|+|++|+|+.+|.. +.+|+.|++++|+++. ++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~~lp~~---~~~L~~L~Ls~N~l~~lp~~----~~~L~~L~l~~n~l~~--l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSLPEL---PPHLESLVASCNSLTELPEL----PQSLKSLLVDNNNLKA--LSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCSCCCSC---CTTCSEEECCSSCCSSCCCC----CTTCCEEECCSSCCSC--CCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCCCCCCC---CCCCCEEECCCCCCcccccc----hhhhhhhhhhhcccch--hhhh---ccccccccc
Confidence 4689999999999975532 57899999999999988743 5689999999999984 4432 246999999
Q ss_pred cCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccc
Q 003911 172 NSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNA 251 (787)
Q Consensus 172 ~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 251 (787)
++|.++.. |. ++ .+++|++|++++|.+....+ .. ..+..+.+..... .....+..++.++.|++++|.
T Consensus 106 ~~n~l~~l-p~-~~--~l~~L~~L~l~~~~~~~~~~-~~--~~l~~l~~~~~~~-----~~~~~l~~l~~l~~L~l~~n~ 173 (353)
T d1jl5a_ 106 SNNQLEKL-PE-LQ--NSSFLKIIDVDNNSLKKLPD-LP--PSLEFIAAGNNQL-----EELPELQNLPFLTAIYADNNS 173 (353)
T ss_dssp CSSCCSSC-CC-CT--TCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCC-----SSCCCCTTCTTCCEEECCSSC
T ss_pred cccccccc-cc-hh--hhccceeecccccccccccc-cc--ccccchhhccccc-----cccccccccccceeccccccc
Confidence 99999854 54 33 79999999999999985433 22 2344444432221 223346678899999999999
Q ss_pred cccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCc
Q 003911 252 FSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDP 331 (787)
Q Consensus 252 l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~ 331 (787)
+...+... ...+.+...++.+. .+|. +..++.|+.+++++|.....+.....+..+. ...+.+...+....
T Consensus 174 ~~~~~~~~---~~~~~l~~~~~~~~-~~~~-~~~l~~L~~l~l~~n~~~~~~~~~~~l~~~~---~~~~~~~~~~~~~~- 244 (353)
T d1jl5a_ 174 LKKLPDLP---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKTLPDLPPSLEALN---VRDNYLTDLPELPQ- 244 (353)
T ss_dssp CSSCCCCC---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSSCCSCCTTCCEEE---CCSSCCSCCCCCCT-
T ss_pred cccccccc---cccccccccccccc-cccc-ccccccccccccccccccccccccccccccc---cccccccccccccc-
Confidence 88654322 34567888888776 5554 6789999999999998876554444444333 33333332221100
Q ss_pred hhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCcccccCchhhcCCCCCCEEecccccccccCC
Q 003911 332 RLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGTISPEFASFKSLQRLILADNNLSGMIP 411 (787)
Q Consensus 332 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip 411 (787)
.+ ....... ....+...........+++.|.+.+. ...+++|++|+|++|+|+ .+|
T Consensus 245 ~l----------------~~~~~~~---~~~~~l~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp 300 (353)
T d1jl5a_ 245 SL----------------TFLDVSE---NIFSGLSELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELP 300 (353)
T ss_dssp TC----------------CEEECCS---SCCSEESCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCC
T ss_pred cc----------------ccccccc---ccccccccccchhcccccccCccccc----cccCCCCCEEECCCCccC-ccc
Confidence 00 0000000 00001111113445667777776643 234688999999999999 788
Q ss_pred ccCcCCCCCCeeeccCCcccccCCC-CCCCceeecCCCCCC
Q 003911 412 EGLSVLGALKELDVSNNQLYGKIPS-FKSNAIVNTDGNPDI 451 (787)
Q Consensus 412 ~~l~~l~~L~~L~Ls~N~l~g~iP~-~~~~~~~~~~gn~~~ 451 (787)
.. +++|+.|+|++|+|+ .+|. ..++..+.+.+|+..
T Consensus 301 ~~---~~~L~~L~L~~N~L~-~l~~~~~~L~~L~L~~N~L~ 337 (353)
T d1jl5a_ 301 AL---PPRLERLIASFNHLA-EVPELPQNLKQLHVEYNPLR 337 (353)
T ss_dssp CC---CTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCCS
T ss_pred cc---cCCCCEEECCCCcCC-ccccccCCCCEEECcCCcCC
Confidence 64 578999999999998 5665 456788999999753
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=3.4e-19 Score=178.59 Aligned_cols=211 Identities=18% Similarity=0.210 Sum_probs=170.1
Q ss_pred CCcccEEEcCC----------CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCC--CCCCCCCCcEEEccc
Q 003911 57 CKWNHVVCIED----------KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLP--SLNGLASLEVVMLSN 124 (787)
Q Consensus 57 C~w~gv~C~~~----------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~L~~ 124 (787)
|.+..|.|... ..+++|++++|+|+...+..|.++++|++|+|++|.+...++ .|.+++++++|++..
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 67888999632 369999999999996555679999999999999999987554 689999999999864
Q ss_pred -ccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCC-CCCcEEecccccc
Q 003911 125 -NQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEF-PGLTILHLAFNQL 202 (787)
Q Consensus 125 -N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l-~~L~~L~L~~N~l 202 (787)
|++..+++..|.++++|++|++++|++........+..+..+..+...++.+....+..|. .+ ..++.|++++|++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~--~~~~~l~~L~l~~n~l 165 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV--GLSFESVILWLNKNGI 165 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSST--TSBSSCEEEECCSSCC
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccc--cccccceeeecccccc
Confidence 7899999999999999999999999998644445667788888888888888877777774 44 4799999999999
Q ss_pred ccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceE-eccccccccCCCC-CCCCCCCCEEecCCCcccccCC
Q 003911 203 IGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEI-WLHSNAFSGPLPD-FSGVKQLESLSLRDNFFTGPVP 280 (787)
Q Consensus 203 ~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L-~L~~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~p 280 (787)
+...+..+ +.++++++ ++++|+++..++. |.++++|++|+|++|+|+...+
T Consensus 166 ~~i~~~~~---------------------------~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~ 218 (242)
T d1xwdc1 166 QEIHNCAF---------------------------NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 218 (242)
T ss_dssp CEECTTTT---------------------------TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCS
T ss_pred cccccccc---------------------------cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCH
Confidence 96555544 34555444 5788889877664 8889999999999999995545
Q ss_pred ccccCCCCCCEEEccC
Q 003911 281 DSLVKLESLKIVNMTN 296 (787)
Q Consensus 281 ~~l~~l~~L~~L~Ls~ 296 (787)
..|.++++|+.+++.+
T Consensus 219 ~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 219 YGLENLKKLRARSTYN 234 (242)
T ss_dssp SSCTTCCEEESSSEES
T ss_pred HHHcCCcccccCcCCC
Confidence 5677777777766644
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.5e-18 Score=168.02 Aligned_cols=175 Identities=24% Similarity=0.394 Sum_probs=122.7
Q ss_pred eCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCC
Q 003911 75 IGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSW 154 (787)
Q Consensus 75 l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 154 (787)
++.+++++.++ ...+.+|++|++++|.|+. ++.+..+++|++|+|++|+|+++++ |+++++|++|++++|.+..
T Consensus 25 l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~- 98 (199)
T d2omxa2 25 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD- 98 (199)
T ss_dssp TTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-
T ss_pred hCCCCCCCccC--HHHhcCCCEEECCCCCCCC-ccccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-
Confidence 34444444332 2346677788888887775 3457777888888888888877764 7778888888888887763
Q ss_pred CCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCcc
Q 003911 155 EIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGID 234 (787)
Q Consensus 155 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~ 234 (787)
++ .+.++++|+.|++++|.+....+ +. .+++|+.|++++|++.. ++ .
T Consensus 99 -~~-~l~~l~~L~~L~l~~~~~~~~~~--~~--~l~~L~~L~l~~n~l~~-~~-~------------------------- 145 (199)
T d2omxa2 99 -IT-PLANLTNLTGLTLFNNQITDIDP--LK--NLTNLNRLELSSNTISD-IS-A------------------------- 145 (199)
T ss_dssp -CG-GGTTCTTCSEEECCSSCCCCCGG--GT--TCTTCSEEECCSSCCCC-CG-G-------------------------
T ss_pred -cc-ccccccccccccccccccccccc--cc--hhhhhHHhhhhhhhhcc-cc-c-------------------------
Confidence 33 47777778888887777765432 33 67888888888887763 22 1
Q ss_pred ccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEE
Q 003911 235 VIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIV 292 (787)
Q Consensus 235 ~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 292 (787)
+..+++|+.|++++|++++. +.+.++++|++|++++|+|+. ++ .++.+++|++|
T Consensus 146 -l~~~~~L~~L~l~~n~l~~l-~~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 146 -LSGLTSLQQLNFSSNQVTDL-KPLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp -GTTCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred -ccccccccccccccccccCC-ccccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 33678888888888888764 347778888888888888873 44 47788888775
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.9e-18 Score=171.21 Aligned_cols=186 Identities=25% Similarity=0.356 Sum_probs=159.2
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEcc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 147 (787)
..++.|++.+++|+ .+ +.+..+++|++|+|++|+|++..| +..+++|++|++++|.++.++ .|.++++|++++++
T Consensus 41 ~~L~~L~l~~~~i~-~l-~~l~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~~i~--~l~~l~~L~~l~l~ 115 (227)
T d1h6ua2 41 DGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVS--AIAGLQSIKTLDLT 115 (227)
T ss_dssp HTCCEEECTTSCCC-CC-TTGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCG--GGTTCTTCCEEECT
T ss_pred CCcCEEECCCCCCC-cc-hhHhcCCCCcEeecCCceeecccc-ccccccccccccccccccccc--cccccccccccccc
Confidence 47999999999999 45 469999999999999999997654 899999999999999999875 48899999999999
Q ss_pred CCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCC
Q 003911 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (787)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~ 227 (787)
++.... ...+...+.+..+.++.+.+....+ +. ..++|++|++++|+++...+
T Consensus 116 ~~~~~~---~~~~~~~~~~~~l~~~~~~~~~~~~--~~--~~~~L~~L~l~~n~~~~~~~-------------------- 168 (227)
T d1h6ua2 116 STQITD---VTPLAGLSNLQVLYLDLNQITNISP--LA--GLTNLQYLSIGNAQVSDLTP-------------------- 168 (227)
T ss_dssp TSCCCC---CGGGTTCTTCCEEECCSSCCCCCGG--GG--GCTTCCEEECCSSCCCCCGG--------------------
T ss_pred cccccc---cchhccccchhhhhchhhhhchhhh--hc--cccccccccccccccccchh--------------------
Confidence 998874 3457788999999999999876543 32 68899999999999874322
Q ss_pred cCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccC
Q 003911 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTN 296 (787)
Q Consensus 228 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 296 (787)
++++++|++|+|++|++++. +.+.++++|++|+|++|+|++ +| .+.++++|++|+|++
T Consensus 169 --------l~~l~~L~~L~Ls~n~l~~l-~~l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 169 --------LANLSKLTTLKADDNKISDI-SPLASLPNLIEVHLKNNQISD-VS-PLANTSNLFIVTLTN 226 (227)
T ss_dssp --------GTTCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEEEEEE
T ss_pred --------hcccccceecccCCCccCCC-hhhcCCCCCCEEECcCCcCCC-Cc-ccccCCCCCEEEeeC
Confidence 44889999999999999864 558899999999999999994 55 389999999999974
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=3e-19 Score=171.91 Aligned_cols=174 Identities=18% Similarity=0.234 Sum_probs=130.4
Q ss_pred cEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCc-CCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccC
Q 003911 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTS-VPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173 (787)
Q Consensus 95 ~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~ 173 (787)
+.++.++|+|+.+|+.+. +++++|+|++|+|+. +++..|.++++|++|+|++|++.. ..+..+..+++|++|++++
T Consensus 11 ~~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~-~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcCccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccc-ccccccccccccceeeecc
Confidence 578889999987766654 678899999999975 667788889999999999998886 5577888888888888888
Q ss_pred ceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccc
Q 003911 174 ANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFS 253 (787)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (787)
|+|++..|..|. ++++|++|+|++|+|++..|..|. .+++|++|+|++|.+.
T Consensus 88 N~l~~l~~~~F~--~l~~L~~L~L~~N~l~~i~~~~f~--------------------------~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 88 NKIKEISNKMFL--GLHQLKTLNLYDNQISCVMPGSFE--------------------------HLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCCEECSSSST--TCTTCCEEECCSSCCCEECTTSST--------------------------TCTTCCEEECTTCCBC
T ss_pred ccccccCHHHHh--CCCcccccccCCccccccCHHHhc--------------------------CCcccccccccccccc
Confidence 888888888886 788888888888888876666654 6778888888888877
Q ss_pred cCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCccccc
Q 003911 254 GPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQGP 302 (787)
Q Consensus 254 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 302 (787)
...+...-...++.+.+..|.++...|..+ ..++.++|+.|.|+-.
T Consensus 140 ~~~~~~~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 140 CNCHLAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKCS 185 (192)
T ss_dssp CSGGGHHHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCCC
T ss_pred cccchHHHhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCcCC
Confidence 554321112345566677777776666543 4456667777776543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=1.1e-17 Score=163.22 Aligned_cols=164 Identities=23% Similarity=0.377 Sum_probs=140.7
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEcc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 147 (787)
..++.|++++++++. ++ .+..+++|++|+|++|+|++.. .+..+++|++|++++|+|++++ .+.++++|+.|+++
T Consensus 46 ~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 46 NSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVKDLS--SLKDLKKLKSLSLE 120 (210)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEEECT
T ss_pred cCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc-ccccCccccccccccccccccc--cccccccccccccc
Confidence 368999999999985 33 4889999999999999999855 5788999999999999999986 38999999999999
Q ss_pred CCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCC
Q 003911 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (787)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~ 227 (787)
+|.+.. ...+..+++|+.+++++|.+++.. .+. .+++|+++++++|++++..+
T Consensus 121 ~~~~~~---~~~l~~l~~l~~l~~~~n~l~~~~--~~~--~l~~L~~l~l~~n~l~~i~~-------------------- 173 (210)
T d1h6ta2 121 HNGISD---INGLVHLPQLESLYLGNNKITDIT--VLS--RLTKLDTLSLEDNQISDIVP-------------------- 173 (210)
T ss_dssp TSCCCC---CGGGGGCTTCCEEECCSSCCCCCG--GGG--GCTTCSEEECCSSCCCCCGG--------------------
T ss_pred cccccc---cccccccccccccccccccccccc--ccc--cccccccccccccccccccc--------------------
Confidence 999874 357899999999999999998643 333 78999999999999985322
Q ss_pred cCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEEecCC
Q 003911 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESLSLRD 272 (787)
Q Consensus 228 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~ 272 (787)
+.++++|++|+|++|+++. ++.+.++++|++|+|++
T Consensus 174 --------l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 174 --------LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFS 209 (210)
T ss_dssp --------GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEE
T ss_pred --------ccCCCCCCEEECCCCCCCC-ChhhcCCCCCCEEEccC
Confidence 3489999999999999986 46799999999999974
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=3.3e-17 Score=158.35 Aligned_cols=160 Identities=23% Similarity=0.406 Sum_probs=137.3
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEcc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 147 (787)
.+++.|++++++++. + +.+..+++|++|+|++|+|++..+ +.++++|++|++++|.+..+++ ++++++|++|+++
T Consensus 40 ~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~l~ 114 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 114 (199)
T ss_dssp TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred cCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc-ccCCcccccccccccccccccc--ccccccccccccc
Confidence 578999999999984 4 358899999999999999998665 9999999999999999998874 8999999999999
Q ss_pred CCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccccceeeccCCCCC
Q 003911 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNA 227 (787)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~ 227 (787)
+|.+.. ...+..+++|+.|++++|++... + .+. .+++|++|++++|++++..+
T Consensus 115 ~~~~~~---~~~~~~l~~L~~L~l~~n~l~~~-~-~l~--~~~~L~~L~l~~n~l~~l~~-------------------- 167 (199)
T d2omxa2 115 NNQITD---IDPLKNLTNLNRLELSSNTISDI-S-ALS--GLTSLQQLNFSSNQVTDLKP-------------------- 167 (199)
T ss_dssp SSCCCC---CGGGTTCTTCSEEECCSSCCCCC-G-GGT--TCTTCSEEECCSSCCCCCGG--------------------
T ss_pred cccccc---ccccchhhhhHHhhhhhhhhccc-c-ccc--ccccccccccccccccCCcc--------------------
Confidence 999874 34688999999999999999753 3 343 78999999999999985322
Q ss_pred cCCCCccccccCccCceEeccccccccCCCCCCCCCCCCEE
Q 003911 228 KLGGGIDVIQNMTSLKEIWLHSNAFSGPLPDFSGVKQLESL 268 (787)
Q Consensus 228 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L 268 (787)
++++++|++|++++|+++. ++.+.++++|+.|
T Consensus 168 --------l~~l~~L~~L~ls~N~i~~-i~~l~~L~~L~~L 199 (199)
T d2omxa2 168 --------LANLTTLERLDISSNKVSD-ISVLAKLTNLESL 199 (199)
T ss_dssp --------GTTCTTCCEEECCSSCCCC-CGGGGGCTTCSEE
T ss_pred --------ccCCCCCCEEECCCCCCCC-CccccCCCCCCcC
Confidence 4489999999999999986 4568889999876
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=8.8e-18 Score=184.68 Aligned_cols=332 Identities=18% Similarity=0.172 Sum_probs=205.8
Q ss_pred CEEEEEeCCCCcccc-CCCCCCCCCCCcEEEeecCCCCCC----CC-CCCCCCCCcEEEcccccCCcCCC----ccc-cC
Q 003911 69 RITRIQIGHQNLQGT-LPSNLQNLTKLERLELQWNSISGP----LP-SLNGLASLEVVMLSNNQFTSVPS----DFF-TG 137 (787)
Q Consensus 69 ~v~~L~l~~~~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~----~~-~~~~l~~L~~L~L~~N~l~~~~~----~~~-~~ 137 (787)
++++||++++++++. +.+.+..+++|+.|+|++|.|+.. +. .+..+++|++|||++|+|+.... ..+ ..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 589999999999863 234466789999999999998741 22 46789999999999999874221 122 23
Q ss_pred CCCCcEEEccCCCCCCCC---CChhhhcCCCCCEEeccCceecccCCCCCC-----------------------------
Q 003911 138 LSSLQSIEIDNNPFSSWE---IPQSLRNASGLQNFSANSANITGQIPSFFG----------------------------- 185 (787)
Q Consensus 138 l~~L~~L~L~~N~l~~~~---~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~----------------------------- 185 (787)
..+|++|+|++|+++... ++..+..+++|++|++++|.++......+.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 458999999999987411 345677889999999999987642111110
Q ss_pred --CCCCCCCcEEeccccccccCC----CcCccc--ccccceeeccCCCCCc-CCCCccccccCccCceEeccccccccC-
Q 003911 186 --PDEFPGLTILHLAFNQLIGGL----PASFSG--SQIQSLWVNGQNGNAK-LGGGIDVIQNMTSLKEIWLHSNAFSGP- 255 (787)
Q Consensus 186 --~~~l~~L~~L~L~~N~l~~~~----p~~~~~--~~l~~L~~~~~~~~~~-~~~~~~~~~~l~~L~~L~L~~N~l~~~- 255 (787)
......++.++++.+.+.... ...+.. .....+....+..... .......+...+.++.+++++|++...
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 001234555555554432110 000000 1122222222111000 000112345678899999999987432
Q ss_pred ----CC-CCCCCCCCCEEecCCCccccc----CCccccCCCCCCEEEccCCcccccCCC------CCCceeeeccccCCC
Q 003911 256 ----LP-DFSGVKQLESLSLRDNFFTGP----VPDSLVKLESLKIVNMTNNLLQGPVPE------FDRSVSLDMAKGSNN 320 (787)
Q Consensus 256 ----~~-~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~------~~~~~~L~~l~~~~n 320 (787)
.+ .......|+.|++++|.+... ....+...+.++.+++++|.++..... ......|+.++++++
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 11 244567899999999988743 334456788999999999998642110 111234555556555
Q ss_pred ccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceEEEEccCCccccc----Cchhhc-CCCC
Q 003911 321 FCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNITVINFQKMNLTGT----ISPEFA-SFKS 395 (787)
Q Consensus 321 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~g~----~p~~~~-~l~~ 395 (787)
.+... ....+.. ......+|+.|+|++|++++. ++..+. ..+.
T Consensus 323 ~l~~~------~~~~l~~--------------------------~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~ 370 (460)
T d1z7xw1 323 SFTAA------CCSHFSS--------------------------VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSV 370 (460)
T ss_dssp CCBGG------GHHHHHH--------------------------HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCC
T ss_pred chhhh------hhhhccc--------------------------ccccccchhhhheeeecccCcccchhhhhhhcccCC
Confidence 43311 1111111 111234799999999999864 344443 4677
Q ss_pred CCEEeccccccccc----CCccCcCCCCCCeeeccCCcccc
Q 003911 396 LQRLILADNNLSGM----IPEGLSVLGALKELDVSNNQLYG 432 (787)
Q Consensus 396 L~~L~Ls~N~l~g~----ip~~l~~l~~L~~L~Ls~N~l~g 432 (787)
|++|+|++|+|+.. +++.+...++|++|||++|+++.
T Consensus 371 L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp CCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred CCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 99999999999742 55567778999999999999874
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.55 E-value=3.1e-15 Score=131.61 Aligned_cols=104 Identities=24% Similarity=0.334 Sum_probs=78.7
Q ss_pred EEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCC
Q 003911 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPF 151 (787)
Q Consensus 72 ~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 151 (787)
.|+|++|+|+ .++ .++.+++|++|+|++|+|+..++.|..+++|++|++++|+|+.++ .|.++++|++|++++|+|
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l~--~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD--GVANLPRLQELLLCNNRL 77 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCSSCCEEECCSSCC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccccC--ccccccccCeEECCCCcc
Confidence 5788888887 444 478888888888888888876667888888888888888888775 377888888888888888
Q ss_pred CCCCCChhhhcCCCCCEEeccCceeccc
Q 003911 152 SSWEIPQSLRNASGLQNFSANSANITGQ 179 (787)
Q Consensus 152 ~~~~~p~~~~~l~~L~~L~l~~n~l~~~ 179 (787)
+.+.....+..+++|+.|++++|.++..
T Consensus 78 ~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 78 QQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred CCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 7533345677777888888888877643
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=2.2e-15 Score=139.57 Aligned_cols=125 Identities=14% Similarity=0.198 Sum_probs=90.1
Q ss_pred CCEEEEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEcc
Q 003911 68 KRITRIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEID 147 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 147 (787)
-++++|+|++|+|+ .++..+..+++|++|+|++|+|+.. +.|..+++|++|+|++|+++.+++..+..+++|++|+|+
T Consensus 18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred CcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCccccccccccccceec
Confidence 36778888888887 4566567778888888888888754 567778888888888888888887777778888888888
Q ss_pred CCCCCCCCCChhhhcCCCCCEEeccCceecccCC---CCCCCCCCCCCcEEe
Q 003911 148 NNPFSSWEIPQSLRNASGLQNFSANSANITGQIP---SFFGPDEFPGLTILH 196 (787)
Q Consensus 148 ~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p---~~~~~~~l~~L~~L~ 196 (787)
+|+|+.+..-..+..+++|++|++++|.++.... ..+. .+++|++||
T Consensus 96 ~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~--~lp~L~~LD 145 (162)
T d1a9na_ 96 NNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIY--KVPQVRVLD 145 (162)
T ss_dssp SCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHH--HCTTCSEET
T ss_pred cccccccccccccccccccchhhcCCCccccccchHHHHHH--HCCCcCeeC
Confidence 8888742212457777888888888887764321 1232 567777776
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=7.3e-15 Score=135.93 Aligned_cols=125 Identities=14% Similarity=0.120 Sum_probs=70.4
Q ss_pred cCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCceecccCCCCCCCCCCCCCcEEeccccccccCCCcCcccccc
Q 003911 136 TGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSANITGQIPSFFGPDEFPGLTILHLAFNQLIGGLPASFSGSQI 215 (787)
Q Consensus 136 ~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l 215 (787)
.+..+|++|||++|+|+ .+|..+..+++|+.|++++|+|+.. + .|. .+++|++|++++|+++...+..+
T Consensus 15 ~n~~~lr~L~L~~n~I~--~i~~~~~~l~~L~~L~Ls~N~i~~l-~-~~~--~l~~L~~L~ls~N~i~~l~~~~~----- 83 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEIRKL-D-GFP--LLRRLKTLLVNNNRICRIGEGLD----- 83 (162)
T ss_dssp ECTTSCEEEECTTSCCC--SCCCGGGGTTCCSEEECCSSCCCEE-C-CCC--CCSSCCEEECCSSCCCEECSCHH-----
T ss_pred cCcCcCcEEECCCCCCC--ccCccccccccCCEEECCCCCCCcc-C-Ccc--cCcchhhhhcccccccCCCcccc-----
Confidence 33444444444444444 2333334444444444444444432 2 232 56667777777777664333222
Q ss_pred cceeeccCCCCCcCCCCccccccCccCceEeccccccccCC--CCCCCCCCCCEEecCCCcccccCCc----cccCCCCC
Q 003911 216 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGPL--PDFSGVKQLESLSLRDNFFTGPVPD----SLVKLESL 289 (787)
Q Consensus 216 ~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L 289 (787)
..+++|++|+|++|+++... ..+..+++|++|++++|.++ ..|. .+..+++|
T Consensus 84 ---------------------~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L 141 (162)
T d1a9na_ 84 ---------------------QALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQV 141 (162)
T ss_dssp ---------------------HHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTC
T ss_pred ---------------------ccccccccceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCc
Confidence 25667777777777776532 24666777888888888777 4443 46778888
Q ss_pred CEEE
Q 003911 290 KIVN 293 (787)
Q Consensus 290 ~~L~ 293 (787)
++||
T Consensus 142 ~~LD 145 (162)
T d1a9na_ 142 RVLD 145 (162)
T ss_dssp SEET
T ss_pred CeeC
Confidence 8876
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=3.1e-14 Score=125.11 Aligned_cols=78 Identities=18% Similarity=0.293 Sum_probs=42.0
Q ss_pred cEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccCc
Q 003911 95 ERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANSA 174 (787)
Q Consensus 95 ~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~n 174 (787)
|.|+|++|+|+.. +.+.++++|++|+|++|+|+.+|+ .|+.+++|++|++++|+|+. +| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~~l-~~l~~l~~L~~L~ls~N~l~~lp~-~~~~l~~L~~L~l~~N~i~~--l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN--VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCCCCCG-GGGGCTTCCEEECCSSCCCC--CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCCC-cccccCCCCCEEECCCCccCcchh-hhhhhhcccccccccccccc--cC-ccccccccCeEECCCC
Confidence 3566666666533 345566666666666666665543 35556666666666666552 22 2444444444444444
Q ss_pred eec
Q 003911 175 NIT 177 (787)
Q Consensus 175 ~l~ 177 (787)
+|+
T Consensus 76 ~i~ 78 (124)
T d1dcea3 76 RLQ 78 (124)
T ss_dssp CCC
T ss_pred ccC
Confidence 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=2.2e-16 Score=173.31 Aligned_cols=313 Identities=19% Similarity=0.208 Sum_probs=181.4
Q ss_pred CCEEEEEeCCCCccc----cCCCCCCCCCCCcEEEeecCCCCCC----CC-CCC-CCCCCcEEEcccccCCcCC----Cc
Q 003911 68 KRITRIQIGHQNLQG----TLPSNLQNLTKLERLELQWNSISGP----LP-SLN-GLASLEVVMLSNNQFTSVP----SD 133 (787)
Q Consensus 68 ~~v~~L~l~~~~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~~-~~~-~l~~L~~L~L~~N~l~~~~----~~ 133 (787)
.+++.|+|++|+++. .+...+..+++|++|||++|+|+.. +. .+. ...+|++|+|++|+++... +.
T Consensus 27 ~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~ 106 (460)
T d1z7xw1 27 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 106 (460)
T ss_dssp TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccc
Confidence 356678888888772 3455667888888888888888531 11 222 2357888888888887532 34
Q ss_pred cccCCCCCcEEEccCCCCCCC------------------------CC--------ChhhhcCCCCCEEeccCceeccc--
Q 003911 134 FFTGLSSLQSIEIDNNPFSSW------------------------EI--------PQSLRNASGLQNFSANSANITGQ-- 179 (787)
Q Consensus 134 ~~~~l~~L~~L~L~~N~l~~~------------------------~~--------p~~~~~l~~L~~L~l~~n~l~~~-- 179 (787)
.+..+++|++|+|++|.+... .. -..+.....++.++++.+.+...
T Consensus 107 ~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~ 186 (460)
T d1z7xw1 107 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGV 186 (460)
T ss_dssp HTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHH
T ss_pred hhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccccccccccccccccccccccccccc
Confidence 567788888888888876520 00 01123344566666655543210
Q ss_pred ---------CCCCC----------C----------CCCCCCCcEEeccccccccCC-----CcCcc-cccccceeeccCC
Q 003911 180 ---------IPSFF----------G----------PDEFPGLTILHLAFNQLIGGL-----PASFS-GSQIQSLWVNGQN 224 (787)
Q Consensus 180 ---------~p~~~----------~----------~~~l~~L~~L~L~~N~l~~~~-----p~~~~-~~~l~~L~~~~~~ 224 (787)
.+... . ....+.++.+++++|++.... +.... ...++.+++.++.
T Consensus 187 ~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~ 266 (460)
T d1z7xw1 187 RVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECG 266 (460)
T ss_dssp HHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred cccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhccccccccccccccccccc
Confidence 00000 0 013567889999998864211 11111 1234555554432
Q ss_pred CCCcCC-CCccccccCccCceEeccccccccCCC-----C-CCCCCCCCEEecCCCcccccCCc----cccCCCCCCEEE
Q 003911 225 GNAKLG-GGIDVIQNMTSLKEIWLHSNAFSGPLP-----D-FSGVKQLESLSLRDNFFTGPVPD----SLVKLESLKIVN 293 (787)
Q Consensus 225 ~~~~~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~-----~-~~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~ 293 (787)
...... .....+...+.++.+++++|.++.... . ......|+.+++++|.++..... .+...++|++|+
T Consensus 267 i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~ 346 (460)
T d1z7xw1 267 ITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQ 346 (460)
T ss_dssp CCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEE
T ss_pred ccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhh
Confidence 221111 111234456677777777777653111 0 12235677777777777644322 233455677777
Q ss_pred ccCCcccccCCCCCCceeeeccccCCCccCCCCCCCCchhhHHHHHHHHhCCChhhhcccCCCCCCCCccccccCCCceE
Q 003911 294 MTNNLLQGPVPEFDRSVSLDMAKGSNNFCLPSPGACDPRLNALLSVVKLMGYPQRFAENWKGNDPCSDWIGVTCTKGNIT 373 (787)
Q Consensus 294 Ls~N~l~~~~p~~~~~~~L~~l~~~~n~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 373 (787)
|++|+++... ...+.+.+ ......|+
T Consensus 347 Ls~N~i~~~g--------------------------------~~~l~~~l----------------------~~~~~~L~ 372 (460)
T d1z7xw1 347 ISNNRLEDAG--------------------------------VRELCQGL----------------------GQPGSVLR 372 (460)
T ss_dssp CCSSBCHHHH--------------------------------HHHHHHHH----------------------TSTTCCCC
T ss_pred eeeecccCcc--------------------------------cchhhhhh----------------------hcccCCCC
Confidence 7777765310 00011000 00123689
Q ss_pred EEEccCCccccc----CchhhcCCCCCCEEecccccccccCCccC----c-CCCCCCeeeccCCcccccC
Q 003911 374 VINFQKMNLTGT----ISPEFASFKSLQRLILADNNLSGMIPEGL----S-VLGALKELDVSNNQLYGKI 434 (787)
Q Consensus 374 ~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l----~-~l~~L~~L~Ls~N~l~g~i 434 (787)
.|+|++|+++.. ++..+..+++|++|+|++|+|+......+ . +...|+.|++++|.+....
T Consensus 373 ~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~ 442 (460)
T d1z7xw1 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEM 442 (460)
T ss_dssp EEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHH
T ss_pred EEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHH
Confidence 999999999853 55667788999999999999985433333 2 3457999999999987543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.47 E-value=8.5e-16 Score=162.10 Aligned_cols=194 Identities=18% Similarity=0.219 Sum_probs=112.1
Q ss_pred CCCCCCCCCCcEEEeecCCCCCCC-----CCCCCCCCCcEEEcccccCCcCCC----------ccccCCCCCcEEEccCC
Q 003911 85 PSNLQNLTKLERLELQWNSISGPL-----PSLNGLASLEVVMLSNNQFTSVPS----------DFFTGLSSLQSIEIDNN 149 (787)
Q Consensus 85 ~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~L~~N~l~~~~~----------~~~~~l~~L~~L~L~~N 149 (787)
...+.+.+.|+.|+|++|.|+..- ..+...++|+.|+++++.+..... ..+...++|++|+|++|
T Consensus 24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n 103 (344)
T d2ca6a1 24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 103 (344)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccc
Confidence 344666777888888888775421 146667788888887776543321 23556778888888888
Q ss_pred CCCCCC---CChhhhcCCCCCEEeccCceecccCCCCCC-----------CCCCCCCcEEeccccccccCCCcCcccccc
Q 003911 150 PFSSWE---IPQSLRNASGLQNFSANSANITGQIPSFFG-----------PDEFPGLTILHLAFNQLIGGLPASFSGSQI 215 (787)
Q Consensus 150 ~l~~~~---~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~-----------~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l 215 (787)
.+.... +...+...++|+.|++++|.+.......++ ....+.|+.|++++|++....-..+.
T Consensus 104 ~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~---- 179 (344)
T d2ca6a1 104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA---- 179 (344)
T ss_dssp CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHH----
T ss_pred ccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccccccccccc----
Confidence 776421 233455667777888877766421111110 01345667777777665421111111
Q ss_pred cceeeccCCCCCcCCCCccccccCccCceEeccccccccC------CCCCCCCCCCCEEecCCCccccc----CCccccC
Q 003911 216 QSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGP------LPDFSGVKQLESLSLRDNFFTGP----VPDSLVK 285 (787)
Q Consensus 216 ~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~------~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~ 285 (787)
..+...++|++|+|++|+++.. ...+...++|+.|+|++|.|+.. +...+..
T Consensus 180 ------------------~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~ 241 (344)
T d2ca6a1 180 ------------------KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241 (344)
T ss_dssp ------------------HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred ------------------chhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccc
Confidence 1233556677777777776531 12345566677777777766532 3344556
Q ss_pred CCCCCEEEccCCccc
Q 003911 286 LESLKIVNMTNNLLQ 300 (787)
Q Consensus 286 l~~L~~L~Ls~N~l~ 300 (787)
+++|++|+|++|.|+
T Consensus 242 ~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 242 WPNLRELGLNDCLLS 256 (344)
T ss_dssp CTTCCEEECTTCCCC
T ss_pred cccchhhhhhcCccC
Confidence 666777777766665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=5.5e-15 Score=150.92 Aligned_cols=222 Identities=15% Similarity=0.191 Sum_probs=112.5
Q ss_pred EEEeCCCCccccCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcC-CCccccCCCCCcEEEccCCC
Q 003911 72 RIQIGHQNLQGTLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSV-PSDFFTGLSSLQSIEIDNNP 150 (787)
Q Consensus 72 ~L~l~~~~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~ 150 (787)
.|||+++++.......+.. ..+..+.++...+...........+|++|||+++.++.. ....+.++++|++|+|+++.
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~ 82 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCB
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccC
Confidence 4666666554322221111 123444554444443333334445666666666665532 22335566666666666666
Q ss_pred CCCCCCChhhhcCCCCCEEeccCc-eecccC-CCCCCCCCCCCCcEEecccc-ccccC-CCcCccc--ccccceeeccCC
Q 003911 151 FSSWEIPQSLRNASGLQNFSANSA-NITGQI-PSFFGPDEFPGLTILHLAFN-QLIGG-LPASFSG--SQIQSLWVNGQN 224 (787)
Q Consensus 151 l~~~~~p~~~~~l~~L~~L~l~~n-~l~~~~-p~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~--~~l~~L~~~~~~ 224 (787)
+.. ..+..+..+++|++|+++++ .++... ...+ ..+++|++|+++++ +++.. +...+.. ..++.|.+.++.
T Consensus 83 l~~-~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~--~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~ 159 (284)
T d2astb2 83 LSD-PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL--SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR 159 (284)
T ss_dssp CCH-HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHH--HHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred CCc-HHHHHHhcCCCCcCccccccccccccccchhh--HHHHhccccccccccccccccchhhhcccccccchhhhcccc
Confidence 554 44555666666666666663 343211 1111 14566666666654 23211 1111110 234444443221
Q ss_pred CCCcCCCCccccccCccCceEeccccc-cccC-CCCCCCCCCCCEEecCC-CcccccCCccccCCCCCCEEEccCC
Q 003911 225 GNAKLGGGIDVIQNMTSLKEIWLHSNA-FSGP-LPDFSGVKQLESLSLRD-NFFTGPVPDSLVKLESLKIVNMTNN 297 (787)
Q Consensus 225 ~~~~~~~~~~~~~~l~~L~~L~L~~N~-l~~~-~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N 297 (787)
.+-...+....+.++++|++|+|++|. +++. +..+..+++|++|+|++ +.+++.....++++++|+.|+++++
T Consensus 160 ~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 160 KNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 111111111223457778888887753 5543 33466777888888877 3677666667777788888887765
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=1.1e-14 Score=148.76 Aligned_cols=102 Identities=15% Similarity=0.151 Sum_probs=61.7
Q ss_pred cEEEeecCCCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCEEeccC
Q 003911 95 ERLELQWNSISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQNFSANS 173 (787)
Q Consensus 95 ~~L~L~~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~l~~ 173 (787)
++|||+++.+..... .+.. ..+..+.++...+...... .....+|++|||+++.+....++..+..+++|++|++++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~-~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhh-hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 467888777643211 1111 2345666766666544333 334567888888877766423344566677777777777
Q ss_pred ceecccCCCCCCCCCCCCCcEEecccc
Q 003911 174 ANITGQIPSFFGPDEFPGLTILHLAFN 200 (787)
Q Consensus 174 n~l~~~~p~~~~~~~l~~L~~L~L~~N 200 (787)
+.++...+..++ .+++|++|+|+++
T Consensus 81 ~~l~~~~~~~l~--~~~~L~~L~Ls~c 105 (284)
T d2astb2 81 LRLSDPIVNTLA--KNSNLVRLNLSGC 105 (284)
T ss_dssp CBCCHHHHHHHT--TCTTCSEEECTTC
T ss_pred cCCCcHHHHHHh--cCCCCcCcccccc
Confidence 777666555554 5677777777664
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=1.3e-12 Score=119.64 Aligned_cols=96 Identities=15% Similarity=0.173 Sum_probs=69.0
Q ss_pred CCccccCCCCCCCCCCCcEEEeecC-CCCCCCC-CCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCC
Q 003911 78 QNLQGTLPSNLQNLTKLERLELQWN-SISGPLP-SLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWE 155 (787)
Q Consensus 78 ~~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 155 (787)
+++. .+|..+..+++|++|++++| .|+.+.+ +|.++++|+.|+|++|+|+.+++.+|.++++|++|+|++|+|+ .
T Consensus 18 ~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~--~ 94 (156)
T d2ifga3 18 DGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE--S 94 (156)
T ss_dssp SCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS--C
T ss_pred CCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc--c
Confidence 3444 55777888888888888765 4777665 6888888888888888888888888888888888888888887 4
Q ss_pred CChhhhcCCCCCEEeccCcee
Q 003911 156 IPQSLRNASGLQNFSANSANI 176 (787)
Q Consensus 156 ~p~~~~~l~~L~~L~l~~n~l 176 (787)
+|.......+|+.|++++|.+
T Consensus 95 l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 95 LSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp CCSTTTCSCCCCEEECCSSCC
T ss_pred cChhhhccccccccccCCCcc
Confidence 454433333455555555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.34 E-value=2.7e-14 Score=150.39 Aligned_cols=210 Identities=18% Similarity=0.203 Sum_probs=148.1
Q ss_pred CCCEEEEEeCCCCccc----cCCCCCCCCCCCcEEEeecCCCCCCCC-----------CCCCCCCCcEEEcccccCCcCC
Q 003911 67 DKRITRIQIGHQNLQG----TLPSNLQNLTKLERLELQWNSISGPLP-----------SLNGLASLEVVMLSNNQFTSVP 131 (787)
Q Consensus 67 ~~~v~~L~l~~~~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~-----------~~~~l~~L~~L~L~~N~l~~~~ 131 (787)
...+++|+|++|.+.. .+...+...++|+.|+++++.+..... .+...++|++|+|++|.++...
T Consensus 30 ~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 109 (344)
T d2ca6a1 30 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 109 (344)
T ss_dssp CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred CCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccccc
Confidence 3568999999998864 345678889999999999887654321 2556889999999999998743
Q ss_pred C----ccccCCCCCcEEEccCCCCCCCCCC-------------hhhhcCCCCCEEeccCceecccCC----CCCCCCCCC
Q 003911 132 S----DFFTGLSSLQSIEIDNNPFSSWEIP-------------QSLRNASGLQNFSANSANITGQIP----SFFGPDEFP 190 (787)
Q Consensus 132 ~----~~~~~l~~L~~L~L~~N~l~~~~~p-------------~~~~~l~~L~~L~l~~n~l~~~~p----~~~~~~~l~ 190 (787)
. ..+...++|++|++++|.+.. .-. ......+.|+.|.+++|+++.... ..+. ..+
T Consensus 110 ~~~l~~~l~~~~~L~~L~l~~n~l~~-~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~--~~~ 186 (344)
T d2ca6a1 110 QEPLIDFLSKHTPLEHLYLHNNGLGP-QAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ--SHR 186 (344)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSCCHH-HHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH--HCT
T ss_pred ccchhhhhcccccchheecccccccc-cccccccccccccccccccccCcccceeecccccccccccccccchhh--hhh
Confidence 2 335578999999999998752 111 112356789999999998863322 2222 567
Q ss_pred CCcEEeccccccccCCCcCcccccccceeeccCCCCCcCCCCccccccCccCceEeccccccccC-----CCCCCCCCCC
Q 003911 191 GLTILHLAFNQLIGGLPASFSGSQIQSLWVNGQNGNAKLGGGIDVIQNMTSLKEIWLHSNAFSGP-----LPDFSGVKQL 265 (787)
Q Consensus 191 ~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~l~~L 265 (787)
.|++|+|++|++.......+ ....+..+++|+.|+|++|.++.. ...+..+++|
T Consensus 187 ~L~~L~L~~n~i~~~g~~~~---------------------l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L 245 (344)
T d2ca6a1 187 LLHTVKMVQNGIRPEGIEHL---------------------LLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 245 (344)
T ss_dssp TCCEEECCSSCCCHHHHHHH---------------------HHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTC
T ss_pred hhcccccccccccccccccc---------------------hhhhhcchhhhcccccccccccccccccccccccccccc
Confidence 89999999999863210000 001244788999999999998642 2246778999
Q ss_pred CEEecCCCcccccCCccc----cC--CCCCCEEEccCCccc
Q 003911 266 ESLSLRDNFFTGPVPDSL----VK--LESLKIVNMTNNLLQ 300 (787)
Q Consensus 266 ~~L~L~~N~l~~~~p~~l----~~--l~~L~~L~Ls~N~l~ 300 (787)
++|+|++|.|++.....+ .. .+.|++|++++|+++
T Consensus 246 ~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp CEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred hhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence 999999999986533333 22 356778888887765
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=4.7e-12 Score=115.84 Aligned_cols=110 Identities=15% Similarity=0.121 Sum_probs=96.4
Q ss_pred CCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccc-cCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhcCCCCCE
Q 003911 90 NLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNN-QFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRNASGLQN 168 (787)
Q Consensus 90 ~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~ 168 (787)
.....+.++.+++.+...+..+.++++|++|++++| .|+.+++++|.++++|+.|+|++|+|+. ..|..|..+++|++
T Consensus 6 ~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~-i~~~~f~~l~~L~~ 84 (156)
T d2ifga3 6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF-VAPDAFHFTPRLSR 84 (156)
T ss_dssp CCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE-ECTTGGGSCSCCCE
T ss_pred CcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCC-cccccccccccccc
Confidence 344556789999999988778999999999999866 5999999999999999999999999995 34778999999999
Q ss_pred EeccCceecccCCCCCCCCCCCCCcEEeccccccc
Q 003911 169 FSANSANITGQIPSFFGPDEFPGLTILHLAFNQLI 203 (787)
Q Consensus 169 L~l~~n~l~~~~p~~~~~~~l~~L~~L~L~~N~l~ 203 (787)
|+|++|+|+...+..|. ..+|++|+|++|.+.
T Consensus 85 L~Ls~N~l~~l~~~~~~---~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 85 LNLSFNALESLSWKTVQ---GLSLQELVLSGNPLH 116 (156)
T ss_dssp EECCSSCCSCCCSTTTC---SCCCCEEECCSSCCC
T ss_pred eeccCCCCcccChhhhc---cccccccccCCCccc
Confidence 99999999977777773 457999999999986
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.30 E-value=8.4e-15 Score=140.50 Aligned_cols=55 Identities=18% Similarity=0.332 Sum_probs=24.7
Q ss_pred CccCceEeccccccccCC--CCCCCCCCCCEEecCCCcccccCCcc----------ccCCCCCCEEE
Q 003911 239 MTSLKEIWLHSNAFSGPL--PDFSGVKQLESLSLRDNFFTGPVPDS----------LVKLESLKIVN 293 (787)
Q Consensus 239 l~~L~~L~L~~N~l~~~~--~~~~~l~~L~~L~L~~N~l~~~~p~~----------l~~l~~L~~L~ 293 (787)
+++|+.|+|++|+|+... ..+..+++|+.|+|++|+++...+.. +..+++|+.||
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 344444444444444321 12444445555555555444322221 44566666665
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.29 E-value=1.3e-14 Score=139.16 Aligned_cols=119 Identities=21% Similarity=0.255 Sum_probs=99.5
Q ss_pred cCCCCCCCCCCCcEEEeecCCCCCCCCCCCCCCCCcEEEcccccCCcCCCccccCCCCCcEEEccCCCCCCCCCChhhhc
Q 003911 83 TLPSNLQNLTKLERLELQWNSISGPLPSLNGLASLEVVMLSNNQFTSVPSDFFTGLSSLQSIEIDNNPFSSWEIPQSLRN 162 (787)
Q Consensus 83 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~p~~~~~ 162 (787)
.++..+..|++|++|+|++|+|+.+ +.+.++++|++|+|++|+|+.+++ .+..+++|++|++++|+++. + ..+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~~i~~-~~~~~~~L~~L~l~~N~i~~--l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIKKIEN-LDAVADTLEELWISYNQIAS--L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEECSCSS-HHHHHHHCCEEECSEEECCC--H-HHHHH
T ss_pred hhhhHHhcccccceeECcccCCCCc-ccccCCccccChhhcccccccccc-cccccccccccccccccccc--c-ccccc
Confidence 4456788999999999999999965 579999999999999999998864 35566789999999999984 4 45889
Q ss_pred CCCCCEEeccCceecccCC-CCCCCCCCCCCcEEeccccccccCCCc
Q 003911 163 ASGLQNFSANSANITGQIP-SFFGPDEFPGLTILHLAFNQLIGGLPA 208 (787)
Q Consensus 163 l~~L~~L~l~~n~l~~~~p-~~~~~~~l~~L~~L~L~~N~l~~~~p~ 208 (787)
+++|+.|++++|+|+.... ..+. .+++|++|+|++|.+....+.
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~--~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLA--ALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHT--TTTTCSEEEECSSHHHHHHCT
T ss_pred cccccccccccchhcccccccccc--CCCccceeecCCCccccCccc
Confidence 9999999999999986532 3454 899999999999998865544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.60 E-value=1e-07 Score=94.71 Aligned_cols=150 Identities=15% Similarity=0.083 Sum_probs=103.7
Q ss_pred HHHhhcCCCcccceeccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCe
Q 003911 587 VLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNE 665 (787)
Q Consensus 587 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 665 (787)
+++...+.|+..+..+-++.+.||+... +++.+++|+..... ......+.+|...++.+. +--+.+++++..+++.
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~--~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRY--KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGG--TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCc--ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 4555667787776655555679999865 46678888876532 222345778888888774 4446788888888889
Q ss_pred eEEEEEecCCCCHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 003911 666 KLLVFEYMPQGTLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLHGLA----------------------------- 716 (787)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----------------------------- 716 (787)
.++||++++|.++.+.... ......++.++++.+..||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~----------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT----------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred eEEEEEecccccccccccc----------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 9999999999887554311 1112234556666666666321
Q ss_pred ---------------------------CCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 717 ---------------------------HQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 717 ---------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
...++|+|+.|.||++++++.+.|+||+.+..-
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 123799999999999998766679999988753
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.31 E-value=3.4e-09 Score=97.10 Aligned_cols=65 Identities=14% Similarity=0.225 Sum_probs=32.1
Q ss_pred CCCCCcEEEcccccCCcCCC--ccccCCCCCcEEEccCCCCCCCCCCh-hhhcCCCCCEEeccCceeccc
Q 003911 113 GLASLEVVMLSNNQFTSVPS--DFFTGLSSLQSIEIDNNPFSSWEIPQ-SLRNASGLQNFSANSANITGQ 179 (787)
Q Consensus 113 ~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~p~-~~~~l~~L~~L~l~~n~l~~~ 179 (787)
.+++|++|+|++|+|+.+.+ ..+..+++|++|+|++|+|+. +++ .+....+|+.|++++|.+...
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~--l~~l~~l~~~~L~~L~L~~Npl~~~ 130 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS--ERELDKIKGLKLEELWLDGNSLSDT 130 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC--GGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc--chhhhhhhccccceeecCCCCcCcC
Confidence 45555555555555555432 334455555555555555553 222 222333455555555555443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.28 E-value=2.3e-08 Score=91.35 Aligned_cols=56 Identities=18% Similarity=0.123 Sum_probs=29.6
Q ss_pred CceEeccccccccCCCCCCCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCCcccc
Q 003911 242 LKEIWLHSNAFSGPLPDFSGVKQLESLSLRDNFFTGPVPDSLVKLESLKIVNMTNNLLQG 301 (787)
Q Consensus 242 L~~L~L~~N~l~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 301 (787)
.+.|+++++... +.+..+..+..+...+|..+ .++..+..+++|++|+|++|+|+.
T Consensus 24 ~~~Ldls~l~~~---~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~ 79 (162)
T d1koha1 24 QQALDLKGLRSD---PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYR 79 (162)
T ss_dssp SCCBCCCCCSSC---TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCC
T ss_pred hCeeecccCCCC---chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccC
Confidence 444555544322 23333444444444444443 444455567777777777777664
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.19 E-value=1.8e-06 Score=85.01 Aligned_cols=132 Identities=20% Similarity=0.170 Sum_probs=86.9
Q ss_pred eeccccc-eEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcC--CCccceEEeEEEeCCeeEEEEEecCCC
Q 003911 600 ILGRGGF-GTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR--HRHLVALLGHCLDGNEKLLVFEYMPQG 676 (787)
Q Consensus 600 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (787)
.+..|.. +.||+....++..+++|...... ...+..|.+.++.+. .-.+.+++++..+++..++||||++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4455553 68999988778889999765432 235677888887773 334677888888888899999999886
Q ss_pred CHHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 003911 677 TLSRHIFNWAEEGLKPLEWNRRLTIALDVARGVEYLH------------------------------------------- 713 (787)
Q Consensus 677 sL~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH------------------------------------------- 713 (787)
++.+.. ... ..++.++++.+.-||
T Consensus 92 ~~~~~~----------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (255)
T d1nd4a_ 92 DLLSSH----------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 158 (255)
T ss_dssp ETTTSC----------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred cccccc----------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHH
Confidence 653210 000 011122222222333
Q ss_pred --------hC----CCCCeEEcCCCCCCEEECCCCcEEEeecccceec
Q 003911 714 --------GL----AHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 749 (787)
Q Consensus 714 --------~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 749 (787)
.. .+..++|+|+.|.|||++++..+.|+||+.+..-
T Consensus 159 ~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 159 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 206 (255)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence 10 1124899999999999998766789999988653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.72 E-value=5.1e-05 Score=79.26 Aligned_cols=78 Identities=13% Similarity=0.135 Sum_probs=50.4
Q ss_pred cceeccccceEEEEEEEe-CCcEEEEEEeeccc--c---cchhHHHHHHHHHHHHhc-CC--CccceEEeEEEeCCeeEE
Q 003911 598 ENILGRGGFGTVYKGELH-DGTKIAVKRMEAGV--I---SGKGLTEFKSEIAVLTKV-RH--RHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~---~~~~~~~~~~E~~~l~~l-~h--~niv~~~~~~~~~~~~~l 668 (787)
.+.||.|....||++... +++.|+||.-.... . ......+...|.+.++.+ .+ ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 356899999999999765 46789999754311 0 112334566788888777 33 345566544 5556789
Q ss_pred EEEecCCCC
Q 003911 669 VFEYMPQGT 677 (787)
Q Consensus 669 v~e~~~~gs 677 (787)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.34 E-value=1.5e-05 Score=72.55 Aligned_cols=64 Identities=16% Similarity=0.094 Sum_probs=42.7
Q ss_pred cccCccCceEeccccccccCC-----CCCCCCCCCCEEecCCCccccc-------CCccccCCCCCCEEEccCCcc
Q 003911 236 IQNMTSLKEIWLHSNAFSGPL-----PDFSGVKQLESLSLRDNFFTGP-------VPDSLVKLESLKIVNMTNNLL 299 (787)
Q Consensus 236 ~~~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~L~~N~l~~~-------~p~~l~~l~~L~~L~Ls~N~l 299 (787)
+...+.|++|+|++|.++... ..+...+.|++|+|++|++... +...+...+.|+.|+++.+..
T Consensus 68 L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 68 IETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred hhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 335567777777777776421 1356667788888888866522 345555678888888877654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.26 E-value=3.5e-05 Score=69.95 Aligned_cols=85 Identities=19% Similarity=0.166 Sum_probs=43.9
Q ss_pred CCEEEEEeCCC-Ccccc----CCCCCCCCCCCcEEEeecCCCCCC--CC---CCCCCCCCcEEEcccccCCcC----CCc
Q 003911 68 KRITRIQIGHQ-NLQGT----LPSNLQNLTKLERLELQWNSISGP--LP---SLNGLASLEVVMLSNNQFTSV----PSD 133 (787)
Q Consensus 68 ~~v~~L~l~~~-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~--~~---~~~~l~~L~~L~L~~N~l~~~----~~~ 133 (787)
..+++|+|+++ .++.. +-..+...+.|++|+|++|.|+.. .. .+...+.|++|+|++|.|+.- ...
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 45666666653 34321 223455556666666666666431 11 233455666666666666531 112
Q ss_pred cccCCCCCcEEEccCCCCC
Q 003911 134 FFTGLSSLQSIEIDNNPFS 152 (787)
Q Consensus 134 ~~~~l~~L~~L~L~~N~l~ 152 (787)
++...++|++|+|++|.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTTTCCCSEEECCCCSSC
T ss_pred HHHhCCcCCEEECCCCcCC
Confidence 3445555666666666544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.20 E-value=0.00051 Score=69.42 Aligned_cols=137 Identities=12% Similarity=0.057 Sum_probs=78.9
Q ss_pred eEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCcc--ceEE-----eEEEeCCeeEEEEEecCCCCHH
Q 003911 607 GTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL--VALL-----GHCLDGNEKLLVFEYMPQGTLS 679 (787)
Q Consensus 607 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~-----~~~~~~~~~~lv~e~~~~gsL~ 679 (787)
-.||+++.++|+.|++|+.+.... ..+++..|.+.+..+....+ +..+ ......+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 589999999999999999876432 34667888888888742222 1111 1234456678999999764331
Q ss_pred ----HH----------HHhhhhc----CCCCCC-------------------HHHHHHHHHHHHHHHHHHHh----CCCC
Q 003911 680 ----RH----------IFNWAEE----GLKPLE-------------------WNRRLTIALDVARGVEYLHG----LAHQ 718 (787)
Q Consensus 680 ----~~----------l~~~~~~----~~~~l~-------------------~~~~~~i~~qi~~~L~~LH~----~~~~ 718 (787)
+. ++..... .....+ ......+...+...++.+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 01 1110000 001111 11111222222233333322 1245
Q ss_pred CeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 719 SFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 719 ~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
++||+|+.|.|||++++ ..++||+.+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 79999999999999754 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.94 E-value=0.0012 Score=66.20 Aligned_cols=161 Identities=12% Similarity=0.019 Sum_probs=84.7
Q ss_pred eeHHHHHhhcCCCccccee-----ccccceEEEEEEEeCCcEEEEEEeecccccchhHHHHHHHHHHHHhcCCCcc--ce
Q 003911 583 ISIQVLRNVTNNFSEENIL-----GRGGFGTVYKGELHDGTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVRHRHL--VA 655 (787)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~ 655 (787)
.+.++++.+..+|.+.+.. ..|---+.|+.+..+| .+++|++.... ..+++..|++++..+...++ +.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC----CHHHHHHHHHHHHhhhhccccccc
Confidence 3456777777788765443 4565677899987755 48999886521 22455666777777632222 21
Q ss_pred EEe------EEEeCCeeEEEEEecCCCCHHH--------------HHHhhhhcCC----C------------------CC
Q 003911 656 LLG------HCLDGNEKLLVFEYMPQGTLSR--------------HIFNWAEEGL----K------------------PL 693 (787)
Q Consensus 656 ~~~------~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~~~----~------------------~l 693 (787)
.+. +.........++.+..+..... .++....... . ..
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 111 1223445667777776643311 0000000000 0 00
Q ss_pred CHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEEECCCCcEEEeeccccee
Q 003911 694 EWNRRLTIALDVARGVEYLHG-LAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 748 (787)
Q Consensus 694 ~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 748 (787)
........+..+...+.-.+. .-+.++||+|+.++||+++.+...-|+||+.+..
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 001111222222222222221 1246899999999999999887778999998863
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.68 E-value=0.0019 Score=66.92 Aligned_cols=73 Identities=15% Similarity=0.142 Sum_probs=50.0
Q ss_pred cceeccccceEEEEEEEeC--------CcEEEEEEeecccccchhHHHHHHHHHHHHhcC-CCccceEEeEEEeCCeeEE
Q 003911 598 ENILGRGGFGTVYKGELHD--------GTKIAVKRMEAGVISGKGLTEFKSEIAVLTKVR-HRHLVALLGHCLDGNEKLL 668 (787)
Q Consensus 598 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 668 (787)
.+.|+.|-.-.+|++...+ .+.|++++.-. . .......+|.++++.+. +.-.+++++++.+ .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c---chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 4678888889999998753 35677776542 1 12345668999988884 4445577777643 68
Q ss_pred EEEecCCCCH
Q 003911 669 VFEYMPQGTL 678 (787)
Q Consensus 669 v~e~~~~gsL 678 (787)
||||++|..+
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.46 E-value=0.00011 Score=66.50 Aligned_cols=63 Identities=21% Similarity=0.278 Sum_probs=35.3
Q ss_pred cCccCceEeccc-cccccCC-----CCCCCCCCCCEEecCCCcccccC----CccccCCCCCCEEEccCCccc
Q 003911 238 NMTSLKEIWLHS-NAFSGPL-----PDFSGVKQLESLSLRDNFFTGPV----PDSLVKLESLKIVNMTNNLLQ 300 (787)
Q Consensus 238 ~l~~L~~L~L~~-N~l~~~~-----~~~~~l~~L~~L~L~~N~l~~~~----p~~l~~l~~L~~L~Ls~N~l~ 300 (787)
+.++|++|+|++ |.++... ..+...++|+.|+|++|.++... -..+...+.|+.+++++|.++
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 456777777776 3453211 12445666777777777665332 223344566666666666554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.17 E-value=0.00015 Score=65.52 Aligned_cols=65 Identities=17% Similarity=0.150 Sum_probs=41.3
Q ss_pred cccCccCceEeccccccccCC-----CCCCCCCCCCEEec--CCCcccc----cCCccccCCCCCCEEEccCCccc
Q 003911 236 IQNMTSLKEIWLHSNAFSGPL-----PDFSGVKQLESLSL--RDNFFTG----PVPDSLVKLESLKIVNMTNNLLQ 300 (787)
Q Consensus 236 ~~~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~L--~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~ 300 (787)
+...++++.+++++|.+.... ..+...++|+.++| ++|.+.. .+...+...+.|+.|+++.+...
T Consensus 70 l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 70 LKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 335567777777777765321 23555677776444 5666753 34555667888999988877543
|